Citrus Sinensis ID: 005749
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 679 | 2.2.26 [Sep-21-2011] | |||||||
| P33543 | 674 | Putative kinase-like prot | yes | no | 0.977 | 0.985 | 0.743 | 0.0 | |
| Q9SCT4 | 836 | Probably inactive leucine | no | no | 0.823 | 0.668 | 0.359 | 7e-86 | |
| C0LGP9 | 784 | Probable leucine-rich rep | no | no | 0.814 | 0.705 | 0.365 | 7e-84 | |
| Q9LP77 | 655 | Probable inactive recepto | no | no | 0.798 | 0.827 | 0.329 | 2e-73 | |
| Q9LVM0 | 654 | Probable inactive recepto | no | no | 0.833 | 0.865 | 0.315 | 2e-72 | |
| Q9C9Y8 | 640 | Probable inactive recepto | no | no | 0.789 | 0.837 | 0.321 | 7e-72 | |
| O48788 | 658 | Probable inactive recepto | no | no | 0.848 | 0.875 | 0.316 | 7e-72 | |
| Q9M9C5 | 670 | Probable leucine-rich rep | no | no | 0.686 | 0.695 | 0.347 | 2e-69 | |
| Q9LVI6 | 647 | Probable inactive recepto | no | no | 0.712 | 0.748 | 0.340 | 2e-66 | |
| Q9FHK7 | 640 | Probable leucine-rich rep | no | no | 0.868 | 0.921 | 0.303 | 1e-62 |
| >sp|P33543|TMKL1_ARATH Putative kinase-like protein TMKL1 OS=Arabidopsis thaliana GN=TMKL1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 974 bits (2519), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 499/671 (74%), Positives = 577/671 (85%), Gaps = 7/671 (1%)
Query: 10 YIVFFFCLTESLASSSPASASSDVELLLGKIKSSLQGDDENLLLSSWNISVPLCQWRGLK 69
+++FFF L + S SSDV+LLLGKIKSSLQG+ E+LLLSSWN SVP+CQWRG+K
Sbjct: 10 HVIFFFVLILHCHCGTSLSGSSDVKLLLGKIKSSLQGNSESLLLSSWNSSVPVCQWRGVK 69
Query: 70 WISTNGSPLSCSDISLPQWANLSLYKDSSIHLLSIQLPSANLTGSLPRELGEFSMLQSLY 129
W+ +NGSPL CSD+S PQW N SL+ DSS+HLLS+QLPSANLTGSLPRE+GEFSMLQS++
Sbjct: 70 WVFSNGSPLQCSDLSSPQWTNTSLFNDSSLHLLSLQLPSANLTGSLPREIGEFSMLQSVF 129
Query: 130 LNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNSLTAALP 189
LN+NSL G+IP ELGY+SSLS++DLS N GVL PSIWNLCD+LVS ++HGN+L+ LP
Sbjct: 130 LNINSLSGSIPLELGYTSSLSDVDLSGNALAGVLPPSIWNLCDKLVSFKIHGNNLSGVLP 189
Query: 190 EPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRLSLE 249
EPALPNSTC +LQ LDLG NKFSG FPEF+TRF+ +K LD+S+N+F G +PEGL L LE
Sbjct: 190 EPALPNSTCGNLQVLDLGGNKFSGEFPEFITRFKGVKSLDLSSNVFEGLVPEGLGVLELE 249
Query: 250 KLNLSHNNFSGVLPVFSESKFGAEVFEGNSPALCGFPLRDCSGNSRLSSGAIAGLVIGLM 309
LNLSHNNFSG+LP F ESKFGAE FEGNSP+LCG PL+ C G+SRLS GA+AGLVIGLM
Sbjct: 250 SLNLSHNNFSGMLPDFGESKFGAESFEGNSPSLCGLPLKPCLGSSRLSPGAVAGLVIGLM 309
Query: 310 TGAVVFASLLIGYVQNKKRKNRGDSEEEFEEGEDEENGMSGGSAAGGAGGEGKLIIFQGG 369
+GAVV ASLLIGY+QNKKRK+ E +D E G GGEGKL++FQGG
Sbjct: 310 SGAVVVASLLIGYLQNKKRKS------SIESEDDLEEGDEEDEIGEKEGGEGKLVVFQGG 363
Query: 370 EHLTLEDVLNATGQVIEKTTYGTAYKAKLADGATIALRLLREGSCKDRSSCLPVIRQLGK 429
E+LTL+DVLNATGQV+EKT+YGT YKAKL+DG IALRLLREG+CKDRSSCLPVIRQLG+
Sbjct: 364 ENLTLDDVLNATGQVMEKTSYGTVYKAKLSDGGNIALRLLREGTCKDRSSCLPVIRQLGR 423
Query: 430 VRHENLIPLRAFYQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIAR 489
+RHENL+PLRAFYQGKRGEKLLIYDY P+ +LHDLLH++ KP LNWARRHKIALGIAR
Sbjct: 424 IRHENLVPLRAFYQGKRGEKLLIYDYLPNISLHDLLHESKPRKPALNWARRHKIALGIAR 483
Query: 490 GLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKADGYK 549
GLAYLHTG E+PI HGN+RSKNVLVDDFF +RLTEFGLD++MV AVADE+V+ AK+DGYK
Sbjct: 484 GLAYLHTGQEVPIIHGNIRSKNVLVDDFFFARLTEFGLDKIMVQAVADEIVSQAKSDGYK 543
Query: 550 APELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNG-EFVDLPSIVKVAVLEETTME 608
APEL +MKKC+ R+DVYAFGILLLEIL+GKKPGKSGRNG EFVDLPS+VK AVLEETTME
Sbjct: 544 APELHKMKKCNPRSDVYAFGILLLEILMGKKPGKSGRNGNEFVDLPSLVKAAVLEETTME 603
Query: 609 VFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRPRNRSALYSP 668
VFD+E MKGIRSPMEEGLV ALKLAMGCCAPV +VRP+M+EVVKQLEENRPRNRSALYSP
Sbjct: 604 VFDLEAMKGIRSPMEEGLVHALKLAMGCCAPVTTVRPSMEEVVKQLEENRPRNRSALYSP 663
Query: 669 TETRSEIGTPF 679
TETRS+ TPF
Sbjct: 664 TETRSDAETPF 674
|
Does not seem to have conserved a kinase activity. Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9SCT4|IMK2_ARATH Probably inactive leucine-rich repeat receptor-like protein kinase IMK2 OS=Arabidopsis thaliana GN=IMK2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 318 bits (816), Expect = 7e-86, Method: Compositional matrix adjust.
Identities = 217/603 (35%), Positives = 328/603 (54%), Gaps = 44/603 (7%)
Query: 87 QWANLS-----LYKDSSIHLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPF 141
Q NLS + + S L ++ L +G++P L + S+L+ + ++ N L G+IP
Sbjct: 222 QHNNLSGSIPDFFVNGSHPLKTLNLDHNRFSGAVPVSLCKHSLLEEVSISHNQLSGSIPR 281
Query: 142 ELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDL 201
E G L +D S N G + S NL LVSL L N L +P+ +L
Sbjct: 282 ECGGLPHLQSLDFSYNSINGTIPDSFSNLSS-LVSLNLESNHLKGPIPDAI---DRLHNL 337
Query: 202 QYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRLS-LEKLNLSHNNFSG 260
L+L NK +G PE + +K+LD+S N F+G IP L L+ L N+S+N SG
Sbjct: 338 TELNLKRNKINGPIPETIGNISGIKKLDLSENNFTGPIPLSLVHLAKLSSFNVSYNTLSG 397
Query: 261 VLPVFSESKFGAEVFEGNSPALCGF-------------PLRDCSGNS---------RLSS 298
+P KF + F GN LCG+ PL +S +LS
Sbjct: 398 PVPPVLSKKFNSSSFLGNI-QLCGYSSSNPCPAPDHHHPLTLSPTSSQEPRKHHHRKLSV 456
Query: 299 GAIAGLVIGLMTGAVVFASLLIGYVQNKKRK--NRGDSEEEFEEGEDEENGMSGGSAAGG 356
+ + IG + ++ ++ KKR + D +++ E + G++G ++AGG
Sbjct: 457 KDVILIAIGALLAILLLLCCILLCCLIKKRAALKQKDGKDKTSE-KTVSAGVAGTASAGG 515
Query: 357 AGGEGKLIIFQGGEHLTLEDVLNATGQVIEKTTYGTAYKAKLADGATIALRLLREGSCKD 416
G GKL+ F G T +D+L AT +++ K+TYGTAYKA L DG +A++ LRE + K
Sbjct: 516 EMG-GKLVHFDGPFVFTADDLLCATAEIMGKSTYGTAYKATLEDGNEVAVKRLREKTTKG 574
Query: 417 RSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLN 476
+ LGK+RH+NL+ LRA+Y G +GEKLL++DY +L LH + ++
Sbjct: 575 VKEFEGEVTALGKIRHQNLLALRAYYLGPKGEKLLVFDYMSKGSLSAFLHAR-GPETLIP 633
Query: 477 WARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVA 536
W R KIA GI+RGLA+LH+ + H N+ + N+L+D+ + + ++GL +LM A A
Sbjct: 634 WETRMKIAKGISRGLAHLHSNEN--MIHENLTASNILLDEQTNAHIADYGLSRLMTAAAA 691
Query: 537 DEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSI 596
++A A GY+APE ++K S++TDVY+ GI++LE+L GK PG+ NG +DLP
Sbjct: 692 TNVIATAGTLGYRAPEFSKIKNASAKTDVYSLGIIILELLTGKSPGEP-TNG--MDLPQW 748
Query: 597 VKVAVLEETTMEVFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEE 656
V V EE T EVFD+E+M+ +S +E L+ LKLA+ C P + RP ++VV+QLEE
Sbjct: 749 VASIVKEEWTNEVFDLELMRETQSVGDE-LLNTLKLALHCVDPSPAARPEANQVVEQLEE 807
Query: 657 NRP 659
RP
Sbjct: 808 IRP 810
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|C0LGP9|IMK3_ARATH Probable leucine-rich repeat receptor-like protein kinase IMK3 OS=Arabidopsis thaliana GN=IMK3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 311 bits (798), Expect = 7e-84, Method: Compositional matrix adjust.
Identities = 217/594 (36%), Positives = 323/594 (54%), Gaps = 41/594 (6%)
Query: 96 DSSIHLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSS-SLSEIDL 154
DSS LL + L +L+G +P L S LQ L L+ N+L G I G S +L + L
Sbjct: 195 DSS-KLLRLNLSFNSLSGQIPVSLSRSSSLQFLALDHNNLSGPILDTWGSKSLNLRVLSL 253
Query: 155 SANLFTGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGS 214
N +G S+ NL +L N + LP S + L+ +D+ N SG
Sbjct: 254 DHNSLSGPFPFSLCNLT-QLQDFSFSHNRIRGTLPSEL---SKLTKLRKMDISGNSVSGH 309
Query: 215 FPEFVTRFEALKELDISNNLFSGSIPEGLTRL-SLEKLNLSHNNFSGVLPVFSESKFGAE 273
PE + +L LD+S N +G IP ++ L SL N+S+NN SG +P KF +
Sbjct: 310 IPETLGNISSLIHLDLSQNKLTGEIPISISDLESLNFFNVSYNNLSGPVPTLLSQKFNSS 369
Query: 274 VFEGNSPALCGF-------------PLRDCSGNSR-LSSGAIAGLVIGLMTGAVVFASLL 319
F GNS LCG+ P ++ + R LS+ I I + +GA++ L+
Sbjct: 370 SFVGNS-LLCGYSVSTPCPTLPSPSPEKERKPSHRNLSTKDI----ILIASGALLIVMLI 424
Query: 320 IGYVQNKKRKNRGDSEEEFEEGEDEENGMSGGSAAGG---AGGE--GKLIIFQGGEHLTL 374
+ V + + + E + + GE ++ + GG AGGE GKL+ F G T
Sbjct: 425 LVCVLCCLLRKKAN-ETKAKGGEAGPGAVAAKTEKGGEAEAGGETGGKLVHFDGPMAFTA 483
Query: 375 EDVLNATGQVIEKTTYGTAYKAKLADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHEN 434
+D+L AT +++ K+TYGT YKA L DG+ +A++ LRE K + I LG++RH N
Sbjct: 484 DDLLCATAEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKSQKEFENEINVLGRIRHPN 543
Query: 435 LIPLRAFYQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPV-LNWARRHKIALGIARGLAY 493
L+ LRA+Y G +GEKL+++DY +L LH G V +NW R + G+ARGL Y
Sbjct: 544 LLALRAYYLGPKGEKLVVFDYMSRGSLATFLH--ARGPDVHINWPTRMSLIKGMARGLFY 601
Query: 494 LHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKADGYKAPEL 553
LHT I HGN+ S NVL+D+ ++++++GL +LM A ++A A A GY+APEL
Sbjct: 602 LHT--HANIIHGNLTSSNVLLDENITAKISDYGLSRLMTAAAGSSVIATAGALGYRAPEL 659
Query: 554 QRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDME 613
++KK +++TDVY+ G+++LE+L GK P ++ NG VDLP V AV EE T EVFD+E
Sbjct: 660 SKLKKANTKTDVYSLGVIILELLTGKSPSEA-LNG--VDLPQWVATAVKEEWTNEVFDLE 716
Query: 614 IMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRPRNRSALYS 667
++ + + M + ++ LKLA+ C S RP +V+ QL E RP +A S
Sbjct: 717 LLNDVNT-MGDEILNTLKLALHCVDATPSTRPEAQQVMTQLGEIRPEETTATTS 769
|
Can phosphorylate AGL24. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LP77|Y1848_ARATH Probable inactive receptor kinase At1g48480 OS=Arabidopsis thaliana GN=RKL1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 277 bits (708), Expect = 2e-73, Method: Compositional matrix adjust.
Identities = 213/647 (32%), Positives = 326/647 (50%), Gaps = 105/647 (16%)
Query: 66 RGLKWISTNGSPLSCSDISLPQWANLSLYKDSSIHLLSIQLPSANLTGSLPREL-GEFSM 124
R +W SP C+ WA + K S + +++LP L+G +P + G +
Sbjct: 50 RTFRWNIKQTSP--CN------WAGV---KCESNRVTALRLPGVALSGDIPEGIFGNLTQ 98
Query: 125 LQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNSL 184
L++L L +N+L G++P +L SS+L L L GN
Sbjct: 99 LRTLSLRLNALSGSLPKDLSTSSNLRH-------------------------LYLQGNRF 133
Query: 185 TAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLT 244
+ +PE + S L L+L SN F+G T LK L + NN SGSIP+
Sbjct: 134 SGEIPEVLF---SLSHLVRLNLASNSFTGEISSGFTNLTKLKTLFLENNQLSGSIPD--L 188
Query: 245 RLSLEKLNLSHNNFSGVLPVFSESKFGAEVFEGNSPALCGFPLRDC-----------SGN 293
L L + N+S+N+ +G +P + +F ++ F S LCG PL+ C SG
Sbjct: 189 DLPLVQFNVSNNSLNGSIPK-NLQRFESDSFLQTS--LCGKPLKLCPDEETVPSQPTSGG 245
Query: 294 SR----------------LSSGAIAGLVIGLMTG-AVVFASLLIGYVQNKKRKNRGDSEE 336
+R LS GAIAG+VIG + G A++ L++ + +++R
Sbjct: 246 NRTPPSVEGSEEKKKKNKLSGGAIAGIVIGCVVGFALIVLILMVLCRKKSNKRSRAVDIS 305
Query: 337 EFEEGEDE--------ENG------------MSG-GSAAGGAGGEGKLIIFQGG--EHLT 373
++ E E +NG M+G G A+ G G K ++F G +
Sbjct: 306 TIKQQEPEIPGDKEAVDNGNVYSVSAAAAAAMTGNGKASEGNGPATKKLVFFGNATKVFD 365
Query: 374 LEDVLNATGQVIEKTTYGTAYKAKLADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHE 433
LED+L A+ +V+ K T+GTAYKA L +A++ L++ D+ I +G + HE
Sbjct: 366 LEDLLRASAEVLGKGTFGTAYKAVLDAVTVVAVKRLKDVMMADKE-FKEKIELVGAMDHE 424
Query: 434 NLIPLRAFYQGKRGEKLLIYDYFPSRTLHDLLH-DTIAGKPVLNWARRHKIALGIARGLA 492
NL+PLRA+Y R EKLL+YD+ P +L LLH + AG+ LNW R +IA+G ARGL
Sbjct: 425 NLVPLRAYY-FSRDEKLLVYDFMPMGSLSALLHGNRGAGRSPLNWDVRSRIAIGAARGLD 483
Query: 493 YLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKADGYKAPE 552
YLH+ +HGN++S N+L+ +++++FGL QL V +A GY+APE
Sbjct: 484 YLHS-QGTSTSHGNIKSSNILLTKSHDAKVSDFGLAQL----VGSSATNPNRATGYRAPE 538
Query: 553 LQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDM 612
+ K+ S + DVY+FG++LLE++ GK P S N E VDLP VK +E EVFD
Sbjct: 539 VTDPKRVSQKGDVYSFGVVLLELITGKAPSNSVMNEEGVDLPRWVKSVARDEWRREVFDS 598
Query: 613 EIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRP 659
E++ + + EE + + ++L + C + RP M EVV+++E RP
Sbjct: 599 ELL-SLATDEEEMMAEMVQLGLECTSQHPDQRPEMSEVVRKMENLRP 644
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9LVM0|Y5830_ARATH Probable inactive receptor kinase At5g58300 OS=Arabidopsis thaliana GN=At5g58300 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 274 bits (700), Expect = 2e-72, Method: Compositional matrix adjust.
Identities = 219/695 (31%), Positives = 332/695 (47%), Gaps = 129/695 (18%)
Query: 6 LCCCYIVFFFCLTESLASSSPASASSDVELLLGKIKSSLQGDDENLLLSSWNISVPLCQW 65
L C + F F +T + S + A +SD + LL ++ SVP
Sbjct: 23 LSTCLVSFLF-VTTTFCSYAIADLNSDRQALL-----------------AFAASVP--HL 62
Query: 66 RGLKWISTNGSPLSCSDISLPQWANLSLYKD-SSIHLLSIQLPSANLTGSLP-RELGEFS 123
R L W STN C W ++ D +S+H L +LP L G +P LG+
Sbjct: 63 RRLNWNSTNHI---CK-----SWVGVTCTSDGTSVHAL--RLPGIGLLGPIPPNTLGKLE 112
Query: 124 MLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNS 183
L+ L L N L G +P ++ SL I L N F+G
Sbjct: 113 SLRILSLRSNLLSGNLPPDIHSLPSLDYIYLQHNNFSG---------------------- 150
Query: 184 LTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGL 243
+P+ L LDL N F+G P + L L + NN SG +P L
Sbjct: 151 --------EVPSFVSRQLNILDLSFNSFTGKIPATFQNLKQLTGLSLQNNKLSGPVP-NL 201
Query: 244 TRLSLEKLNLSHNNFSGVLPVFSESKFGAEVFEGNSPALCGFPLRDCSGNS-------RL 296
+SL +LNLS+N+ +G +P + F + F GN+ LCG PL+ C+ +S +
Sbjct: 202 DTVSLRRLNLSNNHLNGSIPS-ALGGFPSSSFSGNT-LLCGLPLQPCATSSPPPSLTPHI 259
Query: 297 SSGAIAGLVIGLMTGAVVFASLLIGYVQN-----------------KKRKNRGDS----- 334
S+ + + + S +I KK+ R DS
Sbjct: 260 STPPLPPFPHKEGSKRKLHVSTIIPIAAGGAALLLLITVIILCCCIKKKDKREDSIVKVK 319
Query: 335 ------EEEFEEGEDEENGMSGGSAAGGAGGEGKLIIFQGGEH-LTLEDVLNATGQVIEK 387
++EF G E + KL+ F G + LED+L A+ +V+ K
Sbjct: 320 TLTEKAKQEFGSGVQEPE-------------KNKLVFFNGCSYNFDLEDLLRASAEVLGK 366
Query: 388 TTYGTAYKAKLADGATIALRLLREGSCKDRS--SCLPVIRQLGKVRHENLIPLRAFYQGK 445
+YGTAYKA L + T+ ++ L+E + R + +I ++G H +++PLRA+Y K
Sbjct: 367 GSYGTAYKAVLEESTTVVVKRLKEVAAGKREFEQQMEIISRVGN--HPSVVPLRAYYYSK 424
Query: 446 RGEKLLIYDYFPSRTLHDLLH-DTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITH 504
EKL++ DY+P+ L LLH + + K L+W R KI L A+G+A+LH +H
Sbjct: 425 -DEKLMVCDYYPAGNLSSLLHGNRGSEKTPLDWDSRVKITLSAAKGIAHLHAAGGPKFSH 483
Query: 505 GNVRSKNVLVDDFFVSRLTEFGLDQLM-VPAVADEMVALAKADGYKAPELQRMKKCSSRT 563
GN++S NV++ + +++FGL LM VP +A + GY+APE+ +K + ++
Sbjct: 484 GNIKSSNVIMKQESDACISDFGLTPLMAVP------IAPMRGAGYRAPEVMETRKHTHKS 537
Query: 564 DVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIRSPME 623
DVY+FG+L+LE+L GK P +S + VDLP V+ V EE T EVFD+E+M+ +E
Sbjct: 538 DVYSFGVLILEMLTGKSPVQSPSRDDMVDLPRWVQSVVREEWTSEVFDIELMRFQN--IE 595
Query: 624 EGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENR 658
E +VQ L++AM C A V VRPTMD+VV+ +EE R
Sbjct: 596 EEMVQMLQIAMACVAQVPEVRPTMDDVVRMIEEIR 630
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9C9Y8|Y3868_ARATH Probable inactive receptor kinase At3g08680 OS=Arabidopsis thaliana GN=At3g08680 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 272 bits (695), Expect = 7e-72, Method: Compositional matrix adjust.
Identities = 206/640 (32%), Positives = 317/640 (49%), Gaps = 104/640 (16%)
Query: 55 SWNISVPLC-QWRGLKWISTNGSPLSCSDISLPQWANLSLYKDSSIHLLSIQLPSANLTG 113
+WN ++P+C W G+ +CS ++ + +++LP + L G
Sbjct: 46 NWNSTIPICASWTGI----------TCSK--------------NNARVTALRLPGSGLYG 81
Query: 114 SLPRELGE-FSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCD 172
LP + E L+ + L N L+G IP + + + N F+G + P L
Sbjct: 82 PLPEKTFEKLDALRIISLRSNHLQGNIPSVILSLPFIRSLYFHENNFSGTIPPV---LSH 138
Query: 173 RLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISN 232
RLV+L DL +N SG+ P + L +L + N
Sbjct: 139 RLVNL---------------------------DLSANSLSGNIPTSLQNLTQLTDLSLQN 171
Query: 233 NLFSGSIPEGLTRLSLEKLNLSHNNFSGVLPVFSESKFGAEVFEGNSPALCGFPLRDCSG 292
N SG IP RL + LNLS NN +G +P +S F A F+GNS LCG PL C
Sbjct: 172 NSLSGPIPNLPPRL--KYLNLSFNNLNGSVPSSVKS-FPASSFQGNS-LLCGAPLTPCPE 227
Query: 293 NSR--------------------------LSSGAIAGLVIGLMTGAVVFASLL--IGYVQ 324
N+ LS+GAI G+ +G G+V+ +L I
Sbjct: 228 NTTAPSPSPTTPTEGPGTTNIGRGTAKKVLSTGAIVGIAVG---GSVLLFIILAIITLCC 284
Query: 325 NKKRKNRGDSEE--EFEEGEDEENGMSGGSAAGGAGGEGKLIIFQGGEH-LTLEDVLNAT 381
KKR DS + + G + GS A + KL+ F+G + LED+L A+
Sbjct: 285 AKKRDGGQDSTAVPKAKPGRSDNKAEEFGSGVQEAE-KNKLVFFEGSSYNFDLEDLLRAS 343
Query: 382 GQVIEKTTYGTAYKAKLADGATIALRLLREGSCKDRSSCLPVIRQLGKVR-HENLIPLRA 440
+V+ K +YGT YKA L +G T+ ++ L+E + R + +G++ H N+ PLRA
Sbjct: 344 AEVLGKGSYGTTYKAILEEGTTVVVKRLKEVAAGKRE-FEQQMEAVGRISPHVNVAPLRA 402
Query: 441 FYQGKRGEKLLIYDYFPSRTLHDLLH-DTIAGKPVLNWARRHKIALGIARGLAYLHTGHE 499
+Y K EKLL+YDY+ LLH + G+ L+W R +I L ARG++++H+
Sbjct: 403 YYFSK-DEKLLVYDYYQGGNFSMLLHGNNEGGRAALDWETRLRICLEAARGISHIHSASG 461
Query: 500 IPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKADGYKAPELQRMKKC 559
+ HGN++S NVL+ +++FG+ LM + + +++ GY+APE +K
Sbjct: 462 AKLLHGNIKSPNVLLTQELHVCVSDFGIAPLM----SHHTLIPSRSLGYRAPEAIETRKH 517
Query: 560 SSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIR 619
+ ++DVY+FG+LLLE+L GK GK+ + E VDLP V+ V EE T EVFD+E++K
Sbjct: 518 TQKSDVYSFGVLLLEMLTGKAAGKTTGHEEVVDLPKWVQSVVREEWTGEVFDVELIKQQH 577
Query: 620 SPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRP 659
+ +EE +VQ L++AM C + RP+M+EVV +EE RP
Sbjct: 578 N-VEEEMVQMLQIAMACVSKHPDSRPSMEEVVNMMEEIRP 616
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|O48788|Y2267_ARATH Probable inactive receptor kinase At2g26730 OS=Arabidopsis thaliana GN=At2g26730 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 272 bits (695), Expect = 7e-72, Method: Compositional matrix adjust.
Identities = 221/698 (31%), Positives = 338/698 (48%), Gaps = 122/698 (17%)
Query: 1 MAFLKLCCCYIVFFFCLTESLASSSPASASSDVELLLGKIKSSLQGDDENLLLSSWNISV 60
MA + + LT+ + S S A + + L Q EN L WN S
Sbjct: 1 MASISWVLNSLFSILLLTQRVNSESTAEKQALLTFLQ-------QIPHENRL--QWNESD 51
Query: 61 PLCQWRGLKWISTNGSPLSCSDISLPQWANLSLYKDSSIHLLSIQLPSANLTGSLPR-EL 119
C W G++ C+ SSIH S++LP L G +P L
Sbjct: 52 SACNWVGVE----------CNS------------NQSSIH--SLRLPGTGLVGQIPSGSL 87
Query: 120 GEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRL 179
G + L+ L L N L G IP + + L + L N F+G S L
Sbjct: 88 GRLTELRVLSLRSNRLSGQIPSDFSNLTHLRSLYLQHNEFSGEFPTSFTQL--------- 138
Query: 180 HGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSI 239
++L LD+ SN F+GS P V L L + NN FSG++
Sbjct: 139 -------------------NNLIRLDISSNNFTGSIPFSVNNLTHLTGLFLGNNGFSGNL 179
Query: 240 PEGLTRLSLEKLNLSHNNFSGVLPVFSESKFGAEVFEGNSPALCGFPLRDCSG------- 292
P L L N+S+NN +G +P S S+F AE F GN LCG PL+ C
Sbjct: 180 PS--ISLGLVDFNVSNNNLNGSIPS-SLSRFSAESFTGNV-DLCGGPLKPCKSFFVSPSP 235
Query: 293 -----------NSRLSSGAIAGLVIGLMTGAVVFASLLIGYVQNKKRKNRGDSEEEFEE- 340
+S+ S + A +V ++ A+V LL + RK RG +E ++
Sbjct: 236 SPSLINPSNRLSSKKSKLSKAAIVAIIVASALVALLLLALLLFLCLRKRRGSNEARTKQP 295
Query: 341 ------------------GEDEENGMSGGSAAGGAGGEGKLIIFQGGEH-LTLEDVLNAT 381
++E G S G GG KL+ +GG + LED+L A+
Sbjct: 296 KPAGVATRNVDLPPGASSSKEEVTGTSSG--MGGETERNKLVFTEGGVYSFDLEDLLRAS 353
Query: 382 GQVIEKTTYGTAYKAKLADGATIALRLLRE--GSCKDRSSCLPVIRQLGKVRHENLIPLR 439
+V+ K + GT+YKA L +G T+ ++ L++ S K+ + + V+ GK++H N+IPLR
Sbjct: 354 AEVLGKGSVGTSYKAVLEEGTTVVVKRLKDVMASKKEFETQMEVV---GKIKHPNVIPLR 410
Query: 440 AFYQGKRGEKLLIYDYFPSRTLHDLLHDTI-AGKPVLNWARRHKIALGIARGLAYLHTGH 498
A+Y K EKLL++D+ P+ +L LLH + +G+ L+W R +IA+ ARGLA+LH
Sbjct: 411 AYYYSK-DEKLLVFDFMPTGSLSALLHGSRGSGRTPLDWDNRMRIAITAARGLAHLHVSA 469
Query: 499 EIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKADGYKAPELQRMKK 558
++ HGN+++ N+L+ + ++++GL+QL + +A GY APE+ +K
Sbjct: 470 KL--VHGNIKASNILLHPNQDTCVSDYGLNQLFSNSSPPNRLA-----GYHAPEVLETRK 522
Query: 559 CSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGI 618
+ ++DVY+FG+LLLE+L GK P ++ E +DLP V V EE T EVFD+E+M+
Sbjct: 523 VTFKSDVYSFGVLLLELLTGKSPNQASLGEEGIDLPRWVLSVVREEWTAEVFDVELMR-- 580
Query: 619 RSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEE 656
+EE +VQ L++AM C + V RP M EV++ +E+
Sbjct: 581 YHNIEEEMVQLLQIAMACVSTVPDQRPVMQEVLRMIED 618
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9M9C5|Y1680_ARATH Probable leucine-rich repeat receptor-like protein kinase At1g68400 OS=Arabidopsis thaliana GN=At1g68400 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 264 bits (675), Expect = 2e-69, Method: Compositional matrix adjust.
Identities = 194/558 (34%), Positives = 292/558 (52%), Gaps = 92/558 (16%)
Query: 177 LRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFS 236
L L N+L+ P P L N T L+ L L +N+FSG+FP +T L LD+S N FS
Sbjct: 96 LSLKHNNLSG--PIPNLSNLTA--LKLLFLSNNQFSGNFPTSITSLTRLYRLDLSFNNFS 151
Query: 237 GSIPEGL-------------TRLS----------LEKLNLSHNNFSGVLPVFSESKFGAE 273
G IP L R S L+ N+S NNF+G +P S S+F
Sbjct: 152 GQIPPDLTDLTHLLTLRLESNRFSGQIPNINLSDLQDFNVSGNNFNGQIPN-SLSQFPES 210
Query: 274 VFEGNSPALCGFPLRDCS----------------------------------------GN 293
VF N P+LCG PL C+
Sbjct: 211 VFTQN-PSLCGAPLLKCTKLSSDPTKPGRPDEAKASPLNKPETVPSSPTSIHGGDKSNNT 269
Query: 294 SRLSSGAIAGLVIGLMTGAVVFASLLI------GYVQNKKRKNRGDSEEE--FEEGEDEE 345
SR+S+ ++ +++G + F SLL+ Y NKK+ ++ E+ +
Sbjct: 270 SRISTISLIAIILGDFI-ILSFVSLLLYYCFWRQYAVNKKKHSKILEGEKIVYSSNPYPT 328
Query: 346 NGMSGGSAAGGAGGEGKLIIFQGGEHLTLEDVLNATGQVIEKTTYGTAYKAKLADGATIA 405
+ + + G +GK++ F+G LED+L A+ +++ K +GTAYKA L DG +A
Sbjct: 329 STQNNNNQNQQVGDKGKMVFFEGTRRFELEDLLRASAEMLGKGGFGTAYKAVLEDGNEVA 388
Query: 406 LRLLREG-SCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRTLHDL 464
++ L++ + + + LG++RH NL+ L+A+Y R EKLL+YDY P+ +L L
Sbjct: 389 VKRLKDAVTVAGKKEFEQQMEVLGRLRHTNLVSLKAYYFA-REEKLLVYDYMPNGSLFWL 447
Query: 465 LHDTIA-GKPVLNWARRHKIALGIARGLAYLH-TGHEIPITHGNVRSKNVLVDDFFVSRL 522
LH G+ L+W R KIA G ARGLA++H + + +THG+++S NVL+D +R+
Sbjct: 448 LHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHGSCKTLKLTHGDIKSTNVLLDRSGNARV 507
Query: 523 TEFGLDQLMVPAVADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPG 582
++FGL + P+ +AK++GY+APEL +K + ++DVY+FG+LLLEIL GK P
Sbjct: 508 SDFGL-SIFAPS-----QTVAKSNGYRAPELIDGRKHTQKSDVYSFGVLLLEILTGKCPN 561
Query: 583 --KSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIRSPMEEGLVQALKLAMGCCAPV 640
++G +G VDLP V+ V EE T EVFD+E+M+ +EE +V L++AM C A
Sbjct: 562 MVETGHSGGAVDLPRWVQSVVREEWTAEVFDLELMR--YKDIEEEMVGLLQIAMACTAVA 619
Query: 641 ASVRPTMDEVVKQLEENR 658
A RP M VVK +E+ R
Sbjct: 620 ADHRPKMGHVVKLIEDIR 637
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LVI6|RLK90_ARATH Probable inactive receptor kinase RLK902 OS=Arabidopsis thaliana GN=RLK902 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 254 bits (649), Expect = 2e-66, Method: Compositional matrix adjust.
Identities = 202/593 (34%), Positives = 290/593 (48%), Gaps = 109/593 (18%)
Query: 164 APSIWN--LCD--RLVSLRLHGNSLTAALPEPALPNST---------------------- 197
+P W LCD R+ +LRL G +L+ +PE N T
Sbjct: 58 SPCNWTGVLCDGGRVTALRLPGETLSGHIPEGIFGNLTQLRTLSLRLNGLTGSLPLDLGS 117
Query: 198 CSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEG---LTRLS---LE-- 249
CSDL+ L L N+FSG PE + L L+++ N FSG I G LTRL LE
Sbjct: 118 CSDLRRLYLQGNRFSGEIPEVLFSLSNLVRLNLAENEFSGEISSGFKNLTRLKTLYLENN 177
Query: 250 --------------KLNLSHNNFSGVLPVFSESKFGAEVFEGNSPALCGFPLRDCS---- 291
+ N+S+N +G +P S KF ++ F G S LCG PL CS
Sbjct: 178 KLSGSLLDLDLSLDQFNVSNNLLNGSIPK-SLQKFDSDSFVGTS--LCGKPLVVCSNEGT 234
Query: 292 --------GN--------------SRLSSGAIAGLVIGLMTG-AVVFASLLIGYVQNKKR 328
GN +LS GAIAG+VIG + G +++ L++ + +
Sbjct: 235 VPSQPISVGNIPGTVEGSEEKKKRKKLSGGAIAGIVIGCVVGLSLIVMILMVLFRKKGNE 294
Query: 329 KNRGDSEEEFEEGEDEENGMSGGSAAG-------------------GAGGEGKLIIFQGG 369
+ R + E E G A + G KL+ F
Sbjct: 295 RTRAIDLATIKHHEVEIPGEKAAVEAPENRSYVNEYSPSAVKAVEVNSSGMKKLVFFGNA 354
Query: 370 EHL-TLEDVLNATGQVIEKTTYGTAYKAKLADGATIALRLLREGSCKDRSSCLPVIRQLG 428
+ LED+L A+ +V+ K T+GTAYKA L +A++ L++ + DR I +G
Sbjct: 355 TKVFDLEDLLRASAEVLGKGTFGTAYKAVLDAVTLVAVKRLKDVTMADRE-FKEKIEVVG 413
Query: 429 KVRHENLIPLRAFYQGKRGEKLLIYDYFPSRTLHDLLH-DTIAGKPVLNWARRHKIALGI 487
+ HENL+PLRA+Y EKLL+YD+ P +L LLH + AG+P LNW R IALG
Sbjct: 414 AMDHENLVPLRAYYYSG-DEKLLVYDFMPMGSLSALLHGNKGAGRPPLNWEVRSGIALGA 472
Query: 488 ARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKADG 547
ARGL YLH+ + +HGNV+S N+L+ + +R+++FGL QL V+ +A G
Sbjct: 473 ARGLDYLHSQDPLS-SHGNVKSSNILLTNSHDARVSDFGLAQL----VSASSTTPNRATG 527
Query: 548 YKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTM 607
Y+APE+ ++ S + DVY+FG++LLE+L GK P S N E +DL V EE
Sbjct: 528 YRAPEVTDPRRVSQKADVYSFGVVLLELLTGKAPSNSVMNEEGMDLARWVHSVAREEWRN 587
Query: 608 EVFDMEIMKGIRS--PMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENR 658
EVFD E+M I + +EE + + L+L + C RP M EVV++++E R
Sbjct: 588 EVFDSELMS-IETVVSVEEEMAEMLQLGIDCTEQHPDKRPVMVEVVRRIQELR 639
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9FHK7|Y5516_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g05160 OS=Arabidopsis thaliana GN=At5g05160 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 241 bits (615), Expect = 1e-62, Method: Compositional matrix adjust.
Identities = 210/693 (30%), Positives = 322/693 (46%), Gaps = 103/693 (14%)
Query: 13 FFFCLTESLASSSPASASSDVELLLGKIKSSLQGDDENLLLSSWNISVPLCQWRGLKWIS 72
FFF L + A A +SD + LL S N WN ++ LC WI
Sbjct: 13 FFFLLLAATAVLVSADLASDEQALLNFAASVPHPPKLN-----WNKNLSLCS----SWIG 63
Query: 73 TNGSPLSCSDISLPQWANLSLYKDSSIHLLSIQLPSANLTGSLP-RELGEFSMLQSLYLN 131
++C + + + +++++LP L GS+P LG+ L+ L L
Sbjct: 64 -----ITCDE------------SNPTSRVVAVRLPGVGLYGSIPPATLGKLDALKVLSLR 106
Query: 132 VNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNSLTAALPEP 191
NSL GT+P ++ SL + L N F+G L T +LP
Sbjct: 107 SNSLFGTLPSDILSLPSLEYLYLQHNNFSGELT--------------------TNSLP-- 144
Query: 192 ALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRLSLEKL 251
S L LDL N SG+ P + + L + NN F G I + L S++ +
Sbjct: 145 ----SISKQLVVLDLSYNSLSGNIPSGLRNLSQITVLYLQNNSFDGPI-DSLDLPSVKVV 199
Query: 252 NLSHNNFSGVLPVFSESKFGAEVFEGNSPALCGFPLRDCSGNS----------------- 294
NLS+NN SG +P + K F GNS LCG PL CSG +
Sbjct: 200 NLSYNNLSGPIPEHLK-KSPEYSFIGNS-LLCGPPLNACSGGAISPSSNLPRPLTENLHP 257
Query: 295 ---RLSSGAIAGLVIGLMTGAVVFASLLIGYVQNKKRKNRGDSEEEFEE--GEDEENGMS 349
R S I +V+G + + + + K +K G E + G + +
Sbjct: 258 VRRRQSKAYIIAIVVGCSVAVLFLGIVFLVCLVKKTKKEEGGGEGVRTQMGGVNSKKPQD 317
Query: 350 GGSAAGGAGGEGKLIIFQGGEH-LTLEDVLNATGQVIEKTTYGTAYKAKLADGATIALRL 408
GS + KL F+ H LED+L A+ +V+ K ++GTAYKA L D + ++
Sbjct: 318 FGSGVQDPE-KNKLFFFERCNHNFDLEDLLKASAEVLGKGSFGTAYKAVLEDTTAVVVKR 376
Query: 409 LRE--GSCKDRSSCLPVIRQLGKV-RHENLIPLRAFYQGKRGEKLLIYDYFPSRTLHDLL 465
LRE S K+ + ++ GK+ +H N +PL A+Y K EKLL+Y Y +L ++
Sbjct: 377 LREVVASKKEFEQQMEIV---GKINQHSNFVPLLAYYYSK-DEKLLVYKYMTKGSLFGIM 432
Query: 466 HDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEF 525
H + V +W R KIA G ++ ++YLH+ + HG+++S N+L+ + L++
Sbjct: 433 HGNRGDRGV-DWETRMKIATGTSKAISYLHS---LKFVHGDIKSSNILLTEDLEPCLSDT 488
Query: 526 GLDQLM-VPAVADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKP-GK 583
L L +P + GY APE+ ++ S R+DVY+FG+++LE+L GK P +
Sbjct: 489 SLVTLFNLPTHTPRTI------GYNAPEVIETRRVSQRSDVYSFGVVILEMLTGKTPLTQ 542
Query: 584 SGRNGE--FVDLPSIVKVAVLEETTMEVFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVA 641
G E +DLP V+ V EE T EVFD+E++K +EE +VQ L+LA+ C A
Sbjct: 543 PGLEDERVVIDLPRWVRSVVREEWTAEVFDVELLK--FQNIEEEMVQMLQLALACVARNP 600
Query: 642 SVRPTMDEVVKQLEENRPRNRSALYSPTETRSE 674
RP M+EV + +E+ R ++S T SE
Sbjct: 601 ESRPKMEEVARMIEDVRRLDQSQQLQQNRTSSE 633
|
Probable leucine-rich repeat receptor-like protein kinase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 679 | ||||||
| 224069914 | 678 | predicted protein [Populus trichocarpa] | 0.991 | 0.992 | 0.807 | 0.0 | |
| 255560229 | 687 | Serine/threonine-protein kinase PBS1, pu | 0.997 | 0.985 | 0.804 | 0.0 | |
| 225464208 | 668 | PREDICTED: putative kinase-like protein | 0.941 | 0.956 | 0.816 | 0.0 | |
| 356566443 | 699 | PREDICTED: putative kinase-like protein | 0.951 | 0.924 | 0.773 | 0.0 | |
| 449475529 | 729 | PREDICTED: LOW QUALITY PROTEIN: putative | 0.946 | 0.882 | 0.791 | 0.0 | |
| 449443907 | 712 | PREDICTED: putative kinase-like protein | 0.946 | 0.903 | 0.790 | 0.0 | |
| 297831322 | 674 | hypothetical protein ARALYDRAFT_342637 [ | 0.977 | 0.985 | 0.752 | 0.0 | |
| 15230141 | 674 | putative kinase-like protein TMKL1 [Arab | 0.977 | 0.985 | 0.743 | 0.0 | |
| 356524541 | 689 | PREDICTED: putative kinase-like protein | 0.927 | 0.914 | 0.752 | 0.0 | |
| 147833136 | 628 | hypothetical protein VITISV_008676 [Viti | 0.865 | 0.936 | 0.756 | 0.0 |
| >gi|224069914|ref|XP_002303085.1| predicted protein [Populus trichocarpa] gi|222844811|gb|EEE82358.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1098 bits (2839), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 552/684 (80%), Positives = 610/684 (89%), Gaps = 11/684 (1%)
Query: 1 MAFLKLCCCYIVFFFCLTESLASSSPA-----SASSDVELLLGKIKSSLQGDDENLLLSS 55
MA LKL YI F+ L S+SP SAS+DVELLLGKIK+SLQG+ ENLLLSS
Sbjct: 1 MAVLKLYSIYI--FYTLISINFSASPTQSLLLSASTDVELLLGKIKASLQGNTENLLLSS 58
Query: 56 WNISVPLCQWRGLKWISTNGSPLSCSDISLPQWANLSLYKDSSIHLLSIQLPSANLTGSL 115
WN SVPLCQWRGLKW+ +NGSPLSC D+S PQW NLSLYKD S+HLLS+QLPSANLTGSL
Sbjct: 59 WNSSVPLCQWRGLKWVFSNGSPLSCIDLSAPQWTNLSLYKDPSLHLLSLQLPSANLTGSL 118
Query: 116 PRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLV 175
PRELG FSMLQSLYLN+NSL GTIP ELGYSSSLS+IDLS N+F+G LAPS+WNLCDRLV
Sbjct: 119 PRELGGFSMLQSLYLNINSLGGTIPLELGYSSSLSDIDLSDNVFSGALAPSVWNLCDRLV 178
Query: 176 SLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLF 235
SLRLHGNSLT +LPEPALPN+TC++LQ+LDLGSNKFSGSFPEFVTRF+ + ELD+S N+F
Sbjct: 179 SLRLHGNSLTGSLPEPALPNTTCNNLQFLDLGSNKFSGSFPEFVTRFQGINELDLSGNMF 238
Query: 236 SGSIPEGLTRLSLEKLNLSHNNFSGVLPVFSESKFGAEVFEGNSPALCGFPLRDCSGNSR 295
SG IPE LT L LEKLNLSHNNFSGVLP F ESKFG EVFEGN P+LCG PLR CSG+SR
Sbjct: 239 SGPIPETLTGLKLEKLNLSHNNFSGVLPFFGESKFGVEVFEGNDPSLCGLPLRSCSGSSR 298
Query: 296 LSSGAIAGLVIGLMTGAVVFASLLIGYVQNKKRKNRGDSEEEFEEGEDEENGMSGGSAAG 355
LS GAIAG+VIGLMTG VV ASLLIGY+QNK+RK GDS+++ EE E+G G G
Sbjct: 299 LSPGAIAGIVIGLMTGVVVLASLLIGYMQNKRRKGMGDSDDDMEE----ESGDDGVGGVG 354
Query: 356 GAGGEGKLIIFQGGEHLTLEDVLNATGQVIEKTTYGTAYKAKLADGATIALRLLREGSCK 415
G GGEGKLI+FQGGEHLTLEDVLNATGQV+EKT+YGT YKAKLADG TIALRL+REGSCK
Sbjct: 355 GVGGEGKLILFQGGEHLTLEDVLNATGQVMEKTSYGTVYKAKLADGGTIALRLMREGSCK 414
Query: 416 DRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVL 475
DRSSCLPVI+QLGK+RH++L+PLRAFYQGKRGEKLLIYDY P+RTLHDLLH+ AGKPVL
Sbjct: 415 DRSSCLPVIKQLGKIRHDSLLPLRAFYQGKRGEKLLIYDYLPNRTLHDLLHEAKAGKPVL 474
Query: 476 NWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAV 535
NWARRHKIAL IARGLAYLHTG E PITHGNVRSKNVLVD+FFV+RLTEFGLD+LM+P V
Sbjct: 475 NWARRHKIALAIARGLAYLHTGLETPITHGNVRSKNVLVDEFFVARLTEFGLDKLMIPTV 534
Query: 536 ADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPS 595
ADE+VALAK DGYKAPELQRMKKC+SRTDVYAFGILLLEILIGKKPGK+GR+ +F DLPS
Sbjct: 535 ADEIVALAKTDGYKAPELQRMKKCNSRTDVYAFGILLLEILIGKKPGKNGRSNDFADLPS 594
Query: 596 IVKVAVLEETTMEVFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLE 655
+VKVAVLEETTMEVFD+E++KG+RSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLE
Sbjct: 595 MVKVAVLEETTMEVFDLEVLKGVRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLE 654
Query: 656 ENRPRNRSALYSPTETRSEIGTPF 679
ENRPRNRSALYSP ETRSEIGTPF
Sbjct: 655 ENRPRNRSALYSPNETRSEIGTPF 678
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255560229|ref|XP_002521132.1| Serine/threonine-protein kinase PBS1, putative [Ricinus communis] gi|223539701|gb|EEF41283.1| Serine/threonine-protein kinase PBS1, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1067 bits (2760), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 554/689 (80%), Positives = 615/689 (89%), Gaps = 12/689 (1%)
Query: 1 MAFLKLCCCYIVFFFCLTESLASSSPASASS----------DVELLLGKIKSSLQGDDEN 50
MA KLC + V FF + SS+ S S DVELLLGKIK+SLQG+ EN
Sbjct: 1 MAISKLCSLHTVCFFLMAIIFTSSTALSNESLSSSASSTSTDVELLLGKIKASLQGNTEN 60
Query: 51 LLLSSWNISVPLCQWRGLKWISTNGSPLSCSDISLPQWANLSLYKDSSIHLLSIQLPSAN 110
LLLSSWN SVPLCQWRGLKW+ +NGSPLSC+DIS P+W NLSLYKD S+HLLS+QLPSAN
Sbjct: 61 LLLSSWNSSVPLCQWRGLKWVFSNGSPLSCNDISAPEWTNLSLYKDPSLHLLSLQLPSAN 120
Query: 111 LTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNL 170
LTGSLPRELGEFSMLQSLYLN+NS+ GTIP ELGY +SLS+IDLS NLF+GVLAPSIWNL
Sbjct: 121 LTGSLPRELGEFSMLQSLYLNINSMTGTIPLELGYGTSLSDIDLSGNLFSGVLAPSIWNL 180
Query: 171 CDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDI 230
C+RL+SL+LHGNSL+ +LPEPALPNSTC +LQ+LDLGSNKFSG FPEF TRF+ LKELD+
Sbjct: 181 CERLLSLKLHGNSLSGSLPEPALPNSTCKNLQFLDLGSNKFSGDFPEFFTRFQGLKELDL 240
Query: 231 SNNLFSGSIPEGLTRLSLEKLNLSHNNFSGVLPVFSESKFGAEVFEGNSPALCGFPLRDC 290
S+N+ SGSIP+ LT L+LEKLNLSHNNFSG+LPVF ESKFG EVFEGN P+LCG PLR C
Sbjct: 241 SDNVLSGSIPQSLTSLNLEKLNLSHNNFSGMLPVFGESKFGMEVFEGNDPSLCGLPLRSC 300
Query: 291 SGNSRLSSGAIAGLVIGLMTGAVVFASLLIGYVQNKKRKNRGDSEEEFEEGEDEENGMSG 350
SG+SRLSSGAIAG+VIGLMTG VV ASL IGY+QNKKRK R DSE+E EE EDEENG SG
Sbjct: 301 SGSSRLSSGAIAGIVIGLMTGVVVLASLSIGYMQNKKRKGREDSEDELEEVEDEENGGSG 360
Query: 351 GSAAGGAGGEGKLIIFQGGEHLTLEDVLNATGQVIEKTTYGTAYKAKLADGATIALRLLR 410
G+A G EGKLI+FQGGEHLTL+DVLNATGQV EKTTYGT YKAKLADG TIALRLLR
Sbjct: 361 GNAGSGG--EGKLILFQGGEHLTLDDVLNATGQVTEKTTYGTVYKAKLADGGTIALRLLR 418
Query: 411 EGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRTLHDLLHDTIA 470
EGSCKDRSSC+ VI+QLGK+RHENLIPLRAFYQGKRGEKLLIYDY P+R+L+DLLH+T A
Sbjct: 419 EGSCKDRSSCVTVIKQLGKIRHENLIPLRAFYQGKRGEKLLIYDYLPNRSLYDLLHETKA 478
Query: 471 GKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQL 530
GKPVLNW+RRHKIALGIARGLAYLHTG E PITHGNVRSKNVLVD++FVSRLTEFGLD+L
Sbjct: 479 GKPVLNWSRRHKIALGIARGLAYLHTGLETPITHGNVRSKNVLVDEYFVSRLTEFGLDKL 538
Query: 531 MVPAVADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEF 590
MVP+VADE+V LAKADGYKAPELQRMKKC+SRTDVYAFGILLLEILIGKKPGK+GRNG+F
Sbjct: 539 MVPSVADEIVVLAKADGYKAPELQRMKKCNSRTDVYAFGILLLEILIGKKPGKNGRNGDF 598
Query: 591 VDLPSIVKVAVLEETTMEVFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEV 650
VDLP++VKVAVLEETTMEVFD+E+++GIRSPMEEGLVQALKLAMGCCAPV SVRP MDEV
Sbjct: 599 VDLPAMVKVAVLEETTMEVFDVELLRGIRSPMEEGLVQALKLAMGCCAPVPSVRPAMDEV 658
Query: 651 VKQLEENRPRNRSALYSPTETRSEIGTPF 679
VKQLEENRPRNRSALYSP ETRSE+GTPF
Sbjct: 659 VKQLEENRPRNRSALYSPAETRSEVGTPF 687
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225464208|ref|XP_002264706.1| PREDICTED: putative kinase-like protein TMKL1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1055 bits (2729), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 529/648 (81%), Positives = 588/648 (90%), Gaps = 9/648 (1%)
Query: 33 VELLLGKIKSSLQGD-DENLLLSSWNISVPLCQWRGLKWISTNGSPLSCSDISLPQWANL 91
VELLL KIK SLQG +NLLLSSWN SVPLCQWRGLKW+ +NGSPL C+D+S P W NL
Sbjct: 29 VELLLNKIKPSLQGSYSDNLLLSSWNTSVPLCQWRGLKWVFSNGSPLLCTDLSSPHWTNL 88
Query: 92 SLYKDSSIHLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSE 151
SL KD S+HLLS+QLPSANLTGSLP+ELGE S LQSLYLNVNSL GTIP ELGYS SLS+
Sbjct: 89 SLSKDPSLHLLSLQLPSANLTGSLPKELGELSALQSLYLNVNSLTGTIPLELGYSPSLSD 148
Query: 152 IDLSANLFTGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKF 211
+DL N +G L P+IWNLCDRLVSLRLH N L+ ++PEP LPNSTC++LQ+LDLG N+F
Sbjct: 149 LDLGNNQLSGALTPAIWNLCDRLVSLRLHANRLSGSVPEPVLPNSTCNNLQFLDLGDNQF 208
Query: 212 SGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRLSLEKLNLSHNNFSGVLPVFSESKFG 271
SGSFPEFVTRF+ LKELD+ NNLFSGSIPEGL +L+LEKLNLS+NNFSGVLPVF ESK+G
Sbjct: 209 SGSFPEFVTRFDGLKELDLGNNLFSGSIPEGLAKLNLEKLNLSYNNFSGVLPVFGESKYG 268
Query: 272 AEVFEGNSPALCGFPLRDCSGNSRLSSGAIAGLVIGLMTGAVVFASLLIGYVQNKKRKNR 331
EVFEGN+ LCG PLR C NS LS GAIAG+VIGLMTG+VV ASLLIGYVQ KKRK+R
Sbjct: 269 VEVFEGNNAGLCGSPLRSCKSNSGLSPGAIAGIVIGLMTGSVVLASLLIGYVQGKKRKSR 328
Query: 332 GDSEEEFEEGEDEENGMSGGSAAGGAGGEGKLIIFQGGEHLTLEDVLNATGQVIEKTTYG 391
G++EEEFEEGED+ENG SGGS G+GKLI+FQGGEHLTLEDVLNATGQV+EKT+YG
Sbjct: 329 GENEEEFEEGEDDENG-SGGS------GDGKLILFQGGEHLTLEDVLNATGQVMEKTSYG 381
Query: 392 TAYKAKLADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLL 451
T YKAKLADG +IALRLLREGSCKD +SCLPVI+QLG+VRHENLIPLRAFYQGKRGEKLL
Sbjct: 382 TVYKAKLADGGSIALRLLREGSCKDSNSCLPVIKQLGRVRHENLIPLRAFYQGKRGEKLL 441
Query: 452 IYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKN 511
IYDY P+R+LHDLLH+T AGKPVLNWARRHKIALGIARGLA+LHT E PITHGNVRSKN
Sbjct: 442 IYDYLPNRSLHDLLHETRAGKPVLNWARRHKIALGIARGLAFLHT-VEAPITHGNVRSKN 500
Query: 512 VLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGIL 571
VL+D+FFV+RLTEFGLD++MVPAVADEMVALAK DGYKAPELQ+MKKC+SRTDVYAFGIL
Sbjct: 501 VLIDEFFVARLTEFGLDKVMVPAVADEMVALAKTDGYKAPELQKMKKCNSRTDVYAFGIL 560
Query: 572 LLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIRSPMEEGLVQALK 631
LLEILIGKKPGK+GR+G+FVDLPS+VKVAVLEETTMEVFD+E++KGIRSPMEEGLVQALK
Sbjct: 561 LLEILIGKKPGKNGRSGDFVDLPSMVKVAVLEETTMEVFDVEVLKGIRSPMEEGLVQALK 620
Query: 632 LAMGCCAPVASVRPTMDEVVKQLEENRPRNRSALYSPTETRSEIGTPF 679
LAMGCCAPVASVRPTMDEVVKQLEENRPRNRSALYSP+ETRSEIGTPF
Sbjct: 621 LAMGCCAPVASVRPTMDEVVKQLEENRPRNRSALYSPSETRSEIGTPF 668
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356566443|ref|XP_003551441.1| PREDICTED: putative kinase-like protein TMKL1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1018 bits (2631), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 503/650 (77%), Positives = 576/650 (88%), Gaps = 4/650 (0%)
Query: 32 DVELLLGKIKSSLQGDD-ENLLLSSWNISVPLCQWRGLKWISTNGSPLSCSDISLPQWAN 90
DVELLLGKIK+SLQG + +NL+LSSWN S PLCQW+GL W+ +NG+PLSC+D+S PQW N
Sbjct: 52 DVELLLGKIKASLQGSNSDNLVLSSWNSSTPLCQWKGLIWVFSNGTPLSCTDLSSPQWTN 111
Query: 91 LSLYKDSSIHLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLS 150
L+L KD S+HL S++LPSANL+GSLPRELG F MLQSLYLN+NSL+GTIP ELGYSSSLS
Sbjct: 112 LTLLKDPSLHLFSLRLPSANLSGSLPRELGGFPMLQSLYLNINSLEGTIPLELGYSSSLS 171
Query: 151 EIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNK 210
EIDL N+ GVL PSIWNLC+RLVSLRLHGNSL+ + EPALPNS+C +LQ LDLG NK
Sbjct: 172 EIDLGDNMLGGVLPPSIWNLCERLVSLRLHGNSLSGLVSEPALPNSSCKNLQVLDLGGNK 231
Query: 211 FSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRLSLEKLNLSHNNFSGVLPVFS-ESK 269
FSGSFPEF+T+F LK+LD+ NN+F G+IP+GL LSLEKLNLSHNNFSGVLP+F ESK
Sbjct: 232 FSGSFPEFITKFGGLKQLDLGNNMFMGAIPQGLAGLSLEKLNLSHNNFSGVLPLFGGESK 291
Query: 270 FGAEVFEGNSPALCGFPLRDCSGNSRLSSGAIAGLVIGLMTGAVVFASLLIGYVQNKKRK 329
FG + FEGNSP+LCG PL C+ S LSSGA+AG+VI LMTGAVV ASLLIGY+QNKK+K
Sbjct: 292 FGVDAFEGNSPSLCGPPLGSCARTSTLSSGAVAGIVISLMTGAVVLASLLIGYMQNKKKK 351
Query: 330 NRGDSEEEFEEGEDEENGMSGGSAAGGAGGEGKLIIFQGGEHLTLEDVLNATGQVIEKTT 389
G+SE+E + E+++ G + G EGKL++F GGE+LTL+DVLNATGQV+EKT
Sbjct: 352 GSGESEDELNDEEEDDEENGGNAIGGAG--EGKLMLFAGGENLTLDDVLNATGQVLEKTC 409
Query: 390 YGTAYKAKLADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEK 449
YGTAYKAKLADG TIALRLLREGSCKD++SCL VI+QLGK+RHENLIPLRAFYQGKRGEK
Sbjct: 410 YGTAYKAKLADGGTIALRLLREGSCKDKASCLSVIKQLGKIRHENLIPLRAFYQGKRGEK 469
Query: 450 LLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRS 509
LLIYDY P RTLHDLLH+ AGKPVLNWARRHKIALGIARGLAYLHTG E+P+TH NVRS
Sbjct: 470 LLIYDYLPLRTLHDLLHEAKAGKPVLNWARRHKIALGIARGLAYLHTGLEVPVTHANVRS 529
Query: 510 KNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKADGYKAPELQRMKKCSSRTDVYAFG 569
KNVLVDDFF +RLT+FGLD+LM+P++ADEMVALAK DGYKAPELQRMKKC+SRTDVYAFG
Sbjct: 530 KNVLVDDFFTARLTDFGLDKLMIPSIADEMVALAKTDGYKAPELQRMKKCNSRTDVYAFG 589
Query: 570 ILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIRSPMEEGLVQA 629
ILLLEILIGKKPGK+GRNGE+VDLPS+VKVAVLEETTMEVFD+E++KGIRSPME+GLVQA
Sbjct: 590 ILLLEILIGKKPGKNGRNGEYVDLPSMVKVAVLEETTMEVFDVELLKGIRSPMEDGLVQA 649
Query: 630 LKLAMGCCAPVASVRPTMDEVVKQLEENRPRNRSALYSPTETRSEIGTPF 679
LKLAMGCCAPVASVRP+MDEVV+QLEENRPRNRSALYSPTETRS TPF
Sbjct: 650 LKLAMGCCAPVASVRPSMDEVVRQLEENRPRNRSALYSPTETRSGSVTPF 699
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449475529|ref|XP_004154481.1| PREDICTED: LOW QUALITY PROTEIN: putative kinase-like protein TMKL1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 998 bits (2579), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 514/649 (79%), Positives = 586/649 (90%), Gaps = 6/649 (0%)
Query: 32 DVELLLGKIKSSLQGDDENLLLSSWNISVPLCQWRGLKWISTNGSPLSCSDISLPQWANL 91
DV+LLLGKI++SL+GD +NLLLSSWN SVPLCQWRGLKW+ T G+PL C+ S PQW+NL
Sbjct: 86 DVQLLLGKIRASLEGDTQNLLLSSWNYSVPLCQWRGLKWVFTTGTPLVCTAASSPQWSNL 145
Query: 92 SLYKDSSIHLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSE 151
+L+KD S+H+LS+QLPSANLTGSLP+ELGEF+MLQSLYL++NSL GTIP ELGYSSSLS+
Sbjct: 146 TLFKDPSLHVLSLQLPSANLTGSLPKELGEFTMLQSLYLSINSLTGTIPLELGYSSSLSD 205
Query: 152 IDLSANLFTGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKF 211
IDLS+NL TGVL PSIWNLCD+LVS+RLHGNSL+ +LPEPALPNSTC +L+ LDLG+N+
Sbjct: 206 IDLSSNLLTGVLPPSIWNLCDKLVSVRLHGNSLSGSLPEPALPNSTCRNLEALDLGNNQI 265
Query: 212 SGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRLSLEKLNLSHNNFSGVLPVFSESKFG 271
SG+FPEFVTRF LKELD+ NL SG IP+ L +L LEKLNLS+NNFSG+LPVFS SKFG
Sbjct: 266 SGTFPEFVTRFPGLKELDLGKNLLSGQIPQSLGQLELEKLNLSNNNFSGILPVFSNSKFG 325
Query: 272 AEVFEGNSPALCGFPLRDCSGNSRLSSGAIAGLVIGLMTGAVVFASLLIGYVQNKKRKNR 331
E FEGNSP LCG PL+ C+ S LSSGAIAGLVIGLMTG VV ASLLIGY+QNKK+K+
Sbjct: 326 VEAFEGNSPGLCGEPLKSCAVPSHLSSGAIAGLVIGLMTGTVVLASLLIGYMQNKKKKSS 385
Query: 332 GDSEEEFEEGEDEENGMSGGSAAGGAGGEGKLIIFQGGEHLTLEDVLNATGQVIEKTTYG 391
+SE+E +EGEDEENG S G+ EGKLI+F+GGE+LTL+DVLNATGQV+EKT+YG
Sbjct: 386 SESEDENDEGEDEENGGSVGAGG-----EGKLILFEGGENLTLDDVLNATGQVMEKTSYG 440
Query: 392 TAYKAKLADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLL 451
T YKAKLADG TIALRLLREGSCKDR+SCL VI+QLGK+RHENLIPLRAFYQGKRGEKLL
Sbjct: 441 TIYKAKLADGGTIALRLLREGSCKDRNSCLSVIKQLGKIRHENLIPLRAFYQGKRGEKLL 500
Query: 452 IYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKN 511
IYDY RTLHD LH++ AGKPVLNWARRHKIALGIARGLA+LHTG E+PITHGN+RSKN
Sbjct: 501 IYDYLSIRTLHDFLHESRAGKPVLNWARRHKIALGIARGLAHLHTGLEVPITHGNIRSKN 560
Query: 512 VLVDDF-FVSRLTEFGLDQLMVPAVADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGI 570
VLVDD F RLTEFGLD+LM+P+VADE+V+LAK+DGYKAPELQRMKKC+SRTDVYAFGI
Sbjct: 561 VLVDDHSFAVRLTEFGLDKLMIPSVADEIVSLAKSDGYKAPELQRMKKCNSRTDVYAFGI 620
Query: 571 LLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIRSPMEEGLVQAL 630
LLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTM+VFD+E++KGIRSPME+G+VQAL
Sbjct: 621 LLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMDVFDVEVLKGIRSPMEDGIVQAL 680
Query: 631 KLAMGCCAPVASVRPTMDEVVKQLEENRPRNRSALYSPTETRSEIGTPF 679
KLAMGCCAPVASVRP++DEVVKQLEENRPRNRSALYSPTETRSE GTPF
Sbjct: 681 KLAMGCCAPVASVRPSIDEVVKQLEENRPRNRSALYSPTETRSENGTPF 729
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449443907|ref|XP_004139717.1| PREDICTED: putative kinase-like protein TMKL1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 998 bits (2579), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 513/649 (79%), Positives = 586/649 (90%), Gaps = 6/649 (0%)
Query: 32 DVELLLGKIKSSLQGDDENLLLSSWNISVPLCQWRGLKWISTNGSPLSCSDISLPQWANL 91
DV+LLLGKI++SL+GD +NLLLSSWN SVPLCQWRGLKW+ T G+PL C+ S PQW+NL
Sbjct: 69 DVQLLLGKIRASLEGDTQNLLLSSWNYSVPLCQWRGLKWVFTTGTPLVCTAASSPQWSNL 128
Query: 92 SLYKDSSIHLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSE 151
+L+KD S+H+LS+QLPSANLTGSLP+ELGEF+MLQSLYL++NSL GTIP ELGYSSSLS+
Sbjct: 129 TLFKDPSLHVLSLQLPSANLTGSLPKELGEFTMLQSLYLSINSLTGTIPLELGYSSSLSD 188
Query: 152 IDLSANLFTGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKF 211
IDLS+NL TGVL PSIWNLCD+LVS+RLHGNSL+ +LPEPALPNSTC +L+ LDLG+N+
Sbjct: 189 IDLSSNLLTGVLPPSIWNLCDKLVSVRLHGNSLSGSLPEPALPNSTCRNLEALDLGNNQI 248
Query: 212 SGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRLSLEKLNLSHNNFSGVLPVFSESKFG 271
SG+FPEFV+RF LKELD+ NL SG IP+ L +L LEKLNLS+NNFSG+LPVFS SKFG
Sbjct: 249 SGTFPEFVSRFPGLKELDLGKNLLSGQIPQSLGQLELEKLNLSNNNFSGILPVFSNSKFG 308
Query: 272 AEVFEGNSPALCGFPLRDCSGNSRLSSGAIAGLVIGLMTGAVVFASLLIGYVQNKKRKNR 331
E FEGNSP LCG PL+ C+ S LSSGAIAGLVIGLMTG VV ASLLIGY+QNKK+K+
Sbjct: 309 VEAFEGNSPGLCGEPLKSCAVPSHLSSGAIAGLVIGLMTGTVVLASLLIGYMQNKKKKSS 368
Query: 332 GDSEEEFEEGEDEENGMSGGSAAGGAGGEGKLIIFQGGEHLTLEDVLNATGQVIEKTTYG 391
+SE+E +EGEDEENG S G+ EGKLI+F+GGE+LTL+DVLNATGQV+EKT+YG
Sbjct: 369 SESEDENDEGEDEENGGSVGAGG-----EGKLILFEGGENLTLDDVLNATGQVMEKTSYG 423
Query: 392 TAYKAKLADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLL 451
T YKAKLADG TIALRLLREGSCKDR+SCL VI+QLGK+RHENLIPLRAFYQGKRGEKLL
Sbjct: 424 TIYKAKLADGGTIALRLLREGSCKDRNSCLSVIKQLGKIRHENLIPLRAFYQGKRGEKLL 483
Query: 452 IYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKN 511
IYDY RTLHD LH++ AGKPVLNWARRHKIALGIARGLA+LHTG E+PITHGN+RSKN
Sbjct: 484 IYDYLSIRTLHDFLHESRAGKPVLNWARRHKIALGIARGLAHLHTGLEVPITHGNIRSKN 543
Query: 512 VLVDDF-FVSRLTEFGLDQLMVPAVADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGI 570
VLVDD F RLTEFGLD+LM+P+VADE+V+LAK+DGYKAPELQRMKKC+SRTDVYAFGI
Sbjct: 544 VLVDDHSFAVRLTEFGLDKLMIPSVADEIVSLAKSDGYKAPELQRMKKCNSRTDVYAFGI 603
Query: 571 LLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIRSPMEEGLVQAL 630
LLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTM+VFD+E++KGIRSPME+G+VQAL
Sbjct: 604 LLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMDVFDVEVLKGIRSPMEDGIVQAL 663
Query: 631 KLAMGCCAPVASVRPTMDEVVKQLEENRPRNRSALYSPTETRSEIGTPF 679
KLAMGCCAPVASVRP++DEVVKQLEENRPRNRSALYSPTETRSE GTPF
Sbjct: 664 KLAMGCCAPVASVRPSIDEVVKQLEENRPRNRSALYSPTETRSENGTPF 712
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297831322|ref|XP_002883543.1| hypothetical protein ARALYDRAFT_342637 [Arabidopsis lyrata subsp. lyrata] gi|297329383|gb|EFH59802.1| hypothetical protein ARALYDRAFT_342637 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 982 bits (2538), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 505/671 (75%), Positives = 578/671 (86%), Gaps = 7/671 (1%)
Query: 10 YIVFFFCLTESLASSSPASASSDVELLLGKIKSSLQGDDENLLLSSWNISVPLCQWRGLK 69
+++FFF L + S SSDV+LLLGKIKSSLQG+ E+LLLSSWN SVP+CQWRG+K
Sbjct: 10 HVIFFFVLILHCHYGTSLSGSSDVKLLLGKIKSSLQGNSESLLLSSWNSSVPVCQWRGVK 69
Query: 70 WISTNGSPLSCSDISLPQWANLSLYKDSSIHLLSIQLPSANLTGSLPRELGEFSMLQSLY 129
W+ +NGSPL CSD+S PQW N SLY DSS+HLLS+QLPSANLTGSLPRE+GEFSMLQS++
Sbjct: 70 WVFSNGSPLQCSDLSSPQWTNNSLYNDSSLHLLSLQLPSANLTGSLPREIGEFSMLQSVF 129
Query: 130 LNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNSLTAALP 189
LN+NSL G+IP ELGY+SSLS++DLS N GVL PSIWNLCD+LVS ++HGN+L+ LP
Sbjct: 130 LNINSLSGSIPLELGYTSSLSDVDLSGNALAGVLPPSIWNLCDKLVSFKIHGNNLSGVLP 189
Query: 190 EPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRLSLE 249
EPALPNSTCS+LQ LDLG NKFSG FPEF+TRF+ LK LD+S+N+F G +PEGL L LE
Sbjct: 190 EPALPNSTCSNLQVLDLGGNKFSGEFPEFITRFKGLKSLDLSSNVFEGLVPEGLGVLQLE 249
Query: 250 KLNLSHNNFSGVLPVFSESKFGAEVFEGNSPALCGFPLRDCSGNSRLSSGAIAGLVIGLM 309
LNLSHNNFSG+LP F ESKFGAE FEGNSP+LCG PL+ C G+SRLS GA+AGLVIGLM
Sbjct: 250 SLNLSHNNFSGMLPDFGESKFGAESFEGNSPSLCGLPLKPCLGSSRLSPGAVAGLVIGLM 309
Query: 310 TGAVVFASLLIGYVQNKKRKNRGDSEEEFEEGEDEENGMSGGSAAGGAGGEGKLIIFQGG 369
+GAVV ASLLIGY+QNKKRK+ E +D E G GGEGKLI+FQGG
Sbjct: 310 SGAVVVASLLIGYLQNKKRKS------SIESEDDLEEGDEEDEIGEKEGGEGKLIVFQGG 363
Query: 370 EHLTLEDVLNATGQVIEKTTYGTAYKAKLADGATIALRLLREGSCKDRSSCLPVIRQLGK 429
E+LTL+DVLNATGQV+EKT+YGT YKAKL DG IALRLLREG+CKDRSSCLPVIRQLG+
Sbjct: 364 ENLTLDDVLNATGQVMEKTSYGTVYKAKLIDGGNIALRLLREGTCKDRSSCLPVIRQLGR 423
Query: 430 VRHENLIPLRAFYQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIAR 489
+RHENL+PLRAFYQGKRGEKLLIYDY P+ +LHDLLH++ GKP LNWARRHKIALGIAR
Sbjct: 424 IRHENLVPLRAFYQGKRGEKLLIYDYLPNISLHDLLHESKPGKPALNWARRHKIALGIAR 483
Query: 490 GLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKADGYK 549
GLAYLHTG E+PI HGN+RSKNVLVDDFF +RLTEFGLD++MV AVADE+V+ AK+DGYK
Sbjct: 484 GLAYLHTGQEVPIIHGNIRSKNVLVDDFFYARLTEFGLDKIMVQAVADEIVSQAKSDGYK 543
Query: 550 APELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNG-EFVDLPSIVKVAVLEETTME 608
APEL +MKKC+ R+DVYAFGILLLEIL+GKKPGKSGRNG EFVDLPS+VK AVLEETTME
Sbjct: 544 APELHKMKKCNPRSDVYAFGILLLEILMGKKPGKSGRNGNEFVDLPSLVKAAVLEETTME 603
Query: 609 VFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRPRNRSALYSP 668
VFD+E MKGIRSPMEEGLV ALKLAMGCCAPV +VRPTM+EVVKQLEENRPRNRSALYSP
Sbjct: 604 VFDLEAMKGIRSPMEEGLVHALKLAMGCCAPVTTVRPTMEEVVKQLEENRPRNRSALYSP 663
Query: 669 TETRSEIGTPF 679
TETRS+ TPF
Sbjct: 664 TETRSDAETPF 674
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15230141|ref|NP_189109.1| putative kinase-like protein TMKL1 [Arabidopsis thaliana] gi|464900|sp|P33543.1|TMKL1_ARATH RecName: Full=Putative kinase-like protein TMKL1; Flags: Precursor gi|313190|emb|CAA51385.1| TMKL1 [Arabidopsis thaliana] gi|9279794|dbj|BAB01215.1| receptor kinase [Arabidopsis thaliana] gi|20259336|gb|AAM13993.1| putative kinase TMKL1 precursor [Arabidopsis thaliana] gi|332643413|gb|AEE76934.1| putative kinase-like protein TMKL1 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 974 bits (2519), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 499/671 (74%), Positives = 577/671 (85%), Gaps = 7/671 (1%)
Query: 10 YIVFFFCLTESLASSSPASASSDVELLLGKIKSSLQGDDENLLLSSWNISVPLCQWRGLK 69
+++FFF L + S SSDV+LLLGKIKSSLQG+ E+LLLSSWN SVP+CQWRG+K
Sbjct: 10 HVIFFFVLILHCHCGTSLSGSSDVKLLLGKIKSSLQGNSESLLLSSWNSSVPVCQWRGVK 69
Query: 70 WISTNGSPLSCSDISLPQWANLSLYKDSSIHLLSIQLPSANLTGSLPRELGEFSMLQSLY 129
W+ +NGSPL CSD+S PQW N SL+ DSS+HLLS+QLPSANLTGSLPRE+GEFSMLQS++
Sbjct: 70 WVFSNGSPLQCSDLSSPQWTNTSLFNDSSLHLLSLQLPSANLTGSLPREIGEFSMLQSVF 129
Query: 130 LNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNSLTAALP 189
LN+NSL G+IP ELGY+SSLS++DLS N GVL PSIWNLCD+LVS ++HGN+L+ LP
Sbjct: 130 LNINSLSGSIPLELGYTSSLSDVDLSGNALAGVLPPSIWNLCDKLVSFKIHGNNLSGVLP 189
Query: 190 EPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRLSLE 249
EPALPNSTC +LQ LDLG NKFSG FPEF+TRF+ +K LD+S+N+F G +PEGL L LE
Sbjct: 190 EPALPNSTCGNLQVLDLGGNKFSGEFPEFITRFKGVKSLDLSSNVFEGLVPEGLGVLELE 249
Query: 250 KLNLSHNNFSGVLPVFSESKFGAEVFEGNSPALCGFPLRDCSGNSRLSSGAIAGLVIGLM 309
LNLSHNNFSG+LP F ESKFGAE FEGNSP+LCG PL+ C G+SRLS GA+AGLVIGLM
Sbjct: 250 SLNLSHNNFSGMLPDFGESKFGAESFEGNSPSLCGLPLKPCLGSSRLSPGAVAGLVIGLM 309
Query: 310 TGAVVFASLLIGYVQNKKRKNRGDSEEEFEEGEDEENGMSGGSAAGGAGGEGKLIIFQGG 369
+GAVV ASLLIGY+QNKKRK+ E +D E G GGEGKL++FQGG
Sbjct: 310 SGAVVVASLLIGYLQNKKRKS------SIESEDDLEEGDEEDEIGEKEGGEGKLVVFQGG 363
Query: 370 EHLTLEDVLNATGQVIEKTTYGTAYKAKLADGATIALRLLREGSCKDRSSCLPVIRQLGK 429
E+LTL+DVLNATGQV+EKT+YGT YKAKL+DG IALRLLREG+CKDRSSCLPVIRQLG+
Sbjct: 364 ENLTLDDVLNATGQVMEKTSYGTVYKAKLSDGGNIALRLLREGTCKDRSSCLPVIRQLGR 423
Query: 430 VRHENLIPLRAFYQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIAR 489
+RHENL+PLRAFYQGKRGEKLLIYDY P+ +LHDLLH++ KP LNWARRHKIALGIAR
Sbjct: 424 IRHENLVPLRAFYQGKRGEKLLIYDYLPNISLHDLLHESKPRKPALNWARRHKIALGIAR 483
Query: 490 GLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKADGYK 549
GLAYLHTG E+PI HGN+RSKNVLVDDFF +RLTEFGLD++MV AVADE+V+ AK+DGYK
Sbjct: 484 GLAYLHTGQEVPIIHGNIRSKNVLVDDFFFARLTEFGLDKIMVQAVADEIVSQAKSDGYK 543
Query: 550 APELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNG-EFVDLPSIVKVAVLEETTME 608
APEL +MKKC+ R+DVYAFGILLLEIL+GKKPGKSGRNG EFVDLPS+VK AVLEETTME
Sbjct: 544 APELHKMKKCNPRSDVYAFGILLLEILMGKKPGKSGRNGNEFVDLPSLVKAAVLEETTME 603
Query: 609 VFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRPRNRSALYSP 668
VFD+E MKGIRSPMEEGLV ALKLAMGCCAPV +VRP+M+EVVKQLEENRPRNRSALYSP
Sbjct: 604 VFDLEAMKGIRSPMEEGLVHALKLAMGCCAPVTTVRPSMEEVVKQLEENRPRNRSALYSP 663
Query: 669 TETRSEIGTPF 679
TETRS+ TPF
Sbjct: 664 TETRSDAETPF 674
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356524541|ref|XP_003530887.1| PREDICTED: putative kinase-like protein TMKL1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 964 bits (2492), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 478/635 (75%), Positives = 557/635 (87%), Gaps = 5/635 (0%)
Query: 32 DVELLLGKIKSSLQGDD-ENLLLSSWNISVPLCQWRGLKWISTNGSPLSCSDISLPQWAN 90
DV+LLLGKIK+SLQG + +NL+LSSWN S PLCQW GLKW+ +NG+PLSC+D+S PQW N
Sbjct: 55 DVQLLLGKIKASLQGSNSDNLVLSSWNSSTPLCQWSGLKWVFSNGTPLSCTDLSSPQWTN 114
Query: 91 LSLYKDSSIHLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLS 150
L+L+KD S+HLLS++LPSANL+GSLPRELG F MLQSLYLN+NSL+GTIP ELGYSSSLS
Sbjct: 115 LTLHKDPSLHLLSLRLPSANLSGSLPRELGGFPMLQSLYLNINSLEGTIPLELGYSSSLS 174
Query: 151 EIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNK 210
EIDL N+ +GVL PSIWNLC+RLVSLRLHGNSL+ ++ EPALPNS+C ++Q LDLG NK
Sbjct: 175 EIDLGDNMLSGVLPPSIWNLCERLVSLRLHGNSLSGSVSEPALPNSSCKNMQLLDLGGNK 234
Query: 211 FSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRLSLEKLNLSHNNFSGVLPVFS-ESK 269
FSGSFPEF+T+F LK+LD+ NN+F G+IP+GLT L LEKLNLSHNNFSGVLP+F ESK
Sbjct: 235 FSGSFPEFITKFGGLKQLDLGNNMFMGTIPQGLTGLRLEKLNLSHNNFSGVLPLFGGESK 294
Query: 270 FGAEVFEGNSPALCGFPLRDCSGNSRLSSGAIAGLVIGLMTGAVVFASLLIGYVQNKKRK 329
FG + FEGNSP+LCG PL C+ S LSSGA+AG+VI LMTGAVV ASLLIGY+QNKKR+
Sbjct: 295 FGVDAFEGNSPSLCGPPLGSCARTSTLSSGAVAGIVISLMTGAVVLASLLIGYMQNKKRE 354
Query: 330 NRGDSEEEFEEGEDEENGMSGGSAAGGAGGEGKLIIFQGGEHLTLEDVLNATGQVIEKTT 389
G+SE+E + E+++ G + G EGKL++F GGE LTL+DVLNATGQV+EKT
Sbjct: 355 GSGESEDELNDEEEDDEDNGGNAIGGAG--EGKLMLFAGGESLTLDDVLNATGQVLEKTC 412
Query: 390 YGTAYKAKLADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEK 449
YGTAYKAKLA+G TIALRLLREGSCKD++SCL VIRQLGK+RHENLIPLRAFYQGKRGEK
Sbjct: 413 YGTAYKAKLAEGGTIALRLLREGSCKDKASCLSVIRQLGKIRHENLIPLRAFYQGKRGEK 472
Query: 450 LLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRS 509
LLIYDY P RTLHDLLH+ AGKPVLNWARRHKIALG+ARGLAYLHTG E+P+TH NVRS
Sbjct: 473 LLIYDYLPLRTLHDLLHEAKAGKPVLNWARRHKIALGMARGLAYLHTGLEVPVTHANVRS 532
Query: 510 KNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKADGYKAPELQRMKKCSSRTDVYAFG 569
KNVLVDDFF +RLT+FGLD+LM+P++ADEMVALAK DGYKAPELQRMKKC+SRTDVYAFG
Sbjct: 533 KNVLVDDFFAARLTDFGLDKLMIPSIADEMVALAKTDGYKAPELQRMKKCNSRTDVYAFG 592
Query: 570 ILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIRSPMEEGLVQA 629
ILLLEILIGKKPGK+GRNGE+VDLPS+VKVAVLEETTMEVFD+E++KGIRSPME+GLVQA
Sbjct: 593 ILLLEILIGKKPGKNGRNGEYVDLPSMVKVAVLEETTMEVFDVELLKGIRSPMEDGLVQA 652
Query: 630 LKLAMGCCAPVASVRPTMD-EVVKQLEENRPRNRS 663
LKLAMGCCAPVASVRPT+ + V+ L P N +
Sbjct: 653 LKLAMGCCAPVASVRPTLQKQEVEVLPHFEPFNST 687
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147833136|emb|CAN75299.1| hypothetical protein VITISV_008676 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 952 bits (2462), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 490/648 (75%), Positives = 546/648 (84%), Gaps = 60/648 (9%)
Query: 33 VELLLGKIKSSLQGD-DENLLLSSWNISVPLCQWRGLKWISTNGSPLSCSDISLPQWANL 91
VELLL KIK SLQG +NLLLSSWN SVPLCQWRGLKW+ +NGSPL C+D+S P W NL
Sbjct: 40 VELLLNKIKPSLQGSYSDNLLLSSWNTSVPLCQWRGLKWVFSNGSPLLCTDLSSPHWTNL 99
Query: 92 SLYKDSSIHLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSE 151
SL KD S+HLLS+QLPSANLTGSLP+ELGE S LQSLYLNVNSL GTIP ELGYS SLS+
Sbjct: 100 SLSKDPSLHLLSLQLPSANLTGSLPKELGELSALQSLYLNVNSLTGTIPLELGYSPSLSD 159
Query: 152 IDLSANLFTGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKF 211
+DL N +G L P+IWNLCDRLVSLRLH N L+ ++PEP LPNSTC++LQ+LDLG N+F
Sbjct: 160 LDLGNNQLSGALTPAIWNLCDRLVSLRLHANRLSGSVPEPVLPNSTCNNLQFLDLGDNQF 219
Query: 212 SGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRLSLEKLNLSHNNFSGVLPVFSESKFG 271
SGSFPEFVTRF+ LKELD+ NNLFSGSIPEGL +L+LEKLNLS+NNFSGVLPVF ESK G
Sbjct: 220 SGSFPEFVTRFDGLKELDLGNNLFSGSIPEGLAKLNLEKLNLSYNNFSGVLPVFGESKNG 279
Query: 272 AEVFEGNSPALCGFPLRDCSGNSRLSSGAIAGLVIGLMTGAVVFASLLIGYVQNKKRKNR 331
V+ KKRK+R
Sbjct: 280 ---------------------------------------------------VEGKKRKSR 288
Query: 332 GDSEEEFEEGEDEENGMSGGSAAGGAGGEGKLIIFQGGEHLTLEDVLNATGQVIEKTTYG 391
G++EEEFEEGED+ENG SGGS G+GKLI+FQGGEHLTLEDVLNATGQV+EKT+YG
Sbjct: 289 GENEEEFEEGEDDENG-SGGS------GDGKLILFQGGEHLTLEDVLNATGQVMEKTSYG 341
Query: 392 TAYKAKLADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLL 451
T YKAKLADG +IALRLLREGSCKD +SCLPVI+QLG+VRHENLIPLRAFYQGKRGEKLL
Sbjct: 342 TVYKAKLADGGSIALRLLREGSCKDSNSCLPVIKQLGRVRHENLIPLRAFYQGKRGEKLL 401
Query: 452 IYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKN 511
IYDY P+R+LHDLLH+T AGKPVLNWARRHKIALGIARGLA+LHT E PITHGNVRSKN
Sbjct: 402 IYDYLPNRSLHDLLHETRAGKPVLNWARRHKIALGIARGLAFLHT-VEAPITHGNVRSKN 460
Query: 512 VLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGIL 571
VL+D+FFV+RLTEFGLD++MVPAVADEMVALAK DGYKAPELQ+MKKC+SRTDVYAFGIL
Sbjct: 461 VLIDEFFVARLTEFGLDKVMVPAVADEMVALAKTDGYKAPELQKMKKCNSRTDVYAFGIL 520
Query: 572 LLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIRSPMEEGLVQALK 631
LLEILIGKKPGK+GR+G+FVDLPS+VKVAVLEETTMEVFD+E++KGIRSPMEEGLVQALK
Sbjct: 521 LLEILIGKKPGKNGRSGDFVDLPSMVKVAVLEETTMEVFDVEVLKGIRSPMEEGLVQALK 580
Query: 632 LAMGCCAPVASVRPTMDEVVKQLEENRPRNRSALYSPTETRSEIGTPF 679
LAMGCCAPVASVRPTMDEVVKQLEENRPRNRSALYSP+ETRSEIGTPF
Sbjct: 581 LAMGCCAPVASVRPTMDEVVKQLEENRPRNRSALYSPSETRSEIGTPF 628
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 679 | ||||||
| TAIR|locus:2093121 | 674 | TMKL1 "transmembrane kinase-li | 0.977 | 0.985 | 0.706 | 2.7e-258 | |
| TAIR|locus:2098267 | 836 | IMK2 "inflorescence meristem r | 0.851 | 0.691 | 0.324 | 9.2e-68 | |
| TAIR|locus:2198090 | 655 | RKL1 "receptor-like kinase 1" | 0.432 | 0.448 | 0.368 | 7.7e-66 | |
| TAIR|locus:2043858 | 658 | AT2G26730 [Arabidopsis thalian | 0.418 | 0.431 | 0.360 | 2e-65 | |
| TAIR|locus:2161308 | 654 | AT5G58300 [Arabidopsis thalian | 0.422 | 0.438 | 0.382 | 2.6e-65 | |
| TAIR|locus:2202359 | 670 | AT1G68400 [Arabidopsis thalian | 0.848 | 0.859 | 0.311 | 1.4e-64 | |
| TAIR|locus:2077898 | 640 | AT3G08680 [Arabidopsis thalian | 0.525 | 0.557 | 0.310 | 4.8e-62 | |
| TAIR|locus:2088500 | 647 | RLK902 "receptor-like kinase 9 | 0.792 | 0.831 | 0.313 | 6.6e-58 | |
| TAIR|locus:2044913 | 672 | AT2G36570 [Arabidopsis thalian | 0.425 | 0.430 | 0.352 | 3.7e-57 | |
| TAIR|locus:2005629 | 1140 | AT1G75640 [Arabidopsis thalian | 0.835 | 0.497 | 0.313 | 9.3e-55 |
| TAIR|locus:2093121 TMKL1 "transmembrane kinase-like 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2486 (880.2 bits), Expect = 2.7e-258, P = 2.7e-258
Identities = 474/671 (70%), Positives = 549/671 (81%)
Query: 10 YIVFFFCLTEXXXXXXXXXXXXDVELLLGKIKSSLQGDDENLLLSSWNISVPLCQWRGLK 69
+++FFF L DV+LLLGKIKSSLQG+ E+LLLSSWN SVP+CQWRG+K
Sbjct: 10 HVIFFFVLILHCHCGTSLSGSSDVKLLLGKIKSSLQGNSESLLLSSWNSSVPVCQWRGVK 69
Query: 70 WISTNGSPLSCSDISLPQWANLSLYKDSSIHLLSIQLPSANLTGSLPRELGEFSMLQSLY 129
W+ +NGSPL CSD+S PQW N SL+ DSS+HLLS+QLPSANLTGSLPRE+GEFSMLQS++
Sbjct: 70 WVFSNGSPLQCSDLSSPQWTNTSLFNDSSLHLLSLQLPSANLTGSLPREIGEFSMLQSVF 129
Query: 130 LNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNSLTAALP 189
LN+NSL G+IP ELGY+SSLS++DLS N GVL PSIWNLCD+LVS ++HGN+L+ LP
Sbjct: 130 LNINSLSGSIPLELGYTSSLSDVDLSGNALAGVLPPSIWNLCDKLVSFKIHGNNLSGVLP 189
Query: 190 EPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRLSLE 249
EPALPNSTC +LQ LDLG NKFSG FPEF+TRF+ +K LD+S+N+F G +PEGL L LE
Sbjct: 190 EPALPNSTCGNLQVLDLGGNKFSGEFPEFITRFKGVKSLDLSSNVFEGLVPEGLGVLELE 249
Query: 250 KLNLSHNNFSGVLPVFSESKFGAEVFEGNSPALCGFPLRDCSGNSRLSSGAIAGLVIGLM 309
LNLSHNNFSG+LP F ESKFGAE FEGNSP+LCG PL+ C G+SRLS GA+AGLVIGLM
Sbjct: 250 SLNLSHNNFSGMLPDFGESKFGAESFEGNSPSLCGLPLKPCLGSSRLSPGAVAGLVIGLM 309
Query: 310 TGAVVFASLLIGYVQNKKRKNRXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXKLIIFQGG 369
+GAVV ASLLIGY+QNKKRK+ KL++FQGG
Sbjct: 310 SGAVVVASLLIGYLQNKKRKS------SIESEDDLEEGDEEDEIGEKEGGEGKLVVFQGG 363
Query: 370 EHLTLEDVLNATGQVIEKTTYGTAYKAKLADGATIALRLLREGSCKDRSSCLPVIRQLGK 429
E+LTL+DVLNATGQV+EKT+YGT YKAKL+DG IALRLLREG+CKDRSSCLPVIRQLG+
Sbjct: 364 ENLTLDDVLNATGQVMEKTSYGTVYKAKLSDGGNIALRLLREGTCKDRSSCLPVIRQLGR 423
Query: 430 VRHENLIPLRAFYQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIAR 489
+RHENL+PLRAFYQGKRGEKLLIYDY P+ +LHDLLH++ KP LNWARRHKIALGIAR
Sbjct: 424 IRHENLVPLRAFYQGKRGEKLLIYDYLPNISLHDLLHESKPRKPALNWARRHKIALGIAR 483
Query: 490 GLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKADGYK 549
GLAYLHTG E+PI HGN+RSKNVLVDDFF +RLTEFGLD++MV AVADE+V+ AK+DGYK
Sbjct: 484 GLAYLHTGQEVPIIHGNIRSKNVLVDDFFFARLTEFGLDKIMVQAVADEIVSQAKSDGYK 543
Query: 550 APELQRMKKCSSRTDVYAFXXXXXXXXXXXXXXXSGRNG-EFVDLPSIVKVAVLEETTME 608
APEL +MKKC+ R+DVYAF SGRNG EFVDLPS+VK AVLEETTME
Sbjct: 544 APELHKMKKCNPRSDVYAFGILLLEILMGKKPGKSGRNGNEFVDLPSLVKAAVLEETTME 603
Query: 609 VFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRPRNRSALYSP 668
VFD+E MKGIRSPMEEGLV ALKLAMGCCAPV +VRP+M+EVVKQLEENRPRNRSALYSP
Sbjct: 604 VFDLEAMKGIRSPMEEGLVHALKLAMGCCAPVTTVRPSMEEVVKQLEENRPRNRSALYSP 663
Query: 669 TETRSEIGTPF 679
TETRS+ TPF
Sbjct: 664 TETRSDAETPF 674
|
|
| TAIR|locus:2098267 IMK2 "inflorescence meristem receptor-like kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 688 (247.2 bits), Expect = 9.2e-68, P = 9.2e-68
Identities = 199/614 (32%), Positives = 298/614 (48%)
Query: 74 NGS-PLSCSDISLPQWAN---LSLYKDSSIHLLSIQLPSANLTGSLPRELGEFSMLQSLY 129
NGS PL ++ +++ +SL K S + +SI L+GS+PRE G LQSL
Sbjct: 236 NGSHPLKTLNLDHNRFSGAVPVSLCKHSLLEEVSIS--HNQLSGSIPRECGGLPHLQSLD 293
Query: 130 LNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNSLTAALP 189
+ NS+ GTIP SSL ++L +N G + +I L L L L N + +P
Sbjct: 294 FSYNSINGTIPDSFSNLSSLVSLNLESNHLKGPIPDAIDRL-HNLTELNLKRNKINGPIP 352
Query: 190 EPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRLSLE 249
E + N S ++ LDL N F+G P + L ++S N SG +P L++
Sbjct: 353 E-TIGN--ISGIKKLDLSENNFTGPIPLSLVHLAKLSSFNVSYNTLSGPVPPVLSK---- 405
Query: 250 KLNLSHNNFSGVLPVFSESKFGAEVFEGNSPALCGFPLRDCSGNS----RLSSGAIAGLV 305
K N S +F G + + S + L P +LS + +
Sbjct: 406 KFNSS--SFLGNIQLCGYSSSNPCPAPDHHHPLTLSPTSSQEPRKHHHRKLSVKDVILIA 463
Query: 306 IGLMTGAVVFASLLIGYVQNKKRKNRXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXKLII 365
IG + ++ ++ KKR KL+
Sbjct: 464 IGALLAILLLLCCILLCCLIKKRAALKQKDGKDKTSEKTVSAGVAGTASAGGEMGGKLVH 523
Query: 366 FQGGEHLTLEDVLNATGQVIEKTTYGTAYKAKLADGATIALRLLREGSCKDRSSCLPVIR 425
F G T +D+L AT +++ K+TYGTAYKA L DG +A++ LRE + K +
Sbjct: 524 FDGPFVFTADDLLCATAEIMGKSTYGTAYKATLEDGNEVAVKRLREKTTKGVKEFEGEVT 583
Query: 426 QLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIAL 485
LGK+RH+NL+ LRA+Y G +GEKLL++DY +L LH + ++ W R KIA
Sbjct: 584 ALGKIRHQNLLALRAYYLGPKGEKLLVFDYMSKGSLSAFLHAR-GPETLIPWETRMKIAK 642
Query: 486 GIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKA 545
GI+RGLA+LH+ + H N+ + N+L+D+ + + ++GL +LM A A ++A A
Sbjct: 643 GISRGLAHLHSNENM--IHENLTASNILLDEQTNAHIADYGLSRLMTAAAATNVIATAGT 700
Query: 546 DGYKAPELQRMKKCSSRTDVYAFXXXXXXXXXXXXXXXSGRNGEFVDLPSIVKVAVLEET 605
GY+APE ++K S++TDVY+ NG +DLP V V EE
Sbjct: 701 LGYRAPEFSKIKNASAKTDVYSLGIIILELLTGKSPGEP-TNG--MDLPQWVASIVKEEW 757
Query: 606 TMEVFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRPRNRSAL 665
T EVFD+E+M+ +S +E L+ LKLA+ C P + RP ++VV+QLEE RP
Sbjct: 758 TNEVFDLELMRETQSVGDE-LLNTLKLALHCVDPSPAARPEANQVVEQLEEIRPE----- 811
Query: 666 YSPTETRSEIGTPF 679
TE +E TPF
Sbjct: 812 ---TEVETET-TPF 821
|
|
| TAIR|locus:2198090 RKL1 "receptor-like kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 462 (167.7 bits), Expect = 7.7e-66, Sum P(2) = 7.7e-66
Identities = 112/304 (36%), Positives = 170/304 (55%)
Query: 362 KLIIFQGGEHL-TLEDVLNATGQVIEKTTYGTAYKAKLADGATIALRLLREGSCKDRSSC 420
KL+ F + LED+L A+ +V+ K T+GTAYKA L +A++ L++ D+
Sbjct: 353 KLVFFGNATKVFDLEDLLRASAEVLGKGTFGTAYKAVLDAVTVVAVKRLKDVMMADKEF- 411
Query: 421 LPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRTLHDLLHDTI-AGKPVLNWAR 479
I +G + HENL+PLRA+Y R EKLL+YD+ P +L LLH AG+ LNW
Sbjct: 412 KEKIELVGAMDHENLVPLRAYYFS-RDEKLLVYDFMPMGSLSALLHGNRGAGRSPLNWDV 470
Query: 480 RHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEM 539
R +IA+G ARGL YLH+ +HGN++S N+L+ +++++FGL QL+ + +
Sbjct: 471 RSRIAIGAARGLDYLHS-QGTSTSHGNIKSSNILLTKSHDAKVSDFGLAQLVGSSATNPN 529
Query: 540 VALAKADGYKAPELQRMKKCSSRTDVYAFXXXXXXXXXXXXXXXSGRNGEFVDLPSIVKV 599
+A GY+APE+ K+ S + DVY+F S N E VDLP VK
Sbjct: 530 ----RATGYRAPEVTDPKRVSQKGDVYSFGVVLLELITGKAPSNSVMNEEGVDLPRWVKS 585
Query: 600 AVLEETTMEVFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRP 659
+E EVFD E++ + + EE + + ++L + C + RP M EVV+++E RP
Sbjct: 586 VARDEWRREVFDSELLS-LATDEEEMMAEMVQLGLECTSQHPDQRPEMSEVVRKMENLRP 644
Query: 660 RNRS 663
+ S
Sbjct: 645 YSGS 648
|
|
| TAIR|locus:2043858 AT2G26730 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 462 (167.7 bits), Expect = 2.0e-65, Sum P(2) = 2.0e-65
Identities = 109/302 (36%), Positives = 179/302 (59%)
Query: 362 KLIIFQGGEH-LTLEDVLNATGQVIEKTTYGTAYKAKLADGATIALRLLRE--GSCKDRS 418
KL+ +GG + LED+L A+ +V+ K + GT+YKA L +G T+ ++ L++ S K+
Sbjct: 333 KLVFTEGGVYSFDLEDLLRASAEVLGKGSVGTSYKAVLEEGTTVVVKRLKDVMASKKEFE 392
Query: 419 SCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRTLHDLLHDTI-AGKPVLNW 477
+ + V+ GK++H N+IPLRA+Y K EKLL++D+ P+ +L LLH + +G+ L+W
Sbjct: 393 TQMEVV---GKIKHPNVIPLRAYYYSK-DEKLLVFDFMPTGSLSALLHGSRGSGRTPLDW 448
Query: 478 ARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVAD 537
R +IA+ ARGLA+LH ++ HGN+++ N+L+ + ++++GL+QL +
Sbjct: 449 DNRMRIAITAARGLAHLHVSAKL--VHGNIKASNILLHPNQDTCVSDYGLNQLFSNSSPP 506
Query: 538 EMVALAKADGYKAPELQRMKKCSSRTDVYAFXXXXXXXXXXXXXXXSGRNGEFVDLPSIV 597
+A GY APE+ +K + ++DVY+F + E +DLP V
Sbjct: 507 NRLA-----GYHAPEVLETRKVTFKSDVYSFGVLLLELLTGKSPNQASLGEEGIDLPRWV 561
Query: 598 KVAVLEETTMEVFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEE- 656
V EE T EVFD+E+M+ +EE +VQ L++AM C + V RP M EV++ +E+
Sbjct: 562 LSVVREEWTAEVFDVELMR--YHNIEEEMVQLLQIAMACVSTVPDQRPVMQEVLRMIEDV 619
Query: 657 NR 658
NR
Sbjct: 620 NR 621
|
|
| TAIR|locus:2161308 AT5G58300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 490 (177.5 bits), Expect = 2.6e-65, Sum P(2) = 2.6e-65
Identities = 115/301 (38%), Positives = 174/301 (57%)
Query: 362 KLIIFQGGEH-LTLEDVLNATGQVIEKTTYGTAYKAKLADGATIALRLLREGSCKDRS-- 418
KL+ F G + LED+L A+ +V+ K +YGTAYKA L + T+ ++ L+E + R
Sbjct: 340 KLVFFNGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTVVVKRLKEVAAGKREFE 399
Query: 419 SCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRTLHDLLHDTIAG-KPVLNW 477
+ +I ++G H +++PLRA+Y K EKL++ DY+P+ L LLH K L+W
Sbjct: 400 QQMEIISRVGN--HPSVVPLRAYYYSK-DEKLMVCDYYPAGNLSSLLHGNRGSEKTPLDW 456
Query: 478 ARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVAD 537
R KI L A+G+A+LH +HGN++S NV++ + +++FGL LM AV
Sbjct: 457 DSRVKITLSAAKGIAHLHAAGGPKFSHGNIKSSNVIMKQESDACISDFGLTPLM--AVP- 513
Query: 538 EMVALAKADGYKAPELQRMKKCSSRTDVYAFXXXXXXXXXXXXXXXSGRNGEFVDLPSIV 597
+A + GY+APE+ +K + ++DVY+F S + VDLP V
Sbjct: 514 --IAPMRGAGYRAPEVMETRKHTHKSDVYSFGVLILEMLTGKSPVQSPSRDDMVDLPRWV 571
Query: 598 KVAVLEETTMEVFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEEN 657
+ V EE T EVFD+E+M+ +EE +VQ L++AM C A V VRPTMD+VV+ +EE
Sbjct: 572 QSVVREEWTSEVFDIELMRF--QNIEEEMVQMLQIAMACVAQVPEVRPTMDDVVRMIEEI 629
Query: 658 R 658
R
Sbjct: 630 R 630
|
|
| TAIR|locus:2202359 AT1G68400 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 658 (236.7 bits), Expect = 1.4e-64, P = 1.4e-64
Identities = 193/620 (31%), Positives = 314/620 (50%)
Query: 53 LSSWNISVPLCQWRGLKWISTNGSPLSCSDISLPQWANLSLYKDSSIHLLSIQLPSANLT 112
L+SWN + CQW G+ + L DI+L + SL +S+ +LS++ NL+
Sbjct: 48 LNSWNTTTNPCQWTGVSCNRNRVTRLVLEDINLTGSIS-SLTSLTSLRVLSLK--HNNLS 104
Query: 113 GSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCD 172
G +P L + L+ L+L+ N G P + + L +DLS N F+G + P + +L
Sbjct: 105 GPIPN-LSNLTALKLLFLSNNQFSGNFPTSITSLTRLYRLDLSFNNFSGQIPPDLTDLT- 162
Query: 173 RLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISN 232
L++LRL N + +P N SDLQ ++ N F+G P +++F + + N
Sbjct: 163 HLLTLRLESNRFSGQIP-----NINLSDLQDFNVSGNNFNGQIPNSLSQFP--ESVFTQN 215
Query: 233 NLFSGSIPEGLTRLSLEKLNLSHNNFSGVLPVFSESKFGAEVFEGNSPALCGFPLRDCSG 292
G+ T+LS + + + P+ +K E + ++ G D S
Sbjct: 216 PSLCGAPLLKCTKLSSDPTKPGRPDEAKASPL---NK--PETVPSSPTSIHG---GDKSN 267
Query: 293 N-SRLSSGAIAGLVIGLMTGAVVFASLLI------GYVQNKKRKNRXXXXXXXXXXXXX- 344
N SR+S+ ++ +++G + F SLL+ Y NKK+ ++
Sbjct: 268 NTSRISTISLIAIILGDFI-ILSFVSLLLYYCFWRQYAVNKKKHSKILEGEKIVYSSNPY 326
Query: 345 -XXXXXXXXXXXXXXXXXKLIIFQGGEHLTLEDVLNATGQVIEKTTYGTAYKAKLADGAT 403
K++ F+G LED+L A+ +++ K +GTAYKA L DG
Sbjct: 327 PTSTQNNNNQNQQVGDKGKMVFFEGTRRFELEDLLRASAEMLGKGGFGTAYKAVLEDGNE 386
Query: 404 IALRLLREG-SCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRTLH 462
+A++ L++ + + + LG++RH NL+ L+A+Y R EKLL+YDY P+ +L
Sbjct: 387 VAVKRLKDAVTVAGKKEFEQQMEVLGRLRHTNLVSLKAYYFA-REEKLLVYDYMPNGSLF 445
Query: 463 DLLHDTIA-GKPVLNWARRHKIALGIARGLAYLHTGHE-IPITHGNVRSKNVLVDDFFVS 520
LLH G+ L+W R KIA G ARGLA++H + + +THG+++S NVL+D +
Sbjct: 446 WLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHGSCKTLKLTHGDIKSTNVLLDRSGNA 505
Query: 521 RLTEFGLDQLMVPAVADEMVALAKADGYKAPELQRMKKCSSRTDVYAFXXXXXXXXXXX- 579
R+++FGL + P+ +AK++GY+APEL +K + ++DVY+F
Sbjct: 506 RVSDFGLS-IFAPSQT-----VAKSNGYRAPELIDGRKHTQKSDVYSFGVLLLEILTGKC 559
Query: 580 -XXXXSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIRSPMEEGLVQALKLAMGCCA 638
+G +G VDLP V+ V EE T EVFD+E+M+ +EE +V L++AM C A
Sbjct: 560 PNMVETGHSGGAVDLPRWVQSVVREEWTAEVFDLELMR--YKDIEEEMVGLLQIAMACTA 617
Query: 639 PVASVRPTMDEVVKQLEENR 658
A RP M VVK +E+ R
Sbjct: 618 VAADHRPKMGHVVKLIEDIR 637
|
|
| TAIR|locus:2077898 AT3G08680 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 469 (170.2 bits), Expect = 4.8e-62, Sum P(2) = 4.8e-62
Identities = 114/367 (31%), Positives = 189/367 (51%)
Query: 296 LSSGAIAGLVIGLMTGAVVFASLLIGYVQNKKRKNRXXXXXXXXXXXXXXXXXXXXXXXX 355
LS+GAI G+ +G + +++ K+ +
Sbjct: 257 LSTGAIVGIAVGGSVLLFIILAIITLCCAKKRDGGQDSTAVPKAKPGRSDNKAEEFGSGV 316
Query: 356 XXXXXXKLIIFQGGEH-LTLEDVLNATGQVIEKTTYGTAYKAKLADGATIALRLLREGSC 414
KL+ F+G + LED+L A+ +V+ K +YGT YKA L +G T+ ++ L+E +
Sbjct: 317 QEAEKNKLVFFEGSSYNFDLEDLLRASAEVLGKGSYGTTYKAILEEGTTVVVKRLKEVAA 376
Query: 415 KDRSSCLPVIRQLGKVR-HENLIPLRAFYQGKRGEKLLIYDYFPSRTLHDLLH-DTIAGK 472
R + +G++ H N+ PLRA+Y K EKLL+YDY+ LLH + G+
Sbjct: 377 GKREF-EQQMEAVGRISPHVNVAPLRAYYFSK-DEKLLVYDYYQGGNFSMLLHGNNEGGR 434
Query: 473 PVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMV 532
L+W R +I L ARG++++H+ + HGN++S NVL+ +++FG+
Sbjct: 435 AALDWETRLRICLEAARGISHIHSASGAKLLHGNIKSPNVLLTQELHVCVSDFGI----A 490
Query: 533 PAVADEMVALAKADGYKAPELQRMKKCSSRTDVYAFXXXXXXXXXXXXXXXSGRNGEFVD 592
P ++ + +++ GY+APE +K + ++DVY+F + + E VD
Sbjct: 491 PLMSHHTLIPSRSLGYRAPEAIETRKHTQKSDVYSFGVLLLEMLTGKAAGKTTGHEEVVD 550
Query: 593 LPSIVKVAVLEETTMEVFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVK 652
LP V+ V EE T EVFD+E++K + +EE +VQ L++AM C + RP+M+EVV
Sbjct: 551 LPKWVQSVVREEWTGEVFDVELIKQQHN-VEEEMVQMLQIAMACVSKHPDSRPSMEEVVN 609
Query: 653 QLEENRP 659
+EE RP
Sbjct: 610 MMEEIRP 616
|
|
| TAIR|locus:2088500 RLK902 "receptor-like kinase 902" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 595 (214.5 bits), Expect = 6.6e-58, P = 6.6e-58
Identities = 183/584 (31%), Positives = 284/584 (48%)
Query: 103 SIQLPSANLTGSLPREL-GEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTG 161
+++LP L+G +P + G + L++L L +N L G++P +LG S L + L N F+G
Sbjct: 74 ALRLPGETLSGHIPEGIFGNLTQLRTLSLRLNGLTGSLPLDLGSCSDLRRLYLQGNRFSG 133
Query: 162 VLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTR 221
+ +++L + LV L L N + + N T YL+ +NK SGS +
Sbjct: 134 EIPEVLFSLSN-LVRLNLAENEFSGEISS-GFKNLTRLKTLYLE--NNKLSGSLLDLDL- 188
Query: 222 FEALKELDISNNLFSGSIPEGLTRLSLEKLNLSHNNFSGVLPVFS-ESKFGAE-VFEGNS 279
+L + ++SNNL +GSIP+ L + + + + L V S E ++ + GN
Sbjct: 189 --SLDQFNVSNNLLNGSIPKSLQKFDSDSF-VGTSLCGKPLVVCSNEGTVPSQPISVGNI 245
Query: 280 PALCGFPLRDCSGNSRLSSGAIAGLVIGLMTGAVVFASLLIGYVQNKKRKN--------- 330
P + +LS GAIAG+VIG + G + +L+ + K +
Sbjct: 246 PGTVEGS-EEKKKRKKLSGGAIAGIVIGCVVGLSLIVMILMVLFRKKGNERTRAIDLATI 304
Query: 331 ----------RXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXKLIIFQGG--EHLTLEDVL 378
+ K ++F G + LED+L
Sbjct: 305 KHHEVEIPGEKAAVEAPENRSYVNEYSPSAVKAVEVNSSGMKKLVFFGNATKVFDLEDLL 364
Query: 379 NATGQVIEKTTYGTAYKAKLADGAT-IALRLLREGSCKDRSSCLPVIRQLGKVRHENLIP 437
A+ +V+ K T+GTAYKA L D T +A++ L++ + DR I +G + HENL+P
Sbjct: 365 RASAEVLGKGTFGTAYKAVL-DAVTLVAVKRLKDVTMADREF-KEKIEVVGAMDHENLVP 422
Query: 438 LRAFYQGKRGEKLLIYDYFPSRTLHDLLHDTI-AGKPVLNWARRHKIALGIARGLAYLHT 496
LRA+Y EKLL+YD+ P +L LLH AG+P LNW R IALG ARGL YLH+
Sbjct: 423 LRAYYYSG-DEKLLVYDFMPMGSLSALLHGNKGAGRPPLNWEVRSGIALGAARGLDYLHS 481
Query: 497 GHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKADGYKAPELQRM 556
+ +HGNV+S N+L+ + +R+++FGL QL V+ +A GY+APE+
Sbjct: 482 QDPLS-SHGNVKSSNILLTNSHDARVSDFGLAQL----VSASSTTPNRATGYRAPEVTDP 536
Query: 557 KKCSSRTDVYAFXXXXXXXXXXXXXXXSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMK 616
++ S + DVY+F S N E +DL V EE EVFD E+M
Sbjct: 537 RRVSQKADVYSFGVVLLELLTGKAPSNSVMNEEGMDLARWVHSVAREEWRNEVFDSELMS 596
Query: 617 GIRS--PMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENR 658
I + +EE + + L+L + C RP M EVV++++E R
Sbjct: 597 -IETVVSVEEEMAEMLQLGIDCTEQHPDKRPVMVEVVRRIQELR 639
|
|
| TAIR|locus:2044913 AT2G36570 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 458 (166.3 bits), Expect = 3.7e-57, Sum P(2) = 3.7e-57
Identities = 111/315 (35%), Positives = 171/315 (54%)
Query: 362 KLIIFQGGEHLTLEDVLNATGQVIEKTTYGTAYKAKLADGAT-IALRLLREGSCKDRSSC 420
+L+ F+ + L+D+L A+ +++ K + GT YKA L DG+T +A++ L++ + R
Sbjct: 340 RLVFFERRKQFELDDLLKASAEMLGKGSLGTVYKAVLDDGSTTVAVKRLKDANPCPRKEF 399
Query: 421 LPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRTLHDLLHDTIA-GKPVLNWAR 479
+ +G+++H+N++ LRA+Y K EKLL+Y+Y P+ +LH LLH G+ L+W
Sbjct: 400 EQYMEIIGRLKHQNVVKLRAYYYAKE-EKLLVYEYLPNGSLHSLLHGNRGPGRIPLDWTT 458
Query: 480 RHKIALGIARGLAYLHTGHEIP-ITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADE 538
R + LG ARGLA +H + I I HGN++S NVL+D V+ + +FGL L+ P
Sbjct: 459 RISLMLGAARGLAKIHDEYSISKIPHGNIKSSNVLLDRNGVALIADFGLSLLLNP----- 513
Query: 539 MVALAKADGYKAPELQRMKKCSSRTDVYAFXXXXXXXXX---------------XXXXXX 583
+ A+A+ GY+APE +K+ S + DVY+F
Sbjct: 514 VHAIARLGGYRAPEQSEIKRLSQKADVYSFGVLLLEVLTGKAPSIFPSPSRPRSAASVAV 573
Query: 584 SGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASV 643
VDLP V+ V EE T EVFD E+++ +EE +V L + + C P
Sbjct: 574 EEEEEAVVDLPKWVRSVVKEEWTAEVFDPELLR--YKNIEEEMVAMLHIGLACVVPQPEK 631
Query: 644 RPTMDEVVKQLEENR 658
RPTM EVVK +EE R
Sbjct: 632 RPTMAEVVKMVEEIR 646
|
|
| TAIR|locus:2005629 AT1G75640 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 575 (207.5 bits), Expect = 9.3e-55, P = 9.3e-55
Identities = 188/600 (31%), Positives = 281/600 (46%)
Query: 97 SSIHLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSA 156
S + L + L S +G +P+ G LQ L L+ N + GTIP E+G SSL ++L +
Sbjct: 552 SLVSLKYLNLSSNLFSGHIPKNYGFLKSLQVLSLSHNRISGTIPPEIGNCSSLEVLELGS 611
Query: 157 NLFTGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFP 216
N G + + L L L L NSLT ++P+ S S L+ L L SN SG P
Sbjct: 612 NSLKGHIPVYVSKL-SLLKKLDLSHNSLTGSIPDQI---SKDSSLESLLLNSNSLSGRIP 667
Query: 217 EFVTRFEALKELDISNNLFSGSIPEGLTRLS-LEKLNLSHNNFSGVLPVFSESKF-GAEV 274
E ++R L LD+S+N + +IP L+RL L NLS N+ G +P ++F V
Sbjct: 668 ESLSRLTNLTALDLSSNRLNSTIPSSLSRLRFLNYFNLSRNSLEGEIPEALAARFTNPTV 727
Query: 275 FEGNSPALCGFPLR-DCSGNSRLSSGAIAGLVIGLMTGAVVFASLLIGYVQNK-KRKNRX 332
F N P LCG PL +C R + LV + GA++ GYV + K +N+
Sbjct: 728 FVKN-PGLCGKPLGIECPNVRRRRRRKLILLVTLAVAGALLLLLCCCGYVFSLWKWRNKL 786
Query: 333 XXXXXXXXXXXXXXXXXXXXXXXXXXXXX---KLIIFQGGEHLTLEDVLNATGQ-----V 384
KL++F +TL + L AT Q V
Sbjct: 787 RLGLSRDKKGTPSRTSRASSGGTRGEDNNGGPKLVMFNN--KITLAETLEATRQFDEENV 844
Query: 385 IEKTTYGTAYKAKLADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQG 444
+ + YG +KA DG +++R L +G+ ++ LG+V+H+N+ LR +Y G
Sbjct: 845 LSRGRYGLVFKATFRDGMVLSVRRLMDGASITDATFRNQAEALGRVKHKNITVLRGYYCG 904
Query: 445 KRGEKLLIYDYFPSRTLHDLLHDTI-AGKPVLNWARRHKIALGIARGLAYLHTGHEIPIT 503
+LL+YDY P+ L LL + VLNW RH IALGIARGL++LH+ + I
Sbjct: 905 PPDLRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLIALGIARGLSFLHS---LSII 961
Query: 504 HGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAK---ADGYKAPELQRMKKCS 560
HG+++ +NVL D F + L+EFGLD+L A+E + + GY APE + S
Sbjct: 962 HGDLKPQNVLFDADFEAHLSEFGLDRLTALTPAEEPSTSSTPVGSLGYIAPEAGLTGETS 1021
Query: 561 SRTDVYAFXXXXXXXXXXXXXXXSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMK--GI 618
+DVY+F E D+ VK + + +E+ + +++
Sbjct: 1022 KESDVYSFGIVLLEILTGKKAVMFT---EDEDIVKWVKRQLQKGQIVELLEPGLLELDPE 1078
Query: 619 RSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRPRNRSALYS-PTETRSEIGT 677
S EE L+ +K+ + C RP+M +VV LE R +L + PT S T
Sbjct: 1079 SSEWEEFLL-GIKVGLLCTGGDVVDRPSMADVVFMLEGCRVGPAISLSADPTSPTSPAAT 1137
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
ID ![]() | Name ![]() | Annotated EC number ![]() | Identity ![]() | Query coverage ![]() | Hit coverage ![]() | RBH(Q2H) ![]() | RBH(H2Q) ![]() |
| P33543 | TMKL1_ARATH | No assigned EC number | 0.7436 | 0.9779 | 0.9851 | yes | no |
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 679 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-46 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 9e-24 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-22 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-22 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-20 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-20 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-19 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-19 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-18 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 7e-18 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-17 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 9e-17 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-15 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-14 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 5e-14 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-13 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 6e-13 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-12 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 7e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 9e-12 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-11 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-11 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-11 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 6e-11 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-10 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-10 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 5e-10 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 5e-10 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-09 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-09 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-09 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-09 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 4e-09 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 4e-09 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 5e-09 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 6e-09 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 6e-09 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 7e-09 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-08 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-08 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-08 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-08 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-08 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-08 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 7e-08 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 7e-08 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 8e-08 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-07 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-07 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-07 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 4e-07 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 5e-07 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 5e-07 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 6e-07 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 6e-07 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 7e-07 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 9e-07 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 9e-07 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 9e-07 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-06 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-06 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-06 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-06 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-06 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-06 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-06 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-06 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-06 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-06 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-06 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 4e-06 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 4e-06 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 5e-06 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 5e-06 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 5e-06 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 6e-06 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 6e-06 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 6e-06 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 7e-06 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 7e-06 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 8e-06 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 8e-06 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 8e-06 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 8e-06 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 9e-06 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 9e-06 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-05 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-05 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-05 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-05 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-05 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-05 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-05 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-05 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-05 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-05 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 3e-05 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-05 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 4e-05 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 5e-05 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 6e-05 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 6e-05 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 7e-05 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 7e-05 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 8e-05 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 9e-05 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-04 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-04 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-04 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-04 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-04 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-04 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-04 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-04 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-04 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-04 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-04 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-04 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-04 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-04 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-04 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 4e-04 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 4e-04 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 4e-04 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 4e-04 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 5e-04 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 5e-04 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 6e-04 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 7e-04 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 7e-04 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 7e-04 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 7e-04 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 7e-04 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 9e-04 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 0.001 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 0.001 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 0.001 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 0.001 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 0.001 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 0.001 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 0.001 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 0.001 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 0.002 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 0.002 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 0.002 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 0.002 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 0.002 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 0.002 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 0.002 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 0.002 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 0.002 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 0.003 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 0.003 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 0.003 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 0.003 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 0.003 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 0.003 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 0.004 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 0.004 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 0.004 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 0.004 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 0.004 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 0.004 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 0.004 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 177 bits (450), Expect = 1e-46
Identities = 159/570 (27%), Positives = 260/570 (45%), Gaps = 71/570 (12%)
Query: 104 IQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVL 163
+ + + NL G + + LQ L L N G +P G S L +DLS N F+G +
Sbjct: 433 LDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFG-SKRLENLDLSRNQFSGAV 491
Query: 164 APSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFE 223
+ +L + L+ L+L N L+ +P+ S+C L LDL N+ SG P +
Sbjct: 492 PRKLGSLSE-LMQLKLSENKLSGEIPDEL---SSCKKLVSLDLSHNQLSGQIPASFSEMP 547
Query: 224 ALKELDISNNLFSGSIPEGLTRL-SLEKLNLSHNNFSGVLPVFSESKF---GAEVFEGNS 279
L +LD+S N SG IP+ L + SL ++N+SHN+ G LP S F A GN
Sbjct: 548 VLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLP--STGAFLAINASAVAGNI 605
Query: 280 PALCG----FPLRDCSGNSRLSSGAIAGLVIGLMTGAVVFASLL-IGYVQNKKRKNRGDS 334
LCG L C R+ I GA + +L+ G+V + R N
Sbjct: 606 D-LCGGDTTSGLPPC---KRVRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNN---L 658
Query: 335 EEEFEEGEDEENGMSGGSAAGGAGGEGKLIIFQG--GEHLTLEDVLNATGQ--VIEKTTY 390
E + E ED G +L F + +T+ D+L++ + VI +
Sbjct: 659 ELKRVENED---------------GTWELQFFDSKVSKSITINDILSSLKEENVISRGKK 703
Query: 391 GTAYKAKLADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKL 450
G +YK K ++ + + S I +GK++H N++ L + ++G
Sbjct: 704 GASYKGKSIKN---GMQFVVKEINDVNSIPSSEIADMGKLQHPNIVKLIGLCRSEKG-AY 759
Query: 451 LIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSK 510
LI++Y + L ++L + L+W RR KIA+GIA+ L +LH + GN+ +
Sbjct: 760 LIHEYIEGKNLSEVLRN-------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPE 812
Query: 511 NVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGI 570
+++D L +L +P + + Y APE + K + ++D+Y FG+
Sbjct: 813 KIIIDGKDEPHL------RLSLPGLLCTDTKCFISSAYVAPETRETKDITEKSDIYGFGL 866
Query: 571 LLLEILIGKKPG--KSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIRSPM---EEG 625
+L+E+L GK P + G +G SIV+ A + + DM I IR + +
Sbjct: 867 ILIELLTGKSPADAEFGVHG------SIVEWARYCYSDCHL-DMWIDPSIRGDVSVNQNE 919
Query: 626 LVQALKLAMGCCAPVASVRPTMDEVVKQLE 655
+V+ + LA+ C A + RP ++V+K LE
Sbjct: 920 IVEVMNLALHCTATDPTARPCANDVLKTLE 949
|
Length = 968 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 99.6 bits (249), Expect = 9e-24
Identities = 51/195 (26%), Positives = 91/195 (46%), Gaps = 12/195 (6%)
Query: 385 IEKTTYGTAYKAK-LADGATIAL-RLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFY 442
+ + +GT Y A+ G +A+ + +E S L I L K+ H N++ L +
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 443 QGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPI 502
+ L+ +Y +L DLL + + L+ +I L I GL YLH I
Sbjct: 61 E-DENHLYLVMEYCEGGSLKDLLKE---NEGKLSEDEILRILLQILEGLEYLH---SNGI 113
Query: 503 THGNVRSKNVLVD-DFFVSRLTEFGLDQLMVPAVADEMVALAKADGYKAPE-LQRMKKCS 560
H +++ +N+L+D D +L +FGL +L+ + + Y APE L S
Sbjct: 114 IHRDLKPENILLDSDNGKVKLADFGLSKLLTSDK-SLLKTIVGTPAYMAPEVLLGKGYYS 172
Query: 561 SRTDVYAFGILLLEI 575
++D+++ G++L E+
Sbjct: 173 EKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 1e-22
Identities = 68/174 (39%), Positives = 98/174 (56%), Gaps = 7/174 (4%)
Query: 91 LSLYKDSSIHLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLS 150
SL +S+ L+ L S L G +PRELG+ L+ +YL N+L G IP+E+G +SL+
Sbjct: 182 NSLTNLTSLEFLT--LASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLN 239
Query: 151 EIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNK 210
+DL N TG + S+ NL + L L L+ N L+ +P P++ + L LDL N
Sbjct: 240 HLDLVYNNLTGPIPSSLGNLKN-LQYLFLYQNKLSGPIP-PSIFSLQ--KLISLDLSDNS 295
Query: 211 FSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRL-SLEKLNLSHNNFSGVLP 263
SG PE V + + L+ L + +N F+G IP LT L L+ L L N FSG +P
Sbjct: 296 LSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIP 349
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 3e-22
Identities = 84/265 (31%), Positives = 132/265 (49%), Gaps = 27/265 (10%)
Query: 8 CCYIVFFFCLTESLASSSPASASSDVELLLGKIKSSLQGDDENLLLSSWNISVPLCQWRG 67
C Y++F L + + ++ELLL KSS+ D LS+WN S +C W+G
Sbjct: 9 CPYLIFMLFF---LFLNFSMLHAEELELLL-SFKSSIN--DPLKYLSNWNSSADVCLWQG 62
Query: 68 LKWISTNGSPLSCSDISLPQWANLSLYKDSSI----HLLSIQLPSANLTGSLPRELGEFS 123
+ N S + D+S N+S S+I ++ +I L + L+G +P ++ F+
Sbjct: 63 I--TCNNSSRVVSIDLS---GKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDI--FT 115
Query: 124 MLQSL-YLNV--NSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLH 180
SL YLN+ N+ G+IP G +L +DLS N+ +G + I L L L
Sbjct: 116 TSSSLRYLNLSNNNFTGSIP--RGSIPNLETLDLSNNMLSGEIPNDI-GSFSSLKVLDLG 172
Query: 181 GNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIP 240
GN L +P +L N T L++L L SN+ G P + + ++LK + + N SG IP
Sbjct: 173 GNVLVGKIP-NSLTNLT--SLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIP 229
Query: 241 EGLTRL-SLEKLNLSHNNFSGVLPV 264
+ L SL L+L +NN +G +P
Sbjct: 230 YEIGGLTSLNHLDLVYNNLTGPIPS 254
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 1e-20
Identities = 62/169 (36%), Positives = 79/169 (46%), Gaps = 9/169 (5%)
Query: 104 IQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVL 163
+ L S N TG +P L LQ L L N G IP LG ++L+ +DLS N TG +
Sbjct: 313 LHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEI 372
Query: 164 APSIWNLCD--RLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTR 221
LC L L L NSL +P +L C L+ + L N FSG P T+
Sbjct: 373 PEG---LCSSGNLFKLILFSNSLEGEIP-KSL--GACRSLRRVRLQDNSFSGELPSEFTK 426
Query: 222 FEALKELDISNNLFSGSIPEGLTRL-SLEKLNLSHNNFSGVLPVFSESK 269
+ LDISNN G I + SL+ L+L+ N F G LP SK
Sbjct: 427 LPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSK 475
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 3e-20
Identities = 61/161 (37%), Positives = 89/161 (55%), Gaps = 5/161 (3%)
Query: 104 IQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVL 163
I L NL+G +P E+G + L L L N+L G IP LG +L + L N +G +
Sbjct: 217 IYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPI 276
Query: 164 APSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFE 223
PSI++L +L+SL L NSL+ +PE + +L+ L L SN F+G P +T
Sbjct: 277 PPSIFSL-QKLISLDLSDNSLSGEIPELVI---QLQNLEILHLFSNNFTGKIPVALTSLP 332
Query: 224 ALKELDISNNLFSGSIPEGL-TRLSLEKLNLSHNNFSGVLP 263
L+ L + +N FSG IP+ L +L L+LS NN +G +P
Sbjct: 333 RLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIP 373
|
Length = 968 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 88.4 bits (220), Expect = 2e-19
Identities = 62/249 (24%), Positives = 99/249 (39%), Gaps = 61/249 (24%)
Query: 424 IRQLGKVRHENLIPLRAFYQG---KRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARR 480
R + K+ H N++ L G + ++ +Y L L +P L+ +
Sbjct: 52 ARIMRKLDHPNVVKLL----GVCTEEEPLYIVMEYMEGGDLLSYLRKN---RPKLSLSDL 104
Query: 481 HKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMV 540
AL IARG+ YL H ++ ++N LV + V ++++FGL
Sbjct: 105 LSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGL-----------SR 150
Query: 541 ALAKADGYK-----------APELQRMKKCSSRTDVYAFGILLLEIL-IGKKP--GKSGR 586
L D Y+ APE + K +S++DV++FG+LL EI +G++P G S
Sbjct: 151 DLYDDDYYRKRGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNE 210
Query: 587 NGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIRSPMEEGLVQAL-KLAMGCCAPVASVRP 645
EV + + G R P L L + C A RP
Sbjct: 211 ---------------------EVLEY-LKNGYRLPQPPNCPPELYDLMLQCWAEDPEDRP 248
Query: 646 TMDEVVKQL 654
T E+V+ L
Sbjct: 249 TFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 87.6 bits (218), Expect = 3e-19
Identities = 67/279 (24%), Positives = 117/279 (41%), Gaps = 53/279 (18%)
Query: 391 GTAYKAKLADGATIALRLLREG-SCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEK 449
GT +A++ L+EG S ++R L + K+ H N++ L +
Sbjct: 18 GTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRLLGVCT-QGEPL 76
Query: 450 LLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRS 509
++ +Y P L D L L ++AL IA+G+ YL H ++ +
Sbjct: 77 YIVTEYMPGGDLLDFLRKH---GEKLTLKDLLQMALQIAKGMEYLE---SKNFVHRDLAA 130
Query: 510 KNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKADGYK------------APELQRMK 557
+N LV + V ++++FGL + + D Y+ APE +
Sbjct: 131 RNCLVTENLVVKISDFGL-----------SRDIYEDDYYRKRGGGKLPIKWMAPESLKDG 179
Query: 558 KCSSRTDVYAFGILLLEIL-IGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMK 616
K +S++DV++FG+LL EI +G++P + + + EV ++ +
Sbjct: 180 KFTSKSDVWSFGVLLWEIFTLGEQP--------YPGM-----------SNEEVLEL-LED 219
Query: 617 GIRSPMEEGLVQAL-KLAMGCCAPVASVRPTMDEVVKQL 654
G R P E L +L + C A RPT E+V+ L
Sbjct: 220 GYRLPRPENCPDELYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.5 bits (210), Expect = 3e-18
Identities = 61/244 (25%), Positives = 101/244 (41%), Gaps = 40/244 (16%)
Query: 424 IRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRTLHDLL-----HDTIAGKPVLNWA 478
R + K+ H N++ L + L+ +Y L D L K L+
Sbjct: 47 ARVMKKLGHPNVVRLLGVCT-EEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLK 105
Query: 479 RRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADE 538
A+ IA+G+ YL H ++ ++N LV + V ++++FGL + + D+
Sbjct: 106 DLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDV----YDD 158
Query: 539 MVALAKADG-----YKAPELQRMKKCSSRTDVYAFGILLLEIL-IGKKPGKSGRNGEFVD 592
K G + APE + +S++DV++FG+LL EI +G P +
Sbjct: 159 DYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATP--------YPG 210
Query: 593 LPSIVKVAVLEETTMEVFDMEIMKGIRSPMEEGLVQAL-KLAMGCCAPVASVRPTMDEVV 651
L EV + + KG R P E L +L + C RPT E+V
Sbjct: 211 LS-----------NEEVLEY-LRKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELV 258
Query: 652 KQLE 655
++LE
Sbjct: 259 ERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 83.4 bits (207), Expect = 7e-18
Identities = 65/246 (26%), Positives = 101/246 (41%), Gaps = 54/246 (21%)
Query: 424 IRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKI 483
R + K+ H N++ L + +++ +Y P L D L L+ +
Sbjct: 52 ARIMRKLDHPNIVKLLGVCT-EEEPLMIVMEYMPGGDLLDYLRKN--RPKELSLSDLLSF 108
Query: 484 ALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALA 543
AL IARG+ YL H ++ ++N LV + V ++++FGL L
Sbjct: 109 ALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGL-----------SRDLY 154
Query: 544 KADGYK-----------APELQRMKKCSSRTDVYAFGILLLEIL-IGKKP--GKSGRNGE 589
D YK APE + K +S++DV++FG+LL EI +G++P G S
Sbjct: 155 DDDYYKVKGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNA--- 211
Query: 590 FVDLPSIVKVAVLEETTMEVFDMEIMKGIRSPMEEGLVQAL-KLAMGCCAPVASVRPTMD 648
EV + + KG R P L KL + C A RPT
Sbjct: 212 ------------------EVLEY-LKKGYRLPKPPNCPPELYKLMLQCWAEDPEDRPTFS 252
Query: 649 EVVKQL 654
E+V+ L
Sbjct: 253 ELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 2e-17
Identities = 64/169 (37%), Positives = 82/169 (48%), Gaps = 14/169 (8%)
Query: 100 HLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLF 159
+L + L + NLTG +P L L L L NSL+G IP LG SL + L N F
Sbjct: 357 NLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSF 416
Query: 160 TGVLAPSIWNLCDRLVS-LRLHGNSLTAALPEPALPNSTCSD---LQYLDLGSNKFSGSF 215
+G L L LV L + N+L + NS D LQ L L NKF G
Sbjct: 417 SGELPSEFTKL--PLVYFLDISNNNLQGRI------NSRKWDMPSLQMLSLARNKFFGGL 468
Query: 216 PEFVTRFEALKELDISNNLFSGSIPEGLTRLS-LEKLNLSHNNFSGVLP 263
P+ + L+ LD+S N FSG++P L LS L +L LS N SG +P
Sbjct: 469 PDS-FGSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIP 516
|
Length = 968 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 9e-17
Identities = 72/282 (25%), Positives = 113/282 (40%), Gaps = 38/282 (13%)
Query: 381 TGQVIEKTTYGTAYKAK-LADGATIALRLL--REGSCKDRSSCLPVIRQLGKVRHENLIP 437
+ + ++GT YKAK G +A+++L R K + IR L ++ H N++
Sbjct: 3 LLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVR 62
Query: 438 LRAFYQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTG 497
L ++ + L+ +Y L D L L+ KIAL I RGL YL
Sbjct: 63 LIDAFE-DKDHLYLVMEYCEGGDLFDYLSR----GGPLSEDEAKKIALQILRGLEYL--- 114
Query: 498 HEIPITHGNVRSKNVLVDDFFVSRLTEFGL--DQLMVPAVADEMVALAKADGYKAPE-LQ 554
H I H +++ +N+L+D+ V ++ +FGL L + V Y APE L
Sbjct: 115 HSNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVG---TPWYMAPEVLL 171
Query: 555 RMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEI 614
+ DV++ G++L E+L GK P SG N I
Sbjct: 172 GGNGYGPKVDVWSLGVILYELLTGKPP-FSGEN----------------ILDQLQLIRRI 214
Query: 615 MKGIRSPMEEGLVQ----ALKLAMGCCAPVASVRPTMDEVVK 652
+ E A L C S RPT +E+++
Sbjct: 215 LGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEILQ 256
|
Length = 260 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 79.0 bits (193), Expect = 1e-15
Identities = 60/286 (20%), Positives = 106/286 (37%), Gaps = 29/286 (10%)
Query: 382 GQVIEKTTYGTAYKAKLADGATIALRLLREGSCKDRSSCLPVIRQLGKVR----HENLIP 437
+ + + ++G Y A+ D +AL++L + +R++ + N++
Sbjct: 5 LRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVK 62
Query: 438 LRAFYQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTG 497
L F+Q G L+ +Y +L DLL P+ I I L YLH
Sbjct: 63 LYDFFQ-DEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALF-ILAQILSALEYLH-- 118
Query: 498 HEIPITHGNVRSKNVLVDDF-FVSRLTEFGLDQLMVPAVADEMVALAKAD-----GYKAP 551
I H +++ +N+L+D V +L +FGL +L+ + + + GY AP
Sbjct: 119 -SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177
Query: 552 ELQRMKKC---SSRTDVYAFGILLLEILIGKKPGKSGRNGEFVD-LPSIVKVAVLEETTM 607
E+ SS +D+++ GI L E+L G P + +N I+
Sbjct: 178 EVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLAS 237
Query: 608 EVFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653
+ S E A L A R + +
Sbjct: 238 PLSP--------SNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275
|
Length = 384 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 73.7 bits (182), Expect = 1e-14
Identities = 62/280 (22%), Positives = 114/280 (40%), Gaps = 42/280 (15%)
Query: 382 GQVIEKTTYGTAYKAK-LADGATIALRLLREGSCKDRSSCLPV-IRQLGKVRHENLIPLR 439
+ + + ++G Y A+ G +A++++++ K + I+ L K++H N++ L
Sbjct: 4 LEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLY 63
Query: 440 AFYQGKRGEKL-LIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGH 498
++ + +KL L+ +Y L DLL + L+ I L YLH
Sbjct: 64 DVFEDE--DKLYLVMEYCEGGDLFDLLKK----RGRLSEDEARFYLRQILSALEYLH--- 114
Query: 499 EIPITHGNVRSKNVLVDDFFVSRLTEFGLD-QLMVPAVADEMVALAKADG---YKAPELQ 554
I H +++ +N+L+D+ +L +FGL QL V G Y APE+
Sbjct: 115 SKGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFV------GTPEYMAPEVL 168
Query: 555 RMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEI 614
K D+++ G++L E+L GK P F ++ +E+F
Sbjct: 169 LGKGYGKAVDIWSLGVILYELLTGKPP--------FPG----------DDQLLELFKKIG 210
Query: 615 MKGIRSPMEEGLV--QALKLAMGCCAPVASVRPTMDEVVK 652
P E + +A L R T +E ++
Sbjct: 211 KPKPPFPPPEWDISPEAKDLIRKLLVKDPEKRLTAEEALQ 250
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 72.2 bits (178), Expect = 5e-14
Identities = 49/201 (24%), Positives = 96/201 (47%), Gaps = 14/201 (6%)
Query: 384 VIEKTTYGTAYKAK-LADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIP-LRAF 441
I K +G YKA+ G +A+++++ S + + + I+ L K +H N++ ++
Sbjct: 7 KIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSY 66
Query: 442 YQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIP 501
K+ E ++ ++ +L DLL T L ++ + + +GL YLH+
Sbjct: 67 L--KKDELWIVMEFCSGGSLKDLLKST---NQTLTESQIAYVCKELLKGLEYLHSNG--- 118
Query: 502 ITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVA-DEMVALAKADGYKAPELQRMKKCS 560
I H ++++ N+L+ +L +FGL + A + MV + APE+ K
Sbjct: 119 IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVG---TPYWMAPEVINGKPYD 175
Query: 561 SRTDVYAFGILLLEILIGKKP 581
+ D+++ GI +E+ GK P
Sbjct: 176 YKADIWSLGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 3e-13
Identities = 73/268 (27%), Positives = 127/268 (47%), Gaps = 32/268 (11%)
Query: 401 GATIALRLL-REGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQG---KRGEK--LLIYD 454
G +A++ L RE ++ S I L + HEN++ Y+G ++G K LI +
Sbjct: 33 GEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVK----YKGCCSEQGGKGLQLIME 88
Query: 455 YFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLV 514
Y P +L D L K LN A+ A I G+AYLH+ H I H ++ ++NVL+
Sbjct: 89 YVPLGSLRDYL-----PKHKLNLAQLLLFAQQICEGMAYLHSQHYI---HRDLAARNVLL 140
Query: 515 DDFFVSRLTEFGLDQLMVPAVADEMVALAKADG-----YKAPELQRMKKCSSRTDVYAFG 569
D+ + ++ +FGL + VP + DG + A E + K S +DV++FG
Sbjct: 141 DNDRLVKIGDFGLAK-AVPE--GHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFG 197
Query: 570 ILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIRSPMEEGLVQA 629
+ L E+L +S +F ++ + + T + + ++ + +G+R P + Q
Sbjct: 198 VTLYELLTHCDSKQSPPK-KFEEM---IGPKQGQMTVVRLIEL-LERGMRLPCPKNCPQE 252
Query: 630 LKLAM-GCCAPVASVRPTMDEVVKQLEE 656
+ + M C A RPT ++ L+E
Sbjct: 253 VYILMKNCWETEAKFRPTFRSLIPILKE 280
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 6e-13
Identities = 59/255 (23%), Positives = 113/255 (44%), Gaps = 42/255 (16%)
Query: 385 IEKTTYGTAYKA-KLADGATIALRL--LREGSCKDRSSCLPVIRQLGKVRHENLIPLRAF 441
I K ++G +K + AD A++ L + + ++R + R L K+ +I R +
Sbjct: 8 IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYII--RYY 65
Query: 442 YQGKRGEKL-LIYDYFPSRTLHDLLHDTIAGKPV---LNWARRHKIALGIARGLAYLHTG 497
KL ++ +Y + LH LL G+P+ W + + I GLA+LH+
Sbjct: 66 ESFLDKGKLNIVMEYAENGDLHKLLKMQR-GRPLPEDQVW----RFFIQILLGLAHLHSK 120
Query: 498 HEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPA--VADEMVALAKADGYKAPELQR 555
I H +++S N+ +D + ++ + G+ +L+ A+ +V Y +PEL
Sbjct: 121 K---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPY---YLSPELCE 174
Query: 556 MKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIM 615
K + ++DV+A G++L E GK P + G + ++I+
Sbjct: 175 DKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALI--------------------LKII 214
Query: 616 KGIRSPMEEGLVQAL 630
+G+ P+ + Q L
Sbjct: 215 RGVFPPVSQMYSQQL 229
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 3e-12
Identities = 55/230 (23%), Positives = 102/230 (44%), Gaps = 36/230 (15%)
Query: 382 GQVIEKTTYGTAYKA---KLADGATI--ALRLLREGSCKDRSSCLPVIRQ---LGKVRHE 433
+V+ +GT YK + I A+++LRE + + ++ + + V H
Sbjct: 12 IKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET--SPKANKEILDEAYVMASVDHP 69
Query: 434 NLIPLRAFYQGKRGEKLLIYDYFPSRTLHDLLH---DTIAGKPVLNWARRHKIALGIARG 490
+++ L + LI P L D + D I + +LNW + IA+G
Sbjct: 70 HVVRLLGICLSSQ--VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ------IAKG 121
Query: 491 LAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKADGYK- 549
++YL + H ++ ++NVLV ++T+FGL +L+ DE A+G K
Sbjct: 122 MSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDV---DEKEY--HAEGGKV 173
Query: 550 -----APELQRMKKCSSRTDVYAFGILLLEIL-IGKKPGKSGRNGEFVDL 593
A E + + ++DV+++G+ + E++ G KP + E DL
Sbjct: 174 PIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDL 223
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 7e-12
Identities = 61/269 (22%), Positives = 113/269 (42%), Gaps = 33/269 (12%)
Query: 387 KTTYGTAYKAK-LADGATIALRL--LREGSCKDRSSCLPVIRQLGKVRHENLIPLR-AFY 442
K +YG+ YK K L+D AL+ L S K+R + IR L V H N+I + AF
Sbjct: 10 KGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFL 69
Query: 443 QGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPI 502
G + ++ +Y P L + + ++ +I + + RGL LH E I
Sbjct: 70 DGNK--LCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH---EQKI 124
Query: 503 THGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKADGYKAPELQRMKKCSSR 562
H +++S N+L+ + ++ + G+ +++ +A + Y APE+ + + S +
Sbjct: 125 LHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQIGTPH---YMAPEVWKGRPYSYK 181
Query: 563 TDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIRSPM 622
+D+++ G LL E+ P E +M+ ++ +G P+
Sbjct: 182 SDIWSLGCLLYEMATFAPP--------------------FEARSMQDLRYKVQRGKYPPI 221
Query: 623 EEGLVQAL-KLAMGCCAPVASVRPTMDEV 650
Q L +RP D++
Sbjct: 222 PPIYSQDLQNFIRSMLQVKPKLRPNCDKI 250
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 9e-12
Identities = 45/129 (34%), Positives = 64/129 (49%), Gaps = 16/129 (12%)
Query: 193 LPN--STCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRL-SLE 249
+PN S LQ ++L N G+ P + +L+ LD+S N F+GSIPE L +L SL
Sbjct: 434 IPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLR 493
Query: 250 KLNLSHNNFSGVLPVFSESKFGAEVFEG------NSPALCGFP-LRDCSGNSRLSSGAIA 302
LNL+ N+ SG +P + G + ++ LCG P LR C LS GA
Sbjct: 494 ILNLNGNSLSGRVP----AALGGRLLHRASFNFTDNAGLCGIPGLRACG--PHLSVGAKI 547
Query: 303 GLVIGLMTG 311
G+ G+
Sbjct: 548 GIAFGVSVA 556
|
Length = 623 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 44/147 (29%), Positives = 77/147 (52%), Gaps = 9/147 (6%)
Query: 429 KVRHENLIPLRAFYQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIA 488
++RH NL+ L ++G ++ +Y +L D L G+ VL K +L +
Sbjct: 55 QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVC 112
Query: 489 RGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKADGY 548
+ YL + + H ++ ++NVLV + V+++++FGL + + D K +
Sbjct: 113 EAMEYLEANNFV---HRDLAARNVLVSEDNVAKVSDFGLTK-EASSTQDTGKLPVK---W 165
Query: 549 KAPELQRMKKCSSRTDVYAFGILLLEI 575
APE R KK S+++DV++FGILL EI
Sbjct: 166 TAPEALREKKFSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 1e-11
Identities = 52/197 (26%), Positives = 90/197 (45%), Gaps = 18/197 (9%)
Query: 382 GQVIEKTTYGTAYKAKLADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAF 441
G I K +G G +A++ L++ S + L + +RH NL+ L
Sbjct: 11 GATIGKGEFGDVMLGDYR-GQKVAVKCLKDDS-TAAQAFLAEASVMTTLRHPNLVQLLGV 68
Query: 442 YQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIP 501
++ +Y +L D L G+ V+ A++ AL + G+ YL E
Sbjct: 69 VLQGNP-LYIVTEYMAKGSLVDYLRSR--GRAVITLAQQLGFALDVCEGMEYLE---EKN 122
Query: 502 ITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKAD---GYKAPELQRMKK 558
H ++ ++NVLV + V+++++FGL + + + APE R KK
Sbjct: 123 FVHRDLAARNVLVSEDLVAKVSDFGLAK-------EASQGQDSGKLPVKWTAPEALREKK 175
Query: 559 CSSRTDVYAFGILLLEI 575
S+++DV++FGILL EI
Sbjct: 176 FSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 3e-11
Identities = 66/251 (26%), Positives = 112/251 (44%), Gaps = 37/251 (14%)
Query: 404 IALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIY-DYFPSRTLH 462
+A++ L+ G+ + L + + K+RH+ L+ L A E + I +Y +L
Sbjct: 33 VAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCS--EEEPIYIVTEYMSKGSLL 89
Query: 463 DLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRL 522
D L K L + +A IA G+AYL + + I H ++ ++N+LV + V ++
Sbjct: 90 DFLKSGEGKK--LRLPQLVDMAAQIAEGMAYLESRNYI---HRDLAARNILVGENLVCKI 144
Query: 523 TEFGLDQLMVPAVADEMVALAKAD---GYKAPELQRMKKCSSRTDVYAFGILLLEILI-G 578
+FGL +L+ DE A A + APE + + ++DV++FGILL EI+ G
Sbjct: 145 ADFGLARLIED---DEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYG 201
Query: 579 KKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIRSPMEEGLVQAL-KLAMGCC 637
+ P P + VLE ++ +G R P + L L + C
Sbjct: 202 RVP-----------YPGMTNREVLE---------QVERGYRMPRPPNCPEELYDLMLQCW 241
Query: 638 APVASVRPTMD 648
RPT +
Sbjct: 242 DKDPEERPTFE 252
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 6e-11
Identities = 73/272 (26%), Positives = 124/272 (45%), Gaps = 36/272 (13%)
Query: 390 YGTAYKAKLADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEK 449
+G + +A++ L+ G+ + L + + K+RH+ L+PL A E
Sbjct: 19 FGEVWMGTWNGTTKVAIKTLKPGTMMPEAF-LQEAQIMKKLRHDKLVPLYAVVSE---EP 74
Query: 450 LLIYDYFPSR-TLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVR 508
+ I F + +L D L + GK L + +A IA G+AY+ + I H ++R
Sbjct: 75 IYIVTEFMGKGSLLDFLKEG-DGK-YLKLPQLVDMAAQIADGMAYIERMNYI---HRDLR 129
Query: 509 SKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKAD---GYKAPELQRMKKCSSRTDV 565
+ N+LV D V ++ +FGL +L+ +E A A + APE + + ++DV
Sbjct: 130 AANILVGDNLVCKIADFGLARLIED---NEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186
Query: 566 YAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIRSPMEEG 625
++FGILL E++ GR V P +V VLE ++ +G R P +G
Sbjct: 187 WSFGILLTELV------TKGR----VPYPGMVNREVLE---------QVERGYRMPCPQG 227
Query: 626 LVQALKLAMGCC-APVASVRPTMDEVVKQLEE 656
++L M C RPT + + LE+
Sbjct: 228 CPESLHELMKLCWKKDPDERPTFEYIQSFLED 259
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 1e-10
Identities = 53/231 (22%), Positives = 102/231 (44%), Gaps = 21/231 (9%)
Query: 432 HENLIPLRAF-YQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARG 490
HEN++ + + LI +Y PS +L D L + +N R + I +G
Sbjct: 65 HENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRH---RDQINLKRLLLFSSQICKG 121
Query: 491 LAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKADG--- 547
+ YL + I H ++ ++N+LV+ + ++++FGL ++ +P D +
Sbjct: 122 MDYLGSQRYI---HRDLAARNILVESEDLVKISDFGLAKV-LPEDKDYYYVKEPGESPIF 177
Query: 548 YKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTM 607
+ APE R K SS +DV++FG+ L E+ P +S +++ + + M
Sbjct: 178 WYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQS-------PPAEFLRMIGIAQGQM 230
Query: 608 EVFDM-EIMK-GIRSPMEEGLVQALKLAMG-CCAPVASVRPTMDEVVKQLE 655
V + E++K G R P + M C RP+ +++ ++
Sbjct: 231 IVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVD 281
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 2e-10
Identities = 59/231 (25%), Positives = 102/231 (44%), Gaps = 30/231 (12%)
Query: 429 KVRHENLIPLRAFYQGKRGEKLLIY-DYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGI 487
K+RH LI L A E + I + +L + L AG+ L + +A +
Sbjct: 57 KLRHPKLIQLYAVCT--LEEPIYIVTELMKYGSLLEYLQG-GAGR-ALKLPQLIDMAAQV 112
Query: 488 ARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKADG 547
A G+AYL + I H ++ ++NVLV + + ++ +FGL +++ + +
Sbjct: 113 ASGMAYLEAQNYI---HRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIK 169
Query: 548 YKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAVLEETT 606
+ APE + S ++DV++FGILL EI+ G+ P P + T
Sbjct: 170 WTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMP-----------YPGM--------TN 210
Query: 607 MEVFDMEIMKGIRSPMEEGLVQAL-KLAMGCCAPVASVRPTMDEVVKQLEE 656
EV + +G R P G + L + + C RPT + + +LE+
Sbjct: 211 AEVLQQ-VDQGYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 5e-10
Identities = 57/193 (29%), Positives = 82/193 (42%), Gaps = 9/193 (4%)
Query: 102 LSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTG 161
L S N SLP L L++L L+ N L +P L S+L+ +DLS N +
Sbjct: 142 LKELDLSDNKIESLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKISD 200
Query: 162 VLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTR 221
+ P L L L L NS+ L S +L L+L +NK PE +
Sbjct: 201 L--PPEIELLSALEELDLSNNSIIELL----SSLSNLKNLSGLELSNNKLE-DLPESIGN 253
Query: 222 FEALKELDISNNLFSGSIPEGLTRLSLEKLNLSHNNFSGVLPVFSESKFGAEVFEGNSPA 281
L+ LD+SNN S SI + +L +L+LS N+ S LP+ + E+
Sbjct: 254 LSNLETLDLSNNQIS-SISSLGSLTNLRELDLSGNSLSNALPLIALLLLLLELLLNLLLT 312
Query: 282 LCGFPLRDCSGNS 294
L L+ S
Sbjct: 313 LKALELKLNSILL 325
|
Length = 394 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 5e-10
Identities = 66/262 (25%), Positives = 115/262 (43%), Gaps = 35/262 (13%)
Query: 390 YGTAYKAKLADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEK 449
+G ++ + +A+++L+ + ++ L ++RH++LI L A GE
Sbjct: 19 FGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCS--VGEP 76
Query: 450 L-LIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVR 508
+ +I + +L L G+ VL A +A +A G+AYL + I H ++
Sbjct: 77 VYIITELMEKGSLLAFLRSP-EGQ-VLPVASLIDMACQVAEGMAYLEEQNSI---HRDLA 131
Query: 509 SKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKADGYK--APELQRMKKCSSRTDVY 566
++N+LV + V ++ +FGL +L+ V ++ K YK APE S+++DV+
Sbjct: 132 ARNILVGEDLVCKVADFGLARLIKEDV---YLSSDKKIPYKWTAPEAASHGTFSTKSDVW 188
Query: 567 AFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIRSPMEEG 625
+FGILL E+ G+ P N E D I G R P
Sbjct: 189 SFGILLYEMFTYGQVPYPGMNNHEVYDQ--------------------ITAGYRMPCPAK 228
Query: 626 LVQAL-KLAMGCCAPVASVRPT 646
Q + K+ + C A RP+
Sbjct: 229 CPQEIYKIMLECWAAEPEDRPS 250
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 2e-09
Identities = 37/121 (30%), Positives = 64/121 (52%), Gaps = 9/121 (7%)
Query: 482 KIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVA 541
KIA+ I + L YLH+ ++ + H +V+ NVL++ +L +FG+ +V +VA + A
Sbjct: 107 KIAVSIVKALEYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDA 164
Query: 542 LAKADGYKAPEL----QRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIV 597
K Y APE K ++DV++ GI ++E+ G+ P S + F L +V
Sbjct: 165 GCKP--YMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT-PFQQLKQVV 221
Query: 598 K 598
+
Sbjct: 222 E 222
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 3e-09
Identities = 63/212 (29%), Positives = 100/212 (47%), Gaps = 33/212 (15%)
Query: 389 TYGTAYKAK-LADGATIALRLLREGSCKD--RSSCLPVIRQLGKVRHENLIPLRAFYQGK 445
TYG Y+A+ G +AL+ +R + +D S L I L +RH N++ L+ GK
Sbjct: 19 TYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGK 78
Query: 446 RGEKL-LIYDYFPSRTLHDL--LHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPI 502
+ + L+ +Y DL L D + + ++ + L + RGL YL HE I
Sbjct: 79 HLDSIFLVMEYCE----QDLASLLDNM--PTPFSESQVKCLMLQLLRGLQYL---HENFI 129
Query: 503 THGNVRSKNVLVDDFFVSRLTEFGL-------DQLMVPAVADEMVALAKADGYKAPE-LQ 554
H +++ N+L+ D ++ +FGL + M P V V L Y+APE L
Sbjct: 130 IHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKV----VTL----WYRAPELLL 181
Query: 555 RMKKCSSRTDVYAFGILLLEILIGKK--PGKS 584
++ D++A G +L E+L K PGKS
Sbjct: 182 GCTTYTTAIDMWAVGCILAELLAHKPLLPGKS 213
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 3e-09
Identities = 51/200 (25%), Positives = 89/200 (44%), Gaps = 34/200 (17%)
Query: 390 YGTAYKAKLAD-GATIALRLLREGSCKDRSSCLPVIRQ---LGKVRHENLIPLRA----- 440
YG Y+ T+A++ L+E D +++ + +++H NL+ L
Sbjct: 19 YGEVYEGVWKKYSLTVAVKTLKE----DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 74
Query: 441 --FYQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGH 498
FY +I ++ L D L + + +N +A I+ + YL +
Sbjct: 75 PPFY--------IITEFMTYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLEKKN 124
Query: 499 EIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKAD---GYKAPELQR 555
I H ++ ++N LV + + ++ +FGL +LM D A A A + APE
Sbjct: 125 FI---HRDLAARNCLVGENHLVKVADFGLSRLMT---GDTYTAHAGAKFPIKWTAPESLA 178
Query: 556 MKKCSSRTDVYAFGILLLEI 575
K S ++DV+AFG+LL EI
Sbjct: 179 YNKFSIKSDVWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 3e-09
Identities = 31/100 (31%), Positives = 58/100 (58%), Gaps = 5/100 (5%)
Query: 482 KIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVA 541
KIA+ + GL YL+ H I H +++ N+LV+ +L +FG+ ++ ++AD V
Sbjct: 107 KIAVAVVEGLTYLYNVHRI--MHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFVG 164
Query: 542 LAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKP 581
+ Y +PE + K + ++DV++ GI ++E+ +GK P
Sbjct: 165 TST---YMSPERIQGGKYTVKSDVWSLGISIIELALGKFP 201
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 4e-09
Identities = 38/156 (24%), Positives = 83/156 (53%), Gaps = 16/156 (10%)
Query: 429 KVRHENLIPLRA--FYQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALG 486
K+ H+NL+ L + G ++ + L + L G+ +++ + + +L
Sbjct: 55 KLHHKNLVRLLGVILHNGLY----IVMELMSKGNLVNFLRTR--GRALVSVIQLLQFSLD 108
Query: 487 IARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKAD 546
+A G+ YL + + H ++ ++N+LV + V+++++FGL ++ V + + +
Sbjct: 109 VAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK--- 162
Query: 547 GYKAPELQRMKKCSSRTDVYAFGILLLEIL-IGKKP 581
+ APE + KK SS++DV+++G+LL E+ G+ P
Sbjct: 163 -WTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAP 197
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 4e-09
Identities = 63/291 (21%), Positives = 120/291 (41%), Gaps = 52/291 (17%)
Query: 383 QVIEKTTYGTAYKAKLA----DGATIALRLLREG-SCKDRSSCLPVIRQLGKVRHENLIP 437
+VI +G ++ L +A++ L+ G + K R L +G+ H N+I
Sbjct: 11 KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIR 70
Query: 438 LRAFYQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTG 497
L K ++I +Y + L L D + GIA G+ YL
Sbjct: 71 LEGVVT-KFKPAMIITEYMENGALDKYLRDHDGEFSSYQLV---GMLRGIAAGMKYLS-- 124
Query: 498 HEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKADGYK------AP 551
++ H ++ ++N+LV+ ++++FGL +++ D+ G K AP
Sbjct: 125 -DMNYVHRDLAARNILVNSNLECKVSDFGLSRVL----EDDPEGTYTTSGGKIPIRWTAP 179
Query: 552 ELQRMKKCSSRTDVYAFGILLLEIL-IGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVF 610
E +K +S +DV++FGI++ E++ G++P ++
Sbjct: 180 EAIAYRKFTSASDVWSFGIVMWEVMSFGERP------------------------YWDMS 215
Query: 611 DMEIMKGI----RSPMEEGLVQAL-KLAMGCCAPVASVRPTMDEVVKQLEE 656
+ E+MK I R P A+ +L + C + RP ++V L++
Sbjct: 216 NHEVMKAINDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDK 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 5e-09
Identities = 55/227 (24%), Positives = 107/227 (47%), Gaps = 22/227 (9%)
Query: 370 EHLTLEDVLNATGQVIEKTTYGTAYKAKLADGATIALRLLREGSCKDRSSCLPVIRQLGK 429
+ LT L TGQ +G K +A+++++EGS + + + + K
Sbjct: 4 KDLTFLKEL-GTGQ------FGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMK 55
Query: 430 VRHENLIPLRAFYQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIAR 489
+ HE L+ L +R ++ +Y + L + L + ++ ++ +
Sbjct: 56 LSHEKLVQLYGVCTKQR-PIYIVTEYMSNGCLLNYLREHGKR---FQPSQLLEMCKDVCE 111
Query: 490 GLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKAD--- 546
G+AYL + I H ++ ++N LVDD ++++FGL + ++ DE + +
Sbjct: 112 GMAYLESKQFI---HRDLAARNCLVDDQGCVKVSDFGLSRYVLD---DEYTSSVGSKFPV 165
Query: 547 GYKAPELQRMKKCSSRTDVYAFGILLLEIL-IGKKPGKSGRNGEFVD 592
+ PE+ K SS++DV+AFG+L+ E+ +GK P + N E V+
Sbjct: 166 RWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVE 212
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 6e-09
Identities = 69/271 (25%), Positives = 120/271 (44%), Gaps = 34/271 (12%)
Query: 390 YGTAYKAKLADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEK 449
+G + +A++ L+ G+ S L + + K+RH+ L+ L A
Sbjct: 19 FGEVWMGTWNGNTKVAVKTLKPGTMSPESF-LEEAQIMKKLRHDKLVQLYAVVS--EEPI 75
Query: 450 LLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRS 509
++ +Y +L D L D G+ L +A +A G+AY+ + I H ++RS
Sbjct: 76 YIVTEYMSKGSLLDFLKDG-EGR-ALKLPNLVDMAAQVAAGMAYIERMNYI---HRDLRS 130
Query: 510 KNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKAD---GYKAPELQRMKKCSSRTDVY 566
N+LV D V ++ +FGL +L+ +E A A + APE + + ++DV+
Sbjct: 131 ANILVGDGLVCKIADFGLARLIED---NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 187
Query: 567 AFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIRSPMEEGL 626
+FGILL E++ GR V P + VLE ++ +G R P +
Sbjct: 188 SFGILLTELV------TKGR----VPYPGMNNREVLE---------QVERGYRMPCPQDC 228
Query: 627 VQAL-KLAMGCCAPVASVRPTMDEVVKQLEE 656
+L +L + C RPT + + LE+
Sbjct: 229 PISLHELMLQCWKKDPEERPTFEYLQSFLED 259
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (139), Expect = 6e-09
Identities = 64/288 (22%), Positives = 121/288 (42%), Gaps = 55/288 (19%)
Query: 383 QVIEKTTYGTAYKAK-LADGATIALRL--LREGSCKDRSSCLPVIRQLGKVRHENLIPLR 439
+ I K ++G Y + +DG L+ L S K+R L ++ L K+ H N+I
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65
Query: 440 AFYQGKRGEKLLI-YDYFPSRTLHDLLHDTI-AGKP-----VLNWARRHKIALGIARGLA 492
++ K KL I +Y L + GKP +L+W + + L
Sbjct: 66 ESFEEK--GKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWF------VQLCLALK 117
Query: 493 YLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAK-ADG---Y 548
YLH+ I H +++ +N+ + + +L +FG+ +++ V LAK G Y
Sbjct: 118 YLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVL-----SSTVDLAKTVVGTPYY 169
Query: 549 KAPELQRMKKCSSRTDVYAFGILLLEILIGKKP--GKSGRNGEFVDLPSIVKVAVLEETT 606
+PEL + K + ++D+++ G +L E+ K P G++ L +
Sbjct: 170 LSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN--------LLELA--------- 212
Query: 607 MEVFDMEIMKGIRSPMEEGLVQALK-LAMGCCAPVASVRPTMDEVVKQ 653
++I+KG P+ L+ L RP++ ++++
Sbjct: 213 -----LKILKGQYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 7e-09
Identities = 65/271 (23%), Positives = 117/271 (43%), Gaps = 34/271 (12%)
Query: 390 YGTAYKAKLADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEK 449
+G + +A++ L+ G+ + L + + K+RHE L+ L A +
Sbjct: 19 FGEVWMGTWNGTTRVAIKTLKPGTMSPEAF-LQEAQVMKKLRHEKLVQLYAVVSEE--PI 75
Query: 450 LLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRS 509
++ +Y +L D L + L + +A IA G+AY+ + H ++R+
Sbjct: 76 YIVTEYMSKGSLLDFLKGEMG--KYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRA 130
Query: 510 KNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKAD---GYKAPELQRMKKCSSRTDVY 566
N+LV + V ++ +FGL +L+ +E A A + APE + + ++DV+
Sbjct: 131 ANILVGENLVCKVADFGLARLIED---NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 187
Query: 567 AFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIRSPMEEGL 626
+FGILL E+ GR V P +V VL+ ++ +G R P
Sbjct: 188 SFGILLTEL------TTKGR----VPYPGMVNREVLD---------QVERGYRMPCPPEC 228
Query: 627 VQAL-KLAMGCCAPVASVRPTMDEVVKQLEE 656
++L L C RPT + + LE+
Sbjct: 229 PESLHDLMCQCWRKEPEERPTFEYLQAFLED 259
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 1e-08
Identities = 34/114 (29%), Positives = 63/114 (55%), Gaps = 11/114 (9%)
Query: 474 VLNWARR------HKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGL 527
VL A+R K+++ + RGLAYL H+I H +V+ N+LV+ +L +FG+
Sbjct: 93 VLKEAKRIPEEILGKVSIAVLRGLAYLREKHQI--MHRDVKPSNILVNSRGEIKLCDFGV 150
Query: 528 DQLMVPAVADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKP 581
++ ++A+ V Y +PE + S ++D+++ G+ L+E+ IG+ P
Sbjct: 151 SGQLIDSMANSFVG---TRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 53/205 (25%), Positives = 94/205 (45%), Gaps = 21/205 (10%)
Query: 389 TYGTAYKAK-LADGATIALR--LLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGK 445
TYG YKA+ G +A++ LR S + L I+ L ++ H N+I L +
Sbjct: 11 TYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVF-RH 69
Query: 446 RGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHG 505
+G+ L++++ DL + L + + +GLA+ H+ I H
Sbjct: 70 KGDLYLVFEFM----DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG---ILHR 122
Query: 506 NVRSKNVLVDDFFVSRLTEFGLDQLMVPAVA---DEMVALAKADGYKAPE-LQRMKKCSS 561
+++ +N+L++ V +L +FGL + V +V Y+APE L K S+
Sbjct: 123 DLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRW----YRAPELLLGDKGYST 178
Query: 562 RTDVYAFGILLLEILIGKK--PGKS 584
D+++ G + E+L + PGKS
Sbjct: 179 PVDIWSVGCIFAELLSRRPLFPGKS 203
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 2e-08
Identities = 33/84 (39%), Positives = 49/84 (58%), Gaps = 1/84 (1%)
Query: 106 LPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAP 165
L + L G +P ++ + LQS+ L+ NS++G IP LG +SL +DLS N F G +
Sbjct: 425 LDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPE 484
Query: 166 SIWNLCDRLVSLRLHGNSLTAALP 189
S+ L L L L+GNSL+ +P
Sbjct: 485 SLGQLTS-LRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 66/272 (24%), Positives = 117/272 (43%), Gaps = 35/272 (12%)
Query: 390 YGTAYKAKLADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEK 449
+G + + +A++ L+ G+ ++ L + ++H+ L+ L A K
Sbjct: 19 FGEVWMGYYNNSTKVAVKTLKPGTMSVQAF-LEEANLMKTLQHDKLVRLYAVVT-KEEPI 76
Query: 450 LLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRS 509
+I +Y +L D L GK +L + + IA G+AY+ + I H ++R+
Sbjct: 77 YIITEYMAKGSLLDFLKSDEGGKVLL--PKLIDFSAQIAEGMAYIERKNYI---HRDLRA 131
Query: 510 KNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKAD---GYKAPELQRMKKCSSRTDVY 566
NVLV + + ++ +FGL +++ +E A A + APE + ++DV+
Sbjct: 132 ANVLVSESLMCKIADFGLARVIED---NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVW 188
Query: 567 AFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIRSP-MEE 624
+FGILL EI+ GK P N + V A+ +G R P ME
Sbjct: 189 SFGILLYEIVTYGKIPYPGMSNSD-------VMSAL-------------QRGYRMPRMEN 228
Query: 625 GLVQALKLAMGCCAPVASVRPTMDEVVKQLEE 656
+ + C A RPT D + L++
Sbjct: 229 CPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.6 bits (135), Expect = 2e-08
Identities = 55/212 (25%), Positives = 99/212 (46%), Gaps = 32/212 (15%)
Query: 389 TYGTAYKAK-LADGATIALRLLREGSCKDRSSCLPV--IRQ---LGKVRHENLIPLRAFY 442
TYG YKA+ G +AL+ +R + K+ P+ IR+ L K+RH N++ L+
Sbjct: 11 TYGQVYKARNKKTGELVALKKIRMENEKEG---FPITAIREIKLLQKLRHPNIVRLKEIV 67
Query: 443 QGK-RGEKLLIYDYFPSRTLHDL--LHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHE 499
K +G ++++Y HDL L D+ K ++ + GL YLH+
Sbjct: 68 TSKGKGSIYMVFEYMD----HDLTGLLDSPEVK--FTESQIKCYMKQLLEGLQYLHSNG- 120
Query: 500 IPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEM----VALAKADGYKAPE-LQ 554
I H +++ N+L+++ V +L +FGL + + + + L Y+ PE L
Sbjct: 121 --ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITL----WYRPPELLL 174
Query: 555 RMKKCSSRTDVYAFGILLLEILIGKK--PGKS 584
+ D+++ G +L E+ +GK G +
Sbjct: 175 GATRYGPEVDMWSVGCILAELFLGKPIFQGST 206
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 55.0 bits (133), Expect = 3e-08
Identities = 32/100 (32%), Positives = 57/100 (57%), Gaps = 5/100 (5%)
Query: 482 KIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVA 541
KIA+ + +GL YLH H+ I H +V+ N+LV+ +L +FG+ +V ++A V
Sbjct: 104 KIAVAVLKGLTYLHEKHK--IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFVG 161
Query: 542 LAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKP 581
+ Y APE + S ++D+++ G+ L+E+ G+ P
Sbjct: 162 TSS---YMAPERIQGNDYSVKSDIWSLGLSLIELATGRFP 198
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.0 bits (131), Expect = 7e-08
Identities = 62/206 (30%), Positives = 101/206 (49%), Gaps = 23/206 (11%)
Query: 389 TYGTAYKAK-LADGATIALRLLREGSCKD--RSSCLPVIRQLGKVRHENLIPLRAFYQGK 445
TYG YKA+ G +AL+ +R + ++ S+ L I L +++H N++ L +
Sbjct: 11 TYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTE 70
Query: 446 RGEKL-LIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITH 504
R KL L+++Y L L D G N + I + RGLAY H+ I H
Sbjct: 71 R--KLYLVFEYC-DMDLKKYL-DKRPGPLSPNLIKS--IMYQLLRGLAYCHSHR---ILH 121
Query: 505 GNVRSKNVLVDDFFVSRLTEFGLD-QLMVP--AVADEMVALAKADGYKAPE-LQRMKKCS 560
+++ +N+L++ V +L +FGL +P E+V L Y+APE L K S
Sbjct: 122 RDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLW----YRAPEILLGSKHYS 177
Query: 561 SRTDVYAFGILLLEILIGKK--PGKS 584
+ D+++ G + E++ GK PG S
Sbjct: 178 TAVDIWSVGCIFAEMITGKPLFPGDS 203
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 7e-08
Identities = 61/204 (29%), Positives = 98/204 (48%), Gaps = 19/204 (9%)
Query: 389 TYGTAYKAKLAD-GATIALR--LLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGK 445
+YG K K + G +A++ L E + + IR L ++RHENL+ L + +
Sbjct: 13 SYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVF--R 70
Query: 446 RGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHG 505
R ++L + F T+ D L G L+ +R K I RG+ + H+ + I H
Sbjct: 71 RKKRLYLVFEFVDHTVLDDLEKYPNG---LDESRVRKYLFQILRGIEFCHSHN---IIHR 124
Query: 506 NVRSKNVLVDDFFVSRLTEFGLDQ-LMVPA-VADEMVALAKADGYKAPELQ-RMKKCSSR 562
+++ +N+LV V +L +FG + L P V + VA Y+APEL K
Sbjct: 125 DIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVA---TRWYRAPELLVGDTKYGRA 181
Query: 563 TDVYAFGILLLEILIGKK--PGKS 584
D++A G L+ E+L G+ PG S
Sbjct: 182 VDIWAVGCLVTEMLTGEPLFPGDS 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 8e-08
Identities = 51/192 (26%), Positives = 93/192 (48%), Gaps = 15/192 (7%)
Query: 404 IALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRTLHD 463
+A++ L++GS + L + +++H L+ L A + +I +Y + +L D
Sbjct: 33 VAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT--QEPIYIITEYMENGSLVD 89
Query: 464 LLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLT 523
L T G L + +A IA G+A++ + I H ++R+ N+LV + ++
Sbjct: 90 FL-KTPEGIK-LTINKLIDMAAQIAEGMAFIERKNYI---HRDLRAANILVSETLCCKIA 144
Query: 524 EFGLDQLMVPAVADEMVALAKAD---GYKAPELQRMKKCSSRTDVYAFGILLLEILI-GK 579
+FGL +L+ +E A A + APE + ++DV++FGILL EI+ G+
Sbjct: 145 DFGLARLIED---NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGR 201
Query: 580 KPGKSGRNGEFV 591
P N E +
Sbjct: 202 IPYPGMTNPEVI 213
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 53.4 bits (129), Expect = 1e-07
Identities = 61/228 (26%), Positives = 98/228 (42%), Gaps = 36/228 (15%)
Query: 381 TGQVIEKTTYGTAYKAKL-ADGATIALRLLREGSCKD-RSSCLPVIRQLGKVRHENLIPL 438
+V+ + + G YK + G AL+ + ++ R L ++ L ++
Sbjct: 5 RVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKC 64
Query: 439 R-AFYQGKRGEKLLIYDYFPSRTLHDLL--HDTIAGKPVLNWARRHKIALGIARGLAYLH 495
AFY K GE ++ +Y +L DLL I +PVL IA I +GL YLH
Sbjct: 65 YGAFY--KEGEISIVLEYMDGGSLADLLKKVGKI-PEPVLA-----YIARQILKGLDYLH 116
Query: 496 TGHEIPITHGNVRSKNVLVD--------DFFVSRLTEFGLDQLM--VPAVADEMVALAKA 545
T I H +++ N+L++ DF +S++ E LDQ V V
Sbjct: 117 TKRHI--IHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVT--------- 165
Query: 546 DGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDL 593
Y +PE + + S D+++ G+ LLE +GK P F +L
Sbjct: 166 --YMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFEL 211
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 62/236 (26%), Positives = 104/236 (44%), Gaps = 43/236 (18%)
Query: 370 EHLTLEDVLNAT--GQVIEKTTYGTAYKAKLADGATIALRLLREGSC----KDRSSCLPV 423
E + EDV+ GQVI A K A+++L+E + +D + L V
Sbjct: 2 EDIKFEDVIGEGNFGQVIR------AMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEV 55
Query: 424 IRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRH-- 481
+ +LG H N+I L + RG + +Y P L D L + + +A+ H
Sbjct: 56 LCKLGH--HPNIINLLGACE-NRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGT 112
Query: 482 ----------KIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLM 531
+ A +A G+ YL I H ++ ++NVLV + S++ +FGL +
Sbjct: 113 ASTLTSQQLLQFASDVATGMQYLSEKQFI---HRDLAARNVLVGENLASKIADFGLSR-- 167
Query: 532 VPAVADEMVALAKADG-----YKAPELQRMKKCSSRTDVYAFGILLLEIL-IGKKP 581
E V + K G + A E ++++DV++FG+LL EI+ +G P
Sbjct: 168 -----GEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTP 218
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 52.6 bits (127), Expect = 2e-07
Identities = 53/211 (25%), Positives = 99/211 (46%), Gaps = 24/211 (11%)
Query: 382 GQVIEKTTYGTAYKAKLAD-GATIALRLLR--EGSCKDRSSCLPVIRQLGKVRHENLIPL 438
G+++ + ++G+ Y A D G +A++ + S ++ + IR L ++H N++
Sbjct: 5 GELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRY 64
Query: 439 RAFYQGKRGEKLLIY-DYFPSRTLHDLLHDTIAGK---PVL-NWARRHKIALGIARGLAY 493
+ + L I+ +Y +L LL GK PV+ + R+ I GLAY
Sbjct: 65 YGSERDEEKNTLNIFLEYVSGGSLSSLLKK--FGKLPEPVIRKYTRQ------ILEGLAY 116
Query: 494 LHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKADG---YKA 550
LH+ I H +++ N+LVD V +L +FG + + E + G + A
Sbjct: 117 LHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVR--GTPYWMA 171
Query: 551 PELQRMKKCSSRTDVYAFGILLLEILIGKKP 581
PE+ R ++ D+++ G ++E+ GK P
Sbjct: 172 PEVIRGEEYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 4e-07
Identities = 51/220 (23%), Positives = 96/220 (43%), Gaps = 43/220 (19%)
Query: 382 GQVIEKTTYGTAYKA-KLADGATIALRLLREGSCKDRSSCLPVIRQLG-------KVRHE 433
G+++ ++G+ Y+ L DG A++ + D + ++QL K++H
Sbjct: 5 GELLGSGSFGSVYEGLNLDDGDFFAVKEVSLAD--DGQTGQEAVKQLEQEIALLSKLQHP 62
Query: 434 NLIPLRAFYQG--KRGEKLLIY-DYFPSRTLHDLLHDTIAGKPVL--NWARRHKIALGIA 488
N++ Y G + + L I+ + P +L LL + + + R+ I
Sbjct: 63 NIVQ----YLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQ------IL 112
Query: 489 RGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKADGY 548
GL YLH + H +++ N+LVD V +L +FG+ A ++V + A +
Sbjct: 113 LGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGM--------AKQVVEFSFAKSF 161
Query: 549 K------APELQRMKKC-SSRTDVYAFGILLLEILIGKKP 581
K APE+ + D+++ G +LE+ GK P
Sbjct: 162 KGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPP 201
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.5 bits (124), Expect = 5e-07
Identities = 53/215 (24%), Positives = 99/215 (46%), Gaps = 34/215 (15%)
Query: 383 QVIEKT---TYGTAYKAK-LADGATIALRLLR-----EGSCKDRSSCLPVIRQLGKVRHE 433
Q +EK TYG YKA+ G +AL+ +R EG S+ + I L ++ H
Sbjct: 2 QKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGV---PSTAIREISLLKELNHP 58
Query: 434 NLIPLR-AFYQGKRGEKLLIYDYFPSRTLHDLLH--DTIAGKPVLNWARRHKIALGIARG 490
N++ L + + L++++ DL D+ L+ + +G
Sbjct: 59 NIVRLLDVVHSENK--LYLVFEFLD----LDLKKYMDSSP-LTGLDPPLIKSYLYQLLQG 111
Query: 491 LAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQ---LMVPAVADEMVALAKADG 547
+AY H H + H +++ +N+L+D +L +FGL + + V E+V L
Sbjct: 112 IAYCH-SHRV--LHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVTL----W 164
Query: 548 YKAPE-LQRMKKCSSRTDVYAFGILLLEILIGKKP 581
Y+APE L ++ S+ D+++ G + E ++ ++P
Sbjct: 165 YRAPEILLGSRQYSTPVDIWSIGCIFAE-MVNRRP 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 5e-07
Identities = 45/196 (22%), Positives = 93/196 (47%), Gaps = 21/196 (10%)
Query: 404 IALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRTLHD 463
+A++++REG+ + + + + K+ H NL+ L K+ ++ +Y + L +
Sbjct: 31 VAIKMIREGAMSE-DDFIEEAKVMMKLSHPNLVQLYGVCT-KQRPIFIVTEYMANGCLLN 88
Query: 464 LLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLT 523
L K L + + + YL + I H ++ ++N LV + V +++
Sbjct: 89 YLR---ERKGKLGTEWLLDMCSDVCEAMEYLESNGFI---HRDLAARNCLVGEDNVVKVS 142
Query: 524 EFGLDQLMVPAVADEMVALAKADGYK------APELQRMKKCSSRTDVYAFGILLLEILI 577
+FGL + ++ D+ + + G K PE+ + SS++DV++FG+L+ E+
Sbjct: 143 DFGLARYVLD---DQYTS---SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFS 196
Query: 578 -GKKPGKSGRNGEFVD 592
GK P + N E V+
Sbjct: 197 EGKMPYERFSNSEVVE 212
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 6e-07
Identities = 28/100 (28%), Positives = 57/100 (57%), Gaps = 5/100 (5%)
Query: 482 KIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVA 541
K+++ + +GL YL H+I H +V+ N+LV+ +L +FG+ ++ ++A+ V
Sbjct: 107 KVSIAVIKGLTYLREKHKI--MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVG 164
Query: 542 LAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKP 581
Y +PE + S ++D+++ G+ L+E+ IG+ P
Sbjct: 165 ---TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 6e-07
Identities = 57/226 (25%), Positives = 102/226 (45%), Gaps = 22/226 (9%)
Query: 370 EHLTLEDVLNATGQVIEKTTYGTAYKAKLADGATIALRLLREGSCKDRSSCLPVIRQLGK 429
E L LE L A GQ +G + A +A++ ++ GS + L +
Sbjct: 6 ESLKLEKKLGA-GQ------FGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKT 57
Query: 430 VRHENLIPLRAFYQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIAR 489
++H+ L+ L A + +I ++ +L D L K L + + IA
Sbjct: 58 LQHDKLVKLHAVV--TKEPIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAE 113
Query: 490 GLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKAD--- 546
G+A++ + I H ++R+ N+LV V ++ +FGL +++ +E A A
Sbjct: 114 GMAFIEQRNYI---HRDLRAANILVSASLVCKIADFGLARVIED---NEYTAREGAKFPI 167
Query: 547 GYKAPELQRMKKCSSRTDVYAFGILLLEIL-IGKKPGKSGRNGEFV 591
+ APE + ++DV++FGILL+EI+ G+ P N E +
Sbjct: 168 KWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI 213
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 7e-07
Identities = 56/214 (26%), Positives = 100/214 (46%), Gaps = 28/214 (13%)
Query: 384 VIEKTTYGTAYKAK-LADGATIALR--LLREGSCKDRSSCLPVIRQLGKVRHENLIPLRA 440
V+ + YG K + A G +A++ E + + L ++ L ++RHEN++ L+
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67
Query: 441 FYQGKRGEKL-LIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGI---ARGLAYLHT 496
+ +R +L L+++Y RTL +LL + G P + I + +AY H
Sbjct: 68 AF--RRKGRLYLVFEYVE-RTLLELLEASPGGLP------PDAVRSYIWQLLQAIAYCH- 117
Query: 497 GHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKADGYKAPELQRM 556
H I H +++ +N+LV + V +L +FG + + A + Y+APEL
Sbjct: 118 SHNI--IHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELL-- 173
Query: 557 KKCSSR----TDVYAFGILLLEILIGKK--PGKS 584
+ DV+A G ++ E+L G+ PG S
Sbjct: 174 -VGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDS 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 9e-07
Identities = 49/194 (25%), Positives = 89/194 (45%), Gaps = 25/194 (12%)
Query: 401 GATIALRLLREGSCKDRSSCLPVIRQL---GKVRHENLIPLRAFYQGKRGEKLL--IYDY 455
G +A++LLR + ++ R+ ++ H N++ L G+ LL +++Y
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVAL--LDSGEAPPGLLFAVFEY 60
Query: 456 FPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLV- 514
P RTL ++L A L ++ L + LA H I H +++ +N++V
Sbjct: 61 VPGRTLREVL----AADGALPAGETGRLMLQVLDALAC---AHNQGIVHRDLKPQNIMVS 113
Query: 515 --DDFFVSRLTEFGLDQLMVPAVADEMVALAKADG-------YKAPELQRMKKCSSRTDV 565
+++ +FG+ L+ P V D VA Y APE R + + +D+
Sbjct: 114 QTGVRPHAKVLDFGIGTLL-PGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDL 172
Query: 566 YAFGILLLEILIGK 579
YA+G++ LE L G+
Sbjct: 173 YAWGLIFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 9e-07
Identities = 58/215 (26%), Positives = 96/215 (44%), Gaps = 29/215 (13%)
Query: 382 GQVIEKTTYGTAYKA-KLADGATIALRLLR-----EGSCKDRSSCLPVIRQLGKVRHENL 435
G I T+G Y A L G +A++ +R + K+ + + V+ L +H NL
Sbjct: 5 GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELL---KHPNL 61
Query: 436 IPLRAFY--QGKRGEKLLIY-DYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLA 492
+ +Y + R EK+ I+ +Y TL +LL +L+ L + GLA
Sbjct: 62 V---KYYGVEVHR-EKVYIFMEYCSGGTLEELLE----HGRILDEHVIRVYTLQLLEGLA 113
Query: 493 YLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPA--VADEMVA-LAKADGYK 549
YLH+ I H +++ N+ +D V +L +FG + E V LA Y
Sbjct: 114 YLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYM 170
Query: 550 APELQRMKKCSSR---TDVYAFGILLLEILIGKKP 581
APE+ K D+++ G ++LE+ GK+P
Sbjct: 171 APEVITGGKGKGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 9e-07
Identities = 27/96 (28%), Positives = 46/96 (47%), Gaps = 7/96 (7%)
Query: 487 IARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEM-VALAKA 545
I L YLH+ I H +++ N+L+D+ +T+F + V D + + +
Sbjct: 109 IVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNI-ATKVTP--DTLTTSTSGT 162
Query: 546 DGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKP 581
GY APE+ + S D ++ G+ E L GK+P
Sbjct: 163 PGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.3 bits (121), Expect = 1e-06
Identities = 46/208 (22%), Positives = 93/208 (44%), Gaps = 22/208 (10%)
Query: 382 GQVIEKTTYGTAYKA-KLADGATIALRLLREGSCKDRSSCLPVIRQ----LGKVRHENLI 436
G +I + +G YK L G +A++ + K + L I Q L ++H N++
Sbjct: 5 GDLIGRGAFGVVYKGLNLETGDFVAIKQIS--LEKIKEEALKSIMQEIDLLKNLKHPNIV 62
Query: 437 PLRAFYQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIA---RGLAY 493
+ +I +Y + +L ++ G +A+ + +GLAY
Sbjct: 63 KYIGSIETS-DSLYIILEYAENGSLRQIIKKF--GP--FP---ESLVAVYVYQVLQGLAY 114
Query: 494 LHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKADGYKAPEL 553
LH E + H ++++ N+L V +L +FG+ + V+ + ++ + APE+
Sbjct: 115 LH---EQGVIHRDIKAANILTTKDGVVKLADFGV-ATKLNDVSKDDASVVGTPYWMAPEV 170
Query: 554 QRMKKCSSRTDVYAFGILLLEILIGKKP 581
M S+ +D+++ G ++E+L G P
Sbjct: 171 IEMSGASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.7 bits (122), Expect = 1e-06
Identities = 45/193 (23%), Positives = 77/193 (39%), Gaps = 46/193 (23%)
Query: 389 TYGTAYKAKLADGAT---IALRLLREGSCKDRSSCLPVIRQLGKVR---HENLIPLR-AF 441
TYG YKAK +G A++ + + R++ +R HEN++ L F
Sbjct: 12 TYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVF 71
Query: 442 YQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHK-----------IALGIARG 490
+ L++DY HDL ++ + R+ K + I G
Sbjct: 72 LEHADKSVYLLFDY----AEHDLWQ-------IIKFHRQAKRVSIPPSMVKSLLWQILNG 120
Query: 491 LAYLHTGHEIPITHGNVRSKNVLV----DDFFVSRLTEFGLDQLMVPAVADEMVALAKAD 546
+ YLH+ + H +++ N+LV + V ++ + GL +L + LA D
Sbjct: 121 VHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAP----LKPLADLD 173
Query: 547 G------YKAPEL 553
Y+APEL
Sbjct: 174 PVVVTIWYRAPEL 186
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 1e-06
Identities = 60/286 (20%), Positives = 110/286 (38%), Gaps = 49/286 (17%)
Query: 383 QVIEKTTYGTAYKAKLADGATIALRLLREG-SCKDRSSCLPVIRQLGKVRHENLIPLRAF 441
+ I K +G YK L +A++ R + L L + H N++ L
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60
Query: 442 YQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIP 501
K+ ++ + P +L L V +++L A G+ YL + + I
Sbjct: 61 CVQKQ-PIYIVMELVPGGSLLTFLRKKKNRLTVKKLL---QMSLDAAAGMEYLESKNCI- 115
Query: 502 ITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKADGYK-------APELQ 554
H ++ ++N LV + V ++++FG M + ++ DG K APE
Sbjct: 116 --HRDLAARNCLVGENNVLKISDFG----MSREEEGGIYTVS--DGLKQIPIKWTAPEAL 167
Query: 555 RMKKCSSRTDVYAFGILLLEIL---IGKKPGKSGRNG-EFVDLPSIVKVAVLEETTMEVF 610
+ +S +DV+++GILL E PG S + E ++
Sbjct: 168 NYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIE------------------ 209
Query: 611 DMEIMKGIRSPMEEGLVQAL-KLAMGCCAPVASVRPTMDEVVKQLE 655
G R P + + + +L + C A RP+ E+ +L+
Sbjct: 210 -----SGYRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 1e-06
Identities = 29/100 (29%), Positives = 55/100 (55%), Gaps = 6/100 (6%)
Query: 482 KIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVA 541
+IA+ + +GL YL + + I H +V+ N+LV+ +L +FG+ +V ++A V
Sbjct: 99 RIAVAVVKGLTYLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYVG 155
Query: 542 LAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKP 581
+ Y APE ++ +DV++ GI +E+ +G+ P
Sbjct: 156 ---TNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 1e-06
Identities = 48/209 (22%), Positives = 96/209 (45%), Gaps = 17/209 (8%)
Query: 383 QVIEKTTYGTAYKAKLADGA----TIALRLLREG-SCKDRSSCLPVIRQLGKVRHENLIP 437
+VI +G + +L +A++ L+ G + K R L +G+ H N+I
Sbjct: 10 EVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIH 69
Query: 438 LRAFYQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTG 497
L R ++I ++ + L L V+ + GIA G+ YL
Sbjct: 70 LEGVVTKSR-PVMIITEFMENGALDSFLRQNDGQFTVIQLV---GMLRGIAAGMKYLS-- 123
Query: 498 HEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKADG----YKAPEL 553
E+ H ++ ++N+LV+ V ++++FGL + + +D + + APE
Sbjct: 124 -EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEA 182
Query: 554 QRMKKCSSRTDVYAFGILLLEIL-IGKKP 581
+K +S +DV+++GI++ E++ G++P
Sbjct: 183 IAYRKFTSASDVWSYGIVMWEVMSYGERP 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 2e-06
Identities = 38/120 (31%), Positives = 57/120 (47%), Gaps = 8/120 (6%)
Query: 482 KIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVA 541
KIA+ + L YL E+ I H +V+ N+L+D +L +FG+ +V ++A A
Sbjct: 111 KIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDA 168
Query: 542 LAKADGYKAPEL---QRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVK 598
+ Y APE R+DV++ GI L E+ GK P N F L +VK
Sbjct: 169 GCRP--YMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFP-YPKWNSVFDQLTQVVK 225
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 47/211 (22%), Positives = 99/211 (46%), Gaps = 9/211 (4%)
Query: 383 QVIEKTTYGTAYKAKLADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFY 442
Q I +G + + +A++ +REG+ + + + + K+ H L+ L
Sbjct: 10 QEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDF-IEEAQVMMKLSHPKLVQLYGVC 68
Query: 443 QGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPI 502
+R L++++ L D L A + + + L + G+AYL + + I
Sbjct: 69 T-ERSPICLVFEFMEHGCLSDYLR---AQRGKFSQETLLGMCLDVCEGMAYLESSNVI-- 122
Query: 503 THGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKADGYKAPELQRMKKCSSR 562
H ++ ++N LV + V ++++FG+ + ++ + +PE+ K SS+
Sbjct: 123 -HRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSK 181
Query: 563 TDVYAFGILLLEILI-GKKPGKSGRNGEFVD 592
+DV++FG+L+ E+ GK P ++ N E V+
Sbjct: 182 SDVWSFGVLMWEVFSEGKTPYENRSNSEVVE 212
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 2e-06
Identities = 49/184 (26%), Positives = 88/184 (47%), Gaps = 18/184 (9%)
Query: 401 GATIALRLLREGSCKDRSSCL-PVIRQLGKVRHENLIPLRAF--YQGKRGEKLLIYDYFP 457
G +A++ L+ S + + L I L + HEN++ + G G KL I ++ P
Sbjct: 33 GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKL-IMEFLP 91
Query: 458 SRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDF 517
S +L + L K +N ++ K A+ I +G+ YL + + H ++ ++NVLV+
Sbjct: 92 SGSLKEYLPRN---KNKINLKQQLKYAVQICKGMDYLGSRQYV---HRDLAARNVLVESE 145
Query: 518 FVSRLTEFGLDQLMVPAVADEMVALAKAD-----GYKAPELQRMKKCSSRTDVYAFGILL 572
++ +FGL + + D+ K D + APE K +DV++FG+ L
Sbjct: 146 HQVKIGDFGLTKAIE---TDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTL 202
Query: 573 LEIL 576
E+L
Sbjct: 203 YELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 3e-06
Identities = 58/218 (26%), Positives = 100/218 (45%), Gaps = 28/218 (12%)
Query: 384 VIEKTTYGTAYKAKL-ADGATI--ALRLLREGSCKDR----SSCLPVIRQLGKVRHENLI 436
VI + +G KA++ DG + A++ ++E + KD + L V+ +LG H N+I
Sbjct: 14 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH--HPNII 71
Query: 437 PLRAFYQGKRGEKLLIYDYFPSRTLHDLLHDT--IAGKPVLNWARRHKIALG-------- 486
L + RG L +Y P L D L + + P A L
Sbjct: 72 NLLGACE-HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 130
Query: 487 --IARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAK 544
+ARG+ YL I H ++ ++N+LV + +V+++ +FGL + V M L
Sbjct: 131 ADVARGMDYLSQKQFI---HRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPV 187
Query: 545 ADGYKAPELQRMKKCSSRTDVYAFGILLLEIL-IGKKP 581
+ A E ++ +DV+++G+LL EI+ +G P
Sbjct: 188 R--WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 223
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 3e-06
Identities = 29/100 (29%), Positives = 57/100 (57%), Gaps = 5/100 (5%)
Query: 482 KIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVA 541
KI++ + RGL YL H+I H +V+ N+LV+ +L +FG+ ++ ++A+ V
Sbjct: 103 KISIAVLRGLTYLREKHKI--MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVG 160
Query: 542 LAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKP 581
Y +PE + + ++D+++ G+ L+E+ IG+ P
Sbjct: 161 ---TRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 3e-06
Identities = 46/205 (22%), Positives = 89/205 (43%), Gaps = 24/205 (11%)
Query: 385 IEKTTYGTAYKA-KLADGATIALRLLREGS--CKDRSSCLPVIRQLGKVRHENLIPLRAF 441
I K +G+ Y A K + G A+++L++ K++ + + R + ++ E+ + +
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63
Query: 442 YQGKRGEKL-LIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEI 500
Y + + L L+ +Y L+ T+ G P +WA+++ + G+ LH
Sbjct: 64 YSFQSKDYLYLVMEYLNGGDCASLIK-TLGGLP-EDWAKQY--IAEVVLGVEDLHQRG-- 117
Query: 501 PITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAK----ADGYKAPELQRM 556
I H +++ +N+L+D +LT+FGL K Y APE
Sbjct: 118 -IIHRDIKPENLLIDQTGHLKLTDFGL---------SRNGLENKKFVGTPDYLAPETILG 167
Query: 557 KKCSSRTDVYAFGILLLEILIGKKP 581
+D ++ G ++ E L G P
Sbjct: 168 VGDDKMSDWWSLGCVIFEFLFGYPP 192
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 4e-06
Identities = 34/125 (27%), Positives = 58/125 (46%), Gaps = 18/125 (14%)
Query: 487 IARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKAD 546
I GL YLH I H +V+++N+ ++D + + G Q P VA + LA
Sbjct: 166 ILEGLRYLH-AQRI--IHRDVKTENIFINDVDQVCIGDLGAAQF--PVVAPAFLGLAGTV 220
Query: 547 GYKAPELQRMKKCSSRTDVYAFGILLLEILI------------GKKPGKSGRNGEFVDLP 594
APE+ K +S+ D+++ GI+L E+L ++ KS + + +
Sbjct: 221 ETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHS-HLLKII 279
Query: 595 SIVKV 599
S +KV
Sbjct: 280 STLKV 284
|
Length = 357 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 4e-06
Identities = 41/163 (25%), Positives = 77/163 (47%), Gaps = 16/163 (9%)
Query: 424 IRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKI 483
++ L +RHEN+I L + + YF + L LH + +P+ ++
Sbjct: 60 LKLLKHLRHENIISLSDIFISPLEDI-----YFVTELLGTDLHRLLTSRPLEKQFIQY-F 113
Query: 484 ALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALA 543
I RGL Y+H+ + H +++ N+L+++ ++ +FGL ++ P +M
Sbjct: 114 LYQILRGLKYVHSAGVV---HRDLKPSNILINENCDLKICDFGLARIQDP----QMTGYV 166
Query: 544 KADGYKAPELQ-RMKKCSSRTDVYAFGILLLEILIGKK--PGK 583
Y+APE+ +K D+++ G + E+L GK PGK
Sbjct: 167 STRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGK 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 5e-06
Identities = 49/278 (17%), Positives = 106/278 (38%), Gaps = 53/278 (19%)
Query: 394 YKAKLADGATIALRLLREGSCKDRSSCLPVIRQ-------LGKVRHENLIPLRAFYQGKR 446
YK + + +R + K +I L ++ N++ + F
Sbjct: 37 YKGIF-NNKEVIIRTFK----KFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFI---- 87
Query: 447 GEKLLIYDYFPSRTL------HDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEI 500
+ I D P +L L + + + L++ + +A+ +GL L+
Sbjct: 88 ---IDIVDDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNK 144
Query: 501 PITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKADGYKAPELQR--MKK 558
P + N+ S + LV + + ++ GL++++ + + Y + ++ +
Sbjct: 145 P--YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMV----YFSYKMLNDIFSE 198
Query: 559 CSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGI 618
+ + D+Y+ G++L EI GK P F +L TT E++D+ I K
Sbjct: 199 YTIKDDIYSLGVVLWEIFTGKIP--------FENL-----------TTKEIYDLIINKNN 239
Query: 619 RSPMEEGLVQALK-LAMGCCAPVASVRPTMDEVVKQLE 655
+ +K + C + + RP + E++ L
Sbjct: 240 SLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLS 277
|
Length = 283 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 5e-06
Identities = 59/262 (22%), Positives = 118/262 (45%), Gaps = 40/262 (15%)
Query: 404 IALRLLREG-SCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRTLH 462
+A++ L+ G + K R L +G+ H N+I L K +++ +Y + +L
Sbjct: 35 VAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVT-KSKPVMIVTEYMENGSLD 93
Query: 463 DLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRL 522
L V+ + GIA G+ YL ++ H ++ ++N+LV+ V ++
Sbjct: 94 AFLRKHDGQFTVIQLV---GMLRGIASGMKYLS---DMGYVHRDLAARNILVNSNLVCKV 147
Query: 523 TEFGLDQLMVPAVADEMVALAKADGYK------APELQRMKKCSSRTDVYAFGILLLEIL 576
++FGL +++ D+ A G K APE +K +S +DV+++GI++ E++
Sbjct: 148 SDFGLSRVL----EDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVM 203
Query: 577 -IGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIRSPMEEGLVQAL-KLAM 634
G++P + ++ + + +EE G R P AL +L +
Sbjct: 204 SYGERP--------YWEMSNQDVIKAIEE------------GYRLPAPMDCPAALHQLML 243
Query: 635 GCCAPVASVRPTMDEVVKQLEE 656
C + RP +++V L++
Sbjct: 244 DCWQKDRNERPKFEQIVSILDK 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 48.3 bits (116), Expect = 5e-06
Identities = 53/212 (25%), Positives = 92/212 (43%), Gaps = 32/212 (15%)
Query: 389 TYGTAYKAK-LADGATIALRLLREGSCKDRS-----SCLPVIRQLGKVRHENLIPLRAFY 442
TY YKA+ G +A++ ++ G K+ + L I+ L +++H N+I L +
Sbjct: 12 TYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVF 71
Query: 443 QGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPI 502
G + L++++ + L ++ D VL A L RGL YLH I
Sbjct: 72 -GHKSNINLVFEFMET-DLEKVIKDKSI---VLTPADIKSYMLMTLRGLEYLH---SNWI 123
Query: 503 THGNVRSKNVLVDDFFVSRLTEFGL-------DQLMVPAVADEMVALAKADGYKAPELQR 555
H +++ N+L+ V +L +FGL ++ M V Y+APEL
Sbjct: 124 LHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRW--------YRAPELLF 175
Query: 556 MKKC-SSRTDVYAFGILLLEILIGKK--PGKS 584
+ D+++ G + E+L+ PG S
Sbjct: 176 GARHYGVGVDMWSVGCIFAELLLRVPFLPGDS 207
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 6e-06
Identities = 36/120 (30%), Positives = 56/120 (46%), Gaps = 9/120 (7%)
Query: 482 KIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVA 541
K+ + I + L YL H + H +V+ N+L+D +L +FG+ +V + A A
Sbjct: 118 KMTVAIVKALHYLKEKHGV--IHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSA 175
Query: 542 LAKADGYKAPELQRMKKCSS----RTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIV 597
A Y APE + R DV++ GI L+E+ G+ P K EF L I+
Sbjct: 176 GCAA--YMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYK-NCKTEFEVLTKIL 232
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 6e-06
Identities = 43/176 (24%), Positives = 72/176 (40%), Gaps = 35/176 (19%)
Query: 429 KVRHENLIPLRAFYQGKRGEKL-LIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGI 487
+ HENLI L Y L ++ + P +L D L + A+ I
Sbjct: 52 SLDHENLIRL---YGVVLTHPLMMVTELAPLGSLLDRLRKD--ALGHFLISTLCDYAVQI 106
Query: 488 ARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKADG 547
A G+ YL + I H ++ ++N+L+ ++ +FGL M AL + +
Sbjct: 107 ANGMRYLESKRFI---HRDLAARNILLASDDKVKIGDFGL-----------MRALPQNED 152
Query: 548 YK-------------APELQRMKKCSSRTDVYAFGILLLEIL-IGKKPGKSGRNGE 589
+ APE R + S +DV+ FG+ L E+ G++P G +G
Sbjct: 153 HYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWA-GLSGS 207
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 6e-06
Identities = 43/184 (23%), Positives = 80/184 (43%), Gaps = 47/184 (25%)
Query: 423 VIRQLGKVRHENLI---------PLRAFYQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKP 473
++R +G E L+ PL F GK+ D + +L+H
Sbjct: 57 IVRMIGVCEAEALMLVMEMASGGPLNKFLSGKK-------DEITVSNVVELMHQ------ 103
Query: 474 VLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVP 533
++ G+ YL H ++ ++NVL+ + +++++FGL + +
Sbjct: 104 -------------VSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALG- 146
Query: 534 AVADEMVALAKADG-----YKAPELQRMKKCSSRTDVYAFGILLLEIL-IGKKPGKSGRN 587
AD+ A++ G + APE +K SSR+DV+++GI + E G+KP K +
Sbjct: 147 --ADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG 204
Query: 588 GEFV 591
E +
Sbjct: 205 PEVM 208
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 7e-06
Identities = 51/245 (20%), Positives = 99/245 (40%), Gaps = 66/245 (26%)
Query: 371 HLTLEDV--LNATGQVIEKTTYGTAYKAKLADGA------TIALRLLREGSCKDRSSCLP 422
+ L V L G+ +G YK +L ++A++ L+E + P
Sbjct: 1 EIPLSAVRFLEELGE----GAFGKVYKGELTGPNERLSATSVAIKTLKE-------NAEP 49
Query: 423 VIRQ--------LGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRTLHDLL-----HDTI 469
++Q + ++H N++ L K ++++Y LH+ L H +
Sbjct: 50 KVQQEFRQEAELMSDLQHPNIVCLLGVCT-KEQPTCMLFEYLAHGDLHEFLVRNSPHSDV 108
Query: 470 A-------GKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRL 522
K L+ + IA+ IA G+ YL + H H ++ ++N LV + ++
Sbjct: 109 GAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGLTVKI 165
Query: 523 TEFGLDQLMVPAVADEMVALAKADGYK------------APELQRMKKCSSRTDVYAFGI 570
++FGL + + AD Y+ PE K ++ +D+++FG+
Sbjct: 166 SDFGLSRDIY-----------SADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGV 214
Query: 571 LLLEI 575
+L EI
Sbjct: 215 VLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 7e-06
Identities = 67/283 (23%), Positives = 122/283 (43%), Gaps = 39/283 (13%)
Query: 383 QVIEKTTYGTAYKAKLA----DGATIALRLLREGSC-KDRSSCLPVIRQLGKVRHENLIP 437
+VI +G + +L +A++ L+ GS K R L +G+ H N+I
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69
Query: 438 LRAFYQGKRGEKLLIYDYFPSRTLHDLL--HDTIAGKPVLNWARRHKIALGIARGLAYLH 495
L K ++I +Y + +L L +D GK + + GIA G+ YL
Sbjct: 70 LEGVVT-KSRPVMIITEYMENGSLDKFLREND---GK--FTVGQLVGMLRGIASGMKYLS 123
Query: 496 TGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKAD-GYKAPELQ 554
E+ H ++ ++N+LV+ V ++++FGL + + + A K + APE
Sbjct: 124 ---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAI 180
Query: 555 RMKKCSSRTDVYAFGILLLEIL-IGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDME 613
+K +S +DV++FGI++ E++ G++P N + +
Sbjct: 181 AYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIK--------------------A 220
Query: 614 IMKGIRSPMEEGLVQAL-KLAMGCCAPVASVRPTMDEVVKQLE 655
+ G R P AL +L + C + RPT ++V L+
Sbjct: 221 VEDGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLD 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 8e-06
Identities = 23/66 (34%), Positives = 34/66 (51%)
Query: 101 LLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFT 160
L+S+ L L+G +P E +L L L+ N L G IP LG SL ++++S N
Sbjct: 525 LVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLH 584
Query: 161 GVLAPS 166
G L +
Sbjct: 585 GSLPST 590
|
Length = 968 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 8e-06
Identities = 59/274 (21%), Positives = 115/274 (41%), Gaps = 52/274 (18%)
Query: 400 DGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQ--GKRGEKLLIYDYFP 457
D +A++ L++ + R L ++HE+++ FY G +++++Y
Sbjct: 34 DKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV---KFYGVCGDGDPLIMVFEYMK 90
Query: 458 SRTLHDLLHD-------TIAGKPV-----LNWARRHKIALGIARGLAYLHTGHEIPITHG 505
L+ L + G+P L ++ IA IA G+ YL + H H
Sbjct: 91 HGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHR 147
Query: 506 NVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKADGYKA------------PEL 553
++ ++N LV + ++ +FG+ + + D Y+ PE
Sbjct: 148 DLATRNCLVGANLLVKIGDFGMSR-----------DVYSTDYYRVGGHTMLPIRWMPPES 196
Query: 554 QRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAVLEETTM---EV 609
+K ++ +DV++FG++L EI GK+P N E ++ I + VLE + EV
Sbjct: 197 IMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIE--CITQGRVLERPRVCPKEV 254
Query: 610 FDMEIMKGIRSPMEE---GLVQALKLAMGCCAPV 640
+D+ + R P + + + A+G P+
Sbjct: 255 YDIMLGCWQREPQQRLNIKEIYKILHALGKATPI 288
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 8e-06
Identities = 32/117 (27%), Positives = 61/117 (52%), Gaps = 10/117 (8%)
Query: 483 IALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVAL 542
+ + G+ YL I H ++ ++N LV V ++++FG+ + ++ DE +
Sbjct: 105 MCQDVCEGMEYLERNSFI---HRDLAARNCLVSSTGVVKVSDFGMTRYVLD---DEYTSS 158
Query: 543 AKAD---GYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPS 595
+ A + PE+ K SS++DV++FG+L+ E+ GK P + N E V++ S
Sbjct: 159 SGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMIS 215
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 8e-06
Identities = 47/181 (25%), Positives = 74/181 (40%), Gaps = 37/181 (20%)
Query: 484 ALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALA 543
+ ++ LAYL + H ++ ++NVLV +L +FGL + + E +
Sbjct: 113 SYQLSTALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYL------EDESYY 163
Query: 544 KADGYK------APELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSI 596
KA K APE ++ +S +DV+ FG+ + EIL+ G KP + +N + +
Sbjct: 164 KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVI----- 218
Query: 597 VKVAVLEETTMEVFDMEIMKGIRSPMEEGLVQALKLAMG-CCAPVASVRPTMDEVVKQLE 655
I G R PM L M C A S RP E+ QL
Sbjct: 219 ---------------GRIENGERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLS 263
Query: 656 E 656
+
Sbjct: 264 D 264
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 9e-06
Identities = 34/109 (31%), Positives = 58/109 (53%), Gaps = 12/109 (11%)
Query: 487 IARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKAD 546
++ G+ YL E H ++ ++NVL+ +++++FGL + + ADE AK
Sbjct: 104 VSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALG---ADENYYKAKTH 157
Query: 547 G-----YKAPELQRMKKCSSRTDVYAFGILLLEIL-IGKKPGKSGRNGE 589
G + APE K SS++DV++FG+L+ E G+KP K + E
Sbjct: 158 GKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE 206
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 9e-06
Identities = 47/193 (24%), Positives = 88/193 (45%), Gaps = 8/193 (4%)
Query: 383 QVIEKTTYGTAYKAKLADGATIALRLLREGSCKD-RSSCLPVIRQLGKVRHENLIPLRAF 441
+++ K +G +K L D +A++ +E ++ + L R L + H N++ L
Sbjct: 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGV 60
Query: 442 YQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIP 501
+R ++ + P D L K L + K AL A G+AYL + + I
Sbjct: 61 CT-QRQPIYIVMELVPG---GDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCI- 115
Query: 502 ITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKADGYKAPELQRMKKCSS 561
H ++ ++N LV + V ++++FG+ + + + APE + SS
Sbjct: 116 --HRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSS 173
Query: 562 RTDVYAFGILLLE 574
+DV+++GILL E
Sbjct: 174 ESDVWSYGILLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 1e-05
Identities = 24/62 (38%), Positives = 37/62 (59%)
Query: 100 HLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLF 159
HL SI L ++ G++P LG + L+ L L+ NS G+IP LG +SL ++L+ N
Sbjct: 443 HLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSL 502
Query: 160 TG 161
+G
Sbjct: 503 SG 504
|
Length = 623 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 47.8 bits (113), Expect = 1e-05
Identities = 42/141 (29%), Positives = 70/141 (49%), Gaps = 24/141 (17%)
Query: 451 LIYDYFPSRTLHDLLH---DTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNV 507
L+ P L D +H D I + +LNW + IA+G+ YL E + H ++
Sbjct: 85 LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWC------VQIAKGMMYLE---ERRLVHRDL 135
Query: 508 RSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKADGYKAP------ELQRMKKCSS 561
++NVLV ++T+FGL +L+ DE ADG K P E +K +
Sbjct: 136 AARNVLVKSPNHVKITDFGLARLL---EGDE--KEYNADGGKMPIKWMALECIHYRKFTH 190
Query: 562 RTDVYAFGILLLEIL-IGKKP 581
++DV+++G+ + E++ G KP
Sbjct: 191 QSDVWSYGVTIWELMTFGGKP 211
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 1e-05
Identities = 30/104 (28%), Positives = 55/104 (52%), Gaps = 1/104 (0%)
Query: 479 RRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADE 538
R H+ L + L +H H + H +++S N+L+ + +L +FG ++ V+D+
Sbjct: 141 REHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDD 200
Query: 539 M-VALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKP 581
+ Y APE+ R K S + D+++ G+LL E+L K+P
Sbjct: 201 VGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRP 244
|
Length = 496 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 2e-05
Identities = 59/282 (20%), Positives = 122/282 (43%), Gaps = 45/282 (15%)
Query: 383 QVIEKTTYGTAYKAK-LADGATIALRLLR-EGSCKD-RSSCLPVIRQLGKVRHENLIPLR 439
+V+ + +G + + AD + ++ + E KD R + + L + H N+I
Sbjct: 6 RVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNII--- 62
Query: 440 AFYQGKRGEKLL--IYDYFPSRTLHDLLHDT----IAGKPVLNWARRHKIALGIARGLAY 493
+Y+ +K L + +Y P TL + + + +L++ + +AL
Sbjct: 63 EYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLAL-------- 114
Query: 494 LHTGHEIPITHGNVRSKNVLVDDF-FVSRLTEFGLDQLMVPAVADEMVALAKADGYKAPE 552
H H I H +++++N+L+D V ++ +FG+ +++ V Y +PE
Sbjct: 115 -HHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVV--GTPCYISPE 171
Query: 553 LQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDM 612
L K + ++D++A G +L E+ K R E +LP++V +
Sbjct: 172 LCEGKPYNQKSDIWALGCVLYELASLK------RAFEAANLPALV--------------L 211
Query: 613 EIMKGIRSPMEEGLVQALK-LAMGCCAPVASVRPTMDEVVKQ 653
+IM G +P+ + L+ L + S RP + +++ Q
Sbjct: 212 KIMSGTFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 2e-05
Identities = 55/223 (24%), Positives = 103/223 (46%), Gaps = 38/223 (17%)
Query: 384 VIEKTTYGTAYKAKLA-DGATI--ALRLLREGSC----KDRSSCLPVIRQLGKVRHENLI 436
VI + +G KA++ DG + A++ ++E + +D + L V+ +LG H N+I
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG--HHPNII 59
Query: 437 PLRAFYQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRH------------KIA 484
L + RG L +Y P L D L + + +A + A
Sbjct: 60 NLLGACE-HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 118
Query: 485 LGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAK 544
+ARG+ YL + H ++ ++N+LV + +V+++ +FGL + + V + K
Sbjct: 119 ADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR-------GQEVYVKK 168
Query: 545 ADG-----YKAPELQRMKKCSSRTDVYAFGILLLEIL-IGKKP 581
G + A E ++ +DV+++G+LL EI+ +G P
Sbjct: 169 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 211
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 2e-05
Identities = 43/174 (24%), Positives = 77/174 (44%), Gaps = 26/174 (14%)
Query: 419 SCLPVIRQLGKV---RHENLI--------PLRAFYQGKRGEKLLIYDYFPSRTLHDLLHD 467
SC V R+L + +H+N++ P ++ Y + + LH
Sbjct: 42 SCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFE---------EIYVVTELMQSDLHK 92
Query: 468 TIAGKPVLNWARRHKIAL-GIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFG 526
I L+ + K+ L I RGL YLH+ I H +++ N+LV+ V ++ +FG
Sbjct: 93 IIVSPQPLS-SDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFG 148
Query: 527 LDQLMVPAVADEMVALAKADGYKAPE-LQRMKKCSSRTDVYAFGILLLEILIGK 579
L ++ P + M Y+APE L + +S D+++ G + E+L +
Sbjct: 149 LARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 50/197 (25%), Positives = 82/197 (41%), Gaps = 43/197 (21%)
Query: 404 IALRLLREG-SCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIY-DYFPSRTL 461
+A+ LR G S K R L LG+ H N++ L RG ++I +Y + L
Sbjct: 36 VAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVIT--RGNTMMIVTEYMSNGAL 93
Query: 462 HDLLHDTIAGKPVLNWARRHKIAL----------GIARGLAYLHTGHEIPITHGNVRSKN 511
L R+H+ L G+A G+ YL E+ H + +
Sbjct: 94 DSFL-------------RKHEGQLVAGQLMGMLPGLASGMKYLS---EMGYVHKGLAAHK 137
Query: 512 VLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKADGYK------APELQRMKKCSSRTDV 565
VLV+ V +++ F D+ A+ K APE + SS +DV
Sbjct: 138 VLVNSDLVCKISGFR------RLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDV 191
Query: 566 YAFGILLLEIL-IGKKP 581
++FGI++ E++ G++P
Sbjct: 192 WSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 54/228 (23%), Positives = 102/228 (44%), Gaps = 40/228 (17%)
Query: 382 GQVIEKTTYGTAYKAK-LADGATIALRLLREGSCK-DRSSCLPVIRQLGKVRHENLIPLR 439
G+V++ TA++ K A T+A+++L+E + + L L +V H ++I L
Sbjct: 14 GKVVK----ATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLY 69
Query: 440 AFYQGKRGEKLLIYDYFPSRTLHDLL--------------------HDTIAGKPVLNWAR 479
+ G LLI +Y +L L + + L
Sbjct: 70 GACS-QDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGD 128
Query: 480 RHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEM 539
A I+RG+ YL E+ + H ++ ++NVLV + ++++FGL + V +E
Sbjct: 129 LISFAWQISRGMQYLA---EMKLVHRDLAARNVLVAEGRKMKISDFGLSR----DVYEED 181
Query: 540 VALAKADG-----YKAPELQRMKKCSSRTDVYAFGILLLEIL-IGKKP 581
+ ++ G + A E ++++DV++FG+LL EI+ +G P
Sbjct: 182 SYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 229
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 2e-05
Identities = 30/100 (30%), Positives = 53/100 (53%), Gaps = 6/100 (6%)
Query: 482 KIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVA 541
KIA + +GL+YLH+ I H +++ N+L+ +L +FG+ +V ++A
Sbjct: 109 KIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFTG 165
Query: 542 LAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKP 581
+ Y APE + K S +DV++ G+ LLE+ + P
Sbjct: 166 TSF---YMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFP 202
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 38/134 (28%), Positives = 67/134 (50%), Gaps = 21/134 (15%)
Query: 467 DTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFG 526
D I + +LNW + IA+G++YL E+ + H ++ ++NVLV ++T+FG
Sbjct: 104 DRIGSQDLLNWC------VQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFG 154
Query: 527 LDQLMVPAVADEMVALAKADGYKAP------ELQRMKKCSSRTDVYAFGILLLEIL-IGK 579
L +L+ D ADG K P E ++ + ++DV+++G+ + E++ G
Sbjct: 155 LARLL-----DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGA 209
Query: 580 KPGKSGRNGEFVDL 593
KP E DL
Sbjct: 210 KPYDGIPAREIPDL 223
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 3e-05
Identities = 57/220 (25%), Positives = 98/220 (44%), Gaps = 42/220 (19%)
Query: 383 QVIEKTTYGTAYKAK-LADGATI----ALRLLREG-SCKDRSSCLPVIRQLGKVRHENL- 435
+V+ +GT YK + +G + A++ LRE S K L + V + ++
Sbjct: 13 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 72
Query: 436 ----IPLRAFYQGKRGEKLLIYDYFPSRTLHDLLH---DTIAGKPVLNWARRHKIALGIA 488
I L + Q LI P L D + D I + +LNW + IA
Sbjct: 73 RLLGICLTSTVQ-------LITQLMPFGCLLDYVREHKDNIGSQYLLNWC------VQIA 119
Query: 489 RGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKADGY 548
+G+ YL + H ++ ++NVLV ++T+FGL +L+ ADE A+G
Sbjct: 120 KGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL---GADEKE--YHAEGG 171
Query: 549 KAP------ELQRMKKCSSRTDVYAFGILLLEIL-IGKKP 581
K P E + + ++DV+++G+ + E++ G KP
Sbjct: 172 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 211
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 3e-05
Identities = 58/217 (26%), Positives = 95/217 (43%), Gaps = 18/217 (8%)
Query: 383 QVIEKTTYGTAYKAKLA-DGATIALRLLREGSCKDRSSCLPVIRQ----LGKVRHENLIP 437
+VI K ++G AK DG A+++L++ +R ++ + L V+H L+
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 438 LRAFYQGKRGEKL-LIYDYFPSRTLH-DLLHDTIAGKPVLNWARRHKIALGIARGLAYLH 495
L Y + EKL + D+ L L + +P R A IA L YLH
Sbjct: 61 LH--YSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEP-----RARFYAAEIASALGYLH 113
Query: 496 TGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKADGYKAPELQR 555
+ I I + +++ +N+L+D LT+FGL + + A +D Y APE+ R
Sbjct: 114 S---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGI-AQSDTTTTFCGTPEYLAPEVIR 169
Query: 556 MKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVD 592
+ + D + G +L E+L G P E D
Sbjct: 170 KQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYD 206
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 4e-05
Identities = 55/224 (24%), Positives = 94/224 (41%), Gaps = 32/224 (14%)
Query: 383 QVIEKTTYGTAYKAK-LADGATIALRLLREGSCKDRSSCLPVIRQ----LGKVRHENLIP 437
+VI K ++G AK ADG A+++L++ + + ++ + L V+H L+
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 438 LRAFYQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHK---------IALGIA 488
L +Q +KL YF + D + G + +R + A IA
Sbjct: 61 LHYSFQTA--DKL----YF--------VLDYVNGGELFFHLQRERSFPEPRARFYAAEIA 106
Query: 489 RGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKADGY 548
L YLH + I + +++ +N+L+D LT+FGL + + + Y
Sbjct: 107 SALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGI-EHSKTTSTFCGTPEY 162
Query: 549 KAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVD 592
APE+ R + D + G +L E+L G P S E D
Sbjct: 163 LAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYD 206
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 5e-05
Identities = 28/97 (28%), Positives = 51/97 (52%), Gaps = 5/97 (5%)
Query: 487 IARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKAD 546
I G+ +LH + I + +++ +NVL+DD RL++ GL + + + A +
Sbjct: 104 ITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGL-AVELKD-GKTITQRAGTN 158
Query: 547 GYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGK 583
GY APE+ + + S D +A G + E++ G+ P K
Sbjct: 159 GYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFK 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 6e-05
Identities = 56/217 (25%), Positives = 99/217 (45%), Gaps = 29/217 (13%)
Query: 383 QVIEKT---TYGTAYKAK-LADGATIALRLLR-----EGSCKDRSSCLPVIRQLGKVRHE 433
Q +EK TYG YKA+ G +AL+ +R EG S+ + I L ++ H
Sbjct: 3 QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGV---PSTAIREISLLKELNHP 59
Query: 434 NLIPLRAFYQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAY 493
N++ L + KL + F + L + + L + + L +GLA+
Sbjct: 60 NIVKLLDVIHTEN--KLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQL--LQGLAF 115
Query: 494 LHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQ---LMVPAVADEMVALAKADGYKA 550
H+ H + H +++ +N+L++ +L +FGL + + V E+V L Y+A
Sbjct: 116 CHS-HR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTL----WYRA 168
Query: 551 PE-LQRMKKCSSRTDVYAFGILLLEILIGKK--PGKS 584
PE L K S+ D+++ G + E++ + PG S
Sbjct: 169 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 6e-05
Identities = 46/213 (21%), Positives = 93/213 (43%), Gaps = 36/213 (16%)
Query: 390 YGTAYKAKLADGA------TIALRLLR---EGSCKDRSSCLPVIRQLGKVRHENLIPLRA 440
+G YK L A +A++ L+ EG ++ ++R +++H N++ L
Sbjct: 18 FGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMR--SRLQHPNIVCLLG 75
Query: 441 FYQGKRGEKLLIYDYFPSRTLHDLL-----HDTIAG-------KPVLNWARRHKIALGIA 488
K +I+ Y LH+ L H + K L A I IA
Sbjct: 76 VVT-KEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIA 134
Query: 489 RGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPA-----VADEMVALA 543
G+ +L + H + H ++ ++NVLV D ++++ GL + + A + + ++ +
Sbjct: 135 AGMEFLSSHH---VVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIR 191
Query: 544 KADGYKAPELQRMKKCSSRTDVYAFGILLLEIL 576
+ +PE K S +D++++G++L E+
Sbjct: 192 ----WMSPEAIMYGKFSIDSDIWSYGVVLWEVF 220
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 7e-05
Identities = 34/135 (25%), Positives = 58/135 (42%), Gaps = 32/135 (23%)
Query: 459 RTLHDLLHDTIA------GKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNV 512
R L H T + L+ + IA +A G+AYL + H ++ ++N
Sbjct: 105 RAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFV---HRDLATRNC 161
Query: 513 LVDDFFVSRLTEFGLDQLMVPAVADEMVALAKADGYKA------------PELQRMKKCS 560
LV + V ++ +FGL + + AD YKA PE + +
Sbjct: 162 LVGENMVVKIADFGLSRNIY-----------SADYYKASENDAIPIRWMPPESIFYNRYT 210
Query: 561 SRTDVYAFGILLLEI 575
+ +DV+A+G++L EI
Sbjct: 211 TESDVWAYGVVLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 7e-05
Identities = 54/206 (26%), Positives = 96/206 (46%), Gaps = 23/206 (11%)
Query: 389 TYGTAYKAKLAD-GATIALRLLREGSCKD---RSSCLPVIRQLGKVRHENLIPLRAFYQG 444
+YG +K + + G +A++ E S D + L IR L +++H NL+ L ++
Sbjct: 13 SYGVVFKCRNRETGQIVAIKKFVE-SEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRR 71
Query: 445 KRGEKL-LIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPIT 503
KR KL L+++Y H +L++ + KI + + + H + I
Sbjct: 72 KR--KLHLVFEYCD----HTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCI--- 122
Query: 504 HGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVAD--EMVALAKADGYKAPELQRMK-KCS 560
H +V+ +N+L+ +L +FG +++ D + VA Y+APEL +
Sbjct: 123 HRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVA---TRWYRAPELLVGDTQYG 179
Query: 561 SRTDVYAFGILLLEILIGKK--PGKS 584
DV+A G + E+L G+ PGKS
Sbjct: 180 PPVDVWAIGCVFAELLTGQPLWPGKS 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 8e-05
Identities = 38/171 (22%), Positives = 79/171 (46%), Gaps = 14/171 (8%)
Query: 409 LREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRTLHDLLHDT 468
LR S ++R + + L +++H N++ R ++G+ G ++ + L+ L +
Sbjct: 35 LRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQ 94
Query: 469 ----IAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTE 524
+ V+ W + IA L YLH H I H +++++NV + + ++ +
Sbjct: 95 KGKLLPENQVVEWF------VQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGD 145
Query: 525 FGLDQLMVPAVADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEI 575
G+ +++ D L Y +PEL K + ++DV+A G + E+
Sbjct: 146 LGIARVL-ENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEM 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 9e-05
Identities = 58/271 (21%), Positives = 117/271 (43%), Gaps = 32/271 (11%)
Query: 401 GATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAF-YQGKRGEKLLIYDYFPSR 459
G +A++ L+ + + I L ++H+N++ + Y R L+ +Y P
Sbjct: 33 GEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYG 92
Query: 460 TLHDLL---HDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDD 516
+L D L + + + +L +A + I +G+ YL + + H ++ ++N+LV+
Sbjct: 93 SLRDYLQKHRERLDHRKLLLYASQ------ICKGMEYLGSKRYV---HRDLATRNILVES 143
Query: 517 FFVSRLTEFGLDQLMVPAVADEMVALAKADG---YKAPELQRMKKCSSRTDVYAFGILLL 573
++ +FGL +++ P + + + APE K S +DV++FG++L
Sbjct: 144 ENRVKIGDFGLTKVL-PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLY 202
Query: 574 EILIGKKPGKSGRNGEFVDLPSIVKVAVL---EETTMEVFDM-EIMK-GIRSPMEEGLVQ 628
E+ S P + ++ ++ M V+ + E++K R P G
Sbjct: 203 ELFTYSDKSCS---------PPAEFMRMMGNDKQGQMIVYHLIELLKNNGRLPAPPGCPA 253
Query: 629 ALKLAMG-CCAPVASVRPTMDEVVKQLEENR 658
+ M C S RP+ E+ Q+E R
Sbjct: 254 EIYAIMKECWNNDPSQRPSFSELALQVEAIR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 1e-04
Identities = 47/233 (20%), Positives = 96/233 (41%), Gaps = 53/233 (22%)
Query: 383 QVIEKTTYGTAYKAKLA------DGATIALRLLREGSCKDRSSCLPVIRQ---LGKVRHE 433
+ + + +G + + D +A++ L+E + + R+ L +HE
Sbjct: 11 RELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA--SNDARKDFEREAELLTNFQHE 68
Query: 434 NLIPLRAFYQ--GKRGEKLLIYDYFPSRTLHDLL-----HDTIAGKP-----VLNWARRH 481
N++ FY + +++++Y L+ L P L ++
Sbjct: 69 NIV---KFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLL 125
Query: 482 KIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVA 541
+IA+ IA G+ YL + H H ++ ++N LV V ++ +FG+ +
Sbjct: 126 QIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVVKIGDFGMSR-----------D 171
Query: 542 LAKADGYK------------APELQRMKKCSSRTDVYAFGILLLEIL-IGKKP 581
+ D Y+ PE +K ++ +DV++FG++L EI GK+P
Sbjct: 172 VYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 49/215 (22%), Positives = 99/215 (46%), Gaps = 16/215 (7%)
Query: 411 EGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRTLHDLLHDTIA 470
E + + + + L ++ L ++ EN++ L+ ++ +RG+ L+++Y + + +LL +
Sbjct: 38 EENEEVKETTLRELKMLRTLKQENIVELKEAFR-RRGKLYLVFEYV-EKNMLELLEEMPN 95
Query: 471 GKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQL 530
G P K+ I + + +H H+ I H +++ +N+L+ V +L +FG +
Sbjct: 96 GVP------PEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARN 149
Query: 531 MVPAVADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKK--PGKSGRNG 588
+ Y++PEL D+++ G +L E+ G+ PG+S
Sbjct: 150 LSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGES---- 205
Query: 589 EFVDLPSIVKV-AVLEETTMEVF-DMEIMKGIRSP 621
E L +I KV L M++F G+R P
Sbjct: 206 EIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFP 240
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 1e-04
Identities = 32/111 (28%), Positives = 54/111 (48%), Gaps = 5/111 (4%)
Query: 471 GKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQL 530
G+P AR A I GL +LH + I + +++ +NVL+DD R+++ GL
Sbjct: 88 GEPGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVE 144
Query: 531 MVPAVADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKP 581
+ ++ A GY APE+ + + D +A G L E++ G+ P
Sbjct: 145 L--KGGKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 1e-04
Identities = 30/101 (29%), Positives = 50/101 (49%), Gaps = 16/101 (15%)
Query: 487 IARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKAD 546
I GL +LH I + +++ NVL+D ++ +FG+ + M KA
Sbjct: 105 IICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKE-------NMNGEGKAS 154
Query: 547 G------YKAPELQRMKKCSSRTDVYAFGILLLEILIGKKP 581
Y APE+ + +K + D ++FG+LL E+LIG+ P
Sbjct: 155 TFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 51/224 (22%), Positives = 86/224 (38%), Gaps = 54/224 (24%)
Query: 384 VIEKTTYGTAYKAK-LADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFY 442
V+ K TYG Y A+ L+ IA++ + E + I ++H N++ Y
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQ----Y 70
Query: 443 QGK--RGEKLLIY-DYFPSRTLHDLLHDT----IAGKPVLNWARRHKIALGIARGLAYLH 495
G I+ + P +L LL + + + + I GL YLH
Sbjct: 71 LGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQ-----ILEGLKYLH 125
Query: 496 TGHEIPITHGNVRSKNVLVDDFF-VSRLTEFGLD-----------------QLMVPAVAD 537
+ I H +++ NVLV+ + V ++++FG Q M P V D
Sbjct: 126 ---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVID 182
Query: 538 EMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKP 581
+ GY AP D+++ G ++E+ GK P
Sbjct: 183 KGPR-----GYGAP-----------ADIWSLGCTIVEMATGKPP 210
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.4 bits (103), Expect = 2e-04
Identities = 58/225 (25%), Positives = 90/225 (40%), Gaps = 56/225 (24%)
Query: 383 QVIEKTTYGTAYKAK-LADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAF 441
Q I TYG YKA+ +A G +A+++++ D I L + RH N++
Sbjct: 9 QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGS 68
Query: 442 YQGKRGEKLLI-YDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIA-------RGLAY 493
Y R +KL I +Y +L D+ T R L IA +GLAY
Sbjct: 69 YL--RRDKLWIVMEYCGGGSLQDIYQVT----------RGPLSELQIAYVCRETLKGLAY 116
Query: 494 LHTGHEIPITHGNVRSKNVL--------VDDFFVS---------RLTEFGLDQLMVPAVA 536
LH +I H +++ N+L + DF VS R + G M P
Sbjct: 117 LHETGKI---HRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAP--- 170
Query: 537 DEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKP 581
E+ A+ + GY + D++A GI +E+ + P
Sbjct: 171 -EVAAVERKGGY-----------DGKCDIWALGITAIELAELQPP 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 2e-04
Identities = 44/191 (23%), Positives = 91/191 (47%), Gaps = 29/191 (15%)
Query: 403 TIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIY---DYFPSR 459
T+A R LRE ++ L +H+N+I +R + + +Y D S
Sbjct: 46 TLAKRTLRE------------LKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLMES- 92
Query: 460 TLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFV 519
LH ++H + +P+ R+ + RGL Y+H+ + + H +++ N+LV++
Sbjct: 93 DLHHIIH---SDQPLTEEHIRY-FLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCE 145
Query: 520 SRLTEFGLDQLMVPAVADE---MVALAKADGYKAPELQ-RMKKCSSRTDVYAFGILLLEI 575
R+ +FG+ + + + + M Y+APEL + + ++ D+++ G + E+
Sbjct: 146 LRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEM 205
Query: 576 LIGKK--PGKS 584
L ++ PGK+
Sbjct: 206 LGRRQLFPGKN 216
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 47/198 (23%), Positives = 93/198 (46%), Gaps = 15/198 (7%)
Query: 383 QVIEKTTYGTAYKAK-LADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAF 441
Q I TYG YKA+ + G A+++++ +D + I + +H N++
Sbjct: 15 QRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGS 74
Query: 442 YQGKRGEKLLI-YDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEI 500
Y R +KL I ++ +L D+ H T P L+ ++ ++ +GL YLH+ ++
Sbjct: 75 YL--RRDKLWICMEFCGGGSLQDIYHVT---GP-LSESQIAYVSRETLQGLYYLHSKGKM 128
Query: 501 PITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKADGYKAPE---LQRMK 557
H +++ N+L+ D +L +FG+ + +A + + APE ++R
Sbjct: 129 ---HRDIKGANILLTDNGHVKLADFGVSAQITATIAKRK-SFIGTPYWMAPEVAAVERKG 184
Query: 558 KCSSRTDVYAFGILLLEI 575
+ D++A GI +E+
Sbjct: 185 GYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 58/224 (25%), Positives = 97/224 (43%), Gaps = 48/224 (21%)
Query: 382 GQVIEKTTYGTAYKAKLADG---ATIALRLLREGSCKDRSSC--LPVIRQLGKVRHENLI 436
G + + TYG YKAK DG AL+ + EG+ S+C + ++R+L +H N+I
Sbjct: 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQI-EGTGISMSACREIALLREL---KHPNVI 61
Query: 437 PLRAFYQGKRGEKL-LIYDYFPSRTLHDLLH-------DTIAGKPVLNWARRHKIALGIA 488
L+ + K+ L++DY HDL H KPV ++ G+
Sbjct: 62 SLQKVFLSHADRKVWLLFDY----AEHDLWHIIKFHRASKANKKPV-------QLPRGMV 110
Query: 489 RGLAY-----LHTGHEIPITHGNVRSKNVLVDDFFVSR----LTEFGLDQLMVPAVADEM 539
+ L Y +H H + H +++ N+LV R + + G +L +
Sbjct: 111 KSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF----NSPL 166
Query: 540 VALAKADG------YKAPELQRMKKCSSRT-DVYAFGILLLEIL 576
LA D Y+APEL + ++ D++A G + E+L
Sbjct: 167 KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 54/237 (22%), Positives = 100/237 (42%), Gaps = 50/237 (21%)
Query: 370 EHLTLEDVLN--ATGQVIEKTTYGTAYKAKLADGATIALRLLREGSC----KDRSSCLPV 423
+ LTL L A GQV++ G + + T+A+++L++ + D S + +
Sbjct: 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETS---TVAVKMLKDDATEKDLSDLVSEMEM 68
Query: 424 IRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRTLHDLLHDT----IAGKPVLNWAR 479
++ +GK H+N+I L + G ++ +Y L D L P
Sbjct: 69 MKMIGK--HKNIINLLGVCTQE-GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPP 125
Query: 480 RHKI--------ALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLM 531
+ A +ARG+ +L + I H ++ ++NVLV + V ++ +FGL +
Sbjct: 126 EETLTQKDLVSFAYQVARGMEFLASKKCI---HRDLAARNVLVTEDHVMKIADFGLAR-- 180
Query: 532 VPAVADEMVALAKADGYK------------APELQRMKKCSSRTDVYAFGILLLEIL 576
+ D Y+ APE + + ++DV++FG+LL EI
Sbjct: 181 ---------DIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIF 228
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 41/201 (20%), Positives = 78/201 (38%), Gaps = 50/201 (24%)
Query: 471 GKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQL 530
G + ++A IA G+AYL H ++ ++N +V + ++ +FG+ +
Sbjct: 112 GLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIGDFGMTRD 168
Query: 531 MVPAVADEMVALAKADGYK------------APELQRMKKCSSRTDVYAFGILLLEIL-I 577
+ + D Y+ APE + ++++DV++FG++L E+ +
Sbjct: 169 -----------IYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATL 217
Query: 578 GKKP--GKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIRSPMEEGLVQALKLAMG 635
++P G S EV I G E + L+L
Sbjct: 218 AEQPYQGLSNE---------------------EVLKFVIDGGHLDLPENCPDKLLELMRM 256
Query: 636 CCAPVASVRPTMDEVVKQLEE 656
C +RPT E+V L++
Sbjct: 257 CWQYNPKMRPTFLEIVSSLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 80/331 (24%), Positives = 135/331 (40%), Gaps = 80/331 (24%)
Query: 382 GQVIEKTTYGTAYKAKLADGATIALRLLRE-GSCKDRS---SCLPVIRQLGKVRHENLIP 437
GQV+ G K K T+A+++L++ + KD S S + +++ +GK H+N+I
Sbjct: 26 GQVVMAEAIGID-KDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGK--HKNIIN 82
Query: 438 LR-AFYQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKP---------------VLNWARRH 481
L A Q G ++ +Y L + L A +P L +
Sbjct: 83 LLGACTQD--GPLYVLVEYASKGNLREYLR---ARRPPGMDYSFDTCKLPEEQLTFKDLV 137
Query: 482 KIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVA 541
A +ARG+ YL + I H ++ ++NVLV + V ++ +FGL +
Sbjct: 138 SCAYQVARGMEYLASQKCI---HRDLAARNVLVTEDNVMKIADFGLAR-----------D 183
Query: 542 LAKADGYK------------APELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGE 589
+ D YK APE + + ++DV++FG+LL EI G S G
Sbjct: 184 VHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIF---TLGGSPYPGI 240
Query: 590 FVDLPSIVKVAVLEETTMEVFDMEIMKGIRSPMEEGLVQALKLAM-GCCAPVASVRPTMD 648
V+ E+F + + +G R L + M C V S RPT
Sbjct: 241 PVE---------------ELFKL-LKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFK 284
Query: 649 EVVKQLEENRPRNRSALYSPTETRSEIGTPF 679
++V+ L+ R + T+ ++ PF
Sbjct: 285 QLVEDLD------RVLTVTSTDEYLDLSVPF 309
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 3e-04
Identities = 34/139 (24%), Positives = 61/139 (43%), Gaps = 20/139 (14%)
Query: 461 LHDLL--HDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFF 518
L L I + A +A G+AYL + H H ++ ++NVL+ +
Sbjct: 82 LLKYLKKRREIPVSDLKELA------HQVAMGMAYLESKH---FVHRDLAARNVLLVNRH 132
Query: 519 VSRLTEFGLDQLMVPAVADEMVALAKADG-----YKAPELQRMKKCSSRTDVYAFGILLL 573
+++++FG+ + + A A G + APE K SS++DV+++G+ L
Sbjct: 133 QAKISDFGMSRALG---AGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLW 189
Query: 574 EIL-IGKKPGKSGRNGEFV 591
E G KP + E +
Sbjct: 190 EAFSYGAKPYGEMKGAEVI 208
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 3e-04
Identities = 35/148 (23%), Positives = 71/148 (47%), Gaps = 14/148 (9%)
Query: 451 LIYDYFPSRTLHDLLH---DTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNV 507
L+ P +L D + D++ + +LNW + IA+G+ YL E + H N+
Sbjct: 85 LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWC------VQIAKGMYYLE---EHRMVHRNL 135
Query: 508 RSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKAD-GYKAPELQRMKKCSSRTDVY 566
++N+L+ + ++ +FG+ L+ P + K + A E + + ++DV+
Sbjct: 136 AARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVW 195
Query: 567 AFGILLLEIL-IGKKPGKSGRNGEFVDL 593
++G+ + E++ G +P R E DL
Sbjct: 196 SYGVTVWEMMSYGAEPYAGMRPHEVPDL 223
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 3e-04
Identities = 47/207 (22%), Positives = 83/207 (40%), Gaps = 40/207 (19%)
Query: 390 YGTAYKAK-LADGATIALRLLREGSCKDRSSCLP--VIRQ---LGKVRHENLIPLRAFYQ 443
+G +KAK G T+AL+ + + + +P +R+ L +H ++ L +
Sbjct: 13 HGIVFKAKDRETGETVALKKV---ALRRLEGGIPNQALREIKALQACQHPYVVKLLDVF- 68
Query: 444 GKRGEKL-LIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIAR--------GLAYL 494
G L+ +Y PS L ++L D + + G+AY+
Sbjct: 69 -PHGSGFVLVMEYMPS-DLSEVLRD-----------EERPLPEAQVKSYMRMLLKGVAYM 115
Query: 495 HTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKADGYKAPEL- 553
H I H +++ N+L+ V ++ +FGL +L Y+APEL
Sbjct: 116 H---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELL 172
Query: 554 --QRMKKCSSRTDVYAFGILLLEILIG 578
R K D++A G + E+L G
Sbjct: 173 YGAR--KYDPGVDLWAVGCIFAELLNG 197
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 4e-04
Identities = 26/100 (26%), Positives = 52/100 (52%), Gaps = 8/100 (8%)
Query: 487 IARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQ-----LMVPAVADEMVA 541
I +GL YLH I H +++ N+LVD+ ++++FG+ + + +
Sbjct: 115 ILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPS 171
Query: 542 LAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKP 581
L + + APE+ + + + D+++ G L++E+L GK P
Sbjct: 172 LQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 4e-04
Identities = 45/161 (27%), Positives = 74/161 (45%), Gaps = 16/161 (9%)
Query: 424 IRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKI 483
+R L K+RH N I R Y + L+ +Y + DLL + KP L +
Sbjct: 66 VRFLQKLRHPNTIQYRGCYL-REHTAWLVMEYCLG-SASDLLE--VHKKP-LQEVEIAAV 120
Query: 484 ALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALA 543
G +GLAYLH+ + I H +V++ N+L+ + + +L +FG +M PA
Sbjct: 121 THGALQGLAYLHSHNMI---HRDVKAGNILLSEPGLVKLGDFGSASIMAPA-----NXFV 172
Query: 544 KADGYKAPEL---QRMKKCSSRTDVYAFGILLLEILIGKKP 581
+ APE+ + + DV++ GI +E+ K P
Sbjct: 173 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 4e-04
Identities = 54/208 (25%), Positives = 101/208 (48%), Gaps = 23/208 (11%)
Query: 385 IEKT---TYGTAYKAK-LADGATIALRLLREGSCKD--RSSCLPVIRQLGKVRHENLIPL 438
IEK TYG YK + G +A++ +R S ++ S+ + I L +++H N++ L
Sbjct: 5 IEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCL 64
Query: 439 RA-FYQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTG 497
+ Q R LI+++ S L L D++ ++ I +G+ + H+
Sbjct: 65 QDVLMQESR--LYLIFEFL-SMDLKKYL-DSLPKGQYMDAELVKSYLYQILQGILFCHSR 120
Query: 498 HEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQ---LMVPAVADEMVALAKADGYKAPE-L 553
+ H +++ +N+L+D+ V +L +FGL + + V E+V L Y+APE L
Sbjct: 121 R---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTL----WYRAPEVL 173
Query: 554 QRMKKCSSRTDVYAFGILLLEILIGKKP 581
+ S+ D+++ G + E + KKP
Sbjct: 174 LGSPRYSTPVDIWSIGTIFAE-MATKKP 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 4e-04
Identities = 47/209 (22%), Positives = 94/209 (44%), Gaps = 25/209 (11%)
Query: 400 DGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQ-GKRGEKL-LIYDYFP 457
D +A++ L++ S R L ++HE+++ FY G+ L ++++Y
Sbjct: 34 DKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIV---KFYGVCVEGDPLIMVFEYMK 90
Query: 458 SRTLHDLLH----DTI---AGKPV--LNWARRHKIALGIARGLAYLHTGHEIPITHGNVR 508
L+ L D + G L ++ IA IA G+ YL + H H ++
Sbjct: 91 HGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLA 147
Query: 509 SKNVLVDDFFVSRLTEFGLDQLMVPA----VADEMVALAKADGYKAPELQRMKKCSSRTD 564
++N LV + + ++ +FG+ + + V + + + PE +K ++ +D
Sbjct: 148 TRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR---WMPPESIMYRKFTTESD 204
Query: 565 VYAFGILLLEILI-GKKPGKSGRNGEFVD 592
V++ G++L EI GK+P N E ++
Sbjct: 205 VWSLGVVLWEIFTYGKQPWYQLSNNEVIE 233
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 5e-04
Identities = 59/220 (26%), Positives = 97/220 (44%), Gaps = 40/220 (18%)
Query: 382 GQVIEKTTYGTAYKAKLADG---ATIALRLLREGSCKDRSSC--LPVIRQLGKVRHENLI 436
G + + TYG YKAK DG AL+ + EG+ S+C + ++R+L +H N+I
Sbjct: 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQI-EGTGISMSACREIALLREL---KHPNVI 61
Query: 437 PLRAFYQGKRGEKL-LIYDYFPSRTLHDLLH------DTIAGKPVLNWARRHKIAL--GI 487
L+ + K+ L++DY HDL H + A K + R +L I
Sbjct: 62 ALQKVFLSHSDRKVWLLFDY----AEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQI 117
Query: 488 ARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSR----LTEFGLDQLMVPAVADEMVALA 543
G+ YLH + H +++ N+LV R + + G +L + LA
Sbjct: 118 LDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLF----NSPLKPLA 170
Query: 544 KADG------YKAPELQRMKKCSSRT-DVYAFGILLLEIL 576
D Y+APEL + ++ D++A G + E+L
Sbjct: 171 DLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 5e-04
Identities = 42/195 (21%), Positives = 90/195 (46%), Gaps = 17/195 (8%)
Query: 391 GTAYKA-KLADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIP-LRAFYQGKRGE 448
GT Y A +A G +A+R + + + I + + ++ N++ L ++ G E
Sbjct: 34 GTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD--E 91
Query: 449 KLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVR 508
++ +Y +L D++ +T + + R + + L +LH+ + H +++
Sbjct: 92 LWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL-----QALEFLHSNQ---VIHRDIK 143
Query: 509 SKNVLVDDFFVSRLTEFGLDQLMVPAVA--DEMVALAKADGYKAPELQRMKKCSSRTDVY 566
S N+L+ +LT+FG + P + MV + APE+ K + D++
Sbjct: 144 SDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPY---WMAPEVVTRKAYGPKVDIW 200
Query: 567 AFGILLLEILIGKKP 581
+ GI+ +E++ G+ P
Sbjct: 201 SLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 6e-04
Identities = 43/175 (24%), Positives = 76/175 (43%), Gaps = 37/175 (21%)
Query: 424 IRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYF-PSRTLHDL----LHDTIAGKPVLNWA 478
+R L ++HEN+I L D F P+R+L + L + G + N
Sbjct: 67 LRLLKHMKHENVIGL--------------LDVFTPARSLEEFNDVYLVTHLMGADLNNIV 112
Query: 479 RRHKIA--------LGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQL 530
+ K+ I RGL Y+H+ I H +++ N+ V++ ++ +FGL +
Sbjct: 113 KCQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR- 168
Query: 531 MVPAVADEMVALAKADGYKAPELQ-RMKKCSSRTDVYAFGILLLEILIGKK--PG 582
DEM Y+APE+ + D+++ G ++ E+L G+ PG
Sbjct: 169 ---HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 220
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 7e-04
Identities = 50/193 (25%), Positives = 85/193 (44%), Gaps = 10/193 (5%)
Query: 385 IEKTTYGTAYKAKL-ADGATIALRLLREGSCKD-RSSCLPVIRQLGKVRHENLIPLRAFY 442
I + +G + +L AD +A++ RE D ++ L R L + H N++ L
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL---- 58
Query: 443 QGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPI 502
G +K IY D L P L ++ A G+ YL + H I
Sbjct: 59 IGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCI-- 116
Query: 503 THGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKAD-GYKAPELQRMKKCSS 561
H ++ ++N LV + V ++++FG+ + V + + + APE + SS
Sbjct: 117 -HRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSS 175
Query: 562 RTDVYAFGILLLE 574
+DV++FGILL E
Sbjct: 176 ESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 7e-04
Identities = 35/172 (20%), Positives = 71/172 (41%), Gaps = 31/172 (18%)
Query: 487 IARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKAD 546
I ++Y+H + I H ++++ N+ + + +L +FG+ +++ E
Sbjct: 110 IVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKIL----GSEYSMAETVV 162
Query: 547 G---YKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLE 603
G Y +PEL + K + ++D++A G +L E+L K+ +
Sbjct: 163 GTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKR--------------------TFD 202
Query: 604 ETTMEVFDMEIMKGIRSPMEEGLVQALKLAMGCCAPV-ASVRPTMDEVVKQL 654
T ++I++G +P+ L + RPT DEV+ Q
Sbjct: 203 ATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 7e-04
Identities = 35/124 (28%), Positives = 55/124 (44%), Gaps = 25/124 (20%)
Query: 483 IALGIARGLAYLHTGHEIPITHGNVRSKNVLVD--------DFFVSRLTEFGLDQLMVPA 534
+A I G+AYLH H I H +++ N+L++ DF VSR+ L Q M P
Sbjct: 173 VARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRI----LAQTMDPC 225
Query: 535 VADEMVALAKADGYKAPE-----LQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGE 589
+ Y +PE L D+++ G+ +LE +G+ P GR G+
Sbjct: 226 NSS-----VGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD 280
Query: 590 FVDL 593
+ L
Sbjct: 281 WASL 284
|
Length = 353 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 7e-04
Identities = 58/222 (26%), Positives = 105/222 (47%), Gaps = 33/222 (14%)
Query: 382 GQVIEKTTYGTAYKAKLADGATIALRLLRE-GSCKDRS---SCLPVIRQLGKVRHENLIP 437
GQV+ YG K++ T+A+++L++ + KD + S + +++ +GK H+N+I
Sbjct: 26 GQVVRAEAYGID-KSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGK--HKNIIN 82
Query: 438 LRAFYQGKRGEKLLIYDYFPSRTLHDLLH--------DTIAGKPV----LNWARRHKIAL 485
L + G +I +Y L + L T V L++ A
Sbjct: 83 LLGVCT-QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAY 141
Query: 486 GIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKA 545
+ARG+ YL + I H ++ ++NVLV + V ++ +FGL + V D +
Sbjct: 142 QVARGMEYLESRRCI---HRDLAARNVLVTEDNVMKIADFGLAR----GVHDIDYYKKTS 194
Query: 546 DG-----YKAPELQRMKKCSSRTDVYAFGILLLEIL-IGKKP 581
+G + APE + + ++DV++FGIL+ EI +G P
Sbjct: 195 NGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSP 236
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 7e-04
Identities = 41/164 (25%), Positives = 73/164 (44%), Gaps = 36/164 (21%)
Query: 483 IALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVAL 542
IA IA G+ YL + H H ++ ++N LV V ++ +FG+ + +
Sbjct: 127 IASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVVKIGDFGMSR-----------DI 172
Query: 543 AKADGYKA------------PELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGE 589
D Y+ PE +K ++ +D+++FG++L EI GK+P N E
Sbjct: 173 YSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE 232
Query: 590 FVDLPSIVKVAVLEETTM---EVFDMEIMKGI--RSPMEEGLVQ 628
++ I + LE EV+ IM+G R P + +++
Sbjct: 233 AIE--CITQGRELERPRTCPPEVYA--IMQGCWQREPQQRMVIK 272
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 41.1 bits (97), Expect = 9e-04
Identities = 45/209 (21%), Positives = 94/209 (44%), Gaps = 26/209 (12%)
Query: 383 QVIEKT---TYGTAYKA-KLADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPL 438
++EK +YG+ YKA G +A++++ D + I L + ++
Sbjct: 6 DILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE--DLQEIIKEISILKQCDSPYIVKY 63
Query: 439 RAFYQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGH 498
Y K + ++ +Y + ++ D++ I K L I +GL YLH+
Sbjct: 64 YGSYF-KNTDLWIVMEYCGAGSVSDIMK--ITNKT-LTEEEIAAILYQTLKGLEYLHSNK 119
Query: 499 EIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKADG------YKAPE 552
H ++++ N+L+++ ++L +FG+ + D M AK + + APE
Sbjct: 120 ---KIHRDIKAGNILLNEEGQAKLADFGVSGQLT----DTM---AKRNTVIGTPFWMAPE 169
Query: 553 LQRMKKCSSRTDVYAFGILLLEILIGKKP 581
+ + +++ D+++ GI +E+ GK P
Sbjct: 170 VIQEIGYNNKADIWSLGITAIEMAEGKPP 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.001
Identities = 43/184 (23%), Positives = 81/184 (44%), Gaps = 23/184 (12%)
Query: 424 IRQLGKVRHENLIPLRAFYQG---KRGEKLL--IYDYFPSRTLHDLLHDTIAGKPVLNWA 478
I+ L ++HE ++ Y G R EK L +Y P ++ D L A L +
Sbjct: 55 IQLLKNLQHERIVQ----YYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGA----LTES 106
Query: 479 RRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLM--VPAVA 536
K I G++YLH+ I H +++ N+L D +L +FG + + +
Sbjct: 107 VTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSG 163
Query: 537 DEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSI 596
+ ++ + +PE+ + + DV++ G ++E+L K P E+ + +I
Sbjct: 164 TGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPW-----AEYEAMAAI 218
Query: 597 VKVA 600
K+A
Sbjct: 219 FKIA 222
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 41.5 bits (98), Expect = 0.001
Identities = 44/177 (24%), Positives = 80/177 (45%), Gaps = 31/177 (17%)
Query: 366 FQGGEHLTLEDVLNATGQVIEKTTYGTAYKA-KLADGATIALRLLREGSCKDRSSCLPV- 423
F G L ++L G+ T+G YKA ++ G +AL+ + + KD P+
Sbjct: 1 FYGCSKLRDYEILGKLGE----GTFGEVYKARQIKTGRVVALKKILMHNEKD---GFPIT 53
Query: 424 ----IRQLGKVRHENLIPL-RAFYQ---GKRGEKLLIYDYFPSRTLHDL---LHDTIAGK 472
I+ L K++H N++PL + + ++ +Y P HDL L +
Sbjct: 54 ALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMD-HDLSGLLEN----- 107
Query: 473 PVLNWARRH--KIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGL 527
P + L + G+ YLH H I H ++++ N+L+D+ + ++ +FGL
Sbjct: 108 PSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGL 161
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 0.001
Identities = 31/105 (29%), Positives = 52/105 (49%), Gaps = 15/105 (14%)
Query: 489 RGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKAD-- 546
R L Y+HT + + H +++ KN+L + ++ +FGL + A D A+ D
Sbjct: 114 RALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLAR---VAFNDTPTAIFWTDYV 167
Query: 547 ---GYKAPEL--QRMKKCSSRTDVYAFGILLLEILIGKK--PGKS 584
Y+APEL K + D+++ G + E+L GK PGK+
Sbjct: 168 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN 212
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.001
Identities = 72/308 (23%), Positives = 124/308 (40%), Gaps = 76/308 (24%)
Query: 382 GQVIEKTTYGTAYKAKLADGATIALRLLR----EGSCKDRSSCLPVIRQLGKVRHENLIP 437
GQV+ G K K + T+A+++L+ E D S + +++ +GK H+N+I
Sbjct: 29 GQVVMAEALGID-KDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK--HKNIIN 85
Query: 438 LR-AFYQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPV---------------LNWARRH 481
L A Q G +I +Y L + L A +P + +
Sbjct: 86 LLGACTQD--GPLYVIVEYASKGNLREYLR---ARRPPGMEYSYDIARVPDEQMTFKDLV 140
Query: 482 KIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVA 541
+ARG+ YL + I H ++ ++NVLV + V ++ +FGL +
Sbjct: 141 SCTYQVARGMEYLASQKCI---HRDLAARNVLVTENNVMKIADFGLAR-----------D 186
Query: 542 LAKADGYK------------APELQRMKKCSSRTDVYAFGILLLEIL-IGKKPGKSGRNG 588
+ D YK APE + + ++DV++FG+L+ EI +G P
Sbjct: 187 VNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP------- 239
Query: 589 EFVDLPSIVKVAVLEETTMEVFDMEIMKGIRSPMEEGLVQALKLAM-GCCAPVASVRPTM 647
P I E+F + + +G R L + M C + S RPT
Sbjct: 240 ----YPGI--------PVEELFKL-LKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTF 286
Query: 648 DEVVKQLE 655
++V+ L+
Sbjct: 287 KQLVEDLD 294
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 40.7 bits (96), Expect = 0.001
Identities = 27/111 (24%), Positives = 51/111 (45%), Gaps = 28/111 (25%)
Query: 483 IALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGL-DQL---------MV 532
+ + +GL YLH+ + I H +++S N+L+ +L +FG QL +V
Sbjct: 121 VCREVLQGLEYLHSQNVI---HRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV 177
Query: 533 --PAVADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKP 581
P + APE+ + K + D+++ GI+ +E+ G+ P
Sbjct: 178 GTPY-------------WMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.001
Identities = 26/96 (27%), Positives = 49/96 (51%), Gaps = 6/96 (6%)
Query: 487 IARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGL-DQLMVPAVADEMVALAKA 545
I +GL YLH+ +I H ++++ NVL+ + +L +FG+ QL +
Sbjct: 110 ILKGLDYLHSEKKI---HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRN--TFVGT 164
Query: 546 DGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKP 581
+ APE+ + S+ D+++ GI +E+ G+ P
Sbjct: 165 PFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.001
Identities = 38/162 (23%), Positives = 70/162 (43%), Gaps = 12/162 (7%)
Query: 424 IRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKI 483
IR + ++ H ++I + L + ++ ++ LL A K + ++
Sbjct: 54 IRLMARLNHPHIIRMLGATCEDSHFNLFV-EWMAGGSVSHLLSKYGAFKEAVIINYTEQL 112
Query: 484 ALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDF-FVSRLTEFGLDQLMVPAV--ADEMV 540
RGL+YLH E I H +V+ N+L+D R+ +FG + A E
Sbjct: 113 L----RGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQ 165
Query: 541 A-LAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKP 581
L + APE+ R ++ DV++ G +++E+ K P
Sbjct: 166 GQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 40.9 bits (95), Expect = 0.001
Identities = 29/134 (21%), Positives = 63/134 (47%), Gaps = 9/134 (6%)
Query: 448 EKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNV 507
E ++ +Y +L D++ +T ++ A+ + + L +LH + H ++
Sbjct: 90 ELFVVMEYLAGGSLTDVVTET-----CMDEAQIAAVCRECLQALEFLHANQ---VIHRDI 141
Query: 508 RSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKADGYKAPELQRMKKCSSRTDVYA 567
+S NVL+ +LT+FG + P + + + APE+ K + D+++
Sbjct: 142 KSDNVLLGMDGSVKLTDFGFCAQITPE-QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWS 200
Query: 568 FGILLLEILIGKKP 581
GI+ +E++ G+ P
Sbjct: 201 LGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 28/96 (29%), Positives = 48/96 (50%), Gaps = 6/96 (6%)
Query: 487 IARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGL-DQLMVPAVADEMVALAKA 545
I+ L YLH E I + +++ NVL+D +LT++G+ + + P D
Sbjct: 105 ISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DTTSTFCGT 159
Query: 546 DGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKP 581
Y APE+ R + D +A G+L+ E++ G+ P
Sbjct: 160 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 48/194 (24%), Positives = 87/194 (44%), Gaps = 43/194 (22%)
Query: 424 IRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYF-PSRTLHDL----LHDTIAGKPVLNWA 478
+R L ++HEN+I L D F P+ ++ + L + G + N
Sbjct: 65 LRLLKHMKHENVIGL--------------LDVFTPATSIENFNEVYLVTNLMGADLNNIV 110
Query: 479 RRHKIA--------LGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQL 530
+ K++ + RGL Y+H+ I H +++ NV V++ R+ +FGL +
Sbjct: 111 KCQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLAR- 166
Query: 531 MVPAVADEMVALAKADGYKAPELQRMKKCSSRT-DVYAFGILLLEILIGKK--PGKSGRN 587
DEM Y+APE+ ++T D+++ G ++ E+L GK PG
Sbjct: 167 ---QADDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGN---- 219
Query: 588 GEFVD-LPSIVKVA 600
+++D L I++V
Sbjct: 220 -DYIDQLKRIMEVV 232
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 40.3 bits (95), Expect = 0.002
Identities = 29/102 (28%), Positives = 45/102 (44%), Gaps = 10/102 (9%)
Query: 487 IARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGL-------DQLMVPAVADEM 539
I L YLH I H +++ N+L+D +LT+FGL Q+ + E
Sbjct: 102 IVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKED 158
Query: 540 VALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKP 581
+ Y APE+ + S D ++ G +L E L+G P
Sbjct: 159 KRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPP 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.002
Identities = 30/110 (27%), Positives = 56/110 (50%), Gaps = 30/110 (27%)
Query: 487 IARGLAYLHTGHEIPITHGNVRSKNVLVD--------DFFVSRLTE--FGLDQLM----- 531
+ GLAYLH+ I H ++++ N+LVD DF +S+ ++ + DQ M
Sbjct: 117 VLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGS 173
Query: 532 VPAVADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKP 581
V +A E++ + GY S++ D+++ G ++LE+ G++P
Sbjct: 174 VFWMAPEVIHS-YSQGY-----------SAKVDIWSLGCVVLEMFAGRRP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.002
Identities = 59/224 (26%), Positives = 99/224 (44%), Gaps = 39/224 (17%)
Query: 380 ATGQVIEKTTYGTAYKAKLADGA---TIALRLLREGSC-KDRSSCLPVIRQLGKVRHENL 435
A G+V E GTA L G+ +A++ LR+G+ +++ L + H N+
Sbjct: 7 AFGEVYE----GTA-TDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNI 61
Query: 436 IPLRAFYQGKRGEKLLIYDYFPSRTLHDLLHD---TIAGKPVLNWARRHKIALGIARGLA 492
+ L + +I + L L D G P+L I L +A+G
Sbjct: 62 VKLLGVCLLNE-PQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 493 YLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVA--LAKADGYK- 549
YL H I H ++ ++N LV +E G D V + D +A + K+D Y+
Sbjct: 121 YLEQMHFI---HRDLAARNCLV--------SEKGYDADRVVKIGDFGLARDIYKSDYYRK 169
Query: 550 -----------APELQRMKKCSSRTDVYAFGILLLEIL-IGKKP 581
APE K ++++DV++FG+L+ EIL +G++P
Sbjct: 170 EGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 40.6 bits (96), Expect = 0.002
Identities = 48/192 (25%), Positives = 80/192 (41%), Gaps = 35/192 (18%)
Query: 405 ALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKL----LIYDYFPSRT 460
A R+LRE I+ L +RHEN+I L + E ++ + +
Sbjct: 43 AKRILRE------------IKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELMET-- 88
Query: 461 LHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVS 520
DL H I L I RGL YLH+ + + H +++ N+LV+
Sbjct: 89 --DL-HKVIKSPQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDL 142
Query: 521 RLTEFGLDQLMVPAVADEMVALAKADG-----YKAPELQRM-KKCSSRTDVYAFGILLLE 574
++ +FGL + + P DE + Y+APEL + + D+++ G + E
Sbjct: 143 KICDFGLARGVDP---DEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAE 199
Query: 575 ILIGKK--PGKS 584
+L K PG+
Sbjct: 200 LLTRKPLFPGRD 211
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.8 bits (94), Expect = 0.002
Identities = 51/206 (24%), Positives = 88/206 (42%), Gaps = 27/206 (13%)
Query: 387 KTTYGTAYKA-KLADGATIALRLLREGSCKDRSSCLPVIRQ---LGKVRHENLIPLRAFY 442
K ++G K G A+++L++ R + + L ++ H ++ L +
Sbjct: 3 KGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAF 62
Query: 443 QGKRGEKL-LIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIP 501
Q + EKL L+ +Y P L L G+ AR A I L YLH+
Sbjct: 63 QTE--EKLYLVLEYAPGGELFSHLSK--EGRFSEERARF--YAAEIVLALEYLHSLG--- 113
Query: 502 ITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKADG------YKAPELQR 555
I + +++ +N+L+D +LT+FGL + ++ + Y APE+
Sbjct: 114 IIYRDLKPENILLDADGHIKLTDFGL-------AKELSSEGSRTNTFCGTPEYLAPEVLL 166
Query: 556 MKKCSSRTDVYAFGILLLEILIGKKP 581
K D ++ G+LL E+L GK P
Sbjct: 167 GKGYGKAVDWWSLGVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.002
Identities = 51/244 (20%), Positives = 101/244 (41%), Gaps = 31/244 (12%)
Query: 410 REGSCKDRSSCLPVIRQLGKVRHENLIPL-RAFYQGKRGEKLLIYDYFPSRTLHDLLHDT 468
R+ S D S + +I++ ++RH N++ + F + R ++ D L + +
Sbjct: 48 RDKSIGDIVSEVTIIKE--QLRHPNIVRYYKTFLENDR--LYIVMDLIEGAPLGEHFNSL 103
Query: 469 IAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLD 528
K R I + + L YLH E I H ++ N+++ + +T+FGL
Sbjct: 104 KEKKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLA 161
Query: 529 QLMVPAVADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNG 588
+ P ++ ++ Y PE+ + + + DV+AFG +L ++ + P S
Sbjct: 162 KQKQPE--SKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYS---- 215
Query: 589 EFVDLPSIVKVAVLEETTMEVFDMEIMKGIRSPMEEGLV-QALKLAMG-CCAPVASVRPT 646
T M +I++ + P+ EG+ + + + C P A RP
Sbjct: 216 ----------------TNMLSLATKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPD 259
Query: 647 MDEV 650
+ +V
Sbjct: 260 IIQV 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.002
Identities = 29/98 (29%), Positives = 52/98 (53%), Gaps = 4/98 (4%)
Query: 484 ALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALA 543
A I GL +LH+ I + +++ N+L+D ++ +FG+ + + A
Sbjct: 102 AAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCG 158
Query: 544 KADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKP 581
D Y APE+ +K ++ D ++FG+LL E+LIG+ P
Sbjct: 159 TPD-YIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 40.1 bits (93), Expect = 0.003
Identities = 26/98 (26%), Positives = 50/98 (51%), Gaps = 10/98 (10%)
Query: 487 IARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKAD 546
I +GL YLH+ +I H ++++ NVL+ + +L +FG+ + D +
Sbjct: 110 ILKGLDYLHSEKKI---HRDIKAANVLLSEHGEVKLADFGV----AGQLTDTQIKRNTFV 162
Query: 547 G---YKAPELQRMKKCSSRTDVYAFGILLLEILIGKKP 581
G + APE+ + S+ D+++ GI +E+ G+ P
Sbjct: 163 GTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.003
Identities = 47/221 (21%), Positives = 84/221 (38%), Gaps = 40/221 (18%)
Query: 389 TYGTAYKAK-LADGATIALRLLR--EGSCKDRSSCLPVIRQLG-------------KVRH 432
TYG KA G +A++ ++ E S D + ++ G +++H
Sbjct: 21 TYGKVEKAYDTLTGKIVAIKKVKIIEIS-NDVTKDRQLVGMCGIHFTTLRELKIMNEIKH 79
Query: 433 ENLIPLRAFYQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLA 492
EN++ L Y + L+ D + L + K L ++ I L I GL
Sbjct: 80 ENIMGLVDVYV-EGDFINLVMDI-----MASDLKKVVDRKIRLTESQVKCILLQILNGLN 133
Query: 493 YLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGL------DQLMVPAVADE-------M 539
LH + H ++ N+ ++ + ++ +FGL DE M
Sbjct: 134 VLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEM 190
Query: 540 VALAKADGYKAPELQRMKKC-SSRTDVYAFGILLLEILIGK 579
+ Y+APEL + D+++ G + E+L GK
Sbjct: 191 TSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.003
Identities = 50/214 (23%), Positives = 87/214 (40%), Gaps = 25/214 (11%)
Query: 383 QVIEKTTYGTAYKAKLADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLR--A 440
+V+ TYG YK + +A + + + + I L K H I A
Sbjct: 22 EVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGA 81
Query: 441 FYQ----GKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHT 496
F + G + L+ ++ + ++ DL+ +T +W I I RGLA+LH
Sbjct: 82 FIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY--ICREILRGLAHLHA 139
Query: 497 GHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVA----LAKADGYKAPE 552
I H +++ +NVL+ + +L +FG V A D V + APE
Sbjct: 140 HKVI---HRDIKGQNVLLTENAEVKLVDFG-----VSAQLDRTVGRRNTFIGTPYWMAPE 191
Query: 553 LQRMKKCSS-----RTDVYAFGILLLEILIGKKP 581
+ + R+D+++ GI +E+ G P
Sbjct: 192 VIACDENPDATYDYRSDIWSLGITAIEMAEGAPP 225
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.003
Identities = 24/85 (28%), Positives = 44/85 (51%), Gaps = 1/85 (1%)
Query: 498 HEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKADGYKAPELQRMK 557
H++ I + +++ +N+L+D LT+FGL + + + + Y APE+ R K
Sbjct: 122 HKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGK 181
Query: 558 KCSSR-TDVYAFGILLLEILIGKKP 581
+ D ++ GIL+ E+L G P
Sbjct: 182 GGHGKAVDWWSLGILIFELLTGASP 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.003
Identities = 52/206 (25%), Positives = 92/206 (44%), Gaps = 18/206 (8%)
Query: 383 QVIEKTTYGTAYKAKL-ADGATIALRLLREGSC--KDRSSCLPVIRQ--LGKVRHENLIP 437
+VI K ++G AK +DG+ A+++L++ + K + + R L ++H L+
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 438 LRAFYQGKRGEKL-LIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHT 496
L Y + EKL + DY L H + + R A +A + YLH+
Sbjct: 61 LH--YSFQTAEKLYFVLDYVNGGEL--FFH--LQRERCFLEPRARFYAAEVASAIGYLHS 114
Query: 497 GHEIPITHGNVRSKNVLVDDFFVSRLTEFGL-DQLMVPAVADEMVALAKADGYKAPELQR 555
+ I + +++ +N+L+D LT+FGL + + P + Y APE+ R
Sbjct: 115 ---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--ETTSTFCGTPEYLAPEVLR 169
Query: 556 MKKCSSRTDVYAFGILLLEILIGKKP 581
+ D + G +L E+L G P
Sbjct: 170 KEPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.003
Identities = 43/181 (23%), Positives = 84/181 (46%), Gaps = 38/181 (20%)
Query: 485 LGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAK 544
L +A+G+ YL H ++ ++N ++D+ F ++ +FGL + + E ++
Sbjct: 105 LQVAKGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDK---EYYSVHN 158
Query: 545 ADGYKAP------ELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIV 597
G K P E + +K ++++DV++FG+LL E++ G P + D+ S
Sbjct: 159 HTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP--------YPDVDS-- 208
Query: 598 KVAVLEETTMEVFDME--IMKGIRSPMEEGLVQAL-KLAMGCCAPVASVRPTMDEVVKQL 654
FD+ +++G R E L ++ + C P +RPT E+V ++
Sbjct: 209 ------------FDITVYLLQGRRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRI 256
Query: 655 E 655
E
Sbjct: 257 E 257
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.004
Identities = 41/193 (21%), Positives = 88/193 (45%), Gaps = 13/193 (6%)
Query: 391 GTAYKA-KLADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIP-LRAFYQGKRGE 448
GT Y A +A G +A++ + + + I + + +H N++ L ++ G E
Sbjct: 33 GTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGD--E 90
Query: 449 KLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVR 508
++ +Y +L D++ +T + + R + L +LH+ I H +++
Sbjct: 91 LWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRE-----CLQALEFLHSNQVI---HRDIK 142
Query: 509 SKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKADGYKAPELQRMKKCSSRTDVYAF 568
S N+L+ +LT+FG + P + + + APE+ K + D+++
Sbjct: 143 SDNILLGMDGSVKLTDFGFCAQITPE-QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSL 201
Query: 569 GILLLEILIGKKP 581
GI+ +E++ G+ P
Sbjct: 202 GIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.004
Identities = 33/151 (21%), Positives = 73/151 (48%), Gaps = 12/151 (7%)
Query: 432 HENLIPLRAFYQGKRGEKL-LIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARG 490
HEN++ + Y G++L ++ ++ L D++ T +N + + L + R
Sbjct: 78 HENVVDMYNSYL--VGDELWVVMEFLEGGALTDIVTHT-----RMNEEQIATVCLSVLRA 130
Query: 491 LAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKADGYKA 550
L+YLH + H +++S ++L+ +L++FG + V +L + A
Sbjct: 131 LSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRK-SLVGTPYWMA 186
Query: 551 PELQRMKKCSSRTDVYAFGILLLEILIGKKP 581
PE+ + D+++ GI+++E++ G+ P
Sbjct: 187 PEVISRLPYGTEVDIWSLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 0.004
Identities = 51/207 (24%), Positives = 96/207 (46%), Gaps = 25/207 (12%)
Query: 385 IEKTTYGTAYKAKLAD-GATIALRLLR-----EGSCKDRSSCLPVIRQLGKVRHENLIPL 438
I + TYGT +KAK + +AL+ +R EG SS L I L +++H+N++ L
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGV---PSSALREICLLKELKHKNIVRL 64
Query: 439 RAFYQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGH 498
+ KL + + + L D+ G + L +GLA+ H+ +
Sbjct: 65 YDVLHSDK--KLTLVFEYCDQDLKKYF-DSCNGDIDPEIVKSFMFQL--LKGLAFCHSHN 119
Query: 499 EIPITHGNVRSKNVLVDDFFVSRLTEFGLDQ---LMVPAVADEMVALAKADGYKAPE-LQ 554
+ H +++ +N+L++ +L +FGL + + V + E+V L Y+ P+ L
Sbjct: 120 ---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTL----WYRPPDVLF 172
Query: 555 RMKKCSSRTDVYAFGILLLEILIGKKP 581
K S+ D+++ G + E+ +P
Sbjct: 173 GAKLYSTSIDMWSAGCIFAELANAGRP 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.004
Identities = 30/95 (31%), Positives = 48/95 (50%), Gaps = 7/95 (7%)
Query: 487 IARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKAD 546
I L YLH EI + +++ +N+L+D +LT+FG + + D L
Sbjct: 110 IVCALEYLH-SKEI--VYRDLKPENILLDKEGHIKLTDFGFAK----KLRDRTWTLCGTP 162
Query: 547 GYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKP 581
Y APE+ + K + D +A GIL+ E+L+G P
Sbjct: 163 EYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 39.7 bits (92), Expect = 0.004
Identities = 52/200 (26%), Positives = 99/200 (49%), Gaps = 26/200 (13%)
Query: 389 TYGTAYKAKL-ADGATIALRLLREGSCKDRSSCLPVIRQ---LGKVRHENLIPLRAFYQG 444
+Y T YK K +G +AL+++R ++ + IR+ L ++H N++ L
Sbjct: 17 SYATVYKGKSKVNGKLVALKVIRLQ--EEEGTPFTAIREASLLKGLKHANIVLLHDIIHT 74
Query: 445 KRGEKL-LIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIAL-GIARGLAYLHTGHEIPI 502
K E L L+++Y +H L + P K+ L + RGL+Y+H + I
Sbjct: 75 K--ETLTLVFEY-----VHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY---I 124
Query: 503 THGNVRSKNVLVDDFFVSRLTEFGLDQLM-VPA--VADEMVALAKADGYKAPE-LQRMKK 558
H +++ +N+L+ D +L +FGL + VP+ ++E+V L Y+ P+ L +
Sbjct: 125 LHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTL----WYRPPDVLLGSTE 180
Query: 559 CSSRTDVYAFGILLLEILIG 578
S+ D++ G + +E++ G
Sbjct: 181 YSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 39.3 bits (91), Expect = 0.004
Identities = 39/193 (20%), Positives = 89/193 (46%), Gaps = 13/193 (6%)
Query: 391 GTAYKA-KLADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIP-LRAFYQGKRGE 448
GT Y A +A G +A++ + + + I + + ++ N++ L ++ G E
Sbjct: 33 GTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD--E 90
Query: 449 KLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVR 508
++ +Y +L D++ +T + + R + + L +LH+ + H +++
Sbjct: 91 LWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL-----QALDFLHSNQ---VIHRDIK 142
Query: 509 SKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKADGYKAPELQRMKKCSSRTDVYAF 568
S N+L+ +LT+FG + P + + + APE+ K + D+++
Sbjct: 143 SDNILLGMDGSVKLTDFGFCAQITPE-QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSL 201
Query: 569 GILLLEILIGKKP 581
GI+ +E++ G+ P
Sbjct: 202 GIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.004
Identities = 39/180 (21%), Positives = 79/180 (43%), Gaps = 15/180 (8%)
Query: 424 IRQLGKVRHENLIPLRAFYQGKRGEKLLIY-DYFPSRTLHDLLHDTIAGKPVLNWARRHK 482
I+ L + HE ++ + L I+ ++ P ++ D L G N R++
Sbjct: 55 IQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSY--GALTENVTRKY- 111
Query: 483 IALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLM--VPAVADEMV 540
I G++YLH+ I H +++ N+L D +L +FG + + + M
Sbjct: 112 -TRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMK 167
Query: 541 ALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVA 600
++ + +PE+ + + D+++ G ++E+L K P EF + +I K+A
Sbjct: 168 SVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPW-----AEFEAMAAIFKIA 222
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 679 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.98 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.94 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.93 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.93 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.93 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.91 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.89 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.87 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.86 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.85 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.83 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.83 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.83 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.82 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.82 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.8 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.8 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.79 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.79 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.78 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.75 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.75 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.73 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.71 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.71 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.7 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.7 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.69 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.69 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.63 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.62 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.61 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.61 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.61 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.51 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.51 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.5 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.49 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.47 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.46 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.41 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.4 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.4 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.4 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.38 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.33 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.32 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.3 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.27 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.25 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.2 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.17 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.17 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.17 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.16 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.16 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.15 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.15 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.12 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.1 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.1 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.05 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.04 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.03 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.02 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.01 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.94 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.92 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.91 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 98.88 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.87 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.87 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 98.85 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.79 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.73 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.71 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.66 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.64 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 98.61 | |
| PF08263 | 43 | LRRNT_2: Leucine rich repeat N-terminal domain; In | 98.58 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 98.57 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.57 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.53 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.49 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.42 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.36 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.35 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.33 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.3 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.22 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.17 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 98.16 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.16 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.03 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 98.01 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.01 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.97 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.96 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-65 Score=614.83 Aligned_cols=517 Identities=27% Similarity=0.467 Sum_probs=370.3
Q ss_pred ccEEEEEcCCCCCcccCCccccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCC--------------------
Q 005749 99 IHLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANL-------------------- 158 (679)
Q Consensus 99 ~~l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~-------------------- 158 (679)
.+++.|+|++|+++|.+|..+..+++|+.|+|++|.++|.+|..+..+++|+.|+|++|.
T Consensus 404 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~~~L~~L~ls 483 (968)
T PLN00113 404 RSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLS 483 (968)
T ss_pred CCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCcccccccceEEECc
Confidence 467888888888888888888888888888888888887777666555555555555554
Q ss_pred ---CCCcChhhHHhhcccCcEEEccCCCCcccCCCCCCCCCCCCCccEEEccCccccccccccccCCCCCCEEEccCCcc
Q 005749 159 ---FTGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLF 235 (679)
Q Consensus 159 ---l~g~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l 235 (679)
++|.+|..+.++ ++|+.|+|++|++++.+|... ..+++|++|+|++|+++|.+|..+..+++|+.|||++|++
T Consensus 484 ~n~l~~~~~~~~~~l-~~L~~L~Ls~N~l~~~~p~~~---~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 559 (968)
T PLN00113 484 RNQFSGAVPRKLGSL-SELMQLKLSENKLSGEIPDEL---SSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQL 559 (968)
T ss_pred CCccCCccChhhhhh-hccCEEECcCCcceeeCChHH---cCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcc
Confidence 444444444443 566666666666666666433 3567888999999999988888888899999999999999
Q ss_pred cccCCcccccc-ccCEEEccCCcCCCCCCCccc-CCCCcccccCCCCCCCCCCC----CCCCCCCCCCCCcchhhhhHHH
Q 005749 236 SGSIPEGLTRL-SLEKLNLSHNNFSGVLPVFSE-SKFGAEVFEGNSPALCGFPL----RDCSGNSRLSSGAIAGLVIGLM 309 (679)
Q Consensus 236 ~g~~p~~~~~l-~L~~l~ls~N~l~g~ip~~~~-~~~~~~~~~~n~~~~c~~p~----~~c~~~~~~s~~~i~~iv~~~~ 309 (679)
+|.+|..+..+ +|+.|++++|+++|.+|.... ..+....+.|| +.+|+.+. .+|..... +....+ ++++++
T Consensus 560 ~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n-~~lc~~~~~~~~~~c~~~~~-~~~~~~-~~~~~~ 636 (968)
T PLN00113 560 SGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGN-IDLCGGDTTSGLPPCKRVRK-TPSWWF-YITCTL 636 (968)
T ss_pred cccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCC-ccccCCccccCCCCCccccc-cceeee-ehhHHH
Confidence 98888888877 589999999999999887532 34556678888 88998642 45643211 111111 122222
Q ss_pred HHHHHHHHHHHhhhhccccCCCCCCchhhcccccccCCCCCCCCCCCCCCCCceeeec--CCccccHHHHHHhhc--Ccc
Q 005749 310 TGAVVFASLLIGYVQNKKRKNRGDSEEEFEEGEDEENGMSGGSAAGGAGGEGKLIIFQ--GGEHLTLEDVLNATG--QVI 385 (679)
Q Consensus 310 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~~~~--~~i 385 (679)
++++++++++++++++++++.......+.+. +..+...+. ....++++++..++. ++|
T Consensus 637 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 698 (968)
T PLN00113 637 GAFLVLALVAFGFVFIRGRNNLELKRVENED------------------GTWELQFFDSKVSKSITINDILSSLKEENVI 698 (968)
T ss_pred HHHHHHHHHHHHHHHHHhhhccccccccccc------------------ccccccccccccchhhhHHHHHhhCCcccEE
Confidence 2222222222223322222211111000000 000111111 123466777666553 689
Q ss_pred ccCCceEEEEEEe-CCCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCChHHH
Q 005749 386 EKTTYGTAYKAKL-ADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRTLHDL 464 (679)
Q Consensus 386 g~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gsL~~~ 464 (679)
|+|+||.||+|+. .++..||||+++.... ....|++++++++|||||+++|+|.+ .+..++|||||++|+|.++
T Consensus 699 g~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~l~~l~HpnIv~~~~~~~~-~~~~~lv~Ey~~~g~L~~~ 773 (968)
T PLN00113 699 SRGKKGASYKGKSIKNGMQFVVKEINDVNS----IPSSEIADMGKLQHPNIVKLIGLCRS-EKGAYLIHEYIEGKNLSEV 773 (968)
T ss_pred ccCCCeeEEEEEECCCCcEEEEEEccCCcc----ccHHHHHHHhhCCCCCcceEEEEEEc-CCCCEEEEeCCCCCcHHHH
Confidence 9999999999995 6799999999875322 23457899999999999999999987 5789999999999999999
Q ss_pred hhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccchhcccc
Q 005749 465 LHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAK 544 (679)
Q Consensus 465 l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~g 544 (679)
++. ++|.++.+|+.|+++||+|||+.+.++|+||||||+||+++.++.+++. ||.+...... ....+
T Consensus 774 l~~-------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~-----~~~~~ 840 (968)
T PLN00113 774 LRN-------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-----TKCFI 840 (968)
T ss_pred Hhc-------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC-----CCccc
Confidence 963 7999999999999999999997766679999999999999999988876 6665543211 22367
Q ss_pred cccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcCCCChHH
Q 005749 545 ADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIRSPMEE 624 (679)
Q Consensus 545 t~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 624 (679)
+..|||||++.+..+++|+|||||||++|||+||+.||+. .......+.+|++...........+|+.+... .....+
T Consensus 841 t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 918 (968)
T PLN00113 841 SSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADA-EFGVHGSIVEWARYCYSDCHLDMWIDPSIRGD-VSVNQN 918 (968)
T ss_pred cccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCc-ccCCCCcHHHHHHHhcCccchhheeCccccCC-CCccHH
Confidence 8899999999999999999999999999999999999843 33334567777776655544445555554322 233456
Q ss_pred HHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCCC
Q 005749 625 GLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRPR 660 (679)
Q Consensus 625 ~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 660 (679)
+..++.+++.+||+.||++||+|+||++.|+++.+.
T Consensus 919 ~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~ 954 (968)
T PLN00113 919 EIVEVMNLALHCTATDPTARPCANDVLKTLESASRS 954 (968)
T ss_pred HHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence 677888999999999999999999999999998653
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-55 Score=459.90 Aligned_cols=288 Identities=34% Similarity=0.560 Sum_probs=247.4
Q ss_pred CCccccHHHHHHhhc-----CccccCCceEEEEEEeCCCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEe
Q 005749 368 GGEHLTLEDVLNATG-----QVIEKTTYGTAYKAKLADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFY 442 (679)
Q Consensus 368 ~~~~~~~~~l~~~~~-----~~ig~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~ 442 (679)
....|+++++..||+ ++||+|+||.||+|.+.+|+.||||++.........+|.+|++++.+++|||+|+++|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 346799999999994 689999999999999999999999988765433144599999999999999999999999
Q ss_pred eCCCC-ceEEEEEecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceE
Q 005749 443 QGKRG-EKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSR 521 (679)
Q Consensus 443 ~~~~~-~~~lv~ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~k 521 (679)
.+ .+ +.+||||||++|+|.++|+..... .++|.+|++||.++|+||+|||+...++||||||||+|||||+++++|
T Consensus 141 ~e-~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aK 217 (361)
T KOG1187|consen 141 LE-GGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAK 217 (361)
T ss_pred ec-CCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEE
Confidence 98 45 599999999999999999975432 789999999999999999999999888999999999999999999999
Q ss_pred EeecccccccCcccccchhcc-cccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHH
Q 005749 522 LTEFGLDQLMVPAVADEMVAL-AKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVA 600 (679)
Q Consensus 522 l~DFGla~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~ 600 (679)
|+|||+|+..... ....... .||.+|+|||++..+..++|+|||||||+|+|++||++|.+.........+.+|+...
T Consensus 218 lsDFGLa~~~~~~-~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~ 296 (361)
T KOG1187|consen 218 LSDFGLAKLGPEG-DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPL 296 (361)
T ss_pred ccCccCcccCCcc-ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHH
Confidence 9999999766431 1111222 7999999999999999999999999999999999999988654444455689999888
Q ss_pred hhcccccccchHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCCC
Q 005749 601 VLEETTMEVFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRPR 660 (679)
Q Consensus 601 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 660 (679)
+.+....+++|+++..+... ..+++.++..++.+|++.+|++||+|.||+++|+.+...
T Consensus 297 ~~~~~~~eiiD~~l~~~~~~-~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 297 LEEGKLREIVDPRLKEGEYP-DEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred HHCcchhheeCCCccCCCCC-hHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 88889999999997643221 126788899999999999999999999999999776544
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-49 Score=414.06 Aligned_cols=254 Identities=29% Similarity=0.463 Sum_probs=209.9
Q ss_pred cCccccCCceEEEEEEeCCCCEEEEEEcccCcccC--cccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCC
Q 005749 382 GQVIEKTTYGTAYKAKLADGATIALRLLREGSCKD--RSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSR 459 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~--~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~g 459 (679)
.+.||+|+||+||+|.++....||||++....... .++|.+|+.+|.+++|||||+++|+|.+.....++|||||++|
T Consensus 46 ~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~G 125 (362)
T KOG0192|consen 46 EEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGG 125 (362)
T ss_pred hhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCC
Confidence 46699999999999999755559999998754322 4589999999999999999999999998444799999999999
Q ss_pred ChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCC-ceEEeecccccccCcccccc
Q 005749 460 TLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFF-VSRLTEFGLDQLMVPAVADE 538 (679)
Q Consensus 460 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~-~~kl~DFGla~~~~~~~~~~ 538 (679)
+|.++++.. .+..+++..+++||.|||+||+|||+++. ||||||||+|||++.++ ++||+|||+++...... ..
T Consensus 126 sL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-~~ 200 (362)
T KOG0192|consen 126 SLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-TS 200 (362)
T ss_pred cHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc-cc
Confidence 999999874 24679999999999999999999999763 99999999999999997 99999999998764321 23
Q ss_pred hhccccccccccccccc--ccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhh
Q 005749 539 MVALAKADGYKAPELQR--MKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMK 616 (679)
Q Consensus 539 ~~~~~gt~~y~aPE~~~--~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~ 616 (679)
.....||+.|||||++. ...|+.|+|||||||+||||+||+.||.+.... .. .......
T Consensus 201 ~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~---~~----------------~~~v~~~ 261 (362)
T KOG0192|consen 201 MTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPV---QV----------------ASAVVVG 261 (362)
T ss_pred ccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHH---HH----------------HHHHHhc
Confidence 34478999999999999 568999999999999999999999999654321 11 1111223
Q ss_pred cCCCChHH-HHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCC
Q 005749 617 GIRSPMEE-GLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRP 659 (679)
Q Consensus 617 ~~~~~~~~-~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 659 (679)
+.++..+. ..+.+..++.+||..||++||++.|++..|+.+..
T Consensus 262 ~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~ 305 (362)
T KOG0192|consen 262 GLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMS 305 (362)
T ss_pred CCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence 33444343 45667789999999999999999999999998754
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-47 Score=382.64 Aligned_cols=256 Identities=21% Similarity=0.348 Sum_probs=211.1
Q ss_pred ccccHHHHHHhhcCccccCCceEEEEEEe-CCCCEEEEEEcccC-cccCcccHHHHHHHHhccCCCCCccceEEeeCCCC
Q 005749 370 EHLTLEDVLNATGQVIEKTTYGTAYKAKL-ADGATIALRLLREG-SCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRG 447 (679)
Q Consensus 370 ~~~~~~~l~~~~~~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~ 447 (679)
..++..|+.+ ...||+|..|+|||+++ .+++.+|+|.+... ....++++.+|++++++.+||+||++||.|.. ++
T Consensus 74 ~~i~~~dle~--~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~-~~ 150 (364)
T KOG0581|consen 74 NGISLSDLER--LGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYS-NG 150 (364)
T ss_pred cccCHHHhhh--hhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEe-CC
Confidence 3467778753 48899999999999995 56889999999554 33456789999999999999999999999998 45
Q ss_pred -ceEEEEEecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeeecCCCCCCeeecCCCceEEeec
Q 005749 448 -EKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHT-GHEIPITHGNVRSKNVLVDDFFVSRLTEF 525 (679)
Q Consensus 448 -~~~lv~ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~-~~~~~ivHrDlkp~NILl~~~~~~kl~DF 525 (679)
++.++||||.+|||+++++.. ..+++...-+|+.+|++||.|||+ ++ ||||||||+|||++..|++||+||
T Consensus 151 ~~isI~mEYMDgGSLd~~~k~~----g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDF 223 (364)
T KOG0581|consen 151 EEISICMEYMDGGSLDDILKRV----GRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDF 223 (364)
T ss_pred ceEEeehhhcCCCCHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccc
Confidence 599999999999999999864 458999999999999999999996 56 999999999999999999999999
Q ss_pred ccccccCcccccchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhccc
Q 005749 526 GLDQLMVPAVADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEET 605 (679)
Q Consensus 526 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~ 605 (679)
|.++.+... ...+++||..|||||.+.+..|+.++||||||++++|+++|+.||... ........+
T Consensus 224 GVS~~lvnS---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~-~~~~~~~~~---------- 289 (364)
T KOG0581|consen 224 GVSGILVNS---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPP-NPPYLDIFE---------- 289 (364)
T ss_pred cccHHhhhh---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCc-CCCCCCHHH----------
Confidence 999987543 346789999999999999999999999999999999999999998543 111111111
Q ss_pred ccccchHhhhhcCCCChH--HHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 606 TMEVFDMEIMKGIRSPME--EGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 606 ~~~~~~~~i~~~~~~~~~--~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
.++. |..+..+..+ ...+++.+++..|+++||.+||+++|++++
T Consensus 290 ---Ll~~-Iv~~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 290 ---LLCA-IVDEPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred ---HHHH-HhcCCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 1111 1222222222 356788899999999999999999999876
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-48 Score=402.00 Aligned_cols=263 Identities=25% Similarity=0.405 Sum_probs=220.0
Q ss_pred ccccHHHHHHhhcCccccCCceEEEEEEeCCCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCCCCce
Q 005749 370 EHLTLEDVLNATGQVIEKTTYGTAYKAKLADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEK 449 (679)
Q Consensus 370 ~~~~~~~l~~~~~~~ig~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 449 (679)
-.+.-+++. ..+.||+|-||.||.|+++....||+|.++... ...++|.+|+++|.+++|+|||+++|+|.. ++.+
T Consensus 201 wei~r~~l~--l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~-~~pi 276 (468)
T KOG0197|consen 201 WEIPREELK--LIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTK-QEPI 276 (468)
T ss_pred eeecHHHHH--HHHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEec-CCce
Confidence 344445553 347899999999999999888899999998863 345789999999999999999999999997 5689
Q ss_pred EEEEEecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeeccccc
Q 005749 450 LLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQ 529 (679)
Q Consensus 450 ~lv~ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 529 (679)
+||||||+.|+|.++|+... +..+...+.+.++.|||+||+||++++ +|||||.++|||++++..+||+|||+|+
T Consensus 277 yIVtE~m~~GsLl~yLr~~~--~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr 351 (468)
T KOG0197|consen 277 YIVTEYMPKGSLLDYLRTRE--GGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLAR 351 (468)
T ss_pred EEEEEecccCcHHHHhhhcC--CCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEccccccc
Confidence 99999999999999999732 456889999999999999999999998 9999999999999999999999999999
Q ss_pred ccCcccccchhcccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHHhhcccccc
Q 005749 530 LMVPAVADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAVLEETTME 608 (679)
Q Consensus 530 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 608 (679)
...++.........-+..|.|||.+..+.++.|||||||||+||||+| |+.||....+.+..
T Consensus 352 ~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~----------------- 414 (468)
T KOG0197|consen 352 LIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVL----------------- 414 (468)
T ss_pred ccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHH-----------------
Confidence 655544443444455678999999999999999999999999999997 88898655443221
Q ss_pred cchHhhhhcCCCChHHHH-HHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCCCC
Q 005749 609 VFDMEIMKGIRSPMEEGL-VQALKLAMGCCAPVASVRPTMDEVVKQLEENRPRN 661 (679)
Q Consensus 609 ~~~~~i~~~~~~~~~~~~-~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 661 (679)
..+.+|++.+.|+.+ .++.+++..||..+|++|||++.+...|+++....
T Consensus 415 ---~~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~ 465 (468)
T KOG0197|consen 415 ---ELLERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTST 465 (468)
T ss_pred ---HHHhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhcc
Confidence 134566665555444 56679999999999999999999999998876443
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-46 Score=393.37 Aligned_cols=244 Identities=21% Similarity=0.375 Sum_probs=209.7
Q ss_pred hcCccccCCceEEEEEEe-CCCCEEEEEEcccC---cccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEec
Q 005749 381 TGQVIEKTTYGTAYKAKL-ADGATIALRLLREG---SCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYF 456 (679)
Q Consensus 381 ~~~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~ 456 (679)
.+++||+|+|+.||.++. .+|+.||+|++.+. ....++...+||++-+.++|||||+++++|++ .+.+|||.|+|
T Consensus 22 ~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FED-s~nVYivLELC 100 (592)
T KOG0575|consen 22 RGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFED-SNNVYIVLELC 100 (592)
T ss_pred eeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeec-CCceEEEEEec
Confidence 368999999999999995 89999999999764 33456788999999999999999999999998 78999999999
Q ss_pred CCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccc
Q 005749 457 PSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVA 536 (679)
Q Consensus 457 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 536 (679)
++++|.++++. ..++++.+++.+++||+.||.|||+++ |+|||||-.|+++++++++||+|||+|..+... .
T Consensus 101 ~~~sL~el~Kr----rk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~-~ 172 (592)
T KOG0575|consen 101 HRGSLMELLKR----RKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD-G 172 (592)
T ss_pred CCccHHHHHHh----cCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc-c
Confidence 99999999985 456999999999999999999999998 999999999999999999999999999987543 2
Q ss_pred cchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhh
Q 005749 537 DEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMK 616 (679)
Q Consensus 537 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~ 616 (679)
+.-.+.+||+.|+|||++....++..+||||+|||||-|++|++||+...-. +.++ +|..
T Consensus 173 Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vk-------------------ety~-~Ik~ 232 (592)
T KOG0575|consen 173 ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVK-------------------ETYN-KIKL 232 (592)
T ss_pred cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHH-------------------HHHH-HHHh
Confidence 3446789999999999999889999999999999999999999999543211 1111 2223
Q ss_pred cCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 617 GIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 617 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
..+..+.....+..+||.++|+.||.+|||+++|+..
T Consensus 233 ~~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 233 NEYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred cCcccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 2233333555677899999999999999999999976
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-46 Score=408.95 Aligned_cols=264 Identities=22% Similarity=0.376 Sum_probs=219.1
Q ss_pred cccHHHHHHhhcCccccCCceEEEEEEeC------CCCEEEEEEcccCccc-CcccHHHHHHHHhccCCCCCccceEEee
Q 005749 371 HLTLEDVLNATGQVIEKTTYGTAYKAKLA------DGATIALRLLREGSCK-DRSSCLPVIRQLGKVRHENLIPLRAFYQ 443 (679)
Q Consensus 371 ~~~~~~l~~~~~~~ig~G~~g~Vy~~~~~------~~~~vAvK~~~~~~~~-~~~~~~~Ei~~l~~l~H~nIv~l~~~~~ 443 (679)
+|+..++. ..+.||+|.||+||+|+.. +.+.||||.+++.... .+.+|.+|++.++.++|||||+++|+|.
T Consensus 482 ~i~r~~i~--~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~ 559 (774)
T KOG1026|consen 482 EIPRSDIV--FKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCR 559 (774)
T ss_pred Eechhhee--ehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEc
Confidence 45555553 3378999999999999843 3568999999987654 6789999999999999999999999999
Q ss_pred CCCCceEEEEEecCCCChHHHhhcccC------C----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCee
Q 005749 444 GKRGEKLLIYDYFPSRTLHDLLHDTIA------G----KPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVL 513 (679)
Q Consensus 444 ~~~~~~~lv~ey~~~gsL~~~l~~~~~------~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NIL 513 (679)
. ++..+||+|||..|||.++|..+.. + ..+++..+.+.||.|||.||+||-+++ +|||||.++|+|
T Consensus 560 ~-~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCL 635 (774)
T KOG1026|consen 560 E-GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCL 635 (774)
T ss_pred c-CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhce
Confidence 8 6889999999999999999975432 1 234889999999999999999999998 999999999999
Q ss_pred ecCCCceEEeecccccccCcccccchh-cccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCccc
Q 005749 514 VDDFFVSRLTEFGLDQLMVPAVADEMV-ALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFV 591 (679)
Q Consensus 514 l~~~~~~kl~DFGla~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~ 591 (679)
+.++..+||+|||++|.....++++.. ...-+++|||||.++.++|+++||||||||||||+++ |+.||.+..+.+..
T Consensus 636 Vge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVI 715 (774)
T KOG1026|consen 636 VGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVI 715 (774)
T ss_pred eccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHH
Confidence 999999999999999987655555433 3345678999999999999999999999999999996 99999777665433
Q ss_pred chhHHHHHHhhcccccccchHhhhhcCC-CChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCCC
Q 005749 592 DLPSIVKVAVLEETTMEVFDMEIMKGIR-SPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRPR 660 (679)
Q Consensus 592 ~l~~~~~~~~~~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 660 (679)
+. +..|.. +..+....++.+|+..||+.+|++||+++||-..|+.....
T Consensus 716 e~--------------------i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~ 765 (774)
T KOG1026|consen 716 EC--------------------IRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA 765 (774)
T ss_pred HH--------------------HHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence 22 122222 22334456788999999999999999999999999988644
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-46 Score=376.43 Aligned_cols=195 Identities=22% Similarity=0.393 Sum_probs=175.3
Q ss_pred CccccCCceEEEEEE-eCCCCEEEEEEcccC--cccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCC
Q 005749 383 QVIEKTTYGTAYKAK-LADGATIALRLLREG--SCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSR 459 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~g 459 (679)
+.||+|+||+||+|+ .+++..||||.+... ..+..+....|+++|+.++|||||++++++++ ++.+|+|||||.+|
T Consensus 16 ~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~-~~~i~lVMEyC~gG 94 (429)
T KOG0595|consen 16 REIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIED-DDFIYLVMEYCNGG 94 (429)
T ss_pred hhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEec-CCeEEEEEEeCCCC
Confidence 459999999999999 456899999999776 44556778999999999999999999999998 68999999999999
Q ss_pred ChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCC------CceEEeecccccccCc
Q 005749 460 TLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDF------FVSRLTEFGLDQLMVP 533 (679)
Q Consensus 460 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~------~~~kl~DFGla~~~~~ 533 (679)
||.++++.+ ..+++..++.++.|+|.||++||+++ ||||||||+||||+.. -.+||+|||+|+.+.+
T Consensus 95 DLs~yi~~~----~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~ 167 (429)
T KOG0595|consen 95 DLSDYIRRR----GRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQP 167 (429)
T ss_pred CHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchhhhCCc
Confidence 999999975 35999999999999999999999999 9999999999999864 4689999999999864
Q ss_pred ccccchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCC
Q 005749 534 AVADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRN 587 (679)
Q Consensus 534 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~ 587 (679)
. ....+.+|++.|||||+++.++|+.|+|+||.|+|+||+++|+.||+..+.
T Consensus 168 ~--~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~ 219 (429)
T KOG0595|consen 168 G--SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETP 219 (429)
T ss_pred h--hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCH
Confidence 3 334678999999999999999999999999999999999999999965443
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-46 Score=359.53 Aligned_cols=263 Identities=20% Similarity=0.305 Sum_probs=215.5
Q ss_pred cccHHHHHHhhcCccccCCceEEEEEE-eCCCCEEEEEEcccCc--ccCcccHHHHHHHHhccCCCCCccceEE-eeCCC
Q 005749 371 HLTLEDVLNATGQVIEKTTYGTAYKAK-LADGATIALRLLREGS--CKDRSSCLPVIRQLGKVRHENLIPLRAF-YQGKR 446 (679)
Q Consensus 371 ~~~~~~l~~~~~~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~-~~~~~ 446 (679)
.-+++|.. ..+.||+|+||+|||++ +.+|..||.|.++-.. .+.+++...|+.+|++++|||||+++++ +....
T Consensus 15 ~~~l~~y~--Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~ 92 (375)
T KOG0591|consen 15 QKTLADYQ--ILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDN 92 (375)
T ss_pred cccHHHHH--HHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccc
Confidence 34455442 23789999999999999 7899999999997442 3446788999999999999999999984 44423
Q ss_pred CceEEEEEecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeeecCCCCCCeeecCCCceEEeec
Q 005749 447 GEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHE-IPITHGNVRSKNVLVDDFFVSRLTEF 525 (679)
Q Consensus 447 ~~~~lv~ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~-~~ivHrDlkp~NILl~~~~~~kl~DF 525 (679)
...+||||||..|||.++++..+..++.+++..+++++.|+++||.++|+.-. .-|+||||||.||+++.+|.+|++||
T Consensus 93 evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDf 172 (375)
T KOG0591|consen 93 EVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDF 172 (375)
T ss_pred hhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccc
Confidence 34899999999999999999887778889999999999999999999998321 12999999999999999999999999
Q ss_pred ccccccCcccccchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhccc
Q 005749 526 GLDQLMVPAVADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEET 605 (679)
Q Consensus 526 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~ 605 (679)
|+++.+... .....+.+||+.||+||.+....|+.|+||||+||++|||+.-++||.+.. ..
T Consensus 173 GL~r~l~s~-~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n---~~-------------- 234 (375)
T KOG0591|consen 173 GLGRFLSSK-TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN---LL-------------- 234 (375)
T ss_pred hhHhHhcch-hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc---HH--------------
Confidence 999988543 233457799999999999999999999999999999999999999996541 11
Q ss_pred ccccchHhhhhcCCCChH--HHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHh
Q 005749 606 TMEVFDMEIMKGIRSPME--EGLVQALKLAMGCCAPVASVRPTMDEVVKQLEE 656 (679)
Q Consensus 606 ~~~~~~~~i~~~~~~~~~--~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 656 (679)
.+..+|..+..++.+ ....++.+++..|+..||+.||+.-.+++.++.
T Consensus 235 ---~L~~KI~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 235 ---SLCKKIEQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred ---HHHHHHHcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 123355666555444 556778889999999999999996666665554
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-46 Score=371.34 Aligned_cols=244 Identities=20% Similarity=0.324 Sum_probs=201.7
Q ss_pred hcCccccCCceEEEEEE-eCCCCEEEEEEcccCccc-------CcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEE
Q 005749 381 TGQVIEKTTYGTAYKAK-LADGATIALRLLREGSCK-------DRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLI 452 (679)
Q Consensus 381 ~~~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~-------~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv 452 (679)
.++.+|+|+||.|-+|. ..+|+.||||++...... ......+|+++|++++|||||+++++|.. .+..|||
T Consensus 176 i~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~-~ds~YmV 254 (475)
T KOG0615|consen 176 ISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEV-PDSSYMV 254 (475)
T ss_pred eeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeec-CCceEEE
Confidence 35889999999999998 778999999999764321 12235799999999999999999999998 6788999
Q ss_pred EEecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCC---CceEEeeccccc
Q 005749 453 YDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDF---FVSRLTEFGLDQ 529 (679)
Q Consensus 453 ~ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~---~~~kl~DFGla~ 529 (679)
||||.||+|.+.+-.. ..+.+...+.++.|++.|+.|||+.| |+||||||+|||+..+ ..+||+|||+|+
T Consensus 255 lE~v~GGeLfd~vv~n----k~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDFGlAK 327 (475)
T KOG0615|consen 255 LEYVEGGELFDKVVAN----KYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDFGLAK 327 (475)
T ss_pred EEEecCccHHHHHHhc----cccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecccchhh
Confidence 9999999999998763 45778888999999999999999998 9999999999999765 789999999999
Q ss_pred ccCcccccchhcccccccccccccccccC---CCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccc
Q 005749 530 LMVPAVADEMVALAKADGYKAPELQRMKK---CSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETT 606 (679)
Q Consensus 530 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 606 (679)
... ....+.+.+||+.|.|||++.+.. +..|.|+||+|||||-+++|.+||.+.....
T Consensus 328 ~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~----------------- 388 (475)
T KOG0615|consen 328 VSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP----------------- 388 (475)
T ss_pred ccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc-----------------
Confidence 874 345678899999999999998543 3458899999999999999999996543321
Q ss_pred cccchHhhhhcCCCCh----HHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 607 MEVFDMEIMKGIRSPM----EEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 607 ~~~~~~~i~~~~~~~~----~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
..+..|.+|.+... .+-..+.++++.+||..||++|||++|++++
T Consensus 389 --sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 389 --SLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred --cHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 12223344433222 2345678899999999999999999999875
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-46 Score=396.88 Aligned_cols=251 Identities=23% Similarity=0.414 Sum_probs=214.3
Q ss_pred cCccccCCceEEEEEEeCC----CCEEEEEEcccCc-ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEec
Q 005749 382 GQVIEKTTYGTAYKAKLAD----GATIALRLLREGS-CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYF 456 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~~----~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~ 456 (679)
.++||.|.||.||+|+++- ...||||.++... ++.+.+|+.|..||.+++||||++|-|+... ....+||+|||
T Consensus 634 e~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTk-s~PvMIiTEyM 712 (996)
T KOG0196|consen 634 EKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTK-SKPVMIITEYM 712 (996)
T ss_pred EEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEec-CceeEEEhhhh
Confidence 4799999999999999653 4589999999875 4567799999999999999999999999886 67899999999
Q ss_pred CCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccc
Q 005749 457 PSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVA 536 (679)
Q Consensus 457 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 536 (679)
+||+|+.+|+.+ +..+++.+..-+.++||.||+||-+.+ +|||||.++|||++.+..+||+|||+++.+.++..
T Consensus 713 ENGsLDsFLR~~---DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~ 786 (996)
T KOG0196|consen 713 ENGSLDSFLRQN---DGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 786 (996)
T ss_pred hCCcHHHHHhhc---CCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecccCCC
Confidence 999999999876 344999999999999999999999988 99999999999999999999999999998754432
Q ss_pred cchhcc--cccccccccccccccCCCCcchhHHHHHHHHHHH-hCCCCCCCCCCCcccchhHHHHHHhhcccccccchHh
Q 005749 537 DEMVAL--AKADGYKAPELQRMKKCSSRTDVYAFGILLLEIL-IGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDME 613 (679)
Q Consensus 537 ~~~~~~--~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~-tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 613 (679)
....+. .-+..|.|||.+..++++.++|||||||||||++ .|..||.+..+.+.. ..
T Consensus 787 ~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVI--------------------ka 846 (996)
T KOG0196|consen 787 AAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVI--------------------KA 846 (996)
T ss_pred ccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHH--------------------HH
Confidence 222222 2346799999999999999999999999999988 599999776654322 24
Q ss_pred hhhcCCCChHHHHH-HHHHHHHhccCcCCCCCCCHHHHHHHHHhhCC
Q 005749 614 IMKGIRSPMEEGLV-QALKLAMGCCAPVASVRPTMDEVVKQLEENRP 659 (679)
Q Consensus 614 i~~~~~~~~~~~~~-~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 659 (679)
+.++++.+.|-+++ .+-+|+..||++|-.+||.+.+|+..|+++..
T Consensus 847 Ie~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIr 893 (996)
T KOG0196|consen 847 IEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIR 893 (996)
T ss_pred HHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhc
Confidence 56777766665555 45589999999999999999999999999764
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=371.26 Aligned_cols=260 Identities=23% Similarity=0.346 Sum_probs=207.2
Q ss_pred CccccCCceEEEEEE-eCCCCEEEEEEcccCcc--cCcccHHHHHHHHhccCCCCCccceEEeeCC-CCceEEEEEecCC
Q 005749 383 QVIEKTTYGTAYKAK-LADGATIALRLLREGSC--KDRSSCLPVIRQLGKVRHENLIPLRAFYQGK-RGEKLLIYDYFPS 458 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~-~~~~~lv~ey~~~ 458 (679)
+.||+|.||.||||+ ..+|+.||+|+++.... ....-..+||.||++++||||+++.+...+. .+.+|||+|||+.
T Consensus 123 ~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMdh 202 (560)
T KOG0600|consen 123 EKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMDH 202 (560)
T ss_pred HHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEecccc
Confidence 789999999999999 78899999999987653 3345578999999999999999999998875 5789999999988
Q ss_pred CChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccc
Q 005749 459 RTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADE 538 (679)
Q Consensus 459 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 538 (679)
||.-++... .-.|+..+++.|+.|++.||+|+|+++ |+|||||.+|||||.+|.+||+|||+|+++.......
T Consensus 203 -DL~GLl~~p---~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~ 275 (560)
T KOG0600|consen 203 -DLSGLLSSP---GVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSAP 275 (560)
T ss_pred -hhhhhhcCC---CcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeeccCCCCcc
Confidence 999998764 346999999999999999999999999 9999999999999999999999999999887776666
Q ss_pred hhcccccccccccccccc-cCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHh--hccccc-------c
Q 005749 539 MVALAKADGYKAPELQRM-KKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAV--LEETTM-------E 608 (679)
Q Consensus 539 ~~~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~--~~~~~~-------~ 608 (679)
.+..+-|.+|+|||++.+ ..|+++.|+||.||||.||++|++.|.+.++-+. +..+.+..- .+..+. .
T Consensus 276 ~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQ--l~kIfklcGSP~e~~W~~~kLP~~~ 353 (560)
T KOG0600|consen 276 YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQ--LHKIFKLCGSPTEDYWPVSKLPHAT 353 (560)
T ss_pred cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHH--HHHHHHHhCCCChhccccccCCccc
Confidence 777888999999999886 4699999999999999999999999977654332 222222110 011111 1
Q ss_pred cchHhhhhcCCCC----hHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 609 VFDMEIMKGIRSP----MEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 609 ~~~~~i~~~~~~~----~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
.+.+. ..+... ........++|+..+|..||++|.|+.++++.
T Consensus 354 ~~kp~--~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 354 IFKPQ--QPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred ccCCC--CcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 11100 000001 11123567789999999999999999988754
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=348.87 Aligned_cols=259 Identities=18% Similarity=0.261 Sum_probs=201.0
Q ss_pred CccccCCceEEEEEE-eCCCCEEEEEEcccCcc--cCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCC
Q 005749 383 QVIEKTTYGTAYKAK-LADGATIALRLLREGSC--KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSR 459 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~g 459 (679)
..+|+|+||+|||++ ..+|+.||||++.+... .-.+..++||++|++++|+|+|.++.+|.. ....++|+|||+.
T Consensus 8 gkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrr-krklhLVFE~~dh- 85 (396)
T KOG0593|consen 8 GKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRR-KRKLHLVFEYCDH- 85 (396)
T ss_pred hccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHh-cceeEEEeeecch-
Confidence 579999999999999 55699999999977543 234568999999999999999999999997 6789999999987
Q ss_pred ChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccch
Q 005749 460 TLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEM 539 (679)
Q Consensus 460 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 539 (679)
++.+-|... ..-++.....+|+.|+++|+.|+|+++ +|||||||+|||++.++.+|++|||+|+.+.. .....
T Consensus 86 TvL~eLe~~---p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-pgd~Y 158 (396)
T KOG0593|consen 86 TVLHELERY---PNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSA-PGDNY 158 (396)
T ss_pred HHHHHHHhc---cCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcC-Ccchh
Confidence 444444443 234788999999999999999999998 99999999999999999999999999999864 23445
Q ss_pred hcccccccccccccccc-cCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHh---------hcccc---
Q 005749 540 VALAKADGYKAPELQRM-KKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAV---------LEETT--- 606 (679)
Q Consensus 540 ~~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~---------~~~~~--- 606 (679)
+.++.|.+|+|||++.+ ..|+...||||.||++.||++|.+.|.+.+.-+....+...-..+ .....
T Consensus 159 TDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv 238 (396)
T KOG0593|consen 159 TDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGV 238 (396)
T ss_pred hhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeee
Confidence 67889999999999887 679999999999999999999999997766543332222111110 01111
Q ss_pred --cccchHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 607 --MEVFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 607 --~~~~~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
.+.-+++-.+ ...+....-.++++..|++.||++|++-+|++..
T Consensus 239 ~lP~~~~~epLe---~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 239 RLPEPEHPEPLE---RKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred ecCCCCCccchh---hhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 1111111111 1112223467799999999999999999998754
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=369.05 Aligned_cols=262 Identities=19% Similarity=0.284 Sum_probs=205.2
Q ss_pred cCccccCCceEEEEEE-eCCCCEEEEEEcccCcccCcc-cHHHHHHHHhccC-CCCCccceEEeeCCCCceEEEEEecCC
Q 005749 382 GQVIEKTTYGTAYKAK-LADGATIALRLLREGSCKDRS-SCLPVIRQLGKVR-HENLIPLRAFYQGKRGEKLLIYDYFPS 458 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~-~~~~Ei~~l~~l~-H~nIv~l~~~~~~~~~~~~lv~ey~~~ 458 (679)
-+.||.|+||.||+|+ .++|..||||+++.......+ --+||++.|++++ |||||++.+++.+.+...++|||||+.
T Consensus 15 i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVfE~Md~ 94 (538)
T KOG0661|consen 15 IRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFEFMDC 94 (538)
T ss_pred HHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHHhhhh
Confidence 3789999999999999 778999999999876443222 2379999999998 999999999999854489999999977
Q ss_pred CChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccc
Q 005749 459 RTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADE 538 (679)
Q Consensus 459 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 538 (679)
+|+++++++ +..+++..++.|+.||++||+|+|.+| +.|||+||+|||+.....+||+|||+||.+... ..
T Consensus 95 -NLYqLmK~R---~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk--pP 165 (538)
T KOG0661|consen 95 -NLYQLMKDR---NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVRSK--PP 165 (538)
T ss_pred -hHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccccccC--CC
Confidence 999999986 567999999999999999999999999 999999999999998899999999999987432 34
Q ss_pred hhccccccccccccccc-ccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHh--hcccccccc--hHh
Q 005749 539 MVALAKADGYKAPELQR-MKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAV--LEETTMEVF--DME 613 (679)
Q Consensus 539 ~~~~~gt~~y~aPE~~~-~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~--~~~~~~~~~--~~~ 613 (679)
.+.++.|.+|+|||++. .+.|+.+.||||+|||++|+++-++.|.+..+.+ ++-.+....- .+..+.+.. ...
T Consensus 166 YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~D--qi~KIc~VLGtP~~~~~~eg~~La~~ 243 (538)
T KOG0661|consen 166 YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEID--QIYKICEVLGTPDKDSWPEGYNLASA 243 (538)
T ss_pred cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHH--HHHHHHHHhCCCccccchhHHHHHHH
Confidence 56788999999999765 5779999999999999999999999997754432 1212211110 000001100 000
Q ss_pred hh------h--cCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 005749 614 IM------K--GIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQL 654 (679)
Q Consensus 614 i~------~--~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L 654 (679)
+- . ....-.+....+.++++.+|+++||.+|||+.|++++-
T Consensus 244 mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p 292 (538)
T KOG0661|consen 244 MNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHP 292 (538)
T ss_pred hccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence 00 0 00011123557888999999999999999999999873
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-44 Score=367.41 Aligned_cols=247 Identities=22% Similarity=0.386 Sum_probs=202.7
Q ss_pred ccHHHHHHhhcCccccCCceEEEEEEeCCCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEE
Q 005749 372 LTLEDVLNATGQVIEKTTYGTAYKAKLADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLL 451 (679)
Q Consensus 372 ~~~~~l~~~~~~~ig~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~l 451 (679)
+.++++..- +-+|.|+.|.||+|+++ ++.||||+++... ..+|+.|++++||||+.+.|+|.. ..-+||
T Consensus 121 iPFe~IsEL--eWlGSGaQGAVF~Grl~-netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtq-sPcyCI 189 (904)
T KOG4721|consen 121 IPFEEISEL--EWLGSGAQGAVFLGRLH-NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQ-SPCYCI 189 (904)
T ss_pred CCHHHhhhh--hhhccCcccceeeeecc-CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecC-CceeEE
Confidence 445555322 78999999999999996 7899999987633 356899999999999999999997 678999
Q ss_pred EEEecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeeccccccc
Q 005749 452 IYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLM 531 (679)
Q Consensus 452 v~ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 531 (679)
|||||+.|-|..+|+. ..++.......+..+||.||.|||.+. |||||||+-||||..+..+||+|||.++..
T Consensus 190 iMEfCa~GqL~~VLka----~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~ 262 (904)
T KOG4721|consen 190 IMEFCAQGQLYEVLKA----GRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKEL 262 (904)
T ss_pred eeeccccccHHHHHhc----cCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhh
Confidence 9999999999999987 456888888999999999999999988 999999999999999999999999999876
Q ss_pred CcccccchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccch
Q 005749 532 VPAVADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFD 611 (679)
Q Consensus 532 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 611 (679)
... .....++||..|||||++...+.++|.||||||||||||+||..||.+.+....+ | + +-
T Consensus 263 ~~~--STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAII----w-------G----VG- 324 (904)
T KOG4721|consen 263 SDK--STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAII----W-------G----VG- 324 (904)
T ss_pred hhh--hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeE----E-------e----cc-
Confidence 433 4456789999999999999999999999999999999999999999653321100 0 0 00
Q ss_pred HhhhhcCCCChHHHHHH-HHHHHHhccCcCCCCCCCHHHHHHHHHhh
Q 005749 612 MEIMKGIRSPMEEGLVQ-ALKLAMGCCAPVASVRPTMDEVVKQLEEN 657 (679)
Q Consensus 612 ~~i~~~~~~~~~~~~~~-~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 657 (679)
-.....+.+..+++ +.-|+++||+..|..||+|++++.+|+=.
T Consensus 325 ---sNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa 368 (904)
T KOG4721|consen 325 ---SNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA 368 (904)
T ss_pred ---CCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence 00111334444444 44467789999999999999999999744
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=351.41 Aligned_cols=234 Identities=24% Similarity=0.311 Sum_probs=197.4
Q ss_pred CccccCCceEEEEEE-eCCCCEEEEEEcccCcc---cCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCC
Q 005749 383 QVIEKTTYGTAYKAK-LADGATIALRLLREGSC---KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPS 458 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~---~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~ 458 (679)
++||+|+||+||.++ .++++.+|+|++++... .+.+...+|..+|.+++||.||+++..|++ .+..|+|+||+.|
T Consensus 31 kviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt-~~kLylVld~~~G 109 (357)
T KOG0598|consen 31 KVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQT-EEKLYLVLDYLNG 109 (357)
T ss_pred eeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEeccc-CCeEEEEEeccCC
Confidence 899999999999999 55699999999987642 345678899999999999999999999998 7899999999999
Q ss_pred CChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccc
Q 005749 459 RTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADE 538 (679)
Q Consensus 459 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 538 (679)
|.|..+|+. +..+++..++.++.+|+.||.|||+.+ ||||||||+|||+|.+|+++|+|||+++..... ...
T Consensus 110 GeLf~hL~~----eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~-~~~ 181 (357)
T KOG0598|consen 110 GELFYHLQR----EGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD-GDA 181 (357)
T ss_pred ccHHHHHHh----cCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcccC-CCc
Confidence 999999986 356999999999999999999999999 999999999999999999999999999964332 233
Q ss_pred hhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcC
Q 005749 539 MVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGI 618 (679)
Q Consensus 539 ~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~ 618 (679)
..+.+||+.|||||++.+..|+.++|-||+||++|||++|.+||...... .+. + ++..+.
T Consensus 182 t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~------~~~-------------~-~I~~~k 241 (357)
T KOG0598|consen 182 TRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVK------KMY-------------D-KILKGK 241 (357)
T ss_pred cccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHH------HHH-------------H-HHhcCc
Confidence 45689999999999999999999999999999999999999999553321 111 1 223332
Q ss_pred CCChHH-HHHHHHHHHHhccCcCCCCCC
Q 005749 619 RSPMEE-GLVQALKLAMGCCAPVASVRP 645 (679)
Q Consensus 619 ~~~~~~-~~~~~~~l~~~cl~~dP~~RP 645 (679)
....+. ...+..+++.+.+..||++|-
T Consensus 242 ~~~~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 242 LPLPPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred CCCCCccCCHHHHHHHHHHhccCHHHhc
Confidence 122222 456778899999999999995
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-43 Score=332.27 Aligned_cols=261 Identities=21% Similarity=0.330 Sum_probs=206.9
Q ss_pred cCccccCCceEEEEEE-eCCCCEEEEEEcccCcccC--cccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCC
Q 005749 382 GQVIEKTTYGTAYKAK-LADGATIALRLLREGSCKD--RSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPS 458 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~--~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~ 458 (679)
.+++|+|.||.||+|+ .++|+.||||+++....++ ....++||+.|+.++|+||+.++++|-+ .+...+|+|||+.
T Consensus 7 ~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~-~~~l~lVfEfm~t 85 (318)
T KOG0659|consen 7 LEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPH-KSNLSLVFEFMPT 85 (318)
T ss_pred hhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccC-CCceEEEEEeccc
Confidence 3789999999999999 7789999999998765432 3468999999999999999999999988 6789999999987
Q ss_pred CChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccc
Q 005749 459 RTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADE 538 (679)
Q Consensus 459 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 538 (679)
+|+..+++. ...++..+++.++.++.+||+|||++. |+||||||.|+|++++|.+||+|||+|+.+......
T Consensus 86 -dLe~vIkd~---~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~- 157 (318)
T KOG0659|consen 86 -DLEVVIKDK---NIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI- 157 (318)
T ss_pred -cHHHHhccc---ccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCCcc-
Confidence 999999876 567999999999999999999999999 999999999999999999999999999988654332
Q ss_pred hhcccccccccccccccc-cCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHH-hh-cccc---cccchH
Q 005749 539 MVALAKADGYKAPELQRM-KKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVA-VL-EETT---MEVFDM 612 (679)
Q Consensus 539 ~~~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~-~~-~~~~---~~~~~~ 612 (679)
....+-|.+|+|||++.+ +.|+...||||.|||+.||+-|.+-|.+.++- .++....+.. .+ ++.+ .+.-|.
T Consensus 158 ~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDi--dQL~~If~~LGTP~~~~WP~~~~lpdY 235 (318)
T KOG0659|consen 158 QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDI--DQLSKIFRALGTPTPDQWPEMTSLPDY 235 (318)
T ss_pred cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchH--HHHHHHHHHcCCCCcccCccccccccH
Confidence 233378899999998876 56999999999999999999999877655432 2222222211 00 1111 122222
Q ss_pred hhhhcCCC-----ChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 613 EIMKGIRS-----PMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 613 ~i~~~~~~-----~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
...+.... -.+....+.++++..++..||.+|+++.|++++
T Consensus 236 ~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 236 VKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred HHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 22221111 123445677999999999999999999999876
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-43 Score=355.95 Aligned_cols=254 Identities=21% Similarity=0.328 Sum_probs=200.4
Q ss_pred hcCccccCCceEEEEEEe-CCCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCCCC-ceEEEEEecCC
Q 005749 381 TGQVIEKTTYGTAYKAKL-ADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRG-EKLLIYDYFPS 458 (679)
Q Consensus 381 ~~~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~-~~~lv~ey~~~ 458 (679)
.++.||+|+||.||++.. ++|...|||.+........+.+.+|+++|.+++|||||+++|......+ ..++.|||+++
T Consensus 21 ~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~ 100 (313)
T KOG0198|consen 21 KGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPG 100 (313)
T ss_pred hhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccCC
Confidence 468999999999999995 4599999999876533235678999999999999999999997555333 68999999999
Q ss_pred CChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecC-CCceEEeecccccccCc--cc
Q 005749 459 RTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDD-FFVSRLTEFGLDQLMVP--AV 535 (679)
Q Consensus 459 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~-~~~~kl~DFGla~~~~~--~~ 535 (679)
|+|.+++.... . .+++..++++++||++||+|||+++ ||||||||+|||++. ++.+||+|||+++.... ..
T Consensus 101 GsL~~~~~~~g--~-~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~ 174 (313)
T KOG0198|consen 101 GSLSDLIKRYG--G-KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTK 174 (313)
T ss_pred CcHHHHHHHcC--C-CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCcccccccccccc
Confidence 99999998753 2 5999999999999999999999988 999999999999999 79999999999987653 11
Q ss_pred ccchhccccccccccccccccc-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhh
Q 005749 536 ADEMVALAKADGYKAPELQRMK-KCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEI 614 (679)
Q Consensus 536 ~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i 614 (679)
........||+.|||||++..+ ....++||||+||++.||+||+.||... .....+.-....
T Consensus 175 ~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-----~~~~~~~~~ig~------------ 237 (313)
T KOG0198|consen 175 SDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-----FEEAEALLLIGR------------ 237 (313)
T ss_pred ccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-----cchHHHHHHHhc------------
Confidence 2223457899999999999953 3345999999999999999999999442 111111111100
Q ss_pred hhcCCCChH-HHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhC
Q 005749 615 MKGIRSPME-EGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENR 658 (679)
Q Consensus 615 ~~~~~~~~~-~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 658 (679)
....+..+ ....+..+++.+|++.||++||||+|++++.....
T Consensus 238 -~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~ 281 (313)
T KOG0198|consen 238 -EDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQ 281 (313)
T ss_pred -cCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhc
Confidence 11011112 22356678999999999999999999999876544
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=368.04 Aligned_cols=264 Identities=24% Similarity=0.360 Sum_probs=207.8
Q ss_pred cccHHHHHHhhcCccccCCceEEEEEEeCCCCEEEEEEcccCcc--cCcccHHHHHHHHhccCCCCCccceEEeeCCCCc
Q 005749 371 HLTLEDVLNATGQVIEKTTYGTAYKAKLADGATIALRLLREGSC--KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGE 448 (679)
Q Consensus 371 ~~~~~~l~~~~~~~ig~G~~g~Vy~~~~~~~~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~ 448 (679)
.+..+|+. .++.||+|+||+||+|++. -.||||++..... +..+.|++|+..+++-||.||+-+.|||.. + .
T Consensus 388 eIp~~ev~--l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~-p-~ 461 (678)
T KOG0193|consen 388 EIPPEEVL--LGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMN-P-P 461 (678)
T ss_pred ccCHHHhh--ccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcC-C-c
Confidence 45666664 4589999999999999985 3799999976543 456789999999999999999999999987 3 4
Q ss_pred eEEEEEecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccc
Q 005749 449 KLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLD 528 (679)
Q Consensus 449 ~~lv~ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 528 (679)
..||+.+|+|-+|+.+++.. +..|+..+.+.||.|||+||.|||.++ |||||||+.||++.++++|||+|||++
T Consensus 462 ~AIiTqwCeGsSLY~hlHv~---etkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLa 535 (678)
T KOG0193|consen 462 LAIITQWCEGSSLYTHLHVQ---ETKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLA 535 (678)
T ss_pred eeeeehhccCchhhhhccch---hhhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccce
Confidence 49999999999999999975 456999999999999999999999998 999999999999999999999999998
Q ss_pred cccCc-ccccchhcccccccccccccccc---cCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcc
Q 005749 529 QLMVP-AVADEMVALAKADGYKAPELQRM---KKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEE 604 (679)
Q Consensus 529 ~~~~~-~~~~~~~~~~gt~~y~aPE~~~~---~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~ 604 (679)
..... ..........|...|||||++.. .+|++.+||||||||+|||++|..||. ....+..- | +...+
T Consensus 536 tvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys-i~~~dqIi---f---mVGrG 608 (678)
T KOG0193|consen 536 TVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS-IQNRDQII---F---MVGRG 608 (678)
T ss_pred eeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-CCChhheE---E---Eeccc
Confidence 65321 11222334467788999998874 468999999999999999999999996 33322111 0 00000
Q ss_pred cccccchHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCCCC
Q 005749 605 TTMEVFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRPRN 661 (679)
Q Consensus 605 ~~~~~~~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 661 (679)
.-..|.. ........++.+|+..||..++++||.+.+|+..|+++.+..
T Consensus 609 --~l~pd~s------~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~ 657 (678)
T KOG0193|consen 609 --YLMPDLS------KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSL 657 (678)
T ss_pred --ccCccch------hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcc
Confidence 0000100 111233347778999999999999999999999999988753
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-43 Score=395.06 Aligned_cols=262 Identities=23% Similarity=0.348 Sum_probs=212.8
Q ss_pred hcCccccCCceEEEEEEeCC--CC----EEEEEEcccCc-ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEE
Q 005749 381 TGQVIEKTTYGTAYKAKLAD--GA----TIALRLLREGS-CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIY 453 (679)
Q Consensus 381 ~~~~ig~G~~g~Vy~~~~~~--~~----~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ 453 (679)
.++.||+|.||.||+|.+.+ |. .||||.++... ..+..+|++|..+|++++|||||+++|+|.+ .+..+|++
T Consensus 696 l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~-~~~~~i~l 774 (1025)
T KOG1095|consen 696 LLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD-SGPPLILL 774 (1025)
T ss_pred eeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC-CCCcEEEe
Confidence 35899999999999999654 43 48999998764 4557789999999999999999999999998 78899999
Q ss_pred EecCCCChHHHhhcccC---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccc
Q 005749 454 DYFPSRTLHDLLHDTIA---GKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQL 530 (679)
Q Consensus 454 ey~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 530 (679)
|||++|||..+|++.+. ....++....+.++.|||+|++||++++ +|||||.++|+||+.+..+||+|||+|+.
T Consensus 775 eyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFGlArD 851 (1025)
T KOG1095|consen 775 EYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFGLARD 851 (1025)
T ss_pred hhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccchhHh
Confidence 99999999999987632 1345889999999999999999999998 99999999999999999999999999996
Q ss_pred cCcccccchhcc-cccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHHhhcccccc
Q 005749 531 MVPAVADEMVAL-AKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAVLEETTME 608 (679)
Q Consensus 531 ~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 608 (679)
+........... .-...|||||.++.+.+++|+|||||||+|||++| |..||.+.++. +
T Consensus 852 iy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~-------------------~ 912 (1025)
T KOG1095|consen 852 IYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNF-------------------E 912 (1025)
T ss_pred hhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchH-------------------H
Confidence 544433322222 33467999999999999999999999999999997 88898655443 2
Q ss_pred cchHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCCCCCCCC
Q 005749 609 VFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRPRNRSAL 665 (679)
Q Consensus 609 ~~~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~ 665 (679)
++......+..++.+.+...+.+++..||+.+|++||++..+++++..+........
T Consensus 913 v~~~~~~ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~~ 969 (1025)
T KOG1095|consen 913 VLLDVLEGGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALGTI 969 (1025)
T ss_pred HHHHHHhCCccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhccCc
Confidence 222222333223333444567799999999999999999999999988865443333
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=362.48 Aligned_cols=244 Identities=18% Similarity=0.288 Sum_probs=206.8
Q ss_pred CccccCCceEEEEEE-eCCCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCCh
Q 005749 383 QVIEKTTYGTAYKAK-LADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRTL 461 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gsL 461 (679)
..||+|+.|.||.|+ ..+++.||||++.......++-.++|+.+|+..+|+|||++++-|.. .++.|+|||||++|+|
T Consensus 279 ~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv-~deLWVVMEym~ggsL 357 (550)
T KOG0578|consen 279 KKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLV-GDELWVVMEYMEGGSL 357 (550)
T ss_pred hhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcc-cceeEEEEeecCCCch
Confidence 689999999999998 77899999999988777777889999999999999999999998887 5889999999999999
Q ss_pred HHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccchhc
Q 005749 462 HDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVA 541 (679)
Q Consensus 462 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 541 (679)
.+.+... .+++.++..|++++++||+|||.++ |+|||||.+|||++.+|.+||+|||++..+..... ...+
T Consensus 358 TDvVt~~-----~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-KR~T 428 (550)
T KOG0578|consen 358 TDVVTKT-----RMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-KRST 428 (550)
T ss_pred hhhhhcc-----cccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC-cccc
Confidence 9999753 4899999999999999999999998 99999999999999999999999999988765533 4567
Q ss_pred ccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcCCCC
Q 005749 542 LAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIRSP 621 (679)
Q Consensus 542 ~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~~~ 621 (679)
.+||+.|||||+.....|++|.||||||++.+||+.|++||..+..-.... ....... +++ ..
T Consensus 429 mVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAly-------LIa~ng~-----P~l-----k~ 491 (550)
T KOG0578|consen 429 MVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-------LIATNGT-----PKL-----KN 491 (550)
T ss_pred ccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHH-------HHhhcCC-----CCc-----CC
Confidence 899999999999999999999999999999999999999995432211000 0000000 011 11
Q ss_pred hHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 622 MEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 622 ~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
.+...+.+.+++.+||+.|+++||++.|+|++
T Consensus 492 ~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 492 PEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred ccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 23345677889999999999999999999986
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=360.28 Aligned_cols=253 Identities=21% Similarity=0.301 Sum_probs=209.5
Q ss_pred ccHHHHHHhhcCccccCCceEEEEEE-eCCCCEEEEEEcccC---cccCcccHHHHHHHHhcc-CCCCCccceEEeeCCC
Q 005749 372 LTLEDVLNATGQVIEKTTYGTAYKAK-LADGATIALRLLREG---SCKDRSSCLPVIRQLGKV-RHENLIPLRAFYQGKR 446 (679)
Q Consensus 372 ~~~~~l~~~~~~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~ 446 (679)
.+..|. .+|++||+|+|++||+|+ ..+++.+|||++.+. .+...+...+|-++|.+| .||.||+|+--|++ .
T Consensus 70 k~~~DF--~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD-~ 146 (604)
T KOG0592|consen 70 KTPNDF--KFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQD-E 146 (604)
T ss_pred CChhhc--chhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeec-c
Confidence 344444 467899999999999999 678999999999764 234456678899999999 89999999999998 6
Q ss_pred CceEEEEEecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecc
Q 005749 447 GEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFG 526 (679)
Q Consensus 447 ~~~~lv~ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 526 (679)
...|+|+||+++|+|.++++.. ..|++...+.++.+|+.||+|||++| ||||||||+|||+|+||++||.|||
T Consensus 147 ~sLYFvLe~A~nGdll~~i~K~----Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFG 219 (604)
T KOG0592|consen 147 ESLYFVLEYAPNGDLLDLIKKY----GSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFG 219 (604)
T ss_pred cceEEEEEecCCCcHHHHHHHh----CcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeecc
Confidence 8899999999999999999875 45999999999999999999999998 9999999999999999999999999
Q ss_pred cccccCccccc----------ch--hcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchh
Q 005749 527 LDQLMVPAVAD----------EM--VALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLP 594 (679)
Q Consensus 527 la~~~~~~~~~----------~~--~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~ 594 (679)
.|+.+.+.... .. ..++||..|.+||++.....++.+|+|+|||++|.|+.|++||.+..+- .
T Consensus 220 sAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney--l--- 294 (604)
T KOG0592|consen 220 SAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY--L--- 294 (604)
T ss_pred ccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH--H---
Confidence 99988643221 11 4578999999999999999999999999999999999999999654321 1
Q ss_pred HHHHHHhhcccccccchHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 005749 595 SIVKVAVLEETTMEVFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQL 654 (679)
Q Consensus 595 ~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L 654 (679)
+|. +|+.-.....+...+.+.+|+.+.+..||.+|++..+|.++.
T Consensus 295 --------------iFq-kI~~l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp 339 (604)
T KOG0592|consen 295 --------------IFQ-KIQALDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHP 339 (604)
T ss_pred --------------HHH-HHHHhcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCc
Confidence 111 122222233333446777899999999999999999887763
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=355.17 Aligned_cols=259 Identities=17% Similarity=0.264 Sum_probs=207.7
Q ss_pred CccccHHHHHHhhcCccccCCceEEEEEEeCCCCEEEEEEcccCcccC---cccHHHHHHHHhccCCCCCccceEEeeC-
Q 005749 369 GEHLTLEDVLNATGQVIEKTTYGTAYKAKLADGATIALRLLREGSCKD---RSSCLPVIRQLGKVRHENLIPLRAFYQG- 444 (679)
Q Consensus 369 ~~~~~~~~l~~~~~~~ig~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~---~~~~~~Ei~~l~~l~H~nIv~l~~~~~~- 444 (679)
...++.+|+.......||+|++|.||+|++ +|+.||||+++...... .+.|.+|+++|.+++|||||+++|++.+
T Consensus 12 ~~~i~~~~i~~~~~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~ 90 (283)
T PHA02988 12 IKCIESDDIDKYTSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDI 90 (283)
T ss_pred ceecCHHHcCCCCCeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEec
Confidence 345677788666668899999999999998 68899999997654333 3567899999999999999999999865
Q ss_pred -C-CCceEEEEEecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCeeecCCCCCCeeecCCCceE
Q 005749 445 -K-RGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTG-HEIPITHGNVRSKNVLVDDFFVSR 521 (679)
Q Consensus 445 -~-~~~~~lv~ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~-~~~~ivHrDlkp~NILl~~~~~~k 521 (679)
. ....++||||+++|+|.+++... ..+++..+.+++.|++.||+|||+. + ++||||||+|||+++++.+|
T Consensus 91 ~~~~~~~~lv~Ey~~~g~L~~~l~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~k 163 (283)
T PHA02988 91 VDDLPRLSLILEYCTRGYLREVLDKE----KDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLK 163 (283)
T ss_pred ccCCCceEEEEEeCCCCcHHHHHhhC----CCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEE
Confidence 2 34679999999999999999763 4589999999999999999999984 5 78999999999999999999
Q ss_pred EeecccccccCcccccchhcccccccccccccccc--cCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHH
Q 005749 522 LTEFGLDQLMVPAVADEMVALAKADGYKAPELQRM--KKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKV 599 (679)
Q Consensus 522 l~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~ 599 (679)
|+|||+++.+.... ....++..|+|||++.+ ..++.++|||||||++|||++|+.||.+.... ++...
T Consensus 164 l~dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~------~~~~~ 233 (283)
T PHA02988 164 IICHGLEKILSSPP----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK------EIYDL 233 (283)
T ss_pred EcccchHhhhcccc----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH------HHHHH
Confidence 99999998653321 23467889999999875 67999999999999999999999999543221 11111
Q ss_pred HhhcccccccchHhhhhcCCCChH-HHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhC
Q 005749 600 AVLEETTMEVFDMEIMKGIRSPME-EGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENR 658 (679)
Q Consensus 600 ~~~~~~~~~~~~~~i~~~~~~~~~-~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 658 (679)
. +..+.+...+ .....+.+++.+||+.||++|||++|+++.|+...
T Consensus 234 i-------------~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 234 I-------------INKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred H-------------HhcCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 1 0111111111 23456778999999999999999999999998764
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-42 Score=363.45 Aligned_cols=258 Identities=21% Similarity=0.354 Sum_probs=201.0
Q ss_pred hcCccccCCceEEEEEEe------CCCCEEEEEEcccCcc-cCcccHHHHHHHHhcc-CCCCCccceEEeeCCCCceEEE
Q 005749 381 TGQVIEKTTYGTAYKAKL------ADGATIALRLLREGSC-KDRSSCLPVIRQLGKV-RHENLIPLRAFYQGKRGEKLLI 452 (679)
Q Consensus 381 ~~~~ig~G~~g~Vy~~~~------~~~~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~~lv 452 (679)
..+.||+|+||.||+|+. .++..||||+++.... ...+.+.+|++++.++ +|||||+++++|....+..++|
T Consensus 11 ~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv 90 (338)
T cd05102 11 LGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPLMVI 90 (338)
T ss_pred eeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCceEEE
Confidence 357899999999999973 2356899999975432 2345789999999999 8999999999988756678999
Q ss_pred EEecCCCChHHHhhcccC----------------------------------------------------------CCCC
Q 005749 453 YDYFPSRTLHDLLHDTIA----------------------------------------------------------GKPV 474 (679)
Q Consensus 453 ~ey~~~gsL~~~l~~~~~----------------------------------------------------------~~~~ 474 (679)
|||+++|+|.+++..... ....
T Consensus 91 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (338)
T cd05102 91 VEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSP 170 (338)
T ss_pred EecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccccccCC
Confidence 999999999999975321 0234
Q ss_pred CCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCccccc-chhccccccccccccc
Q 005749 475 LNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVAD-EMVALAKADGYKAPEL 553 (679)
Q Consensus 475 l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~ 553 (679)
+++..++.++.||++||+|||+++ |+||||||+|||+++++.+||+|||+++........ ......++..|+|||+
T Consensus 171 l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~ 247 (338)
T cd05102 171 LTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPES 247 (338)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCcHH
Confidence 888999999999999999999988 999999999999999999999999999865332111 1123345678999999
Q ss_pred ccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcCC-CChHHHHHHHHH
Q 005749 554 QRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIR-SPMEEGLVQALK 631 (679)
Q Consensus 554 ~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~ 631 (679)
+.+..++.++|||||||++|||++ |..||.+....+ ..... +..+.. .......+.+.+
T Consensus 248 ~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~-----~~~~~--------------~~~~~~~~~~~~~~~~l~~ 308 (338)
T cd05102 248 IFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE-----EFCQR--------------LKDGTRMRAPENATPEIYR 308 (338)
T ss_pred hhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH-----HHHHH--------------HhcCCCCCCCCCCCHHHHH
Confidence 998899999999999999999997 999985432211 01110 111111 111122356778
Q ss_pred HHHhccCcCCCCCCCHHHHHHHHHhhCCC
Q 005749 632 LAMGCCAPVASVRPTMDEVVKQLEENRPR 660 (679)
Q Consensus 632 l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 660 (679)
++.+||+.||++|||+.|+++.|+++...
T Consensus 309 li~~cl~~dp~~RPs~~el~~~l~~~~~~ 337 (338)
T cd05102 309 IMLACWQGDPKERPTFSALVEILGDLLQE 337 (338)
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 99999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=357.57 Aligned_cols=241 Identities=20% Similarity=0.366 Sum_probs=206.5
Q ss_pred CccccCCceEEEEEE-eCCCCEEEEEEcccCcc--cCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCC
Q 005749 383 QVIEKTTYGTAYKAK-LADGATIALRLLREGSC--KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSR 459 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~g 459 (679)
+.||+|+||+||||+ ..+.+.||+|.+.+... ++.+...+|++|+++++|||||.++++|+. ..+.++|+||+.+
T Consensus 8 e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt-~~~~~vVte~a~g- 85 (808)
T KOG0597|consen 8 EMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFET-SAHLWVVTEYAVG- 85 (808)
T ss_pred HHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcc-cceEEEEehhhhh-
Confidence 679999999999999 55789999999976533 445678999999999999999999999998 6899999999987
Q ss_pred ChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccch
Q 005749 460 TLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEM 539 (679)
Q Consensus 460 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 539 (679)
+|+.++.+ +..+++..+..|+.++..||.|||+.+ |+|||+||.|||++..|++|++|||+|+.+... ....
T Consensus 86 ~L~~il~~----d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~-t~vl 157 (808)
T KOG0597|consen 86 DLFTILEQ----DGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN-TSVL 157 (808)
T ss_pred hHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccC-ceee
Confidence 99999987 456999999999999999999999988 999999999999999999999999999987543 3345
Q ss_pred hcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcCC
Q 005749 540 VALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIR 619 (679)
Q Consensus 540 ~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~ 619 (679)
....||+.|||||+..+++|+..+|.||+||++||+++|++||.... +...++ .|.....
T Consensus 158 tsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s------i~~Lv~--------------~I~~d~v 217 (808)
T KOG0597|consen 158 TSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS------ITQLVK--------------SILKDPV 217 (808)
T ss_pred eeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH------HHHHHH--------------HHhcCCC
Confidence 56789999999999999999999999999999999999999994321 111111 2333333
Q ss_pred CChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 620 SPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 620 ~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
.+.......+..++...+..||.+|.+..+++.+
T Consensus 218 ~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 218 KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred CCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 4445667788899999999999999999998765
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=332.29 Aligned_cols=261 Identities=23% Similarity=0.308 Sum_probs=202.4
Q ss_pred CccccCCceEEEEEE-eCCCCEEEEEEcccCcccC--cccHHHHHHHHhccCCCCCccceEEeeCC-CCceEEEEEecCC
Q 005749 383 QVIEKTTYGTAYKAK-LADGATIALRLLREGSCKD--RSSCLPVIRQLGKVRHENLIPLRAFYQGK-RGEKLLIYDYFPS 458 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~--~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~-~~~~~lv~ey~~~ 458 (679)
+.|++|+||.||+|+ .++++.||+|+++....++ .-..++||.+|.+++|||||.+..+.... -+.+|||||||+.
T Consensus 82 nrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~Eh 161 (419)
T KOG0663|consen 82 NRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVEH 161 (419)
T ss_pred hhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHHh
Confidence 789999999999999 6679999999998754322 23468999999999999999999887753 4569999999987
Q ss_pred CChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccc
Q 005749 459 RTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADE 538 (679)
Q Consensus 459 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 538 (679)
||..++... .+++...+++.++.|+++|++|||++. |+|||||++|+|+.+.|.+||+|||+|+.+... ...
T Consensus 162 -DLksl~d~m---~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp-~k~ 233 (419)
T KOG0663|consen 162 -DLKSLMETM---KQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGSP-LKP 233 (419)
T ss_pred -hHHHHHHhc---cCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcCC-ccc
Confidence 999999875 467999999999999999999999999 999999999999999999999999999988554 344
Q ss_pred hhcccccccccccccccc-cCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHH-hh-cccccccchHhhh
Q 005749 539 MVALAKADGYKAPELQRM-KKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVA-VL-EETTMEVFDMEIM 615 (679)
Q Consensus 539 ~~~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~-~~-~~~~~~~~~~~i~ 615 (679)
.+..+-|.+|+|||++.+ ..|+++.|+||+|||+.|++++++.|.+...-+ ++..+++.. .+ +..+.........
T Consensus 234 ~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~d--Ql~~If~llGtPte~iwpg~~~lp~~ 311 (419)
T KOG0663|consen 234 YTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEID--QLDKIFKLLGTPSEAIWPGYSELPAV 311 (419)
T ss_pred CcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHH--HHHHHHHHhCCCccccCCCccccchh
Confidence 567788999999998886 459999999999999999999999987654432 233333221 11 1111111110000
Q ss_pred h----------cCCCChHH--HHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 616 K----------GIRSPMEE--GLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 616 ~----------~~~~~~~~--~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
+ ..+...+. -...-.+++...+.+||.+|.|++|.++.
T Consensus 312 k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 312 KKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred hccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 0 00000111 12456689999999999999999999875
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=342.51 Aligned_cols=253 Identities=17% Similarity=0.292 Sum_probs=201.2
Q ss_pred cCccccCCceEEEEEE-eCCCCEEEEEEcccCccc-CcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCC
Q 005749 382 GQVIEKTTYGTAYKAK-LADGATIALRLLREGSCK-DRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSR 459 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~-~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~g 459 (679)
.++||.|.-++||+|+ ...+..||||++...... +.+.+.+|+..|+.++|||||+++..|.. +...|+||.||.+|
T Consensus 31 ~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv-~~~LWvVmpfMa~G 109 (516)
T KOG0582|consen 31 QEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVV-DSELWVVMPFMAGG 109 (516)
T ss_pred EEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEe-cceeEEeehhhcCC
Confidence 4789999999999999 677899999999876543 35789999999999999999999999987 68999999999999
Q ss_pred ChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCccccc--
Q 005749 460 TLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVAD-- 537 (679)
Q Consensus 460 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~-- 537 (679)
|+.++++..... -+++..+..|.+++++||.|||++| .||||||+.||||+++|.+||+|||..-.+......
T Consensus 110 S~ldIik~~~~~--Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~ 184 (516)
T KOG0582|consen 110 SLLDIIKTYYPD--GLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQV 184 (516)
T ss_pred cHHHHHHHHccc--cccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccCceee
Confidence 999999987543 3899999999999999999999998 999999999999999999999999987665433211
Q ss_pred -chhcccccccccccccccc--cCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccc---cccch
Q 005749 538 -EMVALAKADGYKAPELQRM--KKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETT---MEVFD 611 (679)
Q Consensus 538 -~~~~~~gt~~y~aPE~~~~--~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~---~~~~~ 611 (679)
......||+.|||||+++. ..|+.|+|||||||+..||++|..||...... +.....+..... ....+
T Consensus 185 ~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPm------kvLl~tLqn~pp~~~t~~~~ 258 (516)
T KOG0582|consen 185 TRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPM------KVLLLTLQNDPPTLLTSGLD 258 (516)
T ss_pred EeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChH------HHHHHHhcCCCCCcccccCC
Confidence 1256689999999999553 45999999999999999999999999443221 111111111000 01111
Q ss_pred HhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 612 MEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 612 ~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
... .......+.+++..|+++||++|||++++++.
T Consensus 259 ~d~-------~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 259 KDE-------DKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred hHH-------hhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 111 11223467789999999999999999999875
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=352.46 Aligned_cols=258 Identities=20% Similarity=0.317 Sum_probs=209.7
Q ss_pred cCccccCCceEEEEEEeCCCCEEEEEEcccCcccC-cccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCC
Q 005749 382 GQVIEKTTYGTAYKAKLADGATIALRLLREGSCKD-RSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRT 460 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~-~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gs 460 (679)
.+.||+|.||.|..+....+..||||+++....++ +.+|.+|+++|.+++|||||+++|+|.. ++.+++|+|||++|+
T Consensus 543 ~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~-DePicmI~EYmEnGD 621 (807)
T KOG1094|consen 543 KEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQ-DDPLCMITEYMENGD 621 (807)
T ss_pred hhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeec-CCchHHHHHHHhcCc
Confidence 58999999999999999888999999999876544 5899999999999999999999999997 688999999999999
Q ss_pred hHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccch-
Q 005749 461 LHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEM- 539 (679)
Q Consensus 461 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~- 539 (679)
|.+++..+.. +.++-....+|+.|||.||+||.+.+ +||||+.+.|+|+|.++++||+|||+++.+....+...
T Consensus 622 LnqFl~ahea--pt~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vq 696 (807)
T KOG1094|consen 622 LNQFLSAHEL--PTAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQ 696 (807)
T ss_pred HHHHHHhccC--cccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCCceeee
Confidence 9999987643 22466677889999999999999987 99999999999999999999999999997655444433
Q ss_pred hcccccccccccccccccCCCCcchhHHHHHHHHHHHh--CCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhc
Q 005749 540 VALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI--GKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKG 617 (679)
Q Consensus 540 ~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t--g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~ 617 (679)
...+-++.|||||.+..+++++++|||+||+++||+++ .+.||...++.+ .++-....+..... ..
T Consensus 697 gr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~---vven~~~~~~~~~~---------~~ 764 (807)
T KOG1094|consen 697 GRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ---VVENAGEFFRDQGR---------QV 764 (807)
T ss_pred cceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH---HHHhhhhhcCCCCc---------ce
Confidence 33455678999999999999999999999999999974 788985543321 12222222222111 11
Q ss_pred CCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhh
Q 005749 618 IRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEEN 657 (679)
Q Consensus 618 ~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 657 (679)
.....+-+..++.+++.+||..|.++||+++++...|++.
T Consensus 765 ~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 765 VLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred eccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 1122233445677999999999999999999999999875
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=354.72 Aligned_cols=242 Identities=22% Similarity=0.327 Sum_probs=199.4
Q ss_pred cCccccCCceEEEEEE-eCCCCEEEEEEcccC----cc-cCcccHHHHHHHHhccC-CCCCccceEEeeCCCCceEEEEE
Q 005749 382 GQVIEKTTYGTAYKAK-LADGATIALRLLREG----SC-KDRSSCLPVIRQLGKVR-HENLIPLRAFYQGKRGEKLLIYD 454 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~----~~-~~~~~~~~Ei~~l~~l~-H~nIv~l~~~~~~~~~~~~lv~e 454 (679)
++.||+|+||+||.|+ ..++..||+|++... .. ...+.+.+|+.++++++ ||||++++.++.. ....++|||
T Consensus 22 ~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t-~~~~~ivmE 100 (370)
T KOG0583|consen 22 GRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFAT-PTKIYIVME 100 (370)
T ss_pred eeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEec-CCeEEEEEE
Confidence 5789999999999998 567899999977653 11 23445678999999999 9999999999998 567999999
Q ss_pred ecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCC-CceEEeecccccccCc
Q 005749 455 YFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDF-FVSRLTEFGLDQLMVP 533 (679)
Q Consensus 455 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~-~~~kl~DFGla~~~~~ 533 (679)
|+.+|+|.+++... ..+.+..++++++|++.|++|+|+++ |+||||||+|||+|.+ +.+||+|||++....
T Consensus 101 y~~gGdL~~~i~~~----g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~- 172 (370)
T KOG0583|consen 101 YCSGGDLFDYIVNK----GRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLSAISP- 172 (370)
T ss_pred ecCCccHHHHHHHc----CCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccccccccC-
Confidence 99999999999873 45888999999999999999999998 9999999999999999 999999999999874
Q ss_pred ccccchhcccccccccccccccccC-CC-CcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccch
Q 005749 534 AVADEMVALAKADGYKAPELQRMKK-CS-SRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFD 611 (679)
Q Consensus 534 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 611 (679)
.......+.+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||.+.... ....
T Consensus 173 ~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~------~l~~------------- 233 (370)
T KOG0583|consen 173 GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVP------NLYR------------- 233 (370)
T ss_pred CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHH------HHHH-------------
Confidence 2234566789999999999999877 74 7899999999999999999999552111 1111
Q ss_pred HhhhhcCCCChHHH-HHHHHHHHHhccCcCCCCCCCHHHHHH
Q 005749 612 MEIMKGIRSPMEEG-LVQALKLAMGCCAPVASVRPTMDEVVK 652 (679)
Q Consensus 612 ~~i~~~~~~~~~~~-~~~~~~l~~~cl~~dP~~RPs~~evl~ 652 (679)
.+..+........ .+++..++.+|+..||.+|+++.||+.
T Consensus 234 -ki~~~~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 234 -KIRKGEFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred -HHhcCCccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence 1222221111112 577888999999999999999999993
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-42 Score=362.32 Aligned_cols=254 Identities=23% Similarity=0.360 Sum_probs=204.1
Q ss_pred cCccccCCceEEEEEEeCC--C--CE-EEEEEcccC---cccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEE
Q 005749 382 GQVIEKTTYGTAYKAKLAD--G--AT-IALRLLREG---SCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIY 453 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~~--~--~~-vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ 453 (679)
++.||+|+||.||+|++.. + .. ||||..+.. ......+|.+|.++|++++|||||++||++.. ...+++||
T Consensus 162 ~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~-~~Pl~ivm 240 (474)
T KOG0194|consen 162 GKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVL-EEPLMLVM 240 (474)
T ss_pred cceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcC-CCccEEEE
Confidence 3899999999999999543 2 23 899999853 24556789999999999999999999999987 68899999
Q ss_pred EecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCc
Q 005749 454 DYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVP 533 (679)
Q Consensus 454 ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 533 (679)
|+|+||+|.++|+... ..++..++.+++.+.|.||+|||+++ ++||||-++|+|++.++.+||+|||+++....
T Consensus 241 El~~gGsL~~~L~k~~---~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~ 314 (474)
T KOG0194|consen 241 ELCNGGSLDDYLKKNK---KSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSRAGSQ 314 (474)
T ss_pred EecCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccccccCCcc
Confidence 9999999999998752 35999999999999999999999998 99999999999999999999999999886531
Q ss_pred ccccchhcccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHHhhcccccccchH
Q 005749 534 AVADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDM 612 (679)
Q Consensus 534 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 612 (679)
-.... ....-+..|+|||.+....|++++|||||||++||+++ |..||.+.... +...+
T Consensus 315 ~~~~~-~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~---~v~~k---------------- 374 (474)
T KOG0194|consen 315 YVMKK-FLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY---EVKAK---------------- 374 (474)
T ss_pred eeecc-ccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH---HHHHH----------------
Confidence 11111 11235678999999999999999999999999999997 88898554322 11111
Q ss_pred hhhhcCCCChHHHH-HHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCCCCC
Q 005749 613 EIMKGIRSPMEEGL-VQALKLAMGCCAPVASVRPTMDEVVKQLEENRPRNR 662 (679)
Q Consensus 613 ~i~~~~~~~~~~~~-~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 662 (679)
.+..+++.+.+... .++..++.+||..+|++||+|.++.+.++.+.....
T Consensus 375 I~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 375 IVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred HHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 11334443333333 344467779999999999999999999999875544
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=347.52 Aligned_cols=242 Identities=19% Similarity=0.311 Sum_probs=203.4
Q ss_pred CccccCCceEEEEEE-eCCCCEEEEEEcccCc-ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCC
Q 005749 383 QVIEKTTYGTAYKAK-LADGATIALRLLREGS-CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRT 460 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gs 460 (679)
+.||+|.||.||||. .+.++.||+|++.... ..+.++..+|+.++..++++||.++||.|.. +...+++||||.+|+
T Consensus 19 ~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~-g~~LwiiMey~~gGs 97 (467)
T KOG0201|consen 19 ELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLK-GTKLWIIMEYCGGGS 97 (467)
T ss_pred hhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheee-cccHHHHHHHhcCcc
Confidence 789999999999999 6679999999998764 3456788999999999999999999998887 678999999999999
Q ss_pred hHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccchh
Q 005749 461 LHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMV 540 (679)
Q Consensus 461 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 540 (679)
+.+.++. ...+++..+.-|++++..||.|||+++ .+|||||+.|||+..+|.+|++|||.+-.+....... .
T Consensus 98 v~~lL~~----~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr-~ 169 (467)
T KOG0201|consen 98 VLDLLKS----GNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR-K 169 (467)
T ss_pred hhhhhcc----CCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhhcc-c
Confidence 9999986 344578888889999999999999998 9999999999999999999999999998876554333 7
Q ss_pred cccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcCCC
Q 005749 541 ALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIRS 620 (679)
Q Consensus 541 ~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~~ 620 (679)
+++||+.|||||++....|+.|+||||+|++.+||++|.+|+.......... .|.+..++
T Consensus 170 tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlf--------------------lIpk~~PP 229 (467)
T KOG0201|consen 170 TFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLF--------------------LIPKSAPP 229 (467)
T ss_pred cccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEE--------------------eccCCCCC
Confidence 8899999999999998899999999999999999999999985544321111 01111111
Q ss_pred ChH-HHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 621 PME-EGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 621 ~~~-~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
... ...+.+.+++..|++.||+.||+|.+++++
T Consensus 230 ~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 230 RLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred ccccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 111 334567789999999999999999999875
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-42 Score=341.03 Aligned_cols=264 Identities=22% Similarity=0.287 Sum_probs=202.6
Q ss_pred CccccCCceEEEEEE-eCCCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCCC-C---ceEEEEEecC
Q 005749 383 QVIEKTTYGTAYKAK-LADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKR-G---EKLLIYDYFP 457 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~-~---~~~lv~ey~~ 457 (679)
+++|.|+||.||+|+ .++++.||||++-... +.--+|+++|++++|||||++.-+|.... . ...+||||||
T Consensus 30 ~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~----r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP 105 (364)
T KOG0658|consen 30 RLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK----RYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMP 105 (364)
T ss_pred EEEeecccceEEEEEEcCCCceeEEEEecCCC----CcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhch
Confidence 899999999999999 4567999999986532 23357999999999999999988876532 2 2458999999
Q ss_pred CCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCC-CceEEeecccccccCcccc
Q 005749 458 SRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDF-FVSRLTEFGLDQLMVPAVA 536 (679)
Q Consensus 458 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~-~~~kl~DFGla~~~~~~~~ 536 (679)
. +|.++++.....++.++...++-++.|+.+||+|||+.+ |+||||||.|+|+|.+ |.+||+|||.|+.+..+..
T Consensus 106 ~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~ep 181 (364)
T KOG0658|consen 106 E-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEP 181 (364)
T ss_pred H-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceeeccCCC
Confidence 8 999999876544667888889999999999999999988 9999999999999977 9999999999998855432
Q ss_pred cchhcccccccccccccccc-cCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhc--c-------cc
Q 005749 537 DEMVALAKADGYKAPELQRM-KKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLE--E-------TT 606 (679)
Q Consensus 537 ~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~--~-------~~ 606 (679)
..++.-|..|+|||++.+ ..|+.+.||||.|||+.||+.|++.|.+.+.. .++..+++..-.. + ..
T Consensus 182 --niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~--dQL~eIik~lG~Pt~e~I~~mn~~y 257 (364)
T KOG0658|consen 182 --NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSV--DQLVEIIKVLGTPTREDIKSMNPNY 257 (364)
T ss_pred --ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHH--HHHHHHHHHhCCCCHHHHhhcCccc
Confidence 355677889999998876 56999999999999999999999999775443 2333443322110 0 00
Q ss_pred cccchHhhhhcCC--CChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH--HHhhC
Q 005749 607 MEVFDMEIMKGIR--SPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ--LEENR 658 (679)
Q Consensus 607 ~~~~~~~i~~~~~--~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~--L~~~~ 658 (679)
.+.-.+.+..... .......++.++++.++++++|.+|.++.|++.+ .+++.
T Consensus 258 ~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr 313 (364)
T KOG0658|consen 258 TEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELR 313 (364)
T ss_pred ccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhh
Confidence 1111222222110 1122345788899999999999999999999875 34443
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=334.21 Aligned_cols=268 Identities=26% Similarity=0.364 Sum_probs=198.6
Q ss_pred CccccCCceEEEEEEeCCCCEEEEEEcccCcccCcccHHHHHHHHhc--cCCCCCccceEEeeCC---CCceEEEEEecC
Q 005749 383 QVIEKTTYGTAYKAKLADGATIALRLLREGSCKDRSSCLPVIRQLGK--VRHENLIPLRAFYQGK---RGEKLLIYDYFP 457 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~--l~H~nIv~l~~~~~~~---~~~~~lv~ey~~ 457 (679)
++||+|+||.||||++. ++.||||++... +.+.|.+|-+|.+. ++|+||+++++.-... .-+++||+||.+
T Consensus 216 eli~~Grfg~V~KaqL~-~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~ 291 (534)
T KOG3653|consen 216 ELIGRGRFGCVWKAQLD-NRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHP 291 (534)
T ss_pred HHhhcCccceeehhhcc-CceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeecc
Confidence 67999999999999985 599999999764 46778888888765 5899999999875531 237899999999
Q ss_pred CCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCC------CCCeeecCCCCCCeeecCCCceEEeeccccccc
Q 005749 458 SRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGH------EIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLM 531 (679)
Q Consensus 458 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~------~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 531 (679)
.|+|.++|+. ..++|....+|+..+++||+|||+.. .++|+|||||++|||+..|+++.|+|||+|..+
T Consensus 292 kGsL~dyL~~-----ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~ 366 (534)
T KOG3653|consen 292 KGSLCDYLKA-----NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRL 366 (534)
T ss_pred CCcHHHHHHh-----ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEe
Confidence 9999999986 45899999999999999999999843 568999999999999999999999999999987
Q ss_pred Cccccc-chhcccccccccccccccccC-CC-----CcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcc
Q 005749 532 VPAVAD-EMVALAKADGYKAPELQRMKK-CS-----SRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEE 604 (679)
Q Consensus 532 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~-~~-----~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~ 604 (679)
.+.... .....+||.+|||||++.+.. +. .+.||||+|.|||||+++-.-.+.+...+ +.+.--. ..-...
T Consensus 367 ~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~-Yqlpfe~-evG~hP 444 (534)
T KOG3653|consen 367 EPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPE-YQLPFEA-EVGNHP 444 (534)
T ss_pred cCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCc-ccCchhH-HhcCCC
Confidence 654322 233478999999999988642 22 36899999999999998765442111111 1110000 000000
Q ss_pred cccccchHhhhhcCCCChH------HHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCCCC
Q 005749 605 TTMEVFDMEIMKGIRSPME------EGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRPRN 661 (679)
Q Consensus 605 ~~~~~~~~~i~~~~~~~~~------~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 661 (679)
...++-+..+.+..|+..+ ..+.-+.+.+..||++||+.|.|+.=|.+++.++....
T Consensus 445 t~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~ 507 (534)
T KOG3653|consen 445 TLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW 507 (534)
T ss_pred CHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence 1111111112222222222 34566778999999999999999999999998876443
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-41 Score=332.73 Aligned_cols=274 Identities=21% Similarity=0.314 Sum_probs=208.8
Q ss_pred CccccCCceEEEEEE-eCCCCEEEEEEcccC--cccCcccHHHHHHHHhccCCCCCccceEEeeC----CCCceEEEEEe
Q 005749 383 QVIEKTTYGTAYKAK-LADGATIALRLLREG--SCKDRSSCLPVIRQLGKVRHENLIPLRAFYQG----KRGEKLLIYDY 455 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~----~~~~~~lv~ey 455 (679)
+.||+|+||.|..|. ..+|+.||+|++... .....+...+|+++|+.++|+||+.+++++.. .-..+|+|+|+
T Consensus 28 ~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~el 107 (359)
T KOG0660|consen 28 EPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFEL 107 (359)
T ss_pred ccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehhH
Confidence 679999999999999 678999999999743 33445678899999999999999999998875 23468999999
Q ss_pred cCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcc-
Q 005749 456 FPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPA- 534 (679)
Q Consensus 456 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~- 534 (679)
|+. +|++.++. ++.++...+..++.|+++||.|+|+.+ |+||||||+|+|++.+...||+|||+|+.....
T Consensus 108 Met-DL~~iik~----~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~ 179 (359)
T KOG0660|consen 108 MET-DLHQIIKS----QQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLARYLDKFF 179 (359)
T ss_pred Hhh-HHHHHHHc----CccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccceeeccccC
Confidence 955 99999987 355999999999999999999999998 999999999999999999999999999987542
Q ss_pred cccchhccccccccccccccc-ccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccch--
Q 005749 535 VADEMVALAKADGYKAPELQR-MKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFD-- 611 (679)
Q Consensus 535 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~-- 611 (679)
....++.++.|.+|+|||++. ...|+.+.||||.|||+.||++|++.|.+.+.-+...++..+-..-.++....+-.
T Consensus 180 ~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ 259 (359)
T KOG0660|consen 180 EDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEK 259 (359)
T ss_pred cccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHH
Confidence 223456788999999999776 56799999999999999999999999977654333322221111111111111100
Q ss_pred -HhhhhcC----CCC----hHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH--HHhhCCCCCCC
Q 005749 612 -MEIMKGI----RSP----MEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ--LEENRPRNRSA 664 (679)
Q Consensus 612 -~~i~~~~----~~~----~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~--L~~~~~~~~~~ 664 (679)
....+.. +.+ .+...+..++++.+|+..||.+|+|++|++++ |...-..+.++
T Consensus 260 ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP 323 (359)
T KOG0660|consen 260 ARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEP 323 (359)
T ss_pred HHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCC
Confidence 0011110 111 12334788899999999999999999999987 45544443333
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=351.30 Aligned_cols=242 Identities=19% Similarity=0.275 Sum_probs=194.9
Q ss_pred CccccCCceEEEEEE-eCCCCEEEEEEcccCc---ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCC
Q 005749 383 QVIEKTTYGTAYKAK-LADGATIALRLLREGS---CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPS 458 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~ 458 (679)
++||+|+||.||+|+ ..+|+.||+|+++... ......+.+|++++++++||||+++++++.. .+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~-~~~~~lv~e~~~~ 79 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQT-HDRLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEc-CCEEEEEEeCCCC
Confidence 469999999999999 4579999999987542 2233567889999999999999999999987 6789999999999
Q ss_pred CChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccc
Q 005749 459 RTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADE 538 (679)
Q Consensus 459 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 538 (679)
|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..... ...
T Consensus 80 ~~L~~~l~~~----~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~-~~~ 151 (323)
T cd05571 80 GELFFHLSRE----RVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISD-GAT 151 (323)
T ss_pred CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccC-CCc
Confidence 9999998753 45899999999999999999999988 999999999999999999999999998753221 122
Q ss_pred hhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcC
Q 005749 539 MVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGI 618 (679)
Q Consensus 539 ~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~ 618 (679)
.....||+.|+|||++.+..++.++||||+||++|||++|+.||...... .+ .... ..+.
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~---~~---~~~~--------------~~~~ 211 (323)
T cd05571 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KL---FELI--------------LMEE 211 (323)
T ss_pred ccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH---HH---HHHH--------------HcCC
Confidence 33457899999999999889999999999999999999999999543211 11 1100 1110
Q ss_pred CCChHHHHHHHHHHHHhccCcCCCCCC-----CHHHHHHH
Q 005749 619 RSPMEEGLVQALKLAMGCCAPVASVRP-----TMDEVVKQ 653 (679)
Q Consensus 619 ~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~evl~~ 653 (679)
.........++.+++.+||+.||++|| ++.+++++
T Consensus 212 ~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 212 IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred CCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 111112335677899999999999999 78888753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-40 Score=335.82 Aligned_cols=250 Identities=21% Similarity=0.343 Sum_probs=197.6
Q ss_pred hcCccccCCceEEEEEEeC----CCCEEEEEEcccCcc-cCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEe
Q 005749 381 TGQVIEKTTYGTAYKAKLA----DGATIALRLLREGSC-KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDY 455 (679)
Q Consensus 381 ~~~~ig~G~~g~Vy~~~~~----~~~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey 455 (679)
..+.||+|+||.||+|++. .+..||+|.++.... ...+.|.+|+.++.+++||||+++++++.. ++..++||||
T Consensus 9 ~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~ 87 (266)
T cd05064 9 IERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITR-GNTMMIVTEY 87 (266)
T ss_pred EeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEec-CCCcEEEEEe
Confidence 3478999999999999853 366899999986532 234578999999999999999999999987 6789999999
Q ss_pred cCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCccc
Q 005749 456 FPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAV 535 (679)
Q Consensus 456 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 535 (679)
+++|+|.+++... ...+++..++.++.|++.||+|||+++ ++||||||+||+++.++.+|++|||.+.......
T Consensus 88 ~~~~~L~~~l~~~---~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~ 161 (266)
T cd05064 88 MSNGALDSFLRKH---EGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEA 161 (266)
T ss_pred CCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccccccc
Confidence 9999999999753 235899999999999999999999988 9999999999999999999999999876542221
Q ss_pred ccchhcccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHHhhcccccccchHhh
Q 005749 536 ADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEI 614 (679)
Q Consensus 536 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i 614 (679)
........++..|+|||.+.+..++.++|||||||++||+++ |+.||.+.... +.... +
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~------~~~~~--------------~ 221 (266)
T cd05064 162 IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ------DVIKA--------------V 221 (266)
T ss_pred hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH------HHHHH--------------H
Confidence 111122345678999999998999999999999999999775 99998543221 11111 0
Q ss_pred hhcCCCC-hHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhh
Q 005749 615 MKGIRSP-MEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEEN 657 (679)
Q Consensus 615 ~~~~~~~-~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 657 (679)
..+...+ .......+.+++.+||+.+|++||+++|+.+.|+++
T Consensus 222 ~~~~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 222 EDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred HCCCCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 1111111 122335677899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=346.71 Aligned_cols=251 Identities=22% Similarity=0.356 Sum_probs=213.8
Q ss_pred hcCccccCCceEEEEEEeCC---C--CEEEEEEcccC-cccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEE
Q 005749 381 TGQVIEKTTYGTAYKAKLAD---G--ATIALRLLREG-SCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYD 454 (679)
Q Consensus 381 ~~~~ig~G~~g~Vy~~~~~~---~--~~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~e 454 (679)
.+++||+|.||.||+|.+.+ | -.||||..+.. ..++.+.|+.|.-+|++++|||||+++|+|.+ ...|+|||
T Consensus 393 l~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e--~P~WivmE 470 (974)
T KOG4257|consen 393 LKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE--QPMWIVME 470 (974)
T ss_pred HHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec--cceeEEEe
Confidence 35889999999999998543 2 36899998774 44567889999999999999999999999986 68999999
Q ss_pred ecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcc
Q 005749 455 YFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPA 534 (679)
Q Consensus 455 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 534 (679)
.++-|.|..+|+.. +..++......++.||+.||+|||+.. +|||||..+|||+.....+|++|||+++.+...
T Consensus 471 L~~~GELr~yLq~n---k~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~ 544 (974)
T KOG4257|consen 471 LAPLGELREYLQQN---KDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYLEDD 544 (974)
T ss_pred cccchhHHHHHHhc---cccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhcccc
Confidence 99999999999876 456889999999999999999999988 999999999999999999999999999998776
Q ss_pred cccchhcccccccccccccccccCCCCcchhHHHHHHHHHHH-hCCCCCCCCCCCcccchhHHHHHHhhcccccccchHh
Q 005749 535 VADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEIL-IGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDME 613 (679)
Q Consensus 535 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~-tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 613 (679)
...+.....-++.|||||.+..+++++++|||-|||.+||++ .|.+||.+-.+.+... .
T Consensus 545 ~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~--------------------~ 604 (974)
T KOG4257|consen 545 AYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIG--------------------H 604 (974)
T ss_pred chhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEE--------------------E
Confidence 655555555567899999999999999999999999999998 5999997766654332 2
Q ss_pred hhhcCCCChHHH-HHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCC
Q 005749 614 IMKGIRSPMEEG-LVQALKLAMGCCAPVASVRPTMDEVVKQLEENRP 659 (679)
Q Consensus 614 i~~~~~~~~~~~-~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 659 (679)
+.+|.+.+.++. .+.+..++.+||++||.+||.+.|+...|.++..
T Consensus 605 iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 605 IENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred ecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 345555555544 4556689999999999999999999999877643
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=339.51 Aligned_cols=247 Identities=19% Similarity=0.219 Sum_probs=196.2
Q ss_pred CccccCCceEEEEEE-eCCCCEEEEEEcccCcc---cCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCC
Q 005749 383 QVIEKTTYGTAYKAK-LADGATIALRLLREGSC---KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPS 458 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~---~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~ 458 (679)
+.||+|+||+||+|+ ..+|+.||+|.+..... .....+.+|++++.+++|+||+++++++.+ .+..++||||+++
T Consensus 6 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~-~~~~~lv~e~~~~ 84 (285)
T cd05631 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYET-KDALCLVLTIMNG 84 (285)
T ss_pred EEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEcc-CCeEEEEEEecCC
Confidence 689999999999999 46799999999865421 223467899999999999999999999887 6789999999999
Q ss_pred CChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccc
Q 005749 459 RTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADE 538 (679)
Q Consensus 459 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 538 (679)
|+|.+++.... ...+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++....... .
T Consensus 85 g~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~--~ 157 (285)
T cd05631 85 GDLKFHIYNMG--NPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE--T 157 (285)
T ss_pred CcHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC--e
Confidence 99998886432 235899999999999999999999988 9999999999999999999999999998653221 2
Q ss_pred hhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcC
Q 005749 539 MVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGI 618 (679)
Q Consensus 539 ~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~ 618 (679)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||......... .. .+..+....
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~---~~-------------~~~~~~~~~ 221 (285)
T cd05631 158 VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKR---EE-------------VDRRVKEDQ 221 (285)
T ss_pred ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhH---HH-------------HHHHhhccc
Confidence 23456899999999999999999999999999999999999999654322110 00 011111111
Q ss_pred CCChHHHHHHHHHHHHhccCcCCCCCCC-----HHHHHHH
Q 005749 619 RSPMEEGLVQALKLAMGCCAPVASVRPT-----MDEVVKQ 653 (679)
Q Consensus 619 ~~~~~~~~~~~~~l~~~cl~~dP~~RPs-----~~evl~~ 653 (679)
.........++.+++.+||+.||++||+ ++|+++.
T Consensus 222 ~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 222 EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 1111123356778999999999999997 7888874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=312.66 Aligned_cols=253 Identities=21% Similarity=0.272 Sum_probs=210.2
Q ss_pred ccccHHHHHHhhcCccccCCceEEEEEE-eCCCCEEEEEEcccCc---ccCcccHHHHHHHHhccCCCCCccceEEeeCC
Q 005749 370 EHLTLEDVLNATGQVIEKTTYGTAYKAK-LADGATIALRLLREGS---CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGK 445 (679)
Q Consensus 370 ~~~~~~~l~~~~~~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~ 445 (679)
..++++|+ ..|+.+|+|.||.||.|+ .+++-.||+|++.+.. ..-..++.+|++|-+.++||||+++|++|.+
T Consensus 17 ~~~~l~df--eigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd- 93 (281)
T KOG0580|consen 17 KTWTLDDF--EIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHD- 93 (281)
T ss_pred cccchhhc--cccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheec-
Confidence 45677776 467999999999999999 5668899999997643 2335689999999999999999999999998
Q ss_pred CCceEEEEEecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeec
Q 005749 446 RGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEF 525 (679)
Q Consensus 446 ~~~~~lv~ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 525 (679)
....|+++||.++|++...|+... ...+++.....++.|+|.||.|+|..+ |+||||||+|+|++..+..|++||
T Consensus 94 ~~riyLilEya~~gel~k~L~~~~--~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdf 168 (281)
T KOG0580|consen 94 SKRIYLILEYAPRGELYKDLQEGR--MKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADF 168 (281)
T ss_pred cceeEEEEEecCCchHHHHHHhcc--cccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCC
Confidence 689999999999999999998543 345888889999999999999999988 999999999999999999999999
Q ss_pred ccccccCcccccchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhccc
Q 005749 526 GLDQLMVPAVADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEET 605 (679)
Q Consensus 526 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~ 605 (679)
|-+..-. .....+.+||.-|.+||+..+..++.+.|+|++|++.||++.|.+||.+...++.+.
T Consensus 169 GwsV~~p---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYk------------- 232 (281)
T KOG0580|consen 169 GWSVHAP---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYK------------- 232 (281)
T ss_pred CceeecC---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHH-------------
Confidence 9886543 334567899999999999999999999999999999999999999997654332111
Q ss_pred ccccchHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 606 TMEVFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 606 ~~~~~~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
+|.+-.....+.......+++.+|+..+|.+|.+..|+++.
T Consensus 233 -------rI~k~~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 233 -------RIRKVDLKFPSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred -------HHHHccccCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 11111111112333567789999999999999999999875
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=330.87 Aligned_cols=245 Identities=18% Similarity=0.346 Sum_probs=197.2
Q ss_pred cCccccCCceEEEEEEeCCCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCCh
Q 005749 382 GQVIEKTTYGTAYKAKLADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRTL 461 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gsL 461 (679)
.+.||+|+||.||+|+..++..+|+|.+.... ...+++.+|++++++++||||+++++++.. .+..++||||+++|+|
T Consensus 9 ~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~iv~e~~~~~~L 86 (256)
T cd05114 9 MKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ-QKPLYIVTEFMENGCL 86 (256)
T ss_pred eeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEcc-CCCEEEEEEcCCCCcH
Confidence 36799999999999998888899999986432 334678999999999999999999999987 6789999999999999
Q ss_pred HHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccchhc
Q 005749 462 HDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVA 541 (679)
Q Consensus 462 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 541 (679)
.++++... ..+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||.++............
T Consensus 87 ~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~~ 160 (256)
T cd05114 87 LNYLRQRQ---GKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSG 160 (256)
T ss_pred HHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCceeccCC
Confidence 99987532 34899999999999999999999988 9999999999999999999999999988654332222223
Q ss_pred ccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcCCC
Q 005749 542 LAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIRS 620 (679)
Q Consensus 542 ~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~~ 620 (679)
..++..|+|||.+.+..++.++||||||+++|||++ |+.||...... +..... ..+.+.
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~------~~~~~i--------------~~~~~~ 220 (256)
T cd05114 161 AKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY------EVVEMI--------------SRGFRL 220 (256)
T ss_pred CCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH------HHHHHH--------------HCCCCC
Confidence 345667999999988889999999999999999999 89998543221 111111 111000
Q ss_pred -ChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 005749 621 -PMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQL 654 (679)
Q Consensus 621 -~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L 654 (679)
........+.+++.+||+.+|++||+++|+++.|
T Consensus 221 ~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 221 YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 0111234678999999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=348.84 Aligned_cols=244 Identities=22% Similarity=0.343 Sum_probs=205.9
Q ss_pred hcCccccCCceEEEEEE-eCCCCEEEEEEcccCc---ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEec
Q 005749 381 TGQVIEKTTYGTAYKAK-LADGATIALRLLREGS---CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYF 456 (679)
Q Consensus 381 ~~~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~ 456 (679)
.|+.+|+|+-|.|-.|+ ..+|+.+|||++.... ......+.+||-+|+-++||||+++|+++.+ ..+.|+|.||+
T Consensus 16 LgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~-~~~lylvlEyv 94 (786)
T KOG0588|consen 16 LGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWEN-KQHLYLVLEYV 94 (786)
T ss_pred ccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeecc-CceEEEEEEec
Confidence 35889999999999999 6789999999997653 2334568899999999999999999999998 78999999999
Q ss_pred CCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccc
Q 005749 457 PSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVA 536 (679)
Q Consensus 457 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 536 (679)
++|-|++++-.+ ..+++.++.+++.||+.|+.|+|..+ |+||||||+|+|||.++.+||+|||+|.+-.++
T Consensus 95 ~gGELFdylv~k----G~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g-- 165 (786)
T KOG0588|consen 95 PGGELFDYLVRK----GPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPG-- 165 (786)
T ss_pred CCchhHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCC--
Confidence 999999999874 56899999999999999999999998 999999999999999999999999999875333
Q ss_pred cchhcccccccccccccccccCC-CCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhh
Q 005749 537 DEMVALAKADGYKAPELQRMKKC-SSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIM 615 (679)
Q Consensus 537 ~~~~~~~gt~~y~aPE~~~~~~~-~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~ 615 (679)
.-..+.||++.|.|||++++.+| +.++||||.|||||.|+||+.||+++. +.... .++.
T Consensus 166 klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN------ir~LL--------------lKV~ 225 (786)
T KOG0588|consen 166 KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN------IRVLL--------------LKVQ 225 (786)
T ss_pred ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc------HHHHH--------------HHHH
Confidence 33567799999999999999998 679999999999999999999995321 11111 1223
Q ss_pred hcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 005749 616 KGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQL 654 (679)
Q Consensus 616 ~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L 654 (679)
.|..........+..+|+.+|+..||++|.|++||+++-
T Consensus 226 ~G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP 264 (786)
T KOG0588|consen 226 RGVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHP 264 (786)
T ss_pred cCcccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCc
Confidence 333333334456777899999999999999999999874
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=318.84 Aligned_cols=239 Identities=21% Similarity=0.284 Sum_probs=200.4
Q ss_pred ccHHHHHHhhcCccccCCceEEEEEE-eCCCCEEEEEEcccCcc---cCcccHHHHHHHHhccCCCCCccceEEeeCCCC
Q 005749 372 LTLEDVLNATGQVIEKTTYGTAYKAK-LADGATIALRLLREGSC---KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRG 447 (679)
Q Consensus 372 ~~~~~l~~~~~~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~---~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~ 447 (679)
++++|.. +-+.+|.|+||.|.+++ ..+|..+|+|++....- +..+...+|..+|+.+.||.++++++-|.+ .+
T Consensus 41 ~~l~dfe--~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d-~~ 117 (355)
T KOG0616|consen 41 YSLQDFE--RLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKD-NS 117 (355)
T ss_pred cchhhhh--heeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeecc-CC
Confidence 5566663 33789999999999999 55789999999977532 344567899999999999999999999988 78
Q ss_pred ceEEEEEecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeeccc
Q 005749 448 EKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGL 527 (679)
Q Consensus 448 ~~~lv~ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 527 (679)
..+|||||.+||.|..+++.. ..+++..++.+|.||+.||+|||+.+ |++|||||+|||+|.+|.+||.|||+
T Consensus 118 ~lymvmeyv~GGElFS~Lrk~----~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGF 190 (355)
T KOG0616|consen 118 NLYMVMEYVPGGELFSYLRKS----GRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGF 190 (355)
T ss_pred eEEEEEeccCCccHHHHHHhc----CCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccc
Confidence 999999999999999999874 45999999999999999999999998 99999999999999999999999999
Q ss_pred ccccCcccccchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhccccc
Q 005749 528 DQLMVPAVADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTM 607 (679)
Q Consensus 528 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 607 (679)
|+.+.. ...+.+||+.|+|||.+....|+.++|-|||||++|||+.|.+||.+....
T Consensus 191 AK~v~~----rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~------------------- 247 (355)
T KOG0616|consen 191 AKRVSG----RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPI------------------- 247 (355)
T ss_pred eEEecC----cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChH-------------------
Confidence 997643 356789999999999999999999999999999999999999999654331
Q ss_pred ccchHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCC
Q 005749 608 EVFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVR 644 (679)
Q Consensus 608 ~~~~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~R 644 (679)
++++ +|..+....+.-...++.+|+.+.++.|-.+|
T Consensus 248 ~iY~-KI~~~~v~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 248 QIYE-KILEGKVKFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred HHHH-HHHhCcccCCcccCHHHHHHHHHHHhhhhHhh
Confidence 1222 23444444444445666778888888888777
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=350.20 Aligned_cols=254 Identities=19% Similarity=0.317 Sum_probs=197.7
Q ss_pred hcCccccCCceEEEEEEe------CCCCEEEEEEcccCc-ccCcccHHHHHHHHhcc-CCCCCccceEEeeCCCCceEEE
Q 005749 381 TGQVIEKTTYGTAYKAKL------ADGATIALRLLREGS-CKDRSSCLPVIRQLGKV-RHENLIPLRAFYQGKRGEKLLI 452 (679)
Q Consensus 381 ~~~~ig~G~~g~Vy~~~~------~~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~~lv 452 (679)
.++.||+|+||.||+|+. .++..||||+++... ....+.+.+|++++..+ +|||||+++++|.+ .+..++|
T Consensus 39 ~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~-~~~~~lv 117 (375)
T cd05104 39 FGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTV-GGPTLVI 117 (375)
T ss_pred hhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeecc-CCcceee
Confidence 358999999999999963 246689999997543 23345788999999999 89999999999987 6789999
Q ss_pred EEecCCCChHHHhhcccC--------------------------------------------------------------
Q 005749 453 YDYFPSRTLHDLLHDTIA-------------------------------------------------------------- 470 (679)
Q Consensus 453 ~ey~~~gsL~~~l~~~~~-------------------------------------------------------------- 470 (679)
||||++|+|.++++....
T Consensus 118 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (375)
T cd05104 118 TEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQ 197 (375)
T ss_pred ehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceeccc
Confidence 999999999999965321
Q ss_pred ---------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccc-hh
Q 005749 471 ---------GKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADE-MV 540 (679)
Q Consensus 471 ---------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~-~~ 540 (679)
....+++..+++++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++......... ..
T Consensus 198 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~ 274 (375)
T cd05104 198 DVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKG 274 (375)
T ss_pred ccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccccccC
Confidence 0125789999999999999999999988 9999999999999999999999999998654322111 11
Q ss_pred cccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcCC
Q 005749 541 ALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIR 619 (679)
Q Consensus 541 ~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~ 619 (679)
...++..|+|||++.+..++.++|||||||++|||++ |..||....... ....+. ..+.+
T Consensus 275 ~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--~~~~~~-----------------~~~~~ 335 (375)
T cd05104 275 NARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--KFYKMI-----------------KEGYR 335 (375)
T ss_pred CCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--HHHHHH-----------------HhCcc
Confidence 2334567999999998899999999999999999998 888885432211 111111 11111
Q ss_pred CCh-HHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhh
Q 005749 620 SPM-EEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEEN 657 (679)
Q Consensus 620 ~~~-~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 657 (679)
... .....++.+++.+||+.||++||+|.||++.|++.
T Consensus 336 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 336 MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 111 11134677899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=325.16 Aligned_cols=268 Identities=19% Similarity=0.250 Sum_probs=204.0
Q ss_pred CccccCCceEEEEEE-eCCCCEEEEEEcccCccc--CcccHHHHHHHHhccCCCC-CccceEEeeCCCC-----ceEEEE
Q 005749 383 QVIEKTTYGTAYKAK-LADGATIALRLLREGSCK--DRSSCLPVIRQLGKVRHEN-LIPLRAFYQGKRG-----EKLLIY 453 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~--~~~~~~~Ei~~l~~l~H~n-Iv~l~~~~~~~~~-----~~~lv~ 453 (679)
+.||+|+||+||+|+ ..+|+.||+|+++..... -.....+|+.++++++|+| ||++++++.+... ..++|+
T Consensus 17 eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvf 96 (323)
T KOG0594|consen 17 EKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVF 96 (323)
T ss_pred HHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEEE
Confidence 569999999999999 678999999999876442 3456799999999999999 9999999987432 788999
Q ss_pred EecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCc
Q 005749 454 DYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVP 533 (679)
Q Consensus 454 ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 533 (679)
||+.. +|..++.........++...++.+++|+++||+|||+++ |+||||||.|||++++|.+||+|||+|+...-
T Consensus 97 e~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~i 172 (323)
T KOG0594|consen 97 EFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGLARAFSI 172 (323)
T ss_pred Eeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccchHHHhcC
Confidence 99976 999999876432234677889999999999999999999 99999999999999999999999999996642
Q ss_pred ccccchhccccccccccccccccc-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHH-hh-cccccccc
Q 005749 534 AVADEMVALAKADGYKAPELQRMK-KCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVA-VL-EETTMEVF 610 (679)
Q Consensus 534 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~-~~-~~~~~~~~ 610 (679)
.. ......++|.+|+|||++.+. .|++..||||+||++.||++++..|.+..+. .++....+.. .+ ++.+..+.
T Consensus 173 p~-~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~--~ql~~If~~lGtP~e~~Wp~v~ 249 (323)
T KOG0594|consen 173 PM-RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEI--DQLFRIFRLLGTPNEKDWPGVS 249 (323)
T ss_pred Cc-ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHH--HHHHHHHHHcCCCCccCCCCcc
Confidence 21 224556789999999998876 6999999999999999999999999766542 2222222211 11 11111111
Q ss_pred ---hHh--hhhcC-CCCh----HHHHHHHHHHHHhccCcCCCCCCCHHHHHHH--HHhh
Q 005749 611 ---DME--IMKGI-RSPM----EEGLVQALKLAMGCCAPVASVRPTMDEVVKQ--LEEN 657 (679)
Q Consensus 611 ---~~~--i~~~~-~~~~----~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~--L~~~ 657 (679)
+.. ..... .... +...+...+++.+|++++|.+|.|++.++.+ +++.
T Consensus 250 ~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 250 SLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred ccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 111 00000 0001 1112467899999999999999999999987 5554
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=345.84 Aligned_cols=239 Identities=19% Similarity=0.248 Sum_probs=191.6
Q ss_pred cccCCceEEEEEEe-CCCCEEEEEEcccCc---ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCC
Q 005749 385 IEKTTYGTAYKAKL-ADGATIALRLLREGS---CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRT 460 (679)
Q Consensus 385 ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gs 460 (679)
||+|+||.||+|+. .+++.||+|+++... ......+.+|++++.+++|||||++++++.+ .+..++||||+++|+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~g~ 79 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQS-PEKLYLVLAFINGGE 79 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEec-CCeEEEEEcCCCCCc
Confidence 79999999999995 468899999986532 2334567899999999999999999999887 678999999999999
Q ss_pred hHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccchh
Q 005749 461 LHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMV 540 (679)
Q Consensus 461 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 540 (679)
|.+++... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++..... .....
T Consensus 80 L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~-~~~~~ 151 (312)
T cd05585 80 LFHHLQRE----GRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKD-DDKTN 151 (312)
T ss_pred HHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccC-CCccc
Confidence 99999753 45899999999999999999999988 999999999999999999999999999864322 12233
Q ss_pred cccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcCCC
Q 005749 541 ALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIRS 620 (679)
Q Consensus 541 ~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~~ 620 (679)
...||+.|+|||++.+..++.++|||||||++|||++|+.||.+... ....... ..+...
T Consensus 152 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~------~~~~~~~--------------~~~~~~ 211 (312)
T cd05585 152 TFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV------NEMYRKI--------------LQEPLR 211 (312)
T ss_pred cccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH------HHHHHHH--------------HcCCCC
Confidence 45789999999999988999999999999999999999999954321 1111111 111111
Q ss_pred ChHHHHHHHHHHHHhccCcCCCCCCC---HHHHHH
Q 005749 621 PMEEGLVQALKLAMGCCAPVASVRPT---MDEVVK 652 (679)
Q Consensus 621 ~~~~~~~~~~~l~~~cl~~dP~~RPs---~~evl~ 652 (679)
......+++.+++.+||+.||++||+ +.|+++
T Consensus 212 ~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 212 FPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred CCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 11222356678999999999999985 555554
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-40 Score=342.10 Aligned_cols=259 Identities=19% Similarity=0.305 Sum_probs=196.1
Q ss_pred cCccccCCceEEEEEEeCC-----------------CCEEEEEEcccCcc-cCcccHHHHHHHHhccCCCCCccceEEee
Q 005749 382 GQVIEKTTYGTAYKAKLAD-----------------GATIALRLLREGSC-KDRSSCLPVIRQLGKVRHENLIPLRAFYQ 443 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~~-----------------~~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~ 443 (679)
.+.||+|+||.||+|+.++ +..||+|.++.... ....+|.+|++++.+++||||+++++++.
T Consensus 10 ~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 89 (304)
T cd05096 10 KEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCV 89 (304)
T ss_pred eeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEe
Confidence 4789999999999997532 34799999876432 23457899999999999999999999998
Q ss_pred CCCCceEEEEEecCCCChHHHhhcccC---------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCC
Q 005749 444 GKRGEKLLIYDYFPSRTLHDLLHDTIA---------------GKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVR 508 (679)
Q Consensus 444 ~~~~~~~lv~ey~~~gsL~~~l~~~~~---------------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlk 508 (679)
+ .+..++||||+++|+|.+++..... ....++|..+++++.||+.||+|||+.+ |+|||||
T Consensus 90 ~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH~dlk 165 (304)
T cd05096 90 D-EDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVHRDLA 165 (304)
T ss_pred c-CCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccccCcc
Confidence 7 5789999999999999999865321 1134788999999999999999999988 9999999
Q ss_pred CCCeeecCCCceEEeecccccccCcccccc-hhcccccccccccccccccCCCCcchhHHHHHHHHHHHh--CCCCCCCC
Q 005749 509 SKNVLVDDFFVSRLTEFGLDQLMVPAVADE-MVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI--GKKPGKSG 585 (679)
Q Consensus 509 p~NILl~~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t--g~~p~~~~ 585 (679)
|+|||+++++.+||+|||+++......... .....++..|+|||++..+.++.++||||||+++|||++ +..||...
T Consensus 166 p~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~ 245 (304)
T cd05096 166 TRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGEL 245 (304)
T ss_pred hhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCCcC
Confidence 999999999999999999998654332211 123345778999999988889999999999999999986 55677443
Q ss_pred CCCcccchhHHHHHHhhcccccccchHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHh
Q 005749 586 RNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEE 656 (679)
Q Consensus 586 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 656 (679)
... .....+........ .... ....+.....+.+++.+||+.||++|||+.||.+.|++
T Consensus 246 ~~~---~~~~~~~~~~~~~~-~~~~--------~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 246 TDE---QVIENAGEFFRDQG-RQVY--------LFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CHH---HHHHHHHHHhhhcc-cccc--------ccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 221 11111111111100 0000 00011223567789999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=360.78 Aligned_cols=251 Identities=20% Similarity=0.259 Sum_probs=207.6
Q ss_pred cCccccCCceEEEEEEeCCC-CEEEEEEcccCcccCcccHHHHHHHHhccC-CCCCccceE-EeeCC-----CCceEEEE
Q 005749 382 GQVIEKTTYGTAYKAKLADG-ATIALRLLREGSCKDRSSCLPVIRQLGKVR-HENLIPLRA-FYQGK-----RGEKLLIY 453 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~~~-~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~~-~~~~~-----~~~~~lv~ 453 (679)
.++|.+|||+.||.|+...+ ..+|+|++...++...+...+||++|++|+ |+|||.+++ ..... .-+++|.|
T Consensus 42 ~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllLm 121 (738)
T KOG1989|consen 42 EKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLM 121 (738)
T ss_pred EEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEeeh
Confidence 47899999999999996665 999999998776677788999999999997 999999999 33221 23678999
Q ss_pred EecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCc
Q 005749 454 DYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVP 533 (679)
Q Consensus 454 ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 533 (679)
|||++|+|-+++..+.. ..|++.++++|+.|+++|+++||... +||||||||.+||||+.++..||||||.|.....
T Consensus 122 EyC~gg~Lvd~mn~Rlq--~~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~ 198 (738)
T KOG1989|consen 122 EYCKGGSLVDFMNTRLQ--TRLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFGSATTKIL 198 (738)
T ss_pred hhccCCcHHHHHHHHHh--ccCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCcccccccccC
Confidence 99999999999987664 33999999999999999999999864 7799999999999999999999999999875432
Q ss_pred cc--cc------chhccccccccccccccc---ccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhh
Q 005749 534 AV--AD------EMVALAKADGYKAPELQR---MKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVL 602 (679)
Q Consensus 534 ~~--~~------~~~~~~gt~~y~aPE~~~---~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~ 602 (679)
.. .. .......|+.|+|||++. +..+++|+|||++||+||-|+....||+....-
T Consensus 199 ~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l-------------- 264 (738)
T KOG1989|consen 199 SPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL-------------- 264 (738)
T ss_pred CCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce--------------
Confidence 22 11 112346789999999765 677999999999999999999999999543111
Q ss_pred cccccccchHhhhhcC--CCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCC
Q 005749 603 EETTMEVFDMEIMKGI--RSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRP 659 (679)
Q Consensus 603 ~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 659 (679)
.|+.+. .++.+.+...+.+||..||+.||++||++-+|+..+.++..
T Consensus 265 ----------aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~ 313 (738)
T KOG1989|consen 265 ----------AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELAN 313 (738)
T ss_pred ----------eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence 122221 14457888899999999999999999999999999988864
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=345.37 Aligned_cols=242 Identities=19% Similarity=0.275 Sum_probs=193.8
Q ss_pred CccccCCceEEEEEE-eCCCCEEEEEEcccCc---ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCC
Q 005749 383 QVIEKTTYGTAYKAK-LADGATIALRLLREGS---CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPS 458 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~ 458 (679)
++||+|+||.||+++ ..+|+.||+|+++... ......+.+|++++++++||||+++++++.. .+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~-~~~~~lv~E~~~~ 79 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT-HDRLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEec-CCEEEEEEeCCCC
Confidence 469999999999999 4579999999987542 2234467789999999999999999999987 6789999999999
Q ss_pred CChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccc
Q 005749 459 RTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADE 538 (679)
Q Consensus 459 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 538 (679)
|+|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..... ...
T Consensus 80 ~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~-~~~ 151 (323)
T cd05595 80 GELFFHLSRE----RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-GAT 151 (323)
T ss_pred CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCC-CCc
Confidence 9999988753 45899999999999999999999988 999999999999999999999999998753222 122
Q ss_pred hhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcC
Q 005749 539 MVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGI 618 (679)
Q Consensus 539 ~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~ 618 (679)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||....... ...... ...
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~------~~~~~~--------------~~~ 211 (323)
T cd05595 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER------LFELIL--------------MEE 211 (323)
T ss_pred cccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH------HHHHHh--------------cCC
Confidence 234578999999999998899999999999999999999999995432211 011000 000
Q ss_pred CCChHHHHHHHHHHHHhccCcCCCCCC-----CHHHHHHH
Q 005749 619 RSPMEEGLVQALKLAMGCCAPVASVRP-----TMDEVVKQ 653 (679)
Q Consensus 619 ~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~evl~~ 653 (679)
........+++.+++.+||+.||++|| ++.++++.
T Consensus 212 ~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 212 IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred CCCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 001112235667899999999999998 88888753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=344.65 Aligned_cols=242 Identities=20% Similarity=0.295 Sum_probs=194.7
Q ss_pred CccccCCceEEEEEE-eCCCCEEEEEEcccCc---ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCC
Q 005749 383 QVIEKTTYGTAYKAK-LADGATIALRLLREGS---CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPS 458 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~ 458 (679)
++||+|+||.||+++ ..+|+.||+|++.... ......+.+|+++++.++||||+++++++.. .+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~Ey~~~ 79 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQT-KDRLCFVMEYVNG 79 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc-CCEEEEEEeCCCC
Confidence 469999999999999 4579999999997542 2234567899999999999999999999887 6789999999999
Q ss_pred CChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccc
Q 005749 459 RTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADE 538 (679)
Q Consensus 459 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 538 (679)
|+|.+++... ..+++.+++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++..... ...
T Consensus 80 g~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~-~~~ 151 (328)
T cd05593 80 GELFFHLSRE----RVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITD-AAT 151 (328)
T ss_pred CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCc-ccc
Confidence 9999988753 45899999999999999999999988 999999999999999999999999998754221 122
Q ss_pred hhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcC
Q 005749 539 MVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGI 618 (679)
Q Consensus 539 ~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~ 618 (679)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ....... ...
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~------~~~~~~~--------------~~~ 211 (328)
T cd05593 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------KLFELIL--------------MED 211 (328)
T ss_pred cccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH------HHHHHhc--------------cCC
Confidence 23457899999999999889999999999999999999999999543221 1111100 000
Q ss_pred CCChHHHHHHHHHHHHhccCcCCCCCC-----CHHHHHHH
Q 005749 619 RSPMEEGLVQALKLAMGCCAPVASVRP-----TMDEVVKQ 653 (679)
Q Consensus 619 ~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~evl~~ 653 (679)
.........++.+++.+||+.||++|| ++.|++++
T Consensus 212 ~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 212 IKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred ccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 011112234567899999999999997 89998865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=336.62 Aligned_cols=246 Identities=29% Similarity=0.482 Sum_probs=189.8
Q ss_pred CccccCCceEEEEEEeC-----CCCEEEEEEcccCcc-cCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEec
Q 005749 383 QVIEKTTYGTAYKAKLA-----DGATIALRLLREGSC-KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYF 456 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~~-----~~~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~ 456 (679)
+.||.|.||.||+|.+. .+..|+||.++.... ...+.|.+|++.+++++||||++++|++.. .+..++||||+
T Consensus 5 ~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~-~~~~~lv~e~~ 83 (259)
T PF07714_consen 5 KQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIE-NEPLFLVMEYC 83 (259)
T ss_dssp EEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEES-SSSEEEEEE--
T ss_pred eEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccc-ccccccccccc
Confidence 67999999999999976 366899999966432 336789999999999999999999999996 57799999999
Q ss_pred CCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCccc-
Q 005749 457 PSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAV- 535 (679)
Q Consensus 457 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~- 535 (679)
++|+|.+++.... ...+++..+..|+.||++||+|||+++ ++|+||+++||++++++.+||+|||+++......
T Consensus 84 ~~g~L~~~L~~~~--~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 84 PGGSLDDYLKSKN--KEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp TTEBHHHHHHHTC--TTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred ccccccccccccc--ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence 9999999998752 356899999999999999999999988 9999999999999999999999999998762211
Q ss_pred ccchhcccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHHhhcccccccchHhh
Q 005749 536 ADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEI 614 (679)
Q Consensus 536 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i 614 (679)
............|+|||.+....++.++||||||+++|||++ |+.||.+... .++....
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~------~~~~~~~-------------- 218 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN------EEIIEKL-------------- 218 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH------HHHHHHH--------------
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccc------ccccccc--------------
Confidence 122233456678999999998889999999999999999999 6788744311 1111111
Q ss_pred hhcCC-CChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 005749 615 MKGIR-SPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQL 654 (679)
Q Consensus 615 ~~~~~-~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L 654 (679)
.++.+ .........+.+++..||+.||++||+|+++++.|
T Consensus 219 ~~~~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 219 KQGQRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp HTTEETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred cccccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 11111 11112335577899999999999999999999886
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=340.42 Aligned_cols=250 Identities=21% Similarity=0.321 Sum_probs=197.3
Q ss_pred CccccCCceEEEEEEe-CCCC----EEEEEEcccCc-ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEec
Q 005749 383 QVIEKTTYGTAYKAKL-ADGA----TIALRLLREGS-CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYF 456 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~-~~~~----~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~ 456 (679)
+.||+|+||.||+|++ .++. .||+|.++... ....+.+.+|+.+++.++||||++++|+|.. +..++|+||+
T Consensus 13 ~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~--~~~~~v~e~~ 90 (316)
T cd05108 13 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT--STVQLITQLM 90 (316)
T ss_pred eeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC--CCceeeeecC
Confidence 7899999999999984 3444 38999987543 2335678899999999999999999999886 4678999999
Q ss_pred CCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccc
Q 005749 457 PSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVA 536 (679)
Q Consensus 457 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 536 (679)
++|+|.+++... ...+++..+++++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+.....
T Consensus 91 ~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 164 (316)
T cd05108 91 PFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEK 164 (316)
T ss_pred CCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccccccccCCCc
Confidence 999999999864 235889999999999999999999988 99999999999999999999999999987643222
Q ss_pred c-chhcccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHHhhcccccccchHhh
Q 005749 537 D-EMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEI 614 (679)
Q Consensus 537 ~-~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i 614 (679)
. ......++..|+|||++.+..++.++|||||||++|||++ |+.||.+.... ++.... .
T Consensus 165 ~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~------~~~~~~-~------------ 225 (316)
T cd05108 165 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS------EISSIL-E------------ 225 (316)
T ss_pred ceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH------HHHHHH-h------------
Confidence 1 1122334667999999998899999999999999999997 99998542211 111100 0
Q ss_pred hhcCC-CChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCCC
Q 005749 615 MKGIR-SPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRPR 660 (679)
Q Consensus 615 ~~~~~-~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 660 (679)
.+.. +..+....++.+++.+||+.+|++||++.+++..+.++...
T Consensus 226 -~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~ 271 (316)
T cd05108 226 -KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 271 (316)
T ss_pred -CCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence 0000 11112234677899999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=344.24 Aligned_cols=250 Identities=22% Similarity=0.317 Sum_probs=208.5
Q ss_pred cCccccCCceEEEEEEeCC-CCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCC
Q 005749 382 GQVIEKTTYGTAYKAKLAD-GATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRT 460 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gs 460 (679)
...+|-|.||.||.|.|+. .-.||||.+++.. ...++|++|..+|+.++|||+|+++|+|.. ...+|||+|||.+|+
T Consensus 272 khKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~-EpPFYIiTEfM~yGN 349 (1157)
T KOG4278|consen 272 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTH-EPPFYIITEFMCYGN 349 (1157)
T ss_pred eeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhcc-CCCeEEEEecccCcc
Confidence 3789999999999999654 6799999998754 357899999999999999999999999997 678999999999999
Q ss_pred hHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccchh
Q 005749 461 LHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMV 540 (679)
Q Consensus 461 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 540 (679)
|.++|++..+ ..++.-..+.+|.||+.||+||..++ +|||||.++|+|+.++..+||+|||+++++..+.+....
T Consensus 350 LLdYLRecnr--~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAHA 424 (1157)
T KOG4278|consen 350 LLDYLRECNR--SEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAHA 424 (1157)
T ss_pred HHHHHHHhch--hhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhcCCceeccc
Confidence 9999997653 45777788999999999999999988 999999999999999999999999999999765443323
Q ss_pred cccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcCC
Q 005749 541 ALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIR 619 (679)
Q Consensus 541 ~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~ 619 (679)
...-.+.|.|||-+....++.|+|||+|||+|||+.| |..||.+.+-.+.+. . +.++++
T Consensus 425 GAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~-------L-------------LEkgyR 484 (1157)
T KOG4278|consen 425 GAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYG-------L-------------LEKGYR 484 (1157)
T ss_pred CccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHH-------H-------------Hhcccc
Confidence 3334567999999999999999999999999999996 888986543221111 1 123333
Q ss_pred CC-hHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhC
Q 005749 620 SP-MEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENR 658 (679)
Q Consensus 620 ~~-~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 658 (679)
.. .+.+.+.+.+|+..||++.|.+||+++|+-+.++.+-
T Consensus 485 M~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf 524 (1157)
T KOG4278|consen 485 MDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMF 524 (1157)
T ss_pred ccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence 22 2344567889999999999999999999999998764
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=336.57 Aligned_cols=255 Identities=20% Similarity=0.213 Sum_probs=201.9
Q ss_pred cccHHHHHHhhcCccccCCceEEEEEE-eCCCCEEEEEEcccCcc---cCcccHHHHHHHHhccCCCCCccceEEeeCCC
Q 005749 371 HLTLEDVLNATGQVIEKTTYGTAYKAK-LADGATIALRLLREGSC---KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKR 446 (679)
Q Consensus 371 ~~~~~~l~~~~~~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~---~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~ 446 (679)
+++++|.. +-.+||+|+||.||+|+ ..+|..+|+|++++... .+.+..+.|-.+|...++|.||+++..|++ .
T Consensus 137 r~~~~DFe--~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD-~ 213 (550)
T KOG0605|consen 137 RLSLDDFE--LLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQD-K 213 (550)
T ss_pred cCCcccch--hheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecC-C
Confidence 34555542 23789999999999999 56699999999988643 345567899999999999999999999998 6
Q ss_pred CceEEEEEecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecc
Q 005749 447 GEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFG 526 (679)
Q Consensus 447 ~~~~lv~ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 526 (679)
+..||||||++|||+..+|.. ...|++..++.++.+++.|++-+|+.| +|||||||+|+|||..|++||+|||
T Consensus 214 ~~LYLiMEylPGGD~mTLL~~----~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFG 286 (550)
T KOG0605|consen 214 EYLYLIMEYLPGGDMMTLLMR----KDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFG 286 (550)
T ss_pred CeeEEEEEecCCccHHHHHHh----cCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeecccc
Confidence 899999999999999999987 467999999999999999999999998 9999999999999999999999999
Q ss_pred cccccCc----------------------cccc------------------------chhcccccccccccccccccCCC
Q 005749 527 LDQLMVP----------------------AVAD------------------------EMVALAKADGYKAPELQRMKKCS 560 (679)
Q Consensus 527 la~~~~~----------------------~~~~------------------------~~~~~~gt~~y~aPE~~~~~~~~ 560 (679)
|+.-+.. .... -....+|||-|||||++.+..|+
T Consensus 287 Ls~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~ 366 (550)
T KOG0605|consen 287 LSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYG 366 (550)
T ss_pred ccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCC
Confidence 9853211 0000 01135799999999999999999
Q ss_pred CcchhHHHHHHHHHHHhCCCCCCCCCCCcccc-hhHHHHHHhhcccccccchHhhhhcCCCChHHHHHHHHHHHHhccCc
Q 005749 561 SRTDVYAFGILLLEILIGKKPGKSGRNGEFVD-LPSIVKVAVLEETTMEVFDMEIMKGIRSPMEEGLVQALKLAMGCCAP 639 (679)
Q Consensus 561 ~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~-l~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l~~~cl~~ 639 (679)
..+|.||+|||||||+.|.+||.+.+..+... +..|.... ..+.......+..++|.+|+.
T Consensus 367 ~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l-----------------~fP~~~~~s~eA~DLI~rll~- 428 (550)
T KOG0605|consen 367 KECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETL-----------------KFPEEVDLSDEAKDLITRLLC- 428 (550)
T ss_pred ccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhc-----------------cCCCcCcccHHHHHHHHHHhc-
Confidence 99999999999999999999997665432211 11111100 011222233778899999998
Q ss_pred CCCCCCC---HHHHHHH
Q 005749 640 VASVRPT---MDEVVKQ 653 (679)
Q Consensus 640 dP~~RPs---~~evl~~ 653 (679)
||++|-- ++||.++
T Consensus 429 d~~~RLG~~G~~EIK~H 445 (550)
T KOG0605|consen 429 DPENRLGSKGAEEIKKH 445 (550)
T ss_pred CHHHhcCcccHHHHhcC
Confidence 9999975 6666543
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=348.04 Aligned_cols=255 Identities=20% Similarity=0.322 Sum_probs=197.7
Q ss_pred hcCccccCCceEEEEEEe------CCCCEEEEEEcccCcc-cCcccHHHHHHHHhcc-CCCCCccceEEeeCCCCceEEE
Q 005749 381 TGQVIEKTTYGTAYKAKL------ADGATIALRLLREGSC-KDRSSCLPVIRQLGKV-RHENLIPLRAFYQGKRGEKLLI 452 (679)
Q Consensus 381 ~~~~ig~G~~g~Vy~~~~------~~~~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~~lv 452 (679)
..+.||+|+||.||+|+. .++..||+|+++.... ...+.+.+|+++++.+ +|+|||+++++|.. .+..++|
T Consensus 42 ~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~-~~~~~lv 120 (374)
T cd05106 42 FGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTH-GGPVLVI 120 (374)
T ss_pred ehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecC-CCCeEEe
Confidence 458999999999999873 2245899999976432 2345688999999999 89999999999987 6789999
Q ss_pred EEecCCCChHHHhhcccC--------------------------------------------------------------
Q 005749 453 YDYFPSRTLHDLLHDTIA-------------------------------------------------------------- 470 (679)
Q Consensus 453 ~ey~~~gsL~~~l~~~~~-------------------------------------------------------------- 470 (679)
|||+++|+|.++++....
T Consensus 121 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (374)
T cd05106 121 TEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDE 200 (374)
T ss_pred HhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccccch
Confidence 999999999999864210
Q ss_pred ----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccc-hhccccc
Q 005749 471 ----GKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADE-MVALAKA 545 (679)
Q Consensus 471 ----~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt 545 (679)
....+++..+++|+.||++||+|||+++ |+||||||+|||+++++.+||+|||+++......... .....++
T Consensus 201 ~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~ 277 (374)
T cd05106 201 EDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLP 277 (374)
T ss_pred hccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCCc
Confidence 0134788999999999999999999988 9999999999999999999999999998653322111 1122355
Q ss_pred ccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcCCCCh-H
Q 005749 546 DGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIRSPM-E 623 (679)
Q Consensus 546 ~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~~~~-~ 623 (679)
..|||||++.+..++.++|||||||++|||++ |+.||....... .. ... . ..+..... .
T Consensus 278 ~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~--~~---~~~-~-------------~~~~~~~~~~ 338 (374)
T cd05106 278 VKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS--KF---YKM-V-------------KRGYQMSRPD 338 (374)
T ss_pred cceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH--HH---HHH-H-------------HcccCccCCC
Confidence 67999999988899999999999999999997 999985432211 00 000 0 00000000 1
Q ss_pred HHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhC
Q 005749 624 EGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENR 658 (679)
Q Consensus 624 ~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 658 (679)
...+++.+++.+||+.||++|||+.+|++.|+++.
T Consensus 339 ~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 339 FAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 11356778999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-40 Score=340.17 Aligned_cols=239 Identities=22% Similarity=0.240 Sum_probs=194.5
Q ss_pred CccccCCceEEEEEEe-CCCCEEEEEEcccCc---ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCC
Q 005749 383 QVIEKTTYGTAYKAKL-ADGATIALRLLREGS---CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPS 458 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~ 458 (679)
+.||+|+||.||+|+. .+++.||+|++.... ....+.+.+|++++++++||||+++++++.+ .+..++||||+++
T Consensus 7 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~e~~~~ 85 (291)
T cd05612 7 KTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHD-QRFLYMLMEYVPG 85 (291)
T ss_pred eeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhcc-CCeEEEEEeCCCC
Confidence 7899999999999995 468999999986532 1234568899999999999999999998887 6789999999999
Q ss_pred CChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccc
Q 005749 459 RTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADE 538 (679)
Q Consensus 459 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 538 (679)
|+|.+++... ..+++..++.++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++.....
T Consensus 86 ~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~---- 154 (291)
T cd05612 86 GELFSYLRNS----GRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR---- 154 (291)
T ss_pred CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC----
Confidence 9999999763 45899999999999999999999988 999999999999999999999999999865322
Q ss_pred hhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcC
Q 005749 539 MVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGI 618 (679)
Q Consensus 539 ~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~ 618 (679)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||.+.... ..... +..+.
T Consensus 155 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~------~~~~~--------------i~~~~ 214 (291)
T cd05612 155 TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF------GIYEK--------------ILAGK 214 (291)
T ss_pred cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHH--------------HHhCC
Confidence 22456899999999999888999999999999999999999999543221 11111 11111
Q ss_pred CCChHHHHHHHHHHHHhccCcCCCCCCC-----HHHHHHH
Q 005749 619 RSPMEEGLVQALKLAMGCCAPVASVRPT-----MDEVVKQ 653 (679)
Q Consensus 619 ~~~~~~~~~~~~~l~~~cl~~dP~~RPs-----~~evl~~ 653 (679)
..........+.+++.+||+.||.+||+ ++|++++
T Consensus 215 ~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 215 LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 1111122346778999999999999995 8888766
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=336.61 Aligned_cols=260 Identities=15% Similarity=0.216 Sum_probs=194.5
Q ss_pred CccccCCceEEEEEEe-CCCCEEEEEEcccCc--ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCC
Q 005749 383 QVIEKTTYGTAYKAKL-ADGATIALRLLREGS--CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSR 459 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~g 459 (679)
+.||+|+||.||+|+. .+++.||+|+++... ....+.+.+|++++++++||||+++++++.. .+..++||||++++
T Consensus 7 ~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~ 85 (287)
T cd07848 7 GVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRR-RGKLYLVFEYVEKN 85 (287)
T ss_pred EEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEec-CCEEEEEEecCCCC
Confidence 6799999999999995 468899999987542 2234578899999999999999999999987 67899999999997
Q ss_pred ChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccch
Q 005749 460 TLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEM 539 (679)
Q Consensus 460 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 539 (679)
++..+... ...+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++..........
T Consensus 86 ~l~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 158 (287)
T cd07848 86 MLELLEEM----PNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANY 158 (287)
T ss_pred HHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccccccc
Confidence 77655432 235899999999999999999999988 99999999999999999999999999987643322223
Q ss_pred hcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHH---------HHHhhcccccccc
Q 005749 540 VALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIV---------KVAVLEETTMEVF 610 (679)
Q Consensus 540 ~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~---------~~~~~~~~~~~~~ 610 (679)
....|+..|+|||++.+..++.++|||||||++|||++|+.||.+....+........ .............
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (287)
T cd07848 159 TEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLR 238 (287)
T ss_pred cccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccc
Confidence 3456899999999999888999999999999999999999999654322111000000 0000000000000
Q ss_pred hHhhhhcCCCC-----hHHHHHHHHHHHHhccCcCCCCCCCHHHHHH
Q 005749 611 DMEIMKGIRSP-----MEEGLVQALKLAMGCCAPVASVRPTMDEVVK 652 (679)
Q Consensus 611 ~~~i~~~~~~~-----~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 652 (679)
.+. ... ... .......+.+++.+|++.||++|||++|+++
T Consensus 239 ~~~-~~~-~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 239 FPA-VNH-PQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred cCc-ccC-cccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000 000 000 0012346789999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=326.53 Aligned_cols=255 Identities=25% Similarity=0.318 Sum_probs=197.5
Q ss_pred CccccCCceEEEEEEeCCCCEEEEEEcccCcccCcccHHHHHHHHhc--cCCCCCccceEEeeCCCC---ceEEEEEecC
Q 005749 383 QVIEKTTYGTAYKAKLADGATIALRLLREGSCKDRSSCLPVIRQLGK--VRHENLIPLRAFYQGKRG---EKLLIYDYFP 457 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~--l~H~nIv~l~~~~~~~~~---~~~lv~ey~~ 457 (679)
+.||+|.||.||+|+++ |+.||||++... +++.+.+|.+|.+. +||+||+.+++.-..+.+ +.+||++|-+
T Consensus 217 e~IGkGRyGEVwrG~wr-Ge~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYHe 292 (513)
T KOG2052|consen 217 EIIGKGRFGEVWRGRWR-GEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYHE 292 (513)
T ss_pred EEecCccccceeecccc-CCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeeccc
Confidence 78999999999999996 889999999653 45678888888875 499999999886554332 5799999999
Q ss_pred CCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhc-----CCCCCeeecCCCCCCeeecCCCceEEeecccccccC
Q 005749 458 SRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHT-----GHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMV 532 (679)
Q Consensus 458 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~-----~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 532 (679)
.|||+|+|.. ..++....++++..+|.||+|||. ++.|.|.|||||+.|||+..++.+.|+|+|+|....
T Consensus 293 ~GSL~DyL~r-----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~ 367 (513)
T KOG2052|consen 293 HGSLYDYLNR-----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD 367 (513)
T ss_pred CCcHHHHHhh-----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEec
Confidence 9999999985 468999999999999999999997 567889999999999999999999999999997654
Q ss_pred cccc---cchhcccccccccccccccccC----C--CCcchhHHHHHHHHHHHhC----------CCCCCCCCCCcccch
Q 005749 533 PAVA---DEMVALAKADGYKAPELQRMKK----C--SSRTDVYAFGILLLEILIG----------KKPGKSGRNGEFVDL 593 (679)
Q Consensus 533 ~~~~---~~~~~~~gt~~y~aPE~~~~~~----~--~~k~DV~S~Gvvl~El~tg----------~~p~~~~~~~~~~~l 593 (679)
.... -.....+||..|||||++.... + -..+||||||.|+||++.+ +.||.+-...+.. .
T Consensus 368 ~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs-~ 446 (513)
T KOG2052|consen 368 SDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPS-F 446 (513)
T ss_pred ccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCC-H
Confidence 3321 1234568999999999986421 2 2369999999999999753 2466443322111 0
Q ss_pred hHHHHHHhhcccccccch-----HhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCC
Q 005749 594 PSIVKVAVLEETTMEVFD-----MEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRP 659 (679)
Q Consensus 594 ~~~~~~~~~~~~~~~~~~-----~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 659 (679)
+.+.+++. |.+.. +....+.+..+.+++..||..+|..|-|+-.+.+.|.++..
T Consensus 447 ----------eeMrkVVCv~~~RP~ipn--rW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 447 ----------EEMRKVVCVQKLRPNIPN--RWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred ----------HHHhcceeecccCCCCCc--ccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 11111211 11111 12234667888899999999999999999999999998864
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=343.27 Aligned_cols=240 Identities=18% Similarity=0.235 Sum_probs=194.1
Q ss_pred cCccccCCceEEEEEEe-CCCCEEEEEEcccCc---ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecC
Q 005749 382 GQVIEKTTYGTAYKAKL-ADGATIALRLLREGS---CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFP 457 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~ 457 (679)
.+.||+|+||.||+|+. .+++.||+|.++... ....+.+.+|++++.+++||||+++++++.+ .+..++||||++
T Consensus 23 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~e~~~ 101 (329)
T PTZ00263 23 GETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQD-ENRVYFLLEFVV 101 (329)
T ss_pred EEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEc-CCEEEEEEcCCC
Confidence 47899999999999995 468999999987532 2234568899999999999999999999987 678999999999
Q ss_pred CCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCccccc
Q 005749 458 SRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVAD 537 (679)
Q Consensus 458 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 537 (679)
+|+|.+++... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 102 ~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--- 171 (329)
T PTZ00263 102 GGELFTHLRKA----GRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR--- 171 (329)
T ss_pred CChHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCC---
Confidence 99999999763 45889999999999999999999988 999999999999999999999999999865332
Q ss_pred chhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhc
Q 005749 538 EMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKG 617 (679)
Q Consensus 538 ~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~ 617 (679)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||.+.... ..... +..+
T Consensus 172 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~------~~~~~--------------i~~~ 230 (329)
T PTZ00263 172 -TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF------RIYEK--------------ILAG 230 (329)
T ss_pred -cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH------HHHHH--------------HhcC
Confidence 22457899999999999888999999999999999999999999543211 11110 1111
Q ss_pred CCCChHHHHHHHHHHHHhccCcCCCCCCC-----HHHHHHH
Q 005749 618 IRSPMEEGLVQALKLAMGCCAPVASVRPT-----MDEVVKQ 653 (679)
Q Consensus 618 ~~~~~~~~~~~~~~l~~~cl~~dP~~RPs-----~~evl~~ 653 (679)
...........+.+++.+||+.||++||+ +++++++
T Consensus 231 ~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 231 RLKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred CcCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 10101112245678999999999999997 6777754
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=335.18 Aligned_cols=260 Identities=18% Similarity=0.279 Sum_probs=193.3
Q ss_pred CccccCCceEEEEEEe-CCCCEEEEEEcccCcc-cCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCC
Q 005749 383 QVIEKTTYGTAYKAKL-ADGATIALRLLREGSC-KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRT 460 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gs 460 (679)
+.||+|+||.||+|+. .+++.||+|.++.... .....+.+|++++++++||||+++++++.+ .+..++||||+++ +
T Consensus 11 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~~~-~ 88 (288)
T cd07871 11 DKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHT-ERCLTLVFEYLDS-D 88 (288)
T ss_pred eEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcC-CCeEEEEEeCCCc-C
Confidence 6899999999999994 4689999999875432 234567899999999999999999999887 5789999999975 9
Q ss_pred hHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccchh
Q 005749 461 LHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMV 540 (679)
Q Consensus 461 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 540 (679)
|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++..... .....
T Consensus 89 l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~-~~~~~ 161 (288)
T cd07871 89 LKQYLDNC---GNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVP-TKTYS 161 (288)
T ss_pred HHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCC-Ccccc
Confidence 99988653 235789999999999999999999988 999999999999999999999999998764322 11223
Q ss_pred cccccccccccccccc-cCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHH--hhcccccccc-----hH
Q 005749 541 ALAKADGYKAPELQRM-KKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVA--VLEETTMEVF-----DM 612 (679)
Q Consensus 541 ~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~--~~~~~~~~~~-----~~ 612 (679)
...+++.|+|||++.+ ..++.++||||+||++|||++|+.||.+....+... ...... ...+...... ..
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (288)
T cd07871 162 NEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELH--LIFRLLGTPTEETWPGITSNEEFRS 239 (288)
T ss_pred CceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHHHhCCCChHHhhccccchhhhc
Confidence 4467889999998865 568999999999999999999999996543322111 111000 0000000000 00
Q ss_pred hhhhcCCC-C----hHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 613 EIMKGIRS-P----MEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 613 ~i~~~~~~-~----~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
........ + .+....+..+++.+|++.||++|||++|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 240 YLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred cccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00000000 0 01123467799999999999999999999853
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=357.85 Aligned_cols=248 Identities=16% Similarity=0.228 Sum_probs=198.5
Q ss_pred cCccccCCceEEEEEEe-CC-CCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCC
Q 005749 382 GQVIEKTTYGTAYKAKL-AD-GATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSR 459 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~-~~-~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~g 459 (679)
.+.||+|+||.||+|.. .+ +..||+|.+..........+.+|+++++.++|||||++++++.. .+..++||||+++|
T Consensus 72 ~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~-~~~~~lv~E~~~gg 150 (478)
T PTZ00267 72 TTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKS-DDKLLLIMEYGSGG 150 (478)
T ss_pred EEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEE-CCEEEEEEECCCCC
Confidence 47899999999999983 34 67889998765444444567889999999999999999999987 68999999999999
Q ss_pred ChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCccccc-c
Q 005749 460 TLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVAD-E 538 (679)
Q Consensus 460 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~-~ 538 (679)
+|.++++........+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++........ .
T Consensus 151 ~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~ 227 (478)
T PTZ00267 151 DLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDV 227 (478)
T ss_pred CHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCcccccc
Confidence 999988764433456899999999999999999999988 999999999999999999999999999876433221 2
Q ss_pred hhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcC
Q 005749 539 MVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGI 618 (679)
Q Consensus 539 ~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~ 618 (679)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..... +..+.
T Consensus 228 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~------~~~~~--------------~~~~~ 287 (478)
T PTZ00267 228 ASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR------EIMQQ--------------VLYGK 287 (478)
T ss_pred ccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHH--------------HHhCC
Confidence 23456999999999999889999999999999999999999999542211 11111 11111
Q ss_pred CC-ChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 619 RS-PMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 619 ~~-~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
.. .......++.+++.+||+.||++||++++++..
T Consensus 288 ~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 288 YDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred CCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 11 111223567789999999999999999998753
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=326.22 Aligned_cols=249 Identities=23% Similarity=0.338 Sum_probs=199.3
Q ss_pred cCccccCCceEEEEEEe-CCCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCC
Q 005749 382 GQVIEKTTYGTAYKAKL-ADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRT 460 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gs 460 (679)
.+.||+|+||.||+|.. ++++.||+|.+.... ...+.+.+|++++++++|+||+++++++.. .+..++||||+++++
T Consensus 11 ~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~ 88 (263)
T cd05052 11 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR-EPPFYIITEFMTYGN 88 (263)
T ss_pred eeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcC-CCCcEEEEEeCCCCc
Confidence 36799999999999994 458899999987532 234678999999999999999999999887 678999999999999
Q ss_pred hHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccchh
Q 005749 461 LHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMV 540 (679)
Q Consensus 461 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 540 (679)
|.+++.... ...+++..++.++.|+++||+|||+++ ++||||||+||++++++.+||+|||+++...........
T Consensus 89 L~~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~~ 163 (263)
T cd05052 89 LLDYLRECN--RQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 163 (263)
T ss_pred HHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccceeeccC
Confidence 999997542 345899999999999999999999988 999999999999999999999999999876433222222
Q ss_pred cccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcCC
Q 005749 541 ALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIR 619 (679)
Q Consensus 541 ~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~ 619 (679)
...++..|+|||.+.+..++.++|||||||++|||++ |..||.+.... +..... ..+..
T Consensus 164 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~------~~~~~~--------------~~~~~ 223 (263)
T cd05052 164 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS------QVYELL--------------EKGYR 223 (263)
T ss_pred CCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH------HHHHHH--------------HCCCC
Confidence 2334567999999998899999999999999999998 89998543211 111111 01000
Q ss_pred -CChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhh
Q 005749 620 -SPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEEN 657 (679)
Q Consensus 620 -~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 657 (679)
........++.+++.+||+.||++||++.++++.|+++
T Consensus 224 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 224 MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 11112235677899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=342.28 Aligned_cols=244 Identities=23% Similarity=0.374 Sum_probs=200.6
Q ss_pred ccccCCceEEEEEE-eCCCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCChH
Q 005749 384 VIEKTTYGTAYKAK-LADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRTLH 462 (679)
Q Consensus 384 ~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gsL~ 462 (679)
++|+|.||+||-|+ ..+...+|||.+........+.+..||..-+.++|.|||+++|.+.. ++.+-|.||.+|||||.
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~se-nGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSE-NGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCC-CCeEEEEeecCCCCcHH
Confidence 79999999999999 56677899999988777777888999999999999999999999877 78889999999999999
Q ss_pred HHhhcccCCCCCC--CHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeec-CCCceEEeecccccccCcccccch
Q 005749 463 DLLHDTIAGKPVL--NWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVD-DFFVSRLTEFGLDQLMVPAVADEM 539 (679)
Q Consensus 463 ~~l~~~~~~~~~l--~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~-~~~~~kl~DFGla~~~~~~~~~~~ 539 (679)
++|+.. ..++ .+..+-.+..||++||.|||++. |||||||-+|||++ -.|.+||+|||.++.+..- ..-.
T Consensus 661 sLLrsk---WGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi-nP~T 733 (1226)
T KOG4279|consen 661 SLLRSK---WGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI-NPCT 733 (1226)
T ss_pred HHHHhc---cCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccC-Cccc
Confidence 999864 3445 67888899999999999999988 99999999999997 4689999999999876432 2334
Q ss_pred hcccccccccccccccccC--CCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhc
Q 005749 540 VALAKADGYKAPELQRMKK--CSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKG 617 (679)
Q Consensus 540 ~~~~gt~~y~aPE~~~~~~--~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~ 617 (679)
.++.||.-|||||++..++ |+.++|||||||++.||.||++||........ .+|.-.+.+-
T Consensus 734 ETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA-----------------AMFkVGmyKv 796 (1226)
T KOG4279|consen 734 ETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA-----------------AMFKVGMYKV 796 (1226)
T ss_pred cccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH-----------------hhhhhcceec
Confidence 5678999999999998654 89999999999999999999999943222110 0111111121
Q ss_pred CCCChHHH-HHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 618 IRSPMEEG-LVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 618 ~~~~~~~~-~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
.++.|++ ..+...++.+|+..||.+||++.++++.
T Consensus 797 -HP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 797 -HPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred -CCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence 2344444 4566789999999999999999999875
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=325.60 Aligned_cols=246 Identities=22% Similarity=0.377 Sum_probs=196.9
Q ss_pred cCccccCCceEEEEEEeCCCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCCh
Q 005749 382 GQVIEKTTYGTAYKAKLADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRTL 461 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gsL 461 (679)
.+.||+|+||.||+|+..++..+|+|.++... ...+.+.+|++++.+++||||+++++++.. .+..++||||+++|+|
T Consensus 9 ~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~l 86 (256)
T cd05113 9 LKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTK-QRPIYIVTEYMSNGCL 86 (256)
T ss_pred eeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEcc-CCCcEEEEEcCCCCcH
Confidence 36799999999999998777789999987543 234678999999999999999999999987 5678999999999999
Q ss_pred HHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccchhc
Q 005749 462 HDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVA 541 (679)
Q Consensus 462 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 541 (679)
.+++... ...+++..++.++.||+.||+|||+.+ ++|+||||+||++++++.+||+|||.++............
T Consensus 87 ~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~ 160 (256)
T cd05113 87 LNYLREH---GKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVG 160 (256)
T ss_pred HHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCceeecCC
Confidence 9999753 235899999999999999999999988 9999999999999999999999999988654332222223
Q ss_pred ccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcCCC
Q 005749 542 LAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIRS 620 (679)
Q Consensus 542 ~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~~ 620 (679)
..++..|+|||...+..++.++|||||||++|||++ |+.||...... ...... ..+.+.
T Consensus 161 ~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~------~~~~~~--------------~~~~~~ 220 (256)
T cd05113 161 SKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS------ETVEKV--------------SQGLRL 220 (256)
T ss_pred CccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH------HHHHHH--------------hcCCCC
Confidence 345677999999988889999999999999999998 99998432211 011110 111111
Q ss_pred -ChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHH
Q 005749 621 -PMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLE 655 (679)
Q Consensus 621 -~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~ 655 (679)
........+.+++.+||+.+|++||++.++++.|+
T Consensus 221 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 221 YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 01112356788999999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=326.20 Aligned_cols=249 Identities=23% Similarity=0.376 Sum_probs=199.9
Q ss_pred cCccccCCceEEEEEEeCCCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCCh
Q 005749 382 GQVIEKTTYGTAYKAKLADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRTL 461 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gsL 461 (679)
.+.||+|+||.||+|+..++..||+|.+.... ...+.+.+|+.++++++|+||+++++++.+ .+..+++|||+++|+|
T Consensus 11 ~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L 88 (261)
T cd05072 11 VKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTK-EEPIYIITEYMAKGSL 88 (261)
T ss_pred eeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCCcEEEEecCCCCcH
Confidence 37899999999999998888999999986532 235678999999999999999999998887 6788999999999999
Q ss_pred HHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccchhc
Q 005749 462 HDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVA 541 (679)
Q Consensus 462 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 541 (679)
.++++... ...+++.+++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++.............
T Consensus 89 ~~~l~~~~--~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~ 163 (261)
T cd05072 89 LDFLKSDE--GGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREG 163 (261)
T ss_pred HHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCceeccCC
Confidence 99997542 245889999999999999999999988 9999999999999999999999999998764332222223
Q ss_pred ccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcCC-
Q 005749 542 LAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIR- 619 (679)
Q Consensus 542 ~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~- 619 (679)
..++..|+|||++....++.++|||||||++|||++ |+.||...... .....+ ..+.+
T Consensus 164 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~---~~~~~~-----------------~~~~~~ 223 (261)
T cd05072 164 AKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS---DVMSAL-----------------QRGYRM 223 (261)
T ss_pred CccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH---HHHHHH-----------------HcCCCC
Confidence 345678999999988889999999999999999998 99998543211 111111 01100
Q ss_pred CChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhh
Q 005749 620 SPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEEN 657 (679)
Q Consensus 620 ~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 657 (679)
+.......++.+++.+||..+|++||+++++.+.|+++
T Consensus 224 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 224 PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 11112234677899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=337.35 Aligned_cols=241 Identities=20% Similarity=0.276 Sum_probs=188.7
Q ss_pred CccccCCceEEEEEEe-CCCCEEEEEEcccCc---ccCcccHHHHHHHHhcc-CCCCCccceEEeeCCCCceEEEEEecC
Q 005749 383 QVIEKTTYGTAYKAKL-ADGATIALRLLREGS---CKDRSSCLPVIRQLGKV-RHENLIPLRAFYQGKRGEKLLIYDYFP 457 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~~lv~ey~~ 457 (679)
++||+|+||.||+|+. .+++.||+|.++... ....+.+..|.+++... +||||+++++++.. .+..++||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~-~~~~~lv~e~~~ 79 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQT-KEHLFFVMEYLN 79 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEc-CCEEEEEEcCCC
Confidence 4699999999999995 568899999987532 22344566777777654 89999999999987 678999999999
Q ss_pred CCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCccccc
Q 005749 458 SRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVAD 537 (679)
Q Consensus 458 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 537 (679)
+|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... .
T Consensus 80 gg~L~~~~~~~----~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~ 151 (316)
T cd05592 80 GGDLMFHIQSS----GRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-G 151 (316)
T ss_pred CCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-C
Confidence 99999998753 35899999999999999999999988 9999999999999999999999999997543221 2
Q ss_pred chhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhc
Q 005749 538 EMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKG 617 (679)
Q Consensus 538 ~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~ 617 (679)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.... +..... ...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~------~~~~~i--------------~~~ 211 (316)
T cd05592 152 KASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED------ELFDSI--------------LND 211 (316)
T ss_pred ccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH------HHHHHH--------------HcC
Confidence 233457899999999999888999999999999999999999999543211 111110 010
Q ss_pred CCCChHHHHHHHHHHHHhccCcCCCCCCCHH-HHHH
Q 005749 618 IRSPMEEGLVQALKLAMGCCAPVASVRPTMD-EVVK 652 (679)
Q Consensus 618 ~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~-evl~ 652 (679)
..........++.+++.+||+.||++||++. ++++
T Consensus 212 ~~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 212 RPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred CCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 0011111234567899999999999999875 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=340.26 Aligned_cols=242 Identities=21% Similarity=0.264 Sum_probs=192.8
Q ss_pred CccccCCceEEEEEEe----CCCCEEEEEEcccCc----ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEE
Q 005749 383 QVIEKTTYGTAYKAKL----ADGATIALRLLREGS----CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYD 454 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~----~~~~~vAvK~~~~~~----~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~e 454 (679)
+.||+|+||.||+++. .+++.||+|+++... ......+.+|+++++.++||||+++++++.. ++..++|||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~-~~~~~lv~e 80 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQT-GGKLYLILE 80 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEec-CCeEEEEEe
Confidence 5799999999999984 358899999987532 1233457889999999999999999999987 678999999
Q ss_pred ecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcc
Q 005749 455 YFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPA 534 (679)
Q Consensus 455 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 534 (679)
|+++|+|.+++... ..+.+..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 153 (323)
T cd05584 81 YLSGGELFMHLERE----GIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHE 153 (323)
T ss_pred CCCCchHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccC
Confidence 99999999998753 45788899999999999999999988 999999999999999999999999998754222
Q ss_pred cccchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhh
Q 005749 535 VADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEI 614 (679)
Q Consensus 535 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i 614 (679)
. .......|++.|+|||++.+..++.++|||||||++|||++|+.||...... ..... +
T Consensus 154 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~------~~~~~--------------~ 212 (323)
T cd05584 154 G-TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK------KTIDK--------------I 212 (323)
T ss_pred C-CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH------HHHHH--------------H
Confidence 1 1223457899999999999888999999999999999999999999543211 11111 1
Q ss_pred hhcCCCChHHHHHHHHHHHHhccCcCCCCCC-----CHHHHHHH
Q 005749 615 MKGIRSPMEEGLVQALKLAMGCCAPVASVRP-----TMDEVVKQ 653 (679)
Q Consensus 615 ~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~evl~~ 653 (679)
..+.....+...+++.+++.+||+.||++|| +++++++.
T Consensus 213 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 213 LKGKLNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred HcCCCCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 1111111112235677899999999999999 78887763
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=329.37 Aligned_cols=252 Identities=21% Similarity=0.380 Sum_probs=199.4
Q ss_pred cCccccCCceEEEEEEeCC-C-----CEEEEEEcccCcc-cCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEE
Q 005749 382 GQVIEKTTYGTAYKAKLAD-G-----ATIALRLLREGSC-KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYD 454 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~~-~-----~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~e 454 (679)
.+.||+|+||.||+|.... + ..||+|.++.... .....|.+|++++++++||||+++++++.. .+..+++||
T Consensus 10 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~-~~~~~~~~e 88 (283)
T cd05048 10 LEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTK-EQPTCMLFE 88 (283)
T ss_pred hhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcC-CCceEEEEe
Confidence 3789999999999998533 2 5799999875432 234568999999999999999999999887 678999999
Q ss_pred ecCCCChHHHhhcccCC------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEE
Q 005749 455 YFPSRTLHDLLHDTIAG------------KPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRL 522 (679)
Q Consensus 455 y~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl 522 (679)
|+++|+|.+++...... ...+++..++.++.|++.||+|||+++ ++||||||+||++++++.+||
T Consensus 89 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~~~~L 165 (283)
T cd05048 89 YLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGLTVKI 165 (283)
T ss_pred cCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCCcEEE
Confidence 99999999999754211 145889999999999999999999988 999999999999999999999
Q ss_pred eecccccccCcccc-cchhcccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHH
Q 005749 523 TEFGLDQLMVPAVA-DEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVA 600 (679)
Q Consensus 523 ~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~ 600 (679)
+|||+++....... .......++..|+|||.+.+..++.++|||||||++|||++ |..||.+....+ +...
T Consensus 166 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~---~~~~---- 238 (283)
T cd05048 166 SDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE---VIEM---- 238 (283)
T ss_pred CCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHH----
Confidence 99999986533221 11223356788999999988889999999999999999998 999985433211 1111
Q ss_pred hhcccccccchHhhhhcCCCC-hHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhh
Q 005749 601 VLEETTMEVFDMEIMKGIRSP-MEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEEN 657 (679)
Q Consensus 601 ~~~~~~~~~~~~~i~~~~~~~-~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 657 (679)
+..+.... ......++.+++.+||+.||++||++.||++.|+.+
T Consensus 239 -------------i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 239 -------------IRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred -------------HHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 11111111 123346778899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=330.92 Aligned_cols=248 Identities=19% Similarity=0.227 Sum_probs=194.0
Q ss_pred cccCCceEEEEEE-eCCCCEEEEEEcccCcc---cCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCC
Q 005749 385 IEKTTYGTAYKAK-LADGATIALRLLREGSC---KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRT 460 (679)
Q Consensus 385 ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~---~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gs 460 (679)
||+|+||+||+++ ..+++.||+|.+..... ...+.+..|++++++++|+||+++.+++.. ....++||||+++|+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~-~~~~~lv~e~~~~g~ 79 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQT-KTDLCLVMTIMNGGD 79 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcC-CCeEEEEEeCCCCCC
Confidence 7999999999998 45789999999865422 223567889999999999999999998887 678999999999999
Q ss_pred hHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccchh
Q 005749 461 LHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMV 540 (679)
Q Consensus 461 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 540 (679)
|.+++.........+++..++.++.||+.||+|||+.+ |+||||||+||++++++.+||+|||+++...... ....
T Consensus 80 L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~-~~~~ 155 (280)
T cd05608 80 LRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ-SKTK 155 (280)
T ss_pred HHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCC-cccc
Confidence 99888654333456899999999999999999999988 9999999999999999999999999997654322 1223
Q ss_pred cccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcCCC
Q 005749 541 ALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIRS 620 (679)
Q Consensus 541 ~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~~ 620 (679)
...|++.|+|||++.+..++.++|||||||++|||++|+.||....... ....... .+......
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~--~~~~~~~--------------~~~~~~~~ 219 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV--ENKELKQ--------------RILNDSVT 219 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcch--hHHHHHH--------------hhcccCCC
Confidence 4578999999999999999999999999999999999999995432210 0000000 00011001
Q ss_pred ChHHHHHHHHHHHHhccCcCCCCCC-----CHHHHHHH
Q 005749 621 PMEEGLVQALKLAMGCCAPVASVRP-----TMDEVVKQ 653 (679)
Q Consensus 621 ~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~evl~~ 653 (679)
..+.....+.+++.+||+.||++|| ++++++++
T Consensus 220 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 220 YPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred CcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 1122345677899999999999999 66777764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=338.36 Aligned_cols=251 Identities=20% Similarity=0.320 Sum_probs=192.2
Q ss_pred ccHHHHHHhhcCccccCCceEEEEEEe-CCCCEEEEEEcccCcc-cCcccHHHHHHHHhccCCCCCccceEEeeCCCCce
Q 005749 372 LTLEDVLNATGQVIEKTTYGTAYKAKL-ADGATIALRLLREGSC-KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEK 449 (679)
Q Consensus 372 ~~~~~l~~~~~~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 449 (679)
..++++. ..+.||+|+||.||+|+. .+++.||||++..... ...+.+.+|++++++++|+||+++++++.. .+..
T Consensus 71 ~~~~~~~--~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~ 147 (353)
T PLN00034 71 KSLSELE--RVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDH-NGEI 147 (353)
T ss_pred CCHHHHh--hhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEecc-CCeE
Confidence 3445553 237899999999999994 5789999999865432 234578999999999999999999999987 6789
Q ss_pred EEEEEecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeeccccc
Q 005749 450 LLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQ 529 (679)
Q Consensus 450 ~lv~ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 529 (679)
++||||+++|+|.+.. ..++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++
T Consensus 148 ~lv~e~~~~~~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~ 216 (353)
T PLN00034 148 QVLLEFMDGGSLEGTH--------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSR 216 (353)
T ss_pred EEEEecCCCCcccccc--------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccce
Confidence 9999999999986432 2567788899999999999999988 9999999999999999999999999998
Q ss_pred ccCcccccchhcccccccccccccccc-----cCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcc
Q 005749 530 LMVPAVADEMVALAKADGYKAPELQRM-----KKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEE 604 (679)
Q Consensus 530 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~ 604 (679)
.+.... .......||..|+|||++.. ...+.++|||||||++|||++|+.||......+...+ ....
T Consensus 217 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~---~~~~---- 288 (353)
T PLN00034 217 ILAQTM-DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASL---MCAI---- 288 (353)
T ss_pred eccccc-ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHH---HHHH----
Confidence 764321 12234578999999998743 2345689999999999999999999953322211111 0000
Q ss_pred cccccchHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 605 TTMEVFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 605 ~~~~~~~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
..............++.+++.+||+.||++||++.|++++
T Consensus 289 ---------~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 289 ---------CMSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred ---------hccCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000001112233567889999999999999999999986
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=344.17 Aligned_cols=255 Identities=18% Similarity=0.299 Sum_probs=199.2
Q ss_pred cCccccCCceEEEEEEeC------CCCEEEEEEcccCcc-cCcccHHHHHHHHhccC-CCCCccceEEeeCCCCceEEEE
Q 005749 382 GQVIEKTTYGTAYKAKLA------DGATIALRLLREGSC-KDRSSCLPVIRQLGKVR-HENLIPLRAFYQGKRGEKLLIY 453 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~------~~~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~-H~nIv~l~~~~~~~~~~~~lv~ 453 (679)
+++||+|+||.||+|+.. .+..||||+++.... ...+.+.+|++++++++ |||||+++++|.+ .+..++||
T Consensus 42 ~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~-~~~~~lv~ 120 (400)
T cd05105 42 GRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTK-SGPIYIIT 120 (400)
T ss_pred hheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc-CCceEEEE
Confidence 478999999999999842 234799999975432 33467899999999996 9999999999987 67899999
Q ss_pred EecCCCChHHHhhcccC---------------------------------------------------------------
Q 005749 454 DYFPSRTLHDLLHDTIA--------------------------------------------------------------- 470 (679)
Q Consensus 454 ey~~~gsL~~~l~~~~~--------------------------------------------------------------- 470 (679)
|||++|+|.++++....
T Consensus 121 Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (400)
T cd05105 121 EYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASKY 200 (400)
T ss_pred EecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhhhhh
Confidence 99999999999865310
Q ss_pred -----------------------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceE
Q 005749 471 -----------------------------GKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSR 521 (679)
Q Consensus 471 -----------------------------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~k 521 (679)
....+++..+++++.|+++||+|||+.+ |+||||||+|||+++++.+|
T Consensus 201 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~~~~~~k 277 (400)
T cd05105 201 SDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQGKIVK 277 (400)
T ss_pred hhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEeCCCEEE
Confidence 0134788899999999999999999988 99999999999999999999
Q ss_pred EeecccccccCccccc-chhcccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHH
Q 005749 522 LTEFGLDQLMVPAVAD-EMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKV 599 (679)
Q Consensus 522 l~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~ 599 (679)
|+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||......+ ....
T Consensus 278 L~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~------~~~~ 351 (400)
T cd05105 278 ICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS------TFYN 351 (400)
T ss_pred EEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH------HHHH
Confidence 9999999865332211 1223346678999999988889999999999999999997 899985432211 0000
Q ss_pred HhhcccccccchHhhhhcCCCC-hHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCC
Q 005749 600 AVLEETTMEVFDMEIMKGIRSP-MEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRP 659 (679)
Q Consensus 600 ~~~~~~~~~~~~~~i~~~~~~~-~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 659 (679)
.+..+.+.. ......++.+++.+||+.||++||++.+|.+.|+++.+
T Consensus 352 -------------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 352 -------------KIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred -------------HHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 111111111 11233567789999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=324.23 Aligned_cols=249 Identities=22% Similarity=0.362 Sum_probs=199.9
Q ss_pred cCccccCCceEEEEEEeCCCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCCh
Q 005749 382 GQVIEKTTYGTAYKAKLADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRTL 461 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gsL 461 (679)
.+.||+|+||.||+|...+++.||+|.++... ...+++.+|++++++++||||+++++++.. .+..++||||+++++|
T Consensus 11 ~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L 88 (261)
T cd05068 11 LRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTL-EEPIYIVTELMKYGSL 88 (261)
T ss_pred EEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEec-CCCeeeeeecccCCcH
Confidence 37899999999999998788899999987643 235678999999999999999999999887 6789999999999999
Q ss_pred HHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccchhc
Q 005749 462 HDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVA 541 (679)
Q Consensus 462 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 541 (679)
.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++............
T Consensus 89 ~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 163 (261)
T cd05068 89 LEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREG 163 (261)
T ss_pred HHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCcccccCC
Confidence 99997642 245899999999999999999999988 9999999999999999999999999998764322221122
Q ss_pred ccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcCC-
Q 005749 542 LAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIR- 619 (679)
Q Consensus 542 ~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~- 619 (679)
...+..|+|||++.+..++.++||||||+++|||++ |+.||.+.... .+.. . +.....
T Consensus 164 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~----~-------------~~~~~~~ 223 (261)
T cd05068 164 AKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA---EVLQ----Q-------------VDQGYRM 223 (261)
T ss_pred CcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH---HHHH----H-------------HHcCCCC
Confidence 223457999999998889999999999999999999 99998543211 0000 0 011100
Q ss_pred CChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhh
Q 005749 620 SPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEEN 657 (679)
Q Consensus 620 ~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 657 (679)
+........+.+++.+||+.+|++||+++++++.|++.
T Consensus 224 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 224 PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 11122335677899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=343.19 Aligned_cols=242 Identities=19% Similarity=0.268 Sum_probs=193.3
Q ss_pred CccccCCceEEEEEE-eCCCCEEEEEEcccCc---ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCC
Q 005749 383 QVIEKTTYGTAYKAK-LADGATIALRLLREGS---CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPS 458 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~ 458 (679)
++||+|+||.||+++ ..+|+.||+|+++... ......+.+|++++..++||||+++++++.. .+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~-~~~~~lv~E~~~~ 79 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT-HDRLCFVMEYANG 79 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEc-CCEEEEEEeCCCC
Confidence 469999999999999 4579999999997542 2234567889999999999999999999887 6789999999999
Q ss_pred CChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeeecCCCCCCeeecCCCceEEeecccccccCccccc
Q 005749 459 RTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHT-GHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVAD 537 (679)
Q Consensus 459 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~-~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 537 (679)
|+|.+++... ..+++..+..++.||+.||+|||+ .+ |+||||||+|||+++++.+||+|||+++..... ..
T Consensus 80 ~~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~-~~ 151 (325)
T cd05594 80 GELFFHLSRE----RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD-GA 151 (325)
T ss_pred CcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCC-Cc
Confidence 9999988753 458999999999999999999997 56 999999999999999999999999998754222 12
Q ss_pred chhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhc
Q 005749 538 EMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKG 617 (679)
Q Consensus 538 ~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~ 617 (679)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ....... ..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~------~~~~~i~--------------~~ 211 (325)
T cd05594 152 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------KLFELIL--------------ME 211 (325)
T ss_pred ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH------HHHHHHh--------------cC
Confidence 223457899999999999889999999999999999999999999543221 1111100 00
Q ss_pred CCCChHHHHHHHHHHHHhccCcCCCCCC-----CHHHHHHH
Q 005749 618 IRSPMEEGLVQALKLAMGCCAPVASVRP-----TMDEVVKQ 653 (679)
Q Consensus 618 ~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~evl~~ 653 (679)
.........+++.+++.+||+.||++|+ ++.+++++
T Consensus 212 ~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 212 EIRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CCCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 0001112235677899999999999996 89998865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=324.48 Aligned_cols=249 Identities=22% Similarity=0.362 Sum_probs=203.2
Q ss_pred cCccccCCceEEEEEEeCCCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCCh
Q 005749 382 GQVIEKTTYGTAYKAKLADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRTL 461 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gsL 461 (679)
.+.||+|+||.||+|+..++..+|+|.+........+.+.+|+++++.++|+||+++++++.+ .+..++||||+++++|
T Consensus 11 ~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~e~~~~~~L 89 (261)
T cd05148 11 ERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSV-GEPVYIITELMEKGSL 89 (261)
T ss_pred hhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEec-CCCeEEEEeecccCCH
Confidence 478999999999999988899999999987655556789999999999999999999999987 6789999999999999
Q ss_pred HHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccchhc
Q 005749 462 HDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVA 541 (679)
Q Consensus 462 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 541 (679)
.++++... ...+++.++++++.|++.||+|||+++ |+||||||+||++++++.+||+|||.+......... ...
T Consensus 90 ~~~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~-~~~ 163 (261)
T cd05148 90 LAFLRSPE--GQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL-SSD 163 (261)
T ss_pred HHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCcccc-ccC
Confidence 99997643 345899999999999999999999988 999999999999999999999999999876432211 123
Q ss_pred ccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcCCC
Q 005749 542 LAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIRS 620 (679)
Q Consensus 542 ~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~~ 620 (679)
..++..|+|||.+....++.++||||||+++|||++ |+.||...... ...... ..+.+.
T Consensus 164 ~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~---~~~~~~-----------------~~~~~~ 223 (261)
T cd05148 164 KKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH---EVYDQI-----------------TAGYRM 223 (261)
T ss_pred CCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH---HHHHHH-----------------HhCCcC
Confidence 345678999999988889999999999999999998 89998543211 111110 111111
Q ss_pred -ChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhh
Q 005749 621 -PMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEEN 657 (679)
Q Consensus 621 -~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 657 (679)
........+.+++.+||+.||++|||++++++.|+.+
T Consensus 224 ~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 224 PCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 1122335677899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=337.37 Aligned_cols=256 Identities=21% Similarity=0.343 Sum_probs=199.8
Q ss_pred cCccccCCceEEEEEEeC------CCCEEEEEEcccCcc-cCcccHHHHHHHHhcc-CCCCCccceEEeeCCCCceEEEE
Q 005749 382 GQVIEKTTYGTAYKAKLA------DGATIALRLLREGSC-KDRSSCLPVIRQLGKV-RHENLIPLRAFYQGKRGEKLLIY 453 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~------~~~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~~lv~ 453 (679)
.++||+|+||.||+|+.. +++.||+|+++.... ...+.+.+|++++.++ +|+||++++++|.......+++|
T Consensus 12 ~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~~~v~ 91 (337)
T cd05054 12 GKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPLMVIV 91 (337)
T ss_pred hcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCEEEEE
Confidence 488999999999999732 247899999875432 2235678899999999 89999999999887567889999
Q ss_pred EecCCCChHHHhhcccCC---------------------------------------------------------CCCCC
Q 005749 454 DYFPSRTLHDLLHDTIAG---------------------------------------------------------KPVLN 476 (679)
Q Consensus 454 ey~~~gsL~~~l~~~~~~---------------------------------------------------------~~~l~ 476 (679)
||+++|+|.+++...... ...++
T Consensus 92 ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 171 (337)
T cd05054 92 EYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLT 171 (337)
T ss_pred ecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhhcCCC
Confidence 999999999998642110 12589
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCccccc-chhccccccccccccccc
Q 005749 477 WARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVAD-EMVALAKADGYKAPELQR 555 (679)
Q Consensus 477 ~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~ 555 (679)
|..+..++.||+.||+|||+++ |+||||||+||++++++.+||+|||+++.+...... ......++..|+|||++.
T Consensus 172 ~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 248 (337)
T cd05054 172 LEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIF 248 (337)
T ss_pred HHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcHHhc
Confidence 9999999999999999999987 999999999999999999999999999876432211 122334567899999999
Q ss_pred ccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcCCC-ChHHHHHHHHHHH
Q 005749 556 MKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIRS-PMEEGLVQALKLA 633 (679)
Q Consensus 556 ~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~~-~~~~~~~~~~~l~ 633 (679)
+..++.++|||||||++|||++ |+.||.+....+ .+. . .+..+... ......+++.+++
T Consensus 249 ~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~--~~~----~-------------~~~~~~~~~~~~~~~~~~~~l~ 309 (337)
T cd05054 249 DKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE--EFC----R-------------RLKEGTRMRAPEYATPEIYSIM 309 (337)
T ss_pred CCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH--HHH----H-------------HHhccCCCCCCccCCHHHHHHH
Confidence 9999999999999999999997 999985432211 010 0 01111111 0112345678999
Q ss_pred HhccCcCCCCCCCHHHHHHHHHhhCC
Q 005749 634 MGCCAPVASVRPTMDEVVKQLEENRP 659 (679)
Q Consensus 634 ~~cl~~dP~~RPs~~evl~~L~~~~~ 659 (679)
.+||+.+|++||++.|++++|+++..
T Consensus 310 ~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 310 LDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHccCChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=339.10 Aligned_cols=236 Identities=19% Similarity=0.268 Sum_probs=188.7
Q ss_pred CccccCCceEEEEEEe-CCCCEEEEEEcccCc---ccCcccHHHHHHHHhcc-CCCCCccceEEeeCCCCceEEEEEecC
Q 005749 383 QVIEKTTYGTAYKAKL-ADGATIALRLLREGS---CKDRSSCLPVIRQLGKV-RHENLIPLRAFYQGKRGEKLLIYDYFP 457 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~~lv~ey~~ 457 (679)
++||+|+||.||+|+. .+++.||+|+++... ....+.+..|++++..+ +||||+++++++.+ .+..++||||++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~-~~~~~iv~Ey~~ 79 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQT-PDRLFFVMEFVN 79 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEc-CCEEEEEEcCCC
Confidence 4699999999999995 468999999987532 23345677888888876 69999999999987 678999999999
Q ss_pred CCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCccccc
Q 005749 458 SRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVAD 537 (679)
Q Consensus 458 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 537 (679)
+|+|.+++... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++..... ..
T Consensus 80 ~g~L~~~i~~~----~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~-~~ 151 (320)
T cd05590 80 GGDLMFHIQKS----RRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN-GK 151 (320)
T ss_pred CchHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC-CC
Confidence 99999988753 45899999999999999999999988 999999999999999999999999998754222 12
Q ss_pred chhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhc
Q 005749 538 EMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKG 617 (679)
Q Consensus 538 ~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~ 617 (679)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...... ..+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~------~~~~~i--------------~~~ 211 (320)
T cd05590 152 TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED------DLFEAI--------------LND 211 (320)
T ss_pred cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH------HHHHHH--------------hcC
Confidence 233457899999999999888999999999999999999999999543221 111111 111
Q ss_pred CCCChHHHHHHHHHHHHhccCcCCCCCCCH
Q 005749 618 IRSPMEEGLVQALKLAMGCCAPVASVRPTM 647 (679)
Q Consensus 618 ~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~ 647 (679)
..........++.+++.+|++.||++||++
T Consensus 212 ~~~~~~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 212 EVVYPTWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred CCCCCCCCCHHHHHHHHHHcccCHHHCCCC
Confidence 111111223466789999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=339.40 Aligned_cols=242 Identities=17% Similarity=0.262 Sum_probs=192.2
Q ss_pred CccccCCceEEEEEEe-CCCCEEEEEEcccCc---ccCcccHHHHHHHHhcc-CCCCCccceEEeeCCCCceEEEEEecC
Q 005749 383 QVIEKTTYGTAYKAKL-ADGATIALRLLREGS---CKDRSSCLPVIRQLGKV-RHENLIPLRAFYQGKRGEKLLIYDYFP 457 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~~lv~ey~~ 457 (679)
++||+|+||.||+|+. .+++.||+|+++... ....+.+..|.+++..+ +||||+++++++.+ .+..++||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~-~~~~~lv~E~~~ 79 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQT-KDRLFFVMEYVN 79 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc-CCeEEEEEeCCC
Confidence 4699999999999995 458899999987542 23345677889988866 79999999999987 678999999999
Q ss_pred CCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCccccc
Q 005749 458 SRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVAD 537 (679)
Q Consensus 458 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 537 (679)
+|+|..++... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++..... ..
T Consensus 80 ~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~-~~ 151 (321)
T cd05591 80 GGDLMFQIQRS----RKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILN-GV 151 (321)
T ss_pred CCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccC-Cc
Confidence 99999988753 45899999999999999999999988 999999999999999999999999998754222 11
Q ss_pred chhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhc
Q 005749 538 EMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKG 617 (679)
Q Consensus 538 ~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~ 617 (679)
......||..|+|||++.+..++.++|||||||++|||++|+.||...... ...... ..+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~------~~~~~i--------------~~~ 211 (321)
T cd05591 152 TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED------DLFESI--------------LHD 211 (321)
T ss_pred cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH------HHHHHH--------------HcC
Confidence 223456899999999999889999999999999999999999999543221 111111 111
Q ss_pred CCCChHHHHHHHHHHHHhccCcCCCCCC-------CHHHHHHH
Q 005749 618 IRSPMEEGLVQALKLAMGCCAPVASVRP-------TMDEVVKQ 653 (679)
Q Consensus 618 ~~~~~~~~~~~~~~l~~~cl~~dP~~RP-------s~~evl~~ 653 (679)
..........++.+++.+|++.||++|| +++++++.
T Consensus 212 ~~~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 212 DVLYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 0011111234667899999999999999 77777755
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=342.24 Aligned_cols=269 Identities=21% Similarity=0.316 Sum_probs=212.3
Q ss_pred cccHHHHHHhhcCccccCCceEEEEEEe-CCCCEEEEEEcccCc---ccCcccHHHHHHHHhcc-CCCCCccceEEeeCC
Q 005749 371 HLTLEDVLNATGQVIEKTTYGTAYKAKL-ADGATIALRLLREGS---CKDRSSCLPVIRQLGKV-RHENLIPLRAFYQGK 445 (679)
Q Consensus 371 ~~~~~~l~~~~~~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~ 445 (679)
.++++++ ..-.++|+|.||+|+++.+ .+++.+|||++++.. .++.+....|.+|+... +||.+++++..|++
T Consensus 364 ~~~l~~F--~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT- 440 (694)
T KOG0694|consen 364 PLTLDDF--RLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQT- 440 (694)
T ss_pred cccccce--EEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccccc-
Confidence 5555655 2347999999999999994 568899999998863 45567788898888777 59999999999998
Q ss_pred CCceEEEEEecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeec
Q 005749 446 RGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEF 525 (679)
Q Consensus 446 ~~~~~lv~ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 525 (679)
.++.|.||||+.||++..+.+ ...+++.+++.||..|+.||+|||+++ ||+||||-+|||||.+|.+||+||
T Consensus 441 ~~~l~fvmey~~Ggdm~~~~~-----~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADF 512 (694)
T KOG0694|consen 441 KEHLFFVMEYVAGGDLMHHIH-----TDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADF 512 (694)
T ss_pred CCeEEEEEEecCCCcEEEEEe-----cccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEeccc
Confidence 789999999999999544443 345999999999999999999999999 999999999999999999999999
Q ss_pred ccccccCcccccchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhccc
Q 005749 526 GLDQLMVPAVADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEET 605 (679)
Q Consensus 526 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~ 605 (679)
|+++.... ......+++||+.|||||++.+..|+.+.|-|||||+||||+.|+.||.+.++++
T Consensus 513 GlcKe~m~-~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee---------------- 575 (694)
T KOG0694|consen 513 GLCKEGMG-QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEE---------------- 575 (694)
T ss_pred ccccccCC-CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHH----------------
Confidence 99996432 2335678899999999999999999999999999999999999999997655432
Q ss_pred ccccchHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCH-----HHHHHH----------H--HhhCCCCCCCCCCC
Q 005749 606 TMEVFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTM-----DEVVKQ----------L--EENRPRNRSALYSP 668 (679)
Q Consensus 606 ~~~~~~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~-----~evl~~----------L--~~~~~~~~~~~~~~ 668 (679)
++|.. .............+.+.++.+.+..+|++|--+ .+|.++ | +++.+...+.+..|
T Consensus 576 ---~FdsI-~~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~r~i~PPf~P~i~~~ 651 (694)
T KOG0694|consen 576 ---VFDSI-VNDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLLNRRIKPPFVPTIKGP 651 (694)
T ss_pred ---HHHHH-hcCCCCCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHHHhhccCCCCCCcccCCh
Confidence 22222 121111122234577789999999999999866 344332 2 33445566666666
Q ss_pred ccc
Q 005749 669 TET 671 (679)
Q Consensus 669 ~~~ 671 (679)
.+.
T Consensus 652 ~D~ 654 (694)
T KOG0694|consen 652 EDV 654 (694)
T ss_pred hhh
Confidence 543
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=326.57 Aligned_cols=252 Identities=21% Similarity=0.265 Sum_probs=196.9
Q ss_pred cCccccCCceEEEEEE-eCCCCEEEEEEcccCccc--------------CcccHHHHHHHHhccCCCCCccceEEeeCC-
Q 005749 382 GQVIEKTTYGTAYKAK-LADGATIALRLLREGSCK--------------DRSSCLPVIRQLGKVRHENLIPLRAFYQGK- 445 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~--------------~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~- 445 (679)
...||+|.||.|-+|+ ..+++.||||++.+.... ..+...+||.+|++++|||||+|+.+..++
T Consensus 102 ~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvLDDP~ 181 (576)
T KOG0585|consen 102 IKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVLDDPE 181 (576)
T ss_pred hhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEeecCcc
Confidence 3679999999999999 667999999999653211 124678999999999999999999988874
Q ss_pred CCceEEEEEecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeec
Q 005749 446 RGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEF 525 (679)
Q Consensus 446 ~~~~~lv~ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 525 (679)
.+.+|||+|||..|.+...=.. ...++..++++|++++..||+|||.++ ||||||||+|+|++++|++||+||
T Consensus 182 s~~~YlVley~s~G~v~w~p~d----~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g~VKIsDF 254 (576)
T KOG0585|consen 182 SDKLYLVLEYCSKGEVKWCPPD----KPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDGTVKISDF 254 (576)
T ss_pred cCceEEEEEeccCCccccCCCC----cccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCCcEEeecc
Confidence 4578999999998876532211 333899999999999999999999998 999999999999999999999999
Q ss_pred ccccccCcc----cccchhcccccccccccccccccC----CCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHH
Q 005749 526 GLDQLMVPA----VADEMVALAKADGYKAPELQRMKK----CSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIV 597 (679)
Q Consensus 526 Gla~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~----~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~ 597 (679)
|.+...... .........||+.|+|||+..++. .+.+.||||+||+||=|+.|+.||.+...
T Consensus 255 GVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~---------- 324 (576)
T KOG0585|consen 255 GVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE---------- 324 (576)
T ss_pred ceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH----------
Confidence 998765322 122234568999999999887632 36789999999999999999999954322
Q ss_pred HHHhhcccccccchHhhhhcCC-CChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCC
Q 005749 598 KVAVLEETTMEVFDMEIMKGIR-SPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRP 659 (679)
Q Consensus 598 ~~~~~~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 659 (679)
.+.+++.+-.... +..++......+++.++|.+||++|.+..+|..+.--...
T Consensus 325 ---------~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 325 ---------LELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred ---------HHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 1222222211111 2223445677789999999999999999999887755443
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=322.69 Aligned_cols=254 Identities=19% Similarity=0.272 Sum_probs=202.7
Q ss_pred cCccccCCceEEEEEE-eCCCCEEEEEEcccCcc---cCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecC
Q 005749 382 GQVIEKTTYGTAYKAK-LADGATIALRLLREGSC---KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFP 457 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~---~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~ 457 (679)
.+.||+|+||.||+|+ ..+++.||||.++.... .....+.+|++++++++||||+++++++.+ .+..++|+||++
T Consensus 7 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e~~~ 85 (267)
T cd08228 7 EKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIE-DNELNIVLELAD 85 (267)
T ss_pred eeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEE-CCeEEEEEEecC
Confidence 3789999999999999 45789999998764322 223468899999999999999999999887 678999999999
Q ss_pred CCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCccccc
Q 005749 458 SRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVAD 537 (679)
Q Consensus 458 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 537 (679)
+|+|.+++.........+++..+..++.|+++||+|||+++ ++||||||+||+++.++.++|+|||++....... .
T Consensus 86 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~-~ 161 (267)
T cd08228 86 AGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT-T 161 (267)
T ss_pred CCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccchh-H
Confidence 99999988654333456889999999999999999999988 9999999999999999999999999988764321 1
Q ss_pred chhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhc
Q 005749 538 EMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKG 617 (679)
Q Consensus 538 ~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~ 617 (679)
......++..|+|||.+.+..++.++||||||+++|||++|+.||...... ...+.... ...
T Consensus 162 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~----~~~~~~~~--------------~~~ 223 (267)
T cd08228 162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LFSLCQKI--------------EQC 223 (267)
T ss_pred HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc----HHHHHHHH--------------hcC
Confidence 223446888999999998888999999999999999999999998543211 11111111 111
Q ss_pred CCC--ChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhC
Q 005749 618 IRS--PMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENR 658 (679)
Q Consensus 618 ~~~--~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 658 (679)
..+ +.......+.+++.+||+.+|++||++.||++.+++++
T Consensus 224 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 224 DYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred CCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 111 11233456788999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=328.88 Aligned_cols=255 Identities=20% Similarity=0.339 Sum_probs=201.5
Q ss_pred cCccccCCceEEEEEEe------CCCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEe
Q 005749 382 GQVIEKTTYGTAYKAKL------ADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDY 455 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~------~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey 455 (679)
.+.||+|+||.||+++. .++..+|+|.+........+.+.+|++++++++||||+++++++.. .+..++||||
T Consensus 10 ~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~ 88 (288)
T cd05093 10 KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVE-GDPLIMVFEY 88 (288)
T ss_pred ccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CCccEEEEEc
Confidence 47899999999999984 2345789999876554456679999999999999999999999987 6789999999
Q ss_pred cCCCChHHHhhcccC---------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecc
Q 005749 456 FPSRTLHDLLHDTIA---------GKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFG 526 (679)
Q Consensus 456 ~~~gsL~~~l~~~~~---------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 526 (679)
+++++|.+++..... ....+++..++.++.|++.||+|||+++ ++||||||+||++++++.+||+|||
T Consensus 89 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg 165 (288)
T cd05093 89 MKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKIGDFG 165 (288)
T ss_pred CCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEeccCC
Confidence 999999999975321 1234899999999999999999999988 9999999999999999999999999
Q ss_pred cccccCccccc-chhcccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHHhhcc
Q 005749 527 LDQLMVPAVAD-EMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAVLEE 604 (679)
Q Consensus 527 la~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~~~~~ 604 (679)
+++........ ......++..|+|||++.+..++.++|||||||++|||++ |+.||......+ ....
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~------~~~~----- 234 (288)
T cd05093 166 MSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE------VIEC----- 234 (288)
T ss_pred ccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH------HHHH-----
Confidence 99865332211 1122335678999999998889999999999999999998 898985432211 1110
Q ss_pred cccccchHhhhhcCC-CChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCCC
Q 005749 605 TTMEVFDMEIMKGIR-SPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRPR 660 (679)
Q Consensus 605 ~~~~~~~~~i~~~~~-~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 660 (679)
+..+.. ........++.+++.+||+.||.+|||+.|+++.|+++...
T Consensus 235 ---------i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 235 ---------ITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred ---------HHcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 011100 00111235678899999999999999999999999998644
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=341.64 Aligned_cols=240 Identities=17% Similarity=0.197 Sum_probs=193.5
Q ss_pred cCccccCCceEEEEEEeCC--CCEEEEEEcccCc---ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEec
Q 005749 382 GQVIEKTTYGTAYKAKLAD--GATIALRLLREGS---CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYF 456 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~~--~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~ 456 (679)
.+.||+|+||.||+|+..+ +..||+|++.... ....+.+.+|+++++.++|||||++++++.+ .+..++||||+
T Consensus 35 ~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~-~~~~~lv~Ey~ 113 (340)
T PTZ00426 35 IRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKD-ESYLYLVLEFV 113 (340)
T ss_pred EEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEe-CCEEEEEEeCC
Confidence 4789999999999998543 3689999986432 2334568899999999999999999999987 67899999999
Q ss_pred CCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccc
Q 005749 457 PSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVA 536 (679)
Q Consensus 457 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 536 (679)
++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 114 ~~g~L~~~i~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~-- 184 (340)
T PTZ00426 114 IGGEFFTFLRRN----KRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR-- 184 (340)
T ss_pred CCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecCCC--
Confidence 999999999763 45899999999999999999999988 999999999999999999999999999865322
Q ss_pred cchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhh
Q 005749 537 DEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMK 616 (679)
Q Consensus 537 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~ 616 (679)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.+.... .... .+..
T Consensus 185 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~------~~~~--------------~i~~ 242 (340)
T PTZ00426 185 --TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL------LIYQ--------------KILE 242 (340)
T ss_pred --cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH------HHHH--------------HHhc
Confidence 23457899999999999888999999999999999999999999543211 0000 1111
Q ss_pred cCCCChHHHHHHHHHHHHhccCcCCCCCC-----CHHHHHHH
Q 005749 617 GIRSPMEEGLVQALKLAMGCCAPVASVRP-----TMDEVVKQ 653 (679)
Q Consensus 617 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~evl~~ 653 (679)
+.....+.....+.+++.+|++.||++|+ +++|+++.
T Consensus 243 ~~~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 243 GIIYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred CCCCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 11111111224566899999999999995 88888765
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=337.37 Aligned_cols=258 Identities=19% Similarity=0.295 Sum_probs=198.2
Q ss_pred CccccCCceEEEEEEe-CCCCEEEEEEcccCcc-cCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCC
Q 005749 383 QVIEKTTYGTAYKAKL-ADGATIALRLLREGSC-KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRT 460 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gs 460 (679)
+.||+|+||.||+++. .++..||+|.++.... ...+.+.+|++++++++||||+++++++.. .+..++||||+++|+
T Consensus 11 ~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~ 89 (331)
T cd06649 11 SELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-DGEISICMEHMDGGS 89 (331)
T ss_pred EeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE-CCEEEEEeecCCCCc
Confidence 6799999999999995 4688999999876422 234578999999999999999999999987 678999999999999
Q ss_pred hHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccchh
Q 005749 461 LHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMV 540 (679)
Q Consensus 461 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 540 (679)
|.+++... ..+++..+..++.|++.||.|||+.+ +|+||||||+|||++.++.+||+|||+++..... ...
T Consensus 90 L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---~~~ 160 (331)
T cd06649 90 LDQVLKEA----KRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MAN 160 (331)
T ss_pred HHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc---ccc
Confidence 99999763 35889999999999999999999853 2999999999999999999999999998765332 123
Q ss_pred cccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcc----------------
Q 005749 541 ALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEE---------------- 604 (679)
Q Consensus 541 ~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~---------------- 604 (679)
...|+..|+|||++.+..++.++|||||||++|||++|+.||......+ +...........
T Consensus 161 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (331)
T cd06649 161 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE---LEAIFGRPVVDGEEGEPHSISPRPRPPG 237 (331)
T ss_pred cCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHhcccccccccCCccccCccccccc
Confidence 4568999999999998899999999999999999999999995432211 111110000000
Q ss_pred --------------cccccchHhhhhcCCCC--hHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 005749 605 --------------TTMEVFDMEIMKGIRSP--MEEGLVQALKLAMGCCAPVASVRPTMDEVVKQL 654 (679)
Q Consensus 605 --------------~~~~~~~~~i~~~~~~~--~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L 654 (679)
...+..+. +.....+. ......++.+++.+||+.||++|||++|+++.-
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~ 302 (331)
T cd06649 238 RPVSGHGMDSRPAMAIFELLDY-IVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT 302 (331)
T ss_pred ccccccccccccchhHHHHHHH-HHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 00000000 11111111 112345788999999999999999999999874
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=326.98 Aligned_cols=250 Identities=19% Similarity=0.337 Sum_probs=199.1
Q ss_pred CccccCCceEEEEEEeCC------CCEEEEEEcccCccc-CcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEe
Q 005749 383 QVIEKTTYGTAYKAKLAD------GATIALRLLREGSCK-DRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDY 455 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~~~------~~~vAvK~~~~~~~~-~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey 455 (679)
+.||+|+||.||+|+..+ +..||+|.++..... ..+.+.+|++++++++|+||+++++++.. ....++||||
T Consensus 11 ~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~e~ 89 (280)
T cd05049 11 RELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTE-GDPPIMVFEY 89 (280)
T ss_pred hhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEec-CCCeEEEEec
Confidence 789999999999998533 478999998765433 35689999999999999999999999987 5789999999
Q ss_pred cCCCChHHHhhcccC----------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeec
Q 005749 456 FPSRTLHDLLHDTIA----------GKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEF 525 (679)
Q Consensus 456 ~~~gsL~~~l~~~~~----------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 525 (679)
+++++|.+++..... ....+++..+..++.|++.|++|||+++ ++||||||+||+++.++.+||+||
T Consensus 90 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~kl~d~ 166 (280)
T cd05049 90 MEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVVKIGDF 166 (280)
T ss_pred CCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeEEECCc
Confidence 999999999975421 1345889999999999999999999988 999999999999999999999999
Q ss_pred ccccccCccccc-chhcccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHHhhc
Q 005749 526 GLDQLMVPAVAD-EMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAVLE 603 (679)
Q Consensus 526 Gla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~~~~ 603 (679)
|+++........ ......+++.|+|||++.+..+++++|||||||++|||++ |+.||......+ .....
T Consensus 167 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~---~~~~~------ 237 (280)
T cd05049 167 GMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE---VIECI------ 237 (280)
T ss_pred ccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHH------
Confidence 998765322111 1123345678999999999999999999999999999998 999985432211 11111
Q ss_pred ccccccchHhhhhcCC-CChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHh
Q 005749 604 ETTMEVFDMEIMKGIR-SPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEE 656 (679)
Q Consensus 604 ~~~~~~~~~~i~~~~~-~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 656 (679)
..+.. .........+.+++.+||+.||++||++.||++.|++
T Consensus 238 -----------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 238 -----------TQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred -----------HcCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 11111 1112233567789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=334.34 Aligned_cols=241 Identities=19% Similarity=0.284 Sum_probs=189.8
Q ss_pred CccccCCceEEEEEEe-CCCCEEEEEEcccCc---ccCcccHHHHHHHHhcc-CCCCCccceEEeeCCCCceEEEEEecC
Q 005749 383 QVIEKTTYGTAYKAKL-ADGATIALRLLREGS---CKDRSSCLPVIRQLGKV-RHENLIPLRAFYQGKRGEKLLIYDYFP 457 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~~lv~ey~~ 457 (679)
+.||+|+||+||+|+. .+++.||+|+++... ....+.+..|..++... +||||+++++++.+ .+..++||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~-~~~~~lv~ey~~ 79 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQT-KENLFFVMEYLN 79 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEe-CCEEEEEEeCCC
Confidence 4699999999999995 458899999987642 22344567788888764 89999999999987 678999999999
Q ss_pred CCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCccccc
Q 005749 458 SRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVAD 537 (679)
Q Consensus 458 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 537 (679)
+|+|.+++... ..+++.++..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++..... ..
T Consensus 80 ~g~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~ 151 (316)
T cd05619 80 GGDLMFHIQSC----HKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLG-DA 151 (316)
T ss_pred CCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCC-CC
Confidence 99999999753 35889999999999999999999988 999999999999999999999999998753221 11
Q ss_pred chhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhc
Q 005749 538 EMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKG 617 (679)
Q Consensus 538 ~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~ 617 (679)
......||..|+|||++.+..++.++|||||||++|||++|+.||...... .+...+. ..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~---~~~~~i~-----------------~~ 211 (316)
T cd05619 152 KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE---ELFQSIR-----------------MD 211 (316)
T ss_pred ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH---HHHHHHH-----------------hC
Confidence 223456899999999999889999999999999999999999999543221 1111100 00
Q ss_pred CCCChHHHHHHHHHHHHhccCcCCCCCCCHH-HHHH
Q 005749 618 IRSPMEEGLVQALKLAMGCCAPVASVRPTMD-EVVK 652 (679)
Q Consensus 618 ~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~-evl~ 652 (679)
..........++.+++.+||+.||++||++. ++.+
T Consensus 212 ~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 212 NPCYPRWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred CCCCCccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 0000111234567899999999999999997 6644
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=321.09 Aligned_cols=247 Identities=23% Similarity=0.341 Sum_probs=194.1
Q ss_pred CccccCCceEEEEEEe-CCCCEEEEEEcccCc-ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCC
Q 005749 383 QVIEKTTYGTAYKAKL-ADGATIALRLLREGS-CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRT 460 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gs 460 (679)
+.||+|+||.||+|+. .+++.||+|.+.... ......+.+|++++++++||||+++++++.. .+..++||||+++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~ 79 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ-KQPIYIVMELVQGGD 79 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCeEEEEeeccCCc
Confidence 4699999999999995 579999999886542 2234578999999999999999999999987 678999999999999
Q ss_pred hHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccch-
Q 005749 461 LHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEM- 539 (679)
Q Consensus 461 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~- 539 (679)
|.+++... ...+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+|++|||++...........
T Consensus 80 L~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 153 (252)
T cd05084 80 FLTFLRTE---GPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTG 153 (252)
T ss_pred HHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccC
Confidence 99999753 245899999999999999999999988 99999999999999999999999999876532211110
Q ss_pred hcccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcC
Q 005749 540 VALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGI 618 (679)
Q Consensus 540 ~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~ 618 (679)
.....+..|+|||.+.++.++.++||||||+++|||++ |..||...... ....... ...
T Consensus 154 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~-------~~~~~~~-------------~~~ 213 (252)
T cd05084 154 GMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ-------QTREAIE-------------QGV 213 (252)
T ss_pred CCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH-------HHHHHHH-------------cCC
Confidence 11123456999999988889999999999999999997 88888432211 0011100 000
Q ss_pred C-CChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHh
Q 005749 619 R-SPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEE 656 (679)
Q Consensus 619 ~-~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 656 (679)
. .........+.+++.+||+.+|++|||+.|+.+.|++
T Consensus 214 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 252 (252)
T cd05084 214 RLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQS 252 (252)
T ss_pred CCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhC
Confidence 1 1111223567789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=337.11 Aligned_cols=249 Identities=17% Similarity=0.231 Sum_probs=192.1
Q ss_pred CccccCCceEEEEEEe-CCCCEEEEEEcccCcc---cCcccHHHHHHHHhcc-CCCCCccceEEeeCCCCceEEEEEecC
Q 005749 383 QVIEKTTYGTAYKAKL-ADGATIALRLLREGSC---KDRSSCLPVIRQLGKV-RHENLIPLRAFYQGKRGEKLLIYDYFP 457 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~---~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~~lv~ey~~ 457 (679)
++||+|+||.||+|+. .+++.||+|+++.... ...+.+.+|+.++.++ +|||||++++++.+ .+..++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~-~~~~~lv~E~~~ 79 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT-ESRLFFVIEYVN 79 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEe-CCEEEEEEeCCC
Confidence 4699999999999994 5688999999976422 2234577888888877 89999999999987 678999999999
Q ss_pred CCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCccccc
Q 005749 458 SRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVAD 537 (679)
Q Consensus 458 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 537 (679)
+|+|.+++... ..+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++..... ..
T Consensus 80 ~~~L~~~~~~~----~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~-~~ 151 (329)
T cd05618 80 GGDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-GD 151 (329)
T ss_pred CCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCC-CC
Confidence 99999888653 45899999999999999999999988 999999999999999999999999998754221 12
Q ss_pred chhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCc--ccchhHHHHHHhhcccccccchHhhh
Q 005749 538 EMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGE--FVDLPSIVKVAVLEETTMEVFDMEIM 615 (679)
Q Consensus 538 ~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~--~~~l~~~~~~~~~~~~~~~~~~~~i~ 615 (679)
......||..|+|||++.+..++.++|||||||++|||++|+.||....... ......+.... +.
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~-------------i~ 218 (329)
T cd05618 152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV-------------IL 218 (329)
T ss_pred ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHH-------------Hh
Confidence 2234578999999999999999999999999999999999999995321111 01111111111 11
Q ss_pred hcCCCChHHHHHHHHHHHHhccCcCCCCCCC------HHHHHHH
Q 005749 616 KGIRSPMEEGLVQALKLAMGCCAPVASVRPT------MDEVVKQ 653 (679)
Q Consensus 616 ~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs------~~evl~~ 653 (679)
............++.+++.+||+.||++||+ +.+++++
T Consensus 219 ~~~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 219 EKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred cCCCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 1111111122356678999999999999998 4566544
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=322.91 Aligned_cols=249 Identities=24% Similarity=0.421 Sum_probs=198.4
Q ss_pred cCccccCCceEEEEEEeCC----CCEEEEEEcccCcc-cCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEec
Q 005749 382 GQVIEKTTYGTAYKAKLAD----GATIALRLLREGSC-KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYF 456 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~~----~~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~ 456 (679)
.+.||+|+||.||+|+... ...||||.++.... .....|.+|+.++++++||||+++++++.. .+..++||||+
T Consensus 9 ~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~iv~e~~ 87 (266)
T cd05033 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTK-SRPVMIITEYM 87 (266)
T ss_pred eeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEec-CCceEEEEEcC
Confidence 4789999999999998642 45899999876432 234578999999999999999999999887 67899999999
Q ss_pred CCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccc
Q 005749 457 PSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVA 536 (679)
Q Consensus 457 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 536 (679)
++++|.+++... ...+++..+++++.|++.||+|||+++ |+||||||+||++++++.+|++|||+++.......
T Consensus 88 ~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (266)
T cd05033 88 ENGSLDKFLREN---DGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEA 161 (266)
T ss_pred CCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhccccccc
Confidence 999999999764 235899999999999999999999988 99999999999999999999999999987642111
Q ss_pred -cchhcccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHHhhcccccccchHhh
Q 005749 537 -DEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEI 614 (679)
Q Consensus 537 -~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i 614 (679)
.......++..|+|||.+.+..++.++||||||+++|||++ |..||...... ......
T Consensus 162 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~---~~~~~~----------------- 221 (266)
T cd05033 162 TYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ---DVIKAV----------------- 221 (266)
T ss_pred ceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH---HHHHHH-----------------
Confidence 11122344678999999998889999999999999999998 99998443221 111110
Q ss_pred hhcCC-CChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhh
Q 005749 615 MKGIR-SPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEEN 657 (679)
Q Consensus 615 ~~~~~-~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 657 (679)
..+.. +........+.+++.+||+.+|++||+++||++.|+++
T Consensus 222 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 222 EDGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred HcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11111 11112335677999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=340.37 Aligned_cols=247 Identities=21% Similarity=0.248 Sum_probs=196.7
Q ss_pred CccccCCceEEEEEEeC-CCCEEEEEEcccCc---ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCC
Q 005749 383 QVIEKTTYGTAYKAKLA-DGATIALRLLREGS---CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPS 458 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~ 458 (679)
+.||+|+||.||+|+.. +++.||+|+++... ....+.+.+|++++..++||||+++++++.+ .+..++||||+++
T Consensus 7 ~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~-~~~~~lv~e~~~g 85 (333)
T cd05600 7 TQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQD-DEYLYLAMEYVPG 85 (333)
T ss_pred EEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEc-CCEEEEEEeCCCC
Confidence 68999999999999954 58999999997542 2234568899999999999999999999987 6789999999999
Q ss_pred CChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccc
Q 005749 459 RTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADE 538 (679)
Q Consensus 459 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 538 (679)
|+|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.... .
T Consensus 86 ~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~----~ 154 (333)
T cd05600 86 GDFRTLLNNL----GVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT----Y 154 (333)
T ss_pred CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc----c
Confidence 9999999753 45889999999999999999999988 99999999999999999999999999986532 2
Q ss_pred hhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcC
Q 005749 539 MVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGI 618 (679)
Q Consensus 539 ~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~ 618 (679)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. ..+. .. ...+... ..
T Consensus 155 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~---~~i~---~~---~~~~~~~---~~ 222 (333)
T cd05600 155 ANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETW---ENLK---YW---KETLQRP---VY 222 (333)
T ss_pred cCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHH---HHHH---hc---cccccCC---CC
Confidence 23457899999999999889999999999999999999999999543221110 0000 00 0000000 00
Q ss_pred CCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 619 RSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 619 ~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
..+......++.+++.+||..+|++||+++|+++.
T Consensus 223 ~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 223 DDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 00011234567789999999999999999999976
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=319.84 Aligned_cols=246 Identities=24% Similarity=0.350 Sum_probs=196.4
Q ss_pred CccccCCceEEEEEEeCCCCEEEEEEcccCcc-cCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCCh
Q 005749 383 QVIEKTTYGTAYKAKLADGATIALRLLREGSC-KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRTL 461 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~~~~~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gsL 461 (679)
++||+|+||.||+|...+++.||+|.++.... .....+.+|++++++++||||+++++++.. .+..++||||+++++|
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L 79 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQ-RQPIYIVMELVPGGDF 79 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEec-CCccEEEEECCCCCcH
Confidence 47999999999999988899999999876532 223468899999999999999999999987 6789999999999999
Q ss_pred HHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccchhc
Q 005749 462 HDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVA 541 (679)
Q Consensus 462 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 541 (679)
.+++... ...+++..++.++.|++.||.|+|+++ ++||||||+||++++++.+|++|||++.............
T Consensus 80 ~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~ 153 (250)
T cd05085 80 LSFLRKK---KDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGL 153 (250)
T ss_pred HHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccccCCC
Confidence 9998653 235889999999999999999999988 9999999999999999999999999987643322222222
Q ss_pred ccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcCC-
Q 005749 542 LAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIR- 619 (679)
Q Consensus 542 ~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~- 619 (679)
..++..|+|||++.+..++.++||||||+++||+++ |..||...... .. . ... ..+.+
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~---~~---~-~~~-------------~~~~~~ 213 (250)
T cd05085 154 KQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ---QA---R-EQV-------------EKGYRM 213 (250)
T ss_pred CCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH---HH---H-HHH-------------HcCCCC
Confidence 344567999999988889999999999999999998 99998543211 00 0 000 01100
Q ss_pred CChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHH
Q 005749 620 SPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLE 655 (679)
Q Consensus 620 ~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~ 655 (679)
.........+.+++.+||+.+|++||++.|+++.|.
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 214 SCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 001122356778999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=328.17 Aligned_cols=255 Identities=20% Similarity=0.328 Sum_probs=202.4
Q ss_pred cCccccCCceEEEEEEeC------CCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEe
Q 005749 382 GQVIEKTTYGTAYKAKLA------DGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDY 455 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~------~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey 455 (679)
.+.||+|+||.||+|+.. ++..+|+|.+........+.+.+|++++++++|+||+++++++.. .+..++||||
T Consensus 10 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~ 88 (291)
T cd05094 10 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGD-GDPLIMVFEY 88 (291)
T ss_pred eeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEcc-CCceEEEEec
Confidence 378999999999999742 355799999876554455679999999999999999999999987 6789999999
Q ss_pred cCCCChHHHhhcccC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEe
Q 005749 456 FPSRTLHDLLHDTIA------------GKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLT 523 (679)
Q Consensus 456 ~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~ 523 (679)
+++++|.+++..... ....+++..++.++.|++.||+|||+++ |+||||||+||++++++.+||+
T Consensus 89 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~ 165 (291)
T cd05094 89 MKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLLVKIG 165 (291)
T ss_pred CCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEEC
Confidence 999999999975321 1234899999999999999999999988 9999999999999999999999
Q ss_pred ecccccccCccccc-chhcccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHHh
Q 005749 524 EFGLDQLMVPAVAD-EMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAV 601 (679)
Q Consensus 524 DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~~ 601 (679)
|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |+.||......+ .....
T Consensus 166 dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~------~~~~~- 238 (291)
T cd05094 166 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE------VIECI- 238 (291)
T ss_pred CCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHH-
Confidence 99999765432211 1223346778999999998889999999999999999999 999984432211 11110
Q ss_pred hcccccccchHhhhhcCCC-ChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCCC
Q 005749 602 LEETTMEVFDMEIMKGIRS-PMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRPR 660 (679)
Q Consensus 602 ~~~~~~~~~~~~i~~~~~~-~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 660 (679)
..+... ........+.+++.+||+.+|++||++++|++.|+++.+.
T Consensus 239 -------------~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 239 -------------TQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred -------------hCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 111000 1112235677899999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=335.77 Aligned_cols=245 Identities=17% Similarity=0.299 Sum_probs=207.7
Q ss_pred CccccCCceEEEEEE-eCCCCEEEEEEcccCcc--cCcccHHHHHHHHhccCCCCCccceEEeeCCCCc-eEEEEEecCC
Q 005749 383 QVIEKTTYGTAYKAK-LADGATIALRLLREGSC--KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGE-KLLIYDYFPS 458 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~-~~lv~ey~~~ 458 (679)
+++|+|+||.++..+ ..+++.+++|.+..... ..++....|+.++++++|||||.+++.|.. ++. .+|||+||+|
T Consensus 10 ~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~-~~~~l~Ivm~Y~eG 88 (426)
T KOG0589|consen 10 RQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEE-DGQLLCIVMEYCEG 88 (426)
T ss_pred hhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhc-CCceEEEEEeecCC
Confidence 789999999999998 45688999999976543 345578999999999999999999999998 455 9999999999
Q ss_pred CChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccc
Q 005749 459 RTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADE 538 (679)
Q Consensus 459 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 538 (679)
|++.+.+...+ +..+++.++.+++.|++.|++|||+++ |+|||||+.||++..+..+||+|||+|+.+.+.. ..
T Consensus 89 g~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~-~~ 162 (426)
T KOG0589|consen 89 GDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED-SL 162 (426)
T ss_pred CCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCch-hh
Confidence 99999998764 466999999999999999999999888 9999999999999999999999999999986553 23
Q ss_pred hhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcC
Q 005749 539 MVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGI 618 (679)
Q Consensus 539 ~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~ 618 (679)
..+..||+.||.||.+.+.+|+.|+||||+||++|||++-+++|...+.. ..+ .++..+.
T Consensus 163 a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~------~Li--------------~ki~~~~ 222 (426)
T KOG0589|consen 163 ASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMS------ELI--------------LKINRGL 222 (426)
T ss_pred hheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchH------HHH--------------HHHhhcc
Confidence 45678999999999999999999999999999999999999999543221 111 1223332
Q ss_pred -CCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 005749 619 -RSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQL 654 (679)
Q Consensus 619 -~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L 654 (679)
.+-...+..++..++..|++.+|+.||++.+++.+-
T Consensus 223 ~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P 259 (426)
T KOG0589|consen 223 YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRRP 259 (426)
T ss_pred CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhCh
Confidence 233445667788899999999999999999999873
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=336.35 Aligned_cols=249 Identities=17% Similarity=0.228 Sum_probs=193.3
Q ss_pred CccccCCceEEEEEEe-CCCCEEEEEEcccCcc---cCcccHHHHHHHHhcc-CCCCCccceEEeeCCCCceEEEEEecC
Q 005749 383 QVIEKTTYGTAYKAKL-ADGATIALRLLREGSC---KDRSSCLPVIRQLGKV-RHENLIPLRAFYQGKRGEKLLIYDYFP 457 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~---~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~~lv~ey~~ 457 (679)
++||+|+||.||+|+. .+++.||+|+++.... ...+.+.+|+.++.++ +||||+++++++.+ .+..++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~-~~~~~lv~e~~~ 79 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQT-ESRLFFVIEFVS 79 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEc-CCEEEEEEeCCC
Confidence 4699999999999994 5689999999976422 2234578899999988 79999999999987 678999999999
Q ss_pred CCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCccccc
Q 005749 458 SRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVAD 537 (679)
Q Consensus 458 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 537 (679)
+|+|.+++... ..+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++..... ..
T Consensus 80 ~g~L~~~~~~~----~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-~~ 151 (329)
T cd05588 80 GGDLMFHMQRQ----RKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP-GD 151 (329)
T ss_pred CCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccC-CC
Confidence 99999988653 45899999999999999999999988 999999999999999999999999998753211 12
Q ss_pred chhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCc--ccchhHHHHHHhhcccccccchHhhh
Q 005749 538 EMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGE--FVDLPSIVKVAVLEETTMEVFDMEIM 615 (679)
Q Consensus 538 ~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~--~~~l~~~~~~~~~~~~~~~~~~~~i~ 615 (679)
......||..|+|||++.+..++.++|||||||++|||++|+.||......+ ......+.... +.
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~-------------~~ 218 (329)
T cd05588 152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQV-------------IL 218 (329)
T ss_pred ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHH-------------HH
Confidence 2334578999999999999899999999999999999999999995322111 01111111111 11
Q ss_pred hcCCCChHHHHHHHHHHHHhccCcCCCCCCC------HHHHHHH
Q 005749 616 KGIRSPMEEGLVQALKLAMGCCAPVASVRPT------MDEVVKQ 653 (679)
Q Consensus 616 ~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs------~~evl~~ 653 (679)
............++.+++.+|++.||++||+ ++++++.
T Consensus 219 ~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 219 EKQIRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred cCCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 1111111122356778999999999999997 5677643
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=321.77 Aligned_cols=245 Identities=20% Similarity=0.355 Sum_probs=195.6
Q ss_pred cCccccCCceEEEEEEeCCCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCCh
Q 005749 382 GQVIEKTTYGTAYKAKLADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRTL 461 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gsL 461 (679)
.+.||+|+||.||+|+.+++..+|+|.+.... ...+.+.+|++++++++||||+++++++.. .+..++||||+++++|
T Consensus 9 ~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~e~~~~~~L 86 (256)
T cd05059 9 LKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTK-QRPIFIVTEYMANGCL 86 (256)
T ss_pred hhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcC-CCceEEEEecCCCCCH
Confidence 47899999999999998778899999986532 234578899999999999999999999887 6789999999999999
Q ss_pred HHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccchhc
Q 005749 462 HDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVA 541 (679)
Q Consensus 462 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 541 (679)
.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++............
T Consensus 87 ~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~~ 160 (256)
T cd05059 87 LNYLRER---KGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQG 160 (256)
T ss_pred HHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccccccCC
Confidence 9999754 235899999999999999999999988 9999999999999999999999999988654322111122
Q ss_pred ccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcCC-
Q 005749 542 LAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIR- 619 (679)
Q Consensus 542 ~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~- 619 (679)
..++..|+|||.+.+..++.++||||||+++||+++ |+.||......+ ....+ ..+.+
T Consensus 161 ~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~~-----------------~~~~~~ 220 (256)
T cd05059 161 TKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE---VVESV-----------------SAGYRL 220 (256)
T ss_pred CCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH---HHHHH-----------------HcCCcC
Confidence 234457999999998899999999999999999998 788985432211 11100 01100
Q ss_pred CChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 005749 620 SPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQL 654 (679)
Q Consensus 620 ~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L 654 (679)
........++.+++.+||..+|++|||+.|+++.|
T Consensus 221 ~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 221 YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 00112345678899999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=336.04 Aligned_cols=241 Identities=21% Similarity=0.292 Sum_probs=189.1
Q ss_pred CccccCCceEEEEEEe-CCCCEEEEEEcccCc---ccCcccHHHHHHHH---hccCCCCCccceEEeeCCCCceEEEEEe
Q 005749 383 QVIEKTTYGTAYKAKL-ADGATIALRLLREGS---CKDRSSCLPVIRQL---GKVRHENLIPLRAFYQGKRGEKLLIYDY 455 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l---~~l~H~nIv~l~~~~~~~~~~~~lv~ey 455 (679)
+.||+|+||.||+|+. .+++.||||+++... ....+.+.+|++++ ++++||||+++++++.. .+..++||||
T Consensus 5 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~-~~~~~lv~E~ 83 (324)
T cd05589 5 AVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQT-EDHVCFVMEY 83 (324)
T ss_pred EEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEc-CCEEEEEEcC
Confidence 6799999999999994 568999999997542 22234566666654 56789999999999987 6789999999
Q ss_pred cCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCccc
Q 005749 456 FPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAV 535 (679)
Q Consensus 456 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 535 (679)
+++|+|..+++. ..+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++.....
T Consensus 84 ~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~- 154 (324)
T cd05589 84 AAGGDLMMHIHT-----DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF- 154 (324)
T ss_pred CCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCCC-
Confidence 999999988864 35899999999999999999999988 999999999999999999999999998754222
Q ss_pred ccchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhh
Q 005749 536 ADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIM 615 (679)
Q Consensus 536 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~ 615 (679)
........|++.|+|||.+.+..++.++|||||||++|||++|+.||.+.... ..... +.
T Consensus 155 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~------~~~~~--------------i~ 214 (324)
T cd05589 155 GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE------EVFDS--------------IV 214 (324)
T ss_pred CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH------HHHHH--------------HH
Confidence 12233457899999999999889999999999999999999999999543221 11111 11
Q ss_pred hcCCCChHHHHHHHHHHHHhccCcCCCCCC-----CHHHHHHH
Q 005749 616 KGIRSPMEEGLVQALKLAMGCCAPVASVRP-----TMDEVVKQ 653 (679)
Q Consensus 616 ~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~evl~~ 653 (679)
.+...........+.+++.+||+.||++|| ++.++++.
T Consensus 215 ~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 215 NDEVRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred hCCCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 111111112235567899999999999999 46666653
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=336.76 Aligned_cols=237 Identities=24% Similarity=0.291 Sum_probs=186.8
Q ss_pred CccccCCceEEEEEEe-CCCCEEEEEEcccCcc---cCcccHHHHHH-HHhccCCCCCccceEEeeCCCCceEEEEEecC
Q 005749 383 QVIEKTTYGTAYKAKL-ADGATIALRLLREGSC---KDRSSCLPVIR-QLGKVRHENLIPLRAFYQGKRGEKLLIYDYFP 457 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~---~~~~~~~~Ei~-~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~ 457 (679)
++||+|+||+||+|+. .+|+.||+|++..... .....+..|.. +++.++||||+++++++.. .+..++||||++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~-~~~~~lv~e~~~ 79 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT-ADKLYFVLDYVN 79 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEe-CCEEEEEEcCCC
Confidence 4699999999999995 5799999999875321 22334555555 4578999999999999887 678999999999
Q ss_pred CCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCccccc
Q 005749 458 SRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVAD 537 (679)
Q Consensus 458 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 537 (679)
+|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++..... ..
T Consensus 80 ~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~-~~ 151 (323)
T cd05575 80 GGELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH-SK 151 (323)
T ss_pred CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccC-CC
Confidence 9999999875 345889999999999999999999988 999999999999999999999999998754222 12
Q ss_pred chhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhc
Q 005749 538 EMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKG 617 (679)
Q Consensus 538 ~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~ 617 (679)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.... +..... ..+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~------~~~~~i--------------~~~ 211 (323)
T cd05575 152 TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA------EMYDNI--------------LNK 211 (323)
T ss_pred ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHH------HHHHHH--------------HcC
Confidence 233457899999999999889999999999999999999999999543211 111111 111
Q ss_pred CCCChHHHHHHHHHHHHhccCcCCCCCCCHH
Q 005749 618 IRSPMEEGLVQALKLAMGCCAPVASVRPTMD 648 (679)
Q Consensus 618 ~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ 648 (679)
.....+.....+.+++.+|++.||++||++.
T Consensus 212 ~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 212 PLRLKPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCCCCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 0011112245677899999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=335.88 Aligned_cols=240 Identities=19% Similarity=0.256 Sum_probs=189.5
Q ss_pred CccccCCceEEEEEEe-CCCCEEEEEEcccCc---ccCcccHHHHHHHHhcc-CCCCCccceEEeeCCCCceEEEEEecC
Q 005749 383 QVIEKTTYGTAYKAKL-ADGATIALRLLREGS---CKDRSSCLPVIRQLGKV-RHENLIPLRAFYQGKRGEKLLIYDYFP 457 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~~lv~ey~~ 457 (679)
++||+|+||.||+|+. .+|+.||+|.++... ....+.+..|.+++... +||||+++++++.+ .+..++||||++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-~~~~~lv~E~~~ 79 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQT-KEHLFFVMEFLN 79 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEe-CCEEEEEECCCC
Confidence 4699999999999995 468999999997542 22345567788888754 89999999999987 678999999999
Q ss_pred CCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCccccc
Q 005749 458 SRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVAD 537 (679)
Q Consensus 458 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 537 (679)
+|+|.+++... ..+++.++..++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+++..... ..
T Consensus 80 ~g~L~~~i~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~ 151 (316)
T cd05620 80 GGDLMFHIQDK----GRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG-DN 151 (316)
T ss_pred CCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccC-CC
Confidence 99999998753 45889999999999999999999988 999999999999999999999999998743211 12
Q ss_pred chhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhc
Q 005749 538 EMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKG 617 (679)
Q Consensus 538 ~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~ 617 (679)
......||..|+|||++.+..++.++||||+||++|||++|+.||.+.... ...... ...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~------~~~~~~--------------~~~ 211 (316)
T cd05620 152 RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED------ELFESI--------------RVD 211 (316)
T ss_pred ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH------HHHHHH--------------HhC
Confidence 233457899999999999889999999999999999999999999543211 111110 000
Q ss_pred CCCChHHHHHHHHHHHHhccCcCCCCCCCHH-HHH
Q 005749 618 IRSPMEEGLVQALKLAMGCCAPVASVRPTMD-EVV 651 (679)
Q Consensus 618 ~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~-evl 651 (679)
..........++.+++.+||+.||++||++. +++
T Consensus 212 ~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 212 TPHYPRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 0001111234567899999999999999984 555
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=336.16 Aligned_cols=260 Identities=20% Similarity=0.313 Sum_probs=192.6
Q ss_pred cCccccCCceEEEEEE-eCCCCEEEEEEcccCc--ccCcccHHHHHHHHhccCCCCCccceEEeeCCC----CceEEEEE
Q 005749 382 GQVIEKTTYGTAYKAK-LADGATIALRLLREGS--CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKR----GEKLLIYD 454 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~----~~~~lv~e 454 (679)
.+.||+|+||.||+|+ ..+++.||||+++... ......+.+|++++++++||||+++++++.... ...++|||
T Consensus 5 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e 84 (338)
T cd07859 5 QEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFE 84 (338)
T ss_pred EEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEEEe
Confidence 3689999999999999 5579999999987532 223456889999999999999999999886422 24799999
Q ss_pred ecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcc
Q 005749 455 YFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPA 534 (679)
Q Consensus 455 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 534 (679)
||. ++|.+++... ..+++..+..++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 85 ~~~-~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 156 (338)
T cd07859 85 LME-SDLHQVIKAN----DDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFND 156 (338)
T ss_pred cCC-CCHHHHHHhc----ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCccccccccc
Confidence 996 6899988753 45899999999999999999999988 999999999999999999999999999864322
Q ss_pred ccc--chhcccccccccccccccc--cCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhc-------
Q 005749 535 VAD--EMVALAKADGYKAPELQRM--KKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLE------- 603 (679)
Q Consensus 535 ~~~--~~~~~~gt~~y~aPE~~~~--~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~------- 603 (679)
... ......|+..|+|||++.+ ..++.++|||||||++|||++|+.||.+...... ...+......
T Consensus 157 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~ 233 (338)
T cd07859 157 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQ---LDLITDLLGTPSPETIS 233 (338)
T ss_pred cCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHH---HHHHHHHhCCCCHHHHH
Confidence 111 1234568999999998865 6789999999999999999999999955332111 0111000000
Q ss_pred ----ccccccchHhhhhcCCCChH----HHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 604 ----ETTMEVFDMEIMKGIRSPME----EGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 604 ----~~~~~~~~~~i~~~~~~~~~----~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
....+.+. .+......+.. ...+.+.+++.+||+.||++|||++|+++.
T Consensus 234 ~i~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 234 RVRNEKARRYLS-SMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HhhhhhHHHHHH-hhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 00000000 00000001111 123456789999999999999999999976
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=324.22 Aligned_cols=251 Identities=19% Similarity=0.352 Sum_probs=195.2
Q ss_pred cCccccCCceEEEEEEe-CCCC----EEEEEEcccCcc-cCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEe
Q 005749 382 GQVIEKTTYGTAYKAKL-ADGA----TIALRLLREGSC-KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDY 455 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~-~~~~----~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey 455 (679)
.+.||+|+||+||+|+. .+++ .||+|.+..... ....++..|+..+++++||||+++++++.. ...++++||
T Consensus 12 ~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~--~~~~~i~e~ 89 (279)
T cd05111 12 LKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG--ASLQLVTQL 89 (279)
T ss_pred ccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC--CccEEEEEe
Confidence 37899999999999995 3454 477888754322 223567788889999999999999998864 467899999
Q ss_pred cCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCccc
Q 005749 456 FPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAV 535 (679)
Q Consensus 456 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 535 (679)
+++|+|.+++... ...+++..++.++.||+.||+|||+.+ ++||||||+||++++++.+||+|||+++......
T Consensus 90 ~~~gsL~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~ 163 (279)
T cd05111 90 SPLGSLLDHVRQH---RDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDD 163 (279)
T ss_pred CCCCcHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceeccCCC
Confidence 9999999999754 345899999999999999999999988 9999999999999999999999999998764332
Q ss_pred cc-chhcccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHHhhcccccccchHh
Q 005749 536 AD-EMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDME 613 (679)
Q Consensus 536 ~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 613 (679)
.. ......++..|+|||.+.++.++.++|||||||++||+++ |+.||.+.... .+.+++.
T Consensus 164 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~---~~~~~~~--------------- 225 (279)
T cd05111 164 KKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH---EVPDLLE--------------- 225 (279)
T ss_pred cccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHHH---------------
Confidence 11 1223456778999999988889999999999999999998 99998543221 1111110
Q ss_pred hhhcCCCCh-HHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCCC
Q 005749 614 IMKGIRSPM-EEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRPR 660 (679)
Q Consensus 614 i~~~~~~~~-~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 660 (679)
.+..... ......+.+++.+||..||++|||+.|+++.|..+...
T Consensus 226 --~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~ 271 (279)
T cd05111 226 --KGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD 271 (279)
T ss_pred --CCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence 1100010 11123566789999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=338.16 Aligned_cols=256 Identities=18% Similarity=0.190 Sum_probs=192.1
Q ss_pred CccccCCceEEEEEE-eCCCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCCh
Q 005749 383 QVIEKTTYGTAYKAK-LADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRTL 461 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gsL 461 (679)
+.||+|+||.||+|+ ..+++.||+|... .+.+.+|++++++++|||||++++++.. ....++|+||+. ++|
T Consensus 98 ~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~-~~~~~lv~e~~~-~~L 169 (391)
T PHA03212 98 ETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTY-NKFTCLILPRYK-TDL 169 (391)
T ss_pred EEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEE-CCeeEEEEecCC-CCH
Confidence 689999999999999 5678999999753 2457899999999999999999999987 678999999995 689
Q ss_pred HHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccchhc
Q 005749 462 HDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVA 541 (679)
Q Consensus 462 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 541 (679)
.+++... ..+++..++.|+.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|+............
T Consensus 170 ~~~l~~~----~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~ 242 (391)
T PHA03212 170 YCYLAAK----RNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYG 242 (391)
T ss_pred HHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccccccccccccc
Confidence 8888653 45889999999999999999999988 9999999999999999999999999997643322223345
Q ss_pred ccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcc-----cchhHHHHHHhh--ccc---ccccch
Q 005749 542 LAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEF-----VDLPSIVKVAVL--EET---TMEVFD 611 (679)
Q Consensus 542 ~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~-----~~l~~~~~~~~~--~~~---~~~~~~ 611 (679)
..||+.|+|||++.+..++.++|||||||++|||++|+.|+......+. ..+...+..... ... ....++
T Consensus 243 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~ 322 (391)
T PHA03212 243 WAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLD 322 (391)
T ss_pred ccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHH
Confidence 5799999999999988999999999999999999999988754322110 011111111000 000 000000
Q ss_pred Hhh---hh------cCCCCh---HHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 612 MEI---MK------GIRSPM---EEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 612 ~~i---~~------~~~~~~---~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
... .. ..++.. .....++.+++.+||+.||++|||++|+++.
T Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 323 EIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred HHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 000 00 000001 1223467789999999999999999999864
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=352.84 Aligned_cols=250 Identities=17% Similarity=0.256 Sum_probs=198.0
Q ss_pred cCccccCCceEEEEEE-eCCCCEEEEEEcccCc--ccCcccHHHHHHHHhccCCCCCccceEEeeCCC-------CceEE
Q 005749 382 GQVIEKTTYGTAYKAK-LADGATIALRLLREGS--CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKR-------GEKLL 451 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~-------~~~~l 451 (679)
.+.||+|+||+||+|+ ..+|+.||||++.... ......+.+|+..+..++|+||+++++.+.... ...++
T Consensus 37 ~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~l 116 (496)
T PTZ00283 37 SRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIAL 116 (496)
T ss_pred EEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccceEEEE
Confidence 3789999999999998 5679999999986543 233456889999999999999999887665321 13689
Q ss_pred EEEecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeeccccccc
Q 005749 452 IYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLM 531 (679)
Q Consensus 452 v~ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 531 (679)
||||+++|+|.++++........+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+
T Consensus 117 V~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL~DFGls~~~ 193 (496)
T PTZ00283 117 VLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKLGDFGFSKMY 193 (496)
T ss_pred EEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEEEecccCeec
Confidence 99999999999999865444567899999999999999999999988 999999999999999999999999999876
Q ss_pred Ccccc-cchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccc
Q 005749 532 VPAVA-DEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVF 610 (679)
Q Consensus 532 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 610 (679)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ........
T Consensus 194 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~------~~~~~~~~--------- 258 (496)
T PTZ00283 194 AATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM------EEVMHKTL--------- 258 (496)
T ss_pred cccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHh---------
Confidence 43221 122345799999999999998999999999999999999999999954321 11111111
Q ss_pred hHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 611 DMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 611 ~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
.....+..+...+++.+++.+||+.||++||++.+++++
T Consensus 259 ----~~~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 259 ----AGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred ----cCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 111111112234567789999999999999999999864
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=336.84 Aligned_cols=248 Identities=21% Similarity=0.218 Sum_probs=193.4
Q ss_pred cCccccCCceEEEEEEe----CCCCEEEEEEcccCc----ccCcccHHHHHHHHhcc-CCCCCccceEEeeCCCCceEEE
Q 005749 382 GQVIEKTTYGTAYKAKL----ADGATIALRLLREGS----CKDRSSCLPVIRQLGKV-RHENLIPLRAFYQGKRGEKLLI 452 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~----~~~~~vAvK~~~~~~----~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~~lv 452 (679)
.+.||+|+||.||+++. .+++.||+|++.... ....+.+.+|++++.++ +|+||+++++++.. .+..++|
T Consensus 5 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~-~~~~~lv 83 (332)
T cd05614 5 LKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQT-EAKLHLI 83 (332)
T ss_pred EEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEec-CCEEEEE
Confidence 36899999999999984 358899999986532 12245678899999999 59999999998887 6789999
Q ss_pred EEecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccC
Q 005749 453 YDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMV 532 (679)
Q Consensus 453 ~ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 532 (679)
|||+++|+|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~e~~~~g~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~ 156 (332)
T cd05614 84 LDYVSGGEMFTHLYQR----DNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (332)
T ss_pred EeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcccc
Confidence 9999999999998753 45899999999999999999999988 9999999999999999999999999998654
Q ss_pred cccccchhccccccccccccccccc-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccch
Q 005749 533 PAVADEMVALAKADGYKAPELQRMK-KCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFD 611 (679)
Q Consensus 533 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 611 (679)
...........||..|+|||++.+. .++.++|||||||++|||++|+.||........ . ..+.
T Consensus 157 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~--~-~~~~------------- 220 (332)
T cd05614 157 SEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT--Q-SEVS------------- 220 (332)
T ss_pred ccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCC--H-HHHH-------------
Confidence 3333333456799999999998765 478899999999999999999999954322111 1 1111
Q ss_pred HhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCC-----CHHHHHHH
Q 005749 612 MEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRP-----TMDEVVKQ 653 (679)
Q Consensus 612 ~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~evl~~ 653 (679)
..+..............+.+++.+||+.||++|| +++++++.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 221 RRILKCDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred HHHhcCCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 1111111111112235567899999999999999 67777754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=334.85 Aligned_cols=242 Identities=19% Similarity=0.267 Sum_probs=192.5
Q ss_pred CccccCCceEEEEEEe-CCCCEEEEEEcccCc---ccCcccHHHHHHHHhcc-CCCCCccceEEeeCCCCceEEEEEecC
Q 005749 383 QVIEKTTYGTAYKAKL-ADGATIALRLLREGS---CKDRSSCLPVIRQLGKV-RHENLIPLRAFYQGKRGEKLLIYDYFP 457 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~~lv~ey~~ 457 (679)
++||+|+||+||+|+. .+++.||+|+++... ....+.+.+|++++..+ +||||+++++++.+ .+..++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~-~~~~~lv~e~~~ 79 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQT-KDRLFFVMEYVN 79 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc-CCEEEEEEcCCC
Confidence 4699999999999995 458899999997542 23345677899999887 79999999999987 678999999999
Q ss_pred CCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCccccc
Q 005749 458 SRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVAD 537 (679)
Q Consensus 458 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 537 (679)
+|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++..... ..
T Consensus 80 ~~~L~~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~-~~ 151 (318)
T cd05570 80 GGDLMFHIQRS----GRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILG-GV 151 (318)
T ss_pred CCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcC-CC
Confidence 99999988753 35899999999999999999999988 999999999999999999999999998753221 11
Q ss_pred chhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhc
Q 005749 538 EMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKG 617 (679)
Q Consensus 538 ~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~ 617 (679)
......|+..|+|||++.+..++.++|||||||++|||++|+.||...... ...... ...
T Consensus 152 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~------~~~~~i--------------~~~ 211 (318)
T cd05570 152 TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED------ELFQSI--------------LED 211 (318)
T ss_pred cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH------HHHHHH--------------HcC
Confidence 223446899999999999999999999999999999999999999543211 111111 111
Q ss_pred CCCChHHHHHHHHHHHHhccCcCCCCCCCH-----HHHHHH
Q 005749 618 IRSPMEEGLVQALKLAMGCCAPVASVRPTM-----DEVVKQ 653 (679)
Q Consensus 618 ~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~-----~evl~~ 653 (679)
...........+.+++.+||+.||++||++ .++++.
T Consensus 212 ~~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 212 EVRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred CCCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 001111223567789999999999999999 777654
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=339.77 Aligned_cols=238 Identities=20% Similarity=0.282 Sum_probs=190.3
Q ss_pred CccccCCceEEEEEEe----CCCCEEEEEEcccCcc--cCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEec
Q 005749 383 QVIEKTTYGTAYKAKL----ADGATIALRLLREGSC--KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYF 456 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~----~~~~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~ 456 (679)
+.||+|+||.||+++. .+|+.||+|+++.... .....+.+|++++++++||||+++++++.+ .+..++||||+
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~ 80 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQT-EGKLYLILDFL 80 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEc-CCEEEEEEcCC
Confidence 5799999999999974 3588999999975432 234457789999999999999999999987 67899999999
Q ss_pred CCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccc
Q 005749 457 PSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVA 536 (679)
Q Consensus 457 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 536 (679)
++|+|.+++.. ...+++..++.++.||++||+|||+.+ |+||||||+||++++++.+||+|||+++......
T Consensus 81 ~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~- 152 (318)
T cd05582 81 RGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE- 152 (318)
T ss_pred CCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-
Confidence 99999999865 345899999999999999999999988 9999999999999999999999999988653321
Q ss_pred cchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhh
Q 005749 537 DEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMK 616 (679)
Q Consensus 537 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~ 616 (679)
.......|+..|+|||.+.+..++.++|||||||++|||++|+.||...... ...... ..
T Consensus 153 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~------~~~~~i--------------~~ 212 (318)
T cd05582 153 KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK------ETMTMI--------------LK 212 (318)
T ss_pred CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH------HHHHHH--------------Hc
Confidence 2223457899999999998888999999999999999999999999543211 111100 11
Q ss_pred cCCCChHHHHHHHHHHHHhccCcCCCCCCCHHH
Q 005749 617 GIRSPMEEGLVQALKLAMGCCAPVASVRPTMDE 649 (679)
Q Consensus 617 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~e 649 (679)
............+.+++.+||+.||++||++.+
T Consensus 213 ~~~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 213 AKLGMPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 100111112345678999999999999999554
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=320.66 Aligned_cols=246 Identities=18% Similarity=0.293 Sum_probs=193.7
Q ss_pred ccccCCceEEEEEEeC---CCCEEEEEEcccCcc-cCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCC
Q 005749 384 VIEKTTYGTAYKAKLA---DGATIALRLLREGSC-KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSR 459 (679)
Q Consensus 384 ~ig~G~~g~Vy~~~~~---~~~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~g 459 (679)
.||+|+||.||+|++. ++..||+|++..... ...+.+.+|++++++++||||+++++++.. ...++||||+++|
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~--~~~~lv~e~~~~~ 79 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA--EALMLVMEMASGG 79 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC--CCeEEEEEeCCCC
Confidence 3899999999999753 355799999876532 234568999999999999999999998864 5789999999999
Q ss_pred ChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccc-
Q 005749 460 TLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADE- 538 (679)
Q Consensus 460 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~- 538 (679)
+|.+++... ...+++..+++++.|++.||+|||+++ ++||||||+||+++.++.+||+|||+++.........
T Consensus 80 ~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 153 (257)
T cd05115 80 PLNKFLSGK---KDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYK 153 (257)
T ss_pred CHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCcccee
Confidence 999998753 345899999999999999999999988 9999999999999999999999999998653322111
Q ss_pred -hhcccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhh
Q 005749 539 -MVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMK 616 (679)
Q Consensus 539 -~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~ 616 (679)
.....++..|+|||.+....++.++|||||||++||+++ |+.||.+.... ++.. .+..
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~------~~~~--------------~~~~ 213 (257)
T cd05115 154 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP------EVMS--------------FIEQ 213 (257)
T ss_pred ccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH------HHHH--------------HHHC
Confidence 111223567999999988889999999999999999996 99998543221 1110 0111
Q ss_pred cCC-CChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhh
Q 005749 617 GIR-SPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEEN 657 (679)
Q Consensus 617 ~~~-~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 657 (679)
+.+ ...+...+++.+++.+||..+|++||++.+|.+.|+..
T Consensus 214 ~~~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 214 GKRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 111 11122346677899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=321.60 Aligned_cols=240 Identities=20% Similarity=0.279 Sum_probs=188.0
Q ss_pred CccccCCceEEEEEEeCC-------------CCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCCCCce
Q 005749 383 QVIEKTTYGTAYKAKLAD-------------GATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEK 449 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~~~-------------~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 449 (679)
+.||+|+||.||+|++.+ ...||+|.+..........|..|+.+++.++||||+++++++.. ....
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~-~~~~ 79 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVR-DVEN 79 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCCC
Confidence 468999999999998532 23589999876554455678899999999999999999999987 5788
Q ss_pred EEEEEecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCc-------eEE
Q 005749 450 LLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFV-------SRL 522 (679)
Q Consensus 450 ~lv~ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~-------~kl 522 (679)
++||||+++|+|..++... ...+++..+++++.||++||+|||+.+ |+||||||+|||++.++. +|+
T Consensus 80 ~lv~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l 153 (262)
T cd05077 80 IMVEEFVEFGPLDLFMHRK---SDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKL 153 (262)
T ss_pred EEEEecccCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEe
Confidence 9999999999999988653 345899999999999999999999988 999999999999987654 899
Q ss_pred eecccccccCcccccchhccccccccccccccc-ccCCCCcchhHHHHHHHHHHH-hCCCCCCCCCCCcccchhHHHHHH
Q 005749 523 TEFGLDQLMVPAVADEMVALAKADGYKAPELQR-MKKCSSRTDVYAFGILLLEIL-IGKKPGKSGRNGEFVDLPSIVKVA 600 (679)
Q Consensus 523 ~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~k~DV~S~Gvvl~El~-tg~~p~~~~~~~~~~~l~~~~~~~ 600 (679)
+|||++...... ....++..|+|||.+. +..++.++|||||||++|||+ +|+.|+......+ ... .
T Consensus 154 ~d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~------~~~-~ 221 (262)
T cd05077 154 SDPGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE------KER-F 221 (262)
T ss_pred CCCCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH------HHH-H
Confidence 999998755321 2345778899999886 466899999999999999997 5888874322110 000 0
Q ss_pred hhcccccccchHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHH
Q 005749 601 VLEETTMEVFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLE 655 (679)
Q Consensus 601 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~ 655 (679)
..+..........++.+++.+||+.||++||++.+|++.++
T Consensus 222 --------------~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 222 --------------YEGQCMLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred --------------HhcCccCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 00000011112356778999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=301.36 Aligned_cols=259 Identities=22% Similarity=0.262 Sum_probs=207.0
Q ss_pred CccccCCceEEEEEE-eCCCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCC----CCceEEEEEecC
Q 005749 383 QVIEKTTYGTAYKAK-LADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGK----RGEKLLIYDYFP 457 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~----~~~~~lv~ey~~ 457 (679)
+.+|+|||+-||.++ ..++..+|+|++...+.++.+..++|++..++++|||+++++++.... ..+.|++++|..
T Consensus 27 ~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy~ 106 (302)
T KOG2345|consen 27 RLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLLLPYYK 106 (302)
T ss_pred eeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEEeehhc
Confidence 789999999999999 888999999999887777788899999999999999999999876532 346899999999
Q ss_pred CCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCccccc
Q 005749 458 SRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVAD 537 (679)
Q Consensus 458 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 537 (679)
.|||.+.+......+..+++.+.+.|+.+|++||++||+.. +|+.||||||.|||+.+.+.+++.|||.+....-....
T Consensus 107 ~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i~i~~ 185 (302)
T KOG2345|consen 107 RGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSATQAPIQIEG 185 (302)
T ss_pred cccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCccccceEeec
Confidence 99999999877666678999999999999999999999975 57999999999999999999999999998765322111
Q ss_pred --------chhccccccccccccccc---ccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccc
Q 005749 538 --------EMVALAKADGYKAPELQR---MKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETT 606 (679)
Q Consensus 538 --------~~~~~~gt~~y~aPE~~~---~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 606 (679)
+.....-|..|+|||++. +...++++|||||||+||+|+.|..||+.... ....+ .
T Consensus 186 ~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~-~GgSl------------a 252 (302)
T KOG2345|consen 186 SRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ-QGGSL------------A 252 (302)
T ss_pred hHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh-cCCeE------------E
Confidence 111234577899999876 45678999999999999999999999943222 11110 0
Q ss_pred cccchHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhC
Q 005749 607 MEVFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENR 658 (679)
Q Consensus 607 ~~~~~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 658 (679)
..+....+.. +........+.+++..|++.||.+||++.+++..++.+.
T Consensus 253 LAv~n~q~s~---P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 253 LAVQNAQISI---PNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred Eeeecccccc---CCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 1111111111 111225567788999999999999999999999998764
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=322.52 Aligned_cols=255 Identities=17% Similarity=0.252 Sum_probs=195.4
Q ss_pred hcCccccCCceEEEEEEeCC-CC--EEEEEEcccCc--ccCcccHHHHHHHHhccCCCCCccceEEeeCC-----CCceE
Q 005749 381 TGQVIEKTTYGTAYKAKLAD-GA--TIALRLLREGS--CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGK-----RGEKL 450 (679)
Q Consensus 381 ~~~~ig~G~~g~Vy~~~~~~-~~--~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~-----~~~~~ 450 (679)
.++.||+|+||.||+|+..+ +. .||+|.++... ....+.+.+|++++++++|+||+++++++... ....+
T Consensus 3 i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 82 (272)
T cd05075 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPV 82 (272)
T ss_pred cccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcE
Confidence 35789999999999999654 33 68999987542 23356788999999999999999999987531 12468
Q ss_pred EEEEecCCCChHHHhhcccC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccc
Q 005749 451 LIYDYFPSRTLHDLLHDTIA--GKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLD 528 (679)
Q Consensus 451 lv~ey~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 528 (679)
+||||+++|+|.+++..... ....+++.....++.|++.||+|||+++ |+||||||+|||+++++.+||+|||++
T Consensus 83 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 83 VILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred EEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCCcc
Confidence 99999999999998753221 1345899999999999999999999987 999999999999999999999999999
Q ss_pred cccCcccccc-hhcccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHHhhcccc
Q 005749 529 QLMVPAVADE-MVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAVLEETT 606 (679)
Q Consensus 529 ~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 606 (679)
+.+....... .....+++.|+|||...+..++.++||||||+++|||++ |+.||.+.... ..... .....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~------~~~~~-~~~~~- 231 (272)
T cd05075 160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS------EIYDY-LRQGN- 231 (272)
T ss_pred cccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH------HHHHH-HHcCC-
Confidence 8764322111 122345677999999998889999999999999999999 78888542211 11111 11100
Q ss_pred cccchHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhh
Q 005749 607 MEVFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEEN 657 (679)
Q Consensus 607 ~~~~~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 657 (679)
.....+.....+.+++.+||+.||++|||+.|+++.|+++
T Consensus 232 -----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 232 -----------RLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred -----------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0011112234577899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=319.04 Aligned_cols=248 Identities=23% Similarity=0.379 Sum_probs=197.9
Q ss_pred cCccccCCceEEEEEEeCCCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCCh
Q 005749 382 GQVIEKTTYGTAYKAKLADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRTL 461 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gsL 461 (679)
.+.||+|+||.||+|+..+...||+|+++... ...+.+.+|++++++++||||+++++++.. ...++||||+++|+|
T Consensus 11 ~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~--~~~~lv~e~~~~~~L 87 (262)
T cd05071 11 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE--EPIYIVTEYMSKGSL 87 (262)
T ss_pred eeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEECC--CCcEEEEEcCCCCcH
Confidence 47899999999999998777789999997532 234578999999999999999999998754 568999999999999
Q ss_pred HHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccchhc
Q 005749 462 HDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVA 541 (679)
Q Consensus 462 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 541 (679)
.+++.... ...+++..++.++.|+++||+|||+.+ ++||||||+||++++++.+||+|||.++.+..........
T Consensus 88 ~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~~~ 162 (262)
T cd05071 88 LDFLKGEM--GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 162 (262)
T ss_pred HHHHhhcc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccccccccccC
Confidence 99997532 245799999999999999999999988 9999999999999999999999999998664332222223
Q ss_pred ccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcCC-
Q 005749 542 LAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIR- 619 (679)
Q Consensus 542 ~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~- 619 (679)
..++..|+|||+..+..++.++||||||+++|||++ |+.||......+ .... +..+..
T Consensus 163 ~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~------~~~~--------------~~~~~~~ 222 (262)
T cd05071 163 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE------VLDQ--------------VERGYRM 222 (262)
T ss_pred CcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH------HHHH--------------HhcCCCC
Confidence 345677999999988889999999999999999999 788885432211 0000 001100
Q ss_pred CChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhh
Q 005749 620 SPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEEN 657 (679)
Q Consensus 620 ~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 657 (679)
....+....+.+++.+||+.+|++||++.++++.|++.
T Consensus 223 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 223 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 11123345678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=319.52 Aligned_cols=244 Identities=18% Similarity=0.287 Sum_probs=193.4
Q ss_pred ccccCCceEEEEEEe---CCCCEEEEEEcccCcc--cCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCC
Q 005749 384 VIEKTTYGTAYKAKL---ADGATIALRLLREGSC--KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPS 458 (679)
Q Consensus 384 ~ig~G~~g~Vy~~~~---~~~~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~ 458 (679)
.||+|+||.||+|.+ .++..+|+|+++.... ...+++.+|+.++++++||||+++++++.. +..++||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~lv~e~~~~ 79 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA--ESWMLVMELAEL 79 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC--CCcEEEEecCCC
Confidence 589999999999964 3578999999865432 234578999999999999999999998864 567999999999
Q ss_pred CChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCccccc-
Q 005749 459 RTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVAD- 537 (679)
Q Consensus 459 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~- 537 (679)
|+|.+++... ..+++..+.+++.|++.||+|||+++ |+||||||+||++++++.+||+|||+++.+......
T Consensus 80 ~~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~ 152 (257)
T cd05116 80 GPLNKFLQKN----KHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYY 152 (257)
T ss_pred CcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCee
Confidence 9999999753 35899999999999999999999988 999999999999999999999999999876433211
Q ss_pred -chhcccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhh
Q 005749 538 -EMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIM 615 (679)
Q Consensus 538 -~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~ 615 (679)
......++..|+|||.+....++.++|||||||++|||++ |+.||...... .+.... .
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~------~~~~~i--------------~ 212 (257)
T cd05116 153 KAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN------EVTQMI--------------E 212 (257)
T ss_pred eecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHH--------------H
Confidence 1122234578999999988889999999999999999998 99998543221 111111 1
Q ss_pred hcCC-CChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHh
Q 005749 616 KGIR-SPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEE 656 (679)
Q Consensus 616 ~~~~-~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 656 (679)
.+.. ........++.+++.+||+.||++||++++|.+.|++
T Consensus 213 ~~~~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 213 SGERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred CCCCCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 1111 1111233567789999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=319.47 Aligned_cols=247 Identities=23% Similarity=0.387 Sum_probs=198.0
Q ss_pred cCccccCCceEEEEEEeCCCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCCh
Q 005749 382 GQVIEKTTYGTAYKAKLADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRTL 461 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gsL 461 (679)
.+.||+|+||.||+|...++..||+|.++.... ..+.+.+|++++++++|+||+++++++.. ...+++|||+++++|
T Consensus 11 ~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~--~~~~lv~e~~~~~~L 87 (260)
T cd05070 11 IKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSE--EPIYIVTEYMSKGSL 87 (260)
T ss_pred hheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECC--CCcEEEEEecCCCcH
Confidence 478999999999999988888999999876432 35679999999999999999999998754 568999999999999
Q ss_pred HHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccchhc
Q 005749 462 HDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVA 541 (679)
Q Consensus 462 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 541 (679)
.++++... ...+++.+++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++..+..........
T Consensus 88 ~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~ 162 (260)
T cd05070 88 LDFLKDGE--GRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQG 162 (260)
T ss_pred HHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcccccccC
Confidence 99997532 245899999999999999999999988 9999999999999999999999999998654332222222
Q ss_pred ccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcCCC
Q 005749 542 LAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIRS 620 (679)
Q Consensus 542 ~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~~ 620 (679)
..++..|+|||++.+..++.++||||||+++|||++ |+.||.+.... ..... . ..+...
T Consensus 163 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~---~~~~~---~--------------~~~~~~ 222 (260)
T cd05070 163 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR---EVLEQ---V--------------ERGYRM 222 (260)
T ss_pred CCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH---HHHHH---H--------------HcCCCC
Confidence 345667999999988889999999999999999999 88898543221 11111 0 111011
Q ss_pred -ChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHh
Q 005749 621 -PMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEE 656 (679)
Q Consensus 621 -~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 656 (679)
........+.+++.+||..+|++|||++++.+.|++
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 223 PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 111233567789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=318.42 Aligned_cols=241 Identities=19% Similarity=0.331 Sum_probs=203.4
Q ss_pred CccccCCceEEEEEE-eCCCCEEEEEEcccCcccCcc---cHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCC
Q 005749 383 QVIEKTTYGTAYKAK-LADGATIALRLLREGSCKDRS---SCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPS 458 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~---~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~ 458 (679)
+.+|+|.||.|-+|+ ...|+.||||.+++..-++.+ .+.+||+||..++||||+++|.+|.. .+.+.|||||..+
T Consensus 59 etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFEN-kdKIvivMEYaS~ 137 (668)
T KOG0611|consen 59 ETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFEN-KDKIVIVMEYASG 137 (668)
T ss_pred HHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcC-CceEEEEEEecCC
Confidence 679999999999999 578999999999876544433 47899999999999999999999998 6889999999999
Q ss_pred CChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccc
Q 005749 459 RTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADE 538 (679)
Q Consensus 459 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 538 (679)
|.|++++..+ ..+++.+.+.+++||..|+.|+|.++ ++|||||-+|||+|.++.+||+|||++-++... ..
T Consensus 138 GeLYDYiSer----~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~~--kf 208 (668)
T KOG0611|consen 138 GELYDYISER----GSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYADK--KF 208 (668)
T ss_pred ccHHHHHHHh----ccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhccc--cH
Confidence 9999999874 45999999999999999999999988 999999999999999999999999999887543 44
Q ss_pred hhcccccccccccccccccCC-CCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhc
Q 005749 539 MVALAKADGYKAPELQRMKKC-SSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKG 617 (679)
Q Consensus 539 ~~~~~gt~~y~aPE~~~~~~~-~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~ 617 (679)
..+++|++-|.+||.+.+.+| ++..|-||+||+||.|+.|..||++.+.. .++. .|..|
T Consensus 209 LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk---~lvr-----------------QIs~G 268 (668)
T KOG0611|consen 209 LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK---RLVR-----------------QISRG 268 (668)
T ss_pred HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH---HHHH-----------------Hhhcc
Confidence 678899999999999999988 68899999999999999999999654321 2211 22222
Q ss_pred CCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 005749 618 IRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQL 654 (679)
Q Consensus 618 ~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L 654 (679)
.+.. ++......-+|.+|+..+|++|.|..+|..+-
T Consensus 269 aYrE-P~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 269 AYRE-PETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred cccC-CCCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 2111 11223445688999999999999999998764
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=325.16 Aligned_cols=263 Identities=23% Similarity=0.321 Sum_probs=197.4
Q ss_pred CccccCCceEEEEEEe-----CCCCEEEEEEcccCcc-cCcccHHHHHHHHhccCCCCCccceEEeeCC-CCceEEEEEe
Q 005749 383 QVIEKTTYGTAYKAKL-----ADGATIALRLLREGSC-KDRSSCLPVIRQLGKVRHENLIPLRAFYQGK-RGEKLLIYDY 455 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~-----~~~~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~-~~~~~lv~ey 455 (679)
+.||+|+||+||++++ .++..||+|.++.... ...+.+.+|++++++++||||+++++++... ....++||||
T Consensus 10 ~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~ 89 (283)
T cd05080 10 RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEY 89 (283)
T ss_pred eecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEEecC
Confidence 6899999999988653 3578999999876432 2356788999999999999999999988653 3457899999
Q ss_pred cCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCccc
Q 005749 456 FPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAV 535 (679)
Q Consensus 456 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 535 (679)
+++++|.+++.. ..+++.+++.++.|++.||+|||+++ |+||||||+||++++++.+||+|||+++......
T Consensus 90 ~~~~~l~~~~~~-----~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 161 (283)
T cd05080 90 VPLGSLRDYLPK-----HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH 161 (283)
T ss_pred CCCCCHHHHHHH-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccCCcc
Confidence 999999999974 24899999999999999999999988 9999999999999999999999999998764322
Q ss_pred ccc--hhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHh
Q 005749 536 ADE--MVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDME 613 (679)
Q Consensus 536 ~~~--~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 613 (679)
... .....++..|+|||.+....++.++||||||+++|||++|..|+...... ...+......... ...+...
T Consensus 162 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~-~~~~~~~~~~~~~----~~~~~~~ 236 (283)
T cd05080 162 EYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKK-FEEMIGPKQGQMT----VVRLIEL 236 (283)
T ss_pred hhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcch-hhhhhcccccccc----hhhhhhh
Confidence 111 11234566799999998888999999999999999999999998443211 1111000000000 0000000
Q ss_pred hhhcCCCC-hHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhC
Q 005749 614 IMKGIRSP-MEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENR 658 (679)
Q Consensus 614 i~~~~~~~-~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 658 (679)
+..+...+ ......++.+++.+||+.+|++|||++++++.|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 237 LERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 01111111 1123357788999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=321.24 Aligned_cols=254 Identities=19% Similarity=0.273 Sum_probs=197.1
Q ss_pred cCccccCCceEEEEEEeC-C---CCEEEEEEcccCcc--cCcccHHHHHHHHhccCCCCCccceEEeeCCCC-----ceE
Q 005749 382 GQVIEKTTYGTAYKAKLA-D---GATIALRLLREGSC--KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRG-----EKL 450 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~-~---~~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~-----~~~ 450 (679)
++.||+|+||.||+|+.. + +..||+|+++.... ...+.+.+|++.++.++||||+++++++..... ..+
T Consensus 4 ~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 83 (273)
T cd05035 4 GKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPM 83 (273)
T ss_pred ccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcccE
Confidence 478999999999999853 2 36899999875422 234578999999999999999999998865221 379
Q ss_pred EEEEecCCCChHHHhhcccC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccc
Q 005749 451 LIYDYFPSRTLHDLLHDTIA--GKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLD 528 (679)
Q Consensus 451 lv~ey~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 528 (679)
+|+||+++|+|.+++..... ....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++
T Consensus 84 ~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~ 160 (273)
T cd05035 84 VILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADFGLS 160 (273)
T ss_pred EEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCccce
Confidence 99999999999999865422 1346899999999999999999999988 999999999999999999999999999
Q ss_pred cccCcccccc-hhcccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHHhhcccc
Q 005749 529 QLMVPAVADE-MVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAVLEETT 606 (679)
Q Consensus 529 ~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 606 (679)
+.+....... .....++..|+|||.+.+..++.++|||||||++|||++ |..||.+.... +........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~------~~~~~~~~~--- 231 (273)
T cd05035 161 KKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH------EIYDYLRHG--- 231 (273)
T ss_pred eeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHHHcC---
Confidence 8764332211 112234667999999988889999999999999999999 88888543221 111111000
Q ss_pred cccchHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhh
Q 005749 607 MEVFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEEN 657 (679)
Q Consensus 607 ~~~~~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 657 (679)
...........++.+++.+||+.||++||++.|+++.|+++
T Consensus 232 ----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 232 ----------NRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred ----------CCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00011122345778899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=324.27 Aligned_cols=248 Identities=19% Similarity=0.223 Sum_probs=192.8
Q ss_pred cccCCceEEEEEEe-CCCCEEEEEEcccCcc---cCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCC
Q 005749 385 IEKTTYGTAYKAKL-ADGATIALRLLREGSC---KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRT 460 (679)
Q Consensus 385 ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~---~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gs 460 (679)
||+|+||.||+++. .+|+.||+|.+..... .....+..|++++++++||||+++++++.+ ....++||||+++++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~-~~~~~lv~e~~~g~~ 79 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFES-KTHLCLVMSLMNGGD 79 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEec-CCeEEEEEecCCCCC
Confidence 79999999999994 5699999999865321 123456679999999999999999999887 678999999999999
Q ss_pred hHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccchh
Q 005749 461 LHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMV 540 (679)
Q Consensus 461 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 540 (679)
|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++....... ...
T Consensus 80 L~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~ 152 (277)
T cd05607 80 LKYHIYNVG--ERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TIT 152 (277)
T ss_pred HHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eee
Confidence 998886532 345889999999999999999999988 9999999999999999999999999987654321 122
Q ss_pred cccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcCCC
Q 005749 541 ALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIRS 620 (679)
Q Consensus 541 ~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~~ 620 (679)
...|+..|+|||++.+..++.++||||+||++|||++|+.||...... ............ .....
T Consensus 153 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~--~~~~~~~~~~~~-------------~~~~~ 217 (277)
T cd05607 153 QRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEK--VAKEELKRRTLE-------------DEVKF 217 (277)
T ss_pred ccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcch--hhHHHHHHHhhc-------------ccccc
Confidence 346888999999999888999999999999999999999998543221 010111111100 00000
Q ss_pred ChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHH
Q 005749 621 PMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLE 655 (679)
Q Consensus 621 ~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~ 655 (679)
.......++.+++.+||+.||++||+++|+++.+.
T Consensus 218 ~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~ 252 (277)
T cd05607 218 EHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPR 252 (277)
T ss_pred ccccCCHHHHHHHHHHhccCHhhCCCCccchhhhh
Confidence 11123456788999999999999999987765443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=339.35 Aligned_cols=260 Identities=23% Similarity=0.347 Sum_probs=210.2
Q ss_pred HHHHhhcCccccCCceEEEEEE-eCCC----CEEEEEEcccCc-ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCce
Q 005749 376 DVLNATGQVIEKTTYGTAYKAK-LADG----ATIALRLLREGS-CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEK 449 (679)
Q Consensus 376 ~l~~~~~~~ig~G~~g~Vy~~~-~~~~----~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 449 (679)
|....-..+||+|+||+||||. ...| .+||+|++.... .+..++++.|+-+|.+++|||+++++|+|.. ...
T Consensus 695 Etelkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~--s~~ 772 (1177)
T KOG1025|consen 695 ETELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCML--STL 772 (1177)
T ss_pred hhhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhccc--chH
Confidence 3333445899999999999998 4444 478999987653 3456789999999999999999999999997 358
Q ss_pred EEEEEecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeeccccc
Q 005749 450 LLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQ 529 (679)
Q Consensus 450 ~lv~ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 529 (679)
.||++||+.|+|.++++.+ +..+-....+.|..|||+||.|||.++ +|||||.++|||+..-..+||.|||+|+
T Consensus 773 qlvtq~mP~G~LlDyvr~h---r~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ 846 (1177)
T KOG1025|consen 773 QLVTQLMPLGCLLDYVREH---RDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAK 846 (1177)
T ss_pred HHHHHhcccchHHHHHHHh---hccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhh
Confidence 8999999999999999986 345778889999999999999999888 9999999999999999999999999999
Q ss_pred ccCcccccc-hhcccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHHhhccccc
Q 005749 530 LMVPAVADE-MVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAVLEETTM 607 (679)
Q Consensus 530 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 607 (679)
.+.+..... .....-.+.|||=|.+....|+.++|||||||++||++| |..||.+....+..+
T Consensus 847 ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~d--------------- 911 (1177)
T KOG1025|consen 847 LLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPD--------------- 911 (1177)
T ss_pred ccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhH---------------
Confidence 886543222 223344567999999999999999999999999999997 999986544322211
Q ss_pred ccchHhhhhcCC-CChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCCCCCC
Q 005749 608 EVFDMEIMKGIR-SPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRPRNRS 663 (679)
Q Consensus 608 ~~~~~~i~~~~~-~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~ 663 (679)
.+..+.+ ...+....++..++.+||..|+..||+++++...+.+..+....
T Consensus 912 -----lle~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardpqr 963 (1177)
T KOG1025|consen 912 -----LLEKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDPQR 963 (1177)
T ss_pred -----HHhccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCcce
Confidence 1223333 23344556778899999999999999999999999887654433
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=323.68 Aligned_cols=252 Identities=17% Similarity=0.303 Sum_probs=194.8
Q ss_pred cCccccCCceEEEEEEeC------CCCEEEEEEcccCc-ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEE
Q 005749 382 GQVIEKTTYGTAYKAKLA------DGATIALRLLREGS-CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYD 454 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~------~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~e 454 (679)
.+.||+|+||.||+|+.. ++..||+|++.... .....++.+|+.+++.++||||+++++++.. ....++|||
T Consensus 11 ~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~-~~~~~lv~e 89 (277)
T cd05062 11 SRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ-GQPTLVIME 89 (277)
T ss_pred eeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCCeEEEEe
Confidence 378999999999999743 35689999986532 2234568899999999999999999999887 678999999
Q ss_pred ecCCCChHHHhhcccCC------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccc
Q 005749 455 YFPSRTLHDLLHDTIAG------KPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLD 528 (679)
Q Consensus 455 y~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 528 (679)
|+++|+|.+++...... ...+++..++.++.|+++||+|||+.+ ++||||||+||++++++.+|++|||++
T Consensus 90 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l~dfg~~ 166 (277)
T cd05062 90 LMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMT 166 (277)
T ss_pred cCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEECCCCCc
Confidence 99999999998753211 234688899999999999999999987 999999999999999999999999998
Q ss_pred cccCcccccc-hhcccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHHhhcccc
Q 005749 529 QLMVPAVADE-MVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAVLEETT 606 (679)
Q Consensus 529 ~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 606 (679)
+......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||.+.... ....... .
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~------~~~~~~~-~--- 236 (277)
T cd05062 167 RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE------QVLRFVM-E--- 236 (277)
T ss_pred cccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH------HHHHHHH-c---
Confidence 7653322111 112345678999999998889999999999999999999 68888543221 1111100 0
Q ss_pred cccchHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHh
Q 005749 607 MEVFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEE 656 (679)
Q Consensus 607 ~~~~~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 656 (679)
.............+.+++.+||+.||++|||+.|+++.|++
T Consensus 237 ---------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 237 ---------GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred ---------CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 00001111223467789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=337.34 Aligned_cols=242 Identities=22% Similarity=0.265 Sum_probs=189.0
Q ss_pred CccccCCceEEEEEE-eCCCCEEEEEEcccCc---ccCcccHHHHHH-HHhccCCCCCccceEEeeCCCCceEEEEEecC
Q 005749 383 QVIEKTTYGTAYKAK-LADGATIALRLLREGS---CKDRSSCLPVIR-QLGKVRHENLIPLRAFYQGKRGEKLLIYDYFP 457 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~---~~~~~~~~~Ei~-~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~ 457 (679)
++||+|+||+||+|+ ..+|+.||+|++.... ......+..|.. +++.++||||+++++++.. .+..++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~-~~~~~lv~e~~~ 79 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT-TEKLYFVLDFVN 79 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEec-CCEEEEEEcCCC
Confidence 469999999999999 4579999999986542 122344556655 4677899999999999887 678999999999
Q ss_pred CCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCccccc
Q 005749 458 SRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVAD 537 (679)
Q Consensus 458 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 537 (679)
+|+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++..... ..
T Consensus 80 ~~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~-~~ 151 (325)
T cd05604 80 GGELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ-SD 151 (325)
T ss_pred CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCC-CC
Confidence 9999988865 345899999999999999999999988 999999999999999999999999998753221 12
Q ss_pred chhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhc
Q 005749 538 EMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKG 617 (679)
Q Consensus 538 ~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~ 617 (679)
......|+..|+|||++.+..++.++|||||||++|||++|+.||...... +..+.. ...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~------~~~~~~--------------~~~ 211 (325)
T cd05604 152 TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA------EMYDNI--------------LHK 211 (325)
T ss_pred CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH------HHHHHH--------------HcC
Confidence 233457899999999999989999999999999999999999999543221 111111 111
Q ss_pred CCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 618 IRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 618 ~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
.....+.....+.+++.+|++.+|++||++++.++.
T Consensus 212 ~~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~ 247 (325)
T cd05604 212 PLVLRPGASLTAWSILEELLEKDRQRRLGAKEDFLE 247 (325)
T ss_pred CccCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHH
Confidence 001111233556789999999999999988644333
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=325.41 Aligned_cols=260 Identities=18% Similarity=0.248 Sum_probs=191.5
Q ss_pred CccccCCceEEEEEEe-CCCCEEEEEEcccCcc-cCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCC
Q 005749 383 QVIEKTTYGTAYKAKL-ADGATIALRLLREGSC-KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRT 460 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gs 460 (679)
+.||+|+||.||+|+. .+++.||+|+++.... .....+.+|++++++++||||+++++++.+ ....++||||++ ++
T Consensus 11 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~~-~~ 88 (303)
T cd07869 11 EKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHT-KETLTLVFEYVH-TD 88 (303)
T ss_pred eeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEec-CCeEEEEEECCC-cC
Confidence 7899999999999995 4789999999875432 233467899999999999999999999987 678999999996 58
Q ss_pred hHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccchh
Q 005749 461 LHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMV 540 (679)
Q Consensus 461 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 540 (679)
|.+++... ...+++..+..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++..... .....
T Consensus 89 l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~-~~~~~ 161 (303)
T cd07869 89 LCQYMDKH---PGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVP-SHTYS 161 (303)
T ss_pred HHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCC-CccCC
Confidence 88887653 245888999999999999999999988 999999999999999999999999998754322 11223
Q ss_pred cccccccccccccccc-cCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcc---ccc-----ccch
Q 005749 541 ALAKADGYKAPELQRM-KKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEE---TTM-----EVFD 611 (679)
Q Consensus 541 ~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~---~~~-----~~~~ 611 (679)
...+++.|+|||++.+ ..++.++||||+||++|||++|+.||.+.... .............. ... ..++
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (303)
T cd07869 162 NEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDI--QDQLERIFLVLGTPNEDTWPGVHSLPHFK 239 (303)
T ss_pred CCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccH--HHHHHHHHHHhCCCChhhccchhhccccc
Confidence 4567899999998765 45889999999999999999999999653221 01111110000000 000 0000
Q ss_pred HhhhhcCCC-ChH------HHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 612 MEIMKGIRS-PME------EGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 612 ~~i~~~~~~-~~~------~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
+.......+ ... .....+.+++.+|++.||++|||+.|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h 288 (303)
T cd07869 240 PERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH 288 (303)
T ss_pred cccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence 000000000 000 012456789999999999999999999863
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=318.84 Aligned_cols=250 Identities=20% Similarity=0.336 Sum_probs=192.6
Q ss_pred CccccCCceEEEEEEeC----CCCEEEEEEcccCc-ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecC
Q 005749 383 QVIEKTTYGTAYKAKLA----DGATIALRLLREGS-CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFP 457 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~~----~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~ 457 (679)
+.||+|+||.||+|+.. ++..||+|.+.... ....+.+.+|+.+++.++||||+++++++...++..++||||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999853 24579999986432 23356788999999999999999999988754567899999999
Q ss_pred CCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCccccc
Q 005749 458 SRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVAD 537 (679)
Q Consensus 458 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 537 (679)
+|+|.+++... ....++..++.++.|+++||+|||+.+ ++||||||+|||+++++.+||+|||+++........
T Consensus 81 ~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 81 HGDLRNFIRSE---THNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence 99999999753 234678888999999999999999987 999999999999999999999999999865332111
Q ss_pred ---chhcccccccccccccccccCCCCcchhHHHHHHHHHHHhC-CCCCCCCCCCcccchhHHHHHHhhcccccccchHh
Q 005749 538 ---EMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIG-KKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDME 613 (679)
Q Consensus 538 ---~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg-~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 613 (679)
......++..|+|||.+.+..++.++|||||||++|||++| .+||..... .......
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~------~~~~~~~------------- 215 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS------FDITVYL------------- 215 (262)
T ss_pred eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH------HHHHHHH-------------
Confidence 11233456789999999888899999999999999999995 455532211 1111111
Q ss_pred hhhcCCCCh-HHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhC
Q 005749 614 IMKGIRSPM-EEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENR 658 (679)
Q Consensus 614 i~~~~~~~~-~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 658 (679)
..+..... ......+.+++.+||+.+|++||++.|+++.|+++.
T Consensus 216 -~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 216 -LQGRRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred -hcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 11111111 112346778999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=327.67 Aligned_cols=260 Identities=19% Similarity=0.290 Sum_probs=190.0
Q ss_pred CccccCCceEEEEEEe-C-CCCEEEEEEcccCcc--cCcccHHHHHHHHhcc---CCCCCccceEEeeC----CCCceEE
Q 005749 383 QVIEKTTYGTAYKAKL-A-DGATIALRLLREGSC--KDRSSCLPVIRQLGKV---RHENLIPLRAFYQG----KRGEKLL 451 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~-~-~~~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l---~H~nIv~l~~~~~~----~~~~~~l 451 (679)
+.||+|+||.||+|+. . +++.||+|.++.... .....+.+|+++++++ +||||++++++|.. .....++
T Consensus 7 ~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~~l 86 (290)
T cd07862 7 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTL 86 (290)
T ss_pred eEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCcEEE
Confidence 6799999999999985 3 468899999875432 2234567788877765 69999999998852 2456899
Q ss_pred EEEecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeeccccccc
Q 005749 452 IYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLM 531 (679)
Q Consensus 452 v~ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 531 (679)
||||++ ++|.+++.... ...+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 87 v~e~~~-~~l~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T cd07862 87 VFEHVD-QDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIY 160 (290)
T ss_pred EEccCC-CCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccccceEec
Confidence 999997 59999987532 245899999999999999999999988 999999999999999999999999999865
Q ss_pred CcccccchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHh---hcccccc
Q 005749 532 VPAVADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAV---LEETTME 608 (679)
Q Consensus 532 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~---~~~~~~~ 608 (679)
... .......|+..|+|||.+.+..++.++|||||||++|||++|++||.+....+ .+........ .......
T Consensus 161 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~--~~~~i~~~~~~~~~~~~~~~ 236 (290)
T cd07862 161 SFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD--QLGKILDVIGLPGEEDWPRD 236 (290)
T ss_pred cCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH--HHHHHHHHhCCCChhhchhh
Confidence 332 22334568999999999988889999999999999999999999996543221 1111111100 0000000
Q ss_pred c-chHhhh-hcCCCChH----HHHHHHHHHHHhccCcCCCCCCCHHHHHH
Q 005749 609 V-FDMEIM-KGIRSPME----EGLVQALKLAMGCCAPVASVRPTMDEVVK 652 (679)
Q Consensus 609 ~-~~~~i~-~~~~~~~~----~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 652 (679)
. ...... .....+.+ .....+.+++.+|++.||++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 237 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 0 000000 00000111 12245668999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=323.03 Aligned_cols=252 Identities=20% Similarity=0.339 Sum_probs=196.2
Q ss_pred cCccccCCceEEEEEEe-----CCCCEEEEEEcccCcc-cCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEe
Q 005749 382 GQVIEKTTYGTAYKAKL-----ADGATIALRLLREGSC-KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDY 455 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~-----~~~~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey 455 (679)
.+.||+|+||.||+|+. .++..||+|.+..... .....+.+|++++++++||||+++++++.. ....++||||
T Consensus 10 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~ 88 (283)
T cd05090 10 MEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQ-EQPVCMLFEY 88 (283)
T ss_pred eeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEec-CCceEEEEEc
Confidence 37899999999999984 3467899999975432 233578899999999999999999999887 6789999999
Q ss_pred cCCCChHHHhhcccC-------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEE
Q 005749 456 FPSRTLHDLLHDTIA-------------GKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRL 522 (679)
Q Consensus 456 ~~~gsL~~~l~~~~~-------------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl 522 (679)
+++++|.+++..... ....+++.+.+.++.|++.||+|||+++ ++||||||+||++++++.+||
T Consensus 89 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~~~kl 165 (283)
T cd05090 89 LNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKI 165 (283)
T ss_pred CCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCCcEEe
Confidence 999999999853211 1235889999999999999999999988 999999999999999999999
Q ss_pred eecccccccCcccc-cchhcccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHH
Q 005749 523 TEFGLDQLMVPAVA-DEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVA 600 (679)
Q Consensus 523 ~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~ 600 (679)
+|||+++....... .......++..|+|||++.+..++.++||||||+++|||++ |..||.+.... ...+.+.
T Consensus 166 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~---~~~~~~~-- 240 (283)
T cd05090 166 SDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ---EVIEMVR-- 240 (283)
T ss_pred ccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHHH--
Confidence 99999986533221 11223345677999999988889999999999999999998 88898543211 1111110
Q ss_pred hhcccccccchHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHh
Q 005749 601 VLEETTMEVFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEE 656 (679)
Q Consensus 601 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 656 (679)
.. ...+......+++.+++.+||+.||++||++.+|+++|+.
T Consensus 241 --~~------------~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 241 --KR------------QLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred --cC------------CcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 00 0001111223567789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=316.00 Aligned_cols=254 Identities=22% Similarity=0.313 Sum_probs=203.9
Q ss_pred cCccccCCceEEEEEEeC-CCCEEEEEEcccCc---ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecC
Q 005749 382 GQVIEKTTYGTAYKAKLA-DGATIALRLLREGS---CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFP 457 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~ 457 (679)
.+.||+|+||.||+|... +|+.||+|.++... ....+.+.+|++++++++|+||+++++++.. .+..++||||++
T Consensus 7 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~ 85 (267)
T cd08224 7 EKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIE-NNELNIVLELAD 85 (267)
T ss_pred eeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeec-CCeEEEEEecCC
Confidence 378999999999999955 89999999886432 2235678999999999999999999999987 678999999999
Q ss_pred CCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCccccc
Q 005749 458 SRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVAD 537 (679)
Q Consensus 458 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 537 (679)
+|+|.+++.........+++.+++.++.++++||+|||+.+ |+||||||+||+++.++.++++|||+++...... .
T Consensus 86 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~-~ 161 (267)
T cd08224 86 AGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT-T 161 (267)
T ss_pred CCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccCCC-c
Confidence 99999998754433456899999999999999999999988 9999999999999999999999999987653321 1
Q ss_pred chhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhc
Q 005749 538 EMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKG 617 (679)
Q Consensus 538 ~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~ 617 (679)
......++..|+|||.+.+..++.++|||||||++|||++|+.||..... ...+.... +..+
T Consensus 162 ~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~--------------~~~~ 223 (267)
T cd08224 162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSLCKK--------------IEKC 223 (267)
T ss_pred ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc----cHHHHHhh--------------hhcC
Confidence 12334678889999999888899999999999999999999999854321 11111111 0111
Q ss_pred CCCC--hHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhC
Q 005749 618 IRSP--MEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENR 658 (679)
Q Consensus 618 ~~~~--~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 658 (679)
...+ .+.....+.+++.+||..+|++||++.+|++.|+++.
T Consensus 224 ~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 224 DYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred CCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 1111 1133456778999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=324.17 Aligned_cols=247 Identities=20% Similarity=0.259 Sum_probs=195.4
Q ss_pred CccccCCceEEEEEEe-CCCCEEEEEEcccCcc---cCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCC
Q 005749 383 QVIEKTTYGTAYKAKL-ADGATIALRLLREGSC---KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPS 458 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~---~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~ 458 (679)
++||+|+||+||+++. .+++.||+|++..... .....+.+|++++++++||||+++++++.. .+..++||||+++
T Consensus 6 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~ 84 (285)
T cd05605 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET-KDALCLVLTLMNG 84 (285)
T ss_pred EEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecC-CCeEEEEEeccCC
Confidence 6799999999999994 5789999999865322 223457889999999999999999999887 5789999999999
Q ss_pred CChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccc
Q 005749 459 RTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADE 538 (679)
Q Consensus 459 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 538 (679)
|+|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||+++...... .
T Consensus 85 ~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~--~ 157 (285)
T cd05605 85 GDLKFHIYNMG--NPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE--T 157 (285)
T ss_pred CcHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC--c
Confidence 99998886532 345899999999999999999999988 9999999999999999999999999988653221 1
Q ss_pred hhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcC
Q 005749 539 MVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGI 618 (679)
Q Consensus 539 ~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~ 618 (679)
.....|+..|+|||++.+..++.++||||+||++|||++|+.||.+..... ....+.. .+....
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~---~~~~~~~-------------~~~~~~ 221 (285)
T cd05605 158 IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV---KREEVER-------------RVKEDQ 221 (285)
T ss_pred cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh---HHHHHHH-------------Hhhhcc
Confidence 234468899999999998889999999999999999999999996432211 0001110 111111
Q ss_pred CCChHHHHHHHHHHHHhccCcCCCCCC-----CHHHHHHH
Q 005749 619 RSPMEEGLVQALKLAMGCCAPVASVRP-----TMDEVVKQ 653 (679)
Q Consensus 619 ~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~evl~~ 653 (679)
..........+.+++.+||+.||++|| +++++++.
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 222 EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 111122345667899999999999999 78888665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=321.47 Aligned_cols=261 Identities=19% Similarity=0.296 Sum_probs=197.3
Q ss_pred CccccCCceEEEEEEeC-----CCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCC-CCceEEEEEec
Q 005749 383 QVIEKTTYGTAYKAKLA-----DGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGK-RGEKLLIYDYF 456 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~~-----~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~-~~~~~lv~ey~ 456 (679)
+.||+|+||.||+|+.. ++..||+|.+........+.+.+|++++++++||||+++++++... ....++||||+
T Consensus 10 ~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~ 89 (284)
T cd05081 10 QQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYL 89 (284)
T ss_pred eeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEEEec
Confidence 78999999999999743 5789999998765544556789999999999999999999987542 34689999999
Q ss_pred CCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccc
Q 005749 457 PSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVA 536 (679)
Q Consensus 457 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 536 (679)
++|+|.+++... ...+++..+..++.|++.||+|||+++ |+||||||+||++++++.+||+|||+++.......
T Consensus 90 ~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~ 163 (284)
T cd05081 90 PYGSLRDYLQKH---RERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVLPQDKE 163 (284)
T ss_pred CCCCHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccccCCCc
Confidence 999999999753 235899999999999999999999988 99999999999999999999999999987643321
Q ss_pred cc--hhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccch---
Q 005749 537 DE--MVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFD--- 611 (679)
Q Consensus 537 ~~--~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~--- 611 (679)
.. .....++..|+|||++.+..++.++|||||||++|||++|..|+...... +.... ..........
T Consensus 164 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~-------~~~~~-~~~~~~~~~~~~~ 235 (284)
T cd05081 164 YYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE-------FMRMM-GNDKQGQMIVYHL 235 (284)
T ss_pred ceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh-------hhhhc-ccccccccchHHH
Confidence 11 11122345699999998888999999999999999999988775332110 00000 0000000000
Q ss_pred -HhhhhcCC-CChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhh
Q 005749 612 -MEIMKGIR-SPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEEN 657 (679)
Q Consensus 612 -~~i~~~~~-~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 657 (679)
..+..+.. +.......++.+++.+||+.+|++||||.||++.|+.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 236 IELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 00111111 11122235678899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=332.16 Aligned_cols=236 Identities=20% Similarity=0.259 Sum_probs=186.6
Q ss_pred CccccCCceEEEEEEe-CCCCEEEEEEcccCc---ccCcccHHHHHHHHhccCCC-CCccceEEeeCCCCceEEEEEecC
Q 005749 383 QVIEKTTYGTAYKAKL-ADGATIALRLLREGS---CKDRSSCLPVIRQLGKVRHE-NLIPLRAFYQGKRGEKLLIYDYFP 457 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~-nIv~l~~~~~~~~~~~~lv~ey~~ 457 (679)
+.||+|+||.||+|+. .+++.||+|+++... ....+.+..|++++..++|+ +|+++++++.+ .+..++||||++
T Consensus 6 ~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-~~~~~lv~E~~~ 84 (324)
T cd05587 6 MVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT-MDRLYFVMEYVN 84 (324)
T ss_pred EEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEc-CCEEEEEEcCCC
Confidence 6799999999999995 457899999987532 23345678899999999765 57888888887 678999999999
Q ss_pred CCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCccccc
Q 005749 458 SRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVAD 537 (679)
Q Consensus 458 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 537 (679)
+|+|.+++... ..+++..+..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++..... ..
T Consensus 85 ~g~L~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~-~~ 156 (324)
T cd05587 85 GGDLMYHIQQV----GKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG-GK 156 (324)
T ss_pred CCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC-CC
Confidence 99999998753 45889999999999999999999988 999999999999999999999999998753211 11
Q ss_pred chhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhc
Q 005749 538 EMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKG 617 (679)
Q Consensus 538 ~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~ 617 (679)
......||..|+|||++.+..++.++||||+||++|||++|+.||.+.... .+ .... ...
T Consensus 157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~---~~---~~~i--------------~~~ 216 (324)
T cd05587 157 TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED---EL---FQSI--------------MEH 216 (324)
T ss_pred ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---HH---HHHH--------------HcC
Confidence 223457899999999999989999999999999999999999999543221 11 1100 111
Q ss_pred CCCChHHHHHHHHHHHHhccCcCCCCCCCH
Q 005749 618 IRSPMEEGLVQALKLAMGCCAPVASVRPTM 647 (679)
Q Consensus 618 ~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~ 647 (679)
..........++.+++.+||..||++|++.
T Consensus 217 ~~~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 217 NVSYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred CCCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 001111223467789999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=322.28 Aligned_cols=254 Identities=20% Similarity=0.318 Sum_probs=201.7
Q ss_pred cCccccCCceEEEEEEeCC-----CCEEEEEEcccCc-ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEe
Q 005749 382 GQVIEKTTYGTAYKAKLAD-----GATIALRLLREGS-CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDY 455 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~~-----~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey 455 (679)
.++||+|+||.||+|...+ +..||+|++.... ....+.+.+|+.++++++|+||+++++++.......++++||
T Consensus 11 ~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~~ 90 (280)
T cd05043 11 SDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPY 90 (280)
T ss_pred eeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCEEEEEc
Confidence 4789999999999999655 7889999987542 233566889999999999999999999887656788999999
Q ss_pred cCCCChHHHhhcccCC----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeeccccccc
Q 005749 456 FPSRTLHDLLHDTIAG----KPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLM 531 (679)
Q Consensus 456 ~~~gsL~~~l~~~~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 531 (679)
+++|+|.+++...... ...+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++.+
T Consensus 91 ~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d~g~~~~~ 167 (280)
T cd05043 91 MNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDNALSRDL 167 (280)
T ss_pred CCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECCCCCcccc
Confidence 9999999999764322 156899999999999999999999988 999999999999999999999999999876
Q ss_pred Ccccccc-hhcccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHHhhccccccc
Q 005749 532 VPAVADE-MVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAVLEETTMEV 609 (679)
Q Consensus 532 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 609 (679)
....... .....++..|+|||++.+..++.++||||||+++||+++ |+.||..... ..+..+..
T Consensus 168 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~~~~~----------- 233 (280)
T cd05043 168 FPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP---FEMAAYLK----------- 233 (280)
T ss_pred cCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH---HHHHHHHH-----------
Confidence 4332211 122345677999999988889999999999999999998 9999854321 11111111
Q ss_pred chHhhhhcCCC-ChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhC
Q 005749 610 FDMEIMKGIRS-PMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENR 658 (679)
Q Consensus 610 ~~~~i~~~~~~-~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 658 (679)
.+... ........+.+++.+||..||++|||+.|+++.|+++.
T Consensus 234 ------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~ 277 (280)
T cd05043 234 ------DGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFH 277 (280)
T ss_pred ------cCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 01000 01112346778999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=316.34 Aligned_cols=247 Identities=23% Similarity=0.367 Sum_probs=197.0
Q ss_pred cCccccCCceEEEEEEeCCCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCCh
Q 005749 382 GQVIEKTTYGTAYKAKLADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRTL 461 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gsL 461 (679)
.+.||+|+||.||+|+..++..||+|.+.... ...+.+.+|++++++++|+||+++++++.. +..++||||+++|+|
T Consensus 11 ~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~v~e~~~~~~L 87 (260)
T cd05069 11 DVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE--EPIYIVTEFMGKGSL 87 (260)
T ss_pred eeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC--CCcEEEEEcCCCCCH
Confidence 36799999999999998777789999986543 234678999999999999999999998754 568999999999999
Q ss_pred HHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccchhc
Q 005749 462 HDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVA 541 (679)
Q Consensus 462 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 541 (679)
.++++... ...+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++............
T Consensus 88 ~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~~ 162 (260)
T cd05069 88 LDFLKEGD--GKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQG 162 (260)
T ss_pred HHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCcccccCC
Confidence 99997542 345899999999999999999999988 9999999999999999999999999998654332222223
Q ss_pred ccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcCCC
Q 005749 542 LAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIRS 620 (679)
Q Consensus 542 ~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~~ 620 (679)
..++..|+|||...+..++.++||||||+++|||++ |+.||.+.... ....+ +..+...
T Consensus 163 ~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~-----------------~~~~~~~ 222 (260)
T cd05069 163 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR---EVLEQ-----------------VERGYRM 222 (260)
T ss_pred CccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHH-----------------HHcCCCC
Confidence 345678999999988889999999999999999999 89898543221 11111 0111111
Q ss_pred -ChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHh
Q 005749 621 -PMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEE 656 (679)
Q Consensus 621 -~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 656 (679)
........+.+++.+||+.||++||++++|++.|++
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 223 PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 112233567789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=318.22 Aligned_cols=253 Identities=20% Similarity=0.304 Sum_probs=202.3
Q ss_pred CccccCCceEEEEEE-eCCCCEEEEEEcccCcc---cCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCC
Q 005749 383 QVIEKTTYGTAYKAK-LADGATIALRLLREGSC---KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPS 458 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~---~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~ 458 (679)
+.||+|+||.||+|+ ..++..+|||.+..... ...+++.+|+++++.++||||+++++++.. ++..+++|||+++
T Consensus 8 ~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~~v~e~~~~ 86 (267)
T cd08229 8 KKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE-DNELNIVLELADA 86 (267)
T ss_pred hhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEe-CCeEEEEEEecCC
Confidence 679999999999999 56899999998865322 234578899999999999999999999987 6789999999999
Q ss_pred CChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccc
Q 005749 459 RTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADE 538 (679)
Q Consensus 459 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 538 (679)
++|.+++.........+++..++.++.|+++||+|||+++ ++|+||||+||+++.++.++++|||++....... ..
T Consensus 87 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~-~~ 162 (267)
T cd08229 87 GDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT-TA 162 (267)
T ss_pred CCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhccccCC-cc
Confidence 9999998753333456899999999999999999999988 9999999999999999999999999987653321 11
Q ss_pred hhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcC
Q 005749 539 MVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGI 618 (679)
Q Consensus 539 ~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~ 618 (679)
.....++..|+|||.+.+..++.++||||||+++|||++|..||...... .....+. +....
T Consensus 163 ~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~~--------------~~~~~ 224 (267)
T cd08229 163 AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCKK--------------IEQCD 224 (267)
T ss_pred cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch----HHHHhhh--------------hhcCC
Confidence 23346888999999998888999999999999999999999998543221 1111110 01100
Q ss_pred CC--ChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhC
Q 005749 619 RS--PMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENR 658 (679)
Q Consensus 619 ~~--~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 658 (679)
.+ +......++.+++.+||+.||++||||.+|++.++++-
T Consensus 225 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 225 YPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred CCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 01 11223456778999999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=332.86 Aligned_cols=194 Identities=19% Similarity=0.328 Sum_probs=167.4
Q ss_pred cCccccCCceEEEEEEeC-CCCEEEEEEcccCcc-cCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCC
Q 005749 382 GQVIEKTTYGTAYKAKLA-DGATIALRLLREGSC-KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSR 459 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~g 459 (679)
.+.||+|+||.||+|+.. ++..+|+|.++.... ...+.+.+|++++++++|||||+++++|.+ .+..++||||+++|
T Consensus 10 ~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~ 88 (333)
T cd06650 10 ISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-DGEISICMEHMDGG 88 (333)
T ss_pred eccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEE-CCEEEEEEecCCCC
Confidence 378999999999999954 688999998875422 234578999999999999999999999998 68999999999999
Q ss_pred ChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccch
Q 005749 460 TLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEM 539 (679)
Q Consensus 460 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 539 (679)
+|.+++... ..+++.....++.|++.||+|||+.+ +|+||||||+|||+++++.+||+|||++...... ..
T Consensus 89 ~L~~~l~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~---~~ 159 (333)
T cd06650 89 SLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MA 159 (333)
T ss_pred cHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh---cc
Confidence 999999753 35889999999999999999999742 2999999999999999999999999998765322 12
Q ss_pred hcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 005749 540 VALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSG 585 (679)
Q Consensus 540 ~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~ 585 (679)
....|+..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 160 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred ccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 2346889999999999888999999999999999999999998543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=332.60 Aligned_cols=243 Identities=18% Similarity=0.223 Sum_probs=190.1
Q ss_pred CccccCCceEEEEEEe-CCCCEEEEEEcccCcc---cCcccHHHHHHHHhcc-CCCCCccceEEeeCCCCceEEEEEecC
Q 005749 383 QVIEKTTYGTAYKAKL-ADGATIALRLLREGSC---KDRSSCLPVIRQLGKV-RHENLIPLRAFYQGKRGEKLLIYDYFP 457 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~---~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~~lv~ey~~ 457 (679)
+.||+|+||.||+|+. .+++.||+|+++.... ...+.+.+|+.++.++ +||||+++++++.+ .+..++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~ 79 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQT-TSRLFLVIEYVN 79 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEe-CCEEEEEEeCCC
Confidence 4699999999999994 5688999999976422 2344678899999888 69999999999887 678999999999
Q ss_pred CCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCccccc
Q 005749 458 SRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVAD 537 (679)
Q Consensus 458 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 537 (679)
+|+|.+++... ..+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++..... ..
T Consensus 80 ~~~L~~~~~~~----~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~-~~ 151 (327)
T cd05617 80 GGDLMFHMQRQ----RKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP-GD 151 (327)
T ss_pred CCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCC-CC
Confidence 99999988653 45899999999999999999999988 999999999999999999999999998753221 12
Q ss_pred chhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhc
Q 005749 538 EMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKG 617 (679)
Q Consensus 538 ~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~ 617 (679)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.............+..... ...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~-------------~~~ 218 (327)
T cd05617 152 TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVI-------------LEK 218 (327)
T ss_pred ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHH-------------HhC
Confidence 2234578999999999999999999999999999999999999995433222222111111111 111
Q ss_pred CCCChHHHHHHHHHHHHhccCcCCCCCCCH
Q 005749 618 IRSPMEEGLVQALKLAMGCCAPVASVRPTM 647 (679)
Q Consensus 618 ~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~ 647 (679)
...........+.+++.+||+.||++||++
T Consensus 219 ~~~~p~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 219 PIRIPRFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred CCCCCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 001111123456789999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=336.28 Aligned_cols=255 Identities=19% Similarity=0.319 Sum_probs=198.7
Q ss_pred hcCccccCCceEEEEEEeC------CCCEEEEEEcccCcc-cCcccHHHHHHHHhccC-CCCCccceEEeeCCCCceEEE
Q 005749 381 TGQVIEKTTYGTAYKAKLA------DGATIALRLLREGSC-KDRSSCLPVIRQLGKVR-HENLIPLRAFYQGKRGEKLLI 452 (679)
Q Consensus 381 ~~~~ig~G~~g~Vy~~~~~------~~~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~-H~nIv~l~~~~~~~~~~~~lv 452 (679)
.++.||+|+||.||+|+.. .+..||+|+++.... ...+.+.+|++++.++. |||||+++++|.. .+..++|
T Consensus 41 ~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~-~~~~~iv 119 (401)
T cd05107 41 LGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTK-GGPIYII 119 (401)
T ss_pred hhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc-CCCcEEE
Confidence 4689999999999999853 346899999976432 22346889999999997 9999999999987 6789999
Q ss_pred EEecCCCChHHHhhcccC--------------------------------------------------------------
Q 005749 453 YDYFPSRTLHDLLHDTIA-------------------------------------------------------------- 470 (679)
Q Consensus 453 ~ey~~~gsL~~~l~~~~~-------------------------------------------------------------- 470 (679)
|||+++|+|.++++....
T Consensus 120 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (401)
T cd05107 120 TEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTV 199 (401)
T ss_pred EeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcchhhh
Confidence 999999999999965321
Q ss_pred --------------------------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCC
Q 005749 471 --------------------------------GKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFF 518 (679)
Q Consensus 471 --------------------------------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~ 518 (679)
....+++..++.|+.|++.||+|||+.+ |+||||||+|||+++++
T Consensus 200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiLl~~~~ 276 (401)
T cd05107 200 KYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVLICEGK 276 (401)
T ss_pred hhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEEEeCCC
Confidence 1134788889999999999999999887 99999999999999999
Q ss_pred ceEEeecccccccCcccc-cchhcccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHH
Q 005749 519 VSRLTEFGLDQLMVPAVA-DEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSI 596 (679)
Q Consensus 519 ~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~ 596 (679)
.+|++|||+++....... .......++..|+|||.+....++.++|||||||++|||++ |+.||......+ .
T Consensus 277 ~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~------~ 350 (401)
T cd05107 277 LVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE------Q 350 (401)
T ss_pred EEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH------H
Confidence 999999999986532211 11123356788999999988889999999999999999998 888984332111 0
Q ss_pred HHHHhhcccccccchHhhhhcCCCCh-HHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhC
Q 005749 597 VKVAVLEETTMEVFDMEIMKGIRSPM-EEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENR 658 (679)
Q Consensus 597 ~~~~~~~~~~~~~~~~~i~~~~~~~~-~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 658 (679)
... .+..+.+... .....++.+++.+||..+|++||+++||++.|+++.
T Consensus 351 ~~~-------------~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 351 FYN-------------AIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred HHH-------------HHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 000 0111111111 122356778999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=342.39 Aligned_cols=257 Identities=18% Similarity=0.270 Sum_probs=189.1
Q ss_pred cCccccCCceEEEEEEe-CCCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCC-------CCceEEEE
Q 005749 382 GQVIEKTTYGTAYKAKL-ADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGK-------RGEKLLIY 453 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~-------~~~~~lv~ 453 (679)
.+.||+|+||.||+|+. .+++.||||++... .....+|+.++++++|||||++++++... ....++||
T Consensus 71 ~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~----~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvm 146 (440)
T PTZ00036 71 GNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD----PQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVM 146 (440)
T ss_pred eEEEEeCCCEEEEEEEECCCCCEEEEEEEecC----cchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEEEE
Confidence 47899999999999995 56899999988542 23456799999999999999999887531 12367899
Q ss_pred EecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCC-ceEEeecccccccC
Q 005749 454 DYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFF-VSRLTEFGLDQLMV 532 (679)
Q Consensus 454 ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~-~~kl~DFGla~~~~ 532 (679)
||+++ +|.+++.........+++..++.++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||+|+.+.
T Consensus 147 E~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~ 222 (440)
T PTZ00036 147 EFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLL 222 (440)
T ss_pred ecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeeccccchhcc
Confidence 99985 788777654333456899999999999999999999988 99999999999999664 79999999998764
Q ss_pred cccccchhcccccccccccccccc-cCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhh-c-c-----
Q 005749 533 PAVADEMVALAKADGYKAPELQRM-KKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVL-E-E----- 604 (679)
Q Consensus 533 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~-~-~----- 604 (679)
... ......||+.|+|||++.+ ..++.++|||||||++|||++|.+||.+....+ .+....+..-. . +
T Consensus 223 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~--~~~~i~~~~~~p~~~~~~~~ 298 (440)
T PTZ00036 223 AGQ--RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD--QLVRIIQVLGTPTEDQLKEM 298 (440)
T ss_pred CCC--CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhCCCCHHHHHHh
Confidence 322 2234578999999998865 468999999999999999999999996543321 11111111000 0 0
Q ss_pred -------cccccchHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 605 -------TTMEVFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 605 -------~~~~~~~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
.........+... .......++.+++.+||+.||++|||+.|++++
T Consensus 299 ~~~~~~~~~~~~~~~~l~~~---~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 299 NPNYADIKFPDVKPKDLKKV---FPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred chhhhcccCCccCchhHHHH---hccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 0000000000000 000123567899999999999999999999865
|
|
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=318.95 Aligned_cols=250 Identities=23% Similarity=0.348 Sum_probs=193.8
Q ss_pred CccccCCceEEEEEEeC-CCC--EEEEEEcccCc-ccCcccHHHHHHHHhcc-CCCCCccceEEeeCCCCceEEEEEecC
Q 005749 383 QVIEKTTYGTAYKAKLA-DGA--TIALRLLREGS-CKDRSSCLPVIRQLGKV-RHENLIPLRAFYQGKRGEKLLIYDYFP 457 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~~-~~~--~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~~lv~ey~~ 457 (679)
++||+|+||.||+|+.. ++. .+|+|.++... ....+.+.+|++++.++ +||||+++++++.. .+..++||||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-~~~~~lv~e~~~ 79 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-RGYLYLAIEYAP 79 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEec-CCCceEEEEeCC
Confidence 46999999999999964 344 46888887532 23345788999999999 89999999999987 678999999999
Q ss_pred CCChHHHhhcccC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeec
Q 005749 458 SRTLHDLLHDTIA------------GKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEF 525 (679)
Q Consensus 458 ~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 525 (679)
+|+|.+++..... ....+++.+++.++.|++.||+|||+.+ ++||||||+||++++++.+|++||
T Consensus 80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~df 156 (270)
T cd05047 80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADF 156 (270)
T ss_pred CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCC
Confidence 9999999975321 1235889999999999999999999987 999999999999999999999999
Q ss_pred ccccccCcccccchhcccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHHhhcc
Q 005749 526 GLDQLMVPAVADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAVLEE 604 (679)
Q Consensus 526 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~~~~~ 604 (679)
|++....... .......+..|+|||++....++.++|||||||++|||++ |..||.+.... +.....
T Consensus 157 gl~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~------~~~~~~---- 224 (270)
T cd05047 157 GLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA------ELYEKL---- 224 (270)
T ss_pred CCccccchhh--hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH------HHHHHH----
Confidence 9986432111 1111233567999999988889999999999999999997 99998543221 111111
Q ss_pred cccccchHhhhhcCCC-ChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhC
Q 005749 605 TTMEVFDMEIMKGIRS-PMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENR 658 (679)
Q Consensus 605 ~~~~~~~~~i~~~~~~-~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 658 (679)
..+... .......++.+++.+||+.+|.+|||+.|+++.|+++.
T Consensus 225 ----------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 225 ----------PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred ----------hCCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 010000 01112346778999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=334.56 Aligned_cols=242 Identities=21% Similarity=0.256 Sum_probs=187.5
Q ss_pred CccccCCceEEEEEEe-CCCCEEEEEEcccCc---ccCcccHHHHHH-HHhccCCCCCccceEEeeCCCCceEEEEEecC
Q 005749 383 QVIEKTTYGTAYKAKL-ADGATIALRLLREGS---CKDRSSCLPVIR-QLGKVRHENLIPLRAFYQGKRGEKLLIYDYFP 457 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~Ei~-~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~ 457 (679)
+.||+|+||+||+|+. .+++.||+|++.... ......+..|.. +++.++||||+++++++.. .+..++||||++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~-~~~~~lv~e~~~ 79 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT-ADKLYFVLDYIN 79 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEc-CCeEEEEEeCCC
Confidence 4699999999999994 467899999987532 122234445544 4677899999999999987 678999999999
Q ss_pred CCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCccccc
Q 005749 458 SRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVAD 537 (679)
Q Consensus 458 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 537 (679)
+|+|.+++... ..+++...+.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++..... ..
T Consensus 80 ~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~-~~ 151 (325)
T cd05602 80 GGELFYHLQRE----RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEH-NG 151 (325)
T ss_pred CCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccC-CC
Confidence 99999999753 44788889999999999999999988 999999999999999999999999998754222 12
Q ss_pred chhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhc
Q 005749 538 EMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKG 617 (679)
Q Consensus 538 ~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~ 617 (679)
......||+.|+|||++.+..++.++||||+||++|||++|+.||.+.... +..... ...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~~~i--------------~~~ 211 (325)
T cd05602 152 TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA------EMYDNI--------------LNK 211 (325)
T ss_pred CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH------HHHHHH--------------HhC
Confidence 233457899999999999989999999999999999999999999543221 111111 000
Q ss_pred CCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 618 IRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 618 ~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
.....+.....+.+++.+|++.||.+||++.+.+..
T Consensus 212 ~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ 247 (325)
T cd05602 212 PLQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFME 247 (325)
T ss_pred CcCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHH
Confidence 001111223456789999999999999998754433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=322.32 Aligned_cols=251 Identities=21% Similarity=0.315 Sum_probs=195.8
Q ss_pred cCccccCCceEEEEEEeC------CCCEEEEEEcccCccc-CcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEE
Q 005749 382 GQVIEKTTYGTAYKAKLA------DGATIALRLLREGSCK-DRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYD 454 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~------~~~~vAvK~~~~~~~~-~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~e 454 (679)
.+.||+|+||.||+|+.. ++..||+|+++..... ..+.+.+|+.++.+++||||+++++++.+ .+..++++|
T Consensus 10 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~-~~~~~~~~e 88 (283)
T cd05091 10 MEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTK-EQPLSMIFS 88 (283)
T ss_pred HHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-CCceEEEEE
Confidence 367999999999999853 2578999999754322 23568899999999999999999999987 578999999
Q ss_pred ecCCCChHHHhhccc------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEE
Q 005749 455 YFPSRTLHDLLHDTI------------AGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRL 522 (679)
Q Consensus 455 y~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl 522 (679)
|+++++|.+++.... .....+++..+++++.|++.||+|||+++ |+||||||+||++++++.+||
T Consensus 89 ~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~kl 165 (283)
T cd05091 89 YCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLNVKI 165 (283)
T ss_pred cCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCceEe
Confidence 999999999985321 11235889999999999999999999988 999999999999999999999
Q ss_pred eecccccccCcccc-cchhcccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHH
Q 005749 523 TEFGLDQLMVPAVA-DEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVA 600 (679)
Q Consensus 523 ~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~ 600 (679)
+|||+++....... .......+++.|+|||.+.++.++.++|||||||++|||++ |..||.+.... ++....
T Consensus 166 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~------~~~~~i 239 (283)
T cd05091 166 SDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ------DVIEMI 239 (283)
T ss_pred cccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH------HHHHHH
Confidence 99999886533221 11223345678999999988889999999999999999998 88887443211 111111
Q ss_pred hhcccccccchHhhhhcCCCC-hHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHh
Q 005749 601 VLEETTMEVFDMEIMKGIRSP-MEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEE 656 (679)
Q Consensus 601 ~~~~~~~~~~~~~i~~~~~~~-~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 656 (679)
..+...+ .......+.+++.+||+.+|++||+++||++.|+.
T Consensus 240 --------------~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 240 --------------RNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred --------------HcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 1111111 12233457789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=333.50 Aligned_cols=237 Identities=23% Similarity=0.292 Sum_probs=185.9
Q ss_pred CccccCCceEEEEEEe-CCCCEEEEEEcccCc---ccCcccHHHHHH-HHhccCCCCCccceEEeeCCCCceEEEEEecC
Q 005749 383 QVIEKTTYGTAYKAKL-ADGATIALRLLREGS---CKDRSSCLPVIR-QLGKVRHENLIPLRAFYQGKRGEKLLIYDYFP 457 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~Ei~-~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~ 457 (679)
++||+|+||.||+|+. .+++.||+|++.... ......+.+|.. +++.++|||||++++++.+ .+..++||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~-~~~~~lv~e~~~ 79 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQT-AEKLYFVLDYVN 79 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEc-CCEEEEEEcCCC
Confidence 4799999999999995 568999999986532 122334555654 5788999999999999887 678999999999
Q ss_pred CCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCccccc
Q 005749 458 SRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVAD 537 (679)
Q Consensus 458 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 537 (679)
+|+|.+.+.. ...+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++..... ..
T Consensus 80 ~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-~~ 151 (321)
T cd05603 80 GGELFFHLQR----ERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP-EE 151 (321)
T ss_pred CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCC-CC
Confidence 9999988865 345888899999999999999999988 999999999999999999999999998753222 12
Q ss_pred chhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhc
Q 005749 538 EMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKG 617 (679)
Q Consensus 538 ~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~ 617 (679)
......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ...... +...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~--------------i~~~ 211 (321)
T cd05603 152 TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV------SQMYDN--------------ILHK 211 (321)
T ss_pred ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH------HHHHHH--------------HhcC
Confidence 22345789999999999988899999999999999999999999954321 111111 1111
Q ss_pred CCCChHHHHHHHHHHHHhccCcCCCCCCCHH
Q 005749 618 IRSPMEEGLVQALKLAMGCCAPVASVRPTMD 648 (679)
Q Consensus 618 ~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ 648 (679)
.....+.....+.+++.+|++.||++||++.
T Consensus 212 ~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 212 PLQLPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 1111112335677899999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=320.20 Aligned_cols=251 Identities=21% Similarity=0.350 Sum_probs=197.5
Q ss_pred CccccCCceEEEEEE-eCCCC----EEEEEEcccCc-ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEec
Q 005749 383 QVIEKTTYGTAYKAK-LADGA----TIALRLLREGS-CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYF 456 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~-~~~~~----~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~ 456 (679)
+.||+|+||+||+|+ ..++. .||+|+++... ....+.+.+|+.++..++||||+++++++.. ...++++||+
T Consensus 13 ~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~l~~~~~ 90 (279)
T cd05109 13 KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT--STVQLVTQLM 90 (279)
T ss_pred eecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC--CCcEEEEEcC
Confidence 789999999999998 44555 48999987543 2334578899999999999999999999875 4678999999
Q ss_pred CCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccc
Q 005749 457 PSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVA 536 (679)
Q Consensus 457 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 536 (679)
++|+|.++++.. ...+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.......
T Consensus 91 ~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~ 164 (279)
T cd05109 91 PYGCLLDYVREN---KDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDET 164 (279)
T ss_pred CCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeecccccc
Confidence 999999999763 235899999999999999999999988 99999999999999999999999999987643221
Q ss_pred c-chhcccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHHhhcccccccchHhh
Q 005749 537 D-EMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEI 614 (679)
Q Consensus 537 ~-~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i 614 (679)
. ......++..|+|||...+..++.++|||||||++|||++ |..||...... .+..++.
T Consensus 165 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~~~---------------- 225 (279)
T cd05109 165 EYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR---EIPDLLE---------------- 225 (279)
T ss_pred eeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHHH----------------
Confidence 1 1122234567999999988889999999999999999998 88898432211 1111111
Q ss_pred hhcCC-CChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCCCC
Q 005749 615 MKGIR-SPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRPRN 661 (679)
Q Consensus 615 ~~~~~-~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 661 (679)
.+.. +.......++.+++.+||+.||++||++.|+++.|+++....
T Consensus 226 -~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 226 -KGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred -CCCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 1000 111223456778999999999999999999999999886544
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=324.53 Aligned_cols=253 Identities=23% Similarity=0.382 Sum_probs=198.7
Q ss_pred cCccccCCceEEEEEEeC------CCCEEEEEEcccCc-ccCcccHHHHHHHHhcc-CCCCCccceEEeeCCCCceEEEE
Q 005749 382 GQVIEKTTYGTAYKAKLA------DGATIALRLLREGS-CKDRSSCLPVIRQLGKV-RHENLIPLRAFYQGKRGEKLLIY 453 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~------~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~~lv~ 453 (679)
.+.||+|+||.||+|+.. +...+|+|.+.... ......+.+|++++.++ +|+||+++++++.. .+..++||
T Consensus 17 ~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-~~~~~li~ 95 (293)
T cd05053 17 GKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ-EGPLYVVV 95 (293)
T ss_pred eeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC-CCCeEEEE
Confidence 478999999999999853 23689999987542 22345688999999999 89999999999987 67899999
Q ss_pred EecCCCChHHHhhccc------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceE
Q 005749 454 DYFPSRTLHDLLHDTI------------AGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSR 521 (679)
Q Consensus 454 ey~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~k 521 (679)
||+++|+|.++++... .....+++..+++++.|++.||+|||+.+ |+||||||+||++++++.+|
T Consensus 96 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~~~~~~k 172 (293)
T cd05053 96 EYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVTEDHVMK 172 (293)
T ss_pred EeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEcCCCeEE
Confidence 9999999999997532 12346899999999999999999999987 99999999999999999999
Q ss_pred EeecccccccCcccccc-hhcccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHH
Q 005749 522 LTEFGLDQLMVPAVADE-MVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKV 599 (679)
Q Consensus 522 l~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~ 599 (679)
++|||+++.+....... .....++..|+|||++.+..++.++|||||||++|||++ |..||...... +....
T Consensus 173 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~------~~~~~ 246 (293)
T cd05053 173 IADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE------ELFKL 246 (293)
T ss_pred eCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHH------HHHHH
Confidence 99999998764322111 122334567999999988889999999999999999997 89998443211 11110
Q ss_pred HhhcccccccchHhhhhcCC-CChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhC
Q 005749 600 AVLEETTMEVFDMEIMKGIR-SPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENR 658 (679)
Q Consensus 600 ~~~~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 658 (679)
+..+.. .........+.+++.+||+.||++|||+.|+++.|+++.
T Consensus 247 --------------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 247 --------------LKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred --------------HHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 011110 111122456778999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=339.49 Aligned_cols=247 Identities=19% Similarity=0.229 Sum_probs=190.8
Q ss_pred CccccCCceEEEEEE-eCCCCEEEEEEcccCc---ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCC
Q 005749 383 QVIEKTTYGTAYKAK-LADGATIALRLLREGS---CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPS 458 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~ 458 (679)
+.||+|+||+||+|+ ..+++.||+|+++... ....+.+.+|++++++++|||||++++++.+ .+..++||||+++
T Consensus 7 ~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~-~~~~~lv~E~~~g 85 (381)
T cd05626 7 KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQD-KDNLYFVMDYIPG 85 (381)
T ss_pred EEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEec-CCEEEEEEecCCC
Confidence 689999999999998 5668999999997542 2234568899999999999999999999997 6789999999999
Q ss_pred CChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccc--
Q 005749 459 RTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVA-- 536 (679)
Q Consensus 459 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~-- 536 (679)
|+|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++++||+|||+++.......
T Consensus 86 g~L~~~l~~~----~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~ 158 (381)
T cd05626 86 GDMMSLLIRM----EVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSK 158 (381)
T ss_pred CcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCcccccccccc
Confidence 9999999763 45889999999999999999999988 99999999999999999999999999764311000
Q ss_pred --------------------------------------------cchhcccccccccccccccccCCCCcchhHHHHHHH
Q 005749 537 --------------------------------------------DEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILL 572 (679)
Q Consensus 537 --------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl 572 (679)
.......||..|+|||++.+..++.++|||||||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il 238 (381)
T cd05626 159 YYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVIL 238 (381)
T ss_pred cccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHH
Confidence 001234699999999999988899999999999999
Q ss_pred HHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcCCCChHHHHHHHHHHHHh--ccCcCCCCCCCHHHH
Q 005749 573 LEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIRSPMEEGLVQALKLAMG--CCAPVASVRPTMDEV 650 (679)
Q Consensus 573 ~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l~~~--cl~~dP~~RPs~~ev 650 (679)
|||++|+.||......+. ......... .. . .+......++..+++.+ |+..+|.+||+++|+
T Consensus 239 ~elltG~~Pf~~~~~~~~------~~~i~~~~~---~~--~-----~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~ 302 (381)
T cd05626 239 FEMLVGQPPFLAPTPTET------QLKVINWEN---TL--H-----IPPQVKLSPEAVDLITKLCCSAEERLGRNGADDI 302 (381)
T ss_pred HHHHhCCCCCcCCCHHHH------HHHHHcccc---cc--C-----CCCCCCCCHHHHHHHHHHccCcccccCCCCHHHH
Confidence 999999999954332110 000000000 00 0 01111123456677766 566677779999999
Q ss_pred HHH
Q 005749 651 VKQ 653 (679)
Q Consensus 651 l~~ 653 (679)
+++
T Consensus 303 l~h 305 (381)
T cd05626 303 KAH 305 (381)
T ss_pred hcC
Confidence 876
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=330.59 Aligned_cols=257 Identities=21% Similarity=0.344 Sum_probs=198.0
Q ss_pred hcCccccCCceEEEEEEe------CCCCEEEEEEcccCcc-cCcccHHHHHHHHhcc-CCCCCccceEEeeCCCCceEEE
Q 005749 381 TGQVIEKTTYGTAYKAKL------ADGATIALRLLREGSC-KDRSSCLPVIRQLGKV-RHENLIPLRAFYQGKRGEKLLI 452 (679)
Q Consensus 381 ~~~~ig~G~~g~Vy~~~~------~~~~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~~lv 452 (679)
..+.||+|+||.||+|+. .+++.||||+++.... .....+.+|++++.++ +|||||++++++.......++|
T Consensus 11 ~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv 90 (343)
T cd05103 11 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVI 90 (343)
T ss_pred ccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCceEEE
Confidence 458899999999999973 3578999999976432 2345688999999999 6899999999887656678999
Q ss_pred EEecCCCChHHHhhcccC--------------------------------------------------------------
Q 005749 453 YDYFPSRTLHDLLHDTIA-------------------------------------------------------------- 470 (679)
Q Consensus 453 ~ey~~~gsL~~~l~~~~~-------------------------------------------------------------- 470 (679)
|||+++|+|.+++.....
T Consensus 91 ~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (343)
T cd05103 91 VEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQED 170 (343)
T ss_pred EeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhhhhhh
Confidence 999999999999865311
Q ss_pred -CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccc-cchhcccccccc
Q 005749 471 -GKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVA-DEMVALAKADGY 548 (679)
Q Consensus 471 -~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y 548 (679)
....+++.++.+++.|+++||+|||+++ |+||||||+||++++++.+||+|||+++....... .......++..|
T Consensus 171 ~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y 247 (343)
T cd05103 171 LYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 247 (343)
T ss_pred hhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCcce
Confidence 0124788899999999999999999988 99999999999999999999999999986532211 111223456679
Q ss_pred cccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcCCCChH-HHH
Q 005749 549 KAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIRSPME-EGL 626 (679)
Q Consensus 549 ~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~-~~~ 626 (679)
+|||.+.+..++.++||||||+++|||++ |..||....... . ... . +..+.....+ ...
T Consensus 248 ~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~---~~~-~-------------~~~~~~~~~~~~~~ 308 (343)
T cd05103 248 MAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--E---FCR-R-------------LKEGTRMRAPDYTT 308 (343)
T ss_pred ECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH--H---HHH-H-------------HhccCCCCCCCCCC
Confidence 99999988889999999999999999996 899985432110 0 000 0 0111111111 122
Q ss_pred HHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCC
Q 005749 627 VQALKLAMGCCAPVASVRPTMDEVVKQLEENRP 659 (679)
Q Consensus 627 ~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 659 (679)
+++.+++.+||+.||++||++.||++.|+.+..
T Consensus 309 ~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 309 PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 467889999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=315.80 Aligned_cols=248 Identities=19% Similarity=0.318 Sum_probs=195.3
Q ss_pred CccccCCceEEEEEEeCC----CCEEEEEEcccCcc-cCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecC
Q 005749 383 QVIEKTTYGTAYKAKLAD----GATIALRLLREGSC-KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFP 457 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~~~----~~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~ 457 (679)
+.||+|+||.||+|++.. +..+|+|.+..... ...+.+.+|++++++++|+|||++++++.. +..++||||++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~v~e~~~ 78 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKG--EPLMLVMELAP 78 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC--CceEEEEEeCC
Confidence 469999999999998432 26899999876543 234578999999999999999999998764 56899999999
Q ss_pred CCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCccccc
Q 005749 458 SRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVAD 537 (679)
Q Consensus 458 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 537 (679)
+|+|.+++... ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++........
T Consensus 79 ~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~ 151 (257)
T cd05060 79 LGPLLKYLKKR----REIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY 151 (257)
T ss_pred CCcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcc
Confidence 99999999763 35899999999999999999999988 999999999999999999999999999866433221
Q ss_pred ch--hcccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHHhhcccccccchHhh
Q 005749 538 EM--VALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEI 614 (679)
Q Consensus 538 ~~--~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i 614 (679)
.. ....++..|+|||...+..++.++||||||+++|||++ |+.||...... .+..++. ...
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~---~~~~~~~----~~~--------- 215 (257)
T cd05060 152 YRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA---EVIAMLE----SGE--------- 215 (257)
T ss_pred cccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH---HHHHHHH----cCC---------
Confidence 11 11223457999999988889999999999999999998 99998443211 1111111 000
Q ss_pred hhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhC
Q 005749 615 MKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENR 658 (679)
Q Consensus 615 ~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 658 (679)
...........+.+++.+||..+|++||++.++++.|+++.
T Consensus 216 ---~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 216 ---RLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred ---cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 00111122356778999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=321.88 Aligned_cols=239 Identities=21% Similarity=0.265 Sum_probs=185.8
Q ss_pred ccccCCceEEEEEEeCC-------------------------CCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccc
Q 005749 384 VIEKTTYGTAYKAKLAD-------------------------GATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPL 438 (679)
Q Consensus 384 ~ig~G~~g~Vy~~~~~~-------------------------~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l 438 (679)
.||+|+||.||+|++.. ...||+|++..........|.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 58999999999997421 13589999876544344578889999999999999999
Q ss_pred eEEeeCCCCceEEEEEecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCC
Q 005749 439 RAFYQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFF 518 (679)
Q Consensus 439 ~~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~ 518 (679)
++++.. ....++||||+++|+|..++... ...+++..+..++.||++||+|||+++ |+||||||+|||+++++
T Consensus 82 ~~~~~~-~~~~~lv~ey~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~ 154 (274)
T cd05076 82 HGVCVR-GSENIMVEEFVEHGPLDVCLRKE---KGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLG 154 (274)
T ss_pred EEEEEe-CCceEEEEecCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccC
Confidence 999987 67899999999999999998653 345889999999999999999999987 99999999999998643
Q ss_pred -------ceEEeecccccccCcccccchhcccccccccccccccc-cCCCCcchhHHHHHHHHHHH-hCCCCCCCCCCCc
Q 005749 519 -------VSRLTEFGLDQLMVPAVADEMVALAKADGYKAPELQRM-KKCSSRTDVYAFGILLLEIL-IGKKPGKSGRNGE 589 (679)
Q Consensus 519 -------~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gvvl~El~-tg~~p~~~~~~~~ 589 (679)
.+|++|||++...... ....++..|+|||.+.+ ..++.++|||||||++||++ +|+.||......+
T Consensus 155 ~~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~ 229 (274)
T cd05076 155 LAEGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE 229 (274)
T ss_pred cccCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH
Confidence 3799999988644221 12346778999998865 56899999999999999995 7899985432211
Q ss_pred ccchhHHHHHHhhcccccccchHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHH
Q 005749 590 FVDLPSIVKVAVLEETTMEVFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLE 655 (679)
Q Consensus 590 ~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~ 655 (679)
..... . ... ...+....++.+++.+||+.+|++||+|.+|++.|.
T Consensus 230 ---~~~~~----~-------------~~~-~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 230 ---KERFY----E-------------KKH-RLPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred ---HHHHH----H-------------hcc-CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 00000 0 000 001112346778999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=317.06 Aligned_cols=247 Identities=22% Similarity=0.366 Sum_probs=198.3
Q ss_pred cCccccCCceEEEEEEeCCCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCCh
Q 005749 382 GQVIEKTTYGTAYKAKLADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRTL 461 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gsL 461 (679)
.+.||+|+||.||+|...+++.||+|.+.... ...+++.+|++++++++|+||+++++++.. +..+++|||+++++|
T Consensus 11 ~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~v~e~~~~~~L 87 (260)
T cd05067 11 VKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVTQ--EPIYIITEYMENGSL 87 (260)
T ss_pred eeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEcc--CCcEEEEEcCCCCCH
Confidence 47899999999999998889999999987543 235678999999999999999999998753 578999999999999
Q ss_pred HHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccchhc
Q 005749 462 HDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVA 541 (679)
Q Consensus 462 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 541 (679)
.+++.... ...+++.++..++.|++.||+|||+.+ ++||||||+||++++++.++++|||++.............
T Consensus 88 ~~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~ 162 (260)
T cd05067 88 VDFLKTPE--GIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREG 162 (260)
T ss_pred HHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCcccccC
Confidence 99987532 345899999999999999999999988 9999999999999999999999999987654222222223
Q ss_pred ccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcCCC
Q 005749 542 LAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIRS 620 (679)
Q Consensus 542 ~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~~ 620 (679)
..++..|+|||++....++.++||||||+++||+++ |+.||.+.... +..... ..+...
T Consensus 163 ~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~------~~~~~~--------------~~~~~~ 222 (260)
T cd05067 163 AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP------EVIQNL--------------ERGYRM 222 (260)
T ss_pred CcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH------HHHHHH--------------HcCCCC
Confidence 345678999999988889999999999999999998 99999543221 111110 011001
Q ss_pred C-hHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHh
Q 005749 621 P-MEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEE 656 (679)
Q Consensus 621 ~-~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 656 (679)
+ ......++.+++.+||+.+|++||+++++.+.|+.
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 223 PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 1 11123467889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=337.40 Aligned_cols=261 Identities=19% Similarity=0.286 Sum_probs=194.2
Q ss_pred cCccccCCceEEEEEEe-CCCCEEEEEEcccCcc--cCcccHHHHHHHHhccCCCCCccceEEeeCCC----CceEEEEE
Q 005749 382 GQVIEKTTYGTAYKAKL-ADGATIALRLLREGSC--KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKR----GEKLLIYD 454 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~----~~~~lv~e 454 (679)
.+.||+|+||.||+|+. .+++.||+|++..... ...+.+.+|+++++.++||||+++++++.... ...++|||
T Consensus 5 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 84 (372)
T cd07853 5 DRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTE 84 (372)
T ss_pred cceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEee
Confidence 47899999999999994 5799999999865322 23456889999999999999999999988632 26899999
Q ss_pred ecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcc
Q 005749 455 YFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPA 534 (679)
Q Consensus 455 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 534 (679)
|+. ++|.+.+.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 85 ~~~-~~l~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~ 156 (372)
T cd07853 85 LMQ-SDLHKIIVS----PQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD 156 (372)
T ss_pred ccc-cCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeecccC
Confidence 997 588888764 345899999999999999999999988 999999999999999999999999999865433
Q ss_pred cccchhccccccccccccccccc-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhccccc------
Q 005749 535 VADEMVALAKADGYKAPELQRMK-KCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTM------ 607 (679)
Q Consensus 535 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~------ 607 (679)
.........++..|+|||++.+. .++.++|||||||++|||++|+.||.+....+... .+..........
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~---~i~~~~g~~~~~~~~~~~ 233 (372)
T cd07853 157 ESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLD---LITDLLGTPSLEAMRSAC 233 (372)
T ss_pred ccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHH---HHHHHcCCCCHHHHHHhh
Confidence 32333345678899999998764 47999999999999999999999996543221111 010000000000
Q ss_pred ccchHhhhhc-CCCC--------hHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 608 EVFDMEIMKG-IRSP--------MEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 608 ~~~~~~i~~~-~~~~--------~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
+.....+... ...+ ......++.+++.+|++.||++|||+.|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 234 EGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 0000000000 0000 01123567789999999999999999999875
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=315.13 Aligned_cols=244 Identities=23% Similarity=0.368 Sum_probs=198.4
Q ss_pred CccccCCceEEEEEEe-CCCCEEEEEEcccC--cccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCC
Q 005749 383 QVIEKTTYGTAYKAKL-ADGATIALRLLREG--SCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSR 459 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~g 459 (679)
+.||+|+||.||+|+. .+++.||+|.+... .....+.+.+|++++++++||||+++++++.+ .+..++||||++++
T Consensus 6 ~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~ 84 (256)
T cd08529 6 NKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLD-KGKLNIVMEYAENG 84 (256)
T ss_pred EEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeecc-CCEEEEEEEeCCCC
Confidence 6799999999999995 56899999998643 23345678999999999999999999999987 67899999999999
Q ss_pred ChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccch
Q 005749 460 TLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEM 539 (679)
Q Consensus 460 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 539 (679)
+|.+++.... ...+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+||+|||+++....... ..
T Consensus 85 ~L~~~l~~~~--~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~-~~ 158 (256)
T cd08529 85 DLHKLLKMQR--GRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN-FA 158 (256)
T ss_pred cHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccc-hh
Confidence 9999997642 346899999999999999999999987 99999999999999999999999999887643321 22
Q ss_pred hcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcCC
Q 005749 540 VALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIR 619 (679)
Q Consensus 540 ~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~ 619 (679)
....++..|+|||+..+..++.++||||||+++|||++|+.||...... . .... +..+..
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~---~~~~--------------~~~~~~ 218 (256)
T cd08529 159 NTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG---A---LILK--------------IIRGVF 218 (256)
T ss_pred hccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH---H---HHHH--------------HHcCCC
Confidence 3446788999999999888999999999999999999999999543211 0 0110 111111
Q ss_pred CChH-HHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 620 SPME-EGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 620 ~~~~-~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
+..+ .....+.+++.+||+.+|++||++.++++.
T Consensus 219 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 219 PPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred CCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 1111 334567889999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=330.59 Aligned_cols=239 Identities=23% Similarity=0.365 Sum_probs=198.2
Q ss_pred CccccCCceEEEEEE-eCCCCEEEEEEcccCcc---cCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCC
Q 005749 383 QVIEKTTYGTAYKAK-LADGATIALRLLREGSC---KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPS 458 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~---~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~ 458 (679)
+.||.|+||.||-|+ ..+.+.||||++.-... ....++++|++.|++++|||+|.+.|+|.. ....|+|||||-|
T Consensus 32 rEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLr-e~TaWLVMEYClG 110 (948)
T KOG0577|consen 32 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLR-EHTAWLVMEYCLG 110 (948)
T ss_pred HHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeec-cchHHHHHHHHhc
Confidence 679999999999999 67899999999965433 335689999999999999999999999986 6788999999955
Q ss_pred CChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccc
Q 005749 459 RTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADE 538 (679)
Q Consensus 459 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 538 (679)
|-.|++... +.++.+..+..|+.+.+.||+|||+++ .||||||+.|||+.+.|.+|++|||.|..+.+.
T Consensus 111 -SAsDlleVh---kKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA---- 179 (948)
T KOG0577|consen 111 -SASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAPA---- 179 (948)
T ss_pred -cHHHHHHHH---hccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCch----
Confidence 888888765 456888999999999999999999998 999999999999999999999999999887554
Q ss_pred hhccccccccccccccc---ccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhh
Q 005749 539 MVALAKADGYKAPELQR---MKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIM 615 (679)
Q Consensus 539 ~~~~~gt~~y~aPE~~~---~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~ 615 (679)
..++||++|||||++. .+.|+-|+||||+||+..||..+++|+..... +..... |.
T Consensus 180 -nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA-----MSALYH---------------IA 238 (948)
T KOG0577|consen 180 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-----MSALYH---------------IA 238 (948)
T ss_pred -hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH-----HHHHHH---------------HH
Confidence 4679999999999875 47799999999999999999999999744321 000011 11
Q ss_pred hcC--CCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 005749 616 KGI--RSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQL 654 (679)
Q Consensus 616 ~~~--~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L 654 (679)
... .....+....+..++..|++.-|.+|||.++++..-
T Consensus 239 QNesPtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~ 279 (948)
T KOG0577|consen 239 QNESPTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKHR 279 (948)
T ss_pred hcCCCCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhcc
Confidence 111 122345567788899999999999999999987653
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=323.23 Aligned_cols=255 Identities=21% Similarity=0.346 Sum_probs=199.6
Q ss_pred hcCccccCCceEEEEEEeC--------CCCEEEEEEcccCc-ccCcccHHHHHHHHhcc-CCCCCccceEEeeCCCCceE
Q 005749 381 TGQVIEKTTYGTAYKAKLA--------DGATIALRLLREGS-CKDRSSCLPVIRQLGKV-RHENLIPLRAFYQGKRGEKL 450 (679)
Q Consensus 381 ~~~~ig~G~~g~Vy~~~~~--------~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~~ 450 (679)
.++.||+|+||.||+|+.. ++..||+|.++... ....+.+.+|+.+++.+ +||||+++++++.. .+..+
T Consensus 19 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-~~~~~ 97 (304)
T cd05101 19 LGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ-DGPLY 97 (304)
T ss_pred ecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec-CCceE
Confidence 4588999999999999731 24579999987542 23456789999999999 89999999999987 67899
Q ss_pred EEEEecCCCChHHHhhcccC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCC
Q 005749 451 LIYDYFPSRTLHDLLHDTIA------------GKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFF 518 (679)
Q Consensus 451 lv~ey~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~ 518 (679)
+||||+++|+|.+++..... ....+++.+++.++.||++||+|||+++ |+||||||+||++++++
T Consensus 98 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili~~~~ 174 (304)
T cd05101 98 VIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLVTENN 174 (304)
T ss_pred EEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEEEcCCC
Confidence 99999999999999976421 1235889999999999999999999988 99999999999999999
Q ss_pred ceEEeecccccccCccccc-chhcccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHH
Q 005749 519 VSRLTEFGLDQLMVPAVAD-EMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSI 596 (679)
Q Consensus 519 ~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~ 596 (679)
.+||+|||+++.+...... ......++..|+|||++.+..++.++||||||+++||+++ |..||..... .++
T Consensus 175 ~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~------~~~ 248 (304)
T cd05101 175 VMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV------EEL 248 (304)
T ss_pred cEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH------HHH
Confidence 9999999999876432211 1122345678999999988889999999999999999998 7788743221 111
Q ss_pred HHHHhhcccccccchHhhhhcCC-CChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCC
Q 005749 597 VKVAVLEETTMEVFDMEIMKGIR-SPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRP 659 (679)
Q Consensus 597 ~~~~~~~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 659 (679)
.... ..+.. .........+.+++.+||+.+|++||++.|+++.|+++..
T Consensus 249 ~~~~--------------~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~ 298 (304)
T cd05101 249 FKLL--------------KEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT 298 (304)
T ss_pred HHHH--------------HcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence 1111 01100 0111233567789999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=323.17 Aligned_cols=257 Identities=23% Similarity=0.331 Sum_probs=198.2
Q ss_pred cCccccCCceEEEEEEeCC-CC--EEEEEEcccCc-ccCcccHHHHHHHHhcc-CCCCCccceEEeeCCCCceEEEEEec
Q 005749 382 GQVIEKTTYGTAYKAKLAD-GA--TIALRLLREGS-CKDRSSCLPVIRQLGKV-RHENLIPLRAFYQGKRGEKLLIYDYF 456 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~~-~~--~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~~lv~ey~ 456 (679)
.++||+|+||.||+|+..+ +. .+|+|.++... ....+.+.+|++++.++ +||||+++++++.. .+..++||||+
T Consensus 7 ~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-~~~~~lv~e~~ 85 (297)
T cd05089 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACEN-RGYLYIAIEYA 85 (297)
T ss_pred eeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEcc-CCcceEEEEec
Confidence 4789999999999998643 43 47888887432 23345789999999999 79999999999887 67899999999
Q ss_pred CCCChHHHhhcccC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEee
Q 005749 457 PSRTLHDLLHDTIA------------GKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTE 524 (679)
Q Consensus 457 ~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~D 524 (679)
++|+|.++++.... ....+++..++.|+.|++.||+|||+++ |+||||||+|||+++++.+||+|
T Consensus 86 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~d 162 (297)
T cd05089 86 PYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLASKIAD 162 (297)
T ss_pred CCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeEEECC
Confidence 99999999975321 1135889999999999999999999988 99999999999999999999999
Q ss_pred cccccccCcccccchhcccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHHhhc
Q 005749 525 FGLDQLMVPAVADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAVLE 603 (679)
Q Consensus 525 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~~~~ 603 (679)
||++....... .......+..|+|||++....++.++|||||||++|||++ |..||.+.... .....
T Consensus 163 fg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~------~~~~~---- 230 (297)
T cd05089 163 FGLSRGEEVYV--KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA------ELYEK---- 230 (297)
T ss_pred cCCCcccccee--ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH------HHHHH----
Confidence 99986432111 1111223457999999988889999999999999999997 99998543221 11111
Q ss_pred ccccccchHhhhhcCCCC-hHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCCCCCCC
Q 005749 604 ETTMEVFDMEIMKGIRSP-MEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRPRNRSA 664 (679)
Q Consensus 604 ~~~~~~~~~~i~~~~~~~-~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~ 664 (679)
+..+.... .......+.+++.+||+.+|.+||+++++++.|+++....+..
T Consensus 231 ----------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~~ 282 (297)
T cd05089 231 ----------LPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKAY 282 (297)
T ss_pred ----------HhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhccc
Confidence 11111111 1122356778999999999999999999999999887655443
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=317.13 Aligned_cols=249 Identities=23% Similarity=0.407 Sum_probs=197.1
Q ss_pred cCccccCCceEEEEEEeC-CCC---EEEEEEcccCc-ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEec
Q 005749 382 GQVIEKTTYGTAYKAKLA-DGA---TIALRLLREGS-CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYF 456 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~-~~~---~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~ 456 (679)
.+.||+|+||.||+|+.. ++. .+|+|.++... ....+.+..|++++++++||||+++++++.. .+..++||||+
T Consensus 10 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~ 88 (268)
T cd05063 10 QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTK-FKPAMIITEYM 88 (268)
T ss_pred eeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEcc-CCCcEEEEEcC
Confidence 478999999999999964 333 79999987642 2335678999999999999999999999987 67899999999
Q ss_pred CCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccc
Q 005749 457 PSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVA 536 (679)
Q Consensus 457 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 536 (679)
++++|.+++... ...+++.++..++.|++.||+|||+.+ ++||||||+||++++++.+|++|||++........
T Consensus 89 ~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~ 162 (268)
T cd05063 89 ENGALDKYLRDH---DGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPE 162 (268)
T ss_pred CCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecccccc
Confidence 999999999753 245899999999999999999999988 99999999999999999999999999876543221
Q ss_pred cch--hcccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHHhhcccccccchHh
Q 005749 537 DEM--VALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDME 613 (679)
Q Consensus 537 ~~~--~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 613 (679)
... .....+..|+|||++....++.++|||||||++||+++ |+.||...... .+....
T Consensus 163 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~------~~~~~i------------- 223 (268)
T cd05063 163 GTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH------EVMKAI------------- 223 (268)
T ss_pred cceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH------HHHHHH-------------
Confidence 111 11223457999999988889999999999999999997 99998543221 111111
Q ss_pred hhhcCC-CChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhh
Q 005749 614 IMKGIR-SPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEEN 657 (679)
Q Consensus 614 i~~~~~-~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 657 (679)
..+.. +........+.+++.+||+.+|++||++.+|++.|+++
T Consensus 224 -~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 224 -NDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred -hcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 01101 11122345678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=314.64 Aligned_cols=244 Identities=25% Similarity=0.379 Sum_probs=195.4
Q ss_pred cCccccCCceEEEEEEeCCCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCCh
Q 005749 382 GQVIEKTTYGTAYKAKLADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRTL 461 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gsL 461 (679)
.+.||+|+||.||+|+.. |..||+|.++... ..+.+.+|+.++++++|+|++++++++....+..++||||+++++|
T Consensus 11 ~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L 87 (256)
T cd05082 11 LQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSL 87 (256)
T ss_pred eeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCcH
Confidence 478999999999999864 7889999986532 3457899999999999999999999876546678999999999999
Q ss_pred HHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccchhc
Q 005749 462 HDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVA 541 (679)
Q Consensus 462 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 541 (679)
.++++... ...+++..++.++.|++.||+|||+++ ++||||||+||++++++.+|++|||+++...... ..
T Consensus 88 ~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~----~~ 158 (256)
T cd05082 88 VDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----DT 158 (256)
T ss_pred HHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC----CC
Confidence 99997642 345889999999999999999999988 9999999999999999999999999987543221 22
Q ss_pred ccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcCCC
Q 005749 542 LAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIRS 620 (679)
Q Consensus 542 ~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~~ 620 (679)
..++..|+|||++.+..++.++|||||||++|||++ |+.||..... .+.... +..+...
T Consensus 159 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~------~~~~~~--------------~~~~~~~ 218 (256)
T cd05082 159 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL------KDVVPR--------------VEKGYKM 218 (256)
T ss_pred CccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH------HHHHHH--------------HhcCCCC
Confidence 344567999999988889999999999999999997 9999843211 111111 1111111
Q ss_pred -ChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhh
Q 005749 621 -PMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEEN 657 (679)
Q Consensus 621 -~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 657 (679)
..+...+.+.+++.+||+.+|++|||+.++++.|+++
T Consensus 219 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 219 DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 1112235677899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=321.73 Aligned_cols=256 Identities=23% Similarity=0.330 Sum_probs=198.5
Q ss_pred cCccccCCceEEEEEEeC------CCCEEEEEEcccCcc-cCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEE
Q 005749 382 GQVIEKTTYGTAYKAKLA------DGATIALRLLREGSC-KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYD 454 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~------~~~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~e 454 (679)
.+.||+|+||.||+|+.. ....+|+|.+..... ...+.+.+|++++++++||||+++++.+.. .+..++++|
T Consensus 5 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e 83 (290)
T cd05045 5 GKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQ-DGPLLLIVE 83 (290)
T ss_pred cccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEec-CCCcEEEEE
Confidence 378999999999999842 235789998875432 234578899999999999999999999887 678999999
Q ss_pred ecCCCChHHHhhcccC--------------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee
Q 005749 455 YFPSRTLHDLLHDTIA--------------------GKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLV 514 (679)
Q Consensus 455 y~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl 514 (679)
|+++|+|.+++..... ....+++..++.++.|++.||+|||+.+ ++||||||+||++
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~nill 160 (290)
T cd05045 84 YAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARNVLV 160 (290)
T ss_pred ecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhheEEE
Confidence 9999999999864321 1235889999999999999999999988 9999999999999
Q ss_pred cCCCceEEeecccccccCccccc-chhcccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccc
Q 005749 515 DDFFVSRLTEFGLDQLMVPAVAD-EMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVD 592 (679)
Q Consensus 515 ~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~ 592 (679)
++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |+.||.+.... .
T Consensus 161 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~ 237 (290)
T cd05045 161 AEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE---R 237 (290)
T ss_pred cCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH---H
Confidence 99999999999999865332211 1122345678999999988889999999999999999998 99998443211 1
Q ss_pred hhHHHHHHhhcccccccchHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCCC
Q 005749 593 LPSIVKVAVLEETTMEVFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRPR 660 (679)
Q Consensus 593 l~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 660 (679)
+..... ... . .........++.+++.+||+.+|++||+++|+++.|+++..+
T Consensus 238 ~~~~~~----~~~-----~-------~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~ 289 (290)
T cd05045 238 LFNLLK----TGY-----R-------MERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK 289 (290)
T ss_pred HHHHHh----CCC-----C-------CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence 111110 000 0 011112235677899999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=318.58 Aligned_cols=249 Identities=20% Similarity=0.252 Sum_probs=194.8
Q ss_pred cCccccCCceEEEEEE-eCCCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCC
Q 005749 382 GQVIEKTTYGTAYKAK-LADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRT 460 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gs 460 (679)
.+.||+|+||.||+|+ ..+++.||+|++..........+.+|+.++.+++||||+++++++.. .+..++||||+++++
T Consensus 14 ~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~-~~~~~iv~e~~~~~~ 92 (267)
T cd06646 14 IQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLS-REKLWICMEYCGGGS 92 (267)
T ss_pred hheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEe-CCEEEEEEeCCCCCc
Confidence 3789999999999999 46789999999976544445568899999999999999999999987 678999999999999
Q ss_pred hHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccchh
Q 005749 461 LHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMV 540 (679)
Q Consensus 461 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 540 (679)
|.++++.. ..+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++...... ....
T Consensus 93 L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~-~~~~ 164 (267)
T cd06646 93 LQDIYHVT----GPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATI-AKRK 164 (267)
T ss_pred HHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeecccc-cccC
Confidence 99998753 45899999999999999999999987 9999999999999999999999999998653221 1123
Q ss_pred ccccccccccccccc---ccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhc
Q 005749 541 ALAKADGYKAPELQR---MKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKG 617 (679)
Q Consensus 541 ~~~gt~~y~aPE~~~---~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~ 617 (679)
...++..|+|||.+. ...++.++|||||||++|||++|+.||......+... .+ . ...+.+...
T Consensus 165 ~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~--~~-----~----~~~~~~~~~-- 231 (267)
T cd06646 165 SFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF--LM-----S----KSNFQPPKL-- 231 (267)
T ss_pred ccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe--ee-----e----cCCCCCCCC--
Confidence 346788999999874 3457889999999999999999999984332211000 00 0 000000000
Q ss_pred CCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 005749 618 IRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQL 654 (679)
Q Consensus 618 ~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L 654 (679)
.........+.+++.+||..+|++||+++++++.|
T Consensus 232 --~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 232 --KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred --ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 00112235677899999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=325.19 Aligned_cols=256 Identities=22% Similarity=0.338 Sum_probs=199.2
Q ss_pred hcCccccCCceEEEEEEeC--------CCCEEEEEEcccCc-ccCcccHHHHHHHHhcc-CCCCCccceEEeeCCCCceE
Q 005749 381 TGQVIEKTTYGTAYKAKLA--------DGATIALRLLREGS-CKDRSSCLPVIRQLGKV-RHENLIPLRAFYQGKRGEKL 450 (679)
Q Consensus 381 ~~~~ig~G~~g~Vy~~~~~--------~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~~ 450 (679)
.++.||+|+||.||+|+.. +...+|+|.++... ......+.+|++++.++ +||||+++++++.. .+..+
T Consensus 22 i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~-~~~~~ 100 (307)
T cd05098 22 LGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ-DGPLY 100 (307)
T ss_pred EeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec-CCceE
Confidence 4588999999999999742 23579999997642 23345688899999999 79999999999987 67899
Q ss_pred EEEEecCCCChHHHhhcccC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCC
Q 005749 451 LIYDYFPSRTLHDLLHDTIA------------GKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFF 518 (679)
Q Consensus 451 lv~ey~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~ 518 (679)
+||||+++|+|.+++..... ....+++.++++++.|++.||+|||+.+ ++||||||+||++++++
T Consensus 101 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~~~~ 177 (307)
T cd05098 101 VIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDN 177 (307)
T ss_pred EEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEEcCCC
Confidence 99999999999999976432 1235899999999999999999999987 99999999999999999
Q ss_pred ceEEeecccccccCcccccc-hhcccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHH
Q 005749 519 VSRLTEFGLDQLMVPAVADE-MVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSI 596 (679)
Q Consensus 519 ~~kl~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~ 596 (679)
.+||+|||+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |+.||..... .+.
T Consensus 178 ~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~------~~~ 251 (307)
T cd05098 178 VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV------EEL 251 (307)
T ss_pred cEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH------HHH
Confidence 99999999987653221111 112234467999999988889999999999999999998 8888743211 111
Q ss_pred HHHHhhcccccccchHhhhhcCC-CChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCCC
Q 005749 597 VKVAVLEETTMEVFDMEIMKGIR-SPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRPR 660 (679)
Q Consensus 597 ~~~~~~~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 660 (679)
.... ..+.. ........++.+++.+||..+|++||++.||++.|+++.+.
T Consensus 252 ~~~~--------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 252 FKLL--------------KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred HHHH--------------HcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 1111 11111 11122345677899999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=331.22 Aligned_cols=237 Identities=20% Similarity=0.259 Sum_probs=187.4
Q ss_pred cCccccCCceEEEEEEe-CCCCEEEEEEcccCcc---cCcccHHHHHHHHhcc-CCCCCccceEEeeCCCCceEEEEEec
Q 005749 382 GQVIEKTTYGTAYKAKL-ADGATIALRLLREGSC---KDRSSCLPVIRQLGKV-RHENLIPLRAFYQGKRGEKLLIYDYF 456 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~---~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~~lv~ey~ 456 (679)
.+.||+|+||.||+|+. .+++.||+|.++.... ...+.+..|.+++..+ +|++|+++++++.+ .+..++||||+
T Consensus 5 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-~~~~~lv~E~~ 83 (323)
T cd05616 5 LMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQT-MDRLYFVMEYV 83 (323)
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEec-CCEEEEEEcCC
Confidence 36899999999999994 4678999999875421 2234567788888777 58999999998887 67899999999
Q ss_pred CCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccc
Q 005749 457 PSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVA 536 (679)
Q Consensus 457 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 536 (679)
++|+|.+++... ..+++..++.++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++..... .
T Consensus 84 ~~g~L~~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~-~ 155 (323)
T cd05616 84 NGGDLMYQIQQV----GRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD-G 155 (323)
T ss_pred CCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCC-C
Confidence 999999998753 45899999999999999999999988 999999999999999999999999998754221 1
Q ss_pred cchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhh
Q 005749 537 DEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMK 616 (679)
Q Consensus 537 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~ 616 (679)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+ ... +..
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~---~~---~~~--------------i~~ 215 (323)
T cd05616 156 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED---EL---FQS--------------IME 215 (323)
T ss_pred CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH---HH---HHH--------------HHh
Confidence 1223457899999999999999999999999999999999999999543211 11 111 111
Q ss_pred cCCCChHHHHHHHHHHHHhccCcCCCCCCCH
Q 005749 617 GIRSPMEEGLVQALKLAMGCCAPVASVRPTM 647 (679)
Q Consensus 617 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~ 647 (679)
...........++.+++.+|++.||++|++.
T Consensus 216 ~~~~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 216 HNVAYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred CCCCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 1111111233567789999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=317.32 Aligned_cols=251 Identities=22% Similarity=0.309 Sum_probs=198.8
Q ss_pred cCccccCCceEEEEEEeCC----CCEEEEEEcccCc-ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEec
Q 005749 382 GQVIEKTTYGTAYKAKLAD----GATIALRLLREGS-CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYF 456 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~~----~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~ 456 (679)
.+.||+|+||.||+|+..+ ...||+|...... ....+.+.+|+.++++++||||+++++++.+ +..++||||+
T Consensus 11 ~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~lv~e~~ 88 (270)
T cd05056 11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE--NPVWIVMELA 88 (270)
T ss_pred eeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC--CCcEEEEEcC
Confidence 4789999999999998543 3478999887654 3345678999999999999999999998875 5688999999
Q ss_pred CCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccc
Q 005749 457 PSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVA 536 (679)
Q Consensus 457 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 536 (679)
++|+|.+++... ...+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+|++|||+++.......
T Consensus 89 ~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 162 (270)
T cd05056 89 PLGELRSYLQVN---KYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESY 162 (270)
T ss_pred CCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeecccccc
Confidence 999999999753 235899999999999999999999988 99999999999999999999999999986643322
Q ss_pred cchhcccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhh
Q 005749 537 DEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIM 615 (679)
Q Consensus 537 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~ 615 (679)
.......++..|+|||.+....++.++||||||+++||+++ |+.||......+ ..... .
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~---~~~~~-----------------~ 222 (270)
T cd05056 163 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND---VIGRI-----------------E 222 (270)
T ss_pred eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH---HHHHH-----------------H
Confidence 22222334567999999988889999999999999999986 999985443221 11110 1
Q ss_pred hcCCC-ChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCCC
Q 005749 616 KGIRS-PMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRPR 660 (679)
Q Consensus 616 ~~~~~-~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 660 (679)
.+.+. ..+.....+.+++.+|+..+|++|||+.++++.|+++...
T Consensus 223 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 223 NGERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred cCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 11111 1112235677899999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=320.26 Aligned_cols=251 Identities=20% Similarity=0.323 Sum_probs=197.7
Q ss_pred cCccccCCceEEEEEEeC------CCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEe
Q 005749 382 GQVIEKTTYGTAYKAKLA------DGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDY 455 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~------~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey 455 (679)
.+.||+|+||.||+++.. ++..+|+|.+........+.+.+|++++++++|+||+++++++.+ .+..+++|||
T Consensus 10 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~ 88 (280)
T cd05092 10 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTE-GRPLLMVFEY 88 (280)
T ss_pred ccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEec-CCceEEEEec
Confidence 378999999999999732 366899999887655556789999999999999999999999987 5788999999
Q ss_pred cCCCChHHHhhcccC-----------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEee
Q 005749 456 FPSRTLHDLLHDTIA-----------GKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTE 524 (679)
Q Consensus 456 ~~~gsL~~~l~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~D 524 (679)
+++|+|.+++..... ....+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|
T Consensus 89 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~kL~d 165 (280)
T cd05092 89 MRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVVKIGD 165 (280)
T ss_pred CCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCEEECC
Confidence 999999999975421 1134889999999999999999999988 99999999999999999999999
Q ss_pred cccccccCcccccc-hhcccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHHhh
Q 005749 525 FGLDQLMVPAVADE-MVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAVL 602 (679)
Q Consensus 525 FGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~~~ 602 (679)
||+++......... .....++..|+|||++.+..++.++|||||||++|||++ |+.||......+ .....
T Consensus 166 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~------~~~~~-- 237 (280)
T cd05092 166 FGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE------AIECI-- 237 (280)
T ss_pred CCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH------HHHHH--
Confidence 99987653322111 122234678999999998889999999999999999998 898984432211 11100
Q ss_pred cccccccchHhhhhcCC-CChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHh
Q 005749 603 EETTMEVFDMEIMKGIR-SPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEE 656 (679)
Q Consensus 603 ~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 656 (679)
..+.. .......+.+.+++.+||+.||++||+++||.+.|++
T Consensus 238 ------------~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 238 ------------TQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred ------------HcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 01100 0111223557789999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=335.04 Aligned_cols=195 Identities=19% Similarity=0.263 Sum_probs=168.3
Q ss_pred CccccCCceEEEEEE-eCCCCEEEEEEcccCc---ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCC
Q 005749 383 QVIEKTTYGTAYKAK-LADGATIALRLLREGS---CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPS 458 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~ 458 (679)
+.||+|+||+||+|+ ..+++.||+|+++... ......+.+|++++.+++|+||+++++.+.+ ....++||||+++
T Consensus 7 ~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~-~~~~~lv~E~~~g 85 (363)
T cd05628 7 KVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQD-KLNLYLIMEFLPG 85 (363)
T ss_pred EEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEec-CCeEEEEEcCCCC
Confidence 689999999999998 4568999999997532 2233567889999999999999999999987 6789999999999
Q ss_pred CChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccc--
Q 005749 459 RTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVA-- 536 (679)
Q Consensus 459 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~-- 536 (679)
|+|.+++... ..+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 86 g~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~ 158 (363)
T cd05628 86 GDMMTLLMKK----DTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTE 158 (363)
T ss_pred CcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccccccc
Confidence 9999999763 45899999999999999999999988 99999999999999999999999999876432110
Q ss_pred --------------------------------cchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCC
Q 005749 537 --------------------------------DEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKS 584 (679)
Q Consensus 537 --------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~ 584 (679)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~ 238 (363)
T cd05628 159 FYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS 238 (363)
T ss_pred ccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCC
Confidence 001235799999999999988999999999999999999999999955
Q ss_pred C
Q 005749 585 G 585 (679)
Q Consensus 585 ~ 585 (679)
.
T Consensus 239 ~ 239 (363)
T cd05628 239 E 239 (363)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=336.77 Aligned_cols=246 Identities=20% Similarity=0.236 Sum_probs=196.3
Q ss_pred CccccCCceEEEEEEe-CCCCEEEEEEcccCc---ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCC
Q 005749 383 QVIEKTTYGTAYKAKL-ADGATIALRLLREGS---CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPS 458 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~ 458 (679)
+.||+|+||+||+|+. .+++.||+|+++... ......+.+|++++..++||||+++++++.+ .+..++||||+++
T Consensus 7 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~~ 85 (350)
T cd05573 7 KVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQD-EEHLYLVMEYMPG 85 (350)
T ss_pred EEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheec-CCeEEEEEcCCCC
Confidence 6899999999999995 479999999997542 1334568899999999999999999999887 6789999999999
Q ss_pred CChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCccc---
Q 005749 459 RTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAV--- 535 (679)
Q Consensus 459 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~--- 535 (679)
|+|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 86 ~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~ 158 (350)
T cd05573 86 GDLMNLLIRK----DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDRE 158 (350)
T ss_pred CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCcccCccc
Confidence 9999999763 45899999999999999999999988 9999999999999999999999999998764332
Q ss_pred -------------------------ccchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcc
Q 005749 536 -------------------------ADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEF 590 (679)
Q Consensus 536 -------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~ 590 (679)
........||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~-- 236 (350)
T cd05573 159 YYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ-- 236 (350)
T ss_pred ccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHH--
Confidence 01123456899999999999999999999999999999999999999543311
Q ss_pred cchhHHHHHHhhcccccccchHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCC-HHHHHHH
Q 005749 591 VDLPSIVKVAVLEETTMEVFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPT-MDEVVKQ 653 (679)
Q Consensus 591 ~~l~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs-~~evl~~ 653 (679)
......... .+.. ..+......+++.+++.+|+. ||++||+ ++|+++.
T Consensus 237 ----~~~~~i~~~---~~~~-------~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 237 ----ETYNKIINW---KESL-------RFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred ----HHHHHHhcc---CCcc-------cCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 000000000 0000 001111134567789999997 9999999 9999985
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=318.80 Aligned_cols=251 Identities=20% Similarity=0.301 Sum_probs=194.2
Q ss_pred CccccCCceEEEEEEeC------CCCEEEEEEcccCcc-cCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEe
Q 005749 383 QVIEKTTYGTAYKAKLA------DGATIALRLLREGSC-KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDY 455 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~~------~~~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey 455 (679)
+.||+|+||.||+|... .+..||+|.+..... .....|.+|+.++++++|+||+++++++.+ .+..++||||
T Consensus 12 ~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~e~ 90 (277)
T cd05036 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFE-RLPRFILLEL 90 (277)
T ss_pred eECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc-CCCcEEEEec
Confidence 68999999999999964 367899998865432 234568999999999999999999998887 5678999999
Q ss_pred cCCCChHHHhhcccCC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCC---ceEEeeccccc
Q 005749 456 FPSRTLHDLLHDTIAG---KPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFF---VSRLTEFGLDQ 529 (679)
Q Consensus 456 ~~~gsL~~~l~~~~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~---~~kl~DFGla~ 529 (679)
+++++|.+++...... ...+++..+++++.||+.||+|||+.+ ++||||||+||+++.++ .+|++|||+++
T Consensus 91 ~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~ 167 (277)
T cd05036 91 MAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIADFGMAR 167 (277)
T ss_pred CCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEeccCcccc
Confidence 9999999999764321 235899999999999999999999988 99999999999998754 68999999998
Q ss_pred ccCccccc-chhcccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHHhhccccc
Q 005749 530 LMVPAVAD-EMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAVLEETTM 607 (679)
Q Consensus 530 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 607 (679)
........ .......+..|+|||++.+..++.++|||||||++|||++ |+.||......+ ..........
T Consensus 168 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~------~~~~~~~~~~-- 239 (277)
T cd05036 168 DIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE------VMEFVTGGGR-- 239 (277)
T ss_pred ccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH------HHHHHHcCCc--
Confidence 76322111 1112233567999999998889999999999999999997 999985433211 1111100000
Q ss_pred ccchHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHh
Q 005749 608 EVFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEE 656 (679)
Q Consensus 608 ~~~~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 656 (679)
..........+.+++.+||+.+|++||++.+|++.|++
T Consensus 240 -----------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~ 277 (277)
T cd05036 240 -----------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY 277 (277)
T ss_pred -----------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence 01111223567789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=326.98 Aligned_cols=255 Identities=22% Similarity=0.344 Sum_probs=198.5
Q ss_pred hcCccccCCceEEEEEEeC--------CCCEEEEEEcccCc-ccCcccHHHHHHHHhcc-CCCCCccceEEeeCCCCceE
Q 005749 381 TGQVIEKTTYGTAYKAKLA--------DGATIALRLLREGS-CKDRSSCLPVIRQLGKV-RHENLIPLRAFYQGKRGEKL 450 (679)
Q Consensus 381 ~~~~ig~G~~g~Vy~~~~~--------~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~~ 450 (679)
.++.||+|+||.||+|+.. ++..||+|.++... ....+++.+|+++++++ +||||++++++|.. .+..+
T Consensus 16 i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-~~~~~ 94 (334)
T cd05100 16 LGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ-DGPLY 94 (334)
T ss_pred ecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc-CCceE
Confidence 4588999999999999732 12378999887542 22346789999999999 89999999999987 67899
Q ss_pred EEEEecCCCChHHHhhcccC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCC
Q 005749 451 LIYDYFPSRTLHDLLHDTIA------------GKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFF 518 (679)
Q Consensus 451 lv~ey~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~ 518 (679)
++|||+++|+|.+++..... ....+++.+++.++.|++.||+|||+++ |+||||||+||++++++
T Consensus 95 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~~~~ 171 (334)
T cd05100 95 VLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVTEDN 171 (334)
T ss_pred EEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCC
Confidence 99999999999999975321 1245889999999999999999999988 99999999999999999
Q ss_pred ceEEeecccccccCcccccc-hhcccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHH
Q 005749 519 VSRLTEFGLDQLMVPAVADE-MVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSI 596 (679)
Q Consensus 519 ~~kl~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~ 596 (679)
.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||.+... .++
T Consensus 172 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~------~~~ 245 (334)
T cd05100 172 VMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV------EEL 245 (334)
T ss_pred cEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH------HHH
Confidence 99999999998653321111 112234567999999998889999999999999999998 8888844321 111
Q ss_pred HHHHhhcccccccchHhhhhcCC-CChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCC
Q 005749 597 VKVAVLEETTMEVFDMEIMKGIR-SPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRP 659 (679)
Q Consensus 597 ~~~~~~~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 659 (679)
..... .+.. ........++.+++.+||+.+|++||++.|+++.|+++..
T Consensus 246 ~~~~~--------------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~ 295 (334)
T cd05100 246 FKLLK--------------EGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295 (334)
T ss_pred HHHHH--------------cCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence 11110 1100 1111223567789999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=337.40 Aligned_cols=246 Identities=18% Similarity=0.231 Sum_probs=191.7
Q ss_pred CccccCCceEEEEEEe-CCCCEEEEEEcccCc---ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCC
Q 005749 383 QVIEKTTYGTAYKAKL-ADGATIALRLLREGS---CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPS 458 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~ 458 (679)
+.||+|+||+||+|+. .+++.||||++.... ......+.+|++++..++||||+++++++.+ .+..++||||+++
T Consensus 7 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~-~~~~~lv~E~~~~ 85 (364)
T cd05599 7 KVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQD-ENYLYLIMEYLPG 85 (364)
T ss_pred EEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc-CCeEEEEECCCCC
Confidence 7899999999999994 568999999997532 2233457889999999999999999999997 6889999999999
Q ss_pred CChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCccccc-
Q 005749 459 RTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVAD- 537 (679)
Q Consensus 459 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~- 537 (679)
|+|.+++... ..+++..++.|+.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.+......
T Consensus 86 g~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~ 158 (364)
T cd05599 86 GDMMTLLMKK----DTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTE 158 (364)
T ss_pred cHHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccccccc
Confidence 9999999763 45899999999999999999999988 999999999999999999999999998754221100
Q ss_pred ------------------------------------chhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCC
Q 005749 538 ------------------------------------EMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKP 581 (679)
Q Consensus 538 ------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p 581 (679)
......||+.|+|||++....++.++|||||||++|||++|..|
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~P 238 (364)
T cd05599 159 FYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPP 238 (364)
T ss_pred ccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCC
Confidence 01124689999999999988999999999999999999999999
Q ss_pred CCCCCCCcccchhHHHHHHhhcccccccchHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCC---HHHHHHH
Q 005749 582 GKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPT---MDEVVKQ 653 (679)
Q Consensus 582 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs---~~evl~~ 653 (679)
|.+....+ ......... ..+ .. +......+++.+++.+|+. +|.+|++ ++|++++
T Consensus 239 f~~~~~~~------~~~~i~~~~---~~~--~~-----~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 239 FCSDNPQE------TYRKIINWK---ETL--QF-----PDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCCHHH------HHHHHHcCC---Ccc--CC-----CCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 95432211 010000000 000 00 0001123456678888886 8999998 8888774
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=319.77 Aligned_cols=240 Identities=20% Similarity=0.301 Sum_probs=187.4
Q ss_pred CccccCCceEEEEEEeCC--------CCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEE
Q 005749 383 QVIEKTTYGTAYKAKLAD--------GATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYD 454 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~~~--------~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~e 454 (679)
+.||+|+||.||+|+... ...||+|.+........+.+..|+.+++.++|||||++++++.. .+..++|||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~-~~~~~lv~e 79 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVC-GDESIMVQE 79 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEe-CCCcEEEEe
Confidence 469999999999998532 23488888866544445678899999999999999999999987 578999999
Q ss_pred ecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCc--------eEEeecc
Q 005749 455 YFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFV--------SRLTEFG 526 (679)
Q Consensus 455 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~--------~kl~DFG 526 (679)
|+++|+|.++++.. ...+++..++.++.||+.||+|||+.+ |+||||||+||+++.++. +|++|||
T Consensus 80 ~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g 153 (258)
T cd05078 80 YVKFGSLDTYLKKN---KNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG 153 (258)
T ss_pred cCCCCcHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccc
Confidence 99999999999764 235899999999999999999999988 999999999999987765 5999999
Q ss_pred cccccCcccccchhcccccccccccccccc-cCCCCcchhHHHHHHHHHHHhCC-CCCCCCCCCcccchhHHHHHHhhcc
Q 005749 527 LDQLMVPAVADEMVALAKADGYKAPELQRM-KKCSSRTDVYAFGILLLEILIGK-KPGKSGRNGEFVDLPSIVKVAVLEE 604 (679)
Q Consensus 527 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gvvl~El~tg~-~p~~~~~~~~~~~l~~~~~~~~~~~ 604 (679)
++...... ....++..|+|||++.+ ..++.++|||||||++|||++|. .|+...... ..... .
T Consensus 154 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~------~~~~~--~-- 218 (258)
T cd05078 154 ISITVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ------KKLQF--Y-- 218 (258)
T ss_pred cccccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHH------HHHHH--H--
Confidence 88754321 23457788999999886 45799999999999999999995 555221110 00000 0
Q ss_pred cccccchHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHH
Q 005749 605 TTMEVFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLE 655 (679)
Q Consensus 605 ~~~~~~~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~ 655 (679)
............++.+++.+||+.||++|||++++++.|+
T Consensus 219 -----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 219 -----------EDRHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred -----------HccccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0000011112256778999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=322.28 Aligned_cols=253 Identities=20% Similarity=0.343 Sum_probs=196.5
Q ss_pred CccccCCceEEEEEEe-CCCC----EEEEEEcccCcc-cCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEec
Q 005749 383 QVIEKTTYGTAYKAKL-ADGA----TIALRLLREGSC-KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYF 456 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~-~~~~----~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~ 456 (679)
+.||+|+||.||+|+. .+|. .||+|.+..... .....+.+|+.++++++||||++++++|.. ...++++||+
T Consensus 13 ~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~--~~~~~v~e~~ 90 (303)
T cd05110 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLS--PTIQLVTQLM 90 (303)
T ss_pred cccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC--CCceeeehhc
Confidence 7899999999999984 4454 478888865432 223468899999999999999999999875 3578999999
Q ss_pred CCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccc
Q 005749 457 PSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVA 536 (679)
Q Consensus 457 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 536 (679)
++|+|.+++... ...+++..++.++.|++.||+|||+++ |+||||||+||++++++.+||+|||+++.......
T Consensus 91 ~~g~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~ 164 (303)
T cd05110 91 PHGCLLDYVHEH---KDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEK 164 (303)
T ss_pred CCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccccCccc
Confidence 999999998754 235889999999999999999999988 99999999999999999999999999987643221
Q ss_pred c-chhcccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHHhhcccccccchHhh
Q 005749 537 D-EMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEI 614 (679)
Q Consensus 537 ~-~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i 614 (679)
. ......++..|+|||++.+..++.++|||||||++||+++ |+.||.+.... ...++.. ...
T Consensus 165 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~---~~~~~~~---~~~---------- 228 (303)
T cd05110 165 EYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR---EIPDLLE---KGE---------- 228 (303)
T ss_pred ccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHH---CCC----------
Confidence 1 1122345678999999998889999999999999999997 88998443211 1111111 000
Q ss_pred hhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCCCCC
Q 005749 615 MKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRPRNR 662 (679)
Q Consensus 615 ~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 662 (679)
..+..+.....+.+++.+||..+|++||+++++++.|+++.....
T Consensus 229 ---~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~~ 273 (303)
T cd05110 229 ---RLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDPQ 273 (303)
T ss_pred ---CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhchh
Confidence 001111223467789999999999999999999999999865543
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=300.01 Aligned_cols=241 Identities=22% Similarity=0.368 Sum_probs=199.0
Q ss_pred CccccCCceEEEEEE-eCCCCEEEEEEcccCcccC--------cccHHHHHHHHhcc-CCCCCccceEEeeCCCCceEEE
Q 005749 383 QVIEKTTYGTAYKAK-LADGATIALRLLREGSCKD--------RSSCLPVIRQLGKV-RHENLIPLRAFYQGKRGEKLLI 452 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~--------~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~~lv 452 (679)
+++|+|..++|.++. ..+|..+|+|++....... .+.-.+|+.||+++ .||+|+++.++|.. +...++|
T Consensus 23 eilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes-~sF~FlV 101 (411)
T KOG0599|consen 23 EILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES-DAFVFLV 101 (411)
T ss_pred HHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC-cchhhhh
Confidence 789999999998887 5678999999987543211 23457889999998 69999999999998 6789999
Q ss_pred EEecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccC
Q 005749 453 YDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMV 532 (679)
Q Consensus 453 ~ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 532 (679)
+|.|+.|.|.|+|.. ...+++.+.++|++|+.+|++|||.+. ||||||||+|||+|+++++||+|||+|+.+.
T Consensus 102 Fdl~prGELFDyLts----~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFGFa~~l~ 174 (411)
T KOG0599|consen 102 FDLMPRGELFDYLTS----KVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFGFACQLE 174 (411)
T ss_pred hhhcccchHHHHhhh----heeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEeccceeeccC
Confidence 999999999999987 456999999999999999999999988 9999999999999999999999999999886
Q ss_pred cccccchhcccccccccccccccc------cCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccc
Q 005749 533 PAVADEMVALAKADGYKAPELQRM------KKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETT 606 (679)
Q Consensus 533 ~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 606 (679)
++ .+....+||++|.|||.+.- ..|+...|+|+.||+||.++.|.+||.+... .+
T Consensus 175 ~G--ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ--------ml--------- 235 (411)
T KOG0599|consen 175 PG--EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ--------ML--------- 235 (411)
T ss_pred Cc--hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH--------HH---------
Confidence 54 45678899999999997752 3488899999999999999999999954211 00
Q ss_pred cccchHhhhhcCC----CChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 607 MEVFDMEIMKGIR----SPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 607 ~~~~~~~i~~~~~----~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
+-..|++|.. +...+...+..+++.+|++.||++|.|++|++++
T Consensus 236 ---MLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 236 ---MLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred ---HHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 0011233322 2223445677799999999999999999999876
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=323.30 Aligned_cols=198 Identities=23% Similarity=0.365 Sum_probs=161.9
Q ss_pred cCccccCCceEEEEEEeC---CCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCC-CCceEEEEEecC
Q 005749 382 GQVIEKTTYGTAYKAKLA---DGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGK-RGEKLLIYDYFP 457 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~---~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~-~~~~~lv~ey~~ 457 (679)
+..||+|+||+||+|+.. +++.||+|.+.... ....+.+|++++++++||||+++++++... ....++||||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 578999999999999854 46789999986532 234578999999999999999999988642 456789999996
Q ss_pred CCChHHHhhcccC-----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee----cCCCceEEeecccc
Q 005749 458 SRTLHDLLHDTIA-----GKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLV----DDFFVSRLTEFGLD 528 (679)
Q Consensus 458 ~gsL~~~l~~~~~-----~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl----~~~~~~kl~DFGla 528 (679)
+ +|.+++..... ....+++..++.++.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 5 88888754321 1235889999999999999999999988 9999999999999 45678999999999
Q ss_pred cccCcccc--cchhcccccccccccccccc-cCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 005749 529 QLMVPAVA--DEMVALAKADGYKAPELQRM-KKCSSRTDVYAFGILLLEILIGKKPGKSG 585 (679)
Q Consensus 529 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gvvl~El~tg~~p~~~~ 585 (679)
+....... .......+|+.|+|||++.+ ..++.++||||+||++|||++|++||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 87643221 12234578999999998876 45899999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=334.81 Aligned_cols=247 Identities=17% Similarity=0.191 Sum_probs=193.1
Q ss_pred cCccccCCceEEEEEEe-CCCCEEEEEEcccCc---ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecC
Q 005749 382 GQVIEKTTYGTAYKAKL-ADGATIALRLLREGS---CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFP 457 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~ 457 (679)
.+.||+|+||.||+|+. .+++.||+|.+.... ....+.+.+|+++++.++||||+++++++.+ .+..++||||++
T Consensus 48 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~-~~~~~lv~Ey~~ 126 (370)
T cd05596 48 IKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQD-DKYLYMVMEYMP 126 (370)
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEec-CCEEEEEEcCCC
Confidence 37899999999999994 568999999986432 2233457889999999999999999999887 678999999999
Q ss_pred CCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCccccc
Q 005749 458 SRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVAD 537 (679)
Q Consensus 458 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 537 (679)
+|+|.+++.. ..++...+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++........
T Consensus 127 gg~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~ 198 (370)
T cd05596 127 GGDLVNLMSN-----YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMV 198 (370)
T ss_pred CCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeeccCCCcc
Confidence 9999999864 24788889999999999999999988 999999999999999999999999999865433222
Q ss_pred chhccccccccccccccccc----CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHh
Q 005749 538 EMVALAKADGYKAPELQRMK----KCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDME 613 (679)
Q Consensus 538 ~~~~~~gt~~y~aPE~~~~~----~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 613 (679)
......||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.... ........... .. .
T Consensus 199 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------~~~~~i~~~~~--~~---~ 267 (370)
T cd05596 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------GTYSKIMDHKN--SL---T 267 (370)
T ss_pred cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH------HHHHHHHcCCC--cC---C
Confidence 23345799999999988643 4789999999999999999999999543221 11111000000 00 0
Q ss_pred hhhcCCCChHHHHHHHHHHHHhccCcCCCC--CCCHHHHHHH
Q 005749 614 IMKGIRSPMEEGLVQALKLAMGCCAPVASV--RPTMDEVVKQ 653 (679)
Q Consensus 614 i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~--RPs~~evl~~ 653 (679)
.+.......++.+++.+|++.+|++ ||+++|++++
T Consensus 268 -----~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 268 -----FPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred -----CCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 0111122456778999999999988 9999999765
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=310.06 Aligned_cols=244 Identities=15% Similarity=0.255 Sum_probs=203.6
Q ss_pred CccccCCceEEEEEE-eCCCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCCh
Q 005749 383 QVIEKTTYGTAYKAK-LADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRTL 461 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gsL 461 (679)
+.+|+|+||.||||. .+.|+.||+|.+... .+.+++.+|+.+|++++.|++|++||.|.. ....|+|||||..|+.
T Consensus 39 ~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK-~sDLWIVMEYCGAGSi 115 (502)
T KOG0574|consen 39 GKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFK-HSDLWIVMEYCGAGSI 115 (502)
T ss_pred HHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhcc-CCceEeehhhcCCCcH
Confidence 679999999999998 567999999998764 357789999999999999999999998876 5789999999999999
Q ss_pred HHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccchhc
Q 005749 462 HDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVA 541 (679)
Q Consensus 462 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 541 (679)
.+.++.+ +.++++.++..|+++.++||+|||... -+|||||+.|||++.+|.+|++|||.|..+.... .+..+
T Consensus 116 SDI~R~R---~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM-AKRNT 188 (502)
T KOG0574|consen 116 SDIMRAR---RKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM-AKRNT 188 (502)
T ss_pred HHHHHHh---cCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhH-HhhCc
Confidence 9999876 567999999999999999999999876 7999999999999999999999999998875443 23457
Q ss_pred ccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcCCCC
Q 005749 542 LAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIRSP 621 (679)
Q Consensus 542 ~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~~~ 621 (679)
..||+.|||||+++.-.|+.++||||+|++..||..|++||.+...-...-+ .+... .+. ...
T Consensus 189 VIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFM-------IPT~P-----PPT-----F~K 251 (502)
T KOG0574|consen 189 VIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFM-------IPTKP-----PPT-----FKK 251 (502)
T ss_pred cccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEe-------ccCCC-----CCC-----CCC
Confidence 7899999999999988999999999999999999999999965433211100 00000 000 012
Q ss_pred hHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 622 MEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 622 ~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
.+....++-+++..|+...|++|-|+-+++++
T Consensus 252 PE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 252 PEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred hHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 34556778899999999999999999888765
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=319.18 Aligned_cols=252 Identities=18% Similarity=0.285 Sum_probs=197.5
Q ss_pred cCccccCCceEEEEEEeCC------CCEEEEEEcccCcc-cCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEE
Q 005749 382 GQVIEKTTYGTAYKAKLAD------GATIALRLLREGSC-KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYD 454 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~~------~~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~e 454 (679)
.+.||+|+||.||+|...+ +..||+|.+..... .....+.+|++++..++||||+++++++.. ....++|||
T Consensus 11 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~~v~e 89 (277)
T cd05032 11 IRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVST-GQPTLVVME 89 (277)
T ss_pred EeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcC-CCCcEEEEe
Confidence 4789999999999998542 46899999865432 334578899999999999999999999987 578999999
Q ss_pred ecCCCChHHHhhcccCC------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccc
Q 005749 455 YFPSRTLHDLLHDTIAG------KPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLD 528 (679)
Q Consensus 455 y~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 528 (679)
|+++|+|.+++...... ...+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++
T Consensus 90 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~dfg~~ 166 (277)
T cd05032 90 LMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIGDFGMT 166 (277)
T ss_pred cCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEECCcccc
Confidence 99999999999754321 234789999999999999999999988 999999999999999999999999999
Q ss_pred cccCcccc-cchhcccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHHhhcccc
Q 005749 529 QLMVPAVA-DEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAVLEETT 606 (679)
Q Consensus 529 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 606 (679)
+.+..... .......++..|+|||.+....++.++|||||||++||+++ |+.||...... ....... ..
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~---~~~~~~~----~~-- 237 (277)
T cd05032 167 RDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE---EVLKFVI----DG-- 237 (277)
T ss_pred hhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHH---HHHHHHh----cC--
Confidence 86543321 11223346778999999988889999999999999999998 89898543221 1111110 00
Q ss_pred cccchHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHh
Q 005749 607 MEVFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEE 656 (679)
Q Consensus 607 ~~~~~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 656 (679)
...........++.+++.+||+.+|++|||+.|+++.|++
T Consensus 238 ----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 238 ----------GHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred ----------CCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 0001111124567789999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=338.19 Aligned_cols=246 Identities=18% Similarity=0.210 Sum_probs=188.6
Q ss_pred CccccCCceEEEEEE-eCCCCEEEEEEcccCc---ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCC
Q 005749 383 QVIEKTTYGTAYKAK-LADGATIALRLLREGS---CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPS 458 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~ 458 (679)
+.||+|+||+||+|+ ..+++.||+|++.... ....+.+.+|++++++++|||||++++.+.+ .+..++|||||++
T Consensus 7 ~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~-~~~~~lv~E~~~g 85 (382)
T cd05625 7 KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQD-KDNLYFVMDYIPG 85 (382)
T ss_pred EEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEe-CCEEEEEEeCCCC
Confidence 689999999999999 4568899999987542 1234568899999999999999999999987 6789999999999
Q ss_pred CChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCccc---
Q 005749 459 RTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAV--- 535 (679)
Q Consensus 459 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~--- 535 (679)
|+|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 86 g~L~~~l~~~----~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~ 158 (382)
T cd05625 86 GDMMSLLIRM----GIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158 (382)
T ss_pred CcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCcccccccccc
Confidence 9999998753 35888999999999999999999988 9999999999999999999999999975321000
Q ss_pred -------------------------------------------ccchhcccccccccccccccccCCCCcchhHHHHHHH
Q 005749 536 -------------------------------------------ADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILL 572 (679)
Q Consensus 536 -------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl 572 (679)
........||+.|+|||++.+..++.++||||+||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil 238 (382)
T cd05625 159 YYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 238 (382)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHH
Confidence 0001134689999999999988999999999999999
Q ss_pred HHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCC---HHH
Q 005749 573 LEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPT---MDE 649 (679)
Q Consensus 573 ~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs---~~e 649 (679)
|||++|+.||......+. ........ .. ...+......++..+++.+++ .+|++|++ ++|
T Consensus 239 ~elltG~~Pf~~~~~~~~------~~~i~~~~-------~~---~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~e 301 (382)
T cd05625 239 YEMLVGQPPFLAQTPLET------QMKVINWQ-------TS---LHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADE 301 (382)
T ss_pred HHHHhCCCCCCCCCHHHH------HHHHHccC-------CC---cCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHH
Confidence 999999999954322110 00000000 00 000111122355666777665 49999997 888
Q ss_pred HHHH
Q 005749 650 VVKQ 653 (679)
Q Consensus 650 vl~~ 653 (679)
++++
T Consensus 302 i~~h 305 (382)
T cd05625 302 IKAH 305 (382)
T ss_pred HhcC
Confidence 7754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=323.81 Aligned_cols=254 Identities=22% Similarity=0.333 Sum_probs=196.0
Q ss_pred cCccccCCceEEEEEEeC-CCC--EEEEEEcccCc-ccCcccHHHHHHHHhcc-CCCCCccceEEeeCCCCceEEEEEec
Q 005749 382 GQVIEKTTYGTAYKAKLA-DGA--TIALRLLREGS-CKDRSSCLPVIRQLGKV-RHENLIPLRAFYQGKRGEKLLIYDYF 456 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~-~~~--~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~~lv~ey~ 456 (679)
.+.||+|+||.||+|+.+ ++. .+|+|.++... ....+.+.+|++++.++ +||||+++++++.. .+..++||||+
T Consensus 12 ~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~-~~~~~lv~e~~ 90 (303)
T cd05088 12 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-RGYLYLAIEYA 90 (303)
T ss_pred eeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECC-CCCceEEEEeC
Confidence 478999999999999953 454 45777776432 22345788999999999 89999999999987 67899999999
Q ss_pred CCCChHHHhhcccC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEee
Q 005749 457 PSRTLHDLLHDTIA------------GKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTE 524 (679)
Q Consensus 457 ~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~D 524 (679)
++|+|.++++.... ....+++.+++.++.|++.||+|||+++ |+||||||+|||+++++.+||+|
T Consensus 91 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~kl~d 167 (303)
T cd05088 91 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIAD 167 (303)
T ss_pred CCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcEEeCc
Confidence 99999999975421 1235889999999999999999999988 99999999999999999999999
Q ss_pred cccccccCcccccchhcccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHHhhc
Q 005749 525 FGLDQLMVPAVADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAVLE 603 (679)
Q Consensus 525 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~~~~ 603 (679)
||+++..... ........+..|+|||++.+..++.++|||||||++|||+| |..||...... +.....
T Consensus 168 fg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~------~~~~~~--- 236 (303)
T cd05088 168 FGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA------ELYEKL--- 236 (303)
T ss_pred cccCcccchh--hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH------HHHHHH---
Confidence 9998643211 11111234567999999988889999999999999999998 99998543221 111111
Q ss_pred ccccccchHhhhhcCCC-ChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCCCC
Q 005749 604 ETTMEVFDMEIMKGIRS-PMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRPRN 661 (679)
Q Consensus 604 ~~~~~~~~~~i~~~~~~-~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 661 (679)
..+... ........+.+++.+||+.+|++||+++++++.|+++....
T Consensus 237 -----------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~ 284 (303)
T cd05088 237 -----------PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 284 (303)
T ss_pred -----------hcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 011000 00112345778999999999999999999999999876544
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=324.56 Aligned_cols=262 Identities=17% Similarity=0.253 Sum_probs=192.7
Q ss_pred CccccCCceEEEEEEe-CCCCEEEEEEcccCcc-cCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCC
Q 005749 383 QVIEKTTYGTAYKAKL-ADGATIALRLLREGSC-KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRT 460 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gs 460 (679)
+.||+|+||.||+|+. .+++.||+|.++.... .....+.+|++++++++||||+++++++.. ++..++||||+++ +
T Consensus 12 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~-~ 89 (309)
T cd07872 12 EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHT-DKSLTLVFEYLDK-D 89 (309)
T ss_pred EEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEee-CCeEEEEEeCCCC-C
Confidence 6899999999999994 4688999999875432 234467899999999999999999999987 6789999999975 8
Q ss_pred hHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccchh
Q 005749 461 LHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMV 540 (679)
Q Consensus 461 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 540 (679)
|.+++... ...+++..+..++.|++.||+|||+++ |+||||||+||++++++.+||+|||+++...... ....
T Consensus 90 l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~ 162 (309)
T cd07872 90 LKQYMDDC---GNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPT-KTYS 162 (309)
T ss_pred HHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCc-cccc
Confidence 88888653 345789999999999999999999988 9999999999999999999999999987643221 1122
Q ss_pred cccccccccccccccc-cCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhccccccc------chHh
Q 005749 541 ALAKADGYKAPELQRM-KKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEV------FDME 613 (679)
Q Consensus 541 ~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~------~~~~ 613 (679)
...++..|+|||.+.+ ..++.++|||||||++|||++|+.||.+....+................+... .+..
T Consensus 163 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (309)
T cd07872 163 NEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYN 242 (309)
T ss_pred cccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhh
Confidence 3457889999998764 46899999999999999999999999654332211111000000000000000 0000
Q ss_pred hhhcCC----CChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 614 IMKGIR----SPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 614 i~~~~~----~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
...... ...+....+..+++.+|++.||++|||++|+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 243 FPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred cCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 000000 0001123456789999999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=313.16 Aligned_cols=246 Identities=21% Similarity=0.395 Sum_probs=195.9
Q ss_pred cCccccCCceEEEEEEeCCCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCCh
Q 005749 382 GQVIEKTTYGTAYKAKLADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRTL 461 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gsL 461 (679)
.+.||+|+||.||+|...++..+|+|.+.... ....+|.+|++++++++||||+++++++.. ....++||||+++++|
T Consensus 9 ~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~v~e~~~~~~L 86 (256)
T cd05112 9 VQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTE-RSPICLVFEFMEHGCL 86 (256)
T ss_pred EeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEcc-CCceEEEEEcCCCCcH
Confidence 37899999999999998778899999987532 234578999999999999999999999887 6789999999999999
Q ss_pred HHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccchhc
Q 005749 462 HDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVA 541 (679)
Q Consensus 462 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 541 (679)
.+++... ...+++..++.++.|++.|++|||+.+ ++||||||+||+++.++.+||+|||+++............
T Consensus 87 ~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~ 160 (256)
T cd05112 87 SDYLRAQ---RGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTG 160 (256)
T ss_pred HHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcccccCC
Confidence 9998753 235789999999999999999999988 9999999999999999999999999987653322211222
Q ss_pred ccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcCCC
Q 005749 542 LAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIRS 620 (679)
Q Consensus 542 ~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~~ 620 (679)
..++..|+|||++.++.++.++||||||+++|||++ |+.||...... ...... ..+...
T Consensus 161 ~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~------~~~~~~--------------~~~~~~ 220 (256)
T cd05112 161 TKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS------EVVETI--------------NAGFRL 220 (256)
T ss_pred CccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH------HHHHHH--------------hCCCCC
Confidence 334568999999988889999999999999999998 89998432211 111110 010000
Q ss_pred C-hHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHH
Q 005749 621 P-MEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLE 655 (679)
Q Consensus 621 ~-~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~ 655 (679)
. .......+.+++.+||+.+|++||++.|+++.|.
T Consensus 221 ~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 221 YKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 0 0112356778999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=334.52 Aligned_cols=248 Identities=15% Similarity=0.191 Sum_probs=194.7
Q ss_pred cCccccCCceEEEEEE-eCCCCEEEEEEcccCcc---cCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecC
Q 005749 382 GQVIEKTTYGTAYKAK-LADGATIALRLLREGSC---KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFP 457 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~---~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~ 457 (679)
.+.||+|+||.||+|+ ..+|+.||+|+++.... ...+.+.+|+++++.++|+||+++++++.+ .+..++||||++
T Consensus 6 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~ 84 (330)
T cd05601 6 KSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQD-KDNLYLVMEYQP 84 (330)
T ss_pred EEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEec-CCeEEEEECCCC
Confidence 3689999999999999 45799999999975422 234568899999999999999999999887 678999999999
Q ss_pred CCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCccccc
Q 005749 458 SRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVAD 537 (679)
Q Consensus 458 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 537 (679)
+|+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++........
T Consensus 85 ~~~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~ 158 (330)
T cd05601 85 GGDLLSLLNRY---EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV 158 (330)
T ss_pred CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCCCce
Confidence 99999999764 245899999999999999999999988 999999999999999999999999999876433222
Q ss_pred chhccccccccccccccc------ccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccch
Q 005749 538 EMVALAKADGYKAPELQR------MKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFD 611 (679)
Q Consensus 538 ~~~~~~gt~~y~aPE~~~------~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 611 (679)
......||+.|+|||++. ...++.++|||||||++|||++|+.||...... ........... .
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~------~~~~~i~~~~~---~-- 227 (330)
T cd05601 159 NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA------KTYNNIMNFQR---F-- 227 (330)
T ss_pred eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH------HHHHHHHcCCC---c--
Confidence 223446899999999886 456789999999999999999999999543221 11111000000 0
Q ss_pred HhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 612 MEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 612 ~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
.. .+..+.....+.+++.+|+. +|++||+++++++.
T Consensus 228 ---~~--~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 228 ---LK--FPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred ---cC--CCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 00 01111233566788899997 99999999999864
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=314.30 Aligned_cols=246 Identities=19% Similarity=0.288 Sum_probs=194.8
Q ss_pred cCccccCCceEEEEEEe-CCCCEEEEEEcccCcc-----cCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEe
Q 005749 382 GQVIEKTTYGTAYKAKL-ADGATIALRLLREGSC-----KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDY 455 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~-----~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey 455 (679)
++.||+|++|.||+|.. .+++.||+|.+..... ...+.+.+|++++++++||||+++++++.+ .+..++|+||
T Consensus 7 ~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~v~e~ 85 (263)
T cd06625 7 GKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRD-DETLSIFMEY 85 (263)
T ss_pred cceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEcc-CCeEEEEEEE
Confidence 47899999999999984 5689999999865321 123468899999999999999999999987 6799999999
Q ss_pred cCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCccc
Q 005749 456 FPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAV 535 (679)
Q Consensus 456 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 535 (679)
+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++......
T Consensus 86 ~~~~~l~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~ 158 (263)
T cd06625 86 MPGGSVKDQLKAY----GALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC 158 (263)
T ss_pred CCCCcHHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceeccccc
Confidence 9999999998763 45889999999999999999999988 9999999999999999999999999987653321
Q ss_pred ccch--hcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHh
Q 005749 536 ADEM--VALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDME 613 (679)
Q Consensus 536 ~~~~--~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 613 (679)
.... ....++..|+|||++.+..++.++||||+|+++|||++|+.||...... ....... ...
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~~~~-~~~--------- 223 (263)
T cd06625 159 SSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM-----AAIFKIA-TQP--------- 223 (263)
T ss_pred cccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH-----HHHHHHh-ccC---------
Confidence 1111 2345778899999999888999999999999999999999998543211 0000000 000
Q ss_pred hhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 614 IMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 614 i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
............+.+++.+||..+|++|||+.|+++.
T Consensus 224 ---~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 224 ---TNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred ---CCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 0001111233566789999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=342.16 Aligned_cols=268 Identities=18% Similarity=0.220 Sum_probs=191.2
Q ss_pred CccccCCceEEEEEEe-CCCCEEEEEEcccCcccCcccHHHHHHHHhccCCC------CCccceEEeeCCCCceEEEEEe
Q 005749 383 QVIEKTTYGTAYKAKL-ADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHE------NLIPLRAFYQGKRGEKLLIYDY 455 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~------nIv~l~~~~~~~~~~~~lv~ey 455 (679)
++||+|+||+||+|+. .+++.||||+++... .....+..|++++.+++|. +++++++++....++.++|||+
T Consensus 135 ~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~iv~~~ 213 (467)
T PTZ00284 135 SLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVMPK 213 (467)
T ss_pred EEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEEEEec
Confidence 6899999999999994 568899999996532 2234566788888777654 5888899888756788999999
Q ss_pred cCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCeeecCCCCCCeeecCCC----------------
Q 005749 456 FPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTG-HEIPITHGNVRSKNVLVDDFF---------------- 518 (679)
Q Consensus 456 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~-~~~~ivHrDlkp~NILl~~~~---------------- 518 (679)
+ +++|.+++... ..+++..+..|+.||+.||+|||++ + ||||||||+|||++.++
T Consensus 214 ~-g~~l~~~l~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~ 285 (467)
T PTZ00284 214 Y-GPCLLDWIMKH----GPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPVTNRALPPDPC 285 (467)
T ss_pred c-CCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcccccccccccCCCCc
Confidence 8 67899888753 4589999999999999999999974 6 99999999999998765
Q ss_pred ceEEeecccccccCcccccchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHH
Q 005749 519 VSRLTEFGLDQLMVPAVADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVK 598 (679)
Q Consensus 519 ~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~ 598 (679)
.+||+|||.+.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+.........
T Consensus 286 ~vkl~DfG~~~~~~----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~ 361 (467)
T PTZ00284 286 RVRICDLGGCCDER----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTL 361 (467)
T ss_pred eEEECCCCccccCc----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHc
Confidence 49999999876432 12235678999999999999999999999999999999999999996543322111111000
Q ss_pred HHhhccc------------------ccccchHhhhhcCC--CCh--HHHHHHHHHHHHhccCcCCCCCCCHHHHHHH--H
Q 005749 599 VAVLEET------------------TMEVFDMEIMKGIR--SPM--EEGLVQALKLAMGCCAPVASVRPTMDEVVKQ--L 654 (679)
Q Consensus 599 ~~~~~~~------------------~~~~~~~~i~~~~~--~~~--~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~--L 654 (679)
..+.... .....++....... ... ......+.+|+.+||+.||++|||++|++++ +
T Consensus 362 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~ 441 (467)
T PTZ00284 362 GRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYV 441 (467)
T ss_pred CCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCccc
Confidence 0000000 00000111000000 000 0112456799999999999999999999984 5
Q ss_pred HhhCCCCCC
Q 005749 655 EENRPRNRS 663 (679)
Q Consensus 655 ~~~~~~~~~ 663 (679)
.+..+..+.
T Consensus 442 ~~~~~~~~~ 450 (467)
T PTZ00284 442 LKYYPECRQ 450 (467)
T ss_pred cccCCcccc
Confidence 544443333
|
|
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=322.15 Aligned_cols=259 Identities=19% Similarity=0.268 Sum_probs=195.6
Q ss_pred cCccccCCceEEEEEEeC-----------------CCCEEEEEEcccCc-ccCcccHHHHHHHHhccCCCCCccceEEee
Q 005749 382 GQVIEKTTYGTAYKAKLA-----------------DGATIALRLLREGS-CKDRSSCLPVIRQLGKVRHENLIPLRAFYQ 443 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~-----------------~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~ 443 (679)
.+.||+|+||.||+++.. ++..||+|+++... ....+++.+|++++++++|+||+++++++.
T Consensus 10 ~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~ 89 (296)
T cd05095 10 KEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCI 89 (296)
T ss_pred eeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence 378999999999998632 24478999987543 223467899999999999999999999998
Q ss_pred CCCCceEEEEEecCCCChHHHhhcccCC-------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecC
Q 005749 444 GKRGEKLLIYDYFPSRTLHDLLHDTIAG-------KPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDD 516 (679)
Q Consensus 444 ~~~~~~~lv~ey~~~gsL~~~l~~~~~~-------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~ 516 (679)
. .+..++||||+++|+|.+++...... ...+++.++.+++.|++.||+|||+.+ ++||||||+||++++
T Consensus 90 ~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Nili~~ 165 (296)
T cd05095 90 T-SDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNCLVGK 165 (296)
T ss_pred c-CCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheEEEcC
Confidence 7 67899999999999999999764321 134788999999999999999999988 999999999999999
Q ss_pred CCceEEeecccccccCcccccc-hhcccccccccccccccccCCCCcchhHHHHHHHHHHHh--CCCCCCCCCCCcccch
Q 005749 517 FFVSRLTEFGLDQLMVPAVADE-MVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI--GKKPGKSGRNGEFVDL 593 (679)
Q Consensus 517 ~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t--g~~p~~~~~~~~~~~l 593 (679)
++.+||+|||+++.+....... .....++..|+|||...++.++.++|||||||++|||++ |..||......+.
T Consensus 166 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~--- 242 (296)
T cd05095 166 NYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQV--- 242 (296)
T ss_pred CCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHH---
Confidence 9999999999998653322111 112234567999998888889999999999999999998 6778754322211
Q ss_pred hHHHHHHhhcccccccchHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHh
Q 005749 594 PSIVKVAVLEETTMEVFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEE 656 (679)
Q Consensus 594 ~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 656 (679)
............ .....+........+.+++.+||+.||++||++.||++.|++
T Consensus 243 ~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 243 IENTGEFFRDQG---------RQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred HHHHHHHHhhcc---------ccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 111100000000 000001111223567789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=322.75 Aligned_cols=258 Identities=19% Similarity=0.294 Sum_probs=194.0
Q ss_pred CccccCCceEEEEEEeCC---------------CCEEEEEEcccCcc-cCcccHHHHHHHHhccCCCCCccceEEeeCCC
Q 005749 383 QVIEKTTYGTAYKAKLAD---------------GATIALRLLREGSC-KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKR 446 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~~~---------------~~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~ 446 (679)
+.||+|+||.||+++..+ ...||+|.++.... ...+.|.+|++++++++|+||+++++++.. .
T Consensus 11 ~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~-~ 89 (295)
T cd05097 11 EKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVS-D 89 (295)
T ss_pred hccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEcC-C
Confidence 679999999999997532 23589999876422 234578999999999999999999999987 6
Q ss_pred CceEEEEEecCCCChHHHhhcccC--------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCC
Q 005749 447 GEKLLIYDYFPSRTLHDLLHDTIA--------GKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFF 518 (679)
Q Consensus 447 ~~~~lv~ey~~~gsL~~~l~~~~~--------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~ 518 (679)
+..++||||+++++|.+++..... ....+++..+++++.|++.||+|||+.+ ++||||||+||++++++
T Consensus 90 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nill~~~~ 166 (295)
T cd05097 90 DPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCLVGNHY 166 (295)
T ss_pred CccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEEEcCCC
Confidence 789999999999999999865321 1134789999999999999999999988 99999999999999999
Q ss_pred ceEEeecccccccCcccccc-hhcccccccccccccccccCCCCcchhHHHHHHHHHHHh--CCCCCCCCCCCcccchhH
Q 005749 519 VSRLTEFGLDQLMVPAVADE-MVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI--GKKPGKSGRNGEFVDLPS 595 (679)
Q Consensus 519 ~~kl~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t--g~~p~~~~~~~~~~~l~~ 595 (679)
.+||+|||+++......... .....++..|+|||......++.++|||||||++|||++ |..||......+ ...
T Consensus 167 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~---~~~ 243 (295)
T cd05097 167 TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ---VIE 243 (295)
T ss_pred cEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH---HHH
Confidence 99999999997653322111 122345678999999988889999999999999999998 566774322211 111
Q ss_pred HHHHHhhcccccccchHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHh
Q 005749 596 IVKVAVLEETTMEVFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEE 656 (679)
Q Consensus 596 ~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 656 (679)
.......... ... . ....+...+.+.+++.+||+.||++||++++|++.|++
T Consensus 244 ~~~~~~~~~~-~~~-----~---~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 244 NTGEFFRNQG-RQI-----Y---LSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred HHHHhhhhcc-ccc-----c---CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 1110000000 000 0 00011123578899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=312.07 Aligned_cols=249 Identities=26% Similarity=0.412 Sum_probs=200.5
Q ss_pred CccccCCceEEEEEEeCC----CCEEEEEEcccCcccC-cccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecC
Q 005749 383 QVIEKTTYGTAYKAKLAD----GATIALRLLREGSCKD-RSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFP 457 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~~~----~~~vAvK~~~~~~~~~-~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~ 457 (679)
+.||+|+||.||+|+... +..||+|.++...... .+.+.+|++.+..++|+||+++++++.. ....++||||++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~ 79 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTE-EEPLYLVLEYME 79 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecC-CCceEEEEEecc
Confidence 479999999999999543 8899999998654332 5688999999999999999999999987 788999999999
Q ss_pred CCChHHHhhcccCC-----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccC
Q 005749 458 SRTLHDLLHDTIAG-----KPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMV 532 (679)
Q Consensus 458 ~gsL~~~l~~~~~~-----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 532 (679)
+++|.+++...... ...+++..+..++.|+++||+|||+++ ++||||||+||++++++.+||+|||.+....
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 156 (262)
T cd00192 80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVY 156 (262)
T ss_pred CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEcccccccccc
Confidence 99999999874211 256899999999999999999999988 9999999999999999999999999998764
Q ss_pred cccc-cchhcccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHHhhcccccccc
Q 005749 533 PAVA-DEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVF 610 (679)
Q Consensus 533 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 610 (679)
.... .......++..|+|||.+....++.++||||+|+++|||++ |..||...... ......
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~~~~~~---------- 220 (262)
T cd00192 157 DDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE------EVLEYL---------- 220 (262)
T ss_pred cccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH------HHHHHH----------
Confidence 4321 12234457788999999988889999999999999999998 69998544211 111111
Q ss_pred hHhhhhcCC-CChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHH
Q 005749 611 DMEIMKGIR-SPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLE 655 (679)
Q Consensus 611 ~~~i~~~~~-~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~ 655 (679)
..+.. ........++.+++.+||..+|++|||+.|+++.|+
T Consensus 221 ----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 221 ----RKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ----HcCCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 11111 111222467788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=315.02 Aligned_cols=249 Identities=22% Similarity=0.399 Sum_probs=196.6
Q ss_pred cCccccCCceEEEEEEeC-C---CCEEEEEEcccCcc-cCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEec
Q 005749 382 GQVIEKTTYGTAYKAKLA-D---GATIALRLLREGSC-KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYF 456 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~-~---~~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~ 456 (679)
.+.||+|+||.||+|+.. + +..+|+|.++.... ...+.+.+|+.++.+++||||+++++++.. .+..++||||+
T Consensus 9 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~ 87 (267)
T cd05066 9 EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK-SKPVMIVTEYM 87 (267)
T ss_pred eeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CCccEEEEEcC
Confidence 478999999999999853 2 33799999875432 234678999999999999999999999987 67899999999
Q ss_pred CCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccc
Q 005749 457 PSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVA 536 (679)
Q Consensus 457 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 536 (679)
++++|.+++... ...+++.+++.|+.|++.||+|||+.+ ++||||||+||+++.++.+|++|||+++.+.....
T Consensus 88 ~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd05066 88 ENGSLDAFLRKH---DGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 161 (267)
T ss_pred CCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCcccccccccc
Confidence 999999999753 235899999999999999999999988 99999999999999999999999999987643221
Q ss_pred cch--hcccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHHhhcccccccchHh
Q 005749 537 DEM--VALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDME 613 (679)
Q Consensus 537 ~~~--~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 613 (679)
... ....++..|+|||++.+..++.++||||||+++||+++ |+.||......+ .....
T Consensus 162 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~---~~~~~---------------- 222 (267)
T cd05066 162 AAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD---VIKAI---------------- 222 (267)
T ss_pred eeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH---HHHHH----------------
Confidence 111 11223467999999998889999999999999999886 999985432211 11110
Q ss_pred hhhcCCCC-hHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhh
Q 005749 614 IMKGIRSP-MEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEEN 657 (679)
Q Consensus 614 i~~~~~~~-~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 657 (679)
.++.+.+ .....+.+.+++.+||+.+|++||+|.++++.|+++
T Consensus 223 -~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 223 -EEGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred -hCCCcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 1111111 112235667899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=303.47 Aligned_cols=241 Identities=21% Similarity=0.294 Sum_probs=198.3
Q ss_pred CccccCCceEEEEEE-eCCCCEEEEEEcccC--cccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCC
Q 005749 383 QVIEKTTYGTAYKAK-LADGATIALRLLREG--SCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSR 459 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~g 459 (679)
++||+|.|+.||++. ..+|+.+|+|.+... ...+.+++.+|++|.+.++|||||++.+-+.+ .+..|+|+|+|.|+
T Consensus 17 e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~-~~~~ylvFe~m~G~ 95 (355)
T KOG0033|consen 17 EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE-ESFHYLVFDLVTGG 95 (355)
T ss_pred HHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcc-cceeEEEEecccch
Confidence 689999999999997 567999999998654 33466788999999999999999999998876 68899999999999
Q ss_pred ChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCC---CceEEeecccccccCcccc
Q 005749 460 TLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDF---FVSRLTEFGLDQLMVPAVA 536 (679)
Q Consensus 460 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~---~~~kl~DFGla~~~~~~~~ 536 (679)
+|..-+-.+ ..+++..+-.+++||+++|.|+|.++ |||||+||+|+|+... --+|++|||+|..+. ..
T Consensus 96 dl~~eIV~R----~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~--~g 166 (355)
T KOG0033|consen 96 ELFEDIVAR----EFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN--DG 166 (355)
T ss_pred HHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEeC--Cc
Confidence 997665543 45788889999999999999999998 9999999999999643 457999999999876 23
Q ss_pred cchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhh
Q 005749 537 DEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMK 616 (679)
Q Consensus 537 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~ 616 (679)
.-.....||++|||||++...+|+..+|||+-|||||-|+.|..||++.+....+ . .|+.
T Consensus 167 ~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rly-------------------e-~I~~ 226 (355)
T KOG0033|consen 167 EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLY-------------------E-QIKA 226 (355)
T ss_pred cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHH-------------------H-HHhc
Confidence 3345678999999999999999999999999999999999999999764332111 1 2222
Q ss_pred cCCC----ChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 617 GIRS----PMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 617 ~~~~----~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
+... ..+...++..+++.+|+..||.+|.|+.|.++.
T Consensus 227 g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 227 GAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred cccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence 2221 223345677889999999999999999988764
|
|
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=315.71 Aligned_cols=249 Identities=23% Similarity=0.439 Sum_probs=195.9
Q ss_pred cCccccCCceEEEEEEeC-CC---CEEEEEEcccCc-ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEec
Q 005749 382 GQVIEKTTYGTAYKAKLA-DG---ATIALRLLREGS-CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYF 456 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~-~~---~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~ 456 (679)
.+.||+|+||.||+|+.. ++ ..||+|.+.... ....+.|..|++++++++||||+++++++.+ .+..++||||+
T Consensus 9 ~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~-~~~~~lv~e~~ 87 (269)
T cd05065 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK-SRPVMIITEFM 87 (269)
T ss_pred EeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECC-CCceEEEEecC
Confidence 478999999999999954 33 369999987642 2335679999999999999999999999887 67899999999
Q ss_pred CCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccc
Q 005749 457 PSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVA 536 (679)
Q Consensus 457 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 536 (679)
++|+|.+++... ...+++.+++.++.|++.||+|||+++ ++||||||+||+++.++.+|++|||+++.......
T Consensus 88 ~~~~L~~~l~~~---~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~ 161 (269)
T cd05065 88 ENGALDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 161 (269)
T ss_pred CCCcHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccccCcc
Confidence 999999999754 235899999999999999999999988 99999999999999999999999999886543221
Q ss_pred cc-hhc-c--cccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHHhhcccccccch
Q 005749 537 DE-MVA-L--AKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFD 611 (679)
Q Consensus 537 ~~-~~~-~--~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 611 (679)
.. ... . ..+..|+|||.+.+..++.++|||||||++||+++ |..||...... ....++.
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~---~~~~~i~------------- 225 (269)
T cd05065 162 DPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ---DVINAIE------------- 225 (269)
T ss_pred ccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH---HHHHHHH-------------
Confidence 11 111 1 12357999999998899999999999999999886 99998543221 1111110
Q ss_pred HhhhhcCC-CChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhh
Q 005749 612 MEIMKGIR-SPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEEN 657 (679)
Q Consensus 612 ~~i~~~~~-~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 657 (679)
.... +..++....+.+++.+||+.+|++||++++|++.|+++
T Consensus 226 ----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 226 ----QDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ----cCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0001 11122335567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=312.63 Aligned_cols=248 Identities=21% Similarity=0.284 Sum_probs=196.7
Q ss_pred CccccCCceEEEEEEeCC--CC--EEEEEEcccCcc-cCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecC
Q 005749 383 QVIEKTTYGTAYKAKLAD--GA--TIALRLLREGSC-KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFP 457 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~~~--~~--~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~ 457 (679)
+.||+|+||.||+|+..+ ++ .||+|.+..... ...+.+.+|++++++++||||+++++++.+ ...++||||++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~v~e~~~ 78 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT--HPLMMVTELAP 78 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC--CeEEEEEEecC
Confidence 468999999999998543 33 699999987654 456688999999999999999999999886 68899999999
Q ss_pred CCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCccccc
Q 005749 458 SRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVAD 537 (679)
Q Consensus 458 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 537 (679)
+|+|.+++..... ..+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++........
T Consensus 79 ~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~ 153 (257)
T cd05040 79 LGSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH 153 (257)
T ss_pred CCcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccccccc
Confidence 9999999986432 45899999999999999999999988 999999999999999999999999999876432211
Q ss_pred --chhcccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHHhhcccccccchHhh
Q 005749 538 --EMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEI 614 (679)
Q Consensus 538 --~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i 614 (679)
......++..|+|||++.+..++.++|||||||++|||++ |+.||...... +..........
T Consensus 154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~------~~~~~~~~~~~--------- 218 (257)
T cd05040 154 YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS------QILKKIDKEGE--------- 218 (257)
T ss_pred eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHHHhcCC---------
Confidence 1123456778999999988889999999999999999998 99998433221 11111100000
Q ss_pred hhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHH
Q 005749 615 MKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLE 655 (679)
Q Consensus 615 ~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~ 655 (679)
...........+.+++.+||+.+|++||++.|+++.|.
T Consensus 219 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 219 ---RLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred ---cCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 00001122356778999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=318.81 Aligned_cols=265 Identities=20% Similarity=0.283 Sum_probs=198.2
Q ss_pred cCccccCCceEEEEEEe-----CCCCEEEEEEcccCc-ccCcccHHHHHHHHhccCCCCCccceEEeeCC-CCceEEEEE
Q 005749 382 GQVIEKTTYGTAYKAKL-----ADGATIALRLLREGS-CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGK-RGEKLLIYD 454 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~-----~~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~-~~~~~lv~e 454 (679)
-+.||+|+||.||++++ .++..||+|.++... ....+.+.+|++++++++||||+++++++... ....++|||
T Consensus 9 ~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e 88 (284)
T cd05079 9 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIME 88 (284)
T ss_pred ceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEEEEE
Confidence 37899999999999984 357899999987543 23345789999999999999999999998764 356899999
Q ss_pred ecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcc
Q 005749 455 YFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPA 534 (679)
Q Consensus 455 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 534 (679)
|+++++|.+++... ...+++..+..++.|++.||+|||+++ ++||||||+||+++.++.+||+|||+++.....
T Consensus 89 ~~~g~~L~~~l~~~---~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~ 162 (284)
T cd05079 89 FLPSGSLKEYLPRN---KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETD 162 (284)
T ss_pred ccCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccccccC
Confidence 99999999998653 235899999999999999999999988 999999999999999999999999999876432
Q ss_pred ccc--chhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchH
Q 005749 535 VAD--EMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDM 612 (679)
Q Consensus 535 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 612 (679)
... ......++..|+|||++.+..++.++||||||+++|||++++.|+....... ... .. ....+........
T Consensus 163 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~-~~~---~~-~~~~~~~~~~~~~ 237 (284)
T cd05079 163 KEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLF-LKM---IG-PTHGQMTVTRLVR 237 (284)
T ss_pred ccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchh-hhh---cc-cccccccHHHHHH
Confidence 211 1123456677999999988889999999999999999999887653221100 000 00 0000000000000
Q ss_pred hhhhcCCC-ChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhh
Q 005749 613 EIMKGIRS-PMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEEN 657 (679)
Q Consensus 613 ~i~~~~~~-~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 657 (679)
.+..+... ........+.+++.+||+.+|++||+++++++.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 238 VLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 01111111 1122346788999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=311.95 Aligned_cols=244 Identities=27% Similarity=0.406 Sum_probs=197.9
Q ss_pred cCccccCCceEEEEEEeCCCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCCh
Q 005749 382 GQVIEKTTYGTAYKAKLADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRTL 461 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gsL 461 (679)
.+.||+|+||.||+|... |+.||+|.++.... ..+.+.+|+.++++++|+||+++++++.+ .+..++||||+++++|
T Consensus 11 ~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~v~e~~~~~~L 87 (256)
T cd05039 11 GATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQ-GNPLYIVTEYMAKGSL 87 (256)
T ss_pred eeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcC-CCCeEEEEEecCCCcH
Confidence 478999999999999874 78999999976543 45678999999999999999999999987 6789999999999999
Q ss_pred HHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccchhc
Q 005749 462 HDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVA 541 (679)
Q Consensus 462 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 541 (679)
.+++.... ...+++..+..++.|++.||.|||+++ ++||||||+||++++++.+||+|||.++...... ..
T Consensus 88 ~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~----~~ 158 (256)
T cd05039 88 VDYLRSRG--RAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ----DS 158 (256)
T ss_pred HHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEccccccccccccc----cc
Confidence 99997642 235899999999999999999999988 9999999999999999999999999998763221 12
Q ss_pred ccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcCCC
Q 005749 542 LAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIRS 620 (679)
Q Consensus 542 ~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~~ 620 (679)
...+..|+|||.+....++.++||||||+++||+++ |..||...... .+...+ ..+...
T Consensus 159 ~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~~~-----------------~~~~~~ 218 (256)
T cd05039 159 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVPHV-----------------EKGYRM 218 (256)
T ss_pred CCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH---HHHHHH-----------------hcCCCC
Confidence 334567999999988889999999999999999997 99998433211 111000 001010
Q ss_pred -ChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhh
Q 005749 621 -PMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEEN 657 (679)
Q Consensus 621 -~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 657 (679)
......+.+.+++.+||..+|++||+++|+++.|+.+
T Consensus 219 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 219 EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred CCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 0112235677899999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=312.64 Aligned_cols=248 Identities=23% Similarity=0.407 Sum_probs=199.6
Q ss_pred cCccccCCceEEEEEEeCCCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCCh
Q 005749 382 GQVIEKTTYGTAYKAKLADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRTL 461 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gsL 461 (679)
.+.||+|+||.||+|..++++.||||.+.... ...+++.+|++++++++|+||+++++++.. ....++||||+++++|
T Consensus 11 ~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e~~~~~~L 88 (261)
T cd05034 11 ERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSE-EEPIYIVTEYMSKGSL 88 (261)
T ss_pred eeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeec-CCceEEEEeccCCCCH
Confidence 47899999999999998888899999987543 345679999999999999999999999887 5789999999999999
Q ss_pred HHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccchhc
Q 005749 462 HDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVA 541 (679)
Q Consensus 462 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 541 (679)
.+++.... ...+++..+..++.|++.||+|||+++ ++|+||||+||++++++.+|++|||+++............
T Consensus 89 ~~~i~~~~--~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~ 163 (261)
T cd05034 89 LDFLKSGE--GKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREG 163 (261)
T ss_pred HHHHhccc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhhhhhhc
Confidence 99997642 245899999999999999999999988 9999999999999999999999999988764322222222
Q ss_pred ccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcCCC
Q 005749 542 LAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIRS 620 (679)
Q Consensus 542 ~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~~ 620 (679)
...+..|+|||.+.+..++.++||||||+++||+++ |+.||.+.... .. ... +..+...
T Consensus 164 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~---~~---~~~--------------~~~~~~~ 223 (261)
T cd05034 164 AKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR---EV---LEQ--------------VERGYRM 223 (261)
T ss_pred cCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---HH---HHH--------------HHcCCCC
Confidence 334567999999998889999999999999999998 99998543211 11 000 1111111
Q ss_pred C-hHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHh
Q 005749 621 P-MEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEE 656 (679)
Q Consensus 621 ~-~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 656 (679)
+ ......++.+++.+|+..+|++||+++|+.+.|+.
T Consensus 224 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 224 PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 1 11123567789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=317.78 Aligned_cols=254 Identities=18% Similarity=0.297 Sum_probs=196.3
Q ss_pred cCccccCCceEEEEEEeC------CCCEEEEEEcccCcc-cCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEE
Q 005749 382 GQVIEKTTYGTAYKAKLA------DGATIALRLLREGSC-KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYD 454 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~------~~~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~e 454 (679)
.+.||+|+||.||+|+.+ .+..||+|.+..... .....+.+|+.++++++||||+++++++.. .+..++|||
T Consensus 11 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~e 89 (288)
T cd05061 11 LRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSK-GQPTLVVME 89 (288)
T ss_pred eeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCCcEEEEe
Confidence 378999999999999743 245899999865432 223467899999999999999999999887 578999999
Q ss_pred ecCCCChHHHhhcccC------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccc
Q 005749 455 YFPSRTLHDLLHDTIA------GKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLD 528 (679)
Q Consensus 455 y~~~gsL~~~l~~~~~------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 528 (679)
|+++|+|.+++..... +....++..+..++.|++.||+|||+++ |+||||||+||++++++.+|++|||++
T Consensus 90 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L~Dfg~~ 166 (288)
T cd05061 90 LMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMT 166 (288)
T ss_pred CCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEECcCCcc
Confidence 9999999999975321 1244678889999999999999999988 999999999999999999999999999
Q ss_pred cccCccccc-chhcccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHHhhcccc
Q 005749 529 QLMVPAVAD-EMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAVLEETT 606 (679)
Q Consensus 529 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 606 (679)
+........ ......++..|+|||.+.+..++.++|||||||++|||++ |+.||.+.... +.......
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~------~~~~~~~~---- 236 (288)
T cd05061 167 RDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE------QVLKFVMD---- 236 (288)
T ss_pred ccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHHHc----
Confidence 865332211 1122234677999999988889999999999999999998 78888442211 11111100
Q ss_pred cccchHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhC
Q 005749 607 MEVFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENR 658 (679)
Q Consensus 607 ~~~~~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 658 (679)
.+...........+.+++.+||+.||++|||+.++++.|++..
T Consensus 237 ---------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 237 ---------GGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred ---------CCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 0000111122356788999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=316.22 Aligned_cols=254 Identities=17% Similarity=0.229 Sum_probs=188.7
Q ss_pred CccccCCceEEEEEEeCC---CCEEEEEEcccCcc-cCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCC
Q 005749 383 QVIEKTTYGTAYKAKLAD---GATIALRLLREGSC-KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPS 458 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~~~---~~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~ 458 (679)
+.||+|+||.||+|+..+ +..+|+|.++.... .....+.+|+.++++++||||+++++++.+ ....++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~ 79 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTE-VTPYLLVMEFCPL 79 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CCCcEEEEECCCC
Confidence 368999999999998543 45799999876432 233478899999999999999999999887 5778999999999
Q ss_pred CChHHHhhcccC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCccccc
Q 005749 459 RTLHDLLHDTIA-GKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVAD 537 (679)
Q Consensus 459 gsL~~~l~~~~~-~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 537 (679)
|+|.+++..... .....++..++.++.|+++||+|||+.+ ++||||||+||++++++++|++|||+++........
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~ 156 (269)
T cd05087 80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY 156 (269)
T ss_pred CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCccee
Confidence 999999975432 1234678888899999999999999988 999999999999999999999999998754322111
Q ss_pred -chhccccccccccccccccc-------CCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHHhhcccccc
Q 005749 538 -EMVALAKADGYKAPELQRMK-------KCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAVLEETTME 608 (679)
Q Consensus 538 -~~~~~~gt~~y~aPE~~~~~-------~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 608 (679)
......++..|+|||++... .++.++||||||+++|||++ |+.||......+. .. ... ......
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~---~~---~~~-~~~~~~ 229 (269)
T cd05087 157 VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV---LT---YTV-REQQLK 229 (269)
T ss_pred ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH---HH---HHh-hcccCC
Confidence 12234567889999987632 35789999999999999996 9999954322111 00 000 000011
Q ss_pred cchHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHH
Q 005749 609 VFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLE 655 (679)
Q Consensus 609 ~~~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~ 655 (679)
..++.+. ......+.+++.+|| .+|++|||++||++.|+
T Consensus 230 ~~~~~~~-------~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 230 LPKPRLK-------LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCccC-------CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 1111110 011234567888898 58999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=319.95 Aligned_cols=252 Identities=20% Similarity=0.326 Sum_probs=197.7
Q ss_pred hcCccccCCceEEEEEEe------CCCCEEEEEEcccCcc-cCcccHHHHHHHHhcc-CCCCCccceEEeeCCCCceEEE
Q 005749 381 TGQVIEKTTYGTAYKAKL------ADGATIALRLLREGSC-KDRSSCLPVIRQLGKV-RHENLIPLRAFYQGKRGEKLLI 452 (679)
Q Consensus 381 ~~~~ig~G~~g~Vy~~~~------~~~~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~~lv 452 (679)
.++.||+|+||.||+|+. .++..||+|+++.... ...+.+.+|+++++++ +||||+++++++.. .+..++|
T Consensus 39 ~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-~~~~~lv 117 (302)
T cd05055 39 FGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTI-GGPILVI 117 (302)
T ss_pred EcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEec-CCceEEE
Confidence 458999999999999973 1345899999876432 2345688999999999 79999999999987 6789999
Q ss_pred EEecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccC
Q 005749 453 YDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMV 532 (679)
Q Consensus 453 ~ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 532 (679)
|||+++|+|.++++... ...+++.++..++.|++.||+|||+++ |+|+||||+||++++++.+|++|||+++...
T Consensus 118 ~e~~~~~~L~~~i~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 192 (302)
T cd05055 118 TEYCCYGDLLNFLRRKR--ESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARDIM 192 (302)
T ss_pred EEcCCCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCccccccc
Confidence 99999999999997532 234899999999999999999999988 9999999999999999999999999998654
Q ss_pred ccccc-chhcccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHHhhcccccccc
Q 005749 533 PAVAD-EMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVF 610 (679)
Q Consensus 533 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 610 (679)
..... ......++..|+|||.+.+..++.++|||||||++|||++ |+.||.+....+ .....
T Consensus 193 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~--~~~~~-------------- 256 (302)
T cd05055 193 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS--KFYKL-------------- 256 (302)
T ss_pred CCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH--HHHHH--------------
Confidence 32211 1122345678999999988889999999999999999998 999985432211 00000
Q ss_pred hHhhhhcCCCC-hHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhh
Q 005749 611 DMEIMKGIRSP-MEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEEN 657 (679)
Q Consensus 611 ~~~i~~~~~~~-~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 657 (679)
+..+.... ......++.+++.+||+.+|++||++.|+++.|+++
T Consensus 257 ---~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 257 ---IKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred ---HHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 00111110 111235677899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=318.32 Aligned_cols=247 Identities=19% Similarity=0.247 Sum_probs=193.5
Q ss_pred CccccCCceEEEEEEe-CCCCEEEEEEcccCcc---cCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCC
Q 005749 383 QVIEKTTYGTAYKAKL-ADGATIALRLLREGSC---KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPS 458 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~---~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~ 458 (679)
+.||+|+||+||+|+. .+++.||+|.+..... .....+.+|++++++++|+||+++++++.. ++..++||||+++
T Consensus 6 ~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~-~~~~~lv~e~~~~ 84 (285)
T cd05632 6 RVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYET-KDALCLVLTIMNG 84 (285)
T ss_pred EEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEec-CCEEEEEEEeccC
Confidence 6799999999999994 5789999999865422 223457889999999999999999998887 6789999999999
Q ss_pred CChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccc
Q 005749 459 RTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADE 538 (679)
Q Consensus 459 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 538 (679)
++|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++...... ..
T Consensus 85 ~~L~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~--~~ 157 (285)
T cd05632 85 GDLKFHIYNMG--NPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEG--ES 157 (285)
T ss_pred ccHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCC--Cc
Confidence 99998886532 345899999999999999999999988 999999999999999999999999998765322 12
Q ss_pred hhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcC
Q 005749 539 MVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGI 618 (679)
Q Consensus 539 ~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~ 618 (679)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||........ ...+.. .+....
T Consensus 158 ~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~---~~~~~~-------------~~~~~~ 221 (285)
T cd05632 158 IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK---REEVDR-------------RVLETE 221 (285)
T ss_pred ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHH-------------hhhccc
Confidence 2345689999999999888899999999999999999999999954322100 000000 111100
Q ss_pred CCChHHHHHHHHHHHHhccCcCCCCCCC-----HHHHHHH
Q 005749 619 RSPMEEGLVQALKLAMGCCAPVASVRPT-----MDEVVKQ 653 (679)
Q Consensus 619 ~~~~~~~~~~~~~l~~~cl~~dP~~RPs-----~~evl~~ 653 (679)
..........+.+++.+||+.||++||+ ++++++.
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 222 EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 0111122345678999999999999999 6677664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=327.31 Aligned_cols=237 Identities=19% Similarity=0.247 Sum_probs=187.0
Q ss_pred cCccccCCceEEEEEE-eCCCCEEEEEEcccCc---ccCcccHHHHHHHHhccC-CCCCccceEEeeCCCCceEEEEEec
Q 005749 382 GQVIEKTTYGTAYKAK-LADGATIALRLLREGS---CKDRSSCLPVIRQLGKVR-HENLIPLRAFYQGKRGEKLLIYDYF 456 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~-H~nIv~l~~~~~~~~~~~~lv~ey~ 456 (679)
.++||+|+||.||+|+ ..+|+.||+|++.... ....+.+..|.+++..+. |++|+++++++.+ .+..++||||+
T Consensus 5 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-~~~~~lv~Ey~ 83 (323)
T cd05615 5 LMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQT-VDRLYFVMEYV 83 (323)
T ss_pred EEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEec-CCEEEEEEcCC
Confidence 3689999999999999 4578999999987532 223456778899988885 5677888888887 67899999999
Q ss_pred CCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccc
Q 005749 457 PSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVA 536 (679)
Q Consensus 457 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 536 (679)
++|+|.+++... ..+++.+++.|+.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++..... .
T Consensus 84 ~~g~L~~~i~~~----~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~-~ 155 (323)
T cd05615 84 NGGDLMYHIQQV----GKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD-G 155 (323)
T ss_pred CCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCC-C
Confidence 999999998753 45899999999999999999999988 999999999999999999999999998754222 1
Q ss_pred cchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhh
Q 005749 537 DEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMK 616 (679)
Q Consensus 537 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~ 616 (679)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.... ..... +..
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~------~~~~~--------------i~~ 215 (323)
T cd05615 156 VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED------ELFQS--------------IME 215 (323)
T ss_pred ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH------HHHHH--------------HHh
Confidence 1223456899999999999888999999999999999999999999543211 11111 111
Q ss_pred cCCCChHHHHHHHHHHHHhccCcCCCCCCCH
Q 005749 617 GIRSPMEEGLVQALKLAMGCCAPVASVRPTM 647 (679)
Q Consensus 617 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~ 647 (679)
...........++.+++.+|++.+|++|++.
T Consensus 216 ~~~~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 216 HNVSYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred CCCCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 1111111223566789999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=311.61 Aligned_cols=238 Identities=21% Similarity=0.339 Sum_probs=187.8
Q ss_pred CccccCCceEEEEEEeCCCC-----------EEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEE
Q 005749 383 QVIEKTTYGTAYKAKLADGA-----------TIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLL 451 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~~~~~-----------~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~l 451 (679)
+.||+|+||.||+|+..+.. .|++|.+...... ...|.+|+.++++++||||+++++++.. +..++
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~l 77 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR--DENIM 77 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec--CCcEE
Confidence 46999999999999965432 5788887654333 6788999999999999999999999886 56799
Q ss_pred EEEecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCC-------ceEEee
Q 005749 452 IYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFF-------VSRLTE 524 (679)
Q Consensus 452 v~ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~-------~~kl~D 524 (679)
||||+++|+|.+++.... ..+++..+..++.|++.||+|||+++ |+||||||+||+++.++ .+|++|
T Consensus 78 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~D 151 (259)
T cd05037 78 VEEYVKFGPLDVFLHREK---NNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSD 151 (259)
T ss_pred EEEcCCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCC
Confidence 999999999999998642 25899999999999999999999988 99999999999999887 799999
Q ss_pred cccccccCcccccchhccccccccccccccccc--CCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHHh
Q 005749 525 FGLDQLMVPAVADEMVALAKADGYKAPELQRMK--KCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAV 601 (679)
Q Consensus 525 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~~ 601 (679)
||++..... .....++..|+|||++... .++.++||||||+++|||++ |..|+......+. ..+..
T Consensus 152 fg~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~---~~~~~--- 220 (259)
T cd05037 152 PGIPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEK---ERFYQ--- 220 (259)
T ss_pred CCccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhH---HHHHh---
Confidence 999986533 1223466779999998876 78999999999999999999 5677744321110 00000
Q ss_pred hcccccccchHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHH
Q 005749 602 LEETTMEVFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLE 655 (679)
Q Consensus 602 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~ 655 (679)
.....+. .....+.+++.+||..+|++||++.|+++.|+
T Consensus 221 --------------~~~~~~~-~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 221 --------------DQHRLPM-PDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred --------------cCCCCCC-CCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0000001 01167778999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=330.20 Aligned_cols=195 Identities=20% Similarity=0.321 Sum_probs=169.9
Q ss_pred cCccccCCceEEEEEE-eCCCCEEEEEEcccCcccCcccHHHHHHHHhccC-C-----CCCccceEEeeCCCCceEEEEE
Q 005749 382 GQVIEKTTYGTAYKAK-LADGATIALRLLREGSCKDRSSCLPVIRQLGKVR-H-----ENLIPLRAFYQGKRGEKLLIYD 454 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~-H-----~nIv~l~~~~~~~~~~~~lv~e 454 (679)
.++||+|+||.|.||. .++++.||||+++... .-..+...|+.+|..++ | -|+|++++||.. +++.|||+|
T Consensus 191 ~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~f-r~HlciVfE 268 (586)
T KOG0667|consen 191 LEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYF-RNHLCIVFE 268 (586)
T ss_pred EEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccc-ccceeeeeh
Confidence 4899999999999999 6779999999998743 23446678999999997 4 489999999998 799999999
Q ss_pred ecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCC--CceEEeecccccccC
Q 005749 455 YFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDF--FVSRLTEFGLDQLMV 532 (679)
Q Consensus 455 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~--~~~kl~DFGla~~~~ 532 (679)
.+.. +|+++++.... ..++...++.|+.||+.||.+||+.+ |||+||||+||||.+. ..+||+|||.|....
T Consensus 269 LL~~-NLYellK~n~f--~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~ 342 (586)
T KOG0667|consen 269 LLST-NLYELLKNNKF--RGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCFES 342 (586)
T ss_pred hhhh-hHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccccccC
Confidence 9966 99999998654 44899999999999999999999888 9999999999999753 478999999999764
Q ss_pred cccccchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCC
Q 005749 533 PAVADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNG 588 (679)
Q Consensus 533 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~ 588 (679)
.. ...++.+..|+|||++.+.+|+.+.||||||||+.||++|.+.|.+..+.
T Consensus 343 q~----vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~ 394 (586)
T KOG0667|consen 343 QR----VYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEY 394 (586)
T ss_pred Cc----ceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHH
Confidence 43 23667888999999999999999999999999999999999888765543
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=335.67 Aligned_cols=246 Identities=17% Similarity=0.178 Sum_probs=189.8
Q ss_pred CccccCCceEEEEEE-eCCCCEEEEEEcccCc---ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCC
Q 005749 383 QVIEKTTYGTAYKAK-LADGATIALRLLREGS---CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPS 458 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~ 458 (679)
+.||+|+||.||+|+ ..+++.||||++.... ....+.+.+|++++++++|||||++++++.+ .+..|+||||+++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~-~~~~~lv~E~~~g 85 (377)
T cd05629 7 KVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQD-AQYLYLIMEFLPG 85 (377)
T ss_pred EEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEc-CCeeEEEEeCCCC
Confidence 789999999999998 5679999999986532 2234567889999999999999999999987 6789999999999
Q ss_pred CChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCccccc-
Q 005749 459 RTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVAD- 537 (679)
Q Consensus 459 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~- 537 (679)
|+|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+......
T Consensus 86 g~L~~~l~~~----~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 158 (377)
T cd05629 86 GDLMTMLIKY----DTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSA 158 (377)
T ss_pred CcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccccccc
Confidence 9999999753 45889999999999999999999988 999999999999999999999999998643210000
Q ss_pred ---------------------------------------------chhcccccccccccccccccCCCCcchhHHHHHHH
Q 005749 538 ---------------------------------------------EMVALAKADGYKAPELQRMKKCSSRTDVYAFGILL 572 (679)
Q Consensus 538 ---------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl 572 (679)
......||+.|+|||++.+..++.++|||||||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 238 (377)
T cd05629 159 YYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIM 238 (377)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhh
Confidence 00124689999999999988999999999999999
Q ss_pred HHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCC---CCHHH
Q 005749 573 LEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVR---PTMDE 649 (679)
Q Consensus 573 ~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~R---Ps~~e 649 (679)
|||++|+.||.+....+ .......... .+. .+.......++.+++.+|+. +|.+| +++.|
T Consensus 239 ~elltG~~Pf~~~~~~~------~~~~i~~~~~-------~~~---~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~ 301 (377)
T cd05629 239 FECLIGWPPFCSENSHE------TYRKIINWRE-------TLY---FPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHE 301 (377)
T ss_pred hhhhcCCCCCCCCCHHH------HHHHHHccCC-------ccC---CCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHH
Confidence 99999999995433211 0000000000 000 00011123456788999997 66665 59999
Q ss_pred HHHH
Q 005749 650 VVKQ 653 (679)
Q Consensus 650 vl~~ 653 (679)
++++
T Consensus 302 ~l~h 305 (377)
T cd05629 302 IKSH 305 (377)
T ss_pred HhcC
Confidence 8876
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=332.68 Aligned_cols=246 Identities=16% Similarity=0.195 Sum_probs=189.8
Q ss_pred CccccCCceEEEEEEe-CCCCEEEEEEcccCc---ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCC
Q 005749 383 QVIEKTTYGTAYKAKL-ADGATIALRLLREGS---CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPS 458 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~ 458 (679)
+.||+|+||.||+|+. .+++.||+|.+.... ....+.+.+|+++++.++||||+++++++.+ ++..++||||+++
T Consensus 49 ~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~-~~~~~lv~Ey~~g 127 (370)
T cd05621 49 KVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQD-DKYLYMVMEYMPG 127 (370)
T ss_pred EEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc-CCEEEEEEcCCCC
Confidence 6899999999999995 468899999986432 2234457899999999999999999999987 6789999999999
Q ss_pred CChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccc
Q 005749 459 RTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADE 538 (679)
Q Consensus 459 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 538 (679)
|+|.+++.. ..+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.........
T Consensus 128 g~L~~~l~~-----~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~ 199 (370)
T cd05621 128 GDLVNLMSN-----YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVR 199 (370)
T ss_pred CcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceecccCCcee
Confidence 999999964 24788999999999999999999988 9999999999999999999999999998764332222
Q ss_pred hhccccccccccccccccc----CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhh
Q 005749 539 MVALAKADGYKAPELQRMK----KCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEI 614 (679)
Q Consensus 539 ~~~~~gt~~y~aPE~~~~~----~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i 614 (679)
.....||+.|+|||++.+. .++.++||||+||++|||++|+.||...... ............. .
T Consensus 200 ~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~------~~~~~i~~~~~~~-----~- 267 (370)
T cd05621 200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV------GTYSKIMDHKNSL-----N- 267 (370)
T ss_pred cccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCccc-----C-
Confidence 3456799999999998753 3788999999999999999999999543211 1111000000000 0
Q ss_pred hhcCCCChHHHHHHHHHHHHhccCcCCCC--CCCHHHHHHH
Q 005749 615 MKGIRSPMEEGLVQALKLAMGCCAPVASV--RPTMDEVVKQ 653 (679)
Q Consensus 615 ~~~~~~~~~~~~~~~~~l~~~cl~~dP~~--RPs~~evl~~ 653 (679)
.+........+.+++..|+..++.+ ||++.|++++
T Consensus 268 ----~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 268 ----FPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred ----CCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 0111112345567888888755543 8999999887
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=318.84 Aligned_cols=244 Identities=18% Similarity=0.303 Sum_probs=196.6
Q ss_pred CccccCCceEEEEEE-eCCCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCCh
Q 005749 383 QVIEKTTYGTAYKAK-LADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRTL 461 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gsL 461 (679)
+.||+|+||.||+|+ ..+++.||+|.+........+.+.+|+++++.++|+||+++++++.. ..+.++||||+++++|
T Consensus 26 ~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~-~~~~~lv~e~~~~~~L 104 (296)
T cd06654 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-GDELWVVMEYLAGGSL 104 (296)
T ss_pred EEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEe-CCEEEEeecccCCCCH
Confidence 679999999999999 45789999999876555556678999999999999999999999887 6789999999999999
Q ss_pred HHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccchhc
Q 005749 462 HDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVA 541 (679)
Q Consensus 462 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 541 (679)
.+++.. ..+++.++..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++....... .....
T Consensus 105 ~~~~~~-----~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~-~~~~~ 175 (296)
T cd06654 105 TDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-SKRST 175 (296)
T ss_pred HHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccccc-cccCc
Confidence 999864 34789999999999999999999988 9999999999999999999999999987653322 11233
Q ss_pred ccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcCCCC
Q 005749 542 LAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIRSP 621 (679)
Q Consensus 542 ~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~~~ 621 (679)
..+++.|+|||.+.+..++.++|||||||++|||++|+.||....... .+.... .... +. ...
T Consensus 176 ~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~-----~~~~~~-~~~~------~~-----~~~ 238 (296)
T cd06654 176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR-----ALYLIA-TNGT------PE-----LQN 238 (296)
T ss_pred ccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH-----hHHHHh-cCCC------CC-----CCC
Confidence 468889999999988889999999999999999999999995432211 010000 0000 00 001
Q ss_pred hHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 622 MEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 622 ~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
.+.....+.+++.+||..+|++||++.|+++.
T Consensus 239 ~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 239 PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred ccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 12233556789999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=314.43 Aligned_cols=251 Identities=24% Similarity=0.377 Sum_probs=194.9
Q ss_pred CccccCCceEEEEEEeCC-------CCEEEEEEcccCc-ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEE
Q 005749 383 QVIEKTTYGTAYKAKLAD-------GATIALRLLREGS-CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYD 454 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~~~-------~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~e 454 (679)
+.||+|+||.||+|+..+ ++.+|+|.+.... ......+.+|++++++++||||+++++++.. .+..++|||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e 79 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLL-NEPQYIIME 79 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecC-CCCeEEEEe
Confidence 368999999999998542 2579999886543 2345678999999999999999999999987 678999999
Q ss_pred ecCCCChHHHhhcccC---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCC-----ceEEeecc
Q 005749 455 YFPSRTLHDLLHDTIA---GKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFF-----VSRLTEFG 526 (679)
Q Consensus 455 y~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~-----~~kl~DFG 526 (679)
|+++++|.+++..... ....+++.+++.++.|++.||+|||+.+ ++|+||||+||+++.++ .+|++|||
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg 156 (269)
T cd05044 80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFG 156 (269)
T ss_pred ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCcc
Confidence 9999999999975322 1245889999999999999999999988 99999999999999877 89999999
Q ss_pred cccccCcccc-cchhcccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHHhhcc
Q 005749 527 LDQLMVPAVA-DEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAVLEE 604 (679)
Q Consensus 527 la~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~~~~~ 604 (679)
+++....... .......++..|+|||.+.+..++.++|||||||++|||++ |+.||...... .....+ ...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~---~~~~~~----~~~ 229 (269)
T cd05044 157 LARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ---EVLQHV----TAG 229 (269)
T ss_pred cccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH---HHHHHH----hcC
Confidence 9876533211 11122345678999999998899999999999999999998 99998432211 111100 000
Q ss_pred cccccchHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHh
Q 005749 605 TTMEVFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEE 656 (679)
Q Consensus 605 ~~~~~~~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 656 (679)
............+.+++.+||+.+|++||+++++++.|++
T Consensus 230 ------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 230 ------------GRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred ------------CccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 0001111233567789999999999999999999999874
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=320.53 Aligned_cols=256 Identities=22% Similarity=0.361 Sum_probs=198.5
Q ss_pred hcCccccCCceEEEEEEeC--------CCCEEEEEEcccCcc-cCcccHHHHHHHHhcc-CCCCCccceEEeeCCCCceE
Q 005749 381 TGQVIEKTTYGTAYKAKLA--------DGATIALRLLREGSC-KDRSSCLPVIRQLGKV-RHENLIPLRAFYQGKRGEKL 450 (679)
Q Consensus 381 ~~~~ig~G~~g~Vy~~~~~--------~~~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~~ 450 (679)
.++.||+|+||.||+|+.. +...||+|.++.... .....+.+|+++++++ +||||+++++++.. .+..+
T Consensus 16 ~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-~~~~~ 94 (314)
T cd05099 16 LGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ-EGPLY 94 (314)
T ss_pred eeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc-CCceE
Confidence 4589999999999999732 245799999875422 2345688999999999 69999999999987 67899
Q ss_pred EEEEecCCCChHHHhhcccC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCC
Q 005749 451 LIYDYFPSRTLHDLLHDTIA------------GKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFF 518 (679)
Q Consensus 451 lv~ey~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~ 518 (679)
+||||+++|+|.+++..... ....+++.++++++.|++.||+|||+++ ++||||||+||++++++
T Consensus 95 lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~~~~ 171 (314)
T cd05099 95 VIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLVTEDN 171 (314)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEEcCCC
Confidence 99999999999999976421 1245899999999999999999999988 99999999999999999
Q ss_pred ceEEeecccccccCcccccc-hhcccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHH
Q 005749 519 VSRLTEFGLDQLMVPAVADE-MVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSI 596 (679)
Q Consensus 519 ~~kl~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~ 596 (679)
.+||+|||+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||...... ..
T Consensus 172 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~------~~ 245 (314)
T cd05099 172 VMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE------EL 245 (314)
T ss_pred cEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH------HH
Confidence 99999999998664321111 112234457999999988889999999999999999998 88888433211 11
Q ss_pred HHHHhhcccccccchHhhhhcCC-CChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCCC
Q 005749 597 VKVAVLEETTMEVFDMEIMKGIR-SPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRPR 660 (679)
Q Consensus 597 ~~~~~~~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 660 (679)
... . ..+.. ........++.+++.+||+.+|++||++.|+++.|+++...
T Consensus 246 ~~~-~-------------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~ 296 (314)
T cd05099 246 FKL-L-------------REGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA 296 (314)
T ss_pred HHH-H-------------HcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHH
Confidence 110 0 01100 11112234677899999999999999999999999988643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=308.67 Aligned_cols=247 Identities=21% Similarity=0.334 Sum_probs=196.1
Q ss_pred CccccCCceEEEEEEeCCCCEEEEEEcccCccc-CcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCCh
Q 005749 383 QVIEKTTYGTAYKAKLADGATIALRLLREGSCK-DRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRTL 461 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~-~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gsL 461 (679)
++||+|+||.||+|...+++.||+|.+...... ..+.+.+|++++++++|+||+++++++.. ....++||||+++++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~v~e~~~~~~l 79 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQ-KQPIYIVMELVPGGSL 79 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEec-CCCeEEEEEcCCCCcH
Confidence 469999999999999767999999998765332 45678999999999999999999999887 6789999999999999
Q ss_pred HHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccch-h
Q 005749 462 HDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEM-V 540 (679)
Q Consensus 462 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~-~ 540 (679)
.+++... ...+++..++.++.+++.||+|||+++ ++||||||+||+++.++.+||+|||+++.......... .
T Consensus 80 ~~~l~~~---~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~ 153 (251)
T cd05041 80 LTFLRKK---KNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDG 153 (251)
T ss_pred HHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccc
Confidence 9998653 235789999999999999999999988 99999999999999999999999999986532211111 1
Q ss_pred cccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcCC
Q 005749 541 ALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIR 619 (679)
Q Consensus 541 ~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~ 619 (679)
....+..|+|||.+.+..++.++||||||+++|||++ |..||....... ..... .....
T Consensus 154 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~---~~~~~-----------------~~~~~ 213 (251)
T cd05041 154 LKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ---TRERI-----------------ESGYR 213 (251)
T ss_pred cCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH---HHHHH-----------------hcCCC
Confidence 1233556999999988889999999999999999999 788884432211 00000 00000
Q ss_pred -CChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHh
Q 005749 620 -SPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEE 656 (679)
Q Consensus 620 -~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 656 (679)
........++.+++.+||..+|++||++.|+++.|+.
T Consensus 214 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 214 MPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI 251 (251)
T ss_pred CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence 1111223567789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=329.97 Aligned_cols=252 Identities=22% Similarity=0.367 Sum_probs=203.0
Q ss_pred cCccccCCceEEEEEEeCC--CC--EEEEEEcccCccc-CcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEec
Q 005749 382 GQVIEKTTYGTAYKAKLAD--GA--TIALRLLREGSCK-DRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYF 456 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~~--~~--~vAvK~~~~~~~~-~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~ 456 (679)
.+.||+|.||.|++|.|.. |+ .||||.++..... ...+|++|+.+|.+|+|||+|++||+..+ ....||+|.+
T Consensus 115 ~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~--qp~mMV~ELa 192 (1039)
T KOG0199|consen 115 YELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD--QPAMMVFELA 192 (1039)
T ss_pred HHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc--chhhHHhhhc
Confidence 4789999999999998653 44 6899999887543 56799999999999999999999999986 5789999999
Q ss_pred CCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccc
Q 005749 457 PSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVA 536 (679)
Q Consensus 457 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 536 (679)
+.|||.+.|+... ...|-......++.|||.||.||.+++ +|||||.++|+|+-....+||+|||+.+-+.....
T Consensus 193 plGSLldrLrka~--~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ned 267 (1039)
T KOG0199|consen 193 PLGSLLDRLRKAK--KAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENED 267 (1039)
T ss_pred ccchHHHHHhhcc--ccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCCc
Confidence 9999999998732 456888899999999999999999998 99999999999999999999999999998755432
Q ss_pred cc-h-hcccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHHhhcccccccchHh
Q 005749 537 DE-M-VALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDME 613 (679)
Q Consensus 537 ~~-~-~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 613 (679)
.. + ....-.+.|.|||.+....++.++|||+|||++|||+| |+.||.+....+.. +.+|
T Consensus 268 ~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL----------------~~iD-- 329 (1039)
T KOG0199|consen 268 MYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQIL----------------KNID-- 329 (1039)
T ss_pred ceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHH----------------Hhcc--
Confidence 22 1 12234567999999999999999999999999999997 78898654332111 1111
Q ss_pred hhhcCCCC-hHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH--HHhhCCC
Q 005749 614 IMKGIRSP-MEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ--LEENRPR 660 (679)
Q Consensus 614 i~~~~~~~-~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~--L~~~~~~ 660 (679)
.+.+.+ .+.+...+.+++..||..+|++||||..|.+. +.+..+.
T Consensus 330 --~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l~eaqp~ 377 (1039)
T KOG0199|consen 330 --AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLAEAQPA 377 (1039)
T ss_pred --ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHHHhcCCc
Confidence 222222 33445667899999999999999999999744 3444443
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=336.46 Aligned_cols=246 Identities=18% Similarity=0.223 Sum_probs=189.7
Q ss_pred CccccCCceEEEEEE-eCCCCEEEEEEcccCc---ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCC
Q 005749 383 QVIEKTTYGTAYKAK-LADGATIALRLLREGS---CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPS 458 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~ 458 (679)
+.||+|+||.||+|+ ..+++.||+|++.... ....+.+.+|++++++++||||+++++.+.+ .+..++||||+++
T Consensus 7 ~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~-~~~~~lv~E~~~~ 85 (376)
T cd05598 7 KTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQD-KDNLYFVMDYIPG 85 (376)
T ss_pred EEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEc-CCEEEEEEeCCCC
Confidence 689999999999999 4568999999986532 2234567899999999999999999999987 6899999999999
Q ss_pred CChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCccc---
Q 005749 459 RTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAV--- 535 (679)
Q Consensus 459 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~--- 535 (679)
|+|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|..+....
T Consensus 86 g~L~~~i~~~----~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~ 158 (376)
T cd05598 86 GDMMSLLIRL----GIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158 (376)
T ss_pred CcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccc
Confidence 9999999763 45888999999999999999999988 9999999999999999999999999975321000
Q ss_pred ---------------------------------------ccchhcccccccccccccccccCCCCcchhHHHHHHHHHHH
Q 005749 536 ---------------------------------------ADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEIL 576 (679)
Q Consensus 536 ---------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~ 576 (679)
........||+.|||||++.+..++.++|||||||++|||+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell 238 (376)
T cd05598 159 YYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 238 (376)
T ss_pred ccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehh
Confidence 00011346899999999999889999999999999999999
Q ss_pred hCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCC---CHHHHHHH
Q 005749 577 IGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRP---TMDEVVKQ 653 (679)
Q Consensus 577 tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP---s~~evl~~ 653 (679)
+|+.||.+....+. ....... .... . .+......++..+++.+|+ .+|++|+ ++.|+++.
T Consensus 239 ~G~~Pf~~~~~~~~------~~~i~~~---~~~~--~-----~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 239 VGQPPFLADTPAET------QLKVINW---ETTL--H-----IPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred hCCCCCCCCCHHHH------HHHHhcc---Cccc--c-----CCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 99999965432110 0000000 0000 0 0111112345566777765 4999999 88999876
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=310.64 Aligned_cols=253 Identities=15% Similarity=0.219 Sum_probs=185.9
Q ss_pred ccccCCceEEEEEEeCCCC---EEEEEEcccCc-ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCC
Q 005749 384 VIEKTTYGTAYKAKLADGA---TIALRLLREGS-CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSR 459 (679)
Q Consensus 384 ~ig~G~~g~Vy~~~~~~~~---~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~g 459 (679)
.||+|+||.||+|+..++. .+++|.+.... ....+.|.+|+.+++.++||||++++++|.. ....++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~ 80 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVE-AIPYLLVFEYCELG 80 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecC-CCccEEEEecCCCC
Confidence 5999999999999854433 45667665432 2345679999999999999999999999987 67899999999999
Q ss_pred ChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCccc-ccc
Q 005749 460 TLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAV-ADE 538 (679)
Q Consensus 460 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~-~~~ 538 (679)
+|.++++.........++...+.++.||++||+|||+.+ ++||||||+|||++.++.+||+|||++....... ...
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 999999764332345677788899999999999999988 9999999999999999999999999986432211 111
Q ss_pred hhcccccccccccccccc-------cCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHHhhcccccccc
Q 005749 539 MVALAKADGYKAPELQRM-------KKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVF 610 (679)
Q Consensus 539 ~~~~~gt~~y~aPE~~~~-------~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 610 (679)
.....++..|+|||++.. ..++.++|||||||++|||++ |..||...... +....... +......
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~------~~~~~~~~-~~~~~~~ 230 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR------EVLNHVIK-DQQVKLF 230 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHHHh-hcccccC
Confidence 224467888999998753 245789999999999999997 46677432211 11111111 1111122
Q ss_pred hHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHH
Q 005749 611 DMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLE 655 (679)
Q Consensus 611 ~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~ 655 (679)
++.+.. .....+.+++..|| .+|++||+++||++.|.
T Consensus 231 ~~~~~~-------~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 231 KPQLEL-------PYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCccCC-------CCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 222111 12245567888899 67999999999998873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=316.84 Aligned_cols=250 Identities=20% Similarity=0.334 Sum_probs=195.6
Q ss_pred CccccCCceEEEEEEeC------CCCEEEEEEcccCcc-cCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEe
Q 005749 383 QVIEKTTYGTAYKAKLA------DGATIALRLLREGSC-KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDY 455 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~~------~~~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey 455 (679)
+.||+|+||.||+|+.. ++..||+|.+..... ...+.+.+|++++++++||||+++++++.. .+..++||||
T Consensus 11 ~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~ 89 (288)
T cd05050 11 RDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAV-GKPMCLLFEY 89 (288)
T ss_pred ccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcC-CCccEEEEec
Confidence 68999999999999853 467999999875432 234568899999999999999999999887 5789999999
Q ss_pred cCCCChHHHhhcccC------------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCC
Q 005749 456 FPSRTLHDLLHDTIA------------------GKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDF 517 (679)
Q Consensus 456 ~~~gsL~~~l~~~~~------------------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~ 517 (679)
+++|+|.+++..... ....+++..++.++.|++.||+|||+.+ ++||||||+||+++++
T Consensus 90 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~nil~~~~ 166 (288)
T cd05050 90 MAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRNCLVGEN 166 (288)
T ss_pred CCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhheEecCC
Confidence 999999999974321 1234789999999999999999999988 9999999999999999
Q ss_pred CceEEeecccccccCcccc-cchhcccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhH
Q 005749 518 FVSRLTEFGLDQLMVPAVA-DEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPS 595 (679)
Q Consensus 518 ~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~ 595 (679)
+.+||+|||+++.+..... ........+..|+|||.+.+..++.++|||||||++|||++ |..||.+.... +
T Consensus 167 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~------~ 240 (288)
T cd05050 167 MVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE------E 240 (288)
T ss_pred CceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH------H
Confidence 9999999999876532211 11122234567999999988889999999999999999997 88888433211 1
Q ss_pred HHHHHhhcccccccchHhhhhcCC-CChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHh
Q 005749 596 IVKVAVLEETTMEVFDMEIMKGIR-SPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEE 656 (679)
Q Consensus 596 ~~~~~~~~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 656 (679)
..... ..+.. ........++.+++.+||+.+|++|||+.|+++.|++
T Consensus 241 ~~~~~--------------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 241 VIYYV--------------RDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred HHHHH--------------hcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 11111 11110 1111223567889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=329.61 Aligned_cols=240 Identities=18% Similarity=0.240 Sum_probs=184.2
Q ss_pred cccCCceEEEEEEe-CCCCEEEEEEcccCcc---cCcccHHHHHHHHhcc---CCCCCccceEEeeCCCCceEEEEEecC
Q 005749 385 IEKTTYGTAYKAKL-ADGATIALRLLREGSC---KDRSSCLPVIRQLGKV---RHENLIPLRAFYQGKRGEKLLIYDYFP 457 (679)
Q Consensus 385 ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~---~~~~~~~~Ei~~l~~l---~H~nIv~l~~~~~~~~~~~~lv~ey~~ 457 (679)
||+|+||+||+|+. .+++.||+|++..... .....+..|..++.+. +||||+++++++.+ ....++||||++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~-~~~~~lv~e~~~ 79 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQT-DSDLYLVTDYMS 79 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEec-CCeEEEEEcCCC
Confidence 79999999999994 5689999999865321 1223455677777665 69999999999987 678999999999
Q ss_pred CCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCccccc
Q 005749 458 SRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVAD 537 (679)
Q Consensus 458 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 537 (679)
+|+|.+++.. ...+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++..... ..
T Consensus 80 ~g~L~~~l~~----~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~-~~ 151 (330)
T cd05586 80 GGELFWHLQK----EGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTD-NK 151 (330)
T ss_pred CChHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCC-CC
Confidence 9999998875 345899999999999999999999988 999999999999999999999999998754222 12
Q ss_pred chhccccccccccccccccc-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhh
Q 005749 538 EMVALAKADGYKAPELQRMK-KCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMK 616 (679)
Q Consensus 538 ~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~ 616 (679)
......||..|+|||++.+. .++.++|||||||++|||++|+.||...... +....... .
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~------~~~~~i~~-------------~ 212 (330)
T cd05586 152 TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ------QMYRNIAF-------------G 212 (330)
T ss_pred CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH------HHHHHHHc-------------C
Confidence 23345789999999988754 4899999999999999999999999543211 11110000 0
Q ss_pred cCCCChHHHHHHHHHHHHhccCcCCCCCCC----HHHHHH
Q 005749 617 GIRSPMEEGLVQALKLAMGCCAPVASVRPT----MDEVVK 652 (679)
Q Consensus 617 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs----~~evl~ 652 (679)
....+......++.+++.+||+.||++||+ +.|+++
T Consensus 213 ~~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 213 KVRFPKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred CCCCCCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 001111112345678999999999999994 555554
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=326.88 Aligned_cols=256 Identities=19% Similarity=0.209 Sum_probs=190.3
Q ss_pred cCccccCCceEEEEEEe-CCCCEEEEEEcccCc--ccCcccHHHHHHHHhccCCCCCccceEEeeCCC-----CceEEEE
Q 005749 382 GQVIEKTTYGTAYKAKL-ADGATIALRLLREGS--CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKR-----GEKLLIY 453 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~-----~~~~lv~ 453 (679)
.+.||+|+||.||+|+. .+|..||+|++.... ......+.+|+.+++.++||||+++++++.... ...++||
T Consensus 26 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~ 105 (359)
T cd07876 26 LKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVM 105 (359)
T ss_pred EEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeEEEE
Confidence 37899999999999984 568999999986532 233456789999999999999999999886522 2479999
Q ss_pred EecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCc
Q 005749 454 DYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVP 533 (679)
Q Consensus 454 ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 533 (679)
||+++ +|.+.+.. .+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++....
T Consensus 106 e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 175 (359)
T cd07876 106 ELMDA-NLCQVIHM------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACT 175 (359)
T ss_pred eCCCc-CHHHHHhc------cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCCcccccc
Confidence 99976 67666642 3788999999999999999999988 99999999999999999999999999976432
Q ss_pred ccccchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccc-------
Q 005749 534 AVADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETT------- 606 (679)
Q Consensus 534 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~------- 606 (679)
. .......+|..|+|||++.+..++.++|||||||++|||++|+.||.+....+ .|..........
T Consensus 176 ~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~-----~~~~~~~~~~~~~~~~~~~ 248 (359)
T cd07876 176 N--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHID-----QWNKVIEQLGTPSAEFMNR 248 (359)
T ss_pred C--ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHHhcCCCcHHHHHH
Confidence 2 12234568899999999999899999999999999999999999996543211 111000000000
Q ss_pred --------------------cccchHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 005749 607 --------------------MEVFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQL 654 (679)
Q Consensus 607 --------------------~~~~~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L 654 (679)
.+.+.................++.+++.+||+.||++|||+.|++++-
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 316 (359)
T cd07876 249 LQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHP 316 (359)
T ss_pred HHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCc
Confidence 000000000000000001134577899999999999999999999863
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=312.05 Aligned_cols=246 Identities=22% Similarity=0.304 Sum_probs=191.9
Q ss_pred CccccCCceEEEEEE-eCCCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCCh
Q 005749 383 QVIEKTTYGTAYKAK-LADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRTL 461 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gsL 461 (679)
..||+|+||.||+|+ ..++..||+|.+........+.+.+|++++++++|+||+++++++.. .+..++|+||+++++|
T Consensus 14 ~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~L 92 (268)
T cd06624 14 VVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSE-NGFFKIFMEQVPGGSL 92 (268)
T ss_pred EEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeecc-CCEEEEEEecCCCCCH
Confidence 579999999999999 45688999999876655556688999999999999999999999987 6789999999999999
Q ss_pred HHHhhcccCCCCCC--CHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecC-CCceEEeecccccccCcccccc
Q 005749 462 HDLLHDTIAGKPVL--NWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDD-FFVSRLTEFGLDQLMVPAVADE 538 (679)
Q Consensus 462 ~~~l~~~~~~~~~l--~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~-~~~~kl~DFGla~~~~~~~~~~ 538 (679)
.+++.... ..+ ++..+..++.|++.||+|||+.+ |+||||||+||+++. ++.+||+|||++....... ..
T Consensus 93 ~~~l~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~-~~ 165 (268)
T cd06624 93 SALLRSKW---GPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN-PC 165 (268)
T ss_pred HHHHHHhc---ccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheecccCC-Cc
Confidence 99997532 234 78889999999999999999988 999999999999986 6799999999987653221 11
Q ss_pred hhcccccccccccccccccC--CCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhh
Q 005749 539 MVALAKADGYKAPELQRMKK--CSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMK 616 (679)
Q Consensus 539 ~~~~~gt~~y~aPE~~~~~~--~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~ 616 (679)
.....++..|+|||++.... ++.++||||||+++|||++|+.||....... ...+ .. ....
T Consensus 166 ~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~---~~~~-~~-------------~~~~ 228 (268)
T cd06624 166 TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQ---AAMF-KV-------------GMFK 228 (268)
T ss_pred cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChh---hhHh-hh-------------hhhc
Confidence 22345788999999986543 7899999999999999999999984322110 0000 00 0000
Q ss_pred cCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 617 GIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 617 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
...........++.+++.+||+.+|++|||+.|++..
T Consensus 229 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 229 IHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred cCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 0000111223567789999999999999999999864
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=319.19 Aligned_cols=259 Identities=19% Similarity=0.279 Sum_probs=196.8
Q ss_pred cCccccCCceEEEEEEeCC-----------------CCEEEEEEcccCcc-cCcccHHHHHHHHhccCCCCCccceEEee
Q 005749 382 GQVIEKTTYGTAYKAKLAD-----------------GATIALRLLREGSC-KDRSSCLPVIRQLGKVRHENLIPLRAFYQ 443 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~~-----------------~~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~ 443 (679)
.+.||+|+||.||+|+..+ +..||+|.+..... ...+.+.+|++++++++||||+++++++.
T Consensus 10 ~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 89 (296)
T cd05051 10 VEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCT 89 (296)
T ss_pred cccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEEEEEEe
Confidence 3789999999999998532 24689999876432 33567889999999999999999999998
Q ss_pred CCCCceEEEEEecCCCChHHHhhcccC-------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecC
Q 005749 444 GKRGEKLLIYDYFPSRTLHDLLHDTIA-------GKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDD 516 (679)
Q Consensus 444 ~~~~~~~lv~ey~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~ 516 (679)
. .+..+++|||+++++|.+++..... ....+++..++.++.|++.||+|||+++ |+||||||+||++++
T Consensus 90 ~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~Nili~~ 165 (296)
T cd05051 90 V-DPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRNCLVGK 165 (296)
T ss_pred c-CCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhceeecC
Confidence 7 5789999999999999999976431 1235899999999999999999999988 999999999999999
Q ss_pred CCceEEeecccccccCccccc-chhcccccccccccccccccCCCCcchhHHHHHHHHHHHh--CCCCCCCCCCCcccch
Q 005749 517 FFVSRLTEFGLDQLMVPAVAD-EMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI--GKKPGKSGRNGEFVDL 593 (679)
Q Consensus 517 ~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t--g~~p~~~~~~~~~~~l 593 (679)
++.+||+|||+++........ ......++..|+|||++.+..++.++|||||||++|||++ |..||...... ..
T Consensus 166 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~---~~ 242 (296)
T cd05051 166 NYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ---QV 242 (296)
T ss_pred CCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH---HH
Confidence 999999999998865332211 1223345778999999988889999999999999999998 66777432211 11
Q ss_pred hHHHHHHhhcccccccchHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHh
Q 005749 594 PSIVKVAVLEETTMEVFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEE 656 (679)
Q Consensus 594 ~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 656 (679)
............ ... ..........++.+++.+||+.||++|||+.||++.|++
T Consensus 243 ~~~~~~~~~~~~------~~~---~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 243 IENAGHFFRDDG------RQI---YLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred HHHHHhcccccc------ccc---cCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 111111000000 000 001111223578899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=309.90 Aligned_cols=247 Identities=21% Similarity=0.372 Sum_probs=197.5
Q ss_pred cCccccCCceEEEEEEeCCCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCCh
Q 005749 382 GQVIEKTTYGTAYKAKLADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRTL 461 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gsL 461 (679)
.+.||+|+||.||+|...++..+|+|.+.... ...+.+.+|++++++++|+||+++++++.. ...+++|||+++++|
T Consensus 11 ~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~v~e~~~~~~L 87 (260)
T cd05073 11 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK--EPIYIITEFMAKGSL 87 (260)
T ss_pred EeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC--CCeEEEEEeCCCCcH
Confidence 37899999999999998788889999987542 234678999999999999999999998876 578999999999999
Q ss_pred HHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccchhc
Q 005749 462 HDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVA 541 (679)
Q Consensus 462 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 541 (679)
.+++.... ...+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||.+.............
T Consensus 88 ~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~ 162 (260)
T cd05073 88 LDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREG 162 (260)
T ss_pred HHHHHhCC--ccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCcccccC
Confidence 99997642 345789999999999999999999987 9999999999999999999999999987654322222222
Q ss_pred ccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcCC-
Q 005749 542 LAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIR- 619 (679)
Q Consensus 542 ~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~- 619 (679)
..++..|+|||++....++.++|||||||++||+++ |+.||...... .+..+. ..+..
T Consensus 163 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~---~~~~~~-----------------~~~~~~ 222 (260)
T cd05073 163 AKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP---EVIRAL-----------------ERGYRM 222 (260)
T ss_pred CcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH---HHHHHH-----------------hCCCCC
Confidence 345667999999988889999999999999999998 89998543211 111111 11100
Q ss_pred CChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHh
Q 005749 620 SPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEE 656 (679)
Q Consensus 620 ~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 656 (679)
+.......++.+++.+||+.+|++||++.++.+.|+.
T Consensus 223 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 223 PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1112233567789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=313.34 Aligned_cols=244 Identities=18% Similarity=0.263 Sum_probs=191.8
Q ss_pred CccccCCceEEEEEE-eCCCCEEEEEEcccCc-ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCC
Q 005749 383 QVIEKTTYGTAYKAK-LADGATIALRLLREGS-CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRT 460 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gs 460 (679)
++||+|+||.||+|+ ..+++.||+|.+.... ....+.+.+|++++.+++||||+++++++.. .+..++||||+++++
T Consensus 7 ~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~ 85 (279)
T cd06619 7 EILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFV-ENRISICTEFMDGGS 85 (279)
T ss_pred eeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEE-CCEEEEEEecCCCCC
Confidence 689999999999998 5678999999986542 2234568899999999999999999999987 678999999999999
Q ss_pred hHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccchh
Q 005749 461 LHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMV 540 (679)
Q Consensus 461 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 540 (679)
|..+. .+++..+..++.|++.||+|||+.+ |+|+||||+||+++.++.+||+|||++...... ...
T Consensus 86 l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~---~~~ 151 (279)
T cd06619 86 LDVYR--------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---IAK 151 (279)
T ss_pred hHHhh--------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc---ccc
Confidence 97542 2678889999999999999999988 999999999999999999999999999765322 123
Q ss_pred cccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccc-hhHHHHHHhhcccccccchHhhhhcCC
Q 005749 541 ALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVD-LPSIVKVAVLEETTMEVFDMEIMKGIR 619 (679)
Q Consensus 541 ~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~-l~~~~~~~~~~~~~~~~~~~~i~~~~~ 619 (679)
...++..|+|||++.+..++.++||||||+++|||++|+.||......+... ...+...... .. ...
T Consensus 152 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~-----------~~~ 219 (279)
T cd06619 152 TYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVD-ED-----------PPV 219 (279)
T ss_pred CCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhc-cC-----------CCC
Confidence 4578889999999998889999999999999999999999985432211110 0011110000 00 000
Q ss_pred CChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 620 SPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 620 ~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
.+.....+++.+++.+||+.+|++||+++|+++.
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 220 LPVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred CCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 1111233567889999999999999999999876
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=310.56 Aligned_cols=245 Identities=15% Similarity=0.259 Sum_probs=196.2
Q ss_pred cCccccCCceEEEEEE-eCCCCEEEEEEcccCc-ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCC
Q 005749 382 GQVIEKTTYGTAYKAK-LADGATIALRLLREGS-CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSR 459 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~g 459 (679)
.+.||+|+||.||+++ ..+++.+|+|.++... ....+.+.+|+.++++++|+||+++++.+.+ .+..++||||+++|
T Consensus 5 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~ 83 (255)
T cd08219 5 LRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEA-DGHLYIVMEYCDGG 83 (255)
T ss_pred EEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEE-CCEEEEEEeeCCCC
Confidence 3789999999999999 4578999999986432 3345678899999999999999999999987 68899999999999
Q ss_pred ChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccch
Q 005749 460 TLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEM 539 (679)
Q Consensus 460 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 539 (679)
+|.+++.... ...+++...+.++.|++.||+|||+++ |+|+||||+||++++++.++++|||.+....... ...
T Consensus 84 ~l~~~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~-~~~ 157 (255)
T cd08219 84 DLMQKIKLQR--GKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG-AYA 157 (255)
T ss_pred cHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeecccc-ccc
Confidence 9999886532 345789999999999999999999988 9999999999999999999999999987653321 112
Q ss_pred hcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcCC
Q 005749 540 VALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIR 619 (679)
Q Consensus 540 ~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~ 619 (679)
....++..|+|||++.+..++.++||||||+++|||++|+.||...... .... .+..+..
T Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~------~~~~--------------~~~~~~~ 217 (255)
T cd08219 158 CTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK------NLIL--------------KVCQGSY 217 (255)
T ss_pred ccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHH------HHHH--------------HHhcCCC
Confidence 3356888899999998888999999999999999999999999543211 1111 0111111
Q ss_pred CC-hHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 620 SP-MEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 620 ~~-~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
.+ .......+.+++.+||+.||++||++.|++..
T Consensus 218 ~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 218 KPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 11 11223457789999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=314.70 Aligned_cols=247 Identities=15% Similarity=0.220 Sum_probs=193.8
Q ss_pred CccccCCceEEEEEEeC-CCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCCh
Q 005749 383 QVIEKTTYGTAYKAKLA-DGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRTL 461 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gsL 461 (679)
+.||+|+||.||+|+.. ++..+|+|.+........+.+.+|+++++.++||||+++++++.. .+..++||||+++++|
T Consensus 11 ~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~-~~~~~~v~e~~~~~~l 89 (282)
T cd06643 11 GELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYY-ENNLWILIEFCAGGAV 89 (282)
T ss_pred hhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEee-CCEEEEEEEecCCCcH
Confidence 67999999999999954 578899999876554456678999999999999999999999987 6789999999999999
Q ss_pred HHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccchhc
Q 005749 462 HDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVA 541 (679)
Q Consensus 462 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 541 (679)
..++... ...+++..+..++.|+++||+|||+.+ ++||||||+||+++.++.+|++|||++...... ......
T Consensus 90 ~~~~~~~---~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~-~~~~~~ 162 (282)
T cd06643 90 DAVMLEL---ERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT-IQRRDS 162 (282)
T ss_pred HHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccccc-cccccc
Confidence 9987643 345899999999999999999999988 999999999999999999999999998765322 122234
Q ss_pred cccccccccccccc-----ccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhh
Q 005749 542 LAKADGYKAPELQR-----MKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMK 616 (679)
Q Consensus 542 ~~gt~~y~aPE~~~-----~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~ 616 (679)
..++..|+|||++. +..++.++|||||||++|||++|+.||...... ..+........ +.+
T Consensus 163 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~------~~~~~~~~~~~------~~~-- 228 (282)
T cd06643 163 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM------RVLLKIAKSEP------PTL-- 228 (282)
T ss_pred ccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH------HHHHHHhhcCC------CCC--
Confidence 56888999999874 345788999999999999999999998543211 00000000000 000
Q ss_pred cCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 005749 617 GIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQL 654 (679)
Q Consensus 617 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L 654 (679)
........++.+++.+||+.||++||++.++++.-
T Consensus 229 ---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 263 (282)
T cd06643 229 ---AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHP 263 (282)
T ss_pred ---CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCC
Confidence 00111234677899999999999999999987653
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=325.47 Aligned_cols=258 Identities=16% Similarity=0.187 Sum_probs=190.8
Q ss_pred cCccccCCceEEEEEE-eCCCCEEEEEEcccCc--ccCcccHHHHHHHHhccCCCCCccceEEeeCC-----CCceEEEE
Q 005749 382 GQVIEKTTYGTAYKAK-LADGATIALRLLREGS--CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGK-----RGEKLLIY 453 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~-----~~~~~lv~ 453 (679)
.+.||+|+||.||+|+ ...++.||||++.... ......+.+|+.+++.++||||+++++++... ....++||
T Consensus 29 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv~ 108 (364)
T cd07875 29 LKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVM 108 (364)
T ss_pred EEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEEEEE
Confidence 3789999999999999 4568899999987542 23345678999999999999999999987642 23579999
Q ss_pred EecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCc
Q 005749 454 DYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVP 533 (679)
Q Consensus 454 ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 533 (679)
||+++ +|.+.+.. .+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++....
T Consensus 109 e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 178 (364)
T cd07875 109 ELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 178 (364)
T ss_pred eCCCC-CHHHHHHh------cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCCccccCC
Confidence 99975 77777743 3788999999999999999999988 99999999999999999999999999986532
Q ss_pred ccccchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHH--------------
Q 005749 534 AVADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKV-------------- 599 (679)
Q Consensus 534 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~-------------- 599 (679)
. .......+|..|+|||++.+..++.++|||||||++|||++|+.||.+....+. .......
T Consensus 179 ~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 254 (364)
T cd07875 179 S--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ--WNKVIEQLGTPCPEFMKKLQP 254 (364)
T ss_pred C--CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHhcCCCCHHHHHhhhH
Confidence 2 122345688999999999998999999999999999999999999965432110 0000000
Q ss_pred ----Hhhcccccccch-Hhhhhc-----CCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 600 ----AVLEETTMEVFD-MEIMKG-----IRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 600 ----~~~~~~~~~~~~-~~i~~~-----~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
..........+. ..+... ..........++.+++.+|++.||++|||+.|++++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 255 TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000000000000 000000 000001123467799999999999999999999886
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=320.03 Aligned_cols=199 Identities=22% Similarity=0.356 Sum_probs=161.4
Q ss_pred hcCccccCCceEEEEEEeC---CCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeC-CCCceEEEEEec
Q 005749 381 TGQVIEKTTYGTAYKAKLA---DGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQG-KRGEKLLIYDYF 456 (679)
Q Consensus 381 ~~~~ig~G~~g~Vy~~~~~---~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~-~~~~~~lv~ey~ 456 (679)
.+..||+|+||.||+|+.. ++..||+|.+.... ....+.+|++++++++||||+++++++.. .+...++||||+
T Consensus 5 ~g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07867 5 EGCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYA 82 (317)
T ss_pred eceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeee
Confidence 3468999999999999964 35789999986532 23467899999999999999999998864 245789999999
Q ss_pred CCCChHHHhhccc-----CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee----cCCCceEEeeccc
Q 005749 457 PSRTLHDLLHDTI-----AGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLV----DDFFVSRLTEFGL 527 (679)
Q Consensus 457 ~~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl----~~~~~~kl~DFGl 527 (679)
++ +|.+++.... .....+++..++.++.|++.||+|||+.+ |+||||||+|||+ ++++.+||+|||+
T Consensus 83 ~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07867 83 EH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred CC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence 75 7887775321 11235889999999999999999999988 9999999999999 5668999999999
Q ss_pred ccccCcccc--cchhcccccccccccccccc-cCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 005749 528 DQLMVPAVA--DEMVALAKADGYKAPELQRM-KKCSSRTDVYAFGILLLEILIGKKPGKSG 585 (679)
Q Consensus 528 a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gvvl~El~tg~~p~~~~ 585 (679)
++....... .......+|..|+|||++.+ ..++.++|||||||++|||+||+.||...
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 987643321 12234568899999998876 45899999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=315.80 Aligned_cols=247 Identities=22% Similarity=0.235 Sum_probs=194.0
Q ss_pred CccccCCceEEEEEE-eCCCCEEEEEEcccCccc---CcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCC
Q 005749 383 QVIEKTTYGTAYKAK-LADGATIALRLLREGSCK---DRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPS 458 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~---~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~ 458 (679)
++||+|+||.||+|. ..+++.||+|.+...... ....+.+|+.++++++|+||+++++.+.+ .+..++||||+++
T Consensus 6 ~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~-~~~~~lv~e~~~g 84 (285)
T cd05630 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYET-KDALCLVLTLMNG 84 (285)
T ss_pred EEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEec-CCEEEEEEEecCC
Confidence 679999999999999 457899999998654222 23457789999999999999999999887 6789999999999
Q ss_pred CChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccc
Q 005749 459 RTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADE 538 (679)
Q Consensus 459 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 538 (679)
++|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||++....... .
T Consensus 85 ~~L~~~l~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~--~ 157 (285)
T cd05630 85 GDLKFHIYHMG--EAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ--T 157 (285)
T ss_pred CcHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCc--c
Confidence 99999886432 245899999999999999999999987 9999999999999999999999999987653221 1
Q ss_pred hhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcC
Q 005749 539 MVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGI 618 (679)
Q Consensus 539 ~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~ 618 (679)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||......... ........ .....
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~---~~~~~~~~----------~~~~~- 223 (285)
T cd05630 158 IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR---EEVERLVK----------EVQEE- 223 (285)
T ss_pred ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchH---HHHHhhhh----------hhhhh-
Confidence 22346899999999999889999999999999999999999999543221100 00000000 00000
Q ss_pred CCChHHHHHHHHHHHHhccCcCCCCCCC-----HHHHHHH
Q 005749 619 RSPMEEGLVQALKLAMGCCAPVASVRPT-----MDEVVKQ 653 (679)
Q Consensus 619 ~~~~~~~~~~~~~l~~~cl~~dP~~RPs-----~~evl~~ 653 (679)
......+.+.+++.+||+.||++||| ++|++++
T Consensus 224 --~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 224 --YSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred --cCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 01122345678999999999999999 8888874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=308.06 Aligned_cols=246 Identities=20% Similarity=0.310 Sum_probs=196.2
Q ss_pred cCccccCCceEEEEEE-eCCCCEEEEEEcccCc--ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCC
Q 005749 382 GQVIEKTTYGTAYKAK-LADGATIALRLLREGS--CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPS 458 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~ 458 (679)
.+.||+|++|.||+++ ..+++.||+|.+.... ....+.+.+|++++++++|+|++++++.+...+...++||||+++
T Consensus 5 ~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~ 84 (257)
T cd08223 5 VRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEG 84 (257)
T ss_pred EEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecccCC
Confidence 3689999999999999 4468899999986542 233456889999999999999999998876545568999999999
Q ss_pred CChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccc
Q 005749 459 RTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADE 538 (679)
Q Consensus 459 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 538 (679)
++|.+++.... ...+++.+++.++.+++.|++|||+.+ ++||||||+||+++.++.++|+|||+++..... ...
T Consensus 85 ~~l~~~l~~~~--~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~-~~~ 158 (257)
T cd08223 85 GDLYHKLKEQK--GKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ-CDM 158 (257)
T ss_pred CcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEeccc-CCc
Confidence 99999997632 345899999999999999999999988 999999999999999999999999999865322 122
Q ss_pred hhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcC
Q 005749 539 MVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGI 618 (679)
Q Consensus 539 ~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~ 618 (679)
.....+++.|+|||+..+..++.++||||||++++||++|+.||..... ..+.... ..+.
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~------~~~~~~~--------------~~~~ 218 (257)
T cd08223 159 ASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM------NSLVYRI--------------IEGK 218 (257)
T ss_pred cccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH------HHHHHHH--------------HhcC
Confidence 2344678899999999988899999999999999999999999853221 1111111 1111
Q ss_pred C-CChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 619 R-SPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 619 ~-~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
. .........+.+++.+||+.+|++||++.|++++
T Consensus 219 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 219 LPPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred CCCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 1 1112334567789999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=344.69 Aligned_cols=256 Identities=19% Similarity=0.221 Sum_probs=197.1
Q ss_pred CccccCCceEEEEEEe-CCCCEEEEEEcccCcc---cCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCC
Q 005749 383 QVIEKTTYGTAYKAKL-ADGATIALRLLREGSC---KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPS 458 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~---~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~ 458 (679)
+.||+|+||.||+|+. .+|+.||+|+++.... ...+.|.+|++++++++|||||++++++.+ .+..++||||+++
T Consensus 8 ~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d-~~~lyLVMEY~eG 86 (932)
T PRK13184 8 RLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSD-GDPVYYTMPYIEG 86 (932)
T ss_pred EEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEee-CCEEEEEEEcCCC
Confidence 6899999999999994 5689999999975422 124568999999999999999999999987 6789999999999
Q ss_pred CChHHHhhcccC-------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeeccccccc
Q 005749 459 RTLHDLLHDTIA-------GKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLM 531 (679)
Q Consensus 459 gsL~~~l~~~~~-------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 531 (679)
|+|.+++..... ....+++..+++++.||++||+|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 87 GSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFGLAk~i 163 (932)
T PRK13184 87 YTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIFK 163 (932)
T ss_pred CCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecCcceec
Confidence 999999864211 1234677888999999999999999988 999999999999999999999999999865
Q ss_pred Ccccc-----------------cchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchh
Q 005749 532 VPAVA-----------------DEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLP 594 (679)
Q Consensus 532 ~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~ 594 (679)
..... .......||+.|||||++.+..++.++|||||||++|||+||+.||......+...
T Consensus 164 ~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~~-- 241 (932)
T PRK13184 164 KLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKISY-- 241 (932)
T ss_pred ccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhhh--
Confidence 21100 01113468999999999999999999999999999999999999995432211000
Q ss_pred HHHHHHhhcccccccchHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCC-CHHHHHHHHHhhCC
Q 005749 595 SIVKVAVLEETTMEVFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRP-TMDEVVKQLEENRP 659 (679)
Q Consensus 595 ~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-s~~evl~~L~~~~~ 659 (679)
. . ...++.-. .+.....+.+.+++.+|++.||++|| +++++++.|+....
T Consensus 242 ---~-----~---~i~~P~~~----~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 242 ---R-----D---VILSPIEV----APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred ---h-----h---hccChhhc----cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 0 0 00000000 01112234567899999999999995 67788888877643
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=311.14 Aligned_cols=251 Identities=22% Similarity=0.340 Sum_probs=197.8
Q ss_pred cCccccCCceEEEEEEeC-CCC----EEEEEEcccCcc-cCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEe
Q 005749 382 GQVIEKTTYGTAYKAKLA-DGA----TIALRLLREGSC-KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDY 455 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~-~~~----~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey 455 (679)
.+.||+|+||.||+|... +|. .||+|.+..... ...+.+.+|+.++++++||||+++++++.. ...++||||
T Consensus 12 ~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~v~e~ 89 (279)
T cd05057 12 IKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS--SQVQLITQL 89 (279)
T ss_pred cceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec--CceEEEEec
Confidence 478999999999999853 343 589998876532 234578899999999999999999999886 689999999
Q ss_pred cCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCccc
Q 005749 456 FPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAV 535 (679)
Q Consensus 456 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 535 (679)
+++|+|.+++... ...+++..++.++.|++.||+|||+++ ++||||||+||++++++.+||+|||+++......
T Consensus 90 ~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~ 163 (279)
T cd05057 90 MPLGCLLDYVRNH---KDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDE 163 (279)
T ss_pred CCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcccccccCcc
Confidence 9999999999764 234899999999999999999999987 9999999999999999999999999998764322
Q ss_pred ccc-hhcccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHHhhcccccccchHh
Q 005749 536 ADE-MVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDME 613 (679)
Q Consensus 536 ~~~-~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 613 (679)
... .....++..|+|||.+....++.++||||||+++||+++ |+.||.+.... ++...
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~------~~~~~-------------- 223 (279)
T cd05057 164 KEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV------EIPDL-------------- 223 (279)
T ss_pred cceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH------HHHHH--------------
Confidence 111 112223567999999988889999999999999999998 99998543221 11111
Q ss_pred hhhcCC-CChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCCC
Q 005749 614 IMKGIR-SPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRPR 660 (679)
Q Consensus 614 i~~~~~-~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 660 (679)
+..+.. +........+.+++.+||..+|.+||++.++++.|+++...
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 224 LEKGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred HhCCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 111111 11111234567899999999999999999999999998643
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=322.07 Aligned_cols=187 Identities=21% Similarity=0.306 Sum_probs=159.3
Q ss_pred cCccccCCceEEEEEEe-CCCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCC
Q 005749 382 GQVIEKTTYGTAYKAKL-ADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRT 460 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gs 460 (679)
.+.||+|+||.||+|+. .+++.||+|.... .....|+.++++++|||||++++++.. .+..++||||+. ++
T Consensus 71 ~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~-~~ 142 (357)
T PHA03209 71 IKTLTPGSEGRVFVATKPGQPDPVVLKIGQK------GTTLIEAMLLQNVNHPSVIRMKDTLVS-GAITCMVLPHYS-SD 142 (357)
T ss_pred EEEecCCCCeEEEEEEECCCCceEEEEeCCc------cccHHHHHHHHhCCCCCCcChhheEEe-CCeeEEEEEccC-Cc
Confidence 37899999999999995 4578999998543 234679999999999999999999987 678899999995 58
Q ss_pred hHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccchh
Q 005749 461 LHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMV 540 (679)
Q Consensus 461 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 540 (679)
|.+++... ...+++..++.|+.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..... ....
T Consensus 143 l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--~~~~ 214 (357)
T PHA03209 143 LYTYLTKR---SRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA--PAFL 214 (357)
T ss_pred HHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC--cccc
Confidence 98888653 345899999999999999999999988 999999999999999999999999999754221 1223
Q ss_pred cccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCC
Q 005749 541 ALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKS 584 (679)
Q Consensus 541 ~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~ 584 (679)
...||..|+|||++.+..++.++|||||||++|||+++..|+..
T Consensus 215 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~ 258 (357)
T PHA03209 215 GLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFE 258 (357)
T ss_pred cccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcccc
Confidence 45689999999999988999999999999999999986665433
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=330.47 Aligned_cols=257 Identities=16% Similarity=0.192 Sum_probs=190.1
Q ss_pred CccccCCceEEEEEEe-CCCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCCh
Q 005749 383 QVIEKTTYGTAYKAKL-ADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRTL 461 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gsL 461 (679)
+.||+|+||.||+|+. ..++.||||... ...+.+|++++++++|+|||++++++.. .+..++||||+. ++|
T Consensus 175 ~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~-~~~~~lv~e~~~-~~L 246 (461)
T PHA03211 175 RALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVV-GGLTCLVLPKYR-SDL 246 (461)
T ss_pred EEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEE-CCEEEEEEEccC-CCH
Confidence 6799999999999995 458899999643 2456899999999999999999999887 678999999995 689
Q ss_pred HHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCccccc-chh
Q 005749 462 HDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVAD-EMV 540 (679)
Q Consensus 462 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~-~~~ 540 (679)
.+++... ...++|.+++.|+.|+++||+|||+++ |+||||||+|||++.++.+||+|||+++........ ...
T Consensus 247 ~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 320 (461)
T PHA03211 247 YTYLGAR---LRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHY 320 (461)
T ss_pred HHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceeccccccccccc
Confidence 8888653 235899999999999999999999988 999999999999999999999999999875432211 122
Q ss_pred cccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcc-----cchhHHHHHHhhc-cccccc----c
Q 005749 541 ALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEF-----VDLPSIVKVAVLE-ETTMEV----F 610 (679)
Q Consensus 541 ~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~-----~~l~~~~~~~~~~-~~~~~~----~ 610 (679)
...||..|+|||++.+..++.++|||||||++|||++|..|+........ ..+...+...... ...... +
T Consensus 321 ~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l 400 (461)
T PHA03211 321 GIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRL 400 (461)
T ss_pred ccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHH
Confidence 45689999999999999999999999999999999998876544321110 1111111111000 000000 0
Q ss_pred hHhhh----hcCC-----CChH---HHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 611 DMEIM----KGIR-----SPME---EGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 611 ~~~i~----~~~~-----~~~~---~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
..... ...+ .... .....+.+++.+||+.||++|||+.|+++.
T Consensus 401 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 401 VSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred HHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00000 0000 0001 112356789999999999999999999875
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=311.96 Aligned_cols=247 Identities=19% Similarity=0.260 Sum_probs=193.2
Q ss_pred CccccCCceEEEEEE-eCCCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCCh
Q 005749 383 QVIEKTTYGTAYKAK-LADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRTL 461 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gsL 461 (679)
+.||+|+||.||+|+ ..+++.||+|.++.........+.+|+.+++.++||||+++++++.. .+..++||||+++++|
T Consensus 15 ~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~-~~~~~lv~e~~~~~~L 93 (267)
T cd06645 15 QRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLR-RDKLWICMEFCGGGSL 93 (267)
T ss_pred HHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEe-CCEEEEEEeccCCCcH
Confidence 679999999999998 45689999999876544445567899999999999999999999887 6789999999999999
Q ss_pred HHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccchhc
Q 005749 462 HDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVA 541 (679)
Q Consensus 462 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 541 (679)
.+++... ..+++.+++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++...... ......
T Consensus 94 ~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~-~~~~~~ 165 (267)
T cd06645 94 QDIYHVT----GPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITAT-IAKRKS 165 (267)
T ss_pred HHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCc-cccccc
Confidence 9998753 45899999999999999999999988 999999999999999999999999998765322 122234
Q ss_pred cccccccccccccc---ccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcC
Q 005749 542 LAKADGYKAPELQR---MKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGI 618 (679)
Q Consensus 542 ~~gt~~y~aPE~~~---~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~ 618 (679)
..|+..|+|||++. ...++.++|||||||++|||++|+.||........ . ..... .. ...+.. .
T Consensus 166 ~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~--~----~~~~~-~~---~~~~~~-~-- 232 (267)
T cd06645 166 FIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA--L----FLMTK-SN---FQPPKL-K-- 232 (267)
T ss_pred ccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh--H----Hhhhc-cC---CCCCcc-c--
Confidence 56889999999874 45688999999999999999999999854322110 0 00000 00 000000 0
Q ss_pred CCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 619 RSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 619 ~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
........+.+++.+|++.+|++||++++++++
T Consensus 233 --~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 233 --DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred --ccCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 000112356789999999999999999998763
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=310.29 Aligned_cols=254 Identities=17% Similarity=0.256 Sum_probs=185.2
Q ss_pred CccccCCceEEEEEEeCC---CCEEEEEEcccCcc-cCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCC
Q 005749 383 QVIEKTTYGTAYKAKLAD---GATIALRLLREGSC-KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPS 458 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~~~---~~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~ 458 (679)
+.||+|+||.||+|+..+ ...+|+|.+..... .....+.+|+++++.++|+||+++++++.. .+..++||||+++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~-~~~~~lv~e~~~~ 79 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIE-SIPYLLVLEFCPL 79 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECC-CCceEEEEEeCCC
Confidence 358999999999997533 45788888765432 224568899999999999999999999987 6789999999999
Q ss_pred CChHHHhhcccCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCccccc
Q 005749 459 RTLHDLLHDTIAG-KPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVAD 537 (679)
Q Consensus 459 gsL~~~l~~~~~~-~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 537 (679)
|+|.+++...... ....++...+.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++........
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~ 156 (269)
T cd05042 80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYY 156 (269)
T ss_pred CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhe
Confidence 9999999764321 233568888999999999999999988 999999999999999999999999998754322111
Q ss_pred -chhcccccccccccccccc-------cCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHHhhcccccc
Q 005749 538 -EMVALAKADGYKAPELQRM-------KKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAVLEETTME 608 (679)
Q Consensus 538 -~~~~~~gt~~y~aPE~~~~-------~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 608 (679)
......++..|+|||++.. ..++.++|||||||++|||++ |..||......+ ........ ....
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~------~~~~~~~~-~~~~ 229 (269)
T cd05042 157 ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ------VLKQVVRE-QDIK 229 (269)
T ss_pred eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH------HHHHHhhc-cCcc
Confidence 1122345677999998642 356889999999999999998 777874332211 00000000 0001
Q ss_pred cchHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHH
Q 005749 609 VFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLE 655 (679)
Q Consensus 609 ~~~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~ 655 (679)
...+.+ .........+++..|| .||++|||++||++.|.
T Consensus 230 ~~~~~~-------~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 230 LPKPQL-------DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCCCcc-------cccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 111110 1112244456777888 59999999999998873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=346.08 Aligned_cols=254 Identities=15% Similarity=0.247 Sum_probs=194.8
Q ss_pred CccccCCceEEEEEE-eCCCCEEEEEEcccCc--ccCcccHHHHHHHHhccCCCCCccceEEeeCC-CCceEEEEEecCC
Q 005749 383 QVIEKTTYGTAYKAK-LADGATIALRLLREGS--CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGK-RGEKLLIYDYFPS 458 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~-~~~~~lv~ey~~~ 458 (679)
+.||+|+||+||+|+ ..++..||+|.+.... ......|..|+.++.+++|||||+++++|.+. ....|+||||+++
T Consensus 19 ~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVMEY~~g 98 (1021)
T PTZ00266 19 KKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDA 98 (1021)
T ss_pred EEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEEeCCCC
Confidence 789999999999999 4567899999987542 22345789999999999999999999988643 4568999999999
Q ss_pred CChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC----CCeeecCCCCCCeeecC-----------------C
Q 005749 459 RTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHE----IPITHGNVRSKNVLVDD-----------------F 517 (679)
Q Consensus 459 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~----~~ivHrDlkp~NILl~~-----------------~ 517 (679)
|+|.+++.........+++..++.|+.||+.||+|||+.+. .+||||||||+|||++. .
T Consensus 99 GSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~ 178 (1021)
T PTZ00266 99 GDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGR 178 (1021)
T ss_pred CcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccccccCCC
Confidence 99999997643333569999999999999999999998542 34999999999999964 3
Q ss_pred CceEEeecccccccCcccccchhcccccccccccccccc--cCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhH
Q 005749 518 FVSRLTEFGLDQLMVPAVADEMVALAKADGYKAPELQRM--KKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPS 595 (679)
Q Consensus 518 ~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~ 595 (679)
..+||+|||+++.+.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ...
T Consensus 179 ~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~-----~~q 251 (1021)
T PTZ00266 179 PIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANN-----FSQ 251 (1021)
T ss_pred CceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCc-----HHH
Confidence 458999999998653321 1234578999999998854 4589999999999999999999999954321 111
Q ss_pred HHHHHhhcccccccchHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHH--HHHhh
Q 005749 596 IVKVAVLEETTMEVFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVK--QLEEN 657 (679)
Q Consensus 596 ~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~--~L~~~ 657 (679)
.+.. +..+...+......++.+++..||+.+|.+||++.|++. .+..+
T Consensus 252 li~~--------------lk~~p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i 301 (1021)
T PTZ00266 252 LISE--------------LKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV 301 (1021)
T ss_pred HHHH--------------HhcCCCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence 1111 011111111223456778999999999999999999984 45444
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=311.52 Aligned_cols=245 Identities=20% Similarity=0.305 Sum_probs=191.0
Q ss_pred CccccCCceEEEEEEe-CCCCEEEEEEcccCcccCcccHHHHHHHHhcc-CCCCCccceEEeeCC-----CCceEEEEEe
Q 005749 383 QVIEKTTYGTAYKAKL-ADGATIALRLLREGSCKDRSSCLPVIRQLGKV-RHENLIPLRAFYQGK-----RGEKLLIYDY 455 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~-----~~~~~lv~ey 455 (679)
+.||+|+||.||+|+. .+++.||+|.+.... .....+.+|+.++.++ +|+||+++++++... ....++||||
T Consensus 12 ~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~ 90 (272)
T cd06637 12 ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEF 90 (272)
T ss_pred HheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEEc
Confidence 6799999999999994 568899999986543 3345788999999998 799999999998752 2457999999
Q ss_pred cCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCccc
Q 005749 456 FPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAV 535 (679)
Q Consensus 456 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 535 (679)
+++++|.+++.... ...+++..+..++.|++.||+|||+++ |+||||||+||++++++.+||+|||+++......
T Consensus 91 ~~~~~L~~~l~~~~--~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~~ 165 (272)
T cd06637 91 CGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV 165 (272)
T ss_pred CCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCCceeccccc
Confidence 99999999997632 345899999999999999999999988 9999999999999999999999999998653321
Q ss_pred ccchhccccccccccccccc-----ccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccc
Q 005749 536 ADEMVALAKADGYKAPELQR-----MKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVF 610 (679)
Q Consensus 536 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 610 (679)
.......|+..|+|||++. ...++.++|||||||++|||++|+.||...... ..... .....
T Consensus 166 -~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~-----~~~~~--~~~~~----- 232 (272)
T cd06637 166 -GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM-----RALFL--IPRNP----- 232 (272)
T ss_pred -ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH-----HHHHH--HhcCC-----
Confidence 2233456888999999876 345788999999999999999999998432211 00000 00000
Q ss_pred hHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHH
Q 005749 611 DMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVK 652 (679)
Q Consensus 611 ~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 652 (679)
.+. ........++.+++.+||..+|.+|||+.|+++
T Consensus 233 ~~~------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 233 APR------LKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred CCC------CCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 000 001112346778999999999999999999975
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=325.60 Aligned_cols=257 Identities=16% Similarity=0.169 Sum_probs=190.1
Q ss_pred CccccCCceEEEEEEe-CCCCEEEEEEcccCcc--cCcccHHHHHHHHhccCCCCCccceEEeeCC-----CCceEEEEE
Q 005749 383 QVIEKTTYGTAYKAKL-ADGATIALRLLREGSC--KDRSSCLPVIRQLGKVRHENLIPLRAFYQGK-----RGEKLLIYD 454 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~-----~~~~~lv~e 454 (679)
+.||+|+||.||+|+. ..++.||||++..... ...+.+.+|+.+++.++||||+++++++... ....++|||
T Consensus 23 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e 102 (355)
T cd07874 23 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVME 102 (355)
T ss_pred EEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeEEEhh
Confidence 6899999999999984 5688999999875422 2345678899999999999999999988642 135799999
Q ss_pred ecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcc
Q 005749 455 YFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPA 534 (679)
Q Consensus 455 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 534 (679)
|+++ ++.+.+.. .+++..+..++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 103 ~~~~-~l~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~ 172 (355)
T cd07874 103 LMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 172 (355)
T ss_pred hhcc-cHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcccccCCCc
Confidence 9975 67776643 3789999999999999999999988 999999999999999999999999999865322
Q ss_pred cccchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHH---------------
Q 005749 535 VADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKV--------------- 599 (679)
Q Consensus 535 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~--------------- 599 (679)
.......+|..|+|||++.+..++.++|||||||++|||++|+.||.+....+. ....+..
T Consensus 173 --~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 248 (355)
T cd07874 173 --FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ--WNKVIEQLGTPCPEFMKKLQPT 248 (355)
T ss_pred --cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCCHHHHHhhcHH
Confidence 122345788999999999988899999999999999999999999965432110 0000000
Q ss_pred ---Hhhcc-cccccchHhh-hhcCC----CChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 600 ---AVLEE-TTMEVFDMEI-MKGIR----SPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 600 ---~~~~~-~~~~~~~~~i-~~~~~----~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
..... .......+.. ..... ........++.+++.+|++.||++|||+.|+++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 00000 0000000000 00000 0011123466789999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=308.71 Aligned_cols=243 Identities=21% Similarity=0.329 Sum_probs=193.5
Q ss_pred cCccccCCceEEEEEEe-CCCCEEEEEEcccCcccC---------cccHHHHHHHHhccCCCCCccceEEeeCCCCceEE
Q 005749 382 GQVIEKTTYGTAYKAKL-ADGATIALRLLREGSCKD---------RSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLL 451 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~---------~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~l 451 (679)
+..||+|+||.||+|.. .+++.||+|.+....... .+.+.+|++++++++||||+++++++.. .+..++
T Consensus 5 ~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~l 83 (267)
T cd06628 5 GALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLD-ADHLNI 83 (267)
T ss_pred cceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEe-CCccEE
Confidence 47899999999999984 568899999886543221 2457899999999999999999999887 678999
Q ss_pred EEEecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeeccccccc
Q 005749 452 IYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLM 531 (679)
Q Consensus 452 v~ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 531 (679)
||||+++++|.+++... ..+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++..
T Consensus 84 v~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~~~ 156 (267)
T cd06628 84 FLEYVPGGSVAALLNNY----GAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKL 156 (267)
T ss_pred EEEecCCCCHHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCccc
Confidence 99999999999999763 45889999999999999999999988 999999999999999999999999999876
Q ss_pred Cccccc-----chhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccc
Q 005749 532 VPAVAD-----EMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETT 606 (679)
Q Consensus 532 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 606 (679)
...... ......++..|+|||.+.+..++.++|||||||++|||++|+.||...... .....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~~~~-------- 223 (267)
T cd06628 157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL-----QAIFK-------- 223 (267)
T ss_pred ccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH-----HHHHH--------
Confidence 422111 112345788899999998888999999999999999999999999543211 00000
Q ss_pred cccchHhhhhcCCCC-hHHHHHHHHHHHHhccCcCCCCCCCHHHHHH
Q 005749 607 MEVFDMEIMKGIRSP-MEEGLVQALKLAMGCCAPVASVRPTMDEVVK 652 (679)
Q Consensus 607 ~~~~~~~i~~~~~~~-~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 652 (679)
+.....+. .......+.+++.+||+.||++||++.|+++
T Consensus 224 -------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 224 -------IGENASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred -------HhccCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 00111111 1122356778999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=319.66 Aligned_cols=241 Identities=19% Similarity=0.326 Sum_probs=204.1
Q ss_pred cCccccCCceEEEEEEe-CCCCEEEEEEcccCccc---CcccHHHHHHHHhccC-CCCCccceEEeeCCCCceEEEEEec
Q 005749 382 GQVIEKTTYGTAYKAKL-ADGATIALRLLREGSCK---DRSSCLPVIRQLGKVR-HENLIPLRAFYQGKRGEKLLIYDYF 456 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~---~~~~~~~Ei~~l~~l~-H~nIv~l~~~~~~~~~~~~lv~ey~ 456 (679)
++.||+|.||.||+++. .+|+.+|+|.+.+.... +.+.+.+|+++|+++. |||||.+++.|.+ ....++|||++
T Consensus 40 ~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~-~~~~~lvmEL~ 118 (382)
T KOG0032|consen 40 GRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFED-PDSVYLVMELC 118 (382)
T ss_pred hhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEc-CCeEEEEEEec
Confidence 47899999999999994 45999999999776443 3468999999999998 9999999999998 67999999999
Q ss_pred CCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCC----CceEEeecccccccC
Q 005749 457 PSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDF----FVSRLTEFGLDQLMV 532 (679)
Q Consensus 457 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~----~~~kl~DFGla~~~~ 532 (679)
.||.|.+.+... .+++..+..++.|++.+++|||+.+ |+||||||+|+|+... +.+|++|||++....
T Consensus 119 ~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~ 190 (382)
T KOG0032|consen 119 EGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIK 190 (382)
T ss_pred CCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCCceEcc
Confidence 999999999764 2899999999999999999999988 9999999999999643 579999999999875
Q ss_pred cccccchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchH
Q 005749 533 PAVADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDM 612 (679)
Q Consensus 533 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 612 (679)
. .......+||+.|+|||++....|+.++||||.||++|.|+.|..||.+........
T Consensus 191 ~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~-------------------- 248 (382)
T KOG0032|consen 191 P--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL-------------------- 248 (382)
T ss_pred C--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH--------------------
Confidence 5 345567899999999999999999999999999999999999999997655332111
Q ss_pred hhhhc----CCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 613 EIMKG----IRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 613 ~i~~~----~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
.+..+ ..++.+.....+.+++.+|+..||.+|+|+.+++++
T Consensus 249 ~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 249 AILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred HHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 11111 113334445677789999999999999999999995
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=317.61 Aligned_cols=257 Identities=19% Similarity=0.283 Sum_probs=196.0
Q ss_pred CccccCCceEEEEEE-eCCCCEEEEEEcccCcc-cCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCC
Q 005749 383 QVIEKTTYGTAYKAK-LADGATIALRLLREGSC-KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRT 460 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gs 460 (679)
+.||+|+||.||+++ ..++..+|+|.++.... ...+++.+|++++.+++||||++++++|.+ ++..++||||+++++
T Consensus 7 ~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~ey~~~~~ 85 (308)
T cd06615 7 GELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYS-DGEISICMEHMDGGS 85 (308)
T ss_pred eeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee-CCEEEEEeeccCCCc
Confidence 679999999999999 45688999999875422 234568899999999999999999999987 689999999999999
Q ss_pred hHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccch
Q 005749 461 LHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTG-HEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEM 539 (679)
Q Consensus 461 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~-~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 539 (679)
|.++++.. ..+++..+..++.|+++||.|||+. + ++||||||+||++++++.+||+|||++....... .
T Consensus 86 L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~---~ 155 (308)
T cd06615 86 LDQVLKKA----GRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---A 155 (308)
T ss_pred HHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCcccccccc---c
Confidence 99999763 4588999999999999999999973 5 9999999999999999999999999987653321 2
Q ss_pred hcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhccc--------------
Q 005749 540 VALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEET-------------- 605 (679)
Q Consensus 540 ~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~-------------- 605 (679)
....++..|+|||.+.+..++.++||||||+++|||++|+.||....... ...+.........
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (308)
T cd06615 156 NSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE---LEAMFGRPVSEGEAKESHRPVSGHPPD 232 (308)
T ss_pred ccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhh---HHHhhcCccccccccCCcccccCCCCC
Confidence 34568889999999988889999999999999999999999985432211 1111100000000
Q ss_pred ------ccccchHhhhhcCCCC--hHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 005749 606 ------TMEVFDMEIMKGIRSP--MEEGLVQALKLAMGCCAPVASVRPTMDEVVKQL 654 (679)
Q Consensus 606 ------~~~~~~~~i~~~~~~~--~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L 654 (679)
..+..+. +.....+. ......++.+++.+||..+|++||++.|+++..
T Consensus 233 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 288 (308)
T cd06615 233 SPRPMAIFELLDY-IVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP 288 (308)
T ss_pred ccchhhHHHHHHH-HhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 0000000 01110111 111334678999999999999999999999874
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=311.26 Aligned_cols=252 Identities=19% Similarity=0.282 Sum_probs=196.1
Q ss_pred CccccCCceEEEEEEeC------CCCEEEEEEcccCccc-CcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEe
Q 005749 383 QVIEKTTYGTAYKAKLA------DGATIALRLLREGSCK-DRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDY 455 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~~------~~~~vAvK~~~~~~~~-~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey 455 (679)
+.||+|+||.||+|+.+ +.+.||+|.+...... ..+.+.+|++++++++|+||+++++++.+ .+..++||||
T Consensus 11 ~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~ 89 (275)
T cd05046 11 TTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCRE-AEPHYMILEY 89 (275)
T ss_pred eeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECC-CCcceEEEEe
Confidence 67999999999999954 3467999998664332 34678999999999999999999999887 6789999999
Q ss_pred cCCCChHHHhhcccCC-----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccc
Q 005749 456 FPSRTLHDLLHDTIAG-----KPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQL 530 (679)
Q Consensus 456 ~~~gsL~~~l~~~~~~-----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 530 (679)
+++|+|.+++...... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+|++|||+++.
T Consensus 90 ~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~~~~~~ 166 (275)
T cd05046 90 TDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLLSLSKD 166 (275)
T ss_pred cCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEcccccccc
Confidence 9999999999764321 125899999999999999999999988 99999999999999999999999999875
Q ss_pred cCcccccchhcccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHHhhccccccc
Q 005749 531 MVPAVADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAVLEETTMEV 609 (679)
Q Consensus 531 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 609 (679)
.............++..|+|||.+.+..++.++||||||+++|||++ |..||....... .+... ......
T Consensus 167 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~------~~~~~-~~~~~~-- 237 (275)
T cd05046 167 VYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE------VLNRL-QAGKLE-- 237 (275)
T ss_pred cCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH------HHHHH-HcCCcC--
Confidence 43322222233456777999999988888999999999999999998 788884332211 11100 000000
Q ss_pred chHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHh
Q 005749 610 FDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEE 656 (679)
Q Consensus 610 ~~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 656 (679)
..........+.+++.+||+.+|++||++.|+++.|.+
T Consensus 238 ---------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~ 275 (275)
T cd05046 238 ---------LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275 (275)
T ss_pred ---------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence 00011123467789999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=306.98 Aligned_cols=245 Identities=20% Similarity=0.279 Sum_probs=198.4
Q ss_pred CccccCCceEEEEEE-eCCCCEEEEEEcccCc--ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCC
Q 005749 383 QVIEKTTYGTAYKAK-LADGATIALRLLREGS--CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSR 459 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~g 459 (679)
++||+|+||.||.++ ..+++.+++|.+.... ....+.+.+|++++++++|+||+++++++.+ .+..+++|||++++
T Consensus 6 ~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~~~~e~~~~~ 84 (256)
T cd08221 6 RVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMD-DNTLLIEMEYANGG 84 (256)
T ss_pred eEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEec-CCeEEEEEEecCCC
Confidence 789999999999998 5678999999986542 3345578899999999999999999999987 67899999999999
Q ss_pred ChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccch
Q 005749 460 TLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEM 539 (679)
Q Consensus 460 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 539 (679)
+|.+++.... ...+++..+..++.|+++||+|||+.+ ++||||||+||++++++.+||+|||+++....... ..
T Consensus 85 ~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~-~~ 158 (256)
T cd08221 85 TLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS-MA 158 (256)
T ss_pred cHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc-cc
Confidence 9999997642 345899999999999999999999988 99999999999999999999999999986643321 22
Q ss_pred hcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcC-
Q 005749 540 VALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGI- 618 (679)
Q Consensus 540 ~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~- 618 (679)
....++..|+|||+..+..++.++||||||+++|||++|+.||...... +..... ..+.
T Consensus 159 ~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~------~~~~~~--------------~~~~~ 218 (256)
T cd08221 159 ETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL------NLVVKI--------------VQGNY 218 (256)
T ss_pred cccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH------HHHHHH--------------HcCCC
Confidence 3456888999999998888899999999999999999999998542211 111111 1111
Q ss_pred CCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 005749 619 RSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQL 654 (679)
Q Consensus 619 ~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L 654 (679)
.........++.+++.+||..+|++||++.|+++.+
T Consensus 219 ~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 219 TPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred CCCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 111122345677899999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=323.91 Aligned_cols=250 Identities=16% Similarity=0.190 Sum_probs=188.8
Q ss_pred cCccccCCceEEEEEEe-CCCCEEEEEEcccCc---ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecC
Q 005749 382 GQVIEKTTYGTAYKAKL-ADGATIALRLLREGS---CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFP 457 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~ 457 (679)
.+.||+|+||.||+++. .+++.||+|++.... ....+.+.+|+.++..++|+||+++++++.+ .+..++||||++
T Consensus 6 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~ 84 (331)
T cd05597 6 LKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQD-ENNLYLVMDYYV 84 (331)
T ss_pred EEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEec-CCeEEEEEecCC
Confidence 36899999999999994 568999999986421 2234568899999999999999999999987 688999999999
Q ss_pred CCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCccccc
Q 005749 458 SRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVAD 537 (679)
Q Consensus 458 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 537 (679)
+|+|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++.........
T Consensus 85 g~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 158 (331)
T cd05597 85 GGDLLTLLSKF---EDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV 158 (331)
T ss_pred CCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCCCCc
Confidence 99999999753 245889999999999999999999988 999999999999999999999999998765433222
Q ss_pred chhcccccccccccccccc-----cCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchH
Q 005749 538 EMVALAKADGYKAPELQRM-----KKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDM 612 (679)
Q Consensus 538 ~~~~~~gt~~y~aPE~~~~-----~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 612 (679)
......||+.|+|||++.. ..++.++|||||||++|||++|+.||.+.... +.......... .+.
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~------~~~~~i~~~~~---~~~- 228 (331)
T cd05597 159 QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV------ETYGKIMNHKE---HFQ- 228 (331)
T ss_pred cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHH------HHHHHHHcCCC---ccc-
Confidence 2233468999999999863 45788999999999999999999999543211 11111110000 000
Q ss_pred hhhhcCCCChHHHHHHHHHHHHhccC--cCCCCCCCHHHHHHH
Q 005749 613 EIMKGIRSPMEEGLVQALKLAMGCCA--PVASVRPTMDEVVKQ 653 (679)
Q Consensus 613 ~i~~~~~~~~~~~~~~~~~l~~~cl~--~dP~~RPs~~evl~~ 653 (679)
.....+.....+.+++.+|+. .++..||+++++++.
T Consensus 229 -----~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 229 -----FPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred -----CCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 001111123445567776554 444458899999887
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=316.85 Aligned_cols=259 Identities=19% Similarity=0.271 Sum_probs=191.5
Q ss_pred CccccCCceEEEEEEe-CCCCEEEEEEcccCcc-cCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCC
Q 005749 383 QVIEKTTYGTAYKAKL-ADGATIALRLLREGSC-KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRT 460 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gs 460 (679)
+.||+|+||.||+|+. .+++.||+|.++.... .....+.+|++++++++||||+++++++.. .+..++||||++ ++
T Consensus 12 ~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~-~~~~~lv~e~~~-~~ 89 (301)
T cd07873 12 DKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHT-EKSLTLVFEYLD-KD 89 (301)
T ss_pred eEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEec-CCeEEEEEeccc-cC
Confidence 6799999999999985 4688999999875432 234467899999999999999999999987 678999999997 58
Q ss_pred hHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccchh
Q 005749 461 LHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMV 540 (679)
Q Consensus 461 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 540 (679)
|.+++... ...+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+||+|||+++...... ....
T Consensus 90 l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-~~~~ 162 (301)
T cd07873 90 LKQYLDDC---GNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT-KTYS 162 (301)
T ss_pred HHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCC-Cccc
Confidence 99888754 345889999999999999999999988 9999999999999999999999999987643221 1122
Q ss_pred cccccccccccccccc-cCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhh---cccccccchHhhhh
Q 005749 541 ALAKADGYKAPELQRM-KKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVL---EETTMEVFDMEIMK 616 (679)
Q Consensus 541 ~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~---~~~~~~~~~~~i~~ 616 (679)
...++..|+|||.+.+ ..++.++|||||||++|||++|+.||...+..+ .......... ...+..........
T Consensus 163 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (301)
T cd07873 163 NEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEE---QLHFIFRILGTPTEETWPGILSNEEFK 239 (301)
T ss_pred ccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcCCCChhhchhhhcccccc
Confidence 3456888999998765 457889999999999999999999996543211 1111111100 00000000000000
Q ss_pred -----cCCC-----ChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 617 -----GIRS-----PMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 617 -----~~~~-----~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
.... ..+.....+.+++.+|+..||++|||++|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 240 SYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred ccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0000 001123456789999999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=311.51 Aligned_cols=241 Identities=19% Similarity=0.266 Sum_probs=194.1
Q ss_pred CccccCCceEEEEEEe-CCCCEEEEEEcccCc-ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCC
Q 005749 383 QVIEKTTYGTAYKAKL-ADGATIALRLLREGS-CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRT 460 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gs 460 (679)
+.||+|+||.||+|.. .++..||+|.+.... ....+.+.+|++++++++||||+++++++.. ....++||||+++++
T Consensus 10 ~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~ 88 (277)
T cd06642 10 ERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLK-GTKLWIIMEYLGGGS 88 (277)
T ss_pred HHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhccccc-CCceEEEEEccCCCc
Confidence 5799999999999984 568899999987543 2334578899999999999999999999987 678999999999999
Q ss_pred hHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccchh
Q 005749 461 LHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMV 540 (679)
Q Consensus 461 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 540 (679)
|.+++.. ..+++..+..++.|+++|+.|||+++ ++|+||+|+||++++++.+|++|||++....... ....
T Consensus 89 L~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-~~~~ 159 (277)
T cd06642 89 ALDLLKP-----GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-IKRN 159 (277)
T ss_pred HHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcc-hhhh
Confidence 9998864 35889999999999999999999987 9999999999999999999999999998664321 1222
Q ss_pred cccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcCCC
Q 005749 541 ALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIRS 620 (679)
Q Consensus 541 ~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~~ 620 (679)
...++..|+|||++.+..++.++|||||||++|||++|+.|+........ .. . +..+..+
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~------~~-~-------------~~~~~~~ 219 (277)
T cd06642 160 TFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV------LF-L-------------IPKNSPP 219 (277)
T ss_pred cccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH------Hh-h-------------hhcCCCC
Confidence 34578889999999988899999999999999999999999853322110 00 0 0000001
Q ss_pred -ChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 621 -PMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 621 -~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
........+.+++.+||+.+|++||+|.|++++
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 220 TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 111233567789999999999999999999985
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=314.84 Aligned_cols=244 Identities=18% Similarity=0.303 Sum_probs=196.7
Q ss_pred CccccCCceEEEEEE-eCCCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCCh
Q 005749 383 QVIEKTTYGTAYKAK-LADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRTL 461 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gsL 461 (679)
+.||.|+||.||+|+ ..+++.||+|.+........+.+.+|+++++.++||||+++++++.. .+..++|+||+++++|
T Consensus 25 ~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~L 103 (296)
T cd06655 25 EKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLV-GDELFVVMEYLAGGSL 103 (296)
T ss_pred EEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEec-CceEEEEEEecCCCcH
Confidence 679999999999998 56799999999876555556678899999999999999999999987 6789999999999999
Q ss_pred HHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccchhc
Q 005749 462 HDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVA 541 (679)
Q Consensus 462 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 541 (679)
.+++.. ..+++.++..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++........ ....
T Consensus 104 ~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~~~~ 174 (296)
T cd06655 104 TDVVTE-----TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS-KRST 174 (296)
T ss_pred HHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccccc-cCCC
Confidence 998864 34899999999999999999999988 99999999999999999999999999886543321 1233
Q ss_pred ccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcCCCC
Q 005749 542 LAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIRSP 621 (679)
Q Consensus 542 ~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~~~ 621 (679)
..++..|+|||.+.+..++.++|||||||++|||++|+.||......+ ...... ... .. . ...
T Consensus 175 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~-----~~~~~~-~~~-~~-----~-----~~~ 237 (296)
T cd06655 175 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR-----ALYLIA-TNG-TP-----E-----LQN 237 (296)
T ss_pred cCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHH-hcC-Cc-----c-----cCC
Confidence 467889999999988889999999999999999999999995432210 000000 000 00 0 001
Q ss_pred hHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 622 MEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 622 ~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
.......+.+++.+||..||++||++.++++.
T Consensus 238 ~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 238 PEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred cccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 11223457789999999999999999999865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=314.93 Aligned_cols=260 Identities=20% Similarity=0.268 Sum_probs=189.2
Q ss_pred CccccCCceEEEEEE-eCCCCEEEEEEcccCccc--CcccHHHHHHHHhcc---CCCCCccceEEeeCC----CCceEEE
Q 005749 383 QVIEKTTYGTAYKAK-LADGATIALRLLREGSCK--DRSSCLPVIRQLGKV---RHENLIPLRAFYQGK----RGEKLLI 452 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~--~~~~~~~Ei~~l~~l---~H~nIv~l~~~~~~~----~~~~~lv 452 (679)
+.||+|+||+||+|+ ..+++.||+|.++..... ....+.+|++++.++ +||||+++++++... ....++|
T Consensus 6 ~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~lv 85 (288)
T cd07863 6 AEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLV 85 (288)
T ss_pred eEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEEEE
Confidence 679999999999999 457899999998754322 233567788877665 699999999987642 2457999
Q ss_pred EEecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccC
Q 005749 453 YDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMV 532 (679)
Q Consensus 453 ~ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 532 (679)
|||+++ +|.+++.... ...+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 86 ~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~~~~~ 159 (288)
T cd07863 86 FEHVDQ-DLRTYLDKVP--PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYS 159 (288)
T ss_pred Eccccc-CHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcccccc
Confidence 999985 8988887532 244899999999999999999999988 9999999999999999999999999998654
Q ss_pred cccccchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhh--ccccc---
Q 005749 533 PAVADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVL--EETTM--- 607 (679)
Q Consensus 533 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~--~~~~~--- 607 (679)
... ......++..|+|||++.+..++.++||||+||++|||++|++||......+ .+......... .....
T Consensus 160 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07863 160 CQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD--QLGKIFDLIGLPPEDDWPRDV 235 (288)
T ss_pred Ccc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHH--HHHHHHHHhCCCChhhCcccc
Confidence 221 1233467889999999988889999999999999999999999985432211 11111111000 00000
Q ss_pred ----ccchHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHH
Q 005749 608 ----EVFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVK 652 (679)
Q Consensus 608 ----~~~~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 652 (679)
..+.+..........+....++.+++.+|++.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 236 TLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred cccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 000000000000000122345678999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=308.54 Aligned_cols=244 Identities=19% Similarity=0.330 Sum_probs=188.3
Q ss_pred cCccccCCceEEEEEEe-CCCCEEEEEEcccCcc-----cCcccHHHHHHHHhccCCCCCccceEEeeCC-CCceEEEEE
Q 005749 382 GQVIEKTTYGTAYKAKL-ADGATIALRLLREGSC-----KDRSSCLPVIRQLGKVRHENLIPLRAFYQGK-RGEKLLIYD 454 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~-----~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~-~~~~~lv~e 454 (679)
++.||+|+||.||+|.. .++..||+|++..... +..+.+.+|++++++++||||+++++++.+. ....++++|
T Consensus 7 ~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~e 86 (266)
T cd06651 7 GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFME 86 (266)
T ss_pred cceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEEe
Confidence 47899999999999984 5689999999864321 1234678899999999999999999988753 356789999
Q ss_pred ecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcc
Q 005749 455 YFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPA 534 (679)
Q Consensus 455 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 534 (679)
|+++++|.+++... ..+++...+.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 87 ~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd06651 87 YMPGGSVKDQLKAY----GALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTI 159 (266)
T ss_pred CCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccccccc
Confidence 99999999999753 34889999999999999999999887 999999999999999999999999998765321
Q ss_pred c--ccchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchH
Q 005749 535 V--ADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDM 612 (679)
Q Consensus 535 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 612 (679)
. ........++..|+|||++.+..++.++|||||||++|||++|+.||...... .. ....
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~-----~~-~~~~------------ 221 (266)
T cd06651 160 CMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM-----AA-IFKI------------ 221 (266)
T ss_pred cccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH-----HH-HHHH------------
Confidence 1 11112345788999999999888999999999999999999999998532111 00 0000
Q ss_pred hhhhcCCCChHHHH-HHHHHHHHhccCcCCCCCCCHHHHHH
Q 005749 613 EIMKGIRSPMEEGL-VQALKLAMGCCAPVASVRPTMDEVVK 652 (679)
Q Consensus 613 ~i~~~~~~~~~~~~-~~~~~l~~~cl~~dP~~RPs~~evl~ 652 (679)
......+..+... +.+.+++ +||..+|++||+|+||++
T Consensus 222 -~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 222 -ATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred -hcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 0010111112222 3334455 789899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=313.80 Aligned_cols=242 Identities=18% Similarity=0.306 Sum_probs=196.4
Q ss_pred CccccCCceEEEEEE-eCCCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCCh
Q 005749 383 QVIEKTTYGTAYKAK-LADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRTL 461 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gsL 461 (679)
+.||+|+||.||+|+ ..+++.||+|.+........+.+.+|+.+++.++|+||+++++++.. .+..++||||+++++|
T Consensus 25 ~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L 103 (297)
T cd06656 25 EKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-GDELWVVMEYLAGGSL 103 (297)
T ss_pred eeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEeecccCCCCH
Confidence 689999999999999 46799999999976555555678899999999999999999999987 6789999999999999
Q ss_pred HHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccchhc
Q 005749 462 HDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVA 541 (679)
Q Consensus 462 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 541 (679)
.+++.. ..+++.++..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++........ ....
T Consensus 104 ~~~~~~-----~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~-~~~~ 174 (297)
T cd06656 104 TDVVTE-----TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRST 174 (297)
T ss_pred HHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCcc-CcCc
Confidence 999864 34789999999999999999999988 99999999999999999999999999876543321 1233
Q ss_pred ccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcC-C-
Q 005749 542 LAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGI-R- 619 (679)
Q Consensus 542 ~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~-~- 619 (679)
..++..|+|||.+.+..++.++|||||||++||+++|+.||........... . ...+. .
T Consensus 175 ~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~---------------~----~~~~~~~~ 235 (297)
T cd06656 175 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL---------------I----ATNGTPEL 235 (297)
T ss_pred ccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee---------------e----ccCCCCCC
Confidence 4678899999999988899999999999999999999999954332110000 0 00000 0
Q ss_pred CChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 620 SPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 620 ~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
.........+.+++.+||+.+|++||+++++++.
T Consensus 236 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 236 QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0111223456689999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=318.58 Aligned_cols=196 Identities=18% Similarity=0.231 Sum_probs=162.3
Q ss_pred CccccC--CceEEEEEE-eCCCCEEEEEEcccCcc--cCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecC
Q 005749 383 QVIEKT--TYGTAYKAK-LADGATIALRLLREGSC--KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFP 457 (679)
Q Consensus 383 ~~ig~G--~~g~Vy~~~-~~~~~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~ 457 (679)
++||+| +|++||+++ ..+|+.||+|+++.... ...+.+.+|+++++.++|||||+++++|.. ++..++||||++
T Consensus 4 ~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~-~~~~~lv~e~~~ 82 (327)
T cd08227 4 TVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIA-DNELWVVTSFMA 82 (327)
T ss_pred hhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEE-CCEEEEEEeccC
Confidence 679999 788999998 56799999999976432 223467789999999999999999999987 678999999999
Q ss_pred CCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccc-
Q 005749 458 SRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVA- 536 (679)
Q Consensus 458 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~- 536 (679)
+|+|.+++.... ...+++..++.++.|++.||+|||+++ |+||||||+|||++.++.++++||+.+........
T Consensus 83 ~~~l~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 83 YGSAKDLICTHF--MDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred CCcHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 999999996542 234899999999999999999999988 99999999999999999999999986544321110
Q ss_pred c-----chhcccccccccccccccc--cCCCCcchhHHHHHHHHHHHhCCCCCCC
Q 005749 537 D-----EMVALAKADGYKAPELQRM--KKCSSRTDVYAFGILLLEILIGKKPGKS 584 (679)
Q Consensus 537 ~-----~~~~~~gt~~y~aPE~~~~--~~~~~k~DV~S~Gvvl~El~tg~~p~~~ 584 (679)
. ......++..|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 212 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 212 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 0 0112346677999999875 4589999999999999999999999954
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=315.86 Aligned_cols=244 Identities=17% Similarity=0.256 Sum_probs=195.1
Q ss_pred CccccCCceEEEEEEe-CCCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCCh
Q 005749 383 QVIEKTTYGTAYKAKL-ADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRTL 461 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gsL 461 (679)
..||+|+||.||++.. .++..||+|.+........+.+.+|+.++++++|+||+++++.+.. .+..++||||+++++|
T Consensus 28 ~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~-~~~~~lv~e~~~~~~L 106 (292)
T cd06658 28 IKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLV-GDELWVVMEFLEGGAL 106 (292)
T ss_pred hcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheec-CCeEEEEEeCCCCCcH
Confidence 6799999999999994 5689999999876544455678999999999999999999999887 6789999999999999
Q ss_pred HHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccchhc
Q 005749 462 HDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVA 541 (679)
Q Consensus 462 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 541 (679)
.+++.. ..+++..+..++.||+.||+|||+++ |+||||||+||++++++.+||+|||++....... .....
T Consensus 107 ~~~~~~-----~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~-~~~~~ 177 (292)
T cd06658 107 TDIVTH-----TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV-PKRKS 177 (292)
T ss_pred HHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccccc-ccCce
Confidence 998854 34889999999999999999999988 9999999999999999999999999987653221 12233
Q ss_pred ccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcCCCC
Q 005749 542 LAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIRSP 621 (679)
Q Consensus 542 ~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~~~ 621 (679)
..++..|+|||+..+..++.++||||||+++|||++|+.||....... .... ... .+.+.+ ..
T Consensus 178 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~------~~~~-~~~-----~~~~~~-----~~ 240 (292)
T cd06658 178 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ------AMRR-IRD-----NLPPRV-----KD 240 (292)
T ss_pred eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHH-HHh-----cCCCcc-----cc
Confidence 568889999999988889999999999999999999999985432110 0000 000 000000 01
Q ss_pred hHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 622 MEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 622 ~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
.......+.+++.+||..||++|||++|+++.
T Consensus 241 ~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 241 SHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 11223456688999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=322.74 Aligned_cols=249 Identities=16% Similarity=0.190 Sum_probs=188.8
Q ss_pred CccccCCceEEEEEEeC-CCCEEEEEEcccCc---ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCC
Q 005749 383 QVIEKTTYGTAYKAKLA-DGATIALRLLREGS---CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPS 458 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~ 458 (679)
+.||+|+||.||+++.. +++.+|+|++.... ......+..|+.++..++|+||+++++++.+ .+..++||||+++
T Consensus 7 ~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv~ey~~~ 85 (332)
T cd05623 7 KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQD-ENNLYLVMDYYVG 85 (332)
T ss_pred EEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEec-CCEEEEEEeccCC
Confidence 68999999999999954 57889999986432 2223457889999999999999999999987 6789999999999
Q ss_pred CChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccc
Q 005749 459 RTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADE 538 (679)
Q Consensus 459 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 538 (679)
|+|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.........
T Consensus 86 g~L~~~l~~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~ 159 (332)
T cd05623 86 GDLLTLLSKF---EDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ 159 (332)
T ss_pred CcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccCCcce
Confidence 9999999753 235899999999999999999999988 9999999999999999999999999987653332222
Q ss_pred hhccccccccccccccc-----ccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHh
Q 005749 539 MVALAKADGYKAPELQR-----MKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDME 613 (679)
Q Consensus 539 ~~~~~gt~~y~aPE~~~-----~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 613 (679)
.....||+.|+|||++. ...++.++|||||||++|||++|+.||...... +............
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~------~~~~~i~~~~~~~------ 227 (332)
T cd05623 160 SSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV------ETYGKIMNHKERF------ 227 (332)
T ss_pred ecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHH------HHHHHHhCCCccc------
Confidence 23457899999999886 346889999999999999999999999543211 1111111100000
Q ss_pred hhhcCCCChHHHHHHHHHHHHhccCcC--CCCCCCHHHHHHH
Q 005749 614 IMKGIRSPMEEGLVQALKLAMGCCAPV--ASVRPTMDEVVKQ 653 (679)
Q Consensus 614 i~~~~~~~~~~~~~~~~~l~~~cl~~d--P~~RPs~~evl~~ 653 (679)
...........++.+++.+|+..+ +..|++++|++++
T Consensus 228 ---~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 228 ---QFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred ---cCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 000111122345667788777544 4447899999877
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=305.70 Aligned_cols=243 Identities=17% Similarity=0.283 Sum_probs=195.7
Q ss_pred CccccCCceEEEEEEeCC-CCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCCh
Q 005749 383 QVIEKTTYGTAYKAKLAD-GATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRTL 461 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gsL 461 (679)
+.||+|+||.||+|+..+ ++.+|+|.+..... .+++.+|++++++++|+||+++++++.. ....++++||+++++|
T Consensus 9 ~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~-~~~~~l~~e~~~~~~L 85 (256)
T cd06612 9 EKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFK-NTDLWIVMEYCGAGSV 85 (256)
T ss_pred hhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeec-CCcEEEEEecCCCCcH
Confidence 679999999999999654 88999999875432 6789999999999999999999999987 6789999999999999
Q ss_pred HHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccchhc
Q 005749 462 HDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVA 541 (679)
Q Consensus 462 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 541 (679)
.+++... ...+++..++.++.|++.||.|||+.+ ++||||+|+||++++++.+||+|||++........ ....
T Consensus 86 ~~~l~~~---~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~~~ 158 (256)
T cd06612 86 SDIMKIT---NKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-KRNT 158 (256)
T ss_pred HHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc-cccc
Confidence 9998653 346899999999999999999999988 99999999999999999999999999987643321 2233
Q ss_pred ccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcCCCC
Q 005749 542 LAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIRSP 621 (679)
Q Consensus 542 ~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~~~ 621 (679)
..++..|+|||++.+..++.++||||||+++|||++|+.||.......... ..... .......
T Consensus 159 ~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~-------~~~~~----------~~~~~~~ 221 (256)
T cd06612 159 VIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIF-------MIPNK----------PPPTLSD 221 (256)
T ss_pred ccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhh-------hhccC----------CCCCCCc
Confidence 457888999999988889999999999999999999999985432211000 00000 0000011
Q ss_pred hHHHHHHHHHHHHhccCcCCCCCCCHHHHHH
Q 005749 622 MEEGLVQALKLAMGCCAPVASVRPTMDEVVK 652 (679)
Q Consensus 622 ~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 652 (679)
.......+.+++.+||+.||++|||+.|+++
T Consensus 222 ~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 222 PEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred hhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 1122356778999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=326.42 Aligned_cols=243 Identities=23% Similarity=0.356 Sum_probs=195.7
Q ss_pred cCccccCCceEEEEEE-eCCCCEEEEEEcccC----cccCcccHHHHHHHHhccCCCCCccceEEeeCC-CCceEEEEEe
Q 005749 382 GQVIEKTTYGTAYKAK-LADGATIALRLLREG----SCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGK-RGEKLLIYDY 455 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~----~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~-~~~~~lv~ey 455 (679)
.++||+|+|-+||||. -.+|..||--.++.. .....+.|..|+.+|+.|+|||||++|.++.+. ...+-+|+|.
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 3789999999999999 446888886554322 223457899999999999999999999998873 3347899999
Q ss_pred cCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCC-CceEEeecccccccCcc
Q 005749 456 FPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDF-FVSRLTEFGLDQLMVPA 534 (679)
Q Consensus 456 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~-~~~kl~DFGla~~~~~~ 534 (679)
|..|+|..|.+..+ .++....+.+++||++||.|||++. |||+|||||-+||+|+.+ |.+||+|.|+|..+...
T Consensus 125 ~TSGtLr~Y~kk~~----~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s 199 (632)
T KOG0584|consen 125 FTSGTLREYRKKHR----RVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS 199 (632)
T ss_pred ccCCcHHHHHHHhc----cCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence 99999999998854 4788899999999999999999975 789999999999999865 99999999999987544
Q ss_pred cccchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhh
Q 005749 535 VADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEI 614 (679)
Q Consensus 535 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i 614 (679)
. .....|||-|||||+.. ..|++.+||||||+.|+||+|+..||....+ -.++.+ ++
T Consensus 200 ~---aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n-----~AQIYK--------------KV 256 (632)
T KOG0584|consen 200 H---AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTN-----PAQIYK--------------KV 256 (632)
T ss_pred c---cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCC-----HHHHHH--------------HH
Confidence 3 23478999999999998 8899999999999999999999999954332 122222 22
Q ss_pred hhcCCCCh--HHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 615 MKGIRSPM--EEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 615 ~~~~~~~~--~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
..|..+.. .-..+++.++|.+|+.. .++|||+.|+++.
T Consensus 257 ~SGiKP~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 257 TSGIKPAALSKVKDPEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred HcCCCHHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 23222111 11136788899999999 9999999999875
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=326.78 Aligned_cols=248 Identities=16% Similarity=0.186 Sum_probs=190.5
Q ss_pred cCccccCCceEEEEEEe-CCCCEEEEEEcccCc---ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecC
Q 005749 382 GQVIEKTTYGTAYKAKL-ADGATIALRLLREGS---CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFP 457 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~ 457 (679)
.+.||+|+||.||+|+. .+++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+ .+..++||||++
T Consensus 48 ~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~-~~~~~lv~Ey~~ 126 (371)
T cd05622 48 VKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD-DRYLYMVMEYMP 126 (371)
T ss_pred EEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc-CCEEEEEEcCCC
Confidence 37899999999999995 468899999986432 2233457889999999999999999999987 678999999999
Q ss_pred CCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCccccc
Q 005749 458 SRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVAD 537 (679)
Q Consensus 458 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 537 (679)
+|+|.+++.. ..++...+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++........
T Consensus 127 gg~L~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~ 198 (371)
T cd05622 127 GGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV 198 (371)
T ss_pred CCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCcc
Confidence 9999999864 23788889999999999999999988 999999999999999999999999999876433222
Q ss_pred chhccccccccccccccccc----CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHh
Q 005749 538 EMVALAKADGYKAPELQRMK----KCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDME 613 (679)
Q Consensus 538 ~~~~~~gt~~y~aPE~~~~~----~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 613 (679)
......||+.|+|||++... .++.++|||||||++|||++|+.||...... ............. .
T Consensus 199 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~------~~~~~i~~~~~~~-----~ 267 (371)
T cd05622 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------GTYSKIMNHKNSL-----T 267 (371)
T ss_pred cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH------HHHHHHHcCCCcc-----c
Confidence 33456799999999998753 3789999999999999999999999543211 1111100000000 0
Q ss_pred hhhcCCCChHHHHHHHHHHHHhccCcCCCC--CCCHHHHHHHH
Q 005749 614 IMKGIRSPMEEGLVQALKLAMGCCAPVASV--RPTMDEVVKQL 654 (679)
Q Consensus 614 i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~--RPs~~evl~~L 654 (679)
.+........+.+++.+|+..++.+ ||+++|++++.
T Consensus 268 -----~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 268 -----FPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred -----CCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 0111123455677889999844433 78999988864
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=315.53 Aligned_cols=244 Identities=16% Similarity=0.247 Sum_probs=195.6
Q ss_pred CccccCCceEEEEEEe-CCCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCCh
Q 005749 383 QVIEKTTYGTAYKAKL-ADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRTL 461 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gsL 461 (679)
..||+|+||.||+|+. .+++.||+|.+........+.+.+|+.+++.++||||+++++++.. .+..++||||+++++|
T Consensus 27 ~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~-~~~~~iv~e~~~~~~L 105 (297)
T cd06659 27 IKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLV-GEELWVLMEFLQGGAL 105 (297)
T ss_pred hhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheee-CCeEEEEEecCCCCCH
Confidence 4799999999999994 5789999999876554556678899999999999999999999887 6789999999999999
Q ss_pred HHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccchhc
Q 005749 462 HDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVA 541 (679)
Q Consensus 462 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 541 (679)
.+++.. ..+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++....... .....
T Consensus 106 ~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~-~~~~~ 176 (297)
T cd06659 106 TDIVSQ-----TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PKRKS 176 (297)
T ss_pred HHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccccc-ccccc
Confidence 998754 34899999999999999999999988 9999999999999999999999999987653322 12234
Q ss_pred ccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcCCCC
Q 005749 542 LAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIRSP 621 (679)
Q Consensus 542 ~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~~~ 621 (679)
..++..|+|||++.+..++.++|||||||++|||++|+.||...... .. .... .... .. . ...
T Consensus 177 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~---~~---~~~~-~~~~-~~----~-----~~~ 239 (297)
T cd06659 177 LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV---QA---MKRL-RDSP-PP----K-----LKN 239 (297)
T ss_pred eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HH---HHHH-hccC-CC----C-----ccc
Confidence 56888999999998888999999999999999999999998543211 10 0000 0000 00 0 000
Q ss_pred hHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 622 MEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 622 ~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
.......+.+++.+||+.+|++||+++|+++.
T Consensus 240 ~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 240 AHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred cCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 11123456789999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=321.54 Aligned_cols=250 Identities=18% Similarity=0.188 Sum_probs=190.1
Q ss_pred cCccccCCceEEEEEEe-CCCCEEEEEEcccCc---ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecC
Q 005749 382 GQVIEKTTYGTAYKAKL-ADGATIALRLLREGS---CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFP 457 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~ 457 (679)
.+.||+|+||.||+++. .+++.||+|.+.... ....+.+.+|+.++..++|+||+++++++.+ .+..++||||++
T Consensus 6 ~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~-~~~~~lv~Ey~~ 84 (331)
T cd05624 6 IKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQD-ENYLYLVMDYYV 84 (331)
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc-CCEEEEEEeCCC
Confidence 36899999999999994 468899999986532 2233457889999999999999999999987 688999999999
Q ss_pred CCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCccccc
Q 005749 458 SRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVAD 537 (679)
Q Consensus 458 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 537 (679)
+|+|.+++... ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++........
T Consensus 85 gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 158 (331)
T cd05624 85 GGDLLTLLSKF---EDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV 158 (331)
T ss_pred CCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCCCce
Confidence 99999999753 235889999999999999999999988 999999999999999999999999999866433222
Q ss_pred chhcccccccccccccccc-----cCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchH
Q 005749 538 EMVALAKADGYKAPELQRM-----KKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDM 612 (679)
Q Consensus 538 ~~~~~~gt~~y~aPE~~~~-----~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 612 (679)
......|++.|+|||++.+ +.++.++|||||||++|||++|+.||...... +.......... .+
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~------~~~~~i~~~~~---~~-- 227 (331)
T cd05624 159 QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV------ETYGKIMNHEE---RF-- 227 (331)
T ss_pred eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH------HHHHHHHcCCC---cc--
Confidence 2234568999999998875 46789999999999999999999999543211 11111100000 00
Q ss_pred hhhhcCCCChHHHHHHHHHHHHhccCcCCCC--CCCHHHHHHH
Q 005749 613 EIMKGIRSPMEEGLVQALKLAMGCCAPVASV--RPTMDEVVKQ 653 (679)
Q Consensus 613 ~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~--RPs~~evl~~ 653 (679)
...........++.+++.+|+..++++ |+++++++++
T Consensus 228 ----~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 228 ----QFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred ----cCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 000111122356677888888765544 5688888764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=311.09 Aligned_cols=249 Identities=17% Similarity=0.295 Sum_probs=196.9
Q ss_pred CccccCCceEEEEEE-eCCCCEEEEEEcccCc-ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCC
Q 005749 383 QVIEKTTYGTAYKAK-LADGATIALRLLREGS-CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRT 460 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gs 460 (679)
+.||+|+||+||+|+ ..+|+.||+|++.... ....+.+.+|+++++.++||||+++++++.. .+..++||||+++++
T Consensus 11 ~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~ 89 (284)
T cd06620 11 SDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLN-ENNICMCMEFMDCGS 89 (284)
T ss_pred HHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEec-CCEEEEEEecCCCCC
Confidence 789999999999999 4568999999886543 2335678999999999999999999999998 578999999999999
Q ss_pred hHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccch
Q 005749 461 LHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHT-GHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEM 539 (679)
Q Consensus 461 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~-~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 539 (679)
|.+++... ..+++..+..++.+++.||.|||+ .+ ++||||||+||++++++.++|+|||++....... .
T Consensus 90 L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~---~ 159 (284)
T cd06620 90 LDRIYKKG----GPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI---A 159 (284)
T ss_pred HHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhhhc---c
Confidence 99998753 358999999999999999999997 35 9999999999999999999999999987542221 1
Q ss_pred hcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcc-----cchhHHHHHHhhcccccccchHhh
Q 005749 540 VALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEF-----VDLPSIVKVAVLEETTMEVFDMEI 614 (679)
Q Consensus 540 ~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~-----~~l~~~~~~~~~~~~~~~~~~~~i 614 (679)
....|+..|+|||++.+..++.++|||||||++||+++|+.||......+. .....+.....
T Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~------------- 226 (284)
T cd06620 160 DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIV------------- 226 (284)
T ss_pred CccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHh-------------
Confidence 234688899999999888899999999999999999999999964332110 00111111110
Q ss_pred hhcCC-CChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHH
Q 005749 615 MKGIR-SPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLE 655 (679)
Q Consensus 615 ~~~~~-~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~ 655 (679)
..... .+......++.+++.+||+.||++||++.|++++..
T Consensus 227 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~ 268 (284)
T cd06620 227 QEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPP 268 (284)
T ss_pred hccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence 00000 111123456778999999999999999999998753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=307.48 Aligned_cols=246 Identities=18% Similarity=0.301 Sum_probs=194.4
Q ss_pred cCccccCCceEEEEEEeCCCCEEEEEEcccCcc------cCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEe
Q 005749 382 GQVIEKTTYGTAYKAKLADGATIALRLLREGSC------KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDY 455 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~~~~~vAvK~~~~~~~------~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey 455 (679)
++.||+|+||.||+|...+++.+|+|.++.... ...+.+.+|++++++++|+||+++++++.+ .+..++||||
T Consensus 5 ~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~e~ 83 (265)
T cd06631 5 GEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLD-DNTISIFMEF 83 (265)
T ss_pred cceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeec-CCeEEEEEec
Confidence 478999999999999988899999999865321 112458899999999999999999999987 6889999999
Q ss_pred cCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCccc
Q 005749 456 FPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAV 535 (679)
Q Consensus 456 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 535 (679)
+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+|+||||+||++++++.+||+|||+++......
T Consensus 84 ~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 156 (265)
T cd06631 84 VPGGSISSILNRF----GPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVG 156 (265)
T ss_pred CCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhhcc
Confidence 9999999999753 35789999999999999999999988 9999999999999999999999999987642211
Q ss_pred -----ccchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccc
Q 005749 536 -----ADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVF 610 (679)
Q Consensus 536 -----~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 610 (679)
........++..|+|||++.+..++.++||||||+++|||++|+.||....... .......... .
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-----~~~~~~~~~~-----~ 226 (265)
T cd06631 157 LHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA-----AMFYIGAHRG-----L 226 (265)
T ss_pred ccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH-----HHHHhhhccC-----C
Confidence 111223468889999999998889999999999999999999999995432110 0000000000 0
Q ss_pred hHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHH
Q 005749 611 DMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVK 652 (679)
Q Consensus 611 ~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 652 (679)
..........++.+++.+||+.+|++||++.|+++
T Consensus 227 -------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 227 -------MPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred -------CCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00011123356678999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=307.00 Aligned_cols=248 Identities=18% Similarity=0.312 Sum_probs=194.8
Q ss_pred CccccCCceEEEEEEeCC--CCEEEEEEcccCcc----------cCcccHHHHHHHHhc-cCCCCCccceEEeeCCCCce
Q 005749 383 QVIEKTTYGTAYKAKLAD--GATIALRLLREGSC----------KDRSSCLPVIRQLGK-VRHENLIPLRAFYQGKRGEK 449 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~~~--~~~vAvK~~~~~~~----------~~~~~~~~Ei~~l~~-l~H~nIv~l~~~~~~~~~~~ 449 (679)
+.||+|+||.||+|+... ++.+|+|.+..... ....++.+|+.++.+ ++||||+++++++.+ .+..
T Consensus 6 ~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~-~~~~ 84 (269)
T cd08528 6 EHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE-NDRL 84 (269)
T ss_pred hhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc-CCeE
Confidence 679999999999999654 78999998864321 112346778888865 799999999999987 6889
Q ss_pred EEEEEecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeeecCCCCCCeeecCCCceEEeecccc
Q 005749 450 LLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHT-GHEIPITHGNVRSKNVLVDDFFVSRLTEFGLD 528 (679)
Q Consensus 450 ~lv~ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~-~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 528 (679)
++||||+++++|.+++.........+++..++.++.|++.||.|||+ .+ ++|+||||+||++++++.+||+|||++
T Consensus 85 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~ 161 (269)
T cd08528 85 YIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITDFGLA 161 (269)
T ss_pred EEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEecccce
Confidence 99999999999999886533334568999999999999999999996 45 999999999999999999999999999
Q ss_pred cccCcccccchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccc
Q 005749 529 QLMVPAVADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTME 608 (679)
Q Consensus 529 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 608 (679)
....... ......++..|+|||.+.+..++.++||||||+++|||++|+.||..... .......
T Consensus 162 ~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~------~~~~~~~-------- 225 (269)
T cd08528 162 KQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM------LSLATKI-------- 225 (269)
T ss_pred eeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH------HHHHHHH--------
Confidence 8754332 22345678899999999988899999999999999999999999843211 1111111
Q ss_pred cchHhhhhcCCCC-h-HHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHh
Q 005749 609 VFDMEIMKGIRSP-M-EEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEE 656 (679)
Q Consensus 609 ~~~~~i~~~~~~~-~-~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 656 (679)
..+...+ . ......+.+++.+||+.||++||++.|+..++++
T Consensus 226 ------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 226 ------VEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred ------hhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 0110011 1 1223567789999999999999999999998863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=313.00 Aligned_cols=262 Identities=19% Similarity=0.257 Sum_probs=191.8
Q ss_pred CccccCCceEEEEEEe-CCCCEEEEEEcccCcc--cCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCC
Q 005749 383 QVIEKTTYGTAYKAKL-ADGATIALRLLREGSC--KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSR 459 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~g 459 (679)
+.||+|+||.||+|+. .+++.||+|.++.... ...+.+.+|+.++++++||||+++++++.+ ++..++||||++ +
T Consensus 6 ~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e~~~-~ 83 (285)
T cd07861 6 EKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQ-ESRLYLIFEFLS-M 83 (285)
T ss_pred eEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEee-CCeEEEEEecCC-C
Confidence 6799999999999995 4699999999865432 224568899999999999999999999987 678999999997 5
Q ss_pred ChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccch
Q 005749 460 TLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEM 539 (679)
Q Consensus 460 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 539 (679)
+|.+++..... ...+++..++.++.|+++||+|||+.+ |+||||||+||++++++.+||+|||+++...... ...
T Consensus 84 ~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-~~~ 158 (285)
T cd07861 84 DLKKYLDSLPK-GQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV-RVY 158 (285)
T ss_pred CHHHHHhcCCC-CCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCc-ccc
Confidence 89888865332 356899999999999999999999988 9999999999999999999999999987653221 112
Q ss_pred hcccccccccccccccc-cCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhh--cccc---c--ccch
Q 005749 540 VALAKADGYKAPELQRM-KKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVL--EETT---M--EVFD 611 (679)
Q Consensus 540 ~~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~--~~~~---~--~~~~ 611 (679)
....++..|+|||.+.+ ..++.++|||||||++|||+||+.||.+.... ..+......... +... . ..+.
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (285)
T cd07861 159 THEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEI--DQLFRIFRILGTPTEDVWPGVTSLPDYK 236 (285)
T ss_pred cCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHH--HHHHHHHHHhCCCChhhhhcchhhHHHH
Confidence 23356788999998765 45789999999999999999999999543221 011111000000 0000 0 0000
Q ss_pred HhhhhcCC----CChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 612 MEIMKGIR----SPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 612 ~~i~~~~~----~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
........ .......+++.+++.+||+.||++|||+.+|+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 237 NTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred hhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 00000000 0001123566789999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=323.09 Aligned_cols=253 Identities=17% Similarity=0.239 Sum_probs=200.4
Q ss_pred HHHHHhhcCccccCCceEEEEEEeC-CCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEE
Q 005749 375 EDVLNATGQVIEKTTYGTAYKAKLA-DGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIY 453 (679)
Q Consensus 375 ~~l~~~~~~~ig~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ 453 (679)
+|..... ..+|.|+||.||+|..+ ++-..|.|++...+....++|+.||+||+.++||+||++++.|+. .+..+|+.
T Consensus 31 ~d~WeIi-GELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~-enkLwili 108 (1187)
T KOG0579|consen 31 RDHWEII-GELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYF-ENKLWILI 108 (1187)
T ss_pred HHHHHHH-hhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhc-cCceEEEE
Confidence 4444333 35889999999999944 466678899888777888999999999999999999999997776 57899999
Q ss_pred EecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCc
Q 005749 454 DYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVP 533 (679)
Q Consensus 454 ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 533 (679)
|||.||-.+.++-.- +..+++.++..++.|++.||.|||++. |||||||+.|||+.-+|.++++|||.+.....
T Consensus 109 EFC~GGAVDaimlEL---~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~ 182 (1187)
T KOG0579|consen 109 EFCGGGAVDAIMLEL---GRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKS 182 (1187)
T ss_pred eecCCchHhHHHHHh---ccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchh
Confidence 999999999887664 467999999999999999999999998 99999999999999999999999998754321
Q ss_pred ccccchhccccccccccccccc-----ccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccc
Q 005749 534 AVADEMVALAKADGYKAPELQR-----MKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTME 608 (679)
Q Consensus 534 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 608 (679)
.......+.||++|||||+.+ ..+|+.++||||||++|.||..+.+|...-. .+.-..+....+ .
T Consensus 183 -t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHheln-----pMRVllKiaKSe--P-- 252 (1187)
T KOG0579|consen 183 -TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELN-----PMRVLLKIAKSE--P-- 252 (1187)
T ss_pred -HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccc-----hHHHHHHHhhcC--C--
Confidence 223456789999999999765 5689999999999999999999999962211 111111111000 0
Q ss_pred cchHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 609 VFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 609 ~~~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
|.+ .........+.+++.+|+..||+.||++.+++++
T Consensus 253 ---PTL-----lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 253 ---PTL-----LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred ---Ccc-----cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 011 1123445677899999999999999999998864
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=310.05 Aligned_cols=249 Identities=24% Similarity=0.419 Sum_probs=194.5
Q ss_pred cCccccCCceEEEEEEe-CCCCEEEEEEcccCcccCc--ccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCC
Q 005749 382 GQVIEKTTYGTAYKAKL-ADGATIALRLLREGSCKDR--SSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPS 458 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~--~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~ 458 (679)
.+.||+|+||+||+++. .+++.+|+|.+........ ....+|+.++++++||||+++++++.+ ....++||||+++
T Consensus 4 ~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-~~~~~~v~~~~~~ 82 (260)
T PF00069_consen 4 VKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQD-DNYLYIVMEYCPG 82 (260)
T ss_dssp EEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE-SSEEEEEEEEETT
T ss_pred eEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccc-ccccccccccccc
Confidence 46899999999999995 4567899999987643222 234569999999999999999999987 6889999999999
Q ss_pred CChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccc
Q 005749 459 RTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADE 538 (679)
Q Consensus 459 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 538 (679)
++|.+++.. ...+++..++.++.|+++||+|||+++ |+||||||+||++++++.++|+|||.+.... .....
T Consensus 83 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~-~~~~~ 154 (260)
T PF00069_consen 83 GSLQDYLQK----NKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLS-ENNEN 154 (260)
T ss_dssp EBHHHHHHH----HSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEEST-STTSE
T ss_pred ccccccccc----ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc-ccccc
Confidence 999999983 345899999999999999999999988 9999999999999999999999999987541 11223
Q ss_pred hhccccccccccccccc-ccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhc
Q 005749 539 MVALAKADGYKAPELQR-MKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKG 617 (679)
Q Consensus 539 ~~~~~gt~~y~aPE~~~-~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~ 617 (679)
.....++..|+|||++. +..++.++||||+|+++|||++|..||...... +.......... ......
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~---~~~~~~~~~~~---------~~~~~~ 222 (260)
T PF00069_consen 155 FNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSD---DQLEIIEKILK---------RPLPSS 222 (260)
T ss_dssp BSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHH---HHHHHHHHHHH---------THHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccch---hhhhhhhhccc---------cccccc
Confidence 34567888999999988 788999999999999999999999998543110 11111110000 000000
Q ss_pred CCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHH
Q 005749 618 IRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVK 652 (679)
Q Consensus 618 ~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 652 (679)
..........+.+++.+||+.||++||++.++++
T Consensus 223 -~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 223 -SQQSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp -TTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred -ccccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0001111267889999999999999999999986
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=310.70 Aligned_cols=264 Identities=21% Similarity=0.321 Sum_probs=198.9
Q ss_pred CccccCCceEEEEEEeC-----CCCEEEEEEcccCccc-CcccHHHHHHHHhccCCCCCccceEEeeCC-CCceEEEEEe
Q 005749 383 QVIEKTTYGTAYKAKLA-----DGATIALRLLREGSCK-DRSSCLPVIRQLGKVRHENLIPLRAFYQGK-RGEKLLIYDY 455 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~~-----~~~~vAvK~~~~~~~~-~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~-~~~~~lv~ey 455 (679)
+.||+|+||.||+|++. ++..||||.+...... ..+.|.+|++++++++|+||+++++++... ....++||||
T Consensus 10 ~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~ 89 (284)
T cd05038 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEY 89 (284)
T ss_pred eeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEEEEec
Confidence 78999999999999853 3679999999765432 356799999999999999999999988752 3468999999
Q ss_pred cCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCccc
Q 005749 456 FPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAV 535 (679)
Q Consensus 456 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 535 (679)
+++++|.+++.... ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+|++|||++.......
T Consensus 90 ~~~~~l~~~l~~~~---~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 163 (284)
T cd05038 90 LPSGSLRDYLQRHR---DQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKVLPEDK 163 (284)
T ss_pred CCCCCHHHHHHhCc---cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccccccCC
Confidence 99999999997642 35899999999999999999999988 9999999999999999999999999998764321
Q ss_pred ccc--hhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHh
Q 005749 536 ADE--MVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDME 613 (679)
Q Consensus 536 ~~~--~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 613 (679)
... .....++..|+|||...+..++.++||||||+++|||++|+.|+........ .. .... ........+...
T Consensus 164 ~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~-~~---~~~~-~~~~~~~~~~~~ 238 (284)
T cd05038 164 DYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFL-RM---IGIA-QGQMIVTRLLEL 238 (284)
T ss_pred cceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhc-cc---cccc-cccccHHHHHHH
Confidence 111 1122345569999999888899999999999999999999999754322110 00 0000 000000000111
Q ss_pred hhhcCCCC-hHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhh
Q 005749 614 IMKGIRSP-MEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEEN 657 (679)
Q Consensus 614 i~~~~~~~-~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 657 (679)
+....+.+ ......++.+++.+||+.+|++||+|.||+++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 239 LKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 11111111 112235678899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=323.15 Aligned_cols=258 Identities=15% Similarity=0.199 Sum_probs=192.5
Q ss_pred cCccccCCceEEEEEEeC---CCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCC
Q 005749 382 GQVIEKTTYGTAYKAKLA---DGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPS 458 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~---~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~ 458 (679)
.+.||+|+||.||++... .+..||+|.+... ..+.+|++++++++|||||++++++.. ....++||||+.
T Consensus 97 ~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~- 169 (392)
T PHA03207 97 LSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRW-KSTVCMVMPKYK- 169 (392)
T ss_pred EEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEee-CCEEEEEehhcC-
Confidence 378999999999999743 3578999988642 346789999999999999999999887 678999999996
Q ss_pred CChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccc-c
Q 005749 459 RTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVA-D 537 (679)
Q Consensus 459 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~-~ 537 (679)
++|.+++.. ...+++..++.|+.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++....... .
T Consensus 170 ~~l~~~l~~----~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~ 242 (392)
T PHA03207 170 CDLFTYVDR----SGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTP 242 (392)
T ss_pred CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCcccccc
Confidence 589888843 346899999999999999999999988 99999999999999999999999999976543322 1
Q ss_pred chhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCccc-chhHHHHHHhhcc-cccc----cch
Q 005749 538 EMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFV-DLPSIVKVAVLEE-TTME----VFD 611 (679)
Q Consensus 538 ~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~-~l~~~~~~~~~~~-~~~~----~~~ 611 (679)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.+....... .+....+...... .... .+.
T Consensus 243 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~ 322 (392)
T PHA03207 243 QCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLC 322 (392)
T ss_pred cccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHH
Confidence 223457899999999999889999999999999999999999999665432211 1111111100000 0000 000
Q ss_pred Hhh---hhcCCC--ChH------HHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 612 MEI---MKGIRS--PME------EGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 612 ~~i---~~~~~~--~~~------~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
... ....++ ..+ ....++.+++.+|+..||++|||+.|++++
T Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 323 KHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred HHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000 000000 000 112356678999999999999999999987
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=306.23 Aligned_cols=244 Identities=17% Similarity=0.281 Sum_probs=196.2
Q ss_pred CccccCCceEEEEEE-eCCCCEEEEEEcccCc--ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCC
Q 005749 383 QVIEKTTYGTAYKAK-LADGATIALRLLREGS--CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSR 459 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~g 459 (679)
+.||+|+||.||+++ ..+|+.||+|.+.... ....+++.+|++++++++||||+++++++.. .+..++||||++++
T Consensus 6 ~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~e~~~~~ 84 (256)
T cd08218 6 KKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEE-NGNLYIVMDYCEGG 84 (256)
T ss_pred EEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecC-CCeEEEEEecCCCC
Confidence 689999999999999 4578999999986532 2334578999999999999999999999887 67899999999999
Q ss_pred ChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccch
Q 005749 460 TLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEM 539 (679)
Q Consensus 460 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 539 (679)
+|.+++.... ...+++.+++.++.|++.||+|||+++ ++|+||+|+||+++.++.++++|||++....... ...
T Consensus 85 ~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~ 158 (256)
T cd08218 85 DLYKKINAQR--GVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV-ELA 158 (256)
T ss_pred cHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcch-hhh
Confidence 9999987532 235789999999999999999999988 9999999999999999999999999998653321 122
Q ss_pred hcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcCC
Q 005749 540 VALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIR 619 (679)
Q Consensus 540 ~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~ 619 (679)
....|+..|+|||+..+..++.++|||||||+++||++|+.||..... .+.+.. . ..+..
T Consensus 159 ~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~------~~~~~~-------------~-~~~~~ 218 (256)
T cd08218 159 RTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM------KNLVLK-------------I-IRGSY 218 (256)
T ss_pred hhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH------HHHHHH-------------H-hcCCC
Confidence 234578889999999888899999999999999999999999843211 111111 1 11111
Q ss_pred C-ChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 620 S-PMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 620 ~-~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
+ .......++.+++.+||+.+|++||+++||++.
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 219 PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 1 112234567789999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=311.38 Aligned_cols=246 Identities=17% Similarity=0.252 Sum_probs=193.0
Q ss_pred CccccCCceEEEEEEe-CCCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCCh
Q 005749 383 QVIEKTTYGTAYKAKL-ADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRTL 461 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gsL 461 (679)
+.||+|+||.||+|+. .+++.||+|.+........+.+.+|++++++++||||+++++++.. ++..++||||+++++|
T Consensus 18 ~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~l 96 (292)
T cd06644 18 GELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYW-DGKLWIMIEFCPGGAV 96 (292)
T ss_pred heecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEe-CCeEEEEEecCCCCcH
Confidence 6799999999999995 4589999999976554556678899999999999999999999887 6789999999999999
Q ss_pred HHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccchhc
Q 005749 462 HDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVA 541 (679)
Q Consensus 462 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 541 (679)
..++... ...+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++...... ......
T Consensus 97 ~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~-~~~~~~ 169 (292)
T cd06644 97 DAIMLEL---DRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT-LQRRDS 169 (292)
T ss_pred HHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceecccc-ccccce
Confidence 9887653 235899999999999999999999988 999999999999999999999999998754322 112234
Q ss_pred cccccccccccccc-----ccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhh
Q 005749 542 LAKADGYKAPELQR-----MKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMK 616 (679)
Q Consensus 542 ~~gt~~y~aPE~~~-----~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~ 616 (679)
..++..|+|||++. ...++.++|||||||++|||++|+.||...... ....... ... .+..
T Consensus 170 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~------~~~~~~~-~~~-----~~~~-- 235 (292)
T cd06644 170 FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM------RVLLKIA-KSE-----PPTL-- 235 (292)
T ss_pred ecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH------HHHHHHh-cCC-----CccC--
Confidence 46788999999874 345788999999999999999999998432211 0000000 000 0000
Q ss_pred cCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 617 GIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 617 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
........++.+++.+||..+|++||+++|+++.
T Consensus 236 ---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 236 ---SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred ---CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0011223467789999999999999999999764
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=305.44 Aligned_cols=247 Identities=21% Similarity=0.302 Sum_probs=196.7
Q ss_pred CccccCCceEEEEEEe-CCCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCCh
Q 005749 383 QVIEKTTYGTAYKAKL-ADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRTL 461 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gsL 461 (679)
+.||+|+||.||+|+. .+++.+|+|.+........+.+.+|++++++++||||+++++++.. .+..+++|||+++++|
T Consensus 9 ~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~l~~e~~~~~~l 87 (262)
T cd06613 9 QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLR-RDKLWIVMEYCGGGSL 87 (262)
T ss_pred EEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEe-CCEEEEEEeCCCCCcH
Confidence 6799999999999995 5688999999986655556789999999999999999999999887 6789999999999999
Q ss_pred HHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccchhc
Q 005749 462 HDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVA 541 (679)
Q Consensus 462 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 541 (679)
.+++... ...+++..+..++.|++.||+|||+++ ++|+||||+||++++++.+||+|||++....... .....
T Consensus 88 ~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~~~~ 160 (262)
T cd06613 88 QDIYQVT---RGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATI-AKRKS 160 (262)
T ss_pred HHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhh-hcccc
Confidence 9998763 245899999999999999999999988 9999999999999999999999999987654321 12234
Q ss_pred cccccccccccccccc---CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcC
Q 005749 542 LAKADGYKAPELQRMK---KCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGI 618 (679)
Q Consensus 542 ~~gt~~y~aPE~~~~~---~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~ 618 (679)
..++..|+|||.+... .++.++||||||+++|||++|+.||......+. ... .... .+.+..
T Consensus 161 ~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~-----~~~--~~~~----~~~~~~---- 225 (262)
T cd06613 161 FIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA-----LFL--ISKS----NFPPPK---- 225 (262)
T ss_pred ccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH-----HHH--HHhc----cCCCcc----
Confidence 4678889999998776 789999999999999999999999854322110 000 0000 000000
Q ss_pred CCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHH
Q 005749 619 RSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVK 652 (679)
Q Consensus 619 ~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 652 (679)
.........++.+++.+||..+|.+||++.+|+.
T Consensus 226 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 226 LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0111233456788999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=327.31 Aligned_cols=195 Identities=19% Similarity=0.267 Sum_probs=167.8
Q ss_pred CccccCCceEEEEEEe-CCCCEEEEEEcccCc---ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCC
Q 005749 383 QVIEKTTYGTAYKAKL-ADGATIALRLLREGS---CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPS 458 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~ 458 (679)
+.||+|+||.||+|+. .+++.||+|+++... ......+.+|++++.+++||||+++++.+.+ .+..++||||+++
T Consensus 7 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~-~~~~~lv~E~~~g 85 (360)
T cd05627 7 KVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQD-KRNLYLIMEFLPG 85 (360)
T ss_pred EEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc-CCEEEEEEeCCCC
Confidence 6899999999999994 568999999997532 2234567889999999999999999999987 6789999999999
Q ss_pred CChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccc--
Q 005749 459 RTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVA-- 536 (679)
Q Consensus 459 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~-- 536 (679)
|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 86 g~L~~~l~~~----~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~ 158 (360)
T cd05627 86 GDMMTLLMKK----DTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTE 158 (360)
T ss_pred ccHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccccccc
Confidence 9999999753 45899999999999999999999988 99999999999999999999999999875422100
Q ss_pred --------------------------------cchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCC
Q 005749 537 --------------------------------DEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKS 584 (679)
Q Consensus 537 --------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~ 584 (679)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||.+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~ 238 (360)
T cd05627 159 FYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS 238 (360)
T ss_pred cccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCC
Confidence 001234689999999999999999999999999999999999999954
Q ss_pred C
Q 005749 585 G 585 (679)
Q Consensus 585 ~ 585 (679)
.
T Consensus 239 ~ 239 (360)
T cd05627 239 E 239 (360)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=303.85 Aligned_cols=248 Identities=25% Similarity=0.388 Sum_probs=196.1
Q ss_pred cCccccCCceEEEEEEeCC-----CCEEEEEEcccCccc-CcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEe
Q 005749 382 GQVIEKTTYGTAYKAKLAD-----GATIALRLLREGSCK-DRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDY 455 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~~-----~~~vAvK~~~~~~~~-~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey 455 (679)
.+.||+|+||.||+++..+ +..||+|.++..... ..+.+..|++++.+++|+||+++++++.+ .+..+++|||
T Consensus 4 ~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~i~e~ 82 (258)
T smart00219 4 GKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTE-EEPLMIVMEY 82 (258)
T ss_pred cceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcC-CCeeEEEEec
Confidence 4789999999999999543 388999999765433 45688999999999999999999999987 5789999999
Q ss_pred cCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCccc
Q 005749 456 FPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAV 535 (679)
Q Consensus 456 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 535 (679)
+++++|.+++..... ..+++.++..++.|++.||+|||+.+ ++||||||+||++++++.+|++|||+++......
T Consensus 83 ~~~~~l~~~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 83 MEGGDLLDYLRKNRP--KELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred cCCCCHHHHHHhhhh--ccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 999999999976421 12899999999999999999999988 9999999999999999999999999998764432
Q ss_pred ccchhcccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHHhhcccccccchHhh
Q 005749 536 ADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEI 614 (679)
Q Consensus 536 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i 614 (679)
........++..|+|||.+.+..++.++||||+|++++||++ |..||..... ...........
T Consensus 158 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~------~~~~~~~~~~~---------- 221 (258)
T smart00219 158 YYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN------EEVLEYLKKGY---------- 221 (258)
T ss_pred ccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHhcCC----------
Confidence 222112336788999999988889999999999999999998 7888744211 11111110000
Q ss_pred hhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 005749 615 MKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQL 654 (679)
Q Consensus 615 ~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L 654 (679)
..........++.+++.+|+..||++|||+.|+++.|
T Consensus 222 ---~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 222 ---RLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ---CCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 0011112345677899999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=308.49 Aligned_cols=243 Identities=18% Similarity=0.307 Sum_probs=204.3
Q ss_pred cCccccCCceEEEEEE-eCCCCEEEEEEcccCcccC--cccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCC
Q 005749 382 GQVIEKTTYGTAYKAK-LADGATIALRLLREGSCKD--RSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPS 458 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~--~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~ 458 (679)
.+.||+|-|+.|-+|+ .-+|..||||++.+...+. ...+.+|++.|+-++|||||++|.+... ....|+|+|.-.+
T Consensus 23 ekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDT-QTKlyLiLELGD~ 101 (864)
T KOG4717|consen 23 EKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDT-QTKLYLILELGDG 101 (864)
T ss_pred hhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcc-cceEEEEEEecCC
Confidence 3679999999999999 6789999999998765433 4568899999999999999999998887 6789999999999
Q ss_pred CChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecC-CCceEEeecccccccCccccc
Q 005749 459 RTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDD-FFVSRLTEFGLDQLMVPAVAD 537 (679)
Q Consensus 459 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~-~~~~kl~DFGla~~~~~~~~~ 537 (679)
|+|++++-.+. .-+.+....+++.||..|+.|+|+-+ +|||||||+||.+-+ -|-+|+.|||++-.+.++ .
T Consensus 102 GDl~DyImKHe---~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG--~ 173 (864)
T KOG4717|consen 102 GDLFDYIMKHE---EGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG--K 173 (864)
T ss_pred chHHHHHHhhh---ccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCc--c
Confidence 99999998764 34889999999999999999999998 999999999998754 588999999999877554 4
Q ss_pred chhcccccccccccccccccCCC-CcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhh
Q 005749 538 EMVALAKADGYKAPELQRMKKCS-SRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMK 616 (679)
Q Consensus 538 ~~~~~~gt~~y~aPE~~~~~~~~-~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~ 616 (679)
+..+.+|+..|-|||.+.+..|+ ++.||||+|||||-|+.|+.||......+...+ |+.
T Consensus 174 kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTm--------------------ImD 233 (864)
T KOG4717|consen 174 KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTM--------------------IMD 233 (864)
T ss_pred hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhh--------------------hhc
Confidence 56788999999999999998885 679999999999999999999965443322221 222
Q ss_pred cCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 617 GIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 617 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
..+.-......+..++|..|+..||++|.+.+||+..
T Consensus 234 CKYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 234 CKYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred ccccCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 2233344555677889999999999999999999875
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=308.16 Aligned_cols=241 Identities=19% Similarity=0.277 Sum_probs=195.6
Q ss_pred CccccCCceEEEEEEe-CCCCEEEEEEcccCc-ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCC
Q 005749 383 QVIEKTTYGTAYKAKL-ADGATIALRLLREGS-CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRT 460 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gs 460 (679)
+.||.|+||.||+|+. .+++.||+|.+.... ......+.+|++++++++|+||+++++++.+ ....++|+||+++++
T Consensus 7 ~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e~~~~~~ 85 (274)
T cd06609 7 ECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLK-GSKLWIIMEYCGGGS 85 (274)
T ss_pred hhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEE-CCeEEEEEEeeCCCc
Confidence 6799999999999994 468999999987543 2334578899999999999999999999887 578999999999999
Q ss_pred hHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccchh
Q 005749 461 LHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMV 540 (679)
Q Consensus 461 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 540 (679)
|.+++... .+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.++++|||+++...... ....
T Consensus 86 L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~~~ 156 (274)
T cd06609 86 CLDLLKPG-----KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM-SKRN 156 (274)
T ss_pred HHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccc-cccc
Confidence 99998752 5899999999999999999999988 9999999999999999999999999998764332 2223
Q ss_pred cccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcCCC
Q 005749 541 ALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIRS 620 (679)
Q Consensus 541 ~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~~ 620 (679)
...++..|+|||++.+..++.++||||||+++|||++|+.||....... .... +.....+
T Consensus 157 ~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~------~~~~--------------~~~~~~~ 216 (274)
T cd06609 157 TFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR------VLFL--------------IPKNNPP 216 (274)
T ss_pred cccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH------HHHH--------------hhhcCCC
Confidence 4567888999999998889999999999999999999999995432110 0000 0011011
Q ss_pred ChH-H-HHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 621 PME-E-GLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 621 ~~~-~-~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
..+ . ....+.+++.+||..+|++||+++++++.
T Consensus 217 ~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 217 SLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred CCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 111 1 23467789999999999999999999875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=310.28 Aligned_cols=259 Identities=20% Similarity=0.334 Sum_probs=193.0
Q ss_pred CccccCCceEEEEEEeC-CCCEEEEEEcccCcc--cCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCC
Q 005749 383 QVIEKTTYGTAYKAKLA-DGATIALRLLREGSC--KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSR 459 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~g 459 (679)
..||+|+||.||+|+.. +++.||+|++..... ...+.+.+|++++++++|+||+++++++.. ....++||||++++
T Consensus 7 ~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~~v~e~~~~~ 85 (286)
T cd07847 7 SKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRR-KRKLHLVFEYCDHT 85 (286)
T ss_pred eeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEee-CCEEEEEEeccCcc
Confidence 67999999999999954 689999999865432 234567899999999999999999999987 67899999999998
Q ss_pred ChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccch
Q 005749 460 TLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEM 539 (679)
Q Consensus 460 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 539 (679)
+|..+... ...+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++........ ..
T Consensus 86 ~l~~~~~~----~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-~~ 157 (286)
T cd07847 86 VLNELEKN----PRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPGD-DY 157 (286)
T ss_pred HHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCcc-cc
Confidence 88887654 235899999999999999999999987 99999999999999999999999999987643321 22
Q ss_pred hcccccccccccccccc-cCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcc--cccccchH----
Q 005749 540 VALAKADGYKAPELQRM-KKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEE--TTMEVFDM---- 612 (679)
Q Consensus 540 ~~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~--~~~~~~~~---- 612 (679)
....++..|+|||.+.+ ..++.++||||||+++|||++|+.||.+....+. +..+ ....... ...+.++.
T Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~--~~~~-~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07847 158 TDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQ--LYLI-RKTLGDLIPRHQQIFSTNQFF 234 (286)
T ss_pred cCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHH--HHHH-HHHhCCCChHHhhhccccccc
Confidence 23457788999998875 4578999999999999999999999965432211 1111 0000000 00000000
Q ss_pred -h--hhhc-CCCC----hHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 613 -E--IMKG-IRSP----MEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 613 -~--i~~~-~~~~----~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
. .... ...+ .+.....+.+++.+||+.+|++||++.|++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 235 KGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred ccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 0 0000 0000 01123567789999999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=307.00 Aligned_cols=254 Identities=20% Similarity=0.319 Sum_probs=194.3
Q ss_pred cCccccCCceEEEEEEeC----CCCEEEEEEcccCc--ccCcccHHHHHHHHhccCCCCCccceEEeeCCC-----CceE
Q 005749 382 GQVIEKTTYGTAYKAKLA----DGATIALRLLREGS--CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKR-----GEKL 450 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~----~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~-----~~~~ 450 (679)
.++||+|+||.||+|... +++.||||++.... ....+++.+|++++++++||||+++++++.... ...+
T Consensus 4 ~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 83 (273)
T cd05074 4 GRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPM 83 (273)
T ss_pred hhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccceE
Confidence 368999999999999853 36889999986542 223456889999999999999999999876421 1247
Q ss_pred EEEEecCCCChHHHhhcccC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccc
Q 005749 451 LIYDYFPSRTLHDLLHDTIA--GKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLD 528 (679)
Q Consensus 451 lv~ey~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 528 (679)
+++||+++|+|.+++..... ....+++...+.++.|++.||+|||+++ |+||||||+||++++++.+|++|||++
T Consensus 84 ~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg~~ 160 (273)
T cd05074 84 VILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADFGLS 160 (273)
T ss_pred EEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECccccc
Confidence 88999999999988754321 1234789999999999999999999988 999999999999999999999999999
Q ss_pred cccCcccc-cchhcccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHHhhcccc
Q 005749 529 QLMVPAVA-DEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAVLEETT 606 (679)
Q Consensus 529 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 606 (679)
+....... .......++..|++||.+....++.++||||||+++|||++ |+.||.+.... .+..+.. ..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~---~~~~~~~----~~-- 231 (273)
T cd05074 161 KKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS---EIYNYLI----KG-- 231 (273)
T ss_pred ccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH---HHHHHHH----cC--
Confidence 86543221 11223345677999999988889999999999999999999 88888433211 1111100 00
Q ss_pred cccchHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhh
Q 005749 607 MEVFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEEN 657 (679)
Q Consensus 607 ~~~~~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 657 (679)
......+.....+.+++.+||+.+|++||++.|+++.|+++
T Consensus 232 ----------~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 232 ----------NRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred ----------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00011122335778899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=312.12 Aligned_cols=260 Identities=24% Similarity=0.384 Sum_probs=193.0
Q ss_pred CccccCCceEEEEEEeC-CCCEEEEEEcccCcc--cCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCC
Q 005749 383 QVIEKTTYGTAYKAKLA-DGATIALRLLREGSC--KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSR 459 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~g 459 (679)
+.||+|+||.||+|+.. +++.||+|++..... ...+.+.+|+++++.++||||+++++++.. .+..++||||++++
T Consensus 7 ~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~ 85 (286)
T cd07846 7 GLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRR-KKRLYLVFEFVDHT 85 (286)
T ss_pred eeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhccc-CCeEEEEEecCCcc
Confidence 78999999999999964 589999999865432 234568899999999999999999999987 67899999999999
Q ss_pred ChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccch
Q 005749 460 TLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEM 539 (679)
Q Consensus 460 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 539 (679)
+|.++.... ..+++..++.++.|+++||+|||+.+ ++||||+|+||++++++.+||+|||++....... ...
T Consensus 86 ~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~-~~~ 157 (286)
T cd07846 86 VLDDLEKYP----NGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-EVY 157 (286)
T ss_pred HHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-ccc
Confidence 998876542 34899999999999999999999987 9999999999999999999999999988654332 222
Q ss_pred hcccccccccccccccc-cCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhh-cccccccchHh-hhh
Q 005749 540 VALAKADGYKAPELQRM-KKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVL-EETTMEVFDME-IMK 616 (679)
Q Consensus 540 ~~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~-~~~~~~~~~~~-i~~ 616 (679)
....++..|+|||++.+ ..++.++||||||+++|||++|++||......+ ........... .....+.++.. +..
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd07846 158 TDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDID--QLYHIIKCLGNLIPRHQEIFQKNPLFA 235 (286)
T ss_pred CcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHH--HHHHHHHHhCCCchhhHHHhccchHhh
Confidence 33457889999998875 447889999999999999999999985432211 00000000000 00000000000 000
Q ss_pred cCC-----------CChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 617 GIR-----------SPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 617 ~~~-----------~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
+.. ...+.....+.+++.+||+.+|++||++.++++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 236 GMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred ccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 000 0011223567789999999999999999998863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=303.87 Aligned_cols=241 Identities=22% Similarity=0.410 Sum_probs=192.8
Q ss_pred cCccccCCceEEEEEEeCCCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCCh
Q 005749 382 GQVIEKTTYGTAYKAKLADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRTL 461 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gsL 461 (679)
.+.||+|+||.||+|.. +++.||+|.++... ..+.+.+|+.++++++||||+++++++.. +..++||||+++++|
T Consensus 11 ~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~v~e~~~~~~L 85 (254)
T cd05083 11 GEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILH--NGLYIVMELMSKGNL 85 (254)
T ss_pred eeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcC--CCcEEEEECCCCCCH
Confidence 57899999999999985 67889999986532 34578999999999999999999998875 457999999999999
Q ss_pred HHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccchhc
Q 005749 462 HDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVA 541 (679)
Q Consensus 462 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 541 (679)
.+++.... ...+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++..... ...
T Consensus 86 ~~~l~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~----~~~ 156 (254)
T cd05083 86 VNFLRTRG--RALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMG----VDN 156 (254)
T ss_pred HHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecccc----CCC
Confidence 99997642 345889999999999999999999987 999999999999999999999999998754321 112
Q ss_pred ccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcCC-
Q 005749 542 LAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIR- 619 (679)
Q Consensus 542 ~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~- 619 (679)
...+..|+|||.+.+..++.++||||||+++|||++ |+.||...... ..... +..+..
T Consensus 157 ~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~------~~~~~--------------~~~~~~~ 216 (254)
T cd05083 157 SKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK------EVKEC--------------VEKGYRM 216 (254)
T ss_pred CCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH------HHHHH--------------HhCCCCC
Confidence 234567999999988889999999999999999997 89998543221 11110 011111
Q ss_pred CChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHh
Q 005749 620 SPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEE 656 (679)
Q Consensus 620 ~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 656 (679)
.........+.+++.+||+.+|++||++++++..|++
T Consensus 217 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 217 EPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 1112223567789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=309.70 Aligned_cols=246 Identities=16% Similarity=0.255 Sum_probs=194.5
Q ss_pred CccccCCceEEEEEEe-CCCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCCh
Q 005749 383 QVIEKTTYGTAYKAKL-ADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRTL 461 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gsL 461 (679)
+.||+|+||.||+|+. .++..||+|.+........+.+.+|++++++++||||+++++++.. ++..++||||+++++|
T Consensus 11 ~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L 89 (280)
T cd06611 11 GELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFY-ENKLWILIEFCDGGAL 89 (280)
T ss_pred HHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEec-CCeEEEEeeccCCCcH
Confidence 6799999999999995 4689999999876554455678999999999999999999999987 6789999999999999
Q ss_pred HHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccchhc
Q 005749 462 HDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVA 541 (679)
Q Consensus 462 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 541 (679)
.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++....... .....
T Consensus 90 ~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-~~~~~ 162 (280)
T cd06611 90 DSIMLEL---ERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL-QKRDT 162 (280)
T ss_pred HHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhcccc-cccce
Confidence 9998754 345899999999999999999999988 9999999999999999999999999987643221 12233
Q ss_pred cccccccccccccc-----ccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhh
Q 005749 542 LAKADGYKAPELQR-----MKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMK 616 (679)
Q Consensus 542 ~~gt~~y~aPE~~~-----~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~ 616 (679)
..++..|+|||.+. ...++.++||||||+++|||++|+.||...... ...... .... . +.+
T Consensus 163 ~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~------~~~~~~-~~~~-~----~~~-- 228 (280)
T cd06611 163 FIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM------RVLLKI-LKSE-P----PTL-- 228 (280)
T ss_pred eecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH------HHHHHH-hcCC-C----CCc--
Confidence 46888999999874 345778999999999999999999998543211 000000 0000 0 000
Q ss_pred cCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 617 GIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 617 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
........++.+++.+||+.+|++||++.++++.
T Consensus 229 ---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 229 ---DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred ---CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 0011223467789999999999999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=318.91 Aligned_cols=256 Identities=19% Similarity=0.262 Sum_probs=189.1
Q ss_pred CccccCCceEEEEEE-eCCCCEEEEEEcccCcc--cCcccHHHHHHHHhccCCCCCccceEEeeCC-----CCceEEEEE
Q 005749 383 QVIEKTTYGTAYKAK-LADGATIALRLLREGSC--KDRSSCLPVIRQLGKVRHENLIPLRAFYQGK-----RGEKLLIYD 454 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~-----~~~~~lv~e 454 (679)
+.||+|+||.||+|+ ..+++.||||++..... ...+.+.+|++++++++||||+++++++... ....++++|
T Consensus 21 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~ 100 (343)
T cd07878 21 TPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTN 100 (343)
T ss_pred eecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEEEEee
Confidence 689999999999998 46788999999875422 2345677899999999999999999987532 235789999
Q ss_pred ecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcc
Q 005749 455 YFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPA 534 (679)
Q Consensus 455 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 534 (679)
++ +++|.+++.. ..+++..+..++.|++.||+|||+++ |+||||||+||++++++.+||+|||+++.....
T Consensus 101 ~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 171 (343)
T cd07878 101 LM-GADLNNIVKC-----QKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADDE 171 (343)
T ss_pred cC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCccceecCCC
Confidence 88 6799888763 34899999999999999999999988 999999999999999999999999999865322
Q ss_pred cccchhcccccccccccccccc-cCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhc--cccccc--
Q 005749 535 VADEMVALAKADGYKAPELQRM-KKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLE--ETTMEV-- 609 (679)
Q Consensus 535 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~--~~~~~~-- 609 (679)
.....|+..|+|||++.+ ..++.++|||||||++|||++|+.||......+ .+..+....... .....+
T Consensus 172 ----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 245 (343)
T cd07878 172 ----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYID--QLKRIMEVVGTPSPEVLKKISS 245 (343)
T ss_pred ----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHhCCCCHHHHHhcch
Confidence 234568999999999876 568999999999999999999999995432211 111111000000 000000
Q ss_pred -chHhhhhcCCCCh--------HHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 610 -FDMEIMKGIRSPM--------EEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 610 -~~~~i~~~~~~~~--------~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
............. ....+.+.+++.+|+..||++|||+.|++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 246 EHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred hhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000000000 0112346789999999999999999999976
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=305.70 Aligned_cols=241 Identities=19% Similarity=0.274 Sum_probs=195.2
Q ss_pred CccccCCceEEEEEEe-CCCCEEEEEEcccCc-ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCC
Q 005749 383 QVIEKTTYGTAYKAKL-ADGATIALRLLREGS-CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRT 460 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gs 460 (679)
+.||+|+||.||+|+. .++..||+|.+.... ....+.+.+|++++++++||||+++++++.+ ....++||||+++|+
T Consensus 10 ~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~ 88 (277)
T cd06640 10 ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK-GTKLWIIMEYLGGGS 88 (277)
T ss_pred hhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-CCEEEEEEecCCCCc
Confidence 6799999999999995 468899999987542 2334578899999999999999999999987 678999999999999
Q ss_pred hHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccchh
Q 005749 461 LHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMV 540 (679)
Q Consensus 461 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 540 (679)
|.+++.. ..+++.+...++.|++.||+|||+.+ ++|+||+|+||+++.++.++++|||++....... ....
T Consensus 89 L~~~i~~-----~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~-~~~~ 159 (277)
T cd06640 89 ALDLLRA-----GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-IKRN 159 (277)
T ss_pred HHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCc-cccc
Confidence 9999864 34788999999999999999999987 9999999999999999999999999997654322 1222
Q ss_pred cccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcCC-
Q 005749 541 ALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIR- 619 (679)
Q Consensus 541 ~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~- 619 (679)
...++..|+|||++.+..++.++|||||||++|||++|+.||......... .. +..+..
T Consensus 160 ~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~------~~--------------~~~~~~~ 219 (277)
T cd06640 160 TFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL------FL--------------IPKNNPP 219 (277)
T ss_pred cccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHh------hh--------------hhcCCCC
Confidence 345788899999998888999999999999999999999998543221100 00 001101
Q ss_pred CChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 620 SPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 620 ~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
.........+.+++.+||+.+|++||+++++++.
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 220 TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 1122344567789999999999999999999877
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=303.87 Aligned_cols=250 Identities=16% Similarity=0.236 Sum_probs=197.1
Q ss_pred CccccCCceEEEEEE-eCCCCEEEEEEcccCc--ccCcccHHHHHHHHhccCCCCCccceEEeeCC-CCceEEEEEecCC
Q 005749 383 QVIEKTTYGTAYKAK-LADGATIALRLLREGS--CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGK-RGEKLLIYDYFPS 458 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~-~~~~~lv~ey~~~ 458 (679)
+.||+|+||.||+|. ..+++.||+|.+.... ....+.+..|++++++++||||+++++++... ....+++|||+++
T Consensus 6 ~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~~ 85 (265)
T cd08217 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEG 85 (265)
T ss_pred eeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehhccC
Confidence 679999999999998 5578999999986542 23345688999999999999999999987642 4567999999999
Q ss_pred CChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCC--CCCeeecCCCCCCeeecCCCceEEeecccccccCcccc
Q 005749 459 RTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGH--EIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVA 536 (679)
Q Consensus 459 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~--~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 536 (679)
++|.+++.........+++..++.++.|+++||+|||..+ ..+++|+||||+||++++++.+|++|||++........
T Consensus 86 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~ 165 (265)
T cd08217 86 GDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSS 165 (265)
T ss_pred CCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccccCCcc
Confidence 9999999765433456899999999999999999999332 23399999999999999999999999999987643321
Q ss_pred cchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhh
Q 005749 537 DEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMK 616 (679)
Q Consensus 537 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~ 616 (679)
......++..|+|||.+....++.++||||||+++|||++|+.||...... .+.+. +..
T Consensus 166 -~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~-----------------~~~ 224 (265)
T cd08217 166 -FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL---QLASK-----------------IKE 224 (265)
T ss_pred -cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH---HHHHH-----------------Hhc
Confidence 123446888999999999888999999999999999999999998543211 11111 111
Q ss_pred cCC-CChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 617 GIR-SPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 617 ~~~-~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
+.. .........+.+++.+|++.+|++||++++|+++
T Consensus 225 ~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 225 GKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred CCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 111 1112334667789999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=308.46 Aligned_cols=250 Identities=18% Similarity=0.237 Sum_probs=191.3
Q ss_pred CccccCCceEEEEEEe-CCCCEEEEEEcccCcccCcccHHHHHHHHhcc-CCCCCccceEEeeC----CCCceEEEEEec
Q 005749 383 QVIEKTTYGTAYKAKL-ADGATIALRLLREGSCKDRSSCLPVIRQLGKV-RHENLIPLRAFYQG----KRGEKLLIYDYF 456 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~----~~~~~~lv~ey~ 456 (679)
+.||+|+||.||+|+. .+++.+|+|.+.... .....+.+|+.+++++ +||||+++++++.. ..+..++||||+
T Consensus 24 ~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~ 102 (286)
T cd06638 24 ETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELC 102 (286)
T ss_pred eeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEeec
Confidence 6799999999999984 568899999876532 2235678899999999 69999999998752 235689999999
Q ss_pred CCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccc
Q 005749 457 PSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVA 536 (679)
Q Consensus 457 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 536 (679)
++++|.+++.........+++..+..++.|+++||.|||+.+ |+||||||+||++++++.+||+|||+++......
T Consensus 103 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~- 178 (286)
T cd06638 103 NGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR- 178 (286)
T ss_pred CCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEEccCCceeecccCC-
Confidence 999999988654333456899999999999999999999987 9999999999999999999999999988654321
Q ss_pred cchhcccccccccccccccc-----cCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccch
Q 005749 537 DEMVALAKADGYKAPELQRM-----KKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFD 611 (679)
Q Consensus 537 ~~~~~~~gt~~y~aPE~~~~-----~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 611 (679)
.......|+..|+|||++.. ..++.++|||||||++|||++|+.||....... .... ..........
T Consensus 179 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~-----~~~~--~~~~~~~~~~- 250 (286)
T cd06638 179 LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR-----ALFK--IPRNPPPTLH- 250 (286)
T ss_pred CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH-----HHhh--ccccCCCccc-
Confidence 12233468899999998753 457889999999999999999999985432210 0000 0000000000
Q ss_pred HhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 005749 612 MEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQL 654 (679)
Q Consensus 612 ~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L 654 (679)
.......++.+++.+||+.||++|||+.|+++..
T Consensus 251 ---------~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 251 ---------QPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred ---------CCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 0011124577899999999999999999998753
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=304.20 Aligned_cols=250 Identities=20% Similarity=0.325 Sum_probs=192.3
Q ss_pred cCccccCCceEEEEEE-eCCCCEEEEEEcccCccc----------CcccHHHHHHHHhccCCCCCccceEEeeCCCCceE
Q 005749 382 GQVIEKTTYGTAYKAK-LADGATIALRLLREGSCK----------DRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKL 450 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~----------~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~ 450 (679)
++.||+|+||.||+|+ ..+|+.||+|.++..... ..+.+.+|++++++++||||+++++++.. .+..+
T Consensus 6 ~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 84 (272)
T cd06629 6 GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETT-EEYLS 84 (272)
T ss_pred cceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEecc-CCceE
Confidence 4789999999999998 456899999988642111 12357889999999999999999999887 67899
Q ss_pred EEEEecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccc
Q 005749 451 LIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQL 530 (679)
Q Consensus 451 lv~ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 530 (679)
+||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+|++|||+++.
T Consensus 85 lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~~~ 157 (272)
T cd06629 85 IFLEYVPGGSIGSCLRTY----GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKK 157 (272)
T ss_pred EEEecCCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccccc
Confidence 999999999999999764 45899999999999999999999987 99999999999999999999999999876
Q ss_pred cCccccc-chhcccccccccccccccccC--CCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhccccc
Q 005749 531 MVPAVAD-EMVALAKADGYKAPELQRMKK--CSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTM 607 (679)
Q Consensus 531 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~--~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 607 (679)
....... ......++..|+|||.+.... ++.++||||||+++||+++|+.||...... ....... .....
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-----~~~~~~~--~~~~~ 230 (272)
T cd06629 158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI-----AAMFKLG--NKRSA 230 (272)
T ss_pred ccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH-----HHHHHhh--ccccC
Confidence 5322111 123346788999999887654 789999999999999999999998432211 1111100 00000
Q ss_pred ccchHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 608 EVFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 608 ~~~~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
..+... ........+.+++.+||..+|++||++++|++.
T Consensus 231 ~~~~~~-------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 231 PPIPPD-------VSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred CcCCcc-------ccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 000000 011223567789999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=307.84 Aligned_cols=246 Identities=20% Similarity=0.323 Sum_probs=193.2
Q ss_pred CccccCCceEEEEEEeC-CCCEEEEEEcccCc-ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCC
Q 005749 383 QVIEKTTYGTAYKAKLA-DGATIALRLLREGS-CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRT 460 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gs 460 (679)
+.||+|+||.||+|+.. ++..||+|.++... ......+.+|++++.+++|+||+++++++.. .+..++||||+++++
T Consensus 7 ~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~~~~ 85 (286)
T cd06622 7 DELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFI-EGAVYMCMEYMDAGS 85 (286)
T ss_pred hhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheec-CCeEEEEEeecCCCC
Confidence 78999999999999954 78999999886532 2234578899999999999999999998887 688999999999999
Q ss_pred hHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccch
Q 005749 461 LHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTG-HEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEM 539 (679)
Q Consensus 461 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~-~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 539 (679)
|.+++..... ...+++..+..++.|++.||.|||+. + |+||||||+||+++.++.+||+|||++...... ..
T Consensus 86 l~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~---~~ 158 (286)
T cd06622 86 LDKLYAGGVA-TEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS---LA 158 (286)
T ss_pred HHHHHHhccc-cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCC---cc
Confidence 9998875321 23689999999999999999999974 5 999999999999999999999999998765322 12
Q ss_pred hccccccccccccccccc------CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHh
Q 005749 540 VALAKADGYKAPELQRMK------KCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDME 613 (679)
Q Consensus 540 ~~~~gt~~y~aPE~~~~~------~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 613 (679)
....++..|+|||.+.+. .++.++|||||||++|||++|+.||........ ..... .
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~~~--------------~ 221 (286)
T cd06622 159 KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANI---FAQLS--------------A 221 (286)
T ss_pred ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhH---HHHHH--------------H
Confidence 234578889999988543 358899999999999999999999954322110 00000 0
Q ss_pred hhhcCC-CChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 614 IMKGIR-SPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 614 i~~~~~-~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
+..+.. ...+....++.+++.+||+.+|++||+++++++.
T Consensus 222 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 222 IVDGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred HhhcCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 111111 1112344667789999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=309.41 Aligned_cols=261 Identities=22% Similarity=0.271 Sum_probs=195.7
Q ss_pred cCccccCCceEEEEEEe-CCCCEEEEEEcccCc--ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCC
Q 005749 382 GQVIEKTTYGTAYKAKL-ADGATIALRLLREGS--CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPS 458 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~ 458 (679)
.+.||+|+||.||+|+. .+|+.||+|++.... ....+.+.+|+.++++++||||+++++++.. ....++||||+ +
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~~v~e~~-~ 82 (286)
T cd07832 5 LGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPH-GSGFVLVMEYM-P 82 (286)
T ss_pred EeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEec-CCeeEEEeccc-C
Confidence 36799999999999995 578999999987653 2334678999999999999999999999987 67899999999 9
Q ss_pred CChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccc
Q 005749 459 RTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADE 538 (679)
Q Consensus 459 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 538 (679)
++|.+++... ...+++.+++.++.||++||+|||+.+ ++|+||||+||++++++.++++|||++..........
T Consensus 83 ~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 156 (286)
T cd07832 83 SDLSEVLRDE---ERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRL 156 (286)
T ss_pred CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCc
Confidence 9999998754 245899999999999999999999988 9999999999999999999999999998764432222
Q ss_pred hhccccccccccccccccc-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhccc---c---cccch
Q 005749 539 MVALAKADGYKAPELQRMK-KCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEET---T---MEVFD 611 (679)
Q Consensus 539 ~~~~~gt~~y~aPE~~~~~-~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~---~---~~~~~ 611 (679)
.....++..|+|||.+.+. .++.++||||+|+++|||++|++||.+....+ ....+........ . .+..+
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07832 157 YSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIE---QLAIVFRTLGTPNEETWPGLTSLPD 233 (286)
T ss_pred cccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHH---HHHHHHHHcCCCChHHHhhccCcch
Confidence 3345688899999988654 46899999999999999999988774432211 1111111000000 0 00000
Q ss_pred Hh-h--hhcCC----CChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 612 ME-I--MKGIR----SPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 612 ~~-i--~~~~~----~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
.. + ..... ...++....+.+++.+|++.+|++||++++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 234 YNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred hhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00 0 00000 0001223677899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=308.57 Aligned_cols=260 Identities=19% Similarity=0.257 Sum_probs=190.8
Q ss_pred CccccCCceEEEEEEe-CCCCEEEEEEcccCcc--cCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCC
Q 005749 383 QVIEKTTYGTAYKAKL-ADGATIALRLLREGSC--KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSR 459 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~g 459 (679)
+.||+|+||.||+|+. .+|+.||+|.++.... .....+.+|++++++++||||+++++++.+ .+..++|+||+++
T Consensus 6 ~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~- 83 (284)
T cd07839 6 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHS-DKKLTLVFEYCDQ- 83 (284)
T ss_pred EEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhcc-CCceEEEEecCCC-
Confidence 6799999999999995 5799999999865422 234567899999999999999999999987 6789999999974
Q ss_pred ChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccch
Q 005749 460 TLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEM 539 (679)
Q Consensus 460 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 539 (679)
+|.+++... ...+++..++.++.||++||+|||+.+ |+||||||+||+++.++.+||+|||+++...... ...
T Consensus 84 ~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~-~~~ 156 (284)
T cd07839 84 DLKKYFDSC---NGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPV-RCY 156 (284)
T ss_pred CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCC-CCc
Confidence 888877643 245899999999999999999999988 9999999999999999999999999998653321 112
Q ss_pred hccccccccccccccccc-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhccc------ccccchH
Q 005749 540 VALAKADGYKAPELQRMK-KCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEET------TMEVFDM 612 (679)
Q Consensus 540 ~~~~gt~~y~aPE~~~~~-~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~------~~~~~~~ 612 (679)
....++..|+|||++.+. .++.++|||||||++|||++|+.|+......+ ..+...... ..... ..+..+.
T Consensus 157 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07839 157 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD-DQLKRIFRL-LGTPTEESWPGVSKLPDY 234 (284)
T ss_pred CCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHH-HHHHHHHHH-hCCCChHHhHHhhhcccc
Confidence 234567889999988764 47899999999999999999999864432211 111111000 00000 0000000
Q ss_pred hhhhcCC------CChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 613 EIMKGIR------SPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 613 ~i~~~~~------~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
....... ...+....++.+++.+||+.||++|||++|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 235 KPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred cccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 0000000 0011223567789999999999999999999763
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=303.44 Aligned_cols=248 Identities=20% Similarity=0.296 Sum_probs=194.9
Q ss_pred cCccccCCceEEEEEE-eCCCCEEEEEEcccCcc------cCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEE
Q 005749 382 GQVIEKTTYGTAYKAK-LADGATIALRLLREGSC------KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYD 454 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~------~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~e 454 (679)
++.||+|+||.||+|+ ..+++.||+|.+..... ...+.+.+|++++++++|+||+++++++.+ .+..++|||
T Consensus 5 ~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~~v~e 83 (268)
T cd06630 5 GQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCE-DSHFNLFVE 83 (268)
T ss_pred cceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceecc-CCeEEEEEe
Confidence 4789999999999999 56799999999875331 123578899999999999999999999987 678999999
Q ss_pred ecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCC-ceEEeecccccccCc
Q 005749 455 YFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFF-VSRLTEFGLDQLMVP 533 (679)
Q Consensus 455 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~-~~kl~DFGla~~~~~ 533 (679)
|+++++|.+++... ..+++..+..++.|++.||+|||+++ ++||||||+||+++.++ .+||+|||.+.....
T Consensus 84 ~~~~~~L~~~l~~~----~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~ 156 (268)
T cd06630 84 WMAGGSVSHLLSKY----GAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLAA 156 (268)
T ss_pred ccCCCcHHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccccc
Confidence 99999999999753 35889999999999999999999988 99999999999998775 599999999877643
Q ss_pred cccc---chhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccc
Q 005749 534 AVAD---EMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVF 610 (679)
Q Consensus 534 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 610 (679)
.... ......++..|+|||.+.+..++.++||||+|+++|||++|+.||.......... .+.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~--~~~~~~---------- 224 (268)
T cd06630 157 KGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLA--LIFKIA---------- 224 (268)
T ss_pred ccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHH--HHHHHh----------
Confidence 2111 1123457889999999988889999999999999999999999985432211111 000000
Q ss_pred hHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHH
Q 005749 611 DMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVK 652 (679)
Q Consensus 611 ~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 652 (679)
.........+...+++.+++.+|++.+|++||++.|+++
T Consensus 225 ---~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 225 ---SATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred ---ccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 000011112233466778999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=304.30 Aligned_cols=246 Identities=19% Similarity=0.294 Sum_probs=197.1
Q ss_pred CccccCCceEEEEEEeC-CCCEEEEEEcccCcc-cCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCC
Q 005749 383 QVIEKTTYGTAYKAKLA-DGATIALRLLREGSC-KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRT 460 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gs 460 (679)
+.||+|+||.||+|+.. +++.||+|.+..... ...+.+.+|++++++++||||+++++++.. .+..++++||+++++
T Consensus 7 ~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~~~~ 85 (265)
T cd06605 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYN-NGDISICMEYMDGGS 85 (265)
T ss_pred HHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeec-CCEEEEEEEecCCCc
Confidence 67999999999999954 689999999876532 345678999999999999999999999987 588999999999999
Q ss_pred hHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccch
Q 005749 461 LHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHT-GHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEM 539 (679)
Q Consensus 461 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~-~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 539 (679)
|.+++.... ..+++..+.+++.|++.||+|||+ .+ ++|+||||+||++++++.+||+|||.+........
T Consensus 86 L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--- 156 (265)
T cd06605 86 LDKILKEVQ---GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA--- 156 (265)
T ss_pred HHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHHh---
Confidence 999997642 468899999999999999999999 77 99999999999999999999999999876532211
Q ss_pred hcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcCC
Q 005749 540 VALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIR 619 (679)
Q Consensus 540 ~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~ 619 (679)
....++..|+|||.+.+..++.++||||||+++|||++|+.||...... .....+..+.. .....
T Consensus 157 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~--------------~~~~~ 221 (265)
T cd06605 157 KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDP-PDGIFELLQYI--------------VNEPP 221 (265)
T ss_pred hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccc-cccHHHHHHHH--------------hcCCC
Confidence 1256888999999999889999999999999999999999998543211 11111111111 11111
Q ss_pred CCh--HHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 620 SPM--EEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 620 ~~~--~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
+.. .....++.+++.+||..||++|||+.|++.+
T Consensus 222 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 222 PRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred CCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 111 1134567889999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=301.32 Aligned_cols=243 Identities=19% Similarity=0.310 Sum_probs=194.2
Q ss_pred CccccCCceEEEEEE-eCCCCEEEEEEcccCc--ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCC
Q 005749 383 QVIEKTTYGTAYKAK-LADGATIALRLLREGS--CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSR 459 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~g 459 (679)
+.||+|+||.||+|. ..+++.+|+|.+.... ....+.+.+|++++++++||||+++++.+.. .+..++||||++++
T Consensus 6 ~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~~~ 84 (256)
T cd08220 6 RVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLE-DKALMIVMEYAPGG 84 (256)
T ss_pred EEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEec-CCEEEEEEecCCCC
Confidence 689999999999998 4578999999986542 2335678899999999999999999998886 67899999999999
Q ss_pred ChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCC-CceEEeecccccccCcccccc
Q 005749 460 TLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDF-FVSRLTEFGLDQLMVPAVADE 538 (679)
Q Consensus 460 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~-~~~kl~DFGla~~~~~~~~~~ 538 (679)
+|.+++.... ...+++..+..++.++++||+|||+++ ++||||||+||+++++ +.+|++|||++....... .
T Consensus 85 ~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~--~ 157 (256)
T cd08220 85 TLAEYIQKRC--NSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS--K 157 (256)
T ss_pred CHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc--c
Confidence 9999997642 345899999999999999999999988 9999999999999855 568999999998764321 1
Q ss_pred hhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcC
Q 005749 539 MVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGI 618 (679)
Q Consensus 539 ~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~ 618 (679)
.....++..|+|||.+.+..++.++||||||+++|||++|+.||...... ...... ..+.
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~------~~~~~~--------------~~~~ 217 (256)
T cd08220 158 AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP------ALVLKI--------------MSGT 217 (256)
T ss_pred ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH------HHHHHH--------------HhcC
Confidence 22346788999999999888999999999999999999999998543221 111110 0110
Q ss_pred C-CChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 619 R-SPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 619 ~-~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
. ........++.+++.+||+.+|++|||++|++++
T Consensus 218 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 218 FAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred CCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 0 1111234567789999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=301.98 Aligned_cols=247 Identities=23% Similarity=0.330 Sum_probs=194.5
Q ss_pred cCccccCCceEEEEEEe-CCCCEEEEEEcccCccc--CcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCC
Q 005749 382 GQVIEKTTYGTAYKAKL-ADGATIALRLLREGSCK--DRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPS 458 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~--~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~ 458 (679)
.+.||+|+||.||+|+. .+++.||+|.++..... ..+.+.+|++++++++|+||+++++++.. .+..++|+||+++
T Consensus 5 ~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-~~~~~lv~e~~~~ 83 (264)
T cd06626 5 GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVH-REKVYIFMEYCSG 83 (264)
T ss_pred eeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEec-CCEEEEEEecCCC
Confidence 37899999999999994 57899999998765432 45678999999999999999999999887 6789999999999
Q ss_pred CChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccc
Q 005749 459 RTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADE 538 (679)
Q Consensus 459 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 538 (679)
++|.+++... ..+++..+..++.+++.||+|||+.+ |+|+||||+||++++++.+||+|||++..........
T Consensus 84 ~~L~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~ 156 (264)
T cd06626 84 GTLEELLEHG----RILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM 156 (264)
T ss_pred CcHHHHHhhc----CCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc
Confidence 9999999763 34789999999999999999999988 9999999999999999999999999988764332211
Q ss_pred ---hhcccccccccccccccccC---CCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchH
Q 005749 539 ---MVALAKADGYKAPELQRMKK---CSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDM 612 (679)
Q Consensus 539 ---~~~~~gt~~y~aPE~~~~~~---~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 612 (679)
.....++..|+|||++.+.. ++.++||||||+++||+++|+.||...... . ...... .... .+
T Consensus 157 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~--~---~~~~~~-~~~~-----~~ 225 (264)
T cd06626 157 GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE--F---QIMFHV-GAGH-----KP 225 (264)
T ss_pred cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch--H---HHHHHH-hcCC-----CC
Confidence 11346788899999988765 889999999999999999999999543211 0 000000 0000 00
Q ss_pred hhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHH
Q 005749 613 EIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVK 652 (679)
Q Consensus 613 ~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 652 (679)
.+ +........+.+++.+||+.+|++||++.|++.
T Consensus 226 ~~-----~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 226 PI-----PDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred CC-----CcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00 111112355678999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=301.60 Aligned_cols=243 Identities=21% Similarity=0.313 Sum_probs=193.3
Q ss_pred cCccccCCceEEEEEEeC-CCCEEEEEEcccCcc-----cCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEe
Q 005749 382 GQVIEKTTYGTAYKAKLA-DGATIALRLLREGSC-----KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDY 455 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~-----~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey 455 (679)
+++||+|+||.||+|... ++..||+|.+..... +..+.+.+|++++++++|+||+++++++.+ ....++||||
T Consensus 5 ~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~lv~e~ 83 (258)
T cd06632 5 GELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTERE-EDNLYIFLEL 83 (258)
T ss_pred cceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEec-CCeEEEEEEe
Confidence 378999999999999965 799999999865432 234568899999999999999999999887 6789999999
Q ss_pred cCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCccc
Q 005749 456 FPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAV 535 (679)
Q Consensus 456 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 535 (679)
+++++|.+++... ..+++..+..++.|+++||+|||+.+ ++|+||+|+||+++.++.+||+|||++.......
T Consensus 84 ~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~ 156 (258)
T cd06632 84 VPGGSLAKLLKKY----GSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS 156 (258)
T ss_pred cCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccccc
Confidence 9999999999753 34889999999999999999999988 9999999999999999999999999987653322
Q ss_pred ccchhcccccccccccccccccC-CCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhh
Q 005749 536 ADEMVALAKADGYKAPELQRMKK-CSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEI 614 (679)
Q Consensus 536 ~~~~~~~~gt~~y~aPE~~~~~~-~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i 614 (679)
......++..|+|||.+.... ++.++|+||||+++|||++|+.||...... ....... ..
T Consensus 157 --~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~-----~~~~~~~-~~----------- 217 (258)
T cd06632 157 --FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV-----AAVFKIG-RS----------- 217 (258)
T ss_pred --cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHH-----HHHHHHH-hc-----------
Confidence 123456788899999987666 899999999999999999999998543210 0000000 00
Q ss_pred hhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHH
Q 005749 615 MKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVK 652 (679)
Q Consensus 615 ~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 652 (679)
.......+...+.+.+++.+||+.+|++||++.+++.
T Consensus 218 -~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 218 -KELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred -ccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 0000111122355678999999999999999999975
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=307.34 Aligned_cols=249 Identities=20% Similarity=0.265 Sum_probs=191.5
Q ss_pred CccccCCceEEEEEEe-CCCCEEEEEEcccCcccCcccHHHHHHHHhcc-CCCCCccceEEeeCCC----CceEEEEEec
Q 005749 383 QVIEKTTYGTAYKAKL-ADGATIALRLLREGSCKDRSSCLPVIRQLGKV-RHENLIPLRAFYQGKR----GEKLLIYDYF 456 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~----~~~~lv~ey~ 456 (679)
+.||+|+||.||+|+. .+++.+|+|.+.... ...+.+.+|+.+++++ +||||+++++++...+ +..++||||+
T Consensus 28 ~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~ 106 (291)
T cd06639 28 ETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELC 106 (291)
T ss_pred EEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEEC
Confidence 5799999999999995 578999999986532 2245678899999999 8999999999987522 4689999999
Q ss_pred CCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccc
Q 005749 457 PSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVA 536 (679)
Q Consensus 457 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 536 (679)
++|+|.++++........+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++.......
T Consensus 107 ~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~ 183 (291)
T cd06639 107 NGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL 183 (291)
T ss_pred CCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEeecccchhcccccc
Confidence 999999998753333456899999999999999999999987 99999999999999999999999999886543221
Q ss_pred cchhccccccccccccccccc-----CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccch
Q 005749 537 DEMVALAKADGYKAPELQRMK-----KCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFD 611 (679)
Q Consensus 537 ~~~~~~~gt~~y~aPE~~~~~-----~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 611 (679)
......++..|+|||.+... .++.++|||||||++|||++|+.||...... ..+..+ ........
T Consensus 184 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~--~~~~~~-----~~~~~~~~-- 253 (291)
T cd06639 184 -RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV--KTLFKI-----PRNPPPTL-- 253 (291)
T ss_pred -cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH--HHHHHH-----hcCCCCCC--
Confidence 12234678889999987643 3688999999999999999999998543211 001000 00000000
Q ss_pred HhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 612 MEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 612 ~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
...+.....+.+++.+||+.+|++||++.|++++
T Consensus 254 --------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 254 --------LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred --------CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 0112233567789999999999999999999864
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=303.19 Aligned_cols=257 Identities=18% Similarity=0.230 Sum_probs=196.6
Q ss_pred CccccCCceEEEEEEe-CCCCEEEEEEcccCcc-cCcccHHHHHHHHhccCCCCCccceEEeeCC-CCceEEEEEecCCC
Q 005749 383 QVIEKTTYGTAYKAKL-ADGATIALRLLREGSC-KDRSSCLPVIRQLGKVRHENLIPLRAFYQGK-RGEKLLIYDYFPSR 459 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~-~~~~~lv~ey~~~g 459 (679)
+.||.|++|.||+|+. .+++.+|+|.+..... .....+.+|++++++++||||++++++|.+. .+..++||||++++
T Consensus 7 ~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~ 86 (287)
T cd06621 7 SRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGG 86 (287)
T ss_pred EEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecCCC
Confidence 6799999999999995 5688999999875432 2345789999999999999999999988652 34689999999999
Q ss_pred ChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccch
Q 005749 460 TLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEM 539 (679)
Q Consensus 460 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 539 (679)
+|.+++.........+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 87 ~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~--- 160 (287)
T cd06621 87 SLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA--- 160 (287)
T ss_pred CHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeecccccccccccc---
Confidence 999987653333456889999999999999999999988 99999999999999999999999999876532211
Q ss_pred hcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcCC
Q 005749 540 VALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIR 619 (679)
Q Consensus 540 ~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~ 619 (679)
....++..|+|||.+.+..++.++||||+|+++|||++|+.||...... .....+....... .. .+.+ ....
T Consensus 161 ~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~-~~-----~~~~-~~~~ 232 (287)
T cd06621 161 GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEP-PLGPIELLSYIVN-MP-----NPEL-KDEP 232 (287)
T ss_pred ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCC-CCChHHHHHHHhc-CC-----chhh-ccCC
Confidence 2345778899999998888999999999999999999999999644221 0111111111110 00 0000 0000
Q ss_pred CChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 620 SPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 620 ~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
.......+.+.+++.+||+.+|++|||+.|+++.
T Consensus 233 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 233 GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 1011234567899999999999999999999884
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=302.38 Aligned_cols=245 Identities=18% Similarity=0.283 Sum_probs=189.4
Q ss_pred cCccccCCceEEEEEEe-CCCCEEEEEEcccCcc-----cCcccHHHHHHHHhccCCCCCccceEEeeCC-CCceEEEEE
Q 005749 382 GQVIEKTTYGTAYKAKL-ADGATIALRLLREGSC-----KDRSSCLPVIRQLGKVRHENLIPLRAFYQGK-RGEKLLIYD 454 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~-----~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~-~~~~~lv~e 454 (679)
++.||+|+||.||+|+. .++..||+|.+..... ...+.+.+|++++++++||||+++++++.+. ....+++||
T Consensus 7 ~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e 86 (265)
T cd06652 7 GKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFME 86 (265)
T ss_pred eeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEEE
Confidence 47899999999999994 5689999998864321 1234678899999999999999999988753 345789999
Q ss_pred ecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcc
Q 005749 455 YFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPA 534 (679)
Q Consensus 455 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 534 (679)
|+++++|.+++... ..+++..+++++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++.....
T Consensus 87 ~~~~~~L~~~l~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~ 159 (265)
T cd06652 87 HMPGGSIKDQLKSY----GALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTI 159 (265)
T ss_pred ecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccccccc
Confidence 99999999998753 34788999999999999999999988 999999999999999999999999998865321
Q ss_pred cc--cchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchH
Q 005749 535 VA--DEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDM 612 (679)
Q Consensus 535 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 612 (679)
.. .......++..|+|||.+.+..++.++|||||||++|||++|+.||...... ....+ ..
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-----~~~~~-~~----------- 222 (265)
T cd06652 160 CLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM-----AAIFK-IA----------- 222 (265)
T ss_pred cccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH-----HHHHH-Hh-----------
Confidence 11 1122345788999999998888999999999999999999999998432110 00000 00
Q ss_pred hhhhcCCCC-hHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 613 EIMKGIRSP-MEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 613 ~i~~~~~~~-~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
.....+. .+.....+.+++.+|+. +|++||+++|+++.
T Consensus 223 --~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 223 --TQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred --cCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 0000111 12233556678888885 89999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=309.15 Aligned_cols=258 Identities=21% Similarity=0.318 Sum_probs=194.6
Q ss_pred cCccccCCceEEEEEEeC-CCCEEEEEEcccCc--ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCC
Q 005749 382 GQVIEKTTYGTAYKAKLA-DGATIALRLLREGS--CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPS 458 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~ 458 (679)
.+.||+|+||.||+|+.. +++.||+|.++... ....+.+.+|++++++++|+||+++++++.. .+..++||||+++
T Consensus 6 ~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~iv~e~~~~ 84 (288)
T cd07833 6 LGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR-KGRLYLVFEYVER 84 (288)
T ss_pred EEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE-CCEEEEEEecCCC
Confidence 367999999999999954 68899999987542 2335678999999999999999999999987 6789999999998
Q ss_pred CChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccc
Q 005749 459 RTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADE 538 (679)
Q Consensus 459 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 538 (679)
+.+..+... ...+++..+..++.||+.||+|||+.+ ++||||||+||++++++.+||+|||++..........
T Consensus 85 ~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~ 157 (288)
T cd07833 85 TLLELLEAS----PGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARPASP 157 (288)
T ss_pred CHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCcccc
Confidence 777666543 234899999999999999999999988 9999999999999999999999999998765433222
Q ss_pred hhccccccccccccccccc-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhh------------ccc
Q 005749 539 MVALAKADGYKAPELQRMK-KCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVL------------EET 605 (679)
Q Consensus 539 ~~~~~gt~~y~aPE~~~~~-~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~------------~~~ 605 (679)
.....++..|+|||++.+. .++.++||||||+++|||++|+.||......+ .+.. ...... ...
T Consensus 158 ~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~--~~~~-~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07833 158 LTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDID--QLYL-IQKCLGPLPPSHQELFSSNPR 234 (288)
T ss_pred ccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHH-HHHHhCCCCHHHhhhcccCcc
Confidence 3345678889999999877 78999999999999999999999985432211 0000 000000 000
Q ss_pred -----ccccchHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHH
Q 005749 606 -----TMEVFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVK 652 (679)
Q Consensus 606 -----~~~~~~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 652 (679)
..+..+...... ........++.+++.+||..+|++||+++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 235 FAGVAFPEPSQPESLER--RYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred ccccccCCCCCcHHHHH--hcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 000000000000 000112466789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=305.74 Aligned_cols=245 Identities=20% Similarity=0.295 Sum_probs=189.9
Q ss_pred CccccCCceEEEEEEe-CCCCEEEEEEcccCcccCcccHHHHHHHHhcc-CCCCCccceEEeeC-----CCCceEEEEEe
Q 005749 383 QVIEKTTYGTAYKAKL-ADGATIALRLLREGSCKDRSSCLPVIRQLGKV-RHENLIPLRAFYQG-----KRGEKLLIYDY 455 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~-----~~~~~~lv~ey 455 (679)
+.||+|+||.||+|+. .+++.+|+|.+.... ....++..|+.++.++ +|+||+++++++.. .....+++|||
T Consensus 22 ~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~ 100 (282)
T cd06636 22 EVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEF 100 (282)
T ss_pred eeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEEEe
Confidence 6899999999999994 568999999986532 2345688899999998 69999999998853 13578999999
Q ss_pred cCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCccc
Q 005749 456 FPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAV 535 (679)
Q Consensus 456 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 535 (679)
+++|+|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++.......
T Consensus 101 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~~ 175 (282)
T cd06636 101 CGAGSVTDLVKNTK--GNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV 175 (282)
T ss_pred CCCCcHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCcchhhhhccc
Confidence 99999999997643 245788899999999999999999988 9999999999999999999999999987653221
Q ss_pred ccchhccccccccccccccc-----ccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccc
Q 005749 536 ADEMVALAKADGYKAPELQR-----MKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVF 610 (679)
Q Consensus 536 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 610 (679)
.......|+..|+|||.+. ...++.++|||||||++|||++|+.||.......... . ... ..
T Consensus 176 -~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~-----~--~~~-----~~ 242 (282)
T cd06636 176 -GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF-----L--IPR-----NP 242 (282)
T ss_pred -cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh-----h--Hhh-----CC
Confidence 1223456888999999875 3457889999999999999999999985432110000 0 000 00
Q ss_pred hHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHH
Q 005749 611 DMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVK 652 (679)
Q Consensus 611 ~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 652 (679)
.+. ........++.+++.+||+.||++||++.|+++
T Consensus 243 ~~~------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 243 PPK------LKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred CCC------CcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 000 011123356788999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=305.34 Aligned_cols=244 Identities=16% Similarity=0.246 Sum_probs=195.4
Q ss_pred CccccCCceEEEEEE-eCCCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCCh
Q 005749 383 QVIEKTTYGTAYKAK-LADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRTL 461 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gsL 461 (679)
+.||+|++|.||+|. ..+++.+|+|+++.......+.+.+|+.+++.++||||+++++++.. .+..++|+||+++++|
T Consensus 25 ~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~-~~~~~~v~e~~~~~~L 103 (285)
T cd06648 25 VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLV-GDELWVVMEFLEGGAL 103 (285)
T ss_pred eEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEc-CCeEEEEEeccCCCCH
Confidence 689999999999999 45789999999875544445678899999999999999999999887 6789999999999999
Q ss_pred HHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccchhc
Q 005749 462 HDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVA 541 (679)
Q Consensus 462 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 541 (679)
.+++.. ..+++..+..++.|++.||+|||+++ ++||||||+||++++++.+|++|||++....... .....
T Consensus 104 ~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~-~~~~~ 174 (285)
T cd06648 104 TDIVTH-----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV-PRRKS 174 (285)
T ss_pred HHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCC-ccccc
Confidence 999875 24889999999999999999999988 9999999999999999999999999887553321 12233
Q ss_pred ccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcCCCC
Q 005749 542 LAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIRSP 621 (679)
Q Consensus 542 ~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~~~ 621 (679)
..|+..|+|||...+..++.++||||||+++|||++|+.||...... ......... . .+.+ ..
T Consensus 175 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~------~~~~~~~~~-~-----~~~~-----~~ 237 (285)
T cd06648 175 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL------QAMKRIRDN-L-----PPKL-----KN 237 (285)
T ss_pred ccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH------HHHHHHHhc-C-----CCCC-----cc
Confidence 46888999999998888999999999999999999999998542211 111111000 0 0000 00
Q ss_pred hHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 622 MEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 622 ~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
.......+.+++.+||+.+|++||++.++++.
T Consensus 238 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 238 LHKVSPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred cccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 11123567889999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=306.53 Aligned_cols=244 Identities=18% Similarity=0.296 Sum_probs=195.8
Q ss_pred CccccCCceEEEEEE-eCCCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCCh
Q 005749 383 QVIEKTTYGTAYKAK-LADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRTL 461 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gsL 461 (679)
+.||+|+||.||+|. ..++..||+|.+........+.+.+|+.++++++||||+++++++.. .+..++|+||+++++|
T Consensus 25 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~-~~~~~lv~e~~~~~~L 103 (293)
T cd06647 25 EKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLV-GDELWVVMEYLAGGSL 103 (293)
T ss_pred eEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeee-CCcEEEEEecCCCCcH
Confidence 679999999999998 45788999999875544455678999999999999999999999987 6789999999999999
Q ss_pred HHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccchhc
Q 005749 462 HDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVA 541 (679)
Q Consensus 462 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 541 (679)
.+++.. ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++........ ....
T Consensus 104 ~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~-~~~~ 174 (293)
T cd06647 104 TDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRST 174 (293)
T ss_pred HHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc-cccc
Confidence 999874 34789999999999999999999988 99999999999999999999999998876543321 2233
Q ss_pred ccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcCCCC
Q 005749 542 LAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIRSP 621 (679)
Q Consensus 542 ~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~~~ 621 (679)
..+++.|+|||.+....++.++||||||+++||+++|+.||......+.... . . ... ......
T Consensus 175 ~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~--~---~-~~~-----------~~~~~~ 237 (293)
T cd06647 175 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL--I---A-TNG-----------TPELQN 237 (293)
T ss_pred ccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheee--h---h-cCC-----------CCCCCC
Confidence 4678889999999888899999999999999999999999955432211100 0 0 000 000011
Q ss_pred hHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 622 MEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 622 ~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
.......+.+++.+||+.+|++||++++++.+
T Consensus 238 ~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 238 PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11223456789999999999999999999977
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=303.56 Aligned_cols=242 Identities=19% Similarity=0.234 Sum_probs=184.8
Q ss_pred ccccCCceEEEEEEe-CCCCEEEEEEcccCccc---CcccHHHHHHHHh---ccCCCCCccceEEeeCCCCceEEEEEec
Q 005749 384 VIEKTTYGTAYKAKL-ADGATIALRLLREGSCK---DRSSCLPVIRQLG---KVRHENLIPLRAFYQGKRGEKLLIYDYF 456 (679)
Q Consensus 384 ~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~---~~~~~~~Ei~~l~---~l~H~nIv~l~~~~~~~~~~~~lv~ey~ 456 (679)
+||+|+||.||+++. .+++.+|+|.+...... ....+.+|..++. ..+||||+.+++++.. .+..++||||+
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~-~~~~~lv~e~~ 79 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHT-PDKLCFILDLM 79 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEec-CCeEEEEEecC
Confidence 489999999999995 56899999998654321 1223445544333 3479999999998887 67899999999
Q ss_pred CCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccc
Q 005749 457 PSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVA 536 (679)
Q Consensus 457 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 536 (679)
++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+|++|||++......
T Consensus 80 ~~~~L~~~i~~~----~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~-- 150 (279)
T cd05633 80 NGGDLHYHLSQH----GVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK-- 150 (279)
T ss_pred CCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceecccc--
Confidence 999999998753 45899999999999999999999988 999999999999999999999999998754322
Q ss_pred cchhccccccccccccccc-ccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhh
Q 005749 537 DEMVALAKADGYKAPELQR-MKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIM 615 (679)
Q Consensus 537 ~~~~~~~gt~~y~aPE~~~-~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~ 615 (679)
......|+..|+|||.+. +..++.++|||||||++|||++|+.||.......... ..... .
T Consensus 151 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~----~~~~~-------------~ 212 (279)
T cd05633 151 -KPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE----IDRMT-------------L 212 (279)
T ss_pred -CccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH----HHHHh-------------h
Confidence 112346889999999886 4568999999999999999999999995433221111 10000 0
Q ss_pred hcCCCChHHHHHHHHHHHHhccCcCCCCCC-----CHHHHHHH
Q 005749 616 KGIRSPMEEGLVQALKLAMGCCAPVASVRP-----TMDEVVKQ 653 (679)
Q Consensus 616 ~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~evl~~ 653 (679)
.......+....++.+++.+||..||++|| +++|++++
T Consensus 213 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 213 TVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred cCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 000011122345677899999999999999 59998886
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=304.31 Aligned_cols=245 Identities=20% Similarity=0.325 Sum_probs=188.2
Q ss_pred CccccCCceEEEEEEe-CCCCEEEEEEcccCcc-cCcccHHHHHHH-HhccCCCCCccceEEeeCCCCceEEEEEecCCC
Q 005749 383 QVIEKTTYGTAYKAKL-ADGATIALRLLREGSC-KDRSSCLPVIRQ-LGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSR 459 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~-~~~~~~~~Ei~~-l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~g 459 (679)
+.||+|+||.||+|+. .+|+.||+|+++.... .....+..|+.+ ++..+||||+++++++.. .+..+++|||++ |
T Consensus 7 ~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~-~~~~~lv~e~~~-~ 84 (283)
T cd06617 7 EELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFR-EGDVWICMEVMD-T 84 (283)
T ss_pred EEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEec-CCcEEEEhhhhc-c
Confidence 6799999999999995 5699999999876432 233456667775 556689999999999987 678999999997 5
Q ss_pred ChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccc
Q 005749 460 TLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTG-HEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADE 538 (679)
Q Consensus 460 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~-~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 538 (679)
+|.+++.........+++..++.++.|++.||+|||++ + ++||||||+||+++.++.+||+|||+++...... .
T Consensus 85 ~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--~ 159 (283)
T cd06617 85 SLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV--A 159 (283)
T ss_pred cHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccccc--c
Confidence 89888875433345689999999999999999999986 6 9999999999999999999999999998653221 1
Q ss_pred hhcccccccccccccccc----cCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhh
Q 005749 539 MVALAKADGYKAPELQRM----KKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEI 614 (679)
Q Consensus 539 ~~~~~gt~~y~aPE~~~~----~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i 614 (679)
.....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...... ...+...
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~------------------ 220 (283)
T cd06617 160 KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP-FQQLKQV------------------ 220 (283)
T ss_pred cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC-HHHHHHH------------------
Confidence 122457888999998764 45688999999999999999999998432211 0000000
Q ss_pred hhcCCC--ChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 615 MKGIRS--PMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 615 ~~~~~~--~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
..+... +......++.+++.+||..+|++||+++++++.
T Consensus 221 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 221 VEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred HhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 011001 111223567789999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=306.38 Aligned_cols=239 Identities=22% Similarity=0.278 Sum_probs=192.7
Q ss_pred CccccCCceEEEEEEe-CCCCEEEEEEcccCc---ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCC
Q 005749 383 QVIEKTTYGTAYKAKL-ADGATIALRLLREGS---CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPS 458 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~ 458 (679)
+.||+|+||.||+++. .+++.||+|.+.... ....+.+.+|++++++++||||+++++++.+ .+..++||||+++
T Consensus 7 ~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e~~~~ 85 (290)
T cd05580 7 KTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQD-DSNLYLVMEYVPG 85 (290)
T ss_pred EEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEc-CCeEEEEEecCCC
Confidence 6899999999999994 468999999986532 2234568899999999999999999999987 6789999999999
Q ss_pred CChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccc
Q 005749 459 RTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADE 538 (679)
Q Consensus 459 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 538 (679)
++|.+++... ..+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.+||+|||+++.....
T Consensus 86 ~~L~~~~~~~----~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~---- 154 (290)
T cd05580 86 GELFSHLRKS----GRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR---- 154 (290)
T ss_pred CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC----
Confidence 9999999763 45899999999999999999999988 999999999999999999999999999876433
Q ss_pred hhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcC
Q 005749 539 MVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGI 618 (679)
Q Consensus 539 ~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~ 618 (679)
.....+++.|+|||.+.+...+.++||||||+++|||++|+.||...... . .... +..+.
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~---~~~~--------------~~~~~ 214 (290)
T cd05580 155 TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI---Q---IYEK--------------ILEGK 214 (290)
T ss_pred CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH---H---HHHH--------------HhcCC
Confidence 23446888999999998888899999999999999999999998543210 0 0000 01111
Q ss_pred CCChHHHHHHHHHHHHhccCcCCCCCC-----CHHHHHHH
Q 005749 619 RSPMEEGLVQALKLAMGCCAPVASVRP-----TMDEVVKQ 653 (679)
Q Consensus 619 ~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~evl~~ 653 (679)
..........+.+++.+||..||.+|| +++|+++.
T Consensus 215 ~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 215 VRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred ccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 011111235667899999999999999 66777643
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=305.49 Aligned_cols=261 Identities=23% Similarity=0.320 Sum_probs=192.9
Q ss_pred cCccccCCceEEEEEEe-CCCCEEEEEEcccCccc-----CcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEe
Q 005749 382 GQVIEKTTYGTAYKAKL-ADGATIALRLLREGSCK-----DRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDY 455 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~-----~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey 455 (679)
.+.||+|+||.||+|.. .+++.||+|.++..... ....+..|++++++++|+||+++++++.+ .+..++||||
T Consensus 5 ~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~lv~e~ 83 (298)
T cd07841 5 GKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH-KSNINLVFEF 83 (298)
T ss_pred eeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeec-CCEEEEEEcc
Confidence 36799999999999995 46899999999765322 23356789999999999999999999988 6789999999
Q ss_pred cCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCccc
Q 005749 456 FPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAV 535 (679)
Q Consensus 456 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 535 (679)
+ +|+|.+++.... ..+++..++.++.||++||+|||+++ |+|+||||+||+++.++.+||+|||+++......
T Consensus 84 ~-~~~L~~~i~~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 156 (298)
T cd07841 84 M-ETDLEKVIKDKS---IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN 156 (298)
T ss_pred c-CCCHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccCCC
Confidence 9 889999997632 35899999999999999999999988 9999999999999999999999999998764321
Q ss_pred ccchhcccccccccccccccc-cCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhh--cccc---ccc
Q 005749 536 ADEMVALAKADGYKAPELQRM-KKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVL--EETT---MEV 609 (679)
Q Consensus 536 ~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~--~~~~---~~~ 609 (679)
.......++..|+|||.+.+ ..++.++|||||||++|||++|..||......+ .+......... .... ...
T Consensus 157 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 233 (298)
T cd07841 157 -RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID--QLGKIFEALGTPTEENWPGVTSL 233 (298)
T ss_pred -ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHH--HHHHHHHHcCCCchhhhhhcccc
Confidence 12223346778999998754 467899999999999999999977775432211 11111110000 0000 000
Q ss_pred chHhhhhcCCC-----ChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 610 FDMEIMKGIRS-----PMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 610 ~~~~i~~~~~~-----~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
.+......... .......++.+++.+||+.||++|||+.|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 234 PDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 00000000000 011223567789999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=297.26 Aligned_cols=246 Identities=22% Similarity=0.246 Sum_probs=199.6
Q ss_pred CccccCCceEEEEEEeCC-CCEEEEEEcccCcc---cCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCC
Q 005749 383 QVIEKTTYGTAYKAKLAD-GATIALRLLREGSC---KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPS 458 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~~~-~~~vAvK~~~~~~~---~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~ 458 (679)
+.||.|..|+||++++.+ +..+|+|++.+... +.......|-+||+.++||.+..+|+.+.. +...|++||||+|
T Consensus 83 k~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet-~~~~cl~meyCpG 161 (459)
T KOG0610|consen 83 KRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFET-DKYSCLVMEYCPG 161 (459)
T ss_pred HHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeec-cceeEEEEecCCC
Confidence 679999999999999654 68999999987543 334567789999999999999999999998 6889999999999
Q ss_pred CChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCc-----
Q 005749 459 RTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVP----- 533 (679)
Q Consensus 459 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~----- 533 (679)
|+|+.+.+... ...+++..++.++.+|.-||+|||-.| ||.|||||+||||.++|++.|+||.++.....
T Consensus 162 GdL~~LrqkQp--~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~ 236 (459)
T KOG0610|consen 162 GDLHSLRQKQP--GKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLV 236 (459)
T ss_pred ccHHHHHhhCC--CCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCCCeee
Confidence 99999887643 466999999999999999999999888 99999999999999999999999998643210
Q ss_pred ----------------------------c-c---------------------ccchhcccccccccccccccccCCCCcc
Q 005749 534 ----------------------------A-V---------------------ADEMVALAKADGYKAPELQRMKKCSSRT 563 (679)
Q Consensus 534 ----------------------------~-~---------------------~~~~~~~~gt~~y~aPE~~~~~~~~~k~ 563 (679)
. . ......++||-.|.|||++.+...+.+.
T Consensus 237 ~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAV 316 (459)
T KOG0610|consen 237 KSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAV 316 (459)
T ss_pred ccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCchh
Confidence 0 0 0112345788899999999999999999
Q ss_pred hhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcCC-CChHHHHHHHHHHHHhccCcCCC
Q 005749 564 DVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIR-SPMEEGLVQALKLAMGCCAPVAS 642 (679)
Q Consensus 564 DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~l~~~cl~~dP~ 642 (679)
|-|+|||++|||+.|+.||.+....+... . .+.+... +..+.......+||.+.|.+||+
T Consensus 317 DWWtfGIflYEmLyG~TPFKG~~~~~Tl~---------------N----Iv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~ 377 (459)
T KOG0610|consen 317 DWWTFGIFLYEMLYGTTPFKGSNNKETLR---------------N----IVGQPLKFPEEPEVSSAAKDLIRKLLVKDPS 377 (459)
T ss_pred hHHHHHHHHHHHHhCCCCcCCCCchhhHH---------------H----HhcCCCcCCCCCcchhHHHHHHHHHhccChh
Confidence 99999999999999999998776543211 1 1111111 12224456778999999999999
Q ss_pred CCCC----HHHHHHH
Q 005749 643 VRPT----MDEVVKQ 653 (679)
Q Consensus 643 ~RPs----~~evl~~ 653 (679)
+|.- +.||.++
T Consensus 378 kRlg~~rGA~eIK~H 392 (459)
T KOG0610|consen 378 KRLGSKRGAAEIKRH 392 (459)
T ss_pred hhhccccchHHhhcC
Confidence 9998 7777654
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=299.93 Aligned_cols=253 Identities=18% Similarity=0.271 Sum_probs=197.1
Q ss_pred cCccccCCceEEEEEE-eCCCCEEEEEEcccCc-ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCC
Q 005749 382 GQVIEKTTYGTAYKAK-LADGATIALRLLREGS-CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSR 459 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~g 459 (679)
.+.||.|+||+||+|. ..++..+|+|++.... ....+.+.+|+++++.++|+||+++++.+.. .+..++||||++++
T Consensus 6 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~iv~e~~~~~ 84 (267)
T cd06610 6 IEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVV-GDELWLVMPYLSGG 84 (267)
T ss_pred eeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEee-CCEEEEEEeccCCC
Confidence 4789999999999999 4568899999987543 2345678999999999999999999998887 67899999999999
Q ss_pred ChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCccccc--
Q 005749 460 TLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVAD-- 537 (679)
Q Consensus 460 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~-- 537 (679)
+|.+++..... ...+++.....++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++..+......
T Consensus 85 ~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~ 160 (267)
T cd06610 85 SLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTR 160 (267)
T ss_pred cHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccc
Confidence 99999976432 245899999999999999999999988 999999999999999999999999998766443221
Q ss_pred -chhccccccccccccccccc-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhh
Q 005749 538 -EMVALAKADGYKAPELQRMK-KCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIM 615 (679)
Q Consensus 538 -~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~ 615 (679)
......++..|+|||++... .++.++|||||||++|||++|+.||......+ ...... ... .+...
T Consensus 161 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~--~~~~~~----~~~------~~~~~ 228 (267)
T cd06610 161 KVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK--VLMLTL----QND------PPSLE 228 (267)
T ss_pred cccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh--hHHHHh----cCC------CCCcC
Confidence 12334688899999998766 78999999999999999999999995432211 011110 000 00000
Q ss_pred hcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 616 KGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 616 ~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
.. .........+.+++.+||+.||++||++.|+++.
T Consensus 229 ~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 229 TG--ADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred Cc--cccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 00 0011234567789999999999999999999863
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=307.44 Aligned_cols=247 Identities=22% Similarity=0.243 Sum_probs=194.1
Q ss_pred CccccCCceEEEEEEeC-CCCEEEEEEcccCccc---CcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCC
Q 005749 383 QVIEKTTYGTAYKAKLA-DGATIALRLLREGSCK---DRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPS 458 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~---~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~ 458 (679)
+.||+|+||.||+|+.. +++.||+|.+...... ..+.+..|+++++.++|+||+++++++.+ ....++||||+.+
T Consensus 7 ~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~e~~~~ 85 (316)
T cd05574 7 KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQT-ETYLCLVMDYCPG 85 (316)
T ss_pred eeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeec-CCEEEEEEEecCC
Confidence 67999999999999954 5999999999764322 34568899999999999999999999887 6789999999999
Q ss_pred CChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccc--
Q 005749 459 RTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVA-- 536 (679)
Q Consensus 459 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~-- 536 (679)
++|.+++.... ...+++..++.++.|+++||+|||+.+ ++||||||+||+++.++.++|+|||++........
T Consensus 86 ~~L~~~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (316)
T cd05574 86 GELFRLLQRQP--GKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV 160 (316)
T ss_pred CCHHHHHHhCC--CCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence 99999987532 346899999999999999999999988 99999999999999999999999999875432110
Q ss_pred --------------------------cchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcc
Q 005749 537 --------------------------DEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEF 590 (679)
Q Consensus 537 --------------------------~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~ 590 (679)
.......|+..|+|||++.+..++.++||||||+++|||++|+.||.......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~- 239 (316)
T cd05574 161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDE- 239 (316)
T ss_pred ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHH-
Confidence 01113457888999999998889999999999999999999999995433211
Q ss_pred cchhHHHHHHhhcccccccchHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCC----HHHHHHH
Q 005749 591 VDLPSIVKVAVLEETTMEVFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPT----MDEVVKQ 653 (679)
Q Consensus 591 ~~l~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs----~~evl~~ 653 (679)
.+.. ... ... ..+........+.+++.+||+.||++||+ ++|+++.
T Consensus 240 ----~~~~-~~~---------~~~---~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 240 ----TFSN-ILK---------KEV---TFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred ----HHHH-Hhc---------CCc---cCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 0000 000 000 00111113467788999999999999999 6666663
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=301.86 Aligned_cols=241 Identities=19% Similarity=0.287 Sum_probs=193.7
Q ss_pred CccccCCceEEEEEEe-CCCCEEEEEEcccCcc-cCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCC
Q 005749 383 QVIEKTTYGTAYKAKL-ADGATIALRLLREGSC-KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRT 460 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gs 460 (679)
+.||+|+||.||+|.. .++..||+|.+..... ...+.+.+|++++.+++||||+++++++.. ++..++||||+++++
T Consensus 10 ~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~ 88 (277)
T cd06641 10 EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK-DTKLWIIMEYLGGGS 88 (277)
T ss_pred eeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEe-CCeEEEEEEeCCCCc
Confidence 6799999999999984 5688999999865432 234568899999999999999999999987 678999999999999
Q ss_pred hHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccchh
Q 005749 461 LHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMV 540 (679)
Q Consensus 461 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 540 (679)
|.+++.. ..+++..+..++.|++.|+.|||+.+ ++|+||||+||+++.++.++++|||++....... ....
T Consensus 89 l~~~i~~-----~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~-~~~~ 159 (277)
T cd06641 89 ALDLLEP-----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-IKRN 159 (277)
T ss_pred HHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccch-hhhc
Confidence 9999864 34889999999999999999999988 9999999999999999999999999987654321 1122
Q ss_pred cccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcCCC
Q 005749 541 ALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIRS 620 (679)
Q Consensus 541 ~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~~ 620 (679)
...++..|+|||.+.+..++.++|||||||++|||++|..||...... .+.... ..+..+
T Consensus 160 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~------~~~~~~--------------~~~~~~ 219 (277)
T cd06641 160 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM------KVLFLI--------------PKNNPP 219 (277)
T ss_pred cccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH------HHHHHH--------------hcCCCC
Confidence 346788899999998888899999999999999999999998432211 111100 000001
Q ss_pred -ChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 621 -PMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 621 -~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
.......++.+++.+||+.+|++||++.+++++
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 220 TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 111223557789999999999999999999995
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=301.99 Aligned_cols=258 Identities=19% Similarity=0.253 Sum_probs=189.4
Q ss_pred CccccCCceEEEEEE-eCCCCEEEEEEcccCcc-cCcccHHHHHHHHhccC-CCCCccceEEeeCC-CCceEEEEEecCC
Q 005749 383 QVIEKTTYGTAYKAK-LADGATIALRLLREGSC-KDRSSCLPVIRQLGKVR-HENLIPLRAFYQGK-RGEKLLIYDYFPS 458 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~-H~nIv~l~~~~~~~-~~~~~lv~ey~~~ 458 (679)
+.||+|+||.||+|+ ..+++.||+|.++.... .......+|+.++.++. |+||+++++++.+. .+..++||||++
T Consensus 5 ~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~- 83 (282)
T cd07831 5 GKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMD- 83 (282)
T ss_pred eeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecCC-
Confidence 679999999999999 45789999999876422 22334567999999985 99999999998872 278899999997
Q ss_pred CChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccc
Q 005749 459 RTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADE 538 (679)
Q Consensus 459 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 538 (679)
|+|.+.+... ...+++.+++.++.|++.||+|||+.+ ++||||||+||++++ +.+||+|||+++.......
T Consensus 84 ~~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~-- 154 (282)
T cd07831 84 MNLYELIKGR---KRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP-- 154 (282)
T ss_pred ccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCCC--
Confidence 5888888653 245899999999999999999999988 999999999999999 9999999999987643221
Q ss_pred hhccccccccccccccc-ccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcc-----------cc
Q 005749 539 MVALAKADGYKAPELQR-MKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEE-----------TT 606 (679)
Q Consensus 539 ~~~~~gt~~y~aPE~~~-~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~-----------~~ 606 (679)
.....++..|+|||++. +..++.++|||||||++|||++|+.||.+.... +...+........ ..
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
T cd07831 155 YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNEL---DQIAKIHDVLGTPDAEVLKKFRKSRH 231 (282)
T ss_pred cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHH---HHHHHHHHHcCCCCHHHHHhhccccc
Confidence 12345788999999765 455788999999999999999999999554321 1111111110000 00
Q ss_pred cc-cchHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 607 ME-VFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 607 ~~-~~~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
.. .+............+.....+.+++.+||+.+|++||+++++++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 232 MNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred ccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 00 000000000000012234678899999999999999999999864
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=307.06 Aligned_cols=241 Identities=21% Similarity=0.319 Sum_probs=189.7
Q ss_pred CccccCCceEEEEEEe-CCCCEEEEEEcccCcc---cCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCC
Q 005749 383 QVIEKTTYGTAYKAKL-ADGATIALRLLREGSC---KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPS 458 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~---~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~ 458 (679)
+.||+|+||.||+|+. .+++.||+|.+..... ...+.+.+|++++++++||||++++++|.+ .+..++||||++
T Consensus 21 ~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~~- 98 (307)
T cd06607 21 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLR-EHTAWLVMEYCL- 98 (307)
T ss_pred eeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEe-CCeEEEEHHhhC-
Confidence 6899999999999995 4689999999864432 223468899999999999999999999987 678999999997
Q ss_pred CChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccc
Q 005749 459 RTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADE 538 (679)
Q Consensus 459 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 538 (679)
|++.+++... ...+++..+..++.|++.||.|||+.+ |+||||+|+||++++++.+||+|||++......
T Consensus 99 g~l~~~~~~~---~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~---- 168 (307)
T cd06607 99 GSASDILEVH---KKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA---- 168 (307)
T ss_pred CCHHHHHHHc---ccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCCC----
Confidence 5787777543 235899999999999999999999988 999999999999999999999999998765322
Q ss_pred hhccccccccccccccc---ccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhh
Q 005749 539 MVALAKADGYKAPELQR---MKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIM 615 (679)
Q Consensus 539 ~~~~~gt~~y~aPE~~~---~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~ 615 (679)
....++..|+|||++. ...++.++||||||+++|||++|+.||...... ..... ....
T Consensus 169 -~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~------~~~~~-~~~~----------- 229 (307)
T cd06607 169 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYH-IAQN----------- 229 (307)
T ss_pred -CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHH------HHHHH-HhcC-----------
Confidence 2346788899999874 356889999999999999999999998543211 00000 0000
Q ss_pred hcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 005749 616 KGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQL 654 (679)
Q Consensus 616 ~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L 654 (679)
.............+.+++.+||+.+|++||++.+++...
T Consensus 230 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 268 (307)
T cd06607 230 DSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR 268 (307)
T ss_pred CCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 000011122345678899999999999999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=299.76 Aligned_cols=246 Identities=18% Similarity=0.286 Sum_probs=194.7
Q ss_pred cCccccCCceEEEEEEe-CCCCEEEEEEcccCc--ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCC
Q 005749 382 GQVIEKTTYGTAYKAKL-ADGATIALRLLREGS--CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPS 458 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~ 458 (679)
.+.||+|+||.||+|+. .+|..||+|.+.... ....+.+.+|++++++++|+||+++++++.. .+..++|+||+++
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~-~~~~~lv~e~~~~ 83 (257)
T cd08225 5 IKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQE-NGRLFIVMEYCDG 83 (257)
T ss_pred EEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheecc-CCeEEEEEecCCC
Confidence 36799999999999995 468899999986542 2345578899999999999999999999887 6789999999999
Q ss_pred CChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCC-ceEEeecccccccCccccc
Q 005749 459 RTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFF-VSRLTEFGLDQLMVPAVAD 537 (679)
Q Consensus 459 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~-~~kl~DFGla~~~~~~~~~ 537 (679)
++|.+++.... ...+++..++.++.|+++||+|||+.+ ++|+||||+||++++++ .+|++|||.+....... .
T Consensus 84 ~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~-~ 157 (257)
T cd08225 84 GDLMKRINRQR--GVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM-E 157 (257)
T ss_pred CcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc-c
Confidence 99999987532 235799999999999999999999988 99999999999999885 46999999987664321 1
Q ss_pred chhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhc
Q 005749 538 EMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKG 617 (679)
Q Consensus 538 ~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~ 617 (679)
......|++.|+|||+..+..++.++||||||+++|||++|+.||..... .+++...... . +
T Consensus 158 ~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~-~----~------- 219 (257)
T cd08225 158 LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL------HQLVLKICQG-Y----F------- 219 (257)
T ss_pred cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHHHHHHhcc-c----C-------
Confidence 22234588899999999888899999999999999999999999843221 1111111110 0 0
Q ss_pred CCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 618 IRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 618 ~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
....+....++.+++.+||..+|++|||+.|+++.
T Consensus 220 -~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 220 -APISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred -CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 01111223467789999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=302.45 Aligned_cols=261 Identities=18% Similarity=0.238 Sum_probs=191.3
Q ss_pred CccccCCceEEEEEEe-CCCCEEEEEEcccCcc--cCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCC
Q 005749 383 QVIEKTTYGTAYKAKL-ADGATIALRLLREGSC--KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSR 459 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~g 459 (679)
+.||+|+||.||+|+. .+++.||||.++.... ...+.+.+|++++++++||||+++++++.+ .+..++||||+. +
T Consensus 6 ~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e~~~-~ 83 (284)
T cd07860 6 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT-ENKLYLVFEFLH-Q 83 (284)
T ss_pred eeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhccc-CCcEEEEeeccc-c
Confidence 6799999999999995 4689999999875432 233578899999999999999999999887 678999999996 5
Q ss_pred ChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccch
Q 005749 460 TLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEM 539 (679)
Q Consensus 460 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 539 (679)
+|.+++.... ...+++..++.++.|++.||+|||+.+ ++||||+|+||++++++.+||+|||+++...... ...
T Consensus 84 ~l~~~~~~~~--~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~-~~~ 157 (284)
T cd07860 84 DLKKFMDASP--LSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTY 157 (284)
T ss_pred CHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCc-ccc
Confidence 8998886532 345899999999999999999999988 9999999999999999999999999987653321 112
Q ss_pred hcccccccccccccccccC-CCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcc-cccccch------
Q 005749 540 VALAKADGYKAPELQRMKK-CSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEE-TTMEVFD------ 611 (679)
Q Consensus 540 ~~~~gt~~y~aPE~~~~~~-~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~-~~~~~~~------ 611 (679)
....++..|+|||++.+.. ++.++||||||+++|||+||+.||...... ..+.......-... .....+.
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07860 158 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI--DQLFRIFRTLGTPDEVVWPGVTSLPDYK 235 (284)
T ss_pred ccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH--HHHHHHHHHhCCCChhhhhhhhHHHHHH
Confidence 2335678899999876544 688999999999999999999998543221 11111111100000 0000000
Q ss_pred HhhhhcCCCC----hHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 612 MEIMKGIRSP----MEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 612 ~~i~~~~~~~----~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
.......... .+....++.+++.+||+.||++||+++|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 236 PSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred hhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 0000000000 01112456789999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=306.62 Aligned_cols=246 Identities=22% Similarity=0.321 Sum_probs=193.2
Q ss_pred CccccCCceEEEEEE-eCCCCEEEEEEcccCcc---cCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCC
Q 005749 383 QVIEKTTYGTAYKAK-LADGATIALRLLREGSC---KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPS 458 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~---~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~ 458 (679)
+.||+|+||.||+|+ ..++..||+|.+..... +....+.+|++++++++|||++++++++.+ ....++||||+++
T Consensus 31 ~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~g 109 (317)
T cd06635 31 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLR-EHTAWLVMEYCLG 109 (317)
T ss_pred heeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-CCeEEEEEeCCCC
Confidence 679999999999999 45689999999865322 223468899999999999999999999987 6788999999975
Q ss_pred CChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccc
Q 005749 459 RTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADE 538 (679)
Q Consensus 459 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 538 (679)
+|.+.+... ...+++.++..++.|++.||.|||+.+ |+||||+|+||+++.++.+||+|||++......
T Consensus 110 -~l~~~~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~---- 178 (317)
T cd06635 110 -SASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPA---- 178 (317)
T ss_pred -CHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCCc----
Confidence 888877543 345899999999999999999999988 999999999999999999999999998754322
Q ss_pred hhccccccccccccccc---ccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhh
Q 005749 539 MVALAKADGYKAPELQR---MKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIM 615 (679)
Q Consensus 539 ~~~~~gt~~y~aPE~~~---~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~ 615 (679)
....++..|+|||++. .+.++.++|||||||++|||++|+.||...... ...... ..
T Consensus 179 -~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~------~~~~~~-------------~~ 238 (317)
T cd06635 179 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHI-------------AQ 238 (317)
T ss_pred -ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH------HHHHHH-------------Hh
Confidence 2346788899999874 456899999999999999999999998543211 000000 00
Q ss_pred hcC-CCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCCC
Q 005749 616 KGI-RSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRPR 660 (679)
Q Consensus 616 ~~~-~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 660 (679)
... ..........+.+++.+||+.+|++||++.++++.+......
T Consensus 239 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 284 (317)
T cd06635 239 NESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRER 284 (317)
T ss_pred ccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccC
Confidence 000 011122335677899999999999999999999877655433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=307.39 Aligned_cols=249 Identities=16% Similarity=0.204 Sum_probs=193.3
Q ss_pred CccccCCceEEEEEEe-CCCCEEEEEEcccCcc---cCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCC
Q 005749 383 QVIEKTTYGTAYKAKL-ADGATIALRLLREGSC---KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPS 458 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~---~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~ 458 (679)
+.||+|+||.||+++. .+++.||+|.+..... ...+.+.+|+++++.++||||+++++.+.. ++..++||||+++
T Consensus 7 ~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~g 85 (305)
T cd05609 7 KLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFET-KRHLCMVMEYVEG 85 (305)
T ss_pred eEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEec-CCEEEEEEecCCC
Confidence 6799999999999994 4688999999876432 234567899999999999999999999887 6789999999999
Q ss_pred CChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccc--
Q 005749 459 RTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVA-- 536 (679)
Q Consensus 459 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~-- 536 (679)
++|.+++... ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+|++|||+++.......
T Consensus 86 ~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~ 158 (305)
T cd05609 86 GDCATLLKNI----GALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTN 158 (305)
T ss_pred CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcCcccc
Confidence 9999999763 45899999999999999999999987 99999999999999999999999999874211100
Q ss_pred ------------cchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcc
Q 005749 537 ------------DEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEE 604 (679)
Q Consensus 537 ------------~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~ 604 (679)
.......++..|+|||.+....++.++||||||+++||+++|+.||.+.... ++........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~------~~~~~~~~~~ 232 (305)
T cd05609 159 LYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE------ELFGQVISDD 232 (305)
T ss_pred ccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhcc
Confidence 0011235678899999998888999999999999999999999999543221 1111100000
Q ss_pred cccccchHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHh
Q 005749 605 TTMEVFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEE 656 (679)
Q Consensus 605 ~~~~~~~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 656 (679)
.. ...........+.+++.+||+.||++||++.++.+.|+.
T Consensus 233 ----~~-------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 233 ----IE-------WPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred ----cC-------CCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 00 000001223557789999999999999997777776665
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=303.76 Aligned_cols=259 Identities=19% Similarity=0.283 Sum_probs=189.3
Q ss_pred CccccCCceEEEEEEeC-CCCEEEEEEcccCcc-cCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCC
Q 005749 383 QVIEKTTYGTAYKAKLA-DGATIALRLLREGSC-KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRT 460 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gs 460 (679)
+.||+|+||.||+|+.. +++.||+|.+..... .....+.+|++++++++|+||+++++++.+ .+..++||||+++ +
T Consensus 11 ~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~-~ 88 (291)
T cd07844 11 DKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHT-KKTLTLVFEYLDT-D 88 (291)
T ss_pred EEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEec-CCeEEEEEecCCC-C
Confidence 68999999999999954 689999999875432 223467889999999999999999999987 6789999999985 9
Q ss_pred hHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccchh
Q 005749 461 LHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMV 540 (679)
Q Consensus 461 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 540 (679)
|.+++... ...+++...+.++.|+++||+|||+.+ |+||||||+||++++++.+||+|||+++...... ....
T Consensus 89 L~~~~~~~---~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~-~~~~ 161 (291)
T cd07844 89 LKQYMDDC---GGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPS-KTYS 161 (291)
T ss_pred HHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCC-cccc
Confidence 99988754 235889999999999999999999988 9999999999999999999999999987542211 1112
Q ss_pred cccccccccccccccc-cCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHh--hcccccc---------
Q 005749 541 ALAKADGYKAPELQRM-KKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAV--LEETTME--------- 608 (679)
Q Consensus 541 ~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~--~~~~~~~--------- 608 (679)
...++..|+|||++.+ ..++.++||||+|+++|||++|+.||....... ..+....+... .......
T Consensus 162 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (291)
T cd07844 162 NEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVE-DQLHKIFRVLGTPTEETWPGVSSNPEFKP 240 (291)
T ss_pred ccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHH-HHHHHHHHhcCCCChhhhhhhhhcccccc
Confidence 2346788999998865 458899999999999999999999995433110 00000000000 0000000
Q ss_pred ----cchHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHH
Q 005749 609 ----VFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVK 652 (679)
Q Consensus 609 ----~~~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 652 (679)
............. .....+..+++.+|++.+|++|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 241 YSFPFYPPRPLINHAPR-LDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred ccccccCChhHHHhCcC-CCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0000000000000 011256678999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=302.45 Aligned_cols=244 Identities=21% Similarity=0.250 Sum_probs=190.0
Q ss_pred cccCCceEEEEEE-eCCCCEEEEEEcccCc---ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCC
Q 005749 385 IEKTTYGTAYKAK-LADGATIALRLLREGS---CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRT 460 (679)
Q Consensus 385 ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gs 460 (679)
||+|+||+||+|. ..+|+.||+|.+.... ....+.+.+|++++++++||||+++++++.. .+..++||||+++++
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~e~~~~~~ 79 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFET-KDDLCLVMTLMNGGD 79 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEec-CCeEEEEEecCCCCc
Confidence 6899999999998 4568999999986532 2234467889999999999999999999887 678999999999999
Q ss_pred hHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccchh
Q 005749 461 LHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMV 540 (679)
Q Consensus 461 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 540 (679)
|.+++.... ...+++..++.++.|++.||.|||+.+ ++||||+|+||++++++.+||+|||.+...... ....
T Consensus 80 L~~~l~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~--~~~~ 152 (277)
T cd05577 80 LKYHIYNVG--EPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGG--KKIK 152 (277)
T ss_pred HHHHHHHcC--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccC--Cccc
Confidence 999987643 245899999999999999999999988 999999999999999999999999998765331 1222
Q ss_pred cccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcCCC
Q 005749 541 ALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIRS 620 (679)
Q Consensus 541 ~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~~ 620 (679)
...++..|+|||.+.+..++.++||||||+++|||++|+.||....... ........ +......
T Consensus 153 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~--------------~~~~~~~ 216 (277)
T cd05577 153 GRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKV--EKEELKRR--------------TLEMAVE 216 (277)
T ss_pred cccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccc--cHHHHHhc--------------ccccccc
Confidence 3457788999999988889999999999999999999999995433210 00000000 0000001
Q ss_pred ChHHHHHHHHHHHHhccCcCCCCCC-----CHHHHHH
Q 005749 621 PMEEGLVQALKLAMGCCAPVASVRP-----TMDEVVK 652 (679)
Q Consensus 621 ~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~evl~ 652 (679)
......+.+.+++.+||+.||++|| ++.++++
T Consensus 217 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 217 YPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred CCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 1112245677899999999999999 5555554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=300.94 Aligned_cols=248 Identities=21% Similarity=0.288 Sum_probs=192.2
Q ss_pred CccccCCceEEEEEEe-CCCCEEEEEEcccCcccCcccHHHHHHHHhcc-CCCCCccceEEeeCC-----CCceEEEEEe
Q 005749 383 QVIEKTTYGTAYKAKL-ADGATIALRLLREGSCKDRSSCLPVIRQLGKV-RHENLIPLRAFYQGK-----RGEKLLIYDY 455 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~-----~~~~~lv~ey 455 (679)
+.||+|+||.||+|+. .+++.+|+|.+..... ..+.+.+|+++++++ +|+||+++++++... ....++||||
T Consensus 12 ~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~ 90 (275)
T cd06608 12 EVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMEL 90 (275)
T ss_pred eeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEEEEc
Confidence 7899999999999995 4688999999876432 346789999999999 799999999998752 2347999999
Q ss_pred cCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCccc
Q 005749 456 FPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAV 535 (679)
Q Consensus 456 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 535 (679)
+++++|.+++.........+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++......
T Consensus 91 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~- 166 (275)
T cd06608 91 CGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGVSAQLDST- 166 (275)
T ss_pred CCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCccceecccc-
Confidence 9999999998764322356899999999999999999999988 999999999999999999999999998765332
Q ss_pred ccchhcccccccccccccccc-----cCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccc
Q 005749 536 ADEMVALAKADGYKAPELQRM-----KKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVF 610 (679)
Q Consensus 536 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 610 (679)
........++..|+|||++.. ..++.++|||||||++|||++|+.||...... ..+ .. . ....
T Consensus 167 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~---~~-~-~~~~----- 234 (275)
T cd06608 167 LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM--RAL---FK-I-PRNP----- 234 (275)
T ss_pred hhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH--HHH---HH-h-hccC-----
Confidence 222334568889999998753 34678999999999999999999999532211 000 00 0 0000
Q ss_pred hHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHH
Q 005749 611 DMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVK 652 (679)
Q Consensus 611 ~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 652 (679)
.+. ..........+.+++.+||..||++|||+.|+++
T Consensus 235 ~~~-----~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 235 PPT-----LKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred CCC-----CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 000 0111123456778999999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=341.54 Aligned_cols=245 Identities=21% Similarity=0.318 Sum_probs=197.4
Q ss_pred cCccccCCceEEEEEE-eCCCCEEEEEEcccCc--ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCC
Q 005749 382 GQVIEKTTYGTAYKAK-LADGATIALRLLREGS--CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPS 458 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~ 458 (679)
+.+||.|.||.||.|. ..+|...|+|-++-.. .+......+|+.++..++|||+|+++|+=.+ ++..+|.||||++
T Consensus 1240 g~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvH-Rekv~IFMEyC~~ 1318 (1509)
T KOG4645|consen 1240 GNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVH-REKVYIFMEYCEG 1318 (1509)
T ss_pred ccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeec-HHHHHHHHHHhcc
Confidence 5799999999999999 7889999999986543 3345678899999999999999999998776 7889999999999
Q ss_pred CChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCccc---
Q 005749 459 RTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAV--- 535 (679)
Q Consensus 459 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~--- 535 (679)
|+|.+++... ...++.....+..|++.|++|||+++ ||||||||.||+++.+|.+|.+|||.|..+....
T Consensus 1319 GsLa~ll~~g----ri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~ 1391 (1509)
T KOG4645|consen 1319 GSLASLLEHG----RIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTM 1391 (1509)
T ss_pred CcHHHHHHhc----chhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecCchhcC
Confidence 9999999863 34677777889999999999999999 9999999999999999999999999998875442
Q ss_pred ccchhcccccccccccccccccC---CCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchH
Q 005749 536 ADEMVALAKADGYKAPELQRMKK---CSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDM 612 (679)
Q Consensus 536 ~~~~~~~~gt~~y~aPE~~~~~~---~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 612 (679)
........||+.|||||++.+.. ..-++||||+|||+.||+||+.||...++. |.-+.
T Consensus 1392 ~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne-------~aIMy------------ 1452 (1509)
T KOG4645|consen 1392 PGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE-------WAIMY------------ 1452 (1509)
T ss_pred CHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch-------hHHHh------------
Confidence 22345678999999999998543 466899999999999999999999433221 11110
Q ss_pred hhhhcCCCChHHH-HHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 613 EIMKGIRSPMEEG-LVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 613 ~i~~~~~~~~~~~-~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
.+.-|..++.|+. ..+-.+++.+|++.||++|-++.|+++.
T Consensus 1453 ~V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1453 HVAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred HHhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 1122223444433 4556689999999999999887766554
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=300.88 Aligned_cols=243 Identities=23% Similarity=0.333 Sum_probs=193.1
Q ss_pred cccCCceEEEEEEeC-CCCEEEEEEcccCcc---cCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCC
Q 005749 385 IEKTTYGTAYKAKLA-DGATIALRLLREGSC---KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRT 460 (679)
Q Consensus 385 ig~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~---~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gs 460 (679)
||+|+||.||+++.. +|+.+|+|.+..... ...+.+.+|++++.+++||||+++++.+.. ....++||||+++++
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~ 79 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQG-KKNLYLVMEYLPGGD 79 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheec-CcEEEEEEecCCCCc
Confidence 689999999999965 499999999875432 345578899999999999999999998887 678999999999999
Q ss_pred hHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccc----
Q 005749 461 LHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVA---- 536 (679)
Q Consensus 461 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~---- 536 (679)
|.+++... ..+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.+||+|||++........
T Consensus 80 L~~~l~~~----~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 152 (265)
T cd05579 80 LASLLENV----GSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLN 152 (265)
T ss_pred HHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccc
Confidence 99999763 35899999999999999999999988 99999999999999999999999999876432211
Q ss_pred ---cchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHh
Q 005749 537 ---DEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDME 613 (679)
Q Consensus 537 ---~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 613 (679)
.......++..|+|||......++.++||||||+++||+++|+.||...... .....
T Consensus 153 ~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~------~~~~~-------------- 212 (265)
T cd05579 153 DDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE------EIFQN-------------- 212 (265)
T ss_pred cccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH------HHHHH--------------
Confidence 1223345778899999998888999999999999999999999998543211 11111
Q ss_pred hhhcCCCChHH--HHHHHHHHHHhccCcCCCCCCCHHHHHHHHH
Q 005749 614 IMKGIRSPMEE--GLVQALKLAMGCCAPVASVRPTMDEVVKQLE 655 (679)
Q Consensus 614 i~~~~~~~~~~--~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~ 655 (679)
+..+....... ....+.+++.+||+.+|++|||+.++.+.|+
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 213 ILNGKIEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred HhcCCcCCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 01111111111 1466778999999999999999966665554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=297.31 Aligned_cols=245 Identities=22% Similarity=0.348 Sum_probs=199.1
Q ss_pred CccccCCceEEEEEEeC-CCCEEEEEEcccCcc-cCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCC
Q 005749 383 QVIEKTTYGTAYKAKLA-DGATIALRLLREGSC-KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRT 460 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gs 460 (679)
+.||+|++|.||+|+.. +++.||+|++..... ...+.+.+|++.+.+++|+||+++++++.. .+..++||||+++++
T Consensus 7 ~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~e~~~~~~ 85 (264)
T cd06623 7 KVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYK-EGEISIVLEYMDGGS 85 (264)
T ss_pred eeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcc-CCeEEEEEEecCCCc
Confidence 78999999999999955 599999999876543 345679999999999999999999999987 688999999999999
Q ss_pred hHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccch
Q 005749 461 LHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHT-GHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEM 539 (679)
Q Consensus 461 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~-~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 539 (679)
|.+++... ..+++..++.++.|+++||+|||+ .+ ++||||+|+||+++.++.++|+|||.+......... .
T Consensus 86 L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~-~ 157 (264)
T cd06623 86 LADLLKKV----GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ-C 157 (264)
T ss_pred HHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCCCc-c
Confidence 99999763 458999999999999999999999 88 999999999999999999999999998876433221 1
Q ss_pred hcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcCC
Q 005749 540 VALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIR 619 (679)
Q Consensus 540 ~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~ 619 (679)
....++..|+|||.+....++.++||||||+++|||++|+.||..........+.... .....
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~-----------------~~~~~ 220 (264)
T cd06623 158 NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAI-----------------CDGPP 220 (264)
T ss_pred cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHH-----------------hcCCC
Confidence 2345788899999999888999999999999999999999998554321111111111 11111
Q ss_pred CC-hHH-HHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 620 SP-MEE-GLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 620 ~~-~~~-~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
.. ... ....+.+++.+||..+|++||++.|+++.
T Consensus 221 ~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 221 PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 11 111 34567789999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=298.03 Aligned_cols=242 Identities=17% Similarity=0.226 Sum_probs=192.3
Q ss_pred cccCCceEEEEEEe-CCCCEEEEEEcccCcc---cCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCC
Q 005749 385 IEKTTYGTAYKAKL-ADGATIALRLLREGSC---KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRT 460 (679)
Q Consensus 385 ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~---~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gs 460 (679)
||+|+||.||+|+. .+++.||+|.+..... ...+.+.+|++++++++||||+++++++.+ ....++||||+++++
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~ 79 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKD-KKYIYMLMEYCLGGE 79 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEc-CCccEEEEecCCCCc
Confidence 68999999999995 4589999999875432 234578999999999999999999999887 678999999999999
Q ss_pred hHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccchh
Q 005749 461 LHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMV 540 (679)
Q Consensus 461 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 540 (679)
|.+++... ..+++..+..++.|++.||+|||+++ ++|+||||+||+++.++.+||+|||+++...... ...
T Consensus 80 L~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~ 150 (262)
T cd05572 80 LWTILRDR----GLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTW 150 (262)
T ss_pred HHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccc
Confidence 99999763 34889999999999999999999988 9999999999999999999999999998764332 223
Q ss_pred cccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcCCC
Q 005749 541 ALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIRS 620 (679)
Q Consensus 541 ~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~~ 620 (679)
...++..|+|||.+....++.++|+||||+++|||++|+.||...... ........... .....
T Consensus 151 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~~------------~~~~~ 214 (262)
T cd05572 151 TFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED----PMEIYNDILKG------------NGKLE 214 (262)
T ss_pred cccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC----HHHHHHHHhcc------------CCCCC
Confidence 346788999999998888999999999999999999999999544321 11111110000 00001
Q ss_pred ChHHHHHHHHHHHHhccCcCCCCCCC-----HHHHHH
Q 005749 621 PMEEGLVQALKLAMGCCAPVASVRPT-----MDEVVK 652 (679)
Q Consensus 621 ~~~~~~~~~~~l~~~cl~~dP~~RPs-----~~evl~ 652 (679)
.......++.+++.+||+.+|++||+ ++|+++
T Consensus 215 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 215 FPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred CCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 11112467789999999999999999 666655
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=300.35 Aligned_cols=243 Identities=18% Similarity=0.289 Sum_probs=193.1
Q ss_pred CccccCCceEEEEEE-eCCCCEEEEEEcccCc-ccCcccHHHHHHHHhccC---CCCCccceEEeeCCCCceEEEEEecC
Q 005749 383 QVIEKTTYGTAYKAK-LADGATIALRLLREGS-CKDRSSCLPVIRQLGKVR---HENLIPLRAFYQGKRGEKLLIYDYFP 457 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~---H~nIv~l~~~~~~~~~~~~lv~ey~~ 457 (679)
+.||+|+||.||+|+ ..+++.||+|.++... ....+++.+|++++++++ |||++++++++.. ....++||||++
T Consensus 7 ~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~-~~~~~lv~e~~~ 85 (277)
T cd06917 7 ELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLK-GPRLWIIMEYAE 85 (277)
T ss_pred hheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeee-CCEEEEEEecCC
Confidence 679999999999999 4678999999987542 234457889999999997 9999999999887 678999999999
Q ss_pred CCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCccccc
Q 005749 458 SRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVAD 537 (679)
Q Consensus 458 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 537 (679)
+++|.+++.. ..+++...+.++.|++.||.|||+.+ |+|+||+|+||++++++.++++|||++....... .
T Consensus 86 ~~~L~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-~ 156 (277)
T cd06917 86 GGSVRTLMKA-----GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS-S 156 (277)
T ss_pred CCcHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCCc-c
Confidence 9999999864 25899999999999999999999988 9999999999999999999999999998764432 2
Q ss_pred chhcccccccccccccccc-cCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhh
Q 005749 538 EMVALAKADGYKAPELQRM-KKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMK 616 (679)
Q Consensus 538 ~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~ 616 (679)
......|+..|+|||.+.+ ..++.++|||||||++|||++|+.||....... .... .... ..+.+.
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~------~~~~-~~~~-----~~~~~~- 223 (277)
T cd06917 157 KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR------AMML-IPKS-----KPPRLE- 223 (277)
T ss_pred ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh------hhhc-cccC-----CCCCCC-
Confidence 2234468889999998765 446899999999999999999999995432211 0000 0000 000000
Q ss_pred cCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 617 GIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 617 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
......++.+++.+||+.||++||++.|+++.
T Consensus 224 -----~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 224 -----DNGYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred -----cccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 01134567789999999999999999999874
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=305.76 Aligned_cols=201 Identities=23% Similarity=0.364 Sum_probs=165.4
Q ss_pred CccccCCceEEEEEEeC---CCCEEEEEEcccCc---ccCcccHHHHHHHHhccCCCCCccceEEeeCC-CCceEEEEEe
Q 005749 383 QVIEKTTYGTAYKAKLA---DGATIALRLLREGS---CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGK-RGEKLLIYDY 455 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~~---~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~-~~~~~lv~ey 455 (679)
+.||+|+||.||+|+.. +++.||+|.+.... ....+.+.+|++++.+++||||+++++++.+. ....++||||
T Consensus 6 ~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~ 85 (316)
T cd07842 6 GCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLFDY 85 (316)
T ss_pred EEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEEEeC
Confidence 67999999999999954 58999999998743 33345678999999999999999999999873 2678999999
Q ss_pred cCCCChHHHhhcccCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecC----CCceEEeecccccc
Q 005749 456 FPSRTLHDLLHDTIAG-KPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDD----FFVSRLTEFGLDQL 530 (679)
Q Consensus 456 ~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~----~~~~kl~DFGla~~ 530 (679)
+++ ++.+++...... ...+++..++.++.|++.||+|||+.+ |+||||||+||+++. ++.+||+|||+++.
T Consensus 86 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~ 161 (316)
T cd07842 86 AEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARL 161 (316)
T ss_pred CCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCCccccc
Confidence 975 777777543322 236889999999999999999999988 999999999999999 99999999999987
Q ss_pred cCcccc--cchhcccccccccccccccc-cCCCCcchhHHHHHHHHHHHhCCCCCCCCCC
Q 005749 531 MVPAVA--DEMVALAKADGYKAPELQRM-KKCSSRTDVYAFGILLLEILIGKKPGKSGRN 587 (679)
Q Consensus 531 ~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~ 587 (679)
...... .......++..|+|||.+.+ ..++.++|||||||+++||++|+.||.+...
T Consensus 162 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~ 221 (316)
T cd07842 162 FNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREA 221 (316)
T ss_pred cCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcc
Confidence 543221 11223467888999998765 4578999999999999999999999965443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=301.98 Aligned_cols=258 Identities=22% Similarity=0.340 Sum_probs=193.1
Q ss_pred CccccCCceEEEEEEeC-CCCEEEEEEcccCc--ccCcccHHHHHHHHhccCCCCCccceEEeeCC-CCceEEEEEecCC
Q 005749 383 QVIEKTTYGTAYKAKLA-DGATIALRLLREGS--CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGK-RGEKLLIYDYFPS 458 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~-~~~~~lv~ey~~~ 458 (679)
+.||+|+||.||+|+.. +++.+|+|.+.... ....+.+.+|++++++++|+|++++++++... .+..++||||+++
T Consensus 5 ~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~ 84 (287)
T cd07840 5 AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDH 84 (287)
T ss_pred EEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEeccccc
Confidence 57999999999999954 58999999998753 23345688999999999999999999999873 2789999999975
Q ss_pred CChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccc
Q 005749 459 RTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADE 538 (679)
Q Consensus 459 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 538 (679)
+|.+++... ...+++..++.++.|+++||+|||+.+ ++|+||||+||++++++.+||+|||++..........
T Consensus 85 -~l~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~ 157 (287)
T cd07840 85 -DLTGLLDSP---EVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSAD 157 (287)
T ss_pred -cHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCCccc
Confidence 898888653 246899999999999999999999988 9999999999999999999999999998764432212
Q ss_pred hhcccccccccccccccc-cCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHh--hccccc---c----
Q 005749 539 MVALAKADGYKAPELQRM-KKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAV--LEETTM---E---- 608 (679)
Q Consensus 539 ~~~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~--~~~~~~---~---- 608 (679)
.....++..|+|||.+.+ ..++.++||||||+++|||++|+.||....... .+........ ...... +
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07840 158 YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELE--QLEKIFELCGSPTDENWPGVSKLPWF 235 (287)
T ss_pred ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhCCCchhhccccccchhh
Confidence 233456778999997764 457899999999999999999999985433211 1111110000 000000 0
Q ss_pred -------cchHhhhhcCCCChHH-HHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 609 -------VFDMEIMKGIRSPMEE-GLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 609 -------~~~~~i~~~~~~~~~~-~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
.....+.. .... ....+.+++.+||..+|++||+++++++.
T Consensus 236 ~~~~~~~~~~~~~~~----~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 236 ENLKPKKPYKRRLRE----FFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred hhccccccchhHHHH----HhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 00000000 0001 14567899999999999999999999763
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=304.03 Aligned_cols=244 Identities=16% Similarity=0.253 Sum_probs=194.6
Q ss_pred CccccCCceEEEEEEe-CCCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCCh
Q 005749 383 QVIEKTTYGTAYKAKL-ADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRTL 461 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gsL 461 (679)
..||+|+||.||+|.. .+++.||+|++........+.+.+|+.++++++|+||+++++++.. .+..++||||+++++|
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~L 104 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV-GDELWVVMEFLEGGAL 104 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEe-CCEEEEEEecCCCCcH
Confidence 5799999999999985 5789999999865544455678999999999999999999999987 6789999999999999
Q ss_pred HHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccchhc
Q 005749 462 HDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVA 541 (679)
Q Consensus 462 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 541 (679)
.+++.. ..+++.....++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++....... .....
T Consensus 105 ~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~-~~~~~ 175 (292)
T cd06657 105 TDIVTH-----TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKS 175 (292)
T ss_pred HHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccccc-ccccc
Confidence 998754 34789999999999999999999988 9999999999999999999999999987653321 12233
Q ss_pred ccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcCCCC
Q 005749 542 LAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIRSP 621 (679)
Q Consensus 542 ~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~~~ 621 (679)
..++..|+|||.+.+..++.++||||||+++|||++|+.||.+.... ........... ..+ ..
T Consensus 176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~---~~~~~~~~~~~---------~~~-----~~ 238 (292)
T cd06657 176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL---KAMKMIRDNLP---------PKL-----KN 238 (292)
T ss_pred cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhhCC---------ccc-----CC
Confidence 46788999999988888899999999999999999999998543211 11111110000 000 01
Q ss_pred hHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 622 MEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 622 ~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
.......+.+++.+||+.+|.+||++.+++++
T Consensus 239 ~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 239 LHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred cccCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 11223456788999999999999999999884
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=300.65 Aligned_cols=260 Identities=19% Similarity=0.280 Sum_probs=188.0
Q ss_pred CccccCCceEEEEEEe-CCCCEEEEEEcccCccc-CcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCC
Q 005749 383 QVIEKTTYGTAYKAKL-ADGATIALRLLREGSCK-DRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRT 460 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~-~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gs 460 (679)
+.||+|+||.||+|+. .++..||+|.+...... ....+.+|++++++++|+||+++++++.. .+..++||||+. ++
T Consensus 11 ~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~-~~~~~lv~e~~~-~~ 88 (291)
T cd07870 11 EKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHT-KETLTFVFEYMH-TD 88 (291)
T ss_pred EEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEec-CCeEEEEEeccc-CC
Confidence 6799999999999984 56899999998754322 23467899999999999999999999987 678999999996 67
Q ss_pred hHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccchh
Q 005749 461 LHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMV 540 (679)
Q Consensus 461 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 540 (679)
+.+++... ...+.+..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++...... ....
T Consensus 89 l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~~~ 161 (291)
T cd07870 89 LAQYMIQH---PGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPS-QTYS 161 (291)
T ss_pred HHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCCC-CCCC
Confidence 87776543 234788889999999999999999988 9999999999999999999999999987643221 1122
Q ss_pred cccccccccccccccc-cCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHH-Hhhcccc------cccchH
Q 005749 541 ALAKADGYKAPELQRM-KKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKV-AVLEETT------MEVFDM 612 (679)
Q Consensus 541 ~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~-~~~~~~~------~~~~~~ 612 (679)
...++..|+|||.+.+ ..++.++|||||||++|||++|+.||...... ...+.+.... ....... .....+
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (291)
T cd07870 162 SEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDV-FEQLEKIWTVLGVPTEDTWPGVSKLPNYKP 240 (291)
T ss_pred CccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhH-HHHHHHHHHHcCCCChhhhhhhhhcccccc
Confidence 3356888999998875 35788999999999999999999999543221 1111110000 0000000 000000
Q ss_pred hhhhcCCC-Ch------HHHHHHHHHHHHhccCcCCCCCCCHHHHHH
Q 005749 613 EIMKGIRS-PM------EEGLVQALKLAMGCCAPVASVRPTMDEVVK 652 (679)
Q Consensus 613 ~i~~~~~~-~~------~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 652 (679)
........ .. ......+.+++.+|++.||++|||++|++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 241 EWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 00000000 00 011346678999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=286.33 Aligned_cols=267 Identities=18% Similarity=0.307 Sum_probs=212.6
Q ss_pred cHHHHHHhhcCccccCCceEEEEEE-eCCCCEEEEEEcccCcccCcccHHHHHHHHhcc-CCCCCccceEEeeCCCCceE
Q 005749 373 TLEDVLNATGQVIEKTTYGTAYKAK-LADGATIALRLLREGSCKDRSSCLPVIRQLGKV-RHENLIPLRAFYQGKRGEKL 450 (679)
Q Consensus 373 ~~~~l~~~~~~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~~ 450 (679)
+++|+++-|++++|+|+|+.|--+. +.+|.++|||++.+.....+....+|++++... .|+||+++++||.+ +..+|
T Consensus 74 ~F~d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEd-d~~FY 152 (463)
T KOG0607|consen 74 KFEDMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFED-DTRFY 152 (463)
T ss_pred hHHHHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcc-cceEE
Confidence 4899999999999999999999998 889999999999988777788899999999999 49999999999998 78999
Q ss_pred EEEEecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCC---ceEEeeccc
Q 005749 451 LIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFF---VSRLTEFGL 527 (679)
Q Consensus 451 lv~ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~---~~kl~DFGl 527 (679)
+|||-|.||+|..+++++ ..+++.++.++..+|+.||.|||.++ |.||||||+|||-.+.. -+||+||.+
T Consensus 153 LVfEKm~GGplLshI~~~----~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDL 225 (463)
T KOG0607|consen 153 LVFEKMRGGPLLSHIQKR----KHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDL 225 (463)
T ss_pred EEEecccCchHHHHHHHh----hhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeecccc
Confidence 999999999999999874 56999999999999999999999998 99999999999986543 479999988
Q ss_pred ccccC------cccccchhccccccccccccccc-----ccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCccc-chhH
Q 005749 528 DQLMV------PAVADEMVALAKADGYKAPELQR-----MKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFV-DLPS 595 (679)
Q Consensus 528 a~~~~------~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~-~l~~ 595 (679)
+..+. +.......+.+|+..|||||+.. ...|+.++|.||+|||+|-|+.|.+||.+.-..+.. +.-+
T Consensus 226 gSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe 305 (463)
T KOG0607|consen 226 GSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGE 305 (463)
T ss_pred ccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCC
Confidence 76432 12233445668888999999754 345899999999999999999999999764332110 0000
Q ss_pred HHHHHhhcccccccchHhhhhcCCCChHHH----HHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 596 IVKVAVLEETTMEVFDMEIMKGIRSPMEEG----LVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 596 ~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~----~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
..+ ...+.+=..|.+|.+...+++ ..+..+++...+..|+.+|-++.++++.
T Consensus 306 ~Cr------~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnh 361 (463)
T KOG0607|consen 306 VCR------VCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNH 361 (463)
T ss_pred ccH------HHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCC
Confidence 000 001112224556666555543 3455578888899999999999999884
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=330.67 Aligned_cols=256 Identities=24% Similarity=0.339 Sum_probs=207.4
Q ss_pred hhcCccccCCceEEEEEEeC--------CCCEEEEEEcccCc-ccCcccHHHHHHHHhcc-CCCCCccceEEeeCCCCce
Q 005749 380 ATGQVIEKTTYGTAYKAKLA--------DGATIALRLLREGS-CKDRSSCLPVIRQLGKV-RHENLIPLRAFYQGKRGEK 449 (679)
Q Consensus 380 ~~~~~ig~G~~g~Vy~~~~~--------~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~ 449 (679)
..++.+|+|.||.|++|... ....||||+++... ..+.+.+..|+++|..+ +|+|||.++|+|.. ++..
T Consensus 299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~-~~~~ 377 (609)
T KOG0200|consen 299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ-DGPL 377 (609)
T ss_pred cccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc-CCce
Confidence 44569999999999999843 14579999998753 34567899999999999 69999999999998 7899
Q ss_pred EEEEEecCCCChHHHhhccc---C--C-----C--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCC
Q 005749 450 LLIYDYFPSRTLHDLLHDTI---A--G-----K--PVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDF 517 (679)
Q Consensus 450 ~lv~ey~~~gsL~~~l~~~~---~--~-----~--~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~ 517 (679)
++|+||+..|+|.++++..+ . . . ..++....+.++.|||.|++||++.. +|||||.++|||+.++
T Consensus 378 ~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRNVLi~~~ 454 (609)
T KOG0200|consen 378 YVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARNVLITKN 454 (609)
T ss_pred EEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhhEEecCC
Confidence 99999999999999998765 0 0 1 24889999999999999999999987 9999999999999999
Q ss_pred CceEEeecccccccCcccccchhccc--ccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchh
Q 005749 518 FVSRLTEFGLDQLMVPAVADEMVALA--KADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLP 594 (679)
Q Consensus 518 ~~~kl~DFGla~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~ 594 (679)
..+||+|||+|+.............. -...|||||.+....|+.|+|||||||+||||+| |..||.+....
T Consensus 455 ~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~------ 528 (609)
T KOG0200|consen 455 KVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT------ 528 (609)
T ss_pred CEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcH------
Confidence 99999999999975444333322222 2456999999999999999999999999999997 88898542111
Q ss_pred HHHHHHhhcccccccchHhhhhcCCCChHHH-HHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhC
Q 005749 595 SIVKVAVLEETTMEVFDMEIMKGIRSPMEEG-LVQALKLAMGCCAPVASVRPTMDEVVKQLEENR 658 (679)
Q Consensus 595 ~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~-~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 658 (679)
.+++ ..+..|.+...|+. ..++.+++..||+.+|++||++.|+++.++...
T Consensus 529 ------------~~l~-~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l 580 (609)
T KOG0200|consen 529 ------------EELL-EFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL 580 (609)
T ss_pred ------------HHHH-HHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence 1111 13455656444544 567779999999999999999999999998853
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=303.61 Aligned_cols=241 Identities=20% Similarity=0.252 Sum_probs=197.5
Q ss_pred CccccCCceEEEEEE-eCCCCEEEEEEcccCc---ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCC
Q 005749 383 QVIEKTTYGTAYKAK-LADGATIALRLLREGS---CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPS 458 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~ 458 (679)
++||+|+||.||-++ ..+|+.+|.|.+.+.. .....-.++|-++|.+++.+.||.+-..|.+ .+..++|+..|.|
T Consensus 191 RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeT-kd~LClVLtlMNG 269 (591)
T KOG0986|consen 191 RVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFET-KDALCLVLTLMNG 269 (591)
T ss_pred EEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecC-CCceEEEEEeecC
Confidence 799999999999999 4569999999986543 2334457899999999999999999777877 6899999999999
Q ss_pred CChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccc
Q 005749 459 RTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADE 538 (679)
Q Consensus 459 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 538 (679)
|||.-++.+.. .+.+++++++.++.+|+.||++||.++ ||.||+||+|||+|++|+++|+|.|+|..+.... .
T Consensus 270 GDLkfHiyn~g--~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~--~ 342 (591)
T KOG0986|consen 270 GDLKFHIYNHG--NPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPEGK--P 342 (591)
T ss_pred CceeEEeeccC--CCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCCCC--c
Confidence 99999887754 467999999999999999999999988 9999999999999999999999999999875543 3
Q ss_pred hhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcC
Q 005749 539 MVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGI 618 (679)
Q Consensus 539 ~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~ 618 (679)
....+||.+|||||++..+.|+...|-||+||++|||+.|+.||...... .-.+.+|..+++..
T Consensus 343 ~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeK----------------vk~eEvdrr~~~~~ 406 (591)
T KOG0986|consen 343 IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEK----------------VKREEVDRRTLEDP 406 (591)
T ss_pred cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhh----------------hhHHHHHHHHhcch
Confidence 34458999999999999999999999999999999999999999543221 11223344444332
Q ss_pred CCChHHHHHHHHHHHHhccCcCCCCCCCH
Q 005749 619 RSPMEEGLVQALKLAMGCCAPVASVRPTM 647 (679)
Q Consensus 619 ~~~~~~~~~~~~~l~~~cl~~dP~~RPs~ 647 (679)
....+...++..++....+..||++|--.
T Consensus 407 ~ey~~kFS~eakslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 407 EEYSDKFSEEAKSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred hhcccccCHHHHHHHHHHHccCHHHhccC
Confidence 22233445566677778889999999743
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=292.11 Aligned_cols=268 Identities=21% Similarity=0.241 Sum_probs=196.4
Q ss_pred CccccCCceEEEEEEeC---C--CCEEEEEEcccCcc--cCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEe
Q 005749 383 QVIEKTTYGTAYKAKLA---D--GATIALRLLREGSC--KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDY 455 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~~---~--~~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey 455 (679)
..||+|.||.||||.-. + ...+|+|+++.... .-.....+|+..++.++|||||.+..++...+..+++++||
T Consensus 30 g~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l~fdY 109 (438)
T KOG0666|consen 30 GKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVWLLFDY 109 (438)
T ss_pred ceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEEEehh
Confidence 67999999999999632 2 23789999986533 22346789999999999999999999888767789999999
Q ss_pred cCCCChHHHhhcccC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCC----CceEEeecccccc
Q 005749 456 FPSRTLHDLLHDTIA-GKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDF----FVSRLTEFGLDQL 530 (679)
Q Consensus 456 ~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~----~~~kl~DFGla~~ 530 (679)
.+. +|.+.++.++. ....++....+.|+.||+.|+.|||++. |+||||||.|||+..+ |.+||+|||+|+.
T Consensus 110 AEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~ 185 (438)
T KOG0666|consen 110 AEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIADLGLARL 185 (438)
T ss_pred hhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEeecccHHHH
Confidence 988 99998875532 2356888899999999999999999999 9999999999999877 9999999999998
Q ss_pred cCcccc--cchhccccccccccccccccc-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCc----cc---chhHHHHHH
Q 005749 531 MVPAVA--DEMVALAKADGYKAPELQRMK-KCSSRTDVYAFGILLLEILIGKKPGKSGRNGE----FV---DLPSIVKVA 600 (679)
Q Consensus 531 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~----~~---~l~~~~~~~ 600 (679)
+...-. ......+-|.+|+|||++.+. .||++.||||.|||+.||+|-++.|.+....- .. .+..+....
T Consensus 186 ~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vL 265 (438)
T KOG0666|consen 186 FNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFEVL 265 (438)
T ss_pred hhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHHHHc
Confidence 754322 123456789999999998864 58999999999999999999999886643211 11 122221111
Q ss_pred h--hcccccc---cchH-----hhhhcCCCC--hHHH-------HHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 005749 601 V--LEETTME---VFDM-----EIMKGIRSP--MEEG-------LVQALKLAMGCCAPVASVRPTMDEVVKQL 654 (679)
Q Consensus 601 ~--~~~~~~~---~~~~-----~i~~~~~~~--~~~~-------~~~~~~l~~~cl~~dP~~RPs~~evl~~L 654 (679)
- .++.+.. .-+. .+....+.. .... .+..++++.+++.+||.+|.|++++++..
T Consensus 266 G~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~ 338 (438)
T KOG0666|consen 266 GTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP 338 (438)
T ss_pred CCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc
Confidence 0 0011100 0000 000011111 1111 13367899999999999999999988764
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=303.92 Aligned_cols=264 Identities=19% Similarity=0.267 Sum_probs=188.0
Q ss_pred CccccCCceEEEEEEe-CCCCEEEEEEcccCcc--cCcccHHHHHHHHhccCCCCCccceEEeeCCC-------CceEEE
Q 005749 383 QVIEKTTYGTAYKAKL-ADGATIALRLLREGSC--KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKR-------GEKLLI 452 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~-------~~~~lv 452 (679)
+.||+|+||.||+|+. .+++.||||.+..... .....+.+|++++++++||||+++++++.... ...++|
T Consensus 18 ~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv 97 (310)
T cd07865 18 AKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLV 97 (310)
T ss_pred EEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCceEEEE
Confidence 6799999999999994 5699999999865422 22335678999999999999999999887521 345999
Q ss_pred EEecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccC
Q 005749 453 YDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMV 532 (679)
Q Consensus 453 ~ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 532 (679)
|||+.+ +|.+.+... ...+++.+++.++.|++.||+|||+++ ++|+||||+||+++.++.+||+|||++....
T Consensus 98 ~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 170 (310)
T cd07865 98 FEFCEH-DLAGLLSNK---NVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGLARAFS 170 (310)
T ss_pred EcCCCc-CHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCCCccccc
Confidence 999975 888887653 235899999999999999999999988 9999999999999999999999999998654
Q ss_pred ccccc---chhccccccccccccccccc-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccc
Q 005749 533 PAVAD---EMVALAKADGYKAPELQRMK-KCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTME 608 (679)
Q Consensus 533 ~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 608 (679)
..... ......++..|+|||.+.+. .++.++||||||+++|||++|..||.+........................
T Consensus 171 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (310)
T cd07865 171 LSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPG 250 (310)
T ss_pred CCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccc
Confidence 32211 11233567889999987654 478899999999999999999999854432111111111000000000000
Q ss_pred -----cchH-hhhhcCCCChH------HHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 609 -----VFDM-EIMKGIRSPME------EGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 609 -----~~~~-~i~~~~~~~~~------~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
.++. ........... .....+.+++.+||..||++|||++|+++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 251 VDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred ccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 0000 00000000000 012456689999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=298.09 Aligned_cols=242 Identities=18% Similarity=0.229 Sum_probs=185.3
Q ss_pred ccccCCceEEEEEEe-CCCCEEEEEEcccCccc---CcccHHHHHH---HHhccCCCCCccceEEeeCCCCceEEEEEec
Q 005749 384 VIEKTTYGTAYKAKL-ADGATIALRLLREGSCK---DRSSCLPVIR---QLGKVRHENLIPLRAFYQGKRGEKLLIYDYF 456 (679)
Q Consensus 384 ~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~---~~~~~~~Ei~---~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~ 456 (679)
+||+|+||.||+|+. .+++.||+|.+...... ....+..|.. .++..+||||+++++++.+ .+..++||||+
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~-~~~~~~v~e~~ 79 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT-PDKLSFILDLM 79 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeec-CCEEEEEEecC
Confidence 489999999999984 56899999998754321 1122444443 3444579999999998887 67899999999
Q ss_pred CCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccc
Q 005749 457 PSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVA 536 (679)
Q Consensus 457 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 536 (679)
++|+|.+++.. ...+++..++.++.|+++||+|||+.+ |+||||||+||++++++.+||+|||+++......
T Consensus 80 ~g~~L~~~l~~----~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~- 151 (278)
T cd05606 80 NGGDLHYHLSQ----HGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK- 151 (278)
T ss_pred CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC-
Confidence 99999998865 345899999999999999999999988 9999999999999999999999999987653221
Q ss_pred cchhccccccccccccccccc-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhh
Q 005749 537 DEMVALAKADGYKAPELQRMK-KCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIM 615 (679)
Q Consensus 537 ~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~ 615 (679)
.....|+..|+|||++.++ .++.++||||+||++|||++|+.||........... . ....
T Consensus 152 --~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~----~-------------~~~~ 212 (278)
T cd05606 152 --PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI----D-------------RMTL 212 (278)
T ss_pred --CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHH----H-------------HHhh
Confidence 2234688999999998754 689999999999999999999999965422211110 0 0000
Q ss_pred hcCCCChHHHHHHHHHHHHhccCcCCCCCC-----CHHHHHHH
Q 005749 616 KGIRSPMEEGLVQALKLAMGCCAPVASVRP-----TMDEVVKQ 653 (679)
Q Consensus 616 ~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~evl~~ 653 (679)
............++.+++.+|+..+|++|| ++.|+++.
T Consensus 213 ~~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 213 TMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred ccCCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 000011111235677899999999999999 99999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=301.62 Aligned_cols=257 Identities=21% Similarity=0.289 Sum_probs=191.0
Q ss_pred CccccCCceEEEEEEeC-CCCEEEEEEcccCccc--CcccHHHHHHHHhccCCCCCccceEEeeCC-CCceEEEEEecCC
Q 005749 383 QVIEKTTYGTAYKAKLA-DGATIALRLLREGSCK--DRSSCLPVIRQLGKVRHENLIPLRAFYQGK-RGEKLLIYDYFPS 458 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~--~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~-~~~~~lv~ey~~~ 458 (679)
+.||+|+||.||+|+.. +++.+|+|.++..... ....+.+|++++++++||||+++++++... .+..++||||+++
T Consensus 11 ~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~~ 90 (293)
T cd07843 11 NRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEH 90 (293)
T ss_pred hhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEehhcCc
Confidence 78999999999999954 6889999999754322 233567899999999999999999988762 2789999999975
Q ss_pred CChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccc
Q 005749 459 RTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADE 538 (679)
Q Consensus 459 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 538 (679)
+|.+++... ...+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++...... ..
T Consensus 91 -~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-~~ 162 (293)
T cd07843 91 -DLKSLMETM---KQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL-KP 162 (293)
T ss_pred -CHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccCCc-cc
Confidence 999988754 235899999999999999999999988 9999999999999999999999999988664321 12
Q ss_pred hhccccccccccccccccc-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHH-------------hh--
Q 005749 539 MVALAKADGYKAPELQRMK-KCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVA-------------VL-- 602 (679)
Q Consensus 539 ~~~~~gt~~y~aPE~~~~~-~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~-------------~~-- 602 (679)
.....++..|+|||.+.+. .++.++||||||+++|||++|+.||......+. +....... +.
T Consensus 163 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (293)
T cd07843 163 YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQ--LNKIFKLLGTPTEKIWPGFSELPGA 240 (293)
T ss_pred cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHHHhCCCchHHHHHhhccchh
Confidence 2334567889999988754 468999999999999999999999854332110 00000000 00
Q ss_pred c-ccccccchHhhhhcCCCChHH--HHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 603 E-ETTMEVFDMEIMKGIRSPMEE--GLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 603 ~-~~~~~~~~~~i~~~~~~~~~~--~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
. ..........+.. ..+. ....+.+++.+||+.||++|||+.|+++.
T Consensus 241 ~~~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 241 KKKTFTKYPYNQLRK----KFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred cccccccccchhhhc----cccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0 0000000001100 1111 24556789999999999999999999863
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=299.56 Aligned_cols=261 Identities=17% Similarity=0.309 Sum_probs=193.1
Q ss_pred CccccCCceEEEEEEe-CCCCEEEEEEcccCcc-cCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCC
Q 005749 383 QVIEKTTYGTAYKAKL-ADGATIALRLLREGSC-KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRT 460 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gs 460 (679)
+.||+|++|.||+|+. .+|+.||+|.++.... ...+.+.+|++++++++|+||+++++++.+ .+..++||||+++ +
T Consensus 6 ~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~-~ 83 (284)
T cd07836 6 EKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHT-ENKLMLVFEYMDK-D 83 (284)
T ss_pred eeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEee-CCcEEEEEecCCc-c
Confidence 6799999999999995 4689999999876532 234567899999999999999999999987 6789999999985 8
Q ss_pred hHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccchh
Q 005749 461 LHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMV 540 (679)
Q Consensus 461 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 540 (679)
|.+++..... ...+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+|++|||+++...... ....
T Consensus 84 l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~-~~~~ 158 (284)
T cd07836 84 LKKYMDTHGV-RGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPV-NTFS 158 (284)
T ss_pred HHHHHHhcCC-CCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc-cccc
Confidence 9888865432 345899999999999999999999988 9999999999999999999999999987653221 1122
Q ss_pred cccccccccccccccc-cCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHh-hcc-cc-----cccchH
Q 005749 541 ALAKADGYKAPELQRM-KKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAV-LEE-TT-----MEVFDM 612 (679)
Q Consensus 541 ~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~-~~~-~~-----~~~~~~ 612 (679)
...++..|+|||++.+ ..++.++|||||||++|||++|+.||.+....+. ......... ... .. ...+..
T Consensus 159 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07836 159 NEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQ--LLKIFRIMGTPTESTWPGISQLPEYKP 236 (284)
T ss_pred cccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHH--HHHHHHHhCCCChhhHHHHhcCchhcc
Confidence 3456788999998765 4578899999999999999999999965433211 111110000 000 00 000000
Q ss_pred hhhhc----CCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHH
Q 005749 613 EIMKG----IRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVK 652 (679)
Q Consensus 613 ~i~~~----~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 652 (679)
..... .....+.....+.+++.+|++.||++||++.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 237 TFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred cccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00000 00001122356778999999999999999999985
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=297.45 Aligned_cols=243 Identities=19% Similarity=0.224 Sum_probs=194.4
Q ss_pred cCccccCCceEEEEEEeC-CCCEEEEEEcccCcc---cCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecC
Q 005749 382 GQVIEKTTYGTAYKAKLA-DGATIALRLLREGSC---KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFP 457 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~---~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~ 457 (679)
.+.||+|+||.||+|+.. +++.||+|.+..... ...+.+.+|++++++++||||+++++++.+ ....++|+||++
T Consensus 5 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~ 83 (258)
T cd05578 5 LRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQD-EENMYLVVDLLL 83 (258)
T ss_pred EEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcC-CCeEEEEEeCCC
Confidence 368999999999999954 699999999975432 235678999999999999999999998887 678999999999
Q ss_pred CCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCccccc
Q 005749 458 SRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVAD 537 (679)
Q Consensus 458 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 537 (679)
+++|.+++... ..+++..+..++.|+++||.|||+.+ ++|+||||+||++++++.++|+|||++.......
T Consensus 84 ~~~L~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-- 154 (258)
T cd05578 84 GGDLRYHLSQK----VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-- 154 (258)
T ss_pred CCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc--
Confidence 99999999763 45899999999999999999999988 9999999999999999999999999988654332
Q ss_pred chhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhc
Q 005749 538 EMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKG 617 (679)
Q Consensus 538 ~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~ 617 (679)
......++..|+|||.+....++.++||||||+++|||++|+.||....... ..+....... .
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~~~~~~~~-------------~ 217 (258)
T cd05578 155 LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI----RDQIRAKQET-------------A 217 (258)
T ss_pred cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH----HHHHHHHhcc-------------c
Confidence 2234467888999999988889999999999999999999999996543321 1111111000 0
Q ss_pred CCCChHHHHHHHHHHHHhccCcCCCCCCCH--HHHH
Q 005749 618 IRSPMEEGLVQALKLAMGCCAPVASVRPTM--DEVV 651 (679)
Q Consensus 618 ~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~--~evl 651 (679)
.....+.....+.+++.+||+.||.+||++ +|++
T Consensus 218 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 218 DVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred cccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 011111223567789999999999999999 5554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=304.69 Aligned_cols=260 Identities=24% Similarity=0.293 Sum_probs=190.6
Q ss_pred CccccCCceEEEEEEe-CCCCEEEEEEcccCccc--CcccHHHHHHHHhccCCCCCccceEEeeCC-CCceEEEEEecCC
Q 005749 383 QVIEKTTYGTAYKAKL-ADGATIALRLLREGSCK--DRSSCLPVIRQLGKVRHENLIPLRAFYQGK-RGEKLLIYDYFPS 458 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~--~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~-~~~~~lv~ey~~~ 458 (679)
+.||+|+||.||+|+. .+|+.||+|.++..... ....+.+|++++++++|+||+++++++.+. .+..++||||+.+
T Consensus 13 ~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~ 92 (309)
T cd07845 13 NRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQ 92 (309)
T ss_pred eeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEecCCC
Confidence 6799999999999995 56999999998754322 233567899999999999999999998753 2568999999975
Q ss_pred CChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccc
Q 005749 459 RTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADE 538 (679)
Q Consensus 459 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 538 (679)
+|.+++... ...+++.++..++.|+++||+|||+.+ ++||||||+||++++++.+||+|||+++...... ..
T Consensus 93 -~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~-~~ 164 (309)
T cd07845 93 -DLASLLDNM---PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA-KP 164 (309)
T ss_pred -CHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecCCcc-CC
Confidence 888888753 245899999999999999999999988 9999999999999999999999999998764321 12
Q ss_pred hhcccccccccccccccc-cCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcc--cccccchH---
Q 005749 539 MVALAKADGYKAPELQRM-KKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEE--TTMEVFDM--- 612 (679)
Q Consensus 539 ~~~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~--~~~~~~~~--- 612 (679)
.....++..|+|||.+.+ ..++.++||||+||++|||++|+.||......+. +.... ...... .....++.
T Consensus 165 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~--~~~~~-~~~~~~~~~~~~~~~~~~~ 241 (309)
T cd07845 165 MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQ--LDLII-QLLGTPNESIWPGFSDLPL 241 (309)
T ss_pred CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHH-HhcCCCChhhchhhhcccc
Confidence 223345778999998865 4578999999999999999999999964432111 11111 000000 00000000
Q ss_pred ----hhhhcCCCC----hHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 613 ----EIMKGIRSP----MEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 613 ----~i~~~~~~~----~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
.+....... .....++..+++.+|++.||++|||+.|++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 242 VGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred cccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000000000 01124566789999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=301.30 Aligned_cols=265 Identities=18% Similarity=0.201 Sum_probs=190.0
Q ss_pred cCccccCCceEEEEEEe-CCCCEEEEEEcccCcc--cCcccHHHHHHHHhccC-CCCCccceEEeeCCCC----ceEEEE
Q 005749 382 GQVIEKTTYGTAYKAKL-ADGATIALRLLREGSC--KDRSSCLPVIRQLGKVR-HENLIPLRAFYQGKRG----EKLLIY 453 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~-H~nIv~l~~~~~~~~~----~~~lv~ 453 (679)
.+.||+|+||.||+|+. .+++.||+|.++.... .....+.+|++++++++ ||||+++++++..... ..++||
T Consensus 6 ~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~ 85 (295)
T cd07837 6 LEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVF 85 (295)
T ss_pred eeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEEe
Confidence 36899999999999995 5689999999865432 23456889999999995 6999999998876322 279999
Q ss_pred EecCCCChHHHhhcccCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecC-CCceEEeeccccccc
Q 005749 454 DYFPSRTLHDLLHDTIAG-KPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDD-FFVSRLTEFGLDQLM 531 (679)
Q Consensus 454 ey~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~-~~~~kl~DFGla~~~ 531 (679)
||+++ +|.+++...... ...+++..++.++.||++||+|||+.+ |+||||||+||+++. ++.+||+|||+++..
T Consensus 86 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~ 161 (295)
T cd07837 86 EYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAF 161 (295)
T ss_pred eccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecccceec
Confidence 99986 898888654322 346899999999999999999999988 999999999999998 899999999998865
Q ss_pred Ccccccchhcccccccccccccccc-cCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHh-h-cccccc
Q 005749 532 VPAVADEMVALAKADGYKAPELQRM-KKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAV-L-EETTME 608 (679)
Q Consensus 532 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~-~-~~~~~~ 608 (679)
.... .......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||.+.... ..+........ . ......
T Consensus 162 ~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 238 (295)
T cd07837 162 SIPV-KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSEL--QQLLHIFKLLGTPTEQVWPG 238 (295)
T ss_pred CCCc-cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHH--HHHHHHHHHhCCCChhhCcc
Confidence 3221 11223356788999998764 45789999999999999999999999653221 11111111000 0 000000
Q ss_pred cchHh---hhhcCC-----CChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 609 VFDME---IMKGIR-----SPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 609 ~~~~~---i~~~~~-----~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
..... ...... ...+....++.+++.+||+.||++||+++|++..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 239 VSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred hhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 00000 000000 0011234567789999999999999999999753
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=309.32 Aligned_cols=266 Identities=19% Similarity=0.275 Sum_probs=195.7
Q ss_pred CccccCCceEEEEEE-eCCCCEEEEEEcccCc--ccCcccHHHHHHHHhccCCCCCccceEEeeCCC----CceEEEEEe
Q 005749 383 QVIEKTTYGTAYKAK-LADGATIALRLLREGS--CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKR----GEKLLIYDY 455 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~----~~~~lv~ey 455 (679)
+.||+|+||+||+|+ ..+++.||||.++... ......+.+|+.+++.++|+||+++++++.... ...++||||
T Consensus 11 ~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~ 90 (337)
T cd07858 11 KPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYEL 90 (337)
T ss_pred EEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEEEeC
Confidence 689999999999999 5579999999987542 223456788999999999999999999876522 357999999
Q ss_pred cCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCccc
Q 005749 456 FPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAV 535 (679)
Q Consensus 456 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 535 (679)
+. ++|.+++... ..+++..+..++.|++.||+|||+++ ++||||||+||+++.++.+||+|||+++......
T Consensus 91 ~~-~~L~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~ 162 (337)
T cd07858 91 MD-TDLHQIIRSS----QTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG 162 (337)
T ss_pred CC-CCHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCccccccCCCc
Confidence 96 6898888652 45899999999999999999999988 9999999999999999999999999998654321
Q ss_pred ccchhcccccccccccccccc-cCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhc---ccccccch
Q 005749 536 ADEMVALAKADGYKAPELQRM-KKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLE---ETTMEVFD 611 (679)
Q Consensus 536 ~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~---~~~~~~~~ 611 (679)
.......++..|+|||.+.. ..++.++|||||||++|||++|+.||.+....+.. ......... .......+
T Consensus 163 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 238 (337)
T cd07858 163 -DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQL---KLITELLGSPSEEDLGFIRN 238 (337)
T ss_pred -ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHH---HHHHHHhCCCChHHhhhcCc
Confidence 22234467888999998764 46899999999999999999999999543221100 000000000 00000000
Q ss_pred H-------hhhhcCCCC----hHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH--HHhhCCC
Q 005749 612 M-------EIMKGIRSP----MEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ--LEENRPR 660 (679)
Q Consensus 612 ~-------~i~~~~~~~----~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~--L~~~~~~ 660 (679)
. .+....... .+....++.+++.+||+.+|++|||++|+++. ++.+...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~ 300 (337)
T cd07858 239 EKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDP 300 (337)
T ss_pred hhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCc
Confidence 0 000000000 11234567899999999999999999999988 6665443
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=294.56 Aligned_cols=244 Identities=22% Similarity=0.339 Sum_probs=198.4
Q ss_pred CccccCCceEEEEEE-eCCCCEEEEEEcccCc--ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCC
Q 005749 383 QVIEKTTYGTAYKAK-LADGATIALRLLREGS--CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSR 459 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~g 459 (679)
+.||+|+||.||+++ ..+++.+|+|.+.... ......+.+|++++++++|+||+++++++.+ ....++||||++++
T Consensus 6 ~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~v~e~~~~~ 84 (256)
T cd08530 6 KKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLD-GNKLCIVMEYAPFG 84 (256)
T ss_pred eeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhcc-CCEEEEEehhcCCC
Confidence 679999999999998 5578899999987543 2334577899999999999999999999887 58899999999999
Q ss_pred ChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccch
Q 005749 460 TLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEM 539 (679)
Q Consensus 460 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 539 (679)
+|.+++.........+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+|++|||+++..... ..
T Consensus 85 ~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~---~~ 158 (256)
T cd08530 85 DLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN---MA 158 (256)
T ss_pred CHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC---Cc
Confidence 999998764433456899999999999999999999988 999999999999999999999999999876443 12
Q ss_pred hcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcCC
Q 005749 540 VALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIR 619 (679)
Q Consensus 540 ~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~ 619 (679)
....++..|+|||.+.+..++.++|+||+|+++|||++|+.||...... .+.. .+..+..
T Consensus 159 ~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~---~~~~-----------------~~~~~~~ 218 (256)
T cd08530 159 KTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ---DLRY-----------------KVQRGKY 218 (256)
T ss_pred ccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHH-----------------HHhcCCC
Confidence 2345788899999999888999999999999999999999998543211 0000 1111111
Q ss_pred -CChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 620 -SPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 620 -~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
........++.+++.+|+..+|++||++.|+++.
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 219 PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 1122344667899999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=285.36 Aligned_cols=265 Identities=21% Similarity=0.308 Sum_probs=203.8
Q ss_pred CccccCCceEEEEEE-eCCCCEEEEEEcccC--cccCcccHHHHHHHHhccCCCCCccceEEeeCC-------CCceEEE
Q 005749 383 QVIEKTTYGTAYKAK-LADGATIALRLLREG--SCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGK-------RGEKLLI 452 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~-------~~~~~lv 452 (679)
..||+|.||.||+|+ ..+|+.||+|++--. .+......++|+++|..++|+|++.++.+|... ...+|+|
T Consensus 23 ~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylV 102 (376)
T KOG0669|consen 23 AKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYLV 102 (376)
T ss_pred HhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeeee
Confidence 689999999999999 456888999876432 223355679999999999999999999988642 3358999
Q ss_pred EEecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccC
Q 005749 453 YDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMV 532 (679)
Q Consensus 453 ~ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 532 (679)
+++|+. +|..+|... ...++..++.+++.++..||.|+|+.. |+|||+||.|+||+.++..||+|||+|+.+.
T Consensus 103 f~~ceh-DLaGlLsn~---~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGlar~fs 175 (376)
T KOG0669|consen 103 FDFCEH-DLAGLLSNR---KVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGLARAFS 175 (376)
T ss_pred HHHhhh-hHHHHhcCc---cccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeecccccccee
Confidence 999987 999999865 356899999999999999999999988 9999999999999999999999999998764
Q ss_pred ccc---ccchhcccccccccccccccc-cCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccc
Q 005749 533 PAV---ADEMVALAKADGYKAPELQRM-KKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTME 608 (679)
Q Consensus 533 ~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 608 (679)
... ....+..+-|.+|++||.+.+ ..|+++.|||.-|||+.||.||.+.+.+.++.....++...-.....+.+.+
T Consensus 176 ~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~ 255 (376)
T KOG0669|consen 176 TSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPN 255 (376)
T ss_pred cccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCC
Confidence 322 112334456899999998876 5699999999999999999999999877666554444444333333333333
Q ss_pred cchHhhhhcC---------CCChHHHH------HHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 005749 609 VFDMEIMKGI---------RSPMEEGL------VQALKLAMGCCAPVASVRPTMDEVVKQL 654 (679)
Q Consensus 609 ~~~~~i~~~~---------~~~~~~~~------~~~~~l~~~cl~~dP~~RPs~~evl~~L 654 (679)
+....+.+.. ....++.+ ++.++++.+++..||.+|++++++++.-
T Consensus 256 ~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~ 316 (376)
T KOG0669|consen 256 VDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHD 316 (376)
T ss_pred cccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchh
Confidence 3322222221 11112222 3677899999999999999999998764
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=299.20 Aligned_cols=261 Identities=19% Similarity=0.255 Sum_probs=191.8
Q ss_pred CccccCCceEEEEEEe-CCCCEEEEEEcccCcc--cCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCC
Q 005749 383 QVIEKTTYGTAYKAKL-ADGATIALRLLREGSC--KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSR 459 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~g 459 (679)
+.||+|++|.||+|+. .+|+.||+|++..... ...+.+.+|++++++++||||+++++++.+ .+..++||||++ +
T Consensus 5 ~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~-~~~~~iv~e~~~-~ 82 (283)
T cd07835 5 EKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHS-ENKLYLVFEFLD-L 82 (283)
T ss_pred eEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheecc-CCeEEEEEeccC-c
Confidence 6799999999999994 5799999999875432 223568899999999999999999999987 688999999995 6
Q ss_pred ChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccch
Q 005749 460 TLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEM 539 (679)
Q Consensus 460 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 539 (679)
+|.+++.... ...+++..++.++.|+++||+|||+.+ ++||||+|+||++++++.+||+|||+++....... ..
T Consensus 83 ~l~~~~~~~~--~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~ 156 (283)
T cd07835 83 DLKKYMDSSP--LTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR-TY 156 (283)
T ss_pred CHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-cc
Confidence 9999987542 135899999999999999999999987 99999999999999999999999999976532211 11
Q ss_pred hccccccccccccccccc-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhh-cccc----cc--cch
Q 005749 540 VALAKADGYKAPELQRMK-KCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVL-EETT----ME--VFD 611 (679)
Q Consensus 540 ~~~~gt~~y~aPE~~~~~-~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~-~~~~----~~--~~~ 611 (679)
....++..|+|||++.+. .++.++||||||+++|||++|+.||...... ..+....+.... .... .. .+.
T Consensus 157 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07835 157 THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEI--DQLFRIFRTLGTPDEDVWPGVTSLPDYK 234 (283)
T ss_pred CccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCChHHhhhhhhchhhh
Confidence 223467889999987654 5789999999999999999999998543211 111111111000 0000 00 000
Q ss_pred HhhhhcCCCC----hHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 612 MEIMKGIRSP----MEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 612 ~~i~~~~~~~----~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
.......... .+.....+.+++.+||+.||++||+++|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 235 PTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0000000000 11122567789999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=290.99 Aligned_cols=245 Identities=22% Similarity=0.348 Sum_probs=197.7
Q ss_pred CccccCCceEEEEEEeC-CCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCCh
Q 005749 383 QVIEKTTYGTAYKAKLA-DGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRTL 461 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gsL 461 (679)
+.||+|++|.||+++.. +++.+++|++........+.+.+|++++++++|+||+++++++.. ....++++||+++++|
T Consensus 6 ~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~l~~e~~~~~~L 84 (253)
T cd05122 6 EKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLK-KDELWIVMEFCSGGSL 84 (253)
T ss_pred eeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEec-CCeEEEEEecCCCCcH
Confidence 67999999999999964 789999999987654456789999999999999999999999887 5789999999999999
Q ss_pred HHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccchhc
Q 005749 462 HDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVA 541 (679)
Q Consensus 462 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 541 (679)
.+++... ...+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.+||+|||.+........ ...
T Consensus 85 ~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~~ 156 (253)
T cd05122 85 KDLLKST---NQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--RNT 156 (253)
T ss_pred HHHHhhc---CCCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc--ccc
Confidence 9998764 246899999999999999999999987 99999999999999999999999999887644321 234
Q ss_pred ccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcCCCC
Q 005749 542 LAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIRSP 621 (679)
Q Consensus 542 ~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~~~ 621 (679)
..++..|+|||.+....++.++||||||++++||++|+.||...... ........ .... .. ..
T Consensus 157 ~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~-~~~~-----~~-----~~ 219 (253)
T cd05122 157 MVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM------KALFKIAT-NGPP-----GL-----RN 219 (253)
T ss_pred eecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH------HHHHHHHh-cCCC-----Cc-----Cc
Confidence 56788899999998888999999999999999999999998543211 11000000 0000 00 00
Q ss_pred hHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 622 MEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 622 ~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
.......+.+++.+||+.||++|||+.|+++.
T Consensus 220 ~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 220 PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred ccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11113567789999999999999999999863
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=309.42 Aligned_cols=265 Identities=18% Similarity=0.259 Sum_probs=193.3
Q ss_pred cCccccCCceEEEEEE-eCCCCEEEEEEcccCc-ccCcccHHHHHHHHhccCCCCCccceEEeeCC----CCceEEEEEe
Q 005749 382 GQVIEKTTYGTAYKAK-LADGATIALRLLREGS-CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGK----RGEKLLIYDY 455 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~----~~~~~lv~ey 455 (679)
.+.||+|+||.||+|+ ..+|+.||+|.+.... ......+.+|+.++++++||||+++++++... ....++|+||
T Consensus 10 ~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~ 89 (336)
T cd07849 10 LSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQEL 89 (336)
T ss_pred EEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEEehh
Confidence 3789999999999998 5679999999986532 22345678899999999999999999987642 2357999999
Q ss_pred cCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCccc
Q 005749 456 FPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAV 535 (679)
Q Consensus 456 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 535 (679)
+.+ +|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 90 ~~~-~l~~~~~~-----~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~ 160 (336)
T cd07849 90 MET-DLYKLIKT-----QHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEH 160 (336)
T ss_pred ccc-CHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceeeccccc
Confidence 975 88887754 35899999999999999999999988 9999999999999999999999999987653321
Q ss_pred cc--chhcccccccccccccccc-cCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcc---ccccc
Q 005749 536 AD--EMVALAKADGYKAPELQRM-KKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEE---TTMEV 609 (679)
Q Consensus 536 ~~--~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~---~~~~~ 609 (679)
.. ......|+..|+|||.+.+ ..++.++|||||||++|||++|+.||.+.... .........+... ....+
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 237 (336)
T cd07849 161 DHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYL---HQLNLILGVLGTPSQEDLNCI 237 (336)
T ss_pred cccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHcCCCCHHHHHHh
Confidence 11 1123467889999998654 56899999999999999999999999543221 1111111000000 00000
Q ss_pred chHh-------hhhcCCCC----hHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH--HHhhC
Q 005749 610 FDME-------IMKGIRSP----MEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ--LEENR 658 (679)
Q Consensus 610 ~~~~-------i~~~~~~~----~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~--L~~~~ 658 (679)
.+.. .......+ .+....++.+++.+||+.+|++|||+.|+++. ++...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 238 ISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred hchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence 0000 00000000 01224567899999999999999999999987 55443
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=301.40 Aligned_cols=250 Identities=21% Similarity=0.257 Sum_probs=188.0
Q ss_pred CccccCCceEEEEEE-eCCCCEEEEEEcccCcc-cCcccHHHHHHHHhccC-CCCCccceEEeeCCCCceEEEEEecCCC
Q 005749 383 QVIEKTTYGTAYKAK-LADGATIALRLLREGSC-KDRSSCLPVIRQLGKVR-HENLIPLRAFYQGKRGEKLLIYDYFPSR 459 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~-H~nIv~l~~~~~~~~~~~~lv~ey~~~g 459 (679)
+.||+|+||.||+++ ..+++.||+|.+..... .....+.+|+.++.++. |+||+++++++.. .+..+++|||+..
T Consensus 10 ~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~-~~~~~~~~e~~~~- 87 (288)
T cd06616 10 GEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFR-EGDCWICMELMDI- 87 (288)
T ss_pred HHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEec-CCcEEEEEecccC-
Confidence 689999999999999 45689999999875432 33457889999999996 9999999998887 6788999999864
Q ss_pred ChHHHhhcc-cCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCeeecCCCCCCeeecCCCceEEeecccccccCccccc
Q 005749 460 TLHDLLHDT-IAGKPVLNWARRHKIALGIARGLAYLHTG-HEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVAD 537 (679)
Q Consensus 460 sL~~~l~~~-~~~~~~l~~~~~~~i~~~ia~gL~~LH~~-~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 537 (679)
++.++.... ......+++..+..++.+++.||+|||+. + ++||||||+||+++.++.+||+|||+++......
T Consensus 88 ~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-- 162 (288)
T cd06616 88 SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSI-- 162 (288)
T ss_pred CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhccCC--
Confidence 665543211 11135689999999999999999999974 5 9999999999999999999999999987653221
Q ss_pred chhccccccccccccccccc---CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhh
Q 005749 538 EMVALAKADGYKAPELQRMK---KCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEI 614 (679)
Q Consensus 538 ~~~~~~gt~~y~aPE~~~~~---~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i 614 (679)
......++..|+|||++... .++.++|||||||++|||++|+.||.... ............. .+.+
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~~~~~~~~~~~~------~~~~ 231 (288)
T cd06616 163 AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-----SVFDQLTQVVKGD------PPIL 231 (288)
T ss_pred ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-----hHHHHHhhhcCCC------CCcC
Confidence 11233578889999998765 68999999999999999999999984322 0001000000000 0000
Q ss_pred hhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 615 MKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 615 ~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
.. ........++.+++.+||+.+|++|||++||++.
T Consensus 232 ~~---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 232 SN---SEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CC---cCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 0111234567899999999999999999999876
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=307.68 Aligned_cols=261 Identities=17% Similarity=0.273 Sum_probs=192.5
Q ss_pred CccccCCceEEEEEE-eCCCCEEEEEEcccCcc--cCcccHHHHHHHHhccCCCCCccceEEeeCC---CCceEEEEEec
Q 005749 383 QVIEKTTYGTAYKAK-LADGATIALRLLREGSC--KDRSSCLPVIRQLGKVRHENLIPLRAFYQGK---RGEKLLIYDYF 456 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~---~~~~~lv~ey~ 456 (679)
+.||+|+||.||+|+ ..+|+.||+|++..... ...+.+.+|+.++++++||||+++++++... ....++||||+
T Consensus 11 ~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~ 90 (334)
T cd07855 11 ENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLM 90 (334)
T ss_pred eeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEEehh
Confidence 679999999999999 45699999999875422 3345678899999999999999999987642 34689999999
Q ss_pred CCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccc
Q 005749 457 PSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVA 536 (679)
Q Consensus 457 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 536 (679)
. ++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++.......
T Consensus 91 ~-~~l~~~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 162 (334)
T cd07855 91 E-SDLHHIIHSD----QPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT 162 (334)
T ss_pred h-hhHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccceeecccCc
Confidence 6 5899988652 44899999999999999999999988 99999999999999999999999999976533211
Q ss_pred c---chhcccccccccccccccc-cCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcc---ccccc
Q 005749 537 D---EMVALAKADGYKAPELQRM-KKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEE---TTMEV 609 (679)
Q Consensus 537 ~---~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~---~~~~~ 609 (679)
. ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||.+...... ...+....... .....
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~---~~~~~~~~g~~~~~~~~~~ 239 (334)
T cd07855 163 EHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQ---LKLILSVLGSPSEEVLNRI 239 (334)
T ss_pred CCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHH---HHHHHHHhCCChhHhhhhh
Confidence 1 1123467889999998765 4589999999999999999999999965432111 11111000000 00000
Q ss_pred chHhh-------hhcCCCC----hHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 005749 610 FDMEI-------MKGIRSP----MEEGLVQALKLAMGCCAPVASVRPTMDEVVKQL 654 (679)
Q Consensus 610 ~~~~i-------~~~~~~~----~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L 654 (679)
.+..+ ....... .+....++.+++.+||+.+|++||++++++..-
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~ 295 (334)
T cd07855 240 GSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHP 295 (334)
T ss_pred chhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhCh
Confidence 00000 0000000 012346778999999999999999999998853
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=302.69 Aligned_cols=262 Identities=16% Similarity=0.149 Sum_probs=188.5
Q ss_pred CccccCCceEEEEEEeCCCCEEEEEEcccC--cccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCC
Q 005749 383 QVIEKTTYGTAYKAKLADGATIALRLLREG--SCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRT 460 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~~~~~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gs 460 (679)
+.+|.|+++.||+++. +++.||||++... .....+.+.+|++++++++|+||+++++++.. .+..+++|||+++|+
T Consensus 8 ~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~-~~~~~~~~e~~~~~~ 85 (314)
T cd08216 8 KCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIV-DSELYVVSPLMAYGS 85 (314)
T ss_pred HhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeec-CCeEEEEEeccCCCC
Confidence 3444555555555544 6999999998754 23345679999999999999999999999887 678999999999999
Q ss_pred hHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccc----
Q 005749 461 LHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVA---- 536 (679)
Q Consensus 461 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~---- 536 (679)
|.+++.... ...+++.....++.|+++||+|||+++ |+||||||+||+++.++.+|++|||.+........
T Consensus 86 l~~~l~~~~--~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~ 160 (314)
T cd08216 86 CEDLLKTHF--PEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV 160 (314)
T ss_pred HHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence 999998643 234889999999999999999999988 99999999999999999999999998875432111
Q ss_pred --cchhcccccccccccccccc--cCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhc---------
Q 005749 537 --DEMVALAKADGYKAPELQRM--KKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLE--------- 603 (679)
Q Consensus 537 --~~~~~~~gt~~y~aPE~~~~--~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~--------- 603 (679)
.......++..|+|||++.. ..++.++|||||||++|||++|+.||....... .+.+........
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 238 (314)
T cd08216 161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKVRGTVPCLLDKSTYPL 238 (314)
T ss_pred cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhccCccccccCchhh
Confidence 11123456778999999875 358899999999999999999999996432211 111110000000
Q ss_pred --ccccc----cchHhhhhcCC-CChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 604 --ETTME----VFDMEIMKGIR-SPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 604 --~~~~~----~~~~~i~~~~~-~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
....+ ..++....... ........++.+++.+||+.||++|||++|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 239 YEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred hcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 00000 00000000000 1111223567789999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=292.06 Aligned_cols=246 Identities=19% Similarity=0.341 Sum_probs=198.5
Q ss_pred CccccCCceEEEEEEe-CCCCEEEEEEcccCcc--cCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCC
Q 005749 383 QVIEKTTYGTAYKAKL-ADGATIALRLLREGSC--KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSR 459 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~g 459 (679)
+.||+|+||.||+++. +++..||+|++..... ...+.+.+|++++++++|+|++++++.+.. .+..++|+||++++
T Consensus 6 ~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~-~~~~~lv~e~~~~~ 84 (258)
T cd08215 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEE-KGKLCIVMEYADGG 84 (258)
T ss_pred eeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEec-CCEEEEEEEecCCC
Confidence 6799999999999995 4689999999876533 345678899999999999999999999887 58899999999999
Q ss_pred ChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccch
Q 005749 460 TLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEM 539 (679)
Q Consensus 460 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 539 (679)
+|.+++.........+++..+..++.+++.||.|||+.+ ++|+||+|+||++++++.++|+|||.+....... ...
T Consensus 85 ~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~ 160 (258)
T cd08215 85 DLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV-DLA 160 (258)
T ss_pred cHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc-cee
Confidence 999999875332356899999999999999999999987 9999999999999999999999999988654332 122
Q ss_pred hcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcCC
Q 005749 540 VALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIR 619 (679)
Q Consensus 540 ~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~ 619 (679)
....+++.|+|||......++.++||||+|++++||++|+.||..... .+...... ....
T Consensus 161 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~------~~~~~~~~--------------~~~~ 220 (258)
T cd08215 161 KTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL------LELALKIL--------------KGQY 220 (258)
T ss_pred cceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH------HHHHHHHh--------------cCCC
Confidence 334678889999999888899999999999999999999999844321 11111111 1000
Q ss_pred CCh-HHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 620 SPM-EEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 620 ~~~-~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
... ......+.+++.+||..+|++||++.|+++.
T Consensus 221 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 221 PPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 111 1223567789999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=262.91 Aligned_cols=260 Identities=18% Similarity=0.246 Sum_probs=194.5
Q ss_pred CccccCCceEEEEEE-eCCCCEEEEEEcccCcc--cCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCC
Q 005749 383 QVIEKTTYGTAYKAK-LADGATIALRLLREGSC--KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSR 459 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~g 459 (679)
+.||+|.||+||||+ .++++.||+|.++.... .-....++||.+++.++|+|||+++++... +....+|+|||..
T Consensus 8 ekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhs-dkkltlvfe~cdq- 85 (292)
T KOG0662|consen 8 EKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS-DKKLTLVFEFCDQ- 85 (292)
T ss_pred HhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhcc-CceeEEeHHHhhH-
Confidence 689999999999999 67799999999876533 335678999999999999999999998876 6788999999966
Q ss_pred ChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccch
Q 005749 460 TLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEM 539 (679)
Q Consensus 460 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 539 (679)
+|..+.... +..++.+..+.++.|+++||.|+|+++ +.|||+||.|.|++.+|+.|++|||+|+.+.-... -.
T Consensus 86 dlkkyfdsl---ng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipvr-cy 158 (292)
T KOG0662|consen 86 DLKKYFDSL---NGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR-CY 158 (292)
T ss_pred HHHHHHHhc---CCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCceE-ee
Confidence 888887654 345899999999999999999999999 99999999999999999999999999997644322 12
Q ss_pred hccccccccccccccccc-CCCCcchhHHHHHHHHHHH-hCCCCCCCCCCCcccchhHHHHH--Hhhccccc---ccchH
Q 005749 540 VALAKADGYKAPELQRMK-KCSSRTDVYAFGILLLEIL-IGKKPGKSGRNGEFVDLPSIVKV--AVLEETTM---EVFDM 612 (679)
Q Consensus 540 ~~~~gt~~y~aPE~~~~~-~~~~k~DV~S~Gvvl~El~-tg~~p~~~~~~~~~~~l~~~~~~--~~~~~~~~---~~~~~ 612 (679)
...+-|.+|++|.++-+. -|++..|+||-||++.|+. .|++.|.+.+-.+. +..+.+. ...++.+. +.-|.
T Consensus 159 saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddq--lkrif~~lg~p~ed~wps~t~lpdy 236 (292)
T KOG0662|consen 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ--LKRIFRLLGTPTEDQWPSMTKLPDY 236 (292)
T ss_pred eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHH--HHHHHHHhCCCccccCCccccCCCC
Confidence 234578899999988765 4899999999999999998 47776755433322 2222221 11122221 11121
Q ss_pred hhhhcCC--CC----hHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 613 EIMKGIR--SP----MEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 613 ~i~~~~~--~~----~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
....-+. .. .+.-...-.+++++.+.-+|.+|.++++.++.
T Consensus 237 k~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 237 KPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred cccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 1111000 00 11112233478888888999999999988753
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=297.34 Aligned_cols=246 Identities=18% Similarity=0.304 Sum_probs=196.1
Q ss_pred CccccCCceEEEEEEeC-CCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCCh
Q 005749 383 QVIEKTTYGTAYKAKLA-DGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRTL 461 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gsL 461 (679)
+.||+|+||.||+|+.. ++..||+|.+..... ..+.+.+|++++++++|+||+++++++.. .+..++|+||+++++|
T Consensus 25 ~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~e~~~~~~L 102 (286)
T cd06614 25 EKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLV-GDELWVVMEYMDGGSL 102 (286)
T ss_pred HhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEE-CCEEEEEEeccCCCcH
Confidence 67999999999999965 689999999976543 45678999999999999999999999987 5889999999999999
Q ss_pred HHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccchhc
Q 005749 462 HDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVA 541 (679)
Q Consensus 462 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 541 (679)
.+++.... ..+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++....... .....
T Consensus 103 ~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~-~~~~~ 175 (286)
T cd06614 103 TDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK-SKRNS 175 (286)
T ss_pred HHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccch-hhhcc
Confidence 99998742 36899999999999999999999987 9999999999999999999999999887653321 12233
Q ss_pred ccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcCCCC
Q 005749 542 LAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIRSP 621 (679)
Q Consensus 542 ~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~~~ 621 (679)
..++..|+|||.+.+..++.++|||||||++|||++|+.||...... ....... ...... ...
T Consensus 176 ~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~------~~~~~~~-~~~~~~----------~~~ 238 (286)
T cd06614 176 VVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL------RALFLIT-TKGIPP----------LKN 238 (286)
T ss_pred ccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHH-hcCCCC----------Ccc
Confidence 45778899999998888999999999999999999999998432211 0000000 000000 001
Q ss_pred hHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 005749 622 MEEGLVQALKLAMGCCAPVASVRPTMDEVVKQL 654 (679)
Q Consensus 622 ~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L 654 (679)
.......+.+++.+||+.+|.+||++.++++.-
T Consensus 239 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~ 271 (286)
T cd06614 239 PEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHP 271 (286)
T ss_pred hhhCCHHHHHHHHHHhccChhhCcCHHHHhhCh
Confidence 111235677899999999999999999998643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=299.55 Aligned_cols=252 Identities=19% Similarity=0.222 Sum_probs=195.3
Q ss_pred cCccccCCceEEEEEEe----CCCCEEEEEEcccCc----ccCcccHHHHHHHHhcc-CCCCCccceEEeeCCCCceEEE
Q 005749 382 GQVIEKTTYGTAYKAKL----ADGATIALRLLREGS----CKDRSSCLPVIRQLGKV-RHENLIPLRAFYQGKRGEKLLI 452 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~----~~~~~vAvK~~~~~~----~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~~lv 452 (679)
.+.||+|+||.||+++. .+++.||||.++... ....+.+.+|++++.++ +||||+++++.+.. ....++|
T Consensus 5 ~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~-~~~~~lv 83 (288)
T cd05583 5 LRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQT-DTKLHLI 83 (288)
T ss_pred EEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeec-CCEEEEE
Confidence 36899999999999984 357899999987532 12345688999999999 59999999998887 6788999
Q ss_pred EEecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccC
Q 005749 453 YDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMV 532 (679)
Q Consensus 453 ~ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 532 (679)
|||+++|+|.+++... ..+++..++.++.|+++||+|||+.+ ++||||||+||+++.++.++++|||+++...
T Consensus 84 ~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 156 (288)
T cd05583 84 LDYVNGGELFTHLYQR----EHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (288)
T ss_pred EecCCCCcHHHHHhhc----CCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccccc
Confidence 9999999999998752 45889999999999999999999987 9999999999999999999999999988754
Q ss_pred cccccchhcccccccccccccccccC--CCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccc
Q 005749 533 PAVADEMVALAKADGYKAPELQRMKK--CSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVF 610 (679)
Q Consensus 533 ~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 610 (679)
...........++..|+|||...+.. .+.++||||||+++|||++|+.||...... .......+
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~--~~~~~~~~------------ 222 (288)
T cd05583 157 AEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ--NSQSEISR------------ 222 (288)
T ss_pred cccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc--chHHHHHH------------
Confidence 43222223346788999999987654 788999999999999999999998432211 11111111
Q ss_pred hHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhh
Q 005749 611 DMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEEN 657 (679)
Q Consensus 611 ~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 657 (679)
.+.....+........+.+++.+||+.||++|||+.++.+.|+..
T Consensus 223 --~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 223 --RILKSKPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred --HHHccCCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 111111111122235667899999999999999999888777654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=314.22 Aligned_cols=281 Identities=17% Similarity=0.200 Sum_probs=205.0
Q ss_pred cCccccCCceEEEEEE-eCCCCEEEEEEcccCc-ccCcccHHHHHHHHhccCCCCCccceEEeeCC-----CCceEEEEE
Q 005749 382 GQVIEKTTYGTAYKAK-LADGATIALRLLREGS-CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGK-----RGEKLLIYD 454 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~-----~~~~~lv~e 454 (679)
.+.+|+|+||.||+|+ ..+|+.||||.++... ....+...+|+++|++++|+|||+++++=.+. .....+|||
T Consensus 18 ~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmE 97 (732)
T KOG4250|consen 18 DERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVME 97 (732)
T ss_pred hhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEe
Confidence 3789999999999999 7789999999998753 45567789999999999999999999875542 235689999
Q ss_pred ecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeec--CCC--ceEEeecccccc
Q 005749 455 YFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVD--DFF--VSRLTEFGLDQL 530 (679)
Q Consensus 455 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~--~~~--~~kl~DFGla~~ 530 (679)
||.+|||...|..... ..-+++.+.+.+..++..||.|||+++ |+||||||.||++- .+| .-||+|||.||.
T Consensus 98 yC~gGsL~~~L~~PEN-~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Are 173 (732)
T KOG4250|consen 98 YCSGGSLRKVLNSPEN-AYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARE 173 (732)
T ss_pred ecCCCcHHHHhcCccc-ccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeeccccccc
Confidence 9999999999987654 345999999999999999999999988 99999999999984 333 359999999998
Q ss_pred cCcccccchhcccccccccccccccc-cCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccc---
Q 005749 531 MVPAVADEMVALAKADGYKAPELQRM-KKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETT--- 606 (679)
Q Consensus 531 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~--- 606 (679)
+.+.. .....+||..|.+||+... +.|+..+|.|||||++||.+||..||.......-..-..|.... .....
T Consensus 174 l~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~t-kkp~~v~i 250 (732)
T KOG4250|consen 174 LDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIIT-KKPSGVAI 250 (732)
T ss_pred CCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhc-cCCCceeE
Confidence 86543 5678899999999999994 88999999999999999999999999543222110001111110 00000
Q ss_pred ---cccchHhhhhcCCCC----hHHHHHHHHHHHHhccCcCCCCCC--CHHHHHHHHHhhCCCCCCCCCCCc
Q 005749 607 ---MEVFDMEIMKGIRSP----MEEGLVQALKLAMGCCAPVASVRP--TMDEVVKQLEENRPRNRSALYSPT 669 (679)
Q Consensus 607 ---~~~~~~~i~~~~~~~----~~~~~~~~~~l~~~cl~~dP~~RP--s~~evl~~L~~~~~~~~~~~~~~~ 669 (679)
.+.-.+.-.....+. .+.....+-..+..++..+|++|= .+.+....+..+.......+++..
T Consensus 251 ~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~~vvhiFs~~ 322 (732)
T KOG4250|consen 251 GAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNLKVVHIFSMV 322 (732)
T ss_pred eeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhhheeEEEeec
Confidence 000000000000011 111222333566677888888888 777777777777655554444443
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=305.44 Aligned_cols=257 Identities=17% Similarity=0.214 Sum_probs=190.3
Q ss_pred CccccCCceEEEEEE-eCCCCEEEEEEcccCc--ccCcccHHHHHHHHhccCCCCCccceEEeeCCC-----CceEEEEE
Q 005749 383 QVIEKTTYGTAYKAK-LADGATIALRLLREGS--CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKR-----GEKLLIYD 454 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~-----~~~~lv~e 454 (679)
+.||+|+||.||+|+ ..+++.||+|.+.... ....+.+.+|++++++++||||+++++++.... ...++|||
T Consensus 22 ~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e 101 (353)
T cd07850 22 KPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVME 101 (353)
T ss_pred EEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEEEEEe
Confidence 789999999999999 4579999999986432 223456778999999999999999999886421 35799999
Q ss_pred ecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcc
Q 005749 455 YFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPA 534 (679)
Q Consensus 455 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 534 (679)
|+.+ +|.+.+.. .+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++.....
T Consensus 102 ~~~~-~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 171 (353)
T cd07850 102 LMDA-NLCQVIQM------DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 171 (353)
T ss_pred ccCC-CHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCccceeCCCC
Confidence 9965 88888753 2788999999999999999999988 999999999999999999999999999865332
Q ss_pred cccchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHH----------------
Q 005749 535 VADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVK---------------- 598 (679)
Q Consensus 535 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~---------------- 598 (679)
. ......++..|+|||.+.+..++.++|||||||++|||++|+.||......+. ......
T Consensus 172 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 247 (353)
T cd07850 172 F--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQ--WNKIIEQLGTPSDEFMSRLQPT 247 (353)
T ss_pred C--CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHH--HHHHHHhcCCCCHHHHHHhhhh
Confidence 1 12334578889999999988999999999999999999999999954332110 000000
Q ss_pred --HHhhcccc--cccchHhhhhcCC-----CChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 599 --VAVLEETT--MEVFDMEIMKGIR-----SPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 599 --~~~~~~~~--~~~~~~~i~~~~~-----~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
........ ...+......... .........+.+++.+|++.||++|||+.|+++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 248 VRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred hhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000000 0000000000000 0011234567799999999999999999999976
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=293.96 Aligned_cols=242 Identities=17% Similarity=0.206 Sum_probs=185.6
Q ss_pred CccccCCceEEEEEEe-CCCCEEEEEEcccCccc---CcccHHHHHHHH-hccCCCCCccceEEeeCCCCceEEEEEecC
Q 005749 383 QVIEKTTYGTAYKAKL-ADGATIALRLLREGSCK---DRSSCLPVIRQL-GKVRHENLIPLRAFYQGKRGEKLLIYDYFP 457 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~---~~~~~~~Ei~~l-~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~ 457 (679)
+.||+|+||.||+|+. .+++.||+|.++..... ....+..|..++ ...+|+||+++++++.. .+..++|+||++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~ 80 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQS-KDYLYLVMEYLN 80 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEc-CCeEEEEEeccC
Confidence 4689999999999994 56899999998654321 122344555444 44589999999999987 678999999999
Q ss_pred CCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCccccc
Q 005749 458 SRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVAD 537 (679)
Q Consensus 458 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 537 (679)
+++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.+||+|||+++....
T Consensus 81 ~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---- 149 (260)
T cd05611 81 GGDCASLIKTL----GGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---- 149 (260)
T ss_pred CCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc----
Confidence 99999999753 45889999999999999999999988 99999999999999999999999999875432
Q ss_pred chhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhc
Q 005749 538 EMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKG 617 (679)
Q Consensus 538 ~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~ 617 (679)
.....++..|+|||.+.+..++.++||||||+++|||++|..||...... ........ .. ..
T Consensus 150 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~-~~---------~~- 211 (260)
T cd05611 150 -NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD------AVFDNILS-RR---------IN- 211 (260)
T ss_pred -cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHHh-cc---------cC-
Confidence 12345788899999998888899999999999999999999999543221 11110000 00 00
Q ss_pred CCCC-hHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 005749 618 IRSP-MEEGLVQALKLAMGCCAPVASVRPTMDEVVKQL 654 (679)
Q Consensus 618 ~~~~-~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L 654 (679)
.... .+.....+.+++.+||+.+|++||++.++.+.|
T Consensus 212 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l 249 (260)
T cd05611 212 WPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIK 249 (260)
T ss_pred CCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence 0000 112345678999999999999999876555544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=304.96 Aligned_cols=264 Identities=20% Similarity=0.346 Sum_probs=193.4
Q ss_pred cCccccCCceEEEEEEeC-CCCEEEEEEcccC--cccCcccHHHHHHHHhcc-CCCCCccceEEeeCC-CCceEEEEEec
Q 005749 382 GQVIEKTTYGTAYKAKLA-DGATIALRLLREG--SCKDRSSCLPVIRQLGKV-RHENLIPLRAFYQGK-RGEKLLIYDYF 456 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~-~~~~~lv~ey~ 456 (679)
.+.||+|+||.||+|... +++.||+|++... .......+.+|+.+++++ +||||++++++|... ....++||||+
T Consensus 12 ~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~ 91 (337)
T cd07852 12 LQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYM 91 (337)
T ss_pred hHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEeccc
Confidence 378999999999999954 6889999988543 223345677899999999 999999999988653 34689999999
Q ss_pred CCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccc
Q 005749 457 PSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVA 536 (679)
Q Consensus 457 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 536 (679)
+ ++|.+++... .+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++.......
T Consensus 92 ~-~~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~ 162 (337)
T cd07852 92 E-TDLHAVIRAN-----ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEE 162 (337)
T ss_pred c-cCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhccccccc
Confidence 7 4999888652 5889999999999999999999988 99999999999999999999999999986643321
Q ss_pred ----cchhcccccccccccccccc-cCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHH----------h
Q 005749 537 ----DEMVALAKADGYKAPELQRM-KKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVA----------V 601 (679)
Q Consensus 537 ----~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~----------~ 601 (679)
.......++..|+|||.+.+ ..++.++||||||+++|||++|+.||.+....+. ........ .
T Consensus 163 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd07852 163 NPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQ--LEKIIEVIGPPSAEDIESI 240 (337)
T ss_pred cccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHHHhCCCCHHHHHHH
Confidence 12234568889999998764 5578999999999999999999999854332111 00000000 0
Q ss_pred hcccccccchHhhhhcCCCCh----HHHHHHHHHHHHhccCcCCCCCCCHHHHHHH--HHhh
Q 005749 602 LEETTMEVFDMEIMKGIRSPM----EEGLVQALKLAMGCCAPVASVRPTMDEVVKQ--LEEN 657 (679)
Q Consensus 602 ~~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~--L~~~ 657 (679)
......+.++ .+........ +....++.+++.+||+.||++|||+.++++. ++..
T Consensus 241 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~ 301 (337)
T cd07852 241 KSPFAATMLD-SLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF 301 (337)
T ss_pred HhhhHHHhhh-hcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence 0000000110 0000000111 1123567889999999999999999999986 4444
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=304.13 Aligned_cols=262 Identities=17% Similarity=0.208 Sum_probs=188.8
Q ss_pred ccccC--CceEEEEEEe-CCCCEEEEEEcccCcc--cCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCC
Q 005749 384 VIEKT--TYGTAYKAKL-ADGATIALRLLREGSC--KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPS 458 (679)
Q Consensus 384 ~ig~G--~~g~Vy~~~~-~~~~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~ 458 (679)
.||+| +||+||+|+. .+|+.||+|++..... ...+.+.+|+.+++.++||||++++++|.. .+..++|+||+.+
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~-~~~~~~v~e~~~~ 83 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTT-GSWLWVISPFMAY 83 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEec-CCceEEEEecccC
Confidence 46666 9999999994 5799999999875432 224578899999999999999999999987 6789999999999
Q ss_pred CChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccc
Q 005749 459 RTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADE 538 (679)
Q Consensus 459 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 538 (679)
++|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+|++||+.+..........
T Consensus 84 ~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 84 GSANSLLKTYF--PEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred CCHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence 99999987643 234889999999999999999999988 9999999999999999999999998654321111000
Q ss_pred ------hhccccccccccccccccc--CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHH---------h
Q 005749 539 ------MVALAKADGYKAPELQRMK--KCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVA---------V 601 (679)
Q Consensus 539 ------~~~~~gt~~y~aPE~~~~~--~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~---------~ 601 (679)
.....++..|+|||++.+. .++.++|||||||++|||++|+.||....... ......... .
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 236 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQ--MLLQKLKGPPYSPLDITTF 236 (328)
T ss_pred cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHH--HHHHHhcCCCCCCcccccc
Confidence 0112345669999998763 47899999999999999999999995543211 000000000 0
Q ss_pred h-------cc--ccc-ccchHh--------hh-hcCC-CChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 602 L-------EE--TTM-EVFDME--------IM-KGIR-SPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 602 ~-------~~--~~~-~~~~~~--------i~-~~~~-~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
. .. ... .+.+.. +. .... +........+.+++.+||+.||++|||++|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 237 PCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred chhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 0 00 000 000000 00 0000 1122345678899999999999999999999865
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=296.88 Aligned_cols=254 Identities=13% Similarity=0.172 Sum_probs=178.0
Q ss_pred cCccccCCceEEEEEEeCC----CCEEEEEEcccCcccCc-----------ccHHHHHHHHhccCCCCCccceEEeeCCC
Q 005749 382 GQVIEKTTYGTAYKAKLAD----GATIALRLLREGSCKDR-----------SSCLPVIRQLGKVRHENLIPLRAFYQGKR 446 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~~----~~~vAvK~~~~~~~~~~-----------~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~ 446 (679)
.++||+|+||+||+|+..+ +..+|+|+......... .....+...+..++|+||+++++++....
T Consensus 17 ~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~ 96 (294)
T PHA02882 17 DKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGCGSFKR 96 (294)
T ss_pred eeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEeeeEec
Confidence 4789999999999999644 45667665433221110 11223334456678999999998765422
Q ss_pred C---ceEEEEEecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEe
Q 005749 447 G---EKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLT 523 (679)
Q Consensus 447 ~---~~~lv~ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~ 523 (679)
. ..++++|++.. ++.+.+... ...++..++.|+.|+++||+|||+.+ |+||||||+|||+++++.+||+
T Consensus 97 ~~~~~~~~~~~~~~~-~~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~~~~l~ 168 (294)
T PHA02882 97 CRMYYRFILLEKLVE-NTKEIFKRI----KCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNNRGYII 168 (294)
T ss_pred CCceEEEEEEehhcc-CHHHHHHhh----ccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCcEEEE
Confidence 2 34677887754 666666542 23578888999999999999999987 9999999999999999999999
Q ss_pred ecccccccCcccc------cchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHH
Q 005749 524 EFGLDQLMVPAVA------DEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIV 597 (679)
Q Consensus 524 DFGla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~ 597 (679)
|||+|+.+..... .......||+.|+|||+..+..++.++|||||||++|||++|+.||.+..... .+....
T Consensus 169 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~--~~~~~~ 246 (294)
T PHA02882 169 DYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNG--NLIHAA 246 (294)
T ss_pred EcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccch--HHHHHh
Confidence 9999986532211 11123468999999999999999999999999999999999999996542221 111111
Q ss_pred HHHhhcccccccchHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHH
Q 005749 598 KVAVLEETTMEVFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLE 655 (679)
Q Consensus 598 ~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~ 655 (679)
...+. ..+..+. ...+.....+.+++..||..+|++||++.++.+.++
T Consensus 247 ~~~~~---------~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 247 KCDFI---------KRLHEGK-IKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHHHH---------HHhhhhh-hccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 10000 0111110 001122356778999999999999999999998763
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=296.72 Aligned_cols=247 Identities=20% Similarity=0.252 Sum_probs=190.8
Q ss_pred CccccCCceEEEEEEe----CCCCEEEEEEcccCcc----cCcccHHHHHHHHhcc-CCCCCccceEEeeCCCCceEEEE
Q 005749 383 QVIEKTTYGTAYKAKL----ADGATIALRLLREGSC----KDRSSCLPVIRQLGKV-RHENLIPLRAFYQGKRGEKLLIY 453 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~----~~~~~vAvK~~~~~~~----~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~~lv~ 453 (679)
+.||+|+||.||+|+. .+|..||+|+++.... ...+.+.+|++++.++ +|+||+++++++.. +...++||
T Consensus 6 ~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~-~~~~~lv~ 84 (290)
T cd05613 6 KVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT-DTKLHLIL 84 (290)
T ss_pred eeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeec-CCeEEEEE
Confidence 6899999999999985 4689999999875321 2245678899999999 59999999998887 67889999
Q ss_pred EecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCc
Q 005749 454 DYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVP 533 (679)
Q Consensus 454 ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 533 (679)
||+++++|.+++... ..+++..+..++.|+++||+|||+.+ ++||||||+||++++++.+||+|||+++....
T Consensus 85 e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 157 (290)
T cd05613 85 DYINGGELFTHLSQR----ERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFHE 157 (290)
T ss_pred ecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCccceeccc
Confidence 999999999999763 45889999999999999999999988 99999999999999999999999999986543
Q ss_pred ccccchhccccccccccccccccc--CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccch
Q 005749 534 AVADEMVALAKADGYKAPELQRMK--KCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFD 611 (679)
Q Consensus 534 ~~~~~~~~~~gt~~y~aPE~~~~~--~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 611 (679)
..........|+..|+|||.+... .++.++||||||+++|||++|+.||...... .....+...
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~--~~~~~~~~~------------ 223 (290)
T cd05613 158 DEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK--NSQAEISRR------------ 223 (290)
T ss_pred ccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc--ccHHHHHHH------------
Confidence 322223345688899999988753 4678999999999999999999998432111 111111111
Q ss_pred HhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCC-----CHHHHHHH
Q 005749 612 MEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRP-----TMDEVVKQ 653 (679)
Q Consensus 612 ~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~evl~~ 653 (679)
+.....+........+.+++.+||+.||++|| ++++++..
T Consensus 224 --~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 224 --ILKSEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred --hhccCCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 11111111122335667899999999999997 66666654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=321.09 Aligned_cols=267 Identities=14% Similarity=0.143 Sum_probs=181.6
Q ss_pred cCccccCCceEEEEEEeCC--CCEEEEEEcc--------------c---CcccCcccHHHHHHHHhccCCCCCccceEEe
Q 005749 382 GQVIEKTTYGTAYKAKLAD--GATIALRLLR--------------E---GSCKDRSSCLPVIRQLGKVRHENLIPLRAFY 442 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~~--~~~vAvK~~~--------------~---~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~ 442 (679)
.+.||+|+||+||+++.+. +..+++|.+. . ........+.+|+++|++++|||||++++++
T Consensus 153 i~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 232 (501)
T PHA03210 153 IDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILKIEEIL 232 (501)
T ss_pred EeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCcEeEEE
Confidence 3789999999999987532 2222222110 0 0111234578999999999999999999999
Q ss_pred eCCCCceEEEEEecCCCChHHHhhcccC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceE
Q 005749 443 QGKRGEKLLIYDYFPSRTLHDLLHDTIA-GKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSR 521 (679)
Q Consensus 443 ~~~~~~~~lv~ey~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~k 521 (679)
.. .+..++|+|++. ++|.+++..... ........+.+.|+.|++.||+|||+++ |+||||||+|||++.++.+|
T Consensus 233 ~~-~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl~~~~~vk 307 (501)
T PHA03210 233 RS-EANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFLNCDGKIV 307 (501)
T ss_pred EE-CCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEE
Confidence 87 678899999995 478777754321 1122345667889999999999999988 99999999999999999999
Q ss_pred EeecccccccCcccccchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCC-CcccchhHHHHHH
Q 005749 522 LTEFGLDQLMVPAVADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRN-GEFVDLPSIVKVA 600 (679)
Q Consensus 522 l~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~-~~~~~l~~~~~~~ 600 (679)
|+|||+++.+............||..|+|||++.+..++.++|||||||++|||++|..++..... .....+.......
T Consensus 308 L~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~~~ 387 (501)
T PHA03210 308 LGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSL 387 (501)
T ss_pred EEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHHhc
Confidence 999999987644332233345789999999999998999999999999999999998764333222 1111222211110
Q ss_pred h-hccccc----ccchHhh---hhcCCCChHH------HHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 601 V-LEETTM----EVFDMEI---MKGIRSPMEE------GLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 601 ~-~~~~~~----~~~~~~i---~~~~~~~~~~------~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
. ..+... +.++... ........+. ....+.+++.+|++.||++|||+.|++++
T Consensus 388 ~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 388 SVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred ccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 0 000000 0000000 0000000011 11345677899999999999999999875
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=300.44 Aligned_cols=262 Identities=21% Similarity=0.277 Sum_probs=190.1
Q ss_pred cCccccCCceEEEEEEe-CCCCEEEEEEcccCcc--cCcccHHHHHHHHhccCCCCCccceEEeeCCC---------Cce
Q 005749 382 GQVIEKTTYGTAYKAKL-ADGATIALRLLREGSC--KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKR---------GEK 449 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~---------~~~ 449 (679)
.+.||+|+||.||+|+. .+|+.||+|.++.... .....+.+|++++++++||||+++++++.+.. +..
T Consensus 12 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~ 91 (302)
T cd07864 12 IGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAF 91 (302)
T ss_pred eeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccCCcE
Confidence 47899999999999995 4689999999975432 23356788999999999999999999887632 378
Q ss_pred EEEEEecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeeccccc
Q 005749 450 LLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQ 529 (679)
Q Consensus 450 ~lv~ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 529 (679)
++|+||+++ ++.+.+... ...+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++.
T Consensus 92 ~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~ 164 (302)
T cd07864 92 YLVFEYMDH-DLMGLLESG---LVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLAR 164 (302)
T ss_pred EEEEcccCc-cHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEeCcccccc
Confidence 999999986 777777643 345899999999999999999999988 9999999999999999999999999998
Q ss_pred ccCcccccchhcccccccccccccccc-cCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhccc---
Q 005749 530 LMVPAVADEMVALAKADGYKAPELQRM-KKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEET--- 605 (679)
Q Consensus 530 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~--- 605 (679)
..............++..|+|||.+.+ ..++.++|||||||++|||++|+.||...... ..+..... ......
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~--~~~~~~~~-~~~~~~~~~ 241 (302)
T cd07864 165 LYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQEL--AQLELISR-LCGSPCPAV 241 (302)
T ss_pred cccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHH-HhCCCChhh
Confidence 764332222222345778999998764 45789999999999999999999998543211 11111111 100000
Q ss_pred cccc--------chHh--hhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 606 TMEV--------FDME--IMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 606 ~~~~--------~~~~--i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
.... .+.. ...............+.+++.+||+.||++||+++++++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 242 WPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred cccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0000 0000 0000000001123567899999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=291.13 Aligned_cols=234 Identities=22% Similarity=0.248 Sum_probs=182.0
Q ss_pred cccCCceEEEEEE-eCCCCEEEEEEcccCcccCcccHHHHHHHHhcc-CCCCCccceEEeeCCCCceEEEEEecCCCChH
Q 005749 385 IEKTTYGTAYKAK-LADGATIALRLLREGSCKDRSSCLPVIRQLGKV-RHENLIPLRAFYQGKRGEKLLIYDYFPSRTLH 462 (679)
Q Consensus 385 ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~~lv~ey~~~gsL~ 462 (679)
+|+|+||.||+++ ..++..+|+|.+........ |+.....+ +||||+++++++.. .+..++||||+++++|.
T Consensus 24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~-~~~~~iv~e~~~~~~L~ 97 (267)
T PHA03390 24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTT-LKGHVLIMDYIKDGDLF 97 (267)
T ss_pred ecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEec-CCeeEEEEEcCCCCcHH
Confidence 6999999999999 45788999999865422111 22222222 79999999999987 67899999999999999
Q ss_pred HHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCC-ceEEeecccccccCcccccchhc
Q 005749 463 DLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFF-VSRLTEFGLDQLMVPAVADEMVA 541 (679)
Q Consensus 463 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~-~~kl~DFGla~~~~~~~~~~~~~ 541 (679)
+++... ..+++..++.++.|+++||+|||+.+ ++||||||+||+++.++ .++|+|||+++..... ..
T Consensus 98 ~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~-----~~ 165 (267)
T PHA03390 98 DLLKKE----GKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP-----SC 165 (267)
T ss_pred HHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccceecCCC-----cc
Confidence 999763 36899999999999999999999988 99999999999999998 9999999998765322 23
Q ss_pred ccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcCCCC
Q 005749 542 LAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIRSP 621 (679)
Q Consensus 542 ~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~~~ 621 (679)
..++..|+|||++.+..++.++||||||+++|||++|+.||...... ......+.... ......
T Consensus 166 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~---------------~~~~~~ 229 (267)
T PHA03390 166 YDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDE-ELDLESLLKRQ---------------QKKLPF 229 (267)
T ss_pred CCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcc-hhhHHHHHHhh---------------cccCCc
Confidence 46788999999999888999999999999999999999999643222 11111111111 000011
Q ss_pred hHHHHHHHHHHHHhccCcCCCCCCC-HHHHHH
Q 005749 622 MEEGLVQALKLAMGCCAPVASVRPT-MDEVVK 652 (679)
Q Consensus 622 ~~~~~~~~~~l~~~cl~~dP~~RPs-~~evl~ 652 (679)
.+...+.+.+++.+||+.+|.+||+ ++|+++
T Consensus 230 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 230 IKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred ccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 1233456778999999999999996 688874
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=327.47 Aligned_cols=247 Identities=21% Similarity=0.322 Sum_probs=184.1
Q ss_pred CccccCCceEEEEEE-eCCCCEEEEEEcccCc-ccCcccHHHHHHHHhccCCCCCccceEEeeCCCC-------------
Q 005749 383 QVIEKTTYGTAYKAK-LADGATIALRLLREGS-CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRG------------- 447 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~------------- 447 (679)
+++|+||||.|||++ .-||+.+|||++.... ........+|++.+++++|||||+++..+.+...
T Consensus 485 ~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~~~~ 564 (1351)
T KOG1035|consen 485 ELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVASDSE 564 (1351)
T ss_pred HHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccccccchh
Confidence 799999999999999 5689999999997653 2334568899999999999999999865432100
Q ss_pred --------------------------------------------------------------------------------
Q 005749 448 -------------------------------------------------------------------------------- 447 (679)
Q Consensus 448 -------------------------------------------------------------------------------- 447 (679)
T Consensus 565 ~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~~d~ 644 (1351)
T KOG1035|consen 565 SRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVILDD 644 (1351)
T ss_pred hhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCccccCc
Confidence
Q ss_pred -------------------------ceEEEEEecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCe
Q 005749 448 -------------------------EKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPI 502 (679)
Q Consensus 448 -------------------------~~~lv~ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~i 502 (679)
..||=||||+.-++.++++...... .....++++++|+.||+|+|+.+ |
T Consensus 645 ~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~---~~d~~wrLFreIlEGLaYIH~~g---i 718 (1351)
T KOG1035|consen 645 TSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS---QRDEAWRLFREILEGLAYIHDQG---I 718 (1351)
T ss_pred chhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch---hhHHHHHHHHHHHHHHHHHHhCc---e
Confidence 1367799999988888887642211 45678899999999999999988 9
Q ss_pred eecCCCCCCeeecCCCceEEeecccccccC-----------------cccccchhccccccccccccccccc---CCCCc
Q 005749 503 THGNVRSKNVLVDDFFVSRLTEFGLDQLMV-----------------PAVADEMVALAKADGYKAPELQRMK---KCSSR 562 (679)
Q Consensus 503 vHrDlkp~NILl~~~~~~kl~DFGla~~~~-----------------~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~k 562 (679)
|||||||.||++|++..+||+|||+|.... .......+..+||.-|+|||++.+. .|+.|
T Consensus 719 IHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~K 798 (1351)
T KOG1035|consen 719 IHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSK 798 (1351)
T ss_pred eeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccch
Confidence 999999999999999999999999998721 0011134566899999999998854 49999
Q ss_pred chhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcCCCChHHHHHHHHHHHHhccCcCCC
Q 005749 563 TDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVAS 642 (679)
Q Consensus 563 ~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~ 642 (679)
+|+||+|||++||+. ||...++. +.... .+.. ..+... .....+.++.-.+++.+++++||.
T Consensus 799 iDmYSLGIVlFEM~y---PF~TsMER-----a~iL~-~LR~--------g~iP~~-~~f~~~~~~~e~slI~~Ll~hdP~ 860 (1351)
T KOG1035|consen 799 IDMYSLGIVLFEMLY---PFGTSMER-----ASILT-NLRK--------GSIPEP-ADFFDPEHPEEASLIRWLLSHDPS 860 (1351)
T ss_pred hhhHHHHHHHHHHhc---cCCchHHH-----HHHHH-hccc--------CCCCCC-cccccccchHHHHHHHHHhcCCCc
Confidence 999999999999985 55322111 11110 0111 111110 011334556677899999999999
Q ss_pred CCCCHHHHHHH
Q 005749 643 VRPTMDEVVKQ 653 (679)
Q Consensus 643 ~RPs~~evl~~ 653 (679)
+|||+.|+++.
T Consensus 861 kRPtA~eLL~s 871 (1351)
T KOG1035|consen 861 KRPTATELLNS 871 (1351)
T ss_pred cCCCHHHHhhc
Confidence 99999999863
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=297.43 Aligned_cols=259 Identities=21% Similarity=0.288 Sum_probs=194.9
Q ss_pred CccccCCceEEEEEEe-CCCCEEEEEEcccCccc--CcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCC
Q 005749 383 QVIEKTTYGTAYKAKL-ADGATIALRLLREGSCK--DRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSR 459 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~--~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~g 459 (679)
+.||+|++|.||+|+. .+++.+|+|.++..... ....+.+|++++++++|+||+++++++.+ .+..++|+||+++
T Consensus 5 ~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~v~e~~~~- 82 (283)
T cd05118 5 GKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRH-KGDLYLVFEFMDT- 82 (283)
T ss_pred eeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhcc-CCCEEEEEeccCC-
Confidence 5799999999999995 57899999998764322 34578899999999999999999999887 6889999999976
Q ss_pred ChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccch
Q 005749 460 TLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEM 539 (679)
Q Consensus 460 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 539 (679)
+|.+++... ...+++..+..++.|++.||+|||+.+ |+|+||||+||++++++.+||+|||.+....... ...
T Consensus 83 ~l~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~~ 155 (283)
T cd05118 83 DLYKLIKDR---QRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RPY 155 (283)
T ss_pred CHHHHHHhh---cccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-ccc
Confidence 888888763 246899999999999999999999988 9999999999999999999999999988764432 122
Q ss_pred hccccccccccccccccc-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhc---ccccccch----
Q 005749 540 VALAKADGYKAPELQRMK-KCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLE---ETTMEVFD---- 611 (679)
Q Consensus 540 ~~~~gt~~y~aPE~~~~~-~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~---~~~~~~~~---- 611 (679)
....++..|+|||.+.+. .++.++||||+|+++|||++|+.||......+ ........... .......+
T Consensus 156 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd05118 156 THYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEID---QLFKIFRTLGTPDPEVWPKFTSLARN 232 (283)
T ss_pred cCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcCCCchHhcccchhhhhh
Confidence 234577889999998766 78999999999999999999999985433211 10000000000 00000000
Q ss_pred --HhhhhcCCCC----hHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 612 --MEIMKGIRSP----MEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 612 --~~i~~~~~~~----~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
.......... .+....++.+++.+||+.||.+||++++++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 233 YKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 0000000011 11234677899999999999999999999863
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=300.11 Aligned_cols=246 Identities=17% Similarity=0.209 Sum_probs=190.4
Q ss_pred CccccCCceEEEEEEeCCCCEEEEEEcccCc--ccCcccHHHHHHHHhcc-CCCCCccceEEeeCCCCceEEEEEecCCC
Q 005749 383 QVIEKTTYGTAYKAKLADGATIALRLLREGS--CKDRSSCLPVIRQLGKV-RHENLIPLRAFYQGKRGEKLLIYDYFPSR 459 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~~~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~~lv~ey~~~g 459 (679)
+.||+||.+.||++...+.+.+|+|++.... ......|..|+..|.++ .|.+||++++|-.. ++..||||||=+.
T Consensus 367 k~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~-d~~lYmvmE~Gd~- 444 (677)
T KOG0596|consen 367 KQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVT-DGYLYMVMECGDI- 444 (677)
T ss_pred HhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeecc-CceEEEEeecccc-
Confidence 7899999999999998888999998876532 33456799999999999 49999999998777 7899999998754
Q ss_pred ChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccc-
Q 005749 460 TLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADE- 538 (679)
Q Consensus 460 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~- 538 (679)
||..+|+.+.. ...+| .++.|..|++.++.++|.++ |||.||||.|+|+-+ |.+||+|||+|..+......-
T Consensus 445 DL~kiL~k~~~--~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DTTsI~ 517 (677)
T KOG0596|consen 445 DLNKILKKKKS--IDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDTTSIV 517 (677)
T ss_pred cHHHHHHhccC--CCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe-eeEEeeeechhcccCcccccee
Confidence 99999987532 22345 78899999999999999999 999999999999975 789999999999886554332
Q ss_pred hhccccccccccccccccc-----------CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhccccc
Q 005749 539 MVALAKADGYKAPELQRMK-----------KCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTM 607 (679)
Q Consensus 539 ~~~~~gt~~y~aPE~~~~~-----------~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 607 (679)
....+||..||+||.+... +.+.++||||+|||||+|+.|+.||.+.. ..|.+..
T Consensus 518 kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~-------n~~aKl~------- 583 (677)
T KOG0596|consen 518 KDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII-------NQIAKLH------- 583 (677)
T ss_pred eccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH-------HHHHHHH-------
Confidence 3467899999999987532 25689999999999999999999993221 1122211
Q ss_pred ccchHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 608 EVFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 608 ~~~~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
.+.++...-. .+..+ ...+++++++.||+.||.+||+..|+++.
T Consensus 584 aI~~P~~~Ie-fp~~~-~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 584 AITDPNHEIE-FPDIP-ENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred hhcCCCcccc-ccCCC-CchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 1111110000 00011 11238899999999999999999999875
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=291.78 Aligned_cols=244 Identities=17% Similarity=0.281 Sum_probs=189.9
Q ss_pred cCccccCCceEEEEEE-eCCCCEEEEEEcccCc-----ccCcccHHHHHHHHhccCCCCCccceEEeeCC-CCceEEEEE
Q 005749 382 GQVIEKTTYGTAYKAK-LADGATIALRLLREGS-----CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGK-RGEKLLIYD 454 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~-----~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~-~~~~~lv~e 454 (679)
++.||+|+||.||+|+ ..++..||+|.+.... ......+.+|++++++++|+||+++++++.+. .+..++++|
T Consensus 7 ~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e 86 (264)
T cd06653 7 GKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVE 86 (264)
T ss_pred eeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEEEE
Confidence 5789999999999999 4569999999875321 12234788999999999999999999988753 345789999
Q ss_pred ecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcc
Q 005749 455 YFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPA 534 (679)
Q Consensus 455 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 534 (679)
|+++++|.+++... ..+++...++++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||+++.....
T Consensus 87 ~~~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 159 (264)
T cd06653 87 YMPGGSIKDQLKAY----GALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTI 159 (264)
T ss_pred eCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccccccc
Confidence 99999999998753 34789999999999999999999988 999999999999999999999999999865321
Q ss_pred c--ccchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchH
Q 005749 535 V--ADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDM 612 (679)
Q Consensus 535 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 612 (679)
. ........++..|+|||++.+..++.++|||||||++|||++|+.||...... ....+
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~~-------------- 220 (264)
T cd06653 160 CMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM-----AAIFK-------------- 220 (264)
T ss_pred cccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH-----HHHHH--------------
Confidence 1 11122346788999999998888999999999999999999999998432111 00000
Q ss_pred hhhhcCCCC-hHHHHHHHHHHHHhccCcCCCCCCCHHHHHH
Q 005749 613 EIMKGIRSP-MEEGLVQALKLAMGCCAPVASVRPTMDEVVK 652 (679)
Q Consensus 613 ~i~~~~~~~-~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 652 (679)
.......+. .......+.+++.+||+ +|..||++.+++.
T Consensus 221 ~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 221 IATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred HHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 001111111 12233567789999999 4799999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=296.74 Aligned_cols=259 Identities=18% Similarity=0.288 Sum_probs=192.2
Q ss_pred cCccccCCceEEEEEEeC-CCCEEEEEEcccCcc-cCcccHHHHHHHHhccC-CCCCccceEEeeCCCCceEEEEEecCC
Q 005749 382 GQVIEKTTYGTAYKAKLA-DGATIALRLLREGSC-KDRSSCLPVIRQLGKVR-HENLIPLRAFYQGKRGEKLLIYDYFPS 458 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~-H~nIv~l~~~~~~~~~~~~lv~ey~~~ 458 (679)
.+.||+|+||+||+|+.. +++.||+|++..... .+.....+|+..+++++ |+||+++++++.+ .+..++||||+ +
T Consensus 4 ~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~-~~~~~lv~e~~-~ 81 (283)
T cd07830 4 IKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRE-NDELYFVFEYM-E 81 (283)
T ss_pred heeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhc-CCcEEEEEecC-C
Confidence 367999999999999964 588999999875432 22234567999999999 9999999999987 78999999999 7
Q ss_pred CChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccc
Q 005749 459 RTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADE 538 (679)
Q Consensus 459 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 538 (679)
|+|.+++.... ...+++..+..++.|++.||.|||+++ ++|+||||+||++++++.++|+|||+++...... .
T Consensus 82 ~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~--~ 154 (283)
T cd07830 82 GNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP--P 154 (283)
T ss_pred CCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCC--C
Confidence 89999887642 245899999999999999999999988 9999999999999999999999999998654321 1
Q ss_pred hhccccccccccccccc-ccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccc-h---------hHHHHHHhhccccc
Q 005749 539 MVALAKADGYKAPELQR-MKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVD-L---------PSIVKVAVLEETTM 607 (679)
Q Consensus 539 ~~~~~gt~~y~aPE~~~-~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~-l---------~~~~~~~~~~~~~~ 607 (679)
.....++..|+|||.+. ...++.++||||||+++|||++|+.||......+... . ..|........
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 231 (283)
T cd07830 155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLAS--- 231 (283)
T ss_pred cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhc---
Confidence 22345788899999875 4457899999999999999999999985543211100 0 00100000000
Q ss_pred ccchHhhhhcCCCC----hHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 608 EVFDMEIMKGIRSP----MEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 608 ~~~~~~i~~~~~~~----~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
..+..+....... .+.....+.+++.+||+.||++||+++|++..
T Consensus 232 -~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 232 -KLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred -cccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 0000000000000 11123567899999999999999999999753
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=302.92 Aligned_cols=260 Identities=20% Similarity=0.244 Sum_probs=190.5
Q ss_pred cCccccCCceEEEEEE-eCCCCEEEEEEcccCcccC--------------cccHHHHHHHHhccCCCCCccceEEeeCCC
Q 005749 382 GQVIEKTTYGTAYKAK-LADGATIALRLLREGSCKD--------------RSSCLPVIRQLGKVRHENLIPLRAFYQGKR 446 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~--------------~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~ 446 (679)
++.||+|+||+||+|+ ..+++.||||.++...... ...+.+|++++++++|+||+++++++.. .
T Consensus 14 ~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~ 92 (335)
T PTZ00024 14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVE-G 92 (335)
T ss_pred hhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEec-C
Confidence 4689999999999999 4579999999986542211 1247799999999999999999999987 6
Q ss_pred CceEEEEEecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecc
Q 005749 447 GEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFG 526 (679)
Q Consensus 447 ~~~~lv~ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 526 (679)
+..++||||+. |+|.+++.. ...+++.....++.|++.||+|||+.+ |+||||||+||+++.++.+|++|||
T Consensus 93 ~~~~lv~e~~~-~~l~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl~dfg 164 (335)
T PTZ00024 93 DFINLVMDIMA-SDLKKVVDR----KIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFG 164 (335)
T ss_pred CcEEEEEeccc-cCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEECCcc
Confidence 78999999997 599998865 345899999999999999999999988 9999999999999999999999999
Q ss_pred cccccCccc-------------ccchhccccccccccccccccc-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccc
Q 005749 527 LDQLMVPAV-------------ADEMVALAKADGYKAPELQRMK-KCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVD 592 (679)
Q Consensus 527 la~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~ 592 (679)
+++...... ........++..|+|||.+.+. .++.++|||||||++|||++|+.||.+....+ .
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~--~ 242 (335)
T PTZ00024 165 LARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID--Q 242 (335)
T ss_pred ceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--H
Confidence 987654110 1111223467789999988754 46899999999999999999999995443211 1
Q ss_pred hhHHHHHHhhccc---ccccc--------hHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 593 LPSIVKVAVLEET---TMEVF--------DMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 593 l~~~~~~~~~~~~---~~~~~--------~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
+ ..+........ +.+.. .................++.+++.+||+.+|++||+++|++..
T Consensus 243 ~-~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 243 L-GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred H-HHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 1 11111100000 00000 0000000000001123567789999999999999999999874
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=296.59 Aligned_cols=261 Identities=21% Similarity=0.263 Sum_probs=188.6
Q ss_pred CccccCCceEEEEEEe-CCCCEEEEEEcccCcc--cCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCC
Q 005749 383 QVIEKTTYGTAYKAKL-ADGATIALRLLREGSC--KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSR 459 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~g 459 (679)
+.||+|++|.||+|+. .+|+.||+|.++.... ...+.+.+|++++++++||||+++++++.+ ....++||||++ +
T Consensus 8 ~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~-~ 85 (294)
T PLN00009 8 EKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHS-EKRLYLVFEYLD-L 85 (294)
T ss_pred EEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEec-CCeEEEEEeccc-c
Confidence 6799999999999995 4789999999865432 223568899999999999999999999987 678999999996 5
Q ss_pred ChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecC-CCceEEeecccccccCcccccc
Q 005749 460 TLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDD-FFVSRLTEFGLDQLMVPAVADE 538 (679)
Q Consensus 460 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~-~~~~kl~DFGla~~~~~~~~~~ 538 (679)
+|.+++.... ...+++..+..++.||+.||+|||+++ ++||||||+||++++ ++.+||+|||++...... ...
T Consensus 86 ~l~~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~-~~~ 159 (294)
T PLN00009 86 DLKKHMDSSP--DFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP-VRT 159 (294)
T ss_pred cHHHHHHhCC--CCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCC-ccc
Confidence 8888875432 234678888999999999999999988 999999999999985 567999999999765322 111
Q ss_pred hhcccccccccccccccc-cCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHh-h-ccccc---ccchH
Q 005749 539 MVALAKADGYKAPELQRM-KKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAV-L-EETTM---EVFDM 612 (679)
Q Consensus 539 ~~~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~-~-~~~~~---~~~~~ 612 (679)
.....++..|+|||++.+ ..++.++|||||||++|||+||+.||......+ .......... . ...+. ...+.
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (294)
T PLN00009 160 FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEID--ELFKIFRILGTPNEETWPGVTSLPDY 237 (294)
T ss_pred cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCChhhccccccchhh
Confidence 223456788999998865 457899999999999999999999995432211 1111000000 0 00000 00000
Q ss_pred hhh-hcCCCC-----hHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 613 EIM-KGIRSP-----MEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 613 ~i~-~~~~~~-----~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
... ...... .+....++.+++.+|++.+|++||++.++++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 238 KSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred hhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 000000 11223457789999999999999999999864
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=301.09 Aligned_cols=268 Identities=19% Similarity=0.255 Sum_probs=200.0
Q ss_pred cCccccCCceEEEEEEe-CCCCEEEEEEcccCc--ccCcccHHHHHHHHhccCCCCCccceEEeeCCC----CceEEEEE
Q 005749 382 GQVIEKTTYGTAYKAKL-ADGATIALRLLREGS--CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKR----GEKLLIYD 454 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~----~~~~lv~e 454 (679)
.+.||+|+||.||+|+. .+++.||+|++.... ....+.+.+|+++++.++|+||+++++++.... ...++|||
T Consensus 5 ~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e 84 (330)
T cd07834 5 LKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTE 84 (330)
T ss_pred eeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEEec
Confidence 37899999999999995 458999999987643 334567899999999999999999999988632 37899999
Q ss_pred ecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcc
Q 005749 455 YFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPA 534 (679)
Q Consensus 455 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 534 (679)
|+++ +|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||++......
T Consensus 85 ~~~~-~l~~~l~~~----~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~ 156 (330)
T cd07834 85 LMET-DLHKVIKSP----QPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPD 156 (330)
T ss_pred chhh-hHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEeeccc
Confidence 9984 899888753 36899999999999999999999988 999999999999999999999999999876443
Q ss_pred cc--cchhccccccccccccccccc-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhccc---c--
Q 005749 535 VA--DEMVALAKADGYKAPELQRMK-KCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEET---T-- 606 (679)
Q Consensus 535 ~~--~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~---~-- 606 (679)
.. .......++..|+|||.+.+. .++.++||||||+++|||++|+.||.+....+. ...+........ .
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~ 233 (330)
T cd07834 157 EDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQ---LNLIVEVLGTPSEEDLKF 233 (330)
T ss_pred ccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHH---HHHHHHhcCCCChhHhhh
Confidence 21 122344678889999999877 789999999999999999999999965432111 000000000000 0
Q ss_pred --cccchHhhhh-cCCCC------hHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH--HHhhCCC
Q 005749 607 --MEVFDMEIMK-GIRSP------MEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ--LEENRPR 660 (679)
Q Consensus 607 --~~~~~~~i~~-~~~~~------~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~--L~~~~~~ 660 (679)
.......+.. ..... .+.....+.+++.+||+.+|++||+++++++. +++....
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~ 298 (330)
T cd07834 234 ITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDP 298 (330)
T ss_pred ccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhccc
Confidence 0000000000 00000 01123567789999999999999999999986 6666544
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=288.39 Aligned_cols=243 Identities=19% Similarity=0.336 Sum_probs=195.8
Q ss_pred cCccccCCceEEEEEEe-CCCCEEEEEEcccCcc--cCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCC
Q 005749 382 GQVIEKTTYGTAYKAKL-ADGATIALRLLREGSC--KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPS 458 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~ 458 (679)
.+.||+|++|.||+|+. .+++.||+|.+..... ...+.+.+|++++++++|+|++++++++.+ .+..+++|||+++
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~v~e~~~~ 83 (254)
T cd06627 5 GDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIET-SDSLYIILEYAEN 83 (254)
T ss_pred eeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEe-CCEEEEEEecCCC
Confidence 37899999999999985 4688999999976543 345678999999999999999999999887 5789999999999
Q ss_pred CChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccc
Q 005749 459 RTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADE 538 (679)
Q Consensus 459 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 538 (679)
++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++........ .
T Consensus 84 ~~L~~~~~~~----~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~ 155 (254)
T cd06627 84 GSLRQIIKKF----GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK-D 155 (254)
T ss_pred CcHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCcc-c
Confidence 9999998763 45899999999999999999999988 99999999999999999999999999987643322 1
Q ss_pred hhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcC
Q 005749 539 MVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGI 618 (679)
Q Consensus 539 ~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~ 618 (679)
.....++..|+|||...+..++.++||||+|+++|||++|+.||..... ........ . ...
T Consensus 156 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~-----~~~~~~~~-~-------------~~~ 216 (254)
T cd06627 156 DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP-----MAALFRIV-Q-------------DDH 216 (254)
T ss_pred ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH-----HHHHHHHh-c-------------cCC
Confidence 2334678889999998877789999999999999999999999854321 11111100 0 000
Q ss_pred CCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHH
Q 005749 619 RSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVK 652 (679)
Q Consensus 619 ~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 652 (679)
..........+.+++.+||..+|++||++.+++.
T Consensus 217 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 217 PPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 1111122356678999999999999999999875
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=301.09 Aligned_cols=264 Identities=20% Similarity=0.291 Sum_probs=191.4
Q ss_pred cCccccCCceEEEEEE-eCCCCEEEEEEcccCc--ccCcccHHHHHHHHhccCCCCCccceEEeeCCC-----CceEEEE
Q 005749 382 GQVIEKTTYGTAYKAK-LADGATIALRLLREGS--CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKR-----GEKLLIY 453 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~-----~~~~lv~ 453 (679)
.+.||+|+||.||+|+ ..+|+.||+|++.... ......+.+|++++++++||||+++++++.... ...++|+
T Consensus 20 ~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~ 99 (342)
T cd07879 20 LKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVM 99 (342)
T ss_pred EEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEEe
Confidence 3789999999999999 4579999999986532 222346889999999999999999999887521 3469999
Q ss_pred EecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCc
Q 005749 454 DYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVP 533 (679)
Q Consensus 454 ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 533 (679)
||+.. +|.++.. ..+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 100 e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~ 169 (342)
T cd07879 100 PYMQT-DLQKIMG------HPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHADA 169 (342)
T ss_pred ccccc-CHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCCcCCCC
Confidence 99975 7776653 24889999999999999999999988 99999999999999999999999999886532
Q ss_pred ccccchhcccccccccccccccc-cCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHH-hhcccccccch
Q 005749 534 AVADEMVALAKADGYKAPELQRM-KKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVA-VLEETTMEVFD 611 (679)
Q Consensus 534 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~-~~~~~~~~~~~ 611 (679)
. .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||....... .+....... .......+..+
T Consensus 170 ~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 243 (342)
T cd07879 170 E----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD--QLTQILKVTGVPGPEFVQKLE 243 (342)
T ss_pred C----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhcCCCCHHHHHHhc
Confidence 1 223457888999998875 468899999999999999999999996432111 010000000 00000000000
Q ss_pred ----HhhhhcCC----CC----hHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH--HHhhCCCC
Q 005749 612 ----MEIMKGIR----SP----MEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ--LEENRPRN 661 (679)
Q Consensus 612 ----~~i~~~~~----~~----~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~--L~~~~~~~ 661 (679)
........ .. .+.....+.+++.+||+.||++||+++|++.. ++...+..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~ 307 (342)
T cd07879 244 DKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDAD 307 (342)
T ss_pred ccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccccc
Confidence 00000000 00 01123457799999999999999999999966 77765443
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=293.63 Aligned_cols=259 Identities=21% Similarity=0.272 Sum_probs=190.1
Q ss_pred CccccCCceEEEEEEeC-CCCEEEEEEcccCccc--CcccHHHHHHHHhcc---CCCCCccceEEeeCCCCc-----eEE
Q 005749 383 QVIEKTTYGTAYKAKLA-DGATIALRLLREGSCK--DRSSCLPVIRQLGKV---RHENLIPLRAFYQGKRGE-----KLL 451 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~--~~~~~~~Ei~~l~~l---~H~nIv~l~~~~~~~~~~-----~~l 451 (679)
+.||+|+||.||+|+.+ +++.||+|+++..... ....+.+|+.++.++ +|+||+++++++.. .+. .++
T Consensus 5 ~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~-~~~~~~~~~~l 83 (287)
T cd07838 5 AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHG-PRTDRELKLTL 83 (287)
T ss_pred EEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEee-ccCCCCceeEE
Confidence 67999999999999965 4899999999754322 234567788777665 59999999999987 344 899
Q ss_pred EEEecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeeccccccc
Q 005749 452 IYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLM 531 (679)
Q Consensus 452 v~ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 531 (679)
+|||+.+ +|.+++.... ...+++..++.++.|+++||+|||+.+ ++|+||||+||++++++.+||+|||++...
T Consensus 84 ~~e~~~~-~l~~~l~~~~--~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~~~ 157 (287)
T cd07838 84 VFEHVDQ-DLATYLSKCP--KPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIY 157 (287)
T ss_pred Eehhccc-CHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcceec
Confidence 9999975 8998886532 235899999999999999999999988 999999999999999999999999998776
Q ss_pred CcccccchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhc---ccccc
Q 005749 532 VPAVADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLE---ETTME 608 (679)
Q Consensus 532 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~---~~~~~ 608 (679)
.... ......++..|+|||.+.+..++.++|||||||++|||++|+.||......+ .+..+....... .....
T Consensus 158 ~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07838 158 SFEM--ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD--QLDKIFDVIGLPSEEEWPRN 233 (287)
T ss_pred cCCc--ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHH--HHHHHHHHcCCCChHhcCCC
Confidence 3321 1223457788999999998889999999999999999999999985433211 111111110000 00000
Q ss_pred cc--hHhhhhcCCC----ChHHHHHHHHHHHHhccCcCCCCCCCHHHHHH
Q 005749 609 VF--DMEIMKGIRS----PMEEGLVQALKLAMGCCAPVASVRPTMDEVVK 652 (679)
Q Consensus 609 ~~--~~~i~~~~~~----~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 652 (679)
.. .......... ..+.....+.+++.+||+.||++||+++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 234 VSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred cccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 00 0000000000 11223466778999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=277.64 Aligned_cols=251 Identities=20% Similarity=0.324 Sum_probs=191.9
Q ss_pred cHHHHHHhhcCccccCCceEEEEEEe-CCCCEEEEEEcccCc-ccCcccHHHHHHHHhccC-CCCCccceEEeeCCCCce
Q 005749 373 TLEDVLNATGQVIEKTTYGTAYKAKL-ADGATIALRLLREGS-CKDRSSCLPVIRQLGKVR-HENLIPLRAFYQGKRGEK 449 (679)
Q Consensus 373 ~~~~l~~~~~~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~-H~nIv~l~~~~~~~~~~~ 449 (679)
.+.|+..- ..+|.|+.|.|++++. .+|..+|||.++... .++.+.++..++++.+-+ .|.||+.+|||.. +...
T Consensus 90 dindl~~l--~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~-n~dV 166 (391)
T KOG0983|consen 90 DINDLENL--GDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFIT-NTDV 166 (391)
T ss_pred ChHHhhhH--HhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEee-CchH
Confidence 34455322 5699999999999995 458999999997753 344556777777776664 8999999999998 5778
Q ss_pred EEEEEecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeeccccc
Q 005749 450 LLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQ 529 (679)
Q Consensus 450 ~lv~ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 529 (679)
++-||.|.. -+..+++.- ..++++...=++...+.+||.||.+++ +|+|||+||+|||+|+.|.+|++|||++-
T Consensus 167 ~IcMelMs~-C~ekLlkri---k~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsG 240 (391)
T KOG0983|consen 167 FICMELMST-CAEKLLKRI---KGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISG 240 (391)
T ss_pred HHHHHHHHH-HHHHHHHHh---cCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccc
Confidence 888999853 455555433 456888888899999999999999876 49999999999999999999999999998
Q ss_pred ccCcccccchhcccccccccccccccc---cCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccc
Q 005749 530 LMVPAVADEMVALAKADGYKAPELQRM---KKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETT 606 (679)
Q Consensus 530 ~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 606 (679)
.+.+...+ ....|.+.|||||.+.- ..|+.++|||||||+++||+||+.||.+... ++..+...
T Consensus 241 rlvdSkAh--trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~t-dFe~ltkv---------- 307 (391)
T KOG0983|consen 241 RLVDSKAH--TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKT-DFEVLTKV---------- 307 (391)
T ss_pred eeeccccc--ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCc-cHHHHHHH----------
Confidence 77554433 34578899999998873 4689999999999999999999999965322 22221111
Q ss_pred cccchHhhhhcCCCCh---HHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 607 MEVFDMEIMKGIRSPM---EEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 607 ~~~~~~~i~~~~~~~~---~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
.....+.. ....+.+.+++..|+..|+.+||...+++++
T Consensus 308 --------ln~ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 308 --------LNEEPPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred --------HhcCCCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 11111111 1245778889999999999999999988765
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=296.90 Aligned_cols=244 Identities=22% Similarity=0.312 Sum_probs=190.0
Q ss_pred CccccCCceEEEEEEe-CCCCEEEEEEcccCcc---cCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCC
Q 005749 383 QVIEKTTYGTAYKAKL-ADGATIALRLLREGSC---KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPS 458 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~---~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~ 458 (679)
+.||+|+||.||+|+. .++..||+|.+..... ...+++.+|+++++.++|+|++++++++.. ....++||||+.
T Consensus 21 ~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~- 98 (308)
T cd06634 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-EHTAWLVMEYCL- 98 (308)
T ss_pred HheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEc-CCeeEEEEEccC-
Confidence 6799999999999994 5688999999864322 223467889999999999999999999987 678999999997
Q ss_pred CChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccc
Q 005749 459 RTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADE 538 (679)
Q Consensus 459 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 538 (679)
|++.+.+... ...+++.++..++.|++.||.|||+.+ ++||||||+||+++.++.+|++|||++......
T Consensus 99 ~~l~~~~~~~---~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~---- 168 (308)
T cd06634 99 GSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---- 168 (308)
T ss_pred CCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc----
Confidence 5888877543 245889999999999999999999988 999999999999999999999999998765322
Q ss_pred hhccccccccccccccc---ccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhh
Q 005749 539 MVALAKADGYKAPELQR---MKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIM 615 (679)
Q Consensus 539 ~~~~~gt~~y~aPE~~~---~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~ 615 (679)
....++..|+|||.+. ...++.++|||||||++|||++|+.||...... ..... ...... +
T Consensus 169 -~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~-~~~~~~-----~--- 232 (308)
T cd06634 169 -NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYH-IAQNES-----P--- 232 (308)
T ss_pred -ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH------HHHHH-HhhcCC-----C---
Confidence 2346788999999874 356788999999999999999999998442211 00000 000000 0
Q ss_pred hcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhh
Q 005749 616 KGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEEN 657 (679)
Q Consensus 616 ~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 657 (679)
..........+.+++.+||+.+|++||++.++++.....
T Consensus 233 ---~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~ 271 (308)
T cd06634 233 ---ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVL 271 (308)
T ss_pred ---CcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccc
Confidence 001112335577899999999999999999999875433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=296.37 Aligned_cols=241 Identities=20% Similarity=0.285 Sum_probs=188.3
Q ss_pred cCccccCCceEEEEEEe-CCCCEEEEEEcccCcc---cCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecC
Q 005749 382 GQVIEKTTYGTAYKAKL-ADGATIALRLLREGSC---KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFP 457 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~---~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~ 457 (679)
.+.||+|+||+||+|+. .+++.||+|.+..... ...+.+.+|++++++++|||++++++++.+ ....++||||+.
T Consensus 26 ~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~ 104 (313)
T cd06633 26 LHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLK-EHTAWLVMEYCL 104 (313)
T ss_pred ceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEe-CCEEEEEEecCC
Confidence 36799999999999994 5689999999865432 223467889999999999999999999987 678999999996
Q ss_pred CCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCccccc
Q 005749 458 SRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVAD 537 (679)
Q Consensus 458 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 537 (679)
|++.+++... ...+++.+++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++.....
T Consensus 105 -~~l~~~l~~~---~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~---- 173 (313)
T cd06633 105 -GSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP---- 173 (313)
T ss_pred -CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC----
Confidence 5788877643 345899999999999999999999988 99999999999999999999999999864322
Q ss_pred chhccccccccccccccc---ccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhh
Q 005749 538 EMVALAKADGYKAPELQR---MKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEI 614 (679)
Q Consensus 538 ~~~~~~gt~~y~aPE~~~---~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i 614 (679)
.....++..|+|||++. ...++.++|||||||++|||++|..||...... ........... . .
T Consensus 174 -~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~------~~~~~~~~~~~-~-----~- 239 (313)
T cd06633 174 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIAQNDS-P-----T- 239 (313)
T ss_pred -CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHHhcCC-C-----C-
Confidence 22346788899999874 456888999999999999999999998543211 11110000000 0 0
Q ss_pred hhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 615 MKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 615 ~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
...+.....+.+++.+||+.+|.+||++.++++.
T Consensus 240 -----~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 240 -----LQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred -----CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0011122456789999999999999999999865
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-34 Score=295.82 Aligned_cols=247 Identities=21% Similarity=0.319 Sum_probs=187.4
Q ss_pred cCccccCCceEEEEEEeCC-CCEEEEEEcccCcc-cCcccHHHHHHHHhccC-CCCCccceEEeeCCCCceEEEEEecCC
Q 005749 382 GQVIEKTTYGTAYKAKLAD-GATIALRLLREGSC-KDRSSCLPVIRQLGKVR-HENLIPLRAFYQGKRGEKLLIYDYFPS 458 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~~-~~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~-H~nIv~l~~~~~~~~~~~~lv~ey~~~ 458 (679)
.+.||+|+||.||+|+..+ ++.||||.++.... .....+.+|++++.+.. ||||+++++++.+ ....+++|||+++
T Consensus 20 ~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-~~~~~~v~e~~~~ 98 (296)
T cd06618 20 LGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFIT-DSDVFICMELMST 98 (296)
T ss_pred eeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeec-CCeEEEEeeccCc
Confidence 4789999999999999754 89999999975432 23345677888777775 9999999999987 6789999999864
Q ss_pred CChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCeeecCCCCCCeeecCCCceEEeecccccccCccccc
Q 005749 459 RTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTG-HEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVAD 537 (679)
Q Consensus 459 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~-~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 537 (679)
++.+++... ...+++..+..++.|+++||+|||+. + |+||||+|+||++++++.+||+|||++..+.....
T Consensus 99 -~l~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~- 170 (296)
T cd06618 99 -CLDKLLKRI---QGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA- 170 (296)
T ss_pred -CHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccCCCc-
Confidence 777776543 23689999999999999999999973 5 99999999999999999999999999876533221
Q ss_pred chhcccccccccccccccccC----CCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHh
Q 005749 538 EMVALAKADGYKAPELQRMKK----CSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDME 613 (679)
Q Consensus 538 ~~~~~~gt~~y~aPE~~~~~~----~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 613 (679)
.....++..|+|||.+.+.. ++.++||||||+++|||++|+.||...... . +.......... +.
T Consensus 171 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~----~~~~~~~~~~~------~~ 238 (296)
T cd06618 171 -KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-F----EVLTKILQEEP------PS 238 (296)
T ss_pred -ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-H----HHHHHHhcCCC------CC
Confidence 12335778899999987553 788999999999999999999998432111 0 11111111000 00
Q ss_pred hhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 005749 614 IMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQL 654 (679)
Q Consensus 614 i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L 654 (679)
+ +.......++.+++.+||..||++||++++++++-
T Consensus 239 ~-----~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~ 274 (296)
T cd06618 239 L-----PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHP 274 (296)
T ss_pred C-----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence 0 00111235678899999999999999999998763
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=303.86 Aligned_cols=241 Identities=18% Similarity=0.291 Sum_probs=197.9
Q ss_pred CccccCCceEEEEEE-eCCCCEEEEEEcccCcc--cCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCC
Q 005749 383 QVIEKTTYGTAYKAK-LADGATIALRLLREGSC--KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSR 459 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~g 459 (679)
..||+|.|+.|..|+ ..++..||+|.+++..- .....+.+|+++|..++|||||+++.+... ....|+||||+.+|
T Consensus 62 ~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t-~~~lylV~eya~~g 140 (596)
T KOG0586|consen 62 KTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIET-EATLYLVMEYASGG 140 (596)
T ss_pred eeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeee-cceeEEEEEeccCc
Confidence 689999999999999 55799999999987643 234558999999999999999999999987 68999999999999
Q ss_pred ChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccch
Q 005749 460 TLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEM 539 (679)
Q Consensus 460 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 539 (679)
.+++++.... ......+..++.|+.+|++|||+++ |||||||++||||+.++.+||+|||++..+.. ....
T Consensus 141 e~~~yl~~~g----r~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~--~~~l 211 (596)
T KOG0586|consen 141 ELFDYLVKHG----RMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDY--GLML 211 (596)
T ss_pred hhHHHHHhcc----cchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeecc--cccc
Confidence 9999998753 2455888899999999999999999 99999999999999999999999999988753 3445
Q ss_pred hcccccccccccccccccCC-CCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcC
Q 005749 540 VALAKADGYKAPELQRMKKC-SSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGI 618 (679)
Q Consensus 540 ~~~~gt~~y~aPE~~~~~~~-~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~ 618 (679)
.+.+|++.|.|||++.+..| ++++|+||+|+++|-|+.|..||++..-.+. -++.+...+
T Consensus 212 qt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~L-------------------r~rvl~gk~ 272 (596)
T KOG0586|consen 212 QTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKEL-------------------RPRVLRGKY 272 (596)
T ss_pred cccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccc-------------------cchheeeee
Confidence 67899999999999998776 7899999999999999999999965433211 111111111
Q ss_pred CCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 619 RSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 619 ~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
+-+. --..+.-+++.+++..+|.+|++++++.+.
T Consensus 273 rIp~-~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 273 RIPF-YMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred cccc-eeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 1111 111234468888999999999999999875
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=290.49 Aligned_cols=246 Identities=20% Similarity=0.307 Sum_probs=190.2
Q ss_pred cCccccCCceEEEEEEeC-CCCEEEEEEcccCc-----ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEe
Q 005749 382 GQVIEKTTYGTAYKAKLA-DGATIALRLLREGS-----CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDY 455 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~-~~~~vAvK~~~~~~-----~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey 455 (679)
.+.||+|+||.||+++.. .+..+++|.++... .....++..|+.++++++||||+++++++.+ ....++||||
T Consensus 5 ~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~ 83 (260)
T cd08222 5 QQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLE-RDAFCIITEY 83 (260)
T ss_pred eeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhc-CCceEEEEEe
Confidence 368999999999999843 45556666665422 1223356789999999999999999999887 5789999999
Q ss_pred cCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCccc
Q 005749 456 FPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAV 535 (679)
Q Consensus 456 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 535 (679)
+++++|.+++.........+++..++.++.|++.||+|||+.+ ++|+||||+||++++ +.+|++|||+++......
T Consensus 84 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~ 159 (260)
T cd08222 84 CEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC 159 (260)
T ss_pred CCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecCCCc
Confidence 9999999998754333456999999999999999999999988 999999999999986 569999999987654321
Q ss_pred ccchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhh
Q 005749 536 ADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIM 615 (679)
Q Consensus 536 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~ 615 (679)
.......++..|+|||...+..++.++||||||+++|||++|..||..... ...... +.
T Consensus 160 -~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~------~~~~~~--------------~~ 218 (260)
T cd08222 160 -DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF------LSVVLR--------------IV 218 (260)
T ss_pred -ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHHHHH--------------HH
Confidence 122344678889999998888889999999999999999999999843211 111111 11
Q ss_pred hcCCCC-hHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 616 KGIRSP-MEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 616 ~~~~~~-~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
.+..+. ......++.+++.+||..+|++||++.|+++.
T Consensus 219 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 219 EGPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred cCCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 111111 12334577789999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=299.64 Aligned_cols=261 Identities=21% Similarity=0.314 Sum_probs=187.7
Q ss_pred CccccCCceEEEEEEe-CCCCEEEEEEcccCccc--CcccHHHHHHHHhccCCCCCccceEEeeCCC-------CceEEE
Q 005749 383 QVIEKTTYGTAYKAKL-ADGATIALRLLREGSCK--DRSSCLPVIRQLGKVRHENLIPLRAFYQGKR-------GEKLLI 452 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~--~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~-------~~~~lv 452 (679)
+.||+|+||.||+|+. .+++.||+|++...... ....+.+|++++++++||||+++++++.... ...++|
T Consensus 14 ~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~lv 93 (311)
T cd07866 14 GKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMV 93 (311)
T ss_pred EEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCceEEEE
Confidence 6799999999999994 46899999998654322 2346789999999999999999999876432 247999
Q ss_pred EEecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccC
Q 005749 453 YDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMV 532 (679)
Q Consensus 453 ~ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 532 (679)
|||+.. ++.+.+... ...+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+||+|||+++...
T Consensus 94 ~~~~~~-~l~~~~~~~---~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 166 (311)
T cd07866 94 TPYMDH-DLSGLLENP---SVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLARPYD 166 (311)
T ss_pred EecCCc-CHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCccchhcc
Confidence 999975 777777643 345899999999999999999999988 9999999999999999999999999997653
Q ss_pred ccccc----------chhcccccccccccccccc-cCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHh
Q 005749 533 PAVAD----------EMVALAKADGYKAPELQRM-KKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAV 601 (679)
Q Consensus 533 ~~~~~----------~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~ 601 (679)
..... ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||.+........ .......
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~--~~~~~~~ 244 (311)
T cd07866 167 GPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLH--LIFKLCG 244 (311)
T ss_pred CCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHHHhC
Confidence 22111 1123356778999998765 458899999999999999999999985433221111 1000000
Q ss_pred --hccc------ccccchHhhhhcCCCCh----HHHHHHHHHHHHhccCcCCCCCCCHHHHHH
Q 005749 602 --LEET------TMEVFDMEIMKGIRSPM----EEGLVQALKLAMGCCAPVASVRPTMDEVVK 652 (679)
Q Consensus 602 --~~~~------~~~~~~~~i~~~~~~~~----~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 652 (679)
.... .....+........... ....+.+.+++.+|++.||++|||+.|++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 245 TPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred CCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 0000 00000000000000001 112256779999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=282.05 Aligned_cols=272 Identities=22% Similarity=0.305 Sum_probs=215.8
Q ss_pred ccccHHHHHHhhcCccccCCceEEEEEE-eCCCCEEEEEEcccCcc---cCcccHHHHHHHHhccCCCCCccceEEeeCC
Q 005749 370 EHLTLEDVLNATGQVIEKTTYGTAYKAK-LADGATIALRLLREGSC---KDRSSCLPVIRQLGKVRHENLIPLRAFYQGK 445 (679)
Q Consensus 370 ~~~~~~~l~~~~~~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~---~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~ 445 (679)
.+++++|+. +-+++|+|.||+|-+++ ..+++.+|+|++++.-- ++...-+.|-++|...+||.+..+...|+.
T Consensus 163 ~kvTm~dFd--fLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt- 239 (516)
T KOG0690|consen 163 NKVTMEDFD--FLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQT- 239 (516)
T ss_pred ceeccchhh--HHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhcc-
Confidence 456777663 33899999999999999 66899999999987532 223345678889999999999988777887
Q ss_pred CCceEEEEEecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeec
Q 005749 446 RGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEF 525 (679)
Q Consensus 446 ~~~~~lv~ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 525 (679)
.++.|+||||..||.|.-+|.. ...+++.+.+.+..+|..||.|||+++ ||.||||.+|.|+|.+|++||+||
T Consensus 240 ~drlCFVMeyanGGeLf~HLsr----er~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDF 312 (516)
T KOG0690|consen 240 QDRLCFVMEYANGGELFFHLSR----ERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDF 312 (516)
T ss_pred CceEEEEEEEccCceEeeehhh----hhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeec
Confidence 7899999999999999988876 456999999999999999999999988 999999999999999999999999
Q ss_pred ccccccCcccccchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhccc
Q 005749 526 GLDQLMVPAVADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEET 605 (679)
Q Consensus 526 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~ 605 (679)
|+++.-.. ......+++||+.|.|||++....|+.+.|-|.+|||||||+.|+.||+..+......+
T Consensus 313 GLCKE~I~-~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeL------------ 379 (516)
T KOG0690|consen 313 GLCKEEIK-YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFEL------------ 379 (516)
T ss_pred ccchhccc-ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHH------------
Confidence 99985322 24456788999999999999999999999999999999999999999976554322222
Q ss_pred ccccchHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCC-----CHHHHHHH------------HHhhCCCCCCCCCCC
Q 005749 606 TMEVFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRP-----TMDEVVKQ------------LEENRPRNRSALYSP 668 (679)
Q Consensus 606 ~~~~~~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~evl~~------------L~~~~~~~~~~~~~~ 668 (679)
.++... .....-.++...++...+..||.+|. .+.||.+. .+++.+..++.+.+.
T Consensus 380 -------Il~ed~-kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~Kki~PPfKPqVtSe 451 (516)
T KOG0690|consen 380 -------ILMEDL-KFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYRKKIEPPFKPQVTSE 451 (516)
T ss_pred -------HHhhhc-cCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHHHHhccCCCCCCCcccc
Confidence 111211 11222335566778888999999997 46666553 245567777777777
Q ss_pred cccc
Q 005749 669 TETR 672 (679)
Q Consensus 669 ~~~~ 672 (679)
+++|
T Consensus 452 tDTr 455 (516)
T KOG0690|consen 452 TDTR 455 (516)
T ss_pred cchh
Confidence 6655
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=285.76 Aligned_cols=246 Identities=21% Similarity=0.282 Sum_probs=196.7
Q ss_pred CccccCCceEEEEEEeC-CCCEEEEEEcccCcc--cCcccHHHHHHHHhccCCCCCccceEEeeCCC--CceEEEEEecC
Q 005749 383 QVIEKTTYGTAYKAKLA-DGATIALRLLREGSC--KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKR--GEKLLIYDYFP 457 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~--~~~~lv~ey~~ 457 (679)
+.||+|++|.||+|+.. +++.|++|++..... ...+.+.+|++++++++|+||+++++++.. . ...++|+||++
T Consensus 6 ~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~~lv~e~~~ 84 (260)
T cd06606 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERD-EEKNTLNIFLEYVS 84 (260)
T ss_pred eEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEec-CCCCeEEEEEEecC
Confidence 68999999999999955 799999999876542 345678999999999999999999999887 4 68899999999
Q ss_pred CCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCccccc
Q 005749 458 SRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVAD 537 (679)
Q Consensus 458 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 537 (679)
+++|.+++... ..+++..+..++.|+++||+|||+.+ ++|+||+|+||++++++.+||+|||.+.........
T Consensus 85 ~~~L~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 157 (260)
T cd06606 85 GGSLSSLLKKF----GKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG 157 (260)
T ss_pred CCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEeccccccc
Confidence 99999999763 36899999999999999999999987 999999999999999999999999998876443211
Q ss_pred -chhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhh
Q 005749 538 -EMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMK 616 (679)
Q Consensus 538 -~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~ 616 (679)
......++..|+|||......++.++||||||++++||++|+.||..... ........... .
T Consensus 158 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~------------~ 220 (260)
T cd06606 158 EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN-----PMAALYKIGSS------------G 220 (260)
T ss_pred ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-----hHHHHHhcccc------------C
Confidence 12345678889999999888899999999999999999999999854331 00000000000 0
Q ss_pred cCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 617 GIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 617 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
............+.+++.+|++.+|++||++.|+++.
T Consensus 221 ~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 221 EPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred CCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 0001111224567789999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=293.51 Aligned_cols=243 Identities=21% Similarity=0.290 Sum_probs=194.0
Q ss_pred cCccccCCceEEEEEEe-CCCCEEEEEEcccCc---ccCcccHHHHHHHHhccC-CCCCccceEEeeCCCCceEEEEEec
Q 005749 382 GQVIEKTTYGTAYKAKL-ADGATIALRLLREGS---CKDRSSCLPVIRQLGKVR-HENLIPLRAFYQGKRGEKLLIYDYF 456 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~-H~nIv~l~~~~~~~~~~~~lv~ey~ 456 (679)
.+.||+|+||.||+|+. .+++.||+|++.... ....+.+.+|++++.+++ ||||+++++++.+ .+..++||||+
T Consensus 6 ~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~-~~~~~lv~e~~ 84 (280)
T cd05581 6 GKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQD-EENLYFVLEYA 84 (280)
T ss_pred eeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcC-CceEEEEEcCC
Confidence 36799999999999995 479999999986532 223456889999999998 9999999999887 67899999999
Q ss_pred CCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccc
Q 005749 457 PSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVA 536 (679)
Q Consensus 457 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 536 (679)
++++|.+++... ..+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.++++|||++........
T Consensus 85 ~~~~L~~~l~~~----~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~ 157 (280)
T cd05581 85 PNGELLQYIRKY----GSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSS 157 (280)
T ss_pred CCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCCccc
Confidence 999999999763 36999999999999999999999988 99999999999999999999999999886543221
Q ss_pred -------------------cchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHH
Q 005749 537 -------------------DEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIV 597 (679)
Q Consensus 537 -------------------~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~ 597 (679)
.......++..|+|||......++.++||||||++++|+++|+.||...... . ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~---~~ 231 (280)
T cd05581 158 PESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY---L---TF 231 (280)
T ss_pred cccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH---H---HH
Confidence 1122345678899999988888999999999999999999999998543210 0 00
Q ss_pred HHHhhcccccccchHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCH----HHHHH
Q 005749 598 KVAVLEETTMEVFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTM----DEVVK 652 (679)
Q Consensus 598 ~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~----~evl~ 652 (679)
+. +............+.+.+++.+||+.+|++||++ +++++
T Consensus 232 ~~--------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 232 QK--------------ILKLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred HH--------------HHhcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 00 0111111112224567789999999999999999 77764
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=292.42 Aligned_cols=259 Identities=22% Similarity=0.288 Sum_probs=193.7
Q ss_pred CccccCCceEEEEEEe-CCCCEEEEEEcccCc--ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCC
Q 005749 383 QVIEKTTYGTAYKAKL-ADGATIALRLLREGS--CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSR 459 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~g 459 (679)
+.||+|+||.||+|+. .+++.||+|.+.... ....+.+..|++++++++|+||+++++++.+ .+..++||||++ +
T Consensus 5 ~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~~v~e~~~-~ 82 (282)
T cd07829 5 EKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHT-ERKLYLVFEYCD-M 82 (282)
T ss_pred hcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhc-CCceEEEecCcC-c
Confidence 6799999999999995 459999999997653 2334567899999999999999999999987 578999999998 5
Q ss_pred ChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccch
Q 005749 460 TLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEM 539 (679)
Q Consensus 460 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 539 (679)
+|.+++.... ..+++..++.++.|+++||+|||+++ |+||||+|+||++++++.+||+|||+++....... ..
T Consensus 83 ~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-~~ 155 (282)
T cd07829 83 DLKKYLDKRP---GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-TY 155 (282)
T ss_pred CHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc-cc
Confidence 9999997642 35899999999999999999999988 99999999999999999999999999887643221 22
Q ss_pred hccccccccccccccccc-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhc---ccc---ccc--c
Q 005749 540 VALAKADGYKAPELQRMK-KCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLE---ETT---MEV--F 610 (679)
Q Consensus 540 ~~~~gt~~y~aPE~~~~~-~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~---~~~---~~~--~ 610 (679)
....++..|+|||.+.+. .++.++|||||||++||+++|+.||......+ .+..... .... ... ... +
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~--~~~~~~~-~~~~~~~~~~~~~~~~~~~ 232 (282)
T cd07829 156 THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEID--QLFKIFQ-ILGTPTEESWPGVTKLPDY 232 (282)
T ss_pred CccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHH--HHHHHHH-HhCCCcHHHHHhhcccccc
Confidence 233456789999988766 78999999999999999999999985433211 0000000 0000 000 000 0
Q ss_pred hHhhhhcCC----CChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 611 DMEIMKGIR----SPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 611 ~~~i~~~~~----~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
+........ ...+.....+.+++.+||+.||++||++++++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 233 KPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred cccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 000000000 0011124568899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=286.38 Aligned_cols=236 Identities=22% Similarity=0.271 Sum_probs=189.3
Q ss_pred cccCCceEEEEEEeC-CCCEEEEEEcccCccc---CcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCC
Q 005749 385 IEKTTYGTAYKAKLA-DGATIALRLLREGSCK---DRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRT 460 (679)
Q Consensus 385 ig~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~---~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gs 460 (679)
||+|+||.||+++.. +++.+|+|.++..... ..+.+..|++++++++|+||+++++.+.. ++..++||||+++++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e~~~~~~ 79 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQT-EEKLYLVLEYAPGGE 79 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeec-CCeeEEEEecCCCCc
Confidence 689999999999954 5899999998764322 34578899999999999999999998887 678999999999999
Q ss_pred hHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccchh
Q 005749 461 LHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMV 540 (679)
Q Consensus 461 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 540 (679)
|.+++... ..+++.....++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++....... ....
T Consensus 80 L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~ 151 (250)
T cd05123 80 LFSHLSKE----GRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTN 151 (250)
T ss_pred HHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC-Cccc
Confidence 99999763 35899999999999999999999988 9999999999999999999999999987653321 1223
Q ss_pred cccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcCCC
Q 005749 541 ALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIRS 620 (679)
Q Consensus 541 ~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~~ 620 (679)
...++..|+|||...+...+.++|+||||+++||+++|+.||..... ....... ......
T Consensus 152 ~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~------~~~~~~~--------------~~~~~~ 211 (250)
T cd05123 152 TFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR------KEIYEKI--------------LKDPLR 211 (250)
T ss_pred CCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH------HHHHHHH--------------hcCCCC
Confidence 45678889999999888889999999999999999999999954321 1111111 010001
Q ss_pred ChHHHHHHHHHHHHhccCcCCCCCCCHHH
Q 005749 621 PMEEGLVQALKLAMGCCAPVASVRPTMDE 649 (679)
Q Consensus 621 ~~~~~~~~~~~l~~~cl~~dP~~RPs~~e 649 (679)
........+.+++.+||..||++||++.+
T Consensus 212 ~~~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 212 FPEFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 11111356678999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=296.10 Aligned_cols=256 Identities=20% Similarity=0.317 Sum_probs=190.3
Q ss_pred CccccCCceEEEEEE-eCCCCEEEEEEcccCc--ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCC
Q 005749 383 QVIEKTTYGTAYKAK-LADGATIALRLLREGS--CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSR 459 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~g 459 (679)
+.||+|+||.||+|+ ..+++.||+|++.... ....+.+.+|++++.+++||||++++++|.......++|+||+ ++
T Consensus 16 ~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~-~~ 94 (328)
T cd07856 16 QPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL-GT 94 (328)
T ss_pred EeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeehh-cc
Confidence 789999999999998 5579999999886432 2234678899999999999999999999876556789999999 56
Q ss_pred ChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccch
Q 005749 460 TLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEM 539 (679)
Q Consensus 460 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 539 (679)
+|.++++. ..+++.....++.|+++||+|||+.+ |+||||||+||++++++.+||+|||++...... .
T Consensus 95 ~L~~~~~~-----~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~----~ 162 (328)
T cd07856 95 DLHRLLTS-----RPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQDPQ----M 162 (328)
T ss_pred CHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccccCCC----c
Confidence 89988864 34788888999999999999999988 999999999999999999999999998754321 2
Q ss_pred hcccccccccccccccc-cCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccc-hh--------HHHHHHhhccccccc
Q 005749 540 VALAKADGYKAPELQRM-KKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVD-LP--------SIVKVAVLEETTMEV 609 (679)
Q Consensus 540 ~~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~-l~--------~~~~~~~~~~~~~~~ 609 (679)
....++..|+|||.+.+ ..++.++||||||+++|||++|+.||.......... +. ++.... ......+.
T Consensus 163 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 241 (328)
T cd07856 163 TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTI-CSENTLRF 241 (328)
T ss_pred CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc-cchhhHHH
Confidence 23456788999998765 568999999999999999999999995433211000 00 000000 00000000
Q ss_pred chHhhhhcCCCChH----HHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 610 FDMEIMKGIRSPME----EGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 610 ~~~~i~~~~~~~~~----~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
+. ........+.. .....+.+++.+||+.+|++||++++++..
T Consensus 242 ~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 242 VQ-SLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred Hh-hccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00 00000011111 123567889999999999999999999876
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=298.24 Aligned_cols=260 Identities=18% Similarity=0.282 Sum_probs=187.7
Q ss_pred CccccCCceEEEEEE-eCCCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCCC-------------Cc
Q 005749 383 QVIEKTTYGTAYKAK-LADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKR-------------GE 448 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~-------------~~ 448 (679)
+.||+|+||.||+|+ ..+|+.||+|.+........+.+.+|++++++++||||+++++++.... ..
T Consensus 11 ~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 90 (342)
T cd07854 11 RPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNS 90 (342)
T ss_pred EEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccccccce
Confidence 689999999999999 4568999999987665555667899999999999999999998766421 24
Q ss_pred eEEEEEecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecC-CCceEEeeccc
Q 005749 449 KLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDD-FFVSRLTEFGL 527 (679)
Q Consensus 449 ~~lv~ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~-~~~~kl~DFGl 527 (679)
.++||||++ ++|.+++.. ..+++..++.++.||+.||+|||+.+ |+||||||+||+++. ++.+|++|||+
T Consensus 91 ~~lv~e~~~-~~L~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~kl~dfg~ 161 (342)
T cd07854 91 VYIVQEYME-TDLANVLEQ-----GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGL 161 (342)
T ss_pred EEEEeeccc-ccHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEEECCccc
Confidence 789999997 489888853 34889999999999999999999988 999999999999984 56789999999
Q ss_pred ccccCccccc--chhcccccccccccccccc-cCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHH-hhc
Q 005749 528 DQLMVPAVAD--EMVALAKADGYKAPELQRM-KKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVA-VLE 603 (679)
Q Consensus 528 a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~-~~~ 603 (679)
++........ ......++..|+|||.+.. ..++.++|||||||++|||++|+.||......+ ......... ...
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~ 239 (342)
T cd07854 162 ARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELE--QMQLILESVPVVR 239 (342)
T ss_pred ceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhcCCCC
Confidence 8765322111 1122356788999997654 567889999999999999999999995432211 000000000 000
Q ss_pred c-c---ccccchHhhh---hcCCCCh----HHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 604 E-T---TMEVFDMEIM---KGIRSPM----EEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 604 ~-~---~~~~~~~~i~---~~~~~~~----~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
. . ........+. .....+. +....++.+++.+||+.||++|||+.|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 240 EEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred hHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 0 0 0000000000 0000011 1123567789999999999999999999854
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=296.31 Aligned_cols=261 Identities=20% Similarity=0.232 Sum_probs=187.7
Q ss_pred cCccccCCceEEEEEEeC-C--CCEEEEEEcccCcc--cCcccHHHHHHHHhcc-CCCCCccceEEeeC---CCCceEEE
Q 005749 382 GQVIEKTTYGTAYKAKLA-D--GATIALRLLREGSC--KDRSSCLPVIRQLGKV-RHENLIPLRAFYQG---KRGEKLLI 452 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~-~--~~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~---~~~~~~lv 452 (679)
.+.||+|+||.||+++.. + +..||+|.+..... ...+.+.+|++++.++ +||||+++++++.. .....+++
T Consensus 5 ~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~ 84 (332)
T cd07857 5 IKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLY 84 (332)
T ss_pred EEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEEEE
Confidence 367999999999999953 4 78999999875322 2245678999999999 59999999987542 12457888
Q ss_pred EEecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccC
Q 005749 453 YDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMV 532 (679)
Q Consensus 453 ~ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 532 (679)
+||+. ++|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+||++++++.+||+|||+++...
T Consensus 85 ~e~~~-~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~~~~ 156 (332)
T cd07857 85 EELME-ADLHQIIRS----GQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFS 156 (332)
T ss_pred Eeccc-CCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCceecc
Confidence 99986 589998865 345899999999999999999999988 9999999999999999999999999998654
Q ss_pred ccccc---chhcccccccccccccccc-cCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhh---ccc
Q 005749 533 PAVAD---EMVALAKADGYKAPELQRM-KKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVL---EET 605 (679)
Q Consensus 533 ~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~---~~~ 605 (679)
..... ......|+..|+|||++.+ ..++.++||||+||++|||++|+.||...... .........+. .+.
T Consensus 157 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~ 233 (332)
T cd07857 157 ENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYV---DQLNQILQVLGTPDEET 233 (332)
T ss_pred cccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHH---HHHHHHHHHhCCCCHHH
Confidence 32211 1233468889999998765 46899999999999999999999998543211 11110000000 000
Q ss_pred ccccchH-------hhhhcCCCCh----HHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 606 TMEVFDM-------EIMKGIRSPM----EEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 606 ~~~~~~~-------~i~~~~~~~~----~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
..+..++ .......... +.....+.+++.+|++.||++|||+.|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 234 LSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred HHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000000 0000000000 1123567789999999999999999999765
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=282.42 Aligned_cols=252 Identities=19% Similarity=0.251 Sum_probs=202.6
Q ss_pred CccccCCceEEEEEEeC------CCCEEEEEEcccC-cccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEe
Q 005749 383 QVIEKTTYGTAYKAKLA------DGATIALRLLREG-SCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDY 455 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~~------~~~~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey 455 (679)
.++-+|.||.||+|.+. +.+.|-||.++.. ++-....++.|--.+..+.|||+.++.+++.......+++|.+
T Consensus 290 ~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~~ 369 (563)
T KOG1024|consen 290 CLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYPA 369 (563)
T ss_pred hhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEec
Confidence 46889999999999654 3446677777654 3334556888888899999999999999998767788999999
Q ss_pred cCCCChHHHhhccc----CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeeccccccc
Q 005749 456 FPSRTLHDLLHDTI----AGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLM 531 (679)
Q Consensus 456 ~~~gsL~~~l~~~~----~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 531 (679)
+.-|+|..+|...+ ...+.++-.+...++.|++.|++|||+++ |||.||.++|++||+...+||+|=.+++.+
T Consensus 370 ~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~LqVkltDsaLSRDL 446 (563)
T KOG1024|consen 370 TGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQLQVKLTDSALSRDL 446 (563)
T ss_pred cCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhheeEEeccchhcccc
Confidence 99999999998332 22456788889999999999999999998 999999999999999999999999999988
Q ss_pred Ccccccchh-cccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHHhhccccccc
Q 005749 532 VPAVADEMV-ALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAVLEETTMEV 609 (679)
Q Consensus 532 ~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 609 (679)
.+...+-.. ....+..||+||.+....|+.++|||||||+||||+| |+.||...+..+.
T Consensus 447 FP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm------------------- 507 (563)
T KOG1024|consen 447 FPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEM------------------- 507 (563)
T ss_pred CcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHH-------------------
Confidence 776554432 2235668999999999999999999999999999997 8999844322111
Q ss_pred chHhhhhcCCCChH-HHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhh
Q 005749 610 FDMEIMKGIRSPME-EGLVQALKLAMGCCAPVASVRPTMDEVVKQLEEN 657 (679)
Q Consensus 610 ~~~~i~~~~~~~~~-~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 657 (679)
..-+++|++...| .+..++..++.-||+.+|++||++++++..|.+.
T Consensus 508 -~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF 555 (563)
T KOG1024|consen 508 -EHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEF 555 (563)
T ss_pred -HHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence 1123455554444 3345667888899999999999999999999874
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=274.78 Aligned_cols=247 Identities=18% Similarity=0.238 Sum_probs=198.5
Q ss_pred HhhcCccccCCceEEEEEE-eCCCCEEEEEEcccCcccCcccHHHHHHHHhcc-CCCCCccceEEeeCC---CCceEEEE
Q 005749 379 NATGQVIEKTTYGTAYKAK-LADGATIALRLLREGSCKDRSSCLPVIRQLGKV-RHENLIPLRAFYQGK---RGEKLLIY 453 (679)
Q Consensus 379 ~~~~~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~---~~~~~lv~ 453 (679)
....++||-|-.|.|-.+. ..+++.+|+|++.+. ....+|++.--.. .|||||+++++|... .....+||
T Consensus 64 ~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVm 138 (400)
T KOG0604|consen 64 SISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVM 138 (400)
T ss_pred eehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeee
Confidence 3445899999999999998 567999999999763 4457788764333 699999999998742 34568999
Q ss_pred EecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecC---CCceEEeecccccc
Q 005749 454 DYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDD---FFVSRLTEFGLDQL 530 (679)
Q Consensus 454 ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~---~~~~kl~DFGla~~ 530 (679)
|+|+||.|.+.++++. ...+++.++-.|+.||+.|+.|||+.+ |.||||||+|+|... +-.+|++|||+|+.
T Consensus 139 E~meGGeLfsriq~~g--~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfGFAK~ 213 (400)
T KOG0604|consen 139 ECMEGGELFSRIQDRG--DQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFGFAKE 213 (400)
T ss_pred ecccchHHHHHHHHcc--cccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccccccc
Confidence 9999999999998764 567999999999999999999999988 999999999999964 56789999999997
Q ss_pred cCcccccchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccc
Q 005749 531 MVPAVADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVF 610 (679)
Q Consensus 531 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 610 (679)
-.. .....+.+-|+.|.|||++..++|+..+|+||+||++|-|+.|.+||++..... ...-.
T Consensus 214 t~~--~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a----------------ispgM 275 (400)
T KOG0604|consen 214 TQE--PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA----------------ISPGM 275 (400)
T ss_pred cCC--CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc----------------CChhH
Confidence 532 233456688999999999999999999999999999999999999996643311 11222
Q ss_pred hHhhhhcCCCChHHH----HHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 611 DMEIMKGIRSPMEEG----LVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 611 ~~~i~~~~~~~~~~~----~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
..+|..|.+.+..++ .+...+++...+..+|++|.|+.|+++.
T Consensus 276 k~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 276 KRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred HhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 334555555444333 3455678999999999999999999875
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=292.95 Aligned_cols=259 Identities=22% Similarity=0.301 Sum_probs=190.4
Q ss_pred CccccCCceEEEEEE-eCCCCEEEEEEcccCcc--cCcccHHHHHHHHhccCCCCCccceEEeeCCC-----CceEEEEE
Q 005749 383 QVIEKTTYGTAYKAK-LADGATIALRLLREGSC--KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKR-----GEKLLIYD 454 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~-----~~~~lv~e 454 (679)
+.||+|+||.||+|+ ..++..||||++..... ...+.+.+|++++++++||||+++++++.... ...++|||
T Consensus 21 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e 100 (343)
T cd07880 21 KQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMP 100 (343)
T ss_pred EEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEEEEe
Confidence 679999999999998 56799999999864322 22346789999999999999999999887532 24589999
Q ss_pred ecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcc
Q 005749 455 YFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPA 534 (679)
Q Consensus 455 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 534 (679)
|+ +++|.+++.. ..+++..++.++.|+++||+|||+.+ |+||||||+||++++++.+|++|||++......
T Consensus 101 ~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~ 171 (343)
T cd07880 101 FM-GTDLGKLMKH-----EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTDSE 171 (343)
T ss_pred cC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccccccccC
Confidence 99 6799888864 34899999999999999999999988 999999999999999999999999998865322
Q ss_pred cccchhcccccccccccccccc-cCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchH-
Q 005749 535 VADEMVALAKADGYKAPELQRM-KKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDM- 612 (679)
Q Consensus 535 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~- 612 (679)
.....++..|+|||.+.+ ..++.++||||+|+++||+++|+.||.+..... ......... ......+..
T Consensus 172 ----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~--~~~~~~~~~---~~~~~~~~~~ 242 (343)
T cd07880 172 ----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLD--QLMEIMKVT---GTPSKEFVQK 242 (343)
T ss_pred ----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhc---CCCCHHHHHh
Confidence 223457888999998875 458899999999999999999999995432210 011100000 000000000
Q ss_pred -------hhhhcCC----C----ChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH--HHhhCC
Q 005749 613 -------EIMKGIR----S----PMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ--LEENRP 659 (679)
Q Consensus 613 -------~i~~~~~----~----~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~--L~~~~~ 659 (679)
....... . ..+.....+.+++.+|++.||++|||+.+++.. ++....
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~ 306 (343)
T cd07880 243 LQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHD 306 (343)
T ss_pred hcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcC
Confidence 0000000 0 001123457789999999999999999999943 454433
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=297.62 Aligned_cols=256 Identities=18% Similarity=0.273 Sum_probs=187.3
Q ss_pred CccccCCceEEEEEE-eCCCCEEEEEEcccCc--ccCcccHHHHHHHHhccCCCCCccceEEeeCC-----CCceEEEEE
Q 005749 383 QVIEKTTYGTAYKAK-LADGATIALRLLREGS--CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGK-----RGEKLLIYD 454 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~-----~~~~~lv~e 454 (679)
+.||+|+||.||+|+ ..+++.||+|++.... ....+.+.+|++++.+++||||+++++++... ....+++++
T Consensus 23 ~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~~ 102 (345)
T cd07877 23 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTH 102 (345)
T ss_pred EEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEEEEeh
Confidence 579999999999998 5679999999987532 22345678899999999999999999987642 134678888
Q ss_pred ecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcc
Q 005749 455 YFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPA 534 (679)
Q Consensus 455 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 534 (679)
++ +++|.+++.. ..+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+||+|||+++....
T Consensus 103 ~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~- 172 (345)
T cd07877 103 LM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDD- 172 (345)
T ss_pred hc-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEEEecccccccccc-
Confidence 77 7799888764 34899999999999999999999988 99999999999999999999999999876432
Q ss_pred cccchhcccccccccccccccc-cCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhh--cccccccc-
Q 005749 535 VADEMVALAKADGYKAPELQRM-KKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVL--EETTMEVF- 610 (679)
Q Consensus 535 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~--~~~~~~~~- 610 (679)
......++..|+|||.+.+ ..++.++|||||||++|||++|+.||....... .+......... ........
T Consensus 173 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 247 (345)
T cd07877 173 ---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID--QLKLILRLVGTPGAELLKKISS 247 (345)
T ss_pred ---cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCCHHHHhhccc
Confidence 2233467888999998765 568899999999999999999999985432211 11111100000 00000000
Q ss_pred --hHhhhhc---CC-CChH----HHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 611 --DMEIMKG---IR-SPME----EGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 611 --~~~i~~~---~~-~~~~----~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
....... .. .... ...+++.+++.+|++.||++||++.++++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 248 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 0000000 00 0000 123467799999999999999999999876
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-33 Score=295.14 Aligned_cols=256 Identities=19% Similarity=0.273 Sum_probs=188.5
Q ss_pred CccccCCceEEEEEEe-CCCCEEEEEEcccCc--ccCcccHHHHHHHHhccCCCCCccceEEeeCCC-----CceEEEEE
Q 005749 383 QVIEKTTYGTAYKAKL-ADGATIALRLLREGS--CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKR-----GEKLLIYD 454 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~-----~~~~lv~e 454 (679)
..||+|+||.||+|+. .+++.||+|++.... ....+.+.+|+.++++++||||+++++++.... ...++|+|
T Consensus 21 ~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e 100 (343)
T cd07851 21 SPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTH 100 (343)
T ss_pred EEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEEEEe
Confidence 6899999999999995 468899999986532 223456778999999999999999998776522 13899999
Q ss_pred ecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcc
Q 005749 455 YFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPA 534 (679)
Q Consensus 455 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 534 (679)
|+ +++|.+++.. ..+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+||+|||++......
T Consensus 101 ~~-~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~ 171 (343)
T cd07851 101 LM-GADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARHTDDE 171 (343)
T ss_pred cC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEcccccccccccc
Confidence 99 5699998864 35899999999999999999999988 999999999999999999999999999865322
Q ss_pred cccchhcccccccccccccccc-cCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHH--hhcccccccch
Q 005749 535 VADEMVALAKADGYKAPELQRM-KKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVA--VLEETTMEVFD 611 (679)
Q Consensus 535 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~--~~~~~~~~~~~ 611 (679)
.....++..|+|||.+.+ ..++.++|||||||++||+++|+.||......+ .+....... ..+........
T Consensus 172 ----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~--~~~~i~~~~~~~~~~~~~~~~~ 245 (343)
T cd07851 172 ----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHID--QLKRIMNLVGTPDEELLQKISS 245 (343)
T ss_pred ----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHhcCCCCHHHHhhccc
Confidence 234467888999998764 367899999999999999999999995432211 011100000 00000000000
Q ss_pred ---Hhhhh----cCCCChH----HHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 612 ---MEIMK----GIRSPME----EGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 612 ---~~i~~----~~~~~~~----~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
..... ..+.... ....++.+++.+|++.+|++|||+.||++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 246 ESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred hhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 00000 0000011 124567899999999999999999999874
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-33 Score=278.42 Aligned_cols=220 Identities=17% Similarity=0.107 Sum_probs=174.2
Q ss_pred CCceEEEEEE-eCCCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCChHHHhh
Q 005749 388 TTYGTAYKAK-LADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRTLHDLLH 466 (679)
Q Consensus 388 G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gsL~~~l~ 466 (679)
|.||.||+++ ..+++.+|+|+++... .+.+|...+....||||+++++++.+ .+..++||||+++|+|.+++.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~ 77 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVS-EDSVFLVLQHAEGGKLWSHIS 77 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheec-CCeEEEEEecCCCCCHHHHHH
Confidence 8899999999 5678999999997643 23445555556679999999999887 678999999999999999987
Q ss_pred cccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccchhcccccc
Q 005749 467 DTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKAD 546 (679)
Q Consensus 467 ~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~ 546 (679)
.. ..+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.++++|||.+...... .....++.
T Consensus 78 ~~----~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~ 146 (237)
T cd05576 78 KF----LNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVEN 146 (237)
T ss_pred Hh----cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCc
Confidence 53 34899999999999999999999988 999999999999999999999999987655322 12334567
Q ss_pred cccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcCCCChHHHH
Q 005749 547 GYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIRSPMEEGL 626 (679)
Q Consensus 547 ~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 626 (679)
.|+|||......++.++||||+|+++|||++|+.|+...... . ....... ......
T Consensus 147 ~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-~----------------~~~~~~~-------~~~~~~ 202 (237)
T cd05576 147 MYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-I----------------NTHTTLN-------IPEWVS 202 (237)
T ss_pred cccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-c----------------ccccccC-------CcccCC
Confidence 799999998888999999999999999999999886321110 0 0000000 001123
Q ss_pred HHHHHHHHhccCcCCCCCCCHH
Q 005749 627 VQALKLAMGCCAPVASVRPTMD 648 (679)
Q Consensus 627 ~~~~~l~~~cl~~dP~~RPs~~ 648 (679)
+.+.+++.+|++.||++||++.
T Consensus 203 ~~~~~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 203 EEARSLLQQLLQFNPTERLGAG 224 (237)
T ss_pred HHHHHHHHHHccCCHHHhcCCC
Confidence 4567899999999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=274.75 Aligned_cols=262 Identities=21% Similarity=0.266 Sum_probs=191.6
Q ss_pred cccHHHHHHhhcCccccCCceEEEEEE-eCCCCEEEEEEcccCcc-cCcccHHHHHHHHhc-cCCCCCccceEEeeCCCC
Q 005749 371 HLTLEDVLNATGQVIEKTTYGTAYKAK-LADGATIALRLLREGSC-KDRSSCLPVIRQLGK-VRHENLIPLRAFYQGKRG 447 (679)
Q Consensus 371 ~~~~~~l~~~~~~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~-l~H~nIv~l~~~~~~~~~ 447 (679)
.|+-+++... ..||.|.||+|+|-. .+.|+..|||+++.... ++.++++.|.+...+ =+.||||++||.+.. .+
T Consensus 60 ~F~~~~Lqdl--g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~-EG 136 (361)
T KOG1006|consen 60 TFTSDNLQDL--GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFS-EG 136 (361)
T ss_pred ccccchHHHH--HHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhc-CC
Confidence 3444444322 579999999999998 55699999999987643 556788889886554 479999999999887 68
Q ss_pred ceEEEEEecCCCChHHHhhc-ccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecc
Q 005749 448 EKLLIYDYFPSRTLHDLLHD-TIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFG 526 (679)
Q Consensus 448 ~~~lv~ey~~~gsL~~~l~~-~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 526 (679)
..|+-||.|.- ||..+.+. +...+..+++...-.|...+.+||.||-... .|+|||+||+|||+|..|.+|++|||
T Consensus 137 dcWiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFG 213 (361)
T KOG1006|consen 137 DCWICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFG 213 (361)
T ss_pred ceeeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeeccc
Confidence 89999999964 77665432 1111345788877888888999999998753 49999999999999999999999999
Q ss_pred cccccCcccccchhcccccccccccccccc--cCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcc
Q 005749 527 LDQLMVPAVADEMVALAKADGYKAPELQRM--KKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEE 604 (679)
Q Consensus 527 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~ 604 (679)
++-.+..+... +.-.|...|||||.+.. ..|+.++||||+|++|+|++||+.||..... ..+.+......
T Consensus 214 IcGqLv~SiAk--T~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-----vfeql~~Vv~g- 285 (361)
T KOG1006|consen 214 ICGQLVDSIAK--TVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-----VFEQLCQVVIG- 285 (361)
T ss_pred chHhHHHHHHh--hhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-----HHHHHHHHHcC-
Confidence 98776443322 23367788999999873 3489999999999999999999999843211 11111100000
Q ss_pred cccccchHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 605 TTMEVFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 605 ~~~~~~~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
|+.++.. ....-+....+.+++..|+..|-++||...++.+.
T Consensus 286 ------dpp~l~~-~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 286 ------DPPILLF-DKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred ------CCCeecC-cccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 0111100 01112356778899999999999999999988764
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=299.26 Aligned_cols=247 Identities=20% Similarity=0.285 Sum_probs=200.9
Q ss_pred CccccCCceEEEEEE-eCCCCEEEEEEcccCcccCcccHHHHHHHHhcc-CCCCCccceEEeeC----CCCceEEEEEec
Q 005749 383 QVIEKTTYGTAYKAK-LADGATIALRLLREGSCKDRSSCLPVIRQLGKV-RHENLIPLRAFYQG----KRGEKLLIYDYF 456 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~----~~~~~~lv~ey~ 456 (679)
++||+|.+|.||+++ .++++.+|+|++..... ..++...|.++++.. .|||++.++|+|.- .++++|+|||||
T Consensus 25 evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC 103 (953)
T KOG0587|consen 25 EVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVMEFC 103 (953)
T ss_pred EEEeeccceeEEEEeeeecCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEeecc
Confidence 789999999999999 78899999999877543 345677888898887 79999999998863 267899999999
Q ss_pred CCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccc
Q 005749 457 PSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVA 536 (679)
Q Consensus 457 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 536 (679)
.+||..|+++... ...+.|..+..|++++++|+.|||.+. ++|||||-.|||++.++.+|+.|||.+..+... .
T Consensus 104 ~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLvDFGvSaQldsT-~ 177 (953)
T KOG0587|consen 104 GGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDST-V 177 (953)
T ss_pred CCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEeeeeeeeeeecc-c
Confidence 9999999999876 466999999999999999999999988 999999999999999999999999999887543 3
Q ss_pred cchhcccccccccccccccc-----cCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccch
Q 005749 537 DEMVALAKADGYKAPELQRM-----KKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFD 611 (679)
Q Consensus 537 ~~~~~~~gt~~y~aPE~~~~-----~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 611 (679)
....+..||+.|||||++.- ..|+.++|+||+|++..||..|.+|+.+..... ..+...+ .-.
T Consensus 178 grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr---------aLF~IpR---NPP 245 (953)
T KOG0587|consen 178 GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR---------ALFLIPR---NPP 245 (953)
T ss_pred ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh---------hhccCCC---CCC
Confidence 34567789999999998863 247789999999999999999999985433211 0010000 000
Q ss_pred HhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 612 MEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 612 ~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
+++ ........++.++|..|+..|-++||++.++++.
T Consensus 246 PkL-----krp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 246 PKL-----KRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred ccc-----cchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 111 1124557788999999999999999999988754
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=313.06 Aligned_cols=139 Identities=19% Similarity=0.293 Sum_probs=123.8
Q ss_pred CccccCCceEEEEEEeC-CCCEEEEEEcccCccc---CcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCC
Q 005749 383 QVIEKTTYGTAYKAKLA-DGATIALRLLREGSCK---DRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPS 458 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~---~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~ 458 (679)
+.||+|+||.||+|+.. +++.||||+++..... ....+.+|++++..++||||+++++++.. .+..|+||||+++
T Consensus 10 ~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~-~~~~~lVmEy~~g 88 (669)
T cd05610 10 KPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQS-ANNVYLVMEYLIG 88 (669)
T ss_pred EEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEE-CCEEEEEEeCCCC
Confidence 68999999999999954 6899999999754321 23568899999999999999999998887 6789999999999
Q ss_pred CChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeeccccc
Q 005749 459 RTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQ 529 (679)
Q Consensus 459 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 529 (679)
++|.+++... ..+++..++.|+.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 89 ~~L~~li~~~----~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 89 GDVKSLLHIY----GYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999753 35889999999999999999999987 9999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=282.25 Aligned_cols=259 Identities=17% Similarity=0.265 Sum_probs=199.1
Q ss_pred CccccCCceEEEEEE-eCCCCEEEEEEcccCcccCcccHHHHHHHHhccCC--C----CCccceEEeeCCCCceEEEEEe
Q 005749 383 QVIEKTTYGTAYKAK-LADGATIALRLLREGSCKDRSSCLPVIRQLGKVRH--E----NLIPLRAFYQGKRGEKLLIYDY 455 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H--~----nIv~l~~~~~~~~~~~~lv~ey 455 (679)
..+|+|.||.|-.+. .+.+..||||+++... +.++..+-|++++.++.+ | -+|++.+||.- .++.|+|+|.
T Consensus 95 ~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdy-rghiCivfel 172 (415)
T KOG0671|consen 95 DLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDY-RGHICIVFEL 172 (415)
T ss_pred hhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhc-cCceEEEEec
Confidence 569999999999998 4458899999998643 346678889999999942 2 37888888887 7899999999
Q ss_pred cCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecC-------------------
Q 005749 456 FPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDD------------------- 516 (679)
Q Consensus 456 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~------------------- 516 (679)
+ |-|+.++|.... ..+++...++.|+.|++++++|||+.+ ++|-||||+|||+.+
T Consensus 173 l-G~S~~dFlk~N~--y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ 246 (415)
T KOG0671|consen 173 L-GLSTFDFLKENN--YIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPL 246 (415)
T ss_pred c-ChhHHHHhccCC--ccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCccceeccC
Confidence 8 559999998753 466899999999999999999999988 999999999999841
Q ss_pred -CCceEEeecccccccCcccccchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhH
Q 005749 517 -FFVSRLTEFGLDQLMVPAVADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPS 595 (679)
Q Consensus 517 -~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~ 595 (679)
+..+||.|||.|..-.+. ....+.|..|+|||++.+-.++.++||||+||||.|++||...|...++.++..+.+
T Consensus 247 ks~~I~vIDFGsAtf~~e~----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMe 322 (415)
T KOG0671|consen 247 KSTAIKVIDFGSATFDHEH----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMME 322 (415)
T ss_pred CCcceEEEecCCcceeccC----cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHH
Confidence 345799999999865332 245678999999999999999999999999999999999999997766655544433
Q ss_pred HHHHHhhccccccc----------ch-------H---------hhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHH
Q 005749 596 IVKVAVLEETTMEV----------FD-------M---------EIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDE 649 (679)
Q Consensus 596 ~~~~~~~~~~~~~~----------~~-------~---------~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~e 649 (679)
.+-..++....... +| . ............+..++++|+.+|+..||.+|+|+.|
T Consensus 323 rIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~E 402 (415)
T KOG0671|consen 323 RILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLRE 402 (415)
T ss_pred HhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHH
Confidence 33222211111111 00 0 0001111222345567899999999999999999999
Q ss_pred HHHH
Q 005749 650 VVKQ 653 (679)
Q Consensus 650 vl~~ 653 (679)
++++
T Consensus 403 AL~H 406 (415)
T KOG0671|consen 403 ALSH 406 (415)
T ss_pred HhcC
Confidence 9875
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=281.96 Aligned_cols=251 Identities=19% Similarity=0.278 Sum_probs=194.7
Q ss_pred CccccCCceEEEEEE-eCCCCEEEEEEcccCc---c----cCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEE
Q 005749 383 QVIEKTTYGTAYKAK-LADGATIALRLLREGS---C----KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYD 454 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~---~----~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~e 454 (679)
.++|+|+|+.||||. +...+.||||+-.... . ...+...+|.+|-+.++||.||++|+||.-+.+.+|-|+|
T Consensus 469 hLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTVLE 548 (775)
T KOG1151|consen 469 HLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVLE 548 (775)
T ss_pred HHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccceeeee
Confidence 479999999999999 6678899999864321 1 1123467899999999999999999999876788999999
Q ss_pred ecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecC---CCceEEeeccccccc
Q 005749 455 YFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDD---FFVSRLTEFGLDQLM 531 (679)
Q Consensus 455 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~---~~~~kl~DFGla~~~ 531 (679)
||+|.+|+-+|+.+ ..+++.+++.|+.||..||.||.... +||||-||||.|||+.+ .|.+||.|||+++++
T Consensus 549 YceGNDLDFYLKQh----klmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIM 623 (775)
T KOG1151|consen 549 YCEGNDLDFYLKQH----KLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIM 623 (775)
T ss_pred ecCCCchhHHHHhh----hhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeeecchhhhc
Confidence 99999999999884 56899999999999999999999864 77999999999999953 588999999999998
Q ss_pred Ccccccc------hhccccccccccccccccc----CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHh
Q 005749 532 VPAVADE------MVALAKADGYKAPELQRMK----KCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAV 601 (679)
Q Consensus 532 ~~~~~~~------~~~~~gt~~y~aPE~~~~~----~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~ 601 (679)
....... .....||++|.+||.+.-+ +++.|.||||.|||+|..+.|++||...... .++.+
T Consensus 624 dddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ-----QdILq--- 695 (775)
T KOG1151|consen 624 DDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ-----QDILQ--- 695 (775)
T ss_pred cCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH-----HHHHh---
Confidence 6554331 2345799999999987643 3688999999999999999999999432211 01111
Q ss_pred hcccccccchHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHH
Q 005749 602 LEETTMEVFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVK 652 (679)
Q Consensus 602 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 652 (679)
+....+. .+-..++.+....+..++|.+|+++.-++|....++..
T Consensus 696 -eNTIlkA-----tEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 696 -ENTILKA-----TEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred -hhchhcc-----eeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 1110000 00011334455567778999999999999988777654
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=8e-33 Score=276.81 Aligned_cols=234 Identities=21% Similarity=0.271 Sum_probs=187.6
Q ss_pred CccccCCceEEEEEEe-CCCCEEEEEEcccC---cccCcccHHHHHHHHhcc-CCCCCccceEEeeCCCCceEEEEEecC
Q 005749 383 QVIEKTTYGTAYKAKL-ADGATIALRLLREG---SCKDRSSCLPVIRQLGKV-RHENLIPLRAFYQGKRGEKLLIYDYFP 457 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~~lv~ey~~ 457 (679)
.+||+|+||.|.+|.. .+.+.+|||++++. ..++.+.-..|-++|+-- +-|.+|+++.+|++ -++.|+||||+.
T Consensus 355 ~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQT-mDRLyFVMEyvn 433 (683)
T KOG0696|consen 355 MVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQT-MDRLYFVMEYVN 433 (683)
T ss_pred EEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhh-hhheeeEEEEec
Confidence 7899999999999984 45778999999875 234455566777887766 57889999998887 689999999999
Q ss_pred CCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCccccc
Q 005749 458 SRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVAD 537 (679)
Q Consensus 458 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 537 (679)
+|+|.-.+++. ..+.++.+..+|.+||-||-|||+++ |+.||||.+||++|.+|++||+|||+++.---. ..
T Consensus 434 GGDLMyhiQQ~----GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~-~~ 505 (683)
T KOG0696|consen 434 GGDLMYHIQQV----GKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIFD-GV 505 (683)
T ss_pred CchhhhHHHHh----cccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccccccccC-Cc
Confidence 99999988874 34788889999999999999999999 999999999999999999999999999853211 23
Q ss_pred chhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhc
Q 005749 538 EMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKG 617 (679)
Q Consensus 538 ~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~ 617 (679)
...+++||+.|+|||.+..++|+..+|-|||||+||||+.|++||++.++.+... .|++.
T Consensus 506 TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~--------------------aI~eh 565 (683)
T KOG0696|consen 506 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQ--------------------AIMEH 565 (683)
T ss_pred ceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHH--------------------HHHHc
Confidence 3467899999999999999999999999999999999999999997665432211 11221
Q ss_pred CCCChHHHHHHHHHHHHhccCcCCCCCC
Q 005749 618 IRSPMEEGLVQALKLAMGCCAPVASVRP 645 (679)
Q Consensus 618 ~~~~~~~~~~~~~~l~~~cl~~dP~~RP 645 (679)
..........+.+++....+...|.+|.
T Consensus 566 nvsyPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 566 NVSYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred cCcCcccccHHHHHHHHHHhhcCCcccc
Confidence 1122222334556677777778888885
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=8e-33 Score=307.42 Aligned_cols=264 Identities=18% Similarity=0.217 Sum_probs=203.6
Q ss_pred CccccCCceEEEEEEe-CCCCEEEEEEcccCc---ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCC
Q 005749 383 QVIEKTTYGTAYKAKL-ADGATIALRLLREGS---CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPS 458 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~ 458 (679)
++||+|+||.|..++. .+++.+|+|++.+.. ..+...|..|-.+|..-+.+-||+++..|.+ ..+.|+|||||+|
T Consensus 81 KvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD-~~~LYlVMdY~pG 159 (1317)
T KOG0612|consen 81 KVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD-ERYLYLVMDYMPG 159 (1317)
T ss_pred HHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC-ccceEEEEecccC
Confidence 7899999999999994 568899999998742 3345578899999999999999999988998 7899999999999
Q ss_pred CChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccc
Q 005749 459 RTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADE 538 (679)
Q Consensus 459 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 538 (679)
|||-.++... . .+++..++.|+..|..||.-+|+.| +|||||||+|||||.+|++|++|||.+-.+..+..-.
T Consensus 160 GDlltLlSk~---~-~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V~ 232 (1317)
T KOG0612|consen 160 GDLLTLLSKF---D-RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTVR 232 (1317)
T ss_pred chHHHHHhhc---C-CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchhHHhcCCCCcEE
Confidence 9999999875 2 5899999999999999999999988 9999999999999999999999999887776554445
Q ss_pred hhccccccccccccccc----c-cCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHh
Q 005749 539 MVALAKADGYKAPELQR----M-KKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDME 613 (679)
Q Consensus 539 ~~~~~gt~~y~aPE~~~----~-~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 613 (679)
....+|||-|++||++. + +.|++.+|-||+||++|||+.|..||+...- +.-. .++++-+
T Consensus 233 s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadsl------veTY---------~KIm~hk 297 (1317)
T KOG0612|consen 233 SSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSL------VETY---------GKIMNHK 297 (1317)
T ss_pred eccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHH------HHHH---------HHHhchh
Confidence 56778999999999876 3 6799999999999999999999999954321 1111 0111100
Q ss_pred hhhcCCCC-hHHHHHHHHHHHHhccCcCCCCCCC---HHHHHHH----------HHhhCCCCCCCCCCCcccc
Q 005749 614 IMKGIRSP-MEEGLVQALKLAMGCCAPVASVRPT---MDEVVKQ----------LEENRPRNRSALYSPTETR 672 (679)
Q Consensus 614 i~~~~~~~-~~~~~~~~~~l~~~cl~~dP~~RPs---~~evl~~----------L~~~~~~~~~~~~~~~~~~ 672 (679)
.....| ..+...+..+||.+.+ -+|+.|.. ++++-.+ |++..++.-+++.++++++
T Consensus 298 --~~l~FP~~~~VSeeakdLI~~ll-~~~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP~vPevssd~DTs 367 (1317)
T KOG0612|consen 298 --ESLSFPDETDVSEEAKDLIEALL-CDREVRLGRNGIEDIKNHPFFEGIDWDNIRESVPPVVPEVSSDDDTS 367 (1317)
T ss_pred --hhcCCCcccccCHHHHHHHHHHh-cChhhhcccccHHHHHhCccccCCChhhhhhcCCCCCCcCCCCCccc
Confidence 011111 1223345556666543 35778877 7777654 4555566666666666554
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-32 Score=283.11 Aligned_cols=244 Identities=19% Similarity=0.306 Sum_probs=193.7
Q ss_pred cCccccCCceEEEEEE-eCCCCEEEEEEcccCc--ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCC
Q 005749 382 GQVIEKTTYGTAYKAK-LADGATIALRLLREGS--CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPS 458 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~ 458 (679)
++++|+|.||+||-|+ .++|+.||||++.+.. .+..+++.+|+.||++++||.||.+--.|++ .+.+++|||-+.|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET-~ervFVVMEKl~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFET-PERVFVVMEKLHG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecC-CceEEEEehhhcc
Confidence 5899999999999999 6689999999997653 3455789999999999999999999888887 6899999999965
Q ss_pred CChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCC---CceEEeecccccccCccc
Q 005749 459 RTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDF---FVSRLTEFGLDQLMVPAV 535 (679)
Q Consensus 459 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~---~~~kl~DFGla~~~~~~~ 535 (679)
+..+++-... +..+++..-..++.||+.||.|||.++ |+|+||||+|||+.+. -.+||+|||+|+++.+.
T Consensus 648 -DMLEMILSsE--kgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk- 720 (888)
T KOG4236|consen 648 -DMLEMILSSE--KGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK- 720 (888)
T ss_pred -hHHHHHHHhh--cccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchh-
Confidence 6666554443 345888888999999999999999988 9999999999999643 57899999999998543
Q ss_pred ccchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhh
Q 005749 536 ADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIM 615 (679)
Q Consensus 536 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~ 615 (679)
......+||+.|.|||++....|+..-|+||.|||+|--+.|..||..+. ++.+.++.+ ..+
T Consensus 721 -sFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE-----dIndQIQNA------------aFM 782 (888)
T KOG4236|consen 721 -SFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE-----DINDQIQNA------------AFM 782 (888)
T ss_pred -hhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc-----chhHHhhcc------------ccc
Confidence 33456789999999999999999999999999999999999999994322 121111100 001
Q ss_pred hcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHH
Q 005749 616 KGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVK 652 (679)
Q Consensus 616 ~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 652 (679)
. ...+..+.....+++|...++..-++|-|.+..+.
T Consensus 783 y-Pp~PW~eis~~AidlIn~LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 783 Y-PPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLS 818 (888)
T ss_pred c-CCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence 1 01223344566778888888888888888776554
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=266.23 Aligned_cols=235 Identities=25% Similarity=0.355 Sum_probs=190.7
Q ss_pred CceEEEEEEeC-CCCEEEEEEcccCcccC-cccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCChHHHhh
Q 005749 389 TYGTAYKAKLA-DGATIALRLLREGSCKD-RSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRTLHDLLH 466 (679)
Q Consensus 389 ~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~-~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gsL~~~l~ 466 (679)
+||.||+|+.. +++.+|+|++....... .+.+.+|++.+++++|+||+++++++.. ....++++||+++++|.+++.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-~~~~~l~~e~~~~~~L~~~~~ 79 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFED-EDKLYLVMEYCDGGDLFDLLK 79 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheee-CCEEEEEEeCCCCCCHHHHHH
Confidence 58999999965 58999999998765444 6789999999999999999999999887 578999999999999999987
Q ss_pred cccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccchhcccccc
Q 005749 467 DTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKAD 546 (679)
Q Consensus 467 ~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~ 546 (679)
.. ..+++..+..++.++++++.|||+.+ ++|+||+|+||++++++.++++|||.+....... ......++.
T Consensus 80 ~~----~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~ 150 (244)
T smart00220 80 KR----GRLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTP 150 (244)
T ss_pred hc----cCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCc
Confidence 63 22899999999999999999999987 9999999999999999999999999998764331 233456788
Q ss_pred cccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcCCCChHH--
Q 005749 547 GYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIRSPMEE-- 624 (679)
Q Consensus 547 ~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~-- 624 (679)
.|++||......++.++||||||++++|+++|..||...... ....... ..........
T Consensus 151 ~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~-----~~~~~~~--------------~~~~~~~~~~~~ 211 (244)
T smart00220 151 EYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL-----LELFKKI--------------GKPKPPFPPPEW 211 (244)
T ss_pred CCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH-----HHHHHHH--------------hccCCCCccccc
Confidence 899999998888899999999999999999999998542111 1111111 1111111111
Q ss_pred -HHHHHHHHHHhccCcCCCCCCCHHHHHH
Q 005749 625 -GLVQALKLAMGCCAPVASVRPTMDEVVK 652 (679)
Q Consensus 625 -~~~~~~~l~~~cl~~dP~~RPs~~evl~ 652 (679)
...++.+++.+|+..+|++||++.++++
T Consensus 212 ~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 212 KISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred cCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 3356778999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-32 Score=286.11 Aligned_cols=233 Identities=18% Similarity=0.237 Sum_probs=185.8
Q ss_pred CccccCCceEEEEEE-eCCCCEEEEEEcccCcccCcccHHHHHHHHhcc-CCCCCccceEEeeCCCCceEEEEEecCCCC
Q 005749 383 QVIEKTTYGTAYKAK-LADGATIALRLLREGSCKDRSSCLPVIRQLGKV-RHENLIPLRAFYQGKRGEKLLIYDYFPSRT 460 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~~lv~ey~~~gs 460 (679)
..+|.|+|+.|-++. ..+++..|||++... ..+-.+|+.++... +||||+++.+.|.+ ..+.|+|||++.++-
T Consensus 328 ~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~~~-~~~~~~v~e~l~g~e 402 (612)
T KOG0603|consen 328 EELGEGSFSAVKYCESSPTDQEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVYED-GKEIYLVMELLDGGE 402 (612)
T ss_pred cccCCCCccceeeeeccccccchhheecccc----ccccccccchhhhhcCCCcceeecceecC-CceeeeeehhccccH
Confidence 559999999999988 667899999999765 22334567676666 69999999999998 789999999999988
Q ss_pred hHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee-cCCCceEEeecccccccCcccccch
Q 005749 461 LHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLV-DDFFVSRLTEFGLDQLMVPAVADEM 539 (679)
Q Consensus 461 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl-~~~~~~kl~DFGla~~~~~~~~~~~ 539 (679)
+.+.+... +.+. ..+..|+.+++.++.|||+++ ||||||||+|||+ ++.++++|+|||.++..... .
T Consensus 403 ll~ri~~~----~~~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~----~ 470 (612)
T KOG0603|consen 403 LLRRIRSK----PEFC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS----C 470 (612)
T ss_pred HHHHHHhc----chhH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh----h
Confidence 77776542 2233 677789999999999999988 9999999999999 58899999999999976443 3
Q ss_pred hcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcCC
Q 005749 540 VALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIR 619 (679)
Q Consensus 540 ~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~ 619 (679)
.+.+-|..|.|||+.....|++++|+||||++||||++|+.||.....+ .++.. .+.. .
T Consensus 471 ~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~ei~~-----------------~i~~--~ 529 (612)
T KOG0603|consen 471 DTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IEIHT-----------------RIQM--P 529 (612)
T ss_pred cccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HHHHH-----------------hhcC--C
Confidence 3445678899999999999999999999999999999999999544332 11100 1111 1
Q ss_pred CChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 620 SPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 620 ~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
...........+|+.+||+.||.+||+|.++...
T Consensus 530 ~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 530 KFSECVSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred ccccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 1123334567789999999999999999998765
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=298.21 Aligned_cols=258 Identities=17% Similarity=0.173 Sum_probs=163.9
Q ss_pred cCccccCCceEEEEEEeC-C----CCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEee-----CCCCceEE
Q 005749 382 GQVIEKTTYGTAYKAKLA-D----GATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQ-----GKRGEKLL 451 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~-~----~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~-----~~~~~~~l 451 (679)
.+.||+|+||.||+|+.. + +..||+|++..... .+.+..| .+....+.+++.+...+. ....+.++
T Consensus 137 ~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~L 212 (566)
T PLN03225 137 GKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSKKEDEYWL 212 (566)
T ss_pred eEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccccCCceEE
Confidence 478999999999999954 4 68999998764321 1111111 122222333333322211 22567899
Q ss_pred EEEecCCCChHHHhhcccCC----------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeec
Q 005749 452 IYDYFPSRTLHDLLHDTIAG----------------KPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVD 515 (679)
Q Consensus 452 v~ey~~~gsL~~~l~~~~~~----------------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~ 515 (679)
||||+++++|.+++...... ........+..|+.|++.||+|||+++ |+||||||+|||++
T Consensus 213 V~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLKP~NILl~ 289 (566)
T PLN03225 213 VWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVKPQNIIFS 289 (566)
T ss_pred EEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCCHHHEEEe
Confidence 99999999999998753210 001123445689999999999999988 99999999999998
Q ss_pred C-CCceEEeecccccccCcccccchhccccccccccccccccc----------------------CCCCcchhHHHHHHH
Q 005749 516 D-FFVSRLTEFGLDQLMVPAVADEMVALAKADGYKAPELQRMK----------------------KCSSRTDVYAFGILL 572 (679)
Q Consensus 516 ~-~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~k~DV~S~Gvvl 572 (679)
+ ++.+||+|||+|+.+............+++.|||||.+... .++.++|||||||++
T Consensus 290 ~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL 369 (566)
T PLN03225 290 EGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIF 369 (566)
T ss_pred CCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHHHH
Confidence 6 58999999999987644333334456789999999965322 244567999999999
Q ss_pred HHHHhCCCCCCCCCCC-------cccchhHHHHHHhhcccccccchHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCC
Q 005749 573 LEILIGKKPGKSGRNG-------EFVDLPSIVKVAVLEETTMEVFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRP 645 (679)
Q Consensus 573 ~El~tg~~p~~~~~~~-------~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP 645 (679)
|||+++..++...... ...+...|...... ...+.+..+. ...........+++.+|++.||++||
T Consensus 370 ~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~------~~~~~~~~~~-~~~d~~~~~~~dLi~~mL~~dP~kR~ 442 (566)
T PLN03225 370 LQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEP------RASPDLRRGF-EVLDLDGGAGWELLKSMMRFKGRQRI 442 (566)
T ss_pred HHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhcc------ccchhhhhhh-hhccccchHHHHHHHHHccCCcccCC
Confidence 9999977664221000 00001111110000 0000000000 00001112345899999999999999
Q ss_pred CHHHHHHH
Q 005749 646 TMDEVVKQ 653 (679)
Q Consensus 646 s~~evl~~ 653 (679)
|++|++++
T Consensus 443 ta~e~L~H 450 (566)
T PLN03225 443 SAKAALAH 450 (566)
T ss_pred CHHHHhCC
Confidence 99999985
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=246.33 Aligned_cols=205 Identities=20% Similarity=0.348 Sum_probs=167.2
Q ss_pred ccHHHHHHhhcCccccCCceEEEEEE-eCCCCEEEEEEcccC-cccCcccHHHHHHHHhc-cCCCCCccceEEeeCCCCc
Q 005749 372 LTLEDVLNATGQVIEKTTYGTAYKAK-LADGATIALRLLREG-SCKDRSSCLPVIRQLGK-VRHENLIPLRAFYQGKRGE 448 (679)
Q Consensus 372 ~~~~~l~~~~~~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~-~~~~~~~~~~Ei~~l~~-l~H~nIv~l~~~~~~~~~~ 448 (679)
+.-+++ .....||+|+||.|-+-+ ..+|+..|+|.++.. ..+..+..++|+.+..+ ..+|.+|++||.+.. .+.
T Consensus 43 V~ad~L--~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~r-egd 119 (282)
T KOG0984|consen 43 VPADDL--VGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFR-EGD 119 (282)
T ss_pred cchhhh--hhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhc-ccc
Confidence 333444 344789999999998888 568999999999765 23345567888887554 479999999998876 688
Q ss_pred eEEEEEecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccc
Q 005749 449 KLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLD 528 (679)
Q Consensus 449 ~~lv~ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 528 (679)
.++-||.|.. ||+.+-++-...+..+++...=+||..|.+||.|||++- .++|||+||+|||++.+|++|++|||++
T Consensus 120 vwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIs 196 (282)
T KOG0984|consen 120 VWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGIS 196 (282)
T ss_pred EEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccc
Confidence 9999999965 888877654444677899999999999999999999954 4999999999999999999999999999
Q ss_pred cccCcccccchhcccccccccccccccc----cCCCCcchhHHHHHHHHHHHhCCCCCCC
Q 005749 529 QLMVPAVADEMVALAKADGYKAPELQRM----KKCSSRTDVYAFGILLLEILIGKKPGKS 584 (679)
Q Consensus 529 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~k~DV~S~Gvvl~El~tg~~p~~~ 584 (679)
-.+..+..... ..|...|||||.+.. ..|+-|+||||+|+++.||++++.||..
T Consensus 197 G~L~dSiAkt~--daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~ 254 (282)
T KOG0984|consen 197 GYLVDSIAKTM--DAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES 254 (282)
T ss_pred eeehhhhHHHH--hcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence 87755443322 356677999998763 3689999999999999999999999854
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-31 Score=286.54 Aligned_cols=256 Identities=16% Similarity=0.191 Sum_probs=176.4
Q ss_pred cCccccCCceEEEEEEe-----------------CCCCEEEEEEcccCcccC--------------cccHHHHHHHHhcc
Q 005749 382 GQVIEKTTYGTAYKAKL-----------------ADGATIALRLLREGSCKD--------------RSSCLPVIRQLGKV 430 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~-----------------~~~~~vAvK~~~~~~~~~--------------~~~~~~Ei~~l~~l 430 (679)
.++||+|+||+||+|.. .+++.||||++....... .+.+..|+.++.++
T Consensus 150 ~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l~~l 229 (507)
T PLN03224 150 RDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMCAKI 229 (507)
T ss_pred eeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHHHHh
Confidence 37899999999999963 245689999986543222 23345677788888
Q ss_pred CCCCC-----ccceEEeeCC-------CCceEEEEEecCCCChHHHhhcccC--------------------CCCCCCHH
Q 005749 431 RHENL-----IPLRAFYQGK-------RGEKLLIYDYFPSRTLHDLLHDTIA--------------------GKPVLNWA 478 (679)
Q Consensus 431 ~H~nI-----v~l~~~~~~~-------~~~~~lv~ey~~~gsL~~~l~~~~~--------------------~~~~l~~~ 478 (679)
+|.++ ++++++|... .+..++||||+++|+|.++++.... ....++|.
T Consensus 230 ~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~~ 309 (507)
T PLN03224 230 KRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDIN 309 (507)
T ss_pred hcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCHH
Confidence 77655 6777777531 3568999999999999999874311 01235788
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccchhcccccccccccccccccC
Q 005749 479 RRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKADGYKAPELQRMKK 558 (679)
Q Consensus 479 ~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 558 (679)
.++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+............+++.|+|||.+....
T Consensus 310 ~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~~ 386 (507)
T PLN03224 310 VIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMPQ 386 (507)
T ss_pred HHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhcCCC
Confidence 89999999999999999988 999999999999999999999999999765432222222234578999999875322
Q ss_pred --------------------C--CCcchhHHHHHHHHHHHhCCC-CCCCCCCC--c----ccchhHHHHHHhhccccccc
Q 005749 559 --------------------C--SSRTDVYAFGILLLEILIGKK-PGKSGRNG--E----FVDLPSIVKVAVLEETTMEV 609 (679)
Q Consensus 559 --------------------~--~~k~DV~S~Gvvl~El~tg~~-p~~~~~~~--~----~~~l~~~~~~~~~~~~~~~~ 609 (679)
+ ..+.||||+||+++||++|.. |+.+.... + ...+..|... . ...
T Consensus 387 ~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~--~----~~~ 460 (507)
T PLN03224 387 SCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMY--K----GQK 460 (507)
T ss_pred CCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhh--c----ccC
Confidence 1 234799999999999999875 65321110 0 0011111100 0 000
Q ss_pred chHhhhhcCCCChHHHHHHHHHHHHhccCcCC---CCCCCHHHHHHH
Q 005749 610 FDMEIMKGIRSPMEEGLVQALKLAMGCCAPVA---SVRPTMDEVVKQ 653 (679)
Q Consensus 610 ~~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP---~~RPs~~evl~~ 653 (679)
++ ............+++.+++..+| .+|+|++|++++
T Consensus 461 ~~-------~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 461 YD-------FSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred CC-------cccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 00 01112234567788898898765 789999999864
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-32 Score=278.74 Aligned_cols=249 Identities=19% Similarity=0.275 Sum_probs=200.4
Q ss_pred cHHHHHHhhcCccccCCceEEEEEEeCCCC-EEEEEEcccCc---ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCc
Q 005749 373 TLEDVLNATGQVIEKTTYGTAYKAKLADGA-TIALRLLREGS---CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGE 448 (679)
Q Consensus 373 ~~~~l~~~~~~~ig~G~~g~Vy~~~~~~~~-~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~ 448 (679)
.++|+..- ..+|-|+||.|-+++..+.. .+|+|.+++.. .+..+....|-.+|...+.|.||++|.-|.+ ...
T Consensus 418 ~l~dl~~i--aTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd-~ky 494 (732)
T KOG0614|consen 418 KLSDLKRI--ATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRD-SKY 494 (732)
T ss_pred chhhhhhh--hhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhcc-chh
Confidence 34444322 46999999999999965433 48999887653 3445667899999999999999999999988 688
Q ss_pred eEEEEEecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccc
Q 005749 449 KLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLD 528 (679)
Q Consensus 449 ~~lv~ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 528 (679)
+|++||-|-||.|-..|+++ ..++....+.|+..+.+|++|||+++ ||.|||||+|.++|.+|-+||.|||+|
T Consensus 495 vYmLmEaClGGElWTiLrdR----g~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFA 567 (732)
T KOG0614|consen 495 VYMLMEACLGGELWTILRDR----GSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFA 567 (732)
T ss_pred hhhhHHhhcCchhhhhhhhc----CCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhH
Confidence 99999999999999999874 56899999999999999999999999 999999999999999999999999999
Q ss_pred cccCcccccchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccc
Q 005749 529 QLMVPAVADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTME 608 (679)
Q Consensus 529 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 608 (679)
+.+..+ .+..+++||+.|.|||.+.....+.++|.||+|+++|||++|.+||.+.+....+.+
T Consensus 568 Kki~~g--~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~--------------- 630 (732)
T KOG0614|consen 568 KKIGSG--RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNL--------------- 630 (732)
T ss_pred HHhccC--CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHH---------------
Confidence 988543 456789999999999999999999999999999999999999999966543221111
Q ss_pred cchHhhhhcCC--CChHHHHHHHHHHHHhccCcCCCCCCC-----HHHHHHH
Q 005749 609 VFDMEIMKGIR--SPMEEGLVQALKLAMGCCAPVASVRPT-----MDEVVKQ 653 (679)
Q Consensus 609 ~~~~~i~~~~~--~~~~~~~~~~~~l~~~cl~~dP~~RPs-----~~evl~~ 653 (679)
|++|.. ..+........+++.+.+..+|.+|.- ..+|-++
T Consensus 631 -----ILkGid~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH 677 (732)
T KOG0614|consen 631 -----ILKGIDKIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKH 677 (732)
T ss_pred -----HHhhhhhhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhh
Confidence 111110 111222345567889999999999985 5555544
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=291.10 Aligned_cols=239 Identities=20% Similarity=0.333 Sum_probs=184.0
Q ss_pred cCccccCCce-EEEEEEeCCCCEEEEEEcccCcccCcccHHHHHHHHhcc-CCCCCccceEEeeCCCCceEEEEEecCCC
Q 005749 382 GQVIEKTTYG-TAYKAKLADGATIALRLLREGSCKDRSSCLPVIRQLGKV-RHENLIPLRAFYQGKRGEKLLIYDYFPSR 459 (679)
Q Consensus 382 ~~~ig~G~~g-~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~~lv~ey~~~g 459 (679)
.+++|.|+-| .||+|.++ |+.||||++-... .+-..+||+.|+.- +|||||++++.-.+ +...||..|.|..
T Consensus 514 ~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d-~qF~YIalELC~~- 587 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVYE-GREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQD-RQFLYIALELCAC- 587 (903)
T ss_pred HHHcccCCCCcEEEEEeeC-CceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccC-CceEEEEehHhhh-
Confidence 3678999988 57999985 8899999986532 34567999999888 69999999876555 6789999999976
Q ss_pred ChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecC---C--CceEEeecccccccCcc
Q 005749 460 TLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDD---F--FVSRLTEFGLDQLMVPA 534 (679)
Q Consensus 460 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~---~--~~~kl~DFGla~~~~~~ 534 (679)
+|.+++...........-...+.+..|+++||+|||+.+ ||||||||.||||+. + .+++|+|||+++.+..+
T Consensus 588 sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~ 664 (903)
T KOG1027|consen 588 SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGG 664 (903)
T ss_pred hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccCCC
Confidence 999999874111111111345788999999999999977 999999999999975 2 57899999999988655
Q ss_pred ccc--chhcccccccccccccccccCCCCcchhHHHHHHHHHHHhC-CCCCCCCCCCcccchhHHHHHHhhcccccccch
Q 005749 535 VAD--EMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIG-KKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFD 611 (679)
Q Consensus 535 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg-~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 611 (679)
... ......||.+|+|||++....-+.++||||+|||+|+.++| ++||.+....+.
T Consensus 665 ~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~--------------------- 723 (903)
T KOG1027|consen 665 KSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA--------------------- 723 (903)
T ss_pred cchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh---------------------
Confidence 332 24456799999999999988888899999999999999986 899944322110
Q ss_pred HhhhhcCC-----CChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 612 MEIMKGIR-----SPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 612 ~~i~~~~~-----~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
.|..+.. .+.++. +..++|.+|+..+|..||++.+|+.+
T Consensus 724 -NIl~~~~~L~~L~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 724 -NILTGNYTLVHLEPLPDC--EAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred -hhhcCccceeeeccCchH--HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 1111111 111222 77899999999999999999999754
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=272.12 Aligned_cols=199 Identities=20% Similarity=0.292 Sum_probs=169.4
Q ss_pred CccccCCceEEEEEE-eCCCCEEEEEEcccCccc---CcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCC
Q 005749 383 QVIEKTTYGTAYKAK-LADGATIALRLLREGSCK---DRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPS 458 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~---~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~ 458 (679)
+.||-|+||+|.+++ .++...+|+|.+++...- .....+.|-+||+..+.+-||+||..|.+ .+..|+||||++|
T Consensus 635 k~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQD-kdnLYFVMdYIPG 713 (1034)
T KOG0608|consen 635 KTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQD-KDNLYFVMDYIPG 713 (1034)
T ss_pred eeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEecc-CCceEEEEeccCC
Confidence 469999999999998 566788999999876432 23456789999999999999999999998 6899999999999
Q ss_pred CChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccC------
Q 005749 459 RTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMV------ 532 (679)
Q Consensus 459 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~------ 532 (679)
|++..+|-. ...|.+..++.++.++..|+++.|..| +|||||||+|||||.+|++||.|||++.-+.
T Consensus 714 GDmMSLLIr----mgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdsk 786 (1034)
T KOG0608|consen 714 GDMMSLLIR----MGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 786 (1034)
T ss_pred ccHHHHHHH----hccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceeccccc
Confidence 999999876 356889999999999999999999888 9999999999999999999999999974321
Q ss_pred ---ccccc--------------------------------chhcccccccccccccccccCCCCcchhHHHHHHHHHHHh
Q 005749 533 ---PAVAD--------------------------------EMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI 577 (679)
Q Consensus 533 ---~~~~~--------------------------------~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t 577 (679)
.+... .....+||+.|+|||++....|+.-+|-||.|||||||+.
T Consensus 787 YYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~ 866 (1034)
T KOG0608|consen 787 YYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLV 866 (1034)
T ss_pred cccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhh
Confidence 00000 0113579999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCc
Q 005749 578 GKKPGKSGRNGE 589 (679)
Q Consensus 578 g~~p~~~~~~~~ 589 (679)
|+.||...+..+
T Consensus 867 g~~pf~~~tp~~ 878 (1034)
T KOG0608|consen 867 GQPPFLADTPGE 878 (1034)
T ss_pred CCCCccCCCCCc
Confidence 999997766554
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-32 Score=259.15 Aligned_cols=264 Identities=20% Similarity=0.279 Sum_probs=199.0
Q ss_pred cCccccCCceEEEEEE-eCCCCEEEEEEcccCcc--cCcccHHHHHHHHhccCCCCCccceEEeeCCC----CceEEEEE
Q 005749 382 GQVIEKTTYGTAYKAK-LADGATIALRLLREGSC--KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKR----GEKLLIYD 454 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~----~~~~lv~e 454 (679)
++-||-|+||.||.+. -++|+.||.|++..... ...+.+.+|+++|..++|.|++..+++..-.. .++|+|+|
T Consensus 58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TE 137 (449)
T KOG0664|consen 58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTE 137 (449)
T ss_pred CCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHH
Confidence 3789999999999998 56899999999865422 34567899999999999999999988766421 25689999
Q ss_pred ecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcc
Q 005749 455 YFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPA 534 (679)
Q Consensus 455 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 534 (679)
.|.. +|+..+-. .+.++...++-+..||++||+|||+.+ |.||||||.|.|++.+...||+|||+|+.....
T Consensus 138 LmQS-DLHKIIVS----PQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d 209 (449)
T KOG0664|consen 138 LMQS-DLHKIIVS----PQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQR 209 (449)
T ss_pred HHHh-hhhheecc----CCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccchh
Confidence 9966 88888765 466888899999999999999999998 999999999999999999999999999987666
Q ss_pred cccchhcccccccccccccccc-cCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhccccc------
Q 005749 535 VADEMVALAKADGYKAPELQRM-KKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTM------ 607 (679)
Q Consensus 535 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~------ 607 (679)
....++..+-|..|+|||.+++ +.|+.+.||||.||++.|++.++..|.....-+..+++.. .+......
T Consensus 210 ~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItd---LLGTPs~EaMr~AC 286 (449)
T KOG0664|consen 210 DRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIID---LLGTPSQEAMKYAC 286 (449)
T ss_pred hhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHH---HhCCCcHHHHHHHh
Confidence 6666666677889999999987 4689999999999999999999988855444333322211 11110000
Q ss_pred ccchHhhhhc-CCCC----------hHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHh
Q 005749 608 EVFDMEIMKG-IRSP----------MEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEE 656 (679)
Q Consensus 608 ~~~~~~i~~~-~~~~----------~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 656 (679)
+--...+..+ .+.+ ....-.+.+.+.++++..||++|.+..+.+..+..
T Consensus 287 EGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~ 346 (449)
T KOG0664|consen 287 EGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYL 346 (449)
T ss_pred hhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccc
Confidence 0000011111 1111 11222455678888999999999999999887643
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9e-30 Score=237.29 Aligned_cols=255 Identities=20% Similarity=0.289 Sum_probs=195.1
Q ss_pred CccccCCceEEEEEE-eCCCCEEEEEEcccCcccCcccHHHHHHHHhccC-CCCCccceEEeeCC-CCceEEEEEecCCC
Q 005749 383 QVIEKTTYGTAYKAK-LADGATIALRLLREGSCKDRSSCLPVIRQLGKVR-HENLIPLRAFYQGK-RGEKLLIYDYFPSR 459 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~~~~~~~-~~~~~lv~ey~~~g 459 (679)
+.+|+|.|+.||.|. ..+.+.++||++++.. .+.+.+|++||..++ ||||++++++..++ .....+|+||+.+.
T Consensus 44 rk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~ 120 (338)
T KOG0668|consen 44 RKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNT 120 (338)
T ss_pred HHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhccc
Confidence 679999999999999 6788999999998753 456889999999997 99999999998875 34567999999998
Q ss_pred ChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCC-CceEEeecccccccCcccccc
Q 005749 460 TLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDF-FVSRLTEFGLDQLMVPAVADE 538 (679)
Q Consensus 460 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~-~~~kl~DFGla~~~~~~~~~~ 538 (679)
+...+. +.++...++.++.++++||.|+|+.| |+|||+||.|+++|.. -..+++|+|+|.++.+....
T Consensus 121 Dfk~ly-------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eY- 189 (338)
T KOG0668|consen 121 DFKQLY-------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY- 189 (338)
T ss_pred cHHHHh-------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcCCCcee-
Confidence 776654 34788889999999999999999999 9999999999999954 57899999999998766443
Q ss_pred hhcccccccccccccccc-cCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccc------cccch
Q 005749 539 MVALAKADGYKAPELQRM-KKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETT------MEVFD 611 (679)
Q Consensus 539 ~~~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~------~~~~~ 611 (679)
...+.+..|.-||++.. ..|+..-|+|||||++.+|+..+.||..+... ..+++.+++..-.++-. .-.+|
T Consensus 190 -nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN-~DQLVkIakVLGt~el~~Yl~KY~i~Ld 267 (338)
T KOG0668|consen 190 -NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN-YDQLVKIAKVLGTDELYAYLNKYQIDLD 267 (338)
T ss_pred -eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCC-HHHHHHHHHHhChHHHHHHHHHHccCCC
Confidence 23356677899998764 56888999999999999999999998665432 33444444332211100 00122
Q ss_pred Hhhh----hcCCCChH---------HHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 612 MEIM----KGIRSPME---------EGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 612 ~~i~----~~~~~~~~---------~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
++.. ...+.+.. -..++.++++.+.+.+|..+|||++|++.+
T Consensus 268 p~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 268 PQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred hhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 2211 11111111 113788999999999999999999998865
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.9e-30 Score=249.26 Aligned_cols=192 Identities=19% Similarity=0.302 Sum_probs=167.0
Q ss_pred CccccCCceEEEEEE-eCCCCEEEEEEcccCcc---cCcccHHHHHHHHhcc-CCCCCccceEEeeCCCCceEEEEEecC
Q 005749 383 QVIEKTTYGTAYKAK-LADGATIALRLLREGSC---KDRSSCLPVIRQLGKV-RHENLIPLRAFYQGKRGEKLLIYDYFP 457 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~---~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~~lv~ey~~ 457 (679)
++||+|+|++|..++ .++.+.+|+|++++.-. ++.+=...|-.+..+. +||.+|.++.+|.+ ....++|.||++
T Consensus 256 ~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqt-esrlffvieyv~ 334 (593)
T KOG0695|consen 256 RVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQT-ESRLFFVIEYVN 334 (593)
T ss_pred eeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcc-cceEEEEEEEec
Confidence 789999999999999 45688999999986532 2233355666666665 79999999999988 688999999999
Q ss_pred CCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCccccc
Q 005749 458 SRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVAD 537 (679)
Q Consensus 458 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 537 (679)
+|+|.-+++. ...++++.++.+..+|..||.|||+++ |+.||||.+|+|+|..|++|+.|+|+.+.-... ..
T Consensus 335 ggdlmfhmqr----qrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l~~-gd 406 (593)
T KOG0695|consen 335 GGDLMFHMQR----QRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGP-GD 406 (593)
T ss_pred Ccceeeehhh----hhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCCCC-Cc
Confidence 9999888776 355999999999999999999999998 999999999999999999999999999864322 34
Q ss_pred chhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCC
Q 005749 538 EMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGK 583 (679)
Q Consensus 538 ~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~ 583 (679)
...+++||+.|+|||.+.+..|+...|-|++||+|+||+.|+.||+
T Consensus 407 ~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfd 452 (593)
T KOG0695|consen 407 TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFD 452 (593)
T ss_pred ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcc
Confidence 4567899999999999999999999999999999999999999995
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.4e-28 Score=236.83 Aligned_cols=210 Identities=25% Similarity=0.447 Sum_probs=180.3
Q ss_pred cccCCceEEEEEEeCC-CCEEEEEEcccCccc-CcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCChH
Q 005749 385 IEKTTYGTAYKAKLAD-GATIALRLLREGSCK-DRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRTLH 462 (679)
Q Consensus 385 ig~G~~g~Vy~~~~~~-~~~vAvK~~~~~~~~-~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gsL~ 462 (679)
||+|.+|.||+++..+ ++.+++|++...... ..+.+.+|++.+++++|++|+++++++.. ....++++||+++++|.
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-~~~~~~~~e~~~~~~l~ 79 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFED-ENHLYLVMEYCEGGSLK 79 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeec-CCeEEEEEecCCCCcHH
Confidence 6899999999999654 899999999865332 24679999999999999999999999987 57899999999999999
Q ss_pred HHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecC-CCceEEeecccccccCcccccchhc
Q 005749 463 DLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDD-FFVSRLTEFGLDQLMVPAVADEMVA 541 (679)
Q Consensus 463 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~-~~~~kl~DFGla~~~~~~~~~~~~~ 541 (679)
+++.... ..+++..+..++.+++++++|||+.+ ++|+||+|.||+++. ++.++|+|||.+........ ....
T Consensus 80 ~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~ 152 (215)
T cd00180 80 DLLKENE---GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKT 152 (215)
T ss_pred HHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhc
Confidence 9987531 35899999999999999999999987 999999999999999 89999999999886543321 1233
Q ss_pred cccccccccccccccc-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcCCC
Q 005749 542 LAKADGYKAPELQRMK-KCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIRS 620 (679)
Q Consensus 542 ~~gt~~y~aPE~~~~~-~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~~ 620 (679)
..+...|++||..... .++.+.|+|++|++++|+
T Consensus 153 ~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------------------- 187 (215)
T cd00180 153 IVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------------------- 187 (215)
T ss_pred ccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------------------
Confidence 4577789999998876 788999999999999998
Q ss_pred ChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 621 PMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 621 ~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
..+.+++.+|++.+|++||+++++++.
T Consensus 188 ------~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 ------PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred ------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 345578999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.1e-29 Score=242.19 Aligned_cols=253 Identities=16% Similarity=0.194 Sum_probs=189.2
Q ss_pred CccccCCceEEEEEE-eCCCCEEEEEEcccC--cccCcccHHHHHHHHhccCCCCCccceEEeeCC-----CCceEEEEE
Q 005749 383 QVIEKTTYGTAYKAK-LADGATIALRLLREG--SCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGK-----RGEKLLIYD 454 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~-----~~~~~lv~e 454 (679)
..+|.|.- .|..|. .-.++.||+|++... .....+...+|...+..+.|+||++++.+|.-. -.+.|+|||
T Consensus 23 ~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e 101 (369)
T KOG0665|consen 23 KPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVME 101 (369)
T ss_pred cccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHH
Confidence 45666766 555554 234889999987543 223455678999999999999999999988742 125799999
Q ss_pred ecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcc
Q 005749 455 YFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPA 534 (679)
Q Consensus 455 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 534 (679)
||.. +|.+.+.- .++-.+...|..|++.|++|||+.+ |+||||||+||++..++.+||.|||+|+.....
T Consensus 102 ~m~~-nl~~vi~~------elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~ 171 (369)
T KOG0665|consen 102 LMDA-NLCQVILM------ELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD 171 (369)
T ss_pred hhhh-HHHHHHHH------hcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhcccCcc
Confidence 9965 99998873 2677888999999999999999998 999999999999999999999999999864332
Q ss_pred cccchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhh
Q 005749 535 VADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEI 614 (679)
Q Consensus 535 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i 614 (679)
-.++.++.|..|+|||++.+..+.+.+||||.||++.||++|+..|.+.+ .+.+|.+..-.-+...+.+-..+
T Consensus 172 --~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d-----~idQ~~ki~~~lgtpd~~F~~qL 244 (369)
T KOG0665|consen 172 --FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKD-----HIDQWNKIIEQLGTPDPSFMKQL 244 (369)
T ss_pred --cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCch-----HHHHHHHHHHHhcCCCHHHHHHh
Confidence 34567788999999999998889999999999999999999999886432 33444333221111111110000
Q ss_pred -----------------------hh----cCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 615 -----------------------MK----GIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 615 -----------------------~~----~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
.. ......+..+....+++.+|+..||++|.++++++++
T Consensus 245 ~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 245 QPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred hHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 00 0001112334566789999999999999999999886
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.5e-28 Score=247.24 Aligned_cols=126 Identities=19% Similarity=0.319 Sum_probs=107.3
Q ss_pred CccccCCceEEEEEE-eCCCCEEEEEEcccCcccCcccHHHHHHHHhccC-----C---CCCccceEEeeCC---CCceE
Q 005749 383 QVIEKTTYGTAYKAK-LADGATIALRLLREGSCKDRSSCLPVIRQLGKVR-----H---ENLIPLRAFYQGK---RGEKL 450 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~-----H---~nIv~l~~~~~~~---~~~~~ 450 (679)
+.||-|-|++||+|+ .++.+.||+|+.+... ...+..+.||++|++++ | .+||+|+++|... ..++|
T Consensus 84 rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVC 162 (590)
T KOG1290|consen 84 RKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQHVC 162 (590)
T ss_pred EeccccccceeEEEeeccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCCcEEE
Confidence 789999999999999 6778999999987643 34567889999999984 2 4799999999752 45899
Q ss_pred EEEEecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee
Q 005749 451 LIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLV 514 (679)
Q Consensus 451 lv~ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl 514 (679)
||+|++ |-+|..++.... .+-++...+++|++||+.||.|||.++ +|||-||||+|||+
T Consensus 163 MVfEvL-GdnLLklI~~s~--YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 163 MVFEVL-GDNLLKLIKYSN--YRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred EEehhh-hhHHHHHHHHhC--CCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 999999 558888887654 344889999999999999999999976 59999999999998
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-29 Score=258.01 Aligned_cols=261 Identities=18% Similarity=0.224 Sum_probs=198.4
Q ss_pred CccccCCceEEEEEE-eCCCCEEEEEEcccCcccCcccHHHHHHHHhccC------CCCCccceEEeeCCCCceEEEEEe
Q 005749 383 QVIEKTTYGTAYKAK-LADGATIALRLLREGSCKDRSSCLPVIRQLGKVR------HENLIPLRAFYQGKRGEKLLIYDY 455 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~------H~nIv~l~~~~~~~~~~~~lv~ey 455 (679)
...|+|-|++|.+|+ ..-|..||||+++.... ..+.=++|+++|.+|+ .-|+++++-.|.. .++.|||+|-
T Consensus 438 ~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~-M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~h-knHLClVFE~ 515 (752)
T KOG0670|consen 438 GYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV-MHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKH-KNHLCLVFEP 515 (752)
T ss_pred eccccceeeeeeeccccCCCCeeEEEEeecchH-HhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhh-cceeEEEehh
Confidence 467899999999999 44588999999987432 2345578999999995 3578999888887 6899999998
Q ss_pred cCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCC-CceEEeecccccccCcc
Q 005749 456 FPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDF-FVSRLTEFGLDQLMVPA 534 (679)
Q Consensus 456 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~-~~~kl~DFGla~~~~~~ 534 (679)
+. .+|.++|+.... ..-|....++.++.|+..||..|-..+ |+|.||||+|||+++. ...||||||.|......
T Consensus 516 Ls-lNLRevLKKyG~-nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~en 590 (752)
T KOG0670|consen 516 LS-LNLREVLKKYGR-NVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDFGSASFASEN 590 (752)
T ss_pred hh-chHHHHHHHhCc-ccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccCccccccccc
Confidence 84 499999998754 344788889999999999999999877 9999999999999875 56799999999876433
Q ss_pred cccchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcc----------
Q 005749 535 VADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEE---------- 604 (679)
Q Consensus 535 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~---------- 604 (679)
..+.+.-+..|+|||.+.+-+|+...|+||.||.||||+||+..|.+.++.+...+...++..++..
T Consensus 591 ---eitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dq 667 (752)
T KOG0670|consen 591 ---EITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQ 667 (752)
T ss_pred ---cccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhh
Confidence 3344456678999999999999999999999999999999999998877654332222221111110
Q ss_pred c----------------------ccccch------Hhhhhc--CCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 605 T----------------------TMEVFD------MEIMKG--IRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 605 ~----------------------~~~~~~------~~i~~~--~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
. .+..+. ..+... +....+....++.+|+..|+..||++|.|..+++++
T Consensus 668 HFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~H 746 (752)
T KOG0670|consen 668 HFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALKH 746 (752)
T ss_pred hcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhcC
Confidence 0 011111 122222 222334556678899999999999999999998764
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-28 Score=255.56 Aligned_cols=191 Identities=22% Similarity=0.329 Sum_probs=165.0
Q ss_pred cCccccCCceEEEEEEe-CCCCEEEEEEcccCc--------ccCcccHHHHHHHHhccC---CCCCccceEEeeCCCCce
Q 005749 382 GQVIEKTTYGTAYKAKL-ADGATIALRLLREGS--------CKDRSSCLPVIRQLGKVR---HENLIPLRAFYQGKRGEK 449 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~--------~~~~~~~~~Ei~~l~~l~---H~nIv~l~~~~~~~~~~~ 449 (679)
-+.+|+|+||.|+.|.+ ++...|+||++.+.. ..+....-.||+||..++ |+||++++++|++ ++.+
T Consensus 566 lq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd-dd~y 644 (772)
T KOG1152|consen 566 LQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED-DDYY 644 (772)
T ss_pred eeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec-CCee
Confidence 37899999999999995 457789999986542 122335678999999997 9999999999998 7899
Q ss_pred EEEEEe-cCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccc
Q 005749 450 LLIYDY-FPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLD 528 (679)
Q Consensus 450 ~lv~ey-~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 528 (679)
|++||- =++-+|++++.- ++.+++..+..|+.||+.|+++||+.+ |||||||-+||.+|.+|-+||+|||.|
T Consensus 645 yl~te~hg~gIDLFd~IE~----kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidfgsa 717 (772)
T KOG1152|consen 645 YLETEVHGEGIDLFDFIEF----KPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDFGSA 717 (772)
T ss_pred EEEecCCCCCcchhhhhhc----cCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeeccch
Confidence 999995 456799999976 466999999999999999999999998 999999999999999999999999998
Q ss_pred cccCcccccchhcccccccccccccccccCC-CCcchhHHHHHHHHHHHhCCCCCC
Q 005749 529 QLMVPAVADEMVALAKADGYKAPELQRMKKC-SSRTDVYAFGILLLEILIGKKPGK 583 (679)
Q Consensus 529 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DV~S~Gvvl~El~tg~~p~~ 583 (679)
.....+ ....+.||..|.|||++.+.+| +..-|||++|++||.++...-||+
T Consensus 718 a~~ksg---pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 718 AYTKSG---PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred hhhcCC---CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 765332 3346789999999999999887 677999999999999999999984
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.5e-29 Score=264.79 Aligned_cols=246 Identities=21% Similarity=0.288 Sum_probs=195.7
Q ss_pred CccccCCceEEEEEE-eCCCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCCh
Q 005749 383 QVIEKTTYGTAYKAK-LADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRTL 461 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gsL 461 (679)
..+|.|.||.||||+ .+.++..|+|+++.....+..-...|+-+++..+|||||.++|-|.. ++..++.||||.+|+|
T Consensus 21 qrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr-~dklwicMEycgggsl 99 (829)
T KOG0576|consen 21 QRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLR-RDKLWICMEYCGGGSL 99 (829)
T ss_pred eeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhh-hcCcEEEEEecCCCcc
Confidence 689999999999999 67899999999998776777778899999999999999999998886 6889999999999999
Q ss_pred HHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccchhc
Q 005749 462 HDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVA 541 (679)
Q Consensus 462 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 541 (679)
.+.-+.. .++++.++..++++..+||+|||+.+ -+|||||-.|||+++.|.+|++|||.+..+... ..+...
T Consensus 100 Qdiy~~T----gplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitat-i~Krks 171 (829)
T KOG0576|consen 100 QDIYHVT----GPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITAT-IAKRKS 171 (829)
T ss_pred cceeeec----ccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhh-hhhhhc
Confidence 9988764 56899999999999999999999988 899999999999999999999999998776433 234567
Q ss_pred cccccccccccccc---ccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcC
Q 005749 542 LAKADGYKAPELQR---MKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGI 618 (679)
Q Consensus 542 ~~gt~~y~aPE~~~---~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~ 618 (679)
+.||++|||||+.. .+.|..++|||+.|+...|+..-++|..+-. ......+-. ...+++--.+.
T Consensus 172 fiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlh--------pmr~l~LmT---kS~~qpp~lkD- 239 (829)
T KOG0576|consen 172 FIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLH--------PMRALFLMT---KSGFQPPTLKD- 239 (829)
T ss_pred ccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccc--------hHHHHHHhh---ccCCCCCcccC-
Confidence 89999999999765 4569999999999999999988888853221 111111111 11111111110
Q ss_pred CCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHH
Q 005749 619 RSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVK 652 (679)
Q Consensus 619 ~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 652 (679)
.....+.+-++++.|+-.+|++||+++.+++
T Consensus 240 ---k~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 240 ---KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred ---CccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 1122344557888899999999999876653
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.2e-27 Score=234.03 Aligned_cols=196 Identities=24% Similarity=0.420 Sum_probs=168.8
Q ss_pred cCccccCCceEEEEEEeCC-CCEEEEEEcccCccc-CcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCC
Q 005749 382 GQVIEKTTYGTAYKAKLAD-GATIALRLLREGSCK-DRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSR 459 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~~-~~~vAvK~~~~~~~~-~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~g 459 (679)
.+.||+|++|.||+|+..+ ++.+|+|.+...... ..+.+.+|++.+++++|+|++++++++.. ....++++||++++
T Consensus 4 ~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~-~~~~~~v~e~~~~~ 82 (225)
T smart00221 4 GKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFED-PEPLYLVMEYCEGG 82 (225)
T ss_pred eeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeec-CCceEEEEeccCCC
Confidence 3679999999999999654 899999999876544 56788999999999999999999999887 57899999999999
Q ss_pred ChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccch
Q 005749 460 TLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEM 539 (679)
Q Consensus 460 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 539 (679)
+|.+++..... .+++.....++.+++.++.|||+.+ ++|+|++|+||+++.++.++|+|||.+...........
T Consensus 83 ~L~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~ 156 (225)
T smart00221 83 DLFDYLRKKGG---KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALL 156 (225)
T ss_pred CHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccc
Confidence 99999976421 1789999999999999999999987 99999999999999999999999999887644321122
Q ss_pred hcccccccccccccc-cccCCCCcchhHHHHHHHHHHHhCCCCCCC
Q 005749 540 VALAKADGYKAPELQ-RMKKCSSRTDVYAFGILLLEILIGKKPGKS 584 (679)
Q Consensus 540 ~~~~gt~~y~aPE~~-~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~ 584 (679)
....++..|++||.. ....++.++|||+||++++||++|+.||..
T Consensus 157 ~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 157 KTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 344677789999998 667788899999999999999999999944
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.5e-27 Score=222.67 Aligned_cols=259 Identities=18% Similarity=0.258 Sum_probs=184.8
Q ss_pred ccccHHHHHHhhcCccccCCceEEEEEEeC-CCCEEEEEEcccCcccCcccHHHHHHHHhcc-CCCCCccceEEeeCCCC
Q 005749 370 EHLTLEDVLNATGQVIEKTTYGTAYKAKLA-DGATIALRLLREGSCKDRSSCLPVIRQLGKV-RHENLIPLRAFYQGKRG 447 (679)
Q Consensus 370 ~~~~~~~l~~~~~~~ig~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~ 447 (679)
+.++++|.. ...+.+|+|.||.+-+++.+ ..+.+++|.+.... ....+|.+|...--.+ .|.||+.-|++-....+
T Consensus 18 ~kv~l~d~y-~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d 95 (378)
T KOG1345|consen 18 KKVDLEDVY-TINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSD 95 (378)
T ss_pred cccchhhhh-hHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCc
Confidence 456666664 33578999999999999954 57789999987643 3456788888765555 59999998775443367
Q ss_pred ceEEEEEecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeec--CCCceEEeec
Q 005749 448 EKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVD--DFFVSRLTEF 525 (679)
Q Consensus 448 ~~~lv~ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~--~~~~~kl~DF 525 (679)
..++++||+|.|+|.+-+... -+-+....+++.|++.|+.|||+++ +||||||.+||||- +..++|++||
T Consensus 96 ~YvF~qE~aP~gdL~snv~~~-----GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDF 167 (378)
T KOG1345|consen 96 AYVFVQEFAPRGDLRSNVEAA-----GIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDF 167 (378)
T ss_pred eEEEeeccCccchhhhhcCcc-----cccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeec
Confidence 888999999999999988753 2667888999999999999999998 99999999999994 3468999999
Q ss_pred ccccccCcccccchhcccccccccccccccc---c--CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHH
Q 005749 526 GLDQLMVPAVADEMVALAKADGYKAPELQRM---K--KCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVA 600 (679)
Q Consensus 526 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~--~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~ 600 (679)
|..+...... ....-+..|.|||.... + ...+.+|||.||++++.++||+.||.. .........+|.+..
T Consensus 168 G~t~k~g~tV----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQk-a~~~d~~Y~~~~~w~ 242 (378)
T KOG1345|consen 168 GLTRKVGTTV----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQK-ASIMDKPYWEWEQWL 242 (378)
T ss_pred ccccccCcee----hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchh-hhccCchHHHHHHHh
Confidence 9987543221 12223455899997653 2 257789999999999999999999952 222222333333322
Q ss_pred hhcccccccchHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 005749 601 VLEETTMEVFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQL 654 (679)
Q Consensus 601 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L 654 (679)
.+... .+.+. .....+..+++..+-+.++|++|=...++.++-
T Consensus 243 --~rk~~-----~~P~~----F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~r 285 (378)
T KOG1345|consen 243 --KRKNP-----ALPKK----FNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMR 285 (378)
T ss_pred --cccCc-----cCchh----hcccCHHHHHHHHHhcCCcccccchhHHHHHHH
Confidence 22111 11111 112235566777888899999996666655554
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.5e-27 Score=276.00 Aligned_cols=197 Identities=15% Similarity=0.175 Sum_probs=140.2
Q ss_pred ccCC-CCCccceEEeeCC------CCceEEEEEecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 005749 429 KVRH-ENLIPLRAFYQGK------RGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIP 501 (679)
Q Consensus 429 ~l~H-~nIv~l~~~~~~~------~~~~~lv~ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ 501 (679)
.++| +||++++++|... ...++.++||+ +++|.+++... ...+++.+++.|+.||++||+|||+++
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~g--- 100 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP---DRSVDAFECFHVFRQIVEIVNAAHSQG--- 100 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc---cccccHHHHHHHHHHHHHHHHHHHhCC---
Confidence 4556 6888888887321 23567778888 55999999753 345899999999999999999999988
Q ss_pred eeecCCCCCCeeecC-------------------CCceEEeecccccccCcccc---------------cchhccccccc
Q 005749 502 ITHGNVRSKNVLVDD-------------------FFVSRLTEFGLDQLMVPAVA---------------DEMVALAKADG 547 (679)
Q Consensus 502 ivHrDlkp~NILl~~-------------------~~~~kl~DFGla~~~~~~~~---------------~~~~~~~gt~~ 547 (679)
|+||||||+|||++. ++.+|++|||+++....... .......||+.
T Consensus 101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 180 (793)
T PLN00181 101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW 180 (793)
T ss_pred eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence 999999999999954 45566777777654211000 00112357888
Q ss_pred ccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcCCCChHHHHH
Q 005749 548 YKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIRSPMEEGLV 627 (679)
Q Consensus 548 y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 627 (679)
|||||++.+..++.++|||||||+||||++|..|+.... ...... .. ..+. +......+
T Consensus 181 Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--------~~~~~~-~~----~~~~--------~~~~~~~~ 239 (793)
T PLN00181 181 YTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS--------RTMSSL-RH----RVLP--------PQILLNWP 239 (793)
T ss_pred eEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH--------HHHHHH-HH----hhcC--------hhhhhcCH
Confidence 999999999999999999999999999999888863210 000000 00 0000 11112234
Q ss_pred HHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 628 QALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 628 ~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
+..+++.+||+.+|.+||+|.|++++
T Consensus 240 ~~~~~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 240 KEASFCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHHHHHHHhCCCChhhCcChHHHhhc
Confidence 55678889999999999999999874
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.2e-26 Score=232.33 Aligned_cols=257 Identities=22% Similarity=0.314 Sum_probs=189.3
Q ss_pred CccccCCceEEEEEEe-C---CCCEEEEEEcccCcccCcccHHHHHHHHhccC-CCCCccceEEeeCCCCceEEEEEecC
Q 005749 383 QVIEKTTYGTAYKAKL-A---DGATIALRLLREGSCKDRSSCLPVIRQLGKVR-HENLIPLRAFYQGKRGEKLLIYDYFP 457 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~-~---~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~~~~~~~~~~~~lv~ey~~ 457 (679)
+.||+|.|++||+|.. . ....||+|.+...+ ......+|++.|..+. +.||+++.+++.. ++...+|+||++
T Consensus 42 ~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rn-nd~v~ivlp~~~ 118 (418)
T KOG1167|consen 42 NKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRN-NDQVAIVLPYFE 118 (418)
T ss_pred ccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhcc-CCeeEEEecccC
Confidence 7899999999999984 3 47799999998754 3456889999999995 9999999998887 789999999999
Q ss_pred CCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCC-CceEEeecccccccC----
Q 005749 458 SRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDF-FVSRLTEFGLDQLMV---- 532 (679)
Q Consensus 458 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~-~~~kl~DFGla~~~~---- 532 (679)
.-+-.++... ++..++..+++.+.+||+|+|+.+ ||||||||+|+|.+.. +.-.|.|||+|....
T Consensus 119 H~~f~~l~~~-------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~ 188 (418)
T KOG1167|consen 119 HDRFRDLYRS-------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQ 188 (418)
T ss_pred ccCHHHHHhc-------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechhHHHHHhhhh
Confidence 9888888764 778999999999999999999998 9999999999999854 667899999987210
Q ss_pred -------------c-cc----------------c---------cchhcccccccccccccccc-cCCCCcchhHHHHHHH
Q 005749 533 -------------P-AV----------------A---------DEMVALAKADGYKAPELQRM-KKCSSRTDVYAFGILL 572 (679)
Q Consensus 533 -------------~-~~----------------~---------~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gvvl 572 (679)
+ .. . .......||+||+|||++.. ...++++||||-|||+
T Consensus 189 ~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~ 268 (418)
T KOG1167|consen 189 TEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVIL 268 (418)
T ss_pred hhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeecccee
Confidence 0 00 0 00113479999999998774 4578999999999999
Q ss_pred HHHHhCCCCCCCCCCCcccchhHHHHHH---------hhccc--cc---------------ccch-HhhhhcCC------
Q 005749 573 LEILIGKKPGKSGRNGEFVDLPSIVKVA---------VLEET--TM---------------EVFD-MEIMKGIR------ 619 (679)
Q Consensus 573 ~El~tg~~p~~~~~~~~~~~l~~~~~~~---------~~~~~--~~---------------~~~~-~~i~~~~~------ 619 (679)
+-+++++.||..... +...+.+.+... ...+. .. +.++ ..+.+...
T Consensus 269 Lslls~~~PFf~a~d-d~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~ 347 (418)
T KOG1167|consen 269 LSLLSRRYPFFKAKD-DADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTERE 347 (418)
T ss_pred ehhhccccccccCcc-ccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeec
Confidence 999999999854332 223232222111 11111 00 0010 01111000
Q ss_pred CChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 620 SPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 620 ~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
...+......++++.+|+..||.+|.|++|++++
T Consensus 348 ~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 348 IGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred cccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 0011112366799999999999999999999875
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-25 Score=214.33 Aligned_cols=168 Identities=21% Similarity=0.206 Sum_probs=125.4
Q ss_pred CChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccc
Q 005749 459 RTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADE 538 (679)
Q Consensus 459 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 538 (679)
|||.++++.+ +..+++.+++.|+.||++||+|||+++ ||+|||++.++.+|+ ||+++.....
T Consensus 1 GsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~---- 62 (176)
T smart00750 1 VSLADILEVR---GRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPE---- 62 (176)
T ss_pred CcHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeeccc----
Confidence 6899999764 345999999999999999999999854 999999999999999 9998865332
Q ss_pred hhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcC
Q 005749 539 MVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGI 618 (679)
Q Consensus 539 ~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~ 618 (679)
...|++.|||||++.+..++.++|||||||++|||++|+.||...... ............ .. ++ . .
T Consensus 63 --~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~-----~~~~~~~~~~~~--~~-~~---~-~ 128 (176)
T smart00750 63 --QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEEREL-----SAILEILLNGMP--AD-DP---R-D 128 (176)
T ss_pred --cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchh-----cHHHHHHHHHhc--cC-Cc---c-c
Confidence 126889999999999999999999999999999999999998433211 111111110000 00 00 0 0
Q ss_pred CCChHHHH--HHHHHHHHhccCcCCCCCCCHHHHHHHHHhhC
Q 005749 619 RSPMEEGL--VQALKLAMGCCAPVASVRPTMDEVVKQLEENR 658 (679)
Q Consensus 619 ~~~~~~~~--~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 658 (679)
+....... .++.+++.+||+.+|++||++.|+++++....
T Consensus 129 ~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 129 RSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred cccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence 01111112 25789999999999999999999999987664
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.2e-25 Score=269.41 Aligned_cols=225 Identities=30% Similarity=0.495 Sum_probs=181.0
Q ss_pred ChHHHHHHHHHHHhhCCCCCCcccCCCCCCCCCCcccccceeecCCCCC--cccCCCCCCccccccccCCCCccEEEEEc
Q 005749 29 ASSDVELLLGKIKSSLQGDDENLLLSSWNISVPLCQWRGLKWISTNGSP--LSCSDISLPQWANLSLYKDSSIHLLSIQL 106 (679)
Q Consensus 29 ~~~~~~~ll~~~k~~~~~~~~~~~l~~W~~~~~~C~w~Gv~c~~~~~~~--l~c~~~~~~~~~~l~~~~~~~~~l~~l~l 106 (679)
.+.|..+|+ +||+++.+ +...+++|+.+++||.|.||+|+.. +.+ ++.+...... .+........+|+.|+|
T Consensus 27 ~~~~~~~l~-~~~~~~~~--~~~~~~~w~~~~~~c~w~gv~c~~~-~~v~~L~L~~~~i~~--~~~~~~~~l~~L~~L~L 100 (968)
T PLN00113 27 HAEELELLL-SFKSSIND--PLKYLSNWNSSADVCLWQGITCNNS-SRVVSIDLSGKNISG--KISSAIFRLPYIQTINL 100 (968)
T ss_pred CHHHHHHHH-HHHHhCCC--CcccCCCCCCCCCCCcCcceecCCC-CcEEEEEecCCCccc--cCChHHhCCCCCCEEEC
Confidence 447888888 99999964 6677899988889999999998542 221 1111111000 01111123346888999
Q ss_pred CCCCCcccCCcccc-CCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEEccCCCCc
Q 005749 107 PSANLTGSLPRELG-EFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNSLT 185 (679)
Q Consensus 107 ~~n~l~g~ip~~l~-~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N~l~ 185 (679)
++|+++|.+|..+. .+++|++|+|++|+++|.+|. +.+++|++|||++|.+++.+|..+.++ ++|++|+|++|.++
T Consensus 101 s~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~~~~~~p~~~~~l-~~L~~L~L~~n~l~ 177 (968)
T PLN00113 101 SNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSF-SSLKVLDLGGNVLV 177 (968)
T ss_pred CCCccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEECcCCcccccCChHHhcC-CCCCEEECccCccc
Confidence 99999999998765 899999999999999988885 568899999999999998888887775 89999999999999
Q ss_pred ccCCCCCCCCCCCCCccEEEccCccccccccccccCCCCCCEEEccCCcccccCCcccccc-ccCEEEccCCcCCCCCCC
Q 005749 186 AALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRL-SLEKLNLSHNNFSGVLPV 264 (679)
Q Consensus 186 ~~~p~~~~~~~~~~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l-~L~~l~ls~N~l~g~ip~ 264 (679)
+.+|... ..+++|++|+|++|++++.+|..++++++|+.|+|++|++++.+|..+..+ +|+.|++++|+++|.+|.
T Consensus 178 ~~~p~~~---~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~ 254 (968)
T PLN00113 178 GKIPNSL---TNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPS 254 (968)
T ss_pred ccCChhh---hhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceeccccCh
Confidence 8888644 467899999999999999999999999999999999999999999998887 699999999999999886
Q ss_pred c
Q 005749 265 F 265 (679)
Q Consensus 265 ~ 265 (679)
.
T Consensus 255 ~ 255 (968)
T PLN00113 255 S 255 (968)
T ss_pred h
Confidence 4
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.5e-25 Score=211.44 Aligned_cols=246 Identities=22% Similarity=0.305 Sum_probs=184.2
Q ss_pred CccccCCceEEEEEEeCCCCEEEEEEcccC--cccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCC
Q 005749 383 QVIEKTTYGTAYKAKLADGATIALRLLREG--SCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRT 460 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~~~~~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gs 460 (679)
..|.+...|..|+|+++ |..+++|++... .....++|..|.-.|+.+.||||+.++|.|.. ..+..+|..||+.||
T Consensus 196 tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacns-ppnlv~isq~mp~gs 273 (448)
T KOG0195|consen 196 TKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNS-PPNLVIISQYMPFGS 273 (448)
T ss_pred hhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccC-CCCceEeeeeccchH
Confidence 45778889999999997 445566777543 33445689999999999999999999999998 578899999999999
Q ss_pred hHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccchh
Q 005749 461 LHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMV 540 (679)
Q Consensus 461 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 540 (679)
|+.+|++.. ...++-.++.+++.++|+|++|||+-.. -|..--|.+..+++|++.+++|+= +-+++..+ ..
T Consensus 274 lynvlhe~t--~vvvd~sqav~faldiargmaflhslep-~ipr~~lns~hvmidedltarism-ad~kfsfq-----e~ 344 (448)
T KOG0195|consen 274 LYNVLHEQT--SVVVDHSQAVRFALDIARGMAFLHSLEP-MIPRFYLNSKHVMIDEDLTARISM-ADTKFSFQ-----EV 344 (448)
T ss_pred HHHHHhcCc--cEEEecchHHHHHHHHHhhHHHHhhcch-hhhhhhcccceEEecchhhhheec-ccceeeee-----cc
Confidence 999999754 3557888999999999999999999652 244446899999999999998861 11221111 11
Q ss_pred cccccccccccccccccCC---CCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhc
Q 005749 541 ALAKADGYKAPELQRMKKC---SSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKG 617 (679)
Q Consensus 541 ~~~gt~~y~aPE~~~~~~~---~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~ 617 (679)
...-.+.||+||.++..+- -.++|+|||.+++||+.|+..||.+-.+-+.. -+..++|
T Consensus 345 gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg-------------------mkialeg 405 (448)
T KOG0195|consen 345 GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG-------------------MKIALEG 405 (448)
T ss_pred ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh-------------------hhhhhcc
Confidence 2234577999999886543 34799999999999999999999554332211 1112333
Q ss_pred CCCChH-HHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhC
Q 005749 618 IRSPME-EGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENR 658 (679)
Q Consensus 618 ~~~~~~-~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 658 (679)
.+...+ .....+.+++.-|...||.+||.++.|+-.|+++.
T Consensus 406 lrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 406 LRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred ccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 333222 23345667788899999999999999999998764
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.3e-23 Score=217.78 Aligned_cols=167 Identities=20% Similarity=0.224 Sum_probs=126.7
Q ss_pred cCccccCCceEEEEEEeC--CCCEEEEEEcccCc-----ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEE
Q 005749 382 GQVIEKTTYGTAYKAKLA--DGATIALRLLREGS-----CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYD 454 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~--~~~~vAvK~~~~~~-----~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~e 454 (679)
++.||+|+||+||+|+.. +++.||||++.... ....+.|.+|+++|.+++|+|||..+.. .+..++|||
T Consensus 23 ~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~----~~~~~LVmE 98 (365)
T PRK09188 23 TAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA----TGKDGLVRG 98 (365)
T ss_pred ccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE----cCCcEEEEE
Confidence 478999999999999854 57888999875331 1124568999999999999999963322 245799999
Q ss_pred ecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCC-CCCCeeecCCCceEEeecccccccCc
Q 005749 455 YFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNV-RSKNVLVDDFFVSRLTEFGLDQLMVP 533 (679)
Q Consensus 455 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDl-kp~NILl~~~~~~kl~DFGla~~~~~ 533 (679)
|+++++|... .. . . ...++.++++||+|||+++ |+|||| ||+|||++.++.+||+|||+|+.+..
T Consensus 99 ~~~G~~L~~~-~~----~---~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~ 164 (365)
T PRK09188 99 WTEGVPLHLA-RP----H---G---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRR 164 (365)
T ss_pred ccCCCCHHHh-Cc----c---c---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECccceeccc
Confidence 9999999732 11 0 1 1467889999999999988 999999 99999999999999999999997643
Q ss_pred ccc-------cchhcccccccccccccccccC------CCCcchhH
Q 005749 534 AVA-------DEMVALAKADGYKAPELQRMKK------CSSRTDVY 566 (679)
Q Consensus 534 ~~~-------~~~~~~~gt~~y~aPE~~~~~~------~~~k~DV~ 566 (679)
... .......++..|+|||++.-.+ .+..+|-|
T Consensus 165 ~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 165 RGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred CcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 321 1123556788899999886432 23446766
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.1e-21 Score=199.66 Aligned_cols=259 Identities=16% Similarity=0.148 Sum_probs=187.6
Q ss_pred cCccccCCceEEEEEEeCCC--CEEEEEEcccCcccCcccHHHHHHHHhccCC----CCCccceEEeeCCCCceEEEEEe
Q 005749 382 GQVIEKTTYGTAYKAKLADG--ATIALRLLREGSCKDRSSCLPVIRQLGKVRH----ENLIPLRAFYQGKRGEKLLIYDY 455 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~~~--~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H----~nIv~l~~~~~~~~~~~~lv~ey 455 (679)
.+.||+|+||.||++...+. ..+|+|............+..|+.++..+.+ +++.++++.........++||+.
T Consensus 23 ~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~iVM~l 102 (322)
T KOG1164|consen 23 GKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFIVMSL 102 (322)
T ss_pred eeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEEEEec
Confidence 47899999999999995443 5788888766543333378899999998873 57888888774225678999998
Q ss_pred cCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCC-----CceEEeeccccc-
Q 005749 456 FPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDF-----FVSRLTEFGLDQ- 529 (679)
Q Consensus 456 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~-----~~~kl~DFGla~- 529 (679)
+ |.+|.++..... ...++..+..+|+.|++.+|++||+.+ ++||||||+|+++... ..+.+.|||+++
T Consensus 103 ~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~ 176 (322)
T KOG1164|consen 103 L-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARR 176 (322)
T ss_pred c-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCCCcc
Confidence 8 679999886543 356999999999999999999999988 9999999999999865 468999999998
Q ss_pred -ccCccccc------c-hhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHh
Q 005749 530 -LMVPAVAD------E-MVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAV 601 (679)
Q Consensus 530 -~~~~~~~~------~-~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~ 601 (679)
.+...... . .....||..|++++.-.+...+.+.|+||++.++.|+..|..||......... ..+....
T Consensus 177 ~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~---~~~~~~~ 253 (322)
T KOG1164|consen 177 FKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLK---SKFEKDP 253 (322)
T ss_pred ccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchH---HHHHHHh
Confidence 32211110 1 12345999999999999999999999999999999999999998554332111 0000000
Q ss_pred hcccccccchHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCCCC
Q 005749 602 LEETTMEVFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRPRN 661 (679)
Q Consensus 602 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 661 (679)
... . ........+. ++.++...+-..+..++|....+...+++.....
T Consensus 254 ~~~----~-----~~~~~~~~~~---~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 254 RKL----L-----TDRFGDLKPE---EFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred hhh----c-----cccccCCChH---HHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 000 0 0000111222 3334444455588999999999999988776544
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-20 Score=197.86 Aligned_cols=256 Identities=24% Similarity=0.304 Sum_probs=191.5
Q ss_pred CccccCCceEEEEEEeCCCCEEEEEEcccCccc---CcccHHHHHHHHhccCCC-CCccceEEeeCCCCceEEEEEecCC
Q 005749 383 QVIEKTTYGTAYKAKLADGATIALRLLREGSCK---DRSSCLPVIRQLGKVRHE-NLIPLRAFYQGKRGEKLLIYDYFPS 458 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~---~~~~~~~Ei~~l~~l~H~-nIv~l~~~~~~~~~~~~lv~ey~~~ 458 (679)
+.||.|+||.||++... ..+|+|.+...... ....+.+|+.+++.+.|+ +|+++++++.. ....+++++|+.+
T Consensus 6 ~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-~~~~~~~~~~~~~ 82 (384)
T COG0515 6 RKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQD-EGSLYLVMEYVDG 82 (384)
T ss_pred EeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEec-CCEEEEEEecCCC
Confidence 57889999999999976 88999999776433 366799999999999988 79999999965 5567999999999
Q ss_pred CChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCC-ceEEeecccccccCccccc
Q 005749 459 RTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFF-VSRLTEFGLDQLMVPAVAD 537 (679)
Q Consensus 459 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~-~~kl~DFGla~~~~~~~~~ 537 (679)
+++.+++...... ..+.......++.|++.+++|+|+.+ ++|||+||+||+++... .+++.|||.++........
T Consensus 83 ~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 83 GSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred CcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 9999777653211 25888999999999999999999988 99999999999999988 7999999999865433221
Q ss_pred -----chhcccccccccccccccc---cCCCCcchhHHHHHHHHHHHhCCCCCCCCCCC-cccchhHHHHHHhhcccccc
Q 005749 538 -----EMVALAKADGYKAPELQRM---KKCSSRTDVYAFGILLLEILIGKKPGKSGRNG-EFVDLPSIVKVAVLEETTME 608 (679)
Q Consensus 538 -----~~~~~~gt~~y~aPE~~~~---~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~-~~~~l~~~~~~~~~~~~~~~ 608 (679)
......|+..|+|||.+.+ ..++...|+||+|++++++++|..|+...... ........+..... .
T Consensus 159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~----~- 233 (384)
T COG0515 159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPT----P- 233 (384)
T ss_pred ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCC----c-
Confidence 2356689999999999987 57889999999999999999999997443321 00111111111000 0
Q ss_pred cchHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 609 VFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 609 ~~~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
......... . .......+.+++..|+..+|..|.++.+....
T Consensus 234 ~~~~~~~~~--~-~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 234 SLASPLSPS--N-PELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred ccccccCcc--c-cchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 000000000 0 01122456688889999999999999887765
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.86 E-value=7.4e-23 Score=229.03 Aligned_cols=256 Identities=18% Similarity=0.251 Sum_probs=183.3
Q ss_pred HHhhcCccccCCceEEEEEE-eCCCCEEEEEEcc----cCc-ccC-cccHHHHHHHHhccCCCCCccceEEeeCCCCceE
Q 005749 378 LNATGQVIEKTTYGTAYKAK-LADGATIALRLLR----EGS-CKD-RSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKL 450 (679)
Q Consensus 378 ~~~~~~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~----~~~-~~~-~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~ 450 (679)
....++++|.|++|.|+... .......+.|..+ ... ..+ ...+..|+.+-..++|+|++..+..+.+ .....
T Consensus 319 y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~-~~~~~ 397 (601)
T KOG0590|consen 319 YGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQE-IDGIL 397 (601)
T ss_pred cCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhh-cccch
Confidence 34456899999999888776 4445555555443 111 111 1125567777788999999888777665 33444
Q ss_pred EEEEecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccc
Q 005749 451 LIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQL 530 (679)
Q Consensus 451 lv~ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 530 (679)
-+||||++ +|..++... ..+....+..++.|+..|++|+|+.+ |.|||+|++|+++..++.+||+|||.+..
T Consensus 398 ~~mE~~~~-Dlf~~~~~~----~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~v 469 (601)
T KOG0590|consen 398 QSMEYCPY-DLFSLVMSN----GKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASV 469 (601)
T ss_pred hhhhcccH-HHHHHHhcc----cccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCccee
Confidence 45999999 999999763 24788889999999999999999998 99999999999999999999999999876
Q ss_pred cCcccc---cchhcccccccccccccccccCCCC-cchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccc
Q 005749 531 MVPAVA---DEMVALAKADGYKAPELQRMKKCSS-RTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETT 606 (679)
Q Consensus 531 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~-k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 606 (679)
..-... ......+|+..|+|||.+.+..|.+ ..||||.|+++..|++|+.||......+... ......
T Consensus 470 f~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~--------~~~~~~ 541 (601)
T KOG0590|consen 470 FRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF--------KTNNYS 541 (601)
T ss_pred eccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch--------hhhccc
Confidence 543322 3455678999999999999999876 5899999999999999999996443321110 000000
Q ss_pred cccchHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 607 MEVFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 607 ~~~~~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
. ...+..+..............++.++++.||.+|.|+++|++.
T Consensus 542 ~---~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 542 D---QRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred c---ccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 0 0011111111112223345568889999999999999999874
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.9e-21 Score=184.20 Aligned_cols=138 Identities=12% Similarity=0.158 Sum_probs=108.9
Q ss_pred CccccCCceEEEEEEeCCCCEEEEEEcccCccc--C-------cccH-----------------HHHHHHHhccCCCCCc
Q 005749 383 QVIEKTTYGTAYKAKLADGATIALRLLREGSCK--D-------RSSC-----------------LPVIRQLGKVRHENLI 436 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~--~-------~~~~-----------------~~Ei~~l~~l~H~nIv 436 (679)
+.||+|+||.||+|+..+|+.||||+++..... . ...| .+|++.+.++.|+++.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~ 82 (190)
T cd05147 3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP 82 (190)
T ss_pred CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence 679999999999999879999999999764221 1 1122 3499999999988875
Q ss_pred cceEEeeCCCCceEEEEEecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHH-hcCCCCCeeecCCCCCCeeec
Q 005749 437 PLRAFYQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYL-HTGHEIPITHGNVRSKNVLVD 515 (679)
Q Consensus 437 ~l~~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~L-H~~~~~~ivHrDlkp~NILl~ 515 (679)
....+... ..++||||++++++...... ...+++.....++.|++.+|+|+ |+.+ |+||||||+|||++
T Consensus 83 ~p~~~~~~---~~~iVmE~i~g~~l~~~~~~----~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~ 152 (190)
T cd05147 83 CPEPILLK---SHVLVMEFIGDDGWAAPRLK----DAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH 152 (190)
T ss_pred CCcEEEec---CCEEEEEEeCCCCCcchhhh----cCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE
Confidence 54433222 34899999998877654322 23588999999999999999999 6777 99999999999998
Q ss_pred CCCceEEeeccccccc
Q 005749 516 DFFVSRLTEFGLDQLM 531 (679)
Q Consensus 516 ~~~~~kl~DFGla~~~ 531 (679)
+ +.++++|||+|...
T Consensus 153 ~-~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 D-GKLYIIDVSQSVEH 167 (190)
T ss_pred C-CcEEEEEccccccC
Confidence 4 78999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.2e-20 Score=199.77 Aligned_cols=218 Identities=28% Similarity=0.375 Sum_probs=162.7
Q ss_pred HhccCCCCCccceEEeeCCCCceEEEEEecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecC
Q 005749 427 LGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGN 506 (679)
Q Consensus 427 l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrD 506 (679)
|+.+.|.|+.+++|.+.+ ....++|.+||..|+|.+.+... ...++|.....++++|++||+|+|+.. -..|+.
T Consensus 1 l~~l~h~n~~~f~g~~~~-~~~~~~i~~~c~rGsl~D~i~~~---~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~ 74 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVD-GPEMIVIWEYCSRGSLLDILSNE---DIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGA 74 (484)
T ss_pred CcccchhhhhhheeeEec-CCceEEEEeeecCccHHhHHhcc---ccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeee
Confidence 457899999999999998 58899999999999999999874 466999999999999999999999854 139999
Q ss_pred CCCCCeeecCCCceEEeecccccccCccc-ccchhccccccccccccccccc-------CCCCcchhHHHHHHHHHHHhC
Q 005749 507 VRSKNVLVDDFFVSRLTEFGLDQLMVPAV-ADEMVALAKADGYKAPELQRMK-------KCSSRTDVYAFGILLLEILIG 578 (679)
Q Consensus 507 lkp~NILl~~~~~~kl~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-------~~~~k~DV~S~Gvvl~El~tg 578 (679)
+++.|+++|..+.+|++|||+........ ...........-|.|||.+... ..+.++||||||++++|+++.
T Consensus 75 l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r 154 (484)
T KOG1023|consen 75 LKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFR 154 (484)
T ss_pred eccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhc
Confidence 99999999999999999999987763210 0011111233459999988753 146789999999999999999
Q ss_pred CCCCCCCCCCcc-cchhHHHHHHhhcccccccchHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhh
Q 005749 579 KKPGKSGRNGEF-VDLPSIVKVAVLEETTMEVFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEEN 657 (679)
Q Consensus 579 ~~p~~~~~~~~~-~~l~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 657 (679)
+.||........ .+++..++. .....+.|.+... .+..+++..++..||..+|++||++++|-..++.+
T Consensus 155 ~~~~~~~~~~~~~~eii~~~~~-----~~~~~~rP~i~~~-----~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~ 224 (484)
T KOG1023|consen 155 SGPFDLRNLVEDPDEIILRVKK-----GGSNPFRPSIELL-----NELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTI 224 (484)
T ss_pred cCccccccccCChHHHHHHHHh-----cCCCCcCcchhhh-----hhcchHHHHHHHHhcccChhhCccHHHHHhhhhhh
Confidence 999965433221 112222111 1122233332211 12234678899999999999999999999998877
Q ss_pred CCC
Q 005749 658 RPR 660 (679)
Q Consensus 658 ~~~ 660 (679)
...
T Consensus 225 ~~~ 227 (484)
T KOG1023|consen 225 NKG 227 (484)
T ss_pred ccc
Confidence 654
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=6.1e-20 Score=178.16 Aligned_cols=138 Identities=12% Similarity=0.161 Sum_probs=111.0
Q ss_pred CccccCCceEEEEEEeCCCCEEEEEEcccCcccC--------------------------cccHHHHHHHHhccCCCCCc
Q 005749 383 QVIEKTTYGTAYKAKLADGATIALRLLREGSCKD--------------------------RSSCLPVIRQLGKVRHENLI 436 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~--------------------------~~~~~~Ei~~l~~l~H~nIv 436 (679)
..||+|+||.||+|+..+|+.||||+++...... ...+.+|.+.+.+++|++|.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 82 (190)
T cd05145 3 GCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGVP 82 (190)
T ss_pred ceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCCC
Confidence 6799999999999997789999999987652110 01135788999999999986
Q ss_pred cceEEeeCCCCceEEEEEecCCCChHHH-hhcccCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeeecCCCCCCeee
Q 005749 437 PLRAFYQGKRGEKLLIYDYFPSRTLHDL-LHDTIAGKPVLNWARRHKIALGIARGLAYLHT-GHEIPITHGNVRSKNVLV 514 (679)
Q Consensus 437 ~l~~~~~~~~~~~~lv~ey~~~gsL~~~-l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~-~~~~~ivHrDlkp~NILl 514 (679)
....+... ..++||||++++++... +.. ..++.....+++.|++.++.++|+ .+ |+||||||+||++
T Consensus 83 ~p~~~~~~---~~~lVmE~~~g~~~~~~~l~~-----~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll 151 (190)
T cd05145 83 VPEPILLK---KNVLVMEFIGDDGSPAPRLKD-----VPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILY 151 (190)
T ss_pred CceEEEec---CCEEEEEEecCCCchhhhhhh-----ccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEE
Confidence 65554433 34899999998865443 332 346788899999999999999999 77 9999999999999
Q ss_pred cCCCceEEeecccccccC
Q 005749 515 DDFFVSRLTEFGLDQLMV 532 (679)
Q Consensus 515 ~~~~~~kl~DFGla~~~~ 532 (679)
+ ++.++|+|||+++...
T Consensus 152 ~-~~~~~liDFG~a~~~~ 168 (190)
T cd05145 152 H-DGKPYIIDVSQAVELD 168 (190)
T ss_pred E-CCCEEEEEcccceecC
Confidence 9 7899999999998764
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.8e-20 Score=182.01 Aligned_cols=163 Identities=16% Similarity=0.227 Sum_probs=126.7
Q ss_pred CccccCCceEEEEEEeCCCCEEEEEEcccCcccCcc---------cHHHHHHHHhccCCCCCccceEEeeCC-------C
Q 005749 383 QVIEKTTYGTAYKAKLADGATIALRLLREGSCKDRS---------SCLPVIRQLGKVRHENLIPLRAFYQGK-------R 446 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~---------~~~~Ei~~l~~l~H~nIv~l~~~~~~~-------~ 446 (679)
+++|.|+||.||.+.. ++..+|+|.+++....... .+.+|++.+.+++|++|..+.+++... .
T Consensus 37 ~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~~~~~ 115 (232)
T PRK10359 37 KVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAERKTLRYA 115 (232)
T ss_pred EEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeeccccccccc
Confidence 7899999999999766 5778999999865433222 268999999999999999998886642 2
Q ss_pred CceEEEEEecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecc
Q 005749 447 GEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFG 526 (679)
Q Consensus 447 ~~~~lv~ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 526 (679)
+..++||||++|.+|.++.. ++. ....+++.+|..+|+.+ ++|||+||+||++++++ ++++|||
T Consensus 116 ~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g-i~liDfg 179 (232)
T PRK10359 116 HTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG-LRIIDLS 179 (232)
T ss_pred CCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-EEEEECC
Confidence 35799999999999988732 222 24569999999999988 99999999999999988 9999999
Q ss_pred cccccCcccccchhcccccccccccccccccCCCCcchhHHHHHHHHHH
Q 005749 527 LDQLMVPAVADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEI 575 (679)
Q Consensus 527 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El 575 (679)
..+......... .+.....|..++|+||||+++.-.
T Consensus 180 ~~~~~~e~~a~d-------------~~vler~y~~~~di~~lg~~~~~~ 215 (232)
T PRK10359 180 GKRCTAQRKAKD-------------RIDLERHYGIKNEIKDLGYYLLIY 215 (232)
T ss_pred CcccccchhhHH-------------HHHHHhHhcccccccceeEeehHH
Confidence 877553221111 133345577899999999987654
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.9e-20 Score=175.30 Aligned_cols=195 Identities=17% Similarity=0.231 Sum_probs=157.2
Q ss_pred CccccCCceEEEEEE-eCCCCEEEEEEcccCcccCcccHHHHHHHHhccCC-CCCccceEEeeCCCCceEEEEEecCCCC
Q 005749 383 QVIEKTTYGTAYKAK-LADGATIALRLLREGSCKDRSSCLPVIRQLGKVRH-ENLIPLRAFYQGKRGEKLLIYDYFPSRT 460 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H-~nIv~l~~~~~~~~~~~~lv~ey~~~gs 460 (679)
+.||.|+||.+|.|. ..+|..||+|+-... ....++..|.++.+.++| ..|-.+..|..+ ...-.+|||.. |.|
T Consensus 21 rkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~--a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e-~~ynvlVMdLL-GPs 96 (341)
T KOG1163|consen 21 RKIGSGSFGDIYLGISITSGEEVAIKLESSK--AKHPQLLYESKVYRILQGGVGIPHIRHYGTE-KDYNVLVMDLL-GPS 96 (341)
T ss_pred EeecCCchhheeeeeeccCCceEEEEeeccc--CCCcchhHHHHHHHHhccCCCCchhhhhccc-cccceeeeecc-Ccc
Confidence 689999999999999 788999999995442 234567889999999976 344444444444 66788999988 779
Q ss_pred hHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecC---CCceEEeecccccccCcccc-
Q 005749 461 LHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDD---FFVSRLTEFGLDQLMVPAVA- 536 (679)
Q Consensus 461 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~---~~~~kl~DFGla~~~~~~~~- 536 (679)
|.++..-. ...++..+.+-++-|+..-++|+|.++ ++||||||+|.|..- ...+.++|||+|+.+.+...
T Consensus 97 LEdLfnfC---~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~ 170 (341)
T KOG1163|consen 97 LEDLFNFC---SRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTR 170 (341)
T ss_pred HHHHHHHH---hhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhcccccc
Confidence 99988755 345889999999999999999999999 999999999999863 35678999999997644322
Q ss_pred -----cchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCC
Q 005749 537 -----DEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRN 587 (679)
Q Consensus 537 -----~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~ 587 (679)
.+.....||..|.+-....+...+.+.|+=|+|.+|...-.|..||.+...
T Consensus 171 ~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka 226 (341)
T KOG1163|consen 171 QHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKA 226 (341)
T ss_pred ccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccch
Confidence 123456799999887777777778899999999999999999999976543
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=5.2e-19 Score=174.17 Aligned_cols=197 Identities=18% Similarity=0.265 Sum_probs=163.0
Q ss_pred hhcCccccCCceEEEEEE-eCCCCEEEEEEcccCcccCcccHHHHHHHHhccC-CCCCccceEEeeCCCCceEEEEEecC
Q 005749 380 ATGQVIEKTTYGTAYKAK-LADGATIALRLLREGSCKDRSSCLPVIRQLGKVR-HENLIPLRAFYQGKRGEKLLIYDYFP 457 (679)
Q Consensus 380 ~~~~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~~~~~~~~~~~~lv~ey~~ 457 (679)
..|+.||+|.||..+.|+ +-+++.||||.-...+ +.-++..|.+..+.+. .+.|-..|-|-.+ .-+-.||+|.+
T Consensus 31 rVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqe-G~~NiLVidLL- 106 (449)
T KOG1165|consen 31 RVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQE-GKYNILVIDLL- 106 (449)
T ss_pred eeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccc-cchhhhhhhhh-
Confidence 457899999999999999 7789999999854432 3456778888888774 6788777655444 55678999988
Q ss_pred CCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCC-----CceEEeecccccccC
Q 005749 458 SRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDF-----FVSRLTEFGLDQLMV 532 (679)
Q Consensus 458 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~-----~~~kl~DFGla~~~~ 532 (679)
|.||.|+..-. +..++..++.-||.|++.-++|+|++. +|.|||||+|+||..- ..+.+.|||+|+.+.
T Consensus 107 GPSLEDLFD~C---gR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr 180 (449)
T KOG1165|consen 107 GPSLEDLFDLC---GRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR 180 (449)
T ss_pred CcCHHHHHHHh---cCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence 77999988765 456999999999999999999999999 9999999999999743 457899999999886
Q ss_pred ccccc------chhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 005749 533 PAVAD------EMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGR 586 (679)
Q Consensus 533 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~ 586 (679)
+.... +.....||..||+-..-.+.+.+.+.|+=|+|-+++..+-|..||.+-.
T Consensus 181 Dp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLK 240 (449)
T KOG1165|consen 181 DPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 240 (449)
T ss_pred CccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccccc
Confidence 55432 2345679999999988888899999999999999999999999997643
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.1e-19 Score=182.73 Aligned_cols=256 Identities=18% Similarity=0.257 Sum_probs=170.6
Q ss_pred ccccHHHHHHhhcCccccCCceEEEEEEeCC-CC-----------------------------------EEEEEEcccCc
Q 005749 370 EHLTLEDVLNATGQVIEKTTYGTAYKAKLAD-GA-----------------------------------TIALRLLREGS 413 (679)
Q Consensus 370 ~~~~~~~l~~~~~~~ig~G~~g~Vy~~~~~~-~~-----------------------------------~vAvK~~~~~~ 413 (679)
..|+++|. ..|+.||+|....||.|++.+ |. +.|+|++..-+
T Consensus 152 skFtiddy--eiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~ 229 (598)
T KOG4158|consen 152 SKFTIDDY--EIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFE 229 (598)
T ss_pred cccchhhh--cccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccc
Confidence 46888887 578999999999999997542 11 34667664322
Q ss_pred ccC-cccHH----HHH--------------HHHhc--------cCCCCCccceEEeeCC---------------------
Q 005749 414 CKD-RSSCL----PVI--------------RQLGK--------VRHENLIPLRAFYQGK--------------------- 445 (679)
Q Consensus 414 ~~~-~~~~~----~Ei--------------~~l~~--------l~H~nIv~l~~~~~~~--------------------- 445 (679)
..+ ...++ +|. ...+. -+|||||++.++|.+.
T Consensus 230 ~~s~~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p 309 (598)
T KOG4158|consen 230 HDSGDAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYP 309 (598)
T ss_pred cCCchHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecc
Confidence 111 11111 110 01111 2599999999987652
Q ss_pred -----CCceEEEEEecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee--cCCC
Q 005749 446 -----RGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLV--DDFF 518 (679)
Q Consensus 446 -----~~~~~lv~ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl--~~~~ 518 (679)
....|+||.-++. +|.+++... ..+...+.-|+.|+++|+.|||.++ |.|||+|++|||+ |+|+
T Consensus 310 ~g~g~~~tlylvMkrY~~-tLr~yl~~~-----~~s~r~~~~~laQlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~ 380 (598)
T KOG4158|consen 310 SGAGEPKTLYLVMKRYRQ-TLREYLWTR-----HRSYRTGRVILAQLLEAVTHLHKHG---VAHRDLKSDNILLELDDDE 380 (598)
T ss_pred cccCCCceEEEehhcchh-hHHHHHhcC-----CCchHHHHHHHHHHHHHHHHHHHcc---chhhcccccceEEEecCCC
Confidence 1145899988866 999999763 3556667778999999999999999 9999999999998 4444
Q ss_pred --ceEEeecccccccCc-----ccccchhcccccccccccccccccC------CCCcchhHHHHHHHHHHHhCCCCCCCC
Q 005749 519 --VSRLTEFGLDQLMVP-----AVADEMVALAKADGYKAPELQRMKK------CSSRTDVYAFGILLLEILIGKKPGKSG 585 (679)
Q Consensus 519 --~~kl~DFGla~~~~~-----~~~~~~~~~~gt~~y~aPE~~~~~~------~~~k~DV~S~Gvvl~El~tg~~p~~~~ 585 (679)
...|+|||++---.. ..........|...-||||+....+ --.|+|.|+.|.+.||+++..-||++.
T Consensus 381 ~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~r 460 (598)
T KOG4158|consen 381 IPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKR 460 (598)
T ss_pred CcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCccccc
Confidence 357899998643211 1112223445677789999876422 135899999999999999999999652
Q ss_pred CCCcccchhHHHHHHhhcccccccchHhhhhcCCCChHHHH-HHHHHHHHhccCcCCCCCCCHHHHHHHHH
Q 005749 586 RNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIRSPMEEGL-VQALKLAMGCCAPVASVRPTMDEVVKQLE 655 (679)
Q Consensus 586 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~-~~~~~l~~~cl~~dP~~RPs~~evl~~L~ 655 (679)
.. ...+...+ .+...+..++.+ +.+.+++...++.||++||+..-..+.|+
T Consensus 461 Ge-m~L~~r~Y------------------qe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 461 GE-MLLDTRTY------------------QESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred ch-heechhhh------------------hhhhCCCCcccCChHHHHHHHHHhcCCccccCCccHHHhHHH
Confidence 11 11111110 111113333333 44557888899999999999877766664
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.5e-20 Score=206.64 Aligned_cols=246 Identities=16% Similarity=0.253 Sum_probs=175.6
Q ss_pred hcCccccCCceEEEEEEeCCCCEEEEEEcccCc-ccCcccHHHHHHH--HhccCCCCCccceEEeeCCCCceEEEEEecC
Q 005749 381 TGQVIEKTTYGTAYKAKLADGATIALRLLREGS-CKDRSSCLPVIRQ--LGKVRHENLIPLRAFYQGKRGEKLLIYDYFP 457 (679)
Q Consensus 381 ~~~~ig~G~~g~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~~Ei~~--l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~ 457 (679)
..+.+|++.|=+|.+|+.+.|. |+||++-+.. .-..+.|.++++- ...++|||.+.+.-+-.. +...|||=+|..
T Consensus 27 ~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t-~kAAylvRqyvk 104 (1431)
T KOG1240|consen 27 YVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVT-DKAAYLVRQYVK 104 (1431)
T ss_pred eecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHh-hHHHHHHHHHHh
Confidence 3478999999999999998887 8889886543 3445556555444 444589999998765444 456788888987
Q ss_pred CCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeeccccccc--Cccc
Q 005749 458 SRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLM--VPAV 535 (679)
Q Consensus 458 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~--~~~~ 535 (679)
. +|+|.+.. ++-+...+.+.|+.|++.||.-+|..+ |+|+|||.+|||++.-.-+.|+||..-|-. +.+.
T Consensus 105 h-nLyDRlST----RPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN 176 (1431)
T KOG1240|consen 105 H-NLYDRLST----RPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN 176 (1431)
T ss_pred h-hhhhhhcc----chHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence 6 89999876 456888889999999999999999988 999999999999999989999999765432 1111
Q ss_pred ccch----hcccccccccccccccc----------cC-CCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHH
Q 005749 536 ADEM----VALAKADGYKAPELQRM----------KK-CSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKV 599 (679)
Q Consensus 536 ~~~~----~~~~gt~~y~aPE~~~~----------~~-~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~ 599 (679)
.... .+...-..|.|||.+.. .. .+++-||||.|||+.||++ |++||. +.+....
T Consensus 177 Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~---------LSQL~aY 247 (1431)
T KOG1240|consen 177 PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT---------LSQLLAY 247 (1431)
T ss_pred cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc---------HHHHHhH
Confidence 1111 11223346999997643 12 5788999999999999986 677772 2222211
Q ss_pred HhhcccccccchH-hhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHh
Q 005749 600 AVLEETTMEVFDM-EIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEE 656 (679)
Q Consensus 600 ~~~~~~~~~~~~~-~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 656 (679)
.- ....++ .+++++.. ..+..++..|++.||++|-++++.++.-+.
T Consensus 248 r~-----~~~~~~e~~Le~Ied------~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG 294 (1431)
T KOG1240|consen 248 RS-----GNADDPEQLLEKIED------VSLRNLILSMIQRDPSKRLSAEDYLQKYRG 294 (1431)
T ss_pred hc-----cCccCHHHHHHhCcC------ccHHHHHHHHHccCchhccCHHHHHHhhhc
Confidence 10 101111 11222111 245678999999999999999999998544
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=5.6e-19 Score=172.50 Aligned_cols=135 Identities=11% Similarity=0.123 Sum_probs=106.3
Q ss_pred cCccccCCceEEEEEEeCCCCEEEEEEcccCcccCcccHHHHHHHHhcc-----CCCCCccceEEeeCCC--CceE-EEE
Q 005749 382 GQVIEKTTYGTAYKAKLADGATIALRLLREGSCKDRSSCLPVIRQLGKV-----RHENLIPLRAFYQGKR--GEKL-LIY 453 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l-----~H~nIv~l~~~~~~~~--~~~~-lv~ 453 (679)
.++||+|+||.||. .-.++.. +||++........+.+.+|+++++.+ +||||++++|++.+.. +..+ +|+
T Consensus 7 ~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~ 84 (210)
T PRK10345 7 QSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIA 84 (210)
T ss_pred cceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEe
Confidence 37899999999996 3334444 79988765444567899999999999 5799999999998743 2333 789
Q ss_pred Ee--cCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHH-HHHhcCCCCCeeecCCCCCCeeecC----CCceEEeecc
Q 005749 454 DY--FPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGL-AYLHTGHEIPITHGNVRSKNVLVDD----FFVSRLTEFG 526 (679)
Q Consensus 454 ey--~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL-~~LH~~~~~~ivHrDlkp~NILl~~----~~~~kl~DFG 526 (679)
|| +++|+|.+++... .+++. ..++.+++.++ +|||+++ |+||||||+|||++. +..++|+||+
T Consensus 85 e~~G~~~~tL~~~l~~~-----~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 85 DFDGKPSITLTEFAEQC-----RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred cCCCCcchhHHHHHHcc-----cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 99 6689999999652 25555 35678888888 9999998 999999999999974 3479999954
Q ss_pred cc
Q 005749 527 LD 528 (679)
Q Consensus 527 la 528 (679)
-+
T Consensus 155 G~ 156 (210)
T PRK10345 155 GE 156 (210)
T ss_pred CC
Confidence 33
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.9e-20 Score=198.39 Aligned_cols=186 Identities=25% Similarity=0.325 Sum_probs=156.7
Q ss_pred ccccCCceEEEEEE----eCCCCEEEEEEcccCcc--cCcccHHHHHHHHhccC-CCCCccceEEeeCCCCceEEEEEec
Q 005749 384 VIEKTTYGTAYKAK----LADGATIALRLLREGSC--KDRSSCLPVIRQLGKVR-HENLIPLRAFYQGKRGEKLLIYDYF 456 (679)
Q Consensus 384 ~ig~G~~g~Vy~~~----~~~~~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~-H~nIv~l~~~~~~~~~~~~lv~ey~ 456 (679)
++|+|.||.|+.++ .+.|..+|+|.+++... ........|..++..++ ||.+|++...++. +...+++++|.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt-~~kl~l~ld~~ 79 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQT-DGKLYLILDFL 79 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeecc-ccchhHhhhhc
Confidence 47899999999876 23477889999876543 22235567788888887 9999999888887 68899999999
Q ss_pred CCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccc
Q 005749 457 PSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVA 536 (679)
Q Consensus 457 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 536 (679)
.+|+|...+.. ...++......+...++-+++++|+.+ |+|||+|++||+++.+|++|+.|||+++..-...
T Consensus 80 rgg~lft~l~~----~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~- 151 (612)
T KOG0603|consen 80 RGGDLFTRLSK----EVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK- 151 (612)
T ss_pred ccchhhhcccc----CCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhh-
Confidence 99999988876 355788888889999999999999988 9999999999999999999999999998754332
Q ss_pred cchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCC
Q 005749 537 DEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKS 584 (679)
Q Consensus 537 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~ 584 (679)
..+||.-|||||.+. .....+|-||||++++||+||..||..
T Consensus 152 ----~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 152 ----IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred ----hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 228999999999987 567899999999999999999999943
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.5e-18 Score=166.16 Aligned_cols=186 Identities=14% Similarity=0.076 Sum_probs=137.2
Q ss_pred cCccccCCceEEEEEEeCCCCEEEEEEcccCcccC----cccHHHHHHHHhccC-CCCCccceEEeeCCCCceEEEEEec
Q 005749 382 GQVIEKTTYGTAYKAKLADGATIALRLLREGSCKD----RSSCLPVIRQLGKVR-HENLIPLRAFYQGKRGEKLLIYDYF 456 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~----~~~~~~Ei~~l~~l~-H~nIv~l~~~~~~~~~~~~lv~ey~ 456 (679)
...+++|+||+||.+.- ++..++.+.+.....-. ...|.+|+++|+++. |++|.+++++ +..+++|||+
T Consensus 7 ~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~-----~~~~lvmeyI 80 (218)
T PRK12274 7 NEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW-----DGRHLDRSYL 80 (218)
T ss_pred ceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE-----cCEEEEEeee
Confidence 36899999999997766 67788877776543211 125789999999995 5889998885 2469999999
Q ss_pred CCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCC-CCCCeeecCCCceEEeecccccccCccc
Q 005749 457 PSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNV-RSKNVLVDDFFVSRLTEFGLDQLMVPAV 535 (679)
Q Consensus 457 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDl-kp~NILl~~~~~~kl~DFGla~~~~~~~ 535 (679)
.|.+|.+.+.. ....++.|++++|+++|+++ |+|||| ||+|||++.++.++|+|||+|.......
T Consensus 81 ~G~~L~~~~~~-----------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~ 146 (218)
T PRK12274 81 AGAAMYQRPPR-----------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA 146 (218)
T ss_pred cCccHHhhhhh-----------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence 99998754321 11357789999999999998 999999 7999999999999999999998654322
Q ss_pred c-----c--c-----hhcccccccccccccccc-cCCC-CcchhHHHHHHHHHHHhCCCCCCCCCC
Q 005749 536 A-----D--E-----MVALAKADGYKAPELQRM-KKCS-SRTDVYAFGILLLEILIGKKPGKSGRN 587 (679)
Q Consensus 536 ~-----~--~-----~~~~~gt~~y~aPE~~~~-~~~~-~k~DV~S~Gvvl~El~tg~~p~~~~~~ 587 (679)
. . . ......++.|++|+.... ...+ ...+-++-|.-+|.++||..+..++.+
T Consensus 147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~ 212 (218)
T PRK12274 147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNE 212 (218)
T ss_pred hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence 1 0 0 001124566777764332 1233 467888999999999999998755443
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.75 E-value=2.7e-18 Score=173.09 Aligned_cols=231 Identities=16% Similarity=0.178 Sum_probs=141.8
Q ss_pred cCccccCCceEEEEEEe-CCCCEEEEEEcccCc---ccCcccHHHHHHHHhccC----------CCCCccceEEeeC---
Q 005749 382 GQVIEKTTYGTAYKAKL-ADGATIALRLLREGS---CKDRSSCLPVIRQLGKVR----------HENLIPLRAFYQG--- 444 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~----------H~nIv~l~~~~~~--- 444 (679)
++.||.|+++.||.++. ++|+.+|||++.... ....+++.+|.-....+. |-.++--++...-
T Consensus 17 ~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~ 96 (288)
T PF14531_consen 17 GRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGK 96 (288)
T ss_dssp EEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS
T ss_pred ccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCC
Confidence 47899999999999995 569999999985433 223455666654444432 2222222222211
Q ss_pred ------CC--C-----ceEEEEEecCCCChHHHhhc---ccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCC
Q 005749 445 ------KR--G-----EKLLIYDYFPSRTLHDLLHD---TIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVR 508 (679)
Q Consensus 445 ------~~--~-----~~~lv~ey~~~gsL~~~l~~---~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlk 508 (679)
.. . ..+++|+-+. +||.+++.. .......+....++.+..|+.+-+++||+.+ +||+|||
T Consensus 97 ~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHgdi~ 172 (288)
T PF14531_consen 97 PPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHGDIK 172 (288)
T ss_dssp -SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEEST-S
T ss_pred CcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEecccc
Confidence 00 0 2356777774 488888653 2111123445667788899999999999999 9999999
Q ss_pred CCCeeecCCCceEEeecccccccCcccccchhcccccccccccccccc--------cCCCCcchhHHHHHHHHHHHhCCC
Q 005749 509 SKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKADGYKAPELQRM--------KKCSSRTDVYAFGILLLEILIGKK 580 (679)
Q Consensus 509 p~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~k~DV~S~Gvvl~El~tg~~ 580 (679)
|+|++++.+|.++|+||+.......... . ...+..|.+||.... -.++.+.|.|++|+++|.|..+..
T Consensus 173 ~~nfll~~~G~v~Lg~F~~~~r~g~~~~--~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l 248 (288)
T PF14531_consen 173 PENFLLDQDGGVFLGDFSSLVRAGTRYR--C--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL 248 (288)
T ss_dssp GGGEEE-TTS-EEE--GGGEEETTEEEE--G--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred eeeEEEcCCCCEEEcChHHHeecCceee--c--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence 9999999999999999987664422111 1 234467999997643 247889999999999999999999
Q ss_pred CCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCC
Q 005749 581 PGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVR 644 (679)
Q Consensus 581 p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~R 644 (679)
||.......... | . .. ... +..+.+.+++..+++.+|++|
T Consensus 249 Pf~~~~~~~~~~---~----------------~-f~---~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 249 PFGLSSPEADPE---W----------------D-FS---RCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp STCCCGGGSTSG---G----------------G-GT---TSS----HHHHHHHHHHT-SSGGGS
T ss_pred CCCCCCcccccc---c----------------c-ch---hcC-CcCHHHHHHHHHHccCCcccC
Confidence 995432211000 0 1 11 111 333455678899999999988
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.5e-17 Score=189.14 Aligned_cols=135 Identities=33% Similarity=0.483 Sum_probs=95.4
Q ss_pred CCChHHHHHHHHHHHhhCCCCCCcccCCCCCCCCCCc-----ccccceeecCCCCCcccCCCCCCccccccccCCCCccE
Q 005749 27 ASASSDVELLLGKIKSSLQGDDENLLLSSWNISVPLC-----QWRGLKWISTNGSPLSCSDISLPQWANLSLYKDSSIHL 101 (679)
Q Consensus 27 ~~~~~~~~~ll~~~k~~~~~~~~~~~l~~W~~~~~~C-----~w~Gv~c~~~~~~~l~c~~~~~~~~~~l~~~~~~~~~l 101 (679)
.....|..+|+ .+|+++.. +. ..+|+. ++| .|.||.|..... . ....+
T Consensus 368 ~t~~~~~~aL~-~~k~~~~~--~~--~~~W~g--~~C~p~~~~w~Gv~C~~~~~--------~------------~~~~v 420 (623)
T PLN03150 368 KTLLEEVSALQ-TLKSSLGL--PL--RFGWNG--DPCVPQQHPWSGADCQFDST--------K------------GKWFI 420 (623)
T ss_pred ccCchHHHHHH-HHHHhcCC--cc--cCCCCC--CCCCCcccccccceeeccCC--------C------------CceEE
Confidence 34556888888 99999864 22 248964 344 699999532110 0 00137
Q ss_pred EEEEcCCCCCcccCCccccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEEccC
Q 005749 102 LSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHG 181 (679)
Q Consensus 102 ~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~ 181 (679)
+.|+|++|++.|.+|.+|+.|++|+.|+|++|+|+|.+|..++.+++|+.|||++|+|+|.+|..+..+ ++|+.|+|++
T Consensus 421 ~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L-~~L~~L~Ls~ 499 (623)
T PLN03150 421 DGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL-TSLRILNLNG 499 (623)
T ss_pred EEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcC-CCCCEEECcC
Confidence 888888888988888888888888888888888888888888888888888888888888777666544 5555555555
Q ss_pred CCCcccCC
Q 005749 182 NSLTAALP 189 (679)
Q Consensus 182 N~l~~~~p 189 (679)
|+|+|.+|
T Consensus 500 N~l~g~iP 507 (623)
T PLN03150 500 NSLSGRVP 507 (623)
T ss_pred CcccccCC
Confidence 55544433
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=3.5e-17 Score=161.74 Aligned_cols=134 Identities=16% Similarity=0.321 Sum_probs=112.6
Q ss_pred CccccCCceEEEEEEeCCCCEEEEEEcccCcccC--------cccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEE
Q 005749 383 QVIEKTTYGTAYKAKLADGATIALRLLREGSCKD--------RSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYD 454 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~--------~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~e 454 (679)
+.||+|++|.||+|+. +|..|++|+........ ...+.+|++++..++|++|.....++.+ ....++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~-~~~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVD-PENFIIVME 79 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEe-CCCCEEEEE
Confidence 5789999999999987 67789999866432211 2357889999999999999887777665 467899999
Q ss_pred ecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccc
Q 005749 455 YFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQL 530 (679)
Q Consensus 455 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 530 (679)
|+++++|.+++... .+ .+..++.+++.+|.++|+.+ ++|||++|+||+++ ++.++++|||+++.
T Consensus 80 ~~~G~~L~~~~~~~-------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 80 YIEGEPLKDLINSN-------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EeCCcCHHHHHHhc-------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999998642 22 78899999999999999988 99999999999999 78999999998864
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.71 E-value=6.6e-17 Score=161.79 Aligned_cols=140 Identities=15% Similarity=0.163 Sum_probs=106.9
Q ss_pred cCccccCCceEEEEEE--eCCCCEEEEEEcccCcccC------------------------cccHHHHHHHHhccCCCCC
Q 005749 382 GQVIEKTTYGTAYKAK--LADGATIALRLLREGSCKD------------------------RSSCLPVIRQLGKVRHENL 435 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~--~~~~~~vAvK~~~~~~~~~------------------------~~~~~~Ei~~l~~l~H~nI 435 (679)
.+.||+|+||.||+|+ ..+|+.||+|+++...... ...+.+|++.+.++.+..
T Consensus 33 ~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~~~- 111 (237)
T smart00090 33 GGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYEAG- 111 (237)
T ss_pred CCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHhcC-
Confidence 4789999999999998 6789999999987542100 012568999999997633
Q ss_pred ccceEEeeCCCCceEEEEEecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeec
Q 005749 436 IPLRAFYQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVD 515 (679)
Q Consensus 436 v~l~~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~ 515 (679)
+.+..++.. ...++||||+++++|...... ...+.......++.|++.+++|||+++ .|+||||||+||+++
T Consensus 112 i~~p~~~~~--~~~~lV~E~~~g~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp~NIli~ 183 (237)
T smart00090 112 VPVPKPIAW--RRNVLVMEFIGGDGLPAPRLK----DVEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSEYNILVH 183 (237)
T ss_pred CCCCeeeEe--cCceEEEEEecCCcccccccc----cCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCChhhEEEE
Confidence 322222222 235899999999888765432 223556667899999999999999865 399999999999999
Q ss_pred CCCceEEeeccccccc
Q 005749 516 DFFVSRLTEFGLDQLM 531 (679)
Q Consensus 516 ~~~~~kl~DFGla~~~ 531 (679)
++.++++|||.+...
T Consensus 184 -~~~i~LiDFg~a~~~ 198 (237)
T smart00090 184 -DGKVVIIDVSQSVEL 198 (237)
T ss_pred -CCCEEEEEChhhhcc
Confidence 789999999998754
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.71 E-value=6.9e-17 Score=158.07 Aligned_cols=130 Identities=20% Similarity=0.298 Sum_probs=105.7
Q ss_pred ccccCCceEEEEEEeCCCCEEEEEEcccCcccC--------cccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEe
Q 005749 384 VIEKTTYGTAYKAKLADGATIALRLLREGSCKD--------RSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDY 455 (679)
Q Consensus 384 ~ig~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~--------~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey 455 (679)
+||+|+||.||+|.+ +|..|++|......... .+.+.+|++++..++|+++.....++.. ....++||||
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~-~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVD-PDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEE-CCCCEEEEEE
Confidence 489999999999995 57889999865432111 2456789999999999886655555554 4567999999
Q ss_pred cCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccc
Q 005749 456 FPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQL 530 (679)
Q Consensus 456 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 530 (679)
+++++|.+++.... . .++.+++++|.++|+.+ ++|+|++|.||+++ ++.+++.|||+++.
T Consensus 79 ~~g~~l~~~~~~~~-------~----~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 79 IEGKPLKDVIEEGN-------D----ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred ECCccHHHHHhhcH-------H----HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999999875421 0 78999999999999988 99999999999999 78999999999875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.70 E-value=4.6e-17 Score=185.84 Aligned_cols=188 Identities=19% Similarity=0.269 Sum_probs=147.6
Q ss_pred CccccCCceEEEEEEeCCCCEEEEEEcccCcccCcccHHHHHHHHhccC---CCCCccceEEeeCCCCceEEEEEecCCC
Q 005749 383 QVIEKTTYGTAYKAKLADGATIALRLLREGSCKDRSSCLPVIRQLGKVR---HENLIPLRAFYQGKRGEKLLIYDYFPSR 459 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~---H~nIv~l~~~~~~~~~~~~lv~ey~~~g 459 (679)
..||+|+||+||+|...+|+.||+|+-++...= +|---.+++.+|+ -+-|..+...+.. .+.-++|+||.+.|
T Consensus 704 ~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~-~~~S~lv~ey~~~G 779 (974)
T KOG1166|consen 704 KEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVF-QNASVLVSEYSPYG 779 (974)
T ss_pred eeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHcc-CCcceeeeeccccc
Confidence 679999999999999888999999997765321 1212234445554 2233344333333 45678999999999
Q ss_pred ChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeec-------CCCceEEeecccccccC
Q 005749 460 TLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVD-------DFFVSRLTEFGLDQLMV 532 (679)
Q Consensus 460 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~-------~~~~~kl~DFGla~~~~ 532 (679)
+|.+++.. ...++|.....++.|+++-+++||..+ |||+||||+|.||. +...++|+|||.+-.+.
T Consensus 780 tlld~~N~----~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~ 852 (974)
T KOG1166|consen 780 TLLDLINT----NKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMK 852 (974)
T ss_pred cHHHhhcc----CCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEecccceeee
Confidence 99999984 456899999999999999999999988 99999999999994 23568999999986542
Q ss_pred cc-cccchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCC
Q 005749 533 PA-VADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKP 581 (679)
Q Consensus 533 ~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p 581 (679)
-- ........++|-.+-.+|+..+..++..+|-|.+.-+++-|+.|+.-
T Consensus 853 lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 853 LFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred EcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 11 12334566788889999999999999999999999999999998853
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.3e-16 Score=155.92 Aligned_cols=136 Identities=18% Similarity=0.153 Sum_probs=106.9
Q ss_pred hhcCccccCCceEEEEEEeCCCCEEEEEEcccCccc----------------------CcccHHHHHHHHhccCCCC--C
Q 005749 380 ATGQVIEKTTYGTAYKAKLADGATIALRLLREGSCK----------------------DRSSCLPVIRQLGKVRHEN--L 435 (679)
Q Consensus 380 ~~~~~ig~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~----------------------~~~~~~~Ei~~l~~l~H~n--I 435 (679)
...+.||+|+||.||+|...+|+.||||+++..... ....+.+|+.++.++.|++ +
T Consensus 18 ~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~v 97 (198)
T cd05144 18 SLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFPV 97 (198)
T ss_pred hcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCCC
Confidence 345889999999999999888999999987643210 0123678899999998874 3
Q ss_pred ccceEEeeCCCCceEEEEEecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeec
Q 005749 436 IPLRAFYQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVD 515 (679)
Q Consensus 436 v~l~~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~ 515 (679)
...++ ....++||||+++++|.+.... .....++.+++.++.++|+.+ |+||||||+||+++
T Consensus 98 ~~~~~-----~~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~Nill~ 159 (198)
T cd05144 98 PKPID-----WNRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYKHG---IIHGDLSEFNILVD 159 (198)
T ss_pred Cceee-----cCCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHHCC---CCcCCCCcccEEEc
Confidence 33333 2356899999999998765431 234578899999999999987 99999999999999
Q ss_pred CCCceEEeecccccccCc
Q 005749 516 DFFVSRLTEFGLDQLMVP 533 (679)
Q Consensus 516 ~~~~~kl~DFGla~~~~~ 533 (679)
+++.++|+|||++.....
T Consensus 160 ~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 160 DDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred CCCcEEEEECCccccCCC
Confidence 999999999999975543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.69 E-value=5e-18 Score=178.09 Aligned_cols=174 Identities=21% Similarity=0.249 Sum_probs=131.2
Q ss_pred ceEEEEEecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeeccc
Q 005749 448 EKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGL 527 (679)
Q Consensus 448 ~~~lv~ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 527 (679)
..|+.|++|...+|.+++..+.. ....++...+.++.|++.|++| ++ .+|||+||.||....+..+||+|||+
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~-~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRT-GEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCc-ccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhh
Confidence 47899999999999999975544 3457888999999999999999 56 89999999999999999999999999
Q ss_pred ccccCccc-----ccchhcccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHHh
Q 005749 528 DQLMVPAV-----ADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAV 601 (679)
Q Consensus 528 a~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~~ 601 (679)
........ ....+...||..||+||.+.+..|+.|+||||+|++|+|+++ =..++.. ...
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er--------------~~t 468 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER--------------IAT 468 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH--------------HHh
Confidence 87664433 234456689999999999999999999999999999999987 2222210 000
Q ss_pred hcccccccchHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHH
Q 005749 602 LEETTMEVFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEV 650 (679)
Q Consensus 602 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev 650 (679)
........+++. .-...++-..++.+++...|.+||++.++
T Consensus 469 ~~d~r~g~ip~~--------~~~d~p~e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 469 LTDIRDGIIPPE--------FLQDYPEEYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred hhhhhcCCCChH--------HhhcCcHHHHHHHHhcCCCcccCchHHHH
Confidence 000001111111 22334556679999999999999955544
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.3e-16 Score=179.57 Aligned_cols=133 Identities=19% Similarity=0.260 Sum_probs=106.8
Q ss_pred cCccccCCceEEEEEEeCCCCEEEEEEcccCc-cc------CcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEE
Q 005749 382 GQVIEKTTYGTAYKAKLADGATIALRLLREGS-CK------DRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYD 454 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~~~~~vAvK~~~~~~-~~------~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~e 454 (679)
.+.||+|+||+||+|++.+...++.+++.... .. ..+.+.+|++++.+++|++++....++.+ ....++|||
T Consensus 338 ~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~-~~~~~lv~E 416 (535)
T PRK09605 338 DHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVD-PEEKTIVME 416 (535)
T ss_pred cceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEe-CCCCEEEEE
Confidence 58899999999999997654433333222211 11 12458899999999999999887777665 457889999
Q ss_pred ecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeeccccccc
Q 005749 455 YFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLM 531 (679)
Q Consensus 455 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 531 (679)
|+++++|.+++. ....++.+++++|.|||+.+ ++|||+||+|||+ +++.++|+|||+++..
T Consensus 417 ~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 417 YIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred ecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 999999998875 34678999999999999988 9999999999999 5779999999998753
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.9e-15 Score=140.08 Aligned_cols=134 Identities=17% Similarity=0.189 Sum_probs=112.5
Q ss_pred CccccCCceEEEEEEeCCCCEEEEEEcccCcccCcccHHHHHHHHhccCC--CCCccceEEeeCCCCceEEEEEecCCCC
Q 005749 383 QVIEKTTYGTAYKAKLADGATIALRLLREGSCKDRSSCLPVIRQLGKVRH--ENLIPLRAFYQGKRGEKLLIYDYFPSRT 460 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H--~nIv~l~~~~~~~~~~~~lv~ey~~~gs 460 (679)
+.||+|.++.||+++..+ ..+++|....... ...+.+|+..+..++| .++.++++++.. .+..+++|||++++.
T Consensus 4 ~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~-~~~~~~v~e~~~g~~ 79 (155)
T cd05120 4 KLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGES-DGWSYLLMEWIEGET 79 (155)
T ss_pred eecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCC-CCccEEEEEecCCee
Confidence 568999999999999754 7899999866432 4578999999999987 588888887776 578999999999876
Q ss_pred hHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeeccccccc
Q 005749 461 LHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLM 531 (679)
Q Consensus 461 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 531 (679)
+..+ +......++.+++++++++|.....+++|+|++|+||++++.+.+++.|||.++..
T Consensus 80 ~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 80 LDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred cccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 6543 45667788999999999999865456999999999999999899999999998753
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.62 E-value=3.6e-15 Score=144.38 Aligned_cols=136 Identities=18% Similarity=0.215 Sum_probs=97.9
Q ss_pred cCccccCCceEEEEEEeCCCCEEEEEEcccCccc--CcccH----------------------HHHHHHHhccCCCC--C
Q 005749 382 GQVIEKTTYGTAYKAKLADGATIALRLLREGSCK--DRSSC----------------------LPVIRQLGKVRHEN--L 435 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~--~~~~~----------------------~~Ei~~l~~l~H~n--I 435 (679)
++.||+|+||.||+|+..+++.||||+++..... ....+ ..|.+.+.++++.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 3679999999999999878999999998754211 11111 35566666665443 3
Q ss_pred ccceEEeeCCCCceEEEEEecCCCChHH-HhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeeecCCCCCCee
Q 005749 436 IPLRAFYQGKRGEKLLIYDYFPSRTLHD-LLHDTIAGKPVLNWARRHKIALGIARGLAYLHT-GHEIPITHGNVRSKNVL 513 (679)
Q Consensus 436 v~l~~~~~~~~~~~~lv~ey~~~gsL~~-~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~-~~~~~ivHrDlkp~NIL 513 (679)
.+.+++ ...++||||++++++.. .+.... .. .....++.+++.++.++|. .+ |+||||||+||+
T Consensus 82 ~~~~~~-----~~~~lv~e~~~g~~~~~~~l~~~~-----~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nil 147 (187)
T cd05119 82 PKPIDL-----NRHVLVMEFIGGDGIPAPRLKDVR-----LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNIL 147 (187)
T ss_pred CceEec-----CCCEEEEEEeCCCCccChhhhhhh-----hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEE
Confidence 333332 24689999999965432 121110 11 5677899999999999998 77 999999999999
Q ss_pred ecCCCceEEeecccccccC
Q 005749 514 VDDFFVSRLTEFGLDQLMV 532 (679)
Q Consensus 514 l~~~~~~kl~DFGla~~~~ 532 (679)
++ ++.++++|||.+....
T Consensus 148 i~-~~~~~liDfg~a~~~~ 165 (187)
T cd05119 148 VD-DGKVYIIDVPQAVEID 165 (187)
T ss_pred EE-CCcEEEEECccccccc
Confidence 99 8999999999987553
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.61 E-value=8.9e-18 Score=150.76 Aligned_cols=158 Identities=23% Similarity=0.359 Sum_probs=138.5
Q ss_pred cEEEEEcCCCCCcccCCccccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEEc
Q 005749 100 HLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRL 179 (679)
Q Consensus 100 ~l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~L 179 (679)
+++.|.|++|.++ .+|+.|+.|.+|+.|++++|++. .+|..+.++++|+.|+++-|++. .+|..++.. +.|+.|||
T Consensus 34 ~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~-p~levldl 109 (264)
T KOG0617|consen 34 NITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSF-PALEVLDL 109 (264)
T ss_pred hhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCC-chhhhhhc
Confidence 5788899999988 78999999999999999999998 79999999999999999999998 577888776 89999999
Q ss_pred cCCCCcccCCCCCCCCCCCCCccEEEccCccccccccccccCCCCCCEEEccCCcccccCCcccccc-ccCEEEccCCcC
Q 005749 180 HGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRL-SLEKLNLSHNNF 258 (679)
Q Consensus 180 s~N~l~~~~p~~~~~~~~~~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l-~L~~l~ls~N~l 258 (679)
++|++....-++.+ ..++.|+.|+|+.|.|. .+|..++++++|+.|.+..|.+- ++|..++.+ .|+.|.+.+|.+
T Consensus 110 tynnl~e~~lpgnf--f~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl 185 (264)
T KOG0617|consen 110 TYNNLNENSLPGNF--FYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRL 185 (264)
T ss_pred cccccccccCCcch--hHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhccccee
Confidence 99999864322222 24678999999999998 88999999999999999999987 789999998 699999999999
Q ss_pred CCCCCCc
Q 005749 259 SGVLPVF 265 (679)
Q Consensus 259 ~g~ip~~ 265 (679)
+-..|..
T Consensus 186 ~vlppel 192 (264)
T KOG0617|consen 186 TVLPPEL 192 (264)
T ss_pred eecChhh
Confidence 8666654
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.61 E-value=7.8e-15 Score=147.17 Aligned_cols=142 Identities=20% Similarity=0.254 Sum_probs=109.2
Q ss_pred HHHhhcCccc-cCCceEEEEEEeCCCCEEEEEEcccCc-------------ccCcccHHHHHHHHhccCCCCC--ccceE
Q 005749 377 VLNATGQVIE-KTTYGTAYKAKLADGATIALRLLREGS-------------CKDRSSCLPVIRQLGKVRHENL--IPLRA 440 (679)
Q Consensus 377 l~~~~~~~ig-~G~~g~Vy~~~~~~~~~vAvK~~~~~~-------------~~~~~~~~~Ei~~l~~l~H~nI--v~l~~ 440 (679)
.....+.+|| .|+.|+||+++.. +..++||.+.... ......+.+|++++.+++|++| ++.++
T Consensus 31 ~~~~~~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~ 109 (239)
T PRK01723 31 FWQQQARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIA 109 (239)
T ss_pred HHhhcCceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEe
Confidence 3345568898 8999999999885 7788998875321 0123457889999999998885 66676
Q ss_pred EeeCCCCc---eEEEEEecCC-CChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecC
Q 005749 441 FYQGKRGE---KLLIYDYFPS-RTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDD 516 (679)
Q Consensus 441 ~~~~~~~~---~~lv~ey~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~ 516 (679)
+.....+. .++||||+++ .+|.+++.. ..++.. .+.+++.+|.+||+.+ |+||||||.|||++.
T Consensus 110 ~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~-----~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~ 177 (239)
T PRK01723 110 ARVVRHGLFYRADILIERIEGARDLVALLQE-----APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDP 177 (239)
T ss_pred eeeeecCcceeeeEEEEecCCCCCHHHHHhc-----CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcC
Confidence 64432222 3599999997 699988864 224443 3578999999999998 999999999999999
Q ss_pred CCceEEeeccccccc
Q 005749 517 FFVSRLTEFGLDQLM 531 (679)
Q Consensus 517 ~~~~kl~DFGla~~~ 531 (679)
++.++|+|||.+...
T Consensus 178 ~~~v~LIDfg~~~~~ 192 (239)
T PRK01723 178 DGKFWLIDFDRGELR 192 (239)
T ss_pred CCCEEEEECCCcccC
Confidence 899999999988753
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.61 E-value=4.3e-16 Score=174.40 Aligned_cols=202 Identities=21% Similarity=0.309 Sum_probs=136.6
Q ss_pred cCccccCCceEEEEEEeC-CCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCC
Q 005749 382 GQVIEKTTYGTAYKAKLA-DGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRT 460 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gs 460 (679)
-+.|..|+||.||..+.+ ..+.+|+|+-+. . . ++ +||..+- +..+.| ||
T Consensus 88 IklisngAygavylvrh~~trqrfa~kiNkq-~-----l------il-----Rnilt~a-------~npfvv------gD 137 (1205)
T KOG0606|consen 88 IKLISNGAYGAVYLVRHKETRQRFAMKINKQ-N-----L------IL-----RNILTFA-------GNPFVV------GD 137 (1205)
T ss_pred eEeeccCCCCceeeeeccccccchhhccccc-c-----h------hh-----hcccccc-------CCccee------ch
Confidence 378999999999999854 477888854322 1 1 11 1232221 223333 56
Q ss_pred hHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCccc-----
Q 005749 461 LHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAV----- 535 (679)
Q Consensus 461 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~----- 535 (679)
-...++.. .+++.. .+.+++|+|+.+ |+|||+||+|.+|..-|++|+.|||+.+......
T Consensus 138 c~tllk~~----g~lPvd--------mvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~ 202 (1205)
T KOG0606|consen 138 CATLLKNI----GPLPVD--------MVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLK 202 (1205)
T ss_pred hhhhcccC----CCCcch--------hhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhccchhh
Confidence 66666542 223222 267899999988 9999999999999999999999999987532110
Q ss_pred -------cc--chhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccc
Q 005749 536 -------AD--EMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETT 606 (679)
Q Consensus 536 -------~~--~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 606 (679)
.+ .....+||+.|+|||++....|+...|-|++|+|+||.+.|+.||.+++..+...
T Consensus 203 eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg-------------- 268 (1205)
T KOG0606|consen 203 EGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFG-------------- 268 (1205)
T ss_pred hcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHh--------------
Confidence 01 1224589999999999999999999999999999999999999997765432211
Q ss_pred cccchHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCC
Q 005749 607 MEVFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRP 645 (679)
Q Consensus 607 ~~~~~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP 645 (679)
.++...+. +.+..+...++..+++.+.++.+|..|-
T Consensus 269 -~visd~i~--wpE~dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 269 -QVISDDIE--WPEEDEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred -hhhhhhcc--ccccCcCCCHHHHHHHHHHHHhChHhhc
Confidence 00100100 0111233345667788888899999885
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.51 E-value=6.4e-14 Score=152.65 Aligned_cols=151 Identities=19% Similarity=0.244 Sum_probs=107.0
Q ss_pred HHHHHHhhc-CccccCCceEEEEEEeCCCCEEEEEEcccCcccC------------------------------------
Q 005749 374 LEDVLNATG-QVIEKTTYGTAYKAKLADGATIALRLLREGSCKD------------------------------------ 416 (679)
Q Consensus 374 ~~~l~~~~~-~~ig~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~------------------------------------ 416 (679)
++++....+ +.||.|++|.||+|++++|+.||||+.++.-.+.
T Consensus 113 ~~~~F~~fd~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~ 192 (437)
T TIGR01982 113 LEELFAEFEEKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEK 192 (437)
T ss_pred HHHHHhhCCCcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHH
Confidence 344444433 5799999999999999999999999986641100
Q ss_pred ----cccHHHHHHHHhccC----CCCCccceEEeeCCCCceEEEEEecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHH
Q 005749 417 ----RSSCLPVIRQLGKVR----HENLIPLRAFYQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIA 488 (679)
Q Consensus 417 ----~~~~~~Ei~~l~~l~----H~nIv~l~~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia 488 (679)
.-+|.+|.+.+.+++ |.+-|.+-.+|.+.....++||||++|++|.++...... .. .+..++..++
T Consensus 193 ~l~~Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~---~~---~~~~ia~~~~ 266 (437)
T TIGR01982 193 TLRRELDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA---GL---DRKALAENLA 266 (437)
T ss_pred HHHHHHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc---CC---CHHHHHHHHH
Confidence 013556666665553 333344433444334567999999999999887653211 12 2345666666
Q ss_pred H-HHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCc
Q 005749 489 R-GLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVP 533 (679)
Q Consensus 489 ~-gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 533 (679)
. .+..+|..+ ++|+|+||.||++++++++++.|||++..+.+
T Consensus 267 ~~~l~ql~~~g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 267 RSFLNQVLRDG---FFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred HHHHHHHHhCC---ceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 6 467889877 99999999999999999999999999987754
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.51 E-value=2.1e-14 Score=151.08 Aligned_cols=176 Identities=27% Similarity=0.351 Sum_probs=138.9
Q ss_pred CcccCCCCCCc--cccccccCCCCccEEEEEcCCCCCcccCCccccCCCCCCeeecccCcccccCCcccCCCCCCCEEEc
Q 005749 77 PLSCSDISLPQ--WANLSLYKDSSIHLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDL 154 (679)
Q Consensus 77 ~l~c~~~~~~~--~~~l~~~~~~~~~l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~L 154 (679)
.+.|++..... +..+..+ -.+..+.|++++|.+...=+.+|-+|++|+.++|.+|.|+ .||...+...+|+.|+|
T Consensus 56 lldcs~~~lea~~~~~l~g~--lp~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L 132 (873)
T KOG4194|consen 56 LLDCSDRELEAIDKSRLKGF--LPSQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDL 132 (873)
T ss_pred eeecCccccccccccccCCc--CccceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEee
Confidence 35576654432 2233322 2235788999999999888889999999999999999999 89988777888999999
Q ss_pred cCCCCCCcChhhHHhhcccCcEEEccCCCCcccCCCCCCCCCCCCCccEEEccCccccccccccccCCCCCCEEEccCCc
Q 005749 155 SANLFTGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNL 234 (679)
Q Consensus 155 s~N~l~g~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~ 234 (679)
.+|.++..-..++..+ +.|+.||||.|.++. +|...+|.. .++++|+|++|+|+..--..|..+.+|.+|.|++|+
T Consensus 133 ~~N~I~sv~se~L~~l-~alrslDLSrN~is~-i~~~sfp~~--~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNr 208 (873)
T KOG4194|consen 133 RHNLISSVTSEELSAL-PALRSLDLSRNLISE-IPKPSFPAK--VNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNR 208 (873)
T ss_pred eccccccccHHHHHhH-hhhhhhhhhhchhhc-ccCCCCCCC--CCceEEeeccccccccccccccccchheeeecccCc
Confidence 9999987655566554 899999999999994 565555532 489999999999986666778889999999999999
Q ss_pred ccccCCcccccc-ccCEEEccCCcCC
Q 005749 235 FSGSIPEGLTRL-SLEKLNLSHNNFS 259 (679)
Q Consensus 235 l~g~~p~~~~~l-~L~~l~ls~N~l~ 259 (679)
++-..+..|.++ .|+.|+|..|+|.
T Consensus 209 ittLp~r~Fk~L~~L~~LdLnrN~ir 234 (873)
T KOG4194|consen 209 ITTLPQRSFKRLPKLESLDLNRNRIR 234 (873)
T ss_pred ccccCHHHhhhcchhhhhhcccccee
Confidence 995445556657 6999999999875
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.50 E-value=2.6e-15 Score=168.50 Aligned_cols=249 Identities=19% Similarity=0.199 Sum_probs=178.9
Q ss_pred CccccCCceEEEEEEeC--CCCEEEEEEcccCc--ccCcccHHHHHHHHhccC-CCCCccceEEeeCCCCceEEEEEecC
Q 005749 383 QVIEKTTYGTAYKAKLA--DGATIALRLLREGS--CKDRSSCLPVIRQLGKVR-HENLIPLRAFYQGKRGEKLLIYDYFP 457 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~~--~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~-H~nIv~l~~~~~~~~~~~~lv~ey~~ 457 (679)
+.||+|+|+.|-..... ....+|+|.+.... ....+....|..+-..+. |+|++++++.... .+..+++.+|..
T Consensus 26 ~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~-~~~~~~~~~~s~ 104 (601)
T KOG0590|consen 26 RSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSS-PRSYLLSLSYSD 104 (601)
T ss_pred ccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCC-CcccccccCccc
Confidence 55899999999888743 34566777765443 122233445666666665 9999999998877 678899999999
Q ss_pred CCChHHHh-hcccCCCCCCCHHHHHHHHHHHHHHHHHHh-cCCCCCeeecCCCCCCeeecCCC-ceEEeecccccccCc-
Q 005749 458 SRTLHDLL-HDTIAGKPVLNWARRHKIALGIARGLAYLH-TGHEIPITHGNVRSKNVLVDDFF-VSRLTEFGLDQLMVP- 533 (679)
Q Consensus 458 ~gsL~~~l-~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH-~~~~~~ivHrDlkp~NILl~~~~-~~kl~DFGla~~~~~- 533 (679)
++++.+.+ +... ...+....-.+..|+..|+.|+| ..+ +.|||+||+|.+++..+ ..|++|||+|..+..
T Consensus 105 g~~~f~~i~~~~~---~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~ 178 (601)
T KOG0590|consen 105 GGSLFSKISHPDS---TGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAYRNK 178 (601)
T ss_pred ccccccccccCCc---cCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhcccccc
Confidence 99999888 4321 13455566789999999999999 766 99999999999999999 999999999987755
Q ss_pred -ccccchhcccc-ccccccccccccc-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccc
Q 005749 534 -AVADEMVALAK-ADGYKAPELQRMK-KCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVF 610 (679)
Q Consensus 534 -~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 610 (679)
+........+| ++.|+|||...+. ...+..|+||.|+++.-+++|..|+......+. ....|.... ..+
T Consensus 179 ~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~-~~~~~~~~~-------~~~ 250 (601)
T KOG0590|consen 179 NGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG-RYSSWKSNK-------GRF 250 (601)
T ss_pred CCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccc-cceeecccc-------ccc
Confidence 22223345577 9999999998874 457889999999999999999999854433221 111111100 000
Q ss_pred hHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 611 DMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 611 ~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
...+.........++..+++..+|+.|.+.+++...
T Consensus 251 -------~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d 286 (601)
T KOG0590|consen 251 -------TQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLD 286 (601)
T ss_pred -------ccCccccCChhhhhcccccccCCchhcccccccccc
Confidence 011122233455678888888999999998877543
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.49 E-value=6.3e-16 Score=138.94 Aligned_cols=138 Identities=25% Similarity=0.424 Sum_probs=121.4
Q ss_pred cEEEEEcCCCCCcccCCccccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCc-ChhhHHhhcccCcEEE
Q 005749 100 HLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGV-LAPSIWNLCDRLVSLR 178 (679)
Q Consensus 100 ~l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~-~p~~~~~~~~~L~~L~ 178 (679)
++..|++.+|.+. .+|..|+.|++|+.|+++-|++. .+|..+|.++.|+.|||.+|+++.. +|-.++.+ +.|+.|+
T Consensus 57 nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldltynnl~e~~lpgnff~m-~tlraly 133 (264)
T KOG0617|consen 57 NLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDLTYNNLNENSLPGNFFYM-TTLRALY 133 (264)
T ss_pred hhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhccccccccccCCcchhHH-HHHHHHH
Confidence 5778888877776 89999999999999999999998 8999999999999999999999864 56667776 7899999
Q ss_pred ccCCCCcccCCCCCCCCCCCCCccEEEccCccccccccccccCCCCCCEEEccCCcccccCCcccccc
Q 005749 179 LHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRL 246 (679)
Q Consensus 179 Ls~N~l~~~~p~~~~~~~~~~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l 246 (679)
|+.|.|.-. |+.. ..+++|+.|.+..|.+- ++|.+++.+++|++|.+.+|+++ .+|+.++.+
T Consensus 134 l~dndfe~l-p~dv---g~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl~-vlppel~~l 195 (264)
T KOG0617|consen 134 LGDNDFEIL-PPDV---GKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRLT-VLPPELANL 195 (264)
T ss_pred hcCCCcccC-Chhh---hhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccceee-ecChhhhhh
Confidence 999999854 4333 57899999999999998 79999999999999999999998 677777765
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.47 E-value=4.2e-14 Score=139.71 Aligned_cols=206 Identities=22% Similarity=0.327 Sum_probs=143.6
Q ss_pred HHHHhccCCCCCccceEEeeCC----CCceEEEEEecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC
Q 005749 424 IRQLGKVRHENLIPLRAFYQGK----RGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHE 499 (679)
Q Consensus 424 i~~l~~l~H~nIv~l~~~~~~~----~~~~~lv~ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~ 499 (679)
+..+-.+.|-|||+++.|+.+. ..+..++.|||..|++.++|+........+....-.+++.||..||.|||+. .
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~ 196 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-D 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-C
Confidence 4556677899999999998763 2356899999999999999987655455566677789999999999999995 5
Q ss_pred CCeeecCCCCCCeeecCCCceEEeecccccccCccc----ccchhcccccccccccccccccCCCCcchhHHHHHHHHHH
Q 005749 500 IPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAV----ADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEI 575 (679)
Q Consensus 500 ~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El 575 (679)
|+|+|+++.-+-|.+..++-+|++--- ........ ........+-++|.|||+-.....+.++|||+||+..+||
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~a-p~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlem 275 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSVA-PDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEM 275 (458)
T ss_pred CccccCCcchhheeecCCceEEecccC-ccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHH
Confidence 889999999999999999888875321 11111110 1111223467789999988777788899999999999999
Q ss_pred HhCCCC-CCCCCCCcccchhHHHHHHhhcccccccchHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 005749 576 LIGKKP-GKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQL 654 (679)
Q Consensus 576 ~tg~~p-~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L 654 (679)
..+..- ..+...-+. .+.....+ -+... ..-.+++.+|++..|..||+|++++.+.
T Consensus 276 ailEiq~tnseS~~~~----------------ee~ia~~i-~~len------~lqr~~i~kcl~~eP~~rp~ar~llfHp 332 (458)
T KOG1266|consen 276 AILEIQSTNSESKVEV----------------EENIANVI-IGLEN------GLQRGSITKCLEGEPNGRPDARLLLFHP 332 (458)
T ss_pred HHheeccCCCcceeeh----------------hhhhhhhe-eeccC------ccccCcCcccccCCCCCCcchhhhhcCc
Confidence 887653 222111000 00000000 00000 1112478899999999999999987653
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.46 E-value=1e-14 Score=154.25 Aligned_cols=157 Identities=26% Similarity=0.395 Sum_probs=95.6
Q ss_pred cEEEEEcCCCCCc-ccCCccccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEE
Q 005749 100 HLLSIQLPSANLT-GSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLR 178 (679)
Q Consensus 100 ~l~~l~l~~n~l~-g~ip~~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~ 178 (679)
++.++.+..|+|. .-||++|-+|..|+.||||+|+|. ..|..+..-.++-+|+||+|++. .||..++-.++.|-.||
T Consensus 79 ~LRsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLD 156 (1255)
T KOG0444|consen 79 RLRSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLFLD 156 (1255)
T ss_pred hhHHHhhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccc-cCCchHHHhhHhHhhhc
Confidence 4566667777775 347777777777777777777776 67777777777777777777776 35555554446677777
Q ss_pred ccCCCCcccCCCC----------------------C---------------------CCC--CCCCCccEEEccCccccc
Q 005749 179 LHGNSLTAALPEP----------------------A---------------------LPN--STCSDLQYLDLGSNKFSG 213 (679)
Q Consensus 179 Ls~N~l~~~~p~~----------------------~---------------------~~~--~~~~~L~~L~l~~N~l~g 213 (679)
||+|+|...+|.. . +|. ..+.+|..+|||.|++.
T Consensus 157 LS~NrLe~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp- 235 (1255)
T KOG0444|consen 157 LSNNRLEMLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP- 235 (1255)
T ss_pred cccchhhhcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-
Confidence 7777776444420 0 010 01345556666666665
Q ss_pred cccccccCCCCCCEEEccCCcccccCCcccccc-ccCEEEccCCcCCC
Q 005749 214 SFPEFVTRFEALKELDISNNLFSGSIPEGLTRL-SLEKLNLSHNNFSG 260 (679)
Q Consensus 214 ~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l-~L~~l~ls~N~l~g 260 (679)
.+|+.+-++.+|+.|+||+|+|+ .+....+.. .|++|+||.|+++-
T Consensus 236 ~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt~ 282 (1255)
T KOG0444|consen 236 IVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLTV 282 (1255)
T ss_pred cchHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhcc
Confidence 55666666666666666666665 222222222 46777777777763
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.41 E-value=2.4e-12 Score=147.47 Aligned_cols=39 Identities=5% Similarity=0.015 Sum_probs=27.8
Q ss_pred CCCCChHHHHHHHHHHHhhCCCCCCcccCCC----CCCCCCCccccc
Q 005749 25 SPASASSDVELLLGKIKSSLQGDDENLLLSS----WNISVPLCQWRG 67 (679)
Q Consensus 25 ~~~~~~~~~~~ll~~~k~~~~~~~~~~~l~~----W~~~~~~C~w~G 67 (679)
.......+.+.++ ++.+.|.. .+.+.+ |+..+++|.-..
T Consensus 57 ~~~~~~~~~~~~~-~~~~~l~~---p~~~~~~~~~~~~~~~fc~~~~ 99 (754)
T PRK15370 57 PETASPEEIKSKF-ECLRMLAF---PAYADNIQYSRGGADQYCILSE 99 (754)
T ss_pred CCCCCHHHHHHHH-HHHHHhcC---CchhhccccccCCCCcccccCC
Confidence 4445667788887 88888876 334555 988889997655
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.40 E-value=2e-14 Score=152.00 Aligned_cols=151 Identities=26% Similarity=0.389 Sum_probs=103.6
Q ss_pred cEEEEEcCCCCCcccCCccccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCC-CcChhhHHhhcccCcEEE
Q 005749 100 HLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFT-GVLAPSIWNLCDRLVSLR 178 (679)
Q Consensus 100 ~l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~-g~~p~~~~~~~~~L~~L~ 178 (679)
+++.|.|....|. .+|.+++.|.+|++|.+++|+|. .+-.++..++.|+.+++..|+|. .-||++++.+ ..|+.||
T Consensus 33 ~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~~R~N~LKnsGiP~diF~l-~dLt~lD 109 (1255)
T KOG0444|consen 33 QMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVIVRDNNLKNSGIPTDIFRL-KDLTILD 109 (1255)
T ss_pred heeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHhhhccccccCCCCchhccc-ccceeee
Confidence 4666666666554 67778888888888888888776 56667777777777777777774 2367777775 7777778
Q ss_pred ccCCCCcccCCCCCCCCCCCCCccEEEccCccccccccc-cccCCCCCCEEEccCCcccccCCcccccc-ccCEEEccCC
Q 005749 179 LHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPE-FVTRFEALKELDISNNLFSGSIPEGLTRL-SLEKLNLSHN 256 (679)
Q Consensus 179 Ls~N~l~~~~p~~~~~~~~~~~L~~L~l~~N~l~g~~p~-~~~~l~~L~~L~ls~N~l~g~~p~~~~~l-~L~~l~ls~N 256 (679)
||+|+|.. .|... ..-+++-+|+||+|+|. +||. .+-+++.|-+||||+|+|. .+|+.+..+ .|++|+|++|
T Consensus 110 LShNqL~E-vP~~L---E~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~N 183 (1255)
T KOG0444|consen 110 LSHNQLRE-VPTNL---EYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNN 183 (1255)
T ss_pred cchhhhhh-cchhh---hhhcCcEEEEcccCccc-cCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCC
Confidence 88887774 34322 23356777777777777 4553 4566777777777777776 556655555 4777777777
Q ss_pred cCC
Q 005749 257 NFS 259 (679)
Q Consensus 257 ~l~ 259 (679)
.+.
T Consensus 184 PL~ 186 (1255)
T KOG0444|consen 184 PLN 186 (1255)
T ss_pred hhh
Confidence 653
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.40 E-value=1.1e-14 Score=147.03 Aligned_cols=173 Identities=29% Similarity=0.436 Sum_probs=112.6
Q ss_pred cEEEEEcCCCCCcccCCccccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEEc
Q 005749 100 HLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRL 179 (679)
Q Consensus 100 ~l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~L 179 (679)
+++.++.++|++. .+|++++++..|..|+..+|+++ ++|..++++.+|..|++.+|.+.. +|+...++ +.|++||+
T Consensus 115 ~l~~l~~s~n~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~-l~~~~i~m-~~L~~ld~ 190 (565)
T KOG0472|consen 115 SLVKLDCSSNELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKA-LPENHIAM-KRLKHLDC 190 (565)
T ss_pred hhhhhhcccccee-ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhh-CCHHHHHH-HHHHhccc
Confidence 4455556666655 45556666666666666666665 566666666666666666666553 23333332 55666666
Q ss_pred cCCCCcccCCCC-----------------CCC-CCCCCCccEEEccCcccccccccccc-CCCCCCEEEccCCcccccCC
Q 005749 180 HGNSLTAALPEP-----------------ALP-NSTCSDLQYLDLGSNKFSGSFPEFVT-RFEALKELDISNNLFSGSIP 240 (679)
Q Consensus 180 s~N~l~~~~p~~-----------------~~~-~~~~~~L~~L~l~~N~l~g~~p~~~~-~l~~L~~L~ls~N~l~g~~p 240 (679)
..|-++..+|+- ++| +..|+.|.+|.++.|++. .+|.+.. ++++|..|||.+|++. ++|
T Consensus 191 ~~N~L~tlP~~lg~l~~L~~LyL~~Nki~~lPef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~P 268 (565)
T KOG0472|consen 191 NSNLLETLPPELGGLESLELLYLRRNKIRFLPEFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVP 268 (565)
T ss_pred chhhhhcCChhhcchhhhHHHHhhhcccccCCCCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCc
Confidence 666555332220 111 135777888888888887 6777655 8999999999999998 789
Q ss_pred cccccc-ccCEEEccCCcCCCCCCCcccCCCCcccccCC
Q 005749 241 EGLTRL-SLEKLNLSHNNFSGVLPVFSESKFGAEVFEGN 278 (679)
Q Consensus 241 ~~~~~l-~L~~l~ls~N~l~g~ip~~~~~~~~~~~~~~n 278 (679)
..+..+ +|+.||+|+|.+++-.+..+......-...||
T Consensus 269 de~clLrsL~rLDlSNN~is~Lp~sLgnlhL~~L~leGN 307 (565)
T KOG0472|consen 269 DEICLLRSLERLDLSNNDISSLPYSLGNLHLKFLALEGN 307 (565)
T ss_pred hHHHHhhhhhhhcccCCccccCCcccccceeeehhhcCC
Confidence 988888 59999999999998777655443333344566
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.40 E-value=5.9e-13 Score=142.98 Aligned_cols=254 Identities=17% Similarity=0.195 Sum_probs=179.3
Q ss_pred cccHHHHHHhhcCcccc--CCceEEEEEEe---CCCCEEEEEEcccC--cccCcccHHHHHHHHhccC-CCCCccceEEe
Q 005749 371 HLTLEDVLNATGQVIEK--TTYGTAYKAKL---ADGATIALRLLREG--SCKDRSSCLPVIRQLGKVR-HENLIPLRAFY 442 (679)
Q Consensus 371 ~~~~~~l~~~~~~~ig~--G~~g~Vy~~~~---~~~~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~-H~nIv~l~~~~ 442 (679)
.+++.+-......-+|. |.+|.||.++. +++..+|+|.-+.. .......-.+|+..-.+++ |+|.|+.+..+
T Consensus 108 ~~s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~ 187 (524)
T KOG0601|consen 108 FDSFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAW 187 (524)
T ss_pred ccchhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccc
Confidence 34455554445577899 99999999986 46889999984332 2233344456676666774 99999988877
Q ss_pred eCCCCceEEEEEecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHH----HHHHHhcCCCCCeeecCCCCCCeeecCC-
Q 005749 443 QGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIAR----GLAYLHTGHEIPITHGNVRSKNVLVDDF- 517 (679)
Q Consensus 443 ~~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~----gL~~LH~~~~~~ivHrDlkp~NILl~~~- 517 (679)
.+ .+..++-+|++. .+|.++.+.. ...++....+.+..+... ||.++|+.. ++|-|+||.||.+.++
T Consensus 188 e~-~~~lfiqtE~~~-~sl~~~~~~~---~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~ 259 (524)
T KOG0601|consen 188 EG-SGILFIQTELCG-ESLQSYCHTP---CNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDW 259 (524)
T ss_pred cc-CCcceeeecccc-chhHHhhhcc---cccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheeccccc
Confidence 76 688899999985 5888888764 233666777788888888 999999988 9999999999999999
Q ss_pred CceEEeecccccccCcccccc----hhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccch
Q 005749 518 FVSRLTEFGLDQLMVPAVADE----MVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDL 593 (679)
Q Consensus 518 ~~~kl~DFGla~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l 593 (679)
...++.|||+...+....... .....|...|++||... +.++.++|+|++|.+..|..++..+.....+..+..+
T Consensus 260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~ 338 (524)
T KOG0601|consen 260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQL 338 (524)
T ss_pred ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCCCcccc
Confidence 889999999988775443111 11224556799999876 5688999999999999999999887654433322221
Q ss_pred hHHHHHHhhcccccccchHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHH
Q 005749 594 PSIVKVAVLEETTMEVFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVK 652 (679)
Q Consensus 594 ~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 652 (679)
..+. ...+...+ ...+....+..+++.+|..|++.+++.+
T Consensus 339 r~~~------------ip~e~~~~-------~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 339 RQGY------------IPLEFCEG-------GSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred cccc------------CchhhhcC-------cchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 1100 00011111 1122223677899999999999776654
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.38 E-value=4.4e-14 Score=148.78 Aligned_cols=164 Identities=25% Similarity=0.294 Sum_probs=135.8
Q ss_pred CccEEEEEcCCCCCcccCCccccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEE
Q 005749 98 SIHLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSL 177 (679)
Q Consensus 98 ~~~l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L 177 (679)
..++..|+|..|++...--..+-+|+.|+.|+||+|.|...-++.+..+.+|++||||+|+++..-+.++.. +..|+.|
T Consensus 268 l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~-L~~Le~L 346 (873)
T KOG4194|consen 268 LEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRV-LSQLEEL 346 (873)
T ss_pred ecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHH-HHHhhhh
Confidence 347889999999999777778899999999999999999888899999999999999999999755555544 4899999
Q ss_pred EccCCCCcccCCCCCCCCCCCCCccEEEccCccccccccc---cccCCCCCCEEEccCCcccccCCcccccc-ccCEEEc
Q 005749 178 RLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPE---FVTRFEALKELDISNNLFSGSIPEGLTRL-SLEKLNL 253 (679)
Q Consensus 178 ~Ls~N~l~~~~p~~~~~~~~~~~L~~L~l~~N~l~g~~p~---~~~~l~~L~~L~ls~N~l~g~~p~~~~~l-~L~~l~l 253 (679)
+|++|+++- +-++.+ ..+++|+.|||++|.|++.|.+ .|..++.|+.|++.+|+|....-..+..+ .|+.|||
T Consensus 347 nLs~Nsi~~-l~e~af--~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL 423 (873)
T KOG4194|consen 347 NLSHNSIDH-LAEGAF--VGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDL 423 (873)
T ss_pred cccccchHH-HHhhHH--HHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecC
Confidence 999999984 333332 3578999999999999988864 47779999999999999984444456666 6999999
Q ss_pred cCCcCCCCCCCc
Q 005749 254 SHNNFSGVLPVF 265 (679)
Q Consensus 254 s~N~l~g~ip~~ 265 (679)
.+|.|...=|..
T Consensus 424 ~~NaiaSIq~nA 435 (873)
T KOG4194|consen 424 GDNAIASIQPNA 435 (873)
T ss_pred CCCcceeecccc
Confidence 999987665543
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.33 E-value=4.1e-12 Score=140.03 Aligned_cols=150 Identities=13% Similarity=0.174 Sum_probs=98.7
Q ss_pred HHHHHHhhc-CccccCCceEEEEEEeCC-CCEEEEEEcccCccc--------------------------C---------
Q 005749 374 LEDVLNATG-QVIEKTTYGTAYKAKLAD-GATIALRLLREGSCK--------------------------D--------- 416 (679)
Q Consensus 374 ~~~l~~~~~-~~ig~G~~g~Vy~~~~~~-~~~vAvK~~~~~~~~--------------------------~--------- 416 (679)
++++...++ +.||+|++|.||+|++++ |+.||||+.++.-.. +
T Consensus 115 ~~~~F~~fd~~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~ 194 (537)
T PRK04750 115 VEEWFDDFDIKPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFE 194 (537)
T ss_pred HHHHHHhcChhhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHH
Confidence 344444333 579999999999999877 999999999754100 0
Q ss_pred -----cccHHHHHHHHhccC----CCCCccceEEeeCCCCceEEEEEecCCCChHHHhhcccCC--CCCCCHHHHHHHHH
Q 005749 417 -----RSSCLPVIRQLGKVR----HENLIPLRAFYQGKRGEKLLIYDYFPSRTLHDLLHDTIAG--KPVLNWARRHKIAL 485 (679)
Q Consensus 417 -----~~~~~~Ei~~l~~l~----H~nIv~l~~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~--~~~l~~~~~~~i~~ 485 (679)
+-+|.+|...+.+++ +.+.|.+-.+|.+-....++||||+.|+.+.++-.-...+ ...+.......++.
T Consensus 195 ~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~ 274 (537)
T PRK04750 195 KTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFT 274 (537)
T ss_pred HHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHH
Confidence 013455555555553 4445555555554345788999999999998753211111 01122222333333
Q ss_pred HHHHHHHHHhcCCCCCeeecCCCCCCeeecCCC----ceEEeecccccccCc
Q 005749 486 GIARGLAYLHTGHEIPITHGNVRSKNVLVDDFF----VSRLTEFGLDQLMVP 533 (679)
Q Consensus 486 ~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~----~~kl~DFGla~~~~~ 533 (679)
|+ +..+ ++|+|+||.||+++.++ .+++.|||+...+.+
T Consensus 275 Qi-------f~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 275 QV-------FRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HH-------HhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 33 3456 99999999999999888 999999999887654
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.32 E-value=2.1e-12 Score=147.11 Aligned_cols=135 Identities=31% Similarity=0.369 Sum_probs=70.5
Q ss_pred EEEEEcCCCCCcccCCccccCCCCCCeeecccCcccccCCc---ccCC--------------CCCCCEEEccCCCCCCcC
Q 005749 101 LLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPF---ELGY--------------SSSLSEIDLSANLFTGVL 163 (679)
Q Consensus 101 l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip~---~l~~--------------l~~L~~L~Ls~N~l~g~~ 163 (679)
+..|+|++|+++ .+|. .+++|+.|+|++|+|++ +|. .+.. ..+|++|+|++|+|++ +
T Consensus 284 L~~L~Ls~N~Lt-~LP~---~p~~L~~LdLS~N~L~~-Lp~lp~~L~~L~Ls~N~L~~LP~lp~~Lq~LdLS~N~Ls~-L 357 (788)
T PRK15387 284 LCKLWIFGNQLT-SLPV---LPPGLQELSVSDNQLAS-LPALPSELCKLWAYNNQLTSLPTLPSGLQELSVSDNQLAS-L 357 (788)
T ss_pred cCEEECcCCccc-cccc---cccccceeECCCCcccc-CCCCcccccccccccCccccccccccccceEecCCCccCC-C
Confidence 445566666655 3443 23667777777777764 332 1111 1357777777777775 3
Q ss_pred hhhHHhhcccCcEEEccCCCCcccCCCCCCCCCCCCCccEEEccCccccccccccccCCCCCCEEEccCCcccccCCccc
Q 005749 164 APSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGL 243 (679)
Q Consensus 164 p~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~ 243 (679)
|+. .++|+.|++++|+|+. +|. ...+|+.|+|++|+|++ +|.. .++|+.|++++|+|++ +|...
T Consensus 358 P~l----p~~L~~L~Ls~N~L~~-LP~------l~~~L~~LdLs~N~Lt~-LP~l---~s~L~~LdLS~N~Lss-IP~l~ 421 (788)
T PRK15387 358 PTL----PSELYKLWAYNNRLTS-LPA------LPSGLKELIVSGNRLTS-LPVL---PSELKELMVSGNRLTS-LPMLP 421 (788)
T ss_pred CCC----Ccccceehhhcccccc-Ccc------cccccceEEecCCcccC-CCCc---ccCCCEEEccCCcCCC-CCcch
Confidence 321 2345556666666653 332 11345666666666652 4432 2345555666665552 44322
Q ss_pred cccccCEEEccCCcCC
Q 005749 244 TRLSLEKLNLSHNNFS 259 (679)
Q Consensus 244 ~~l~L~~l~ls~N~l~ 259 (679)
. +|+.|++++|+|+
T Consensus 422 ~--~L~~L~Ls~NqLt 435 (788)
T PRK15387 422 S--GLLSLSVYRNQLT 435 (788)
T ss_pred h--hhhhhhhccCccc
Confidence 1 2444555555554
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.30 E-value=1.7e-11 Score=116.50 Aligned_cols=130 Identities=16% Similarity=0.161 Sum_probs=97.6
Q ss_pred CccccCCceEEEEEEeCCCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCcc-ceEEeeCCCCceEEEEEecCCCCh
Q 005749 383 QVIEKTTYGTAYKAKLADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIP-LRAFYQGKRGEKLLIYDYFPSRTL 461 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~-l~~~~~~~~~~~~lv~ey~~~gsL 461 (679)
+.++.|.++.||+++.. +..|++|....... ....+.+|++++..+.+.+++. ++.+.. ...++||||+++.++
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~---~~~~lv~e~i~G~~l 78 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP---ETGVLITEFIEGSEL 78 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC---CCCeEEEEecCCCcc
Confidence 46788999999999975 77899999765432 2346789999999997666554 444322 345899999999877
Q ss_pred HHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCC--CCCeeecCCCCCCeeecCCCceEEeecccccc
Q 005749 462 HDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGH--EIPITHGNVRSKNVLVDDFFVSRLTEFGLDQL 530 (679)
Q Consensus 462 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~--~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 530 (679)
.+. . . ....++.+++++|+.||+.. ...++|+|++|.||+++ ++.+++.|||.+..
T Consensus 79 ~~~--~-------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 79 LTE--D-------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ccc--c-------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 543 0 0 11345678999999999876 22369999999999999 66899999998764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.27 E-value=1.1e-12 Score=132.87 Aligned_cols=208 Identities=22% Similarity=0.255 Sum_probs=144.7
Q ss_pred eeecCCCCCcccCCCCCCcc-ccccccCCCCccEEEEEcCCCCCcccCCccccCCCCCCeeecccCcccccCCcccCCCC
Q 005749 69 KWISTNGSPLSCSDISLPQW-ANLSLYKDSSIHLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSS 147 (679)
Q Consensus 69 ~c~~~~~~~l~c~~~~~~~~-~~l~~~~~~~~~l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~ 147 (679)
+|.+..|..+.|+..+...+ .++. ...+.|+|..|.++..-|..|+.+++|+.||||+|+|+-.-|+.+..+.
T Consensus 42 ~Cs~~~g~~VdCr~~GL~eVP~~LP------~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~ 115 (498)
T KOG4237|consen 42 TCSDVEGGIVDCRGKGLTEVPANLP------PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLA 115 (498)
T ss_pred ccCCCCCceEEccCCCcccCcccCC------CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhH
Confidence 45554566677887654322 1222 2478899999999855556899999999999999999988899998898
Q ss_pred CCCEEEccC-CCCCCcChhhHHhh------------------------cccCcEEEccCCCCcccCCCCC----------
Q 005749 148 SLSEIDLSA-NLFTGVLAPSIWNL------------------------CDRLVSLRLHGNSLTAALPEPA---------- 192 (679)
Q Consensus 148 ~L~~L~Ls~-N~l~g~~p~~~~~~------------------------~~~L~~L~Ls~N~l~~~~p~~~---------- 192 (679)
+|..|-+-+ |+++. +|...++. +++|..|.|..|.+.. ++.+.
T Consensus 116 ~l~~Lvlyg~NkI~~-l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~-i~~~tf~~l~~i~tl 193 (498)
T KOG4237|consen 116 SLLSLVLYGNNKITD-LPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQS-ICKGTFQGLAAIKTL 193 (498)
T ss_pred hhhHHHhhcCCchhh-hhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhh-hccccccchhccchH
Confidence 887766655 88874 44433322 2455556666665542 22100
Q ss_pred ------------------------------------------------------------------CCC--------CCC
Q 005749 193 ------------------------------------------------------------------LPN--------STC 198 (679)
Q Consensus 193 ------------------------------------------------------------------~~~--------~~~ 198 (679)
++. ..+
T Consensus 194 hlA~np~icdCnL~wla~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L 273 (498)
T KOG4237|consen 194 HLAQNPFICDCNLPWLADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKL 273 (498)
T ss_pred hhhcCccccccccchhhhHHhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhc
Confidence 000 124
Q ss_pred CCccEEEccCccccccccccccCCCCCCEEEccCCcccccCCcccccc-ccCEEEccCCcCCCCCCCcccCCC--Ccccc
Q 005749 199 SDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRL-SLEKLNLSHNNFSGVLPVFSESKF--GAEVF 275 (679)
Q Consensus 199 ~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l-~L~~l~ls~N~l~g~ip~~~~~~~--~~~~~ 275 (679)
++|+.|+|++|++++.-+.+|..+..+++|.|..|+|.-.--..+..+ .|+.|+|.+|+|+-.-|......+ +...+
T Consensus 274 ~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l 353 (498)
T KOG4237|consen 274 PNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNL 353 (498)
T ss_pred ccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeeh
Confidence 689999999999998888999999999999999999974333445555 599999999999988887654332 22234
Q ss_pred cCCCCCCCCC
Q 005749 276 EGNSPALCGF 285 (679)
Q Consensus 276 ~~n~~~~c~~ 285 (679)
.+| |..|.+
T Consensus 354 ~~N-p~~CnC 362 (498)
T KOG4237|consen 354 LSN-PFNCNC 362 (498)
T ss_pred ccC-cccCcc
Confidence 466 777755
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.25 E-value=2e-11 Score=140.04 Aligned_cols=55 Identities=29% Similarity=0.549 Sum_probs=24.3
Q ss_pred CccEEEccCccccccccccccCCCCCCEEEccCCcccccCCccccccccCEEEccCCcCC
Q 005749 200 DLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRLSLEKLNLSHNNFS 259 (679)
Q Consensus 200 ~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~L~~l~ls~N~l~ 259 (679)
+|++|++++|.+++ +|..+. ++|+.|++++|+|+ .+|..+. -+|+.|+|++|+|+
T Consensus 326 sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~-~LP~~lp-~~L~~LdLs~N~Lt 380 (754)
T PRK15370 326 GLKTLEAGENALTS-LPASLP--PELQVLDVSKNQIT-VLPETLP-PTITTLDVSRNALT 380 (754)
T ss_pred cceeccccCCcccc-CChhhc--CcccEEECCCCCCC-cCChhhc-CCcCEEECCCCcCC
Confidence 34444444444442 333322 34555555555554 2333322 13555555555555
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.20 E-value=1.1e-12 Score=132.76 Aligned_cols=151 Identities=29% Similarity=0.369 Sum_probs=118.7
Q ss_pred EEEEEcCCCCCcccCCccccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEEcc
Q 005749 101 LLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLH 180 (679)
Q Consensus 101 l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls 180 (679)
|+..+++.|.+. ++|..+..++.+.+.-+..|+..+.+|..+..+++|..|+|++|-+. .+|.+++.+ ..|+.||+|
T Consensus 390 Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~isfv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~l-v~Lq~LnlS 466 (565)
T KOG0472|consen 390 VTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNKISFVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSL-VRLQTLNLS 466 (565)
T ss_pred eEEEecccchHh-hhhhhhHHHHHHHHHHHhhcCccccchHHHHhhhcceeeecccchhh-hcchhhhhh-hhhheeccc
Confidence 788899999887 78888877777666544444444589999999999999999999988 478888877 679999999
Q ss_pred CCCCcccCCCCCCCCCCCCCccEEEccCccccccccccccCCCCCCEEEccCCcccccCCcccccc-ccCEEEccCCcCC
Q 005749 181 GNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRL-SLEKLNLSHNNFS 259 (679)
Q Consensus 181 ~N~l~~~~p~~~~~~~~~~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l-~L~~l~ls~N~l~ 259 (679)
.|+|.. +|... -.+..|+.+-.++|++...-|+-+.++.+|.+|||.+|.+. .||+.++++ +|++|++++|.|+
T Consensus 467 ~NrFr~-lP~~~---y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 467 FNRFRM-LPECL---YELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred cccccc-chHHH---hhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccC
Confidence 999973 45422 11234566666778887433444899999999999999997 889999998 7999999999998
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.17 E-value=3.7e-10 Score=122.68 Aligned_cols=168 Identities=19% Similarity=0.258 Sum_probs=124.7
Q ss_pred eCCCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCChHHHhhcccCCCCCCCH
Q 005749 398 LADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNW 477 (679)
Q Consensus 398 ~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~~l~~ 477 (679)
..++.+|.|...+.......+...+-++.|+.+|||||++++..+.. .+..|+|+|-+. -|..++++ +..
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~-~~~~ylvTErV~--Pl~~~lk~-------l~~ 103 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEE-EGTLYLVTERVR--PLETVLKE-------LGK 103 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcc-cCceEEEeeccc--cHHHHHHH-------hHH
Confidence 56788888888776554334456777889999999999999998887 679999999874 57777765 335
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccchhccccccccccccccccc
Q 005749 478 ARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKADGYKAPELQRMK 557 (679)
Q Consensus 478 ~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 557 (679)
......+.||+.||.|||+.+ .++|++|.-+.|+++..|+-||++|-++........ ......--..|..|+.+...
T Consensus 104 ~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s 180 (690)
T KOG1243|consen 104 EEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPS 180 (690)
T ss_pred HHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCcc
Confidence 566778899999999999755 399999999999999999999999987754322211 00111111235666644322
Q ss_pred CCCCcchhHHHHHHHHHHHhCCC
Q 005749 558 KCSSRTDVYAFGILLLEILIGKK 580 (679)
Q Consensus 558 ~~~~k~DV~S~Gvvl~El~tg~~ 580 (679)
. -..|.|-|||++||++.|..
T Consensus 181 ~--~s~D~~~Lg~li~el~ng~~ 201 (690)
T KOG1243|consen 181 E--WSIDSWGLGCLIEELFNGSL 201 (690)
T ss_pred c--cchhhhhHHHHHHHHhCccc
Confidence 2 34699999999999999943
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.17 E-value=8.8e-11 Score=134.08 Aligned_cols=137 Identities=27% Similarity=0.381 Sum_probs=73.7
Q ss_pred EEEEcCCCCCcccCCccccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhH--------------
Q 005749 102 LSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSI-------------- 167 (679)
Q Consensus 102 ~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~-------------- 167 (679)
..|+|+.|+|+ .+|+.+. ++|+.|+|++|+|+ .+|.. +++|++|+|++|+|+. +|...
T Consensus 204 ~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt-~LP~l---p~~Lk~LdLs~N~Lts-LP~lp~sL~~L~Ls~N~L~ 275 (788)
T PRK15387 204 AVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPAL---PPELRTLEVSGNQLTS-LPVLPPGLLELSIFSNPLT 275 (788)
T ss_pred cEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCC-CCCCC---CCCCcEEEecCCccCc-ccCcccccceeeccCCchh
Confidence 45677777777 6777665 36777777777777 46642 4667777777777764 33210
Q ss_pred --HhhcccCcEEEccCCCCcccCCCCCCCCCCCCCccEEEccCccccccccccccCCCCCCEEEccCCcccccCCccccc
Q 005749 168 --WNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTR 245 (679)
Q Consensus 168 --~~~~~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~ 245 (679)
....++|+.|+|++|+++. +|. ..++|+.|+|++|+|++ +|... .+|+.|++++|+|++ +|...
T Consensus 276 ~Lp~lp~~L~~L~Ls~N~Lt~-LP~------~p~~L~~LdLS~N~L~~-Lp~lp---~~L~~L~Ls~N~L~~-LP~lp-- 341 (788)
T PRK15387 276 HLPALPSGLCKLWIFGNQLTS-LPV------LPPGLQELSVSDNQLAS-LPALP---SELCKLWAYNNQLTS-LPTLP-- 341 (788)
T ss_pred hhhhchhhcCEEECcCCcccc-ccc------cccccceeECCCCcccc-CCCCc---ccccccccccCcccc-ccccc--
Confidence 0011234444455554442 221 12457777777777764 34321 234444444444442 33211
Q ss_pred cccCEEEccCCcCCC
Q 005749 246 LSLEKLNLSHNNFSG 260 (679)
Q Consensus 246 l~L~~l~ls~N~l~g 260 (679)
.+|+.|+|++|+|++
T Consensus 342 ~~Lq~LdLS~N~Ls~ 356 (788)
T PRK15387 342 SGLQELSVSDNQLAS 356 (788)
T ss_pred cccceEecCCCccCC
Confidence 135666666666664
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.17 E-value=4e-12 Score=141.06 Aligned_cols=128 Identities=34% Similarity=0.420 Sum_probs=92.7
Q ss_pred CCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEEccCCCCcccCCCCCCCCCCCCCcc
Q 005749 123 SMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQ 202 (679)
Q Consensus 123 ~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~ 202 (679)
+.|+.|+|.+|.|+...-+-+.+..+|+.|+|++|+|. .+|.+....+..|+.|+||+|+|+. +|... ..|..|+
T Consensus 359 ~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~-~fpas~~~kle~LeeL~LSGNkL~~-Lp~tv---a~~~~L~ 433 (1081)
T KOG0618|consen 359 AALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLN-SFPASKLRKLEELEELNLSGNKLTT-LPDTV---ANLGRLH 433 (1081)
T ss_pred HHHHHHHHhcCcccccchhhhccccceeeeeecccccc-cCCHHHHhchHHhHHHhcccchhhh-hhHHH---HhhhhhH
Confidence 35666777777777665556777788888888888887 3555555555788888888888873 44432 3567888
Q ss_pred EEEccCccccccccccccCCCCCCEEEccCCcccc-cCCccccccccCEEEccCCc
Q 005749 203 YLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSG-SIPEGLTRLSLEKLNLSHNN 257 (679)
Q Consensus 203 ~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g-~~p~~~~~l~L~~l~ls~N~ 257 (679)
+|...+|++. .+| ++..++.|+.+|+|.|+|+. .+|...-..+|++|||++|.
T Consensus 434 tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~ 487 (1081)
T KOG0618|consen 434 TLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNT 487 (1081)
T ss_pred HHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCc
Confidence 8888888887 677 77888888888888888873 34544443468888888886
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.16 E-value=7.3e-13 Score=139.64 Aligned_cols=153 Identities=32% Similarity=0.474 Sum_probs=125.6
Q ss_pred EEEEEcCCCCCcccCCccccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEEcc
Q 005749 101 LLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLH 180 (679)
Q Consensus 101 l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls 180 (679)
.+..+|+.|.+. .+|.++..+..|..|.|..|.|. .||..+.++..|++|||+.|+++ .+|..++.+ + |+.|-++
T Consensus 77 t~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~l-p-Lkvli~s 151 (722)
T KOG0532|consen 77 TVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDL-P-LKVLIVS 151 (722)
T ss_pred hhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcC-c-ceeEEEe
Confidence 345678888887 78989999999999999999998 89999999999999999999998 567788776 4 9999999
Q ss_pred CCCCcccCCCCCCCCCCCCCccEEEccCccccccccccccCCCCCCEEEccCCcccccCCccccccccCEEEccCCcCCC
Q 005749 181 GNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRLSLEKLNLSHNNFSG 260 (679)
Q Consensus 181 ~N~l~~~~p~~~~~~~~~~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~L~~l~ls~N~l~g 260 (679)
+|+++. +|+++ .....|..||.+.|++. .+|..++.+.+|+.|.+..|++. .+|..+..++|..||+|+|+++
T Consensus 152 NNkl~~-lp~~i---g~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~LpLi~lDfScNkis- 224 (722)
T KOG0532|consen 152 NNKLTS-LPEEI---GLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSLPLIRLDFSCNKIS- 224 (722)
T ss_pred cCcccc-CCccc---ccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCCceeeeecccCcee-
Confidence 999984 45443 24567888899999887 78888888888888888888887 6777777888888888888887
Q ss_pred CCCCc
Q 005749 261 VLPVF 265 (679)
Q Consensus 261 ~ip~~ 265 (679)
.||..
T Consensus 225 ~iPv~ 229 (722)
T KOG0532|consen 225 YLPVD 229 (722)
T ss_pred ecchh
Confidence 45654
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.16 E-value=2.3e-11 Score=130.86 Aligned_cols=240 Identities=17% Similarity=0.166 Sum_probs=168.2
Q ss_pred CccccCCceEEEEEEe--CCCCEEEEEEcccCcccC--cccHHHHHHHHhcc-CCCCCccceEEeeCCCCceEEEEEecC
Q 005749 383 QVIEKTTYGTAYKAKL--ADGATIALRLLREGSCKD--RSSCLPVIRQLGKV-RHENLIPLRAFYQGKRGEKLLIYDYFP 457 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~--~~~~~vAvK~~~~~~~~~--~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~~lv~ey~~ 457 (679)
..||.|.|+.||+... .++..+++|.+....... ...-+.|+.+...+ .|.++++.+..+.. ..+.|+=-|||.
T Consensus 271 ~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~-~r~~~ip~e~~~ 349 (524)
T KOG0601|consen 271 SKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQ-LRQGYIPLEFCE 349 (524)
T ss_pred EEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccc-cccccCchhhhc
Confidence 5699999999999873 468899999987653322 22234566555555 58888887665554 456678899999
Q ss_pred CCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCC-CceEEeecccccccCcccc
Q 005749 458 SRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDF-FVSRLTEFGLDQLMVPAVA 536 (679)
Q Consensus 458 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~-~~~kl~DFGla~~~~~~~~ 536 (679)
++++...... ...++...++++..|++.++.++|+.. ++|+|+||+||++..+ +..+++|||++..+.-
T Consensus 350 ~~s~~l~~~~----~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~--- 419 (524)
T KOG0601|consen 350 GGSSSLRSVT----SQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWTRLAF--- 419 (524)
T ss_pred CcchhhhhHH----HHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccccccccccce---
Confidence 9988766632 356888899999999999999999877 9999999999999886 7889999999864311
Q ss_pred cchhccccccccc--ccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhh
Q 005749 537 DEMVALAKADGYK--APELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEI 614 (679)
Q Consensus 537 ~~~~~~~gt~~y~--aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i 614 (679)
. .......-+++ +++......+..+.|+||||.-+.|.+++...-...... . .+
T Consensus 420 ~-~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~--~---------------------~i 475 (524)
T KOG0601|consen 420 S-SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQS--L---------------------TI 475 (524)
T ss_pred e-cccccccccccccchhhccccccccccccccccccccccccCcccCcccccc--e---------------------ee
Confidence 1 11122233344 555666677889999999999999999988653221110 0 11
Q ss_pred hhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhh
Q 005749 615 MKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEEN 657 (679)
Q Consensus 615 ~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 657 (679)
..+..+..+....+...+...+...++..||.+.+.....+..
T Consensus 476 ~~~~~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 476 RSGDTPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred ecccccCCCchHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 2221222222234555677778899999999988877665443
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.15 E-value=4.8e-11 Score=136.14 Aligned_cols=132 Identities=36% Similarity=0.573 Sum_probs=95.9
Q ss_pred CcEEEccCCCCcccCCCCCCCCCCCCCccEEEccCccccccccccccCCCCCCEEEccCCcccccCCcccccc-ccCEEE
Q 005749 174 LVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRL-SLEKLN 252 (679)
Q Consensus 174 L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l-~L~~l~ 252 (679)
++.|+|++|.++|.+|..+ ..+++|+.|+|++|+|+|.+|..++.+++|+.|+|++|+|+|.+|..++.+ +|+.|+
T Consensus 420 v~~L~L~~n~L~g~ip~~i---~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~ 496 (623)
T PLN03150 420 IDGLGLDNQGLRGFIPNDI---SKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILN 496 (623)
T ss_pred EEEEECCCCCccccCCHHH---hCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEE
Confidence 6778888888888877643 456788888888888888888888888888888888888888888888877 588888
Q ss_pred ccCCcCCCCCCCcccCC---CCcccccCCCCCCCCCCC-CCCCCCCCCCCCcchhhhhHHHHH
Q 005749 253 LSHNNFSGVLPVFSESK---FGAEVFEGNSPALCGFPL-RDCSGNSRLSSGAIAGLVIGLMTG 311 (679)
Q Consensus 253 ls~N~l~g~ip~~~~~~---~~~~~~~~n~~~~c~~p~-~~c~~~~~~s~~~i~~iv~~~~~~ 311 (679)
|++|+|+|.+|...... .....+.+| +.+|+.|. ..|... .+.+.+++++++++++
T Consensus 497 Ls~N~l~g~iP~~l~~~~~~~~~l~~~~N-~~lc~~p~l~~C~~~--~~~~~~i~~~~~~~~~ 556 (623)
T PLN03150 497 LNGNSLSGRVPAALGGRLLHRASFNFTDN-AGLCGIPGLRACGPH--LSVGAKIGIAFGVSVA 556 (623)
T ss_pred CcCCcccccCChHHhhccccCceEEecCC-ccccCCCCCCCCccc--CCCceEEEEEhHHHHH
Confidence 88888888888654321 122345566 78998765 678532 2334455555555543
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.15 E-value=5.4e-10 Score=110.97 Aligned_cols=143 Identities=22% Similarity=0.264 Sum_probs=110.9
Q ss_pred CccccCCceEEEEEEeCCCCEEEEEEcccCcc-cCcccHHHHHHHHhccCCC--CCccceEEeeCCC--CceEEEEEecC
Q 005749 383 QVIEKTTYGTAYKAKLADGATIALRLLREGSC-KDRSSCLPVIRQLGKVRHE--NLIPLRAFYQGKR--GEKLLIYDYFP 457 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~~~~~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~H~--nIv~l~~~~~~~~--~~~~lv~ey~~ 457 (679)
+.|+.|..+.||+++..+|+.+++|....... .....+.+|++++..+++. ++.+++.+..... +..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 46889999999999987778999999765432 2456789999999999764 4566777665421 35689999999
Q ss_pred CCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCC---------------------------------------
Q 005749 458 SRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGH--------------------------------------- 498 (679)
Q Consensus 458 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~--------------------------------------- 498 (679)
+.++.+.+.. ..++..++..++.++++.|.+||+..
T Consensus 84 G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 84 GRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred CEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 9888776531 23677788889999999999998631
Q ss_pred --------------CCCeeecCCCCCCeeecC--CCceEEeecccccc
Q 005749 499 --------------EIPITHGNVRSKNVLVDD--FFVSRLTEFGLDQL 530 (679)
Q Consensus 499 --------------~~~ivHrDlkp~NILl~~--~~~~kl~DFGla~~ 530 (679)
...++|+|+++.||+++. ++.+.|.||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 134799999999999998 66789999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.12 E-value=7e-10 Score=106.59 Aligned_cols=135 Identities=12% Similarity=0.121 Sum_probs=96.7
Q ss_pred CccccCCceEEEEEEeCC-------CCEEEEEEcccCcc----------cC------------cccH----HHHHHHHhc
Q 005749 383 QVIEKTTYGTAYKAKLAD-------GATIALRLLREGSC----------KD------------RSSC----LPVIRQLGK 429 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~~~-------~~~vAvK~~~~~~~----------~~------------~~~~----~~Ei~~l~~ 429 (679)
..||.|.-+.||.|.-.+ +..+|||+.+.... .+ ++.+ .+|++.|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 578999999999998543 47999998753210 00 1122 388999998
Q ss_pred cCC--CCCccceEEeeCCCCceEEEEEecCCCChH-HHhhcccCCCCCCCHHHHHHHHHHHHHHHHHH-hcCCCCCeeec
Q 005749 430 VRH--ENLIPLRAFYQGKRGEKLLIYDYFPSRTLH-DLLHDTIAGKPVLNWARRHKIALGIARGLAYL-HTGHEIPITHG 505 (679)
Q Consensus 430 l~H--~nIv~l~~~~~~~~~~~~lv~ey~~~gsL~-~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~L-H~~~~~~ivHr 505 (679)
+.. -++-+.+++ ..-++||||+.++.+. ..+++ ..++..+...+..+++.+|.+| |..+ +||+
T Consensus 83 l~~~Gv~vP~pi~~-----~~~~lvME~Ig~~~~~~~~Lkd-----~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHG 149 (197)
T cd05146 83 MQKAGIPCPEVVVL-----KKHVLVMSFIGDDQVPAPKLKD-----AKLNDEEMKNAYYQVLSMMKQLYKECN---LVHA 149 (197)
T ss_pred HHHcCCCCCeEEEe-----cCCEEEEEEcCCCCccchhhhc-----cccCHHHHHHHHHHHHHHHHHHHHhCC---eecC
Confidence 853 344455543 3568999999765442 22322 2345556678889999999999 7777 9999
Q ss_pred CCCCCCeeecCCCceEEeeccccccc
Q 005749 506 NVRSKNVLVDDFFVSRLTEFGLDQLM 531 (679)
Q Consensus 506 Dlkp~NILl~~~~~~kl~DFGla~~~ 531 (679)
||++.|||+++ +.+.++|||.+-..
T Consensus 150 DLs~~NIL~~~-~~v~iIDF~qav~~ 174 (197)
T cd05146 150 DLSEYNMLWHD-GKVWFIDVSQSVEP 174 (197)
T ss_pred CCCHHHEEEEC-CcEEEEECCCceeC
Confidence 99999999974 68999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.10 E-value=2.7e-11 Score=127.59 Aligned_cols=161 Identities=23% Similarity=0.256 Sum_probs=105.6
Q ss_pred ccEEEEEcCCCCCcccCCccccCCCC---CCeeecccCcccc----cCCcccCCC-CCCCEEEccCCCCCCcChhhHH--
Q 005749 99 IHLLSIQLPSANLTGSLPRELGEFSM---LQSLYLNVNSLKG----TIPFELGYS-SSLSEIDLSANLFTGVLAPSIW-- 168 (679)
Q Consensus 99 ~~l~~l~l~~n~l~g~ip~~l~~l~~---L~~L~L~~N~l~g----~ip~~l~~l-~~L~~L~Ls~N~l~g~~p~~~~-- 168 (679)
.+++.|++++|.+.+..+..+..+.+ |++|++++|.+++ .+...+..+ ++|+.|+|++|.+++.....+.
T Consensus 81 ~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~ 160 (319)
T cd00116 81 CGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKA 160 (319)
T ss_pred CceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHH
Confidence 35888888888888777777766665 8888888888873 344445566 7888888888888854322222
Q ss_pred -hhcccCcEEEccCCCCcccCCCCCCC-CCCCCCccEEEccCcccccc----ccccccCCCCCCEEEccCCcccccCCcc
Q 005749 169 -NLCDRLVSLRLHGNSLTAALPEPALP-NSTCSDLQYLDLGSNKFSGS----FPEFVTRFEALKELDISNNLFSGSIPEG 242 (679)
Q Consensus 169 -~~~~~L~~L~Ls~N~l~~~~p~~~~~-~~~~~~L~~L~l~~N~l~g~----~p~~~~~l~~L~~L~ls~N~l~g~~p~~ 242 (679)
..+++|+.|+|++|.+++........ ...+++|++|+|++|.+++. ++..+..+++|+.|++++|.+++.....
T Consensus 161 ~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~ 240 (319)
T cd00116 161 LRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAA 240 (319)
T ss_pred HHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHH
Confidence 22257888888888887421100000 01235788888888888643 3445667788888888888887522222
Q ss_pred cc------ccccCEEEccCCcCC
Q 005749 243 LT------RLSLEKLNLSHNNFS 259 (679)
Q Consensus 243 ~~------~l~L~~l~ls~N~l~ 259 (679)
+. .-+|+.|++++|.++
T Consensus 241 l~~~~~~~~~~L~~L~l~~n~i~ 263 (319)
T cd00116 241 LASALLSPNISLLTLSLSCNDIT 263 (319)
T ss_pred HHHHHhccCCCceEEEccCCCCC
Confidence 11 125888888888876
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.10 E-value=6.9e-12 Score=139.22 Aligned_cols=171 Identities=31% Similarity=0.429 Sum_probs=95.2
Q ss_pred cEEEEEcCCCCCcccCCccccCCCCCCeeecccCcccc----------------------cCCcccCCCCCCCEEEccCC
Q 005749 100 HLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKG----------------------TIPFELGYSSSLSEIDLSAN 157 (679)
Q Consensus 100 ~l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g----------------------~ip~~l~~l~~L~~L~Ls~N 157 (679)
+++.++++.|+++ .+|..++.+.+|+.|+.++|+|+. -+|+.+..++.|++|||..|
T Consensus 242 nl~~~dis~n~l~-~lp~wi~~~~nle~l~~n~N~l~~lp~ri~~~~~L~~l~~~~nel~yip~~le~~~sL~tLdL~~N 320 (1081)
T KOG0618|consen 242 NLQYLDISHNNLS-NLPEWIGACANLEALNANHNRLVALPLRISRITSLVSLSAAYNELEYIPPFLEGLKSLRTLDLQSN 320 (1081)
T ss_pred cceeeecchhhhh-cchHHHHhcccceEecccchhHHhhHHHHhhhhhHHHHHhhhhhhhhCCCcccccceeeeeeehhc
Confidence 4566666666665 345666666666666666666541 35555666777778888777
Q ss_pred CCCCcChhhHHhh-------------------------------------------------cccCcEEEccCCCCcccC
Q 005749 158 LFTGVLAPSIWNL-------------------------------------------------CDRLVSLRLHGNSLTAAL 188 (679)
Q Consensus 158 ~l~g~~p~~~~~~-------------------------------------------------~~~L~~L~Ls~N~l~~~~ 188 (679)
+|.. +|+.+... ..+|+.|+|++|+|.. +
T Consensus 321 ~L~~-lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~-f 398 (1081)
T KOG0618|consen 321 NLPS-LPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNS-F 398 (1081)
T ss_pred cccc-cchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeeccccccc-C
Confidence 7753 23221110 0245555555555542 2
Q ss_pred CCCCCCCCCCCCccEEEccCccccccccccccCCCCCCEEEccCCcccccCCcccccc-ccCEEEccCCcCCCC-CCCcc
Q 005749 189 PEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRL-SLEKLNLSHNNFSGV-LPVFS 266 (679)
Q Consensus 189 p~~~~~~~~~~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l-~L~~l~ls~N~l~g~-ip~~~ 266 (679)
|...+ ..+..|+.|+||+|+|+ .+|..+..+..|++|...+|+|. .+| .+..+ .|+.+|+|.|+|+-. +|...
T Consensus 399 pas~~--~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~ 473 (1081)
T KOG0618|consen 399 PASKL--RKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEAL 473 (1081)
T ss_pred CHHHH--hchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhC
Confidence 22211 23445555555555555 45555555555666555555655 556 44444 599999999999743 44433
Q ss_pred c-CCCCcccccCC
Q 005749 267 E-SKFGAEVFEGN 278 (679)
Q Consensus 267 ~-~~~~~~~~~~n 278 (679)
. .......+.||
T Consensus 474 p~p~LkyLdlSGN 486 (1081)
T KOG0618|consen 474 PSPNLKYLDLSGN 486 (1081)
T ss_pred CCcccceeeccCC
Confidence 3 33344445566
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.05 E-value=8.1e-12 Score=131.89 Aligned_cols=149 Identities=26% Similarity=0.341 Sum_probs=115.1
Q ss_pred EEEEEcCCCCCcccCCccccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEEcc
Q 005749 101 LLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLH 180 (679)
Q Consensus 101 l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls 180 (679)
|..+.|..|.+. .||..+++|..|++|||+.|+++ .+|..+..|+ |+.|-+++|+++ .+|+.++ +...|..||.+
T Consensus 100 Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig-~~~tl~~ld~s 174 (722)
T KOG0532|consen 100 LESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVSNNKLT-SLPEEIG-LLPTLAHLDVS 174 (722)
T ss_pred HHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEEEecCccc-cCCcccc-cchhHHHhhhh
Confidence 445566666665 78888899999999999999998 7888888775 888999999887 4677777 45788888999
Q ss_pred CCCCcccCCCCCCCCCCCCCccEEEccCccccccccccccCCCCCCEEEccCCcccccCCcccccc-ccCEEEccCCcCC
Q 005749 181 GNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRL-SLEKLNLSHNNFS 259 (679)
Q Consensus 181 ~N~l~~~~p~~~~~~~~~~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l-~L~~l~ls~N~l~ 259 (679)
.|.+... |... ..+.+|+.|.+..|++. .+|.++..| .|..||+|+|+++ .||-.|..+ .|++|-|.+|.|.
T Consensus 175 ~nei~sl-psql---~~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLq 247 (722)
T KOG0532|consen 175 KNEIQSL-PSQL---GYLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQ 247 (722)
T ss_pred hhhhhhc-hHHh---hhHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeecccCcee-ecchhhhhhhhheeeeeccCCCC
Confidence 8888743 3222 34567888888888887 677777755 4778888888887 788888877 4888888888887
Q ss_pred CC
Q 005749 260 GV 261 (679)
Q Consensus 260 g~ 261 (679)
.+
T Consensus 248 SP 249 (722)
T KOG0532|consen 248 SP 249 (722)
T ss_pred CC
Confidence 54
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.04 E-value=6.6e-11 Score=124.57 Aligned_cols=163 Identities=24% Similarity=0.269 Sum_probs=116.5
Q ss_pred ccEEEEEcCCCCCcc----cCCccccCC-CCCCeeecccCccccc----CCcccCCCCCCCEEEccCCCCCCcChhhHHh
Q 005749 99 IHLLSIQLPSANLTG----SLPRELGEF-SMLQSLYLNVNSLKGT----IPFELGYSSSLSEIDLSANLFTGVLAPSIWN 169 (679)
Q Consensus 99 ~~l~~l~l~~n~l~g----~ip~~l~~l-~~L~~L~L~~N~l~g~----ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~ 169 (679)
.+++.|++++|++++ .+...+..+ ++|+.|+|++|.+++. ++..+..+.+|++|+|++|.+++...+.+..
T Consensus 108 ~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~ 187 (319)
T cd00116 108 SSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAE 187 (319)
T ss_pred CcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHH
Confidence 359999999999983 345567778 9999999999999953 4445667789999999999998643222222
Q ss_pred h---cccCcEEEccCCCCcccCCCCCC-CCCCCCCccEEEccCcccccccccccc-----CCCCCCEEEccCCcccc---
Q 005749 170 L---CDRLVSLRLHGNSLTAALPEPAL-PNSTCSDLQYLDLGSNKFSGSFPEFVT-----RFEALKELDISNNLFSG--- 237 (679)
Q Consensus 170 ~---~~~L~~L~Ls~N~l~~~~p~~~~-~~~~~~~L~~L~l~~N~l~g~~p~~~~-----~l~~L~~L~ls~N~l~g--- 237 (679)
. .++|+.|+|++|.+++....... ....+++|++|++++|.+++.....+. ..+.|+.|++++|.++.
T Consensus 188 ~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~ 267 (319)
T cd00116 188 GLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGA 267 (319)
T ss_pred HHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHH
Confidence 2 25899999999998743221100 012467899999999999863333222 24799999999999972
Q ss_pred -cCCcccccc-ccCEEEccCCcCCCC
Q 005749 238 -SIPEGLTRL-SLEKLNLSHNNFSGV 261 (679)
Q Consensus 238 -~~p~~~~~l-~L~~l~ls~N~l~g~ 261 (679)
.+...+... +|+.+++++|.++..
T Consensus 268 ~~l~~~~~~~~~L~~l~l~~N~l~~~ 293 (319)
T cd00116 268 KDLAEVLAEKESLLELDLRGNKFGEE 293 (319)
T ss_pred HHHHHHHhcCCCccEEECCCCCCcHH
Confidence 223333333 699999999998854
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.03 E-value=3.3e-09 Score=98.42 Aligned_cols=131 Identities=18% Similarity=0.296 Sum_probs=95.4
Q ss_pred CccccCCceEEEEEEeCCCCEEEEEEcccCcccC--------cccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEE
Q 005749 383 QVIEKTTYGTAYKAKLADGATIALRLLREGSCKD--------RSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYD 454 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~--------~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~e 454 (679)
..+++|+-+.+|.+.+.+ ..+.+|.=.++.... .+.-.+|.+++.+++---|-.-+-|..+ .+...|+||
T Consensus 2 ~~i~~GAEa~i~~~~~~g-~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD-~~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLG-LPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVD-PDNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeeeccC-cceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEc-CCCCEEEEE
Confidence 467899999999997753 345555422221111 2346789999998865444333333444 567889999
Q ss_pred ecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccc
Q 005749 455 YFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQL 530 (679)
Q Consensus 455 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 530 (679)
|+++..|.+.+... +..++..+-.-+.-||..+ |+|+||.++||++..+. +.++|||+++.
T Consensus 80 ~I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 80 YIEGELLKDALEEA-----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred EeCChhHHHHHHhc-----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 99998888888652 2456777777788899998 99999999999998764 99999999874
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.02 E-value=1.4e-09 Score=132.98 Aligned_cols=162 Identities=24% Similarity=0.311 Sum_probs=90.6
Q ss_pred ccEEEEEcCCCCCcccCCccccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhh--------
Q 005749 99 IHLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNL-------- 170 (679)
Q Consensus 99 ~~l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~-------- 170 (679)
.+|+.|+|++++..+.+| .++.+++|++|+|++|..-..+|..++++++|+.|++++|..-+.+|..+ ++
T Consensus 634 ~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL~~L~L 711 (1153)
T PLN03210 634 TGLRNIDLRGSKNLKEIP-DLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSLYRLNL 711 (1153)
T ss_pred CCCCEEECCCCCCcCcCC-ccccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCCCCEEeC
Confidence 345566666655555555 35566666666666655444566666666666666666543333444332 21
Q ss_pred ------------cccCcEEEccCCCCcccCCCCC-CC--------------------------CCCCCCccEEEccCccc
Q 005749 171 ------------CDRLVSLRLHGNSLTAALPEPA-LP--------------------------NSTCSDLQYLDLGSNKF 211 (679)
Q Consensus 171 ------------~~~L~~L~Ls~N~l~~~~p~~~-~~--------------------------~~~~~~L~~L~l~~N~l 211 (679)
.++|+.|+|++|.++. +|... ++ ...+++|+.|+|++|..
T Consensus 712 sgc~~L~~~p~~~~nL~~L~L~~n~i~~-lP~~~~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~ 790 (1153)
T PLN03210 712 SGCSRLKSFPDISTNISWLDLDETAIEE-FPSNLRLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPS 790 (1153)
T ss_pred CCCCCccccccccCCcCeeecCCCcccc-ccccccccccccccccccchhhccccccccchhhhhccccchheeCCCCCC
Confidence 1344445555555432 22210 00 00124677778887777
Q ss_pred cccccccccCCCCCCEEEccCCcccccCCccccccccCEEEccCCcCCCCCC
Q 005749 212 SGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRLSLEKLNLSHNNFSGVLP 263 (679)
Q Consensus 212 ~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~L~~l~ls~N~l~g~ip 263 (679)
.+.+|..++++++|+.|+|++|..-+.+|..+...+|+.|++++|..-..+|
T Consensus 791 l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~~L~sL~~L~Ls~c~~L~~~p 842 (1153)
T PLN03210 791 LVELPSSIQNLHKLEHLEIENCINLETLPTGINLESLESLDLSGCSRLRTFP 842 (1153)
T ss_pred ccccChhhhCCCCCCEEECCCCCCcCeeCCCCCccccCEEECCCCCcccccc
Confidence 7778888888888888888876544567765532256666666654444444
|
syringae 6; Provisional |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.01 E-value=1.6e-09 Score=132.62 Aligned_cols=105 Identities=22% Similarity=0.223 Sum_probs=80.6
Q ss_pred ccEEEEEcCCCCCcccCCccccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEE
Q 005749 99 IHLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLR 178 (679)
Q Consensus 99 ~~l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~ 178 (679)
.+|+.|+|.+|++. .+|..+..+++|+.|+|++|...+.+|. ++.+++|+.|+|++|.....+|..+..+ ++|+.|+
T Consensus 611 ~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L-~~L~~L~ 687 (1153)
T PLN03210 611 ENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYL-NKLEDLD 687 (1153)
T ss_pred cCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhcc-CCCCEEe
Confidence 46888999988876 6888889999999999998865567874 8889999999999987767788887775 8999999
Q ss_pred ccCCCCcccCCCCCCCCCCCCCccEEEccCcc
Q 005749 179 LHGNSLTAALPEPALPNSTCSDLQYLDLGSNK 210 (679)
Q Consensus 179 Ls~N~l~~~~p~~~~~~~~~~~L~~L~l~~N~ 210 (679)
+++|..-+.+|... .+++|+.|+|++|.
T Consensus 688 L~~c~~L~~Lp~~i----~l~sL~~L~Lsgc~ 715 (1153)
T PLN03210 688 MSRCENLEILPTGI----NLKSLYRLNLSGCS 715 (1153)
T ss_pred CCCCCCcCccCCcC----CCCCCCEEeCCCCC
Confidence 99976555666532 24445555555443
|
syringae 6; Provisional |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.94 E-value=2.9e-10 Score=128.40 Aligned_cols=241 Identities=19% Similarity=0.186 Sum_probs=160.6
Q ss_pred CccccCCceEEEEEE-eCCCCEEEEEEcccCc---ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCC
Q 005749 383 QVIEKTTYGTAYKAK-LADGATIALRLLREGS---CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPS 458 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~ 458 (679)
+-+-+|.++.++.++ -..|...+.|...... ..+.+....+-.++-..+||-+++...-+. .....+++++|..+
T Consensus 810 ~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~-~rsP~~L~~~~~~~ 888 (1205)
T KOG0606|consen 810 KPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFP-CRSPLPLVGHYLNG 888 (1205)
T ss_pred ccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCC-CCCCcchhhHHhcc
Confidence 367789999998887 3345555555544322 122333444444444456677665533322 25678999999999
Q ss_pred CChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCc-----
Q 005749 459 RTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVP----- 533 (679)
Q Consensus 459 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~----- 533 (679)
++|...|+... ..+..-.+.....+..+++|||... ++|||++|.|++...++..+++|||......-
T Consensus 889 ~~~~Skl~~~~----~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~ 961 (1205)
T KOG0606|consen 889 GDLPSKLHNSG----CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTT 961 (1205)
T ss_pred CCchhhhhcCC----CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCccccccccccccCcC
Confidence 99999998742 3454455566677788999999876 89999999999999999999999984432100
Q ss_pred -c---------------c---------ccchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCC
Q 005749 534 -A---------------V---------ADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNG 588 (679)
Q Consensus 534 -~---------------~---------~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~ 588 (679)
. . ........+|+.|.+||...+......+|.|++|++++|.++|.+||......
T Consensus 962 ~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq 1041 (1205)
T KOG0606|consen 962 DLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQ 1041 (1205)
T ss_pred CcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchh
Confidence 0 0 00122456889999999999999999999999999999999999999654432
Q ss_pred cccchhHHHHHHhhcccccccchHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHH
Q 005749 589 EFVDLPSIVKVAVLEETTMEVFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMD 648 (679)
Q Consensus 589 ~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ 648 (679)
...+ .+....+. ......+...+..+++.+.+..+|.+|-.|.
T Consensus 1042 ~~f~---------------ni~~~~~~--~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1042 QIFE---------------NILNRDIP--WPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred hhhh---------------ccccCCCC--CCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 2110 00000000 0111122334555677777888888887765
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.92 E-value=1.2e-09 Score=102.80 Aligned_cols=122 Identities=23% Similarity=0.312 Sum_probs=40.1
Q ss_pred cEEEEEcCCCCCcccCCcccc-CCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEE
Q 005749 100 HLLSIQLPSANLTGSLPRELG-EFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLR 178 (679)
Q Consensus 100 ~l~~l~l~~n~l~g~ip~~l~-~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~ 178 (679)
+++.|+|.+|.++- | +.++ .|.+|+.|+|++|.|+ .++ .+..++.|++|+|++|+++. +++.+...+++|+.|+
T Consensus 20 ~~~~L~L~~n~I~~-I-e~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~~-i~~~l~~~lp~L~~L~ 94 (175)
T PF14580_consen 20 KLRELNLRGNQIST-I-ENLGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRISS-ISEGLDKNLPNLQELY 94 (175)
T ss_dssp ------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS---S--CHHHHHH-TT--EEE
T ss_pred cccccccccccccc-c-cchhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCCc-cccchHHhCCcCCEEE
Confidence 46677777777763 3 2455 4677888888888877 444 36667778888888888775 3334443347788888
Q ss_pred ccCCCCcccCCCCCCCCCCCCCccEEEccCccccccccc----cccCCCCCCEEE
Q 005749 179 LHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPE----FVTRFEALKELD 229 (679)
Q Consensus 179 Ls~N~l~~~~p~~~~~~~~~~~L~~L~l~~N~l~g~~p~----~~~~l~~L~~L~ 229 (679)
|++|++...-. ..+...+++|++|+|.+|.++.. +. .+..+++|+.||
T Consensus 95 L~~N~I~~l~~--l~~L~~l~~L~~L~L~~NPv~~~-~~YR~~vi~~lP~Lk~LD 146 (175)
T PF14580_consen 95 LSNNKISDLNE--LEPLSSLPKLRVLSLEGNPVCEK-KNYRLFVIYKLPSLKVLD 146 (175)
T ss_dssp -TTS---SCCC--CGGGGG-TT--EEE-TT-GGGGS-TTHHHHHHHH-TT-SEET
T ss_pred CcCCcCCChHH--hHHHHcCCCcceeeccCCcccch-hhHHHHHHHHcChhheeC
Confidence 88887764211 11223456667777776666522 21 244566666665
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.91 E-value=1.1e-08 Score=94.44 Aligned_cols=141 Identities=17% Similarity=0.238 Sum_probs=100.5
Q ss_pred CccccCCceEEEEEEeCCCCEEEEEEc-ccCcc-------cCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEE
Q 005749 383 QVIEKTTYGTAYKAKLADGATIALRLL-REGSC-------KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYD 454 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~~~~~~vAvK~~-~~~~~-------~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~e 454 (679)
.+|-+|+-+.|+++.+. |+...||.= .+... -.+...++|++.+.+++--.|.--.-++.+ ...-.++||
T Consensus 13 ~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D-~~~~~i~ME 90 (229)
T KOG3087|consen 13 ELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFID-TYGGQIYME 90 (229)
T ss_pred eeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEe-cCCCeEEEE
Confidence 67889999999999985 666666643 22211 113456889999999875555443334444 456679999
Q ss_pred ecCC-CChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCC---ceEEeecccccc
Q 005749 455 YFPS-RTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFF---VSRLTEFGLDQL 530 (679)
Q Consensus 455 y~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~---~~kl~DFGla~~ 530 (679)
|+++ -++.+++..... ...........+..|-+-+.-||.++ |+|+||..+||++..++ .+.+.|||++..
T Consensus 91 ~~~g~~~vk~~i~~~~~--~~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 91 FIDGASTVKDFILSTME--DESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred eccchhHHHHHHHHHcc--CcccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 9976 477888776432 11222333678889999999999998 99999999999997664 457999999763
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.88 E-value=1.3e-09 Score=118.49 Aligned_cols=153 Identities=31% Similarity=0.483 Sum_probs=106.2
Q ss_pred ccEEEEEcCCCCCcccCCccccCCC-CCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEE
Q 005749 99 IHLLSIQLPSANLTGSLPRELGEFS-MLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSL 177 (679)
Q Consensus 99 ~~l~~l~l~~n~l~g~ip~~l~~l~-~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L 177 (679)
..+..|++.+|+++ .||+..+.++ +|+.|++++|.+. .+|..++++++|+.|++++|+++. +|+..... +.|+.|
T Consensus 116 ~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~~-l~~~~~~~-~~L~~L 191 (394)
T COG4886 116 TNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLSD-LPKLLSNL-SNLNNL 191 (394)
T ss_pred cceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCchhhh-hhhhhhhh-hhhhhe
Confidence 35788888888887 7888888885 9999999999998 787788899999999999999984 44544343 789999
Q ss_pred EccCCCCcccCCCCCCCCCCCCCccEEEccCccccccccccccCCCCCCEEEccCCcccccCCcccccc-ccCEEEccCC
Q 005749 178 RLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRL-SLEKLNLSHN 256 (679)
Q Consensus 178 ~Ls~N~l~~~~p~~~~~~~~~~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l-~L~~l~ls~N 256 (679)
++++|+++.. |... ..+..|++|.+++|.+. .++..+..+.++..|.+.+|++. .+|..+..+ .++.|++++|
T Consensus 192 ~ls~N~i~~l-~~~~---~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~-~~~~~~~~l~~l~~L~~s~n 265 (394)
T COG4886 192 DLSGNKISDL-PPEI---ELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNN 265 (394)
T ss_pred eccCCccccC-chhh---hhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceee-eccchhccccccceeccccc
Confidence 9999999853 3221 12345777777777433 34555666666666666666664 224444444 3666666666
Q ss_pred cCCCC
Q 005749 257 NFSGV 261 (679)
Q Consensus 257 ~l~g~ 261 (679)
.++-.
T Consensus 266 ~i~~i 270 (394)
T COG4886 266 QISSI 270 (394)
T ss_pred ccccc
Confidence 66543
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.87 E-value=3.7e-08 Score=100.08 Aligned_cols=151 Identities=14% Similarity=0.131 Sum_probs=107.0
Q ss_pred HHHHHHhhcCccccCCceEEEEEEeCCCCEEEEEEcccCccc-----------CcccHHHHHHHHhccCCCCC--ccceE
Q 005749 374 LEDVLNATGQVIEKTTYGTAYKAKLADGATIALRLLREGSCK-----------DRSSCLPVIRQLGKVRHENL--IPLRA 440 (679)
Q Consensus 374 ~~~l~~~~~~~ig~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~-----------~~~~~~~Ei~~l~~l~H~nI--v~l~~ 440 (679)
++.+..--++++-+.....|++..+ +|+.+.||........ ....+.+|.+.+.++...+| ...++
T Consensus 19 f~~~~~~~~e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa 97 (268)
T PRK15123 19 FEEVKTLQGEVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVA 97 (268)
T ss_pred HHHHHhcCCcEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeE
Confidence 4555444456666555566777766 5778999976433211 11147899999988854443 34455
Q ss_pred EeeCC----CCceEEEEEecCCC-ChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeec
Q 005749 441 FYQGK----RGEKLLIYDYFPSR-TLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVD 515 (679)
Q Consensus 441 ~~~~~----~~~~~lv~ey~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~ 515 (679)
+.... ...-++|||++++. +|.+++.... ....+...+..++.+++..+.-||..+ |+|+|++++|||++
T Consensus 98 ~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~ 172 (268)
T PRK15123 98 FGERGSNPATRTSFIITEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLH 172 (268)
T ss_pred EEEecCCCccceeEEEEeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEe
Confidence 54321 23478999999986 8999886422 123456677899999999999999999 99999999999998
Q ss_pred C-------CCceEEeecccccc
Q 005749 516 D-------FFVSRLTEFGLDQL 530 (679)
Q Consensus 516 ~-------~~~~kl~DFGla~~ 530 (679)
. +..+.++||+.++.
T Consensus 173 ~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 173 LPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred ccccCCCCCceEEEEECCcccc
Confidence 5 46889999998754
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.87 E-value=2.8e-08 Score=104.93 Aligned_cols=170 Identities=22% Similarity=0.319 Sum_probs=127.3
Q ss_pred ceEEEEEE-eCCCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeC---CCCceEEEEEecCC-CChHHH
Q 005749 390 YGTAYKAK-LADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQG---KRGEKLLIYDYFPS-RTLHDL 464 (679)
Q Consensus 390 ~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~---~~~~~~lv~ey~~~-gsL~~~ 464 (679)
-.+.||+. ..||..+++|+++............-+++++++.|+|||++..++.. .+...++||+|+|+ ++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 35789998 66899999999954433333233455889999999999999998773 24568999999986 577776
Q ss_pred hhcccC-----------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCc
Q 005749 465 LHDTIA-----------GKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVP 533 (679)
Q Consensus 465 l~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 533 (679)
-..... .....++...+.++.|+..||.++|+.| ..-+-|.+.+||++.+.+++|+..|....+..
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 543211 1344778899999999999999999998 77799999999999999999988877665533
Q ss_pred ccccchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCC
Q 005749 534 AVADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKK 580 (679)
Q Consensus 534 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~ 580 (679)
+.. |.+.+ -.+-|.=.||.+++.|.||..
T Consensus 446 d~~---------------~~le~---~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 446 DPT---------------EPLES---QQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred CCC---------------cchhH---HhhhhHHHHHHHHHHHhhccc
Confidence 210 11111 235688899999999999843
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.85 E-value=2.2e-09 Score=116.67 Aligned_cols=155 Identities=35% Similarity=0.506 Sum_probs=112.4
Q ss_pred cEEEEEcCCCCCcccCCccccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEEc
Q 005749 100 HLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRL 179 (679)
Q Consensus 100 ~l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~L 179 (679)
++..|++++|.+. .+|..++.+++|+.|++++|.++ .+|...+.+++|+.|++++|+++. +|+.+.. +..|+.|.+
T Consensus 141 nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~ls~N~i~~-l~~~~~~-~~~L~~l~~ 216 (394)
T COG4886 141 NLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKISD-LPPEIEL-LSALEELDL 216 (394)
T ss_pred hcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhheeccCCcccc-Cchhhhh-hhhhhhhhh
Confidence 6788888888876 56667888888888888888888 677777678888888888888874 5554322 356888888
Q ss_pred cCCCCcccCCCCCCCCCCCCCccEEEccCccccccccccccCCCCCCEEEccCCcccccCCcccccc-ccCEEEccCCcC
Q 005749 180 HGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRL-SLEKLNLSHNNF 258 (679)
Q Consensus 180 s~N~l~~~~p~~~~~~~~~~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l-~L~~l~ls~N~l 258 (679)
++|++...+. ....+.++..|.+.+|++. .++..++.+++|+.|++++|+++ .++. +..+ +++.|++++|.+
T Consensus 217 ~~N~~~~~~~----~~~~~~~l~~l~l~~n~~~-~~~~~~~~l~~l~~L~~s~n~i~-~i~~-~~~~~~l~~L~~s~n~~ 289 (394)
T COG4886 217 SNNSIIELLS----SLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQIS-SISS-LGSLTNLRELDLSGNSL 289 (394)
T ss_pred cCCcceecch----hhhhcccccccccCCceee-eccchhccccccceecccccccc-cccc-ccccCccCEEeccCccc
Confidence 8885332211 1134567777778888876 44677788888888888888887 4444 4454 688888888888
Q ss_pred CCCCCCc
Q 005749 259 SGVLPVF 265 (679)
Q Consensus 259 ~g~ip~~ 265 (679)
+..+|..
T Consensus 290 ~~~~~~~ 296 (394)
T COG4886 290 SNALPLI 296 (394)
T ss_pred cccchhh
Confidence 8777654
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.79 E-value=8e-10 Score=108.29 Aligned_cols=142 Identities=24% Similarity=0.269 Sum_probs=105.3
Q ss_pred cccCCccccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEEccCCCCcccCCCC
Q 005749 112 TGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNSLTAALPEP 191 (679)
Q Consensus 112 ~g~ip~~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~~ 191 (679)
.|++-.++..-..|+.||||+|.|+ .|-.++.-++.++.|++|+|.+... ..+.. +++|+.||||+|.++.. ..+
T Consensus 273 ~G~~~~~~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~-L~~L~~LDLS~N~Ls~~-~Gw 347 (490)
T KOG1259|consen 273 NGSALVSADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAE-LPQLQLLDLSGNLLAEC-VGW 347 (490)
T ss_pred CCceEEecchHhhhhhccccccchh-hhhhhhhhccceeEEeccccceeee--hhhhh-cccceEeecccchhHhh-hhh
Confidence 4455455556678999999999998 7877888889999999999999743 34444 48999999999998842 211
Q ss_pred CCCCCCCCCccEEEccCccccccccccccCCCCCCEEEccCCcccccC-Cccccccc-cCEEEccCCcCCCCCC
Q 005749 192 ALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSI-PEGLTRLS-LEKLNLSHNNFSGVLP 263 (679)
Q Consensus 192 ~~~~~~~~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~-p~~~~~l~-L~~l~ls~N~l~g~ip 263 (679)
...+.+++.|.|+.|.+.. + .-++++-+|..||+++|++...- -..++++. |+.+.|.+|.+++.+.
T Consensus 348 ---h~KLGNIKtL~La~N~iE~-L-SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~vd 416 (490)
T KOG1259|consen 348 ---HLKLGNIKTLKLAQNKIET-L-SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSVD 416 (490)
T ss_pred ---HhhhcCEeeeehhhhhHhh-h-hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccch
Confidence 1346789999999998862 2 34677888999999999986311 23455553 8889999999987654
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.73 E-value=7.2e-08 Score=92.38 Aligned_cols=125 Identities=22% Similarity=0.326 Sum_probs=80.9
Q ss_pred EEEEEEeCCCCEEEEEEcccCcc-------------c--------C-----cccHHHHHHHHhccCCC--CCccceEEee
Q 005749 392 TAYKAKLADGATIALRLLREGSC-------------K--------D-----RSSCLPVIRQLGKVRHE--NLIPLRAFYQ 443 (679)
Q Consensus 392 ~Vy~~~~~~~~~vAvK~~~~~~~-------------~--------~-----~~~~~~Ei~~l~~l~H~--nIv~l~~~~~ 443 (679)
.||.|...+|..+|||..+.... . . .....+|.+.|.++... ++-+.+++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 48999998999999999653210 0 0 12357899999999765 344555432
Q ss_pred CCCCceEEEEEecC--CCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHH-HhcCCCCCeeecCCCCCCeeecCCCce
Q 005749 444 GKRGEKLLIYDYFP--SRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAY-LHTGHEIPITHGNVRSKNVLVDDFFVS 520 (679)
Q Consensus 444 ~~~~~~~lv~ey~~--~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~-LH~~~~~~ivHrDlkp~NILl~~~~~~ 520 (679)
.-.+||||++ +..+..+.... ++......++.+++..+.. +|..+ |+|+|+.+.||+++++ .+
T Consensus 80 ----~~~ivME~I~~~G~~~~~l~~~~------~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~ 145 (188)
T PF01163_consen 80 ----RNVIVMEYIGEDGVPLPRLKDVD------LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KV 145 (188)
T ss_dssp ----TTEEEEE--EETTEEGGCHHHCG------GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CE
T ss_pred ----CCEEEEEecCCCccchhhHHhcc------ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eE
Confidence 3479999998 54454433221 1133455677788886666 46777 9999999999999987 99
Q ss_pred EEeeccccccc
Q 005749 521 RLTEFGLDQLM 531 (679)
Q Consensus 521 kl~DFGla~~~ 531 (679)
.++|||.+...
T Consensus 146 ~iIDf~qav~~ 156 (188)
T PF01163_consen 146 YIIDFGQAVDS 156 (188)
T ss_dssp EE--GTTEEET
T ss_pred EEEecCcceec
Confidence 99999987644
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.71 E-value=5.9e-09 Score=98.24 Aligned_cols=109 Identities=29% Similarity=0.320 Sum_probs=28.0
Q ss_pred cCCCCCCeeecccCcccccCCcccC-CCCCCCEEEccCCCCCCcChhhHHhhcccCcEEEccCCCCcccCCCCCCCCCCC
Q 005749 120 GEFSMLQSLYLNVNSLKGTIPFELG-YSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTC 198 (679)
Q Consensus 120 ~~l~~L~~L~L~~N~l~g~ip~~l~-~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~~~~~ 198 (679)
.+..+++.|+|++|.|+ .|. .++ .+.+|+.|||++|.++.. +.+..+ ++|+.|++++|+++.. ++... ..+
T Consensus 16 ~n~~~~~~L~L~~n~I~-~Ie-~L~~~l~~L~~L~Ls~N~I~~l--~~l~~L-~~L~~L~L~~N~I~~i-~~~l~--~~l 87 (175)
T PF14580_consen 16 NNPVKLRELNLRGNQIS-TIE-NLGATLDKLEVLDLSNNQITKL--EGLPGL-PRLKTLDLSNNRISSI-SEGLD--KNL 87 (175)
T ss_dssp ----------------------S--TT-TT--EEE-TTS--S----TT-----TT--EEE--SS---S--CHHHH--HH-
T ss_pred ccccccccccccccccc-ccc-chhhhhcCCCEEECCCCCCccc--cCccCh-hhhhhcccCCCCCCcc-ccchH--HhC
Confidence 34456777777777776 343 455 466777777777777643 234333 6677777777766632 11100 124
Q ss_pred CCccEEEccCccccccc-cccccCCCCCCEEEccCCccc
Q 005749 199 SDLQYLDLGSNKFSGSF-PEFVTRFEALKELDISNNLFS 236 (679)
Q Consensus 199 ~~L~~L~l~~N~l~g~~-p~~~~~l~~L~~L~ls~N~l~ 236 (679)
++|++|+|++|+|...- =..+..+++|+.|+|.+|.++
T Consensus 88 p~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~ 126 (175)
T PF14580_consen 88 PNLQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVC 126 (175)
T ss_dssp TT--EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGG
T ss_pred CcCCEEECcCCcCCChHHhHHHHcCCCcceeeccCCccc
Confidence 56666666666665210 123445556666666666554
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.66 E-value=1.5e-07 Score=92.63 Aligned_cols=137 Identities=18% Similarity=0.187 Sum_probs=97.4
Q ss_pred HHHHhhcCccccCCceEEEEEEeCCCCEEEEEEcccCcc----------------------cCcccHHHHHHHHhccCCC
Q 005749 376 DVLNATGQVIEKTTYGTAYKAKLADGATIALRLLREGSC----------------------KDRSSCLPVIRQLGKVRHE 433 (679)
Q Consensus 376 ~l~~~~~~~ig~G~~g~Vy~~~~~~~~~vAvK~~~~~~~----------------------~~~~~~~~Ei~~l~~l~H~ 433 (679)
+...+.|+.||.|.-+.||.|..++|.++|||.=+.... ..+....+|.++|.++.-.
T Consensus 90 ~~ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~ 169 (304)
T COG0478 90 GIVEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPE 169 (304)
T ss_pred ChHHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhc
Confidence 334567899999999999999999999999997532210 0123467899999998644
Q ss_pred --CCccceEEeeCCCCceEEEEEecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCC
Q 005749 434 --NLIPLRAFYQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKN 511 (679)
Q Consensus 434 --nIv~l~~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~N 511 (679)
.+-+.++ .+...+||||+++--|...= ++....-.|+..|++-+.-.-..| |||+|+.+-|
T Consensus 170 G~~VP~P~~-----~nRHaVvMe~ieG~eL~~~r---------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefN 232 (304)
T COG0478 170 GVKVPKPIA-----WNRHAVVMEYIEGVELYRLR---------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFN 232 (304)
T ss_pred CCCCCCccc-----cccceeeeehcccceeeccc---------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchhe
Confidence 5555555 34668999999886554321 122233344555555554444556 9999999999
Q ss_pred eeecCCCceEEeeccccc
Q 005749 512 VLVDDFFVSRLTEFGLDQ 529 (679)
Q Consensus 512 ILl~~~~~~kl~DFGla~ 529 (679)
|+++++|.+.++||--+.
T Consensus 233 IlV~~dg~~~vIDwPQ~v 250 (304)
T COG0478 233 ILVTEDGDIVVIDWPQAV 250 (304)
T ss_pred EEEecCCCEEEEeCcccc
Confidence 999999999999996443
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.64 E-value=3.6e-09 Score=103.81 Aligned_cols=129 Identities=22% Similarity=0.281 Sum_probs=101.3
Q ss_pred cEEEEEcCCCCCcccCCccccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEEc
Q 005749 100 HLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRL 179 (679)
Q Consensus 100 ~l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~L 179 (679)
.++.++|++|.++ .|-....-++.++.|++|+|.|. .+- .+..+++|+.||||+|.|+.. ..+..-+.+.+.|.|
T Consensus 285 ~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~-~v~-nLa~L~~L~~LDLS~N~Ls~~--~Gwh~KLGNIKtL~L 359 (490)
T KOG1259|consen 285 ELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIR-TVQ-NLAELPQLQLLDLSGNLLAEC--VGWHLKLGNIKTLKL 359 (490)
T ss_pred hhhhccccccchh-hhhhhhhhccceeEEecccccee-eeh-hhhhcccceEeecccchhHhh--hhhHhhhcCEeeeeh
Confidence 5677999999887 67777788899999999999998 343 488899999999999999854 233333478999999
Q ss_pred cCCCCcccCCCCCCCCCCCCCccEEEccCcccccc-ccccccCCCCCCEEEccCCccccc
Q 005749 180 HGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGS-FPEFVTRFEALKELDISNNLFSGS 238 (679)
Q Consensus 180 s~N~l~~~~p~~~~~~~~~~~L~~L~l~~N~l~g~-~p~~~~~l~~L~~L~ls~N~l~g~ 238 (679)
++|.+....- ...+-+|.+||+++|+|..- --..+++++-|+.|.|.+|.+.+.
T Consensus 360 a~N~iE~LSG-----L~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~ 414 (490)
T KOG1259|consen 360 AQNKIETLSG-----LRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGS 414 (490)
T ss_pred hhhhHhhhhh-----hHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCcccc
Confidence 9999874211 12456899999999999731 124589999999999999999854
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.61 E-value=5.2e-09 Score=106.47 Aligned_cols=88 Identities=28% Similarity=0.325 Sum_probs=73.3
Q ss_pred hhcccCcEEEccCCCCcccCCCCCCCCCCCCCccEEEccCccccccccccccCCCCCCEEEccCCcccccCCcccccc-c
Q 005749 169 NLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRL-S 247 (679)
Q Consensus 169 ~~~~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l-~ 247 (679)
..+++|+.|+|++|++++.-+ +++ .....+++|.|..|+|.-.--..|.++..|++|+|.+|+|+-.-|..|..+ +
T Consensus 271 ~~L~~L~~lnlsnN~i~~i~~-~aF--e~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~ 347 (498)
T KOG4237|consen 271 KKLPNLRKLNLSNNKITRIED-GAF--EGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFS 347 (498)
T ss_pred hhcccceEeccCCCccchhhh-hhh--cchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccce
Confidence 334789999999999997544 333 456799999999999985555678899999999999999997778888777 7
Q ss_pred cCEEEccCCcCC
Q 005749 248 LEKLNLSHNNFS 259 (679)
Q Consensus 248 L~~l~ls~N~l~ 259 (679)
|..|+|-.|.|.
T Consensus 348 l~~l~l~~Np~~ 359 (498)
T KOG4237|consen 348 LSTLNLLSNPFN 359 (498)
T ss_pred eeeeehccCccc
Confidence 999999999875
|
|
| >PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=98.58 E-value=5.8e-08 Score=69.01 Aligned_cols=40 Identities=40% Similarity=0.645 Sum_probs=29.8
Q ss_pred hHHHHHHHHHHHhhCCCCCCcccCCCCCCC--CCCcccccceee
Q 005749 30 SSDVELLLGKIKSSLQGDDENLLLSSWNIS--VPLCQWRGLKWI 71 (679)
Q Consensus 30 ~~~~~~ll~~~k~~~~~~~~~~~l~~W~~~--~~~C~w~Gv~c~ 71 (679)
+.|+++|+ +||+++.. ++...+.+|+.+ .+||+|.||+|+
T Consensus 2 ~~d~~aLl-~~k~~l~~-~~~~~l~~W~~~~~~~~C~W~GV~Cd 43 (43)
T PF08263_consen 2 NQDRQALL-AFKKSLNN-DPSGVLSSWNPSSDSDPCSWSGVTCD 43 (43)
T ss_dssp HHHHHHHH-HHHHCTT--SC-CCCTT--TT--S-CCCSTTEEE-
T ss_pred cHHHHHHH-HHHHhccc-ccCcccccCCCcCCCCCeeeccEEeC
Confidence 57889999 99999985 356789999987 699999999963
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A. |
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.57 E-value=1.6e-08 Score=104.40 Aligned_cols=158 Identities=23% Similarity=0.193 Sum_probs=107.5
Q ss_pred CccEEEEEcCCCCCccc--CCccccCCCCCCeeecccCcccccCCccc-CCCCCCCEEEccCCCCCCcChhhHHhhcccC
Q 005749 98 SIHLLSIQLPSANLTGS--LPRELGEFSMLQSLYLNVNSLKGTIPFEL-GYSSSLSEIDLSANLFTGVLAPSIWNLCDRL 174 (679)
Q Consensus 98 ~~~l~~l~l~~n~l~g~--ip~~l~~l~~L~~L~L~~N~l~g~ip~~l-~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L 174 (679)
+.+++.|+|+.|=|..- +-.-..+|++|+.|+|+.|.|.-.+.... ..++.|+.|.|+.+.|+..--..+...+++|
T Consensus 145 ~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~~fPsl 224 (505)
T KOG3207|consen 145 LPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLSWKDVQWILLTFPSL 224 (505)
T ss_pred CCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhhhheEEeccCCCCHHHHHHHHHhCCcH
Confidence 45788888888877632 33345678888888888888874333322 3567888888888888743222333445889
Q ss_pred cEEEccCCCCcccCCCCCCCCCCCCCccEEEccCcccccccc--ccccCCCCCCEEEccCCccccc-CCcc------ccc
Q 005749 175 VSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFP--EFVTRFEALKELDISNNLFSGS-IPEG------LTR 245 (679)
Q Consensus 175 ~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~l~~N~l~g~~p--~~~~~l~~L~~L~ls~N~l~g~-~p~~------~~~ 245 (679)
+.|+|.+|..-+. ...+...+..|+.|||++|++- ..+ ...+.|+.|..|+++.+.++.. +|+. ...
T Consensus 225 ~~L~L~~N~~~~~---~~~~~~i~~~L~~LdLs~N~li-~~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f 300 (505)
T KOG3207|consen 225 EVLYLEANEIILI---KATSTKILQTLQELDLSNNNLI-DFDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTF 300 (505)
T ss_pred HHhhhhcccccce---ecchhhhhhHHhhccccCCccc-ccccccccccccchhhhhccccCcchhcCCCccchhhhccc
Confidence 9999999852211 1222234668999999999987 444 4577889999999999988742 2333 111
Q ss_pred cccCEEEccCCcCC
Q 005749 246 LSLEKLNLSHNNFS 259 (679)
Q Consensus 246 l~L~~l~ls~N~l~ 259 (679)
.+|+.|+++.|++.
T Consensus 301 ~kL~~L~i~~N~I~ 314 (505)
T KOG3207|consen 301 PKLEYLNISENNIR 314 (505)
T ss_pred ccceeeecccCccc
Confidence 27999999999985
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.57 E-value=3.1e-08 Score=76.66 Aligned_cols=60 Identities=32% Similarity=0.375 Sum_probs=30.5
Q ss_pred CCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEEccCCCC
Q 005749 124 MLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNSL 184 (679)
Q Consensus 124 ~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N~l 184 (679)
+|++|+|++|+|+...+..+..+++|++|++++|.++.. ++..+..+++|++|++++|+|
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i-~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSI-PPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEE-ETTTTTTSTTESEEEETSSSB
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCcc-CHHHHcCCCCCCEEeCcCCcC
Confidence 455566666655533333455555566666665555532 332223335555555555543
|
... |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.53 E-value=3.9e-07 Score=100.18 Aligned_cols=151 Identities=17% Similarity=0.236 Sum_probs=100.7
Q ss_pred cHHHHHHhhc-CccccCCceEEEEEEeCCCCEEEEEEcccCccc--------------------------C---------
Q 005749 373 TLEDVLNATG-QVIEKTTYGTAYKAKLADGATIALRLLREGSCK--------------------------D--------- 416 (679)
Q Consensus 373 ~~~~l~~~~~-~~ig~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~--------------------------~--------- 416 (679)
.++|+...++ +-|+.++-|.||+|++++|+.||||+.++.-.. +
T Consensus 120 ~iee~F~eF~~~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~ 199 (517)
T COG0661 120 PIEELFSEFEPEPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFE 199 (517)
T ss_pred CHHHHHHHcCCCchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHH
Confidence 4566666665 789999999999999999999999997642100 0
Q ss_pred -----cccHHHHHHHHhccC-----CCCCccceEEeeCCCCceEEEEEecCCCChHHHhhcccCCCCCCCHHHHHHHHHH
Q 005749 417 -----RSSCLPVIRQLGKVR-----HENLIPLRAFYQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALG 486 (679)
Q Consensus 417 -----~~~~~~Ei~~l~~l~-----H~nIv~l~~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ 486 (679)
+-++.+|..-+.+++ .+++ ++=.+|++-.+...|+|||++|-.+.+...-.. ..++- ..|+..
T Consensus 200 ~~l~~ElDy~~EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~---~g~d~---k~ia~~ 272 (517)
T COG0661 200 KRLREELDYRREAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS---AGIDR---KELAEL 272 (517)
T ss_pred HHHHHHhCHHHHHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHHh---cCCCH---HHHHHH
Confidence 012445555555553 2333 233344433467899999999998888743322 12442 233333
Q ss_pred HHHH-HHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCc
Q 005749 487 IARG-LAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVP 533 (679)
Q Consensus 487 ia~g-L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 533 (679)
++++ +.-+-..+ ++|.|..|.||+++.+++.-+-|||+...+.+
T Consensus 273 ~~~~f~~q~~~dg---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 273 LVRAFLRQLLRDG---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred HHHHHHHHHHhcC---ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 3332 22222345 99999999999999999999999999877654
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.49 E-value=1.2e-07 Score=73.22 Aligned_cols=60 Identities=28% Similarity=0.359 Sum_probs=54.1
Q ss_pred cEEEEEcCCCCCcccCCccccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCC
Q 005749 100 HLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLF 159 (679)
Q Consensus 100 ~l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l 159 (679)
+|+.|+|++|++...-+..|..+++|++|+|++|.|+..-|..+..+++|++|+|++|+|
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 588999999999955556899999999999999999977777899999999999999975
|
... |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.42 E-value=2.3e-06 Score=84.03 Aligned_cols=108 Identities=26% Similarity=0.307 Sum_probs=83.6
Q ss_pred cccHHHHHHHHhccCCCC--CccceEEeeCCC---CceEEEEEecCCC-ChHHHhhcccCCCCCCCHHHHHHHHHHHHHH
Q 005749 417 RSSCLPVIRQLGKVRHEN--LIPLRAFYQGKR---GEKLLIYDYFPSR-TLHDLLHDTIAGKPVLNWARRHKIALGIARG 490 (679)
Q Consensus 417 ~~~~~~Ei~~l~~l~H~n--Iv~l~~~~~~~~---~~~~lv~ey~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~g 490 (679)
...+.+|.+.+.+++... ..+.+++..... ...++|+|++++. +|.+++.... ..+......++.++++.
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~----~~~~~~~~~ll~~l~~~ 130 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE----QLDPSQRRELLRALARL 130 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc----ccchhhHHHHHHHHHHH
Confidence 346788888888875433 345556555421 2358999999874 8999987632 25666788999999999
Q ss_pred HHHHhcCCCCCeeecCCCCCCeeecCCC---ceEEeeccccccc
Q 005749 491 LAYLHTGHEIPITHGNVRSKNVLVDDFF---VSRLTEFGLDQLM 531 (679)
Q Consensus 491 L~~LH~~~~~~ivHrDlkp~NILl~~~~---~~kl~DFGla~~~ 531 (679)
++-||..+ |+|+|+++.|||++.+. .+.++||+-++..
T Consensus 131 i~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 131 IAKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 99999999 99999999999999887 8899999977653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.36 E-value=3.8e-06 Score=86.92 Aligned_cols=260 Identities=18% Similarity=0.205 Sum_probs=153.2
Q ss_pred hcCccccCCceEEEEEE-eCCCCEEEEEEcccCcccCcccHHHHHHHHhcc-CCCCCccceEE-----eeCCCCc-eEEE
Q 005749 381 TGQVIEKTTYGTAYKAK-LADGATIALRLLREGSCKDRSSCLPVIRQLGKV-RHENLIPLRAF-----YQGKRGE-KLLI 452 (679)
Q Consensus 381 ~~~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~-----~~~~~~~-~~lv 452 (679)
.+.-+|+|+-+.+|-.- . +..|| |+.+....... .+.++.|.+. .||-+-.=+.| +....+. .-+.
T Consensus 15 ~gr~LgqGgea~ly~l~e~--~d~VA-KIYh~Pppa~~---aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl 88 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEV--RDQVA-KIYHAPPPAAQ---AQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL 88 (637)
T ss_pred CCccccCCccceeeecchh--hchhh-eeecCCCchHH---HHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence 35789999999999643 2 22344 44433221111 1224445544 56644331111 1111222 5567
Q ss_pred EEecCCC-ChHHHhhc--ccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeeccccc
Q 005749 453 YDYFPSR-TLHDLLHD--TIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQ 529 (679)
Q Consensus 453 ~ey~~~g-sL~~~l~~--~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 529 (679)
|..+++. -+..++.. ++..-+..+|...++.++.+|.+.+-||.++ .+-+|+.++|+|+.+++.+.+.|=..-.
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEccccee
Confidence 7776654 23333332 2233466899999999999999999999998 7789999999999999999998743222
Q ss_pred ccCcccccchhccccccccccccccc-----ccCCCCcchhHHHHHHHHHHHhC-CCCCCCCCCCcc--cchh-HHHHHH
Q 005749 530 LMVPAVADEMVALAKADGYKAPELQR-----MKKCSSRTDVYAFGILLLEILIG-KKPGKSGRNGEF--VDLP-SIVKVA 600 (679)
Q Consensus 530 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~DV~S~Gvvl~El~tg-~~p~~~~~~~~~--~~l~-~~~~~~ 600 (679)
... ........+|...|.+||... +-.-+...|-|.+||++++++.| ++||.+...... ..+- ++....
T Consensus 166 i~~--ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~ 243 (637)
T COG4248 166 INA--NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGR 243 (637)
T ss_pred ecc--CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcce
Confidence 211 111122346777899999765 33456789999999999999876 999976422110 0000 111111
Q ss_pred hhcccccccchHhhhhcCC-----CChHHHHHHHHHHHHhccCc--CCCCCCCHHHHHHHHHhhC
Q 005749 601 VLEETTMEVFDMEIMKGIR-----SPMEEGLVQALKLAMGCCAP--VASVRPTMDEVVKQLEENR 658 (679)
Q Consensus 601 ~~~~~~~~~~~~~i~~~~~-----~~~~~~~~~~~~l~~~cl~~--dP~~RPs~~evl~~L~~~~ 658 (679)
+.. .-+ -..+++ .+..--.+.+-.+..+|+.. ++.-|||++--+..|.++.
T Consensus 244 f~y-----a~~--~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~ 301 (637)
T COG4248 244 FAY-----ASD--QRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALR 301 (637)
T ss_pred eee-----chh--ccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHH
Confidence 100 000 011111 12222234455677788864 4778999998888887664
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.35 E-value=3.2e-06 Score=92.68 Aligned_cols=154 Identities=15% Similarity=0.183 Sum_probs=100.6
Q ss_pred cHHHHHHhhc-CccccCCceEEEEEEeCCCCEEEEEEcccCccc------------------------------------
Q 005749 373 TLEDVLNATG-QVIEKTTYGTAYKAKLADGATIALRLLREGSCK------------------------------------ 415 (679)
Q Consensus 373 ~~~~l~~~~~-~~ig~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~------------------------------------ 415 (679)
+++|+...+. +.||.-+.|.||+|++++|+.||||+-++.-.+
T Consensus 156 ~ie~if~~f~~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L 235 (538)
T KOG1235|consen 156 PIEDIFSEFDEEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSL 235 (538)
T ss_pred CHHHHHHhcCcchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhh
Confidence 4566665554 789999999999999999999999995542110
Q ss_pred -CcccHHHHHHHHhcc----CCCCC---ccceEEeeCCCCceEEEEEecCCCChHHHhhcccCCCCCCCHHHHHHHHHHH
Q 005749 416 -DRSSCLPVIRQLGKV----RHENL---IPLRAFYQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGI 487 (679)
Q Consensus 416 -~~~~~~~Ei~~l~~l----~H~nI---v~l~~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i 487 (679)
.+-+|.+|.+-..++ +|-+. |.+=.+|++-.....|+||||+|..+.+.-.-. +..++...+..-+.++
T Consensus 236 ~~ELDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~---~~gi~~~~i~~~l~~~ 312 (538)
T KOG1235|consen 236 PQELDFTKEAKNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAID---KRGISPHDILNKLVEA 312 (538)
T ss_pred HhhcchHHHHHhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHH---HcCCCHHHHHHHHHHH
Confidence 012456666554444 35552 223344554456789999999998777653322 1235555444333333
Q ss_pred HHHHHHHhcCCCCCeeecCCCCCCeeecC----CCceEEeecccccccCcc
Q 005749 488 ARGLAYLHTGHEIPITHGNVRSKNVLVDD----FFVSRLTEFGLDQLMVPA 534 (679)
Q Consensus 488 a~gL~~LH~~~~~~ivHrDlkp~NILl~~----~~~~kl~DFGla~~~~~~ 534 (679)
..-+-+- .| ++|+|=.|-||+++. ++.+.+-|||+...+...
T Consensus 313 ~~~qIf~--~G---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~ 358 (538)
T KOG1235|consen 313 YLEQIFK--TG---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK 358 (538)
T ss_pred HHHHHHh--cC---CccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence 2222222 24 999999999999984 678899999998876543
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.33 E-value=1.3e-05 Score=77.33 Aligned_cols=139 Identities=9% Similarity=0.097 Sum_probs=100.6
Q ss_pred cccCCceEEEEEEeCCCCEEEEEEcccCc------ccCcccHHHHHHHHhccCCCC--CccceEEeeCC----CCceEEE
Q 005749 385 IEKTTYGTAYKAKLADGATIALRLLREGS------CKDRSSCLPVIRQLGKVRHEN--LIPLRAFYQGK----RGEKLLI 452 (679)
Q Consensus 385 ig~G~~g~Vy~~~~~~~~~vAvK~~~~~~------~~~~~~~~~Ei~~l~~l~H~n--Iv~l~~~~~~~----~~~~~lv 452 (679)
-|+||.+-|++-.++ |+.+=+|+-...- ......|.+|+..+.++...+ +.+.. ++... ..+-+||
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 356888899998775 4467778764211 224567999999999985433 33333 33211 2245899
Q ss_pred EEecCC-CChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCc--eEEeeccccc
Q 005749 453 YDYFPS-RTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFV--SRLTEFGLDQ 529 (679)
Q Consensus 453 ~ey~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~--~kl~DFGla~ 529 (679)
+|-+.+ -||.+++.+.. ....+...+..+..+|++.+.-||+.+ +.|+|+-+.||+++.++. ++++||--++
T Consensus 104 Te~L~g~~~L~~~l~~~~--~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 104 TEDMAGFISIADWYAQHA--VSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EEeCCCCccHHHHHhcCC--cCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 997763 48998886532 124577788899999999999999998 999999999999986666 8999997655
Q ss_pred c
Q 005749 530 L 530 (679)
Q Consensus 530 ~ 530 (679)
.
T Consensus 179 ~ 179 (216)
T PRK09902 179 R 179 (216)
T ss_pred h
Confidence 3
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.30 E-value=1.7e-07 Score=102.64 Aligned_cols=149 Identities=19% Similarity=0.250 Sum_probs=95.5
Q ss_pred HHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccch--------hccccccccccccccccc
Q 005749 486 GIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEM--------VALAKADGYKAPELQRMK 557 (679)
Q Consensus 486 ~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~--------~~~~gt~~y~aPE~~~~~ 557 (679)
+++.|+.|+|.+ .++||++|.|++|.++..+..||+.|+.+....+...... .-......|.|||++...
T Consensus 107 ~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~ 184 (700)
T KOG2137|consen 107 NVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT 184 (700)
T ss_pred cccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence 445899999974 4699999999999999999999999998765433211100 011223459999999988
Q ss_pred CCCCcchhHHHHHHHHHHH-hCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcCCCChHHHHHHHHHHHHhc
Q 005749 558 KCSSRTDVYAFGILLLEIL-IGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIRSPMEEGLVQALKLAMGC 636 (679)
Q Consensus 558 ~~~~k~DV~S~Gvvl~El~-tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l~~~c 636 (679)
..+.++|+||+||++|-+. .|+.-+........+.. ... ..+.. ..++.... ..++.+=+.+.
T Consensus 185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~----~~~--------~~~~~-~~~~s~~~---p~el~~~l~k~ 248 (700)
T KOG2137|consen 185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSF----SRN--------LLNAG-AFGYSNNL---PSELRESLKKL 248 (700)
T ss_pred cccccccceeeeeEEEEEecCCcchhhccCCcchhhh----hhc--------ccccc-cccccccC---cHHHHHHHHHH
Confidence 8899999999999999998 45544422211111110 000 00000 01111112 24455566778
Q ss_pred cCcCCCCCCCHHHHHH
Q 005749 637 CAPVASVRPTMDEVVK 652 (679)
Q Consensus 637 l~~dP~~RPs~~evl~ 652 (679)
+..++..||++.++..
T Consensus 249 l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 249 LNGDSAVRPTLDLLLS 264 (700)
T ss_pred hcCCcccCcchhhhhc
Confidence 8899999997776644
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.22 E-value=3.2e-07 Score=99.40 Aligned_cols=179 Identities=15% Similarity=0.112 Sum_probs=128.5
Q ss_pred cccCCceEEEEEEeCCCCEEEEEEcccCcccCcccHHHHHHHHhccCCCC-CccceEEeeCCCCceEEEEEecCCC-ChH
Q 005749 385 IEKTTYGTAYKAKLADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHEN-LIPLRAFYQGKRGEKLLIYDYFPSR-TLH 462 (679)
Q Consensus 385 ig~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~n-Iv~l~~~~~~~~~~~~lv~ey~~~g-sL~ 462 (679)
.++++++++||.+--..+....+.+... ....-++++|.+++||| .++.++-+.. +...+++++|+..+ +-.
T Consensus 250 fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~-E~~~~i~~~i~s~~rs~~ 323 (829)
T KOG0576|consen 250 FVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDG-EDYLWIPMRICSTGRSSA 323 (829)
T ss_pred HHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCc-ccccchhhhhhcCCcccc
Confidence 5688999999988322333335554432 45567899999999999 6666555544 56778999999887 222
Q ss_pred HHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccchhcc
Q 005749 463 DLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVAL 542 (679)
Q Consensus 463 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 542 (679)
..... ....+...+...+.+.-.++++|+|+.. =+||| ||+..+ ...|..||+.+..+.... .....
T Consensus 324 ~~~~~---se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--~~~t~ 390 (829)
T KOG0576|consen 324 LEMTV---SEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--KPRTA 390 (829)
T ss_pred ccCCh---hhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCccc--ccccC
Confidence 11111 1222444455667777789999999854 48999 787765 678999999988765432 34566
Q ss_pred cccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCC
Q 005749 543 AKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPG 582 (679)
Q Consensus 543 ~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~ 582 (679)
.+++.|+|||+...+.+..+.|+|+.|+--.++.-|-+|-
T Consensus 391 ~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 391 IGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred CCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 7899999999999999999999999998777777777764
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.17 E-value=3.4e-05 Score=76.79 Aligned_cols=141 Identities=14% Similarity=0.155 Sum_probs=83.0
Q ss_pred CccccCCceEEEEEEeCCCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCC--ccceEEeeCCCCceEEEEEecCCCC
Q 005749 383 QVIEKTTYGTAYKAKLADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENL--IPLRAFYQGKRGEKLLIYDYFPSRT 460 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nI--v~l~~~~~~~~~~~~lv~ey~~~gs 460 (679)
..||+|..+.||+. .+..+++|...... ......+|.++++.+..-.+ .+.+++... .+...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~-~~~~glv~e~i~G~~ 80 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVED-GGRLGLIYELIVGKR 80 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEec-CCeeeeeeeecCCcc
Confidence 57899999999984 24567788876532 23456889999998864444 455666554 566789999999863
Q ss_pred -hHHHhhc-------------------ccCCCCCCCHHHHH-HHHH----------HHHH-HHHHHhcC-CCCCeeecCC
Q 005749 461 -LHDLLHD-------------------TIAGKPVLNWARRH-KIAL----------GIAR-GLAYLHTG-HEIPITHGNV 507 (679)
Q Consensus 461 -L~~~l~~-------------------~~~~~~~l~~~~~~-~i~~----------~ia~-gL~~LH~~-~~~~ivHrDl 507 (679)
+...+.. +.-........... ++-. .+.. ...+|... ..+.++|+|+
T Consensus 81 ~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~ 160 (226)
T TIGR02172 81 SFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF 160 (226)
T ss_pred chhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence 2211110 00000001111100 0000 0111 11222211 1234789999
Q ss_pred CCCCeeecCCCceEEeecccccc
Q 005749 508 RSKNVLVDDFFVSRLTEFGLDQL 530 (679)
Q Consensus 508 kp~NILl~~~~~~kl~DFGla~~ 530 (679)
.|.||++++++ +.+.||+.+..
T Consensus 161 ~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 161 QIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCCcEEEcCCC-cEEEechhcCc
Confidence 99999999887 99999997753
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.16 E-value=3.4e-07 Score=94.75 Aligned_cols=137 Identities=23% Similarity=0.222 Sum_probs=95.7
Q ss_pred cCCCCCCeeecccCcccccCC--cccCCCCCCCEEEccCCCCCCcCh-hhHHhhcccCcEEEccCCCCcccCCCCCCCCC
Q 005749 120 GEFSMLQSLYLNVNSLKGTIP--FELGYSSSLSEIDLSANLFTGVLA-PSIWNLCDRLVSLRLHGNSLTAALPEPALPNS 196 (679)
Q Consensus 120 ~~l~~L~~L~L~~N~l~g~ip--~~l~~l~~L~~L~Ls~N~l~g~~p-~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~~~ 196 (679)
.++.+|+...|.+.... .++ .....|++++.||||.|.|...-| -.+...+++|+.|+|+.|+|.-.+.... ..
T Consensus 118 sn~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~--~~ 194 (505)
T KOG3207|consen 118 SNLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNT--TL 194 (505)
T ss_pred hhHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccc--hh
Confidence 56889999999998886 344 246678999999999999875422 2455557899999999999975443221 12
Q ss_pred CCCCccEEEccCccccc-cccccccCCCCCCEEEccCCcccccCCcccccc-ccCEEEccCCcCC
Q 005749 197 TCSDLQYLDLGSNKFSG-SFPEFVTRFEALKELDISNNLFSGSIPEGLTRL-SLEKLNLSHNNFS 259 (679)
Q Consensus 197 ~~~~L~~L~l~~N~l~g-~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l-~L~~l~ls~N~l~ 259 (679)
.+++|+.|.|+.|.|+. .+-..+..+++|+.|+|+.|..-+.--....-+ .|+.|||++|++-
T Consensus 195 ~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li 259 (505)
T KOG3207|consen 195 LLSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLI 259 (505)
T ss_pred hhhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCccc
Confidence 46789999999999983 233345678999999999985211111111112 4889999999874
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.16 E-value=6.4e-08 Score=105.40 Aligned_cols=126 Identities=30% Similarity=0.340 Sum_probs=77.4
Q ss_pred CCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEEccCCCCcccCCCCCCCCCCCCCccE
Q 005749 124 MLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQY 203 (679)
Q Consensus 124 ~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~ 203 (679)
.|.+.+.++|.|. ..-..+.-++.|+.|||++|+|+.. ..+ ..++.|++|||++|.|+ .+|. +....|. |+.
T Consensus 165 ~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v--~~L-r~l~~LkhLDlsyN~L~-~vp~--l~~~gc~-L~~ 236 (1096)
T KOG1859|consen 165 KLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKV--DNL-RRLPKLKHLDLSYNCLR-HVPQ--LSMVGCK-LQL 236 (1096)
T ss_pred hHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhh--HHH-Hhcccccccccccchhc-cccc--cchhhhh-hee
Confidence 4555667777776 4555566667777777777777643 233 33467777777777777 3342 2223344 778
Q ss_pred EEccCccccccccccccCCCCCCEEEccCCcccccCCc-ccccc-ccCEEEccCCcCC
Q 005749 204 LDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPE-GLTRL-SLEKLNLSHNNFS 259 (679)
Q Consensus 204 L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~-~~~~l-~L~~l~ls~N~l~ 259 (679)
|.+++|.++.. ..+.++.+|..||+++|-|++.--- .++.+ .|..|+|.+|.+.
T Consensus 237 L~lrnN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 237 LNLRNNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred eeecccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 88888877632 2356777788888888877653210 11222 4777777777653
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.03 E-value=6.5e-07 Score=97.81 Aligned_cols=125 Identities=25% Similarity=0.302 Sum_probs=75.8
Q ss_pred EEEEEcCCCCCcccCCccccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEEcc
Q 005749 101 LLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLH 180 (679)
Q Consensus 101 l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls 180 (679)
+..+++..|.+.- +-..++.+++|..|+|.+|+|. .+...+..+++|++|||++|.++... .+..+ +.|+.|+++
T Consensus 74 l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~-~i~~~l~~~~~L~~L~ls~N~I~~i~--~l~~l-~~L~~L~l~ 148 (414)
T KOG0531|consen 74 LKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIE-KIENLLSSLVNLQVLDLSFNKITKLE--GLSTL-TLLKELNLS 148 (414)
T ss_pred HHhhccchhhhhh-hhcccccccceeeeeccccchh-hcccchhhhhcchheecccccccccc--chhhc-cchhhheec
Confidence 3444455555442 3334667777777777777777 34443666777777777777776542 23333 557777777
Q ss_pred CCCCcccCCCCCCCCCCCCCccEEEccCcccccccccc-ccCCCCCCEEEccCCccc
Q 005749 181 GNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEF-VTRFEALKELDISNNLFS 236 (679)
Q Consensus 181 ~N~l~~~~p~~~~~~~~~~~L~~L~l~~N~l~g~~p~~-~~~l~~L~~L~ls~N~l~ 236 (679)
+|.++.. +. ...+.+|+.+++++|++... ... ...+.+|+.+++.+|.+.
T Consensus 149 ~N~i~~~-~~----~~~l~~L~~l~l~~n~i~~i-e~~~~~~~~~l~~l~l~~n~i~ 199 (414)
T KOG0531|consen 149 GNLISDI-SG----LESLKSLKLLDLSYNRIVDI-ENDELSELISLEELDLGGNSIR 199 (414)
T ss_pred cCcchhc-cC----CccchhhhcccCCcchhhhh-hhhhhhhccchHHHhccCCchh
Confidence 7777642 11 12256777777777777633 221 356667777777777765
|
|
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=98.01 E-value=4.9e-06 Score=59.25 Aligned_cols=38 Identities=29% Similarity=0.406 Sum_probs=28.2
Q ss_pred CCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCC
Q 005749 123 SMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTG 161 (679)
Q Consensus 123 ~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g 161 (679)
++|++|+|++|+|+ .+|+.+++|++|++|+|++|+++.
T Consensus 1 ~~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~~ 38 (44)
T PF12799_consen 1 KNLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPISD 38 (44)
T ss_dssp TT-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCSB
T ss_pred CcceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCCC
Confidence 46788888888887 577778888888888888888774
|
... |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.01 E-value=5.6e-05 Score=74.09 Aligned_cols=136 Identities=15% Similarity=0.190 Sum_probs=92.0
Q ss_pred CccccCCceEEEEEEeCCCCEEEEEEcccCcccC-------------------ccc-----HHHHHHHHhccC--CCCCc
Q 005749 383 QVIEKTTYGTAYKAKLADGATIALRLLREGSCKD-------------------RSS-----CLPVIRQLGKVR--HENLI 436 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~-------------------~~~-----~~~Ei~~l~~l~--H~nIv 436 (679)
..|..|.-+.||+|...++..+|||+.+...... ..+ ..+|+.-|.++. +-.+-
T Consensus 54 g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP 133 (268)
T COG1718 54 GCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP 133 (268)
T ss_pred eeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence 4677888899999998889999999986432110 000 245666666663 33334
Q ss_pred cceEEeeCCCCceEEEEEecCCC-ChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeeecCCCCCCeee
Q 005749 437 PLRAFYQGKRGEKLLIYDYFPSR-TLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHT-GHEIPITHGNVRSKNVLV 514 (679)
Q Consensus 437 ~l~~~~~~~~~~~~lv~ey~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~-~~~~~ivHrDlkp~NILl 514 (679)
+-+++. .-.+||||+... .-.-.|+ ...+.......+..++.+++.-|-. .+ +||+||..=|||+
T Consensus 134 ~Pi~~~-----~nVLvMEfIg~~g~pAP~Lk-----Dv~~e~~e~~~~~~~~v~~~~~l~~~a~---LVHgDLSEyNiL~ 200 (268)
T COG1718 134 EPIAFR-----NNVLVMEFIGDDGLPAPRLK-----DVPLELEEAEGLYEDVVEYMRRLYKEAG---LVHGDLSEYNILV 200 (268)
T ss_pred Cceeec-----CCeEEEEeccCCCCCCCCcc-----cCCcCchhHHHHHHHHHHHHHHHHHhcC---cccccchhhheEE
Confidence 444432 346999999653 1111222 1223333566778888888888877 55 9999999999999
Q ss_pred cCCCceEEeecccccccC
Q 005749 515 DDFFVSRLTEFGLDQLMV 532 (679)
Q Consensus 515 ~~~~~~kl~DFGla~~~~ 532 (679)
. ++.+.|+|||-|....
T Consensus 201 ~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 201 H-DGEPYIIDVSQAVTID 217 (268)
T ss_pred E-CCeEEEEECccccccC
Confidence 9 7899999999876543
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.97 E-value=3.3e-05 Score=74.37 Aligned_cols=101 Identities=20% Similarity=0.112 Sum_probs=80.0
Q ss_pred HHHHHHHhccCC-CCCccceEEeeCCCCceEEEEEecCCCChHHH---hhcccCCCCCCCHHHHHHHHHHHHHHHHHHhc
Q 005749 421 LPVIRQLGKVRH-ENLIPLRAFYQGKRGEKLLIYDYFPSRTLHDL---LHDTIAGKPVLNWARRHKIALGIARGLAYLHT 496 (679)
Q Consensus 421 ~~Ei~~l~~l~H-~nIv~l~~~~~~~~~~~~lv~ey~~~gsL~~~---l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~ 496 (679)
..|.-+|..+.+ +++.+++|+|.. ++|.||...+++... +.+ -..-+|..|.+||.++++.++++++
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~-----~~v~E~~~~~~~~~~~~~l~~----~~~~~w~~R~~iA~~lL~~l~~l~~ 77 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR-----FYVVEYVGAGSLYGIYRPLSQ----FLQSPWEQRAKIALQLLELLEELDH 77 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC-----EEEEEeecCcccccccccccc----ccccCHHHHHHHHHHHHHHHHHHhc
Confidence 357788888876 699999999853 678999987765421 111 1225899999999999999999998
Q ss_pred CCCCCeeecCCCCCCeeecCCCceEEeecccccc
Q 005749 497 GHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQL 530 (679)
Q Consensus 497 ~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 530 (679)
...-.+.-.|++++|+-+++++++|+.|...+..
T Consensus 78 ~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 78 GPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred CCCCcEEEeecchHHeEEeCCCcEEEEechhcch
Confidence 5444477899999999999999999999986654
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.96 E-value=0.00012 Score=73.93 Aligned_cols=141 Identities=15% Similarity=0.153 Sum_probs=83.3
Q ss_pred cccCCc-eEEEEEEeCCCCEEEEEEcccCcccCcccHHHHHHHHhccC-CCCCccceEEeeCCCCceEEEEEecCCCChH
Q 005749 385 IEKTTY-GTAYKAKLADGATIALRLLREGSCKDRSSCLPVIRQLGKVR-HENLIPLRAFYQGKRGEKLLIYDYFPSRTLH 462 (679)
Q Consensus 385 ig~G~~-g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~~~~~~~~~~~~lv~ey~~~gsL~ 462 (679)
|..|.. ..||+.... +..+.||...... .....+|++++..+. +--+.+++++... .+..++||||++|.++.
T Consensus 6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~-~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSD-DGRAWLLTSAVPGVPAA 80 (244)
T ss_pred cCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEec-CCccEEEEEeeCCccHh
Confidence 344555 789999865 4678888875532 346778999988884 3334456666654 45679999999998776
Q ss_pred HHhh-------------------cccCCCCCCCH--HHHHHH-----------------------HHHHHHHHHHHh-cC
Q 005749 463 DLLH-------------------DTIAGKPVLNW--ARRHKI-----------------------ALGIARGLAYLH-TG 497 (679)
Q Consensus 463 ~~l~-------------------~~~~~~~~l~~--~~~~~i-----------------------~~~ia~gL~~LH-~~ 497 (679)
.... ........+.. ...... ..++...|.... ..
T Consensus 81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 160 (244)
T cd05150 81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE 160 (244)
T ss_pred HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence 4421 00000001110 000000 111111111111 11
Q ss_pred CCCCeeecCCCCCCeeecCCCceEEeecccccc
Q 005749 498 HEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQL 530 (679)
Q Consensus 498 ~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 530 (679)
..+.++|+|+.|.|||++++....|.||+.+..
T Consensus 161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred CceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 134489999999999999987788999987653
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 679 | ||||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 4e-25 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 6e-25 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 4e-19 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 5e-19 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 2e-16 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 3e-16 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-15 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-15 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 5e-15 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-14 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 6e-12 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-11 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 3e-11 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-08 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 3e-07 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-06 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-06 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-06 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-06 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 4e-06 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 5e-06 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 6e-06 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 7e-06 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 7e-06 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 8e-06 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-05 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-05 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-05 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-05 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-05 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-05 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-05 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 4e-05 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 4e-05 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-05 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-04 | ||
| 2z7x_B | 520 | Crystal Structure Of The Tlr1-Tlr2 Heterodimer Indu | 1e-04 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-04 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-04 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-04 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-04 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-04 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-04 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-04 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-04 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-04 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-04 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-04 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-04 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-04 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-04 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-04 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-04 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-04 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-04 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-04 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 3e-04 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-04 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-04 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-04 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-04 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-04 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-04 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-04 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-04 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-04 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 4e-04 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 4e-04 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 5e-04 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 5e-04 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 5e-04 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 6e-04 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 6e-04 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-04 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-04 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 7e-04 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 7e-04 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 7e-04 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 7e-04 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 7e-04 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 8e-04 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 8e-04 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-04 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 9e-04 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 9e-04 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 9e-04 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 9e-04 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 9e-04 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 9e-04 |
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2Z7X|B Chain B, Crystal Structure Of The Tlr1-Tlr2 Heterodimer Induced By Binding Of A Tri-Acylated Lipopeptide Length = 520 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 679 | |||
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 1e-53 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 1e-51 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 2e-45 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 6e-41 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 2e-36 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 8e-36 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 8e-31 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 3e-30 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 3e-10 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 4e-45 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 4e-42 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 2e-36 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 2e-33 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 3e-33 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 5e-31 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 1e-30 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 3e-30 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 4e-30 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 1e-29 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 6e-29 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 1e-28 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 2e-28 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 3e-28 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 1e-27 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 2e-25 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 1e-24 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 1e-20 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 6e-20 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 2e-15 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 7e-15 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 1e-11 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 3e-27 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 6e-27 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 3e-26 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 3e-26 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 6e-26 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 1e-23 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 2e-23 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 3e-22 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 9e-18 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 8e-14 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 3e-26 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 2e-23 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 2e-23 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 4e-23 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 7e-23 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 1e-22 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 2e-22 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 4e-22 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 5e-22 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 2e-21 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 4e-21 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 4e-19 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 1e-08 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 2e-25 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 7e-23 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 2e-22 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 8e-20 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 3e-22 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 1e-19 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 3e-12 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 8e-22 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 3e-20 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 3e-19 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 8e-19 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 8e-19 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 1e-18 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 9e-18 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 2e-17 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 2e-17 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 9e-16 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 1e-12 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 2e-09 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 9e-22 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 1e-19 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 4e-18 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 8e-18 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 2e-16 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 1e-15 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 4e-13 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 1e-09 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 4e-06 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 2e-19 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 4e-16 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 5e-15 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 3e-14 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 9e-07 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 3e-06 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 5e-19 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 2e-15 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 3e-14 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 1e-11 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 7e-04 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 3e-18 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 8e-16 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 5e-15 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 2e-05 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 5e-18 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 1e-17 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 3e-14 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 6e-14 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 1e-11 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 4e-11 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 1e-07 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 1e-06 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 2e-06 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 1e-17 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 8e-17 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 2e-16 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 7e-16 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 6e-14 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 3e-12 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 7e-11 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 6e-08 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 6e-17 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 8e-17 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 2e-14 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 2e-12 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 5e-12 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 8e-12 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 1e-09 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 6e-08 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 8e-08 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 2e-16 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 3e-13 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 3e-13 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 2e-11 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 2e-05 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 3e-16 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 1e-14 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 8e-14 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 1e-11 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 7e-11 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 1e-15 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 5e-15 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 9e-09 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 4e-08 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 2e-07 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 9e-07 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 2e-05 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 2e-15 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 4e-15 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 6e-15 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 2e-14 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 5e-12 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 1e-11 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 4e-11 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 2e-15 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 4e-15 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 5e-13 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 5e-13 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 3e-06 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 2e-15 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 4e-15 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 1e-14 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 3e-14 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 6e-13 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 4e-04 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 5e-15 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 2e-14 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 1e-13 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 3e-13 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 3e-13 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 9e-13 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 1e-12 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 3e-06 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 8e-15 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 8e-15 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 1e-14 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 1e-13 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 7e-13 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 2e-12 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 2e-12 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 8e-12 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 1e-11 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 2e-14 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 3e-14 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 3e-14 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 4e-14 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 3e-11 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 5e-14 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 5e-14 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 1e-13 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 1e-13 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 2e-12 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 5e-09 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 1e-13 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 1e-13 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 2e-13 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 9e-13 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 6e-09 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 2e-13 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 3e-12 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 5e-12 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 5e-12 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 2e-13 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 2e-12 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 5e-12 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 9e-07 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 3e-13 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 4e-13 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 2e-08 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 4e-07 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 9e-06 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 2e-05 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 4e-13 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 4e-13 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 6e-13 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 8e-13 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 1e-12 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 1e-11 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 7e-13 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 1e-12 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 1e-11 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 2e-11 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 6e-08 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 2e-12 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 4e-12 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 5e-12 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 5e-12 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 5e-12 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 9e-12 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 1e-11 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 8e-11 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 1e-10 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 2e-09 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 1e-11 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 1e-11 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 2e-11 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 2e-11 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 2e-11 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 2e-11 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 2e-11 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 2e-11 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 1e-10 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 3e-10 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 5e-05 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 3e-11 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 5e-11 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 5e-11 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 6e-11 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 7e-11 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 8e-11 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 1e-10 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 1e-10 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 1e-10 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 2e-10 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 3e-09 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 5e-09 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 8e-09 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 2e-08 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 2e-10 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 2e-10 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 3e-10 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 2e-10 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 3e-10 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 9e-10 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 2e-09 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 3e-09 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 3e-08 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 5e-06 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 4e-10 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 7e-08 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 3e-05 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 3e-05 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 4e-10 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 9e-06 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 6e-10 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 7e-10 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 7e-10 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 8e-10 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 9e-10 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 1e-09 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 4e-07 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 1e-09 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 1e-09 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 3e-09 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 2e-06 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 2e-09 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 2e-09 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 2e-09 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 2e-09 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 2e-09 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 5e-09 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 6e-09 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 8e-09 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 2e-08 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 6e-06 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 1e-08 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 1e-08 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 1e-08 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 7e-08 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 6e-04 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 1e-08 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 1e-08 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 1e-08 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 2e-08 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 3e-08 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 3e-08 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 3e-08 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 7e-04 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 4e-08 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 5e-08 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 5e-08 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 7e-08 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 7e-08 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 7e-08 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 8e-04 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 8e-08 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 1e-07 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 5e-07 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 2e-06 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 1e-04 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 8e-08 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 9e-08 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 1e-07 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 2e-07 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 2e-07 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 2e-07 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 8e-07 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 4e-05 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 3e-04 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 2e-07 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 2e-07 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 3e-07 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 4e-07 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 4e-07 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 5e-07 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 5e-07 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 6e-07 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 5e-06 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 7e-07 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 7e-07 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 1e-06 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 4e-06 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 3e-04 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 8e-07 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 9e-07 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 5e-06 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 6e-05 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 1e-04 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 1e-06 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 1e-06 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 1e-06 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 1e-06 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 2e-06 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 4e-05 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 1e-04 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 3e-04 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 2e-06 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 2e-06 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 5e-06 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 6e-05 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 5e-06 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 5e-06 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 4e-04 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 8e-06 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 1e-05 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 1e-05 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 1e-05 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 7e-05 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 1e-05 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 2e-05 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 4e-04 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 2e-05 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 2e-05 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 3e-05 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 3e-05 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 4e-05 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 9e-04 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 4e-05 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 9e-05 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 1e-04 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 1e-04 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 1e-04 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 2e-04 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 2e-04 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 2e-04 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 2e-04 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 2e-04 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 2e-04 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 2e-04 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 2e-04 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 3e-04 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 3e-04 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 4e-04 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 4e-04 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 4e-04 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 5e-04 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 6e-04 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 6e-04 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 7e-04 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 7e-04 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 7e-04 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 8e-04 |
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 1e-53
Identities = 88/297 (29%), Positives = 151/297 (50%), Gaps = 24/297 (8%)
Query: 373 TLEDVLNATGQ-----VIEKTTYGTAYKAKLADGATIALRLLREGSCKDRSSCLPVIRQ- 426
+L ++ A+ ++ + +G YK +LADG +A++ L+E + Q
Sbjct: 21 SLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGE------LQF 74
Query: 427 ------LGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARR 480
+ H NL+ LR F E+LL+Y Y + ++ L + +P L+W +R
Sbjct: 75 QTEVEMISMAVHRNLLRLRGFCM-TPTERLLVYPYMANGSVASCLRERPESQPPLDWPKR 133
Query: 481 HKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMV 540
+IALG ARGLAYLH + I H +V++ N+L+D+ F + + +FGL +LM
Sbjct: 134 QRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT 193
Query: 541 ALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGR--NGEFVDLPSIVK 598
A+ G+ APE K S +TDV+ +G++LLE++ G++ R N + V L VK
Sbjct: 194 AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 253
Query: 599 VAVLEETTMEVFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLE 655
+ E+ + D+++ + +E + Q +++A+ C RP M EVV+ LE
Sbjct: 254 GLLKEKKLEALVDVDLQG---NYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 180 bits (460), Expect = 1e-51
Identities = 84/315 (26%), Positives = 141/315 (44%), Gaps = 15/315 (4%)
Query: 349 SGGSAAGGAGGEGKLIIFQGGEHLTLEDVLNATG-----QVIEKTTYGTAYKAKLADGAT 403
S + + ++ + L D+ AT +I +G YK L DGA
Sbjct: 6 SKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAK 65
Query: 404 IALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRTLHD 463
+AL+ S + I L RH +L+ L F +R E +LIY Y + L
Sbjct: 66 VALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCD-ERNEMILIYKYMENGNLKR 124
Query: 464 LLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLT 523
L+ + ++W +R +I +G ARGL YLHT I H +V+S N+L+D+ FV ++T
Sbjct: 125 HLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKIT 181
Query: 524 EFGLDQLMVPAVADEMV--ALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKP 581
+FG+ + + + + GY PE + + ++DVY+FG++L E+L +
Sbjct: 182 DFGISKKG-TELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSA 240
Query: 582 GKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVA 641
E V+L + ++ D + IR E L + A+ C A +
Sbjct: 241 IVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRP---ESLRKFGDTAVKCLALSS 297
Query: 642 SVRPTMDEVVKQLEE 656
RP+M +V+ +LE
Sbjct: 298 EDRPSMGDVLWKLEY 312
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 2e-45
Identities = 66/255 (25%), Positives = 111/255 (43%), Gaps = 26/255 (10%)
Query: 20 SLASSSPASASSDVELLLGKIKSSLQGDDENLLLSSWNISVPLCQWRG-------LKWIS 72
S +S S ++ L+ K L + LL W+ + C + G + I
Sbjct: 1 SFQASPSQSLYREIHQLI-SFKDVLPDKN---LLPDWSSNKNPCTFDGVTCRDDKVTSID 56
Query: 73 TNGSPLSCSDISLPQW-ANLSLYKDSSIHLLSIQLPSANLTGSLPRELGEFSMLQSLYLN 131
+ PL+ ++ +L+ L S+ L ++++ GS+ + L SL L+
Sbjct: 57 LSSKPLNVGFSAVSSSLLSLT-------GLESLFLSNSHINGSVS-GFKCSASLTSLDLS 108
Query: 132 VNSLKGTIP--FELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNSLTAALP 189
NSL G + LG S L +++S+N S + L L L NS++ A
Sbjct: 109 RNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANV 168
Query: 190 EPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRL-SL 248
+ + C +L++L + NK SG V+R L+ LD+S+N FS IP L +L
Sbjct: 169 VGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPF-LGDCSAL 225
Query: 249 EKLNLSHNNFSGVLP 263
+ L++S N SG
Sbjct: 226 QHLDISGNKLSGDFS 240
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 158 bits (403), Expect = 6e-41
Identities = 61/173 (35%), Positives = 93/173 (53%), Gaps = 5/173 (2%)
Query: 92 SLYKDSSIHLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSE 151
+L ++ L + L + TG +P L S L SL+L+ N L GTIP LG S L +
Sbjct: 387 NLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRD 446
Query: 152 IDLSANLFTGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKF 211
+ L N+ G + + + L +L L N LT +P L N C++L ++ L +N+
Sbjct: 447 LKLWLNMLEGEIPQELMYVK-TLETLILDFNDLTGEIP-SGLSN--CTNLNWISLSNNRL 502
Query: 212 SGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRL-SLEKLNLSHNNFSGVLP 263
+G P+++ R E L L +SNN FSG+IP L SL L+L+ N F+G +P
Sbjct: 503 TGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIP 555
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 2e-36
Identities = 63/255 (24%), Positives = 93/255 (36%), Gaps = 48/255 (18%)
Query: 57 NISVPLCQWRGLKWI--STN---GS-PLSCSDISLPQWANL-------SLYKDSSIHLLS 103
NI L R L W+ +TN G+ P + S AN + D
Sbjct: 529 NIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECH 588
Query: 104 IQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVL 163
G +L S + G + S+ +D+S N+ +G +
Sbjct: 589 GAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYI 648
Query: 164 APSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFE 223
I G+ L L+LG N SGS P+ V
Sbjct: 649 PKEI-------------GS---------------MPYLFILNLGHNDISGSIPDEVGDLR 680
Query: 224 ALKELDISNNLFSGSIPEGLTRL-SLEKLNLSHNNFSGVLP---VFSESKFGAEVFEGNS 279
L LD+S+N G IP+ ++ L L +++LS+NN SG +P F F F N
Sbjct: 681 GLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQF--ETFPPAKFLNN- 737
Query: 280 PALCGFPLRDCSGNS 294
P LCG+PL C ++
Sbjct: 738 PGLCGYPLPRCDPSN 752
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 8e-36
Identities = 59/168 (35%), Positives = 75/168 (44%), Gaps = 6/168 (3%)
Query: 100 HLLSIQLPSANLTGSLPREL-GEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANL 158
L + L TG +P L G L L L+ N G +P G S L + LS+N
Sbjct: 270 SLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNN 329
Query: 159 FTGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPE- 217
F+G L L L L N + LP +L N + S L LDL SN FSG
Sbjct: 330 FSGELPMDTLLKMRGLKVLDLSFNEFSGELP-ESLTNLSAS-LLTLDLSSNNFSGPILPN 387
Query: 218 -FVTRFEALKELDISNNLFSGSIPEGLTRLS-LEKLNLSHNNFSGVLP 263
L+EL + NN F+G IP L+ S L L+LS N SG +P
Sbjct: 388 LCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIP 435
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 8e-31
Identities = 48/182 (26%), Positives = 75/182 (41%), Gaps = 15/182 (8%)
Query: 84 SLPQW-ANLSLYKDSSIHLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFE 142
+P+W L +L ++L + + +G++P ELG+ L L LN N GTIP
Sbjct: 505 EIPKWIGRLE-------NLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAA 557
Query: 143 LGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQ 202
+ S ++AN G I N GN L + S
Sbjct: 558 MFKQSG----KIAANFIAGKRYVYIKN-DGMKKECHGAGNLLEFQGIRSEQ-LNRLSTRN 611
Query: 203 YLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRL-SLEKLNLSHNNFSGV 261
++ S + G ++ LD+S N+ SG IP+ + + L LNL HN+ SG
Sbjct: 612 PCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGS 671
Query: 262 LP 263
+P
Sbjct: 672 IP 673
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-30
Identities = 39/155 (25%), Positives = 66/155 (42%), Gaps = 7/155 (4%)
Query: 110 NLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWN 169
LTG +P+ +G L L L+ NS G IP ELG SL +DL+ NLF G + +++
Sbjct: 501 RLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFK 560
Query: 170 LCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELD 229
S ++ N + + N + +F G E + R +
Sbjct: 561 Q-----SGKIAANFIAGKRY-VYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCN 614
Query: 230 ISNNLFSGSIPEGLTRLS-LEKLNLSHNNFSGVLP 263
I++ ++ G + L++S+N SG +P
Sbjct: 615 ITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIP 649
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 62.2 bits (152), Expect = 3e-10
Identities = 20/76 (26%), Positives = 34/76 (44%), Gaps = 5/76 (6%)
Query: 197 TCSD--LQYLDLGSNKFS---GSFPEFVTRFEALKELDISNNLFSGSIPEGLTRLSLEKL 251
TC D + +DL S + + + L+ L +SN+ +GS+ SL L
Sbjct: 46 TCRDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSL 105
Query: 252 NLSHNNFSGVLPVFSE 267
+LS N+ SG + +
Sbjct: 106 DLSRNSLSGPVTTLTS 121
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 4e-45
Identities = 64/319 (20%), Positives = 113/319 (35%), Gaps = 67/319 (21%)
Query: 30 SSDVELLLGKIKSSLQGDDENLLLSSWNISVPLCQ--WRG-----------LKWISTNGS 76
D + LL +IK L G+ L SSW + C W G + + +G
Sbjct: 5 PQDKQALL-QIKKDL-GNPTTL--SSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGL 60
Query: 77 PLSCSDISLPQWANLS------LYKDSSI------------HLLSIQLPSANLTGSLPRE 118
L ANL + +++ L + + N++G++P
Sbjct: 61 NLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDF 120
Query: 119 LGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLR 178
L + L +L + N+L GT+P + +L I N +G + S + S+
Sbjct: 121 LSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMT 180
Query: 179 LHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGS 238
+ N LT +P P N +L ++DL N G + +++ ++ N +
Sbjct: 181 ISRNRLTGKIP-PTFAN---LNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFD 236
Query: 239 IPEGLTRL-SLEKLNLSHNNFSGVLPVFSE-------------------------SKFGA 272
+ + + +L L+L +N G LP +F
Sbjct: 237 LGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDV 295
Query: 273 EVFEGNSPALCGFPLRDCS 291
+ N LCG PL C+
Sbjct: 296 SAYANN-KCLCGSPLPACT 313
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 4e-42
Identities = 76/277 (27%), Positives = 132/277 (47%), Gaps = 27/277 (9%)
Query: 390 YGTAYKAKLADGATIALRLLREGSCKDRSSC------LPVIRQLGKVRHENLIPLRAF-Y 442
+G YK + + T+A++ L D ++ I+ + K +HENL+ L F
Sbjct: 44 FGVVYKGYV-NNTTVAVKKLAAMV--DITTEELKQQFDQEIKVMAKCQHENLVELLGFSS 100
Query: 443 QGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPI 502
G + L+Y Y P+ +L D L G P L+W R KIA G A G+ +L HE
Sbjct: 101 DGD--DLCLVYVYMPNGSLLDRLSCL-DGTPPLSWHMRCKIAQGAANGINFL---HENHH 154
Query: 503 THGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMV--ALAKADGYKAPELQRMKKCS 560
H +++S N+L+D+ F +++++FGL + A ++ + Y APE R + +
Sbjct: 155 IHRDIKSANILLDEAFTAKISDFGLARAS-EKFAQTVMTSRIVGTTAYMAPEALR-GEIT 212
Query: 561 SRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIM-KGIR 619
++D+Y+FG++LLEI+ G R + L I + EE T+E + + K +
Sbjct: 213 PKSDIYSFGVVLLEIITGLPAVDEHREPQL--LLDIKEEIEDEEKTIE----DYIDKKMN 266
Query: 620 SPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEE 656
+ +A C + RP + +V + L+E
Sbjct: 267 DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQE 303
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-36
Identities = 63/300 (21%), Positives = 118/300 (39%), Gaps = 38/300 (12%)
Query: 382 GQVIEKTTYGTAYKAKLADGATIALRLLREGSCKDRSSCLPV--IRQLGKVRHENLIPLR 439
+V + +G +KA+L +A+++ D+ S + L ++HEN++
Sbjct: 29 LEVKARGRFGCVWKAQL-LNEYVAVKIFPIQ---DKQSWQNEYEVYSLPGMKHENILQFI 84
Query: 440 AF---YQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHT 496
+ LI + +L D L V++W IA +ARGLAYLH
Sbjct: 85 GAEKRGTSVDVDLWLITAFHEKGSLSDFLK-----ANVVSWNELCHIAETMARGLAYLHE 139
Query: 497 -------GHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKAD--G 547
GH+ I+H +++SKNVL+ + + + +FGL L A +
Sbjct: 140 DIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGL-ALKFEAGKSAGDTHGQVGTRR 198
Query: 548 YKAPE-----LQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVL 602
Y APE + + R D+YA G++L E+ G E+ + +
Sbjct: 199 YMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAA-DGPVDEY--MLPFEEEIGQ 255
Query: 603 EETTMEVFDMEIMKGIRSPM------EEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEE 656
+ ++ ++ + K R + G+ + C A R + V +++ +
Sbjct: 256 HPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQ 315
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-33
Identities = 61/278 (21%), Positives = 122/278 (43%), Gaps = 33/278 (11%)
Query: 382 GQVIEKTTYGTAYKAKLADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAF 441
+V+ + +G KAK +A++ + S +R + + +RQL +V H N++ L
Sbjct: 13 EEVVGRGAFGVVCKAKW-RAKDVAIKQIESES--ERKAFIVELRQLSRVNHPNIVKLYGA 69
Query: 442 YQGKRGEKL-LIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEI 500
+ L+ +Y +L+++LH P A L ++G+AYLH+
Sbjct: 70 CL----NPVCLVMEYAEGGSLYNVLHGA-EPLPYYTAAHAMSWCLQCSQGVAYLHSMQPK 124
Query: 501 PITHGNVRSKNVLVD-DFFVSRLTEFGLDQLMVPAVADEMVALAKADGYKAPELQRMKKC 559
+ H +++ N+L+ V ++ +FG + M + + APE+
Sbjct: 125 ALIHRDLKPPNLLLVAGGTVLKICDFGTACDI----QTHMTNNKGSAAWMAPEVFEGSNY 180
Query: 560 SSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIR 619
S + DV+++GI+L E++ +KP F ++ + + G R
Sbjct: 181 SEKCDVFSWGIILWEVITRRKP--------FDEIGGPAFRIM----------WAVHNGTR 222
Query: 620 SPMEEGLVQALK-LAMGCCAPVASVRPTMDEVVKQLEE 656
P+ + L + ++ L C + S RP+M+E+VK +
Sbjct: 223 PPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTH 260
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 3e-33
Identities = 63/282 (22%), Positives = 120/282 (42%), Gaps = 36/282 (12%)
Query: 382 GQVIEKTTYGTAYKAKLADGATIALRLLREGSCKDRSSC--LPVIRQLGKVRHENLIPLR 439
+ + G +K + G I +++L+ R S +L H N++P+
Sbjct: 15 LTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVL 73
Query: 440 AFYQGKRGEKL-LIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGH 498
Q LI + P +L+++LH+ V++ ++ K AL +ARG+A+LHT
Sbjct: 74 GACQSPPAPHPTLITHWMPYGSLYNVLHEG--TNFVVDQSQAVKFALDMARGMAFLHT-L 130
Query: 499 EIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKADGYKAPELQRMKK 558
E I + S++V++D+ +R++ + + A + APE + K
Sbjct: 131 EPLIPRHALNSRSVMIDEDMTARISMADVKFSF------QSPGRMYAPAWVAPEALQKKP 184
Query: 559 CSSRT---DVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIM 615
+ D+++F +LL E++ + P F DL + ME+ +
Sbjct: 185 EDTNRRSADMWSFAVLLWELVTREVP--------FADLSN-----------MEIGMKVAL 225
Query: 616 KGIRSPMEEGLVQAL-KLAMGCCAPVASVRPTMDEVVKQLEE 656
+G+R + G+ + KL C + RP D +V LE+
Sbjct: 226 EGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEK 267
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 5e-31
Identities = 71/295 (24%), Positives = 134/295 (45%), Gaps = 38/295 (12%)
Query: 382 GQVIEKTTYGTAYKAKLADGATIALRLLREG--SCKDRSSCLPVIRQLGKVRHENLIPLR 439
+ I ++GT ++A+ G+ +A+++L E + + L + + ++RH N++
Sbjct: 42 KEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIV--- 97
Query: 440 AFYQG--KRGEKL-LIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHT 496
F G + L ++ +Y +L+ LLH + A + L+ RR +A +A+G+ YLH
Sbjct: 98 LFM-GAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQ-LDERRRLSMAYDVAKGMNYLHN 155
Query: 497 GHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKADGYKAPELQRM 556
PI H N++S N+LVD + ++ +FGL +L + + A + APE+ R
Sbjct: 156 -RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK-ASTFLSSKSAAGTPEWMAPEVLRD 213
Query: 557 KKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMK 616
+ + ++DVY+FG++L E+ ++P + +L +V K
Sbjct: 214 EPSNEKSDVYSFGVILWELATLQQP--------WGNLNP-----------AQVVAAVGFK 254
Query: 617 GIRSPMEEGLVQALK-LAMGCCAPVASVRPTMDEVVKQLEE-----NRPRNRSAL 665
R + L + + GC RP+ ++ L P NRS L
Sbjct: 255 CKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPPNRSDL 309
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-30
Identities = 60/310 (19%), Positives = 116/310 (37%), Gaps = 47/310 (15%)
Query: 382 GQVIEKTTYGTAYKAKLADGATIALRLLREGSCKD----RSSCLPVIRQLGKVRHENLIP 437
++I + YG YK L D +A+++ + ++ ++ I ++ + H+N+
Sbjct: 18 LELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEKN-----IYRVPLMEHDNIAR 71
Query: 438 L----RAFYQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAY 493
R E LL+ +Y+P+ +L L +W ++A + RGLAY
Sbjct: 72 FIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS-----LHTSDWVSSCRLAHSVTRGLAY 126
Query: 494 LHT------GHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKAD- 546
LHT ++ I+H ++ S+NVLV + +++FGL + A
Sbjct: 127 LHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAI 186
Query: 547 ------GYKAPE-------LQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDL 593
Y APE L+ + + D+YA G++ EI + G + +
Sbjct: 187 SEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQM 246
Query: 594 PSIVKVAVLEETTMEVFDMEIMKGIR-------SPMEEGLVQALKLAMGCCAPVASVRPT 646
+V T ++ + + R + + C A R T
Sbjct: 247 AFQTEVG-NHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLT 305
Query: 647 MDEVVKQLEE 656
+++ E
Sbjct: 306 AQXAEERMAE 315
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 3e-30
Identities = 65/291 (22%), Positives = 114/291 (39%), Gaps = 48/291 (16%)
Query: 382 GQVIEKTTYGTAYKAKLADGATIALRLLREGSCKDRSSCLPVIRQ----LGKVRHENLIP 437
++I +G Y+A G +A++ R +D S + +RQ ++H N+I
Sbjct: 12 EEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII- 69
Query: 438 LRAFYQG--KRGEKL-LIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYL 494
A G + L L+ ++ L+ +L + A+ IARG+ YL
Sbjct: 70 --ALR-GVCLKEPNLCLVMEFARGGPLNRVLS-----GKRIPPDILVNWAVQIARGMNYL 121
Query: 495 HTGHEIPITHGNVRSKNVLVDDFFVSRLTE--------FGLDQLMVPAVADEMVALAKAD 546
H +PI H +++S N+L+ + FGL + ++ A A
Sbjct: 122 HDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW---HRTTKMSAAGAY 178
Query: 547 GYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETT 606
+ APE+ R S +DV+++G+LL E+L G+ P F +
Sbjct: 179 AWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP--------FRGI-----------DG 219
Query: 607 MEVFDMEIMKGIRSPMEEGLVQAL-KLAMGCCAPVASVRPTMDEVVKQLEE 656
+ V M + P+ + KL C P RP+ ++ QL
Sbjct: 220 LAVAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 4e-30
Identities = 56/291 (19%), Positives = 115/291 (39%), Gaps = 44/291 (15%)
Query: 382 GQVIEKTTYGTAYKAK-LADGATIALRLLREGSCKDRSSCLPVIRQ-------LGKVRHE 433
+ I K +G +K + + D + +A++ L G + + + ++ + + H
Sbjct: 24 EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 434 NLIPLRAFYQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAY 493
N++ L ++ ++ P L+ L D + W+ + ++ L IA G+ Y
Sbjct: 84 NIVKLYGLM---HNPPRMVMEFVPCGDLYHRLLDK---AHPIKWSVKLRLMLDIALGIEY 137
Query: 494 LHTGHEIPITHGNVRSKNVLVDDF-----FVSRLTEFGLDQLMVPAVADEMVALAKADGY 548
+ PI H ++RS N+ + +++ +FGL Q + L +
Sbjct: 138 MQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQS----VHSVSGLLGNFQW 192
Query: 549 KAPEL--QRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETT 606
APE + + + D Y+F ++L IL G+ P F +
Sbjct: 193 MAPETIGAEEESYTEKADTYSFAMILYTILTGEGP--------FDEYSYG---------K 235
Query: 607 MEVFDMEIMKGIRSPMEEGLVQALK-LAMGCCAPVASVRPTMDEVVKQLEE 656
++ +M +G+R + E L+ + C + RP +VK+L E
Sbjct: 236 IKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 1e-29
Identities = 70/312 (22%), Positives = 124/312 (39%), Gaps = 53/312 (16%)
Query: 382 GQVIEKTTYGTAYKAKLADGATIALRLLREGSC--KDRSSCLPVIRQLGKVRHENLIPLR 439
G++I K +G Y + +A+RL+ + + + RHEN++
Sbjct: 38 GELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVV--- 92
Query: 440 AFYQG--KRGEKL-LIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHT 496
F G L +I RTL+ ++ D K VL+ + +IA I +G+ YLH
Sbjct: 93 LFM-GACMSPPHLAIITSLCKGRTLYSVVRDA---KIVLDVNKTRQIAQEIVKGMGYLHA 148
Query: 497 GHEIPITHGNVRSKNVLVDDFFVSRLTEFGL----DQLMVPAVADEMVALAKADGYKAPE 552
I H +++SKNV D+ V +T+FGL L D++ + APE
Sbjct: 149 ---KGILHKDLKSKNVFYDNGKV-VITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPE 204
Query: 553 LQRM---------KKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLE 603
+ R S +DV+A G + E+ + P F P+ +
Sbjct: 205 IIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP--------FKTQPAEAIIWQ-- 254
Query: 604 ETTMEVFDMEIMKGIRSPM-EEGLVQALK-LAMGCCAPVASVRPTMDEVVKQLEENRPRN 661
+ G++ + + G+ + + + + C A RPT +++ LE+ RN
Sbjct: 255 ----------MGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN 304
Query: 662 RSALYSPTETRS 673
R + +S
Sbjct: 305 RRLSHPGHFWKS 316
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 61/310 (19%), Positives = 104/310 (33%), Gaps = 58/310 (18%)
Query: 382 GQVIEKTTYGTAYKAKLADGATIALRLLREGSCKDRSSCL--PVIRQLGKVRHENLIPLR 439
+ + K YG ++ G +A+++ +D S + +RHEN++
Sbjct: 13 LECVGKGRYGEVWRGSW-QGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENIL--- 65
Query: 440 AFY------QGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAY 493
F + + LI Y +L+D L L+ +I L IA GLA+
Sbjct: 66 GFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAH 120
Query: 494 LHT-----GHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKADG- 547
LH + I H +++SKN+LV + + GL + + V G
Sbjct: 121 LHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGT 180
Query: 548 --YKAPEL------QRMKKCSSRTDVYAFGILLLEILIGKKPGK---------SGRNGEF 590
Y APE+ R D++AFG++L E+
Sbjct: 181 KRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPND 240
Query: 591 VDLPSIVKVAVLE----ETTMEVFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPT 646
+ KV ++ F + + M+E C S R T
Sbjct: 241 PSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKE-----------CWYQNPSARLT 289
Query: 647 MDEVVKQLEE 656
+ K L +
Sbjct: 290 ALRIKKTLTK 299
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-28
Identities = 69/303 (22%), Positives = 116/303 (38%), Gaps = 44/303 (14%)
Query: 382 GQVIEKTTYGTAYKAKLADGATIALRLLREGSCKDRSSCL--PVIRQLGKVRHENLIPLR 439
+ I K YG + K G +A+++ + +S I Q +RHEN++
Sbjct: 42 VKQIGKGRYGEVWMGKW-RGEKVAVKVFFT---TEEASWFRETEIYQTVLMRHENIL--- 94
Query: 440 AFY------QGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAY 493
F G + LI DY + +L+D L L+ K+A GL +
Sbjct: 95 GFIAADIKGTGSWTQLYLITDYHENGSLYDYLK-----STTLDAKSMLKLAYSSVSGLCH 149
Query: 494 LHT-----GHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKADG- 547
LHT + I H +++SKN+LV + + GL + + + G
Sbjct: 150 LHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGT 209
Query: 548 --YKAPEL------QRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKV 599
Y PE+ + + D+Y+FG++L E+ G E LP V
Sbjct: 210 KRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGG---IVEEYQLPYHDLV 266
Query: 600 AVLEETTMEVFDMEIMKGIR------SPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653
+ + ++ ++ +K +R +E L Q KL C A + R T V K
Sbjct: 267 P-SDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325
Query: 654 LEE 656
L +
Sbjct: 326 LAK 328
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-28
Identities = 65/310 (20%), Positives = 111/310 (35%), Gaps = 58/310 (18%)
Query: 382 GQVIEKTTYGTAYKAKLADGATIALRLLREGSCKDRSSCL--PVIRQLGKVRHENLIPLR 439
+ I K +G ++ K G +A+++ ++ S I Q +RHEN++
Sbjct: 47 QESIGKGRFGEVWRGKW-RGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENIL--- 99
Query: 440 AFY------QGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAY 493
F G + L+ DY +L D L+ + + K+AL A GLA+
Sbjct: 100 GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEGMIKLALSTASGLAH 154
Query: 494 LH-----TGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKADG- 547
LH T + I H +++SKN+LV + + GL A +A G
Sbjct: 155 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 214
Query: 548 --YKAPEL------QRMKKCSSRTDVYAFGILLLEILIGKKPGK---------SGRNGEF 590
Y APE+ + + R D+YA G++ EI G
Sbjct: 215 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 274
Query: 591 VDLPSIVKVAVLEETTMEV----FDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPT 646
+ + KV ++ + E ++ + M E C + R T
Sbjct: 275 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRE-----------CWYANGAARLT 323
Query: 647 MDEVVKQLEE 656
+ K L +
Sbjct: 324 ALRIKKTLSQ 333
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-27
Identities = 43/230 (18%), Positives = 68/230 (29%), Gaps = 22/230 (9%)
Query: 50 NLLLSSWNISVPLCQWRGLKWISTNGSPLSCSDISLPQWANL-SLYK------------- 95
+ + L+++ + + LS SL
Sbjct: 331 TFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSS 390
Query: 96 --DSSIHLLSIQLPSANLTGSLPRE-LGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEI 152
L + +NL L L ++ + SSL +
Sbjct: 391 NFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVL 450
Query: 153 DLSANLFTGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFS 212
++ N F P I+ L L L L L A + S LQ L++ N F
Sbjct: 451 KMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNS--LSSLQVLNMSHNNFF 507
Query: 213 GSFPEFVTRFEALKELDISNNLFSGSIPEGLTRL--SLEKLNLSHNNFSG 260
+L+ LD S N S + L SL LNL+ N+F+
Sbjct: 508 SLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFAC 557
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-25
Identities = 41/217 (18%), Positives = 70/217 (32%), Gaps = 18/217 (8%)
Query: 57 NISVPLCQWRGLKWISTNGSP------LSCSDISLPQWANLSLYKDSSIHLLSIQLPSAN 110
NI+ C I N LS + + + + L + L
Sbjct: 9 NITY-QCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFP----ELQVLDLSRCE 63
Query: 111 LTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNL 170
+ S L +L L N ++ SSL ++ + I +L
Sbjct: 64 IQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHL 123
Query: 171 CDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALK---- 226
L L + N + + N ++L++LDL SNK + + +
Sbjct: 124 -KTLKELNVAHNLIQSFKLPEYFSN--LTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNL 180
Query: 227 ELDISNNLFSGSIPEGLTRLSLEKLNLSHNNFSGVLP 263
LD+S N + P + L KL L +N S +
Sbjct: 181 SLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVM 217
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-24
Identities = 38/188 (20%), Positives = 64/188 (34%), Gaps = 11/188 (5%)
Query: 78 LSCSDISLPQWANLSLYKDSSIHLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKG 137
S + +L S+ L + + G + + L+ L L+ N +
Sbjct: 333 TSNKGGNAFSEVDLP-----SLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI- 386
Query: 138 TIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNST 197
T+ L +D + + S++ L+ L +
Sbjct: 387 TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRV-AFNGIFNG-- 443
Query: 198 CSDLQYLDLGSNKFSGSF-PEFVTRFEALKELDISNNLFSGSIPEGLTRL-SLEKLNLSH 255
S L+ L + N F +F P+ T L LD+S P L SL+ LN+SH
Sbjct: 444 LSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSH 503
Query: 256 NNFSGVLP 263
NNF +
Sbjct: 504 NNFFSLDT 511
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 1e-20
Identities = 37/168 (22%), Positives = 60/168 (35%), Gaps = 8/168 (4%)
Query: 110 NLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWN 169
+ S LQ L +L F +G+ +L E++++ NL P ++
Sbjct: 87 PIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFS 146
Query: 170 LCDRLVSLRLHGNSLTAALPE--PALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKE 227
L L L N + + L +L LDL N + P L +
Sbjct: 147 NLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLS-LDLSLNPMNFIQPGAFKEIR-LHK 204
Query: 228 LDISNNLFSGSIPE----GLTRLSLEKLNLSHNNFSGVLPVFSESKFG 271
L + NN S ++ + GL L + +L L G L F +S
Sbjct: 205 LTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALE 252
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 6e-20
Identities = 33/152 (21%), Positives = 50/152 (32%), Gaps = 13/152 (8%)
Query: 118 ELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSAN--LFTGVLAPSIWNLCDRLV 175
+ + L S KG F SL +DLS N F G + S + L
Sbjct: 318 QFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGT-TSLK 376
Query: 176 SLRLHGNSLTAALPEPALPNST--CSDLQYLDLGSNKFSGSFP-EFVTRFEALKELDISN 232
L L N + + ++ L++LD + L LDIS+
Sbjct: 377 YLDLSFNGVI------TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISH 430
Query: 233 NLFSGSIPEGLTRL-SLEKLNLSHNNFSGVLP 263
+ L SLE L ++ N+F
Sbjct: 431 THTRVAFNGIFNGLSSLEVLKMAGNSFQENFL 462
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 2e-15
Identities = 22/179 (12%), Positives = 46/179 (25%), Gaps = 12/179 (6%)
Query: 100 HLLSIQLPSANLTGSLPRELGEFSMLQ----SLYLNVNSLKGTIPFELGYSSSLSEIDLS 155
+L + L S + +L + SL L++N + P L ++ L
Sbjct: 150 NLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFK-EIRLHKLTLR 208
Query: 156 ANLFTGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFS--- 212
N + + + L RL S L L + + +
Sbjct: 209 NNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLD 268
Query: 213 ---GSFPEFVTRFEALKELDISNNLFSGSIPEGLTRLSLEKLNLSHNNFSGVLPVFSES 268
+ + + + + L L + F + +S
Sbjct: 269 YYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYN-FGWQHLELVNCKFGQFPTLKLKS 326
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 7e-15
Identities = 33/201 (16%), Positives = 64/201 (31%), Gaps = 30/201 (14%)
Query: 97 SSIHLLSIQLPSANLTGSLPRE-LGEFSMLQSLYLNVNSLKGTIPFELG--------YSS 147
I L + L + + ++ + + + L+ L + + E +
Sbjct: 198 KEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNL 257
Query: 148 SLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNSLTAALPEP---------------- 191
++ E L+ + ++N + S L ++
Sbjct: 258 TIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFG 317
Query: 192 ALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNN--LFSGSIPEGLTRL-SL 248
P L+ L SNK +F E +L+ LD+S N F G + SL
Sbjct: 318 QFPTLKLKSLKRLTFTSNKGGNAFSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSL 375
Query: 249 EKLNLSHNNFSGVLPVFSESK 269
+ L+LS N + F +
Sbjct: 376 KYLDLSFNGVITMSSNFLGLE 396
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 1e-11
Identities = 24/147 (16%), Positives = 45/147 (30%), Gaps = 29/147 (19%)
Query: 110 NLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWN 169
L P S LQ L ++ N+ F +SL +D S N + +
Sbjct: 481 QLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQH 540
Query: 170 LCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFP--EFVTRFEALKE 227
S L +L+L N F+ + F+ + ++
Sbjct: 541 F---------------------------PSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQ 573
Query: 228 LDISNNLFSGSIPEGLTRLSLEKLNLS 254
L + + P + + LN++
Sbjct: 574 LLVEVERMECATPSDKQGMPVLSLNIT 600
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 61/295 (20%), Positives = 125/295 (42%), Gaps = 41/295 (13%)
Query: 370 EHLTLEDVLNATGQVIEKTTYGTAYKAKLADGATIALRLLREGSCKDRS--SCLPVIRQL 427
+T+ + +G +GT YK K +A+++L + + + + L
Sbjct: 24 GQITVGQRI-GSGS------FGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVL 74
Query: 428 GKVRHENLIPLRAFYQGKRGEKL-LIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALG 486
K RH N++ F +L ++ + +L+ LH + + IA
Sbjct: 75 RKTRHVNIL---LFMGYSTAPQLAIVTQWCEGSSLYHHLHA---SETKFEMKKLIDIARQ 128
Query: 487 IARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVP-AVADEMVALAKA 545
ARG+ YLH I H +++S N+ + + ++ +FGL + + + L+ +
Sbjct: 129 TARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGS 185
Query: 546 DGYKAPELQRMK---KCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVL 602
+ APE+ RM+ S ++DVYAFGI+L E++ G+ P + ++ + ++
Sbjct: 186 ILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP--------YSNINNRDQI--- 234
Query: 603 EETTMEVFDMEIMKGIRSPMEEGLVQALK-LAMGCCAPVASVRPTMDEVVKQLEE 656
+E+ + S + + +K L C RP+ ++ ++EE
Sbjct: 235 ----IEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEE 285
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 6e-27
Identities = 58/305 (19%), Positives = 108/305 (35%), Gaps = 53/305 (17%)
Query: 370 EHLTLEDVLNATGQVIEKTTYGTAYKAKL-ADGATIALRLLREGSCKDRSSCLPVIRQLG 428
L +VL G +G A K G + ++ L + + + L ++ +
Sbjct: 10 SDLIHGEVL-GKGC------FGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMR 62
Query: 429 KVRHENLIPLRAFYQG--KRGEKL-LIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIAL 485
+ H N++ G + ++L I +Y TL ++ W++R A
Sbjct: 63 CLEHPNVLKF----IGVLYKDKRLNFITEYIKGGTLRGIIKSM---DSQYPWSQRVSFAK 115
Query: 486 GIARGLAYLHTGHEIPITHGNVRSKNVLVD--------DFFVSRL-----TEFGLDQLMV 532
IA G+AYLH + I H ++ S N LV DF ++RL T+ + +
Sbjct: 116 DIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLK 172
Query: 533 PAVADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVD 592
+ + + APE+ + + DV++FGI+L EI+
Sbjct: 173 KPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDY------- 225
Query: 593 LPSIVKVAVLEETTMEVFDMEIMKGIRSPMEEGLVQAL-KLAMGCCAPVASVRPTMDEVV 651
LP + + + + + + CC RP+ ++
Sbjct: 226 LPRTMDFGLNVR-----------GFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLE 274
Query: 652 KQLEE 656
LE
Sbjct: 275 HWLET 279
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 3e-26
Identities = 41/168 (24%), Positives = 57/168 (33%), Gaps = 18/168 (10%)
Query: 108 SANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGV----- 162
L + + S+ L+ N + S LS I+L N+ T +
Sbjct: 418 DGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSL 477
Query: 163 --LAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVT 220
+ N L S+ L N LT L +T L +DL N FS FP
Sbjct: 478 KDENENFKNTY-LLTSIDLRFNKLT-KLS-DDFRATTLPYLVGIDLSYNSFSK-FPTQPL 533
Query: 221 RFEALKELDISNNL------FSGSIPEGLTRL-SLEKLNLSHNNFSGV 261
LK I N PEG+T SL +L + N+ V
Sbjct: 534 NSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRKV 581
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 6e-26
Identities = 35/248 (14%), Positives = 73/248 (29%), Gaps = 32/248 (12%)
Query: 36 LLGKIKSSLQGD--DENLLLSSWNI-SVP--LCQWRGLKWISTNGSPLSCSDISLPQWAN 90
IK S + D + S NI V + + L+ +
Sbjct: 171 QQKSIKKSSRITLKDTQIGQLSNNITFVSKAVMRLTKLRQ-------FYMGNSPFVAENI 223
Query: 91 LSLYKDSSIHLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLS 150
+++ + + + L + + +P L +
Sbjct: 224 CEAWENENSEYA-------QQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQ 276
Query: 151 EIDLSANLFTGVLA-PSIWN------LCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQY 203
I+++ N W + +++ + + N+L E +L L
Sbjct: 277 LINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQK--MKKLGM 334
Query: 204 LDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRL--SLEKLNLSHNNFSGV 261
L+ N+ G P F L L+++ N + IP +E L+ +HN +
Sbjct: 335 LECLYNQLEGKLPAF-GSEIKLASLNLAYNQITE-IPANFCGFTEQVENLSFAHNKLKYI 392
Query: 262 LPVFSESK 269
+F
Sbjct: 393 PNIFDAKS 400
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-23
Identities = 25/173 (14%), Positives = 56/173 (32%), Gaps = 13/173 (7%)
Query: 110 NLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWN 169
L G LP G L SL L N + G++ + + + N +
Sbjct: 341 QLEGKLP-AFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAK 399
Query: 170 LCDRLVSLRLHGNSLTAALPE--PALPNST--CSDLQYLDLGSNKFSGSFPEFVTRFEAL 225
+ ++ N + + + L + ++ ++L +N+ S E + L
Sbjct: 400 SVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPL 459
Query: 226 KELDISNNLFSG-------SIPEGLTRL-SLEKLNLSHNNFSGVLPVFSESKF 270
+++ N+ + E L ++L N + + F +
Sbjct: 460 SSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTL 512
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-23
Identities = 37/318 (11%), Positives = 94/318 (29%), Gaps = 59/318 (18%)
Query: 25 SPASASSDVELLLGKIKSSLQGDDENL------LLSSWNISVPLCQWRGLKWISTNGSP- 77
S + L L +I +L G + + ++WN + L W +S N +
Sbjct: 23 SRTAEYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSLNSNGR 82
Query: 78 -----------------------------LSCSDISLPQWANLSLYKDSSIHLLSIQLPS 108
L + + +++ Q
Sbjct: 83 VTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMR 142
Query: 109 ANLTGSLPRELG--EFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPS 166
+ + +FS L +N + + +I + ++I +N T ++ +
Sbjct: 143 MHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKA 201
Query: 167 IWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALK 226
+ L +L + + A C + + + + + L
Sbjct: 202 VMRLT-KLRQFYMGNSPFVAENI--------CEAWENENSEYAQQYKTEDLKWDNLKDLT 252
Query: 227 ELDISNNLFSGSIPEGLTRL-SLEKLNLSHNNFSGVLPVFSESKFGAEVFEGNSPALCGF 285
++++ N +P L L ++ +N++ N + + + A+ G
Sbjct: 253 DVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEK------ 306
Query: 286 PLR--DCSGNSRLSSGAI 301
++ N+ L + +
Sbjct: 307 -IQIIYIGYNN-LKTFPV 322
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-22
Identities = 37/198 (18%), Positives = 65/198 (32%), Gaps = 23/198 (11%)
Query: 81 SDISLPQWANLSLYKDSSIHLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKG--- 137
+ + L I++ SI L + ++ S L S+ L N L
Sbjct: 415 GSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPK 474
Query: 138 ----TIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPAL 193
+ L+ IDL N T + LV + L NS +
Sbjct: 475 NSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK------F 528
Query: 194 PNS--TCSDLQYLDLG------SNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTR 245
P S L+ + N+ +PE +T +L +L I +N + E +T
Sbjct: 529 PTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIR-KVNEKITP 587
Query: 246 LSLEKLNLSHNNFSGVLP 263
++ L++ N +
Sbjct: 588 -NISVLDIKDNPNISIDL 604
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 9e-18
Identities = 29/158 (18%), Positives = 46/158 (29%), Gaps = 16/158 (10%)
Query: 108 SANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSS--SLSEIDLSANLFTGVLAP 165
N +L S+ L N L + + ++ L IDLS N F+
Sbjct: 473 PKNSLKDENENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFSK-FPT 530
Query: 166 SIWNLC-----DRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVT 220
N GN PE + + C L L +GSN +
Sbjct: 531 QPLNSSTLKGFGIRNQRDAQGNRTLREWPE-GI--TLCPSLTQLQIGSNDIRKVNEKI-- 585
Query: 221 RFEALKELDISNNLFSGSIPEGL-TRLSLEKLNLSHNN 257
+ LDI +N + + L ++
Sbjct: 586 -TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDK 622
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 8e-14
Identities = 24/142 (16%), Positives = 41/142 (28%), Gaps = 17/142 (11%)
Query: 100 HLLSIQLPSANLTGSLPREL--GEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSAN 157
L SI L LT L + L + L+ NS P + SS+L +
Sbjct: 489 LLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQ 546
Query: 158 L------FTGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKF 211
I C L L++ N + + ++ LD+ N
Sbjct: 547 RDAQGNRTLREWPEGITL-CPSLTQLQIGSNDIRK------VNEKITPNISVLDIKDNPN 599
Query: 212 SGSFPEFVTRFEALKELDISNN 233
+V + + +
Sbjct: 600 ISIDLSYVCPYIEAGMYMLFYD 621
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 3e-26
Identities = 37/158 (23%), Positives = 59/158 (37%), Gaps = 6/158 (3%)
Query: 110 NLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWN 169
L+ + + L L+L NS++ +L +DLS N + +
Sbjct: 84 ELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQ 143
Query: 170 LCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELD 229
L + L L L N + A L L S L+ L+L SN+ P L L
Sbjct: 144 L-ENLQELLLSNNKIQA-LKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLF 201
Query: 230 ISNNLFSGSIPE----GLTRLSLEKLNLSHNNFSGVLP 263
++N S+ E L S+ L+LS++ S
Sbjct: 202 LNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSN 239
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-23
Identities = 34/157 (21%), Positives = 60/157 (38%), Gaps = 7/157 (4%)
Query: 110 NLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWN 169
++ P + ML+ L L N L + ++L+E+ L +N +
Sbjct: 60 TISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVK 119
Query: 170 LCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFE--ALKE 227
L++L L N L+ + +LQ L L +NK E + F +LK+
Sbjct: 120 Q-KNLITLDLSHNGLS-STKLGTQVQ--LENLQELLLSNNKIQALKSEELDIFANSSLKK 175
Query: 228 LDISNNLFSGSIPEGLTRL-SLEKLNLSHNNFSGVLP 263
L++S+N P + L L L++ L
Sbjct: 176 LELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLT 212
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-23
Identities = 37/171 (21%), Positives = 63/171 (36%), Gaps = 10/171 (5%)
Query: 100 HLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLF 159
+L + L S ++ + L +L L+ N L T +L E+ LS N
Sbjct: 98 NLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKI 157
Query: 160 TGVLAPSIWNLCDR-LVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEF 218
+ + + + L L L N + L L L + + S E
Sbjct: 158 QALKSEELDIFANSSLKKLELSSNQIK-EFSPGCFHA--IGRLFGLFLNNVQLGPSLTEK 214
Query: 219 VTRFEA---LKELDISNNLFSGSIPE---GLTRLSLEKLNLSHNNFSGVLP 263
+ A ++ L +SN+ S + GL +L L+LS+NN + V
Sbjct: 215 LCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGN 265
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-23
Identities = 39/167 (23%), Positives = 59/167 (35%), Gaps = 7/167 (4%)
Query: 100 HLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLF 159
++ + L L +S L SL + N++ P L ++L N
Sbjct: 26 NITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNEL 85
Query: 160 TGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFV 219
+ + + L L L NS+ + +L LDL N S +
Sbjct: 86 SQLSDKTFAFC-TNLTELHLMSNSIQ-KIKNNPF--VKQKNLITLDLSHNGLSSTKLGTQ 141
Query: 220 TRFEALKELDISNNLFSGSIPEGLTRL---SLEKLNLSHNNFSGVLP 263
+ E L+EL +SNN E L SL+KL LS N P
Sbjct: 142 VQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSP 188
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 7e-23
Identities = 31/173 (17%), Positives = 54/173 (31%), Gaps = 6/173 (3%)
Query: 110 NLTGSLPRELGEF--SMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSI 167
+ EL F S L+ L L+ N +K P L + L+ L +
Sbjct: 156 KIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKL 215
Query: 168 WNLCD--RLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEAL 225
+ +L L + L+ ++L LDL N + + L
Sbjct: 216 CLELANTSIRNLSLSNSQLST-TSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQL 274
Query: 226 KELDISNNLFSGSIPEGLTRL-SLEKLNLSHNNFSGVLPVFSESKFGAEVFEG 277
+ + N L L ++ LNL + + + S K F+
Sbjct: 275 EYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQW 327
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 1e-22
Identities = 34/177 (19%), Positives = 63/177 (35%), Gaps = 14/177 (7%)
Query: 100 HLLSIQLPSANLTGSLPRELG--EFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSAN 157
+ ++ L ++ L+ + +++ L L L+ N+L + L L N
Sbjct: 223 SIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYN 282
Query: 158 LFTGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPN------STCSDLQYLDLGSNKF 211
+ + S+ L + L L + ++ +LP L++L++ N
Sbjct: 283 NIQHLFSHSLHGL-FNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDI 341
Query: 212 SGSFPEFVTRFEALKELDISNNLFSGSIPE-----GLTRLSLEKLNLSHNNFSGVLP 263
G T LK L +SN+ S L L LNL+ N S +
Sbjct: 342 PGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIES 398
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-22
Identities = 36/166 (21%), Positives = 65/166 (39%), Gaps = 11/166 (6%)
Query: 103 SIQLPSANLTG----SLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANL 158
++ A+ + +P +L + + L L N L+ S L+ +D+ N
Sbjct: 3 TVSHEVADCSHLKLTQVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNT 60
Query: 159 FTGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEF 218
+ + L L L L N L+ L + C++L L L SN
Sbjct: 61 ISKLEPELCQKL-PMLKVLNLQHNELS-QLSDKTFAF--CTNLTELHLMSNSIQKIKNNP 116
Query: 219 VTRFEALKELDISNNLFSGSIPEGLTRL-SLEKLNLSHNNFSGVLP 263
+ + L LD+S+N S + +L +L++L LS+N +
Sbjct: 117 FVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKS 162
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 4e-22
Identities = 44/196 (22%), Positives = 69/196 (35%), Gaps = 12/196 (6%)
Query: 78 LSCSDISLPQWANLSLYKDSSIHLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKG 137
LS S SL N + + L + L ++ L+ L L +N +
Sbjct: 360 LSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQ 419
Query: 138 TIPF-ELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNS 196
+ E ++ EI LS N + + S + L L L +L + P
Sbjct: 420 ELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALV-PSLQRLMLRRVALK-NVDSSPSPFQ 477
Query: 197 TCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNN--------LFSGSIPEGLTRLS- 247
+L LDL +N + + + E L+ LD+ +N G L LS
Sbjct: 478 PLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSH 537
Query: 248 LEKLNLSHNNFSGVLP 263
L LNL N F +
Sbjct: 538 LHILNLESNGFDEIPV 553
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 5e-22
Identities = 40/163 (24%), Positives = 57/163 (34%), Gaps = 11/163 (6%)
Query: 110 NLTGSLPRELGEFSMLQSLYLNVNSLKG--TIPFELGYSSSLSEIDLSANLFTGVLAPSI 167
LQ L L +LK + P +L+ +DLS N + +
Sbjct: 441 KYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDML 500
Query: 168 WNLCDRLVSLRLHGNSLTAALPEPALPN------STCSDLQYLDLGSNKFSGSFPEFVTR 221
L ++L L L N+L L + A P S L L+L SN F E
Sbjct: 501 EGL-EKLEILDLQHNNLAR-LWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKD 558
Query: 222 FEALKELDISNNLFSGSIPEGLTRL-SLEKLNLSHNNFSGVLP 263
LK +D+ N + SL+ LNL N + V
Sbjct: 559 LFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEK 601
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 2e-21
Identities = 31/171 (18%), Positives = 55/171 (32%), Gaps = 8/171 (4%)
Query: 96 DSSIHLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLS 155
+ + A+L L+ L + N + G +L + LS
Sbjct: 302 NLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLS 361
Query: 156 ANLFTGVLAPSI--WNLCDR-LVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFS 212
+ + + +L L L L N ++ + A S L+ LDLG N+
Sbjct: 362 NSFTSLRTLTNETFVSLAHSPLHILNLTKNKIS-KIESDAF--SWLGHLEVLDLGLNEIG 418
Query: 213 GSFPEFV-TRFEALKELDISNNLFSGSIPEGLTRL-SLEKLNLSHNNFSGV 261
E + E+ +S N + + SL++L L V
Sbjct: 419 QELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNV 469
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 4e-21
Identities = 33/165 (20%), Positives = 56/165 (33%), Gaps = 14/165 (8%)
Query: 110 NLTGSLP-RELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGV-LAPSI 167
+ L +E + +YL+ N SL + L V +PS
Sbjct: 416 EIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSP 475
Query: 168 WNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFS--------GSFPEFV 219
+ L L L N++ + + L L+ LDL N + G F+
Sbjct: 476 FQPLRNLTILDLSNNNIAN-INDDMLEG--LEKLEILDLQHNNLARLWKHANPGGPIYFL 532
Query: 220 TRFEALKELDISNNLFSGSIPEGLTRL-SLEKLNLSHNNFSGVLP 263
L L++ +N F E L L+ ++L NN + +
Sbjct: 533 KGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPA 577
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 4e-19
Identities = 33/174 (18%), Positives = 53/174 (30%), Gaps = 14/174 (8%)
Query: 101 LLSIQLPSANLTG--SLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANL 158
L + L L S P L L L+ N++ L L +DL N
Sbjct: 456 LQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNN 515
Query: 159 FT-------GVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKF 211
L L L N +P + +L+ +DLG N
Sbjct: 516 LARLWKHANPGGPIYFLKGLSHLHILNLESNGFDE-IPVEVFKD--LFELKIIDLGLNNL 572
Query: 212 SGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRL--SLEKLNLSHNNFSGVLP 263
+ +LK L++ NL + + +L +L++ N F
Sbjct: 573 NTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCE 626
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 1e-08
Identities = 26/141 (18%), Positives = 41/141 (29%), Gaps = 5/141 (3%)
Query: 49 ENLLLS----SWNISVPLCQWRGLKWISTNGSPLSCSDISLPQWANLSLYKDSSIHLLSI 104
L LS + L L+ + + L+ + K S HL +
Sbjct: 483 TILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLS-HLHIL 541
Query: 105 QLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLA 164
L S + L+ + L +N+L SL ++L NL T V
Sbjct: 542 NLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEK 601
Query: 165 PSIWNLCDRLVSLRLHGNSLT 185
L L + N
Sbjct: 602 KVFGPAFRNLTELDMRFNPFD 622
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-25
Identities = 30/183 (16%), Positives = 50/183 (27%), Gaps = 17/183 (9%)
Query: 98 SIHLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSAN 157
++ A + L + L +P L L ++++ N
Sbjct: 466 AVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACN 525
Query: 158 LFTGV---------LAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGS 208
LA ++ + N+L +L L LD
Sbjct: 526 RGISAAQLKADWTRLADDEDTGP-KIQIFYMGYNNLEEFPASASLQK--MVKLGLLDCVH 582
Query: 209 NKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRL--SLEKLNLSHNNFSGVLPVFS 266
NK F L +L + N IPE +E L SHN + +F+
Sbjct: 583 NKVR-HLEAF-GTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLKYIPNIFN 639
Query: 267 ESK 269
Sbjct: 640 AKS 642
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 103 bits (257), Expect = 7e-23
Identities = 35/224 (15%), Positives = 71/224 (31%), Gaps = 26/224 (11%)
Query: 84 SLPQWANLSLYKDSSIHLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLK------- 136
S + + S+ I+ ++ L + S + ++ L+ N +
Sbjct: 658 SEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSL 717
Query: 137 GTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNS 196
+ L+ IDL N T + L ++ + N ++ P
Sbjct: 718 KPKDGNYKNTYLLTTIDLRFNKLTSLSDDFRATTLPYLSNMDVSYNCFSS------FPTQ 771
Query: 197 --TCSDLQYLDL------GSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRLSL 248
S L+ + N+ +P +T +L +L I +N + E LT L
Sbjct: 772 PLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIR-KVDEKLTP-QL 829
Query: 249 EKLNLSHNNFSGV--LPVFSESKFGAEVFEGNS-PALCGFPLRD 289
L+++ N + V + G V + + G
Sbjct: 830 YILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQDIRGCDALG 873
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-22
Identities = 29/272 (10%), Positives = 70/272 (25%), Gaps = 54/272 (19%)
Query: 23 SSSPASASSDVELLLGKIKSSLQGD---------DENLLLSSWNISVPLCQWRGLKWIST 73
+ L I +L G + + +WN + L W +
Sbjct: 260 QLKETAEYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDL 319
Query: 74 NGSPLSCSDISLPQWANLSLYKDSSIHLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVN 133
+ + + + L G +P +G+ + L+ L +
Sbjct: 320 DNNG----------------------RVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTH 357
Query: 134 SLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPAL 193
S + + + + + RL L +++ +
Sbjct: 358 SETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPI 417
Query: 194 PNSTCSDLQYLDLG--SNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRL----- 246
+ L+ +G +N+ + + + R L+ + +N+ F+
Sbjct: 418 KKDSRISLKDTQIGNLTNRIT-FISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDY 476
Query: 247 ---------------SLEKLNLSHNNFSGVLP 263
L + L + LP
Sbjct: 477 AKQYENEELSWSNLKDLTDVELYNCPNMTQLP 508
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 93.4 bits (232), Expect = 8e-20
Identities = 23/168 (13%), Positives = 50/168 (29%), Gaps = 13/168 (7%)
Query: 114 SLPRELGEFSMLQSLYLNVNSLKGTIPFELGY-SSSLSEIDLSANLFTGVLAPSIWNLCD 172
L G L L L+ N ++ IP + + + + S N +
Sbjct: 587 HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVY 644
Query: 173 RLVSLRLHGNSLTAALPE--PALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDI 230
+ S+ N + + ++ + + + L N+ E + + +
Sbjct: 645 VMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIIL 704
Query: 231 SNNLFS-------GSIPEGLTRL-SLEKLNLSHNNFSGVLPVFSESKF 270
SNNL + L ++L N + + F +
Sbjct: 705 SNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTSLSDDFRATTL 752
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 8e-22
Identities = 43/189 (22%), Positives = 64/189 (33%), Gaps = 7/189 (3%)
Query: 78 LSCSDISLPQWANLSLYKDSSIHLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKG 137
+ D+ + + + SI L FS LQ L L L
Sbjct: 233 GTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS- 291
Query: 138 TIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNST 197
+P L S+L ++ LSAN F + S N L L + GN+ L L N
Sbjct: 292 ELPSGLVGLSTLKKLVLSANKFENLCQISASNF-PSLTHLSIKGNTKRLELGTGCLEN-- 348
Query: 198 CSDLQYLDLGSNK--FSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRL-SLEKLNLS 254
+L+ LDL + S + L+ L++S N E LE L+L+
Sbjct: 349 LENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLA 408
Query: 255 HNNFSGVLP 263
Sbjct: 409 FTRLKVKDA 417
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 3e-20
Identities = 49/188 (26%), Positives = 72/188 (38%), Gaps = 6/188 (3%)
Query: 78 LSCSDISLPQWANLSLYKDSSIHLLSIQLPSANLTGSLPRE-LGEFSMLQSLYLNVNSLK 136
LS DI NL L S + L++ S N SL E E L+ L L LK
Sbjct: 357 LSHDDIETSDCCNLQLRNLSHLQSLNL---SYNEPLSLKTEAFKECPQLELLDLAFTRLK 413
Query: 137 GTIPFE-LGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPN 195
L ++LS +L + +++ L L L GN +
Sbjct: 414 VKDAQSPFQNLHLLKVLNLSHSLLDI-SSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSL 472
Query: 196 STCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRLSLEKLNLSH 255
T L+ L L S T + + +D+S+N + S E L+ L LNL+
Sbjct: 473 QTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIYLNLAS 532
Query: 256 NNFSGVLP 263
N+ S +LP
Sbjct: 533 NHISIILP 540
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 3e-19
Identities = 39/190 (20%), Positives = 61/190 (32%), Gaps = 14/190 (7%)
Query: 78 LSCSDISLPQ-WANLSLYKDSSIHLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLK 136
+C ++ L + L +S L L L L L +
Sbjct: 17 YNCENLGLNEIPGTLP----NSTECLEFS--FNVLPTIQNTTFSRLINLTFLDLTRCQIY 70
Query: 137 GTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNS 196
L + L+AN + ++ L L ++ ++ L N
Sbjct: 71 WIHEDTFQSQHRLDTLVLTANPLIFMAETALSGP-KALKHLFFIQTGIS-SIDFIPLHN- 127
Query: 197 TCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPE---GLTRLSLEKLNL 253
L+ L LGSN S E LK LD NN E L + + LNL
Sbjct: 128 -QKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNL 186
Query: 254 SHNNFSGVLP 263
+ N+ +G+ P
Sbjct: 187 NGNDIAGIEP 196
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 8e-19
Identities = 25/167 (14%), Positives = 52/167 (31%), Gaps = 6/167 (3%)
Query: 100 HLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLF 159
L ++ L + L L L+ L+ + L +L + L +N
Sbjct: 82 RLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHI 141
Query: 160 TGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFV 219
+ + P + ++L L N++ L + + + + L+L N +
Sbjct: 142 SSIKLPKGFPT-EKLKVLDFQNNAIH-YLSKEDMSSLQQATNLSLNLNGNDIA-GIEPGA 198
Query: 220 TRFEALKELDISNNLFSGSIPEGLTRL---SLEKLNLSHNNFSGVLP 263
+ L+ I +GL SL + + P
Sbjct: 199 FDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISP 245
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 8e-19
Identities = 40/174 (22%), Positives = 63/174 (36%), Gaps = 9/174 (5%)
Query: 100 HLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTI-PFELGYSSSLSEIDLSANL 158
L + L + F L L + N+ + + L +L E+DLS +
Sbjct: 302 TLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDD 361
Query: 159 FT--GVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFP 216
+ NL L SL L N + L A C L+ LDL +
Sbjct: 362 IETSDCCNLQLRNL-SHLQSLNLSYNEPLS-LKTEAFKE--CPQLELLDLAFTRLKVKDA 417
Query: 217 E-FVTRFEALKELDISNNLFSGSIPEGLTRL-SLEKLNLSHNNFSGVLPVFSES 268
+ LK L++S++L S + L +L+ LNL N+F + S
Sbjct: 418 QSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNS 471
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 1e-18
Identities = 36/166 (21%), Positives = 57/166 (34%), Gaps = 4/166 (2%)
Query: 100 HLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLF 159
L + L + +L+ LP L S L+ L L+ N + SL+ + + N
Sbjct: 279 GLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTK 337
Query: 160 TGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFV 219
L + L L L + + L S LQ L+L N+ E
Sbjct: 338 RLELGTGCLENLENLRELDLSHDDIE-TSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAF 396
Query: 220 TRFEALKELDISNNLFSGSIPEG-LTRL-SLEKLNLSHNNFSGVLP 263
L+ LD++ + L L+ LNLSH+
Sbjct: 397 KECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSE 442
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 9e-18
Identities = 28/157 (17%), Positives = 51/157 (32%), Gaps = 5/157 (3%)
Query: 110 NLTGSLPRELGEFSMLQSLYLNVNSLK-GTIPFELGYSSSLSEIDLSANLFTGVLAPSIW 168
+ ++ +L LN+N I S+ ++ V+ +
Sbjct: 164 AIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLK 223
Query: 169 NLC-DRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKE 227
N L + ++ ++L + F F L+E
Sbjct: 224 NSTIQSLWLGTFEDMDDED-ISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQE 282
Query: 228 LDISNNLFSGSIPEGLTRL-SLEKLNLSHNNFSGVLP 263
LD++ S +P GL L +L+KL LS N F +
Sbjct: 283 LDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQ 318
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 2e-17
Identities = 28/166 (16%), Positives = 52/166 (31%), Gaps = 6/166 (3%)
Query: 100 HLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLF 159
+L + L + L +L L N L L +L +
Sbjct: 58 NLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGI 117
Query: 160 TGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFV 219
+ + + N L SL L N ++ ++ P L+ LD +N E +
Sbjct: 118 SSIDFIPLHNQ-KTLESLYLGSNHIS-SIKLPKGFP--TEKLKVLDFQNNAIHYLSKEDM 173
Query: 220 TRFEALK--ELDISNNLFSGSIPEGLTRLSLEKLNLSHNNFSGVLP 263
+ + L+++ N +G P + LN V+
Sbjct: 174 SSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIF 219
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 2e-17
Identities = 29/155 (18%), Positives = 59/155 (38%), Gaps = 8/155 (5%)
Query: 110 NLTGSLPRE-LGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGV--LAPS 166
L + +L+ L L+ + L + +L ++L N F +
Sbjct: 411 RLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTN 470
Query: 167 IWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALK 226
RL L L L++ + + A + + ++DL N+ + S E ++ + +
Sbjct: 471 SLQTLGRLEILVLSFCDLSS-IDQHAFTS--LKMMNHVDLSHNRLTSSSIEALSHLKGI- 526
Query: 227 ELDISNNLFSGSIPEGLTRL-SLEKLNLSHNNFSG 260
L++++N S +P L L +NL N
Sbjct: 527 YLNLASNHISIILPSLLPILSQQRTINLRQNPLDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 9e-16
Identities = 28/183 (15%), Positives = 53/183 (28%), Gaps = 26/183 (14%)
Query: 110 NLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWN 169
++ L L+SLYL N + + + L +D N + + +
Sbjct: 116 GISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSS 175
Query: 170 LCD-RLVSLRLHGNSLTAALPE----------------------PALPNSTCSDLQYLDL 206
L +SL L+GN + P L NST L
Sbjct: 176 LQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTF 235
Query: 207 GSNKFSGSFPEFVTRFEA--LKELDISNNLFSGSIPEGLTRL-SLEKLNLSHNNFSGVLP 263
P ++ +++ + F L++L+L+ + S +
Sbjct: 236 EDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSELPS 295
Query: 264 VFS 266
Sbjct: 296 GLV 298
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 1e-12
Identities = 25/132 (18%), Positives = 42/132 (31%), Gaps = 8/132 (6%)
Query: 110 NLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFE---LGYSSSLSEIDLSANLFTGVLAPS 166
L S + LQ L L N + L L + LS + +
Sbjct: 436 LLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSS-IDQH 494
Query: 167 IWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALK 226
+ + + L N LT+ AL + YL+L SN S P + +
Sbjct: 495 AFTSLKMMNHVDLSHNRLTS-SSIEALSHLK---GIYLNLASNHISIILPSLLPILSQQR 550
Query: 227 ELDISNNLFSGS 238
+++ N +
Sbjct: 551 TINLRQNPLDCT 562
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 2e-09
Identities = 16/89 (17%), Positives = 27/89 (30%), Gaps = 7/89 (7%)
Query: 176 SLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLF 235
+ L +P LPNS + L+ N +R L LD++
Sbjct: 16 TYNCENLGLNE-IP-GTLPNS----TECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQI 69
Query: 236 SGSIPEGLTRL-SLEKLNLSHNNFSGVLP 263
+ L+ L L+ N +
Sbjct: 70 YWIHEDTFQSQHRLDTLVLTANPLIFMAE 98
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 9e-22
Identities = 34/168 (20%), Positives = 54/168 (32%), Gaps = 6/168 (3%)
Query: 100 HLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFE-LGYSSSLSEIDLSANL 158
L + L S N + LQ L ++LK F L +D+S
Sbjct: 377 SLRHLDL-SFNGAIIMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTN 435
Query: 159 FTGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEF 218
L L +L++ GNS N ++L +LDL +
Sbjct: 436 TKIDFDGIFLGL-TSLNTLKMAGNSFKDNTLSNVFAN--TTNLTFLDLSKCQLEQISWGV 492
Query: 219 VTRFEALKELDISNNLFSGSIPEGLTRL-SLEKLNLSHNNFSGVLPVF 265
L+ L++S+N +L SL L+ S N +
Sbjct: 493 FDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGIL 540
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 1e-19
Identities = 27/152 (17%), Positives = 47/152 (30%), Gaps = 5/152 (3%)
Query: 110 NLTGSLPRE-LGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIW 168
L L L ++ + K +SL+ + ++ N F +++
Sbjct: 410 TLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVF 469
Query: 169 NLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKEL 228
L L L L + LQ L++ N + +L L
Sbjct: 470 ANTTNLTFLDLSKCQLE-QISWGVFDT--LHRLQLLNMSHNNLLFLDSSHYNQLYSLSTL 526
Query: 229 DISNNLFSGSIPEGLTRL-SLEKLNLSHNNFS 259
D S N S SL NL++N+ +
Sbjct: 527 DCSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 4e-18
Identities = 30/158 (18%), Positives = 48/158 (30%), Gaps = 10/158 (6%)
Query: 110 NLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWN 169
L FS LQ L L+ ++ LS + L+ N S
Sbjct: 43 PLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSG 102
Query: 170 LCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSG-SFPEFVTRFEALKEL 228
L L +L L +L + L+ L++ N P + + L +
Sbjct: 103 L-TSLENLVAVETKLA-SLESFPIGQ--LITLKKLNVAHNFIHSCKLPAYFSNLTNLVHV 158
Query: 229 DISNNLFSGSIPEGLTRL-----SLEKLNLSHNNFSGV 261
D+S N L L L++S N +
Sbjct: 159 DLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFI 196
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 8e-18
Identities = 32/177 (18%), Positives = 59/177 (33%), Gaps = 8/177 (4%)
Query: 100 HLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLF 159
HL ++ L + P + L++L L F +G +L +++++ N
Sbjct: 81 HLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFI 140
Query: 160 TGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPN--STCSDLQYLDLGSNKFSGSFPE 217
P+ ++ LV + L N + + L LD+ N +
Sbjct: 141 HSCKLPAYFSNLTNLVHVDLSYNYIQ-TITVNDLQFLRENPQVNLSLDMSLNPID-FIQD 198
Query: 218 FVTRFEALKELDISNNLFSGSIPEGLTR--LSLEKLNLSHNNFSGV--LPVFSESKF 270
+ L EL + N S +I + + L L F L +F S
Sbjct: 199 QAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIM 255
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 2e-16
Identities = 34/202 (16%), Positives = 63/202 (31%), Gaps = 21/202 (10%)
Query: 71 ISTNGSPLSCSDISLPQWANLSLYKDSSIHLLSIQLPSANLTGSLPRELGEFSMLQSLYL 130
S+N +++ L ++++ ++ L + L
Sbjct: 216 NSSNIMKTCLQNLAGLHV--HRLILGEFKDERNLEIFEPSIMEGLCD-----VTIDEFRL 268
Query: 131 NVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNSLTAALPE 190
+ + +++S + L+ + + + SL + L
Sbjct: 269 TYTNDFSDDIVKFHCLANVSAMSLAGVSIKYL--EDVPK-HFKWQSLSIIRCQLK----- 320
Query: 191 PALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIP---EGLTRLS 247
P L+ L L NK S SF + +L LD+S N S S L S
Sbjct: 321 -QFPTLDLPFLKSLTLTMNKGSISFKK--VALPSLSYLDLSRNALSFSGCCSYSDLGTNS 377
Query: 248 LEKLNLSHNNFSGVLPVFSESK 269
L L+LS N + F +
Sbjct: 378 LRHLDLSFNGAIIMSANFMGLE 399
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 1e-15
Identities = 29/136 (21%), Positives = 48/136 (35%), Gaps = 8/136 (5%)
Query: 127 SLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNSLTA 186
+ L +P ++ SS IDLS N + + S N L L L +
Sbjct: 15 TYQCMDQKLS-KVPDDI--PSSTKNIDLSFNPLKILKSYSFSNFS-ELQWLDLSRCEIET 70
Query: 187 ALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRL 246
+ + A L L L N P + +L+ L + + +L
Sbjct: 71 -IEDKAWHG--LHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQL 127
Query: 247 -SLEKLNLSHNNFSGV 261
+L+KLN++HN
Sbjct: 128 ITLKKLNVAHNFIHSC 143
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 4e-13
Identities = 15/142 (10%), Positives = 33/142 (23%), Gaps = 7/142 (4%)
Query: 125 LQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNSL 184
SL +++N + I + L E+ L N + + + L RL
Sbjct: 183 NLSLDMSLNPID-FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEF 241
Query: 185 TAALPEPALPNSTCSDLQ-----YLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSI 239
S L L + + ++ +
Sbjct: 242 KDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIK-YL 300
Query: 240 PEGLTRLSLEKLNLSHNNFSGV 261
+ + L++
Sbjct: 301 EDVPKHFKWQSLSIIRCQLKQF 322
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 1e-09
Identities = 18/90 (20%), Positives = 32/90 (35%), Gaps = 7/90 (7%)
Query: 175 VSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNL 234
++ + L+ +P +P+S + +DL N + F L+ LD+S
Sbjct: 14 ITYQCMDQKLSK-VP-DDIPSS----TKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCE 67
Query: 235 FSGSIPEGLTRL-SLEKLNLSHNNFSGVLP 263
+ L L L L+ N P
Sbjct: 68 IETIEDKAWHGLHHLSNLILTGNPIQSFSP 97
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 4e-06
Identities = 18/86 (20%), Positives = 27/86 (31%), Gaps = 1/86 (1%)
Query: 100 HLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLF 159
+L + L L LQ L ++ N+L SLS +D S N
Sbjct: 474 NLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRI 533
Query: 160 TGVLAPSIWNLCDRLVSLRLHGNSLT 185
+ + L L NS+
Sbjct: 534 ET-SKGILQHFPKSLAFFNLTNNSVA 558
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 2e-19
Identities = 31/153 (20%), Positives = 52/153 (33%), Gaps = 10/153 (6%)
Query: 108 SANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSI 167
+ N + +++YL N + + G S + +DL N V +
Sbjct: 107 ANNNISRVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAEL 164
Query: 168 WNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKE 227
D L L L N + + + L+ LDL SNK + +
Sbjct: 165 AASSDTLEHLNLQYNFIY-DVK----GQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTW 218
Query: 228 LDISNNLFSGSIPEGLTRL-SLEKLNLSHNNFS 259
+ + NN I + L +LE +L N F
Sbjct: 219 ISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFH 250
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 4e-16
Identities = 37/160 (23%), Positives = 67/160 (41%), Gaps = 15/160 (9%)
Query: 108 SANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSI 167
S+N+ +L S L++L LN N ++ EL S+ + + N + ++ S
Sbjct: 66 SSNVLYETL-DLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSCSR 118
Query: 168 WNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSG-SFPEFVTRFEALK 226
++ L N +T L + S +QYLDL N+ +F E + L+
Sbjct: 119 GQG---KKNIYLANNKITM-LRDLDEGC--RSRVQYLDLKLNEIDTVNFAELAASSDTLE 172
Query: 227 ELDISNNLFSGSIPEGLTRLSLEKLNLSHNNFSGVLPVFS 266
L++ N + + L+ L+LS N + + P F
Sbjct: 173 HLNLQYNFIY-DVKGQVVFAKLKTLDLSSNKLAFMGPEFQ 211
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 5e-15
Identities = 28/162 (17%), Positives = 59/162 (36%), Gaps = 15/162 (9%)
Query: 101 LLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFT 160
++ ++L +L ++ L L+ N L +L + L ++LS+N+
Sbjct: 12 YKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY 71
Query: 161 GVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVT 220
+ +L L +L L+ N + L ++ L +N S +
Sbjct: 72 ET--LDLESL-STLRTLDLNNNYVQ------ELLVGP--SIETLHAANNNIS-RVSC--S 117
Query: 221 RFEALKELDISNNLFSGSIPEGLTRL-SLEKLNLSHNNFSGV 261
R + K + ++NN + ++ L+L N V
Sbjct: 118 RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTV 159
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 3e-14
Identities = 27/148 (18%), Positives = 57/148 (38%), Gaps = 13/148 (8%)
Query: 114 SLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDR 173
++ + + + +SLK + + ++ E+DLS N + + A + +
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPF-TK 59
Query: 174 LVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNN 233
L L L N L L +L L+ LDL +N +++ L +NN
Sbjct: 60 LELLNLSSNVLYETLDLESLST-----LRTLDLNNNYVQ-ELLV----GPSIETLHAANN 109
Query: 234 LFSGSIPEGLTRLSLEKLNLSHNNFSGV 261
S + + + + L++N + +
Sbjct: 110 NIS-RVSCSRGQ-GKKNIYLANNKITML 135
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 9e-07
Identities = 16/66 (24%), Positives = 23/66 (34%), Gaps = 1/66 (1%)
Query: 199 SDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRL-SLEKLNLSHNN 257
+ + + + + +KELD+S N S L LE LNLS N
Sbjct: 10 NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNV 69
Query: 258 FSGVLP 263
L
Sbjct: 70 LYETLD 75
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 3e-06
Identities = 23/143 (16%), Positives = 41/143 (28%), Gaps = 23/143 (16%)
Query: 84 SLPQWANLSLYKDSSIHLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFEL 143
+ + L ++ L S L + E + + + L N L I L
Sbjct: 183 DVKGQVVFA-------KLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKAL 233
Query: 144 GYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALP--------N 195
+S +L DL N F ++ R+ ++ E
Sbjct: 234 RFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGA 293
Query: 196 STCSDL------QYLDLGSNKFS 212
C DL + + LG +
Sbjct: 294 YCCEDLPAPFADRLIALGHHHHH 316
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 89.5 bits (222), Expect = 5e-19
Identities = 31/153 (20%), Positives = 52/153 (33%), Gaps = 10/153 (6%)
Query: 108 SANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSI 167
+ N + +++YL N + + G S + +DL N V +
Sbjct: 107 ANNNISRVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAEL 164
Query: 168 WNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKE 227
D L L L N + + + L+ LDL SNK + +
Sbjct: 165 AASSDTLEHLNLQYNFIY-DVK----GQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTW 218
Query: 228 LDISNNLFSGSIPEGLTRL-SLEKLNLSHNNFS 259
+ + NN I + L +LE +L N F
Sbjct: 219 ISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFH 250
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 78.4 bits (193), Expect = 2e-15
Identities = 28/162 (17%), Positives = 60/162 (37%), Gaps = 15/162 (9%)
Query: 101 LLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFT 160
++ ++L +L ++ L L+ N L +L + L ++LS+N+
Sbjct: 12 YKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY 71
Query: 161 GVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVT 220
+ +L L +L L+ N + P+ ++ L +N S +
Sbjct: 72 ET--LDLESL-STLRTLDLNNNYVQEL---LVGPS-----IETLHAANNNIS-RVSC--S 117
Query: 221 RFEALKELDISNNLFSGSIPEGLTRL-SLEKLNLSHNNFSGV 261
R + K + ++NN + ++ L+L N V
Sbjct: 118 RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTV 159
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 74.9 bits (184), Expect = 3e-14
Identities = 27/150 (18%), Positives = 58/150 (38%), Gaps = 13/150 (8%)
Query: 114 SLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDR 173
++ + + + +SLK + + ++ E+DLS N + + A + +
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPF-TK 59
Query: 174 LVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNN 233
L L L N L L +L L+ LDL +N + +++ L +NN
Sbjct: 60 LELLNLSSNVLYETLDLESLST-----LRTLDLNNNYVQE-----LLVGPSIETLHAANN 109
Query: 234 LFSGSIPEGLTRLSLEKLNLSHNNFSGVLP 263
S + + + + L++N + +
Sbjct: 110 NIS-RVSCSRGQ-GKKNIYLANNKITMLRD 137
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 66.4 bits (162), Expect = 1e-11
Identities = 22/153 (14%), Positives = 41/153 (26%), Gaps = 11/153 (7%)
Query: 114 SLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDR 173
+ E + + + L N L I L +S +L DL N F ++ R
Sbjct: 205 FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQR 263
Query: 174 LVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEAL-----KEL 228
+ ++ C+ G+ F R AL L
Sbjct: 264 VQTVAKQTVKKL-----TGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALL 318
Query: 229 DISNNLFSGSIPEGLTRLSLEKLNLSHNNFSGV 261
+ E + +++ + V
Sbjct: 319 SGQGSETERLECERENQARQREIDALKEQYRTV 351
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 41.8 bits (98), Expect = 7e-04
Identities = 16/169 (9%), Positives = 41/169 (24%), Gaps = 26/169 (15%)
Query: 114 SLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLC-- 171
+ + L L+ L N +S + ++ + +
Sbjct: 228 LIEKALRFSQNLEHFDLRGNGFH-CGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVP 286
Query: 172 ------------------DRLVSLRLHGNSLTA----ALPEPALPNSTCSDLQYLDLGSN 209
DRL++L+ ++L + + + +D
Sbjct: 287 TLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKE 346
Query: 210 KFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRL-SLEKLNLSHNN 257
++ + R +A L+ + G L+
Sbjct: 347 QYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVG 395
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 3e-18
Identities = 34/161 (21%), Positives = 62/161 (38%), Gaps = 19/161 (11%)
Query: 114 SLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNL--- 170
LP + +F+ L++L L N L+ +P + + L E+ + A L + +
Sbjct: 118 ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDAS 176
Query: 171 -----CDRLVSLRLHGNSLTAALPEPALPNSTC--SDLQYLDLGSNKFSGSFPEFVTRFE 223
L SLRL + +LP S +L+ L + ++ S + +
Sbjct: 177 GEHQGLVNLQSLRLEWTGIR------SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLP 229
Query: 224 ALKELDISNNLFSGSIPEGLTRL-SLEKLNLSHNNFSGVLP 263
L+ELD+ + P L++L L + LP
Sbjct: 230 KLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLP 270
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 8e-16
Identities = 39/203 (19%), Positives = 66/203 (32%), Gaps = 34/203 (16%)
Query: 84 SLPQWANLSLYKDSSIHLLSIQLPSANLT---------GSLPRELGEFSM--LQSLYLNV 132
L QW + H Q S N + L + + +L L
Sbjct: 31 VLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRS 90
Query: 133 NSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPA 192
L P + S L + + A L ++ L +L L N L A
Sbjct: 91 VPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFA-GLETLTLARNPLRA------ 141
Query: 193 LPNS--TCSDLQYLDLGSNKFSGSFPEFVTRFEA---------LKELDISNNLFSGSIPE 241
LP S + + L+ L + + PE + +A L+ L + S+P
Sbjct: 142 LPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPA 200
Query: 242 GLTRL-SLEKLNLSHNNFSGVLP 263
+ L +L+ L + ++ S L
Sbjct: 201 SIANLQNLKSLKIRNSPLSA-LG 222
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 5e-15
Identities = 32/170 (18%), Positives = 65/170 (38%), Gaps = 17/170 (10%)
Query: 91 LSLYKDSSIHLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLS 150
LS+ + +LP + E LQSL L ++ ++P + +L
Sbjct: 155 LSIRACPELT----ELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLK 209
Query: 151 EIDLSANLFTGVLAPSIWNLCDRLVSLRLHG-NSLTAALPEPALPNS--TCSDLQYLDLG 207
+ + + + L P+I +L +L L L G +L P + L+ L L
Sbjct: 210 SLKIRNSPLSA-LGPAIHHLP-KLEELDLRGCTALRN------YPPIFGGRAPLKRLILK 261
Query: 208 SNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRL-SLEKLNLSHN 256
+ P + R L++LD+ + +P + +L + + + +
Sbjct: 262 DCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPH 311
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 2e-05
Identities = 18/95 (18%), Positives = 34/95 (35%), Gaps = 8/95 (8%)
Query: 106 LPSANLTGSLPRELGEFSMLQSLYL-NVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLA 164
L + P G + L+ L L + ++L T+P ++ + L ++DL + L
Sbjct: 236 LRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCVNLSRLP 294
Query: 165 PSIWNLCDRLVSLRLHGNSLTAALPE-----PALP 194
I L + + + PA P
Sbjct: 295 SLIAQL-PANCIILVPPHLQAQLDQHRPVARPAEP 328
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 5e-18
Identities = 40/188 (21%), Positives = 68/188 (36%), Gaps = 15/188 (7%)
Query: 78 LSCSDISLPQWANLSLYKDSSIHLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSL-- 135
L + Q+ L L + S + +A LP L+ L L+ N L
Sbjct: 309 LELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPS-------LEFLDLSRNGLSF 361
Query: 136 KGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPN 195
KG ++SL +DLS N + S + ++L L ++L +
Sbjct: 362 KGCCSQSDFGTTSLKYLDLSFNGVITM--SSNFLGLEQLEHLDFQHSNLKQMSEFSVFLS 419
Query: 196 STCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEG-LTRL-SLEKLNL 253
+L YLD+ +F +L+ L ++ N F + T L +L L+L
Sbjct: 420 LR--NLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDL 477
Query: 254 SHNNFSGV 261
S +
Sbjct: 478 SQCQLEQL 485
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 1e-17
Identities = 42/185 (22%), Positives = 74/185 (40%), Gaps = 10/185 (5%)
Query: 78 LSCSDISLPQWANLSLYKDSSIHLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKG 137
LS + +S + S + +S+ L + S N ++ L+ L ++LK
Sbjct: 354 LSRNGLSFKGCCSQSDFGTTSLKYLDL---SFNGVITMSSNFLGLEQLEHLDFQHSNLKQ 410
Query: 138 TIPFE-LGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNS 196
F +L +D+S V I+N L L++ GNS
Sbjct: 411 MSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTE- 468
Query: 197 TCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEG-LTRL-SLEKLNLS 254
+L +LDL + P +L+ L++++N S+P+G RL SL+K+ L
Sbjct: 469 -LRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLK-SVPDGIFDRLTSLQKIWLH 526
Query: 255 HNNFS 259
N +
Sbjct: 527 TNPWD 531
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 3e-14
Identities = 31/143 (21%), Positives = 53/143 (37%), Gaps = 7/143 (4%)
Query: 125 LQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNSL 184
L +L L N ++ SSL ++ + I +L L L + N +
Sbjct: 78 LSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHL-KTLKELNVAHNLI 136
Query: 185 TAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALK----ELDISNNLFSGSIP 240
+ N ++L++LDL SNK + + + LD+S N + P
Sbjct: 137 QSFKLPEYFSN--LTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQP 194
Query: 241 EGLTRLSLEKLNLSHNNFSGVLP 263
+ L KL L +N S +
Sbjct: 195 GAFKEIRLHKLTLRNNFDSLNVM 217
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 6e-14
Identities = 41/219 (18%), Positives = 69/219 (31%), Gaps = 21/219 (9%)
Query: 110 NLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWN 169
L F LQ L L+ ++ S LS + L+ N LA ++
Sbjct: 39 PLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQS-LALGAFS 97
Query: 170 LCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKF-SGSFPEFVTRFEALKEL 228
L L +L +L + + L+ L++ N S PE+ + L+ L
Sbjct: 98 GLSSLQKLVAVETNLA-SLENFPIGHLK--TLKELNVAHNLIQSFKLPEYFSNLTNLEHL 154
Query: 229 DISNNLFSGSIPEGLTRLS-----LEKLNLSHNNFSGVLP-VF----------SESKFGA 272
D+S+N L L L+LS N + + P F +
Sbjct: 155 DLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSL 214
Query: 273 EVFEGNSPALCGFPLRDCSGNSRLSSGAIAGLVIGLMTG 311
V + L G + + G + + G
Sbjct: 215 NVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEG 253
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 26/122 (21%), Positives = 46/122 (37%), Gaps = 7/122 (5%)
Query: 139 IPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTC 198
IP L S +DLS N + + S ++ L L L + + + A +
Sbjct: 22 IPDNL--PFSTKNLDLSFNPLRHLGSYSFFSF-PELQVLDLSRCEIQT-IEDGAY--QSL 75
Query: 199 SDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRL-SLEKLNLSHNN 257
S L L L N + +L++L + + L +L++LN++HN
Sbjct: 76 SHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNL 135
Query: 258 FS 259
Sbjct: 136 IQ 137
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 4e-11
Identities = 25/116 (21%), Positives = 43/116 (37%), Gaps = 3/116 (2%)
Query: 125 LQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNSL 184
L L ++ + SSL + ++ N F P I+ L L L L
Sbjct: 423 LIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQL 482
Query: 185 TAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIP 240
L A + + LQ L++ SN+ R +L+++ + N + S P
Sbjct: 483 EQ-LSPTAFNSLS--SLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 535
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 1e-07
Identities = 33/201 (16%), Positives = 64/201 (31%), Gaps = 30/201 (14%)
Query: 97 SSIHLLSIQLPSANLTGSLPRE-LGEFSMLQSLYLNVNSLKGTIP--------FELGYSS 147
I L + L + + ++ + + + L+ L + + E +
Sbjct: 198 KEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNL 257
Query: 148 SLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNSLTAALPEP---------------- 191
++ E L+ + ++N + S L ++
Sbjct: 258 TIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFG 317
Query: 192 ALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNL--FSGSIPEGLTRL-SL 248
P L+ L SNK +F E +L+ LD+S N F G + SL
Sbjct: 318 QFPTLKLKSLKRLTFTSNKGGNAFSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSL 375
Query: 249 EKLNLSHNNFSGVLPVFSESK 269
+ L+LS N + F +
Sbjct: 376 KYLDLSFNGVITMSSNFLGLE 396
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 1e-06
Identities = 22/179 (12%), Positives = 48/179 (26%), Gaps = 18/179 (10%)
Query: 96 DSSIHLLSIQLPSANLTGSLPRELGEFSMLQ----SLYLNVNSLKGTIPFELGYSSSLSE 151
+ +L + L S + +L + SL L++N + I L +
Sbjct: 146 SNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLHK 204
Query: 152 IDLSANLFTGVLAPSIWNLCDRLVSLRLHGNSLTA--------ALPEPALPNSTCSDLQY 203
+ L N + + L L +H L + AL ++
Sbjct: 205 LTLRNNFDSLNVMK---TCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEE 261
Query: 204 LDLGSNKFSGS-FPEFVTRFEALKELDISNNLFSGSIPEGLTRLSLEKLNLSHNNFSGV 261
L + + + + + + + + L L + F
Sbjct: 262 FRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNFGWQHLELVNCKFGQF 319
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 2e-06
Identities = 15/86 (17%), Positives = 24/86 (27%), Gaps = 7/86 (8%)
Query: 179 LHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGS 238
+ +P++ + LDL N F L+ LD+S
Sbjct: 14 CMELNFYK------IPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTI 67
Query: 239 IPEGLTRL-SLEKLNLSHNNFSGVLP 263
L L L L+ N +
Sbjct: 68 EDGAYQSLSHLSTLILTGNPIQSLAL 93
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 83.4 bits (206), Expect = 1e-17
Identities = 38/193 (19%), Positives = 67/193 (34%), Gaps = 12/193 (6%)
Query: 78 LSCSDISL--PQWANLSLYKDSSIHLLSIQLPSANLTGSLPRELGEFSM--LQSLYLNVN 133
L+ ++ + L +++L+++ S + EL ++ L+ L +
Sbjct: 100 LTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQA 159
Query: 134 SLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLC----DRLVSLRLHGNSLTAALP 189
++ +LS +DLS N G I LC L L L +
Sbjct: 160 HSLNFSCEQVRVFPALSTLDLSDNPELG-ERGLISALCPLKFPTLQVLALRNAGMETPSG 218
Query: 190 EPALPNSTCSDLQYLDLGSNKFSGSFPE-FVTRFEALKELDISNNLFSGSIPEGLTRLSL 248
+ + LQ LDL N + L L++S +P+GL L
Sbjct: 219 VCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLPA-KL 276
Query: 249 EKLNLSHNNFSGV 261
L+LS+N
Sbjct: 277 SVLDLSYNRLDRN 289
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 81.1 bits (200), Expect = 8e-17
Identities = 50/256 (19%), Positives = 71/256 (27%), Gaps = 23/256 (8%)
Query: 24 SSPASASSDVELLLGKIKSSLQGDDENL--LLSSWNISVPLCQW----RGLKWISTNGSP 77
S P S LG L G +L LL + L Q+ + L
Sbjct: 18 SDPKPDWSSAFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRA 77
Query: 78 LSCSDISLPQWANLSLYKDSSIHLLSIQLPSANLTGSLPRELGEFSM--LQSLYLNVNSL 135
L +L L + L + +TG+ P L E + L L L S
Sbjct: 78 ARIPSRILFG----ALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSW 133
Query: 136 KGTIPFELGYSS----SLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNSLTAALPEP 191
+ L + ++ + L +L L N
Sbjct: 134 ATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPA-LSTLDLSDNPELGERGLI 192
Query: 192 -ALPNSTCSDLQYLDLGSNKF---SGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRL- 246
AL LQ L L + SG L+ LD+S+N +
Sbjct: 193 SALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWP 252
Query: 247 -SLEKLNLSHNNFSGV 261
L LNLS V
Sbjct: 253 SQLNSLNLSFTGLKQV 268
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 79.6 bits (196), Expect = 2e-16
Identities = 36/217 (16%), Positives = 61/217 (28%), Gaps = 17/217 (7%)
Query: 50 NLLLSSWNISVPLCQWRGLKWISTNGSPLSCSDISLPQWANLSLYKDSSIHLLSIQLPSA 109
+ + + L ++ + D L L + L + + A
Sbjct: 105 LEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLA-----ELQQWLKPGLKVLSIAQA 159
Query: 110 NLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFE----LGYSSSLSEIDLSANLFTGV--L 163
+ ++ F L +L L+ N G +L + L +
Sbjct: 160 HSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGV 219
Query: 164 APSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFE 223
++ +L L L NSL A P+ S L L+L
Sbjct: 220 CSALAAARVQLQGLDLSHNSLRDAAGAPSC--DWPSQLNSLNLSFTGLKQVPKGL---PA 274
Query: 224 ALKELDISNNLFSGSIPEGLTRLSLEKLNLSHNNFSG 260
L LD+S N P + L+L N F
Sbjct: 275 KLSVLDLSYNRLD-RNPSPDELPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 78.0 bits (192), Expect = 7e-16
Identities = 39/180 (21%), Positives = 59/180 (32%), Gaps = 18/180 (10%)
Query: 97 SSIHLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELG--YSSSLSEIDL 154
+ + + ++PS L G+L + S LQ L L + GT P L L+ ++L
Sbjct: 71 KRLTVRAARIPSRILFGAL--RVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNL 128
Query: 155 SANLFTGV---LAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKF 211
+ LA L L L + + L LDL N
Sbjct: 129 RNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLN-FSCEQV--RVFPALSTLDLSDNPE 185
Query: 212 SGSFPEFVT----RFEALKELDISNNLF---SGSIPEGLTRL-SLEKLNLSHNNFSGVLP 263
G +F L+ L + N SG L+ L+LSHN+
Sbjct: 186 LGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAG 245
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 72.2 bits (177), Expect = 6e-14
Identities = 27/123 (21%), Positives = 38/123 (30%), Gaps = 11/123 (8%)
Query: 119 LGEFSMLQSLYL---NVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLV 175
+F LQ L L + + G L +DLS N + +L
Sbjct: 197 PLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLN 256
Query: 176 SLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLF 235
SL L L +P + L LDL N+ P + L + N F
Sbjct: 257 SLNLSFTGLK------QVPKGLPAKLSVLDLSYNRLD-RNP-SPDELPQVGNLSLKGNPF 308
Query: 236 SGS 238
S
Sbjct: 309 LDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 67.2 bits (164), Expect = 3e-12
Identities = 35/181 (19%), Positives = 49/181 (27%), Gaps = 12/181 (6%)
Query: 100 HLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIP-----FELGYSSSLSEIDL 154
L L + L + L L V + + + S L E+ L
Sbjct: 43 RSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTL 102
Query: 155 SANLFTGVLAPSIWNLCDR-LVSLRLHGNSLTAALPE-PALPNSTCSDLQYLDLGSNKFS 212
TG P + L L L S L L+ L +
Sbjct: 103 ENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSL 162
Query: 213 GSFPEFVTRFEALKELDISNNLFSGSIPEGLTRL-----SLEKLNLSHNNFSGVLPVFSE 267
E V F AL LD+S+N G +L+ L L + V S
Sbjct: 163 NFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSA 222
Query: 268 S 268
Sbjct: 223 L 223
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 63.0 bits (153), Expect = 7e-11
Identities = 39/195 (20%), Positives = 61/195 (31%), Gaps = 16/195 (8%)
Query: 109 ANLTGSLPREL--GEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPS 166
N G+ EL G S+ L ++ S SL + + A +
Sbjct: 28 FNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFG 87
Query: 167 IWNLCD--RLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRF-- 222
+ L L L +T P P L +T DL L+L + ++
Sbjct: 88 ALRVLGISGLQELTLENLEVTGTAP-PPLLEATGPDLNILNLRNVSWATRDAWLAELQQW 146
Query: 223 --EALKELDISNNLFSGSIPEGLTRL-SLEKLNLSHNNFSGVLPVFSESKFGAEVFEGNS 279
LK L I+ E + +L L+LS N G + S +
Sbjct: 147 LKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLIS------ALCPLKF 200
Query: 280 PALCGFPLRDCSGNS 294
P L LR+ +
Sbjct: 201 PTLQVLALRNAGMET 215
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 54.1 bits (130), Expect = 6e-08
Identities = 24/148 (16%), Positives = 51/148 (34%), Gaps = 8/148 (5%)
Query: 122 FSMLQSLYLNVNSLKGTIPFEL-GYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLH 180
FS + + + + G EL G SL + + + + L L +
Sbjct: 17 FSDPKPDWSSAFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVR 76
Query: 181 GNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRF--EALKELDISNNLFSGS 238
+ + + AL S LQ L L + + +G+ P + L L++ N ++
Sbjct: 77 AARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR 136
Query: 239 IPE-----GLTRLSLEKLNLSHNNFSGV 261
+ L+ L+++ +
Sbjct: 137 DAWLAELQQWLKPGLKVLSIAQAHSLNF 164
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 6e-17
Identities = 47/212 (22%), Positives = 85/212 (40%), Gaps = 26/212 (12%)
Query: 382 GQVIEKTTYGTAYKAK-LADGATIALR--LLREGSCKDRSSCLPVIRQLGKVRHENLIPL 438
I + ++ T YK +A R+ + +R L ++H N++
Sbjct: 31 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 90
Query: 439 RAFYQGKRGEKLLIY---DYFPSRTLHDLL--HDTIAGKPVLNWARRHKIALGIARGLAY 493
++ K I + S TL L + K + +W R+ I +GL +
Sbjct: 91 YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQ------ILKGLQF 144
Query: 494 LHTGHEIPITHGNVRSKNVLVDDFF-VSRLTEFGLDQLMVPAVADEMVALAKADG---YK 549
LHT PI H +++ N+ + ++ + GL L + A ++ G +
Sbjct: 145 LHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVI------GTPEFM 197
Query: 550 APELQRMKKCSSRTDVYAFGILLLEILIGKKP 581
APE+ +K DVYAFG+ +LE+ + P
Sbjct: 198 APEMYE-EKYDESVDVYAFGMCMLEMATSEYP 228
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 8e-17
Identities = 38/213 (17%), Positives = 67/213 (31%), Gaps = 8/213 (3%)
Query: 53 LSSWNISVPLCQWRGLKWISTNGSPLSCSDISLPQWANLSLYKDSSIHLLSIQLPSANLT 112
S + + L + + + S +++ L L + L N +
Sbjct: 213 FSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPS 272
Query: 113 GS-LPRELG--EFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWN 169
S + ELG E ++ L++ L + + I + + ++ S
Sbjct: 273 ESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQ 331
Query: 170 LCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFS--GSFPEFVTRFEALKE 227
L L L N + + + LQ L L N E + + L
Sbjct: 332 HLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTS 391
Query: 228 LDISNNLFSGSIPEGLTRL-SLEKLNLSHNNFS 259
LDIS N F +P+ + LNLS
Sbjct: 392 LDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR 423
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 2e-14
Identities = 37/163 (22%), Positives = 65/163 (39%), Gaps = 22/163 (13%)
Query: 101 LLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLK--GTIPFELGYSSSLSEIDLSANL 158
++ L ++ G+ P LQ+L L+ N L+ L +L+ +D+S N
Sbjct: 346 MVEEYLKNSACKGAWPS-------LQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNT 398
Query: 159 FTGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEF 218
F + S +++ L L + + L+ LD+ +N SF F
Sbjct: 399 FH-PMPDSCQWP-EKMRFLNLSSTGIRV------VKTCIPQTLEVLDVSNNNLD-SFSLF 449
Query: 219 VTRFEALKELDISNNLFSGSIPEGLTRLSLEKLNLSHNNFSGV 261
+ R L+EL IS N ++P+ L + +S N V
Sbjct: 450 LPR---LQELYISRNKLK-TLPDASLFPVLLVMKISRNQLKSV 488
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 2e-12
Identities = 36/150 (24%), Positives = 60/150 (40%), Gaps = 20/150 (13%)
Query: 114 SLPRELGEFS---MLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNL 170
S+ + L SL ++ N+ +P + + ++LS+ V +
Sbjct: 375 SMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRVVK----TCI 429
Query: 171 CDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDI 230
L L + N+L + LP LQ L + NK + P+ F L + I
Sbjct: 430 PQTLEVLDVSNNNLDS-FSLF-LPR-----LQELYISRNKLK-TLPDASL-FPVLLVMKI 480
Query: 231 SNNLFSGSIPEG-LTRL-SLEKLNLSHNNF 258
S N S+P+G RL SL+K+ L N +
Sbjct: 481 SRNQLK-SVPDGIFDRLTSLQKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 5e-12
Identities = 32/157 (20%), Positives = 56/157 (35%), Gaps = 10/157 (6%)
Query: 110 NLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWN 169
+ T S+P L + ++SL L+ N + +L ++L + L ++ + +
Sbjct: 16 SFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRIN-TIEGDAFY 71
Query: 170 LCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSG-SFPEFVTRFEALKEL 228
L L L N L++ L S L+YL+L N + L+ L
Sbjct: 72 SLGSLEHLDLSDNHLSS-LSSSWFGP--LSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTL 128
Query: 229 DISNNLFSGSIPEG-LTRL-SLEKLNLSHNNFSGVLP 263
I N I L SL +L + +
Sbjct: 129 RIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQS 165
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 8e-12
Identities = 24/138 (17%), Positives = 48/138 (34%), Gaps = 3/138 (2%)
Query: 125 LQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNSL 184
L+ L L+ N L G SSL ++L N + + S++ L +LR+
Sbjct: 76 LEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVET 135
Query: 185 TAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLT 244
+ + T L L++ + + + + L + + + +
Sbjct: 136 FSEIRRIDFAGLT--SLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFAD 193
Query: 245 RL-SLEKLNLSHNNFSGV 261
L S+ L L N +
Sbjct: 194 ILSSVRYLELRDTNLARF 211
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 1e-09
Identities = 27/176 (15%), Positives = 54/176 (30%), Gaps = 17/176 (9%)
Query: 100 HLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKG---TIPFELGYSSSLSEIDLSA 156
+ + L + L S ++ L L +L + SS + ++
Sbjct: 173 DIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRG 232
Query: 157 NLFTGVLAPSIWNLCDRLVSL------RLHGNSLTAALPE-----PALPNSTCSDLQYLD 205
++ T + L ++ L N L P L ++ L
Sbjct: 233 SVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLH 292
Query: 206 LGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRL--SLEKLNLSHNNFS 259
+ + E +K + + N+ +P ++ SLE L+LS N
Sbjct: 293 IPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMV 347
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 6e-08
Identities = 22/95 (23%), Positives = 39/95 (41%), Gaps = 13/95 (13%)
Query: 171 CDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDI 230
CD S T+ +P+ + ++ LDL NK + + L+ L +
Sbjct: 4 CDASGVCDGRSRSFTS------IPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLIL 57
Query: 231 SNNLFSGSIPE----GLTRLSLEKLNLSHNNFSGV 261
++ + +I L SLE L+LS N+ S +
Sbjct: 58 KSSRIN-TIEGDAFYSLG--SLEHLDLSDNHLSSL 89
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 8e-08
Identities = 23/128 (17%), Positives = 46/128 (35%), Gaps = 13/128 (10%)
Query: 108 SANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSI 167
S N +P ++ L L+ ++ + + +L +D+S N S
Sbjct: 395 SRNTFHPMPDSCQWPEKMRFLNLSSTGIR-VVKTCI--PQTLEVLDVSNNNLD-----SF 446
Query: 168 WNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKE 227
RL L + N L LP+ +L L + + N+ R +L++
Sbjct: 447 SLFLPRLQELYISRNKLKT-LPDASLFPV----LLVMKISRNQLKSVPDGIFDRLTSLQK 501
Query: 228 LDISNNLF 235
+ + N +
Sbjct: 502 IWLHTNPW 509
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 2e-16
Identities = 31/140 (22%), Positives = 51/140 (36%), Gaps = 8/140 (5%)
Query: 125 LQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNSL 184
L+ L L+ N + T+ L +D + + S++ L+ L +
Sbjct: 80 LKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHT 138
Query: 185 TAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFV-TRFEALKELDISNNLFSGSIPEG- 242
S L+ L + N F +F + T L LD+S +
Sbjct: 139 RV-AFNGIFNG--LSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTA 194
Query: 243 LTRL-SLEKLNLSHNNFSGV 261
L SL+ LN+SHNNF +
Sbjct: 195 FNSLSSLQVLNMSHNNFFSL 214
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 3e-13
Identities = 32/150 (21%), Positives = 56/150 (37%), Gaps = 8/150 (5%)
Query: 116 PRELGEFSMLQSLYLNVNSL--KGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDR 173
+ + L L L+ N L KG ++SL +DLS N ++ + L ++
Sbjct: 45 HGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGL-EQ 102
Query: 174 LVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNN 233
L L ++L + +L YLD+ +F +L+ L ++ N
Sbjct: 103 LEHLDFQHSNLKQMSEFSVFLS--LRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGN 160
Query: 234 LFSGSIPEG-LTRLS-LEKLNLSHNNFSGV 261
F + T L L L+LS +
Sbjct: 161 SFQENFLPDIFTELRNLTFLDLSQCQLEQL 190
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 3e-13
Identities = 33/138 (23%), Positives = 51/138 (36%), Gaps = 7/138 (5%)
Query: 125 LQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNSL 184
L L ++ + SSL + ++ N F P I+ L L L L
Sbjct: 128 LIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQL 187
Query: 185 TAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEG-L 243
L A + + LQ L++ N F +L+ LD S N + + L
Sbjct: 188 EQ-LSPTAFNSLS--SLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM-TSKKQEL 243
Query: 244 TRL--SLEKLNLSHNNFS 259
SL LNL+ N+F+
Sbjct: 244 QHFPSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 2e-11
Identities = 38/163 (23%), Positives = 58/163 (35%), Gaps = 18/163 (11%)
Query: 108 SANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFT--GVLAP 165
S LT S+P + S L L N L+ + L+++ LS+N + G +
Sbjct: 16 SKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQ 72
Query: 166 SIWNLCDRLVSLRLHGNSLTAALPE--PALPNSTCSDLQYLDLGSNKFSGSFPEFV-TRF 222
S + L L L N + + L L++LD + V
Sbjct: 73 SDFGT-TSLKYLDLSFNGVIT-MSSNFLGLEQ-----LEHLDFQHSNLKQMSEFSVFLSL 125
Query: 223 EALKELDISNNLFSGSIPEG-LTRL-SLEKLNLSHNNFSGVLP 263
L LDIS+ G L SLE L ++ N+F
Sbjct: 126 RNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFL 167
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 25/98 (25%), Positives = 38/98 (38%), Gaps = 13/98 (13%)
Query: 176 SLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNN-L 234
+R + LT+ +P +P S L+L SNK + L +L +S+N L
Sbjct: 11 EIRCNSKGLTS-VP-TGIP----SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGL 64
Query: 235 FSGSIP----EGLTRLSLEKLNLSHNNFSGVLPVFSES 268
G T SL+ L+LS N + F
Sbjct: 65 SFKGCCSQSDFGTT--SLKYLDLSFNGVITMSSNFLGL 100
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 3e-16
Identities = 43/154 (27%), Positives = 63/154 (40%), Gaps = 20/154 (12%)
Query: 108 SANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSI 167
S N LP EL S L+ + ++ NSLK +P SL I N + P +
Sbjct: 139 SNNQLEKLP-ELQNSSFLKIIDVDNNSLK-KLPDLPP---SLEFIAAGNNQLEEL--PEL 191
Query: 168 WNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKE 227
NL L ++ NSL LP+ S L+ + G+N PE L
Sbjct: 192 QNLP-FLTAIYADNNSLK------KLPDLPLS-LESIVAGNNILE-ELPEL-QNLPFLTT 241
Query: 228 LDISNNLFSGSIPEGLTRLSLEKLNLSHNNFSGV 261
+ NNL ++P+ SLE LN+ N + +
Sbjct: 242 IYADNNLLK-TLPDLPP--SLEALNVRDNYLTDL 272
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 1e-14
Identities = 50/177 (28%), Positives = 73/177 (41%), Gaps = 37/177 (20%)
Query: 100 HLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLF 159
L I + L LP EL L ++Y + NSLK +P SL I N+
Sbjct: 174 SLEFIAAGNNQLE-ELP-ELQNLPFLTAIYADNNSLK-KLPDLPL---SLESIVAGNNIL 227
Query: 160 TGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFV 219
+ P + NL L ++ N L LP+ S L+ L++ N + PE
Sbjct: 228 EEL--PELQNL-PFLTTIYADNNLLKT------LPDLPPS-LEALNVRDNYLT-DLPEL- 275
Query: 220 TRFEALKELDISNNLFSG--SIPEGLTRL---------------SLEKLNLSHNNFS 259
++L LD+S N+FSG +P L L SLE+LN+S+N
Sbjct: 276 --PQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI 330
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 8e-14
Identities = 34/173 (19%), Positives = 53/173 (30%), Gaps = 28/173 (16%)
Query: 97 SSIHLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSA 156
S+ L S+NLT +P E Y + + P G ++ L
Sbjct: 9 SNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRD 67
Query: 157 NLFTGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFP 216
L + L L+ L+ +LP L+ L N + P
Sbjct: 68 CLDR------------QAHELELNNLGLS------SLPEL-PPHLESLVASCNSLT-ELP 107
Query: 217 EFVTRFEALKELDISNNLFSGSIPEGLTRLSLEKLNLSHNNFSGVLPVFSESK 269
E ++L + + S P LE L +S+N LP S
Sbjct: 108 ELPQSLKSLLVDNNNLKALSDLPP------LLEYLGVSNNQLE-KLPELQNSS 153
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 1e-11
Identities = 39/245 (15%), Positives = 73/245 (29%), Gaps = 49/245 (20%)
Query: 49 ENLLLSSWNISVP--LCQWRGLKWISTNGSPLSCSDISLPQWANLSLYK-------DSSI 99
E+++ + + L L I + + L P L++ +
Sbjct: 218 ESIVAGNNILEELPELQNLPFLTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQ 277
Query: 100 HLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLF 159
L + + + L L L + N ++ ++ SL E+++S N
Sbjct: 278 SLTFLDVSENIFS-GLSELPPN---LYYLNASSNEIR-SLCDLP---PSLEELNVSNNKL 329
Query: 160 TGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFV 219
+ L RL L N L +P + L+ L + N FP+
Sbjct: 330 I-----ELPALPPRLERLIASFNHLAE------VPELPQN-LKQLHVEYNPLR-EFPDIP 376
Query: 220 TRFE----------------ALKELDISNNLFSGSIPEGLTRLSLEKLNLSHNNFSGVLP 263
E LK+L + N P+ S+E L ++
Sbjct: 377 ESVEDLRMNSHLAEVPELPQNLKQLHVETNPLR-EFPDIPE--SVEDLRMNSERVVDPYE 433
Query: 264 VFSES 268
E+
Sbjct: 434 FAHET 438
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 7e-11
Identities = 29/175 (16%), Positives = 55/175 (31%), Gaps = 34/175 (19%)
Query: 100 HLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLF 159
+L + S + SL L+ L ++ N L +P L + S N
Sbjct: 298 NLYYLNASSNEIR-SLCDLPPS---LEELNVSNNKLI-ELPALPP---RLERLIASFNHL 349
Query: 160 TGVLAPSIWNLCDRLVSLRLHGNSLTAALPE--------------PALPNSTCSDLQYLD 205
+ NL L + N L P+ +P +L+ L
Sbjct: 350 A-EVPELPQNL----KQLHVEYNPLRE-FPDIPESVEDLRMNSHLAEVPEL-PQNLKQLH 402
Query: 206 LGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRLS-LEKLNLSHNNFS 259
+ +N FP+ E++++L +++ LE H++
Sbjct: 403 VETNPLR-EFPDIP---ESVEDLRMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 79.5 bits (196), Expect = 1e-15
Identities = 51/189 (26%), Positives = 85/189 (44%), Gaps = 22/189 (11%)
Query: 84 SLPQWANLSLYKDSSIHLLSIQLPSA---------NLTGSLPRELGEFSMLQSLYLNVNS 134
S N ++ +H+L S LT ++ G + L++L L +N
Sbjct: 300 SNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQ 359
Query: 135 LKGTIPFELGYS---SSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNSLTAALPEP 191
LK + + SL ++D+S N + + L+SL + N LT +
Sbjct: 360 LK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRC 418
Query: 192 ALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEG-LTRL-SLE 249
P ++ LDL SNK S P+ V + EAL+EL++++N S+P+G RL SL+
Sbjct: 419 LPPR-----IKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQ 471
Query: 250 KLNLSHNNF 258
K+ L N +
Sbjct: 472 KIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 77.2 bits (190), Expect = 5e-15
Identities = 42/194 (21%), Positives = 72/194 (37%), Gaps = 13/194 (6%)
Query: 73 TNGSPLSCSDISLPQWANLSL--YKDSSIHLLSIQLPSANLTGSLPREL-GEFSMLQSLY 129
T S S++ L + Y +S+ LSI +++ G + FS +
Sbjct: 247 TTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKN 306
Query: 130 LNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLR---LHGNSLTA 186
V+ + S +D S NL T + C L L L N L
Sbjct: 307 FTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVF----ENCGHLTELETLILQMNQLKE 362
Query: 187 ALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFV-TRFEALKELDISNNLFSGSIPEGLTR 245
L + A + LQ LD+ N S + + ++L L++S+N+ + +I L
Sbjct: 363 -LSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPP 421
Query: 246 LSLEKLNLSHNNFS 259
++ L+L N
Sbjct: 422 -RIKVLDLHSNKIK 434
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 9e-09
Identities = 39/218 (17%), Positives = 75/218 (34%), Gaps = 21/218 (9%)
Query: 53 LSSWNISVPLCQWRGLKWISTNGSPLSCSDISLPQWANLSLYKDSSIHLLSIQLPSANLT 112
S+ +S+ K + + + + S + L L +++ SI
Sbjct: 205 KCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRI--LQLVWHTTVWYFSISNVKLQGQ 262
Query: 113 GSLPRELGEFSMLQSLYL-NVNSLKGTIPFELGYS--SSLSEIDLSANLFTGVLAPSIWN 169
+ L++L + V S P Y S+++ + + + T ++ +
Sbjct: 263 LDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVS-GTRMVHMLCPS 321
Query: 170 LCDRLVSLRLHGNSLTAALPEPALPNSTCS---DLQYLDLGSNKFSGSFPEFVTRFE--- 223
+ L N LT C +L+ L L N+ +
Sbjct: 322 KISPFLHLDFSNNLLTD------TVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMK 374
Query: 224 ALKELDISNNLFSGSIPEGL-TRL-SLEKLNLSHNNFS 259
+L++LDIS N S +G + SL LN+S N +
Sbjct: 375 SLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILT 412
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 55.3 bits (133), Expect = 4e-08
Identities = 30/152 (19%), Positives = 51/152 (33%), Gaps = 13/152 (8%)
Query: 108 SANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSI 167
L +P++L L ++ N + ++ S L + +S N +
Sbjct: 9 KNGLI-HVPKDL--SQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVF 65
Query: 168 WNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPE--FVTRFEAL 225
+ L L L N L + N L++LDL N F + P L
Sbjct: 66 KFNQE-LEYLDLSHNKLV-KISCHPTVN-----LKHLDLSFNAFD-ALPICKEFGNMSQL 117
Query: 226 KELDISNNLFSGSIPEGLTRLSLEKLNLSHNN 257
K L +S S + L++ K+ L
Sbjct: 118 KFLGLSTTHLEKSSVLPIAHLNISKVLLVLGE 149
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 52.9 bits (127), Expect = 2e-07
Identities = 32/217 (14%), Positives = 71/217 (32%), Gaps = 28/217 (12%)
Query: 68 LKWISTNGSPLSCSDISLPQWANLSLYKDSSI-------HLLSIQLPSANLTGSLPRELG 120
L + L S+I N Y S + L ++ L + T + +
Sbjct: 182 LDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRIL 241
Query: 121 EF---SMLQSLYLNVNSLKGTIPFEL--GYSSSLSEIDLSANLFTGVLAPSIWNLCDRLV 175
+ + + ++ L+G + F +SL + + + + V + +
Sbjct: 242 QLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIH-QVVSDVFGFPQSYIYEIFS 300
Query: 176 SL---RLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISN 232
++ + L S S +LD +N + + E L+ L +
Sbjct: 301 NMNIKNFTVSGTRMV---HMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQM 357
Query: 233 NLFSGSIPE------GLTRLSLEKLNLSHNNFSGVLP 263
N + + + SL++L++S N+ S
Sbjct: 358 NQLK-ELSKIAEMTTQMK--SLQQLDISQNSVSYDEK 391
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 51.0 bits (122), Expect = 9e-07
Identities = 32/178 (17%), Positives = 63/178 (35%), Gaps = 24/178 (13%)
Query: 110 NLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWN 169
++ ++ S L+ L ++ N ++ ++ L +DLS N +
Sbjct: 32 YISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVKI--S---- 85
Query: 170 LCDRLVSLR---LHGNSLTAALPEPA----LPNSTCSDLQYLDLGSNKF-SGSFPEFVTR 221
C V+L+ L N+ A LP + L++L L + S
Sbjct: 86 -CHPTVNLKHLDLSFNAFDA-LPICKEFGNMSQ-----LKFLGLSTTHLEKSSVLPIAHL 138
Query: 222 FEALKELDISNNLFSGSIPEGLTRLSLEKLNL---SHNNFSGVLPVFSESKFGAEVFE 276
+ L + PEGL + E L++ ++ F +L V ++ E+
Sbjct: 139 NISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSN 196
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 46.8 bits (111), Expect = 2e-05
Identities = 20/85 (23%), Positives = 30/85 (35%), Gaps = 9/85 (10%)
Query: 179 LHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGS 238
N L +P L T L++ N S + + L+ L IS+N
Sbjct: 7 RSKNGLIH-VP-KDLSQKT----TILNISQNYISELWTSDILSLSKLRILIISHNRIQ-Y 59
Query: 239 IPEG-LTRL-SLEKLNLSHNNFSGV 261
+ LE L+LSHN +
Sbjct: 60 LDISVFKFNQELEYLDLSHNKLVKI 84
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 79.5 bits (196), Expect = 2e-15
Identities = 39/174 (22%), Positives = 68/174 (39%), Gaps = 8/174 (4%)
Query: 97 SSIHLLSIQLPSANLTGSLPRELGEFSM-LQSLYLNVNSLKG-TIPFELGYSSSLSEIDL 154
++IH + +P L+G+ L + ++ ++L+ N L+ I + L L + L
Sbjct: 375 TTIHFIP-SIPDIFLSGNKLVTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILIL 433
Query: 155 SANLFTGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNST---CSDLQYLDLGSNKF 211
+ N F+ + L L L N L E L S LQ L L N
Sbjct: 434 NQNRFSSCSGDQTPSENPSLEQLFLGENMLQL-AWETELCWDVFEGLSHLQVLYLNHNYL 492
Query: 212 SGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRLSLEKLNLSHNNFSGVLPVF 265
+ P + AL+ L +++N + + +LE L++S N P
Sbjct: 493 NSLPPGVFSHLTALRGLSLNSNRLT-VLSHNDLPANLEILDISRNQLLAPNPDV 545
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 78.3 bits (193), Expect = 4e-15
Identities = 34/178 (19%), Positives = 56/178 (31%), Gaps = 7/178 (3%)
Query: 100 HLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFE-LGYSSSLSEIDLSANL 158
+ L + LQ L L TI E +L +DL ++
Sbjct: 25 TTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSK 84
Query: 159 FTGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSG-SFPE 217
L P + L LRL+ L+ A+ + + L LDL N+
Sbjct: 85 IY-FLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRN-LKALTRLDLSKNQIRSLYLHP 142
Query: 218 FVTRFEALKELDISNNLFSGSIPE---GLTRLSLEKLNLSHNNFSGVLPVFSESKFGA 272
+ +LK +D S+N L +L +L+ N+ + V
Sbjct: 143 SFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNP 200
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 77.9 bits (192), Expect = 6e-15
Identities = 28/169 (16%), Positives = 55/169 (32%), Gaps = 11/169 (6%)
Query: 96 DSSIHLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIP---FELGYSSSLSEI 152
+ + S ++ S L + +++K F SS+ +
Sbjct: 213 GNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIK-DPDQNTFAGLARSSVRHL 271
Query: 153 DLSANLFTGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFS 212
DLS + + L L L L N + + + A +LQ L+L N
Sbjct: 272 DLSHGFVFSLNSRVFETL-KDLKVLNLAYNKINK-IADEAFYG--LDNLQVLNLSYNLLG 327
Query: 213 GSFPEFVTRFEALKELDISNNLFSGSIPEGLTRL--SLEKLNLSHNNFS 259
+ + +D+ N + I + + L+ L+L N +
Sbjct: 328 ELYSSNFYGLPKVAYIDLQKNHIA-IIQDQTFKFLEKLQTLDLRDNALT 375
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 76.0 bits (187), Expect = 2e-14
Identities = 32/156 (20%), Positives = 57/156 (36%), Gaps = 11/156 (7%)
Query: 110 NLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWN 169
NLT +P+ L + + L L+ N ++ + L ++L + + +
Sbjct: 15 NLT-QVPQVL---NTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFR 70
Query: 170 LCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSF--PEFVTRFEALKE 227
L L L + + L A L L L S + + +AL
Sbjct: 71 NLPNLRILDLGSSKIY-FLHPDAFQG--LFHLFELRLYFCGLSDAVLKDGYFRNLKALTR 127
Query: 228 LDISNN-LFSGSIPEGLTRL-SLEKLNLSHNNFSGV 261
LD+S N + S + +L SL+ ++ S N V
Sbjct: 128 LDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLV 163
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 68.3 bits (167), Expect = 5e-12
Identities = 35/190 (18%), Positives = 57/190 (30%), Gaps = 49/190 (25%)
Query: 125 LQSLYLNVNSLKGTI--PFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGN 182
L L L L + +L+ +DLS N + + + L S+ N
Sbjct: 99 LFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSN 158
Query: 183 SLTAALPEPALPNSTCSDLQYLDLGSNKF----SGSFPEFVTRFE--ALKELDISNNLFS 236
+ + E L L + L +N S + + + F L+ LD+S N ++
Sbjct: 159 QIFL-VCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWT 217
Query: 237 GSIP---------------------------------------EGLTRLSLEKLNLSHNN 257
I GL R S+ L+LSH
Sbjct: 218 VDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGF 277
Query: 258 FSGVLP-VFS 266
+ VF
Sbjct: 278 VFSLNSRVFE 287
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 66.8 bits (163), Expect = 1e-11
Identities = 41/182 (22%), Positives = 69/182 (37%), Gaps = 20/182 (10%)
Query: 90 NLSLYKDSSIHLLSIQLPSANLTGSLPRELGEFSM------LQSLYLNVNSLKGTIPFE- 142
LS K ++ +++ +L+ + L LQ L LN N + +
Sbjct: 387 FLSGNKLVTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFS-SCSGDQ 445
Query: 143 -LGYSSSLSEIDLSANLFTGV----LAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNST 197
+ SL ++ L N+ L ++ L L L+ N L + LP +
Sbjct: 446 TPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNS-LPPGVFSH-- 502
Query: 198 CSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRLSLEKLNLSHNN 257
+ L+ L L SN+ + L+ LDIS N P+ SL L+++HN
Sbjct: 503 LTALRGLSLNSNRLT-VLSHNDL-PANLEILDISRNQLLAPNPDVFV--SLSVLDITHNK 558
Query: 258 FS 259
F
Sbjct: 559 FI 560
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 65.6 bits (160), Expect = 4e-11
Identities = 27/192 (14%), Positives = 66/192 (34%), Gaps = 12/192 (6%)
Query: 70 WISTNGSPLSCSDISLPQWANLSLYKDSSIHLLSIQLPSANLTGSLPRELGEFSMLQSLY 129
++ + ++ + + + + L + R L+ L
Sbjct: 237 ILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLN 296
Query: 130 LNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNSLTAALP 189
L N + +L ++LS NL + + + + L ++ + L N + +
Sbjct: 297 LAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGL-PKVAYIDLQKNHIA-IIQ 354
Query: 190 EPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRLSLE 249
+ LQ LDL N + + ++ ++ +S N ++P+ L+
Sbjct: 355 DQTFKF--LEKLQTLDLRDNALT-----TIHFIPSIPDIFLSGNKLV-TLPKIN--LTAN 404
Query: 250 KLNLSHNNFSGV 261
++LS N +
Sbjct: 405 LIHLSENRLENL 416
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 2e-15
Identities = 33/156 (21%), Positives = 59/156 (37%), Gaps = 12/156 (7%)
Query: 105 QLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLA 164
L AN++ +L L ++ L + NS+ + + + L+ + L N T
Sbjct: 187 SLFHANVSYNLLSTLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLTDT-- 241
Query: 165 PSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEA 224
+ N LV + L N L + L+ L + +N+ + +
Sbjct: 242 AWLLNY-PGLVEVDLSYNELEK-IMYHPFVK--MQRLERLYISNNRLV-ALNLYGQPIPT 296
Query: 225 LKELDISNNLFSGSIPEGLTRL-SLEKLNLSHNNFS 259
LK LD+S+N + + LE L L HN+
Sbjct: 297 LKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV 331
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 4e-15
Identities = 38/164 (23%), Positives = 62/164 (37%), Gaps = 13/164 (7%)
Query: 96 DSSIHLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLS 155
I + + ++ + + L L L N+L + L Y L E+DLS
Sbjct: 202 AIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLT-DTAWLLNYPG-LVEVDLS 256
Query: 156 ANLFTGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSF 215
N + + RL L + N L A L P T L+ LDL N
Sbjct: 257 YNELE-KIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPT---LKVLDLSHNHLL-HV 310
Query: 216 PEFVTRFEALKELDISNNLFSGSIPEGLTRLSLEKLNLSHNNFS 259
+F+ L+ L + +N ++ +L+ L LSHN++
Sbjct: 311 ERNQPQFDRLENLYLDHNSIV-TLKLSTHH-TLKNLTLSHNDWD 352
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 5e-13
Identities = 30/146 (20%), Positives = 52/146 (35%), Gaps = 20/146 (13%)
Query: 123 SMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGN 182
+ LQ+L L+ N L + SL ++S NL + + P + L N
Sbjct: 165 TSLQNLQLSSNRLT-HVDL--SLIPSLFHANVSYNLLSTLAIPI------AVEELDASHN 215
Query: 183 SLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEG 242
S+ + +L L L N + + L E+D+S N I
Sbjct: 216 SINV------VRGPVNVELTILKLQHNNLT-DTAWL-LNYPGLVEVDLSYNELE-KIMYH 266
Query: 243 -LTRL-SLEKLNLSHNNFSGVLPVFS 266
++ LE+L +S+N +
Sbjct: 267 PFVKMQRLERLYISNNRLVALNLYGQ 292
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 5e-13
Identities = 34/188 (18%), Positives = 64/188 (34%), Gaps = 21/188 (11%)
Query: 78 LSCSDISLPQWANLSLYKDSSIHLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKG 137
C D +L ++ D I + + + +L + + ++++
Sbjct: 10 YKCIDSNLQ---YDCVFYDVHIDMQTQDVYFGFEDITLNN-------QKIVTFKNSTMR- 58
Query: 138 TIPFE-LGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNS 196
+P L + ++L+ + + + L + N++ LP N
Sbjct: 59 KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYA-HTIQKLYMGFNAIR-YLPPHVFQN- 115
Query: 197 TCSDLQYLDLGSNKFSGSFPEFV-TRFEALKELDISNNLFSGSIPEGLTR--LSLEKLNL 253
L L L N S S P + L L +SNN I + + SL+ L L
Sbjct: 116 -VPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQL 172
Query: 254 SHNNFSGV 261
S N + V
Sbjct: 173 SSNRLTHV 180
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 3e-06
Identities = 13/97 (13%), Positives = 35/97 (36%), Gaps = 4/97 (4%)
Query: 169 NLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKEL 228
NL V +H + T + + T ++ + + ++ + F ++ L
Sbjct: 16 NLQYDCVFYDVHIDMQTQDVYF-GFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELL 74
Query: 229 DISNNLFSGSIPEG-LTRL-SLEKLNLSHNNFSGVLP 263
++++ I +++KL + N + P
Sbjct: 75 NLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPP 110
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 2e-15
Identities = 31/149 (20%), Positives = 59/149 (39%), Gaps = 15/149 (10%)
Query: 118 ELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSL 177
L + L VN + P + + L+ + + N T + + NL +L L
Sbjct: 194 PLASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDL--SPLANL-SQLTWL 248
Query: 178 RLHGNSLTAALPEPALPN-STCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFS 236
+ N ++ + + L+ L++GSN+ S + L L ++NN
Sbjct: 249 EIGTNQISD------INAVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLG 300
Query: 237 GSIPEGLTRL-SLEKLNLSHNNFSGVLPV 264
E + L +L L LS N+ + + P+
Sbjct: 301 NEDMEVIGGLTNLTTLFLSQNHITDIRPL 329
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 76.4 bits (189), Expect = 4e-15
Identities = 31/156 (19%), Positives = 55/156 (35%), Gaps = 17/156 (10%)
Query: 108 SANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSI 167
AN S L + L L + + +K P + L + L+ N + +
Sbjct: 140 GANHNLSDLSPLSNMTGLNYLTVTESKVKDVTPI--ANLTDLYSLSLNYNQIEDI--SPL 195
Query: 168 WNLCDRLVSLRLHGNSLTAALPEPALPN-STCSDLQYLDLGSNKFSGSFPEFVTRFEALK 226
+L L + N +T + + + L L +G+NK + + L
Sbjct: 196 ASL-TSLHYFTAYVNQIT------DITPVANMTRLNSLKIGNNKITDL--SPLANLSQLT 246
Query: 227 ELDISNNLFSGSIPEGLTRL-SLEKLNLSHNNFSGV 261
L+I N S + L L+ LN+ N S +
Sbjct: 247 WLEIGTNQISD--INAVKDLTKLKMLNVGSNQISDI 280
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 1e-14
Identities = 25/143 (17%), Positives = 55/143 (38%), Gaps = 15/143 (10%)
Query: 119 LGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLR 178
+ + L SL + N + P L S L+ +++ N + + ++ +L +L L
Sbjct: 217 VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDI--NAVKDL-TKLKMLN 271
Query: 179 LHGNSLTAALPEPALPN-STCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSG 237
+ N ++ + + S L L L +N+ E + L L +S N +
Sbjct: 272 VGSNQISD------ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITD 325
Query: 238 SIP-EGLTRLSLEKLNLSHNNFS 259
P L+ ++ + ++
Sbjct: 326 IRPLASLS--KMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 73.7 bits (182), Expect = 3e-14
Identities = 29/148 (19%), Positives = 56/148 (37%), Gaps = 16/148 (10%)
Query: 118 ELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSL 177
L + L+ LYLN +++ P L + + ++L AN L+P + N+ L L
Sbjct: 105 ALQNLTNLRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLSP-LSNM-TGLNYL 160
Query: 178 RLHGNSLTAALPEPALPN-STCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFS 236
+ + + + + +DL L L N+ + +L N +
Sbjct: 161 TVTESKVK------DVTPIANLTDLYSLSLNYNQIEDI--SPLASLTSLHYFTAYVNQIT 212
Query: 237 GSIP-EGLTRLSLEKLNLSHNNFSGVLP 263
P +T L L + +N + + P
Sbjct: 213 DITPVANMT--RLNSLKIGNNKITDLSP 238
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 69.5 bits (171), Expect = 6e-13
Identities = 33/150 (22%), Positives = 56/150 (37%), Gaps = 17/150 (11%)
Query: 119 LGEFSMLQSLYLNVNSLKGTIPFE-LGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSL 177
+ + L S+ + E L S++++ ++ + I L L L
Sbjct: 18 DADLAEGIRAVLQKASVTDVVTQEEL---ESITKLVVAGEKVASI--QGIEYL-TNLEYL 71
Query: 178 RLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSG 237
L+GN +T P L L L +G+NK + + L+EL ++ + S
Sbjct: 72 NLNGNQITDISPLSNLVK-----LTNLYIGTNKITD--ISALQNLTNLRELYLNEDNISD 124
Query: 238 SIP-EGLTRLSLEKLNLSHNNFSGVLPVFS 266
P LT + LNL N+ L S
Sbjct: 125 ISPLANLT--KMYSLNLGANHNLSDLSPLS 152
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 42.1 bits (100), Expect = 4e-04
Identities = 17/68 (25%), Positives = 29/68 (42%), Gaps = 3/68 (4%)
Query: 118 ELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSL 177
L S L SL+LN N L +G ++L+ + LS N T + + +L ++ S
Sbjct: 282 VLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDI--RPLASL-SKMDSA 338
Query: 178 RLHGNSLT 185
+
Sbjct: 339 DFANQVIK 346
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 77.3 bits (190), Expect = 5e-15
Identities = 38/164 (23%), Positives = 62/164 (37%), Gaps = 13/164 (7%)
Query: 96 DSSIHLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLS 155
I + + ++ + + L L L N+L + L Y L E+DLS
Sbjct: 208 AIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLT-DTAWLLNYPG-LVEVDLS 262
Query: 156 ANLFTGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSF 215
N + + RL L + N L A L P T L+ LDL N
Sbjct: 263 YNELE-KIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPT---LKVLDLSHNHLL-HV 316
Query: 216 PEFVTRFEALKELDISNNLFSGSIPEGLTRLSLEKLNLSHNNFS 259
+F+ L+ L + +N ++ +L+ L LSHN++
Sbjct: 317 ERNQPQFDRLENLYLDHNSIV-TLKLSTHH-TLKNLTLSHNDWD 358
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 75.7 bits (186), Expect = 2e-14
Identities = 33/156 (21%), Positives = 59/156 (37%), Gaps = 12/156 (7%)
Query: 105 QLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLA 164
L AN++ +L L ++ L + NS+ + + + L+ + L N T
Sbjct: 193 SLFHANVSYNLLSTLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLTDT-- 247
Query: 165 PSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEA 224
+ N LV + L N L + L+ L + +N+ + +
Sbjct: 248 AWLLNY-PGLVEVDLSYNELEK-IMYHPFVK--MQRLERLYISNNRLV-ALNLYGQPIPT 302
Query: 225 LKELDISNNLFSGSIPEGLTRL-SLEKLNLSHNNFS 259
LK LD+S+N + + LE L L HN+
Sbjct: 303 LKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV 337
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 73.0 bits (179), Expect = 1e-13
Identities = 35/146 (23%), Positives = 56/146 (38%), Gaps = 18/146 (12%)
Query: 118 ELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSL 177
+L L ++ N L L ++ E+D S N V + L L
Sbjct: 187 DLSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSINVVRG----PVNVELTIL 237
Query: 178 RLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFV-TRFEALKELDISNNLFS 236
+L N+LT L N L +DL N+ + + L+ L ISNN
Sbjct: 238 KLQHNNLT---DTAWLLN--YPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV 291
Query: 237 GSIPEGLTRL-SLEKLNLSHNNFSGV 261
++ + +L+ L+LSHN+ V
Sbjct: 292 -ALNLYGQPIPTLKVLDLSHNHLLHV 316
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 71.9 bits (176), Expect = 3e-13
Identities = 31/156 (19%), Positives = 68/156 (43%), Gaps = 14/156 (8%)
Query: 108 SANLTGSLPRE-LGEFSMLQSLYLNVNSLKGTIPFELGYS-SSLSEIDLSANLFTGVLAP 165
+ + +Q LY+ N+++ +P + + L+ + L N + L
Sbjct: 83 NDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLPR 140
Query: 166 SIWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEAL 225
I++ +L +L + N+L + + + LQ L L SN+ + + +L
Sbjct: 141 GIFHNTPKLTTLSMSNNNLER-IEDDTFQA--TTSLQNLQLSSNRLT-HVDL--SLIPSL 194
Query: 226 KELDISNNLFSGSIPEGLTRLSLEKLNLSHNNFSGV 261
++S NL S ++ +++E+L+ SHN+ + V
Sbjct: 195 FHANVSYNLLS-TLAIP---IAVEELDASHNSINVV 226
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 71.9 bits (176), Expect = 3e-13
Identities = 39/200 (19%), Positives = 70/200 (35%), Gaps = 28/200 (14%)
Query: 78 LSCSDISLPQWANLSLYKDSSIHLLSIQLPSA-------NLT---------GSLPRE-LG 120
C D +L ++ D I + + + N LP L
Sbjct: 16 YKCIDSNLQY---DCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLD 72
Query: 121 EFSMLQSLYLNVNSLKGTIPFE-LGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRL 179
F ++ L LN ++ I Y+ ++ ++ + N + N+ L L L
Sbjct: 73 SFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNV-PLLTVLVL 130
Query: 180 HGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSI 239
N L+ +LP N L L + +N + +L+ L +S+N + +
Sbjct: 131 ERNDLS-SLPRGIFHN--TPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HV 186
Query: 240 PEGLTRLSLEKLNLSHNNFS 259
L SL N+S+N S
Sbjct: 187 DLSLIP-SLFHANVSYNLLS 205
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 70.3 bits (172), Expect = 9e-13
Identities = 30/144 (20%), Positives = 51/144 (35%), Gaps = 20/144 (13%)
Query: 125 LQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNSL 184
LQ+L L+ N L + SL ++S NL + + P + L NS+
Sbjct: 173 LQNLQLSSNRLT-HVDL--SLIPSLFHANVSYNLLSTLAIPI------AVEELDASHNSI 223
Query: 185 TAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEG-L 243
+ +L L L N + + L E+D+S N I
Sbjct: 224 NV------VRGPVNVELTILKLQHNNLT-DTAWL-LNYPGLVEVDLSYNELE-KIMYHPF 274
Query: 244 TRL-SLEKLNLSHNNFSGVLPVFS 266
++ LE+L +S+N +
Sbjct: 275 VKMQRLERLYISNNRLVALNLYGQ 298
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 69.6 bits (170), Expect = 1e-12
Identities = 25/159 (15%), Positives = 54/159 (33%), Gaps = 7/159 (4%)
Query: 105 QLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLA 164
P + L + +++++ + FE ++ + + L
Sbjct: 9 VKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLP 67
Query: 165 PSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEA 224
++ + ++ L L+ + + A +Q L +G N P
Sbjct: 68 AALLDSFRQVELLNLNDLQIEE-IDTYAFAY--AHTIQKLYMGFNAIRYLPPHVFQNVPL 124
Query: 225 LKELDISNNLFSGSIPEGL-TRL-SLEKLNLSHNNFSGV 261
L L + N S S+P G+ L L++S+NN +
Sbjct: 125 LTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERI 162
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 3e-06
Identities = 13/97 (13%), Positives = 35/97 (36%), Gaps = 4/97 (4%)
Query: 169 NLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKEL 228
NL V +H + T + + T ++ + + ++ + F ++ L
Sbjct: 22 NLQYDCVFYDVHIDMQTQDVYF-GFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELL 80
Query: 229 DISNNLFSGSIPEG-LTRL-SLEKLNLSHNNFSGVLP 263
++++ I +++KL + N + P
Sbjct: 81 NLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPP 116
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 8e-15
Identities = 64/309 (20%), Positives = 116/309 (37%), Gaps = 61/309 (19%)
Query: 370 EHLTLEDVLNATGQVIEKTTYGTAYKAKLADGAT-IALRLLREG-SCKDRSSCLPVIRQL 427
E L L + + G +G + +L T +A++ RE ++ L R L
Sbjct: 114 EDLVLGEQIGR-GN------FGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARIL 166
Query: 428 GKVRHENLIPLRAFYQG---KRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIA 484
+ H N++ L G ++ ++ + L L ++
Sbjct: 167 KQYSHPNIVRL----IGVCTQKQPIYIVMELVQGGDFLTFLRT---EGARLRVKTLLQMV 219
Query: 485 LGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAK 544
A G+ YL + I H ++ ++N LV + V ++++FG+ + A
Sbjct: 220 GDAAAGMEYLESKCCI---HRDLAARNCLVTEKNVLKISDFGMSREEA---DGVYAA--- 270
Query: 545 ADGYK-------APELQRMKKCSSRTDVYAFGILLLEIL-IGKKP--GKSGRNGEFVDLP 594
+ G + APE + SS +DV++FGILL E +G P S +
Sbjct: 271 SGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ-------- 322
Query: 595 SIVKVAVLEETTMEVFDMEIMKGIRSPMEEGLVQAL-KLAMGCCAPVASVRPTMDEVVKQ 653
+ + + KG R P E A+ +L C A RP+ + ++
Sbjct: 323 -------------QTREF-VEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQE 368
Query: 654 LEENRPRNR 662
L+ R R+R
Sbjct: 369 LQSIRKRHR 377
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 8e-15
Identities = 44/165 (26%), Positives = 62/165 (37%), Gaps = 17/165 (10%)
Query: 101 LLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFT 160
L + L L L + L L L N + P L + L+E+ L AN +
Sbjct: 223 LDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQIS 278
Query: 161 GVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVT 220
+ + L L +L L+ N L P L N L YL L N S P V+
Sbjct: 279 NI--SPLAGL-TALTNLELNENQLEDISPISNLKN-----LTYLTLYFNNISDISP--VS 328
Query: 221 RFEALKELDISNNLFSGSIPEGLTRL-SLEKLNLSHNNFSGVLPV 264
L+ L NN S L L ++ L+ HN S + P+
Sbjct: 329 SLTKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTPL 371
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 1e-14
Identities = 40/149 (26%), Positives = 63/149 (42%), Gaps = 17/149 (11%)
Query: 118 ELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSL 177
L + + L+SL N + P LG ++L E+ L+ N + ++ +L L L
Sbjct: 194 VLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASL-TNLTDL 248
Query: 178 RLHGNSLTAALPEPALPN-STCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFS 236
L N ++ L S + L L LG+N+ S P + AL L+++ N
Sbjct: 249 DLANNQISN------LAPLSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLE 300
Query: 237 GSIP-EGLTRLSLEKLNLSHNNFSGVLPV 264
P L +L L L NN S + PV
Sbjct: 301 DISPISNLK--NLTYLTLYFNNISDISPV 327
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 1e-13
Identities = 36/167 (21%), Positives = 65/167 (38%), Gaps = 17/167 (10%)
Query: 100 HLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLF 159
+L + L + ++ P L + L L L N + P L ++L+ ++L+ N
Sbjct: 244 NLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQL 299
Query: 160 TGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFV 219
+ I NL L L L+ N+++ P +L LQ L +NK S +
Sbjct: 300 EDI--SPISNLK-NLTYLTLYFNNISDISPVSSLTK-----LQRLFFYNNKVSD--VSSL 349
Query: 220 TRFEALKELDISNNLFSGSIP-EGLTRLSLEKLNLSHNNFSGVLPVF 265
+ L +N S P LT + +L L+ ++ +
Sbjct: 350 ANLTNINWLSAGHNQISDLTPLANLT--RITQLGLNDQAWTNAPVNY 394
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 7e-13
Identities = 49/255 (19%), Positives = 88/255 (34%), Gaps = 59/255 (23%)
Query: 49 ENLLLSSWNIS--VPLCQWRGLKWISTNGSPLSCSDISLPQWANLSLYKDSSIHLLSIQL 106
+L N++ V + + + + S+ L+ +L I
Sbjct: 27 MKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIK----SIDGVEYLN-------NLTQINF 75
Query: 107 PSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPS 166
+ LT P L + L + +N N + P L ++L+ + L N T +
Sbjct: 76 SNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDI--DP 129
Query: 167 IWNLCDRLVSLRLHGNSLTAALPEPALPN----------------STCSDLQYLDLGSNK 210
+ NL L L L N+++ L + + + L+ LD+ SNK
Sbjct: 130 LKNL-TNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNK 188
Query: 211 FSGSFPEFVTRFEALKELDISNNLFSGSIP-EGLTRL--------------------SLE 249
S + + L+ L +NN S P LT L +L
Sbjct: 189 VSD--ISVLAKLTNLESLIATNNQISDITPLGILTNLDELSLNGNQLKDIGTLASLTNLT 246
Query: 250 KLNLSHNNFSGVLPV 264
L+L++N S + P+
Sbjct: 247 DLDLANNQISNLAPL 261
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 2e-12
Identities = 24/140 (17%), Positives = 54/140 (38%), Gaps = 12/140 (8%)
Query: 118 ELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSL 177
L + L +L LN N L+ P + +L+ + L N + + + +L +L L
Sbjct: 282 PLAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDI--SPVSSL-TKLQRL 336
Query: 178 RLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSG 237
+ N ++ L N + +L G N+ S P + + +L +++ ++
Sbjct: 337 FFYNNKVSDVSSLANLTN-----INWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTN 389
Query: 238 SIPEGLTRLSLEKLNLSHNN 257
+ +S+ +
Sbjct: 390 APVNYKANVSIPNTVKNVTG 409
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 2e-12
Identities = 35/179 (19%), Positives = 71/179 (39%), Gaps = 28/179 (15%)
Query: 100 HLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLF 159
+ L N+T ++ + + +L + + + Y ++L++I+ S N
Sbjct: 25 EKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI--KSIDGVEYLNNLTQINFSNNQL 80
Query: 160 TGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPN-----------------STCSDLQ 202
T + + NL +LV + ++ N + P L N ++L
Sbjct: 81 TDI--TPLKNLT-KLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLN 137
Query: 203 YLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRLSLEKLNLSHNNFSGV 261
L+L SN S ++ +L++L N + LT +LE+L++S N S +
Sbjct: 138 RLELSSNTISD--ISALSGLTSLQQLSFGNQVTDLKPLANLT--TLERLDISSNKVSDI 192
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 8e-12
Identities = 35/216 (16%), Positives = 71/216 (32%), Gaps = 28/216 (12%)
Query: 49 ENLLLSSWNISV--PLCQWRGLKWISTNGSPLSCSDISLPQWANLSLYKDSSIHLLSIQL 106
+L L++ IS PL L + + +S ++ A L+ L +++L
Sbjct: 246 TDLDLANNQISNLAPLSGLTKLTELKLGANQIS----NISPLAGLT-------ALTNLEL 294
Query: 107 PSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPS 166
L P + L L L N++ P + + L + N + V S
Sbjct: 295 NENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--SS 348
Query: 167 IWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALK 226
+ NL + + L N ++ P L + L L ++ + +
Sbjct: 349 LANLTN-INWLSAGHNQISDLTPLANLTR-----ITQLGLNDQAWTNAPVNYKANVSIPN 402
Query: 227 ELDISNNLFSGSIPEGLTRL-SLEKLNLSHNNFSGV 261
+ P ++ S + +++ N S
Sbjct: 403 TVKNVTGAL--IAPATISDGGSYTEPDITWNLPSYT 436
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 1e-11
Identities = 26/145 (17%), Positives = 50/145 (34%), Gaps = 17/145 (11%)
Query: 119 LGEFSMLQSLYLNVNSLKGTIPF-ELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSL 177
+ L ++ T+ +L ++ + + + L + L +
Sbjct: 20 DTALAEKMKTVLGKTNVTDTVSQTDL---DQVTTLQADRLGIKSI--DGVEYL-NNLTQI 73
Query: 178 RLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSG 237
N LT P L L + + +N+ + P + L L + NN +
Sbjct: 74 NFSNNQLTDITPLKNLTK-----LVDILMNNNQIADITP--LANLTNLTGLTLFNNQITD 126
Query: 238 SIP-EGLTRLSLEKLNLSHNNFSGV 261
P + LT +L +L LS N S +
Sbjct: 127 IDPLKNLT--NLNRLELSSNTISDI 149
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 2e-14
Identities = 62/320 (19%), Positives = 118/320 (36%), Gaps = 32/320 (10%)
Query: 370 EHLTLEDVLN--ATGQVIEKTTYGTAYKAKLADGATIALRLLREGSCKDRSSCLPVIRQL 427
HL L G V GA +A++ L+ + I+ L
Sbjct: 23 RHLKYISQLGKGNFGSVEL----CRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQIL 78
Query: 428 GKVRHENLIPLRAFYQGKRGEKL-LIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALG 486
+ + ++ R G + L L+ +Y PS L D L + L+ +R +
Sbjct: 79 KALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQR---HRARLDASRLLLYSSQ 135
Query: 487 IARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKAD 546
I +G+ YL + + H ++ ++N+LV+ ++ +FGL +L+ D+ + +
Sbjct: 136 ICKGMEYLGSRRCV---HRDLAARNILVESEAHVKIADFGLAKLLP---LDKDYYVVREP 189
Query: 547 GYK------APELQRMKKCSSRTDVYAFGILLLEIL-IGKKPGKSGRNGEFVDLPSIVKV 599
G + APE S ++DV++FG++L E+ K +
Sbjct: 190 G-QSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVP 248
Query: 600 AVLEETTMEVFDMEIMKGIRSPMEEGLVQAL-KLAMGCCAPVASVRPTMDEVVKQLEENR 658
A+ + ++ + +G R P + +L C AP RP+ + QL+
Sbjct: 249 AL-----SRLLEL-LEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLW 302
Query: 659 PRNRSALYSPTETRSEIGTP 678
+ T G
Sbjct: 303 -SGSRGCETHAFTAHPEGKH 321
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 3e-14
Identities = 57/300 (19%), Positives = 121/300 (40%), Gaps = 34/300 (11%)
Query: 370 EHLTLEDVLNATGQVIEKTTYGTAYKAKL-----ADGATIALRLLREGSCKDRSSCLPVI 424
HL L G +G+ + G +A++ L+ + + I
Sbjct: 41 RHLKFLQQLGK-GN------FGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREI 93
Query: 425 RQLGKVRHENLIPLRAF-YQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKI 483
L ++H+N++ + Y R LI +Y P +L D L K ++ + +
Sbjct: 94 EILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQY 150
Query: 484 ALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALA 543
I +G+ YL T I H ++ ++N+LV++ ++ +FGL +++ D+
Sbjct: 151 TSQICKGMEYLGTKRYI---HRDLATRNILVENENRVKIGDFGLTKVLP---QDKEYYKV 204
Query: 544 KADGYK------APELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIV 597
K G + APE K S +DV++FG++L E+ + KS + +
Sbjct: 205 KEPG-ESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDK 263
Query: 598 KVAVLEETTMEVFDMEIMKGIRSPMEEGLVQAL-KLAMGCCAPVASVRPTMDEVVKQLEE 656
+ + + ++ + R P +G + + C + RP+ ++ ++++
Sbjct: 264 QGQM---IVFHLIEL-LKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQ 319
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 74.9 bits (184), Expect = 3e-14
Identities = 50/201 (24%), Positives = 76/201 (37%), Gaps = 33/201 (16%)
Query: 67 GLKWISTNGSPLSCSDISLPQWANLSLYK-------DSSIHLLSIQLPSANLTGSLPREL 119
GL + G+ L+ + P LS+ L + + LT SLP
Sbjct: 122 GLCKLWIFGNQLTSLPVLPPGLQELSVSDNQLASLPALPSELCKLWAYNNQLT-SLPMLP 180
Query: 120 GEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRL 179
LQ L ++ N L ++P L ++ N T S+ L L L +
Sbjct: 181 SG---LQELSVSDNQLA-SLPTLPS---ELYKLWAYNNRLT-----SLPALPSGLKELIV 228
Query: 180 HGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSI 239
GN LT+ LP S+L+ L + N+ + S P + L L + N + +
Sbjct: 229 SGNRLTS------LPVL-PSELKELMVSGNRLT-SLPMLPSG---LLSLSVYRNQLT-RL 276
Query: 240 PEGLTRL-SLEKLNLSHNNFS 259
PE L L S +NL N S
Sbjct: 277 PESLIHLSSETTVNLEGNPLS 297
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 74.5 bits (183), Expect = 4e-14
Identities = 49/239 (20%), Positives = 87/239 (36%), Gaps = 41/239 (17%)
Query: 22 ASSSPASASSDVELLLGKIKSSLQGDDENLLLSSWNI-SVPLCQWRGLKWISTNGSPLSC 80
++PA S ++ K+++ L + L + + ++P C + + + L+
Sbjct: 16 RRAAPAEESRGRAAVVQKMRACLNNGNAVLNVGESGLTTLPDCLPAHITTLVIPDNNLT- 74
Query: 81 SDISLPQWANLSLYKDSSIHLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIP 140
SLP A L ++++ LT SLP L + L
Sbjct: 75 ---SLP--ALPP-------ELRTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHLPALP- 120
Query: 141 FELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSD 200
S L ++ + N T S+ L L L + N L +LP
Sbjct: 121 ------SGLCKLWIFGNQLT-----SLPVLPPGLQELSVSDNQLA------SLPALPSE- 162
Query: 201 LQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRLSLEKLNLSHNNFS 259
L L +N+ + S P L+EL +S+N + S+P + L KL +N +
Sbjct: 163 LCKLWAYNNQLT-SLPM---LPSGLQELSVSDNQLA-SLPTLPS--ELYKLWAYNNRLT 214
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 65.7 bits (160), Expect = 3e-11
Identities = 43/217 (19%), Positives = 75/217 (34%), Gaps = 30/217 (13%)
Query: 49 ENLLLSSWNISVPLCQWRGLKWISTNGSPLSCSDISLPQWANLSLYKDSSIHLLSIQLP- 107
L + ++ GL+ +S + + L+ + L Y ++ + L +
Sbjct: 124 CKLWIFGNQLTSLPVLPPGLQELSVSDNQLASLPALPSELCKLWAY-NNQLTSLPMLPSG 182
Query: 108 ------SANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTG 161
S N SLP E L L+ N L ++P L E+ +S N T
Sbjct: 183 LQELSVSDNQLASLPTLPSE---LYKLWAYNNRLT-SLPALPS---GLKELIVSGNRLT- 234
Query: 162 VLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTR 221
S+ L L L + GN LT+ LP S L L + N+ + PE +
Sbjct: 235 ----SLPVLPSELKELMVSGNRLTS------LPML-PSGLLSLSVYRNQLT-RLPESLIH 282
Query: 222 FEALKELDISNNLFSGSIPEGLTRLSLEKLNLSHNNF 258
+ +++ N S + L ++
Sbjct: 283 LSSETTVNLEGNPLSERTLQALREITS--APGYSGPI 317
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 73.1 bits (179), Expect = 5e-14
Identities = 30/276 (10%), Positives = 88/276 (31%), Gaps = 34/276 (12%)
Query: 382 GQVIEKTTYGTAYKAK------LADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENL 435
++ + + Y+A + L++ + + + ++ +L
Sbjct: 70 HHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMF 129
Query: 436 IPLRAFYQGKRGEKLLIYDYFPSRTLHDLL-HDTIAGKPVLNWARRHKIALGIARGLAYL 494
+ + + + +L+ + + TL + + + V+ A+ + + +
Sbjct: 130 MKFYSAHLFQ-NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQV 188
Query: 495 HTGHEIPITHGNVRSKNVLVDDFFVS-----------RLTEFGL-DQLMVPAVADEMVAL 542
H I HG+++ N ++ + F+ L + G + + A
Sbjct: 189 HDCE---IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAK 245
Query: 543 AKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVL 602
+ G++ E+ K + + D + + +L G GE + +
Sbjct: 246 CETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC-KPEGLFRRLPH 304
Query: 603 EETTMEVFD----------MEIMKGIRSPMEEGLVQ 628
+ E F + + +R +++ Q
Sbjct: 305 LDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ 340
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 5e-14
Identities = 58/300 (19%), Positives = 122/300 (40%), Gaps = 34/300 (11%)
Query: 370 EHLTLEDVLNATGQVIEKTTYGTAYKAKL-----ADGATIALRLLREGSCKDRSSCLPVI 424
HL L G +G+ + G +A++ L+ + + I
Sbjct: 10 RHLKFLQQLGK-GN------FGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREI 62
Query: 425 RQLGKVRHENLIPLRAF-YQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKI 483
L ++H+N++ + Y R LI +Y P +L D L K ++ + +
Sbjct: 63 EILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQY 119
Query: 484 ALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALA 543
I +G+ YL T I H ++ ++N+LV++ ++ +FGL +++ D+
Sbjct: 120 TSQICKGMEYLGTKRYI---HRDLATRNILVENENRVKIGDFGLTKVLP---QDKEFFKV 173
Query: 544 KADGYK------APELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIV 597
K G + APE K S +DV++FG++L E+ + KS + +
Sbjct: 174 KEPG-ESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDK 232
Query: 598 KVAVLEETTMEVFDMEIMKGIRSPMEEGLVQALKLAMGCC-APVASVRPTMDEVVKQLEE 656
+ + + ++ + R P +G + + M C + RP+ ++ ++++
Sbjct: 233 QGQM---IVFHLIEL-LKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQ 288
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 1e-13
Identities = 69/297 (23%), Positives = 120/297 (40%), Gaps = 53/297 (17%)
Query: 370 EHLTLEDVLNATGQVIEKTTYGTAYKAKLADGATIALRLLREGSCKDRSSCLPVIRQLGK 429
E L LE L A GQ +G + A +A++ ++ GS + L +
Sbjct: 188 ESLKLEKKLGA-GQ------FGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKT 239
Query: 430 VRHENLIPLRAFYQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIAR 489
++H+ L+ L A + +I ++ +L D L + + IA
Sbjct: 240 LQHDKLVKLHAVVTKEP--IYIITEFMAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAE 295
Query: 490 GLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKADGYK 549
G+A++ + I H ++R+ N+LV V ++ +FGL +++ +E A +G K
Sbjct: 296 GMAFIEQRNYI---HRDLRAANILVSASLVCKIADFGLARVIE---DNEYTA---REGAK 346
Query: 550 ------APELQRMKKCSSRTDVYAFGILLLEIL-IGKKP--GKSGRNGEFVDLPSIVKVA 600
APE + ++DV++FGILL+EI+ G+ P G S
Sbjct: 347 FPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP-------------- 392
Query: 601 VLEETTMEVFDMEIMKGIRSPMEEGLVQALKLAMGCC-APVASVRPTMDEVVKQLEE 656
EV + +G R P E + L M C RPT + + L++
Sbjct: 393 -------EVIRA-LERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 441
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 72.9 bits (179), Expect = 1e-13
Identities = 41/141 (29%), Positives = 58/141 (41%), Gaps = 12/141 (8%)
Query: 125 LQSLYLNVNSLKGTIPFE-LGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRL-HGN 182
L +L L N L IP Y S L E+ L N + +N L+ L L
Sbjct: 125 LNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELK 182
Query: 183 SLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEG 242
L + E A +L+YL+LG P T L+EL++S N F I G
Sbjct: 183 KLEY-ISEGAFEG--LFNLKYLNLGMCNIK-DMPNL-TPLVGLEELEMSGNHFP-EIRPG 236
Query: 243 -LTRL-SLEKLNLSHNNFSGV 261
L SL+KL + ++ S +
Sbjct: 237 SFHGLSSLKKLWVMNSQVSLI 257
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 2e-12
Identities = 37/173 (21%), Positives = 62/173 (35%), Gaps = 18/173 (10%)
Query: 100 HLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLF 159
+ L+ +P+ + S + L L N+++ + L + L N
Sbjct: 55 QFSKVVCTRRGLS-EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSI 111
Query: 160 TGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFS----GSF 215
+ + L L +L L N LT +P A + L+ L L +N +F
Sbjct: 112 RQIEVGAFNGL-ASLNTLELFDNWLTV-IPSGAFEYLS--KLRELWLRNNPIESIPSYAF 167
Query: 216 PEFVTRFEALKELDISNNLFSGSIPEG-LTRL-SLEKLNLSHNNFSGVLPVFS 266
R +L LD+ I EG L +L+ LNL N +P +
Sbjct: 168 ----NRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMPNLT 215
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 5e-09
Identities = 28/135 (20%), Positives = 50/135 (37%), Gaps = 7/135 (5%)
Query: 100 HLLSIQLPSANLTGSLPRE-LGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANL 158
L+ + L + L+ L L + ++K +P L L E+++S N
Sbjct: 172 SLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNH 229
Query: 159 FTGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEF 218
F + S L L L + + ++ + A + L L+L N S +
Sbjct: 230 FPEIRPGSFHGL-SSLKKLWVMNSQVSL-IERNAFDG--LASLVELNLAHNNLSSLPHDL 285
Query: 219 VTRFEALKELDISNN 233
T L EL + +N
Sbjct: 286 FTPLRYLVELHLHHN 300
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 73.0 bits (179), Expect = 1e-13
Identities = 74/309 (23%), Positives = 125/309 (40%), Gaps = 50/309 (16%)
Query: 370 EHLTLEDVLNATGQVIEKTTYGTAYKAKLADGATIALRLLREGSCKDRSSCLPVIRQLGK 429
E L LE L G +G + +A++ L+ G+ + L + + K
Sbjct: 267 ESLRLEVKLGQ-GC------FGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKK 318
Query: 430 VRHENLIPLRAFYQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIAR 489
+RHE L+ L A + ++ +Y +L D L L + +A IA
Sbjct: 319 LRHEKLVQLYAVVSEEP--IYIVTEYMSKGSLLDFLKG--ETGKYLRLPQLVDMAAQIAS 374
Query: 490 GLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKADGYK 549
G+AY+ + + H ++R+ N+LV + V ++ +FGL +L+ +E A G K
Sbjct: 375 GMAYVERMNYV---HRDLRAANILVGENLVCKVADFGLARLIE---DNEYTA---RQGAK 425
Query: 550 ------APELQRMKKCSSRTDVYAFGILLLEIL-IGKKPGKSGRNGEFVDLPSIVKVAVL 602
APE + + ++DV++FGILL E+ G+ P P +
Sbjct: 426 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP-----------YPGM------ 468
Query: 603 EETTMEVFDMEIMKGIRSPMEEGLVQALKLAMGCC-APVASVRPTMDEVVKQLEENRPRN 661
EV D + +G R P ++L M C RPT + + LE+ +
Sbjct: 469 --VNREVLDQ-VERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF-TS 524
Query: 662 RSALYSPTE 670
Y P E
Sbjct: 525 TEPQYQPGE 533
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 1e-13
Identities = 74/309 (23%), Positives = 125/309 (40%), Gaps = 50/309 (16%)
Query: 370 EHLTLEDVLNATGQVIEKTTYGTAYKAKLADGATIALRLLREGSCKDRSSCLPVIRQLGK 429
E L LE L G +G + +A++ L+ G+ + L + + K
Sbjct: 184 ESLRLEVKLGQ-GC------FGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKK 235
Query: 430 VRHENLIPLRAFYQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIAR 489
+RHE L+ L A + ++ +Y +L D L L + +A IA
Sbjct: 236 LRHEKLVQLYAVVSEEP--IYIVTEYMSKGSLLDFLKG--ETGKYLRLPQLVDMAAQIAS 291
Query: 490 GLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKADGYK 549
G+AY+ + + H ++R+ N+LV + V ++ +FGL +L+ +E A G K
Sbjct: 292 GMAYVERMNYV---HRDLRAANILVGENLVCKVADFGLARLIE---DNEYTA---RQGAK 342
Query: 550 ------APELQRMKKCSSRTDVYAFGILLLEIL-IGKKPGKSGRNGEFVDLPSIVKVAVL 602
APE + + ++DV++FGILL E+ G+ P P +
Sbjct: 343 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP-----------YPGM------ 385
Query: 603 EETTMEVFDMEIMKGIRSPMEEGLVQALKLAMGCC-APVASVRPTMDEVVKQLEENRPRN 661
EV D + +G R P ++L M C RPT + + LE+ +
Sbjct: 386 --VNREVLDQ-VERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF-TS 441
Query: 662 RSALYSPTE 670
Y P E
Sbjct: 442 TEPQYQPGE 450
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 2e-13
Identities = 41/141 (29%), Positives = 56/141 (39%), Gaps = 12/141 (8%)
Query: 125 LQSLYLNVNSLKGTIPFE-LGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRL-HGN 182
L +L L N L TIP Y S L E+ L N + +N L L L
Sbjct: 114 LNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELK 171
Query: 183 SLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEG 242
L+ + E A S+L+YL+L P T L ELD+S N S +I G
Sbjct: 172 RLSY-ISEGAFEG--LSNLRYLNLAMCNLR-EIPNL-TPLIKLDELDLSGNHLS-AIRPG 225
Query: 243 -LTRL-SLEKLNLSHNNFSGV 261
L L+KL + + +
Sbjct: 226 SFQGLMHLQKLWMIQSQIQVI 246
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 9e-13
Identities = 38/173 (21%), Positives = 63/173 (36%), Gaps = 18/173 (10%)
Query: 100 HLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLF 159
+ NL +P + + + L L+ N ++ + L + LS N
Sbjct: 44 QFSKVICVRKNLR-EVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHI 100
Query: 160 TGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFS----GSF 215
+ + L L +L L N LT +P A + L+ L L +N +F
Sbjct: 101 RTIEIGAFNGL-ANLNTLELFDNRLTT-IPNGAFVYLS--KLKELWLRNNPIESIPSYAF 156
Query: 216 PEFVTRFEALKELDISNNLFSGSIPEG-LTRL-SLEKLNLSHNNFSGVLPVFS 266
R +L+ LD+ I EG L +L LNL+ N + P +
Sbjct: 157 ----NRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLREI-PNLT 204
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 6e-09
Identities = 28/135 (20%), Positives = 49/135 (36%), Gaps = 7/135 (5%)
Query: 100 HLLSIQLPSANLTGSLPRE-LGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANL 158
L + L + S L+ L L + +L+ IP L L E+DLS N
Sbjct: 161 SLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNH 218
Query: 159 FTGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEF 218
+ + S L L L + + + + A N L ++L N + +
Sbjct: 219 LSAIRPGSFQGL-MHLQKLWMIQSQIQV-IERNAFDNLQ--SLVEINLAHNNLTLLPHDL 274
Query: 219 VTRFEALKELDISNN 233
T L+ + + +N
Sbjct: 275 FTPLHHLERIHLHHN 289
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 2e-13
Identities = 29/164 (17%), Positives = 55/164 (33%), Gaps = 12/164 (7%)
Query: 100 HLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLF 159
HL +Q L ++P+E+ L L N + + L + L N
Sbjct: 34 HLRVVQCSDLGLK-AVPKEI--SPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKI 90
Query: 160 TGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFV 219
+ + + L +L L + N L +P + L L + N+
Sbjct: 91 SKIHEKAFSPL-RKLQKLYISKNHLVE-IPPNLPSS-----LVELRIHDNRIRKVPKGVF 143
Query: 220 TRFEALKELDISNN-LFSGSIPEG-LTRLSLEKLNLSHNNFSGV 261
+ + +++ N L + G L L L +S +G+
Sbjct: 144 SGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTGI 187
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 3e-12
Identities = 38/172 (22%), Positives = 66/172 (38%), Gaps = 18/172 (10%)
Query: 100 HLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFE-LGYSSSLSEIDLSAN- 157
L + + +L +P L S L L ++ N ++ +P +++ I++ N
Sbjct: 103 KLQKLYISKNHLV-EIPPNL--PSSLVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNP 158
Query: 158 LFTGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPE 217
L P ++ +L LR+ LT +P L L L NK +
Sbjct: 159 LENSGFEPGAFDGL-KLNYLRISEAKLTG------IPKDLPETLNELHLDHNKIQ-AIEL 210
Query: 218 FV-TRFEALKELDISNNLFSGSIPEG-LTRL-SLEKLNLSHNNFSGVLPVFS 266
R+ L L + +N I G L+ L +L +L+L +N S V
Sbjct: 211 EDLLRYSKLYRLGLGHNQIR-MIENGSLSFLPTLRELHLDNNKLSRVPAGLP 261
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 5e-12
Identities = 36/143 (25%), Positives = 57/143 (39%), Gaps = 18/143 (12%)
Query: 125 LQSLYLNVNSLKGT-IPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNS 183
+ + + N L+ + L+ + +S TG+ +L + L L L N
Sbjct: 149 MNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTGIPK----DLPETLNELHLDHNK 204
Query: 184 LTAALPEPALPNSTCSDLQYLDLGSNKFS----GSFPEFVTRFEALKELDISNNLFSGSI 239
+ A + L S L L LG N+ GS + L+EL + NN S +
Sbjct: 205 IQA-IELEDLLR--YSKLYRLGLGHNQIRMIENGSL----SFLPTLRELHLDNNKLS-RV 256
Query: 240 PEGLTRL-SLEKLNLSHNNFSGV 261
P GL L L+ + L NN + V
Sbjct: 257 PAGLPDLKLLQVVYLHTNNITKV 279
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 5e-12
Identities = 36/166 (21%), Positives = 62/166 (37%), Gaps = 19/166 (11%)
Query: 101 LLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFE-LGYSSSLSEIDLSANLF 159
L +++ A LT +P++L L L+L+ N ++ I E L S L + L N
Sbjct: 174 LNYLRISEAKLT-GIPKDL--PETLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQI 229
Query: 160 TGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFS----GSF 215
+ S+ L L L L N L+ +P LP+ LQ + L +N + F
Sbjct: 230 RMIENGSLSFL-PTLRELHLDNNKLSR-VP-AGLPD--LKLLQVVYLHTNNITKVGVNDF 284
Query: 216 P--EFVTRFEALKELDISNN-LFSGSIPEGLTR--LSLEKLNLSHN 256
F + + + NN + + R + +
Sbjct: 285 CPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 2e-13
Identities = 35/167 (20%), Positives = 68/167 (40%), Gaps = 19/167 (11%)
Query: 100 HLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFE-LGYSSSLSEIDLSANL 158
L I++ N+T ++P+ L L L+L+ N + + L ++L+++ LS N
Sbjct: 172 KLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNS 227
Query: 159 FTGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFS----GS 214
+ V S+ N L L L+ N L +P L + +Q + L +N S
Sbjct: 228 ISAVDNGSLANTP-HLRELHLNNNKLVK-VP-GGLADHKY--IQVVYLHNNNISAIGSND 282
Query: 215 F--PEFVTRFEALKELDISNN-LFSGSIPEGL-TRL-SLEKLNLSHN 256
F P + T+ + + + +N + I + + L +
Sbjct: 283 FCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 2e-12
Identities = 33/169 (19%), Positives = 58/169 (34%), Gaps = 21/169 (12%)
Query: 100 HLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLF 159
HL +Q L +P++L L L N + + +L + L N
Sbjct: 32 HLRVVQCSDLGLE-KVPKDL--PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 88
Query: 160 TGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFS----GSF 215
+ + + L +L L L N L LPE LQ L + N+ + F
Sbjct: 89 SKISPGAFAPL-VKLERLYLSKNQLKE-LPEKMPKT-----LQELRVHENEITKVRKSVF 141
Query: 216 PEFVTRFEALKELDISNN-LFSGSIPEG-LTRL-SLEKLNLSHNNFSGV 261
+ +++ N L S I G + L + ++ N + +
Sbjct: 142 ----NGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTI 186
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 5e-12
Identities = 37/145 (25%), Positives = 57/145 (39%), Gaps = 21/145 (14%)
Query: 125 LQSLYLNVNSLKGTIPFELGY---SSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHG 181
+ + L N LK + E G LS I ++ T + L L L L G
Sbjct: 147 MIVVELGTNPLK-SSGIENGAFQGMKKLSYIRIADTNITTIPQ----GLPPSLTELHLDG 201
Query: 182 NSLTAALPEPALPNSTCSDLQYLDLGSNKFS----GSFPEFVTRFEALKELDISNNLFSG 237
N +T + +L ++L L L N S GS L+EL ++NN
Sbjct: 202 NKITK-VDAASLKG--LNNLAKLGLSFNSISAVDNGSL----ANTPHLRELHLNNNKLV- 253
Query: 238 SIPEGLTRL-SLEKLNLSHNNFSGV 261
+P GL ++ + L +NN S +
Sbjct: 254 KVPGGLADHKYIQVVYLHNNNISAI 278
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 9e-07
Identities = 27/116 (23%), Positives = 44/116 (37%), Gaps = 9/116 (7%)
Query: 148 SLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLG 207
L + S V P +L L L N +T + + N +L L L
Sbjct: 32 HLRVVQCSDLGLEKV--PK--DLPPDTALLDLQNNKITE-IKDGDFKNLK--NLHTLILI 84
Query: 208 SNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRLSLEKLNLSHNNFSGVLP 263
+NK S P L+ L +S N +PE + + +L++L + N + V
Sbjct: 85 NNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMPK-TLQELRVHENEITKVRK 138
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 71.8 bits (176), Expect = 3e-13
Identities = 44/152 (28%), Positives = 71/152 (46%), Gaps = 11/152 (7%)
Query: 111 LTGSLPRELGEFSMLQSLYLNVNSLK--GTIPFELGYSSSLSEIDLSANLFTGVLAPSIW 168
T S+ + LQ+L L N LK + SSL +D+S N
Sbjct: 365 FTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTC 424
Query: 169 NLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKEL 228
+ ++ L L N LT ++ LP ++ LDL +N+ S P+ VT +AL+EL
Sbjct: 425 AWAESILVLNLSSNMLTGSVFR-CLPPK----VKVLDLHNNRIM-SIPKDVTHLQALQEL 478
Query: 229 DISNNLFSGSIPEG-LTRL-SLEKLNLSHNNF 258
++++N S+P+G RL SL+ + L N +
Sbjct: 479 NVASNQLK-SVPDGVFDRLTSLQYIWLHDNPW 509
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 71.4 bits (175), Expect = 4e-13
Identities = 34/189 (17%), Positives = 74/189 (39%), Gaps = 13/189 (6%)
Query: 78 LSCSDISL---PQWANLSLYKDSSIHLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNS 134
L+ ++++ + + + L+ + + S F+ + L+++
Sbjct: 281 LNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISD 340
Query: 135 LKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLR---LHGNSLTAALPEP 191
SS + ++ + N+FT + C L L+ L N L +
Sbjct: 341 TPFIHMVCPPSPSSFTFLNFTQNVFTDSVF----QGCSTLKRLQTLILQRNGLKN-FFKV 395
Query: 192 ALPNSTCSDLQYLDLGSNKF-SGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRLSLEK 250
AL S L+ LD+ N S ++ E++ L++S+N+ +GS+ L ++
Sbjct: 396 ALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPP-KVKV 454
Query: 251 LNLSHNNFS 259
L+L +N
Sbjct: 455 LDLHNNRIM 463
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 56.4 bits (136), Expect = 2e-08
Identities = 35/254 (13%), Positives = 75/254 (29%), Gaps = 18/254 (7%)
Query: 15 FCLTESLASSSPASASSDVELLLGKIKSSLQGDDENLLLSSWNISVPLCQWRGLKWISTN 74
C+ L S ++ + L +L N+SV L I N
Sbjct: 172 SCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLN 231
Query: 75 GSPLSCSDISLPQWANLSLYKDSSIHLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNS 134
+C + ++ L I+ + ++ L + +
Sbjct: 232 --DENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLF--QFFWPRPVEYLNIYNLT 287
Query: 135 LKGTIPFELGYSSSLSEIDLSA-NLFTGVLAPSIWNLCDRLVSL---RLHGNSLTAALPE 190
+ I E S + L ++ V S L + L +
Sbjct: 288 ITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPF---I 344
Query: 191 PALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFS-----GSIPEGLTR 245
+ + S +L+ N F+ S + + + L+ L + N + + ++
Sbjct: 345 HMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSS 404
Query: 246 LSLEKLNLSHNNFS 259
L L++S N+ +
Sbjct: 405 LET--LDVSLNSLN 416
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 52.2 bits (125), Expect = 4e-07
Identities = 40/123 (32%), Positives = 57/123 (46%), Gaps = 14/123 (11%)
Query: 147 SSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDL 206
S +D S T V P +L R +L L NS++ L P + S S+L+ L L
Sbjct: 31 ELESMVDYSNRNLTHV--PK--DLPPRTKALSLSQNSISE-LRMPDI--SFLSELRVLRL 83
Query: 207 GSNKFSGSFPEFV-TRFEALKELDISNNLFSGSIPEG-LTRLSLEKLNLSHNNFSGVLPV 264
N+ S V + L+ LD+S+N +I + SL L+LS N+F VLPV
Sbjct: 84 SHNRIR-SLDFHVFLFNQDLEYLDVSHNRLQ-NISCCPMA--SLRHLDLSFNDFD-VLPV 138
Query: 265 FSE 267
E
Sbjct: 139 CKE 141
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 47.9 bits (114), Expect = 9e-06
Identities = 30/142 (21%), Positives = 49/142 (34%), Gaps = 23/142 (16%)
Query: 125 LQSLYLNVNSLKGTIPFELGYS-SSLSEIDLSANLFTGVLAPSIWNLCDRLVSLR---LH 180
L+ L L+ N ++ ++ F + L +D+S N + C + SLR L
Sbjct: 78 LRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHNRLQNIS-------CCPMASLRHLDLS 129
Query: 181 GNSLTAALPEPA----LPNSTCSDLQYLDLGSNKF-SGSFPEFVTRFEALKELDISNNLF 235
N LP L L +L L + KF + LD+ +
Sbjct: 130 FNDFDV-LPVCKEFGNLTK-----LTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHI 183
Query: 236 SGSIPEGLTRLSLEKLNLSHNN 257
G E L + L+L +
Sbjct: 184 KGGETESLQIPNTTVLHLVFHP 205
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 46.4 bits (110), Expect = 2e-05
Identities = 34/233 (14%), Positives = 73/233 (31%), Gaps = 10/233 (4%)
Query: 42 SSLQGDDENLLLSSWNIS-VPLCQWRGLKWISTNGSPLSCSDISLPQWANLSLYKDSSIH 100
+ L L L S++I + + S S+ N+S+ +
Sbjct: 167 AHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQ--VNMSVNALGHLQ 224
Query: 101 LLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIP-----FELGYSSSLSEIDLS 155
L +I+L N + L + + ++ T F+ + + +++
Sbjct: 225 LSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIY 284
Query: 156 ANLFTGVLAPSIWNLCDR-LVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGS 214
T + + + L SL + L S +++ L +
Sbjct: 285 NLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFI 344
Query: 215 FPEFVTRFEALKELDISNNLFSGSIPEGLTRL-SLEKLNLSHNNFSGVLPVFS 266
+ L+ + N+F+ S+ +G + L L+ L L N V
Sbjct: 345 HMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVAL 397
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 4e-13
Identities = 66/326 (20%), Positives = 108/326 (33%), Gaps = 45/326 (13%)
Query: 351 GSAAGGAGGEGKLIIFQGGEHLTLEDVLNATGQVIEKTTYGTAYKAK-LADGATIALRLL 409
S +G ++I +H L G + + L DG AL+ +
Sbjct: 11 SSGRENLYFQGHMVII-DNKHYLFIQKL-GEGG------FSYVDLVEGLHDGHFYALKRI 62
Query: 410 REGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEK---LLIYDYFPSRTLHDLLH 466
+DR H N++ L A+ +RG K L+ +F TL + +
Sbjct: 63 LCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIE 122
Query: 467 DTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFG 526
L + + LGI RGL + H H +++ N+L+ D L + G
Sbjct: 123 RLKDKGNFLTEDQILWLLLGICRGLEAI---HAKGYAHRDLKPTNILLGDEGQPVLMDLG 179
Query: 527 LDQLMVPAVADEMVALAKADG--------YKAPEL---QRMKKCSSRTDVYAFGILLLEI 575
V AL D Y+APEL Q RTDV++ G +L +
Sbjct: 180 SMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAM 239
Query: 576 LIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIRSPMEEGLVQALK-LAM 634
+ G+ P + + + + + P AL L
Sbjct: 240 MFGEGP--------YDM----------VFQKGDSVALAVQNQLSIPQSPRHSSALWQLLN 281
Query: 635 GCCAPVASVRPTMDEVVKQLEENRPR 660
RP + ++ QLE +P
Sbjct: 282 SMMTVDPHQRPHIPLLLSQLEALQPP 307
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 71.0 bits (174), Expect = 4e-13
Identities = 70/299 (23%), Positives = 120/299 (40%), Gaps = 55/299 (18%)
Query: 370 EHLTLEDVLNATGQVIEKTTYGTAYKAKL-ADGATIALRLLREGSCKDRSSCLPVIRQLG 428
+T++ L GQ YG Y+ T+A++ L+E + + L +
Sbjct: 220 TDITMKHKLGG-GQ------YGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMK 271
Query: 429 KVRHENLIPLRAFYQG---KRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIAL 485
+++H NL+ L G + +I ++ L D L + + ++ +A
Sbjct: 272 EIKHPNLVQL----LGVCTREPPFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMAT 325
Query: 486 GIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKA 545
I+ + YL + I H N+ ++N LV + + ++ +FGL +LM D A
Sbjct: 326 QISSAMEYLEKKNFI---HRNLAARNCLVGENHLVKVADFGLSRLMT---GDTYTA---H 376
Query: 546 DGYK------APELQRMKKCSSRTDVYAFGILLLEIL-IGKKPGKSGRNGEFVDLPSIVK 598
G K APE K S ++DV+AFG+LL EI G P P I
Sbjct: 377 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP-----------YPGI-- 423
Query: 599 VAVLEETTMEVFDMEIMKGIRSPMEEGLVQALKLAMGCC-APVASVRPTMDEVVKQLEE 656
+V+++ + K R EG + + M C S RP+ E+ + E
Sbjct: 424 ------DLSQVYEL-LEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFET 475
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 6e-13
Identities = 37/166 (22%), Positives = 63/166 (37%), Gaps = 10/166 (6%)
Query: 98 SIHLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSAN 157
S ++ ++P + + + L L N +K E L E++L+ N
Sbjct: 10 SAQDRAVLCHRKRFV-AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNEN 66
Query: 158 LFTGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPE 217
+ + + P +N L +L L N L +P S+L LD+ NK
Sbjct: 67 IVS-AVEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFTG--LSNLTKLDISENKIVILLDY 122
Query: 218 FVTRFEALKELDISNNLFSGSIPEG-LTRL-SLEKLNLSHNNFSGV 261
LK L++ +N I + L SLE+L L N + +
Sbjct: 123 MFQDLYNLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLTSI 167
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 8e-13
Identities = 34/166 (20%), Positives = 67/166 (40%), Gaps = 11/166 (6%)
Query: 100 HLLSIQLPSANLTGSLPREL-GEFSMLQSLYLNVNSLKGTIPFELGYS-SSLSEIDLSAN 157
+L + + S N L + + L+SL + N L I +SL ++ L
Sbjct: 105 NLTKLDI-SENKIVILLDYMFQDLYNLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKC 162
Query: 158 LFTGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPE 217
T + ++ +L L+ LRL ++ A + + + L+ L++ + +
Sbjct: 163 NLTSIPTEALSHL-HGLIVLRLRHLNINA-IRDYSFKR--LYRLKVLEISHWPYLDTMTP 218
Query: 218 FVTRFEALKELDISNNLFSGSIPEG-LTRL-SLEKLNLSHNNFSGV 261
L L I++ + ++P + L L LNLS+N S +
Sbjct: 219 NCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPISTI 263
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 1e-12
Identities = 36/166 (21%), Positives = 62/166 (37%), Gaps = 17/166 (10%)
Query: 101 LLSIQLPSANLTGSLPRE-LGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLF 159
L + L NLT S+P E L L L L ++ + L +++S +
Sbjct: 154 LEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPY 212
Query: 160 TGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFS----GSF 215
+ P+ L SL + +LTA +P A+ + L++L+L N S
Sbjct: 213 LDTMTPNCLYGL-NLTSLSITHCNLTA-VPYLAVRH--LVYLRFLNLSYNPISTIEGSML 268
Query: 216 PEFVTRFEALKELDISNNLFSGSIPEG-LTRL-SLEKLNLSHNNFS 259
L+E+ + + + L L LN+S N +
Sbjct: 269 ----HELLRLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQLT 309
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 38/191 (19%), Positives = 68/191 (35%), Gaps = 36/191 (18%)
Query: 125 LQSLYLNVNSLKGTIPFE-LGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNS 183
L++L L N LK IP S+L+++D+S N +L ++ L SL + N
Sbjct: 82 LRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDND 139
Query: 184 LTAALPEPALPNSTCSDLQYLDLGSNKFS----GSFPEFVTRFEALKELDISNNLFSGSI 239
L + A S + L+ L L + + + L L + + + +I
Sbjct: 140 LVY-ISHRAF--SGLNSLEQLTLEKCNLTSIPTEAL----SHLHGLIVLRLRHLNIN-AI 191
Query: 240 PEG-LTRLS-LEKLNLSHNNFSGVLPVFSESKFGAEVFEGNSPALCGFPLR--DCSGN-- 293
+ RL L+ L +SH + + L G L +
Sbjct: 192 RDYSFKRLYRLKVLEISHWPYLDTMT---------------PNCLYGLNLTSLSITHCNL 236
Query: 294 SRLSSGAIAGL 304
+ + A+ L
Sbjct: 237 TAVPYLAVRHL 247
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 7e-13
Identities = 59/301 (19%), Positives = 114/301 (37%), Gaps = 36/301 (11%)
Query: 370 EHLTLEDVLNATGQVIEKTTYGTAYKAKLA-----DGATIALRLLREGSC-KDRSSCLPV 423
L L G +G + G +A++ L+ S +
Sbjct: 21 RFLKRIRDLGE-GH------FGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKE 73
Query: 424 IRQLGKVRHENLIPLRAF-YQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHK 482
I L + HEN++ + + LI ++ PS +L + L K +N ++ K
Sbjct: 74 IEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPK---NKNKINLKQQLK 130
Query: 483 IALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVAL 542
A+ I +G+ YL + + H ++ ++NVLV+ ++ +FGL + + D+
Sbjct: 131 YAVQICKGMDYLGSRQYV---HRDLAARNVLVESEHQVKIGDFGLTKAIE---TDKEYYT 184
Query: 543 AKADG-----YKAPELQRMKKCSSRTDVYAFGILLLEIL-IGKKPGKSGRNGEFVDLPSI 596
K D + APE K +DV++FG+ L E+L + P+
Sbjct: 185 VKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTH 244
Query: 597 VKVAVLEETTMEVFDMEIMKGIRSPMEEGLVQAL-KLAMGCCAPVASVRPTMDEVVKQLE 655
++ T + + + +G R P + +L C S R + +++ E
Sbjct: 245 GQM-----TVTRLVNT-LKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFE 298
Query: 656 E 656
Sbjct: 299 A 299
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 1e-12
Identities = 38/155 (24%), Positives = 58/155 (37%), Gaps = 8/155 (5%)
Query: 110 NLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWN 169
++ L L+L+ N L + L ++DLS N + P+ ++
Sbjct: 43 RISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFH 102
Query: 170 LCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFV-TRFEALKEL 228
RL +L L L L + LQYL L N + P+ L L
Sbjct: 103 GLGRLHTLHLDRCGLQ-ELGPGLFRG--LAALQYLYLQDNALQ-ALPDDTFRDLGNLTHL 158
Query: 229 DISNNLFSGSIPEG-LTRL-SLEKLNLSHNNFSGV 261
+ N S S+PE L SL++L L N + V
Sbjct: 159 FLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVAHV 192
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 1e-11
Identities = 34/139 (24%), Positives = 52/139 (37%), Gaps = 10/139 (7%)
Query: 125 LQSLYLNVNSLKGTIPFE-LGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNS 183
L+ L L+ N+ ++ L + L L P ++ L L L N+
Sbjct: 82 LEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNA 140
Query: 184 LTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFV-TRFEALKELDISNNLFSGSIPEG 242
L A LP+ + +L +L L N+ S S PE +L L + N + +
Sbjct: 141 LQA-LPDDTFRD--LGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVA-HVHPH 195
Query: 243 -LTRL-SLEKLNLSHNNFS 259
L L L L NN S
Sbjct: 196 AFRDLGRLMTLYLFANNLS 214
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 2e-11
Identities = 33/172 (19%), Positives = 60/172 (34%), Gaps = 18/172 (10%)
Query: 102 LSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTG 161
++ P L ++P + + Q ++L+ N + +L+ + L +N+
Sbjct: 14 VTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLAR 70
Query: 162 VLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFS----GSFPE 217
+ A + L L L L N+ ++ L L L G F
Sbjct: 71 IDAAAFTGL-ALLEQLDLSDNAQLRSVDPATFHG--LGRLHTLHLDRCGLQELGPGLF-- 125
Query: 218 FVTRFEALKELDISNNLFSGSIPEG-LTRL-SLEKLNLSHNNFSGVLP-VFS 266
AL+ L + +N ++P+ L +L L L N S V F
Sbjct: 126 --RGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFR 174
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 6e-08
Identities = 29/110 (26%), Positives = 46/110 (41%), Gaps = 6/110 (5%)
Query: 125 LQSLYLNVNSLKGTIPFE-LGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNS 183
LQ LYL N+L+ +P + +L+ + L N + V + L L L LH N
Sbjct: 131 LQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGL-HSLDRLLLHQNR 188
Query: 184 LTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNN 233
+ + A L L L +N S E + AL+ L +++N
Sbjct: 189 VAH-VHPHAF--RDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDN 235
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 66.8 bits (164), Expect = 2e-12
Identities = 59/300 (19%), Positives = 117/300 (39%), Gaps = 59/300 (19%)
Query: 370 EHLTLEDVLNATGQVIEKTTYGTAYKAKLADGATIALRLLREGSCKDRSSCLPVIRQLGK 429
LT + + GQ +G + + +A++ +REG+ + + K
Sbjct: 8 SELTFVQEIGS-GQ------FGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMK 59
Query: 430 VRHENLIPLRAFYQG---KRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALG 486
+ H L+ L G ++ L+ ++ L D L + + + L
Sbjct: 60 LSHPKLVQL----YGVCLEQAPICLVTEFMEHGCLSDYLRT---QRGLFAAETLLGMCLD 112
Query: 487 IARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKAD 546
+ G+AYL I H ++ ++N LV + V ++++FG+ + ++ D+ + +
Sbjct: 113 VCEGMAYLEEACVI---HRDLAARNCLVGENQVIKVSDFGMTRFVL---DDQYTS---ST 163
Query: 547 GYK------APELQRMKKCSSRTDVYAFGILLLEIL-IGKKP--GKSGRNGEFVDLPSIV 597
G K +PE+ + SS++DV++FG+L+ E+ GK P +S
Sbjct: 164 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS----------- 212
Query: 598 KVAVLEETTMEVFDMEIMKGIRSPMEEGLVQAL-KLAMGCCAPVASVRPTMDEVVKQLEE 656
EV + I G R + ++ C RP +++QL E
Sbjct: 213 ----------EVVED-ISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAE 261
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 4e-12
Identities = 56/310 (18%), Positives = 110/310 (35%), Gaps = 56/310 (18%)
Query: 382 GQVIEKTTYGTAYKAK-LADGATIAL---RLLREGSCKDRSSCLPVIRQLGKVRHENLIP 437
+ I + + Y+A L DG +AL ++ K R+ C+ I L ++ H N+I
Sbjct: 37 EKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIK 96
Query: 438 LRAFYQGKRGEKLLIY-DYFPSRTLHDLLHDTIAGKP------VLNWARRHKIALGIARG 490
A + +L I + + L ++ K V + + +
Sbjct: 97 YYASF--IEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQ------LCSA 148
Query: 491 LAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAK-ADG-- 547
L ++H+ + H +++ NV + V +L + GL + A G
Sbjct: 149 LEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFF-----SSKTTAAHSLVGTP 200
Query: 548 -YKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETT 606
Y +PE + ++D+++ G LL E+ + P G+ ++L S+ K
Sbjct: 201 YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFY----GDKMNLYSLCK-------- 248
Query: 607 MEVFDMEIMKGIRSPMEEGLV-QALK-LAMGCCAPVASVRPTMDEVVKQLEENRPRNRSA 664
+I + P+ + L+ L C P RP + V + A
Sbjct: 249 ------KIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYD-----VAKRMHA 297
Query: 665 LYSPTETRSE 674
+ +
Sbjct: 298 CTASSLEHHH 307
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 5e-12
Identities = 64/302 (21%), Positives = 117/302 (38%), Gaps = 40/302 (13%)
Query: 370 EHLTLEDVLN--ATGQVIEKTTYGTAYKAKLADGATIALRLLREGSC-KDRSSCLPVIRQ 426
+L L G+V G +A++ L+ + + RS I
Sbjct: 31 RYLKKIRDLGEGHFGKVSL----YCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDI 86
Query: 427 LGKVRHENLIPLRAFYQGKRGEKL-LIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIAL 485
L + HE++I + + L L+ +Y P +L D L + + A+ A
Sbjct: 87 LRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLP-----RHSIGLAQLLLFAQ 141
Query: 486 GIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKA 545
I G+AYLH H I H ++ ++NVL+D+ + ++ +FGL + + +
Sbjct: 142 QICEGMAYLHAQHYI---HRDLAARNVLLDNDRLVKIGDFGLAKAVP---EGHEYYRVRE 195
Query: 546 DGYK------APELQRMKKCSSRTDVYAFGILLLEIL-IGKKPGKSGRNGEFVDL---PS 595
DG APE + K +DV++FG+ L E+L +
Sbjct: 196 DG-DSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQ 254
Query: 596 IVKVAVLEETTMEVFDMEIMKGIRSPMEEGLVQAL-KLAMGCCAPVASVRPTMDEVVKQL 654
+ T + + ++ + +G R P + + L C AS RPT + ++ L
Sbjct: 255 M--------TVLRLTEL-LERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPIL 305
Query: 655 EE 656
+
Sbjct: 306 KT 307
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 5e-12
Identities = 44/282 (15%), Positives = 101/282 (35%), Gaps = 36/282 (12%)
Query: 383 QVIEKTTYGTAYKAK-LADGATIALRLLREG--SCKDRSSCLPVIRQLGKVRHENLIPLR 439
I +YG K + +DG + + L G + ++ + + L +++H N++
Sbjct: 12 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 71
Query: 440 AFYQGKRGEKLLIY-DYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGH 498
+ L I +Y L ++ + L+ ++ + L H
Sbjct: 72 DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 131
Query: 499 EIP--ITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKAD----GYKAPE 552
+ + H +++ NV +D +L +FGL +++ + + AK Y +PE
Sbjct: 132 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL-----NHDTSFAKTFVGTPYYMSPE 186
Query: 553 LQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDM 612
+ ++D+++ G LL E+ P F + +
Sbjct: 187 QMNRMSYNEKSDIWSLGCLLYELCALMPP--------F------------TAFSQKELAG 226
Query: 613 EIMKGIRSPMEEGLVQALK-LAMGCCAPVASVRPTMDEVVKQ 653
+I +G + L + RP+++E+++
Sbjct: 227 KIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN 268
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 5e-12
Identities = 69/295 (23%), Positives = 123/295 (41%), Gaps = 53/295 (17%)
Query: 370 EHLTLEDVLNATGQVIEKTTYGTAYKAKLADGATIALRLLREGSCKDRSSCLPVIRQLGK 429
+ L L + G+ +G G +A++ ++ + + L + +
Sbjct: 193 KELKLLQTIGK-GE------FGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQ 242
Query: 430 VRHENLIPLRAFYQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIAR 489
+RH NL+ L ++G ++ +Y +L D L G+ VL K +L +
Sbjct: 243 LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCE 300
Query: 490 GLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKADGYK 549
+ YL + + H ++ ++NVLV + V+++++FGL + + D K
Sbjct: 301 AMEYLEGNNFV---HRDLAARNVLVSEDNVAKVSDFGLTK-------EASST---QDTGK 347
Query: 550 ------APELQRMKKCSSRTDVYAFGILLLEIL-IGKKPGKSGRNGEFVDLPSIVKVAVL 602
APE R KK S+++DV++FGILL EI G+ P P I
Sbjct: 348 LPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP-----------YPRI------ 390
Query: 603 EETTMEVFDMEIMKGIRSPMEEGLVQALKLAMGCC-APVASVRPTMDEVVKQLEE 656
+V + KG + +G A+ M C A+ RPT ++ +QLE
Sbjct: 391 --PLKDVVPR-VEKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEH 442
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 9e-12
Identities = 70/306 (22%), Positives = 130/306 (42%), Gaps = 62/306 (20%)
Query: 370 EHLTLEDVLNATGQVIEKTTYGTAYKAKLADGA-----TIALRLLREG-SCKDRSSCLPV 423
+T + V+ A G+ +G YK L + +A++ L+ G + K R L
Sbjct: 44 SCVTRQKVIGA-GE------FGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGE 96
Query: 424 IRQLGKVRHENLIPLRAFYQG--KRGEKLLI-YDYFPSRTLHDLLHDTIAGKPVLNWARR 480
+G+ H N+I L +G + + ++I +Y + L L + + +
Sbjct: 97 AGIMGQFSHHNIIRL----EGVISKYKPMMIITEYMENGALDKFLRE---KDGEFSVLQL 149
Query: 481 HKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMV 540
+ GIA G+ YL + + H ++ ++N+LV+ V ++++FGL ++ + D+
Sbjct: 150 VGMLRGIAAGMKYLANMNYV---HRDLAARNILVNSNLVCKVSDFGLSRV----LEDDPE 202
Query: 541 ALAKADGYK------APELQRMKKCSSRTDVYAFGILLLEIL-IGKKP--GKSGRNGEFV 591
A G K APE +K +S +DV++FGI++ E++ G++P S
Sbjct: 203 ATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH----- 257
Query: 592 DLPSIVKVAVLEETTMEVFDMEIMKGIRSPMEEGLVQAL-KLAMGCCAPVASVRPTMDEV 650
EV I G R P A+ +L M C + RP ++
Sbjct: 258 ----------------EVMKA-INDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADI 300
Query: 651 VKQLEE 656
V L++
Sbjct: 301 VSILDK 306
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 1e-11
Identities = 28/142 (19%), Positives = 49/142 (34%), Gaps = 17/142 (11%)
Query: 118 ELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSL 177
++ + L L ++N ++ + L+ +D S N T + + L L
Sbjct: 143 DVSHNTQLTELDCHLNKK--ITKLDVTPQTQLTTLDCSFNKITEL---DVSQN-KLLNRL 196
Query: 178 RLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSG 237
N++T L + L +LD SNK + VT L D S N +
Sbjct: 197 NCDTNNITK------LDLNQNIQLTFLDCSSNKLT-EID--VTPLTQLTYFDCSVNPLTE 247
Query: 238 SIPEGLTRLSLEKLNLSHNNFS 259
L+ L L+ +
Sbjct: 248 LDVSTLS--KLTTLHCIQTDLL 267
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 8e-11
Identities = 33/161 (20%), Positives = 60/161 (37%), Gaps = 21/161 (13%)
Query: 100 HLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLF 159
L S+ ++++T + + + + L L N++ +L +++L+ + +N
Sbjct: 43 TLTSLDCHNSSIT-DMT-GIEKLTGLTKLICTSNNITT---LDLSQNTNLTYLACDSNKL 97
Query: 160 TGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFV 219
T + + L +L L N LT L S L YL+ N + V
Sbjct: 98 TNL---DVTPL-TKLTYLNCDTNKLT------KLDVSQNPLLTYLNCARNTLT-EID--V 144
Query: 220 TRFEALKELDISNNLFSGSIP-EGLTRLSLEKLNLSHNNFS 259
+ L ELD N + T L L+ S N +
Sbjct: 145 SHNTQLTELDCHLNKKITKLDVTPQT--QLTTLDCSFNKIT 183
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 36/217 (16%), Positives = 62/217 (28%), Gaps = 34/217 (15%)
Query: 49 ENLLLSSWNI-SVPLCQWRGLKWISTNGSPLSCSDIS-LPQWANLSLYKDSSIHLLSIQL 106
L + NI + L Q L ++ + + L+ D++ L Q
Sbjct: 194 NRLNCDTNNITKLDLNQNIQLTFLDCSSNKLTEIDVTPLTQLTYFDC------------- 240
Query: 107 PSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPS 166
S N L + S L +L+ L I L +++ L L
Sbjct: 241 -SVNPLTELD--VSTLSKLTTLHCIQTDLL-EID--LTHNTQLIYFQAEGCRKIKEL--D 292
Query: 167 IWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALK 226
+ + +L L +T L S L YL L + + + V+ LK
Sbjct: 293 VTHN-TQLYLLDCQAAGITE------LDLSQNPKLVYLYLNNTELT-ELD--VSHNTKLK 342
Query: 227 ELDISNNLFSGSIPEGLTRLSLEKLNLSHNNFSGVLP 263
L N +L + +
Sbjct: 343 SLSCVNAHIQ-DFSSVGKIPALNNNFEAEGQTITMPK 378
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 28/157 (17%), Positives = 57/157 (36%), Gaps = 17/157 (10%)
Query: 110 NLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWN 169
+ + + + L SL + +S+ + + + L+++ ++N T + +
Sbjct: 29 EMQATDTISEEQLATLTSLDCHNSSIT-DMT-GIEKLTGLTKLICTSNNITTL---DLSQ 83
Query: 170 LCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELD 229
L L N LT L + + L YL+ +NK + V++ L L+
Sbjct: 84 N-TNLTYLACDSNKLT------NLDVTPLTKLTYLNCDTNKLT-KLD--VSQNPLLTYLN 133
Query: 230 ISNNLFSGSIPEGLTRLSLEKLNLSHNNFSGVLPVFS 266
+ N + T L +L+ N L V
Sbjct: 134 CARNTLTEIDVSHNT--QLTELDCHLNKKITKLDVTP 168
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 1e-11
Identities = 66/305 (21%), Positives = 123/305 (40%), Gaps = 61/305 (20%)
Query: 370 EHLTLEDVLNATGQVIEKTTYGTAYKAKLADGA----TIALRLLREG-SCKDRSSCLPVI 424
+ +E ++ +G G +L +A++ L+ G + + R L
Sbjct: 49 SRIHIEKII-GSGD------SGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEA 101
Query: 425 RQLGKVRHENLIPLRAFYQG--KRGEKLLI-YDYFPSRTLHDLLHDTIAGKPVLNWARRH 481
+G+ H N+I L +G RG +I +Y + +L L +
Sbjct: 102 SIMGQFDHPNIIRL----EGVVTRGRLAMIVTEYMENGSLDTFLRT---HDGQFTIMQLV 154
Query: 482 KIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVA 541
+ G+ G+ YL + H ++ ++NVLVD V ++++FGL +++ D+ A
Sbjct: 155 GMLRGVGAGMRYLSDLGYV---HRDLAARNVLVDSNLVCKVSDFGLSRVL----EDDPDA 207
Query: 542 LAKADGYK------APELQRMKKCSSRTDVYAFGILLLEIL-IGKKP--GKSGRNGEFVD 592
G K APE + SS +DV++FG+++ E+L G++P + R
Sbjct: 208 AYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR------ 261
Query: 593 LPSIVKVAVLEETTMEVFDMEIMKGIRSPMEEGLVQAL-KLAMGCCAPVASVRPTMDEVV 651
+V + +G R P G AL +L + C + RP ++V
Sbjct: 262 ---------------DVISS-VEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIV 305
Query: 652 KQLEE 656
L+
Sbjct: 306 SVLDA 310
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 45/371 (12%), Positives = 95/371 (25%), Gaps = 46/371 (12%)
Query: 323 VQNKKRKNRGDSEEEFEEGEDEENGMSGGSAAGGAGGEGKLIIFQGGEHLTLEDVL---- 378
++ ++ EE +E ++ A ++ QG L L + L
Sbjct: 15 LKREEELIGYCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGD 74
Query: 379 ---------NATGQ-----VIEKTTYGTAYKAKLADGATIALRLLREGSCKDRSSCLPVI 424
+ V + + + AT A L S ++ ++
Sbjct: 75 RSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLL 134
Query: 425 RQLGKVR---HENLIPLRAFYQGKRGEKLLIYDYFPSRTLHDL---LHDTIAGKPVLNWA 478
V L L+ S L L L +
Sbjct: 135 LPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGIL 194
Query: 479 RRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADE 538
H + + R A L + + HG+ N+ + L + + V
Sbjct: 195 ALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSA----LWKVGTR 247
Query: 539 MVALAKADGYKAPELQRMKKC--SSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSI 596
A + Y E + + + G+ + + P F +
Sbjct: 248 GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP--------FGLVTPG 299
Query: 597 VKVAVLEETTMEVFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVK--QL 654
+K + + + G +P+ + L R E ++ +
Sbjct: 300 IKGSWKRPSLRVPGTDSLAFGSCTPLPDF---VKTLIGRFLNFDRRRRLLPLEAMETPEF 356
Query: 655 EENRPRNRSAL 665
+ + S+L
Sbjct: 357 LQLQNEISSSL 367
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 64.5 bits (158), Expect = 2e-11
Identities = 70/302 (23%), Positives = 121/302 (40%), Gaps = 63/302 (20%)
Query: 370 EHLTLEDVLNATGQVIEKTTYGTAYKAKLADGATIALRLLREGSCKDRSSCLPVIRQLGK 429
E L L + L A GQ +G + +A++ L++GS + L + +
Sbjct: 13 ETLKLVERLGA-GQ------FGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQ 64
Query: 430 VRHENLIPLRA------FYQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKI 483
++H+ L+ L A Y +I +Y + +L D L L + +
Sbjct: 65 LQHQRLVRLYAVVTQEPIY--------IITEYMENGSLVDFLKTP--SGIKLTINKLLDM 114
Query: 484 ALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALA 543
A IA G+A++ + I H ++R+ N+LV D ++ +FGL +L+ ++ A
Sbjct: 115 AAQIAEGMAFIEERNYI---HRDLRAANILVSDTLSCKIADFGLARLI-----EDNEYTA 166
Query: 544 KADG---YK--APELQRMKKCSSRTDVYAFGILLLEIL-IGKKP--GKSGRNGEFVDLPS 595
+ K APE + ++DV++FGILL EI+ G+ P G +
Sbjct: 167 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP--------- 217
Query: 596 IVKVAVLEETTMEVFDMEIMKGIRSPMEEGLVQALKLAMGCC-APVASVRPTMDEVVKQL 654
EV + +G R + + L M C RPT D + L
Sbjct: 218 ------------EVIQN-LERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVL 264
Query: 655 EE 656
E+
Sbjct: 265 ED 266
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 2e-11
Identities = 52/282 (18%), Positives = 106/282 (37%), Gaps = 46/282 (16%)
Query: 390 YGTAYKAKLADGA----TIALRLLREG-SCKDRSSCLPVIRQLGKVRHENLIPLRAFYQG 444
+G Y + D A A++ L + + L + + H N++ L
Sbjct: 34 FGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLP 93
Query: 445 KRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITH 504
G ++ Y L + + L +ARG+ YL + H
Sbjct: 94 PEGLPHVLLPYMCHGDLLQFIRSP---QRNPTVKDLISFGLQVARGMEYLAEQKFV---H 147
Query: 505 GNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKADGYK------APELQRMKK 558
++ ++N ++D+ F ++ +FGL + ++ E ++ + + A E + +
Sbjct: 148 RDLAARNCMLDESFTVKVADFGLARDIL---DREYYSVQQHRHARLPVKWTALESLQTYR 204
Query: 559 CSSRTDVYAFGILLLEIL-IGKKP--GKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIM 615
++++DV++FG+LL E+L G P ++ +
Sbjct: 205 FTTKSDVWSFGVLLWELLTRGAPPYRHIDPF---------------------DLTHF-LA 242
Query: 616 KGIRSPMEEGLVQALKLAMGCC-APVASVRPTMDEVVKQLEE 656
+G R P E +L M C +VRPT +V ++E+
Sbjct: 243 QGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQ 284
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 2e-11
Identities = 60/300 (20%), Positives = 120/300 (40%), Gaps = 59/300 (19%)
Query: 370 EHLTLEDVLNATGQVIEKTTYGTAYKAKLADGATIALRLLREGSCKDRSSCLPVIRQLGK 429
+ LT L GQ +G K +A+++++EGS + + +
Sbjct: 24 KDLTFLKELGT-GQ------FGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMN 75
Query: 430 VRHENLIPLRAFYQG---KRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALG 486
+ HE L+ L G K+ +I +Y + L + L + + + ++
Sbjct: 76 LSHEKLVQL----YGVCTKQRPIFIITEYMANGCLLNYLRE---MRHRFQTQQLLEMCKD 128
Query: 487 IARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKAD 546
+ + YL + + H ++ ++N LV+D V ++++FGL + ++ DE + +
Sbjct: 129 VCEAMEYLESKQFL---HRDLAARNCLVNDQGVVKVSDFGLSRYVL---DDEYTS---SV 179
Query: 547 GYK------APELQRMKKCSSRTDVYAFGILLLEIL-IGKKP--GKSGRNGEFVDLPSIV 597
G K PE+ K SS++D++AFG+L+ EI +GK P +
Sbjct: 180 GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS----------- 228
Query: 598 KVAVLEETTMEVFDMEIMKGIRSPMEEGLVQAL-KLAMGCCAPVASVRPTMDEVVKQLEE 656
E + I +G+R + + + C A RPT ++ + +
Sbjct: 229 ----------ETAEH-IAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 277
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 2e-11
Identities = 67/308 (21%), Positives = 114/308 (37%), Gaps = 68/308 (22%)
Query: 370 EHLTLEDVLNATGQVIEKTTYGTAYKAKLADGA-----TIALRLLREGSC-KDRSSCLPV 423
VL + G +GT YK +A++ LRE + K L
Sbjct: 15 TEFKKIKVLGS-GA------FGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 67
Query: 424 IRQLGKVRHENLIPLRAFYQG--KRGEKLLIYDYFPSRTLHDLLH---DTIAGKPVLNWA 478
+ V + ++ L G LI P L D + D I + +LNW
Sbjct: 68 AYVMASVDNPHVCRL----LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC 123
Query: 479 RRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADE 538
IA+G+ YL + H ++ ++NVLV ++T+FGL +L+ A+E
Sbjct: 124 V------QIAKGMNYLEDRRLV---HRDLAARNVLVKTPQHVKITDFGLAKLLG---AEE 171
Query: 539 MVALAKADGYK------APELQRMKKCSSRTDVYAFGILLLEIL-IGKKP--GKSGRNGE 589
A+G K A E + + ++DV+++G+ + E++ G KP G
Sbjct: 172 KEY--HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--- 226
Query: 590 FVDLPSIVKVAVLEETTMEVFDMEIMKGIRSPMEEGLVQALKLAMGCC-APVASVRPTMD 648
E+ + + KG R P + + M C A RP
Sbjct: 227 ------------------EISSI-LEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFR 267
Query: 649 EVVKQLEE 656
E++ + +
Sbjct: 268 ELIIEFSK 275
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 2e-11
Identities = 63/320 (19%), Positives = 117/320 (36%), Gaps = 69/320 (21%)
Query: 370 EHLTLEDVLNATGQVIEKTTYGTAYKA--KLADGATI--ALRLLREGSCKDRSSCLPVIR 425
+ L L + L G +G + G T+ A++ L+ + IR
Sbjct: 18 KDLRLLEKLGD-GS------FGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIR 70
Query: 426 Q---LGKVRHENLIPLRA------FYQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLN 476
+ + + H NLI L ++ + P +L D L +
Sbjct: 71 EVNAMHSLDHRNLIRLYGVVLTPPMK--------MVTELAPLGSLLDRLRK---HQGHFL 119
Query: 477 WARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVA 536
+ A+ +A G+ YL + I H ++ ++N+L+ + ++ +FGL + +P
Sbjct: 120 LGTLSRYAVQVAEGMGYLESKRFI---HRDLAARNLLLATRDLVKIGDFGLMRA-LPQND 175
Query: 537 DEMVALAKADGYK------APELQRMKKCSSRTDVYAFGILLLEIL-IGKKP--GKSGRN 587
D V + K APE + + S +D + FG+ L E+ G++P G +G
Sbjct: 176 DHYVM---QEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS- 231
Query: 588 GEFVDLPSIVKVAVLEETTMEVFDMEIMKGIRSPMEEGLVQAL-KLAMGCCAPVASVRPT 646
++ +G R P E Q + + + C A RPT
Sbjct: 232 --------------------QILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPT 271
Query: 647 MDEVVKQLEENRPRNRSALY 666
+ L E +P + A +
Sbjct: 272 FVALRDFLLEAQPTDMRAEF 291
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 2e-11
Identities = 26/148 (17%), Positives = 52/148 (35%), Gaps = 14/148 (9%)
Query: 120 GEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRL 179
+ + L + L ++ E Y+ ++ ++ ++ T I L L LR+
Sbjct: 41 AQMNSLTYITLANINVTDLTGIE--YAHNIKDLTINNIHATNY--NPISGL-SNLERLRI 95
Query: 180 HGNSLTAALPEP--ALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSG 237
G +T+ L + L LD+ + S + + +D+S N
Sbjct: 96 MGKDVTSDKIPNLSGLTS-----LTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT 150
Query: 238 SIPEGLTRL-SLEKLNLSHNNFSGVLPV 264
I L L L+ LN+ + +
Sbjct: 151 DI-MPLKTLPELKSLNIQFDGVHDYRGI 177
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 1e-10
Identities = 22/144 (15%), Positives = 44/144 (30%), Gaps = 10/144 (6%)
Query: 119 LGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLR 178
+ ++ L +N P + S+L + + T P++ L L L
Sbjct: 62 IEYAHNIKDLTINNIHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGL-TSLTLLD 118
Query: 179 LHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGS 238
+ ++ ++ +T + +DL N + LK L+I +
Sbjct: 119 ISHSAHDDSILTK---INTLPKVNSIDLSYNGAITD-IMPLKTLPELKSLNIQFDGVHDY 174
Query: 239 IP-EGLTRLSLEKLNLSHNNFSGV 261
E L +L G
Sbjct: 175 RGIEDFP--KLNQLYAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 3e-10
Identities = 25/136 (18%), Positives = 50/136 (36%), Gaps = 16/136 (11%)
Query: 125 LQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNL--CDRLVSLRLHGN 182
+ L +S ++ +SL+ I L+ T + + + L ++
Sbjct: 25 YLNGLLGQSSTANITEAQM---NSLTYITLANINVT-----DLTGIEYAHNIKDLTINNI 76
Query: 183 SLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEG 242
T P L N L+ L + + ++ +L LDIS++ SI
Sbjct: 77 HATNYNPISGLSN-----LERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTK 131
Query: 243 LTRL-SLEKLNLSHNN 257
+ L + ++LS+N
Sbjct: 132 INTLPKVNSIDLSYNG 147
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 5e-05
Identities = 21/114 (18%), Positives = 42/114 (36%), Gaps = 7/114 (6%)
Query: 100 HLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLF 159
+L +++ ++T L + L L ++ ++ +I ++ ++ IDLS N
Sbjct: 89 NLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGA 148
Query: 160 TGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSG 213
+ P + L L SL + + + P L L S G
Sbjct: 149 ITDIMP-LKTL-PELKSLNIQFDGVHDYRGIEDFPK-----LNQLYAFSQTIGG 195
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 3e-11
Identities = 67/325 (20%), Positives = 134/325 (41%), Gaps = 58/325 (17%)
Query: 370 EHLTLEDVLNATGQVIEKTTYGTAYKA--KLADGATI--ALRLLREG-SCKDRSSCLPVI 424
+++++ V+ G+ +G KL I A++ L+ G + K R L
Sbjct: 45 TNISIDKVV-GAGE------FGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEA 97
Query: 425 RQLGKVRHENLIPLRAFYQGKRGEKLLI-YDYFPSRTLHDLLHDTIAGKPVLNWARRHKI 483
+G+ H N+I L + + ++I +Y + +L L + +
Sbjct: 98 SIMGQFDHPNIIRLEGVV--TKSKPVMIVTEYMENGSLDSFLRK---HDAQFTVIQLVGM 152
Query: 484 ALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALA 543
GIA G+ YL + H ++ ++N+L++ V ++++FGL +++ D+ A
Sbjct: 153 LRGIASGMKYLSDMGYV---HRDLAARNILINSNLVCKVSDFGLGRVL----EDDPEAAY 205
Query: 544 KADGYK------APELQRMKKCSSRTDVYAFGILLLEIL-IGKKP--GKSGRNGEFVDLP 594
G K +PE +K +S +DV+++GI+L E++ G++P S +
Sbjct: 206 TTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ-------- 257
Query: 595 SIVKVAVLEETTMEVFDMEIMKGIRSPMEEGLVQAL-KLAMGCCAPVASVRPTMDEVVKQ 653
+V + +G R P AL +L + C + RP +++V
Sbjct: 258 -------------DVIKA-VDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSI 303
Query: 654 LEENRPRNRSALYSPTETRSEIGTP 678
L++ RN +L T +
Sbjct: 304 LDKLI-RNPGSLKIITSAAARPSNL 327
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 5e-11
Identities = 68/301 (22%), Positives = 120/301 (39%), Gaps = 59/301 (19%)
Query: 370 EHLTLEDVLNATGQVIEKTTYGTAYKAKLADGAT-IALRLLREGSCKDRSSCLPVIRQLG 428
+T++ L GQ YG Y+ + +A++ L+E + + L +
Sbjct: 13 TDITMKHKLGG-GQ------YGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMK 64
Query: 429 KVRHENLIPLRAFYQG---KRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIAL 485
+++H NL+ L G + +I ++ L D L + + ++ +A
Sbjct: 65 EIKHPNLVQL----LGVCTREPPFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMAT 118
Query: 486 GIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKA 545
I+ + YL + I H ++ ++N LV + + ++ +FGL +LM D A A A
Sbjct: 119 QISSAMEYLEKKNFI---HRDLAARNCLVGENHLVKVADFGLSRLMT---GDTYTAHAGA 172
Query: 546 DGYK------APELQRMKKCSSRTDVYAFGILLLEIL-IGKKP--GKSGRNGEFVDLPSI 596
K APE K S ++DV+AFG+LL EI G P G
Sbjct: 173 ---KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---------- 219
Query: 597 VKVAVLEETTMEVFDMEIMKGIRSPMEEGLVQALKLAMGCC-APVASVRPTMDEVVKQLE 655
+V+++ + K R EG + + M C S RP+ E+ + E
Sbjct: 220 -----------QVYEL-LEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 267
Query: 656 E 656
Sbjct: 268 T 268
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 5e-11
Identities = 51/318 (16%), Positives = 96/318 (30%), Gaps = 84/318 (26%)
Query: 370 EHLTLEDVLNATGQVIEKTTYGTAYKAKLADGA--------TIALRLLREGSCKDRSSCL 421
E L + L G + +K + + L++L + S
Sbjct: 8 EDLIFNESLGQ-GT------FTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFF 60
Query: 422 PVIRQLGKVRHENLIPLRAFYQG---KRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWA 478
+ K+ H++L+ G E +L+ ++ +L L K +N
Sbjct: 61 EAASMMSKLSHKHLVLN----YGVCVCGDENILVQEFVKFGSLDTYLKK---NKNCINIL 113
Query: 479 RRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTE--------FGLDQL 530
+ ++A +A + +L I HGNV +KN+L+ + G+
Sbjct: 114 WKLEVAKQLAAAMHFLEENTLI---HGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT 170
Query: 531 MVPAVADEMVALAKADGYK------APE-LQRMKKCSSRTDVYAFGILLLEIL-IGKKP- 581
++ D + PE ++ K + TD ++FG L EI G KP
Sbjct: 171 VL-----------PKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPL 219
Query: 582 -GKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIR--SPMEEGLVQALKLAMGCCA 638
+ + +P L L C
Sbjct: 220 SALDSQ---------------------RKLQF-YEDRHQLPAPKAAELAN---LINNCMD 254
Query: 639 PVASVRPTMDEVVKQLEE 656
RP+ +++ L
Sbjct: 255 YEPDHRPSFRAIIRDLNS 272
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 6e-11
Identities = 62/300 (20%), Positives = 121/300 (40%), Gaps = 59/300 (19%)
Query: 370 EHLTLEDVLNATGQVIEKTTYGTAYKAKLADGATIALRLLREGSCKDRSSCLPVIRQLGK 429
E +TL L + GQ +G K +A+++++EGS + + K
Sbjct: 8 EEITLLKELGS-GQ------FGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMK 59
Query: 430 VRHENLIPLRAFYQG---KRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALG 486
+ H L+ G K ++ +Y + L + L L ++ ++
Sbjct: 60 LSHPKLVKF----YGVCSKEYPIYIVTEYISNGCLLNYLRS---HGKGLEPSQLLEMCYD 112
Query: 487 IARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKAD 546
+ G+A+L + I H ++ ++N LVD ++++FG+ + ++ D+ V+ +
Sbjct: 113 VCEGMAFLESHQFI---HRDLAARNCLVDRDLCVKVSDFGMTRYVL---DDQYVS---SV 163
Query: 547 GYK------APELQRMKKCSSRTDVYAFGILLLEIL-IGKKP--GKSGRNGEFVDLPSIV 597
G K APE+ K SS++DV+AFGIL+ E+ +GK P +
Sbjct: 164 GTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS----------- 212
Query: 598 KVAVLEETTMEVFDMEIMKGIRSPMEEGLVQAL-KLAMGCCAPVASVRPTMDEVVKQLEE 656
EV + +G R + ++ C + RPT +++ +E
Sbjct: 213 ----------EVVLK-VSQGHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEP 261
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 7e-11
Identities = 68/328 (20%), Positives = 120/328 (36%), Gaps = 64/328 (19%)
Query: 370 EHLTLEDVLNATGQVIEKTTYGTAYKAKLADGA-----TIALRLLREGSC-KDRSSCLPV 423
VL + G +GT YK +A++ LRE + K L
Sbjct: 15 TEFKKIKVLGS-GA------FGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 67
Query: 424 IRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRTLHDLLH---DTIAGKPVLNWARR 480
+ V + ++ L LI P L D + D I + +LNW
Sbjct: 68 AYVMASVDNPHVCRLLGICLTS--TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCV- 124
Query: 481 HKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMV 540
IA+G+ YL + H ++ ++NVLV ++T+FGL +L+ A+E
Sbjct: 125 -----QIAKGMNYLEDRRLV---HRDLAARNVLVKTPQHVKITDFGLAKLLG---AEEKE 173
Query: 541 ALAKADGYK------APELQRMKKCSSRTDVYAFGILLLEIL-IGKKP--GKSGRNGEFV 591
A+G K A E + + ++DV+++G+ + E++ G KP G
Sbjct: 174 Y--HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS----- 226
Query: 592 DLPSIVKVAVLEETTMEVFDMEIMKGIRSPMEEGLVQAL-KLAMGCCAPVASVRPTMDEV 650
E+ + + KG R P + + + C A RP E+
Sbjct: 227 ----------------EISSI-LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFREL 269
Query: 651 VKQLEENRPRNRSALYSPTETRSEIGTP 678
+ + + + L + R + +P
Sbjct: 270 IIEFSKMARDPQRYLVIQGDERMHLPSP 297
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 62.9 bits (153), Expect = 8e-11
Identities = 62/365 (16%), Positives = 117/365 (32%), Gaps = 80/365 (21%)
Query: 348 MSGGSAAGGAGG------EGKLIIFQGGEHLTLEDVLNATGQVIEKTTYGTAYKAK-LAD 400
M+G + GGA G G+ + G L + VL A G + Y+A+ +
Sbjct: 1 MAGPGSLGGASGRDQSDFVGQTVEL-GELRLRVRRVL-AEG------GFAFVYEAQDVGS 52
Query: 401 GATIALRLLREGSCKDRSSCLPVIRQLGKVR-HENLIPLRAFYQGKR------GEKLLIY 453
G AL+ L + + + + + K+ H N++ + + + L+
Sbjct: 53 GREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLL 112
Query: 454 DYFPSRTLHDLLHDTIAGKP-----VLNWARRHKIALGIARGLAYLHTGHEIPITHGNVR 508
L + L + P VL R + ++H + PI H +++
Sbjct: 113 TELCKGQLVEFLKKMESRGPLSCDTVLKIFY------QTCRAVQHMHR-QKPPIIHRDLK 165
Query: 509 SKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKADG-----------YKAPEL-QRM 556
+N+L+ + +L +FG + A +A Y+ PE+
Sbjct: 166 VENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLY 225
Query: 557 KKC--SSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEI 614
+ D++A G +L + + P F E+ + I
Sbjct: 226 SNFPIGEKQDIWALGCILYLLCFRQHP--------F------------EDGAK----LRI 261
Query: 615 MKG-----IRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRPRNRSALYSPT 669
+ G ++ R ++ EVV QL+E SP
Sbjct: 262 VNGKYSIPPHDTQYTVFHSLIR---AMLQVNPEERLSIAEVVHQLQEIAAARNVNPKSPI 318
Query: 670 ETRSE 674
E
Sbjct: 319 TELLE 323
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 61.8 bits (151), Expect = 1e-10
Identities = 68/295 (23%), Positives = 124/295 (42%), Gaps = 53/295 (17%)
Query: 370 EHLTLEDVLNATGQVIEKTTYGTAYKAKLADGATIALRLLREGSCKDRSSCLPVIRQLGK 429
+ L L + G+ +G G +A++ ++ + + L + +
Sbjct: 21 KELKLLQTIGK-GE------FGDVMLGD-YRGNKVAVKCIKNDA--TAQAFLAEASVMTQ 70
Query: 430 VRHENLIPLRAFYQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIAR 489
+RH NL+ L ++G ++ +Y +L D L G+ VL K +L +
Sbjct: 71 LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCE 128
Query: 490 GLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKADGYK 549
+ YL + + H ++ ++NVLV + V+++++FGL + + D K
Sbjct: 129 AMEYLEGNNFV---HRDLAARNVLVSEDNVAKVSDFGLTK-------EASST---QDTGK 175
Query: 550 ------APELQRMKKCSSRTDVYAFGILLLEIL-IGKKPGKSGRNGEFVDLPSIVKVAVL 602
APE R KK S+++DV++FGILL EI G+ P P I
Sbjct: 176 LPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP-----------YPRI------ 218
Query: 603 EETTMEVFDMEIMKGIRSPMEEGLVQALKLAMGCC-APVASVRPTMDEVVKQLEE 656
+V + KG + +G A+ M C A++RP+ ++ +QLE
Sbjct: 219 --PLKDVVPR-VEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEH 270
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 1e-10
Identities = 31/133 (23%), Positives = 59/133 (44%), Gaps = 17/133 (12%)
Query: 455 YFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLV 514
Y TL D++H + + R ++ + L + H I H +V+ N+++
Sbjct: 97 YVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMI 149
Query: 515 DDFFVSRLTEFGLDQLMVPAVADEMVALAKADG------YKAPELQRMKKCSSRTDVYAF 568
++ +FG+ A+AD ++ + Y +PE R +R+DVY+
Sbjct: 150 SATNAVKVMDFGI----ARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSL 205
Query: 569 GILLLEILIGKKP 581
G +L E+L G+ P
Sbjct: 206 GCVLYEVLTGEPP 218
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 1e-10
Identities = 62/304 (20%), Positives = 117/304 (38%), Gaps = 60/304 (19%)
Query: 370 EHLTLEDVLNATGQVIEKTTYGTAYKAKL-ADGATI--ALRLLREGSC--KDRSSCLPVI 424
+ LTLED +G +GT K A+++L+ + + L
Sbjct: 16 KLLTLEDKELGSGN------FGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEA 69
Query: 425 RQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRTLHDLL--HDTIAGKPVLNWARRHK 482
+ ++ + ++ + + + +L+ + L+ L + + K ++
Sbjct: 70 NVMQQLDNPYIVRMIGICEAES--WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVH--- 124
Query: 483 IALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVAL 542
++ G+ YL + + H ++ ++NVL+ +++++FGL + + ADE
Sbjct: 125 ---QVSMGMKYLEESNFV---HRDLAARNVLLVTQHYAKISDFGLSKALR---ADENYYK 175
Query: 543 AKADGYK------APELQRMKKCSSRTDVYAFGILLLEIL-IGKKP--GKSGRNGEFVDL 593
A+ G K APE K SS++DV++FG+L+ E G+KP G G
Sbjct: 176 AQTHG-KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS------- 227
Query: 594 PSIVKVAVLEETTMEVFDMEIMKGIRSPMEEGLVQAL-KLAMGCCAPVASVRPTMDEVVK 652
EV M + KG R G + + L C RP V
Sbjct: 228 --------------EVTAM-LEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 272
Query: 653 QLEE 656
+L
Sbjct: 273 RLRN 276
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 24/143 (16%), Positives = 53/143 (37%), Gaps = 12/143 (8%)
Query: 125 LQSLYLNVNSLKGTIPFEL-GYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNS 183
L+ L L+ N L + SSL+ ++L N + + S+++ +L LR+
Sbjct: 102 LEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMD 160
Query: 184 LTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEG- 242
+ + L+ L++ ++ P+ + + + L + + E
Sbjct: 161 TFTKIQRKDFAG--LTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIF 217
Query: 243 ------LTRLSLEKLNLSHNNFS 259
+ L L +L +FS
Sbjct: 218 VDVTSSVECLELRDTDLDTFHFS 240
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 3e-09
Identities = 27/142 (19%), Positives = 51/142 (35%), Gaps = 12/142 (8%)
Query: 125 LQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNSL 184
L+ L ++ + L+ P L ++S + L +L ++ + L L L
Sbjct: 176 LEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDL 234
Query: 185 TAALPEPALPN------STCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGS 238
L + + + + + + L EL+ S N S
Sbjct: 235 DT-FHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLK-S 291
Query: 239 IPEG-LTRL-SLEKLNLSHNNF 258
+P+G RL SL+K+ L N +
Sbjct: 292 VPDGIFDRLTSLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 5e-09
Identities = 18/153 (11%), Positives = 48/153 (31%), Gaps = 15/153 (9%)
Query: 125 LQSLYLNVNSLKGTIPFEL-GYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNS 183
L L L N K L + + L + + + + L L + +
Sbjct: 126 LTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASD 185
Query: 184 LTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFV-TRFEALKELDISNNLFSG----S 238
L + +L + ++ +L L + E +++ L++ +
Sbjct: 186 LQS-YEPKSLKS--IQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSE 241
Query: 239 IPEGLTR-----LSLEKLNLSHNNFSGVLPVFS 266
+ G T + + ++ + V+ + +
Sbjct: 242 LSTGETNSLIKKFTFRNVKITDESLFQVMKLLN 274
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 57.1 bits (138), Expect = 8e-09
Identities = 37/158 (23%), Positives = 59/158 (37%), Gaps = 27/158 (17%)
Query: 153 DLSANLFTGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFS 212
S+ + PS L + + SL L N +T + L C +LQ L L SN +
Sbjct: 37 KGSSGSLNSI--PS--GLTEAVKSLDLSNNRIT-YISNSDLQR--CVNLQALVLTSNGIN 89
Query: 213 ----GSFPEFVTRFEALKELDISNNLFSGSIPEGL-TRL-SLEKLNLSHNNFSGVLPVFS 266
SF + +L+ LD+S N S ++ L SL LNL N + +
Sbjct: 90 TIEEDSF----SSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGE--- 141
Query: 267 ESKFGAEVFEGNSPALCGFPLRDCSGNSRLSSGAIAGL 304
+F L + + +++ AGL
Sbjct: 142 -----TSLFSHL-TKLQILRVGNMDTFTKIQRKDFAGL 173
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 23/123 (18%), Positives = 43/123 (34%), Gaps = 12/123 (9%)
Query: 147 SSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPA---LPNSTCSDLQY 203
+ L E+++ A+ P + L LH L E + C +L+
Sbjct: 174 TFLEELEIDASDLQ-SYEPKSLKSIQNVSHLILHMKQHIL-LLEIFVDVTSSVECLELRD 231
Query: 204 LDLGSNKFS----GSFPEFVTRFEALKELDISNNLFSGSIPEGLTRL-SLEKLNLSHNNF 258
DL + FS G + + + I++ + + L ++ L +L S N
Sbjct: 232 TDLDTFHFSELSTGETNSL-IKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQL 289
Query: 259 SGV 261
V
Sbjct: 290 KSV 292
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 2e-10
Identities = 30/133 (22%), Positives = 57/133 (42%), Gaps = 19/133 (14%)
Query: 455 YFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLV 514
Y TL + + L+ I G+ + H I H +++ +N+L+
Sbjct: 92 YIEGPTLSEYIES----HGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILI 144
Query: 515 DDFFVSRLTEFGLDQLMVPAVADEMVALAKADG------YKAPELQRMKKCSSRTDVYAF 568
D ++ +FG+ A A +L + + Y +PE + + TD+Y+
Sbjct: 145 DSNKTLKIFDFGI------AKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSI 198
Query: 569 GILLLEILIGKKP 581
GI+L E+L+G+ P
Sbjct: 199 GIVLYEMLVGEPP 211
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 63.1 bits (153), Expect = 2e-10
Identities = 35/163 (21%), Positives = 66/163 (40%), Gaps = 28/163 (17%)
Query: 102 LSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFEL-GYSSSLSEIDLSANLFT 160
+SI LP N FS+ Q+ + N S + + L
Sbjct: 1 MSIMLPINNN----------FSLSQNSFYNTIS---GTYADYFSAWDKWEKQALPGENRN 47
Query: 161 GVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVT 220
++ L ++ L+L+ +L++ LP++ + L++ N S PE
Sbjct: 48 EAVSLLKECLINQFSELQLNRLNLSS------LPDNLPPQITVLEITQNALI-SLPE--- 97
Query: 221 RFEALKELDISNNLFSGSIPEGLTRLSLEKLNLSHNNFSGVLP 263
+L+ LD +N S ++PE SL+ L++ +N + +LP
Sbjct: 98 LPASLEYLDACDNRLS-TLPELPA--SLKHLDVDNNQLT-MLP 136
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 61.9 bits (150), Expect = 3e-10
Identities = 26/159 (16%), Positives = 53/159 (33%), Gaps = 17/159 (10%)
Query: 114 SLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDR 173
LP +L+ + + N L +P SL + + N T L +
Sbjct: 134 MLPELPA---LLEYINADNNQLT-MLPELPT---SLEVLSVRNNQLT-FLPELP----ES 181
Query: 174 LVSLRLHGNSLTAALPE--PALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDIS 231
L +L + N L + LP +S + N+ + PE + + + +
Sbjct: 182 LEALDVSTNLLES-LPAVPVRNHHSE-ETEIFFRCRENRIT-HIPENILSLDPTCTIILE 238
Query: 232 NNLFSGSIPEGLTRLSLEKLNLSHNNFSGVLPVFSESKF 270
+N S I E L++ + + + + +
Sbjct: 239 DNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTLH 277
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 2e-10
Identities = 57/301 (18%), Positives = 120/301 (39%), Gaps = 54/301 (17%)
Query: 370 EHLTLEDVLNATGQVIEKTTYGTAYKAKL-ADGATI--ALRLLREGSC-KDRSSCLPVIR 425
++L + D+ G +G+ + I A+++L++G+ D + +
Sbjct: 9 DNLLIADIELGCGN------FGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 62
Query: 426 QLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIAL 485
+ ++ + ++ L Q + +L+ + LH L + + + ++
Sbjct: 63 IMHQLDNPYIVRLIGVCQAEA--LMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLH 117
Query: 486 GIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKA 545
++ G+ YL + + H ++ ++NVL+ + +++++FGL + + AD+ A++
Sbjct: 118 QVSMGMKYLEEKNFV---HRDLAARNVLLVNRHYAKISDFGLSKALG---ADDSYYTARS 171
Query: 546 DGYK------APELQRMKKCSSRTDVYAFGILLLEIL-IGKKP--GKSGRNGEFVDLPSI 596
G K APE +K SSR+DV+++G+ + E L G+KP G
Sbjct: 172 AG-KWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---------- 220
Query: 597 VKVAVLEETTMEVFDMEIMKGIRSPMEEGLVQAL-KLAMGCCAPVASVRPTMDEVVKQLE 655
EV I +G R L L C RP V +++
Sbjct: 221 -----------EVMAF-IEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 268
Query: 656 E 656
Sbjct: 269 A 269
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 3e-10
Identities = 37/212 (17%), Positives = 71/212 (33%), Gaps = 27/212 (12%)
Query: 68 LKWISTNGSPLSCSDISLPQWANLSLYKDSSIHLLSIQLPSANLTGSLPRELGEF---SM 124
+ + + I N + + L SI L N + G +
Sbjct: 156 FHVLDLTFNKVKS--ICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTS 213
Query: 125 LQSLYLNVNSLKGTIPFELGYSSSLSEI-------------DLSANLFTGVLAPSIWNL- 170
+ +L L+ N K ++ + + ++I F + L
Sbjct: 214 ITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLE 273
Query: 171 CDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFV-TRFEALKELD 229
+ + L + + A L + S +DL+ L L N+ + + L +L+
Sbjct: 274 ASGVKTCDLSKSKIFA-LLKSVF--SHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLN 329
Query: 230 ISNNLFSGSIPEGL-TRL-SLEKLNLSHNNFS 259
+S N SI + L LE L+LS+N+
Sbjct: 330 LSQNFLG-SIDSRMFENLDKLEVLDLSYNHIR 360
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 9e-10
Identities = 33/144 (22%), Positives = 60/144 (41%), Gaps = 15/144 (10%)
Query: 121 EFSMLQSLYLNVN---SLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSL 177
E S +++ L+ + +L ++ + L ++ L+ N + + + L+ L
Sbjct: 273 EASGVKTCDLSKSKIFALLKSVFSHF---TDLEQLTLAQNEIN-KIDDNAFWGLTHLLKL 328
Query: 178 RLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFV-TRFEALKELDISNNLFS 236
L N L + + N L+ LDL N + + LKEL + N
Sbjct: 329 NLSQNFLGS-IDSRMFENLDK--LEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLK 384
Query: 237 GSIPEG-LTRL-SLEKLNLSHNNF 258
S+P+G RL SL+K+ L N +
Sbjct: 385 -SVPDGIFDRLTSLQKIWLHTNPW 407
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 35/184 (19%), Positives = 49/184 (26%), Gaps = 12/184 (6%)
Query: 103 SIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYS-SSLSEIDLSANLFTG 161
+ L ++ LQ L + + I SSL + L N F
Sbjct: 34 YVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFL- 92
Query: 162 VLAPSIWNLCDRLVSLRLHGNSLTAA-LPEPALPNSTCSDLQYLDLGSNKFSGSFPEFV- 219
L +N L L L +L A L T L+ L L N P
Sbjct: 93 QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLT--SLEMLVLRDNNIKKIQPASFF 150
Query: 220 TRFEALKELDISNNLFSGSIPEG----LTRLSLEKLNLSHNNFSGVLPVFSESKFGAEVF 275
LD++ N SI E L LS + +
Sbjct: 151 LNMRRFHVLDLTFNKVK-SICEEDLLNFQGKHFTLLRLSSITLQD-MNEYWLGWEKCGNP 208
Query: 276 EGNS 279
N+
Sbjct: 209 FKNT 212
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 3e-09
Identities = 40/202 (19%), Positives = 76/202 (37%), Gaps = 26/202 (12%)
Query: 78 LSCSDISLPQWANLSLYKDSSIHLLSIQLPSANLTGSLPR---ELGEFSMLQSLYLNVNS 134
++ L + +K++SI L L S+ + + + +QSL L+ +
Sbjct: 193 QDMNEYWLGWEKCGNPFKNTSITTL--DLSGNGFKESMAKRFFDAIAGTKIQSLILSNSY 250
Query: 135 LKGT------------IPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGN 182
G+ F+ +S + DLS + L S+++ L L L N
Sbjct: 251 NMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQN 309
Query: 183 SLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFV-TRFEALKELDISNNLFSGSIPE 241
+ + + A + L L+L N S + + L+ LD+S N ++ +
Sbjct: 310 EINK-IDDNAFWG--LTHLLKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHIR-ALGD 364
Query: 242 GL-TRL-SLEKLNLSHNNFSGV 261
L +L++L L N V
Sbjct: 365 QSFLGLPNLKELALDTNQLKSV 386
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 3e-08
Identities = 34/196 (17%), Positives = 62/196 (31%), Gaps = 18/196 (9%)
Query: 125 LQSLYLNVNSLKGT-IPFEL-GYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGN 182
L+ L L +L G + +SL + L N + S + R L L N
Sbjct: 105 LEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFN 164
Query: 183 SLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVT--------RFEALKELDISNNL 234
+ + + E L N L L S ++ + ++ LD+S N
Sbjct: 165 KVKS-ICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNG 223
Query: 235 FSGSIPEGLTRL--SLEKLNLSHNNFSGVLPVFSESKFGAEVFEGNSPALCGFPLR--DC 290
F S+ + + +L +N + F + F + L ++ D
Sbjct: 224 FKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNF-KDPDNFTFKGLEASGVKTCDL 282
Query: 291 SGN--SRLSSGAIAGL 304
S + L +
Sbjct: 283 SKSKIFALLKSVFSHF 298
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 5e-06
Identities = 19/82 (23%), Positives = 26/82 (31%), Gaps = 9/82 (10%)
Query: 180 HGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSI 239
L P LP Y+DL N + +R + L+ L + I
Sbjct: 18 INRGLHQV---PELPAHV----NYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVI 70
Query: 240 PEGL-TRL-SLEKLNLSHNNFS 259
L SL L L +N F
Sbjct: 71 RNNTFRGLSSLIILKLDYNQFL 92
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 61.7 bits (149), Expect = 4e-10
Identities = 36/228 (15%), Positives = 61/228 (26%), Gaps = 32/228 (14%)
Query: 56 WNISVPLCQWRGLKWISTNGSPLSCSDISLPQWANLSLYKDSSIHLLSIQLPSANLTGSL 115
+ I T + + + L +L S + L
Sbjct: 306 AASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCEL-SVEKSTVL 364
Query: 116 PRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNL----- 170
EL LQ L TI + L + F+ + A
Sbjct: 365 QSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDD 424
Query: 171 ---------------CDRLVSLRLHGNSLTAALPEPALPN-STCSDLQYLDLGSNKFSGS 214
+ L L LT L + + +LDL N+ +
Sbjct: 425 LRSKFLLENSVLKMEYADVRVLHLAHKDLTV------LCHLEQLLLVTHLDLSHNRLR-A 477
Query: 215 FPEFVTRFEALKELDISNNLFSGSIPEGLTRL-SLEKLNLSHNNFSGV 261
P + L+ L S+N ++ G+ L L++L L +N
Sbjct: 478 LPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQQS 523
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 54.4 bits (130), Expect = 7e-08
Identities = 42/239 (17%), Positives = 67/239 (28%), Gaps = 26/239 (10%)
Query: 33 VELLLGKIKSSLQGDDENLLLSSWNISVPLCQWRGLKWISTNGSPLSCSDISLPQWANLS 92
+ + L D L + ST S L
Sbjct: 322 WTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEKSTVLQSELESCKEL-----QE 376
Query: 93 LYKDSSIHLLSIQLPSANLT--GSLPRELGEFSMLQSL--------YLNVNSLKGTIPFE 142
L ++ LL+I L L L FS L+++ +
Sbjct: 377 LEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVL 436
Query: 143 LGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQ 202
+ + + L+ T + + L + L L N L A PAL + L+
Sbjct: 437 KMEYADVRVLHLAHKDLTVL--CHLEQLL-LVTHLDLSHNRLRAL--PPAL--AALRCLE 489
Query: 203 YLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSG-SIPEGLTRL-SLEKLNLSHNNFS 259
L N + L+EL + NN + + L L LNL N+
Sbjct: 490 VLQASDNALE-NVDGV-ANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 46.3 bits (109), Expect = 3e-05
Identities = 35/174 (20%), Positives = 54/174 (31%), Gaps = 11/174 (6%)
Query: 34 ELLLGKIKSSLQGDDENLLLSSWNISVPLCQWRGLKWISTNGSPLSCSDISLPQWANLSL 93
+ L + D S L + LK + L + L +L
Sbjct: 402 KETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLTVLCHLEQ 461
Query: 94 YKDSSIHLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEID 153
+ + L S N +LP L L+ L + N+L+ + + L E+
Sbjct: 462 LL----LVTHLDL-SHNRLRALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELL 514
Query: 154 LSANLFTGVLAPSIWNL--CDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLD 205
L N +I L C RLV L L GNSL + +
Sbjct: 515 LCNNRLQQS--AAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSIL 566
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 45.9 bits (108), Expect = 3e-05
Identities = 38/267 (14%), Positives = 74/267 (27%), Gaps = 20/267 (7%)
Query: 9 CYIVFFFCLTESLASSSPASAS-SDVELLLGKIKSSLQGDDENLLLSSWNISVPLCQWRG 67
Y + E S + L + + G LL + + +WR
Sbjct: 230 FYHRWLLGRAEPHDVLCCVHVSREEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWRT 289
Query: 68 LK------WISTNGSPLSCSDISLPQWANLSLYKDSSIHLLSIQLPSANLTGSLPRELGE 121
+ P + + LPQ ++ S + + R+
Sbjct: 290 PDGRNRPSHVWLCDLPAASLNDQLPQHTFRVIWTGS--DSQKECVLLKDRPECWCRDSAT 347
Query: 122 FSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHG 181
L L+V + EL L E++ + + +L
Sbjct: 348 DEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCL-------LTIILLMRALDPLL 399
Query: 182 NSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPE 241
L YLD +KF + ++ L +++ + +
Sbjct: 400 YEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT--VLC 457
Query: 242 GLTRLS-LEKLNLSHNNFSGVLPVFSE 267
L +L + L+LSHN + P +
Sbjct: 458 HLEQLLLVTHLDLSHNRLRALPPALAA 484
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 4e-10
Identities = 46/162 (28%), Positives = 69/162 (42%), Gaps = 19/162 (11%)
Query: 101 LLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFT 160
L + NLT +LP +L L+L+ N L L + L++++L T
Sbjct: 12 HLEVNCDKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT 68
Query: 161 GVLAPSIWNLCDRLVSLRLHGNSLTAALPE--PALPNSTCSDLQYLDLGSNKFSGSFPEF 218
+ L L +L L N L +LP LP L LD+ N+ + S P
Sbjct: 69 KL--QVDGTL-PVLGTLDLSHNQLQ-SLPLLGQTLPA-----LTVLDVSFNRLT-SLPLG 118
Query: 219 V-TRFEALKELDISNNLFSGSIPEGL-TRLS-LEKLNLSHNN 257
L+EL + N ++P GL T LEKL+L++NN
Sbjct: 119 ALRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNN 159
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 9e-06
Identities = 21/98 (21%), Positives = 35/98 (35%), Gaps = 8/98 (8%)
Query: 169 NLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKEL 228
+ + + +LTA LP P LP D L L N + + L +L
Sbjct: 8 KVAS-HLEVNCDKRNLTA-LP-PDLP----KDTTILHLSENLLYTFSLATLMPYTRLTQL 60
Query: 229 DISNNLFSGSIPEGLTRLSLEKLNLSHNNFSGVLPVFS 266
++ + + T L L+LSHN + +
Sbjct: 61 NLDRAELT-KLQVDGTLPVLGTLDLSHNQLQSLPLLGQ 97
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 6e-10
Identities = 53/282 (18%), Positives = 109/282 (38%), Gaps = 46/282 (16%)
Query: 390 YGTAYKAKLADGA----TIALRLLREG-SCKDRSSCLPVIRQLGKVRHENLIPLRAFYQG 444
+G Y L D A++ L + S L + H N++ L
Sbjct: 102 FGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR 161
Query: 445 KRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITH 504
G L++ Y L + + + L +A+G+ +L + + H
Sbjct: 162 SEGSPLVVLPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKFLASKKFV---H 215
Query: 505 GNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKADGYK------APELQRMKK 558
++ ++N ++D+ F ++ +FGL + M E ++ G K A E + +K
Sbjct: 216 RDLAARNCMLDEKFTVKVADFGLARDMY---DKEFDSVHNKTGAKLPVKWMALESLQTQK 272
Query: 559 CSSRTDVYAFGILLLEIL-IGKKP--GKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIM 615
++++DV++FG+LL E++ G P + ++ ++
Sbjct: 273 FTTKSDVWSFGVLLWELMTRGAPPYPDVNTF---------------------DITVY-LL 310
Query: 616 KGIRSPMEEGLVQAL-KLAMGCCAPVASVRPTMDEVVKQLEE 656
+G R E L ++ + C P A +RP+ E+V ++
Sbjct: 311 QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 352
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 7e-10
Identities = 57/290 (19%), Positives = 111/290 (38%), Gaps = 46/290 (15%)
Query: 382 GQVIEKTTYGTAYKAKLADGA----TIALRLLREG-SCKDRSSCLPVIRQLGKVRHENLI 436
+VI + +G Y L D A++ L + S L + H N++
Sbjct: 30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89
Query: 437 PLRAFYQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHT 496
L G L++ Y L + + + L +A+G+ YL +
Sbjct: 90 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKYLAS 146
Query: 497 GHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKADGYK------A 550
+ H ++ ++N ++D+ F ++ +FGL + M E ++ G K A
Sbjct: 147 KKFV---HRDLAARNCMLDEKFTVKVADFGLARDMY---DKEYYSVHNKTGAKLPVKWMA 200
Query: 551 PELQRMKKCSSRTDVYAFGILLLEIL-IGKKP--GKSGRNGEFVDLPSIVKVAVLEETTM 607
E + +K ++++DV++FG+LL E++ G P +
Sbjct: 201 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--------------------- 239
Query: 608 EVFDMEIMKGIRSPMEEGLVQALKLAMGCC-APVASVRPTMDEVVKQLEE 656
++ +++G R E L M C P A +RP+ E+V ++
Sbjct: 240 DITVY-LLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 288
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 7e-10
Identities = 57/286 (19%), Positives = 113/286 (39%), Gaps = 51/286 (17%)
Query: 382 GQVIEKTTYGTAYKAK-LADGATIALRL--LREGSCKDRSSCLPVIRQLGKVRHENLIPL 438
Q I + ++G A K DG ++ + S K+R + L ++H N++
Sbjct: 29 LQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQY 88
Query: 439 RAFYQGKRGEKLLIY-DYFPSRTLHDLLHDTIAGKP-----VLNWARRHKIALGIARGLA 492
R + + L I DY L ++ G +L+W + I L
Sbjct: 89 RESF--EENGSLYIVMDYCEGGDLFKRINAQ-KGVLFQEDQILDWFVQ------ICLALK 139
Query: 493 YLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAK-ADG---Y 548
++H I H +++S+N+ + +L +FG + V + V LA+ G Y
Sbjct: 140 HVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFG-----IARVLNSTVELARACIGTPYY 191
Query: 549 KAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTME 608
+PE+ K ++++D++A G +L E+ K F E +M+
Sbjct: 192 LSPEICENKPYNNKSDIWALGCVLYELCTLKHA--------F------------EAGSMK 231
Query: 609 VFDMEIMKGIRSPMEEGLVQALK-LAMGCCAPVASVRPTMDEVVKQ 653
++I+ G P+ L+ L RP+++ ++++
Sbjct: 232 NLVLKIISGSFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 61.1 bits (148), Expect = 8e-10
Identities = 56/300 (18%), Positives = 118/300 (39%), Gaps = 48/300 (16%)
Query: 390 YGTAYKAKL-ADGATI--ALRLLREGSC-KDRSSCLPVIRQLGKVRHENLIPLRAFYQGK 445
+G+ + I A+++L++G+ D + + + ++ + ++ L Q +
Sbjct: 349 FGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE 408
Query: 446 RGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHG 505
+L+ + LH L + + + ++ ++ G+ YL + + H
Sbjct: 409 A--LMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEKNFV---HR 460
Query: 506 NVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKADG---YK--APELQRMKKCS 560
N+ ++NVL+ + +++++FGL + + AD+ A++ G K APE +K S
Sbjct: 461 NLAARNVLLVNRHYAKISDFGLSKALG---ADDSYYTARSAGKWPLKWYAPECINFRKFS 517
Query: 561 SRTDVYAFGILLLEIL-IGKKP--GKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKG 617
SR+DV+++G+ + E L G+KP G EV I +G
Sbjct: 518 SRSDVWSYGVTMWEALSYGQKPYKKMKGP---------------------EVMAF-IEQG 555
Query: 618 IRSPMEEGLVQAL-KLAMGCCAPVASVRPTMDEVVKQLEENRPRNRSALYSPTETRSEIG 676
R L L C RP V +++ + ++ E+
Sbjct: 556 KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY-YSLASKVEGGSAL-EVA 613
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 61.0 bits (148), Expect = 9e-10
Identities = 66/302 (21%), Positives = 105/302 (34%), Gaps = 58/302 (19%)
Query: 370 EHLTLEDVLNATGQVIEKTTYGTAYKA--KLADGATI--ALRLLREGSC-KDRSSCLPVI 424
E + L + GQ +G ++ + + A++ + + R L
Sbjct: 390 ERIELGRCIGE-GQ------FGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEA 442
Query: 425 RQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIA 484
+ + H +++ L +I + L L K L+ A A
Sbjct: 443 LTMRQFDHPHIVKLIGVITENP--VWIIMELCTLGELRSFLQV---RKFSLDLASLILYA 497
Query: 485 LGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAK 544
++ LAYL + + H ++ ++NVLV +L +FGL + M D K
Sbjct: 498 YQLSTALAYLESKRFV---HRDIAARNVLVSSNDCVKLGDFGLSRYM----EDSTYY--K 548
Query: 545 ADGYK------APELQRMKKCSSRTDVYAFGILLLEIL-IGKKP--GKSGRNGEFVDLPS 595
A K APE ++ +S +DV+ FG+ + EIL G KP G
Sbjct: 549 ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--------- 599
Query: 596 IVKVAVLEETTMEVFDMEIMKGIRSPMEEGLVQAL-KLAMGCCAPVASVRPTMDEVVKQL 654
+V I G R PM L L C A S RP E+ QL
Sbjct: 600 ------------DVIGR-IENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQL 646
Query: 655 EE 656
Sbjct: 647 ST 648
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 1e-09
Identities = 25/143 (17%), Positives = 51/143 (35%), Gaps = 7/143 (4%)
Query: 125 LQSLYLNVNSLKGTIPFELGYS-SSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNS 183
+ +Y++++ + Y+ S ++ I++ + P L L +
Sbjct: 57 ISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTG 116
Query: 184 LTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPE--FVTRFEALKELDISNNLFSGSIPE 241
L P+ ST L++ N + S P F L + NN F+ S+
Sbjct: 117 LKM-FPDLTKVYST-DIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQG 173
Query: 242 G-LTRLSLEKLNLSHNNFSGVLP 263
L+ + L+ N + V+
Sbjct: 174 YAFNGTKLDAVYLNKNKYLTVID 196
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 4e-07
Identities = 21/141 (14%), Positives = 47/141 (33%), Gaps = 10/141 (7%)
Query: 125 LQSLYL-NVNSLKGTIPFE-LGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGN 182
+ + + N +L I + L L + + + D L + N
Sbjct: 82 VTHIEIRNTRNLT-YIDPDALKELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDN 140
Query: 183 SLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPE- 241
++P A ++ L L +N F+ S + L + ++ N + I +
Sbjct: 141 PYMTSIPVNAFQGLC-NETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKD 198
Query: 242 ---GLTRLSLEKLNLSHNNFS 259
G+ L++S + +
Sbjct: 199 AFGGVYSG-PSLLDVSQTSVT 218
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 1e-09
Identities = 54/316 (17%), Positives = 112/316 (35%), Gaps = 72/316 (22%)
Query: 370 EHLTLEDVLNATGQVIEKTTYGTAYKAKLADGA----TIALRLLREGSC--KDRSSCLPV 423
+ TL +L G+ +G+ +A+L +A+++L+ D L
Sbjct: 23 QQFTLGRMLGK-GE------FGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLRE 75
Query: 424 IRQLGKVRHENLIPL-----RAFYQGKRGEKLLIYDYFPSRTLHDLL--HDTIAGKPVLN 476
+ + H ++ L R+ +G+ ++I + LH L L
Sbjct: 76 AACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLP 135
Query: 477 WARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVA 536
+ + IA G+ YL + + I H ++ ++N ++ + + +FGL + +
Sbjct: 136 LQTLVRFMVDIACGMEYLSSRNFI---HRDLAARNCMLAEDMTVCVADFGLSRKI----- 187
Query: 537 DEMVALAKADGYK------------APELQRMKKCSSRTDVYAFGILLLEIL-IGKKP-- 581
D Y+ A E + +DV+AFG+ + EI+ G+ P
Sbjct: 188 ------YSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYA 241
Query: 582 GKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIRSPMEEGLVQALKLAMGCC-APV 640
G E+++ ++ G R ++ + M C +
Sbjct: 242 GIENA---------------------EIYNY-LIGGNRLKQPPECMEEVYDLMYQCWSAD 279
Query: 641 ASVRPTMDEVVKQLEE 656
RP+ + +LE
Sbjct: 280 PKQRPSFTCLRMELEN 295
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 1e-09
Identities = 37/183 (20%), Positives = 66/183 (36%), Gaps = 29/183 (15%)
Query: 100 HLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLF 159
+ + I +N+T ++ + + +L + TI + Y ++L ++L N
Sbjct: 20 NAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQI 75
Query: 160 TGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPN-----------------STCSDLQ 202
T + + NL ++ L L GN L L + + S+LQ
Sbjct: 76 TDL--APLKNL-TKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132
Query: 203 YLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRL-SLEKLNLSHNNFSGV 261
L L N+ + + L+ L I N S + L L L L N S +
Sbjct: 133 VLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVS-DL-TPLANLSKLTTLKADDNKISDI 188
Query: 262 LPV 264
P+
Sbjct: 189 SPL 191
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 3e-09
Identities = 38/147 (25%), Positives = 59/147 (40%), Gaps = 15/147 (10%)
Query: 119 LGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLR 178
L + + L L+ N L + S+ +DL++ T V + L L L
Sbjct: 81 LKNLTKITELELSGNPL--KNVSAIAGLQSIKTLDLTSTQITDV--TPLAGL-SNLQVLY 135
Query: 179 LHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGS 238
L N +T P L N LQYL +G+ + S + L L +N S
Sbjct: 136 LDLNQITNISPLAGLTN-----LQYLSIGNAQVSDL--TPLANLSKLTTLKADDNKIS-D 187
Query: 239 IPEGLTRL-SLEKLNLSHNNFSGVLPV 264
I L L +L +++L +N S V P+
Sbjct: 188 IS-PLASLPNLIEVHLKNNQISDVSPL 213
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 28/145 (19%), Positives = 55/145 (37%), Gaps = 14/145 (9%)
Query: 119 LGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLR 178
L S LQ LYL++N + P L ++L + + + + + NL +L +L+
Sbjct: 125 LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDL--TPLANL-SKLTTLK 179
Query: 179 LHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGS 238
N ++ P +LPN L + L +N+ S + L + ++N +
Sbjct: 180 ADDNKISDISPLASLPN-----LIEVHLKNNQISDV--SPLANTSNLFIVTLTNQTITNQ 232
Query: 239 IPEGLTRLSLEKLNLSHNNFSGVLP 263
L + N+ +
Sbjct: 233 PVFYNNNLVV--PNVVKGPSGAPIA 255
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 2e-09
Identities = 57/306 (18%), Positives = 113/306 (36%), Gaps = 64/306 (20%)
Query: 370 EHLTLEDVLNATGQVIEKTTYGTAYKAKLADGA-----TIALRLLREGSC-KDRSSCLPV 423
L VL + G +GT +K + ++++ + S + +
Sbjct: 13 TELRKLKVLGS-GV------FGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDH 65
Query: 424 IRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRTLHDLLH---DTIAGKPVLNWARR 480
+ +G + H +++ L G L+ Y P +L D + + + +LNW
Sbjct: 66 MLAIGSLDHAHIVRLLGLCPGSS--LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGV- 122
Query: 481 HKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMV 540
IA+G+ YL + H N+ ++NVL+ ++ +FG+ L+ D+
Sbjct: 123 -----QIAKGMYYLEEHGMV---HRNLAARNVLLKSPSQVQVADFGVADLLP---PDDKQ 171
Query: 541 ALAKADGYK------APELQRMKKCSSRTDVYAFGILLLEIL-IGKKP--GKSGRNGEFV 591
K A E K + ++DV+++G+ + E++ G +P G
Sbjct: 172 L--LYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA----- 224
Query: 592 DLPSIVKVAVLEETTMEVFDMEIMKGIRSPMEEGLVQALKLAMGCC-APVASVRPTMDEV 650
EV D+ + KG R + + + M C ++RPT E+
Sbjct: 225 ----------------EVPDL-LEKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKEL 267
Query: 651 VKQLEE 656
+
Sbjct: 268 ANEFTR 273
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 2e-09
Identities = 66/302 (21%), Positives = 104/302 (34%), Gaps = 58/302 (19%)
Query: 370 EHLTLEDVLNATGQVIEKTTYGTAYKAKLADGA----TIALRLLREGSC-KDRSSCLPVI 424
E + L + GQ +G ++ +A++ + + R L
Sbjct: 15 ERIELGRCIGE-GQ------FGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEA 67
Query: 425 RQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIA 484
+ + H +++ L +I + L L K L+ A A
Sbjct: 68 LTMRQFDHPHIVKLIGVITENP--VWIIMELCTLGELRSFLQV---RKYSLDLASLILYA 122
Query: 485 LGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAK 544
++ LAYL + + H ++ ++NVLV +L +FGL + M D K
Sbjct: 123 YQLSTALAYLESKRFV---HRDIAARNVLVSSNDCVKLGDFGLSRYM----EDSTYY--K 173
Query: 545 ADGYK------APELQRMKKCSSRTDVYAFGILLLEIL-IGKKP--GKSGRNGEFVDLPS 595
A K APE ++ +S +DV+ FG+ + EIL G KP G
Sbjct: 174 ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--------- 224
Query: 596 IVKVAVLEETTMEVFDMEIMKGIRSPMEEGLVQAL-KLAMGCCAPVASVRPTMDEVVKQL 654
+V I G R PM L L C A S RP E+ QL
Sbjct: 225 ------------DVIGR-IENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQL 271
Query: 655 EE 656
Sbjct: 272 ST 273
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 32/203 (15%), Positives = 62/203 (30%), Gaps = 26/203 (12%)
Query: 396 AKLADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPL-RAFYQGKRGEKLLIYD 454
++ + L + K L I V+ + R + L +
Sbjct: 123 KQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFF 182
Query: 455 YFPS-----RTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRS 509
+P +T ++L + L R ++ L + R LA LH + H +R
Sbjct: 183 LYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRP 239
Query: 510 KNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKADG------YKAPELQRMKK----- 558
++++D LT F V D A++ A + +
Sbjct: 240 VDIVLDQRGGVFLTGFEH------LVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTL 293
Query: 559 CSSRTDVYAFGILLLEILIGKKP 581
+ D + G+ + I P
Sbjct: 294 MTFAFDTWTLGLAIYWIWCADLP 316
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 39/223 (17%), Positives = 68/223 (30%), Gaps = 27/223 (12%)
Query: 380 ATGQ-----VIEKTTYGTAYKAKLADGATIALRLLR----EGSCKDRSSCLPVIRQLGKV 430
TG+ V T + K + LRLLR + K + +
Sbjct: 96 ETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDP 155
Query: 431 RHENLIPLRAFYQGKRGEKLLIYDYFPSRTLHDL---LHDTIAGKPVLNWARRHKIALGI 487
+ + +I +R + L L + L R ++ L +
Sbjct: 156 QKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQV 215
Query: 488 ARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGL----DQLMVPA-----VADE 538
R LA LH + H +R ++++D LT F +V + E
Sbjct: 216 IRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGARVVSSVSRGFEPPE 272
Query: 539 MVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKP 581
+ A Y M + D +A G+++ I P
Sbjct: 273 LEARRATISYHRDRRTLM---TFSFDAWALGLVIYWIWCADLP 312
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 2e-09
Identities = 59/302 (19%), Positives = 113/302 (37%), Gaps = 58/302 (19%)
Query: 370 EHLTLEDVLNATGQVIEKTTYGTAYKAKL--ADGATI--ALRLLREG-SCKDRSSCLPVI 424
E + L +L G +G Y+ G I A++ ++ + ++ +
Sbjct: 12 EDVVLNRILGE-GF------FGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEA 64
Query: 425 RQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIA 484
+ + H +++ L + + +I + +P L L K L +
Sbjct: 65 VIMKNLDHPHIVKLIGIIEEEP--TWIIMELYPYGELGHYLER---NKNSLKVLTLVLYS 119
Query: 485 LGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAK 544
L I + +AYL + + + H ++ +N+LV +L +FGL + + DE K
Sbjct: 120 LQICKAMAYLESINCV---HRDIAVRNILVASPECVKLGDFGLSRY----IEDE--DYYK 170
Query: 545 ADGYK------APELQRMKKCSSRTDVYAFGILLLEIL-IGKKP--GKSGRNGEFVDLPS 595
A + +PE ++ ++ +DV+ F + + EIL GK+P +
Sbjct: 171 ASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK--------- 221
Query: 596 IVKVAVLEETTMEVFDMEIMKGIRSPMEEGLVQAL-KLAMGCCAPVASVRPTMDEVVKQL 654
+V + + KG R P + L L C S RP E+V L
Sbjct: 222 ------------DVIGV-LEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSL 268
Query: 655 EE 656
+
Sbjct: 269 SD 270
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 5e-09
Identities = 38/222 (17%), Positives = 80/222 (36%), Gaps = 43/222 (19%)
Query: 390 YGTAYKAK-LADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQG---- 444
+G +KAK DG T ++ ++ + ++ L K+ H N++ + G
Sbjct: 24 FGQVFKAKHRIDGKTYVIKRVK----YNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYD 79
Query: 445 ----------KRGEKLLIY-DYFPSRTLHDLLHDTIAGKP-----VLNWARRHKIALGIA 488
+ + L I ++ TL + G+ L + I
Sbjct: 80 PETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR-RGEKLDKVLALELFEQ------IT 132
Query: 489 RGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKADG- 547
+G+ Y+H+ + + +++ N+ + D ++ +FGL ++ G
Sbjct: 133 KGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGL-----VTSLKNDGKRTRSKGT 184
Query: 548 --YKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRN 587
Y +PE + D+YA G++L E+L
Sbjct: 185 LRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK 226
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 6e-09
Identities = 63/316 (19%), Positives = 125/316 (39%), Gaps = 67/316 (21%)
Query: 370 EHLTLEDVLN--ATGQVIEKTTYGTAYKAKLADGAT-IALRLLREGSC-KDRS---SCLP 422
+L L A G+V+E TA+ D +A+++L+ + ++ S L
Sbjct: 46 NNLQFGKTLGAGAFGKVVE----ATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELK 101
Query: 423 VIRQLGKVRHENLIPLRAFYQG---KRGEKLLIYDYFP----------SRTLHDLLHDTI 469
++ LG +HEN++ L G G L+I +Y + +
Sbjct: 102 IMSHLG--QHENIVNLL----GACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFA 155
Query: 470 AGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGL-- 527
+ + +A+G+A+L + + I H +V ++NVL+ + V+++ +FGL
Sbjct: 156 IANSTASTRDLLHFSSQVAQGMAFLASKNCI---HRDVAARNVLLTNGHVAKIGDFGLAR 212
Query: 528 DQLMVPAVADEMVALAKADGYK-----APELQRMKKCSSRTDVYAFGILLLEIL-IGKKP 581
D + ++ + K + APE + ++DV+++GILL EI +G P
Sbjct: 213 D------IMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266
Query: 582 GKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIRSPMEEGLVQAL-KLAMGCCAPV 640
P I + + + + G + + + + C A
Sbjct: 267 -----------YPGI-------LVNSKFYKL-VKDGYQMAQPAFAPKNIYSIMQACWALE 307
Query: 641 ASVRPTMDEVVKQLEE 656
+ RPT ++ L+E
Sbjct: 308 PTHRPTFQQICSFLQE 323
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 57.8 bits (139), Expect = 8e-09
Identities = 34/163 (20%), Positives = 63/163 (38%), Gaps = 21/163 (12%)
Query: 100 HLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLF 159
+ L ++T ++ E + + + N + +K ++ + Y +++++ L+ N
Sbjct: 22 ETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQG-IQYLPNVTKLFLNGNKL 77
Query: 160 TGVLAPSIWNLCD--RLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPE 217
T I L + L L L N + L L+ L L N S
Sbjct: 78 T-----DIKPLTNLKNLGWLFLDENKIKDLSSLKDLKK-----LKSLSLEHNGISD--IN 125
Query: 218 FVTRFEALKELDISNNLFSGSIPEGLTRL-SLEKLNLSHNNFS 259
+ L+ L + NN + I L+RL L+ L+L N S
Sbjct: 126 GLVHLPQLESLYLGNNKIT-DI-TVLSRLTKLDTLSLEDNQIS 166
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 56.7 bits (136), Expect = 2e-08
Identities = 35/143 (24%), Positives = 55/143 (38%), Gaps = 21/143 (14%)
Query: 119 LGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNL--CDRLVS 176
+ + L+LN N L P L +L + L N + +L +L S
Sbjct: 61 IQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIK-----DLSSLKDLKKLKS 113
Query: 177 LRLHGNSLTAALPEPALPN-STCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLF 235
L L N ++ + L+ L LG+NK + ++R L L + +N
Sbjct: 114 LSLEHNGISD------INGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQI 165
Query: 236 SGSIPEGLTRL-SLEKLNLSHNN 257
S I L L L+ L LS N+
Sbjct: 166 S-DI-VPLAGLTKLQNLYLSKNH 186
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 48.6 bits (115), Expect = 6e-06
Identities = 28/141 (19%), Positives = 48/141 (34%), Gaps = 13/141 (9%)
Query: 119 LGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLR 178
L + L+SL L N + I L + L + L N T + + L +L +L
Sbjct: 105 LKDLKKLKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKITDI--TVLSRL-TKLDTLS 159
Query: 179 LHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGS 238
L N ++ +P L LQ L L N S + L L++ +
Sbjct: 160 LEDNQISDIVPLAGLTK-----LQNLYLSKNHIS-DLRAL-AGLKNLDVLELFSQECLNK 212
Query: 239 IPEGLTRLS-LEKLNLSHNNF 258
+ L + + +
Sbjct: 213 PINHQSNLVVPNTVKNTDGSL 233
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 1e-08
Identities = 35/131 (26%), Positives = 47/131 (35%), Gaps = 15/131 (11%)
Query: 455 YFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLV 514
L +L L R I I L H TH +V+ +N+LV
Sbjct: 115 LINGVDLAAMLRRQGP----LAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILV 167
Query: 515 DDFFVSRLTEFGLDQLMVPAVADE-MVALAKADG---YKAPELQRMKKCSSRTDVYAFGI 570
+ L +FG+ A DE + L G Y APE + R D+YA
Sbjct: 168 SADDFAYLVDFGI----ASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTC 223
Query: 571 LLLEILIGKKP 581
+L E L G P
Sbjct: 224 VLYECLTGSPP 234
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 53/303 (17%), Positives = 106/303 (34%), Gaps = 76/303 (25%)
Query: 390 YGTAYKAKLADGA------TIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQ 443
+G + A+ + +A++ L+E S R L ++H++++
Sbjct: 54 FGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF----F 109
Query: 444 G---KRGEKLLIYDYFPSRTLHDLL-----------HDTIAGKPVLNWARRHKIALGIAR 489
G + L++++Y L+ L L + +A +A
Sbjct: 110 GVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAA 169
Query: 490 GLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKADGYK 549
G+ YL H + H ++ ++N LV V ++ +FG+ + + D Y+
Sbjct: 170 GMVYLAGLHFV---HRDLATRNCLVGQGLVVKIGDFGMSRDI-----------YSTDYYR 215
Query: 550 ------------APELQRMKKCSSRTDVYAFGILLLEIL-IGKKP--GKSGRNGEFVDLP 594
PE +K ++ +DV++FG++L EI GK+P S
Sbjct: 216 VGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT-------- 267
Query: 595 SIVKVAVLEETTMEVFDMEIMKGIRSPMEEGLVQAL-KLAMGCCAPVASVRPTMDEVVKQ 653
E D I +G + + GC R ++ +V +
Sbjct: 268 -------------EAIDC-ITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313
Query: 654 LEE 656
L+
Sbjct: 314 LQA 316
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 1e-08
Identities = 32/147 (21%), Positives = 49/147 (33%), Gaps = 19/147 (12%)
Query: 125 LQSLYLNVNSLKGTIPFEL-GYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNS 183
L +L L N ++ ++ SSL ++ L L L + N
Sbjct: 78 LSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLAS-LENFPIGHLKTLKELNVAHNL 135
Query: 184 LTAALPEPA----LPNSTCSDLQYLDLGSNKFS----GSFPEFVTRFEALKELDISNNLF 235
+ + P L N L++LDL SNK LD+S N
Sbjct: 136 IQS-FKLPEYFSNLTN-----LEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPM 189
Query: 236 SGSIPEGL-TRLSLEKLNLSHNNFSGV 261
+ I G + L++L L N V
Sbjct: 190 N-FIQPGAFKEIRLKELALDTNQLKSV 215
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 7e-08
Identities = 35/141 (24%), Positives = 55/141 (39%), Gaps = 14/141 (9%)
Query: 125 LQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNSL 184
++L L+ N L+ + L +DLS + + L +L L GN +
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPI 88
Query: 185 TAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFV-TRFEALKELDISNNLFSGSIPE-- 241
+L A + LQ L + S F + LKEL++++NL S
Sbjct: 89 Q-SLALGAFSGLSS--LQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQ-SFKLPE 143
Query: 242 ---GLTRLSLEKLNLSHNNFS 259
LT +LE L+LS N
Sbjct: 144 YFSNLT--NLEHLDLSSNKIQ 162
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 6e-04
Identities = 23/116 (19%), Positives = 45/116 (38%), Gaps = 14/116 (12%)
Query: 125 LQSLYLNVNSLKGTIPFELGYSSSLS---EIDLSANLFT----GVLAPSIWNLCDRLVSL 177
L+ L + N ++ + Y S+L+ +DLS+N L + + +SL
Sbjct: 126 LKELNVAHNLIQ-SFKLP-EYFSNLTNLEHLDLSSNKIQSIYCTDLR-VLHQMPLLNLSL 182
Query: 178 RLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNN 233
L N + + A L+ L L +N+ R +L+++ + N
Sbjct: 183 DLSLNPMNF-IQPGAFKEIR---LKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 1e-08
Identities = 35/212 (16%), Positives = 71/212 (33%), Gaps = 28/212 (13%)
Query: 390 YGTAYKAK-LADGATIAL-RLLREGSCKDRSSCLPVIRQLGKVRHENLI--------PLR 439
+G ++AK D A+ R+ R + ++ L K+ H ++
Sbjct: 18 FGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNT 77
Query: 440 AFYQGKRGEKLLIY---DYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHT 496
K+ +Y L D ++ + I L IA + +LH+
Sbjct: 78 TEKLQPSSPKVYLYIQMQLCRKENLKDWMNGR-CTIEERERSVCLHIFLQIAEAVEFLHS 136
Query: 497 GHEIPITHGNVRSKNVLVD--------DFFVSRLTEFGLDQLMVPAVADEMVALAKADG- 547
+ H +++ N+ DF + + ++ V G
Sbjct: 137 KG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGT 193
Query: 548 --YKAPELQRMKKCSSRTDVYAFGILLLEILI 577
Y +PE S + D+++ G++L E+L
Sbjct: 194 KLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 1e-08
Identities = 48/232 (20%), Positives = 107/232 (46%), Gaps = 28/232 (12%)
Query: 383 QVIEKTTYGTAYKAKLAD-GATIAL-RLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRA 440
++ + T+GT K G ++A+ +++++ ++R L +++ L + H N++ L++
Sbjct: 29 RMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE--LQIMQDLAVLHHPNIVQLQS 86
Query: 441 FY--QGKRGEK----LLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYL 494
++ G+R + ++ +Y P TLH + + + R + L
Sbjct: 87 YFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCL 145
Query: 495 HTGHEIPITHGNVRSKNVLVDDF-FVSRLTEFGLDQLMVPAVADEMVALAKADGYKAPEL 553
H + + H +++ NVLV++ +L +FG + + P ++ VA + Y+APEL
Sbjct: 146 HL-PSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSP--SEPNVAYICSRYYRAPEL 202
Query: 554 QRMKKCSSRT---DVYAFGILLLEILIGKK--PGKSGRNGEFVD-LPSIVKV 599
+ T D+++ G + E+++G+ G + L IV+V
Sbjct: 203 --IFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNS-----AGQLHEIVRV 247
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 1e-08
Identities = 64/317 (20%), Positives = 119/317 (37%), Gaps = 74/317 (23%)
Query: 370 EHLTLEDVLNATGQVIEKTTYGTAYKAKLADGA---TIALRLLREG-SCKDRSSCLPVIR 425
+ +DV+ G +G KA++ A++ ++E S D +
Sbjct: 25 NDIKFQDVIGE-GN------FGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELE 77
Query: 426 QLGKV-RHENLIPLRAFYQG---KRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRH 481
L K+ H N+I L G RG L +Y P L D L + + +A +
Sbjct: 78 VLCKLGHHPNIINL----LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIAN 133
Query: 482 ------------KIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQ 529
A +ARG+ YL I H ++ ++N+LV + +V+++ +FGL +
Sbjct: 134 STASTLSSQQLLHFAADVARGMDYLSQKQFI---HRDLAARNILVGENYVAKIADFGLSR 190
Query: 530 LMVPAVADEMVALAKADGYK------APELQRMKKCSSRTDVYAFGILLLEIL-IGKKP- 581
+ V + K G + A E ++ +DV+++G+LL EI+ +G P
Sbjct: 191 -------GQEVYVKKTMG-RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY 242
Query: 582 -GKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIRSPMEEGLVQAL-KLAMGCCAP 639
G + E+++ + +G R + L C
Sbjct: 243 CGMTCA---------------------ELYEK-LPQGYRLEKPLNCDDEVYDLMRQCWRE 280
Query: 640 VASVRPTMDEVVKQLEE 656
RP+ +++ L
Sbjct: 281 KPYERPSFAQILVSLNR 297
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 58/315 (18%), Positives = 107/315 (33%), Gaps = 71/315 (22%)
Query: 370 EHLTLEDVLNATGQVIEKTTYGTAYKAKLADGA----TIALRLLREGSC--KDRSSCLPV 423
L L +L G+ +G+ + L +A++ ++ + ++ L
Sbjct: 34 NLLILGKILGE-GE------FGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSE 86
Query: 424 IRQLGKVRHENLIPLRA----FYQGKRGEKLLIYDYFPSRTLHDLL--HDTIAGKPVLNW 477
+ H N+I L + ++I + LH L G +
Sbjct: 87 AACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPL 146
Query: 478 ARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVAD 537
K + IA G+ YL + + H ++ ++N ++ D + +FGL + +
Sbjct: 147 QTLLKFMVDIALGMEYLSNRNFL---HRDLAARNCMLRDDMTVCVADFGLSKKI------ 197
Query: 538 EMVALAKADGYK------------APELQRMKKCSSRTDVYAFGILLLEIL-IGKKP--G 582
D Y+ A E + +S++DV+AFG+ + EI G P G
Sbjct: 198 -----YSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPG 252
Query: 583 KSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIRSPMEEGLVQALKLAMGCC-APVA 641
E++D ++ G R E + L M C
Sbjct: 253 VQNH---------------------EMYDY-LLHGHRLKQPEDCLDELYEIMYSCWRTDP 290
Query: 642 SVRPTMDEVVKQLEE 656
RPT + QLE+
Sbjct: 291 LDRPTFSVLRLQLEK 305
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 54.9 bits (133), Expect = 3e-08
Identities = 54/304 (17%), Positives = 110/304 (36%), Gaps = 77/304 (25%)
Query: 390 YGTAYKAKLADGA------TIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQ 443
+G + A+ + + +A++ L++ + R L ++HE+++
Sbjct: 28 FGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF----Y 83
Query: 444 G---KRGEKLLIYDYFPSRTLHDLL------------HDTIAGKPVLNWARRHKIALGIA 488
G +++++Y L+ L K L ++ IA IA
Sbjct: 84 GVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIA 143
Query: 489 RGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKADGY 548
G+ YL + H + H ++ ++N LV + ++ +FG+ + + D Y
Sbjct: 144 SGMVYLASQHFV---HRDLATRNCLVGANLLVKIGDFGMSRDV-----------YSTDYY 189
Query: 549 K------------APELQRMKKCSSRTDVYAFGILLLEIL-IGKKP--GKSGRNGEFVDL 593
+ PE +K ++ +DV++FG++L EI GK+P S
Sbjct: 190 RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT------- 242
Query: 594 PSIVKVAVLEETTMEVFDMEIMKGIRSPMEEGLVQAL-KLAMGCCAPVASVRPTMDEVVK 652
EV + I +G + + + +GC R + E+ K
Sbjct: 243 --------------EVIEC-ITQGRVLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYK 287
Query: 653 QLEE 656
L
Sbjct: 288 ILHA 291
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 3e-08
Identities = 35/143 (24%), Positives = 53/143 (37%), Gaps = 15/143 (10%)
Query: 125 LQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSL---RLHG 181
+ L L N L + L + L+ N + A + L +L +
Sbjct: 39 TKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPA----GIFKELKNLETLWVTD 94
Query: 182 NSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFV-TRFEALKELDISNNLFSGSIP 240
N L A LP +L L L N+ S P V L L + N S+P
Sbjct: 95 NKLQA-LPIGVFDQLV--NLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLP 149
Query: 241 EGL-TRL-SLEKLNLSHNNFSGV 261
+G+ +L SL++L L +N V
Sbjct: 150 KGVFDKLTSLKELRLYNNQLKRV 172
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 54.8 bits (132), Expect = 3e-08
Identities = 36/164 (21%), Positives = 58/164 (35%), Gaps = 18/164 (10%)
Query: 108 SANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYS--SSLSEIDLSANLFTGVLAP 165
L ++P+ L S L L+ N+L + E + ++L + LS N ++
Sbjct: 27 KQQLP-NVPQSL--PSYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-FISS 81
Query: 166 SIWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFV-TRFEA 224
+ L L L N L L E + L+ L L +N
Sbjct: 82 EAFVPVPNLRYLDLSSNHLHT-LDEFLFSDLQ--ALEVLLLYNNHIV-VVDRNAFEDMAQ 137
Query: 225 LKELDISNNLFSGSIPEG----LTRL-SLEKLNLSHNNFSGVLP 263
L++L +S N S P +L L L+LS N +
Sbjct: 138 LQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPL 180
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 41.4 bits (97), Expect = 7e-04
Identities = 26/113 (23%), Positives = 43/113 (38%), Gaps = 7/113 (6%)
Query: 125 LQSLYLNVNSLKGTIPFE-LGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNS 183
L+ L L+ N L T+ +L + L N V+ + + +L L L N
Sbjct: 90 LRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQ 147
Query: 184 LTAALPEPALPNSTC-SDLQYLDLGSNKFSGSFPEFVTRFEALKE--LDISNN 233
++ P + + L LDL SNK + + A + L + NN
Sbjct: 148 ISR-FPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNN 199
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 4e-08
Identities = 45/220 (20%), Positives = 76/220 (34%), Gaps = 35/220 (15%)
Query: 382 GQVIEKTTYGTAYKA-KLADGATIA---LRLLREGSCKDRSSCLPVIRQLGKV-RHENLI 436
+ +YG +K DG A G KDR+ L + KV +H +
Sbjct: 62 LSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGP-KDRARKLAEVGSHEKVGQHPCCV 120
Query: 437 PLRAFYQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKP-----VLNWARRHKIALGIARGL 491
L ++ G L + +L G V + R L
Sbjct: 121 RLEQAWE--EGGILYLQTELCGPSLQQHCEAW--GASLPEAQVWGYLRD------TLLAL 170
Query: 492 AYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGL-DQLMVPAVADEMVALAKADG--- 547
A+LH+ + H +V+ N+ + +L +FGL +L + G
Sbjct: 171 AHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE------GDPR 221
Query: 548 YKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRN 587
Y APEL + + DV++ G+ +LE+ + G
Sbjct: 222 YMAPELLQ-GSYGTAADVFSLGLTILEVACNMELPHGGEG 260
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 55.2 bits (133), Expect = 5e-08
Identities = 24/127 (18%), Positives = 47/127 (37%), Gaps = 16/127 (12%)
Query: 455 YFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLV 514
Y ++L L A L I L+YLH I + + +++ +N+++
Sbjct: 165 YVGGQSLKRSKGQK------LPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIML 215
Query: 515 DDFFVSRLTEFGLDQLMVPAVADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLE 574
+ + +L + G V + G++APE + TD+Y G L
Sbjct: 216 TEEQL-KLIDLGA----VSRINSFGYLYGTP-GFQAPE-IVRTGPTVATDIYTVGRTLAA 268
Query: 575 ILIGKKP 581
+ +
Sbjct: 269 LTLDLPT 275
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 5e-08
Identities = 41/191 (21%), Positives = 73/191 (38%), Gaps = 52/191 (27%)
Query: 482 KIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVA 541
+ IA G+ YL + H + H ++ ++NVLV D ++++ GL +
Sbjct: 132 HLVAQIAAGMEYLSSHHVV---HKDLATRNVLVYDKLNVKISDLGLFRE----------- 177
Query: 542 LAKADGYK------------APELQRMKKCSSRTDVYAFGILLLEIL-IGKKP--GKSGR 586
+ AD YK APE K S +D++++G++L E+ G +P G S +
Sbjct: 178 VYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ 237
Query: 587 NGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIRSPMEEGLVQAL-KLAMGCCAPVASVRP 645
+V +M I P + + L + C S RP
Sbjct: 238 ---------------------DVVEM-IRNRQVLPCPDDCPAWVYALMIECWNEFPSRRP 275
Query: 646 TMDEVVKQLEE 656
++ +L
Sbjct: 276 RFKDIHSRLRA 286
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 54.1 bits (130), Expect = 7e-08
Identities = 44/235 (18%), Positives = 75/235 (31%), Gaps = 55/235 (23%)
Query: 103 SIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGV 162
+ +T +P +L L + L+ L +I++S N V
Sbjct: 13 VFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEV 69
Query: 163 LAPSIWNLCDRLVSLRL-HGNSLTAALPEPALPNSTCSD---LQYLDLGSNKFSGSFPEF 218
+ +++ +L +R+ N+L + + LQYL + + P+
Sbjct: 70 IEADVFSNLPKLHEIRIEKANNLLY------INPEAFQNLPNLQYLLISNTGIK-HLPDV 122
Query: 219 V-TRFEALKELDISNNLFSGSIPE----GLTR----------------------LSLEKL 251
LDI +N+ +I GL+ L++L
Sbjct: 123 HKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDEL 182
Query: 252 NLSHNNFSGVLPVFSESKFGAEVFEGNSPALCGFPLRDCSGN--SRLSSGAIAGL 304
NLS NN LP +VF G G + D S L S + L
Sbjct: 183 NLSDNNNLEELP--------NDVFHG----ASGPVILDISRTRIHSLPSYGLENL 225
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 7e-08
Identities = 36/182 (19%), Positives = 78/182 (42%), Gaps = 33/182 (18%)
Query: 482 KIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVA 541
+ +A+G+A+L + + I H ++ ++N+L+ ++++ +FGL + + ++
Sbjct: 149 SFSYQVAKGMAFLASKNCI---HRDLAARNILLTHGRITKICDFGLARD----IKNDSNY 201
Query: 542 LAKADG---YK--APELQRMKKCSSRTDVYAFGILLLEIL-IGKKPGKSGRNGEFVDLPS 595
+ K + K APE + +DV+++GI L E+ +G P P
Sbjct: 202 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP-----------YPG 250
Query: 596 IVKVAVLEETTMEVFDMEIMKGIRSPMEEGLVQAL-KLAMGCCAPVASVRPTMDEVVKQL 654
+ + + M I +G R E + + C RPT ++V+ +
Sbjct: 251 M-------PVDSKFYKM-IKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 302
Query: 655 EE 656
E+
Sbjct: 303 EK 304
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 7e-08
Identities = 40/142 (28%), Positives = 58/142 (40%), Gaps = 15/142 (10%)
Query: 126 QSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVS---LRLHGN 182
+ L L L + L+ ++L N + A + D L L L N
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSA----GVFDDLTELGTLGLANN 93
Query: 183 SLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFV-TRFEALKELDISNNLFSGSIPE 241
L +LP + + + L L LG N+ S P V R LKEL ++ N SIP
Sbjct: 94 QLA-SLP-LGVFDHL-TQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ-SIPA 148
Query: 242 GL-TRLS-LEKLNLSHNNFSGV 261
G +L+ L+ L+LS N V
Sbjct: 149 GAFDKLTNLQTLSLSTNQLQSV 170
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 8e-04
Identities = 49/211 (23%), Positives = 70/211 (33%), Gaps = 58/211 (27%)
Query: 63 CQWRGLKWI------STNGSPLSCSDI-SLPQWANLSLYKDSSIHLLSIQLPSANLTGSL 115
CQ + L + T L + + +L L K + ++L QL + L
Sbjct: 21 CQGKSLDSVPSGIPADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT------L 74
Query: 116 PRELGEFSM---LQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCD 172
G F L +L L N L L +F D
Sbjct: 75 SA--GVFDDLTELGTLGLANNQLA----------------SLPLGVF------------D 104
Query: 173 RLVS---LRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFV-TRFEALKEL 228
L L L GN L +LP T L+ L L +N+ S P + L+ L
Sbjct: 105 HLTQLDKLYLGGNQLK-SLPSGVFDRLT--KLKELRLNTNQLQ-SIPAGAFDKLTNLQTL 160
Query: 229 DISNNLFSGSIPEG-LTRL-SLEKLNLSHNN 257
+S N S+P G RL L+ + L N
Sbjct: 161 SLSTNQLQ-SVPHGAFDRLGKLQTITL-FGN 189
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 8e-08
Identities = 34/142 (23%), Positives = 52/142 (36%), Gaps = 19/142 (13%)
Query: 119 LGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNL--CDRLVS 176
F+ L S+ + +S+ +I + + S+ + +
Sbjct: 20 DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-----SVQGIQYLPNVTK 72
Query: 177 LRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFS 236
L L+GN LT P L N L +L L NK + + LK L + +N S
Sbjct: 73 LFLNGNKLTDIKPLANLKN-----LGWLFLDENKVK-DL-SSLKDLKKLKSLSLEHNGIS 125
Query: 237 GSIPEGLTRLS-LEKLNLSHNN 257
I GL L LE L L +N
Sbjct: 126 -DI-NGLVHLPQLESLYLGNNK 145
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 1e-07
Identities = 34/163 (20%), Positives = 63/163 (38%), Gaps = 21/163 (12%)
Query: 100 HLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLF 159
+ L ++T ++ E + + + N + +K ++ + Y +++++ L+ N
Sbjct: 25 ETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQG-IQYLPNVTKLFLNGNKL 80
Query: 160 TGVLAPSIWNLCD--RLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPE 217
T I L + L L L N + L L+ L L N S
Sbjct: 81 T-----DIKPLANLKNLGWLFLDENKVKDLSSLKDLKK-----LKSLSLEHNGISD--IN 128
Query: 218 FVTRFEALKELDISNNLFSGSIPEGLTRL-SLEKLNLSHNNFS 259
+ L+ L + NN + I L+RL L+ L+L N S
Sbjct: 129 GLVHLPQLESLYLGNNKIT-DI-TVLSRLTKLDTLSLEDNQIS 169
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 5e-07
Identities = 35/143 (24%), Positives = 55/143 (38%), Gaps = 21/143 (14%)
Query: 119 LGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNL--CDRLVS 176
+ + L+LN N L P L +L + L N + +L +L S
Sbjct: 64 IQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVK-----DLSSLKDLKKLKS 116
Query: 177 LRLHGNSLTAALPEPALPN-STCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLF 235
L L N ++ + L+ L LG+NK + ++R L L + +N
Sbjct: 117 LSLEHNGISD------INGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQI 168
Query: 236 SGSIPEGLTRL-SLEKLNLSHNN 257
S I L L L+ L LS N+
Sbjct: 169 S-DI-VPLAGLTKLQNLYLSKNH 189
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 33/144 (22%), Positives = 47/144 (32%), Gaps = 19/144 (13%)
Query: 119 LGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNL--CDRLVS 176
L L L+L+ N +K + L + L N + I L +L S
Sbjct: 86 LANLKNLGWLFLDENKVKDLSSLK--DLKKLKSLSLEHNGIS-----DINGLVHLPQLES 138
Query: 177 LRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFS 236
L L N +T L L L L N+ S L+ L +S N S
Sbjct: 139 LYLGNNKITDITVLSRLTK-----LDTLSLEDNQIS-DIVPL-AGLTKLQNLYLSKNHIS 191
Query: 237 GSIPEGLTRL-SLEKLNLSHNNFS 259
+ L L +L+ L L
Sbjct: 192 -DL-RALAGLKNLDVLELFSQECL 213
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 28/141 (19%), Positives = 48/141 (34%), Gaps = 13/141 (9%)
Query: 119 LGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLR 178
L + L+SL L N + I L + L + L N T + + L +L +L
Sbjct: 108 LKDLKKLKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKITDI--TVLSRL-TKLDTLS 162
Query: 179 LHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGS 238
L N ++ +P L LQ L L N S + L L++ +
Sbjct: 163 LEDNQISDIVPLAGLTK-----LQNLYLSKNHIS-DLRAL-AGLKNLDVLELFSQECLNK 215
Query: 239 IPEGLTRLS-LEKLNLSHNNF 258
+ L + + +
Sbjct: 216 PINHQSNLVVPNTVKNTDGSL 236
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 8e-08
Identities = 71/322 (22%), Positives = 126/322 (39%), Gaps = 76/322 (23%)
Query: 370 EHLTLEDVLN--ATGQVIEKTTYGTAYKAKLADGATIALRLLREGSC-KDRSSCLPVIRQ 426
+ LTL L A GQV+ G K K + T+A+++L++ + KD S + +
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGID-KDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEM 93
Query: 427 LGKV-RHENLIPLRAFYQG---KRGEKLLIYDYFPSRTLHDLL------------HDTIA 470
+ + +H+N+I L G + G +I +Y L + L
Sbjct: 94 MKMIGKHKNIINL----LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRV 149
Query: 471 GKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQL 530
+ + + +ARG+ YL + I H ++ ++NVLV + V ++ +FGL +
Sbjct: 150 PEEQMTFKDLVSCTYQLARGMEYLASQKCI---HRDLAARNVLVTENNVMKIADFGLARD 206
Query: 531 MVPAVADEMVALAKADGYK------------APELQRMKKCSSRTDVYAFGILLLEIL-I 577
+ D YK APE + + ++DV++FG+L+ EI +
Sbjct: 207 I-----------NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTL 255
Query: 578 GKKP--GKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIRSPMEEGLVQAL-KLAM 634
G P G E+F + + +G R L +
Sbjct: 256 GGSPYPGIPVE---------------------ELFKL-LKEGHRMDKPANCTNELYMMMR 293
Query: 635 GCCAPVASVRPTMDEVVKQLEE 656
C V S RPT ++V+ L+
Sbjct: 294 DCWHAVPSQRPTFKQLVEDLDR 315
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 9e-08
Identities = 69/335 (20%), Positives = 125/335 (37%), Gaps = 76/335 (22%)
Query: 370 EHLTLEDVLN--ATGQVIEKTTYGTAYKAKLADGATI-ALRLLREGSC-KDRS---SCLP 422
E+L VL A G+V+ TAY + A+++L+E + +R S L
Sbjct: 45 ENLEFGKVLGSGAFGKVMN----ATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELK 100
Query: 423 VIRQLGKVRHENLI----------P------------LRAFYQGKRGEKLLIYDYFPSRT 460
++ QLG HEN++ P L + + KR + + ++
Sbjct: 101 MMTQLG--SHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQK 158
Query: 461 LHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVS 520
+ D VL + A +A+G+ +L + H ++ ++NVLV V
Sbjct: 159 RLEEEED----LNVLTFEDLLCFAYQVAKGMEFLEFKSCV---HRDLAARNVLVTHGKVV 211
Query: 521 RLTEFGL--DQLMVPAVADEMVALAKADG---YK--APELQRMKKCSSRTDVYAFGILLL 573
++ +FGL D + + + + + K APE + ++DV+++GILL
Sbjct: 212 KICDFGLARD------IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLW 265
Query: 574 EIL-IGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIRSPMEEGLVQALKL 632
EI +G P P I + + I G + + + +
Sbjct: 266 EIFSLGVNP-----------YPGI-------PVDANFYKL-IQNGFKMDQPFYATEEIYI 306
Query: 633 AMGCC-APVASVRPTMDEVVKQLEENRPRNRSALY 666
M C A + RP+ + L A+Y
Sbjct: 307 IMQSCWAFDSRKRPSFPNLTSFLGCQLADAEEAMY 341
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 1e-07
Identities = 46/190 (24%), Positives = 77/190 (40%), Gaps = 48/190 (25%)
Query: 481 HKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMV 540
+ARG+ YL + I H ++ ++NVLV + V ++ +FGL + +
Sbjct: 206 VSCTYQLARGMEYLASQKCI---HRDLAARNVLVTENNVMKIADFGLARDI--------- 253
Query: 541 ALAKADGYK------------APELQRMKKCSSRTDVYAFGILLLEIL-IGKKPGKSGRN 587
D YK APE + + ++DV++FG+L+ EI +G P
Sbjct: 254 --NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP------ 305
Query: 588 GEFVDLPSIVKVAVLEETTMEVFDMEIMKGIRSPMEEGLVQALKLAMGCC-APVASVRPT 646
P I E+F + + +G R L + M C V S RPT
Sbjct: 306 -----YPGI--------PVEELFKL-LKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPT 351
Query: 647 MDEVVKQLEE 656
++V+ L+
Sbjct: 352 FKQLVEDLDR 361
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 2e-07
Identities = 57/258 (22%), Positives = 122/258 (47%), Gaps = 45/258 (17%)
Query: 367 QGGEHLTLEDVLNATGQVIEKT----------TYGTAYKAKLADGATIAL-RLLREGSCK 415
+ + + TG+ E ++G ++AKL + +A+ ++L++ K
Sbjct: 20 DPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFK 79
Query: 416 DRSSCLPVIRQLGKVRHENLIPLRAFY--QGKRGEKL---LIYDYFPSRTLHDLLHDTIA 470
+R ++ + V+H N++ L+AF+ G + +++ L+ +Y P T++
Sbjct: 80 NRE-----LQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAK 133
Query: 471 GKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVD-DFFVSRLTEFGLDQ 529
K + + R LAY+H+ I I H +++ +N+L+D V +L +FG +
Sbjct: 134 LKQTMPMLLIKLYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAK 190
Query: 530 LMVPAVA--DEMVALAKADGYKAPELQRMKKCSSRT---DVYAFGILLLEILIGKK--PG 582
+++ + + Y+APEL + ++ T D+++ G ++ E++ G+ PG
Sbjct: 191 ILIAGEPNVSYICSRY----YRAPEL--IFGATNYTTNIDIWSTGCVMAELMQGQPLFPG 244
Query: 583 KSGRNGEFVD-LPSIVKV 599
+SG +D L I+KV
Sbjct: 245 ESG-----IDQLVEIIKV 257
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 49/215 (22%), Positives = 81/215 (37%), Gaps = 54/215 (25%)
Query: 482 KIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVA 541
A +ARG+ YL + I H ++ ++NVLV + V ++ +FGL + +
Sbjct: 195 SCAYQVARGMEYLASKKCI---HRDLAARNVLVTEDNVMKIADFGLARDI---------- 241
Query: 542 LAKADGYK------------APELQRMKKCSSRTDVYAFGILLLEIL-IGKKP--GKSGR 586
D YK APE + + ++DV++FG+LL EI +G P G
Sbjct: 242 -HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 300
Query: 587 NGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIRSPMEEGLVQAL-KLAMGCCAPVASVRP 645
E+F + + +G R L + C V S RP
Sbjct: 301 ---------------------ELFKL-LKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRP 338
Query: 646 TMDEVVKQLEE--NRPRNRSALYSPTETRSEIGTP 678
T ++V+ L+ N+ Y + P
Sbjct: 339 TFKQLVEDLDRIVALTSNQEMGYYHHHHHHDYDIP 373
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 2e-07
Identities = 33/142 (23%), Positives = 60/142 (42%), Gaps = 20/142 (14%)
Query: 119 LGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCD--RLVS 176
E S +Q+ + ++++ ++ + + ++L E+ LS N + + L D +L
Sbjct: 37 QKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQIS-----DLSPLKDLTKLEE 89
Query: 177 LRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFS 236
L ++ N L L + L L L +N+ + + + L+ L I NN
Sbjct: 90 LSVNRNRLKN------LNGIPSACLSRLFLDNNELRD--TDSLIHLKNLEILSIRNNKLK 141
Query: 237 GSIPEGLTRL-SLEKLNLSHNN 257
SI L L LE L+L N
Sbjct: 142 -SI-VMLGFLSKLEVLDLHGNE 161
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 8e-07
Identities = 22/144 (15%), Positives = 43/144 (29%), Gaps = 24/144 (16%)
Query: 119 LGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNL--CDRLVS 176
+ L S+ + S + + + S+ + L
Sbjct: 15 DPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ-----SLAGMQFFTNLKE 67
Query: 177 LRLHGNSLTAALPEPALPN-STCSDLQYLDLGSNKFSG-SFPEFVTRFEALKELDISNNL 234
L L N ++ L + L+ L + N+ + L L + NN
Sbjct: 68 LHLSHNQISD------LSPLKDLTKLEELSVNRNRLKNLNGIPSAC----LSRLFLDNNE 117
Query: 235 FSGSIPEGLTRL-SLEKLNLSHNN 257
+ L L +LE L++ +N
Sbjct: 118 LRD--TDSLIHLKNLEILSIRNNK 139
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 4e-05
Identities = 18/126 (14%), Positives = 43/126 (34%), Gaps = 18/126 (14%)
Query: 141 FELGYSSSLSEIDLSANLFTGVLAPSIWNL--CDRLVSLRLHGNSLTAALPEPALPN-ST 197
F ++ + +L T + + + + +++ + L
Sbjct: 13 FPDPGLANAVKQNLGKQSVT-----DLVSQKELSGVQNFNGDNSNIQS------LAGMQF 61
Query: 198 CSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRLSLEKLNLSHNN 257
++L+ L L N+ S + L+EL ++ N ++ G+ L +L L +N
Sbjct: 62 FTNLKELHLSHNQISD--LSPLKDLTKLEELSVNRNRLK-NL-NGIPSACLSRLFLDNNE 117
Query: 258 FSGVLP 263
Sbjct: 118 LRDTDS 123
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 3e-04
Identities = 28/139 (20%), Positives = 51/139 (36%), Gaps = 15/139 (10%)
Query: 119 LGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLR 178
L + + L+ L +N N LK + LS + L N S+ +L L L
Sbjct: 81 LKDLTKLEELSVNRNRLKNLNGIPS---ACLSRLFLDNNELRDT--DSLIHL-KNLEILS 134
Query: 179 LHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGS 238
+ N L + + L L+ LDL N+ + +TR + + +D++
Sbjct: 135 IRNNKLKSIVMLGFLSK-----LEVLDLHGNEITN--TGGLTRLKKVNWIDLTGQKCVNE 187
Query: 239 IPEGLTRLSLEKLNLSHNN 257
+ L + N +
Sbjct: 188 PVKYQPELYI--TNTVKDP 204
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 2e-07
Identities = 66/329 (20%), Positives = 118/329 (35%), Gaps = 85/329 (25%)
Query: 370 EHLTLEDVLN--ATGQVIEKTTYGTAYKAKLADGATI-ALRLLREG-SCKDRSSCLPVIR 425
++L L L G+V++ TA+ K G T A+++L+E S + L
Sbjct: 23 KNLVLGKTLGEGEFGKVVK----ATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFN 78
Query: 426 QLGKVRHENLI----------P------------LRAFYQGKRGEKLLIYDYFPSRTLHD 463
L +V H ++I P LR F + R SR
Sbjct: 79 VLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSS 138
Query: 464 LLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLT 523
L H + L A I++G+ YL + H ++ ++N+LV + +++
Sbjct: 139 LDHP---DERALTMGDLISFAWQISQGMQYLAEMKLV---HRDLAARNILVAEGRKMKIS 192
Query: 524 EFGLDQLMVPAVADEMVALAKADGYK------------APELQRMKKCSSRTDVYAFGIL 571
+FGL + + + D Y A E ++++DV++FG+L
Sbjct: 193 DFGLSRDV-----------YEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVL 241
Query: 572 LLEIL-IGKKP--GKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIRSPMEEGLVQ 628
L EI+ +G P G +F++ + G R + +
Sbjct: 242 LWEIVTLGGNPYPGIPPE---------------------RLFNL-LKTGHRMERPDNCSE 279
Query: 629 ALKLAMGCC-APVASVRPTMDEVVKQLEE 656
+ M C RP ++ K LE+
Sbjct: 280 EMYRLMLQCWKQEPDKRPVFADISKDLEK 308
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 2e-07
Identities = 59/350 (16%), Positives = 124/350 (35%), Gaps = 102/350 (29%)
Query: 370 EHLTLEDVL--NATGQVIEKTTYGTAYKAKLADGAT-IALRLLREGSC-KDRSSCLPVIR 425
E +T+ L + G V E G A + T +A++ + E + ++R L
Sbjct: 25 EKITMSRELGQGSFGMVYE----GVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 80
Query: 426 QLGKVRHENLI----------P------------LRAFYQGKRGEKLLIYDYFPSRTLHD 463
+ + +++ P L+++ + R + +L
Sbjct: 81 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPA-MANNPVLAPPSLSK 139
Query: 464 LLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLT 523
++ +A IA G+AYL+ + H ++ ++N +V + F ++
Sbjct: 140 MIQ----------------MAGEIADGMAYLNANKFV---HRDLAARNCMVAEDFTVKIG 180
Query: 524 EFGLDQLMVPAVADEMVALAKADGYK------------APELQRMKKCSSRTDVYAFGIL 571
+FG+ + + + D Y+ +PE + ++ +DV++FG++
Sbjct: 181 DFGMTRDI-----------YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVV 229
Query: 572 LLEIL-IGKKP--GKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIRSPMEEGLVQ 628
L EI + ++P G S +V +M+G +
Sbjct: 230 LWEIATLAEQPYQGLSNE---------------------QVLRF-VMEGGLLDKPDNCPD 267
Query: 629 AL-KLAMGCCAPVASVRPTMDEVVKQLE---ENRPRNRSALYSPTETRSE 674
L +L C +RP+ E++ ++ E R S YS E
Sbjct: 268 MLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFYYSEENKLPE 317
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 3e-07
Identities = 62/320 (19%), Positives = 117/320 (36%), Gaps = 72/320 (22%)
Query: 370 EHLTLEDVLN--ATGQVIEKTTYGTAYKAKLADGATI-ALRLLREGSC-KDRSSCL---P 422
+ L L L A GQVIE A+ A+++L+EG+ + + +
Sbjct: 27 DRLKLGKPLGRGAFGQVIE----ADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK 82
Query: 423 VIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRTLHDLL------------HDTIA 470
++ +G H N++ L G ++I ++ L L
Sbjct: 83 ILIHIG--HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 140
Query: 471 GKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQL 530
K L + +A+G+ +L + I H ++ ++N+L+ + V ++ +FGL +
Sbjct: 141 YKDFLTLEHLICYSFQVAKGMEFLASRKCI---HRDLAARNILLSEKNVVKICDFGLARD 197
Query: 531 MVPAVADEMVALAKADGYK------------APELQRMKKCSSRTDVYAFGILLLEIL-I 577
+ K Y APE + + ++DV++FG+LL EI +
Sbjct: 198 IY-----------KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSL 246
Query: 578 GKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIRSPMEEGLVQAL-KLAMGC 636
G P P + + E + +G R + + + + C
Sbjct: 247 GASP-----------YPGV-------KIDEEFCRR-LKEGTRMRAPDYTTPEMYQTMLDC 287
Query: 637 CAPVASVRPTMDEVVKQLEE 656
S RPT E+V+ L
Sbjct: 288 WHGEPSQRPTFSELVEHLGN 307
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 52.5 bits (125), Expect = 4e-07
Identities = 75/553 (13%), Positives = 163/553 (29%), Gaps = 153/553 (27%)
Query: 100 HLLSIQLPSANLT-----GSLPRELGEFSMLQSLYLNVNSLKGTIPFE-----LGYSSSL 149
LL ++ P+ N+ GS G+ + + ++ + F+ L +S
Sbjct: 143 ALLELR-PAKNVLIDGVLGS-----GK-TWVALDVCLSYKVQCKMDFKIFWLNLKNCNSP 195
Query: 150 SEI-DLSANLFTGVLAPSIWNLCDRLVSLRLHGNSLTAAL----PEPALPNSTCSDLQYL 204
+ ++ L + P+ + D +++L +S+ A L N L L
Sbjct: 196 ETVLEMLQKLLY-QIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENC----LLVL 250
Query: 205 DLGSNKFSGSFPEFVTRFEALKELDIS---------NNLFSGSIPEGLTRLSLEKLNLSH 255
N V +A ++S + T +SL+ +
Sbjct: 251 L---N---------VQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHS--- 295
Query: 256 NNFSGVLPVFSESKFGAEVFEGNSPALCGFPLRDCSGNSRLSSGAIAGLVIGLMTGAVV- 314
+ P +S + + L P + N + ++ +
Sbjct: 296 ---MTLTPDEVKSLL-LKYLDCRPQDL---PREVLTTNP---------RRLSII-AESIR 338
Query: 315 -FASLLIGYVQ---NKKRKNRGDSEEEFEEGEDEENGMSGGSAAGGAGGEGKLIIFQGGE 370
+ + +K S E E + L +F
Sbjct: 339 DGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDR-------------LSVFPPSA 385
Query: 371 HLTLEDVL-----NATGQVIEKTTYGTAYKAKLADGATIALRLLREGSCKDRSSCLPVIR 425
H+ +L + + KL L E K+ + +P I
Sbjct: 386 HIP-TILLSLIWFDVIKSDVMVVV------NKLHK------YSLVEKQPKESTISIPSIY 432
Query: 426 QLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIAL 485
KV+ EN L + ++ Y +T D + + + H
Sbjct: 433 LELKVKLENEYAL---------HRSIVDHYNIPKTFD---SDDLIPPYLDQYFYSH---- 476
Query: 486 GIARGLAYLHTGHEIPITHGNVRS--KNVLVDDFFVSR-LTEFGLDQLMVPAVADEMVAL 542
+ + H I H + + V +D F+ + + ++ + + L
Sbjct: 477 -----IGH----HLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQL 527
Query: 543 AKADGY---KAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKV 599
Y P+ +R+ V A +L+ L K ++ ++ D ++++
Sbjct: 528 KFYKPYICDNDPKYERL--------VNA----ILDFL--PKIEENLICSKYTD---LLRI 570
Query: 600 AVLEETTMEVFDM 612
A++ E +F+
Sbjct: 571 ALMAEDE-AIFEE 582
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 51.4 bits (123), Expect = 4e-07
Identities = 26/159 (16%), Positives = 51/159 (32%), Gaps = 22/159 (13%)
Query: 455 YFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLV 514
L D ++ I + IA + +LH+ + H +++ N+
Sbjct: 142 LCRKENLKDWMNRRC-SLEDREHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFF 197
Query: 515 D--------DFFVSRLTEFGLDQLMVPAVADEMVALAKADG---YKAPELQRMKKCSSRT 563
DF + + ++ V G Y +PE S +
Sbjct: 198 TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKV 257
Query: 564 DVYAFGILLLEILIGKKPG-------KSGRNGEFVDLPS 595
D+++ G++L E+L RN +F L +
Sbjct: 258 DIFSLGLILFELLYSFSTQMERVRIITDVRNLKFPLLFT 296
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 51.5 bits (123), Expect = 5e-07
Identities = 45/235 (19%), Positives = 94/235 (40%), Gaps = 39/235 (16%)
Query: 429 KVRHENLIPLRAFYQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIA 488
K R +++ ++ E+ + D DL D + + ++ ++ + +A
Sbjct: 150 KRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQ------VA 203
Query: 489 RGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKADG- 547
+G+ +L H ++ ++N+L+ + V ++ +FGL + + + + K D
Sbjct: 204 KGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARD----IYKDPDYVRKGDAR 256
Query: 548 ----YKAPELQRMKKCSSRTDVYAFGILLLEIL-IGKKPGKSGRNGEFVDLPSIVKVAVL 602
+ APE + + ++DV++FG+LL EI +G P P +
Sbjct: 257 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP-----------YPGV------ 299
Query: 603 EETTMEVFDMEIMKGIRSPMEEGLVQALKLAMGCC-APVASVRPTMDEVVKQLEE 656
+ E + +G R + + M C S RPT E+V+ L
Sbjct: 300 -KIDEEFCRR-LKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 352
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 5e-07
Identities = 60/315 (19%), Positives = 112/315 (35%), Gaps = 73/315 (23%)
Query: 370 EHLTLEDVLN--ATGQVIEKTTYGTAYKAKLADGAT-IALRLLREG-SCKDRSSCLPVIR 425
+++TL L A G+V E G +A++ L E S +D L
Sbjct: 30 KNITLIRGLGHGAFGEVYE----GQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 85
Query: 426 QLGKVRHENLIPLRAFYQG---KRGEKLLIYDYFPSRTLHDLLHD---TIAGKPVLNWAR 479
+ K H+N++ G + + ++ + L L + + L
Sbjct: 86 IISKFNHQNIVRC----IGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLD 141
Query: 480 RHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDF---FVSRLTEFGLDQLMVPAVA 536
+A IA G YL H I H ++ ++N L+ V+++ +FG+ + +
Sbjct: 142 LLHVARDIACGCQYLEENHFI---HRDIAARNCLLTCPGPGRVAKIGDFGMARDI----- 193
Query: 537 DEMVALAKADGYK------------APELQRMKKCSSRTDVYAFGILLLEIL-IGKKP-- 581
+A Y+ PE +S+TD ++FG+LL EI +G P
Sbjct: 194 ------YRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYP 247
Query: 582 GKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIRSPMEEGLVQAL-KLAMGCCAPV 640
KS + EV + + G R + + ++ C
Sbjct: 248 SKSNQ---------------------EVLEF-VTSGGRMDPPKNCPGPVYRIMTQCWQHQ 285
Query: 641 ASVRPTMDEVVKQLE 655
RP +++++E
Sbjct: 286 PEDRPNFAIILERIE 300
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 51.1 bits (121), Expect = 6e-07
Identities = 29/183 (15%), Positives = 68/183 (37%), Gaps = 22/183 (12%)
Query: 81 SDISLPQWANLSLYKDSSIHLLSIQLPSANLTGSLPRELG--EFSMLQSLYLNVNSLKGT 138
+++ + NLS+ K +L S+++ S L S+ ++ + L+ L
Sbjct: 175 NNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKL---------- 224
Query: 139 IPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTC 198
L D N+F + + + L L + + E L +
Sbjct: 225 ---VLYVGVEDYGFDGDMNVFRPLFSK---DRFPNLKWLGIVDAEEQNVVVEMFLESDIL 278
Query: 199 SDLQYLDLGSNKFSGS----FPEFVTRFEALKELDISNNLFSGSIPEGLTRLSLEKLNLS 254
L+ +D+ + + + V + + LK +++ N S + + L + K+++S
Sbjct: 279 PQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSLPMKIDVS 338
Query: 255 HNN 257
+
Sbjct: 339 DSQ 341
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 48.4 bits (114), Expect = 5e-06
Identities = 23/168 (13%), Positives = 54/168 (32%), Gaps = 18/168 (10%)
Query: 107 PSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPS 166
S L L +L +L + + + +L +++ + +
Sbjct: 156 ISWIEQVDLSPVLDAMPLLNNLKIKGTN---NLSIGKKPRPNLKSLEIISGGLPDSVVED 212
Query: 167 IWN-LCDRLVSLRL------HGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFV 219
I L L L +G + P +L++L + + E
Sbjct: 213 ILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMF 272
Query: 220 ---TRFEALKELDISNNLFSGS----IPEGLTRLS-LEKLNLSHNNFS 259
L+ +DIS + + + + + ++ L+ +N+ +N S
Sbjct: 273 LESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS 320
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 7e-07
Identities = 64/232 (27%), Positives = 111/232 (47%), Gaps = 46/232 (19%)
Query: 389 TYGTAYKAKLAD-GATIAL--------RLLREGSCKDRSSCLPVIRQLGKVRHENLIPLR 439
++G Y+AKL D G +A+ RE ++ + K+ H N++ LR
Sbjct: 66 SFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE------------LQIMRKLDHCNIVRLR 113
Query: 440 AFY--QGKRGEKL---LIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYL 494
F+ G++ +++ L+ DY P T++ + K L + R LAY+
Sbjct: 114 YFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 172
Query: 495 HTGHEIPITHGNVRSKNVLVD-DFFVSRLTEFGLDQLMVPAVADEMVALAKADGYKAPEL 553
H+ I H +++ +N+L+D D V +L +FG + +V + V+ + Y+APEL
Sbjct: 173 HSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--GEPNVSYICSRYYRAPEL 227
Query: 554 QRMKKCSSRT---DVYAFGILLLEILIGKK--PGKSGRNGEFVD-LPSIVKV 599
+ + T DV++ G +L E+L+G+ PG SG VD L I+KV
Sbjct: 228 --IFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG-----VDQLVEIIKV 272
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 7e-07
Identities = 29/157 (18%), Positives = 55/157 (35%), Gaps = 25/157 (15%)
Query: 125 LQSLYLNVNSLKGT----IPFELGYSSSLSEIDLSANLFTG----VLAPSIWNLCDRLVS 176
Q + L+ L I L + +L+E++L +N + + ++
Sbjct: 30 CQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQK 89
Query: 177 LRLHGNSLTA----ALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFE-----ALKE 227
L L LT L L T LQ L L N + + + L++
Sbjct: 90 LSLQNCCLTGAGCGVLSS-TL--RTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEK 146
Query: 228 LDISNNLFSGSIPEGLTRL-----SLEKLNLSHNNFS 259
L + S + E L + ++L +S+N+ +
Sbjct: 147 LQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDIN 183
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 1e-06
Identities = 37/185 (20%), Positives = 62/185 (33%), Gaps = 35/185 (18%)
Query: 96 DSSIHLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGT----IPFELGYSSSLSE 151
D +H + L + + +Q L L L G + L +L E
Sbjct: 70 DVGVHCVLQGLQTPSCK------------IQKLSLQNCCLTGAGCGVLSSTLRTLPTLQE 117
Query: 152 IDLSANLFT--GV--LAPSIWNLCDRLVSLRLHGNSLTAALPE---PALPNSTCSDLQYL 204
+ LS NL G+ L + + RL L+L SL+AA E L D + L
Sbjct: 118 LHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVL--RAKPDFKEL 175
Query: 205 DLGSNKFSGS-----FPEFVTRFEALKELDISNNLFS----GSIPEGLTRL-SLEKLNLS 254
+ +N + + L+ L + + + + + SL +L L
Sbjct: 176 TVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALG 235
Query: 255 HNNFS 259
N
Sbjct: 236 SNKLG 240
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 4e-06
Identities = 33/157 (21%), Positives = 58/157 (36%), Gaps = 25/157 (15%)
Query: 125 LQSLYLNVNSLK----GTIPFELGYSSSLSEIDLSANLFT--GV--LAPSIWNLCDRLVS 176
L++L++ + G + L SL E+ L+ N G L ++ +L S
Sbjct: 258 LRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLES 317
Query: 177 LRLHGNSLTA----ALPEPALPNSTCSDLQYLDLGSNKFSGS-FPEFVTRFE----ALKE 227
L + S TA L + L L + +N+ + E L+
Sbjct: 318 LWVKSCSFTAACCSHFSS-VLAQNRF--LLELQISNNRLEDAGVRELCQGLGQPGSVLRV 374
Query: 228 LDISNNLFS----GSIPEGLTRL-SLEKLNLSHNNFS 259
L +++ S S+ L SL +L+LS+N
Sbjct: 375 LWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLG 411
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 3e-04
Identities = 26/130 (20%), Positives = 45/130 (34%), Gaps = 21/130 (16%)
Query: 146 SSSLSEIDLSANLFTGVLAPSIWNLCD---RLVSLRLHGNSLTAALPEP---ALPNSTCS 199
S + +D+ + L + +RL LT A + AL
Sbjct: 2 SLDIQSLDIQCEELS---DARWAELLPLLQQCQVVRLDDCGLTEARCKDISSAL--RVNP 56
Query: 200 DLQYLDLGSNKFSGS-----FPEFVTRFEALKELDISNNLFS----GSIPEGLTRL-SLE 249
L L+L SN+ T +++L + N + G + L L +L+
Sbjct: 57 ALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQ 116
Query: 250 KLNLSHNNFS 259
+L+LS N
Sbjct: 117 ELHLSDNLLG 126
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 8e-07
Identities = 53/215 (24%), Positives = 94/215 (43%), Gaps = 26/215 (12%)
Query: 383 QVIEKT---TYGTAYKAK-LADGATIALRLLREGSCKD--RSSCLPVIRQLGKVRHENLI 436
+ + +YG K + G +A++ E + + I+ L ++RHENL+
Sbjct: 28 ENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLV 87
Query: 437 PLRAFYQGKRGEKL-LIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLH 495
L + K+ + L++++ H +L D L++ K I G+ + H
Sbjct: 88 NLLEVCKKKK--RWYLVFEFVD----HTILDDLELFPNGLDYQVVQKYLFQIINGIGFCH 141
Query: 496 TGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLD-QLMVPAVA--DEMVALAKADGYKAPE 552
+ + I H +++ +N+LV V +L +FG L P DE+ Y+APE
Sbjct: 142 SHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRW----YRAPE 194
Query: 553 -LQRMKKCSSRTDVYAFGILLLEILIGKK--PGKS 584
L K DV+A G L+ E+ +G+ PG S
Sbjct: 195 LLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDS 229
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 9e-07
Identities = 26/162 (16%), Positives = 51/162 (31%), Gaps = 31/162 (19%)
Query: 125 LQSLYLNVNSL--KGTIPFELG-----YSSSLSEIDLSANLFT--GV--LAPSIWNLCDR 173
+ SL L N L K + EL ++++ ++L N LA + ++
Sbjct: 140 ITSLNLRGNDLGIKSSD--ELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPAS 197
Query: 174 LVSLRLHGNSLT----AALPEPALPNSTCSDLQYLDLGSNKFSGS----FPEFVTRFEAL 225
+ SL L N L A L + + L+L N G + L
Sbjct: 198 VTSLDLSANLLGLKSYAELAY-IFSSIPNH-VVSLNLCLNCLHGPSLENLKLLKDSLKHL 255
Query: 226 KELDISNNLFSGSIPEGLTRL--------SLEKLNLSHNNFS 259
+ + + ++ E L + ++ +
Sbjct: 256 QTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIH 297
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 5e-06
Identities = 35/164 (21%), Positives = 58/164 (35%), Gaps = 32/164 (19%)
Query: 123 SMLQSLYLNVNSLKGTIPFELGY-----SSSLSEIDLSANLFT--GV--LAPSIWNLCDR 173
+ + SL L+ N L EL +++ +DL N F+ + NL
Sbjct: 80 ANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPAS 139
Query: 174 LVSLRLHGNSLT----AALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRF-----EA 224
+ SL L GN L L + L + + L+L N + + +F +
Sbjct: 140 ITSLNLRGNDLGIKSSDELIQ-ILAAIPAN-VNSLNLRGNNLASKNCAELAKFLASIPAS 197
Query: 225 LKELDISNNLFSGSIPEGLTRLS---------LEKLNLSHNNFS 259
+ LD+S NL + L+ + LNL N
Sbjct: 198 VTSLDLSANLLG---LKSYAELAYIFSSIPNHVVSLNLCLNCLH 238
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 6e-05
Identities = 29/133 (21%), Positives = 51/133 (38%), Gaps = 21/133 (15%)
Query: 146 SSSLSEIDLSANLFT----GVLAPSIWNLCDRLVSLRLHGNSLT----AALPEPALPNST 197
+S++ ++LS N L + + + SL L GN L+ L + L
Sbjct: 50 PASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVK-TLAAIP 108
Query: 198 CSDLQYLDLGSNKFSGS-----FPEFVTRFEALKELDISNNLFSG----SIPEGLTRL-- 246
+ + LDLG N FS F ++ L++ N + + L +
Sbjct: 109 FT-ITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPA 167
Query: 247 SLEKLNLSHNNFS 259
++ LNL NN +
Sbjct: 168 NVNSLNLRGNNLA 180
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 30/162 (18%), Positives = 58/162 (35%), Gaps = 32/162 (19%)
Query: 125 LQSLYLNVNSLKGTIPFELG-----YSSSLSEIDLSANLFT--GV--LAPSIWNLCDRLV 175
+ SL L+ NSL EL ++++ ++LS N + L ++ + +
Sbjct: 53 VTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTIT 112
Query: 176 SLRLHGNSLTA----ALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRF-EALK---- 226
L L N ++ + A N S + L+L N + + L
Sbjct: 113 VLDLGWNDFSSKSSSEFKQ-AFSNLPAS-ITSLNLRGNDLG---IKSSDELIQILAAIPA 167
Query: 227 ---ELDISNNLFS----GSIPEGLTRL--SLEKLNLSHNNFS 259
L++ N + + + L + S+ L+LS N
Sbjct: 168 NVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLG 209
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 1e-06
Identities = 60/315 (19%), Positives = 112/315 (35%), Gaps = 73/315 (23%)
Query: 370 EHLTLEDVLN--ATGQVIEKTTYGTAYKAKLADGAT-IALRLLREG-SCKDRSSCLPVIR 425
+++TL L A G+V E G +A++ L E S +D L
Sbjct: 71 KNITLIRGLGHGAFGEVYE----GQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 126
Query: 426 QLGKVRHENLIPLRAFYQG---KRGEKLLIYDYFPSRTLHDLLHD---TIAGKPVLNWAR 479
+ K H+N++ G + + ++ + L L + + L
Sbjct: 127 IISKFNHQNIVRC----IGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLD 182
Query: 480 RHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDF---FVSRLTEFGLDQLMVPAVA 536
+A IA G YL H I H ++ ++N L+ V+++ +FG+ + +
Sbjct: 183 LLHVARDIACGCQYLEENHFI---HRDIAARNCLLTCPGPGRVAKIGDFGMARDI----- 234
Query: 537 DEMVALAKADGYK------------APELQRMKKCSSRTDVYAFGILLLEIL-IGKKP-- 581
+A Y+ PE +S+TD ++FG+LL EI +G P
Sbjct: 235 ------YRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYP 288
Query: 582 GKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIRSPMEEGLVQAL-KLAMGCCAPV 640
KS + EV + + G R + + ++ C
Sbjct: 289 SKSNQ---------------------EVLEF-VTSGGRMDPPKNCPGPVYRIMTQCWQHQ 326
Query: 641 ASVRPTMDEVVKQLE 655
RP +++++E
Sbjct: 327 PEDRPNFAIILERIE 341
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 1e-06
Identities = 59/334 (17%), Positives = 113/334 (33%), Gaps = 95/334 (28%)
Query: 370 EHLTLEDVL--NATGQVIEKTTYGTAYKAKLADGATI-ALRLLREGSC-KDRSSCLPVIR 425
++ + A G+V + A + T+ A+++L+E + ++
Sbjct: 47 NNIEYVRDIGEGAFGRVFQ----ARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 102
Query: 426 QLGKVRHENLI----------P------------LRAFYQGKRGEKLLIYDYFPSRTLHD 463
+ + + N++ P L F + + + T
Sbjct: 103 LMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRAR 162
Query: 464 LLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVR---SKNVLVDDFFVS 520
+ G P L+ A + IA +A G+AYL + H R ++N LV + V
Sbjct: 163 VSSP---GPPPLSCAEQLCIARQVAAGMAYLSERKFV---H---RDLATRNCLVGENMVV 213
Query: 521 RLTEFGL--DQLMVPAVADEMVALAKADGYK------------APELQRMKKCSSRTDVY 566
++ +FGL + + AD YK PE + ++ +DV+
Sbjct: 214 KIADFGLSRN-------------IYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVW 260
Query: 567 AFGILLLEIL-IGKKP--GKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIRSPME 623
A+G++L EI G +P G + EV + G
Sbjct: 261 AYGVVLWEIFSYGLQPYYGMAHE---------------------EVIYY-VRDGNILACP 298
Query: 624 EGLVQAL-KLAMGCCAPVASVRPTMDEVVKQLEE 656
E L L C + + + RP+ + + L+
Sbjct: 299 ENCPLELYNLMRLCWSKLPADRPSFCSIHRILQR 332
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 49.8 bits (119), Expect = 1e-06
Identities = 28/103 (27%), Positives = 58/103 (56%), Gaps = 11/103 (10%)
Query: 482 KIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVA 541
K+++ + +GL YL H+I H +V+ N+LV+ +L +FG+ ++ ++A+ V
Sbjct: 135 KVSIAVIKGLTYLREKHKI--MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV- 191
Query: 542 LAKADG---YKAPELQRMKKCSSRTDVYAFGILLLEILIGKKP 581
G Y +PE + S ++D+++ G+ L+E+ +G+ P
Sbjct: 192 -----GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 229
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 1e-06
Identities = 42/222 (18%), Positives = 81/222 (36%), Gaps = 51/222 (22%)
Query: 382 GQVIEKTTYGTAYKAK-LADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRA 440
+ + ++G ++ K G A++ +R + + + ++PL
Sbjct: 63 QPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEE-----LVACAGLSSPRIVPLYG 117
Query: 441 FYQGKRGEKLLIY-DYFPSRTLHDLLH-------DTIAGKPVLNWARRHKIALGIARGLA 492
+ G + I+ + +L L+ D GL
Sbjct: 118 AV--REGPWVNIFMELLEGGSLGQLIKQMGCLPEDRAL-----------YYLGQALEGLE 164
Query: 493 YLHTGHEIPITHGNVRSKNVLVD---------DFFVS-RLTEFGLDQLMVPAVADEMVAL 542
YLHT I HG+V++ NVL+ DF + L GL + ++ D +
Sbjct: 165 YLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTG--DYIP-- 217
Query: 543 AKADG---YKAPELQRMKKCSSRTDVYAFGILLLEILIGKKP 581
G + APE+ K C ++ D+++ ++L +L G P
Sbjct: 218 ----GTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 30/165 (18%), Positives = 63/165 (38%), Gaps = 31/165 (18%)
Query: 125 LQSLYLNVNSL-------------KGTIPFELGYSSSLSEIDLSANLFT--GV--LAPSI 167
L+ LYL+ N L + + + + L I N + A +
Sbjct: 124 LEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTF 183
Query: 168 WNLCDRLVSLRLHGNSLTAALPEPALPN--STCSDLQYLDLGSNKFSG----SFPEFVTR 221
+ L ++++ N + E L + C +L+ LDL N F+ + +
Sbjct: 184 QS-HRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKS 242
Query: 222 FEALKELDISNNLFSG----SIPEGLTR---LSLEKLNLSHNNFS 259
+ L+EL +++ L S ++ + ++ + L+ L L +N
Sbjct: 243 WPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIE 287
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 4e-05
Identities = 31/144 (21%), Positives = 45/144 (31%), Gaps = 31/144 (21%)
Query: 143 LGYSSSLSEIDLSANLFT--GV--LAPSIWNLCDRLVSLRLHGNSLT--------AALPE 190
L L + LS N F L + L L LH N L AL E
Sbjct: 90 LLKCPKLHTVRLSDNAFGPTAQEPLIDFLSK-HTPLEHLYLHNNGLGPQAGAKIARALQE 148
Query: 191 PALPNS--TCSDLQYLDLGSNKFSG----SFPEFVTRFEALKELDISNNLFSGSIPEGLT 244
A+ L+ + G N+ + + L + + N PEG+
Sbjct: 149 LAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIR---PEGIE 205
Query: 245 RL---------SLEKLNLSHNNFS 259
L L+ L+L N F+
Sbjct: 206 HLLLEGLAYCQELKVLDLQDNTFT 229
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 23/135 (17%), Positives = 41/135 (30%), Gaps = 27/135 (20%)
Query: 148 SLSEIDLSANLFTGV----LAPSIWNLCDRLVSLRLHGNSLT----AALPEPALPNSTCS 199
S+ L + T + + D + + L GN++ L E + ++
Sbjct: 5 SIEGKSLKLDAITTEDEKSVFAVLLE-DDSVKEIVLSGNTIGTEAARWLSE-NI--ASKK 60
Query: 200 DLQYLDLGSNKFSGSFPEFVTRFEA----------LKELDISNNLFSGSIPEGLTRL--- 246
DL+ + E L + +S+N F + E L
Sbjct: 61 DLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSK 120
Query: 247 --SLEKLNLSHNNFS 259
LE L L +N
Sbjct: 121 HTPLEHLYLHNNGLG 135
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 3e-04
Identities = 31/167 (18%), Positives = 49/167 (29%), Gaps = 39/167 (23%)
Query: 123 SMLQSLYLNVNSL--KGTIPF--ELGYSSSLSEIDLSANLFT-----GVLAPSIWNLCDR 173
L+S+ N L + L + + N +L + C
Sbjct: 159 PPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAY-CQE 217
Query: 174 LVSLRLHGNSLTA----ALPEPALPNSTCSDLQYLDLGSNK--------FSGSFPEFVTR 221
L L L N+ T AL AL + +L+ L L +F +
Sbjct: 218 LKVLDLQDNTFTHLGSSALAI-ALKS--WPNLRELGLNDCLLSARGAAAVVDAFSKLENI 274
Query: 222 FEALKELDISNNLFSGSIPEGLTRL---------SLEKLNLSHNNFS 259
L+ L + N + + L L L L+ N FS
Sbjct: 275 --GLQTLRLQYNEIE---LDAVRTLKTVIDEKMPDLLFLELNGNRFS 316
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 49.1 bits (118), Expect = 2e-06
Identities = 53/215 (24%), Positives = 94/215 (43%), Gaps = 26/215 (12%)
Query: 383 QVIEKT---TYGTAYKAK-LADGATIALRLLREGSCKD--RSSCLPVIRQLGKVRHENLI 436
+ I K +YG +K + G +A++ E + L IR L +++H NL+
Sbjct: 6 EKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLV 65
Query: 437 PLRAFYQGKRGEKL-LIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLH 495
L ++ KR +L L+++Y H +LH+ + + I + + + H
Sbjct: 66 NLLEVFRRKR--RLHLVFEYCD----HTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCH 119
Query: 496 TGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLD-QLMVPAVA--DEMVALAKADGYKAPE 552
+ H +V+ +N+L+ V +L +FG L P+ DE+ Y++PE
Sbjct: 120 KHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATR----WYRSPE 172
Query: 553 -LQRMKKCSSRTDVYAFGILLLEILIGKK--PGKS 584
L + DV+A G + E+L G PGKS
Sbjct: 173 LLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKS 207
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 2e-06
Identities = 26/121 (21%), Positives = 48/121 (39%), Gaps = 14/121 (11%)
Query: 147 SSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPA---LPNSTCSDLQY 203
+E+ L+ N FT + A I+ +L + N +T + E A +
Sbjct: 32 QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASG-----VNE 85
Query: 204 LDLGSNKFSGSFPEFV-TRFEALKELDISNNLFSGSIPEGL-TRL-SLEKLNLSHNNFSG 260
+ L SN+ + + E+LK L + +N + + L S+ L+L N +
Sbjct: 86 ILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQITT 143
Query: 261 V 261
V
Sbjct: 144 V 144
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 5e-06
Identities = 26/112 (23%), Positives = 44/112 (39%), Gaps = 7/112 (6%)
Query: 147 SSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDL 206
S + E+ L + + + + L L LT+ P L L+ L+L
Sbjct: 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSIANLPKLNK-----LKKLEL 71
Query: 207 GSNKFSGSFPEFVTRFEALKELDISNNLFSG-SIPEGLTRL-SLEKLNLSHN 256
N+ SG + L L++S N S E L +L +L+ L+L +
Sbjct: 72 SDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 6e-05
Identities = 28/81 (34%), Positives = 39/81 (48%), Gaps = 4/81 (4%)
Query: 190 EPALPNSTCSDLQYLDLGSNKFS-GSFPEFVTRFEALKELDISNNLFSGSIPEGLTRL-S 247
L N T SD++ L L +++ + G FE L+ L N + SI L +L
Sbjct: 8 HLELRNRTPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNK 65
Query: 248 LEKLNLSHNNFSGVLPVFSES 268
L+KL LS N SG L V +E
Sbjct: 66 LKKLELSDNRVSGGLEVLAEK 86
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 5e-06
Identities = 20/187 (10%), Positives = 41/187 (21%), Gaps = 52/187 (27%)
Query: 396 AKLADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLI-YD 454
+ + L +L ++ + + L+ +
Sbjct: 66 PQGVLPDDVLQETLSRT------------LRLSRIDKPGVARV--LDVVHTRAGGLVVAE 111
Query: 455 YFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLV 514
+ +L ++ P A R +A H + V V
Sbjct: 112 WIRGGSLQEVA----DTSPSPVGAIR--AMQSLAAAADAAH---RAGVALSIDHPSRVRV 162
Query: 515 DDFFVSRLTEFGLDQLMVPAVADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLE 574
D V LA + + D+ G L
Sbjct: 163 SI--------------------DGDVVLA-YPATMPDA-------NPQDDIRGIGASLYA 194
Query: 575 ILIGKKP 581
+L+ + P
Sbjct: 195 LLVNRWP 201
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 5e-06
Identities = 25/130 (19%), Positives = 55/130 (42%), Gaps = 17/130 (13%)
Query: 133 NSLKGTIPFELGYSSSLSEIDLSANLFTGV--LAPSIWNLCDRLVSLRLHGNSLT--AAL 188
++++ + ++ +++L + + + ++ L L L N++ ++L
Sbjct: 9 DAIRIFEERKSVVATEAEKVELH-GMIPPIEKMDATLSTLK-ACKHLALSTNNIEKISSL 66
Query: 189 PEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRL-S 247
S +L+ L LG N + L+EL IS N + S+ G+ +L +
Sbjct: 67 -------SGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA-SL-SGIEKLVN 116
Query: 248 LEKLNLSHNN 257
L L +S+N
Sbjct: 117 LRVLYMSNNK 126
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 4e-04
Identities = 22/152 (14%), Positives = 53/152 (34%), Gaps = 21/152 (13%)
Query: 88 WANLSLYKDSSIHLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVN---SLKGTIPFELG 144
+ + + + + + L + L L+ N + L
Sbjct: 14 FEERKSVVATEAEKVELHGMIPPIEK-MDATLSTLKACKHLALSTNNIEKISS-----LS 67
Query: 145 YSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPN-STCSDLQY 203
+L + L NL + ++ + D L L + N + + L +L+
Sbjct: 68 GMENLRILSLGRNLIKKI--ENLDAVADTLEELWISYNQIAS------LSGIEKLVNLRV 119
Query: 204 LDLGSNKFSGSFPEF--VTRFEALKELDISNN 233
L + +NK + ++ E + + L++L ++ N
Sbjct: 120 LYMSNNKIT-NWGEIDKLAALDKLEDLLLAGN 150
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 47.9 bits (114), Expect = 8e-06
Identities = 43/225 (19%), Positives = 80/225 (35%), Gaps = 48/225 (21%)
Query: 383 QVIEKTTYGTAYKA------------KLAD---GATIALRLLREGSCKDRSSCLPVIRQL 427
+ I G A KL+ T A R RE + +
Sbjct: 68 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRE------------LVLM 115
Query: 428 GKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGI 487
V H+N+I L + ++ + Y + L I + L+ R + +
Sbjct: 116 KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI--QMELDHERMSYLLYQM 173
Query: 488 ARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGL------DQLMVPAVADEMVA 541
G+ +LH+ I H +++ N++V ++ +FGL +M P V
Sbjct: 174 LCGIKHLHSAGII---HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY-- 228
Query: 542 LAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKK--PGKS 584
Y+APE+ D+++ G ++ E++ K PG+
Sbjct: 229 ------YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD 267
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 31/113 (27%), Positives = 51/113 (45%), Gaps = 25/113 (22%)
Query: 482 KIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVA 541
K+ + I + L YL H + H +V+ N+L+D+ +L +FG ++ +V
Sbjct: 128 KMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFG--------ISGRLVD 177
Query: 542 -LAKAD-----GYKAPELQRMKKC-------SSRTDVYAFGILLLEILIGKKP 581
AK Y APE R+ R DV++ GI L+E+ G+ P
Sbjct: 178 DKAKDRSAGCAAYMAPE--RIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 39/195 (20%), Positives = 74/195 (37%), Gaps = 43/195 (22%)
Query: 403 TIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLR-AFYQGKRGEKL----LIYDYFP 457
T A R RE + + V H+N+I L F K E+ ++ +
Sbjct: 66 THAKRAYRE------------LVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD 113
Query: 458 SRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDF 517
+ L ++ L+ R + + G+ +LH+ I H +++ N++V
Sbjct: 114 A-NLCQVIQME------LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSD 163
Query: 518 FVSRLTEFGL------DQLMVPAVADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGIL 571
++ +FGL +M P V Y+APE+ D+++ G +
Sbjct: 164 CTLKILDFGLARTAGTSFMMTPYVVTRY--------YRAPEVILGMGYKENVDIWSVGCI 215
Query: 572 LLEILIGKK--PGKS 584
+ E++ G PG
Sbjct: 216 MGEMIKGGVLFPGTD 230
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 47.0 bits (111), Expect = 1e-05
Identities = 20/125 (16%), Positives = 34/125 (27%), Gaps = 15/125 (12%)
Query: 171 CDRLVSLRLHGNSLTAALPE-PALPNSTCSDLQYLDLGSNKFSGSFPEFV-TRFEALKEL 228
LR + +L P N L L + + + L+ L
Sbjct: 7 PHGSSGLRCTRDGALDSLHHLPGAEN-----LTELYIENQQHLQHLELRDLRGLGELRNL 61
Query: 229 DISNNLFSGSIPEG-LTRL-SLEKLNLSHNNFSGVLPVFSESKFGAEVFEGNSPALCGFP 286
I + + L +LNLS N + + E+ +P C
Sbjct: 62 TIVKSGLR-FVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHC--- 117
Query: 287 LRDCS 291
C+
Sbjct: 118 --SCA 120
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 44.3 bits (104), Expect = 7e-05
Identities = 20/112 (17%), Positives = 37/112 (33%), Gaps = 4/112 (3%)
Query: 147 SSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDL 206
S + + + L + + L L + L L +L+ L +
Sbjct: 8 HGSSGLRCTRDGALDSL-HHLPGA-ENLTELYIENQQHLQHLELRDLRG--LGELRNLTI 63
Query: 207 GSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRLSLEKLNLSHNNF 258
+ P+ L L++S N + + LSL++L LS N
Sbjct: 64 VKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPL 115
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 1e-05
Identities = 38/242 (15%), Positives = 85/242 (35%), Gaps = 35/242 (14%)
Query: 382 GQVIEKTTYGTAYKA-KLADGATIAL---RLLREGSCKDRSSCLPVIRQLGKV-RHENLI 436
+ I +G+ +K K DG A+ + GS D + L + + +H +++
Sbjct: 16 LEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGS-VDEQNALREVYAHAVLGQHSHVV 74
Query: 437 PLRAFYQG-KRGEKLLIY-DYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYL 494
++ + +LI +Y +L D + + A + L + RGL Y+
Sbjct: 75 ---RYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI 131
Query: 495 HTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPA------VADEMVALAKADG- 547
H+ + H +++ N+ + + D+ + + D +
Sbjct: 132 HSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ 188
Query: 548 -------YKAPE-LQRMKKCSSRTDVYAFGILLLEILIGKKPGKSG------RNGEFVDL 593
+ A E LQ + D++A + ++ + ++G R G +
Sbjct: 189 VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEIRQGRLPRI 248
Query: 594 PS 595
P
Sbjct: 249 PQ 250
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 2e-05
Identities = 25/114 (21%), Positives = 41/114 (35%), Gaps = 7/114 (6%)
Query: 145 YSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYL 204
+++ E+ L + L L L L + P LP L+ L
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISVSNLPKLPK-----LKKL 76
Query: 205 DLGSNKFSGSFPEFVTRFEALKELDISNNLFSG-SIPEGLTRL-SLEKLNLSHN 256
+L N+ G + L L++S N S E L +L L+ L+L +
Sbjct: 77 ELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 40.5 bits (95), Expect = 4e-04
Identities = 23/81 (28%), Positives = 35/81 (43%), Gaps = 4/81 (4%)
Query: 190 EPALPNSTCSDLQYLDLGSNKFS-GSFPEFVTRFEALKELDISNNLFSGSIPEGLTRL-S 247
L N T + ++ L L + K + G F L+ L + N S+ L +L
Sbjct: 15 HLELRNRTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLPK 72
Query: 248 LEKLNLSHNNFSGVLPVFSES 268
L+KL LS N G L + +E
Sbjct: 73 LKKLELSENRIFGGLDMLAEK 93
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 46.4 bits (110), Expect = 2e-05
Identities = 36/211 (17%), Positives = 79/211 (37%), Gaps = 29/211 (13%)
Query: 388 TTYGTAYKAK-LADGATIALRLLREGSCKDRSSCLPVIRQ----LGKVRHENLIPLRAFY 442
T A+ G + +R + +C + + ++ H N++P RA +
Sbjct: 38 EDLMTVNLARYKPTGEYVTVRRINLEACSN--EMVTFLQGELHVSKLFNHPNIVPYRATF 95
Query: 443 QGKRGEKL-LIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIAL---GIARGLAYLHTGH 498
+L ++ + + DL+ +N IA G+ + L Y+H
Sbjct: 96 --IADNELWVVTSFMAYGSAKDLICTHFMDG--MN---ELAIAYILQGVLKALDYIHHMG 148
Query: 499 EIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKADGYK------APE 552
+ H +V++ ++L+ L+ + M+ + V +PE
Sbjct: 149 YV---HRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPE 205
Query: 553 L--QRMKKCSSRTDVYAFGILLLEILIGKKP 581
+ Q ++ +++D+Y+ GI E+ G P
Sbjct: 206 VLQQNLQGYDAKSDIYSVGITACELANGHVP 236
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 2e-05
Identities = 38/134 (28%), Positives = 52/134 (38%), Gaps = 9/134 (6%)
Query: 126 QSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNSLT 185
Q LYL+ N + P +L E+ L +N L +++ +L L L N LT
Sbjct: 43 QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLT 101
Query: 186 AALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEG-LT 244
LP L+ L + NK + P + R L L + N SIP G
Sbjct: 102 V-LPSAVFDRLV--HLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLK-SIPHGAFD 156
Query: 245 RL-SLEKLNLSHNN 257
RL SL L N
Sbjct: 157 RLSSLTHAYL-FGN 169
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 3e-05
Identities = 45/223 (20%), Positives = 78/223 (34%), Gaps = 40/223 (17%)
Query: 63 CQWRGLK----WISTNGSPLSCSD---ISLPQWANLSLYKDSSIHLLSIQ-LPSANLTGS 114
+ + L+ + I+ + +
Sbjct: 5 VSTPIKQIFPDDAFAETIKANLKKKSVTDAVTQNELNSIDQIIANNSDIKSVQGIQYLPN 64
Query: 115 LPR---------ELGEF---SMLQSLYLNVNSLKGTIPFELGYS-SSLSEIDLSANLFTG 161
+ ++ + L L L N L+ ++P + ++L E+ L N
Sbjct: 65 VRYLALGGNKLHDISALKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQ- 122
Query: 162 VLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTR 221
L +++ L L L N L + LP+ T +L LDL N+ S PE V
Sbjct: 123 SLPDGVFDKLTNLTYLNLAHNQLQS-LPKGVFDKLT--NLTELDLSYNQLQ-SLPEGV-- 176
Query: 222 FE---ALKELDISNNLFSGSIPEG----LTRLSLEKLNLSHNN 257
F+ LK+L + N S+P+G LT SL+ + L H+N
Sbjct: 177 FDKLTQLKDLRLYQNQLK-SVPDGVFDRLT--SLQYIWL-HDN 215
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 3e-05
Identities = 26/111 (23%), Positives = 40/111 (36%), Gaps = 16/111 (14%)
Query: 153 DLSANLFTGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPN--STCSDLQYLDLGSNK 210
L+A L A N R L L G + + N +T +D N+
Sbjct: 3 KLTAELIE--QAAQYTNAV-RDRELDLRGYKIPV------IENLGATLDQFDAIDFSDNE 53
Query: 211 FSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRL--SLEKLNLSHNNFS 259
+ LK L ++NN I EGL + L +L L++N+
Sbjct: 54 IRKL--DGFPLLRRLKTLLVNNNRIC-RIGEGLDQALPDLTELILTNNSLV 101
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 4e-05
Identities = 25/116 (21%), Positives = 39/116 (33%), Gaps = 17/116 (14%)
Query: 147 SSLSEIDLSANLFTGVLAPSIWNL---CDRLVSLRLHGNSLTAALPEPALPNSTCSDLQY 203
E+DL I NL D+ ++ N + P L L+
Sbjct: 19 VRDRELDLRGYKIP-----VIENLGATLDQFDAIDFSDNEIRKLDGFPLLRR-----LKT 68
Query: 204 LDLGSNKFSGSFPEFVTRFEALKELDISNNLFS--GSIPEGLTRL-SLEKLNLSHN 256
L + +N+ L EL ++NN G + + L L SL L + N
Sbjct: 69 LLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDL-DPLASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 39.6 bits (93), Expect = 9e-04
Identities = 18/86 (20%), Positives = 32/86 (37%), Gaps = 4/86 (4%)
Query: 184 LTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGL 243
LTA L E A + + LDL K + +D S+N + +G
Sbjct: 4 LTAELIEQAAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KL-DGF 60
Query: 244 TRL-SLEKLNLSHNNFSGVLPVFSES 268
L L+ L +++N + ++
Sbjct: 61 PLLRRLKTLLVNNNRICRIGEGLDQA 86
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 4e-05
Identities = 29/110 (26%), Positives = 50/110 (45%), Gaps = 20/110 (18%)
Query: 482 KIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVA 541
KI L + L +L + I H +++ N+L+D +L +FG ++ ++V
Sbjct: 129 KITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFG--------ISGQLVD 178
Query: 542 -LAKADG-----YKAPE----LQRMKKCSSRTDVYAFGILLLEILIGKKP 581
+AK Y APE + R+DV++ GI L E+ G+ P
Sbjct: 179 SIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFP 228
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 9e-05
Identities = 48/210 (22%), Positives = 84/210 (40%), Gaps = 22/210 (10%)
Query: 382 GQVIEKTTYGTAYKAK-LADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRA 440
V+ K TYG Y + L++ IA++ + E + I ++H+N++
Sbjct: 27 RVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQ--- 83
Query: 441 FYQG--KRGEKLLIY-DYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTG 497
Y G + I+ + P +L LL G N I GL YLH
Sbjct: 84 -YLGSFSENGFIKIFMEQVPGGSLSALLRSK-WGPLKDNEQTIGFYTKQILEGLKYLHDN 141
Query: 498 HEIPITHGNVRSKNVLVDDFF-VSRLTEFGLDQLMVPAVADEMVALAKADG---YKAPE- 552
I H +++ NVL++ + V ++++FG +A G Y APE
Sbjct: 142 Q---IVHRDIKGDNVLINTYSGVLKISDFG----TSKRLAGINPCTETFTGTLQYMAPEI 194
Query: 553 -LQRMKKCSSRTDVYAFGILLLEILIGKKP 581
+ + D+++ G ++E+ GK P
Sbjct: 195 IDKGPRGYGKAADIWSLGCTIIEMATGKPP 224
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 1e-04
Identities = 46/230 (20%), Positives = 90/230 (39%), Gaps = 34/230 (14%)
Query: 382 GQVIEKTTYGTAYKAK-LADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRA 440
V+ + +G KA+ D A++ +R + + S+ L + L + H+ ++ A
Sbjct: 11 IAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQYVVRYYA 69
Query: 441 FYQGKRGEKLL---------IY---DYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIA 488
+ +R ++ +Y + TL+DL+H ++ I
Sbjct: 70 AWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHS---ENLNQQRDEYWRLFRQIL 126
Query: 489 RGLAYLHTGHEIPITH-----GNV---RSKNVLVDDFFVSRLTEFGLD--QLMVPAVADE 538
L+Y+H+ I H N+ S+NV + DF +++ LD +L +
Sbjct: 127 EALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183
Query: 539 MVALAKADG---YKAPELQRMKKC-SSRTDVYAFGILLLEILIGKKPGKS 584
L A G Y A E+ + + D+Y+ GI+ E++ G
Sbjct: 184 SDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGME 233
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 43.7 bits (104), Expect = 1e-04
Identities = 51/221 (23%), Positives = 87/221 (39%), Gaps = 43/221 (19%)
Query: 389 TYGTAYKAK-LADGATIALRLLREGSCKDRSSCLPV--IR------QLGKVRHENLIPLR 439
YGT YKA+ G +AL+ +R + LP+ +R +L H N++ L
Sbjct: 21 AYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLM 80
Query: 440 AFYQGKRGEKL----LIYDYFPSRTLHDL--LHDTIAGKPVLNWARRHKIALGIARGLAY 493
R ++ L++++ DL D P L + RGL +
Sbjct: 81 DVCATSRTDREIKVTLVFEHVD----QDLRTYLDKA-PPPGLPAETIKDLMRQFLRGLDF 135
Query: 494 LHTGHEIPITHGNVRSKNVLVD--------DFFVSRLTEFGLDQLMVPAVADEMVALAKA 545
LH I H +++ +N+LV DF ++R + + P V V L
Sbjct: 136 LHANC---IVHRDLKPENILVTSGGTVKLADFGLAR--IYSYQMALTPVV----VTL--- 183
Query: 546 DGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKK--PGKS 584
Y+APE+ ++ D+++ G + E+ K G S
Sbjct: 184 -WYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNS 223
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 1e-04
Identities = 41/227 (18%), Positives = 82/227 (36%), Gaps = 53/227 (23%)
Query: 383 QVIEKTTYGTAYKA------------KLAD---GATIALRLLREGSCKDRSSCLPVIRQL 427
+ YG+ A KL+ A R RE + L
Sbjct: 30 THVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRE------------LLLL 77
Query: 428 GKVRHENLIPLR-AFYQGKRGEKL----LIYDYFPSRTLHDLLHDTIAGKPVLNWARRHK 482
++HEN+I L F L+ + + L ++ + +
Sbjct: 78 KHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLKFSEE--------KI 128
Query: 483 --IALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMV 540
+ + +GL Y+H+ + H +++ N+ V++ ++ +FGL + + +V
Sbjct: 129 QYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVV 185
Query: 541 ALAKADGYKAPE-LQRMKKCSSRTDVYAFGILLLEILIGKK--PGKS 584
Y+APE + + D+++ G ++ E+L GK GK
Sbjct: 186 TRW----YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 228
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 2e-04
Identities = 44/194 (22%), Positives = 78/194 (40%), Gaps = 41/194 (21%)
Query: 403 TIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLR-AFYQGKRGEKL----LIYDYFP 457
A R RE +R L ++HEN+I L F + E+ L+
Sbjct: 70 IHAKRTYRE------------LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG 117
Query: 458 SRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDF 517
+ D L++ + + L + I RGL Y+H+ I H +++ N+ V++
Sbjct: 118 A----D-LNNIVKCQK-LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNED 168
Query: 518 FVSRLTEFGL----DQLMVPAVADEMVALAKADGYKAPE-LQRMKKCSSRTDVYAFGILL 572
++ +FGL M VA Y+APE + + D+++ G ++
Sbjct: 169 CELKILDFGLARHTADEMTGYVATRW--------YRAPEIMLNWMHYNQTVDIWSVGCIM 220
Query: 573 LEILIGKK--PGKS 584
E+L G+ PG
Sbjct: 221 AELLTGRTLFPGTD 234
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 50/225 (22%), Positives = 88/225 (39%), Gaps = 32/225 (14%)
Query: 370 EHLTLED--VLNATGQVIEKTTYGTAYKAKLADGATI-ALRLLREGSCKDRS--SCLPVI 424
+ +T +V+ K +G ++ + A + L + K R +
Sbjct: 179 QPVTKNTFRQY----RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNE 234
Query: 425 RQ-LGKVRHENLIPLRAFYQGKRGEKL-LIYDYFPSRTLHDLLHDTIAGKPVLNWARRHK 482
+Q L KV ++ L Y+ K + L L+ L H G+ AR
Sbjct: 235 KQILEKVNSRFVVSLAYAYETK--DALCLVLTLMNGGDLK--FHIYHMGQAGFPEARAVF 290
Query: 483 IALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVAL 542
A I GL LH I + +++ +N+L+DD R+++ GL A +
Sbjct: 291 YAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGL--------AVHVPEG 339
Query: 543 AKAD------GYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKP 581
GY APE+ + ++ + D +A G LL E++ G+ P
Sbjct: 340 QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 42/194 (21%), Positives = 76/194 (39%), Gaps = 41/194 (21%)
Query: 403 TIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLR-AFYQGKRGEKL----LIYDYFP 457
A R RE +R L +RHEN+I L F + + L+ +
Sbjct: 66 LFAKRAYRE------------LRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMG 113
Query: 458 SRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDF 517
+ D L + + L R + + +GL Y+H I H +++ N+ V++
Sbjct: 114 T----D-LGKLMKHEK-LGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNED 164
Query: 518 FVSRLTEFGL----DQLMVPAVADEMVALAKADGYKAPE-LQRMKKCSSRTDVYAFGILL 572
++ +FGL D M V Y+APE + + + D+++ G ++
Sbjct: 165 CELKILDFGLARQADSEMTGYVVTRW--------YRAPEVILNWMRYTQTVDIWSVGCIM 216
Query: 573 LEILIGKK--PGKS 584
E++ GK G
Sbjct: 217 AEMITGKTLFKGSD 230
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 2e-04
Identities = 21/89 (23%), Positives = 37/89 (41%), Gaps = 18/89 (20%)
Query: 177 LRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFS----GSFPEFVTRFEALKELDISN 232
+RL N++ +P A L+ +DL +N+ S +F +L L +
Sbjct: 37 IRLEQNTIKV-IPPGAFSPYK--KLRRIDLSNNQISELAPDAF----QGLRSLNSLVLYG 89
Query: 233 NLFSGSIPEG----LTRLSLEKLNLSHNN 257
N + +P+ L SL+ L L+ N
Sbjct: 90 NKIT-ELPKSLFEGLF--SLQLLLLNANK 115
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 2e-04
Identities = 33/162 (20%), Positives = 69/162 (42%), Gaps = 19/162 (11%)
Query: 424 IRQLGKVRHENLIPLRAFYQGKRGEKL-LIYDYFPSRTLHDLLHDTIAGKPVLNWARRHK 482
+ +RH N++ L ++ ++ LI +Y P T++ L K + R
Sbjct: 60 VEIQSHLRHPNILRLYGYFHDA--TRVYLILEYAPLGTVYREL--QKLSK--FDEQRTAT 113
Query: 483 IALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVAL 542
+A L+Y H+ + H +++ +N+L+ ++ +FG + ++
Sbjct: 114 YITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC-- 168
Query: 543 AKADG---YKAPELQRMKKCSSRTDVYAFGILLLEILIGKKP 581
G Y PE+ + + D+++ G+L E L+GK P
Sbjct: 169 ----GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 206
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 43.4 bits (102), Expect = 2e-04
Identities = 41/227 (18%), Positives = 69/227 (30%), Gaps = 38/227 (16%)
Query: 87 QWANLSLYKDSSIHLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYS 146
+W + + + + R F L+SL +L
Sbjct: 43 RWFKIDSETREHVTMALCYTAT------PDRLSRRFPNLRSL-------------KLKGK 83
Query: 147 SSLSEIDLSANLFTGVLAP---SIWNLCDRLVSLRLHGNSLT-AALPEPALPNSTCSDLQ 202
+ +L + G + P I N +L S+ ++ L L + DL+
Sbjct: 84 PRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLD--RLAKARADDLE 141
Query: 203 YLDLGS-NKFSG-SFPEFVTRFEALKELDISNNLFSGSIPEGLTRL-----SLEKLNLSH 255
L L + F+ VT +K L + + FS + L L SLE LN
Sbjct: 142 TLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYM 201
Query: 256 NNFSGVLPVFSESKFGAEVFEGNSPALCGFPLRDCSGNSRLSSGAIA 302
F+ + S E N +L + D + A
Sbjct: 202 TEFAKI------SPKDLETIARNCRSLVSVKVGDFEILELVGFFKAA 242
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 2e-04
Identities = 30/110 (27%), Positives = 55/110 (50%), Gaps = 20/110 (18%)
Query: 482 KIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVA 541
KIA+ I + L +LH+ + I H +V+ NVL++ ++ +FG ++ +V
Sbjct: 113 KIAVSIVKALEHLHSKLSV-I-HRDVKPSNVLINALGQVKMCDFG--------ISGYLVD 162
Query: 542 -LAKA-----DGYKAPE----LQRMKKCSSRTDVYAFGILLLEILIGKKP 581
+AK Y APE K S ++D+++ GI ++E+ I + P
Sbjct: 163 DVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFP 212
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 3e-04
Identities = 38/222 (17%), Positives = 84/222 (37%), Gaps = 39/222 (17%)
Query: 383 QVIEKTTYGTAYKAK-LADGATIALRLLREGSCKDRSSCLPVIRQ----LGKVRHENLIP 437
+VI A +A++ + C+ + + + + + H N++
Sbjct: 21 EVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTS---MDELLKEIQAMSQCHHPNIVS 77
Query: 438 LRAFYQGKRGEKL-LIYDYFPSRTLHDLL-HDTIAGKPVLNWARRHKIAL---GIARGLA 492
+ ++L L+ ++ D++ H G+ IA + GL
Sbjct: 78 YYTSFV--VKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLE 135
Query: 493 YLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKADGYK--- 549
YLH +I H +V++ N+L+ + ++ +FG V+ + K
Sbjct: 136 YLHKNGQI---HRDVKAGNILLGEDGSVQIADFG--------VSAFLATGGDITRNKVRK 184
Query: 550 ---------APE-LQRMKKCSSRTDVYAFGILLLEILIGKKP 581
APE +++++ + D+++FGI +E+ G P
Sbjct: 185 TFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP 226
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 43.0 bits (101), Expect = 3e-04
Identities = 34/214 (15%), Positives = 63/214 (29%), Gaps = 22/214 (10%)
Query: 87 QWANLSLYKDSSIHLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYS 146
W + + + + + S + F ++S+ LKG F
Sbjct: 36 SWYEIERWCRRKVFIGNCYAVS------PATVIRRFPKVRSV-----ELKGKPHF----- 79
Query: 147 SSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDL 206
+ + + + ++ + L +RL +T E + + + L L
Sbjct: 80 ADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKS--FKNFKVLVL 137
Query: 207 GS-NKFS-GSFPEFVTRFEALKELDISNNLFSGSIPEGLTRLSLEKLNLSHNNFSGVLPV 264
S FS LKELD+ + L+ +L N S +
Sbjct: 138 SSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASE 197
Query: 265 FSESKFGAEVFEGNSPALCGFPLRDCSGNSRLSS 298
S S E P L L +L++
Sbjct: 198 VSFS--ALERLVTRCPNLKSLKLNRAVPLEKLAT 229
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 42.5 bits (100), Expect = 4e-04
Identities = 41/169 (24%), Positives = 67/169 (39%), Gaps = 25/169 (14%)
Query: 375 EDVLNATGQVIEKTTYGTAYKAKLADGAT---IALRLLREGSCKDRSSCLPVIRQLGKVR 431
ED+ G + + TYG YKAK DG AL+ + S I L +++
Sbjct: 19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS--MSACREIALLRELK 76
Query: 432 HENLIPLRAFYQGKRGEKL-LIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALG---- 486
H N+I L+ + K+ L++DY HDL H + + ++ G
Sbjct: 77 HPNVISLQKVFLSHADRKVWLLFDYAE----HDLWHIIKFHRASKANKKPVQLPRGMVKS 132
Query: 487 ----IARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSR----LTEFGL 527
I G+ YLH + H +++ N+LV R + + G
Sbjct: 133 LLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGF 178
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 4e-04
Identities = 39/198 (19%), Positives = 71/198 (35%), Gaps = 44/198 (22%)
Query: 402 ATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKL----LIYDYFP 457
+ + R+LRE IR L H N++ LR + + L+ +
Sbjct: 70 SFLCKRVLRE------------IRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR 117
Query: 458 SRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDF 517
+ L ++H + V++ I GL LH + H ++ N+L+ D
Sbjct: 118 T-DLAQVIH---DQRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADN 170
Query: 518 FVSRLTEFGL------DQLMVPAVADEMVALAKADGYKAPELQRM---KKCSSRTDVYAF 568
+ +F L D V Y+APEL + K + D+++
Sbjct: 171 NDITICDFNLAREDTADANKTHYVTHRW--------YRAPEL--VMQFKGFTKLVDMWSA 220
Query: 569 GILLLEILIGKK--PGKS 584
G ++ E+ K G +
Sbjct: 221 GCVMAEMFNRKALFRGST 238
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 42.2 bits (100), Expect = 4e-04
Identities = 45/203 (22%), Positives = 83/203 (40%), Gaps = 45/203 (22%)
Query: 402 ATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKL----LIYDYFP 457
ALR LRE I+ L +HEN+I + + E +I +
Sbjct: 50 PLFALRTLRE------------IKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQ 97
Query: 458 SRTLHDLLHDTIAGKPVLNWARRHK--IALGIARGLAYLHTGHEIPITHGNVRSKNVLVD 515
+ D LH I+ + + + H R + LH + + H +++ N+L++
Sbjct: 98 T----D-LHRVISTQMLSD---DHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLIN 146
Query: 516 DFFVSRLTEFGLDQLMVPAVADEMVALAKADG---------YKAPELQRM---KKCSSRT 563
++ +FGL +++ + AD + G Y+APE+ M K S
Sbjct: 147 SNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEV--MLTSAKYSRAM 204
Query: 564 DVYAFGILLLEILIGKK--PGKS 584
DV++ G +L E+ + + PG+
Sbjct: 205 DVWSCGCILAELFLRRPIFPGRD 227
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 5e-04
Identities = 48/264 (18%), Positives = 97/264 (36%), Gaps = 78/264 (29%)
Query: 389 TYGTAYKAKLAD-GATIAL--------RLLREGSCKDRSSCLPVIRQLGKVRHENLIPLR 439
++G + + G AL RE + + + H N+I L
Sbjct: 19 SFGIVCEVFDIESGKRFALKKVLQDPRYKNRE------------LDIMKVLDHVNIIKLV 66
Query: 440 AFYQGKRGEKL-------------------------------------LIYDYFPSRTLH 462
++ E+ +I +Y P TLH
Sbjct: 67 DYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLH 125
Query: 463 DLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVD-DFFVSR 521
+L I + + R + ++H+ I H +++ +N+LV+ +
Sbjct: 126 KVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG---ICHRDIKPQNLLVNSKDNTLK 182
Query: 522 LTEFGLDQLMVPAVADEMVALAKADGYKAPELQRMKKCSSRT---DVYAFGILLLEILIG 578
L +FG + ++P ++ VA + Y+APEL M + T D+++ G + E+++G
Sbjct: 183 LCDFGSAKKLIP--SEPSVAYICSRFYRAPEL--MLGATEYTPSIDLWSIGCVFGELILG 238
Query: 579 KK--PGKSGRNGEFVD-LPSIVKV 599
K G++ +D L I+++
Sbjct: 239 KPLFSGETS-----IDQLVRIIQI 257
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 6e-04
Identities = 33/215 (15%), Positives = 73/215 (33%), Gaps = 55/215 (25%)
Query: 397 KLA-DGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDY 455
K+ LRE I+ + ++ H+N++ + +
Sbjct: 43 KIVLTDPQSVKHALRE------------IKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS 90
Query: 456 FPSRTLHDL----------LHDTIAGKPVLNWARRHK--IALGIARGLAYLHTGHEIPIT 503
L+ + L + + P+L H + RGL Y+H+ + +
Sbjct: 91 LTE--LNSVYIVQEYMETDLANVLEQGPLLE---EHARLFMYQLLRGLKYIHSAN---VL 142
Query: 504 HGNVRSKNVLVD---------DFFVSRLT--EFGLDQLMVPAVADEMVALAKADGYKAPE 552
H +++ N+ ++ DF ++R+ + + + + Y++P
Sbjct: 143 HRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKW--------YRSPR 194
Query: 553 -LQRMKKCSSRTDVYAFGILLLEILIGKK--PGKS 584
L + D++A G + E+L GK G
Sbjct: 195 LLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAH 229
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 6e-04
Identities = 41/135 (30%), Positives = 60/135 (44%), Gaps = 10/135 (7%)
Query: 126 QSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNSLT 185
L L NSLK +SL+++ L N L ++N L L L N L
Sbjct: 31 TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQLQ 89
Query: 186 AALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFV-TRFEALKELDISNNLFSGSIPEG-L 243
+ LP T L+ L L +N+ S P+ V + LK+L + N S+P+G
Sbjct: 90 S-LPNGVFDKLT--QLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLK-SVPDGVF 144
Query: 244 TRL-SLEKLNLSHNN 257
RL SL+ + L H+N
Sbjct: 145 DRLTSLQYIWL-HDN 158
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 7e-04
Identities = 45/206 (21%), Positives = 90/206 (43%), Gaps = 35/206 (16%)
Query: 389 TYGTAYKAK-LADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRG 447
GT Y A +A G +A+R + + + I + + ++ N++ Y G
Sbjct: 32 ASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL--VG 89
Query: 448 EKL-LIYDYFPSRTLHDLLHDT------IAGKPVLNWARRHKIALGIARGLAYLHTGHEI 500
++L ++ +Y +L D++ +T IA + + L +LH+ I
Sbjct: 90 DELWVVMEYLAGGSLTDVVTETCMDEGQIA-----------AVCRECLQALEFLHSNQVI 138
Query: 501 PITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVA--DEMVALAKADG---YKAPELQR 555
H +++S N+L+ +LT+FG + P + MV G + APE+
Sbjct: 139 ---HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV------GTPYWMAPEVVT 189
Query: 556 MKKCSSRTDVYAFGILLLEILIGKKP 581
K + D+++ GI+ +E++ G+ P
Sbjct: 190 RKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 41.7 bits (98), Expect = 7e-04
Identities = 33/218 (15%), Positives = 75/218 (34%), Gaps = 34/218 (15%)
Query: 381 TGQVIEKTTYGTAYKAKLADGATIAL-RLLREGSCKDRSSCLPVIRQ----LGKV-RHEN 434
V+ GT + D +A+ R+L E C + L + H N
Sbjct: 28 PKDVLGHGAEGTIVYRGMFDNRDVAVKRILPE--------CFSFADREVQLLRESDEHPN 79
Query: 435 LIPLRAFYQGKRGEKL-LIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAY 493
+I + + + + + + TL + + + GLA+
Sbjct: 80 VIRYFCTEKDR--QFQYIAIELCAA-TLQEYV---EQKDFAHLGLEPITLLQQTTSGLAH 133
Query: 494 LHTGHEIPITHGNVRSKNVLV-----DDFFVSRLTEFGLDQLMVP--AVADEMVALAKAD 546
L H + I H +++ N+L+ + +++FGL + + + +
Sbjct: 134 L---HSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTE 190
Query: 547 GYKAPEL---QRMKKCSSRTDVYAFGILLLEILIGKKP 581
G+ APE+ + + D+++ G + ++
Sbjct: 191 GWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH 228
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 7e-04
Identities = 30/111 (27%), Positives = 46/111 (41%), Gaps = 12/111 (10%)
Query: 151 EIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNK 210
E+ L+ N + + ++ LV L L N LT + A ++ +Q L LG NK
Sbjct: 33 ELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGAS--HIQELQLGENK 89
Query: 211 FSGSFPEFV-TRFEALKELDISNNLFSGSIPEG----LTRLSLEKLNLSHN 256
+ LK L++ +N S + G L SL LNL+ N
Sbjct: 90 IK-EISNKMFLGLHQLKTLNLYDNQIS-CVMPGSFEHLN--SLTSLNLASN 136
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 8e-04
Identities = 44/209 (21%), Positives = 87/209 (41%), Gaps = 28/209 (13%)
Query: 383 QVIEKTTYGTAYKAK-LADGATIALRLLREGSCKDRSSCLPV-IRQLGKVRHENLIPLRA 440
+ I K ++G +K +A++++ +D + I L + +
Sbjct: 28 EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 87
Query: 441 FYQGKRGEKL-LIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHE 499
Y + KL +I +Y + DLL + + I I +GL YLH+ +
Sbjct: 88 SYL--KDTKLWIIMEYLGGGSALDLLEPGPLDETQIAT-----ILREILKGLDYLHSEKK 140
Query: 500 IPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVA-LAKADGYK------APE 552
I H ++++ NVL+ + +L +FG VA ++ K + + APE
Sbjct: 141 I---HRDIKAANVLLSEHGEVKLADFG--------VAGQLTDTQIKRNTFVGTPFWMAPE 189
Query: 553 LQRMKKCSSRTDVYAFGILLLEILIGKKP 581
+ + S+ D+++ GI +E+ G+ P
Sbjct: 190 VIKQSAYDSKADIWSLGITAIELARGEPP 218
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 679 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.97 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.94 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.94 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.93 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.92 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.92 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.92 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.88 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.88 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.87 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.87 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.83 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.82 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.81 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.81 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.79 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.79 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.79 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.78 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.78 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.78 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.77 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.77 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.77 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.77 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.77 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.77 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.76 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.76 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.76 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.76 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.75 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.75 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.75 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.75 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.75 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.75 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.75 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.75 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.74 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.74 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.74 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.74 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.73 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.73 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.73 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.73 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.73 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.73 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.72 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.72 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.72 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.72 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.71 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.71 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.71 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.71 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.7 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.7 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.7 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.7 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.69 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.69 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.69 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.69 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.69 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.69 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.69 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.69 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.69 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.68 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.68 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.68 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.68 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.67 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.67 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.67 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.67 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.67 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.66 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.66 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.66 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.65 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.65 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.65 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.64 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.64 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.64 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.63 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.63 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.63 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.62 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.62 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.62 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.61 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.61 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.6 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.6 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.59 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.58 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.58 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.58 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.58 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.58 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.58 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.57 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.57 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.56 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.56 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.56 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.56 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.56 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.55 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.55 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.55 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.55 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.55 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.54 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.54 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.54 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.54 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.53 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.52 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.51 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.5 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.46 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.46 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.46 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.45 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.44 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.42 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.39 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.37 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.36 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.35 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.34 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.32 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.29 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.22 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.22 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.18 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.15 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.11 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.04 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.99 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 98.96 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 98.93 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 98.89 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.87 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 98.72 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.68 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.68 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 98.6 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 98.54 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.42 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.41 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.41 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.37 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.36 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.25 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.23 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 98.14 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.14 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.13 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.08 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 98.03 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.83 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.82 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.62 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.58 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.48 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.13 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.03 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 96.99 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.86 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.75 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.75 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 96.74 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.7 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.7 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 96.44 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.36 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.34 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.33 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.29 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.17 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.91 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 95.8 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 95.53 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 95.52 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 95.11 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.97 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 94.79 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 94.76 | |
| 2k1k_A | 38 | Ephrin type-A receptor 1; EPHA1, receptor tyrosine | 94.08 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 93.64 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 86.01 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 85.69 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 85.55 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 85.52 | |
| 2k9y_A | 41 | Ephrin type-A receptor 2; receptor tyrosine kinase | 82.96 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 82.01 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 80.91 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-55 Score=454.90 Aligned_cols=254 Identities=19% Similarity=0.326 Sum_probs=207.5
Q ss_pred cCccccCCceEEEEEEeC------CCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEe
Q 005749 382 GQVIEKTTYGTAYKAKLA------DGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDY 455 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~------~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey 455 (679)
++.||+|+||+||+|++. +++.||||+++.......++|.+|+++|++++|||||+++|+|.+ .+..++||||
T Consensus 18 ~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~-~~~~~lV~Ey 96 (299)
T 4asz_A 18 KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVE-GDPLIMVFEY 96 (299)
T ss_dssp EEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSSEEEEEEC
T ss_pred eeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEee-CCEEEEEEEc
Confidence 478999999999999864 477899999987665566789999999999999999999999998 6789999999
Q ss_pred cCCCChHHHhhccc---------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecc
Q 005749 456 FPSRTLHDLLHDTI---------AGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFG 526 (679)
Q Consensus 456 ~~~gsL~~~l~~~~---------~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 526 (679)
|++|||.++|+... .....++|.++++|+.|||+||+|||+++ ||||||||+|||+++++.+||+|||
T Consensus 97 ~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki~DFG 173 (299)
T 4asz_A 97 MKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKIGDFG 173 (299)
T ss_dssp CTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCS
T ss_pred CCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEECCcc
Confidence 99999999997642 12356999999999999999999999988 9999999999999999999999999
Q ss_pred cccccCccccc-chhcccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHHhhcc
Q 005749 527 LDQLMVPAVAD-EMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAVLEE 604 (679)
Q Consensus 527 la~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~~~~~ 604 (679)
+|+........ ......||+.|||||++.++.|+.|+|||||||++|||+| |+.||.+.... ++ ..
T Consensus 174 la~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~---~~---~~------ 241 (299)
T 4asz_A 174 MSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN---EV---IE------ 241 (299)
T ss_dssp CHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH---HH---HH------
T ss_pred cceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH---HH---HH------
Confidence 99876443322 2234568999999999999999999999999999999998 89999543221 11 11
Q ss_pred cccccchHhhhhcCCCCh-HHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCC
Q 005749 605 TTMEVFDMEIMKGIRSPM-EEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRP 659 (679)
Q Consensus 605 ~~~~~~~~~i~~~~~~~~-~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 659 (679)
.+..+.+.+. +...+++.+++.+||+.||++||||+||++.|+++.+
T Consensus 242 --------~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~ 289 (299)
T 4asz_A 242 --------CITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK 289 (299)
T ss_dssp --------HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --------HHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 1122222111 2233567789999999999999999999999998754
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-55 Score=458.05 Aligned_cols=255 Identities=19% Similarity=0.301 Sum_probs=202.8
Q ss_pred cCccccCCceEEEEEEeC------CCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEe
Q 005749 382 GQVIEKTTYGTAYKAKLA------DGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDY 455 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~------~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey 455 (679)
.+.||+|+||+||+|+++ +++.||||+++.......++|.+|+++|++++|||||+++|+|.+ .+..+|||||
T Consensus 46 ~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~-~~~~~lV~Ey 124 (329)
T 4aoj_A 46 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTE-GRPLLMVFEY 124 (329)
T ss_dssp EEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSSEEEEEEC
T ss_pred EEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-CCEEEEEEEc
Confidence 478999999999999864 478999999987665567789999999999999999999999997 6789999999
Q ss_pred cCCCChHHHhhcccC-----------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEee
Q 005749 456 FPSRTLHDLLHDTIA-----------GKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTE 524 (679)
Q Consensus 456 ~~~gsL~~~l~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~D 524 (679)
|++|+|.++++.... ...+++|.++++|+.|||+||+|||+++ ||||||||+|||+++++.+||+|
T Consensus 125 ~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~Ki~D 201 (329)
T 4aoj_A 125 MRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGD 201 (329)
T ss_dssp CTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECC
T ss_pred CCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcEEEcc
Confidence 999999999976432 1246999999999999999999999988 99999999999999999999999
Q ss_pred cccccccCccccc-chhcccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHHhh
Q 005749 525 FGLDQLMVPAVAD-EMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAVL 602 (679)
Q Consensus 525 FGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~~~ 602 (679)
||+|+........ ......||+.|||||++.+..|+.++|||||||++|||+| |+.||.+.... ++ +.
T Consensus 202 FGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~---~~---~~---- 271 (329)
T 4aoj_A 202 FGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT---EA---ID---- 271 (329)
T ss_dssp CC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHH---HH---HH----
T ss_pred cccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHH---HH---HH----
Confidence 9999976443222 2345679999999999999999999999999999999999 89999543221 11 11
Q ss_pred cccccccchHhhhhcCCCCh-HHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCCC
Q 005749 603 EETTMEVFDMEIMKGIRSPM-EEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRPR 660 (679)
Q Consensus 603 ~~~~~~~~~~~i~~~~~~~~-~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 660 (679)
.+..+.+.+. +...+++.+++.+||+.||++||||+||++.|+.+.+.
T Consensus 272 ----------~i~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 272 ----------CITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp ----------HHHHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ----------HHHcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 1112221111 22345677899999999999999999999999988643
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-55 Score=453.33 Aligned_cols=252 Identities=21% Similarity=0.299 Sum_probs=205.9
Q ss_pred cCccccCCceEEEEEEeC------CCCEEEEEEcccCcc-cCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEE
Q 005749 382 GQVIEKTTYGTAYKAKLA------DGATIALRLLREGSC-KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYD 454 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~------~~~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~e 454 (679)
.+.||+|+||+||+|++. +++.||||+++.... ...++|.+|+++|++++|||||+++|+|.+ .+..++|||
T Consensus 31 ~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~~lV~E 109 (308)
T 4gt4_A 31 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTK-DQPLSMIFS 109 (308)
T ss_dssp EEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSSCEEEEE
T ss_pred eeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEE-CCEEEEEEE
Confidence 468999999999999863 467999999976533 345689999999999999999999999987 678999999
Q ss_pred ecCCCChHHHhhcccC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEE
Q 005749 455 YFPSRTLHDLLHDTIA------------GKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRL 522 (679)
Q Consensus 455 y~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl 522 (679)
||++|||.++|..... ....++|.++++|+.|||+||+|||+++ ||||||||+|||+++++.+||
T Consensus 110 y~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~~~Ki 186 (308)
T 4gt4_A 110 YCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKI 186 (308)
T ss_dssp CCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred cCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCCCEEE
Confidence 9999999999975421 1245999999999999999999999988 999999999999999999999
Q ss_pred eecccccccCccccc-chhcccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHH
Q 005749 523 TEFGLDQLMVPAVAD-EMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVA 600 (679)
Q Consensus 523 ~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~ 600 (679)
+|||+|+........ ......||+.|||||++.++.|+.++|||||||+||||+| |+.||.+.... ++..
T Consensus 187 ~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~---~~~~----- 258 (308)
T 4gt4_A 187 SDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ---DVVE----- 258 (308)
T ss_dssp CCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH---HHHH-----
T ss_pred CCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH---HHHH-----
Confidence 999999976443322 2345679999999999999999999999999999999998 89999553321 1111
Q ss_pred hhcccccccchHhhhhcCCCC-hHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhh
Q 005749 601 VLEETTMEVFDMEIMKGIRSP-MEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEEN 657 (679)
Q Consensus 601 ~~~~~~~~~~~~~i~~~~~~~-~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 657 (679)
.+..+.+.+ .+....++.+++.+||+.||++||||+||++.|+.+
T Consensus 259 ------------~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 259 ------------MIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp ------------HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred ------------HHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 112222222 223345677899999999999999999999999875
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-54 Score=445.60 Aligned_cols=256 Identities=21% Similarity=0.334 Sum_probs=198.6
Q ss_pred hcCccccCCceEEEEEEeCCCCEEEEEEcccCcc--cCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCC
Q 005749 381 TGQVIEKTTYGTAYKAKLADGATIALRLLREGSC--KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPS 458 (679)
Q Consensus 381 ~~~~ig~G~~g~Vy~~~~~~~~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~ 458 (679)
.++.||+|+||+||+|++++ .||||+++.... ...+.|.+|+++|++++|||||+++|++.. +..+||||||++
T Consensus 40 l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~--~~~~iVmEy~~g 115 (307)
T 3omv_A 40 LSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK--DNLAIVTQWCEG 115 (307)
T ss_dssp EEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS--SSCEEEEECCSS
T ss_pred EeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC--CeEEEEEEcCCC
Confidence 34789999999999999753 699999975432 335679999999999999999999998864 578999999999
Q ss_pred CChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCccc-cc
Q 005749 459 RTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAV-AD 537 (679)
Q Consensus 459 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~-~~ 537 (679)
|+|.++++.. ...++|.++++|+.|||+||+|||+++ ||||||||+|||+++++.+||+|||+|+...... ..
T Consensus 116 GsL~~~l~~~---~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~ 189 (307)
T 3omv_A 116 SSLYKHLHVQ---ETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQ 189 (307)
T ss_dssp CBHHHHHHTS---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC--------
T ss_pred CCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCCcce
Confidence 9999999764 346999999999999999999999988 9999999999999999999999999998764332 22
Q ss_pred chhcccccccccccccccc---cCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhh
Q 005749 538 EMVALAKADGYKAPELQRM---KKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEI 614 (679)
Q Consensus 538 ~~~~~~gt~~y~aPE~~~~---~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i 614 (679)
.....+||+.|||||++.+ +.|+.|+|||||||++|||+||+.||.+....+ .+........ ..+.+
T Consensus 190 ~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~------~~~~~~~~~~----~~p~~ 259 (307)
T 3omv_A 190 QVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD------QIIFMVGRGY----ASPDL 259 (307)
T ss_dssp ----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH------HHHHHHHTTC----CCCCS
T ss_pred eecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH------HHHHHHhcCC----CCCCc
Confidence 3456689999999999863 468999999999999999999999995433211 1111111100 00000
Q ss_pred hhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCCC
Q 005749 615 MKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRPR 660 (679)
Q Consensus 615 ~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 660 (679)
. ...+....++.+++.+||+.||++||||.||++.|+.++..
T Consensus 260 ~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~ 301 (307)
T 3omv_A 260 S----KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHS 301 (307)
T ss_dssp T----TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTT
T ss_pred c----cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcc
Confidence 0 01112335677899999999999999999999999987643
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-52 Score=439.36 Aligned_cols=244 Identities=16% Similarity=0.236 Sum_probs=203.4
Q ss_pred CccccCCceEEEEEEe-CCCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCCh
Q 005749 383 QVIEKTTYGTAYKAKL-ADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRTL 461 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gsL 461 (679)
+.||+|+||+||+|+. .+|+.||||+++.......+.+.+|+++|++++|||||+++++|.+ .+..|||||||++|+|
T Consensus 80 ~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~-~~~~~ivmEy~~gg~L 158 (346)
T 4fih_A 80 IKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV-GDELWVVMEFLEGGAL 158 (346)
T ss_dssp EEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEEEECCCTTEEH
T ss_pred EEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-CCEEEEEEeCCCCCcH
Confidence 5799999999999994 5799999999987666667889999999999999999999999998 6899999999999999
Q ss_pred HHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccchhc
Q 005749 462 HDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVA 541 (679)
Q Consensus 462 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 541 (679)
.+++.. ..+++.+++.|+.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+.+... ......
T Consensus 159 ~~~l~~-----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~-~~~~~~ 229 (346)
T 4fih_A 159 TDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE-VPRRKS 229 (346)
T ss_dssp HHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSS-SCCBCC
T ss_pred HHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCC-CCcccc
Confidence 999975 34899999999999999999999998 999999999999999999999999999876433 223456
Q ss_pred ccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcCCCC
Q 005749 542 LAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIRSP 621 (679)
Q Consensus 542 ~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~~~ 621 (679)
.+||+.|||||++.+..|+.++||||+||++|||++|+.||.+.... .....+.. ... + ....
T Consensus 230 ~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~---~~~~~i~~----~~~-----~-----~~~~ 292 (346)
T 4fih_A 230 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL---KAMKMIRD----NLP-----P-----RLKN 292 (346)
T ss_dssp CCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHHHHH----SSC-----C-----CCSC
T ss_pred cccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH---HHHHHHHc----CCC-----C-----CCCc
Confidence 78999999999999999999999999999999999999999543211 11111110 000 0 0011
Q ss_pred hHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 622 MEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 622 ~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
.....+++.+++.+||+.||++|||++|++++
T Consensus 293 ~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 293 LHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 12234567789999999999999999999874
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-52 Score=440.97 Aligned_cols=244 Identities=18% Similarity=0.292 Sum_probs=196.4
Q ss_pred CccccCCceEEEEEE-eCCCCEEEEEEcccCc--ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCC
Q 005749 383 QVIEKTTYGTAYKAK-LADGATIALRLLREGS--CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSR 459 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~g 459 (679)
+.||+|+||+||+|+ ..+|+.||||+++... ....+.+.+|+++|++++|||||++++++.+ ++..|||||||++|
T Consensus 30 ~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~-~~~~yiVmEy~~gg 108 (350)
T 4b9d_A 30 QKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEE-NGSLYIVMDYCEGG 108 (350)
T ss_dssp EEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEEEEECCTTC
T ss_pred EEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEE-CCEEEEEEeCCCCC
Confidence 789999999999999 5679999999997643 2335679999999999999999999999998 68999999999999
Q ss_pred ChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccch
Q 005749 460 TLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEM 539 (679)
Q Consensus 460 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 539 (679)
+|.+++.... ...+++.+++.|+.||+.||+|||+++ ||||||||+|||+++++.+||+|||+|+.+... ....
T Consensus 109 ~L~~~i~~~~--~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~-~~~~ 182 (350)
T 4b9d_A 109 DLFKRINAQK--GVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST-VELA 182 (350)
T ss_dssp BHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHH-HHHH
T ss_pred cHHHHHHHcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCC-cccc
Confidence 9999997542 345799999999999999999999998 999999999999999999999999999977432 2223
Q ss_pred hcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcCC
Q 005749 540 VALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIR 619 (679)
Q Consensus 540 ~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~ 619 (679)
...+||+.|||||++.+..|+.++||||+||++|||++|+.||.+... .+.... +..+..
T Consensus 183 ~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~------~~~~~~--------------i~~~~~ 242 (350)
T 4b9d_A 183 RACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM------KNLVLK--------------IISGSF 242 (350)
T ss_dssp HHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHH--------------HHHTCC
T ss_pred cccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH------HHHHHH--------------HHcCCC
Confidence 456899999999999999999999999999999999999999954321 111111 111111
Q ss_pred -CChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 620 -SPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 620 -~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
+......+++.+++.+||+.||++|||++|+++.
T Consensus 243 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 243 PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1112233567789999999999999999999863
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-52 Score=433.54 Aligned_cols=247 Identities=18% Similarity=0.208 Sum_probs=198.9
Q ss_pred cCccccCCceEEEEEE-eCCCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCC
Q 005749 382 GQVIEKTTYGTAYKAK-LADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRT 460 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gs 460 (679)
.+.||+|+||+||+|+ ..+|+.||||+++... .+.+|+++|++++|||||++++++.+ .+..|||||||++|+
T Consensus 63 ~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~-----~~~~E~~il~~l~HpnIV~l~~~~~~-~~~~~ivmEy~~gg~ 136 (336)
T 4g3f_A 63 QPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV-----FRVEELVACAGLSSPRIVPLYGAVRE-GPWVNIFMELLEGGS 136 (336)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-----CCTHHHHTTTTCCCTTBCCEEEEEEE-TTEEEEEECCCTTCB
T ss_pred CcEeccCCCeEEEEEEECCCCCEEEEEEECHHH-----hHHHHHHHHHhCCCCCCCcEEEEEEE-CCEEEEEEeccCCCc
Confidence 3679999999999999 4579999999997532 23579999999999999999999997 688999999999999
Q ss_pred hHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCC-ceEEeecccccccCccccc--
Q 005749 461 LHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFF-VSRLTEFGLDQLMVPAVAD-- 537 (679)
Q Consensus 461 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~-~~kl~DFGla~~~~~~~~~-- 537 (679)
|.++++.. ..+++.+++.|+.||+.||+|||+++ ||||||||+|||++.++ .+||+|||+|+.+......
T Consensus 137 L~~~l~~~----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~ 209 (336)
T 4g3f_A 137 LGQLIKQM----GCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKS 209 (336)
T ss_dssp HHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC--------
T ss_pred HHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccc
Confidence 99999864 45999999999999999999999988 99999999999999987 6999999999976543211
Q ss_pred --chhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhh
Q 005749 538 --EMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIM 615 (679)
Q Consensus 538 --~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~ 615 (679)
.....+||+.|||||++.+..|+.++|||||||++|||+||+.||.+....+.. ..+. .... ..
T Consensus 210 ~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~---~~i~---~~~~-------~~- 275 (336)
T 4g3f_A 210 LLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLC---LKIA---SEPP-------PI- 275 (336)
T ss_dssp ----CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCH---HHHH---HSCC-------GG-
T ss_pred eecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHH---HHHH---cCCC-------Cc-
Confidence 123457999999999999999999999999999999999999999654433211 1110 0000 00
Q ss_pred hcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhC
Q 005749 616 KGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENR 658 (679)
Q Consensus 616 ~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 658 (679)
... .+...+.+.+++.+||+.||++|||+.|+++.|....
T Consensus 276 ~~~---~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l 315 (336)
T 4g3f_A 276 REI---PPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKAL 315 (336)
T ss_dssp GGS---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hhc---CccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence 000 1122356778999999999999999999999887653
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-52 Score=432.90 Aligned_cols=267 Identities=23% Similarity=0.264 Sum_probs=196.3
Q ss_pred cCccccCCceEEEEEEeCCCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCCC---CceEEEEEecCC
Q 005749 382 GQVIEKTTYGTAYKAKLADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKR---GEKLLIYDYFPS 458 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~---~~~~lv~ey~~~ 458 (679)
++.||+|+||+||+|++ +|+.||||+++.... ....+.+|+..+.+++|||||+++|+|.+.. ...+||||||++
T Consensus 8 ~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~ 85 (303)
T 3hmm_A 8 QESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEH 85 (303)
T ss_dssp EEEEEECSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTT
T ss_pred EEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCC
Confidence 47899999999999998 589999999975321 1122345666677899999999999998633 257999999999
Q ss_pred CChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-----CCCeeecCCCCCCeeecCCCceEEeecccccccCc
Q 005749 459 RTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGH-----EIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVP 533 (679)
Q Consensus 459 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~-----~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 533 (679)
|+|.++++. ..++|..+.+|+.|+++||+|||++. .++||||||||+|||+|+++++||+|||+|+....
T Consensus 86 gsL~~~l~~-----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~ 160 (303)
T 3hmm_A 86 GSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS 160 (303)
T ss_dssp CBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEET
T ss_pred CcHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccC
Confidence 999999975 34899999999999999999999862 34599999999999999999999999999987643
Q ss_pred cccc---chhccccccccccccccccc------CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCccc--c------hhHH
Q 005749 534 AVAD---EMVALAKADGYKAPELQRMK------KCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFV--D------LPSI 596 (679)
Q Consensus 534 ~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~--~------l~~~ 596 (679)
.... .....+||+.|||||++.+. .+++|+|||||||++|||+||+.|+......+.. . ....
T Consensus 161 ~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~ 240 (303)
T 3hmm_A 161 ATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 240 (303)
T ss_dssp TTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHH
T ss_pred CCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHH
Confidence 3221 22345799999999998754 4678999999999999999998887433221110 0 0011
Q ss_pred HHHHhhcccccccchHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCCCC
Q 005749 597 VKVAVLEETTMEVFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRPRN 661 (679)
Q Consensus 597 ~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 661 (679)
......+ +.+++.+... ....+....+.+++.+||+.||++||||.||++.|+++...+
T Consensus 241 ~~~~~~~----~~~rp~~p~~--~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~ 299 (303)
T 3hmm_A 241 MRKVVCE----QKLRPNIPNR--WQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp HHHHHTT----SCCCCCCCGG--GGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred HHHHHhc----ccCCCCCCcc--ccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHc
Confidence 1111111 0111111110 011244567789999999999999999999999999986543
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-52 Score=443.34 Aligned_cols=257 Identities=20% Similarity=0.316 Sum_probs=208.0
Q ss_pred hcCccccCCceEEEEEEeCC------CCEEEEEEcccCcc-cCcccHHHHHHHHhccCC-CCCccceEEeeCCCCceEEE
Q 005749 381 TGQVIEKTTYGTAYKAKLAD------GATIALRLLREGSC-KDRSSCLPVIRQLGKVRH-ENLIPLRAFYQGKRGEKLLI 452 (679)
Q Consensus 381 ~~~~ig~G~~g~Vy~~~~~~------~~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~H-~nIv~l~~~~~~~~~~~~lv 452 (679)
.++.||+|+||+||+|++.. ++.||||+++.... ...+.|.+|+++|.+++| ||||+++|+|....+..++|
T Consensus 68 l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~~iV 147 (353)
T 4ase_A 68 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVI 147 (353)
T ss_dssp EEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEE
T ss_pred EeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCEEEEE
Confidence 35789999999999998532 35899999976543 335679999999999965 89999999997655678999
Q ss_pred EEecCCCChHHHhhcccC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCce
Q 005749 453 YDYFPSRTLHDLLHDTIA------------GKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVS 520 (679)
Q Consensus 453 ~ey~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~ 520 (679)
||||++|+|.++|+.... ....++|.+++.|+.|||+||+|||+++ ||||||||+|||+++++.+
T Consensus 148 ~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~~v 224 (353)
T 4ase_A 148 VEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVV 224 (353)
T ss_dssp EECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCE
T ss_pred EEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCccCccceeeCCCCCE
Confidence 999999999999975421 1345899999999999999999999988 9999999999999999999
Q ss_pred EEeecccccccCcccc-cchhcccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHH
Q 005749 521 RLTEFGLDQLMVPAVA-DEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVK 598 (679)
Q Consensus 521 kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~ 598 (679)
||+|||+|+.+..... .......||+.|||||++.+..|+.++|||||||++|||+| |+.||.+....+ .+
T Consensus 225 Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~------~~- 297 (353)
T 4ase_A 225 KICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE------EF- 297 (353)
T ss_dssp EECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH------HH-
T ss_pred EECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHH------HH-
Confidence 9999999997644322 22345678999999999999999999999999999999998 899996543221 11
Q ss_pred HHhhcccccccchHhhhhcCCCCh-HHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCC
Q 005749 599 VAVLEETTMEVFDMEIMKGIRSPM-EEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRP 659 (679)
Q Consensus 599 ~~~~~~~~~~~~~~~i~~~~~~~~-~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 659 (679)
...+..+.+... +...+++.+++.+||+.||++||||.||+++|+++.+
T Consensus 298 ------------~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq 347 (353)
T 4ase_A 298 ------------CRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 347 (353)
T ss_dssp ------------HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------------HHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHH
Confidence 111222222222 2234567889999999999999999999999998754
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-52 Score=426.02 Aligned_cols=243 Identities=20% Similarity=0.332 Sum_probs=194.9
Q ss_pred CccccCCceEEEEEEe-CCCCEEEEEEcccCc--ccCcccHHHHHHHHhccCCCCCccceEEeeCC---CCceEEEEEec
Q 005749 383 QVIEKTTYGTAYKAKL-ADGATIALRLLREGS--CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGK---RGEKLLIYDYF 456 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~---~~~~~lv~ey~ 456 (679)
+.||+|+||+||+|+. .++..||+|++.... ....+.|.+|+++|++++|||||+++++|.+. .+..|||||||
T Consensus 32 ~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy~ 111 (290)
T 3fpq_A 32 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELM 111 (290)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEECC
T ss_pred eEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEeCC
Confidence 5799999999999994 568999999997543 23356799999999999999999999998642 34579999999
Q ss_pred CCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecC-CCceEEeecccccccCccc
Q 005749 457 PSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDD-FFVSRLTEFGLDQLMVPAV 535 (679)
Q Consensus 457 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~-~~~~kl~DFGla~~~~~~~ 535 (679)
++|+|.++++.. ..+++..++.|+.||+.||+|||+++ ++||||||||+|||++. ++.+||+|||+|+.....
T Consensus 112 ~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~- 185 (290)
T 3fpq_A 112 TSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS- 185 (290)
T ss_dssp CSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTT-
T ss_pred CCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCCC-
Confidence 999999999863 45899999999999999999999875 45999999999999984 799999999999865332
Q ss_pred ccchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhh
Q 005749 536 ADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIM 615 (679)
Q Consensus 536 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~ 615 (679)
.....+||+.|||||++.+ .|+.++|||||||++|||+||+.||.+.... ....... .
T Consensus 186 --~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~-----~~~~~~i--------------~ 243 (290)
T 3fpq_A 186 --FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA-----AQIYRRV--------------T 243 (290)
T ss_dssp --SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-----HHHHHHH--------------T
T ss_pred --ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH-----HHHHHHH--------------H
Confidence 2345689999999998864 6999999999999999999999999543221 1111111 1
Q ss_pred hcCCCC--hHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 616 KGIRSP--MEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 616 ~~~~~~--~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
.+..+. .....+++.+++.+||+.||++|||++|++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 244 SGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp TTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cCCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111110 01122467789999999999999999999863
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-52 Score=429.34 Aligned_cols=244 Identities=19% Similarity=0.287 Sum_probs=202.7
Q ss_pred hcCccccCCceEEEEEE-eCCCCEEEEEEcccCc---ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEec
Q 005749 381 TGQVIEKTTYGTAYKAK-LADGATIALRLLREGS---CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYF 456 (679)
Q Consensus 381 ~~~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~ 456 (679)
..++||+|+||+||+|+ ..+|+.||||++.... ....+.+.+|+++|++++|||||+++++|.+ .+..|+|||||
T Consensus 36 i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-~~~~yivmEy~ 114 (311)
T 4aw0_A 36 FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD-DEKLYFGLSYA 114 (311)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEEEEECCC
T ss_pred EEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe-CCEEEEEEecC
Confidence 35789999999999999 5679999999997542 2345678999999999999999999999998 68899999999
Q ss_pred CCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCccc-
Q 005749 457 PSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAV- 535 (679)
Q Consensus 457 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~- 535 (679)
++|+|.+++... ..+++..++.|+.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+.+....
T Consensus 115 ~gG~L~~~i~~~----~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~ 187 (311)
T 4aw0_A 115 KNGELLKYIRKI----GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 187 (311)
T ss_dssp TTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT
T ss_pred CCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC
Confidence 999999999864 45999999999999999999999998 9999999999999999999999999999875432
Q ss_pred ccchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhh
Q 005749 536 ADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIM 615 (679)
Q Consensus 536 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~ 615 (679)
.......+||+.|||||++.+..|+.++||||+||++|||++|+.||.+.+.. +... .+.
T Consensus 188 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~------~~~~--------------~i~ 247 (311)
T 4aw0_A 188 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEG------LIFA--------------KII 247 (311)
T ss_dssp CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHH--------------HHH
T ss_pred cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH------HHHH--------------HHH
Confidence 22345678999999999999999999999999999999999999999543211 1111 111
Q ss_pred hcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHH
Q 005749 616 KGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVK 652 (679)
Q Consensus 616 ~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 652 (679)
.+.....+...+++.+++.+||+.||++|||++|++.
T Consensus 248 ~~~~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~ 284 (311)
T 4aw0_A 248 KLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 284 (311)
T ss_dssp HTCCCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTC
T ss_pred cCCCCCCcccCHHHHHHHHHHccCCHhHCcChHHHcC
Confidence 1111111223356778999999999999999998753
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-51 Score=440.00 Aligned_cols=244 Identities=16% Similarity=0.241 Sum_probs=203.3
Q ss_pred CccccCCceEEEEEE-eCCCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCCh
Q 005749 383 QVIEKTTYGTAYKAK-LADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRTL 461 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gsL 461 (679)
+.||+|+||+||+|+ ..+|+.||||++........+.+.+|+++|++++|||||+++++|.+ .+..|||||||++|+|
T Consensus 157 ~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~-~~~~~iVmEy~~gG~L 235 (423)
T 4fie_A 157 IKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV-GDELWVVMEFLEGGAL 235 (423)
T ss_dssp EEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEEEEECCTTEEH
T ss_pred eEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEE-CCEEEEEEeCCCCCcH
Confidence 679999999999999 45799999999987666667889999999999999999999999998 6899999999999999
Q ss_pred HHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccchhc
Q 005749 462 HDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVA 541 (679)
Q Consensus 462 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 541 (679)
.++++. ..+++.++..|+.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+.+... ......
T Consensus 236 ~~~i~~-----~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~-~~~~~~ 306 (423)
T 4fie_A 236 TDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE-VPRRKS 306 (423)
T ss_dssp HHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSS-CCCBCC
T ss_pred HHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCC-Cccccc
Confidence 999975 24899999999999999999999998 999999999999999999999999999876443 223456
Q ss_pred ccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcCCCC
Q 005749 542 LAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIRSP 621 (679)
Q Consensus 542 ~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~~~ 621 (679)
.+||+.|||||++.+..|+.++||||+||++|||++|+.||.+.... .....+. ... .+. ...
T Consensus 307 ~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~---~~~~~i~----~~~-----~~~-----~~~ 369 (423)
T 4fie_A 307 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL---KAMKMIR----DNL-----PPR-----LKN 369 (423)
T ss_dssp CEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHHHH----HSC-----CCC-----CSC
T ss_pred cccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH---HHHHHHH----cCC-----CCC-----Ccc
Confidence 78999999999999999999999999999999999999999543221 1111111 000 000 011
Q ss_pred hHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 622 MEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 622 ~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
.....+++.+|+.+||+.||++|||++|++++
T Consensus 370 ~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 370 LHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp TTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 11223567789999999999999999999874
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-51 Score=416.01 Aligned_cols=241 Identities=19% Similarity=0.315 Sum_probs=185.8
Q ss_pred cCccccCCceEEEEEE-eCCCCEEEEEEcccCc---ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecC
Q 005749 382 GQVIEKTTYGTAYKAK-LADGATIALRLLREGS---CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFP 457 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~ 457 (679)
.+.||+|+||+||+|+ ..+|+.||||+++... ....+.+.+|+++|++++|||||++++++.+ .+..|+|||||
T Consensus 18 ~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-~~~~~ivmEy~- 95 (275)
T 3hyh_A 18 VKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKS-KDEIIMVIEYA- 95 (275)
T ss_dssp EEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEEEEECC-
T ss_pred EEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE-CCEEEEEEeCC-
Confidence 3789999999999999 5679999999997543 2234578999999999999999999999998 68899999999
Q ss_pred CCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCccccc
Q 005749 458 SRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVAD 537 (679)
Q Consensus 458 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 537 (679)
+|+|.+++... ..+++.+++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+..... .
T Consensus 96 ~g~L~~~l~~~----~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~--~ 166 (275)
T 3hyh_A 96 GNELFDYIVQR----DKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG--N 166 (275)
T ss_dssp CEEHHHHHHHS----CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC---------
T ss_pred CCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCC--C
Confidence 67999999763 45999999999999999999999998 999999999999999999999999999876432 2
Q ss_pred chhcccccccccccccccccCC-CCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhh
Q 005749 538 EMVALAKADGYKAPELQRMKKC-SSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMK 616 (679)
Q Consensus 538 ~~~~~~gt~~y~aPE~~~~~~~-~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~ 616 (679)
.....+||+.|||||++.+..| +.++||||+||++|||++|+.||.+... ....+. +..
T Consensus 167 ~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~------~~~~~~--------------i~~ 226 (275)
T 3hyh_A 167 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI------PVLFKN--------------ISN 226 (275)
T ss_dssp --------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHH--------------HHH
T ss_pred ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH------HHHHHH--------------HHc
Confidence 3345789999999999998776 5799999999999999999999954321 111111 111
Q ss_pred cCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 617 GIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 617 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
+.........+++.+++.+||+.||++|||++|++++
T Consensus 227 ~~~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 227 GVYTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp TCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred CCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 1111111223567789999999999999999999874
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-51 Score=423.08 Aligned_cols=242 Identities=20% Similarity=0.276 Sum_probs=191.3
Q ss_pred cCccccCCceEEEEEEe----CCCCEEEEEEcccCc--ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEe
Q 005749 382 GQVIEKTTYGTAYKAKL----ADGATIALRLLREGS--CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDY 455 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~----~~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey 455 (679)
.+.||+|+||+||+|+. .+++.||||+++... ......+.+|+++|++++|||||++++++.+ ++..|+||||
T Consensus 29 ~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-~~~~~ivmEy 107 (304)
T 3ubd_A 29 LKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQT-EGKLYLILDF 107 (304)
T ss_dssp EEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEE-TTEEEEEECC
T ss_pred EEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE-CCEEEEEEEc
Confidence 47899999999999984 247899999997643 2334578899999999999999999999998 6899999999
Q ss_pred cCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCccc
Q 005749 456 FPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAV 535 (679)
Q Consensus 456 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 535 (679)
|++|+|.+++... ..+++.+++.|+.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+.....
T Consensus 108 ~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~- 179 (304)
T 3ubd_A 108 LRGGDLFTRLSKE----VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDH- 179 (304)
T ss_dssp CTTCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC-----
T ss_pred CCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceeccCC-
Confidence 9999999999864 45999999999999999999999998 999999999999999999999999999865332
Q ss_pred ccchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhh
Q 005749 536 ADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIM 615 (679)
Q Consensus 536 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~ 615 (679)
.......+||+.|||||++.+..|+.++||||+||++|||+||+.||.+.+.. +.... +.
T Consensus 180 ~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~------~~~~~--------------i~ 239 (304)
T 3ubd_A 180 EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRK------ETMTM--------------IL 239 (304)
T ss_dssp -CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHH--------------HH
T ss_pred CccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHH------HHHHH--------------HH
Confidence 22334678999999999999999999999999999999999999999543221 11111 11
Q ss_pred hcCCCChHHHHHHHHHHHHhccCcCCCCCCCH-----HHHHH
Q 005749 616 KGIRSPMEEGLVQALKLAMGCCAPVASVRPTM-----DEVVK 652 (679)
Q Consensus 616 ~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~-----~evl~ 652 (679)
.+.....+...+++.+++.+||+.||++|||+ +|+++
T Consensus 240 ~~~~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 240 KAKLGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp HCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred cCCCCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 11111112234567789999999999999985 56654
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=411.96 Aligned_cols=246 Identities=17% Similarity=0.267 Sum_probs=185.0
Q ss_pred cCccccCCceEEEEEE-eCCCCEEEEEEcccCcc-cCcccHHHHHHHHhccCCCCCccceEEeeCCC-----------Cc
Q 005749 382 GQVIEKTTYGTAYKAK-LADGATIALRLLREGSC-KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKR-----------GE 448 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~-----------~~ 448 (679)
.+.||+|+||+||+|+ ..+|+.||||+++.... ...+.+.+|+++|++++|||||+++++|.+.+ ..
T Consensus 10 ~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~ 89 (299)
T 4g31_A 10 IQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVY 89 (299)
T ss_dssp EEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------CEE
T ss_pred eeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCCCcE
Confidence 3789999999999999 45799999999975432 23467899999999999999999999987532 23
Q ss_pred eEEEEEecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccc
Q 005749 449 KLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLD 528 (679)
Q Consensus 449 ~~lv~ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 528 (679)
.|+|||||++|+|.+++..... ....++..++.|+.||++||+|||+++ |+||||||+|||++.++.+||+|||+|
T Consensus 90 l~ivmE~~~gg~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~DFGla 165 (299)
T 4g31_A 90 LYIQMQLCRKENLKDWMNGRCT-IEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLV 165 (299)
T ss_dssp EEEEEECCCSCCHHHHHHTCCS-GGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCCCC
T ss_pred EEEEEecCCCCcHHHHHHhcCC-CChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEccCccc
Confidence 6899999999999999986432 233567888999999999999999998 999999999999999999999999999
Q ss_pred cccCccccc-----------chhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHH
Q 005749 529 QLMVPAVAD-----------EMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIV 597 (679)
Q Consensus 529 ~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~ 597 (679)
+.+...... .....+||+.|||||++.+..|+.++|||||||++|||++ ||.+.. +.....
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~-----~~~~~~ 237 (299)
T 4g31_A 166 TAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM-----ERVRTL 237 (299)
T ss_dssp --------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH-----HHHHHH
T ss_pred eecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc-----HHHHHH
Confidence 876443211 1234579999999999999999999999999999999996 773210 000000
Q ss_pred HHHhhcccccccchHhhhhcCCCC-hHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 598 KVAVLEETTMEVFDMEIMKGIRSP-MEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 598 ~~~~~~~~~~~~~~~~i~~~~~~~-~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
. .+.....++ .....+...+++.+||+.||++|||+.|+++.
T Consensus 238 ~--------------~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 238 T--------------DVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp H--------------HHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred H--------------HHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 0 011111111 22334566789999999999999999999873
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=411.04 Aligned_cols=262 Identities=19% Similarity=0.273 Sum_probs=197.0
Q ss_pred cCccccCCceEEEEEE-eCCCCEEEEEEcccCcc--cCcccHHHHHHHHhccCCCCCccceEEeeCC-----CCceEEEE
Q 005749 382 GQVIEKTTYGTAYKAK-LADGATIALRLLREGSC--KDRSSCLPVIRQLGKVRHENLIPLRAFYQGK-----RGEKLLIY 453 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~-----~~~~~lv~ 453 (679)
.+.||+|+||+||+|+ ..+|+.||||+++.... ...+.+.+|+++|++++|||||++++++... .+..||||
T Consensus 59 ~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ivm 138 (398)
T 4b99_A 59 IETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVL 138 (398)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEEEEE
T ss_pred EEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEEEEE
Confidence 3689999999999999 46799999999975432 2345688999999999999999999987642 35789999
Q ss_pred EecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCc
Q 005749 454 DYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVP 533 (679)
Q Consensus 454 ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 533 (679)
|||+ |+|.+++.. ...+++.+++.|+.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+.+..
T Consensus 139 E~~~-g~L~~~i~~----~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~ 210 (398)
T 4b99_A 139 DLME-SDLHQIIHS----SQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARGLCT 210 (398)
T ss_dssp ECCS-EEHHHHHTS----SSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBCC--
T ss_pred eCCC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceeeeccc
Confidence 9996 689999976 356999999999999999999999998 99999999999999999999999999987643
Q ss_pred cc---ccchhccccccccccccccccc-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHh--hccccc
Q 005749 534 AV---ADEMVALAKADGYKAPELQRMK-KCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAV--LEETTM 607 (679)
Q Consensus 534 ~~---~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~--~~~~~~ 607 (679)
.. .......+||+.|||||++.+. .++.++||||+||++|||++|+.||.+....+. +..+..... ......
T Consensus 211 ~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~--l~~I~~~~g~p~~~~~~ 288 (398)
T 4b99_A 211 SPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQ--LQLIMMVLGTPSPAVIQ 288 (398)
T ss_dssp -----CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHH--HHHHHHHHCCCCGGGTC
T ss_pred CccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHH--HHHHHHhcCCCChHHhh
Confidence 21 1234467899999999998765 569999999999999999999999965432211 111111110 000000
Q ss_pred ccc---hHhhhhc----CCCChH----HHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 608 EVF---DMEIMKG----IRSPME----EGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 608 ~~~---~~~i~~~----~~~~~~----~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
... ....... ...+.. ...+++.+|+.+||..||++|||++|++++
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 289 AVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp -----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred hhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000 0000000 001111 123567899999999999999999999875
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-45 Score=384.27 Aligned_cols=273 Identities=28% Similarity=0.425 Sum_probs=226.9
Q ss_pred cCccccCCceEEEEEEeCCCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCCh
Q 005749 382 GQVIEKTTYGTAYKAKLADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRTL 461 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gsL 461 (679)
.+.||+|+||.||+|+..+++.||||++........+.+.+|++++++++||||+++++++.+ .+..++||||+++|+|
T Consensus 44 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~L 122 (321)
T 2qkw_B 44 KFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDE-RNEMILIYKYMENGNL 122 (321)
T ss_dssp CCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCC-TTCCEEEEECCTTCBT
T ss_pred cceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CCeEEEEEEcCCCCcH
Confidence 378999999999999988899999999887655556789999999999999999999999987 6789999999999999
Q ss_pred HHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccc-cchh
Q 005749 462 HDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVA-DEMV 540 (679)
Q Consensus 462 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~-~~~~ 540 (679)
.+++.........+++..++.++.|+++||+|||+++ |+||||||+||+++.++.+||+|||+++....... ....
T Consensus 123 ~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 199 (321)
T 2qkw_B 123 KRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLST 199 (321)
T ss_dssp GGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCCBC
T ss_pred HHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeeccccccccccccccccc
Confidence 9999765443456999999999999999999999988 99999999999999999999999999986532211 1223
Q ss_pred cccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcCCC
Q 005749 541 ALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIRS 620 (679)
Q Consensus 541 ~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~~ 620 (679)
...||+.|+|||++.+..++.++||||||+++|||++|+.||......+......|...........+.+++.+.. .
T Consensus 200 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~ 276 (321)
T 2qkw_B 200 VVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLAD---K 276 (321)
T ss_dssp CCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTT---C
T ss_pred ccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhcc---c
Confidence 4468999999999988899999999999999999999999997766655556666655444444444444433222 2
Q ss_pred ChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCCCC
Q 005749 621 PMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRPRN 661 (679)
Q Consensus 621 ~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 661 (679)
..+.....+.+++.+||+.||++|||++|+++.|+.+.+..
T Consensus 277 ~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~ 317 (321)
T 2qkw_B 277 IRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQ 317 (321)
T ss_dssp SCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred cCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhcc
Confidence 34566778889999999999999999999999999886543
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=391.26 Aligned_cols=192 Identities=20% Similarity=0.333 Sum_probs=163.5
Q ss_pred cCccccCCceEEEEEEe----CCCCEEEEEEcccCcccCcccHHHHHHHHhcc-CCCCCccceEEeeCCCCceEEEEEec
Q 005749 382 GQVIEKTTYGTAYKAKL----ADGATIALRLLREGSCKDRSSCLPVIRQLGKV-RHENLIPLRAFYQGKRGEKLLIYDYF 456 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~----~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~~lv~ey~ 456 (679)
.+.||+|+||+||+|+. .+++.||+|++.... ....+.+|+++|.++ +|||||+++++|.+ .++.|+|||||
T Consensus 26 ~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~-~~~~~lvmE~~ 102 (361)
T 4f9c_A 26 EDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRK-NDHVVIAMPYL 102 (361)
T ss_dssp EEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEE-TTEEEEEEECC
T ss_pred EEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEE-CCEEEEEEeCC
Confidence 36899999999999984 246799999986542 345688999999998 69999999999987 68999999999
Q ss_pred CCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCC-CceEEeecccccccCccc
Q 005749 457 PSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDF-FVSRLTEFGLDQLMVPAV 535 (679)
Q Consensus 457 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~-~~~kl~DFGla~~~~~~~ 535 (679)
++|+|.++++. +++.+++.|+.|++.||+|||+++ |+||||||+|||++.+ +.+||+|||+|+......
T Consensus 103 ~g~~L~~~~~~-------l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~ 172 (361)
T 4f9c_A 103 EHESFLDILNS-------LSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTK 172 (361)
T ss_dssp CCCCHHHHHTT-------CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECTTCS
T ss_pred CcccHHHHHcC-------CCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcc
Confidence 99999999842 899999999999999999999998 9999999999999877 799999999998653221
Q ss_pred c---------------------------cchhccccccccccccccccc-CCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 005749 536 A---------------------------DEMVALAKADGYKAPELQRMK-KCSSRTDVYAFGILLLEILIGKKPGKSGR 586 (679)
Q Consensus 536 ~---------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~S~Gvvl~El~tg~~p~~~~~ 586 (679)
. ......+||+.|||||++.+. .|+.++||||+||++|||++|+.||....
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~ 251 (361)
T 4f9c_A 173 IELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKAS 251 (361)
T ss_dssp CGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCC
Confidence 1 112345799999999998865 48999999999999999999999996543
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-45 Score=382.65 Aligned_cols=287 Identities=30% Similarity=0.506 Sum_probs=232.1
Q ss_pred ccccHHHHHHhhc-----CccccCCceEEEEEEeCCCCEEEEEEcccCcc-cCcccHHHHHHHHhccCCCCCccceEEee
Q 005749 370 EHLTLEDVLNATG-----QVIEKTTYGTAYKAKLADGATIALRLLREGSC-KDRSSCLPVIRQLGKVRHENLIPLRAFYQ 443 (679)
Q Consensus 370 ~~~~~~~l~~~~~-----~~ig~G~~g~Vy~~~~~~~~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~ 443 (679)
..++++++....+ +.||+|+||.||+|+..+|+.||||++..... .....+.+|++++++++||||+++++++.
T Consensus 18 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 97 (326)
T 3uim_A 18 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 97 (326)
T ss_dssp EECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEEC
T ss_pred ceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEe
Confidence 4567777776654 68999999999999988899999999976543 33457899999999999999999999998
Q ss_pred CCCCceEEEEEecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEe
Q 005749 444 GKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLT 523 (679)
Q Consensus 444 ~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~ 523 (679)
+ .+..++||||+++|+|.+++.........+++..++.|+.|++.||+|||+++.++|+||||||+|||+++++.+||+
T Consensus 98 ~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~ 176 (326)
T 3uim_A 98 T-PTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 176 (326)
T ss_dssp C-SSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred c-CCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence 7 678899999999999999998765555679999999999999999999999833339999999999999999999999
Q ss_pred ecccccccCcccccchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCC--CCCcccchhHHHHHHh
Q 005749 524 EFGLDQLMVPAVADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSG--RNGEFVDLPSIVKVAV 601 (679)
Q Consensus 524 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~--~~~~~~~l~~~~~~~~ 601 (679)
|||+++..............||+.|+|||++.+..++.++|||||||++|||++|+.||... ..........|+....
T Consensus 177 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 256 (326)
T 3uim_A 177 DFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 256 (326)
T ss_dssp CCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTT
T ss_pred cCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHh
Confidence 99999876544333344556999999999998888999999999999999999999999521 1122334455555544
Q ss_pred hcccccccchHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCCC
Q 005749 602 LEETTMEVFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRPR 660 (679)
Q Consensus 602 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 660 (679)
.........+..... .........+.+++.+||+.||++|||++||+++|++....
T Consensus 257 ~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~ 312 (326)
T 3uim_A 257 KEKKLEALVDVDLQG---NYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLA 312 (326)
T ss_dssp SSCCSTTSSCTTCTT---SCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCS
T ss_pred hchhhhhhcChhhcc---ccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchh
Confidence 444444444443222 33466778899999999999999999999999999976543
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-45 Score=407.71 Aligned_cols=244 Identities=18% Similarity=0.238 Sum_probs=194.8
Q ss_pred cCccccCCceEEEEEE-eCCCCEEEEEEcccCc---ccCcccHHHH---HHHHhccCCCCCccceEEeeCCCCceEEEEE
Q 005749 382 GQVIEKTTYGTAYKAK-LADGATIALRLLREGS---CKDRSSCLPV---IRQLGKVRHENLIPLRAFYQGKRGEKLLIYD 454 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~---~~~~~~~~~E---i~~l~~l~H~nIv~l~~~~~~~~~~~~lv~e 454 (679)
.++||+|+||+||+|+ ..+|+.||||+++... ......+.+| +++++.++|||||+++++|.+ .+..|+|||
T Consensus 194 ~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~-~~~lylVmE 272 (689)
T 3v5w_A 194 HRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT-PDKLSFILD 272 (689)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC-SSEEEEEEC
T ss_pred EEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEE-CCEEEEEEe
Confidence 4789999999999999 4579999999996532 1222233444 566778899999999999998 689999999
Q ss_pred ecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcc
Q 005749 455 YFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPA 534 (679)
Q Consensus 455 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 534 (679)
||+||+|.+++... ..+++..++.|+.||+.||+|||+++ ||||||||+|||++.+|.+||+|||+|+.+...
T Consensus 273 y~~GGdL~~~l~~~----~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~ 345 (689)
T 3v5w_A 273 LMNGGDLHYHLSQH----GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK 345 (689)
T ss_dssp CCCSCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred cCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeeecCCC
Confidence 99999999999864 45999999999999999999999998 999999999999999999999999999876433
Q ss_pred cccchhcccccccccccccccc-cCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHh
Q 005749 535 VADEMVALAKADGYKAPELQRM-KKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDME 613 (679)
Q Consensus 535 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 613 (679)
...+.+||+.|||||++.. ..|+.++||||+||++|||++|+.||.+....+.. .....
T Consensus 346 ---~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~---~i~~~-------------- 405 (689)
T 3v5w_A 346 ---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH---EIDRM-------------- 405 (689)
T ss_dssp ---CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHH---HHHHH--------------
T ss_pred ---CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHh--------------
Confidence 2345789999999999974 57999999999999999999999999654332211 11111
Q ss_pred hhhcCCCChHHHHHHHHHHHHhccCcCCCCCCC-----HHHHHHH
Q 005749 614 IMKGIRSPMEEGLVQALKLAMGCCAPVASVRPT-----MDEVVKQ 653 (679)
Q Consensus 614 i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs-----~~evl~~ 653 (679)
+............+++.+++.+||+.||++|++ ++||+++
T Consensus 406 i~~~~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 406 TLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp HHHCCCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred hcCCCCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence 111111111223456778999999999999998 6787764
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=413.30 Aligned_cols=247 Identities=16% Similarity=0.270 Sum_probs=202.0
Q ss_pred cCccccCCceEEEEEE-eCCCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCC
Q 005749 382 GQVIEKTTYGTAYKAK-LADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRT 460 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gs 460 (679)
.+.||+|+||+||+|+ ..+|+.||+|++......+.+.+.+|+++|++++|||||+++++|.+ .+..|+|||||++|+
T Consensus 162 ~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-~~~~~iv~E~~~gg~ 240 (573)
T 3uto_A 162 HEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFED-DNEMVMIYEFMSGGE 240 (573)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEC-SSEEEEEEECCCCCB
T ss_pred EEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEE-CCEEEEEEeecCCCc
Confidence 4789999999999999 46799999999977655556788999999999999999999999998 689999999999999
Q ss_pred hHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCC--CceEEeecccccccCcccccc
Q 005749 461 LHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDF--FVSRLTEFGLDQLMVPAVADE 538 (679)
Q Consensus 461 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~--~~~kl~DFGla~~~~~~~~~~ 538 (679)
|.+++... ...+++.++..|+.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+|+.+.... .
T Consensus 241 L~~~i~~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~--~ 312 (573)
T 3uto_A 241 LFEKVADE---HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ--S 312 (573)
T ss_dssp HHHHHTCT---TSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS--E
T ss_pred HHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCCC--c
Confidence 99999653 345899999999999999999999998 9999999999999854 899999999999875432 2
Q ss_pred hhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcC
Q 005749 539 MVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGI 618 (679)
Q Consensus 539 ~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~ 618 (679)
....+||+.|||||++.+..|+.++||||+||++|||++|+.||.+.... +.......... .+...
T Consensus 313 ~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~------~~~~~i~~~~~---~~~~~----- 378 (573)
T 3uto_A 313 VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD------ETLRNVKSCDW---NMDDS----- 378 (573)
T ss_dssp EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH------HHHHHHHTTCC---CCCSG-----
T ss_pred eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH------HHHHHHHhCCC---CCCcc-----
Confidence 34568999999999999999999999999999999999999999653321 11111000000 00000
Q ss_pred CCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 619 RSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 619 ~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
......+++.+|+.+||+.||++|||+.|++++
T Consensus 379 --~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 379 --AFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp --GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred --cccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 011123567789999999999999999999874
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=367.69 Aligned_cols=254 Identities=22% Similarity=0.310 Sum_probs=205.2
Q ss_pred cCccccCCceEEEEEEe-CCCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCC
Q 005749 382 GQVIEKTTYGTAYKAKL-ADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRT 460 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gs 460 (679)
++.||+|+||+||+|+. .+++.||+|++........+.+.+|++++++++||||+++++++.+ .+..++||||+++|+
T Consensus 15 ~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~e~~~~~~ 93 (310)
T 3s95_A 15 GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYK-DKRLNFITEYIKGGT 93 (310)
T ss_dssp EEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-TTEEEEEEECCTTCB
T ss_pred cceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEec-CCeeEEEEEecCCCc
Confidence 47899999999999995 5699999999876555566789999999999999999999999987 688999999999999
Q ss_pred hHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccc--
Q 005749 461 LHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADE-- 538 (679)
Q Consensus 461 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~-- 538 (679)
|.++++.. ...+++.+++.|+.|+++||+|||+++ |+||||||+|||+++++.+||+|||+++.........
T Consensus 94 L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 167 (310)
T 3s95_A 94 LRGIIKSM---DSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEG 167 (310)
T ss_dssp HHHHHHHC---CTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC--------
T ss_pred HHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccccccccc
Confidence 99999864 345899999999999999999999988 9999999999999999999999999998764322111
Q ss_pred -----------hhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhccccc
Q 005749 539 -----------MVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTM 607 (679)
Q Consensus 539 -----------~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 607 (679)
.....||+.|+|||++.+..++.++||||||+++|||++|..|+...........
T Consensus 168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~-------------- 233 (310)
T 3s95_A 168 LRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFG-------------- 233 (310)
T ss_dssp ------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSS--------------
T ss_pred cccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHh--------------
Confidence 1145799999999999999999999999999999999999999854332211100
Q ss_pred ccchHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCC
Q 005749 608 EVFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRP 659 (679)
Q Consensus 608 ~~~~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 659 (679)
........... .+...+.+.+++.+||+.||++|||++|+++.|+++..
T Consensus 234 ~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~ 282 (310)
T 3s95_A 234 LNVRGFLDRYC---PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRM 282 (310)
T ss_dssp BCHHHHHHHTC---CTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhhhccccccC---CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 00000000000 11122456789999999999999999999999998864
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-43 Score=358.54 Aligned_cols=250 Identities=20% Similarity=0.377 Sum_probs=206.2
Q ss_pred cCccccCCceEEEEEEeCCCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCCh
Q 005749 382 GQVIEKTTYGTAYKAKLADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRTL 461 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gsL 461 (679)
.+.||+|+||.||+|+..+++.||+|++.... ...+++.+|++++++++||||+++++++.+ .+..++||||+++++|
T Consensus 15 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L 92 (269)
T 4hcu_A 15 VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLE-QAPICLVFEFMEHGCL 92 (269)
T ss_dssp EEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSSEEEEEECCTTCBH
T ss_pred eheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCceEEEEEeCCCCcH
Confidence 37899999999999998889999999997643 235679999999999999999999999987 6789999999999999
Q ss_pred HHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccchhc
Q 005749 462 HDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVA 541 (679)
Q Consensus 462 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 541 (679)
.+++... ...+++..++.++.|+++||+|||+++ |+||||||+||+++.++.+||+|||+++............
T Consensus 93 ~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 166 (269)
T 4hcu_A 93 SDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG 166 (269)
T ss_dssp HHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTS
T ss_pred HHHHHhc---CcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccccccccccC
Confidence 9999764 345899999999999999999999988 9999999999999999999999999998765443333444
Q ss_pred ccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcCC-
Q 005749 542 LAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIR- 619 (679)
Q Consensus 542 ~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~- 619 (679)
..+++.|+|||.+.+..++.++||||+|+++|||++ |+.||...... ..... +..+..
T Consensus 167 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~------~~~~~--------------~~~~~~~ 226 (269)
T 4hcu_A 167 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS------EVVED--------------ISTGFRL 226 (269)
T ss_dssp TTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHH--------------HHTTCCC
T ss_pred cccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH------HHHHH--------------HhcCccC
Confidence 567788999999998899999999999999999999 99998543211 11111 111111
Q ss_pred CChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCC
Q 005749 620 SPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRP 659 (679)
Q Consensus 620 ~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 659 (679)
.........+.+++.+||+.||++|||++|+++.|+++.+
T Consensus 227 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 227 YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 1111123567789999999999999999999999998754
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-43 Score=373.73 Aligned_cols=253 Identities=22% Similarity=0.361 Sum_probs=203.8
Q ss_pred cCccccCCceEEEEEEe--------CCCCEEEEEEcccCcc-cCcccHHHHHHHHhcc-CCCCCccceEEeeCCCCceEE
Q 005749 382 GQVIEKTTYGTAYKAKL--------ADGATIALRLLREGSC-KDRSSCLPVIRQLGKV-RHENLIPLRAFYQGKRGEKLL 451 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~--------~~~~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~~l 451 (679)
++.||+|+||.||+|+. .++..||||+++.... ...+.+.+|+++++++ +|||||+++++|.+ .+..++
T Consensus 86 ~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~-~~~~~l 164 (370)
T 2psq_A 86 GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ-DGPLYV 164 (370)
T ss_dssp EEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS-SSSCEE
T ss_pred eeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc-CCCEEE
Confidence 47899999999999984 2355799999976532 3346789999999999 89999999999987 678999
Q ss_pred EEEecCCCChHHHhhcccC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCc
Q 005749 452 IYDYFPSRTLHDLLHDTIA------------GKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFV 519 (679)
Q Consensus 452 v~ey~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~ 519 (679)
||||+++|+|.+++..... ....+++..++.++.||++||+|||+++ |+||||||+|||++.++.
T Consensus 165 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~ 241 (370)
T 2psq_A 165 IVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNV 241 (370)
T ss_dssp EEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCC
T ss_pred EEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEECCCCC
Confidence 9999999999999986432 1235899999999999999999999988 999999999999999999
Q ss_pred eEEeecccccccCcccc-cchhcccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHH
Q 005749 520 SRLTEFGLDQLMVPAVA-DEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIV 597 (679)
Q Consensus 520 ~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~ 597 (679)
+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+.... .+...
T Consensus 242 ~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~---~~~~~- 317 (370)
T 2psq_A 242 MKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE---ELFKL- 317 (370)
T ss_dssp EEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GHHHH-
T ss_pred EEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHH-
Confidence 99999999986643322 22234467789999999998999999999999999999999 99998543221 11111
Q ss_pred HHHhhcccccccchHhhhhcCCC-ChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhC
Q 005749 598 KVAVLEETTMEVFDMEIMKGIRS-PMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENR 658 (679)
Q Consensus 598 ~~~~~~~~~~~~~~~~i~~~~~~-~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 658 (679)
+..+.+. .......++.+++.+||+.||++||++.|+++.|+++.
T Consensus 318 ----------------~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il 363 (370)
T 2psq_A 318 ----------------LKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 363 (370)
T ss_dssp ----------------HHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----------------HhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1111111 11223356778999999999999999999999999875
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-43 Score=356.67 Aligned_cols=252 Identities=20% Similarity=0.358 Sum_probs=205.8
Q ss_pred CccccCCceEEEEEEeCCCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCChH
Q 005749 383 QVIEKTTYGTAYKAKLADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRTLH 462 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gsL~ 462 (679)
+.||+|+||.||+|+..++..||+|+++... ...+.+.+|++++.+++||||+++++++.+ .+..++||||+++++|.
T Consensus 14 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~ 91 (268)
T 3sxs_A 14 KELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSK-EYPIYIVTEYISNGCLL 91 (268)
T ss_dssp EEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSSEEEEEECCTTCBHH
T ss_pred eeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEcc-CCceEEEEEccCCCcHH
Confidence 7899999999999999888899999997643 234678999999999999999999999987 67899999999999999
Q ss_pred HHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccchhcc
Q 005749 463 DLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVAL 542 (679)
Q Consensus 463 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 542 (679)
+++... ...+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.............
T Consensus 92 ~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~ 165 (268)
T 3sxs_A 92 NYLRSH---GKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGT 165 (268)
T ss_dssp HHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEECCSC
T ss_pred HHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhhhcccCC
Confidence 999764 235899999999999999999999988 99999999999999999999999999987654433333445
Q ss_pred cccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcCC-C
Q 005749 543 AKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIR-S 620 (679)
Q Consensus 543 ~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~-~ 620 (679)
.+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...... ...... ..+.. .
T Consensus 166 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~~~~~~--------------~~~~~~~ 225 (268)
T 3sxs_A 166 KFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS------EVVLKV--------------SQGHRLY 225 (268)
T ss_dssp CCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH------HHHHHH--------------HTTCCCC
T ss_pred CcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChH------HHHHHH--------------HcCCCCC
Confidence 56778999999988889999999999999999999 99998543211 111100 11111 1
Q ss_pred ChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCCCCC
Q 005749 621 PMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRPRNR 662 (679)
Q Consensus 621 ~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 662 (679)
......+.+.+++.+||+.||++|||++|+++.|+++.++++
T Consensus 226 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~k 267 (268)
T 3sxs_A 226 RPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKDK 267 (268)
T ss_dssp CCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC---
T ss_pred CCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhccC
Confidence 111123467789999999999999999999999999976543
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-43 Score=366.52 Aligned_cols=257 Identities=23% Similarity=0.372 Sum_probs=195.7
Q ss_pred cCccccCCceEEEEEEeCCCCEEEEEEcccCcc--cCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCC
Q 005749 382 GQVIEKTTYGTAYKAKLADGATIALRLLREGSC--KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSR 459 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~~~~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~g 459 (679)
.+.||+|+||+||+|+. +|+.||||++..... ...+.+.+|++++++++|||||++++++.+ .+..++||||+++|
T Consensus 42 ~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~e~~~~~ 119 (309)
T 3p86_A 42 KEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQ-PPNLSIVTEYLSRG 119 (309)
T ss_dssp EEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-TTCCEEEEECCTTC
T ss_pred eeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-CCceEEEEecCCCC
Confidence 47899999999999987 588999999876532 224578999999999999999999999987 67899999999999
Q ss_pred ChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccch
Q 005749 460 TLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEM 539 (679)
Q Consensus 460 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 539 (679)
+|.+++..... ...+++..++.++.|++.||+|||+++ ++|+||||||+|||++.++.+||+|||+++..... ....
T Consensus 120 ~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~-~~~~ 196 (309)
T 3p86_A 120 SLYRLLHKSGA-REQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAST-FLSS 196 (309)
T ss_dssp BHHHHHHSTTH-HHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC-------------
T ss_pred cHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCcccccc-cccc
Confidence 99999976321 123899999999999999999999875 45999999999999999999999999999865332 1223
Q ss_pred hcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcCC
Q 005749 540 VALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIR 619 (679)
Q Consensus 540 ~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~ 619 (679)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...... +......... ...
T Consensus 197 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~------~~~~~~~~~~------------~~~ 258 (309)
T 3p86_A 197 KSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPA------QVVAAVGFKC------------KRL 258 (309)
T ss_dssp -----CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHH------HHHHHHHHSC------------CCC
T ss_pred ccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhcC------------CCC
Confidence 4557899999999999999999999999999999999999999543211 1111100000 000
Q ss_pred CChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCCCC
Q 005749 620 SPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRPRN 661 (679)
Q Consensus 620 ~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 661 (679)
.......+++.+++.+||+.||++|||++|+++.|+.+....
T Consensus 259 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~ 300 (309)
T 3p86_A 259 EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300 (309)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence 111122356778999999999999999999999999987553
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=363.62 Aligned_cols=257 Identities=17% Similarity=0.233 Sum_probs=207.7
Q ss_pred ccccHHHHHHhhc---------------CccccCCceEEEEEEeC-CCCEEEEEEcccCcccCcccHHHHHHHHhccCCC
Q 005749 370 EHLTLEDVLNATG---------------QVIEKTTYGTAYKAKLA-DGATIALRLLREGSCKDRSSCLPVIRQLGKVRHE 433 (679)
Q Consensus 370 ~~~~~~~l~~~~~---------------~~ig~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~ 433 (679)
..++.+++..++. +.||+|+||.||+|+.. +|+.||||+++.......+.+.+|++++++++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 5577888776653 47999999999999965 7999999999876656667899999999999999
Q ss_pred CCccceEEeeCCCCceEEEEEecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCee
Q 005749 434 NLIPLRAFYQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVL 513 (679)
Q Consensus 434 nIv~l~~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NIL 513 (679)
|||++++++.. .+..++||||+++|+|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+||+
T Consensus 103 niv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIl 173 (321)
T 2c30_A 103 NVVEMYKSYLV-GEELWVLMEFLQGGALTDIVSQ-----VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSIL 173 (321)
T ss_dssp TBCCEEEEEEE-TTEEEEEECCCCSCBHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEE
T ss_pred CcceEEEEEEE-CCEEEEEEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEE
Confidence 99999999987 6789999999999999999864 34899999999999999999999988 999999999999
Q ss_pred ecCCCceEEeecccccccCcccccchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccch
Q 005749 514 VDDFFVSRLTEFGLDQLMVPAVADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDL 593 (679)
Q Consensus 514 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l 593 (679)
++.++.+||+|||+++...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||......
T Consensus 174 l~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~----- 247 (321)
T 2c30_A 174 LTLDGRVKLSDFGFCAQISKDV-PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPV----- 247 (321)
T ss_dssp ECTTCCEEECCCTTCEECCSSS-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-----
T ss_pred ECCCCcEEEeeeeeeeecccCc-cccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----
Confidence 9999999999999998764332 2234567999999999999889999999999999999999999999543211
Q ss_pred hHHHHHHhhcccccccchHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 594 PSIVKVAVLEETTMEVFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 594 ~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
....... ....... .......+.+.+++.+||+.||++|||++|+++.
T Consensus 248 -~~~~~~~-~~~~~~~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 248 -QAMKRLR-DSPPPKL----------KNSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp -HHHHHHH-HSSCCCC----------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred -HHHHHHh-cCCCCCc----------CccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111110 0000000 0011223457789999999999999999999875
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=355.17 Aligned_cols=278 Identities=26% Similarity=0.427 Sum_probs=217.8
Q ss_pred ccccHHHHHHhhc-----------CccccCCceEEEEEEeCCCCEEEEEEcccCc----ccCcccHHHHHHHHhccCCCC
Q 005749 370 EHLTLEDVLNATG-----------QVIEKTTYGTAYKAKLADGATIALRLLREGS----CKDRSSCLPVIRQLGKVRHEN 434 (679)
Q Consensus 370 ~~~~~~~l~~~~~-----------~~ig~G~~g~Vy~~~~~~~~~vAvK~~~~~~----~~~~~~~~~Ei~~l~~l~H~n 434 (679)
..|+++++..++. +.||+|+||.||+|+. +++.||||++.... ....+.+.+|++++++++|||
T Consensus 13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 91 (307)
T 2nru_A 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN 91 (307)
T ss_dssp EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTT
T ss_pred CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCC
Confidence 4578888887763 6799999999999997 58899999987542 122457899999999999999
Q ss_pred CccceEEeeCCCCceEEEEEecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee
Q 005749 435 LIPLRAFYQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLV 514 (679)
Q Consensus 435 Iv~l~~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl 514 (679)
|+++++++.+ .+..++||||+++|+|.+++..... ...+++..++.++.|++.||+|||+++ |+||||||+||++
T Consensus 92 i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili 166 (307)
T 2nru_A 92 LVELLGFSSD-GDDLCLVYVYMPNGSLLDRLSCLDG-TPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILL 166 (307)
T ss_dssp BCCEEEEECS-SSSCEEEEECCTTCBHHHHHHTGGG-CCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred eEEEEEEEec-CCceEEEEEecCCCcHHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEE
Confidence 9999999987 6789999999999999999975432 356899999999999999999999988 9999999999999
Q ss_pred cCCCceEEeecccccccCcccc-cchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccch
Q 005749 515 DDFFVSRLTEFGLDQLMVPAVA-DEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDL 593 (679)
Q Consensus 515 ~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l 593 (679)
++++.+||+|||+++....... .......||+.|+|||.+.+ .++.++||||||+++|||++|+.||........ +
T Consensus 167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~ 243 (307)
T 2nru_A 167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQL--L 243 (307)
T ss_dssp CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSB--T
T ss_pred cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHH--H
Confidence 9999999999999986543221 12234578999999998864 588999999999999999999999965443321 1
Q ss_pred hHHHHHHhhcccccccchHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCC
Q 005749 594 PSIVKVAVLEETTMEVFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRP 659 (679)
Q Consensus 594 ~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 659 (679)
..+....... ...+...+..............+.+++.+||+.||++|||++|+++.|+++..
T Consensus 244 ~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 244 LDIKEEIEDE---EKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp THHHHHHHTT---SCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred HHHHHHhhhh---hhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 2222211111 11111111112223345566778899999999999999999999999999864
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=379.17 Aligned_cols=252 Identities=23% Similarity=0.332 Sum_probs=203.2
Q ss_pred cCccccCCceEEEEEEeC-CCCEEEEEEcccCcc-cCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCC
Q 005749 382 GQVIEKTTYGTAYKAKLA-DGATIALRLLREGSC-KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSR 459 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~g 459 (679)
.+.||+|+||.||+|+.. +++.||||.++.... ...+.|.+|+++|++++|||||++++++.. .+..++||||+++|
T Consensus 119 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~~lv~e~~~~g 197 (377)
T 3cbl_A 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ-KQPIYIVMELVQGG 197 (377)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECS-SSSCEEEEECCTTC
T ss_pred eeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEec-CCCcEEEEEcCCCC
Confidence 478999999999999965 799999999976432 234678999999999999999999999987 67899999999999
Q ss_pred ChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccch
Q 005749 460 TLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEM 539 (679)
Q Consensus 460 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 539 (679)
+|.++++.. ...+++..++.++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++..........
T Consensus 198 ~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~ 271 (377)
T 3cbl_A 198 DFLTFLRTE---GARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAAS 271 (377)
T ss_dssp BHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECC
T ss_pred CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeec
Confidence 999999764 235899999999999999999999988 99999999999999999999999999986543322111
Q ss_pred -hcccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhc
Q 005749 540 -VALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKG 617 (679)
Q Consensus 540 -~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~ 617 (679)
....++..|+|||.+.+..++.++|||||||++|||++ |+.||.+.... .... .+..+
T Consensus 272 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~---~~~~-----------------~~~~~ 331 (377)
T 3cbl_A 272 GGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ---QTRE-----------------FVEKG 331 (377)
T ss_dssp SSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH---HHHH-----------------HHHTT
T ss_pred CCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHH-----------------HHHcC
Confidence 12235678999999998889999999999999999998 99998543221 1111 01111
Q ss_pred CCCCh-HHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCCC
Q 005749 618 IRSPM-EEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRPR 660 (679)
Q Consensus 618 ~~~~~-~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 660 (679)
.+.+. .....++.+++.+||+.||++|||++++++.|+++...
T Consensus 332 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 332 GRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 11111 12234677899999999999999999999999988643
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=360.69 Aligned_cols=244 Identities=18% Similarity=0.297 Sum_probs=200.6
Q ss_pred CccccCCceEEEEEE-eCCCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCCh
Q 005749 383 QVIEKTTYGTAYKAK-LADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRTL 461 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gsL 461 (679)
+.||+|+||+||+|+ ..+++.||||++........+.+.+|+.++++++|||||++++++.. .+..++||||+++|+|
T Consensus 26 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~e~~~~~~L 104 (297)
T 3fxz_A 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-GDELWVVMEYLAGGSL 104 (297)
T ss_dssp EEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEEEEECCTTCBH
T ss_pred eeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEE-CCEEEEEEECCCCCCH
Confidence 689999999999999 56799999999977665667789999999999999999999999987 6789999999999999
Q ss_pred HHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccchhc
Q 005749 462 HDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVA 541 (679)
Q Consensus 462 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 541 (679)
.+++... .+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++...... .....
T Consensus 105 ~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 175 (297)
T 3fxz_A 105 TDVVTET-----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-SKRST 175 (297)
T ss_dssp HHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-CCBCC
T ss_pred HHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc-cccCC
Confidence 9999753 4899999999999999999999988 9999999999999999999999999998764432 22345
Q ss_pred ccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcCCCC
Q 005749 542 LAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIRSP 621 (679)
Q Consensus 542 ~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~~~ 621 (679)
..||+.|+|||++.+..++.++|||||||++|||++|+.||...... ........... .. ...
T Consensus 176 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~~~~~~~~~~~-~~----------~~~ 238 (297)
T 3fxz_A 176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL------RALYLIATNGT-PE----------LQN 238 (297)
T ss_dssp CCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHHCS-CC----------CSC
T ss_pred ccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCC-CC----------CCC
Confidence 67999999999999999999999999999999999999999543211 11110000000 00 011
Q ss_pred hHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 622 MEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 622 ~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
.+.....+.+++.+||+.||++|||++|+++.
T Consensus 239 ~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 239 PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 12223557789999999999999999999874
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-43 Score=367.63 Aligned_cols=265 Identities=21% Similarity=0.322 Sum_probs=201.5
Q ss_pred cCccccCCceEEEEEEeCCCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCCC---CceEEEEEecCC
Q 005749 382 GQVIEKTTYGTAYKAKLADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKR---GEKLLIYDYFPS 458 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~---~~~~lv~ey~~~ 458 (679)
.++||+|+||+||+|+.. ++.||||++.... .....+.+|+.++++++|||||++++++.... ...++||||+++
T Consensus 29 ~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~ 106 (322)
T 3soc_A 29 LEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEK 106 (322)
T ss_dssp EEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTT
T ss_pred hheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecCCC
Confidence 378999999999999975 7899999996542 22345677899999999999999999988632 247999999999
Q ss_pred CChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcC----------CCCCeeecCCCCCCeeecCCCceEEeecccc
Q 005749 459 RTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTG----------HEIPITHGNVRSKNVLVDDFFVSRLTEFGLD 528 (679)
Q Consensus 459 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~----------~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 528 (679)
|+|.++++. ..+++..++.|+.|++.||+|||+. + |+||||||+|||++.++.+||+|||++
T Consensus 107 g~L~~~l~~-----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL~DFg~a 178 (322)
T 3soc_A 107 GSLSDFLKA-----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACIADFGLA 178 (322)
T ss_dssp CBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred CCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEEccCCcc
Confidence 999999975 2489999999999999999999987 6 999999999999999999999999999
Q ss_pred cccCcccc-cchhcccccccccccccccc-----cCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhh
Q 005749 529 QLMVPAVA-DEMVALAKADGYKAPELQRM-----KKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVL 602 (679)
Q Consensus 529 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-----~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~ 602 (679)
+....... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+............. ..
T Consensus 179 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~---~~ 255 (322)
T 3soc_A 179 LKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEI---GQ 255 (322)
T ss_dssp EEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHH---CS
T ss_pred cccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhh---cc
Confidence 87643322 12334578999999999886 35667899999999999999999999665433222111100 00
Q ss_pred cccccccchHhhhhcCCC------ChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCC
Q 005749 603 EETTMEVFDMEIMKGIRS------PMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRP 659 (679)
Q Consensus 603 ~~~~~~~~~~~i~~~~~~------~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 659 (679)
.....+..+.......++ .......++.+++.+||+.||++|||++||++.|+++..
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~ 318 (322)
T 3soc_A 256 HPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR 318 (322)
T ss_dssp SCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 000000000000111111 112345668899999999999999999999999998753
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-43 Score=383.82 Aligned_cols=253 Identities=21% Similarity=0.378 Sum_probs=206.9
Q ss_pred cCccccCCceEEEEEEeCCCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCCh
Q 005749 382 GQVIEKTTYGTAYKAKLADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRTL 461 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gsL 461 (679)
.+.||+|+||.||+|+..++..||||+++... ...+.|.+|+++|++++|||||++++++.. +..++|||||++|+|
T Consensus 193 ~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~--~~~~lv~e~~~~g~L 269 (454)
T 1qcf_A 193 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK--EPIYIITEFMAKGSL 269 (454)
T ss_dssp EEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEECS--SSCEEEECCCTTCBH
T ss_pred EEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEeC--CccEEEEeecCCCcH
Confidence 47899999999999999889999999998643 346789999999999999999999999864 578999999999999
Q ss_pred HHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccchhc
Q 005749 462 HDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVA 541 (679)
Q Consensus 462 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 541 (679)
.++++... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++............
T Consensus 270 ~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~ 344 (454)
T 1qcf_A 270 LDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREG 344 (454)
T ss_dssp HHHHHSHH--HHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHTTCS
T ss_pred HHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceeccCC
Confidence 99997542 234789999999999999999999988 9999999999999999999999999998764432222233
Q ss_pred ccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcCCC
Q 005749 542 LAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIRS 620 (679)
Q Consensus 542 ~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~~ 620 (679)
..++..|+|||++....++.++|||||||++|||++ |+.||.+.... +... .+..+.+.
T Consensus 345 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~------~~~~--------------~i~~~~~~ 404 (454)
T 1qcf_A 345 AKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP------EVIR--------------ALERGYRM 404 (454)
T ss_dssp SSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH------HHHH--------------HHHHTCCC
T ss_pred CcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH------HHHH--------------HHHcCCCC
Confidence 456788999999998899999999999999999999 99999543221 1111 11111111
Q ss_pred C-hHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCCCCC
Q 005749 621 P-MEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRPRNR 662 (679)
Q Consensus 621 ~-~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 662 (679)
+ ......++.+++.+||+.||++||||++|++.|+++.....
T Consensus 405 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~~ 447 (454)
T 1qcf_A 405 PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATE 447 (454)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSSC
T ss_pred CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhccc
Confidence 1 12233567789999999999999999999999999875443
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-43 Score=368.17 Aligned_cols=253 Identities=21% Similarity=0.365 Sum_probs=201.8
Q ss_pred cCccccCCceEEEEEEeC----CCCEEEEEEcccCc-ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEec
Q 005749 382 GQVIEKTTYGTAYKAKLA----DGATIALRLLREGS-CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYF 456 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~----~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~ 456 (679)
.+.||+|+||.||+|+.. .+..||||+++... ....+.+.+|++++++++||||+++++++.+ .+..++||||+
T Consensus 54 ~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~ 132 (325)
T 3kul_A 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTR-GRLAMIVTEYM 132 (325)
T ss_dssp EEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECG-GGCCEEEEECC
T ss_pred eeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe-CCccEEEeeCC
Confidence 378999999999999963 34469999997643 2345679999999999999999999999987 67899999999
Q ss_pred CCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccc
Q 005749 457 PSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVA 536 (679)
Q Consensus 457 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 536 (679)
++|+|.++++.. ...+++..++.|+.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 133 ~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 206 (325)
T 3kul_A 133 ENGSLDTFLRTH---DGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPD 206 (325)
T ss_dssp TTCBHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC----
T ss_pred CCCcHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccccCcc
Confidence 999999999754 345899999999999999999999988 99999999999999999999999999987643321
Q ss_pred c--chhcccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHHhhcccccccchHh
Q 005749 537 D--EMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDME 613 (679)
Q Consensus 537 ~--~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 613 (679)
. ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||...... .....
T Consensus 207 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~------~~~~~-------------- 266 (325)
T 3kul_A 207 AAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR------DVISS-------------- 266 (325)
T ss_dssp CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH------HHHHH--------------
T ss_pred ceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH------HHHHH--------------
Confidence 1 1223346778999999998889999999999999999999 99999543221 11111
Q ss_pred hhhcCC-CChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCCCC
Q 005749 614 IMKGIR-SPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRPRN 661 (679)
Q Consensus 614 i~~~~~-~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 661 (679)
+..+.. +........+.+++.+||+.||++|||+.||++.|+++....
T Consensus 267 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~ 315 (325)
T 3kul_A 267 VEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP 315 (325)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred HHcCCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence 111111 111223356778999999999999999999999999987543
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-43 Score=368.54 Aligned_cols=241 Identities=18% Similarity=0.287 Sum_probs=198.8
Q ss_pred CccccCCceEEEEEEe-CCCCEEEEEEcccCcc--cCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCC
Q 005749 383 QVIEKTTYGTAYKAKL-ADGATIALRLLREGSC--KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSR 459 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~g 459 (679)
+.||+|+||.||+|+. .+|+.||||++..... ...+.+.+|+++++.++||||+++++++.+ .+..++||||+++|
T Consensus 21 ~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-~~~~~lv~e~~~~~ 99 (328)
T 3fe3_A 21 KTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIET-EKTLYLIMEYASGG 99 (328)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEEEECCCTTC
T ss_pred EEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-CCEEEEEEECCCCC
Confidence 7899999999999995 6899999999975432 234568899999999999999999999987 68899999999999
Q ss_pred ChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccch
Q 005749 460 TLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEM 539 (679)
Q Consensus 460 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 539 (679)
+|.+++... ..+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++..... ...
T Consensus 100 ~L~~~l~~~----~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~--~~~ 170 (328)
T 3fe3_A 100 EVFDYLVAH----GRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG--GKL 170 (328)
T ss_dssp BHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS--CGG
T ss_pred cHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCC--Ccc
Confidence 999999764 34899999999999999999999988 999999999999999999999999999866433 234
Q ss_pred hcccccccccccccccccCCC-CcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcC
Q 005749 540 VALAKADGYKAPELQRMKKCS-SRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGI 618 (679)
Q Consensus 540 ~~~~gt~~y~aPE~~~~~~~~-~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~ 618 (679)
...+||+.|+|||++.+..+. .++||||+||++|||++|+.||.+... ..... .+..+.
T Consensus 171 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~------~~~~~--------------~i~~~~ 230 (328)
T 3fe3_A 171 DAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL------KELRE--------------RVLRGK 230 (328)
T ss_dssp GTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHH--------------HHHHCC
T ss_pred ccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCH------HHHHH--------------HHHhCC
Confidence 566899999999999887765 799999999999999999999954321 11111 111111
Q ss_pred CCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 619 RSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 619 ~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
........+++.+++.+||+.||++|||++|+++.
T Consensus 231 ~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 231 YRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp CCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred CCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 11111223567789999999999999999999875
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=363.46 Aligned_cols=243 Identities=19% Similarity=0.270 Sum_probs=199.1
Q ss_pred cCccccCCceEEEEEEe-CCCCEEEEEEcccC---cccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecC
Q 005749 382 GQVIEKTTYGTAYKAKL-ADGATIALRLLREG---SCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFP 457 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~ 457 (679)
.+.||+|+||+||+|+. .+|+.||+|+++.. .....+.+.+|++++++++||||+++++++.+ .+..++||||++
T Consensus 10 ~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~~lv~E~~~ 88 (337)
T 1o6l_A 10 LKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT-HDRLCFVMEYAN 88 (337)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC-SSEEEEEEECCT
T ss_pred EEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEe-CCEEEEEEeCCC
Confidence 37899999999999995 46999999999754 23345678899999999999999999999998 678999999999
Q ss_pred CCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCccccc
Q 005749 458 SRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVAD 537 (679)
Q Consensus 458 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 537 (679)
+|+|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..... ..
T Consensus 89 gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~-~~ 160 (337)
T 1o6l_A 89 GGELFFHLSRE----RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-GA 160 (337)
T ss_dssp TCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT-TC
T ss_pred CCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcccC-CC
Confidence 99999999763 45899999999999999999999988 999999999999999999999999999864322 22
Q ss_pred chhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhc
Q 005749 538 EMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKG 617 (679)
Q Consensus 538 ~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~ 617 (679)
.....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.... ...... ..+
T Consensus 161 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~------~~~~~i--------------~~~ 220 (337)
T 1o6l_A 161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------RLFELI--------------LME 220 (337)
T ss_dssp CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHH--------------HHC
T ss_pred cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHH------HHHHHH--------------HcC
Confidence 334567999999999999999999999999999999999999999543211 111111 111
Q ss_pred CCCChHHHHHHHHHHHHhccCcCCCCCC-----CHHHHHHH
Q 005749 618 IRSPMEEGLVQALKLAMGCCAPVASVRP-----TMDEVVKQ 653 (679)
Q Consensus 618 ~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~evl~~ 653 (679)
.........+++.+++.+||+.||++|| +++|++++
T Consensus 221 ~~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 221 EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred CCCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 1111112235677899999999999999 89999775
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=366.83 Aligned_cols=251 Identities=21% Similarity=0.311 Sum_probs=195.6
Q ss_pred cCccccCCceEEEEEEe-CCCCE----EEEEEcccCc-ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEe
Q 005749 382 GQVIEKTTYGTAYKAKL-ADGAT----IALRLLREGS-CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDY 455 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~-~~~~~----vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey 455 (679)
.+.||+|+||+||+|+. .+++. ||+|.++... ....+.+.+|++++++++|||||+++++|.+ +..++|+||
T Consensus 20 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~v~e~ 97 (327)
T 3poz_A 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT--STVQLITQL 97 (327)
T ss_dssp EEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEES--SSEEEEEEC
T ss_pred ceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec--CCeEEEEEe
Confidence 37899999999999994 44543 5888886543 3445679999999999999999999999986 458899999
Q ss_pred cCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCccc
Q 005749 456 FPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAV 535 (679)
Q Consensus 456 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 535 (679)
+++|+|.+++... ...+++..++.|+.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 98 ~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 171 (327)
T 3poz_A 98 MPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171 (327)
T ss_dssp CTTCBHHHHHHHS---TTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTC
T ss_pred cCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEccCCc
Confidence 9999999999864 345899999999999999999999988 9999999999999999999999999998764332
Q ss_pred c-cchhcccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHHhhcccccccchHh
Q 005749 536 A-DEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDME 613 (679)
Q Consensus 536 ~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 613 (679)
. .......+|..|+|||++.+..++.++|||||||++|||++ |+.||.+.... .+...+
T Consensus 172 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~~~~---------------- 232 (327)
T 3poz_A 172 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---EISSIL---------------- 232 (327)
T ss_dssp C-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHHHH----------------
T ss_pred ccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHH---HHHHHH----------------
Confidence 2 12234456889999999999999999999999999999999 99999543322 111111
Q ss_pred hhhcC-CCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCCC
Q 005749 614 IMKGI-RSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRPR 660 (679)
Q Consensus 614 i~~~~-~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 660 (679)
..+. ....+.....+.+++.+||+.||++||++.|+++.|+++...
T Consensus 233 -~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 233 -EKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp -HTTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred -HcCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 1111 111222345677899999999999999999999999987643
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-43 Score=374.40 Aligned_cols=251 Identities=21% Similarity=0.404 Sum_probs=191.9
Q ss_pred cCccccCCceEEEEEEeC----CCCEEEEEEcccCc-ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEec
Q 005749 382 GQVIEKTTYGTAYKAKLA----DGATIALRLLREGS-CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYF 456 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~----~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~ 456 (679)
.+.||+|+||.||+|+.. ++..||||+++... ....+.|.+|++++++++|||||++++++.+ .+..++||||+
T Consensus 50 ~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~ 128 (373)
T 2qol_A 50 DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK-SKPVMIVTEYM 128 (373)
T ss_dssp CEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSSCEEEEECC
T ss_pred eeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee-CCceEEEEeCC
Confidence 478999999999999854 57789999997653 2345679999999999999999999999987 67899999999
Q ss_pred CCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccc
Q 005749 457 PSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVA 536 (679)
Q Consensus 457 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 536 (679)
++|+|.++++.. ...+++.+++.|+.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 129 ~~~sL~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 202 (373)
T 2qol_A 129 ENGSLDSFLRKH---DAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPE 202 (373)
T ss_dssp TTCBHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred CCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccccccCCc
Confidence 999999999764 345899999999999999999999988 99999999999999999999999999987643321
Q ss_pred cc--hhcccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHHhhcccccccchHh
Q 005749 537 DE--MVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDME 613 (679)
Q Consensus 537 ~~--~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 613 (679)
.. .....++..|+|||++.+..++.++|||||||++|||++ |+.||...... +....
T Consensus 203 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~------~~~~~-------------- 262 (373)
T 2qol_A 203 AAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ------DVIKA-------------- 262 (373)
T ss_dssp -----------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH------HHHHH--------------
T ss_pred cceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH------HHHHH--------------
Confidence 11 122345678999999998899999999999999999998 99999543221 11111
Q ss_pred hhhcCC-CChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCC
Q 005749 614 IMKGIR-SPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRP 659 (679)
Q Consensus 614 i~~~~~-~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 659 (679)
+..+.+ +........+.+++.+||+.||++||+++||++.|+++..
T Consensus 263 i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 309 (373)
T 2qol_A 263 VDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309 (373)
T ss_dssp HHTTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHcCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHh
Confidence 111111 1112233567789999999999999999999999998854
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=355.71 Aligned_cols=250 Identities=20% Similarity=0.351 Sum_probs=202.8
Q ss_pred cCccccCCceEEEEEEeCCCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCCh
Q 005749 382 GQVIEKTTYGTAYKAKLADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRTL 461 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gsL 461 (679)
.+.||+|+||.||+|+..++..||+|+++... ...+++.+|++++.+++||||+++++++.+ .+..++||||+++++|
T Consensus 29 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L 106 (283)
T 3gen_A 29 LKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTK-QRPIFIITEYMANGCL 106 (283)
T ss_dssp EEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSSEEEEECCCTTCBH
T ss_pred HhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEec-CCCeEEEEeccCCCcH
Confidence 37899999999999999888899999998643 234679999999999999999999999987 6789999999999999
Q ss_pred HHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccchhc
Q 005749 462 HDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVA 541 (679)
Q Consensus 462 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 541 (679)
.+++... ...+++..++.++.|++.||+|||+++ |+||||||+||++++++.+||+|||+++............
T Consensus 107 ~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 180 (283)
T 3gen_A 107 LNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG 180 (283)
T ss_dssp HHHHHCG---GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHSTTS
T ss_pred HHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccccccccccccC
Confidence 9999764 235899999999999999999999988 9999999999999999999999999998765443333344
Q ss_pred ccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcCCC
Q 005749 542 LAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIRS 620 (679)
Q Consensus 542 ~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~~ 620 (679)
..+|+.|+|||.+.+..++.++||||+|+++|||++ |+.||...... ..... +..+...
T Consensus 181 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~------~~~~~--------------~~~~~~~ 240 (283)
T 3gen_A 181 SKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS------ETAEH--------------IAQGLRL 240 (283)
T ss_dssp TTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH------HHHHH--------------HHTTCCC
T ss_pred CccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh------HHHHH--------------HhcccCC
Confidence 567788999999998889999999999999999998 99998543211 11110 1111111
Q ss_pred -ChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCC
Q 005749 621 -PMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRP 659 (679)
Q Consensus 621 -~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 659 (679)
........+.+++.+||+.||++|||++|+++.|+++..
T Consensus 241 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~ 280 (283)
T 3gen_A 241 YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 280 (283)
T ss_dssp CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhh
Confidence 111123567789999999999999999999999998754
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-42 Score=354.90 Aligned_cols=258 Identities=17% Similarity=0.242 Sum_probs=200.5
Q ss_pred CccccCCceEEEEEE-eCCCCEEEEEEcccCccc---CcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCC
Q 005749 383 QVIEKTTYGTAYKAK-LADGATIALRLLREGSCK---DRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPS 458 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~---~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~ 458 (679)
+.||+|+||.||+|+ ..+++.||+|.+...... ..+.+.+|++++.+++||||+++++++.+ .+..++||||+++
T Consensus 17 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~e~~~g 95 (294)
T 4eqm_A 17 DKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEE-DDCYYLVMEYIEG 95 (294)
T ss_dssp EEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEEC-SSEEEEEEECCCS
T ss_pred EEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeee-CCeEEEEEeCCCC
Confidence 789999999999999 457999999998654322 23578899999999999999999999987 6789999999999
Q ss_pred CChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccc
Q 005749 459 RTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADE 538 (679)
Q Consensus 459 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 538 (679)
++|.+++... ..+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++.........
T Consensus 96 ~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 168 (294)
T 4eqm_A 96 PTLSEYIESH----GPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ 168 (294)
T ss_dssp CBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC-------
T ss_pred CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCccccccccccc
Confidence 9999999764 35899999999999999999999988 9999999999999999999999999998765443333
Q ss_pred hhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcC
Q 005749 539 MVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGI 618 (679)
Q Consensus 539 ~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~ 618 (679)
.....||+.|+|||.+.+..++.++||||+|+++|||++|+.||.+.... ........... . .. ....
T Consensus 169 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~------~~~~~~~~~~~-~-~~----~~~~ 236 (294)
T 4eqm_A 169 TNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAV------SIAIKHIQDSV-P-NV----TTDV 236 (294)
T ss_dssp ------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHH------HHHHHHHSSCC-C-CH----HHHS
T ss_pred cCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHhhccC-C-Cc----chhc
Confidence 44567999999999999999999999999999999999999999543211 11111111000 0 00 0000
Q ss_pred CCChHHHHHHHHHHHHhccCcCCCCCC-CHHHHHHHHHhhCCCCCC
Q 005749 619 RSPMEEGLVQALKLAMGCCAPVASVRP-TMDEVVKQLEENRPRNRS 663 (679)
Q Consensus 619 ~~~~~~~~~~~~~l~~~cl~~dP~~RP-s~~evl~~L~~~~~~~~~ 663 (679)
.. .....+.+++.+||+.||++|| +++++.+.|+++....+.
T Consensus 237 ~~---~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~~ 279 (294)
T 4eqm_A 237 RK---DIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRA 279 (294)
T ss_dssp CT---TSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSST
T ss_pred cc---CCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhccC
Confidence 11 1234567899999999999998 999999999998765443
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=379.68 Aligned_cols=255 Identities=23% Similarity=0.373 Sum_probs=202.0
Q ss_pred cCccccCCceEEEEEEeCCCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCCh
Q 005749 382 GQVIEKTTYGTAYKAKLADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRTL 461 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gsL 461 (679)
.+.||+|+||.||+|+..++..||||+++... ...+.|.+|+++|++++|||||++++++.+ +..++|||||++|+|
T Consensus 189 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~iv~e~~~~gsL 265 (452)
T 1fmk_A 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE--EPIYIVTEYMSKGSL 265 (452)
T ss_dssp EEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSCEEEECCCTTCBH
T ss_pred eeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC--CceEEEehhhcCCCH
Confidence 47899999999999999888899999998643 345689999999999999999999999875 578999999999999
Q ss_pred HHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccchhc
Q 005749 462 HDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVA 541 (679)
Q Consensus 462 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 541 (679)
.+++.... ...+++..++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++............
T Consensus 266 ~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~ 340 (452)
T 1fmk_A 266 LDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 340 (452)
T ss_dssp HHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC------------
T ss_pred HHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCCceecccC
Confidence 99997532 235899999999999999999999988 9999999999999999999999999998764432222334
Q ss_pred ccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcCCC
Q 005749 542 LAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIRS 620 (679)
Q Consensus 542 ~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~~ 620 (679)
..++..|+|||.+....++.++|||||||++|||++ |+.||.+.... +... .+..+.+.
T Consensus 341 ~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~------~~~~--------------~i~~~~~~ 400 (452)
T 1fmk_A 341 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR------EVLD--------------QVERGYRM 400 (452)
T ss_dssp --CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH------HHHH--------------HHHTTCCC
T ss_pred CcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH------HHHH--------------HHHcCCCC
Confidence 456788999999998899999999999999999999 99998543221 1111 11122111
Q ss_pred C-hHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCCCCCCC
Q 005749 621 P-MEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRPRNRSA 664 (679)
Q Consensus 621 ~-~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~ 664 (679)
+ .+.....+.+++.+||+.||++|||++++++.|+++.....+.
T Consensus 401 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~~ 445 (452)
T 1fmk_A 401 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 445 (452)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCC
T ss_pred CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCcc
Confidence 1 1223356778999999999999999999999999987654443
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-42 Score=375.97 Aligned_cols=247 Identities=25% Similarity=0.380 Sum_probs=202.7
Q ss_pred cCccccCCceEEEEEEeCCCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCCh
Q 005749 382 GQVIEKTTYGTAYKAKLADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRTL 461 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gsL 461 (679)
.+.||+|+||.||+|+.. |+.||||+++... ..+.|.+|+++|++++|||||++++++....+..++|||||++|+|
T Consensus 198 ~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L 274 (450)
T 1k9a_A 198 LQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSL 274 (450)
T ss_dssp EEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBH
T ss_pred EeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcH
Confidence 378999999999999985 7899999997643 4678999999999999999999999988755579999999999999
Q ss_pred HHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccchhc
Q 005749 462 HDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVA 541 (679)
Q Consensus 462 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 541 (679)
.++++... ...+++..++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++..... ...
T Consensus 275 ~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~----~~~ 345 (450)
T 1k9a_A 275 VDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----QDT 345 (450)
T ss_dssp HHHHHHHC--TTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC---------
T ss_pred HHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccccc----ccC
Confidence 99998652 334799999999999999999999988 999999999999999999999999999854321 123
Q ss_pred ccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcCCC
Q 005749 542 LAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIRS 620 (679)
Q Consensus 542 ~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~~ 620 (679)
..++..|+|||.+.+..++.++|||||||++|||++ |+.||......+. .. .+..+.+.
T Consensus 346 ~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~---~~-----------------~i~~~~~~ 405 (450)
T 1k9a_A 346 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---VP-----------------RVEKGYKM 405 (450)
T ss_dssp -CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTH---HH-----------------HHHTTCCC
T ss_pred CCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HH-----------------HHHcCCCC
Confidence 357888999999999999999999999999999998 9999965433211 11 11122111
Q ss_pred C-hHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCCC
Q 005749 621 P-MEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRPR 660 (679)
Q Consensus 621 ~-~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 660 (679)
. .....+++.+++.+||+.||++|||+.|+++.|+++...
T Consensus 406 ~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 406 DAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 1 122335677899999999999999999999999988643
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=353.26 Aligned_cols=256 Identities=24% Similarity=0.315 Sum_probs=195.4
Q ss_pred cCccccCCceEEEEEEeCCCCEEEEEEcccCcccCcccHHHHHHHHhc--cCCCCCccceEEeeCC---CCceEEEEEec
Q 005749 382 GQVIEKTTYGTAYKAKLADGATIALRLLREGSCKDRSSCLPVIRQLGK--VRHENLIPLRAFYQGK---RGEKLLIYDYF 456 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~--l~H~nIv~l~~~~~~~---~~~~~lv~ey~ 456 (679)
.+.||+|+||+||+|+. +++.||||++... ..+.+.+|.+++.. ++||||+++++++... ....++||||+
T Consensus 13 ~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~ 88 (301)
T 3q4u_A 13 LECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYH 88 (301)
T ss_dssp EEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEECCC
T ss_pred EEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehhhc
Confidence 37899999999999998 6899999998653 34456677777666 7999999999987542 34589999999
Q ss_pred CCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHh--------cCCCCCeeecCCCCCCeeecCCCceEEeecccc
Q 005749 457 PSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLH--------TGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLD 528 (679)
Q Consensus 457 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH--------~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 528 (679)
++|+|.++++. ..+++..+++|+.|++.||+||| +.+ |+||||||+|||++.++.+||+|||++
T Consensus 89 ~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~a 160 (301)
T 3q4u_A 89 EMGSLYDYLQL-----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIADLGLA 160 (301)
T ss_dssp TTCBHHHHHTT-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred cCCCHHHHHhh-----cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEeeCCCe
Confidence 99999999964 35899999999999999999999 666 999999999999999999999999999
Q ss_pred cccCccccc---chhccccccccccccccccc------CCCCcchhHHHHHHHHHHHhC----------CCCCCCCCCCc
Q 005749 529 QLMVPAVAD---EMVALAKADGYKAPELQRMK------KCSSRTDVYAFGILLLEILIG----------KKPGKSGRNGE 589 (679)
Q Consensus 529 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~k~DV~S~Gvvl~El~tg----------~~p~~~~~~~~ 589 (679)
+........ ......||+.|+|||++.+. .+++++|||||||++|||++| +.||......+
T Consensus 161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~ 240 (301)
T 3q4u_A 161 VMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPND 240 (301)
T ss_dssp EEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS
T ss_pred eecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCC
Confidence 765433221 12334799999999998866 455799999999999999999 77875433221
Q ss_pred ccchhHHHHHHhhcccccccchHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhh
Q 005749 590 FVDLPSIVKVAVLEETTMEVFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEEN 657 (679)
Q Consensus 590 ~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 657 (679)
. .................. ... ........++.+++.+||+.||++|||+.||++.|+++
T Consensus 241 ~-~~~~~~~~~~~~~~~~~~-~~~------~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 241 P-SFEDMRKVVCVDQQRPNI-PNR------WFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp C-CHHHHHHHHTTSCCCCCC-CGG------GGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred c-chhhhhHHHhccCCCCCC-Chh------hccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 1 111111111111100000 000 01123557788999999999999999999999999986
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=357.26 Aligned_cols=264 Identities=19% Similarity=0.297 Sum_probs=201.1
Q ss_pred cCccccCCceEEEEEEe-----CCCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCC-CCceEEEEEe
Q 005749 382 GQVIEKTTYGTAYKAKL-----ADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGK-RGEKLLIYDY 455 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~-----~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~-~~~~~lv~ey 455 (679)
.+.||+|+||+||+|++ .+++.||||++........+.+.+|++++++++||||+++++++... ....++||||
T Consensus 15 ~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~ 94 (295)
T 3ugc_A 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEY 94 (295)
T ss_dssp EEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEEEEEC
T ss_pred hheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEEEEEe
Confidence 37899999999999984 36889999999876555567899999999999999999999998642 3458999999
Q ss_pred cCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCccc
Q 005749 456 FPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAV 535 (679)
Q Consensus 456 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 535 (679)
+++|+|.+++... ...+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 95 ~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 168 (295)
T 3ugc_A 95 LPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 168 (295)
T ss_dssp CTTCBHHHHHHHC---GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC------
T ss_pred CCCCCHHHHHHhc---ccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCcccccccCCc
Confidence 9999999999764 235899999999999999999999988 9999999999999999999999999998764332
Q ss_pred c--cchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccc----c
Q 005749 536 A--DEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTME----V 609 (679)
Q Consensus 536 ~--~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~----~ 609 (679)
. .......++..|+|||.+.+..++.++||||||+++|||++|..|+..... .+.... ....... .
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~-------~~~~~~-~~~~~~~~~~~~ 240 (295)
T 3ugc_A 169 EFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA-------EFMRMI-GNDKQGQMIVFH 240 (295)
T ss_dssp -------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHH-------HHHHHH-CTTCCTHHHHHH
T ss_pred ceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChH-------HHHhhh-cCccccchhHHH
Confidence 1 112234577789999999988999999999999999999999999743210 000000 0000000 0
Q ss_pred chHhhhhcCC-CChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCC
Q 005749 610 FDMEIMKGIR-SPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRP 659 (679)
Q Consensus 610 ~~~~i~~~~~-~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 659 (679)
....+..+.+ +.......++.+++.+||+.||++|||++|+++.|+++..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~ 291 (295)
T 3ugc_A 241 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 291 (295)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence 0011111111 1122334667889999999999999999999999998854
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=362.61 Aligned_cols=245 Identities=20% Similarity=0.307 Sum_probs=197.8
Q ss_pred cCccccCCceEEEEEEe-CCCCEEEEEEcccCccc------CcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEE
Q 005749 382 GQVIEKTTYGTAYKAKL-ADGATIALRLLREGSCK------DRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYD 454 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~------~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~e 454 (679)
.+.||+|+||.||+|+. .+|+.||+|.++..... ..+.+.+|++++.+++|||||++++++.+ .+..++|||
T Consensus 17 ~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~~lv~e 95 (361)
T 2yab_A 17 GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYEN-RTDVVLILE 95 (361)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEEEEEE
T ss_pred eeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEe-CCEEEEEEE
Confidence 47899999999999995 46999999999765322 23568999999999999999999999987 678999999
Q ss_pred ecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCC----ceEEeecccccc
Q 005749 455 YFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFF----VSRLTEFGLDQL 530 (679)
Q Consensus 455 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~----~~kl~DFGla~~ 530 (679)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||+++++ .+||+|||+++.
T Consensus 96 ~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~ 168 (361)
T 2yab_A 96 LVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168 (361)
T ss_dssp CCCSCBHHHHHTT----CSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCSSCEE
T ss_pred cCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEecCCceE
Confidence 9999999999975 345999999999999999999999988 99999999999998876 799999999987
Q ss_pred cCcccccchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccc
Q 005749 531 MVPAVADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVF 610 (679)
Q Consensus 531 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 610 (679)
.... .......||+.|+|||++.+..++.++||||+||++|||++|..||.+.... ........ . ...+
T Consensus 169 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~------~~~~~i~~-~--~~~~ 237 (361)
T 2yab_A 169 IEDG--VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ------ETLANITA-V--SYDF 237 (361)
T ss_dssp CCTT--CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH------HHHHHHHT-T--CCCC
T ss_pred cCCC--CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHh-c--CCCC
Confidence 6432 2234567999999999999889999999999999999999999999543211 11110000 0 0001
Q ss_pred hHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHH
Q 005749 611 DMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVK 652 (679)
Q Consensus 611 ~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 652 (679)
+.... ......+.+++.+||..||++|||+.|+++
T Consensus 238 ~~~~~-------~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 238 DEEFF-------SQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp CHHHH-------TTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred Cchhc-------cCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 11110 112346778999999999999999999985
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=382.03 Aligned_cols=251 Identities=22% Similarity=0.325 Sum_probs=206.6
Q ss_pred cCccccCCceEEEEEEeCC-CCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCC
Q 005749 382 GQVIEKTTYGTAYKAKLAD-GATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRT 460 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gs 460 (679)
.+.||+|+||.||+|+... +..||||+++... ...+.|.+|+++|++++|||||+++++|.. .+..++|||||++|+
T Consensus 225 ~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~~lv~E~~~~g~ 302 (495)
T 1opk_A 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR-EPPFYIITEFMTYGN 302 (495)
T ss_dssp EEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSSCEEEEECCTTCB
T ss_pred eeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEec-CCcEEEEEEccCCCC
Confidence 4789999999999999654 8899999997643 346789999999999999999999999987 678999999999999
Q ss_pred hHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccchh
Q 005749 461 LHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMV 540 (679)
Q Consensus 461 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 540 (679)
|.++++... ...+++..++.|+.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...........
T Consensus 303 L~~~l~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 377 (495)
T 1opk_A 303 LLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 377 (495)
T ss_dssp HHHHHHHSC--TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEECCT
T ss_pred HHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCCceeecC
Confidence 999997643 345899999999999999999999988 999999999999999999999999999876543333333
Q ss_pred cccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcCC
Q 005749 541 ALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIR 619 (679)
Q Consensus 541 ~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~ 619 (679)
...++..|+|||++....++.++|||||||++|||++ |+.||.+.... .+... +..+.+
T Consensus 378 ~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~---~~~~~-----------------~~~~~~ 437 (495)
T 1opk_A 378 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---QVYEL-----------------LEKDYR 437 (495)
T ss_dssp TCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GHHHH-----------------HHTTCC
T ss_pred CCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH---HHHHH-----------------HHcCCC
Confidence 4456788999999998889999999999999999999 99998554321 11111 111111
Q ss_pred CC-hHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCC
Q 005749 620 SP-MEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRP 659 (679)
Q Consensus 620 ~~-~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 659 (679)
.. ......++.+++.+||+.||++||||.||++.|+.+..
T Consensus 438 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 438 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred CCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 11 11223567789999999999999999999999998754
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=367.60 Aligned_cols=256 Identities=21% Similarity=0.333 Sum_probs=203.3
Q ss_pred cCccccCCceEEEEEEe------CCCCEEEEEEcccCcc-cCcccHHHHHHHHhcc-CCCCCccceEEeeCCCCceEEEE
Q 005749 382 GQVIEKTTYGTAYKAKL------ADGATIALRLLREGSC-KDRSSCLPVIRQLGKV-RHENLIPLRAFYQGKRGEKLLIY 453 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~------~~~~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~~lv~ 453 (679)
.+.||+|+||.||+|+. .+++.||||+++.... ...+.+.+|++++.++ +|||||++++++.+.....++||
T Consensus 27 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~iv~ 106 (359)
T 3vhe_A 27 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIV 106 (359)
T ss_dssp EEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEE
T ss_pred ceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCceEEEE
Confidence 47899999999999973 3467999999976432 2345789999999999 79999999999987556699999
Q ss_pred EecCCCChHHHhhcccCC--------------------------------------------------------------
Q 005749 454 DYFPSRTLHDLLHDTIAG-------------------------------------------------------------- 471 (679)
Q Consensus 454 ey~~~gsL~~~l~~~~~~-------------------------------------------------------------- 471 (679)
||+++|+|.++++.....
T Consensus 107 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 186 (359)
T 3vhe_A 107 EFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLY 186 (359)
T ss_dssp ECCTTEEHHHHHHTTTTSBCSCC------------------------------------------------------CTT
T ss_pred EecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcccccchh
Confidence 999999999999864321
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCccc-ccchhcccccccccc
Q 005749 472 KPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAV-ADEMVALAKADGYKA 550 (679)
Q Consensus 472 ~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~-~~~~~~~~gt~~y~a 550 (679)
...+++..++.|+.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++...... ........||+.|+|
T Consensus 187 ~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~a 263 (359)
T 3vhe_A 187 KDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 263 (359)
T ss_dssp TTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCC
T ss_pred ccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCceeEC
Confidence 122899999999999999999999988 9999999999999999999999999998664322 222344568889999
Q ss_pred cccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcCC-CChHHHHHH
Q 005749 551 PELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIR-SPMEEGLVQ 628 (679)
Q Consensus 551 PE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~-~~~~~~~~~ 628 (679)
||++.+..++.++|||||||++|||++ |+.||.+....+. +.. .+..+.. .......++
T Consensus 264 PE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~--~~~-----------------~~~~~~~~~~~~~~~~~ 324 (359)
T 3vhe_A 264 PETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--FCR-----------------RLKEGTRMRAPDYTTPE 324 (359)
T ss_dssp HHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH--HHH-----------------HHHHTCCCCCCTTCCHH
T ss_pred hhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH--HHH-----------------HHHcCCCCCCCCCCCHH
Confidence 999998899999999999999999998 9999955433211 101 0111111 111122356
Q ss_pred HHHHHHhccCcCCCCCCCHHHHHHHHHhhCC
Q 005749 629 ALKLAMGCCAPVASVRPTMDEVVKQLEENRP 659 (679)
Q Consensus 629 ~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 659 (679)
+.+++.+||+.||++|||++|++++|+++..
T Consensus 325 l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 355 (359)
T 3vhe_A 325 MYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 355 (359)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 7789999999999999999999999998753
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=361.33 Aligned_cols=250 Identities=20% Similarity=0.378 Sum_probs=198.4
Q ss_pred CccccCCceEEEEEEe-CCCCE----EEEEEcccCc-ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEec
Q 005749 383 QVIEKTTYGTAYKAKL-ADGAT----IALRLLREGS-CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYF 456 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~-~~~~~----vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~ 456 (679)
+.||+|+||+||+|+. .+++. ||+|.+.... ....+.+.+|+.++++++|||||++++++.+ +..++||||+
T Consensus 19 ~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~v~e~~ 96 (325)
T 3kex_A 19 KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG--SSLQLVTQYL 96 (325)
T ss_dssp EEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB--SSEEEEEECC
T ss_pred eeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CccEEEEEeC
Confidence 7899999999999994 44554 7888875543 3445678899999999999999999999864 5799999999
Q ss_pred CCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccc
Q 005749 457 PSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVA 536 (679)
Q Consensus 457 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 536 (679)
++|+|.+++... ...+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 97 ~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 170 (325)
T 3kex_A 97 PLGSLLDHVRQH---RGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDK 170 (325)
T ss_dssp TTCBSHHHHHSS---GGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTT
T ss_pred CCCCHHHHHHHc---cccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccccCcccc
Confidence 999999999764 245889999999999999999999998 99999999999999999999999999987644322
Q ss_pred c-chhcccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHHhhcccccccchHhh
Q 005749 537 D-EMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEI 614 (679)
Q Consensus 537 ~-~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i 614 (679)
. ......++..|+|||++.+..++.++|||||||++|||++ |+.||.+....+ ....+.
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~~~---------------- 231 (325)
T 3kex_A 171 QLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE---VPDLLE---------------- 231 (325)
T ss_dssp CCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH---HHHHHH----------------
T ss_pred cccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH---HHHHHH----------------
Confidence 2 2234567889999999998899999999999999999999 999996543321 111111
Q ss_pred hhcCC-CChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCCC
Q 005749 615 MKGIR-SPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRPR 660 (679)
Q Consensus 615 ~~~~~-~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 660 (679)
.+.. ........++.+++.+||+.||++||++.|+++.|+++...
T Consensus 232 -~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~ 277 (325)
T 3kex_A 232 -KGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277 (325)
T ss_dssp -TTCBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred -cCCCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 1000 11111223566799999999999999999999999998643
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-42 Score=363.12 Aligned_cols=257 Identities=20% Similarity=0.320 Sum_probs=203.4
Q ss_pred cCccccCCceEEEEEEeC------CCCEEEEEEcccCcc-cCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEE
Q 005749 382 GQVIEKTTYGTAYKAKLA------DGATIALRLLREGSC-KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYD 454 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~------~~~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~e 454 (679)
.+.||+|+||.||+|+.. +++.||||+++.... ...+.+.+|++++++++||||+++++++.+ .+..++|||
T Consensus 52 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~e 130 (343)
T 1luf_A 52 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV-GKPMCLLFE 130 (343)
T ss_dssp EEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSSCEEEEE
T ss_pred eeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc-CCceEEEEe
Confidence 368999999999999963 358999999976532 235678999999999999999999999987 678999999
Q ss_pred ecCCCChHHHhhcccCC--------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee
Q 005749 455 YFPSRTLHDLLHDTIAG--------------------KPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLV 514 (679)
Q Consensus 455 y~~~gsL~~~l~~~~~~--------------------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl 514 (679)
|+++|+|.+++...... ...+++.+++.|+.||++||+|||+++ |+||||||+||++
T Consensus 131 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~ 207 (343)
T 1luf_A 131 YMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLV 207 (343)
T ss_dssp CCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred cCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEE
Confidence 99999999999764211 256899999999999999999999988 9999999999999
Q ss_pred cCCCceEEeecccccccCcccc-cchhcccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccc
Q 005749 515 DDFFVSRLTEFGLDQLMVPAVA-DEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVD 592 (679)
Q Consensus 515 ~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~ 592 (679)
+.++.+||+|||+++....... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.+....
T Consensus 208 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~---- 283 (343)
T 1luf_A 208 GENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE---- 283 (343)
T ss_dssp CGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH----
T ss_pred CCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCChH----
Confidence 9999999999999986543221 22234567889999999998899999999999999999999 99999543211
Q ss_pred hhHHHHHHhhcccccccchHhhhhcCC-CChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCCCCC
Q 005749 593 LPSIVKVAVLEETTMEVFDMEIMKGIR-SPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRPRNR 662 (679)
Q Consensus 593 l~~~~~~~~~~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 662 (679)
+.... +..+.. .........+.+++.+||+.||++||++.|+++.|+++.....
T Consensus 284 --~~~~~--------------~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~ 338 (343)
T 1luf_A 284 --EVIYY--------------VRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAE 338 (343)
T ss_dssp --HHHHH--------------HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC---
T ss_pred --HHHHH--------------HhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhh
Confidence 11111 111111 1111223567789999999999999999999999999876543
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=365.13 Aligned_cols=252 Identities=18% Similarity=0.224 Sum_probs=196.9
Q ss_pred cCccccCCceEEEEEEe-CCCCEEEEEEcccCc---ccCcccHHHHHHHHhcc-CCCCCccceEEeeCCCCceEEEEEec
Q 005749 382 GQVIEKTTYGTAYKAKL-ADGATIALRLLREGS---CKDRSSCLPVIRQLGKV-RHENLIPLRAFYQGKRGEKLLIYDYF 456 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~~lv~ey~ 456 (679)
.++||+|+||+||+|+. .+++.||+|+++... ....+.+.+|..++.++ +|||||++++++.+ .+..++||||+
T Consensus 57 ~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~-~~~~~lV~E~~ 135 (396)
T 4dc2_A 57 LRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT-ESRLFFVIEYV 135 (396)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEEC-SSEEEEEEECC
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEE-CCEEEEEEEcC
Confidence 47899999999999995 468899999997642 23345688999999887 89999999999997 68899999999
Q ss_pred CCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccc
Q 005749 457 PSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVA 536 (679)
Q Consensus 457 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 536 (679)
++|+|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..... .
T Consensus 136 ~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~~~-~ 207 (396)
T 4dc2_A 136 NGGDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-G 207 (396)
T ss_dssp TTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT-T
T ss_pred CCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeecccC-C
Confidence 999999999863 45899999999999999999999998 999999999999999999999999999863222 2
Q ss_pred cchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhh
Q 005749 537 DEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMK 616 (679)
Q Consensus 537 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~ 616 (679)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||......+.... ...+.....+..
T Consensus 208 ~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~-----------~~~~~~~~~i~~ 276 (396)
T 4dc2_A 208 DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ-----------NTEDYLFQVILE 276 (396)
T ss_dssp CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC-----------------CCHHHHHHHHHH
T ss_pred CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccch-----------hhHHHHHHHHhc
Confidence 234466899999999999999999999999999999999999999954322111000 000001111122
Q ss_pred cCCCChHHHHHHHHHHHHhccCcCCCCCCCH------HHHHHH
Q 005749 617 GIRSPMEEGLVQALKLAMGCCAPVASVRPTM------DEVVKQ 653 (679)
Q Consensus 617 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~------~evl~~ 653 (679)
...........++.+++.+||+.||++||++ +|++++
T Consensus 277 ~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H 319 (396)
T 4dc2_A 277 KQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 319 (396)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred cccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence 1111122234567789999999999999996 566553
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-42 Score=348.11 Aligned_cols=250 Identities=20% Similarity=0.368 Sum_probs=205.1
Q ss_pred cCccccCCceEEEEEEeCCCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCCh
Q 005749 382 GQVIEKTTYGTAYKAKLADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRTL 461 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gsL 461 (679)
.+.||+|+||.||+|+..+++.||+|+++.... ..+.+.+|++++++++||||+++++++.+ .+..++||||+++++|
T Consensus 13 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L 90 (267)
T 3t9t_A 13 VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLE-QAPICLVTEFMEHGCL 90 (267)
T ss_dssp EEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSSCEEEECCCTTCBH
T ss_pred eeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEcc-CCCeEEEEeCCCCCcH
Confidence 378999999999999988899999999976432 34679999999999999999999999987 6789999999999999
Q ss_pred HHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccchhc
Q 005749 462 HDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVA 541 (679)
Q Consensus 462 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 541 (679)
.+++... ...+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++............
T Consensus 91 ~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 164 (267)
T 3t9t_A 91 SDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG 164 (267)
T ss_dssp HHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTS
T ss_pred HHHHhhC---cccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccccccccccccccc
Confidence 9999764 345899999999999999999999988 9999999999999999999999999998764433223334
Q ss_pred ccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcCCC
Q 005749 542 LAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIRS 620 (679)
Q Consensus 542 ~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~~ 620 (679)
..++..|+|||.+.+..++.++||||||+++|||++ |+.||...... ..... +..+...
T Consensus 165 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~~~~~--------------i~~~~~~ 224 (267)
T 3t9t_A 165 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS------EVVED--------------ISTGFRL 224 (267)
T ss_dssp TTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHH--------------HHTTCCC
T ss_pred ccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH------HHHHH--------------HhcCCcC
Confidence 567788999999998889999999999999999999 89998543211 11111 1111111
Q ss_pred -ChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCC
Q 005749 621 -PMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRP 659 (679)
Q Consensus 621 -~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 659 (679)
........+.+++.+||+.||++||+++|+++.|+++..
T Consensus 225 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 225 YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 111123567789999999999999999999999998864
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=367.09 Aligned_cols=242 Identities=19% Similarity=0.257 Sum_probs=193.7
Q ss_pred cCccccCCceEEEEEEe-CCCCEEEEEEcccC---cccCcccHHHHHHHHhcc-CCCCCccceEEeeCCCCceEEEEEec
Q 005749 382 GQVIEKTTYGTAYKAKL-ADGATIALRLLREG---SCKDRSSCLPVIRQLGKV-RHENLIPLRAFYQGKRGEKLLIYDYF 456 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~~lv~ey~ 456 (679)
.++||+|+||+||+|+. .+|+.||||+++.. .....+.+.+|.+++..+ +|||||++++++.+ .+..++||||+
T Consensus 28 ~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~-~~~~~lv~E~~ 106 (353)
T 3txo_A 28 IRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQT-PDRLFFVMEFV 106 (353)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-SSEEEEEEECC
T ss_pred EEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEe-CCEEEEEEeCC
Confidence 37899999999999995 56899999999754 223456688999999988 69999999999998 67899999999
Q ss_pred CCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccc
Q 005749 457 PSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVA 536 (679)
Q Consensus 457 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 536 (679)
++|+|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..... .
T Consensus 107 ~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~-~ 178 (353)
T 3txo_A 107 NGGDLMFHIQKS----RRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN-G 178 (353)
T ss_dssp CSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC---
T ss_pred CCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeecccC-C
Confidence 999999999764 45899999999999999999999988 999999999999999999999999999864322 2
Q ss_pred cchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhh
Q 005749 537 DEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMK 616 (679)
Q Consensus 537 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~ 616 (679)
......+||+.|+|||++.+..++.++||||+||++|||++|+.||.+.... +... .+..
T Consensus 179 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~------~~~~--------------~i~~ 238 (353)
T 3txo_A 179 VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED------DLFE--------------AILN 238 (353)
T ss_dssp -------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHH--------------HHHH
T ss_pred ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH------HHHH--------------HHHc
Confidence 2344568999999999999888999999999999999999999999543221 1111 1111
Q ss_pred cCCCChHHHHHHHHHHHHhccCcCCCCCCCH------HHHHH
Q 005749 617 GIRSPMEEGLVQALKLAMGCCAPVASVRPTM------DEVVK 652 (679)
Q Consensus 617 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~------~evl~ 652 (679)
+...........+.+++.+||+.||++||++ +|+++
T Consensus 239 ~~~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 239 DEVVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred CCCCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 1111112233567789999999999999998 67765
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-42 Score=351.70 Aligned_cols=250 Identities=22% Similarity=0.309 Sum_probs=190.6
Q ss_pred cCccccCCceEEEEEEeCC----CCEEEEEEcccCcc-cCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEec
Q 005749 382 GQVIEKTTYGTAYKAKLAD----GATIALRLLREGSC-KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYF 456 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~~----~~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~ 456 (679)
.+.||+|+||.||+|+... +..||+|.++.... ...+.+.+|+.++++++||||+++++++.+ +..++||||+
T Consensus 20 ~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~lv~e~~ 97 (281)
T 1mp8_A 20 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE--NPVWIIMELC 97 (281)
T ss_dssp EEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS--SSCEEEEECC
T ss_pred EeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEcc--CccEEEEecC
Confidence 4789999999999998643 45799999876432 335678999999999999999999999854 5789999999
Q ss_pred CCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccc
Q 005749 457 PSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVA 536 (679)
Q Consensus 457 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 536 (679)
++|+|.+++... ...+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 98 ~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 171 (281)
T 1mp8_A 98 TLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY 171 (281)
T ss_dssp TTEEHHHHHHHT---TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC------------
T ss_pred CCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccccCcccc
Confidence 999999999764 345899999999999999999999988 99999999999999999999999999987654333
Q ss_pred cchhcccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhh
Q 005749 537 DEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIM 615 (679)
Q Consensus 537 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~ 615 (679)
.......+++.|+|||.+.+..++.++||||||+++|||++ |..||.+.... .....+ .
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~---~~~~~i-----------------~ 231 (281)
T 1mp8_A 172 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVIGRI-----------------E 231 (281)
T ss_dssp -------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHHHH-----------------H
T ss_pred cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH---HHHHHH-----------------H
Confidence 33334456788999999998899999999999999999996 99999543322 111111 1
Q ss_pred hcCC-CChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCC
Q 005749 616 KGIR-SPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRP 659 (679)
Q Consensus 616 ~~~~-~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 659 (679)
.+.. +..+...+.+.+++.+||+.||++|||+.|+++.|+++..
T Consensus 232 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 276 (281)
T 1mp8_A 232 NGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 276 (281)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 1111 1112233567789999999999999999999999998753
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=353.45 Aligned_cols=259 Identities=20% Similarity=0.309 Sum_probs=195.6
Q ss_pred CccccCCceEEEEEEeCCCCEEEEEEcccCccc--CcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCC
Q 005749 383 QVIEKTTYGTAYKAKLADGATIALRLLREGSCK--DRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRT 460 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~--~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gs 460 (679)
+.||+|+||+||+|+..+|+.||+|+++..... ..+.+.+|++++++++|||||++++++.+ .+..++||||+++ +
T Consensus 27 ~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~e~~~~-~ 104 (311)
T 3niz_A 27 EKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHS-ERCLTLVFEFMEK-D 104 (311)
T ss_dssp EEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECC-SSCEEEEEECCSE-E
T ss_pred hhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEcc-CCEEEEEEcCCCC-C
Confidence 789999999999999888999999999754322 23578899999999999999999999987 6789999999985 8
Q ss_pred hHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccchh
Q 005749 461 LHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMV 540 (679)
Q Consensus 461 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 540 (679)
|.+++... ...+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++..... .....
T Consensus 105 l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~-~~~~~ 177 (311)
T 3niz_A 105 LKKVLDEN---KTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIP-VRSYT 177 (311)
T ss_dssp HHHHHHTC---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSC-CC---
T ss_pred HHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCC-ccccc
Confidence 88888754 345899999999999999999999988 999999999999999999999999999876432 22234
Q ss_pred cccccccccccccccc-cCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccc---cccchHh-hh
Q 005749 541 ALAKADGYKAPELQRM-KKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETT---MEVFDME-IM 615 (679)
Q Consensus 541 ~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~---~~~~~~~-i~ 615 (679)
...+|+.|+|||++.+ ..++.++||||+||++|||++|+.||.+....+. +...... ...... ....+.. ..
T Consensus 178 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~~~i~~~-~~~~~~~~~~~~~~~~~~~ 254 (311)
T 3niz_A 178 HEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQ--LPKIFSI-LGTPNPREWPQVQELPLWK 254 (311)
T ss_dssp CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTH--HHHHHHH-HCCCCTTTSGGGTTSHHHH
T ss_pred CCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHHH-HCCCChHHhhhhhccchhh
Confidence 4578999999999876 5689999999999999999999999966544322 1111111 110000 0000000 00
Q ss_pred hc----C-CCCh----HHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 616 KG----I-RSPM----EEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 616 ~~----~-~~~~----~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
.. . ..+. +...+++.+++.+||+.||++|||++|+++.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 255 QRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp SCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 00 0 0000 1123567899999999999999999999873
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=356.21 Aligned_cols=254 Identities=15% Similarity=0.162 Sum_probs=203.0
Q ss_pred cCccccCCceEEEEEE-eCCCCEEEEEEcccCcccCcccHHHHHHHHhcc-CCCCCccceEEeeCCCCceEEEEEecCCC
Q 005749 382 GQVIEKTTYGTAYKAK-LADGATIALRLLREGSCKDRSSCLPVIRQLGKV-RHENLIPLRAFYQGKRGEKLLIYDYFPSR 459 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~~lv~ey~~~g 459 (679)
.+.||+|+||.||+|+ ..+|+.||||++.... ..+.+.+|+++++++ +||||+++++++.. .+..++||||+ ++
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-~~~~~lv~e~~-~~ 89 (330)
T 2izr_A 14 GKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPC-GKYNAMVLELL-GP 89 (330)
T ss_dssp EEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEE-TTEEEEEEECC-CC
T ss_pred EEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEec-CCccEEEEEeC-CC
Confidence 3789999999999999 4679999999987543 345799999999999 99999999999987 67899999999 89
Q ss_pred ChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCc-----eEEeecccccccCcc
Q 005749 460 TLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFV-----SRLTEFGLDQLMVPA 534 (679)
Q Consensus 460 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~-----~kl~DFGla~~~~~~ 534 (679)
+|.+++... ...+++..++.|+.|++.||+|||+++ |+||||||+|||++.++. +||+|||+++.....
T Consensus 90 ~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~ 163 (330)
T 2izr_A 90 SLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDP 163 (330)
T ss_dssp BHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCT
T ss_pred CHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecC
Confidence 999999864 346999999999999999999999988 999999999999998887 999999999876433
Q ss_pred ccc------chhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccc
Q 005749 535 VAD------EMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTME 608 (679)
Q Consensus 535 ~~~------~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 608 (679)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+.......+......
T Consensus 164 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~----- 238 (330)
T 2izr_A 164 ETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRA----- 238 (330)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHH-----
T ss_pred CCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhcc-----
Confidence 221 123567999999999999999999999999999999999999999665433221111111000000
Q ss_pred cchHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhC
Q 005749 609 VFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENR 658 (679)
Q Consensus 609 ~~~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 658 (679)
...... ....+++.+++.+||+.||.+||++++|.+.|+++.
T Consensus 239 -~~~~~~-------~~~~p~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~ 280 (330)
T 2izr_A 239 -TPIEVL-------CENFPEMATYLRYVRRLDFFEKPDYDYLRKLFTDLF 280 (330)
T ss_dssp -SCHHHH-------TTTCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred -CCHHHH-------hccChHHHHHHHHHHhCCCCCCCCHHHHHHHHHHHH
Confidence 000000 011237888999999999999999999999998764
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=367.94 Aligned_cols=254 Identities=19% Similarity=0.285 Sum_probs=201.7
Q ss_pred cCccccCCceEEEEEEeC------CCCEEEEEEcccCc-ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEE
Q 005749 382 GQVIEKTTYGTAYKAKLA------DGATIALRLLREGS-CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYD 454 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~------~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~e 454 (679)
.+.||+|+||+||+|+.. +++.||||+++... ......+.+|+.++++++|||||++++++.+ .+..++|||
T Consensus 76 ~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-~~~~~lv~e 154 (367)
T 3l9p_A 76 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ-SLPRFILLE 154 (367)
T ss_dssp EEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSSCEEEEE
T ss_pred eeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEec-CCCCEEEEE
Confidence 478999999999999953 46689999997542 2334578999999999999999999999987 678899999
Q ss_pred ecCCCChHHHhhcccC---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCC---ceEEeecccc
Q 005749 455 YFPSRTLHDLLHDTIA---GKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFF---VSRLTEFGLD 528 (679)
Q Consensus 455 y~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~---~~kl~DFGla 528 (679)
|+++|+|.+++..... ....+++..++.|+.||++||+|||+++ |+||||||+|||++.++ .+||+|||++
T Consensus 155 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~DFG~a 231 (367)
T 3l9p_A 155 LMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMA 231 (367)
T ss_dssp CCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECCCHHH
T ss_pred eCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEECCCccc
Confidence 9999999999986532 1245899999999999999999999998 99999999999999554 5999999999
Q ss_pred cccCccc-ccchhcccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHHhhcccc
Q 005749 529 QLMVPAV-ADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAVLEETT 606 (679)
Q Consensus 529 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 606 (679)
+...... ........+|+.|+|||++.+..++.++|||||||++|||++ |+.||...... +....
T Consensus 232 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~------~~~~~------- 298 (367)
T 3l9p_A 232 RDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ------EVLEF------- 298 (367)
T ss_dssp HHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH------HHHHH-------
T ss_pred cccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH------HHHHH-------
Confidence 8643221 112234567889999999998899999999999999999998 99998543211 11111
Q ss_pred cccchHhhhhcC-CCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCC
Q 005749 607 MEVFDMEIMKGI-RSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRP 659 (679)
Q Consensus 607 ~~~~~~~i~~~~-~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 659 (679)
+..+. ..........+.+++.+||+.||++|||+.||++.|+.+..
T Consensus 299 -------i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~ 345 (367)
T 3l9p_A 299 -------VTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 345 (367)
T ss_dssp -------HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -------HHcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhh
Confidence 11111 11112223567789999999999999999999999988764
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=360.37 Aligned_cols=247 Identities=17% Similarity=0.184 Sum_probs=198.7
Q ss_pred hcCccccCCceEEEEEEe-CCCCEEEEEEcccCc-----ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEE
Q 005749 381 TGQVIEKTTYGTAYKAKL-ADGATIALRLLREGS-----CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYD 454 (679)
Q Consensus 381 ~~~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~-----~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~e 454 (679)
..+.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|++++++++|||||++++++.+ .+..++|||
T Consensus 28 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-~~~~~lv~e 106 (351)
T 3c0i_A 28 LCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSS-DGMLYMVFE 106 (351)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEEEEE
T ss_pred EeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEe-CCEEEEEEe
Confidence 357899999999999994 579999999986431 1235678999999999999999999999987 688999999
Q ss_pred ecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCc---eEEeeccccccc
Q 005749 455 YFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFV---SRLTEFGLDQLM 531 (679)
Q Consensus 455 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~---~kl~DFGla~~~ 531 (679)
||++|+|.+.+.........+++..++.++.||+.||+|||+++ |+||||||+|||++.++. +||+|||+++..
T Consensus 107 ~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~ 183 (351)
T 3c0i_A 107 FMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL 183 (351)
T ss_dssp CCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTTCEEC
T ss_pred CCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcceeEe
Confidence 99999999888765433456899999999999999999999988 999999999999987654 999999999876
Q ss_pred CcccccchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccch
Q 005749 532 VPAVADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFD 611 (679)
Q Consensus 532 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 611 (679)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.. . .....
T Consensus 184 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~----~---~~~~~------------ 243 (351)
T 3c0i_A 184 GESG-LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK----E---RLFEG------------ 243 (351)
T ss_dssp CTTS-CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH----H---HHHHH------------
T ss_pred cCCC-eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH----H---HHHHH------------
Confidence 4332 22334579999999999998899999999999999999999999995421 0 11110
Q ss_pred HhhhhcCCCChH----HHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 612 MEIMKGIRSPME----EGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 612 ~~i~~~~~~~~~----~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
+..+.....+ ....++.+++.+||+.||++|||+.|++++
T Consensus 244 --i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 244 --IIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp --HHHTCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred --HHcCCCCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 1111111111 123567789999999999999999999863
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-42 Score=365.68 Aligned_cols=256 Identities=20% Similarity=0.347 Sum_probs=193.6
Q ss_pred cCccccCCceEEEEEEeC--C--CCEEEEEEcccCc-ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEec
Q 005749 382 GQVIEKTTYGTAYKAKLA--D--GATIALRLLREGS-CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYF 456 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~--~--~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~ 456 (679)
.+.||+|+||+||+|+.. + +..||||.++... ....+.|.+|++++++++|||||++++++....+..++||||+
T Consensus 94 ~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e~~ 173 (373)
T 3c1x_A 94 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 173 (373)
T ss_dssp EEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEECC
T ss_pred CcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEECC
Confidence 478999999999999853 2 2368999987543 2345679999999999999999999999876567889999999
Q ss_pred CCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccc
Q 005749 457 PSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVA 536 (679)
Q Consensus 457 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 536 (679)
++|+|.+++... ...+++..++.++.||++||+|||+++ |+||||||+|||+++++.+||+|||+++.......
T Consensus 174 ~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~ 247 (373)
T 3c1x_A 174 KHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 247 (373)
T ss_dssp TTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred CCCCHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeecccccccccccc
Confidence 999999999764 345889999999999999999999988 99999999999999999999999999986643221
Q ss_pred c---chhcccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHHhhcccccccchH
Q 005749 537 D---EMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDM 612 (679)
Q Consensus 537 ~---~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 612 (679)
. ......+++.|+|||.+.+..++.++|||||||++|||++ |.+||......+ ....+
T Consensus 248 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~---~~~~~--------------- 309 (373)
T 3c1x_A 248 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITVYL--------------- 309 (373)
T ss_dssp ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC---HHHHH---------------
T ss_pred ccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH---HHHHH---------------
Confidence 1 1233457788999999998999999999999999999999 667774433221 11111
Q ss_pred hhhhcCCC-ChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCCCCCC
Q 005749 613 EIMKGIRS-PMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRPRNRS 663 (679)
Q Consensus 613 ~i~~~~~~-~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~ 663 (679)
..+.+. ........+.+++.+||+.||++|||++|+++.|+++......
T Consensus 310 --~~~~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~ 359 (373)
T 3c1x_A 310 --LQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 359 (373)
T ss_dssp --HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred --HcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhccc
Confidence 111111 1112234677899999999999999999999999998754433
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-42 Score=372.31 Aligned_cols=250 Identities=16% Similarity=0.172 Sum_probs=199.2
Q ss_pred cCccccCCceEEEEEEeC-CCCEEEEEEcccC---cccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecC
Q 005749 382 GQVIEKTTYGTAYKAKLA-DGATIALRLLREG---SCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFP 457 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~ 457 (679)
.++||+|+||+||+|+.. +++.||+|+++.. .....+.+.+|+.++..++|||||+++++|.+ .+..++|||||+
T Consensus 79 ~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~-~~~~~lV~Ey~~ 157 (437)
T 4aw2_A 79 LKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD-DNNLYLVMDYYV 157 (437)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC-SSEEEEEECCCT
T ss_pred EEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-CCEEEEEEecCC
Confidence 378999999999999965 5889999999753 22345568999999999999999999999998 688999999999
Q ss_pred CCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCccccc
Q 005749 458 SRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVAD 537 (679)
Q Consensus 458 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 537 (679)
+|+|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++........
T Consensus 158 gg~L~~~l~~~---~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~ 231 (437)
T 4aw2_A 158 GGDLLTLLSKF---EDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV 231 (437)
T ss_dssp TCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCE
T ss_pred CCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchhhhhhcccCCCc
Confidence 99999999763 345899999999999999999999988 999999999999999999999999999876544333
Q ss_pred chhccccccccccccccc-----ccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchH
Q 005749 538 EMVALAKADGYKAPELQR-----MKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDM 612 (679)
Q Consensus 538 ~~~~~~gt~~y~aPE~~~-----~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 612 (679)
.....+||+.|+|||++. ...++.++|||||||++|||++|+.||.+.... +....... .
T Consensus 232 ~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~------~~~~~i~~---------~ 296 (437)
T 4aw2_A 232 QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV------ETYGKIMN---------H 296 (437)
T ss_dssp ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHT---------H
T ss_pred ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChh------HHHHhhhh---------c
Confidence 344568999999999987 456899999999999999999999999643221 11111000 0
Q ss_pred hhhhcCCCChHHHHHHHHHHHHhccCcCCCC--CCCHHHHHHH
Q 005749 613 EIMKGIRSPMEEGLVQALKLAMGCCAPVASV--RPTMDEVVKQ 653 (679)
Q Consensus 613 ~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~--RPs~~evl~~ 653 (679)
...-..........+++.+++.+|+..+|++ ||+++|++++
T Consensus 297 ~~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 297 KERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp HHHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred cccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 0000000111122356778999999888888 9999999875
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=353.79 Aligned_cols=247 Identities=19% Similarity=0.305 Sum_probs=198.3
Q ss_pred hcCccccCCceEEEEEEe-CCCCEEEEEEcccCccc------CcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEE
Q 005749 381 TGQVIEKTTYGTAYKAKL-ADGATIALRLLREGSCK------DRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIY 453 (679)
Q Consensus 381 ~~~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~------~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ 453 (679)
..+.||+|+||.||+|+. .+|+.||+|+++..... ..+.+.+|++++++++|||||++++++.+ .+..++||
T Consensus 15 ~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~ 93 (326)
T 2y0a_A 15 TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN-KTDVILIL 93 (326)
T ss_dssp EEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEEEE
T ss_pred eceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEe-CCEEEEEE
Confidence 357899999999999995 46999999999764321 24568999999999999999999999987 67899999
Q ss_pred EecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCC----ceEEeeccccc
Q 005749 454 DYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFF----VSRLTEFGLDQ 529 (679)
Q Consensus 454 ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~----~~kl~DFGla~ 529 (679)
||+++|+|.+++.. ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++ .+||+|||+++
T Consensus 94 e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~ 166 (326)
T 2y0a_A 94 ELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166 (326)
T ss_dssp ECCCSCBHHHHHTT----SSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EcCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECCCCe
Confidence 99999999999975 345899999999999999999999988 99999999999999887 89999999998
Q ss_pred ccCcccccchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhccccccc
Q 005749 530 LMVPAVADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEV 609 (679)
Q Consensus 530 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 609 (679)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.... ......... . . .
T Consensus 167 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~~~~~~~-~-~-~ 235 (326)
T 2y0a_A 167 KIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ------ETLANVSAV-N-Y-E 235 (326)
T ss_dssp ECCTTS--CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH------HHHHHHHHT-C-C-C
T ss_pred ECCCCC--ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH------HHHHHHHhc-C-C-C
Confidence 764322 233457999999999999889999999999999999999999999543211 111100000 0 0 0
Q ss_pred chHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 610 FDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 610 ~~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
+..... +.....+.+++.+||+.||++|||+.|+++.
T Consensus 236 ~~~~~~-------~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 236 FEDEYF-------SNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp CCHHHH-------TTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred cCcccc-------ccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 000100 1113456789999999999999999999874
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=357.99 Aligned_cols=256 Identities=19% Similarity=0.294 Sum_probs=190.9
Q ss_pred cCccccCCceEEEEEEeCC-CC---EEEEEEcccCc--ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCce------
Q 005749 382 GQVIEKTTYGTAYKAKLAD-GA---TIALRLLREGS--CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEK------ 449 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~~-~~---~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~------ 449 (679)
.+.||+|+||.||+|+... +. .||||+++... ....+.+.+|++++++++||||+++++++... ...
T Consensus 28 ~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~~~~~~ 106 (323)
T 3qup_A 28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRS-RAKGRLPIP 106 (323)
T ss_dssp EEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--------CE
T ss_pred eceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecc-ccccCCCcc
Confidence 4789999999999999543 32 89999997642 23456799999999999999999999999863 333
Q ss_pred EEEEEecCCCChHHHhhcccCC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeeccc
Q 005749 450 LLIYDYFPSRTLHDLLHDTIAG--KPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGL 527 (679)
Q Consensus 450 ~lv~ey~~~gsL~~~l~~~~~~--~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 527 (679)
++||||+++|+|.+++...... ...+++..++.|+.|++.||+|||+++ |+||||||+|||+++++.+||+|||+
T Consensus 107 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~kl~Dfg~ 183 (323)
T 3qup_A 107 MVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVCVADFGL 183 (323)
T ss_dssp EEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC
T ss_pred EEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCEEEeeccc
Confidence 8999999999999999754321 225899999999999999999999988 99999999999999999999999999
Q ss_pred ccccCcccc-cchhcccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHHhhccc
Q 005749 528 DQLMVPAVA-DEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAVLEET 605 (679)
Q Consensus 528 a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~~~~~~ 605 (679)
++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |+.||.+....+ . .....
T Consensus 184 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~---~~~~~---- 253 (323)
T 3qup_A 184 SRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE---I---YNYLI---- 253 (323)
T ss_dssp -----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---H---HHHHH----
T ss_pred cccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH---H---HHHHh----
Confidence 987643322 12233456788999999998899999999999999999999 899985433211 1 11110
Q ss_pred ccccchHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCCC
Q 005749 606 TMEVFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRPR 660 (679)
Q Consensus 606 ~~~~~~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 660 (679)
........+....++.+++.+||+.||++|||+.|+++.|+++...
T Consensus 254 ---------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~ 299 (323)
T 3qup_A 254 ---------GGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGH 299 (323)
T ss_dssp ---------TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ---------cCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 0111111223345678899999999999999999999999998643
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=360.05 Aligned_cols=242 Identities=18% Similarity=0.272 Sum_probs=197.9
Q ss_pred cCccccCCceEEEEEEe-CCCCEEEEEEcccCc---ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecC
Q 005749 382 GQVIEKTTYGTAYKAKL-ADGATIALRLLREGS---CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFP 457 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~ 457 (679)
.+.||+|+||.||+|+. .+++.||+|++.... ....+.+.+|+++++.++|||||++++++.+ .+..++||||+
T Consensus 14 ~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-~~~~~lv~E~~- 91 (336)
T 3h4j_B 14 RETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITT-PTDIVMVIEYA- 91 (336)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEEEEECCC-
T ss_pred EEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEe-CCEEEEEEECC-
Confidence 37899999999999994 679999999986532 2334578999999999999999999999998 67899999999
Q ss_pred CCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCccccc
Q 005749 458 SRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVAD 537 (679)
Q Consensus 458 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 537 (679)
+|+|.+++... ..+++..++.++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++..... .
T Consensus 92 ~g~l~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~--~ 162 (336)
T 3h4j_B 92 GGELFDYIVEK----KRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG--N 162 (336)
T ss_dssp CEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS--B
T ss_pred CCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccCC--c
Confidence 67999988764 35899999999999999999999988 999999999999999999999999999876433 2
Q ss_pred chhcccccccccccccccccCC-CCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhh
Q 005749 538 EMVALAKADGYKAPELQRMKKC-SSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMK 616 (679)
Q Consensus 538 ~~~~~~gt~~y~aPE~~~~~~~-~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~ 616 (679)
.....+||+.|+|||++.+..+ ++++|||||||++|||++|+.||.+....+... .+..
T Consensus 163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~--------------------~i~~ 222 (336)
T 3h4j_B 163 FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFK--------------------KVNS 222 (336)
T ss_dssp TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBC--------------------CCCS
T ss_pred ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHH--------------------HHHc
Confidence 2345679999999999987776 789999999999999999999996543322111 0011
Q ss_pred cCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 005749 617 GIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQL 654 (679)
Q Consensus 617 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L 654 (679)
+.........+.+.+++.+||+.||++|||++|+++.-
T Consensus 223 ~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp 260 (336)
T 3h4j_B 223 CVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDP 260 (336)
T ss_dssp SCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCH
T ss_pred CCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhCh
Confidence 11111112235677899999999999999999998763
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=357.02 Aligned_cols=247 Identities=19% Similarity=0.258 Sum_probs=196.3
Q ss_pred cCccccCCceEEEEEEe-CCCCEEEEEEcccCcc-cCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCC
Q 005749 382 GQVIEKTTYGTAYKAKL-ADGATIALRLLREGSC-KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSR 459 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~g 459 (679)
.+.||+|+||+||+|+. .+++.||||++..... ...+.+.+|+.+++.++|||||++++++.+ .+..++||||+++|
T Consensus 12 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-~~~~~lv~e~~~~~ 90 (323)
T 3tki_A 12 VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE-GNIQYLFLEYCSGG 90 (323)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEEEEECCTTE
T ss_pred eeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEec-CCeEEEEEEcCCCC
Confidence 37899999999999995 4799999999865432 335679999999999999999999999997 67899999999999
Q ss_pred ChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccc-cc
Q 005749 460 TLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVA-DE 538 (679)
Q Consensus 460 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~-~~ 538 (679)
+|.+++.. ...+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.+..... ..
T Consensus 91 ~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 163 (323)
T 3tki_A 91 ELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 163 (323)
T ss_dssp EGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred cHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCCcccc
Confidence 99999975 345899999999999999999999988 99999999999999999999999999986543221 22
Q ss_pred hhcccccccccccccccccCC-CCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhc
Q 005749 539 MVALAKADGYKAPELQRMKKC-SSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKG 617 (679)
Q Consensus 539 ~~~~~gt~~y~aPE~~~~~~~-~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~ 617 (679)
.....||+.|+|||++.+..+ +.++|||||||++|||++|+.||....... .....+.. . ..
T Consensus 164 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~~~~~----~------------~~ 226 (323)
T 3tki_A 164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWKE----K------------KT 226 (323)
T ss_dssp BCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTS-HHHHHHHT----T------------CT
T ss_pred cCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHH-HHHHHHhc----c------------cc
Confidence 345679999999999987665 779999999999999999999995543221 11111100 0 00
Q ss_pred CCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 618 IRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 618 ~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
...+.......+.+++.+||+.||++|||++|+++.
T Consensus 227 ~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 227 YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred cCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 001112233566789999999999999999999876
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=365.61 Aligned_cols=254 Identities=22% Similarity=0.345 Sum_probs=203.9
Q ss_pred cCccccCCceEEEEEEeC--------CCCEEEEEEcccCcc-cCcccHHHHHHHHhcc-CCCCCccceEEeeCCCCceEE
Q 005749 382 GQVIEKTTYGTAYKAKLA--------DGATIALRLLREGSC-KDRSSCLPVIRQLGKV-RHENLIPLRAFYQGKRGEKLL 451 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~--------~~~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~~l 451 (679)
.+.||+|+||.||+|+.. ++..||||+++.... ...+.+.+|+++++++ +|||||++++++.. .+..++
T Consensus 74 ~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~-~~~~~l 152 (382)
T 3tt0_A 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ-DGPLYV 152 (382)
T ss_dssp EEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSSCEE
T ss_pred eeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc-CCceEE
Confidence 478999999999999842 235799999976532 3346789999999999 99999999999987 678999
Q ss_pred EEEecCCCChHHHhhcccC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCc
Q 005749 452 IYDYFPSRTLHDLLHDTIA------------GKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFV 519 (679)
Q Consensus 452 v~ey~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~ 519 (679)
||||+++|+|.+++..... ....+++..++.|+.|++.||+|||+++ |+||||||+|||+++++.
T Consensus 153 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~ 229 (382)
T 3tt0_A 153 IVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNV 229 (382)
T ss_dssp EEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCC
T ss_pred EEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEEEcCCCc
Confidence 9999999999999986531 1245899999999999999999999988 999999999999999999
Q ss_pred eEEeecccccccCcccc-cchhcccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHH
Q 005749 520 SRLTEFGLDQLMVPAVA-DEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIV 597 (679)
Q Consensus 520 ~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~ 597 (679)
+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+... .+..
T Consensus 230 ~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~------~~~~ 303 (382)
T 3tt0_A 230 MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV------EELF 303 (382)
T ss_dssp EEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH------HHHH
T ss_pred EEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH------HHHH
Confidence 99999999987643321 22334567889999999999999999999999999999999 9999854321 1111
Q ss_pred HHHhhcccccccchHhhhhcCC-CChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCC
Q 005749 598 KVAVLEETTMEVFDMEIMKGIR-SPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRP 659 (679)
Q Consensus 598 ~~~~~~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 659 (679)
... ..+.. ........++.+++.+||+.||++|||++||++.|+++..
T Consensus 304 ~~~--------------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 352 (382)
T 3tt0_A 304 KLL--------------KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 352 (382)
T ss_dssp HHH--------------HTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHH--------------HcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 111 11111 1111223567789999999999999999999999998863
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=356.40 Aligned_cols=243 Identities=20% Similarity=0.303 Sum_probs=198.7
Q ss_pred cCccccCCceEEEEEEe-CCCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCC
Q 005749 382 GQVIEKTTYGTAYKAKL-ADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRT 460 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gs 460 (679)
.+.||+|+||.||+|+. .+++.||+|.+.... ...+.+.+|+++++.++|||||++++++.+ .+..++||||+++|+
T Consensus 10 ~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-~~~~~lv~e~~~g~~ 87 (321)
T 1tki_A 10 AEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFES-MEELVMIFEFISGLD 87 (321)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEE-TTEEEEEECCCCCCB
T ss_pred eeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEec-CCEEEEEEEeCCCCC
Confidence 37899999999999995 468899999987532 334568899999999999999999999987 678999999999999
Q ss_pred hHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecC--CCceEEeecccccccCcccccc
Q 005749 461 LHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDD--FFVSRLTEFGLDQLMVPAVADE 538 (679)
Q Consensus 461 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~--~~~~kl~DFGla~~~~~~~~~~ 538 (679)
|.+++... ...+++..++.++.|++.||+|||+++ |+||||||+|||++. ++.+||+|||+++...... .
T Consensus 88 L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~--~ 159 (321)
T 1tki_A 88 IFERINTS---AFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD--N 159 (321)
T ss_dssp HHHHHTSS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC--E
T ss_pred HHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC--c
Confidence 99999753 345899999999999999999999988 999999999999987 7899999999998764332 2
Q ss_pred hhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcC
Q 005749 539 MVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGI 618 (679)
Q Consensus 539 ~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~ 618 (679)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.+.... ..... +..+.
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~~~--------------i~~~~ 219 (321)
T 1tki_A 160 FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ------QIIEN--------------IMNAE 219 (321)
T ss_dssp EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHH--------------HHHTC
T ss_pred cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH------HHHHH--------------HHcCC
Confidence 23457899999999999888999999999999999999999999543221 11111 11111
Q ss_pred CCChH----HHHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 005749 619 RSPME----EGLVQALKLAMGCCAPVASVRPTMDEVVKQL 654 (679)
Q Consensus 619 ~~~~~----~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L 654 (679)
..... ....++.+++.+||..||++|||+.|+++.-
T Consensus 220 ~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp 259 (321)
T 1tki_A 220 YTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHP 259 (321)
T ss_dssp CCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred CCCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcCh
Confidence 11111 1235677899999999999999999999853
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=350.07 Aligned_cols=270 Identities=16% Similarity=0.213 Sum_probs=206.1
Q ss_pred cCccccCCceEEEEEEeC-CCCEEEEEEcccCc-ccCcccHHHHHHHHhccCCCCCccceEEeeCC-CCceEEEEEecCC
Q 005749 382 GQVIEKTTYGTAYKAKLA-DGATIALRLLREGS-CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGK-RGEKLLIYDYFPS 458 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~-~~~~~lv~ey~~~ 458 (679)
.++||+|+||+||+|+.. +++.||||+++... ....+.+.+|++++++++||||+++++++... ....++||||+++
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~ 93 (319)
T 4euu_A 14 SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPC 93 (319)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEECCTT
T ss_pred EEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeCCCC
Confidence 378999999999999954 59999999997643 23456788999999999999999999998863 2377999999999
Q ss_pred CChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee----cCCCceEEeecccccccCcc
Q 005749 459 RTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLV----DDFFVSRLTEFGLDQLMVPA 534 (679)
Q Consensus 459 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl----~~~~~~kl~DFGla~~~~~~ 534 (679)
|+|.+++..... ...+++..++.|+.|++.||+|||+++ |+||||||+|||+ +.++.+||+|||+++.....
T Consensus 94 ~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~ 169 (319)
T 4euu_A 94 GSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD 169 (319)
T ss_dssp CBHHHHHHSGGG-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCTT
T ss_pred CCHHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCceecCCC
Confidence 999999987533 234899999999999999999999988 9999999999999 88889999999999876433
Q ss_pred cccchhccccccccccccccc--------ccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhc---
Q 005749 535 VADEMVALAKADGYKAPELQR--------MKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLE--- 603 (679)
Q Consensus 535 ~~~~~~~~~gt~~y~aPE~~~--------~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~--- 603 (679)
. ......||+.|+|||++. +..++.++|||||||++|||++|+.||........ ...........
T Consensus 170 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~p~ 245 (319)
T 4euu_A 170 E--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR--NKEVMYKIITGKPS 245 (319)
T ss_dssp C--CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGG--CHHHHHHHHHHCCT
T ss_pred C--ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccch--hHHHHHHHhcCCCc
Confidence 2 223457899999999876 46789999999999999999999999954332211 11111111111
Q ss_pred cccccc-------c--hHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCCC
Q 005749 604 ETTMEV-------F--DMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRPR 660 (679)
Q Consensus 604 ~~~~~~-------~--~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 660 (679)
...... + ...+.. ...........+.+++.+||+.||++|||++|+++...+....
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~~ 310 (319)
T 4euu_A 246 GAISGVQKAENGPIDWSGDMPV-SCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (319)
T ss_dssp TCCEEEECSTTCCEEEESSCCT-TCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC-
T ss_pred ccchhhhcccCCccccCccCCc-ccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhhc
Confidence 000000 0 000000 0012244556677899999999999999999999999876543
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=356.07 Aligned_cols=255 Identities=22% Similarity=0.338 Sum_probs=204.1
Q ss_pred cCccccCCceEEEEEEe------CCCCEEEEEEcccCc-ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEE
Q 005749 382 GQVIEKTTYGTAYKAKL------ADGATIALRLLREGS-CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYD 454 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~------~~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~e 454 (679)
.+.||+|+||.||+|+. .+++.||||+++... ....+.+.+|++++++++||||+++++++.+ .+..++|||
T Consensus 28 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~e 106 (314)
T 2ivs_A 28 GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ-DGPLLLIVE 106 (314)
T ss_dssp EEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSSCEEEEE
T ss_pred eeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEec-CCceEEEEe
Confidence 47899999999999984 245799999997643 2334678999999999999999999999987 678999999
Q ss_pred ecCCCChHHHhhcccC--------------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee
Q 005749 455 YFPSRTLHDLLHDTIA--------------------GKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLV 514 (679)
Q Consensus 455 y~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl 514 (679)
|+++|+|.+++..... ....+++..++.++.|+++||+|||+++ |+||||||+||++
T Consensus 107 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dikp~NIli 183 (314)
T 2ivs_A 107 YAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAARNILV 183 (314)
T ss_dssp CCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEE
T ss_pred ecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---CcccccchheEEE
Confidence 9999999999986432 1234899999999999999999999988 9999999999999
Q ss_pred cCCCceEEeecccccccCcccc-cchhcccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccc
Q 005749 515 DDFFVSRLTEFGLDQLMVPAVA-DEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVD 592 (679)
Q Consensus 515 ~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~ 592 (679)
++++.+||+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||.+.... .
T Consensus 184 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~---~ 260 (314)
T 2ivs_A 184 AEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE---R 260 (314)
T ss_dssp ETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---G
T ss_pred cCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---H
Confidence 9999999999999986643322 12234457788999999988889999999999999999999 99999543321 1
Q ss_pred hhHHHHHHhhcccccccchHhhhhcCC-CChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCCC
Q 005749 593 LPSIVKVAVLEETTMEVFDMEIMKGIR-SPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRPR 660 (679)
Q Consensus 593 l~~~~~~~~~~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 660 (679)
+...+ ..+.. .........+.+++.+||+.||++||++.|+++.|+++..+
T Consensus 261 ~~~~~-----------------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 261 LFNLL-----------------KTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp HHHHH-----------------HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHHHh-----------------hcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 11111 11110 11112235677899999999999999999999999987643
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=348.05 Aligned_cols=257 Identities=15% Similarity=0.142 Sum_probs=204.3
Q ss_pred cCccccCCceEEEEEE-eCCCCEEEEEEcccCcccCcccHHHHHHHHhcc-CCCCCccceEEeeCCCCceEEEEEecCCC
Q 005749 382 GQVIEKTTYGTAYKAK-LADGATIALRLLREGSCKDRSSCLPVIRQLGKV-RHENLIPLRAFYQGKRGEKLLIYDYFPSR 459 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~~lv~ey~~~g 459 (679)
.+.||+|+||.||+|+ ..+++.||||++... ...+.+.+|++++.++ +|+||+++++++.. ....++||||+ ++
T Consensus 15 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~-~~~~~lv~e~~-~~ 90 (298)
T 1csn_A 15 GRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQE-GLHNVLVIDLL-GP 90 (298)
T ss_dssp EEEEEECSSCEEEEEEETTTTEEEEEEEEECC--TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEE-TTEEEEEEECC-CC
T ss_pred EEEEeecCCEEEEEEEECCCCcEEEEEEeccC--CccHHHHHHHHHHHHHhcCCCCCeEEeecCC-CceeEEEEEec-CC
Confidence 3789999999999999 467999999998653 2456789999999999 79999999999887 67899999999 99
Q ss_pred ChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCc-----eEEeecccccccCcc
Q 005749 460 TLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFV-----SRLTEFGLDQLMVPA 534 (679)
Q Consensus 460 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~-----~kl~DFGla~~~~~~ 534 (679)
+|.+++... ...+++..++.|+.|++.||+|||+++ |+||||||+||+++.++. +||+|||+++.....
T Consensus 91 ~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~ 164 (298)
T 1csn_A 91 SLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP 164 (298)
T ss_dssp BHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCT
T ss_pred CHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccccccccc
Confidence 999999864 345899999999999999999999988 999999999999987776 999999999876433
Q ss_pred ccc------chhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccc
Q 005749 535 VAD------EMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTME 608 (679)
Q Consensus 535 ~~~------~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 608 (679)
... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.+............+......
T Consensus 165 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~----- 239 (298)
T 1csn_A 165 VTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS----- 239 (298)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH-----
T ss_pred cccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccC-----
Confidence 221 223557899999999999989999999999999999999999999654432221111111100000
Q ss_pred cchHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCCC
Q 005749 609 VFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRPR 660 (679)
Q Consensus 609 ~~~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 660 (679)
...+.+. +....++.+++.+||+.||++||++++|++.|+++...
T Consensus 240 ~~~~~~~-------~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~ 284 (298)
T 1csn_A 240 TPLRELC-------AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER 284 (298)
T ss_dssp SCHHHHT-------TTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred ccHHHHH-------hhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHh
Confidence 0000000 01235677899999999999999999999999998654
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=365.41 Aligned_cols=246 Identities=19% Similarity=0.279 Sum_probs=194.5
Q ss_pred CccccCCceEEEEEEe-CCCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCCh
Q 005749 383 QVIEKTTYGTAYKAKL-ADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRTL 461 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gsL 461 (679)
++||+|+||.||+|+. .+|+.||+|+++.......+.+.+|++++++++|||||++++++.+ .+..++||||+++|+|
T Consensus 95 ~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 95 EILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFES-KNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEEEEEECCTTCEE
T ss_pred eEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEE-CCEEEEEEeCCCCCcH
Confidence 6799999999999994 5799999999987655556789999999999999999999999997 6789999999999999
Q ss_pred HHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee--cCCCceEEeecccccccCcccccch
Q 005749 462 HDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLV--DDFFVSRLTEFGLDQLMVPAVADEM 539 (679)
Q Consensus 462 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl--~~~~~~kl~DFGla~~~~~~~~~~~ 539 (679)
.+++... ...+++..++.++.||++||+|||+.+ |+||||||+|||+ ++++.+||+|||+++...... ..
T Consensus 174 ~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~--~~ 245 (373)
T 2x4f_A 174 FDRIIDE---SYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE--KL 245 (373)
T ss_dssp HHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC--BC
T ss_pred HHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc--cc
Confidence 9988753 245899999999999999999999988 9999999999999 567899999999998764332 22
Q ss_pred hcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcCC
Q 005749 540 VALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIR 619 (679)
Q Consensus 540 ~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~ 619 (679)
....||+.|+|||++.+..++.++|||||||++|||++|+.||.+.... ........... .. ..
T Consensus 246 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~------~~~~~i~~~~~--~~-~~------- 309 (373)
T 2x4f_A 246 KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA------ETLNNILACRW--DL-ED------- 309 (373)
T ss_dssp CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHHTCC--CS-CS-------
T ss_pred ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhccC--CC-Ch-------
Confidence 3456999999999999889999999999999999999999999543211 11111111000 00 00
Q ss_pred CChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 620 SPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 620 ~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
.......+++.+++.+||+.||++|||++|+++.
T Consensus 310 ~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 310 EEFQDISEEAKEFISKLLIKEKSWRISASEALKH 343 (373)
T ss_dssp GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred hhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0011223567889999999999999999999984
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=351.51 Aligned_cols=249 Identities=23% Similarity=0.354 Sum_probs=192.5
Q ss_pred cCccccCCceEEEEEEeCCCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCCh
Q 005749 382 GQVIEKTTYGTAYKAKLADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRTL 461 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gsL 461 (679)
.+.||+|+||.||+|+.. ++.||||++... ...+.|.+|++++++++||||+++++++.+ ..++||||+++|+|
T Consensus 13 ~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~---~~~lv~e~~~~~~L 86 (307)
T 2eva_A 13 EEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN---PVCLVMEYAEGGSL 86 (307)
T ss_dssp EEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT---TTEEEEECCTTCBH
T ss_pred eeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC---CcEEEEEcCCCCCH
Confidence 378999999999999975 789999998643 235678999999999999999999998764 48999999999999
Q ss_pred HHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCc-eEEeecccccccCcccccchh
Q 005749 462 HDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFV-SRLTEFGLDQLMVPAVADEMV 540 (679)
Q Consensus 462 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~-~kl~DFGla~~~~~~~~~~~~ 540 (679)
.+++..... ...+++..++.++.|+++||+|||+.+..+|+||||||+||+++.++. +||+|||+++..... ..
T Consensus 87 ~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~----~~ 161 (307)
T 2eva_A 87 YNVLHGAEP-LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH----MT 161 (307)
T ss_dssp HHHHHCSSS-EECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-------------
T ss_pred HHHHhccCC-CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc----cc
Confidence 999986432 234789999999999999999999943234999999999999998886 799999999765322 23
Q ss_pred cccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcCC-
Q 005749 541 ALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIR- 619 (679)
Q Consensus 541 ~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~- 619 (679)
...||+.|+|||++.+..++.++||||||+++|||++|+.||....... ....... ..+..
T Consensus 162 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~----~~~~~~~--------------~~~~~~ 223 (307)
T 2eva_A 162 NNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPA----FRIMWAV--------------HNGTRP 223 (307)
T ss_dssp ---CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSH----HHHHHHH--------------HTTCCC
T ss_pred cCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccH----HHHHHHH--------------hcCCCC
Confidence 3468999999999998899999999999999999999999995432211 0111100 00100
Q ss_pred CChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCC
Q 005749 620 SPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRP 659 (679)
Q Consensus 620 ~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 659 (679)
.........+.+++.+||+.||++|||++|+++.|+.+..
T Consensus 224 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 263 (307)
T 2eva_A 224 PLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMR 263 (307)
T ss_dssp CCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGG
T ss_pred CcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 1111223457789999999999999999999999998764
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=354.87 Aligned_cols=240 Identities=20% Similarity=0.249 Sum_probs=197.8
Q ss_pred cCccccCCceEEEEEEe-CCCCEEEEEEcccCc---ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecC
Q 005749 382 GQVIEKTTYGTAYKAKL-ADGATIALRLLREGS---CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFP 457 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~ 457 (679)
.+.||+|+||.||+|+. .+|+.||+|+++... ....+.+.+|+.+++.++|||||++++++.+ .+..++||||++
T Consensus 11 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~-~~~~~lv~e~~~ 89 (318)
T 1fot_A 11 LRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD-AQQIFMIMDYIE 89 (318)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC-SSEEEEEECCCC
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEe-CCEEEEEEeCCC
Confidence 37899999999999995 579999999997542 2345678899999999999999999999987 678999999999
Q ss_pred CCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCccccc
Q 005749 458 SRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVAD 537 (679)
Q Consensus 458 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 537 (679)
+|+|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 90 gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~--- 159 (318)
T 1fot_A 90 GGELFSLLRKS----QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--- 159 (318)
T ss_dssp SCBHHHHHHHT----SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC---
T ss_pred CCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCCc---
Confidence 99999999863 45899999999999999999999988 999999999999999999999999999865332
Q ss_pred chhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhc
Q 005749 538 EMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKG 617 (679)
Q Consensus 538 ~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~ 617 (679)
....+||+.|+|||++.+..++.++||||+||++|||++|+.||.+... ...... +..+
T Consensus 160 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~------~~~~~~--------------i~~~ 218 (318)
T 1fot_A 160 -TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT------MKTYEK--------------ILNA 218 (318)
T ss_dssp -BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHH--------------HHHC
T ss_pred -cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH------HHHHHH--------------HHhC
Confidence 2356799999999999999999999999999999999999999954321 111111 1111
Q ss_pred CCCChHHHHHHHHHHHHhccCcCCCCCC-----CHHHHHHH
Q 005749 618 IRSPMEEGLVQALKLAMGCCAPVASVRP-----TMDEVVKQ 653 (679)
Q Consensus 618 ~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~evl~~ 653 (679)
.....+....++.+++.+|++.||++|| +++|++++
T Consensus 219 ~~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 219 ELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred CCCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 1111112235677899999999999999 88998854
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=347.79 Aligned_cols=247 Identities=23% Similarity=0.359 Sum_probs=189.3
Q ss_pred cCccccCCceEEEEEEeCCCCEEEEEEcccCcc----cCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecC
Q 005749 382 GQVIEKTTYGTAYKAKLADGATIALRLLREGSC----KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFP 457 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~~~~~vAvK~~~~~~~----~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~ 457 (679)
.+.||+|+||.||+|+.. ++.||||+++.... ...+.+.+|+++++.++||||+++++++.+ .+..++||||++
T Consensus 12 ~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~ 89 (271)
T 3dtc_A 12 EEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLK-EPNLCLVMEFAR 89 (271)
T ss_dssp EEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECC-C--CEEEEECCT
T ss_pred eeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec-CCceEEEEEcCC
Confidence 378999999999999974 88999999876432 224578899999999999999999999987 678999999999
Q ss_pred CCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecC--------CCceEEeeccccc
Q 005749 458 SRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDD--------FFVSRLTEFGLDQ 529 (679)
Q Consensus 458 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~--------~~~~kl~DFGla~ 529 (679)
+++|.+++.. ..+++..++.++.|++.||+|||+++..+|+||||||+||+++. ++.+||+|||+++
T Consensus 90 ~~~L~~~~~~-----~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~ 164 (271)
T 3dtc_A 90 GGPLNRVLSG-----KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR 164 (271)
T ss_dssp TEEHHHHHTS-----SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC--
T ss_pred CCCHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCccc
Confidence 9999999863 45899999999999999999999988667999999999999986 6789999999998
Q ss_pred ccCcccccchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhccccccc
Q 005749 530 LMVPAVADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEV 609 (679)
Q Consensus 530 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 609 (679)
...... .....|++.|+|||.+.+..++.++||||||+++|||++|+.||.+.... ........
T Consensus 165 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~------- 228 (271)
T 3dtc_A 165 EWHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL------AVAYGVAM------- 228 (271)
T ss_dssp --------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHH------HHHHHHHT-------
T ss_pred cccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHhhhc-------
Confidence 654322 22457899999999999888999999999999999999999999543211 00000000
Q ss_pred chHhhhhcCC-CChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhh
Q 005749 610 FDMEIMKGIR-SPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEEN 657 (679)
Q Consensus 610 ~~~~i~~~~~-~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 657 (679)
.... .........+.+++.+||+.||++|||+.|+++.|+++
T Consensus 229 ------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 229 ------NKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp ------SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred ------CCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 0000 11112235677899999999999999999999999864
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=355.52 Aligned_cols=246 Identities=16% Similarity=0.257 Sum_probs=193.5
Q ss_pred cCccccCCceEEEEEEeC-CCCEEEEEEcccCcc-cCcccHHHHHHHHhccCCCCCccceEEeeCCCC------------
Q 005749 382 GQVIEKTTYGTAYKAKLA-DGATIALRLLREGSC-KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRG------------ 447 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~------------ 447 (679)
.+.||+|+||.||+|+.. +|+.||||+++.... ...+.+.+|++++++++|||||+++++|.+...
T Consensus 11 ~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~ 90 (332)
T 3qd2_B 11 IQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWL 90 (332)
T ss_dssp EEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC---
T ss_pred eeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhhhhh
Confidence 478999999999999964 799999999975432 345679999999999999999999998865221
Q ss_pred --------------------------------------------ceEEEEEecCCCChHHHhhcccCCCCCCCHHHHHHH
Q 005749 448 --------------------------------------------EKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKI 483 (679)
Q Consensus 448 --------------------------------------------~~~lv~ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i 483 (679)
..++||||+++|+|.+++..... ....++..++.+
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~i 169 (332)
T 3qd2_B 91 KDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS-LEDREHGVCLHI 169 (332)
T ss_dssp -----------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS-GGGSCHHHHHHH
T ss_pred ccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC-ccchhhHHHHHH
Confidence 37999999999999999986543 344678889999
Q ss_pred HHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccc-----------cchhcccccccccccc
Q 005749 484 ALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVA-----------DEMVALAKADGYKAPE 552 (679)
Q Consensus 484 ~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~-----------~~~~~~~gt~~y~aPE 552 (679)
+.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++....... .......||+.|+|||
T Consensus 170 ~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 246 (332)
T 3qd2_B 170 FIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPE 246 (332)
T ss_dssp HHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSCHH
T ss_pred HHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccChH
Confidence 999999999999988 99999999999999999999999999987654321 1123456999999999
Q ss_pred cccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcCCC-ChHHHHHHHHH
Q 005749 553 LQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIRS-PMEEGLVQALK 631 (679)
Q Consensus 553 ~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~~-~~~~~~~~~~~ 631 (679)
++.+..++.++|||||||++|||++|..|+. ....... .+.....+ ......+++.+
T Consensus 247 ~~~~~~~~~~~Di~slG~il~el~~~~~~~~--------~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~ 304 (332)
T 3qd2_B 247 QIHGNNYSHKVDIFSLGLILFELLYSFSTQM--------ERVRIIT--------------DVRNLKFPLLFTQKYPQEHM 304 (332)
T ss_dssp HHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH--------HHHHHHH--------------HHHTTCCCHHHHHHCHHHHH
T ss_pred HhcCCCCcchhhHHHHHHHHHHHHHcCCChh--------HHHHHHH--------------HhhccCCCcccccCChhHHH
Confidence 9999899999999999999999999877641 1000000 01111111 12334466788
Q ss_pred HHHhccCcCCCCCCCHHHHHHH
Q 005749 632 LAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 632 l~~~cl~~dP~~RPs~~evl~~ 653 (679)
++.+||+.||++|||++|+++.
T Consensus 305 li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 305 MVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHHHCSSGGGSCCHHHHHHS
T ss_pred HHHHHccCCCCcCCCHHHHhhc
Confidence 9999999999999999999863
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=381.84 Aligned_cols=254 Identities=23% Similarity=0.375 Sum_probs=207.2
Q ss_pred cCccccCCceEEEEEEeCCCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCCh
Q 005749 382 GQVIEKTTYGTAYKAKLADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRTL 461 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gsL 461 (679)
.+.||+|+||.||+|+..++..||||+++... ...+.|.+|+++|++++|||||++++++.+ +..++|||||++|+|
T Consensus 272 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~lv~e~~~~gsL 348 (535)
T 2h8h_A 272 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE--EPIYIVTEYMSKGSL 348 (535)
T ss_dssp EEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSCEEEECCCTTEEH
T ss_pred heecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee--ccceEeeehhcCCcH
Confidence 47899999999999999888899999998643 345689999999999999999999999875 578999999999999
Q ss_pred HHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccchhc
Q 005749 462 HDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVA 541 (679)
Q Consensus 462 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 541 (679)
.++++... ...+++.+++.|+.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++............
T Consensus 349 ~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~ 423 (535)
T 2h8h_A 349 LDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 423 (535)
T ss_dssp HHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHTTCS
T ss_pred HHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCCceecccC
Confidence 99997532 235899999999999999999999988 9999999999999999999999999998765432222233
Q ss_pred ccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcCCC
Q 005749 542 LAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIRS 620 (679)
Q Consensus 542 ~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~~ 620 (679)
..++..|+|||++....++.++|||||||++|||++ |+.||.+.... +... .+..+.+.
T Consensus 424 ~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~------~~~~--------------~i~~~~~~ 483 (535)
T 2h8h_A 424 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR------EVLD--------------QVERGYRM 483 (535)
T ss_dssp TTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH------HHHH--------------HHHTTCCC
T ss_pred CcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH------HHHH--------------HHHcCCCC
Confidence 456788999999998899999999999999999999 89998543221 1111 11112111
Q ss_pred C-hHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCCCCCC
Q 005749 621 P-MEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRPRNRS 663 (679)
Q Consensus 621 ~-~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~ 663 (679)
+ .......+.+++.+||+.||++|||+++|++.|+++......
T Consensus 484 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~ 527 (535)
T 2h8h_A 484 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 527 (535)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCSC
T ss_pred CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccCc
Confidence 1 122235677899999999999999999999999998765444
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=357.56 Aligned_cols=261 Identities=20% Similarity=0.311 Sum_probs=201.7
Q ss_pred cCccccCCceEEEEEEe------CCCCEEEEEEcccCc-ccCcccHHHHHHHHhcc-CCCCCccceEEeeCCCCceEEEE
Q 005749 382 GQVIEKTTYGTAYKAKL------ADGATIALRLLREGS-CKDRSSCLPVIRQLGKV-RHENLIPLRAFYQGKRGEKLLIY 453 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~------~~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~~lv~ 453 (679)
.+.||+|+||.||+|+. .++..||||+++... ....+.+.+|++++.++ +||||+++++++.. .+..++||
T Consensus 50 ~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-~~~~~lv~ 128 (344)
T 1rjb_A 50 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL-SGPIYLIF 128 (344)
T ss_dssp EEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSSCEEEE
T ss_pred eeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee-CCccEEEE
Confidence 47899999999999995 245689999997643 34466899999999999 89999999999987 67899999
Q ss_pred EecCCCChHHHhhcccCC-------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee
Q 005749 454 DYFPSRTLHDLLHDTIAG-------------------KPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLV 514 (679)
Q Consensus 454 ey~~~gsL~~~l~~~~~~-------------------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl 514 (679)
||+++|+|.+++...... ...+++..++.++.|++.||+|||+++ |+||||||+||++
T Consensus 129 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll 205 (344)
T 1rjb_A 129 EYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLV 205 (344)
T ss_dssp ECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSGGGEEE
T ss_pred ecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEE
Confidence 999999999999764321 134899999999999999999999988 9999999999999
Q ss_pred cCCCceEEeecccccccCccccc-chhcccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccc
Q 005749 515 DDFFVSRLTEFGLDQLMVPAVAD-EMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVD 592 (679)
Q Consensus 515 ~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~ 592 (679)
+.++.+||+|||+++........ ......+|+.|+|||.+.+..++.++|||||||++|||+| |+.||.+..... .
T Consensus 206 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--~ 283 (344)
T 1rjb_A 206 THGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA--N 283 (344)
T ss_dssp ETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH--H
T ss_pred cCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHH--H
Confidence 99999999999999876433221 2234457888999999988899999999999999999998 999995543221 1
Q ss_pred hhHHHHHHhhcccccccchHhhhhcCCC-ChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCCCCCCCC
Q 005749 593 LPSIVKVAVLEETTMEVFDMEIMKGIRS-PMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRPRNRSAL 665 (679)
Q Consensus 593 l~~~~~~~~~~~~~~~~~~~~i~~~~~~-~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~ 665 (679)
....+ ..+... .......++.+++.+||+.||++|||+.|+++.|+.+....+.+.
T Consensus 284 ~~~~~-----------------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~ 340 (344)
T 1rjb_A 284 FYKLI-----------------QNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAEEAM 340 (344)
T ss_dssp HHHHH-----------------HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-------
T ss_pred HHHHH-----------------hcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHHHHH
Confidence 11111 111111 111223567789999999999999999999999999887655443
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-41 Score=345.25 Aligned_cols=247 Identities=23% Similarity=0.402 Sum_probs=196.1
Q ss_pred CccccCCceEEEEEEe-CCCCEEEEEEcccCcccC-------cccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEE
Q 005749 383 QVIEKTTYGTAYKAKL-ADGATIALRLLREGSCKD-------RSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYD 454 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~-------~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~e 454 (679)
+.||+|+||+||+|+. .+++.||+|++....... .+.+.+|++++++++||||+++++++.+. .++|||
T Consensus 25 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~lv~e 101 (287)
T 4f0f_A 25 KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP---PRMVME 101 (287)
T ss_dssp EECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT---TEEEEE
T ss_pred hccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC---CeEEEE
Confidence 7899999999999995 579999999986543222 25789999999999999999999998762 379999
Q ss_pred ecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCc-----eEEeeccccc
Q 005749 455 YFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFV-----SRLTEFGLDQ 529 (679)
Q Consensus 455 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~-----~kl~DFGla~ 529 (679)
|+++|+|.+++... ...+++..++.++.|++.||+|||+++ ++|+||||||+||+++.++. +||+|||+++
T Consensus 102 ~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~ 177 (287)
T 4f0f_A 102 FVPCGDLYHRLLDK---AHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ 177 (287)
T ss_dssp CCTTCBHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTCB
T ss_pred ecCCCCHHHHHhcc---cCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCCCCccc
Confidence 99999999988754 346999999999999999999999875 45999999999999988776 9999999998
Q ss_pred ccCcccccchhccccccccccccccc--ccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhccccc
Q 005749 530 LMVPAVADEMVALAKADGYKAPELQR--MKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTM 607 (679)
Q Consensus 530 ~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 607 (679)
.... ......||+.|+|||.+. ...++.++|||||||++|||++|+.||......+. ........
T Consensus 178 ~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~----~~~~~~~~----- 244 (287)
T 4f0f_A 178 QSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI----KFINMIRE----- 244 (287)
T ss_dssp CCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHH----HHHHHHHH-----
T ss_pred cccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHH----HHHHHHhc-----
Confidence 5432 223457899999999984 45578999999999999999999999955433211 11111100
Q ss_pred ccchHhhhhcCCC-ChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhh
Q 005749 608 EVFDMEIMKGIRS-PMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEEN 657 (679)
Q Consensus 608 ~~~~~~i~~~~~~-~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 657 (679)
.+... ......+.+.+++.+||+.||++|||++|+++.|+++
T Consensus 245 --------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 245 --------EGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp --------SCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred --------cCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 01111 1112235677899999999999999999999999864
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=367.47 Aligned_cols=246 Identities=15% Similarity=0.170 Sum_probs=198.3
Q ss_pred CccccCCceEEEEEEe-CCCCEEEEEEcccC---cccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCC
Q 005749 383 QVIEKTTYGTAYKAKL-ADGATIALRLLREG---SCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPS 458 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~ 458 (679)
++||+|+||+||+|+. .+++.||+|+++.. .....+.+.+|+++++.++|||||+++++|.+ .+..++|||||++
T Consensus 75 ~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~-~~~~~lV~E~~~g 153 (410)
T 3v8s_A 75 KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD-DRYLYMVMEYMPG 153 (410)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEEEECCCTT
T ss_pred EEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE-CCEEEEEEeCCCC
Confidence 7899999999999995 46899999998653 22345678999999999999999999999997 6889999999999
Q ss_pred CChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccc
Q 005749 459 RTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADE 538 (679)
Q Consensus 459 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 538 (679)
|+|.++++.. .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.........
T Consensus 154 g~L~~~l~~~-----~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~~ 225 (410)
T 3v8s_A 154 GDLVNLMSNY-----DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVR 225 (410)
T ss_dssp EEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEEE
T ss_pred CcHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccceeEeeccCCccc
Confidence 9999999752 4899999999999999999999988 9999999999999999999999999998765443333
Q ss_pred hhcccccccccccccccccC----CCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhh
Q 005749 539 MVALAKADGYKAPELQRMKK----CSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEI 614 (679)
Q Consensus 539 ~~~~~gt~~y~aPE~~~~~~----~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i 614 (679)
....+||+.|+|||++.+.. ++.++|||||||++|||++|+.||.+.... ........ ...
T Consensus 226 ~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~------~~~~~i~~---------~~~ 290 (410)
T 3v8s_A 226 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------GTYSKIMN---------HKN 290 (410)
T ss_dssp CCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHT---------HHH
T ss_pred ccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChh------hHHHHHHh---------ccc
Confidence 45678999999999987655 789999999999999999999999543211 11111100 000
Q ss_pred hhcCCCChHHHHHHHHHHHHhccCcCCCC--CCCHHHHHHH
Q 005749 615 MKGIRSPMEEGLVQALKLAMGCCAPVASV--RPTMDEVVKQ 653 (679)
Q Consensus 615 ~~~~~~~~~~~~~~~~~l~~~cl~~dP~~--RPs~~evl~~ 653 (679)
.-..+.......++.+++.+||..+|++ ||+++||+++
T Consensus 291 -~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 291 -SLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp -HCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred -cccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 0000111122356778999999999988 9999999976
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=348.34 Aligned_cols=255 Identities=20% Similarity=0.308 Sum_probs=201.7
Q ss_pred cCccccCCceEEEEEEe-CCCC---EEEEEEcccCcc-cCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEec
Q 005749 382 GQVIEKTTYGTAYKAKL-ADGA---TIALRLLREGSC-KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYF 456 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~-~~~~---~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~ 456 (679)
+++||+|+||+||+|+. .++. .||+|.+..... ...+.+.+|++++++++||||+++++++.+..+..++||||+
T Consensus 26 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~ 105 (298)
T 3pls_A 26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYM 105 (298)
T ss_dssp EEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECCC
T ss_pred CceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEecc
Confidence 47899999999999984 3333 799999876432 335678999999999999999999999987555569999999
Q ss_pred CCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccc
Q 005749 457 PSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVA 536 (679)
Q Consensus 457 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 536 (679)
.+|+|.+++... ...+++..++.++.|++.||+|||+++ |+||||||+||++++++.+||+|||+++.......
T Consensus 106 ~~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 179 (298)
T 3pls_A 106 CHGDLLQFIRSP---QRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILDREY 179 (298)
T ss_dssp TTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGG
T ss_pred cCCCHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccCCcc
Confidence 999999999763 345899999999999999999999988 99999999999999999999999999986643321
Q ss_pred ---cchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHh
Q 005749 537 ---DEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDME 613 (679)
Q Consensus 537 ---~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 613 (679)
.......++..|+|||.+.+..++.++||||||+++|||++|..|+...... ..+....
T Consensus 180 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~--~~~~~~~---------------- 241 (298)
T 3pls_A 180 YSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP--FDLTHFL---------------- 241 (298)
T ss_dssp GCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG--GGHHHHH----------------
T ss_pred cccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCH--HHHHHHh----------------
Confidence 1223456788999999999989999999999999999999966665332221 1111111
Q ss_pred hhhcCC-CChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCCCC
Q 005749 614 IMKGIR-SPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRPRN 661 (679)
Q Consensus 614 i~~~~~-~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 661 (679)
..+.. .........+.+++.+||+.||++|||++|+++.|+++....
T Consensus 242 -~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l 289 (298)
T 3pls_A 242 -AQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSAL 289 (298)
T ss_dssp -HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred -hcCCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHH
Confidence 11111 111122346778999999999999999999999999986543
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=346.66 Aligned_cols=250 Identities=19% Similarity=0.299 Sum_probs=198.0
Q ss_pred cCccccCCceEEEEEEeCC----CCEEEEEEcccCc-ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEec
Q 005749 382 GQVIEKTTYGTAYKAKLAD----GATIALRLLREGS-CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYF 456 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~~----~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~ 456 (679)
.+.||+|+||.||+|+..+ +..||+|.++... ....+.+.+|++++++++||||+++++++.+ +..++||||+
T Consensus 17 ~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~v~e~~ 94 (281)
T 3cc6_A 17 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE--EPTWIIMELY 94 (281)
T ss_dssp EEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS--SSCEEEEECC
T ss_pred EEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC--CCCEEEEecC
Confidence 3789999999999998532 3369999997653 2345678999999999999999999999875 4679999999
Q ss_pred CCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccc
Q 005749 457 PSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVA 536 (679)
Q Consensus 457 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 536 (679)
++++|.+++... ...+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++.......
T Consensus 95 ~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 168 (281)
T 3cc6_A 95 PYGELGHYLERN---KNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY 168 (281)
T ss_dssp TTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC-----
T ss_pred CCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCcccccccc
Confidence 999999999764 345899999999999999999999988 99999999999999999999999999987654333
Q ss_pred cchhcccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhh
Q 005749 537 DEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIM 615 (679)
Q Consensus 537 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~ 615 (679)
.......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+ ....+ .
T Consensus 169 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~---~~~~~-----------------~ 228 (281)
T 3cc6_A 169 YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD---VIGVL-----------------E 228 (281)
T ss_dssp ----CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG---HHHHH-----------------H
T ss_pred cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH---HHHHH-----------------h
Confidence 33344567888999999988889999999999999999998 999995433221 11111 1
Q ss_pred hcCC-CChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCC
Q 005749 616 KGIR-SPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRP 659 (679)
Q Consensus 616 ~~~~-~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 659 (679)
.+.. +......+.+.+++.+||+.||++|||+.|+++.|+++..
T Consensus 229 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 273 (281)
T 3cc6_A 229 KGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ 273 (281)
T ss_dssp HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCCCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence 1100 1111223557789999999999999999999999998753
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=348.13 Aligned_cols=254 Identities=20% Similarity=0.332 Sum_probs=199.3
Q ss_pred cCccccCCceEEEEEEeCC----CCEEEEEEcccCcc-cCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEec
Q 005749 382 GQVIEKTTYGTAYKAKLAD----GATIALRLLREGSC-KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYF 456 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~~----~~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~ 456 (679)
.+.||+|+||+||+|+..+ +..||+|.+..... ...+.+.+|++++++++||||+++++++....+..++||||+
T Consensus 30 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~ 109 (298)
T 3f66_A 30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 109 (298)
T ss_dssp EEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEECC
T ss_pred cceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEEeCC
Confidence 4789999999999998543 23689999876432 334678999999999999999999999776567889999999
Q ss_pred CCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccc
Q 005749 457 PSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVA 536 (679)
Q Consensus 457 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 536 (679)
++|+|.+++... ...+++..++.++.|++.||+|||+++ |+||||||+||++++++.+||+|||+++.......
T Consensus 110 ~~~~L~~~l~~~---~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 183 (298)
T 3f66_A 110 KHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEY 183 (298)
T ss_dssp TTCBHHHHHHCT---TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGG
T ss_pred CCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccccccccccch
Confidence 999999999753 345899999999999999999999988 99999999999999999999999999987644322
Q ss_pred c---chhcccccccccccccccccCCCCcchhHHHHHHHHHHHhC-CCCCCCCCCCcccchhHHHHHHhhcccccccchH
Q 005749 537 D---EMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIG-KKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDM 612 (679)
Q Consensus 537 ~---~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg-~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 612 (679)
. ......+|+.|+|||.+.+..++.++||||+|+++|||++| .+||......+ ....
T Consensus 184 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~---~~~~---------------- 244 (298)
T 3f66_A 184 YSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITVY---------------- 244 (298)
T ss_dssp CBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT---HHHH----------------
T ss_pred hccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH---HHHH----------------
Confidence 1 22344677889999999988999999999999999999995 55553322211 1110
Q ss_pred hhhhcCCCC-hHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCCCC
Q 005749 613 EIMKGIRSP-MEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRPRN 661 (679)
Q Consensus 613 ~i~~~~~~~-~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 661 (679)
+..+.... .......+.+++.+||+.||++|||++|+++.|+++....
T Consensus 245 -~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 293 (298)
T 3f66_A 245 -LLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 293 (298)
T ss_dssp -HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred -HhcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 01111111 1112345778999999999999999999999999986543
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=361.29 Aligned_cols=242 Identities=19% Similarity=0.265 Sum_probs=196.6
Q ss_pred cCccccCCceEEEEEEe-CCCCEEEEEEcccCc---ccCcccHHHHHHHHhcc-CCCCCccceEEeeCCCCceEEEEEec
Q 005749 382 GQVIEKTTYGTAYKAKL-ADGATIALRLLREGS---CKDRSSCLPVIRQLGKV-RHENLIPLRAFYQGKRGEKLLIYDYF 456 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~~lv~ey~ 456 (679)
.++||+|+||.||+|+. .+|+.||+|+++... ....+.+..|.+++..+ +||||+++++++.+ .+..++||||+
T Consensus 22 ~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~-~~~~~lv~E~~ 100 (345)
T 1xjd_A 22 HKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT-KENLFFVMEYL 100 (345)
T ss_dssp EEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC-SSEEEEEEECC
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEe-CCEEEEEEeCC
Confidence 37899999999999995 468999999997542 23455678999999887 99999999999998 67899999999
Q ss_pred CCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccc
Q 005749 457 PSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVA 536 (679)
Q Consensus 457 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 536 (679)
++|+|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..... .
T Consensus 101 ~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~-~ 172 (345)
T 1xjd_A 101 NGGDLMYHIQSC----HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLG-D 172 (345)
T ss_dssp TTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT-T
T ss_pred CCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhhcccC-C
Confidence 999999999763 35899999999999999999999988 999999999999999999999999999864322 1
Q ss_pred cchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhh
Q 005749 537 DEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMK 616 (679)
Q Consensus 537 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~ 616 (679)
......+||+.|+|||++.+..++.++||||+||++|||++|+.||.+.... ..... +..
T Consensus 173 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~------~~~~~--------------i~~ 232 (345)
T 1xjd_A 173 AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE------ELFHS--------------IRM 232 (345)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHH--------------HHH
T ss_pred CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH------HHHHH--------------HHh
Confidence 2234568999999999999989999999999999999999999999543211 11111 111
Q ss_pred cCCCChHHHHHHHHHHHHhccCcCCCCCCCHH-HHHH
Q 005749 617 GIRSPMEEGLVQALKLAMGCCAPVASVRPTMD-EVVK 652 (679)
Q Consensus 617 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~-evl~ 652 (679)
+..........++.+++.+||+.||++||++. |+++
T Consensus 233 ~~~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 233 DNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp CCCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred CCCCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence 11111112235677899999999999999997 6653
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-42 Score=359.41 Aligned_cols=267 Identities=20% Similarity=0.282 Sum_probs=204.7
Q ss_pred cCccccCCceEEEEEEe-----CCCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeC-CCCceEEEEEe
Q 005749 382 GQVIEKTTYGTAYKAKL-----ADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQG-KRGEKLLIYDY 455 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~-----~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~-~~~~~~lv~ey 455 (679)
.+.||+|+||.||+|++ .+++.||||++........+.+.+|++++++++||||+++++++.. .....++||||
T Consensus 28 ~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~ 107 (327)
T 3lxl_A 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEY 107 (327)
T ss_dssp EEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEEEEC
T ss_pred hhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEEEEee
Confidence 37899999999999984 4688999999987655556679999999999999999999998874 24568999999
Q ss_pred cCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCccc
Q 005749 456 FPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAV 535 (679)
Q Consensus 456 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 535 (679)
+++++|.+++.... ..+++..++.|+.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++......
T Consensus 108 ~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 181 (327)
T 3lxl_A 108 LPSGCLRDFLQRHR---ARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLLPLDK 181 (327)
T ss_dssp CTTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEECCTTC
T ss_pred cCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccceecccCC
Confidence 99999999997642 35899999999999999999999988 9999999999999999999999999998764332
Q ss_pred cc--chhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccc--cccch
Q 005749 536 AD--EMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETT--MEVFD 611 (679)
Q Consensus 536 ~~--~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~--~~~~~ 611 (679)
.. ......+|..|+|||++.+..++.++||||||+++|||++|+.||..... ............ .....
T Consensus 182 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~-------~~~~~~~~~~~~~~~~~~~ 254 (327)
T 3lxl_A 182 DYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSA-------EFLRMMGCERDVPALSRLL 254 (327)
T ss_dssp SEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHH-------HHHHHCC----CCHHHHHH
T ss_pred ccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccc-------hhhhhcccccccccHHHHH
Confidence 21 22344678889999999988899999999999999999999999843211 000000000000 00001
Q ss_pred HhhhhcCC-CChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCCCC
Q 005749 612 MEIMKGIR-SPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRPRN 661 (679)
Q Consensus 612 ~~i~~~~~-~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 661 (679)
..+..+.. ...+...+.+.+++.+||+.||++|||++|+++.|+++....
T Consensus 255 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 305 (327)
T 3lxl_A 255 ELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305 (327)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred HHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 11111111 112233456778999999999999999999999999987543
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-42 Score=352.55 Aligned_cols=247 Identities=19% Similarity=0.264 Sum_probs=197.2
Q ss_pred cCccccCCceEEEEEEeC-CC-------CEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEE
Q 005749 382 GQVIEKTTYGTAYKAKLA-DG-------ATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIY 453 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~-~~-------~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ 453 (679)
.+.||+|+||.||+|+.. ++ ..||+|++........+.+.+|++++++++||||+++++++.+ .+..++||
T Consensus 13 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~ 91 (289)
T 4fvq_A 13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVC-GDENILVQ 91 (289)
T ss_dssp EEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECC-TTCCEEEE
T ss_pred eeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEe-CCCCEEEE
Confidence 378999999999999843 33 4799999977665666789999999999999999999999987 67889999
Q ss_pred EecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCc--------eEEeec
Q 005749 454 DYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFV--------SRLTEF 525 (679)
Q Consensus 454 ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~--------~kl~DF 525 (679)
||+++|+|.+++... ...+++..++.++.|++.||+|||+++ |+||||||+|||++.++. +||+||
T Consensus 92 e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Df 165 (289)
T 4fvq_A 92 EFVKFGSLDTYLKKN---KNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDP 165 (289)
T ss_dssp ECCTTCBHHHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEEECCC
T ss_pred ECCCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceeeeccC
Confidence 999999999999864 234899999999999999999999988 999999999999998877 999999
Q ss_pred ccccccCcccccchhcccccccccccccccc-cCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcc
Q 005749 526 GLDQLMVPAVADEMVALAKADGYKAPELQRM-KKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEE 604 (679)
Q Consensus 526 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~ 604 (679)
|+++..... ....++..|+|||++.+ ..++.++||||||+++|||++|..|+...... ..........
T Consensus 166 g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~-----~~~~~~~~~~- 234 (289)
T 4fvq_A 166 GISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS-----QRKLQFYEDR- 234 (289)
T ss_dssp CSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH-----HHHHHHHHTT-
T ss_pred cccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccch-----HHHHHHhhcc-
Confidence 999765322 23457888999999887 67899999999999999999966554332211 0111100000
Q ss_pred cccccchHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCCC
Q 005749 605 TTMEVFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRPR 660 (679)
Q Consensus 605 ~~~~~~~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 660 (679)
.........++.+++.+||+.||++|||++|+++.|+++..+
T Consensus 235 --------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p 276 (289)
T 4fvq_A 235 --------------HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP 276 (289)
T ss_dssp --------------CCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--
T ss_pred --------------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence 000011123566899999999999999999999999998653
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=355.41 Aligned_cols=246 Identities=17% Similarity=0.256 Sum_probs=178.7
Q ss_pred cCccccCCceEEEEEEe-CCCCEEEEEEcccCcccCcccHHHHHHHHhccC-CCCCccceEEeeCCCCceEEEEEecCCC
Q 005749 382 GQVIEKTTYGTAYKAKL-ADGATIALRLLREGSCKDRSSCLPVIRQLGKVR-HENLIPLRAFYQGKRGEKLLIYDYFPSR 459 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~~~~~~~~~~~~lv~ey~~~g 459 (679)
++.||+|+||.||+|+. .+++.||||++... ....+.+|++++.+++ |||||++++++.+ .+..++||||+++|
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~-~~~~~lv~e~~~~~ 91 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHD-QLHTFLVMELLNGG 91 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-SSEEEEEECCCCSC
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEc-CCEEEEEEEccCCC
Confidence 47899999999999995 56899999998653 3456789999999997 9999999999997 67899999999999
Q ss_pred ChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCC---ceEEeecccccccCcccc
Q 005749 460 TLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFF---VSRLTEFGLDQLMVPAVA 536 (679)
Q Consensus 460 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~---~~kl~DFGla~~~~~~~~ 536 (679)
+|.+++... ..+++..++.|+.|++.||+|||+++ |+||||||+|||++.++ .+||+|||+++..... .
T Consensus 92 ~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~-~ 163 (325)
T 3kn6_A 92 ELFERIKKK----KHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD-N 163 (325)
T ss_dssp BHHHHHHHC----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC---
T ss_pred cHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCC-C
Confidence 999999863 45999999999999999999999988 99999999999998765 8999999999865433 2
Q ss_pred cchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCccc-chhHHHHHHhhcccccccchHhhh
Q 005749 537 DEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFV-DLPSIVKVAVLEETTMEVFDMEIM 615 (679)
Q Consensus 537 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~-~l~~~~~~~~~~~~~~~~~~~~i~ 615 (679)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||.+....... ...+... .+.
T Consensus 164 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~--------------~i~ 229 (325)
T 3kn6_A 164 QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMK--------------KIK 229 (325)
T ss_dssp --------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHH--------------HHT
T ss_pred CcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHH--------------HHH
Confidence 2234557899999999999999999999999999999999999999654322111 1111111 111
Q ss_pred hcCCCCh----HHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 616 KGIRSPM----EEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 616 ~~~~~~~----~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
.+..... ....+++.+++.+||+.||++|||++|+++.
T Consensus 230 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 230 KGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp TTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred cCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 1111111 1224567889999999999999999998754
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=383.54 Aligned_cols=248 Identities=20% Similarity=0.295 Sum_probs=198.8
Q ss_pred ccccCCceEEEEEEeC---CCCEEEEEEcccCc-ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCC
Q 005749 384 VIEKTTYGTAYKAKLA---DGATIALRLLREGS-CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSR 459 (679)
Q Consensus 384 ~ig~G~~g~Vy~~~~~---~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~g 459 (679)
.||+|+||.||+|++. ++..||||+++... ....+.|.+|+++|++++|||||+++++|.. +..++|||||++|
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~--~~~~lv~E~~~~g 420 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA--EALMLVMEMAGGG 420 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES--SSEEEEEECCTTC
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc--CCeEEEEEeCCCC
Confidence 6999999999999853 46689999998653 3356789999999999999999999999976 5699999999999
Q ss_pred ChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccc-
Q 005749 460 TLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADE- 538 (679)
Q Consensus 460 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~- 538 (679)
+|.+++... ...+++..++.|+.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.........
T Consensus 421 ~L~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 494 (613)
T 2ozo_A 421 PLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYT 494 (613)
T ss_dssp BHHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC-------
T ss_pred cHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceee
Confidence 999999754 345899999999999999999999988 9999999999999999999999999998764332211
Q ss_pred -hhcccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhh
Q 005749 539 -MVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMK 616 (679)
Q Consensus 539 -~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~ 616 (679)
.....+++.|+|||++.+..++.++|||||||++|||++ |+.||.+....+ +.. .+..
T Consensus 495 ~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~---~~~-----------------~i~~ 554 (613)
T 2ozo_A 495 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---VMA-----------------FIEQ 554 (613)
T ss_dssp -------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH---HHH-----------------HHHT
T ss_pred eccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH---HHH-----------------HHHc
Confidence 122345678999999998899999999999999999998 999996543221 111 1112
Q ss_pred cCCCC-hHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCC
Q 005749 617 GIRSP-MEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRP 659 (679)
Q Consensus 617 ~~~~~-~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 659 (679)
+.+.. .+....++.+++.+||+.||++||++++|++.|+.+..
T Consensus 555 ~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~ 598 (613)
T 2ozo_A 555 GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 598 (613)
T ss_dssp TCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 21111 12234677789999999999999999999999998753
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=359.68 Aligned_cols=244 Identities=16% Similarity=0.251 Sum_probs=197.6
Q ss_pred cCccccCCceEEEEEEe-CCCCEEEEEEcccCc---ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecC
Q 005749 382 GQVIEKTTYGTAYKAKL-ADGATIALRLLREGS---CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFP 457 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~ 457 (679)
.+.||+|+||.||+|+. .+++.||+|++.... ....+.+.+|++++++++|||||+++++|.+ .+..++||||++
T Consensus 20 ~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~-~~~~~lv~e~~~ 98 (384)
T 4fr4_A 20 LRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQD-EEDMFMVVDLLL 98 (384)
T ss_dssp EEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-SSEEEEEECCCT
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe-CCEEEEEEecCC
Confidence 37899999999999994 568999999986532 2345678899999999999999999999998 678999999999
Q ss_pred CCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCccccc
Q 005749 458 SRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVAD 537 (679)
Q Consensus 458 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 537 (679)
+|+|.+++.. ...+++..++.|+.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+... .
T Consensus 99 gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~--~ 169 (384)
T 4fr4_A 99 GGDLRYHLQQ----NVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE--T 169 (384)
T ss_dssp TEEHHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTT--C
T ss_pred CCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccCC--C
Confidence 9999999986 345999999999999999999999988 999999999999999999999999999876432 2
Q ss_pred chhcccccccccccccccc---cCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhh
Q 005749 538 EMVALAKADGYKAPELQRM---KKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEI 614 (679)
Q Consensus 538 ~~~~~~gt~~y~aPE~~~~---~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i 614 (679)
......||+.|+|||++.. ..++.++|||||||++|||++|+.||.......... .....
T Consensus 170 ~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~---~~~~~-------------- 232 (384)
T 4fr4_A 170 QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKE---IVHTF-------------- 232 (384)
T ss_dssp CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHH---HHHHH--------------
T ss_pred ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHH---HHHHH--------------
Confidence 3345689999999999874 458999999999999999999999996543322111 11111
Q ss_pred hhcCCCChHHHHHHHHHHHHhccCcCCCCCCC-HHHHHH
Q 005749 615 MKGIRSPMEEGLVQALKLAMGCCAPVASVRPT-MDEVVK 652 (679)
Q Consensus 615 ~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs-~~evl~ 652 (679)
..............+.+++.+||+.||++||+ ++++++
T Consensus 233 ~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 233 ETTVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp HHCCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred hhcccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 11111111223356778999999999999998 677664
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=354.46 Aligned_cols=243 Identities=20% Similarity=0.252 Sum_probs=188.3
Q ss_pred cCccccCCceEEEEEEe----CCCCEEEEEEcccCc----ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEE
Q 005749 382 GQVIEKTTYGTAYKAKL----ADGATIALRLLREGS----CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIY 453 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~----~~~~~vAvK~~~~~~----~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ 453 (679)
.+.||+|+||.||+|+. .+++.||+|+++... ......+.+|++++++++|||||++++++.. .+..++||
T Consensus 22 ~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~ 100 (327)
T 3a62_A 22 LRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT-GGKLYLIL 100 (327)
T ss_dssp EEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC-SSCEEEEE
T ss_pred EEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc-CCEEEEEE
Confidence 37899999999999996 478999999997642 2334568899999999999999999999987 67899999
Q ss_pred EecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCc
Q 005749 454 DYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVP 533 (679)
Q Consensus 454 ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 533 (679)
||+++|+|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 101 e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 173 (327)
T 3a62_A 101 EYLSGGELFMQLERE----GIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIH 173 (327)
T ss_dssp ECCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC-----
T ss_pred eCCCCCcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCccccccc
Confidence 999999999999763 35899999999999999999999988 99999999999999999999999999986432
Q ss_pred ccccchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHh
Q 005749 534 AVADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDME 613 (679)
Q Consensus 534 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 613 (679)
. ........||+.|+|||++.+..++.++|||||||++|||++|+.||.+.... .....
T Consensus 174 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~~~-------------- 232 (327)
T 3a62_A 174 D-GTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK------KTIDK-------------- 232 (327)
T ss_dssp ------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHH--------------
T ss_pred C-CccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHH------HHHHH--------------
Confidence 2 12233457999999999999889999999999999999999999999543211 11111
Q ss_pred hhhcCCCChHHHHHHHHHHHHhccCcCCCCCC-----CHHHHHHH
Q 005749 614 IMKGIRSPMEEGLVQALKLAMGCCAPVASVRP-----TMDEVVKQ 653 (679)
Q Consensus 614 i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~evl~~ 653 (679)
+........+....++.+++.+||+.||++|| +++|++++
T Consensus 233 i~~~~~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 233 ILKCKLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp HHHTCCCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred HHhCCCCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 11111111112235677899999999999999 77788764
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=368.68 Aligned_cols=247 Identities=18% Similarity=0.221 Sum_probs=197.2
Q ss_pred cCccccCCceEEEEEE-eCCCCEEEEEEcccCcc--cCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCC
Q 005749 382 GQVIEKTTYGTAYKAK-LADGATIALRLLREGSC--KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPS 458 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~ 458 (679)
.+.||+|+||.||+|+ ..+|+.||+|++..... ...+.+.+|++++++++|||||++++++.+ .+..++|||||++
T Consensus 16 ~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~~lv~E~~~g 94 (444)
T 3soa_A 16 FEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISE-EGHHYLIFDLVTG 94 (444)
T ss_dssp EEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEEC-SSEEEEEECCCBC
T ss_pred EEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEE-CCEEEEEEEeCCC
Confidence 4789999999999998 56799999999876432 234578999999999999999999999987 6889999999999
Q ss_pred CChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeec---CCCceEEeecccccccCccc
Q 005749 459 RTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVD---DFFVSRLTEFGLDQLMVPAV 535 (679)
Q Consensus 459 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~---~~~~~kl~DFGla~~~~~~~ 535 (679)
|+|.+.+... ..+++..+..++.||+.||+|||+++ |+||||||+|||++ +++.+||+|||+++.....
T Consensus 95 g~L~~~i~~~----~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~- 166 (444)
T 3soa_A 95 GELFEDIVAR----EYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE- 166 (444)
T ss_dssp CBHHHHHHHC----SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTT-
T ss_pred CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEEecCC-
Confidence 9999999763 45899999999999999999999998 99999999999998 4578999999999876433
Q ss_pred ccchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhh
Q 005749 536 ADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIM 615 (679)
Q Consensus 536 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~ 615 (679)
........||+.|+|||++.+..++.++||||+||++|||++|+.||.+.... ........... ...
T Consensus 167 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~------~~~~~i~~~~~--~~~----- 233 (444)
T 3soa_A 167 QQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQH------RLYQQIKAGAY--DFP----- 233 (444)
T ss_dssp CCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHTCC--CCC-----
T ss_pred CceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHH------HHHHHHHhCCC--CCC-----
Confidence 22234567999999999999889999999999999999999999999543211 11111000000 000
Q ss_pred hcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 616 KGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 616 ~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
.+..+...+++.+++.+||+.||++|||+.|+++.
T Consensus 234 ---~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 234 ---SPEWDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp ---TTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ---ccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 00111224567789999999999999999999874
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=352.10 Aligned_cols=264 Identities=20% Similarity=0.276 Sum_probs=201.6
Q ss_pred cCccccCCceEEEEEEe-----CCCCEEEEEEcccCc-ccCcccHHHHHHHHhccCCCCCccceEEeeCC-CCceEEEEE
Q 005749 382 GQVIEKTTYGTAYKAKL-----ADGATIALRLLREGS-CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGK-RGEKLLIYD 454 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~-----~~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~-~~~~~lv~e 454 (679)
.+.||+|+||.||+|++ .+++.||+|+++... ....+.+.+|++++++++||||+++++++... ....++|||
T Consensus 26 ~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e 105 (302)
T 4e5w_A 26 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIME 105 (302)
T ss_dssp EEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEEEEEE
T ss_pred hhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEEEEEE
Confidence 37899999999999983 468899999997543 23456789999999999999999999999863 256899999
Q ss_pred ecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcc
Q 005749 455 YFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPA 534 (679)
Q Consensus 455 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 534 (679)
|+++|+|.+++... ...+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++.....
T Consensus 106 ~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 179 (302)
T 4e5w_A 106 FLPSGSLKEYLPKN---KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETD 179 (302)
T ss_dssp CCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred eCCCCcHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECcccccccccCC
Confidence 99999999999654 345899999999999999999999988 999999999999999999999999999876443
Q ss_pred cc--cchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhh--cccccccc
Q 005749 535 VA--DEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVL--EETTMEVF 610 (679)
Q Consensus 535 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~--~~~~~~~~ 610 (679)
.. .......+|..|+|||.+.+..++.++||||+|+++|||++|..|+.... ......... ........
T Consensus 180 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-------~~~~~~~~~~~~~~~~~~~ 252 (302)
T 4e5w_A 180 KEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPM-------ALFLKMIGPTHGQMTVTRL 252 (302)
T ss_dssp CCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHH-------HHHHHHHCSCCGGGHHHHH
T ss_pred CcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchh-------hHHhhccCCcccccCHHHH
Confidence 22 12234567888999999998889999999999999999999999863210 000000000 00000111
Q ss_pred hHhhhhcCCC-ChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhC
Q 005749 611 DMEIMKGIRS-PMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENR 658 (679)
Q Consensus 611 ~~~i~~~~~~-~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 658 (679)
...+..+... ..+...+.+.+++.+||+.||++|||+.|+++.|+++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 253 VNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 1111222111 12233456788999999999999999999999999864
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=360.09 Aligned_cols=246 Identities=19% Similarity=0.255 Sum_probs=197.2
Q ss_pred cCccccCCceEEEEEEe-CCCCEEEEEEcccCcc--cCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCC
Q 005749 382 GQVIEKTTYGTAYKAKL-ADGATIALRLLREGSC--KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPS 458 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~ 458 (679)
.+.||+|+||.||+|+. .+|+.||+|++..... ...+.+.+|++++++++|||||++++++.+ .+..++||||+++
T Consensus 34 ~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-~~~~~lv~e~~~g 112 (362)
T 2bdw_A 34 KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE-ESFHYLVFDLVTG 112 (362)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEEEECCCCS
T ss_pred eeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe-CCEEEEEEecCCC
Confidence 57899999999999995 5689999999976432 234578899999999999999999999997 6789999999999
Q ss_pred CChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCC---CceEEeecccccccCccc
Q 005749 459 RTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDF---FVSRLTEFGLDQLMVPAV 535 (679)
Q Consensus 459 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~---~~~kl~DFGla~~~~~~~ 535 (679)
|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+++.....
T Consensus 113 g~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~- 184 (362)
T 2bdw_A 113 GELFEDIVAR----EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS- 184 (362)
T ss_dssp CBHHHHHTTC----SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC-
T ss_pred CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceEecCC-
Confidence 9999998753 45899999999999999999999988 9999999999999865 45999999999876432
Q ss_pred ccchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhh
Q 005749 536 ADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIM 615 (679)
Q Consensus 536 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~ 615 (679)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.... ........... .. .
T Consensus 185 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~------~~~~~i~~~~~--~~-~---- 250 (362)
T 2bdw_A 185 -EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH------RLYAQIKAGAY--DY-P---- 250 (362)
T ss_dssp -CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHTCC--CC-C----
T ss_pred -cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHHhCCC--CC-C----
Confidence 2233567999999999999889999999999999999999999999543211 11111000000 00 0
Q ss_pred hcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 616 KGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 616 ~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
........+++.+++.+||+.||++||++.|+++.
T Consensus 251 ---~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 251 ---SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp ---TTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ---cccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00011223567789999999999999999998864
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=358.31 Aligned_cols=239 Identities=18% Similarity=0.220 Sum_probs=197.9
Q ss_pred CccccCCceEEEEEEe-CCCCEEEEEEcccCc---ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCC
Q 005749 383 QVIEKTTYGTAYKAKL-ADGATIALRLLREGS---CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPS 458 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~ 458 (679)
+.||+|+||.||+|+. .+|+.||+|+++... ....+.+.+|++++++++||||+++++++.+ .+..++||||+++
T Consensus 47 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~e~~~g 125 (350)
T 1rdq_E 47 KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD-NSNLYMVMEYVAG 125 (350)
T ss_dssp EEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEEEEEECCTT
T ss_pred EEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc-CCEEEEEEcCCCC
Confidence 7899999999999995 479999999986542 2345678899999999999999999999997 6789999999999
Q ss_pred CChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccc
Q 005749 459 RTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADE 538 (679)
Q Consensus 459 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 538 (679)
|+|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 126 g~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~---- 194 (350)
T 1rdq_E 126 GEMFSHLRRI----GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR---- 194 (350)
T ss_dssp CBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC----
T ss_pred CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccCC----
Confidence 9999999864 34899999999999999999999988 999999999999999999999999999876432
Q ss_pred hhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcC
Q 005749 539 MVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGI 618 (679)
Q Consensus 539 ~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~ 618 (679)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+... ...... +..+.
T Consensus 195 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~------~~~~~~--------------i~~~~ 254 (350)
T 1rdq_E 195 TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP------IQIYEK--------------IVSGK 254 (350)
T ss_dssp BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHH--------------HHHCC
T ss_pred cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH------HHHHHH--------------HHcCC
Confidence 2345799999999999988999999999999999999999999954321 111111 11111
Q ss_pred CCChHHHHHHHHHHHHhccCcCCCCCCC-----HHHHHHH
Q 005749 619 RSPMEEGLVQALKLAMGCCAPVASVRPT-----MDEVVKQ 653 (679)
Q Consensus 619 ~~~~~~~~~~~~~l~~~cl~~dP~~RPs-----~~evl~~ 653 (679)
.........++.+++.+||+.||++||+ ++|++++
T Consensus 255 ~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 255 VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred CCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 1111223356778999999999999998 8888764
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=345.67 Aligned_cols=250 Identities=22% Similarity=0.349 Sum_probs=203.5
Q ss_pred cCccccCCceEEEEEEeCCCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCCh
Q 005749 382 GQVIEKTTYGTAYKAKLADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRTL 461 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gsL 461 (679)
.+.||+|+||.||+|+..++..||+|.++... ...+.+.+|++++++++||||+++++++.. +..++||||+++++|
T Consensus 18 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~v~e~~~~~~L 94 (279)
T 1qpc_A 18 VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ--EPIYIITEYMENGSL 94 (279)
T ss_dssp EEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSCEEEEECCTTCBH
T ss_pred eeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC--CCcEEEEecCCCCCH
Confidence 37899999999999998888899999997643 345679999999999999999999999874 568999999999999
Q ss_pred HHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccchhc
Q 005749 462 HDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVA 541 (679)
Q Consensus 462 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 541 (679)
.+++.... ...+++..++.++.|++.||+|||+++ |+||||||+||++++++.+||+|||+++............
T Consensus 95 ~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 169 (279)
T 1qpc_A 95 VDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG 169 (279)
T ss_dssp HHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTT
T ss_pred HHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCcccccccC
Confidence 99997532 125899999999999999999999988 9999999999999999999999999998765443333334
Q ss_pred ccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcCC-
Q 005749 542 LAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIR- 619 (679)
Q Consensus 542 ~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~- 619 (679)
..++..|+|||.+.+..++.++||||||+++|||++ |+.||.+.... +..... ..+..
T Consensus 170 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~------~~~~~~--------------~~~~~~ 229 (279)
T 1qpc_A 170 AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP------EVIQNL--------------ERGYRM 229 (279)
T ss_dssp CCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH------HHHHHH--------------HTTCCC
T ss_pred CCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH------HHHHHH--------------hcccCC
Confidence 456788999999988889999999999999999999 89998543211 111110 11111
Q ss_pred CChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCC
Q 005749 620 SPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRP 659 (679)
Q Consensus 620 ~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 659 (679)
........++.+++.+||+.||++|||++++++.|+++..
T Consensus 230 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 269 (279)
T 1qpc_A 230 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (279)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence 0111223567789999999999999999999999998753
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=371.06 Aligned_cols=243 Identities=19% Similarity=0.262 Sum_probs=189.1
Q ss_pred cCccccCCceEEEEEE-eCCCCEEEEEEcccC---cccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecC
Q 005749 382 GQVIEKTTYGTAYKAK-LADGATIALRLLREG---SCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFP 457 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~ 457 (679)
.+.||+|+||.||+|+ ..+|+.||||+++.. .......+.+|++++++++||||+++++++.+ .+..++|||||+
T Consensus 153 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~-~~~~~lv~e~~~ 231 (446)
T 4ejn_A 153 LKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT-HDRLCFVMEYAN 231 (446)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEE-TTEEEEEECCCS
T ss_pred eEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEee-CCEEEEEEeeCC
Confidence 4789999999999999 457999999999753 23345678899999999999999999999987 678999999999
Q ss_pred CCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccc
Q 005749 458 SRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHT-GHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVA 536 (679)
Q Consensus 458 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~-~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 536 (679)
+|+|.+++... ..+++..++.++.||+.||+|||+ .+ |+||||||+|||++.++.+||+|||+++..... .
T Consensus 232 ~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-~ 303 (446)
T 4ejn_A 232 GGELFFHLSRE----RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD-G 303 (446)
T ss_dssp SCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTCC---
T ss_pred CCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceeccCC-C
Confidence 99999999763 458999999999999999999998 77 999999999999999999999999999864322 2
Q ss_pred cchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhh
Q 005749 537 DEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMK 616 (679)
Q Consensus 537 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~ 616 (679)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.... ...... ..
T Consensus 304 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~------~~~~~i--------------~~ 363 (446)
T 4ejn_A 304 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------KLFELI--------------LM 363 (446)
T ss_dssp ---CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHH--------------HH
T ss_pred cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH------HHHHHH--------------Hh
Confidence 2344568999999999999999999999999999999999999999543211 111111 11
Q ss_pred cCCCChHHHHHHHHHHHHhccCcCCCCCC-----CHHHHHHH
Q 005749 617 GIRSPMEEGLVQALKLAMGCCAPVASVRP-----TMDEVVKQ 653 (679)
Q Consensus 617 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~evl~~ 653 (679)
..........+++.+++.+||+.||++|| +++|++++
T Consensus 364 ~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 364 EEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred CCCCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 11111112235677899999999999999 99999874
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=356.25 Aligned_cols=250 Identities=17% Similarity=0.219 Sum_probs=196.6
Q ss_pred cCccccCCceEEEEEEe-CCCCEEEEEEcccCccc---CcccHHHHHHHHhcc-CCCCCccceEEeeCCCCceEEEEEec
Q 005749 382 GQVIEKTTYGTAYKAKL-ADGATIALRLLREGSCK---DRSSCLPVIRQLGKV-RHENLIPLRAFYQGKRGEKLLIYDYF 456 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~---~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~~lv~ey~ 456 (679)
.+.||+|+||.||+|+. .+++.||+|+++..... ..+.+.+|++++.++ +|||||++++++.+ .+..++||||+
T Consensus 14 ~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~-~~~~~lv~e~~ 92 (345)
T 3a8x_A 14 LRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT-ESRLFFVIEYV 92 (345)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-SSEEEEEECCC
T ss_pred EEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEe-CCEEEEEEeCC
Confidence 37899999999999995 46889999999764322 234578999999988 89999999999987 68899999999
Q ss_pred CCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccc
Q 005749 457 PSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVA 536 (679)
Q Consensus 457 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 536 (679)
++|+|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..... .
T Consensus 93 ~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~-~ 164 (345)
T 3a8x_A 93 NGGDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-G 164 (345)
T ss_dssp CSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT-T
T ss_pred CCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccCC-C
Confidence 999999999763 35899999999999999999999988 999999999999999999999999999864322 2
Q ss_pred cchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCccc--chhHHHHHHhhcccccccchHhh
Q 005749 537 DEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFV--DLPSIVKVAVLEETTMEVFDMEI 614 (679)
Q Consensus 537 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~--~l~~~~~~~~~~~~~~~~~~~~i 614 (679)
......+||+.|+|||++.+..++.++||||+||++|||++|+.||......+.. ...... ...+
T Consensus 165 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~-------------~~~i 231 (345)
T 3a8x_A 165 DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL-------------FQVI 231 (345)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHH-------------HHHH
T ss_pred CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHH-------------HHHH
Confidence 2334568999999999999989999999999999999999999999543221100 000000 0111
Q ss_pred hhcCCCChHHHHHHHHHHHHhccCcCCCCCCCH------HHHHHH
Q 005749 615 MKGIRSPMEEGLVQALKLAMGCCAPVASVRPTM------DEVVKQ 653 (679)
Q Consensus 615 ~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~------~evl~~ 653 (679)
.............++.+++.+||+.||++||++ +|++++
T Consensus 232 ~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h 276 (345)
T 3a8x_A 232 LEKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 276 (345)
T ss_dssp HHCCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred HcCCCCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence 111111112234567789999999999999996 566553
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=351.40 Aligned_cols=256 Identities=19% Similarity=0.331 Sum_probs=204.7
Q ss_pred cCccccCCceEEEEEEe------CCCCEEEEEEcccCcc-cCcccHHHHHHHHhcc-CCCCCccceEEeeCCCCceEEEE
Q 005749 382 GQVIEKTTYGTAYKAKL------ADGATIALRLLREGSC-KDRSSCLPVIRQLGKV-RHENLIPLRAFYQGKRGEKLLIY 453 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~------~~~~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~~lv~ 453 (679)
.+.||+|+||.||+|+. .+++.||||+++.... ...+.+.+|++++.++ +||||+++++++.. .+..++||
T Consensus 28 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-~~~~~lv~ 106 (313)
T 1t46_A 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI-GGPTLVIT 106 (313)
T ss_dssp EEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSSCEEEE
T ss_pred HHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec-CCCcEEEE
Confidence 47899999999999984 3567999999976532 3356789999999999 99999999999987 67899999
Q ss_pred EecCCCChHHHhhcccCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCc
Q 005749 454 DYFPSRTLHDLLHDTIAG--------------KPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFV 519 (679)
Q Consensus 454 ey~~~gsL~~~l~~~~~~--------------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~ 519 (679)
||+++|+|.+++...... ...+++..++.++.|++.||+|||+++ |+||||||+||+++.++.
T Consensus 107 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~ 183 (313)
T 1t46_A 107 EYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRI 183 (313)
T ss_dssp ECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEETTTE
T ss_pred ecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEcCCCC
Confidence 999999999999864321 225899999999999999999999988 999999999999999999
Q ss_pred eEEeecccccccCccccc-chhcccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHH
Q 005749 520 SRLTEFGLDQLMVPAVAD-EMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIV 597 (679)
Q Consensus 520 ~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~ 597 (679)
+||+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.+..... ......
T Consensus 184 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~~~~ 261 (313)
T 1t46_A 184 TKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS--KFYKMI 261 (313)
T ss_dssp EEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH--HHHHHH
T ss_pred EEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh--HHHHHh
Confidence 999999999876443221 1223456788999999988899999999999999999999 999985543221 111111
Q ss_pred HHHhhcccccccchHhhhhcCCC-ChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCCC
Q 005749 598 KVAVLEETTMEVFDMEIMKGIRS-PMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRPR 660 (679)
Q Consensus 598 ~~~~~~~~~~~~~~~~i~~~~~~-~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 660 (679)
. .+... ........+.+++.+||+.||++|||+.|+++.|+++...
T Consensus 262 ~-----------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 308 (313)
T 1t46_A 262 K-----------------EGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (313)
T ss_dssp H-----------------HTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred c-----------------cCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 1 11001 1112235677899999999999999999999999987643
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=354.43 Aligned_cols=249 Identities=22% Similarity=0.316 Sum_probs=193.7
Q ss_pred CccccCCceEEEEEEe-CCCCE----EEEEEcccCc-ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEec
Q 005749 383 QVIEKTTYGTAYKAKL-ADGAT----IALRLLREGS-CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYF 456 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~-~~~~~----vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~ 456 (679)
+.||+|+||.||+|+. .+++. ||+|.++... ....+.+.+|++++++++||||+++++++.. +..++|+||+
T Consensus 21 ~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~v~~~~ 98 (327)
T 3lzb_A 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT--STVQLITQLM 98 (327)
T ss_dssp EEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEES--SSEEEEECCC
T ss_pred EEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEec--CCceEEEEec
Confidence 7899999999999994 45554 5777775442 3445679999999999999999999999986 3589999999
Q ss_pred CCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccc
Q 005749 457 PSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVA 536 (679)
Q Consensus 457 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 536 (679)
++|+|.+++... ...+++..++.|+.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 99 ~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~ 172 (327)
T 3lzb_A 99 PFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 172 (327)
T ss_dssp SSCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC---------
T ss_pred CCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEccCccc
Confidence 999999999864 345899999999999999999999988 99999999999999999999999999987643322
Q ss_pred -cchhcccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHHhhcccccccchHhh
Q 005749 537 -DEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEI 614 (679)
Q Consensus 537 -~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i 614 (679)
.......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||.+....+ +...+
T Consensus 173 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~~~~~----------------- 232 (327)
T 3lzb_A 173 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSIL----------------- 232 (327)
T ss_dssp -------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHHH-----------------
T ss_pred cccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH---HHHHH-----------------
Confidence 12233456788999999999999999999999999999999 999995433221 11111
Q ss_pred hhcC-CCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCC
Q 005749 615 MKGI-RSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRP 659 (679)
Q Consensus 615 ~~~~-~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 659 (679)
..+. .+..+....++.+++.+||+.||++||++.|+++.|+++..
T Consensus 233 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 233 EKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp HTTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred HcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 1111 11112233567789999999999999999999999998864
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=349.78 Aligned_cols=261 Identities=20% Similarity=0.234 Sum_probs=203.6
Q ss_pred cCccccCCceEEEEEEe-CCCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeC---CCCceEEEEEecC
Q 005749 382 GQVIEKTTYGTAYKAKL-ADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQG---KRGEKLLIYDYFP 457 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~---~~~~~~lv~ey~~ 457 (679)
.+.||+|+||.||+|+. .+++.||||++........+.+.+|++++++++||||+++++++.. .....++||||++
T Consensus 34 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~ 113 (317)
T 2buj_A 34 IQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFK 113 (317)
T ss_dssp EEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEECCT
T ss_pred EEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEEeCC
Confidence 47899999999999995 6799999999876555556789999999999999999999999873 2347899999999
Q ss_pred CCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCccccc
Q 005749 458 SRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVAD 537 (679)
Q Consensus 458 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 537 (679)
+|+|.+++.........+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++........
T Consensus 114 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~ 190 (317)
T 2buj_A 114 RGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEG 190 (317)
T ss_dssp TCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEESCEEEES
T ss_pred CCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchhccccccc
Confidence 99999999875444567999999999999999999999988 999999999999999999999999998765322111
Q ss_pred --------chhcccccccccccccccccC---CCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccc
Q 005749 538 --------EMVALAKADGYKAPELQRMKK---CSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETT 606 (679)
Q Consensus 538 --------~~~~~~gt~~y~aPE~~~~~~---~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 606 (679)
......||+.|+|||++.+.. ++.++||||||+++|||++|+.||....... .....
T Consensus 191 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~~----------- 258 (317)
T 2buj_A 191 SRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG-DSVAL----------- 258 (317)
T ss_dssp HHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTT-SCHHH-----------
T ss_pred ccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhccc-chhhH-----------
Confidence 112345789999999987543 6899999999999999999999983211000 00000
Q ss_pred cccchHhhhhcC-CCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCCCCCC
Q 005749 607 MEVFDMEIMKGI-RSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRPRNRS 663 (679)
Q Consensus 607 ~~~~~~~i~~~~-~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~ 663 (679)
.+.... .+..+.....+.+++.+||+.||++|||++|+++.|+.+.+....
T Consensus 259 ------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~ 310 (317)
T 2buj_A 259 ------AVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPG 310 (317)
T ss_dssp ------HHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCCC
T ss_pred ------HhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCCC
Confidence 000000 011122335677899999999999999999999999998755443
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=343.38 Aligned_cols=258 Identities=15% Similarity=0.154 Sum_probs=203.3
Q ss_pred cCccccCCceEEEEEEe-CCCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCC
Q 005749 382 GQVIEKTTYGTAYKAKL-ADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRT 460 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gs 460 (679)
.+.||+|+||.||+|+. .+++.||||++.... ..+.+.+|++++.+++|++++..++++....+..++||||+ +++
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~ 90 (296)
T 4hgt_A 14 GRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPS 90 (296)
T ss_dssp EEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCB
T ss_pred eeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-CCC
Confidence 47899999999999994 679999999876532 34578999999999999998888887765577889999999 899
Q ss_pred hHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee---cCCCceEEeecccccccCcccc-
Q 005749 461 LHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLV---DDFFVSRLTEFGLDQLMVPAVA- 536 (679)
Q Consensus 461 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl---~~~~~~kl~DFGla~~~~~~~~- 536 (679)
|.+++... ...+++..++.++.|++.||+|||+++ |+||||||+|||+ ++++.+||+|||+++.......
T Consensus 91 L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~ 164 (296)
T 4hgt_A 91 LEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 164 (296)
T ss_dssp HHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTC
T ss_pred HHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccC
Confidence 99999753 345899999999999999999999988 9999999999999 7889999999999987643322
Q ss_pred -----cchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccch
Q 005749 537 -----DEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFD 611 (679)
Q Consensus 537 -----~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 611 (679)
.......||+.|+|||.+.+..++.++|||||||++|||++|+.||.+.................... ..
T Consensus 165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-----~~ 239 (296)
T 4hgt_A 165 QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST-----PI 239 (296)
T ss_dssp CBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS-----CH
T ss_pred ccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccc-----hh
Confidence 12234578999999999999899999999999999999999999997654433222211111100000 00
Q ss_pred HhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCCC
Q 005749 612 MEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRPR 660 (679)
Q Consensus 612 ~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 660 (679)
..... ....++.+++.+||+.||++|||++|+++.|+++..+
T Consensus 240 ~~~~~-------~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~ 281 (296)
T 4hgt_A 240 EVLCK-------GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 281 (296)
T ss_dssp HHHTT-------TSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHH
T ss_pred hhhhc-------cCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHH
Confidence 00000 1135677899999999999999999999999988654
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=347.35 Aligned_cols=260 Identities=19% Similarity=0.246 Sum_probs=193.6
Q ss_pred CccccCCceEEEEEEeCCCCEEEEEEcccCcc--cCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCC
Q 005749 383 QVIEKTTYGTAYKAKLADGATIALRLLREGSC--KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRT 460 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~~~~~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gs 460 (679)
+.||+|+||+||+|+..+|+.||+|+++.... ...+.+.+|++++++++||||+++++++.+ .+..++||||+++ +
T Consensus 8 ~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~-~ 85 (288)
T 1ob3_A 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT-KKRLVLVFEHLDQ-D 85 (288)
T ss_dssp EEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC-SSCEEEEEECCSE-E
T ss_pred hhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEcc-CCeEEEEEEecCC-C
Confidence 68999999999999988899999999975432 234678899999999999999999999987 6789999999986 9
Q ss_pred hHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccchh
Q 005749 461 LHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMV 540 (679)
Q Consensus 461 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 540 (679)
|.+++... ...+++..++.++.|+++||+|||+++ |+||||||+||+++.++.+||+|||+++..... .....
T Consensus 86 l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~ 158 (288)
T 1ob3_A 86 LKKLLDVC---EGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIP-VRKYT 158 (288)
T ss_dssp HHHHHHTS---TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-------
T ss_pred HHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCcc-ccccc
Confidence 99988754 245899999999999999999999988 999999999999999999999999999865322 12223
Q ss_pred cccccccccccccccc-cCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhc--cccc-----ccchH
Q 005749 541 ALAKADGYKAPELQRM-KKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLE--ETTM-----EVFDM 612 (679)
Q Consensus 541 ~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~--~~~~-----~~~~~ 612 (679)
...+|+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.... ..+.......... .... ..+++
T Consensus 159 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T 1ob3_A 159 HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA--DQLMRIFRILGTPNSKNWPNVTELPKYDP 236 (288)
T ss_dssp ---CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred cccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHHCCCChhhchhhhccccccc
Confidence 4568999999999875 45899999999999999999999999553221 1111111110000 0000 00000
Q ss_pred hhhhcCCC----ChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 613 EIMKGIRS----PMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 613 ~i~~~~~~----~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
........ .......++.+++.+||+.||++|||++|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 00000000 001123566789999999999999999999863
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=347.05 Aligned_cols=251 Identities=22% Similarity=0.319 Sum_probs=205.5
Q ss_pred cCccccCCceEEEEEEeC-CCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCC
Q 005749 382 GQVIEKTTYGTAYKAKLA-DGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRT 460 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gs 460 (679)
.+.||+|+||.||+|+.. ++..||+|.+.... ...+.+.+|++++++++||||+++++++.+ .+..++||||+++++
T Consensus 18 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e~~~~~~ 95 (288)
T 3kfa_A 18 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR-EPPFYIITEFMTYGN 95 (288)
T ss_dssp EEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSSEEEEEECCTTEE
T ss_pred EeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEcc-CCCEEEEEEcCCCCc
Confidence 378999999999999954 58899999997532 345678999999999999999999999987 678999999999999
Q ss_pred hHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccchh
Q 005749 461 LHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMV 540 (679)
Q Consensus 461 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 540 (679)
|.+++.... ...+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++...........
T Consensus 96 L~~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 170 (288)
T 3kfa_A 96 LLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 170 (288)
T ss_dssp HHHHHHHCC--TTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSEEET
T ss_pred HHHHHHhcc--cCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCCcccccc
Confidence 999997643 345899999999999999999999988 999999999999999999999999999877544333344
Q ss_pred cccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcCC
Q 005749 541 ALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIR 619 (679)
Q Consensus 541 ~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~ 619 (679)
...+++.|+|||.+.+..++.++||||||+++|||++ |..||...... ...... .....
T Consensus 171 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~---~~~~~~-----------------~~~~~ 230 (288)
T 3kfa_A 171 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---QVYELL-----------------EKDYR 230 (288)
T ss_dssp TEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GHHHHH-----------------HTTCC
T ss_pred CCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHH-----------------hccCC
Confidence 4567788999999998899999999999999999999 99998543221 111111 11101
Q ss_pred -CChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCC
Q 005749 620 -SPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRP 659 (679)
Q Consensus 620 -~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 659 (679)
.......+.+.+++.+||+.||++|||++|+++.|+++..
T Consensus 231 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~ 271 (288)
T 3kfa_A 231 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 271 (288)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHH
Confidence 1111223567789999999999999999999999988753
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=348.50 Aligned_cols=263 Identities=19% Similarity=0.285 Sum_probs=190.1
Q ss_pred CccccCCceEEEEEEe-CCCCEEEEEEcccCcc-cCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCC
Q 005749 383 QVIEKTTYGTAYKAKL-ADGATIALRLLREGSC-KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRT 460 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gs 460 (679)
+.||+|+||.||+|+. .+|+.||+|+++.... ...+.+.+|++++++++|||||++++++.+ .+..++||||++ |+
T Consensus 11 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~e~~~-~~ 88 (317)
T 2pmi_A 11 EKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHT-ENKLTLVFEFMD-ND 88 (317)
T ss_dssp --------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECC-TTEEEEEEECCC-CB
T ss_pred eEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEE-CCeEEEEEEecC-CC
Confidence 7899999999999994 5699999999976432 345678999999999999999999999987 678999999998 59
Q ss_pred hHHHhhcccC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccc
Q 005749 461 LHDLLHDTIA--GKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADE 538 (679)
Q Consensus 461 L~~~l~~~~~--~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 538 (679)
|.+++..... ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 89 L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~-~~ 164 (317)
T 2pmi_A 89 LKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPV-NT 164 (317)
T ss_dssp HHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETTSCC-CC
T ss_pred HHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecCCCc-cc
Confidence 9999876432 1245899999999999999999999988 9999999999999999999999999998764321 22
Q ss_pred hhcccccccccccccccc-cCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhh--cccccc-----cc
Q 005749 539 MVALAKADGYKAPELQRM-KKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVL--EETTME-----VF 610 (679)
Q Consensus 539 ~~~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~--~~~~~~-----~~ 610 (679)
.....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+....+ .+.......-. ...... .+
T Consensus 165 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~i~~~~~~~~~~~~~~~~~~~~~ 242 (317)
T 2pmi_A 165 FSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEE--QLKLIFDIMGTPNESLWPSVTKLPKY 242 (317)
T ss_dssp CCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCSCCTTTCGGGGGCTTC
T ss_pred CCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhCCCChhHhhhhhhhhhc
Confidence 234578999999999876 468999999999999999999999996543211 11111111000 000000 00
Q ss_pred hHhhhhcCCCCh---------HHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 611 DMEIMKGIRSPM---------EEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 611 ~~~i~~~~~~~~---------~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
.+.+........ .....++.+++.+||+.||++|||++|+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 243 NPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp CTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 000000000000 0122467899999999999999999999875
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=365.12 Aligned_cols=248 Identities=15% Similarity=0.161 Sum_probs=197.0
Q ss_pred CccccCCceEEEEEEe-CCCCEEEEEEcccCc---ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCC
Q 005749 383 QVIEKTTYGTAYKAKL-ADGATIALRLLREGS---CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPS 458 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~ 458 (679)
++||+|+||+||+|+. .+|+.||+|+++... ....+.+.+|++++.+++|||||++++++.+ .+..|+||||+++
T Consensus 67 ~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~-~~~~~lVmE~~~g 145 (412)
T 2vd5_A 67 KVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD-ENYLYLVMEYYVG 145 (412)
T ss_dssp EEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC-SSEEEEEECCCCS
T ss_pred EEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee-CCEEEEEEcCCCC
Confidence 6899999999999995 579999999997532 2345678999999999999999999999998 6789999999999
Q ss_pred CChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccc
Q 005749 459 RTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADE 538 (679)
Q Consensus 459 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 538 (679)
|+|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.........
T Consensus 146 g~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~~~ 219 (412)
T 2vd5_A 146 GDLLTLLSKF---GERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVR 219 (412)
T ss_dssp CBHHHHHHHH---SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEE
T ss_pred CcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeechhheeccCCCccc
Confidence 9999999764 235899999999999999999999988 9999999999999999999999999998765443333
Q ss_pred hhccccccccccccccc-------ccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccch
Q 005749 539 MVALAKADGYKAPELQR-------MKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFD 611 (679)
Q Consensus 539 ~~~~~gt~~y~aPE~~~-------~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 611 (679)
....+||+.|+|||++. ...++.++|||||||++|||++|+.||.+.... +.......
T Consensus 220 ~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------~~~~~i~~--------- 284 (412)
T 2vd5_A 220 SLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA------ETYGKIVH--------- 284 (412)
T ss_dssp CSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHT---------
T ss_pred cceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHH------HHHHHHHh---------
Confidence 34568999999999987 356899999999999999999999999543221 11110000
Q ss_pred HhhhhcCCCChHHHHHHHHHHHHhccCcCCCCC---CCHHHHHHH
Q 005749 612 MEIMKGIRSPMEEGLVQALKLAMGCCAPVASVR---PTMDEVVKQ 653 (679)
Q Consensus 612 ~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~R---Ps~~evl~~ 653 (679)
...............+++.+++.+||. +|++| |+++|++++
T Consensus 285 ~~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 285 YKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp HHHHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred cccCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 000000000011223567789999999 99998 689999775
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=346.75 Aligned_cols=245 Identities=16% Similarity=0.197 Sum_probs=189.9
Q ss_pred cCccccCCceEEEEEEe-CCCCEEEEEEcccCcc--------------------------cCcccHHHHHHHHhccCCCC
Q 005749 382 GQVIEKTTYGTAYKAKL-ADGATIALRLLREGSC--------------------------KDRSSCLPVIRQLGKVRHEN 434 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~--------------------------~~~~~~~~Ei~~l~~l~H~n 434 (679)
.+.||+|+||.||+|+. .+++.||||++..... ...+.+.+|++++++++|||
T Consensus 18 ~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 97 (298)
T 2zv2_A 18 KDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPN 97 (298)
T ss_dssp EEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTCCCTT
T ss_pred EeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhCCCCC
Confidence 37899999999999994 5689999999865421 12356899999999999999
Q ss_pred CccceEEeeCC-CCceEEEEEecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCee
Q 005749 435 LIPLRAFYQGK-RGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVL 513 (679)
Q Consensus 435 Iv~l~~~~~~~-~~~~~lv~ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NIL 513 (679)
|+++++++.+. .+..++||||+++++|.+++.. ..+++..++.++.|++.||+|||+++ |+||||||+|||
T Consensus 98 iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil 169 (298)
T 2zv2_A 98 VVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL-----KPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLL 169 (298)
T ss_dssp BCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEE
T ss_pred CCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEE
Confidence 99999999863 4678999999999999886542 45899999999999999999999988 999999999999
Q ss_pred ecCCCceEEeecccccccCcccccchhcccccccccccccccccC---CCCcchhHHHHHHHHHHHhCCCCCCCCCCCcc
Q 005749 514 VDDFFVSRLTEFGLDQLMVPAVADEMVALAKADGYKAPELQRMKK---CSSRTDVYAFGILLLEILIGKKPGKSGRNGEF 590 (679)
Q Consensus 514 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~ 590 (679)
++.++.+||+|||+++...... .......||+.|+|||.+.+.. ++.++|||||||++|||++|+.||.+...
T Consensus 170 ~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~--- 245 (298)
T 2zv2_A 170 VGEDGHIKIADFGVSNEFKGSD-ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI--- 245 (298)
T ss_dssp ECTTSCEEECCCTTCEECSSSS-CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH---
T ss_pred ECCCCCEEEecCCCcccccccc-ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccH---
Confidence 9999999999999998764332 1223457999999999988654 37789999999999999999999954321
Q ss_pred cchhHHHHHHhhcccccccchHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 591 VDLPSIVKVAVLEETTMEVFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 591 ~~l~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
..+....... .. ..+..+....++.+++.+||+.||++|||+.|+++.
T Consensus 246 ---~~~~~~~~~~-~~-----------~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 246 ---MCLHSKIKSQ-AL-----------EFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp ---HHHHHHHHHC-CC-----------CCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred ---HHHHHHHhcc-cC-----------CCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 1111111000 00 001111223567789999999999999999999753
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-41 Score=357.38 Aligned_cols=261 Identities=14% Similarity=0.173 Sum_probs=196.4
Q ss_pred cCccccCCceEEEEEEeCC------CCEEEEEEcccCccc-----------CcccHHHHHHHHhccCCCCCccceEEeeC
Q 005749 382 GQVIEKTTYGTAYKAKLAD------GATIALRLLREGSCK-----------DRSSCLPVIRQLGKVRHENLIPLRAFYQG 444 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~~------~~~vAvK~~~~~~~~-----------~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~ 444 (679)
.+.||+|+||.||+|+..+ ++.||||++...... ....+..|+..+..++||||+++++++..
T Consensus 40 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~ 119 (364)
T 3op5_A 40 GLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLH 119 (364)
T ss_dssp EEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEEEEEE
T ss_pred EEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEeeeee
Confidence 3789999999999998654 478999998654211 11234455666777889999999999876
Q ss_pred C---CCceEEEEEecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeec--CCCc
Q 005749 445 K---RGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVD--DFFV 519 (679)
Q Consensus 445 ~---~~~~~lv~ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~--~~~~ 519 (679)
. ....++||||+ +++|.+++... ...+++..++.|+.||+.||+|||+++ |+||||||+|||++ .++.
T Consensus 120 ~~~~~~~~~lv~e~~-g~~L~~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~~~~~~~ 192 (364)
T 3op5_A 120 DKNGKSYRFMIMDRF-GSDLQKIYEAN---AKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQ 192 (364)
T ss_dssp EETTEEEEEEEEECE-EEEHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEESSCTTC
T ss_pred ccCCcceEEEEEeCC-CCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEecCCCCe
Confidence 2 14579999999 99999999764 356999999999999999999999988 99999999999999 8899
Q ss_pred eEEeecccccccCcccccc------hhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccch
Q 005749 520 SRLTEFGLDQLMVPAVADE------MVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDL 593 (679)
Q Consensus 520 ~kl~DFGla~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l 593 (679)
+||+|||+++.+....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+..... ..
T Consensus 193 ~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~--~~ 270 (364)
T 3op5_A 193 VYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP--KY 270 (364)
T ss_dssp EEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH--HH
T ss_pred EEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCH--HH
Confidence 9999999998764432211 123459999999999999899999999999999999999999996432221 11
Q ss_pred hHHHHHHhhcccccccchHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhC
Q 005749 594 PSIVKVAVLEETTMEVFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENR 658 (679)
Q Consensus 594 ~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 658 (679)
..+....... ...+..++.+. ......++.+++..||+.||++||+++++++.|+++.
T Consensus 271 ~~~~~~~~~~-~~~~~~~~~~~------~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~ 328 (364)
T 3op5_A 271 VRDSKIRYRE-NIASLMDKCFP------AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGL 328 (364)
T ss_dssp HHHHHHHHHH-CHHHHHHHHSC------TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred HHHHHHHhhh-hHHHHHHHhcc------cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Confidence 1111111111 11111111110 0112356778999999999999999999999998875
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=341.99 Aligned_cols=259 Identities=14% Similarity=0.153 Sum_probs=204.4
Q ss_pred cCccccCCceEEEEEEe-CCCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCC
Q 005749 382 GQVIEKTTYGTAYKAKL-ADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRT 460 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gs 460 (679)
.+.||+|+||.||+|+. .+++.||||++.... ..+.+.+|++++++++|++++..++++....+..++||||+ +++
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~ 90 (296)
T 3uzp_A 14 GRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPS 90 (296)
T ss_dssp EEEEEEETTEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCB
T ss_pred EEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-CCC
Confidence 37899999999999994 679999999986543 34578999999999999998888877765567889999999 889
Q ss_pred hHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee---cCCCceEEeecccccccCccccc
Q 005749 461 LHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLV---DDFFVSRLTEFGLDQLMVPAVAD 537 (679)
Q Consensus 461 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl---~~~~~~kl~DFGla~~~~~~~~~ 537 (679)
|.+++... ...+++..++.++.|++.||+|||+++ |+||||||+|||+ ++++.+||+|||+++........
T Consensus 91 L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~ 164 (296)
T 3uzp_A 91 LEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 164 (296)
T ss_dssp HHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTC
T ss_pred HHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccccc
Confidence 99999753 345899999999999999999999988 9999999999999 58899999999999876443221
Q ss_pred ------chhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccch
Q 005749 538 ------EMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFD 611 (679)
Q Consensus 538 ------~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 611 (679)
......||+.|+|||.+.+..++.++|||||||++|||++|+.||.+............+....... ..
T Consensus 165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-----~~ 239 (296)
T 3uzp_A 165 QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST-----PI 239 (296)
T ss_dssp CBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS-----CH
T ss_pred cccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCC-----ch
Confidence 1235578999999999999899999999999999999999999996644332222211111100000 00
Q ss_pred HhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCCCC
Q 005749 612 MEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRPRN 661 (679)
Q Consensus 612 ~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 661 (679)
+.+. ....+++.+++.+||+.||++|||++|+++.|+++....
T Consensus 240 ~~~~-------~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 282 (296)
T 3uzp_A 240 EVLC-------KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 282 (296)
T ss_dssp HHHT-------TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHT
T ss_pred HHHH-------hhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhc
Confidence 0000 111256778999999999999999999999999886443
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=357.68 Aligned_cols=243 Identities=18% Similarity=0.240 Sum_probs=196.8
Q ss_pred cCccccCCceEEEEEEeC-CCCEEEEEEcccCc---ccCcccHHHHHHHHhcc-CCCCCccceEEeeCCCCceEEEEEec
Q 005749 382 GQVIEKTTYGTAYKAKLA-DGATIALRLLREGS---CKDRSSCLPVIRQLGKV-RHENLIPLRAFYQGKRGEKLLIYDYF 456 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~~lv~ey~ 456 (679)
.++||+|+||.||+|+.. +++.||+|+++... ....+.+.+|.+++..+ +||||+++++++.+ .+..++||||+
T Consensus 25 ~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~-~~~~~lv~E~~ 103 (353)
T 2i0e_A 25 LMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT-MDRLYFVMEYV 103 (353)
T ss_dssp EEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEEC-SSEEEEEEECC
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEc-CCEEEEEEeCC
Confidence 378999999999999964 58899999997542 23456688999999988 89999999999987 67899999999
Q ss_pred CCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccc
Q 005749 457 PSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVA 536 (679)
Q Consensus 457 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 536 (679)
++|+|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..... .
T Consensus 104 ~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~-~ 175 (353)
T 2i0e_A 104 NGGDLMYHIQQV----GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD-G 175 (353)
T ss_dssp CSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT-T
T ss_pred CCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCcccccccC-C
Confidence 999999999863 35899999999999999999999988 999999999999999999999999999864322 2
Q ss_pred cchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhh
Q 005749 537 DEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMK 616 (679)
Q Consensus 537 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~ 616 (679)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.... ...+. +..
T Consensus 176 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~------~~~~~--------------i~~ 235 (353)
T 2i0e_A 176 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED------ELFQS--------------IME 235 (353)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHH--------------HHH
T ss_pred cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHH------HHHHH--------------HHh
Confidence 2234568999999999999999999999999999999999999999543211 11111 111
Q ss_pred cCCCChHHHHHHHHHHHHhccCcCCCCCCC-----HHHHHHH
Q 005749 617 GIRSPMEEGLVQALKLAMGCCAPVASVRPT-----MDEVVKQ 653 (679)
Q Consensus 617 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs-----~~evl~~ 653 (679)
+..........++.+++.+||..||++||+ ++|++++
T Consensus 236 ~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 236 HNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred CCCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 111111223356778999999999999995 4777654
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=349.03 Aligned_cols=259 Identities=16% Similarity=0.227 Sum_probs=194.9
Q ss_pred cCccccCCceEEEEEE-eCCCCEEEEEEcccCcccCcccHHHHHHHHhcc-CCCCCccceEEeeCCCCceEEEEEecCCC
Q 005749 382 GQVIEKTTYGTAYKAK-LADGATIALRLLREGSCKDRSSCLPVIRQLGKV-RHENLIPLRAFYQGKRGEKLLIYDYFPSR 459 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~~lv~ey~~~g 459 (679)
+++||+|+||.||+|+ ..+++.||||+++.......+.+.+|++++.++ +||||+++++++.+ .+..++||||+++|
T Consensus 18 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~-~~~~~lv~e~~~~~ 96 (316)
T 2ac3_A 18 EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEE-EDRFYLVFEKMRGG 96 (316)
T ss_dssp CCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-TTEEEEEEECCTTC
T ss_pred CceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEee-CCEEEEEEEcCCCC
Confidence 4789999999999999 567999999999776555567899999999985 79999999999987 68899999999999
Q ss_pred ChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCc---eEEeecccccccCccc-
Q 005749 460 TLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFV---SRLTEFGLDQLMVPAV- 535 (679)
Q Consensus 460 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~---~kl~DFGla~~~~~~~- 535 (679)
+|.+++... ..+++..++.++.|++.||+|||+++ |+||||||+|||++.++. +||+|||+++......
T Consensus 97 ~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~ 169 (316)
T 2ac3_A 97 SILSHIHKR----RHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGD 169 (316)
T ss_dssp BHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------
T ss_pred cHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCc
Confidence 999999864 35899999999999999999999988 999999999999998766 9999999998653221
Q ss_pred -----ccchhcccccccccccccccc-----cCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhccc
Q 005749 536 -----ADEMVALAKADGYKAPELQRM-----KKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEET 605 (679)
Q Consensus 536 -----~~~~~~~~gt~~y~aPE~~~~-----~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~ 605 (679)
........||+.|+|||++.. ..++.++|||||||++|||++|+.||.+....+...... .... .
T Consensus 170 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~----~~~~-~ 244 (316)
T 2ac3_A 170 CSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRG----EACP-A 244 (316)
T ss_dssp ------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC--------CCH-H
T ss_pred cccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccccccc----ccch-h
Confidence 111234468999999999874 568999999999999999999999996654322110000 0000 0
Q ss_pred ccccchHhhhhcCCCChH----HHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 606 TMEVFDMEIMKGIRSPME----EGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 606 ~~~~~~~~i~~~~~~~~~----~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
....+...+..+...... .....+.+++.+||+.||++|||++|+++.
T Consensus 245 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 245 CQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 000000111122111111 123567789999999999999999999874
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=347.40 Aligned_cols=264 Identities=23% Similarity=0.284 Sum_probs=196.1
Q ss_pred cCccccCCceEEEEEEeCCCCEEEEEEcccCcccCcccHHHHHHHHhcc--CCCCCccceEEeeCCC---CceEEEEEec
Q 005749 382 GQVIEKTTYGTAYKAKLADGATIALRLLREGSCKDRSSCLPVIRQLGKV--RHENLIPLRAFYQGKR---GEKLLIYDYF 456 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l--~H~nIv~l~~~~~~~~---~~~~lv~ey~ 456 (679)
.+.||+|+||.||+|+.. ++.||||++... ....+.+|.+++... +||||+++++++.... ...++||||+
T Consensus 42 ~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~ 117 (337)
T 3mdy_A 42 VKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYH 117 (337)
T ss_dssp EEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEECCC
T ss_pred EeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEEecc
Confidence 478999999999999975 899999998643 234455666666554 8999999999988632 5789999999
Q ss_pred CCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-----CCCeeecCCCCCCeeecCCCceEEeeccccccc
Q 005749 457 PSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGH-----EIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLM 531 (679)
Q Consensus 457 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~-----~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 531 (679)
++|+|.++++. ..+++..++.++.|++.||+|||++. .++|+||||||+|||++.++.+||+|||+++..
T Consensus 118 ~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~ 192 (337)
T 3mdy_A 118 ENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKF 192 (337)
T ss_dssp TTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred CCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCceee
Confidence 99999999975 34899999999999999999999871 113999999999999999999999999999766
Q ss_pred Ccccccc---hhcccccccccccccccccCCCCc------chhHHHHHHHHHHHhC----------CCCCCCCCCCcccc
Q 005749 532 VPAVADE---MVALAKADGYKAPELQRMKKCSSR------TDVYAFGILLLEILIG----------KKPGKSGRNGEFVD 592 (679)
Q Consensus 532 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~k------~DV~S~Gvvl~El~tg----------~~p~~~~~~~~~~~ 592 (679)
....... .....||+.|+|||++.+..++.+ +|||||||++|||++| +.||........ .
T Consensus 193 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~-~ 271 (337)
T 3mdy_A 193 ISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDP-S 271 (337)
T ss_dssp C---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSC-C
T ss_pred ccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCC-c
Confidence 4332211 124579999999999987766665 9999999999999999 555533222111 1
Q ss_pred hhHHHHHHhhcccccccchHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCCCCC
Q 005749 593 LPSIVKVAVLEETTMEVFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRPRNR 662 (679)
Q Consensus 593 l~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 662 (679)
...... ..........+... ........++.+++.+||+.||++|||+.||++.|+++.....
T Consensus 272 ~~~~~~-~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 334 (337)
T 3mdy_A 272 YEDMRE-IVCIKKLRPSFPNR------WSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQD 334 (337)
T ss_dssp HHHHHH-HHTTSCCCCCCCGG------GGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTTT
T ss_pred hhhhHH-HHhhhccCcccccc------chhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhcc
Confidence 111111 11100000000000 0112456778899999999999999999999999999876554
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=342.67 Aligned_cols=249 Identities=22% Similarity=0.319 Sum_probs=198.9
Q ss_pred cCccccCCceEEEEEEeCCCCEEEEEEcccCcc--cCcccHHHHHHHHhccCCCCCccceEEeeCC-CCceEEEEEecCC
Q 005749 382 GQVIEKTTYGTAYKAKLADGATIALRLLREGSC--KDRSSCLPVIRQLGKVRHENLIPLRAFYQGK-RGEKLLIYDYFPS 458 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~~~~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~-~~~~~lv~ey~~~ 458 (679)
.+.||+|+||.||+|+.. ++.||||+++.... ...+.+.+|++++++++||||+++++++.+. .+..++||||+++
T Consensus 15 ~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~ 93 (271)
T 3kmu_A 15 LTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPY 93 (271)
T ss_dssp EEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEECCTT
T ss_pred HHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecccCC
Confidence 378999999999999985 88999999976532 2345789999999999999999999999873 2678999999999
Q ss_pred CChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccc
Q 005749 459 RTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADE 538 (679)
Q Consensus 459 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 538 (679)
|+|.+++.... ...+++..++.|+.|++.||+|||+++ ++|+||||||+||++++++.+||+|||++.....
T Consensus 94 ~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~----- 165 (271)
T 3kmu_A 94 GSLYNVLHEGT--NFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQS----- 165 (271)
T ss_dssp CBHHHHHHSCS--SCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC-----
T ss_pred CcHHHHHhhcc--cCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeecc-----
Confidence 99999998642 235899999999999999999999865 4599999999999999999999999998764322
Q ss_pred hhcccccccccccccccccCCCC---cchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhh
Q 005749 539 MVALAKADGYKAPELQRMKKCSS---RTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIM 615 (679)
Q Consensus 539 ~~~~~gt~~y~aPE~~~~~~~~~---k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~ 615 (679)
....||+.|+|||.+.+..++. ++||||||+++|||++|+.||.+.... ....... .
T Consensus 166 -~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~~-------------~ 225 (271)
T 3kmu_A 166 -PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNM------EIGMKVA-------------L 225 (271)
T ss_dssp -TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHH------HHHHHHH-------------H
T ss_pred -cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChH------HHHHHHH-------------h
Confidence 2346889999999988665544 899999999999999999999543211 1111111 1
Q ss_pred hcCCCC-hHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCC
Q 005749 616 KGIRSP-MEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRP 659 (679)
Q Consensus 616 ~~~~~~-~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 659 (679)
.+.... ......++.+++.+||+.||++|||++|+++.|+++..
T Consensus 226 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 226 EGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 111111 11223567789999999999999999999999999864
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-41 Score=346.13 Aligned_cols=250 Identities=18% Similarity=0.294 Sum_probs=202.1
Q ss_pred CccccCCceEEEEEEeC---CCCEEEEEEcccCcc-cCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCC
Q 005749 383 QVIEKTTYGTAYKAKLA---DGATIALRLLREGSC-KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPS 458 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~~---~~~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~ 458 (679)
+.||+|+||.||+|+.. ++..||||+++.... ...+.+.+|++++++++||||+++++++.. +..++||||+++
T Consensus 16 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~lv~e~~~~ 93 (287)
T 1u59_A 16 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA--EALMLVMEMAGG 93 (287)
T ss_dssp EEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES--SSEEEEEECCTT
T ss_pred ccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEecC--CCcEEEEEeCCC
Confidence 48999999999999853 577899999986532 345678999999999999999999999954 579999999999
Q ss_pred CChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCccccc-
Q 005749 459 RTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVAD- 537 (679)
Q Consensus 459 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~- 537 (679)
++|.+++... ...+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++........
T Consensus 94 ~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 167 (287)
T 1u59_A 94 GPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYY 167 (287)
T ss_dssp EEHHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEE
T ss_pred CCHHHHHHhC---CccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeeccCccee
Confidence 9999999753 345899999999999999999999988 999999999999999999999999999876433221
Q ss_pred -chhcccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhh
Q 005749 538 -EMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIM 615 (679)
Q Consensus 538 -~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~ 615 (679)
......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...... .+...+ .
T Consensus 168 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~~~i-----------------~ 227 (287)
T 1u59_A 168 TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVMAFI-----------------E 227 (287)
T ss_dssp CCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH---HHHHHH-----------------H
T ss_pred eccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH---HHHHHH-----------------h
Confidence 1223456788999999988889999999999999999998 99999543321 111111 1
Q ss_pred hcCC-CChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCCC
Q 005749 616 KGIR-SPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRPR 660 (679)
Q Consensus 616 ~~~~-~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 660 (679)
.+.+ ...+...+++.+++.+||+.||++||++.|+++.|+++..+
T Consensus 228 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 273 (287)
T 1u59_A 228 QGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 273 (287)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cCCcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 1111 11122335677899999999999999999999999988643
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=348.28 Aligned_cols=254 Identities=23% Similarity=0.372 Sum_probs=189.4
Q ss_pred cCccccCCceEEEEEEeCCCCEEEEEEcccCcc--cCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCC
Q 005749 382 GQVIEKTTYGTAYKAKLADGATIALRLLREGSC--KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSR 459 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~~~~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~g 459 (679)
.+.||+|+||.||+|+.. ..||+|+++.... ...+.+.+|++++++++||||+++++++.. +..++||||++++
T Consensus 29 ~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~lv~e~~~~~ 104 (289)
T 3og7_A 29 GQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA--PQLAIVTQWCEGS 104 (289)
T ss_dssp EEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS--SSCEEEEECCCEE
T ss_pred eeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeeccC--CccEEEEEecCCC
Confidence 378999999999999864 3699999876432 234678999999999999999999997654 5789999999999
Q ss_pred ChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCccc-ccc
Q 005749 460 TLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAV-ADE 538 (679)
Q Consensus 460 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~-~~~ 538 (679)
+|.+++... ...+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++...... ...
T Consensus 105 ~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 178 (289)
T 3og7_A 105 SLYHHLHAS---ETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQ 178 (289)
T ss_dssp EHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC-------------
T ss_pred cHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecccccccccccc
Confidence 999999654 345899999999999999999999988 9999999999999999999999999998654321 222
Q ss_pred hhccccccccccccccc---ccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhh
Q 005749 539 MVALAKADGYKAPELQR---MKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIM 615 (679)
Q Consensus 539 ~~~~~gt~~y~aPE~~~---~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~ 615 (679)
.....||+.|+|||.+. ...++.++||||||+++|||++|+.||......+ .+...+.. ..... ..
T Consensus 179 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~~~~~~~----~~~~~----~~- 247 (289)
T 3og7_A 179 FEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--QIIEMVGR----GSLSP----DL- 247 (289)
T ss_dssp -----CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH--HHHHHHHH----TSCCC----CT-
T ss_pred ccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH--HHHHHhcc----cccCc----ch-
Confidence 33457899999999886 5678889999999999999999999995433211 11111111 00000 00
Q ss_pred hcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCC
Q 005749 616 KGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRP 659 (679)
Q Consensus 616 ~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 659 (679)
. .........+.+++.+||+.||++|||+.|+++.|+++..
T Consensus 248 ~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 248 S---KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp T---SSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred h---hccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 0 0011223567789999999999999999999999999864
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-41 Score=360.34 Aligned_cols=247 Identities=17% Similarity=0.240 Sum_probs=198.8
Q ss_pred cCccccCCceEEEEEEe-CCCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCC
Q 005749 382 GQVIEKTTYGTAYKAKL-ADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRT 460 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gs 460 (679)
.+.||+|+||.||+|+. .+|+.||+|++......+...+.+|++++++++|||||++++++.+ .+..++||||+++|+
T Consensus 56 ~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-~~~~~lv~E~~~gg~ 134 (387)
T 1kob_A 56 LEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFED-KYEMVLILEFLSGGE 134 (387)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC-SSEEEEEEECCCCCB
T ss_pred EEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEe-CCEEEEEEEcCCCCc
Confidence 37899999999999995 5789999999976544445678999999999999999999999987 688999999999999
Q ss_pred hHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecC--CCceEEeecccccccCcccccc
Q 005749 461 LHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDD--FFVSRLTEFGLDQLMVPAVADE 538 (679)
Q Consensus 461 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~--~~~~kl~DFGla~~~~~~~~~~ 538 (679)
|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+|||++. ++.+||+|||+++...... .
T Consensus 135 L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~--~ 206 (387)
T 1kob_A 135 LFDRIAAE---DYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE--I 206 (387)
T ss_dssp HHHHTTCT---TCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS--C
T ss_pred HHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCCc--c
Confidence 99999753 345899999999999999999999988 999999999999974 4789999999998764332 2
Q ss_pred hhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcC
Q 005749 539 MVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGI 618 (679)
Q Consensus 539 ~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~ 618 (679)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.+.... ........... .++.
T Consensus 207 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~------~~~~~i~~~~~---~~~~------ 271 (387)
T 1kob_A 207 VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL------ETLQNVKRCDW---EFDE------ 271 (387)
T ss_dssp EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH------HHHHHHHHCCC---CCCS------
T ss_pred eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCC---CCCc------
Confidence 23447899999999999889999999999999999999999999543211 11111100000 0000
Q ss_pred CCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 619 RSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 619 ~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
........++.+++.+||+.||++|||+.|+++.
T Consensus 272 -~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 272 -DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp -STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred -cccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 0011223567789999999999999999999875
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=352.22 Aligned_cols=254 Identities=22% Similarity=0.361 Sum_probs=201.6
Q ss_pred cCccccCCceEEEEEEe--------CCCCEEEEEEcccCcc-cCcccHHHHHHHHhcc-CCCCCccceEEeeCCCCceEE
Q 005749 382 GQVIEKTTYGTAYKAKL--------ADGATIALRLLREGSC-KDRSSCLPVIRQLGKV-RHENLIPLRAFYQGKRGEKLL 451 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~--------~~~~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~~l 451 (679)
.+.||+|+||.||+|+. .++..||||+++.... ...+.+.+|+++++++ +||||+++++++.. .+..++
T Consensus 40 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-~~~~~l 118 (334)
T 2pvf_A 40 GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ-DGPLYV 118 (334)
T ss_dssp EEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCCEE
T ss_pred eeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc-CCceEE
Confidence 47899999999999985 3577899999976432 3346789999999999 89999999999987 678999
Q ss_pred EEEecCCCChHHHhhcccCC------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCc
Q 005749 452 IYDYFPSRTLHDLLHDTIAG------------KPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFV 519 (679)
Q Consensus 452 v~ey~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~ 519 (679)
||||+++|+|.+++...... ...+++..++.++.|+++||+|||+++ |+||||||+||+++.++.
T Consensus 119 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~ 195 (334)
T 2pvf_A 119 IVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNV 195 (334)
T ss_dssp EEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCC
T ss_pred EEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEEEcCCCC
Confidence 99999999999999864321 234899999999999999999999988 999999999999999999
Q ss_pred eEEeecccccccCcccc-cchhcccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHH
Q 005749 520 SRLTEFGLDQLMVPAVA-DEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIV 597 (679)
Q Consensus 520 ~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~ 597 (679)
+||+|||+++....... .......+++.|+|||++.+..++.++||||||+++|||++ |+.||.+.... +..
T Consensus 196 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~------~~~ 269 (334)
T 2pvf_A 196 MKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE------ELF 269 (334)
T ss_dssp EEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH------HHH
T ss_pred EEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH------HHH
Confidence 99999999987643321 12233456788999999988889999999999999999999 99998543211 111
Q ss_pred HHHhhcccccccchHhhhhcCC-CChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCC
Q 005749 598 KVAVLEETTMEVFDMEIMKGIR-SPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRP 659 (679)
Q Consensus 598 ~~~~~~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 659 (679)
... ..+.. ........++.+++.+||+.||++|||++|+++.|+++..
T Consensus 270 ~~~--------------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~ 318 (334)
T 2pvf_A 270 KLL--------------KEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318 (334)
T ss_dssp HHH--------------HHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHH--------------hcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 111 11110 1111223567789999999999999999999999999864
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=353.64 Aligned_cols=245 Identities=20% Similarity=0.261 Sum_probs=182.0
Q ss_pred cCccccCCceEEEEEEeC-CCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCC
Q 005749 382 GQVIEKTTYGTAYKAKLA-DGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRT 460 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gs 460 (679)
.+.||+|+||.||+|+.. +++.||||+++... ..+.+.+|++++++++||||+++++++.+ .+..++||||+++|+
T Consensus 58 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~~~~~ 134 (349)
T 2w4o_A 58 ESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFET-PTEISLVLELVTGGE 134 (349)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEEC-SSEEEEEECCCCSCB
T ss_pred eeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEec-CCeEEEEEEeCCCCC
Confidence 378999999999999964 58899999997643 34678899999999999999999999987 678999999999999
Q ss_pred hHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecC---CCceEEeecccccccCccccc
Q 005749 461 LHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDD---FFVSRLTEFGLDQLMVPAVAD 537 (679)
Q Consensus 461 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~---~~~~kl~DFGla~~~~~~~~~ 537 (679)
|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||+++..... .
T Consensus 135 L~~~l~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~--~ 205 (349)
T 2w4o_A 135 LFDRIVEK----GYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ--V 205 (349)
T ss_dssp HHHHHTTC----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC-----------
T ss_pred HHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccCcc--c
Confidence 99999763 45899999999999999999999988 999999999999975 889999999999875432 1
Q ss_pred chhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhc
Q 005749 538 EMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKG 617 (679)
Q Consensus 538 ~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~ 617 (679)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ ........... ...
T Consensus 206 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-----~~~~~i~~~~~--~~~------- 271 (349)
T 2w4o_A 206 LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ-----FMFRRILNCEY--YFI------- 271 (349)
T ss_dssp -------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH-----HHHHHHHTTCC--CCC-------
T ss_pred ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH-----HHHHHHHhCCC--ccC-------
Confidence 2234578999999999998899999999999999999999999995433211 01111100000 000
Q ss_pred CCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 618 IRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 618 ~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
.+.......++.+++.+||+.||++|||+.|+++.
T Consensus 272 -~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 272 -SPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp -TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -CchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00111233567789999999999999999999874
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-41 Score=350.94 Aligned_cols=257 Identities=16% Similarity=0.285 Sum_probs=203.8
Q ss_pred cCccccCCceEEEEEEeC------CCCEEEEEEcccCcc-cCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEE
Q 005749 382 GQVIEKTTYGTAYKAKLA------DGATIALRLLREGSC-KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYD 454 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~------~~~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~e 454 (679)
.+.||+|+||.||+|+.. +++.||+|.+..... .....+.+|++++++++||||+++++++.+ .+..++|||
T Consensus 30 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e 108 (322)
T 1p4o_A 30 SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ-GQPTLVIME 108 (322)
T ss_dssp EEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS-SSSCEEEEE
T ss_pred eeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEcc-CCccEEEEE
Confidence 478999999999999854 477899999975432 234568999999999999999999999987 678999999
Q ss_pred ecCCCChHHHhhcccC------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccc
Q 005749 455 YFPSRTLHDLLHDTIA------GKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLD 528 (679)
Q Consensus 455 y~~~gsL~~~l~~~~~------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 528 (679)
|+++|+|.+++..... ....+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++
T Consensus 109 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~~~kl~Dfg~~ 185 (322)
T 1p4o_A 109 LMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMT 185 (322)
T ss_dssp CCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEECCTTCC
T ss_pred eCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCCeEEECcCccc
Confidence 9999999999975321 1245789999999999999999999988 999999999999999999999999999
Q ss_pred cccCcccc-cchhcccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHHhhcccc
Q 005749 529 QLMVPAVA-DEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAVLEETT 606 (679)
Q Consensus 529 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 606 (679)
+....... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.+.... ........
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~------~~~~~~~~---- 255 (322)
T 1p4o_A 186 RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE------QVLRFVME---- 255 (322)
T ss_dssp CGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH------HHHHHHHT----
T ss_pred cccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH------HHHHHHHc----
Confidence 86543322 12234456888999999998889999999999999999999 88898543211 11111100
Q ss_pred cccchHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCCCC
Q 005749 607 MEVFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRPRN 661 (679)
Q Consensus 607 ~~~~~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 661 (679)
.............+.+++.+||+.||++|||+.|+++.|++.....
T Consensus 256 ---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~ 301 (322)
T 1p4o_A 256 ---------GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPG 301 (322)
T ss_dssp ---------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTT
T ss_pred ---------CCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccC
Confidence 0011111222356778999999999999999999999999986543
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=343.91 Aligned_cols=261 Identities=19% Similarity=0.256 Sum_probs=194.4
Q ss_pred CccccCCceEEEEEEe-CCCCEEEEEEcccCccc--CcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCC
Q 005749 383 QVIEKTTYGTAYKAKL-ADGATIALRLLREGSCK--DRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSR 459 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~--~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~g 459 (679)
+.||+|+||+||+|+. .+++.||+|+++..... ..+.+.+|++++++++|||||++++++.+ .+..++||||+++
T Consensus 8 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~- 85 (292)
T 3o0g_A 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS-DKKLTLVFEFCDQ- 85 (292)
T ss_dssp EEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-TTEEEEEEECCSE-
T ss_pred eEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEe-CCEEEEEEecCCC-
Confidence 6899999999999995 56899999999765332 23678899999999999999999999987 6889999999986
Q ss_pred ChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccch
Q 005749 460 TLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEM 539 (679)
Q Consensus 460 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 539 (679)
++.+.+... ...+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++..... ....
T Consensus 86 ~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~ 158 (292)
T 3o0g_A 86 DLKKYFDSC---NGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIP-VRCY 158 (292)
T ss_dssp EHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSC-CSCC
T ss_pred CHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCc-cccc
Confidence 666666543 345999999999999999999999998 999999999999999999999999999876432 2223
Q ss_pred hcccccccccccccccccC-CCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhh--cccccccchH-h--
Q 005749 540 VALAKADGYKAPELQRMKK-CSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVL--EETTMEVFDM-E-- 613 (679)
Q Consensus 540 ~~~~gt~~y~aPE~~~~~~-~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~--~~~~~~~~~~-~-- 613 (679)
....||+.|+|||++.+.. ++.++|||||||++|||++|..|+...... ...+......... .......... .
T Consensus 159 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 237 (292)
T 3o0g_A 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV-DDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237 (292)
T ss_dssp CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSH-HHHHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred cCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCH-HHHHHHHHHHhCCCChhhhhhhccccccc
Confidence 4457899999999987765 899999999999999999998886443221 1111111111100 0000000000 0
Q ss_pred ------hhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 614 ------IMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 614 ------i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
.........+....++.+++.+||+.||++|||++|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0000001111234567789999999999999999999864
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=341.00 Aligned_cols=241 Identities=17% Similarity=0.214 Sum_probs=198.2
Q ss_pred cCccccCCceEEEEEEe-CCCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCC
Q 005749 382 GQVIEKTTYGTAYKAKL-ADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRT 460 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gs 460 (679)
.+.||+|+||.||+|+. .++..||+|++........+.+.+|++++++++||||+++++++.+ .+..++||||+++++
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~ 92 (277)
T 3f3z_A 14 ENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFED-NTDIYLVMELCTGGE 92 (277)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-SSEEEEEEECCCSCB
T ss_pred eeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCeEEEEEeccCCCc
Confidence 47899999999999995 4578999999987666667789999999999999999999999987 678999999999999
Q ss_pred hHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee---cCCCceEEeecccccccCccccc
Q 005749 461 LHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLV---DDFFVSRLTEFGLDQLMVPAVAD 537 (679)
Q Consensus 461 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl---~~~~~~kl~DFGla~~~~~~~~~ 537 (679)
|.+++... ..+++..++.++.|++.||+|||+++ |+||||||+||++ +.++.+||+|||++.......
T Consensus 93 L~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~-- 163 (277)
T 3f3z_A 93 LFERVVHK----RVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK-- 163 (277)
T ss_dssp HHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS--
T ss_pred HHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc--
Confidence 99998763 45899999999999999999999988 9999999999999 788999999999998764332
Q ss_pred chhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhc
Q 005749 538 EMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKG 617 (679)
Q Consensus 538 ~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~ 617 (679)
......||+.|+|||.+.+ .++.++||||||+++|||++|+.||...... .... .+..+
T Consensus 164 ~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~--------------~~~~~ 222 (277)
T 3f3z_A 164 MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDS------EVML--------------KIREG 222 (277)
T ss_dssp CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHH--------------HHHHC
T ss_pred chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHH------HHHH--------------HHHhC
Confidence 2334578999999998875 4899999999999999999999999543211 1111 11111
Q ss_pred CCCChH----HHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 618 IRSPME----EGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 618 ~~~~~~----~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
...... ...+.+.+++.+||+.||++|||+.|+++.
T Consensus 223 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 223 TFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp CCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred CCCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111111 123567789999999999999999999864
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=351.77 Aligned_cols=251 Identities=24% Similarity=0.416 Sum_probs=195.2
Q ss_pred cCccccCCceEEEEEEeCC-----CCEEEEEEcccCcc-cCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEe
Q 005749 382 GQVIEKTTYGTAYKAKLAD-----GATIALRLLREGSC-KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDY 455 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~~-----~~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey 455 (679)
.+.||+|+||.||+|+... +..||||.++.... .....+.+|++++++++||||+++++++.. .+..++||||
T Consensus 49 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~ 127 (333)
T 1mqb_A 49 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK-YKPMMIITEY 127 (333)
T ss_dssp EEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSSEEEEEEC
T ss_pred ccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec-CCCcEEEEeC
Confidence 3789999999999998542 23599999976432 334578999999999999999999999987 6789999999
Q ss_pred cCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCccc
Q 005749 456 FPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAV 535 (679)
Q Consensus 456 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 535 (679)
+++|+|.+++... ...+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++......
T Consensus 128 ~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 201 (333)
T 1mqb_A 128 MENGALDKFLREK---DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 201 (333)
T ss_dssp CTTEEHHHHHHHT---TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--------
T ss_pred CCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhhcccc
Confidence 9999999999764 345899999999999999999999988 9999999999999999999999999998764332
Q ss_pred cc--chhcccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHHhhcccccccchH
Q 005749 536 AD--EMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDM 612 (679)
Q Consensus 536 ~~--~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 612 (679)
.. ......++..|+|||.+.+..++.++||||||+++|||++ |+.||...... +....
T Consensus 202 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~------~~~~~------------- 262 (333)
T 1mqb_A 202 EATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH------EVMKA------------- 262 (333)
T ss_dssp ---------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHH-------------
T ss_pred ccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH------HHHHH-------------
Confidence 11 1223346778999999998899999999999999999998 99999543211 11111
Q ss_pred hhhhcCC-CChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCC
Q 005749 613 EIMKGIR-SPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRP 659 (679)
Q Consensus 613 ~i~~~~~-~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 659 (679)
+..+.+ +........+.+++.+||+.||++||++.|+++.|+++..
T Consensus 263 -~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~ 309 (333)
T 1mqb_A 263 -INDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 309 (333)
T ss_dssp -HHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred -HHCCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 111111 1111233567789999999999999999999999998754
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-41 Score=382.01 Aligned_cols=247 Identities=18% Similarity=0.276 Sum_probs=196.7
Q ss_pred CccccCCceEEEEEEe---CCCCEEEEEEcccCcc--cCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecC
Q 005749 383 QVIEKTTYGTAYKAKL---ADGATIALRLLREGSC--KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFP 457 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~---~~~~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~ 457 (679)
+.||+|+||.||+|.+ .+++.||||+++.... ...+.+.+|+++|.+++|||||++++++.. +..++|||||+
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~~~lv~E~~~ 452 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA--ESWMLVMEMAE 452 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES--SSEEEEEECCT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec--CCEEEEEEccC
Confidence 5799999999999964 3467899999976432 235679999999999999999999999975 46899999999
Q ss_pred CCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccc-
Q 005749 458 SRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVA- 536 (679)
Q Consensus 458 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~- 536 (679)
+|+|.+++.. ...+++..++.|+.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 453 ~g~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 525 (635)
T 4fl3_A 453 LGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 525 (635)
T ss_dssp TEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC----
T ss_pred CCCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccc
Confidence 9999999975 345899999999999999999999988 99999999999999999999999999987643321
Q ss_pred -cchhcccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHHhhcccccccchHhh
Q 005749 537 -DEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEI 614 (679)
Q Consensus 537 -~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i 614 (679)
.......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+....+ ... .+
T Consensus 526 ~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~------~~~--------------~i 585 (635)
T 4fl3_A 526 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE------VTA--------------ML 585 (635)
T ss_dssp ---------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH------HHH--------------HH
T ss_pred cccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH------HHH--------------HH
Confidence 12233456788999999998899999999999999999998 999995432211 111 11
Q ss_pred hhcCCC-ChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhC
Q 005749 615 MKGIRS-PMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENR 658 (679)
Q Consensus 615 ~~~~~~-~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 658 (679)
..+.+. .......++.+++.+||+.||++||++++|++.|+++.
T Consensus 586 ~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~ 630 (635)
T 4fl3_A 586 EKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 630 (635)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred HcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 111111 11223356778999999999999999999999998763
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-41 Score=359.45 Aligned_cols=243 Identities=22% Similarity=0.259 Sum_probs=187.1
Q ss_pred cCccccCCceEEEEEEe-CCCCEEEEEEcccCcc---cCcccHHHHHHH-HhccCCCCCccceEEeeCCCCceEEEEEec
Q 005749 382 GQVIEKTTYGTAYKAKL-ADGATIALRLLREGSC---KDRSSCLPVIRQ-LGKVRHENLIPLRAFYQGKRGEKLLIYDYF 456 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~---~~~~~~~~Ei~~-l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~ 456 (679)
.++||+|+||.||+|+. .+++.||+|+++.... ...+.+.+|..+ ++.++|||||++++++.+ .+..|+||||+
T Consensus 43 ~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~-~~~~~lv~E~~ 121 (373)
T 2r5t_A 43 LKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT-ADKLYFVLDYI 121 (373)
T ss_dssp EEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEEC-SSEEEEEEECC
T ss_pred EEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEe-CCEEEEEEeCC
Confidence 47899999999999995 4688999999976432 234456777776 577899999999999998 68999999999
Q ss_pred CCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccc
Q 005749 457 PSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVA 536 (679)
Q Consensus 457 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 536 (679)
++|+|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..... .
T Consensus 122 ~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~-~ 193 (373)
T 2r5t_A 122 NGGELFYHLQRE----RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEH-N 193 (373)
T ss_dssp CSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC-C
T ss_pred CCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccccC-C
Confidence 999999999763 35899999999999999999999988 999999999999999999999999999864322 2
Q ss_pred cchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhh
Q 005749 537 DEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMK 616 (679)
Q Consensus 537 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~ 616 (679)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+... .+.... +..
T Consensus 194 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~------~~~~~~--------------i~~ 253 (373)
T 2r5t_A 194 STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT------AEMYDN--------------ILN 253 (373)
T ss_dssp CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH------HHHHHH--------------HHH
T ss_pred CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH------HHHHHH--------------HHh
Confidence 233456899999999999999999999999999999999999999954321 111111 111
Q ss_pred cCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 617 GIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 617 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
+.....+.....+.+++.+||+.||++||++.+.++.
T Consensus 254 ~~~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ 290 (373)
T 2r5t_A 254 KPLQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFME 290 (373)
T ss_dssp SCCCCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHH
T ss_pred cccCCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHH
Confidence 1111111223567789999999999999998543333
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=367.66 Aligned_cols=242 Identities=19% Similarity=0.332 Sum_probs=198.6
Q ss_pred cCccccCCceEEEEEEe-CCCCEEEEEEcccCc---ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecC
Q 005749 382 GQVIEKTTYGTAYKAKL-ADGATIALRLLREGS---CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFP 457 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~ 457 (679)
++.||+|+||.||+|+. .+|+.||||++.... ....+.+.+|+++++.++||||+++++++.+ .+..++||||++
T Consensus 21 ~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~-~~~~~lv~E~~~ 99 (476)
T 2y94_A 21 GDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIST-PSDIFMVMEYVS 99 (476)
T ss_dssp EEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEEEEEECCS
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-CCEEEEEEeCCC
Confidence 47899999999999995 479999999996542 2334578999999999999999999999987 678999999999
Q ss_pred CCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCccccc
Q 005749 458 SRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVAD 537 (679)
Q Consensus 458 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 537 (679)
+|+|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..... .
T Consensus 100 gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~--~ 170 (476)
T 2y94_A 100 GGELFDYICK----NGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG--E 170 (476)
T ss_dssp SEEHHHHTTS----SSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCTT--C
T ss_pred CCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhcccc--c
Confidence 9999999975 345899999999999999999999988 999999999999999999999999999876432 2
Q ss_pred chhcccccccccccccccccCC-CCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhh
Q 005749 538 EMVALAKADGYKAPELQRMKKC-SSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMK 616 (679)
Q Consensus 538 ~~~~~~gt~~y~aPE~~~~~~~-~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~ 616 (679)
.....+||+.|+|||++.+..+ +.++||||+||++|||++|+.||.+.... .... .+..
T Consensus 171 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~------~~~~--------------~i~~ 230 (476)
T 2y94_A 171 FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP------TLFK--------------KICD 230 (476)
T ss_dssp CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH------HHHH--------------HHHT
T ss_pred cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH------HHHH--------------HHhc
Confidence 2345679999999999987765 68999999999999999999999543221 1111 1111
Q ss_pred cCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 617 GIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 617 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
+.........+++.+++.+||+.||++|||++|+++.
T Consensus 231 ~~~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 231 GIFYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp TCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred CCcCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence 1111111223567789999999999999999999974
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=340.93 Aligned_cols=244 Identities=16% Similarity=0.302 Sum_probs=177.4
Q ss_pred cCccccCCceEEEEEEe-CCCCEEEEEEcccCc---ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecC
Q 005749 382 GQVIEKTTYGTAYKAKL-ADGATIALRLLREGS---CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFP 457 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~ 457 (679)
.+.||+|+||.||+|+. .+|+.||||++.... ....+.+.+|++++++++||||+++++++.+ .+..++||||++
T Consensus 16 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~ 94 (278)
T 3cok_A 16 GNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFED-SNYVYLVLEMCH 94 (278)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEEC-SSEEEEEEECCT
T ss_pred eeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEcc-CCeEEEEEecCC
Confidence 37899999999999995 679999999996532 2234678999999999999999999999987 678999999999
Q ss_pred CCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCccccc
Q 005749 458 SRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVAD 537 (679)
Q Consensus 458 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 537 (679)
+++|.+++... ...+++..++.++.|+++||+|||+++ |+||||||+||+++.++.+||+|||++....... .
T Consensus 95 ~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~-~ 167 (278)
T 3cok_A 95 NGEMNRYLKNR---VKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH-E 167 (278)
T ss_dssp TEEHHHHHHTC---SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC-----
T ss_pred CCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccCCC-C
Confidence 99999999864 346899999999999999999999988 9999999999999999999999999998764322 1
Q ss_pred chhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhc
Q 005749 538 EMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKG 617 (679)
Q Consensus 538 ~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~ 617 (679)
......|++.|+|||.+.+..++.++||||||+++|||++|+.||......+... ... ...
T Consensus 168 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~---------------~~~----~~~ 228 (278)
T 3cok_A 168 KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLN---------------KVV----LAD 228 (278)
T ss_dssp ------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC--------------------CC----SSC
T ss_pred cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHH---------------HHh----hcc
Confidence 2234578999999999998889999999999999999999999996543221110 000 000
Q ss_pred CCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 618 IRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 618 ~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
.........++.+++.+||+.||++|||++|+++.
T Consensus 229 -~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 229 -YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp -CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred -cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence 00011123466789999999999999999999863
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=348.77 Aligned_cols=256 Identities=21% Similarity=0.340 Sum_probs=203.5
Q ss_pred cCccccCCceEEEEEEe------CCCCEEEEEEcccCcc-cCcccHHHHHHHHhcc-CCCCCccceEEeeCCCCceEEEE
Q 005749 382 GQVIEKTTYGTAYKAKL------ADGATIALRLLREGSC-KDRSSCLPVIRQLGKV-RHENLIPLRAFYQGKRGEKLLIY 453 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~------~~~~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~~lv~ 453 (679)
.+.||+|+||.||+|+. .+++.||||+++.... ...+.+.+|++++.++ +||||+++++++.......++||
T Consensus 32 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~~lv~ 111 (316)
T 2xir_A 32 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIV 111 (316)
T ss_dssp EEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEE
T ss_pred eeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCceEEEE
Confidence 47899999999999983 3568999999976532 2345789999999999 79999999999987556699999
Q ss_pred EecCCCChHHHhhcccCC------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceE
Q 005749 454 DYFPSRTLHDLLHDTIAG------------KPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSR 521 (679)
Q Consensus 454 ey~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~k 521 (679)
||+++|+|.+++...... ...+++..++.++.|+++||+|||+++ |+||||||+||+++.++.+|
T Consensus 112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~k 188 (316)
T 2xir_A 112 EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVK 188 (316)
T ss_dssp ECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEE
T ss_pred EcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEE
Confidence 999999999999864321 123889999999999999999999988 99999999999999999999
Q ss_pred EeecccccccCcccc-cchhcccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHH
Q 005749 522 LTEFGLDQLMVPAVA-DEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKV 599 (679)
Q Consensus 522 l~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~ 599 (679)
|+|||+++....... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||.+....+ .....
T Consensus 189 l~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~--~~~~~--- 263 (316)
T 2xir_A 189 ICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFCRR--- 263 (316)
T ss_dssp ECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH--HHHHH---
T ss_pred ECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhH--HHHHH---
Confidence 999999987643321 22234567889999999998899999999999999999998 999995543221 11110
Q ss_pred HhhcccccccchHhhhhcCC-CChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCC
Q 005749 600 AVLEETTMEVFDMEIMKGIR-SPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRP 659 (679)
Q Consensus 600 ~~~~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 659 (679)
+..+.. .......+++.+++.+||+.||++|||+.|+++.|+++..
T Consensus 264 --------------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 310 (316)
T 2xir_A 264 --------------LKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 310 (316)
T ss_dssp --------------HHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --------------hccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 111110 1111223567789999999999999999999999998753
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=347.61 Aligned_cols=261 Identities=19% Similarity=0.271 Sum_probs=195.6
Q ss_pred cCccccCCceEEEEEEe-CCCCEEEEEEcccCcc---cCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecC
Q 005749 382 GQVIEKTTYGTAYKAKL-ADGATIALRLLREGSC---KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFP 457 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~---~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~ 457 (679)
.+.||+|+||.||+|+. .+|+.||+|+++.... ...+.+.+|++++++++||||+++++++.. .+..++||||++
T Consensus 37 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~ 115 (310)
T 2wqm_A 37 EKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE-DNELNIVLELAD 115 (310)
T ss_dssp EEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-TTEEEEEEECCC
T ss_pred EEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc-CCcEEEEEecCC
Confidence 37899999999999994 6799999999975322 234578899999999999999999999987 678999999999
Q ss_pred CCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCccccc
Q 005749 458 SRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVAD 537 (679)
Q Consensus 458 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 537 (679)
+++|.+++.........+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++...... .
T Consensus 116 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~-~ 191 (310)
T 2wqm_A 116 AGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT-T 191 (310)
T ss_dssp SCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC------------
T ss_pred CCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeecCCC-c
Confidence 99999999764433556899999999999999999999988 9999999999999999999999999998654321 2
Q ss_pred chhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhc
Q 005749 538 EMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKG 617 (679)
Q Consensus 538 ~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~ 617 (679)
......|+..|+|||.+.+..++.++||||||+++|||++|+.||.+.... .......... ....
T Consensus 192 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~-~~~~---------- 256 (310)
T 2wqm_A 192 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCKKIEQ-CDYP---------- 256 (310)
T ss_dssp -------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC----HHHHHHHHHT-TCSC----------
T ss_pred cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh----HHHHHHHhhc-ccCC----------
Confidence 223456899999999999889999999999999999999999999543221 1111111100 0000
Q ss_pred CCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCCCCCC
Q 005749 618 IRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRPRNRS 663 (679)
Q Consensus 618 ~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~ 663 (679)
.........++.+++.+||+.||++|||++|+++.|+++.+...+
T Consensus 257 -~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~ 301 (310)
T 2wqm_A 257 -PLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTAS 301 (310)
T ss_dssp -CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred -CCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhh
Confidence 000112235677899999999999999999999999998765444
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=359.44 Aligned_cols=267 Identities=17% Similarity=0.201 Sum_probs=198.5
Q ss_pred CccccC--CceEEEEEEeC-CCCEEEEEEcccCcc--cCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecC
Q 005749 383 QVIEKT--TYGTAYKAKLA-DGATIALRLLREGSC--KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFP 457 (679)
Q Consensus 383 ~~ig~G--~~g~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~ 457 (679)
+.||+| +||.||+|+.. +|+.||||+++.... ...+.+.+|++++++++|||||++++++.+ .+..++|||||+
T Consensus 31 ~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~~ 109 (389)
T 3gni_B 31 TVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIA-DNELWVVTSFMA 109 (389)
T ss_dssp EEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEEEEECCT
T ss_pred ecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEE-CCEEEEEEEccC
Confidence 789999 99999999954 799999999976432 234567889999999999999999999997 678999999999
Q ss_pred CCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccc-
Q 005749 458 SRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVA- 536 (679)
Q Consensus 458 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~- 536 (679)
+|+|.+++.... ...+++..++.|+.||+.||+|||+++ |+||||||+|||++.++.+||+|||.+........
T Consensus 110 ~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~ 184 (389)
T 3gni_B 110 YGSAKDLICTHF--MDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQR 184 (389)
T ss_dssp TCBHHHHHHHTC--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEECEETTEE
T ss_pred CCCHHHHHhhhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceeecccccc
Confidence 999999997643 245899999999999999999999988 99999999999999999999999999865422111
Q ss_pred -----cchhcccccccccccccccc--cCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhc------
Q 005749 537 -----DEMVALAKADGYKAPELQRM--KKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLE------ 603 (679)
Q Consensus 537 -----~~~~~~~gt~~y~aPE~~~~--~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~------ 603 (679)
.......||..|+|||++.+ ..++.++|||||||++|||++|+.||.+....+.. ..........
T Consensus 185 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~ 262 (389)
T 3gni_B 185 QRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML--LEKLNGTVPCLLDTST 262 (389)
T ss_dssp CSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHH--HHC-------------
T ss_pred ccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHH--HHHhcCCCCccccccc
Confidence 11223478899999999987 57899999999999999999999999654332211 0000000000
Q ss_pred ---ccc---------cccchHhhhh-------c---CCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH--HHhh
Q 005749 604 ---ETT---------MEVFDMEIMK-------G---IRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ--LEEN 657 (679)
Q Consensus 604 ---~~~---------~~~~~~~i~~-------~---~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~--L~~~ 657 (679)
... .......+.. . ..+......+++.+++.+||+.||++|||++|+++. ++++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~ 340 (389)
T 3gni_B 263 IPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI 340 (389)
T ss_dssp -------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC
T ss_pred cccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHH
Confidence 000 0000000000 0 000111223567889999999999999999999876 4444
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=351.83 Aligned_cols=236 Identities=17% Similarity=0.289 Sum_probs=195.5
Q ss_pred cCccccCCceEEEEEE-eCCCCEEEEEEcccCcc--------cCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEE
Q 005749 382 GQVIEKTTYGTAYKAK-LADGATIALRLLREGSC--------KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLI 452 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~--------~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv 452 (679)
.+.||+|+||.||+|+ ..+++.||||+++.... ...+.+.+|++++++++||||+++++++.+ .+..++|
T Consensus 29 ~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~-~~~~~lv 107 (335)
T 3dls_A 29 MSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN-QGFFQLV 107 (335)
T ss_dssp EEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC-SSEEEEE
T ss_pred EeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee-CCEEEEE
Confidence 4789999999999999 56789999999976532 134578899999999999999999999987 6789999
Q ss_pred EEecCCC-ChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeeccccccc
Q 005749 453 YDYFPSR-TLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLM 531 (679)
Q Consensus 453 ~ey~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 531 (679)
|||+.+| +|.+++... ..+++..++.|+.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++..
T Consensus 108 ~e~~~~g~~l~~~~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~ 180 (335)
T 3dls_A 108 MEKHGSGLDLFAFIDRH----PRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYL 180 (335)
T ss_dssp EECCTTSCBHHHHHHTC----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEeCCCCccHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecccceEC
Confidence 9999777 999999763 45999999999999999999999988 999999999999999999999999999876
Q ss_pred CcccccchhcccccccccccccccccCC-CCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccc
Q 005749 532 VPAVADEMVALAKADGYKAPELQRMKKC-SSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVF 610 (679)
Q Consensus 532 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 610 (679)
.... ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||..... ..
T Consensus 181 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---------------------~~ 237 (335)
T 3dls_A 181 ERGK--LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE---------------------TV 237 (335)
T ss_dssp CTTC--CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG---------------------GT
T ss_pred CCCC--ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH---------------------HH
Confidence 4332 2234578999999999987776 7899999999999999999999943110 00
Q ss_pred hHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 611 DMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 611 ~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
............++.+++.+||+.||++|||++|+++.
T Consensus 238 -----~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 238 -----EAAIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp -----TTCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred -----hhccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00001111123457789999999999999999999986
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-41 Score=349.41 Aligned_cols=254 Identities=18% Similarity=0.271 Sum_probs=189.4
Q ss_pred cCccccCCceEEEEEE-eCCCCEEEEEEcccCcccC---cccHHHHHHHHhccCCCCCccceEEeeCCCC---ceEEEEE
Q 005749 382 GQVIEKTTYGTAYKAK-LADGATIALRLLREGSCKD---RSSCLPVIRQLGKVRHENLIPLRAFYQGKRG---EKLLIYD 454 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~---~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~---~~~lv~e 454 (679)
.+.||+|+||.||+|+ ..+++.||||+++...... .+.+.+|++++++++|||||++++++..... ..++|||
T Consensus 17 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~e 96 (311)
T 3ork_A 17 GEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVME 96 (311)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEEEEE
T ss_pred EEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEEEEe
Confidence 3789999999999999 4679999999997653322 3468899999999999999999999875321 3499999
Q ss_pred ecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcc
Q 005749 455 YFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPA 534 (679)
Q Consensus 455 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 534 (679)
|+++|+|.++++.. ..+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 97 ~~~g~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 169 (311)
T 3ork_A 97 YVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADS 169 (311)
T ss_dssp CCCEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC------
T ss_pred cCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCccccccc
Confidence 99999999999764 35899999999999999999999988 999999999999999999999999999876433
Q ss_pred cc--cchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchH
Q 005749 535 VA--DEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDM 612 (679)
Q Consensus 535 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 612 (679)
.. .......||+.|+|||++.+..++.++||||||+++|||++|+.||.+.... ........... ..+
T Consensus 170 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~------~~~~~~~~~~~----~~~ 239 (311)
T 3ork_A 170 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV------SVAYQHVREDP----IPP 239 (311)
T ss_dssp ------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHCCC----CCH
T ss_pred ccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHhcCCC----CCc
Confidence 21 1223456899999999999889999999999999999999999999543211 11111111000 000
Q ss_pred hhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHH-HHHHhhC
Q 005749 613 EIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVV-KQLEENR 658 (679)
Q Consensus 613 ~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl-~~L~~~~ 658 (679)
.... +....++.+++.+||+.||++||++.+++ ..+.+..
T Consensus 240 ~~~~------~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 240 SARH------EGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp HHHS------TTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred cccc------CCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence 0000 01235677899999999999999765554 5565553
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=357.31 Aligned_cols=247 Identities=17% Similarity=0.254 Sum_probs=187.9
Q ss_pred CccccCCceEEEEEEe-CCCCEEEEEEcccCcccCcccHHHHHHHHhc-cCCCCCccceEEeeC---CCCceEEEEEecC
Q 005749 383 QVIEKTTYGTAYKAKL-ADGATIALRLLREGSCKDRSSCLPVIRQLGK-VRHENLIPLRAFYQG---KRGEKLLIYDYFP 457 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~-l~H~nIv~l~~~~~~---~~~~~~lv~ey~~ 457 (679)
++||+|+||+||+|+. .+|+.||||+++. ...+.+|++++.+ .+|||||+++++|.. ..+..++|||||+
T Consensus 68 ~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~ 142 (400)
T 1nxk_A 68 QVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD 142 (400)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCC
T ss_pred ceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCC
Confidence 6899999999999994 5689999999864 3467889998754 489999999998764 2456899999999
Q ss_pred CCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecC---CCceEEeecccccccCcc
Q 005749 458 SRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDD---FFVSRLTEFGLDQLMVPA 534 (679)
Q Consensus 458 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~---~~~~kl~DFGla~~~~~~ 534 (679)
+|+|.+++.... ...+++..++.|+.||+.||+|||+++ |+||||||+|||++. ++.+||+|||+++.....
T Consensus 143 gg~L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~ 217 (400)
T 1nxk_A 143 GGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH 217 (400)
T ss_dssp SEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTTCEECC--
T ss_pred CCcHHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecccccccCCC
Confidence 999999998642 345899999999999999999999988 999999999999997 789999999999865432
Q ss_pred cccchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCccc-chhHHHHHHhhcccccccchHh
Q 005749 535 VADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFV-DLPSIVKVAVLEETTMEVFDME 613 (679)
Q Consensus 535 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~-~l~~~~~~~~~~~~~~~~~~~~ 613 (679)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+....... .+...+... . ....
T Consensus 218 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~----~-~~~~--- 287 (400)
T 1nxk_A 218 --NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG----Q-YEFP--- 287 (400)
T ss_dssp -----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHT----C-CCCC---
T ss_pred --CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcC----c-ccCC---
Confidence 2234567899999999999999999999999999999999999999654332211 111111100 0 0000
Q ss_pred hhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 005749 614 IMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQL 654 (679)
Q Consensus 614 i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L 654 (679)
.........++.+++.+||+.||++|||+.|++++-
T Consensus 288 -----~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp 323 (400)
T 1nxk_A 288 -----NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP 323 (400)
T ss_dssp -----TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred -----CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 000112335677899999999999999999999863
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-40 Score=343.50 Aligned_cols=247 Identities=21% Similarity=0.316 Sum_probs=198.4
Q ss_pred hcCccccCCceEEEEEEe-CCCCEEEEEEcccCccc------CcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEE
Q 005749 381 TGQVIEKTTYGTAYKAKL-ADGATIALRLLREGSCK------DRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIY 453 (679)
Q Consensus 381 ~~~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~------~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ 453 (679)
..+.||+|+||.||+|+. .+|+.||+|.++..... ..+.+.+|++++++++||||+++++++.+ .+..++||
T Consensus 16 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~ 94 (321)
T 2a2a_A 16 IGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYEN-RTDVVLIL 94 (321)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEEEE
T ss_pred EeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEec-CCEEEEEE
Confidence 357899999999999995 46999999999764322 24568999999999999999999999987 67899999
Q ss_pred EecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCC----ceEEeeccccc
Q 005749 454 DYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFF----VSRLTEFGLDQ 529 (679)
Q Consensus 454 ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~----~~kl~DFGla~ 529 (679)
||+++++|.+++.. ...+++..++.++.|++.||+|||+++ |+||||||+||+++.++ .+||+|||+++
T Consensus 95 e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~ 167 (321)
T 2a2a_A 95 ELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (321)
T ss_dssp CCCCSCBHHHHHHT----CSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCTTCE
T ss_pred EcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCccce
Confidence 99999999999976 345899999999999999999999988 99999999999999887 79999999998
Q ss_pred ccCcccccchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhccccccc
Q 005749 530 LMVPAVADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEV 609 (679)
Q Consensus 530 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 609 (679)
...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||.+.... +....... . ...
T Consensus 168 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~i~~-~--~~~ 236 (321)
T 2a2a_A 168 EIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ------ETLANITS-V--SYD 236 (321)
T ss_dssp ECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH------HHHHHHHT-T--CCC
T ss_pred ecCccc--cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHHh-c--ccc
Confidence 764322 223457899999999999889999999999999999999999999543211 11111000 0 000
Q ss_pred chHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 610 FDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 610 ~~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
+++.... .....+.+++.+||+.||++|||++|+++.
T Consensus 237 ~~~~~~~-------~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 237 FDEEFFS-------HTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp CCHHHHT-------TCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred cChhhhc-------ccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1111111 122457789999999999999999999874
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=345.26 Aligned_cols=257 Identities=19% Similarity=0.216 Sum_probs=192.9
Q ss_pred cCccccCCceEEEEEEe-CCCCEEEEEEcccCcccC---cccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecC
Q 005749 382 GQVIEKTTYGTAYKAKL-ADGATIALRLLREGSCKD---RSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFP 457 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~---~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~ 457 (679)
.+.||+|+||.||+|+. .+++.||+|++......+ .+.+.+|++++.+++||||+++++++.. .+..++||||++
T Consensus 39 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~e~~~ 117 (309)
T 2h34_A 39 RRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEI-DGQLYVDMRLIN 117 (309)
T ss_dssp EEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-TTEEEEEEECCC
T ss_pred EEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEee-CCeEEEEEEecC
Confidence 37899999999999995 478899999997653322 3678899999999999999999999987 678999999999
Q ss_pred CCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCccccc
Q 005749 458 SRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVAD 537 (679)
Q Consensus 458 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 537 (679)
+++|.+++... ..+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++........
T Consensus 118 ~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 190 (309)
T 2h34_A 118 GVDLAAMLRRQ----GPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLT 190 (309)
T ss_dssp CEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC----------
T ss_pred CCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCccccccccc
Confidence 99999999864 35899999999999999999999988 999999999999999999999999999876443333
Q ss_pred chhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhc
Q 005749 538 EMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKG 617 (679)
Q Consensus 538 ~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~ 617 (679)
......|++.|+|||.+.+..++.++||||||+++|||++|+.||..... ........... ..+. .
T Consensus 191 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------~~~~~~~~~~~----~~~~---~ 256 (309)
T 2h34_A 191 QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL-------SVMGAHINQAI----PRPS---T 256 (309)
T ss_dssp ------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH-------HHHHHHHHSCC----CCGG---G
T ss_pred cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH-------HHHHHHhccCC----CCcc---c
Confidence 33455789999999999988999999999999999999999999954211 11111111100 0000 0
Q ss_pred CCCChHHHHHHHHHHHHhccCcCCCCCC-CHHHHHHHHHhhCCCCCC
Q 005749 618 IRSPMEEGLVQALKLAMGCCAPVASVRP-TMDEVVKQLEENRPRNRS 663 (679)
Q Consensus 618 ~~~~~~~~~~~~~~l~~~cl~~dP~~RP-s~~evl~~L~~~~~~~~~ 663 (679)
..+....++.+++.+||+.||++|| +++++++.|++.......
T Consensus 257 ---~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~~ 300 (309)
T 2h34_A 257 ---VRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATADQ 300 (309)
T ss_dssp ---TSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC----
T ss_pred ---cCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhcc
Confidence 0111224567899999999999999 999999999998765443
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=353.06 Aligned_cols=246 Identities=15% Similarity=0.220 Sum_probs=187.5
Q ss_pred CccccCCceEEEEEEe-CCCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCCh
Q 005749 383 QVIEKTTYGTAYKAKL-ADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRTL 461 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gsL 461 (679)
+.||+|+||+||+|+. .+++.||||++.... ...+.+.+|+.++++++|||||++++++.+ .+..++||||+++|+|
T Consensus 26 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~~lv~e~~~~~~L 103 (361)
T 3uc3_A 26 KDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILT-PTHLAIIMEYASGGEL 103 (361)
T ss_dssp EEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEEEEECCCSCBH
T ss_pred EEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEee-CCEEEEEEEeCCCCCH
Confidence 7899999999999995 479999999997643 334678999999999999999999999997 6789999999999999
Q ss_pred HHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCc--eEEeecccccccCcccccch
Q 005749 462 HDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFV--SRLTEFGLDQLMVPAVADEM 539 (679)
Q Consensus 462 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~--~kl~DFGla~~~~~~~~~~~ 539 (679)
.+++... ..+++..++.++.|++.||+|||+++ |+||||||+|||++.++. +||+|||+++..... ...
T Consensus 104 ~~~l~~~----~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~--~~~ 174 (361)
T 3uc3_A 104 YERICNA----GRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH--SQP 174 (361)
T ss_dssp HHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC-----------
T ss_pred HHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcccccccc--CCC
Confidence 9999763 35899999999999999999999988 999999999999987765 999999999854222 223
Q ss_pred hcccccccccccccccccCCCCc-chhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcC
Q 005749 540 VALAKADGYKAPELQRMKKCSSR-TDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGI 618 (679)
Q Consensus 540 ~~~~gt~~y~aPE~~~~~~~~~k-~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~ 618 (679)
....||+.|+|||++.+..++.+ +||||+||++|||++|+.||.+..... .............. .
T Consensus 175 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--~~~~~~~~~~~~~~------------~ 240 (361)
T 3uc3_A 175 KSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPR--DYRKTIQRILSVKY------------S 240 (361)
T ss_dssp ------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CC--CHHHHHHHHHTTCC------------C
T ss_pred CCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHH--HHHHHHHHHhcCCC------------C
Confidence 34579999999999988777665 899999999999999999996543321 11111111111000 0
Q ss_pred CCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 619 RSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 619 ~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
.+......+++.+++.+||+.||++|||+.|++++
T Consensus 241 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 241 IPDDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp CCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 01111123567789999999999999999999986
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=353.65 Aligned_cols=249 Identities=20% Similarity=0.255 Sum_probs=198.8
Q ss_pred cCccccCCceEEEEEEe----CCCCEEEEEEcccCc----ccCcccHHHHHHHHhcc-CCCCCccceEEeeCCCCceEEE
Q 005749 382 GQVIEKTTYGTAYKAKL----ADGATIALRLLREGS----CKDRSSCLPVIRQLGKV-RHENLIPLRAFYQGKRGEKLLI 452 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~----~~~~~vAvK~~~~~~----~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~~lv 452 (679)
.+.||+|+||.||+|+. .+++.||||+++... ....+.+.+|++++.++ +||||+++++++.. .+..++|
T Consensus 59 ~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-~~~~~lv 137 (355)
T 1vzo_A 59 LKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT-ETKLHLI 137 (355)
T ss_dssp EEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE-TTEEEEE
T ss_pred EEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee-CceEEEE
Confidence 47899999999999996 478999999987542 23456678899999999 69999999999987 6789999
Q ss_pred EEecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccC
Q 005749 453 YDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMV 532 (679)
Q Consensus 453 ~ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 532 (679)
|||+++|+|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 138 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 210 (355)
T 1vzo_A 138 LDYINGGELFTHLSQR----ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFV 210 (355)
T ss_dssp ECCCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred eecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCCeecc
Confidence 9999999999999864 35899999999999999999999988 9999999999999999999999999998765
Q ss_pred cccccchhcccccccccccccccc--cCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccc
Q 005749 533 PAVADEMVALAKADGYKAPELQRM--KKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVF 610 (679)
Q Consensus 533 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 610 (679)
...........||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ....+....
T Consensus 211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~--~~~~~~~~~---------- 278 (355)
T 1vzo_A 211 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN--SQAEISRRI---------- 278 (355)
T ss_dssp GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC--CHHHHHHHH----------
T ss_pred cCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccc--hHHHHHHHH----------
Confidence 443334445679999999999885 347899999999999999999999995433221 111111111
Q ss_pred hHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCC-----CHHHHHHHH
Q 005749 611 DMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRP-----TMDEVVKQL 654 (679)
Q Consensus 611 ~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~evl~~L 654 (679)
..............+.+++.+||+.||++|| +++|+++..
T Consensus 279 ----~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 279 ----LKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp ----HHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred ----hccCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 1111111222335567899999999999999 999998764
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=351.51 Aligned_cols=260 Identities=19% Similarity=0.204 Sum_probs=195.3
Q ss_pred HHHHHHhh--cCccccCCceEEEEEEe-CCCCEEEEEEcccC-----cccCcccHHHHHHHHhccCCCCCccceEEeeCC
Q 005749 374 LEDVLNAT--GQVIEKTTYGTAYKAKL-ADGATIALRLLREG-----SCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGK 445 (679)
Q Consensus 374 ~~~l~~~~--~~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~-----~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~ 445 (679)
+.++.... .+.||+|+||.||+|+. .+++.||+|++... .....+.+.+|++++++++|||||++++++.+
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~- 99 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED- 99 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC-
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc-
Confidence 34444333 47899999999999994 56889999998653 22345678999999999999999999999987
Q ss_pred CCceEEEEEecCCCChHHHhhcccCC------------------------------------CCCCCHHHHHHHHHHHHH
Q 005749 446 RGEKLLIYDYFPSRTLHDLLHDTIAG------------------------------------KPVLNWARRHKIALGIAR 489 (679)
Q Consensus 446 ~~~~~lv~ey~~~gsL~~~l~~~~~~------------------------------------~~~l~~~~~~~i~~~ia~ 489 (679)
.+..++||||+++|+|.+++...... ...+++..++.|+.|++.
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 67899999999999999999632110 122467788899999999
Q ss_pred HHHHHhcCCCCCeeecCCCCCCeeecCCC--ceEEeecccccccCccc---ccchhcccccccccccccccc--cCCCCc
Q 005749 490 GLAYLHTGHEIPITHGNVRSKNVLVDDFF--VSRLTEFGLDQLMVPAV---ADEMVALAKADGYKAPELQRM--KKCSSR 562 (679)
Q Consensus 490 gL~~LH~~~~~~ivHrDlkp~NILl~~~~--~~kl~DFGla~~~~~~~---~~~~~~~~gt~~y~aPE~~~~--~~~~~k 562 (679)
||+|||+++ |+||||||+||+++.++ .+||+|||+++.+.... ........||+.|+|||++.+ ..++.+
T Consensus 180 ~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 256 (345)
T 3hko_A 180 ALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK 256 (345)
T ss_dssp HHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred HHHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence 999999988 99999999999998776 89999999998653321 112345679999999999875 678999
Q ss_pred chhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcCCCChHHHHHHHHHHHHhccCcCCC
Q 005749 563 TDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVAS 642 (679)
Q Consensus 563 ~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~ 642 (679)
+|||||||++|||++|+.||.+.... +........... ... +......+.+.+++.+||+.||+
T Consensus 257 ~DiwslG~il~el~~g~~pf~~~~~~------~~~~~~~~~~~~--~~~--------~~~~~~~~~~~~li~~~l~~~p~ 320 (345)
T 3hko_A 257 CDAWSAGVLLHLLLMGAVPFPGVNDA------DTISQVLNKKLC--FEN--------PNYNVLSPLARDLLSNLLNRNVD 320 (345)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCCCC--TTS--------GGGGGSCHHHHHHHHHHSCSCTT
T ss_pred HHHHHHHHHHHHHHHCCCCCCCCChH------HHHHHHHhcccc--cCC--------cccccCCHHHHHHHHHHcCCChh
Confidence 99999999999999999999543221 111111111000 000 00111235677899999999999
Q ss_pred CCCCHHHHHHH
Q 005749 643 VRPTMDEVVKQ 653 (679)
Q Consensus 643 ~RPs~~evl~~ 653 (679)
+||++.|+++.
T Consensus 321 ~Rps~~~~l~h 331 (345)
T 3hko_A 321 ERFDAMRALQH 331 (345)
T ss_dssp TSCCHHHHHHS
T ss_pred HCCCHHHHhcC
Confidence 99999999885
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=345.11 Aligned_cols=240 Identities=19% Similarity=0.210 Sum_probs=187.4
Q ss_pred cCccccCCceEEEEEEeC-CCCEEEEEEcccCcc--cCcccHHHHHHHHhcc-CCCCCccceEEeeCCCCceEEEEEecC
Q 005749 382 GQVIEKTTYGTAYKAKLA-DGATIALRLLREGSC--KDRSSCLPVIRQLGKV-RHENLIPLRAFYQGKRGEKLLIYDYFP 457 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~~lv~ey~~ 457 (679)
.+.||+|+||+||+|+.. +|+.||||++..... .....+..|+..+.++ +|||||+++++|.+ .+..++||||+
T Consensus 62 ~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~-~~~~~lv~e~~- 139 (311)
T 3p1a_A 62 LSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEE-GGILYLQTELC- 139 (311)
T ss_dssp EEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEEEEECC-
T ss_pred eheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEe-CCEEEEEEecc-
Confidence 478999999999999964 799999999865432 2234556666666666 89999999999987 68899999999
Q ss_pred CCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCccccc
Q 005749 458 SRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVAD 537 (679)
Q Consensus 458 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 537 (679)
+++|.+++... ...+++..++.|+.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++..... .
T Consensus 140 ~~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~--~ 211 (311)
T 3p1a_A 140 GPSLQQHCEAW---GASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA--G 211 (311)
T ss_dssp CCBHHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC-----
T ss_pred CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeecccC--C
Confidence 66999988765 345999999999999999999999988 999999999999999999999999998876432 2
Q ss_pred chhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhc
Q 005749 538 EMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKG 617 (679)
Q Consensus 538 ~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~ 617 (679)
......||+.|+|||++.+ .++.++|||||||++|||++|..|+.... .+.. ... ....+....
T Consensus 212 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~--------~~~~--~~~----~~~~~~~~~- 275 (311)
T 3p1a_A 212 AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE--------GWQQ--LRQ----GYLPPEFTA- 275 (311)
T ss_dssp ---CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH--------HHHH--HTT----TCCCHHHHT-
T ss_pred CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc--------HHHH--Hhc----cCCCccccc-
Confidence 2334568999999998875 79999999999999999999977763211 1110 000 011111111
Q ss_pred CCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 618 IRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 618 ~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
....++.+++.+||+.||++|||++|+++.
T Consensus 276 ------~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 276 ------GLSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp ------TSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ------CCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 123567789999999999999999999863
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=350.93 Aligned_cols=270 Identities=23% Similarity=0.331 Sum_probs=193.1
Q ss_pred cCccccCCceEEEEEEeCCCCEEEEEEcccCcccCcccHHHHHHH--HhccCCCCCccceEEeeC----CCCceEEEEEe
Q 005749 382 GQVIEKTTYGTAYKAKLADGATIALRLLREGSCKDRSSCLPVIRQ--LGKVRHENLIPLRAFYQG----KRGEKLLIYDY 455 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~--l~~l~H~nIv~l~~~~~~----~~~~~~lv~ey 455 (679)
.+.||+|+||.||+|+. +++.||||++.... ...+..|.++ +..++||||+++++++.. .....++||||
T Consensus 18 ~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~ 93 (336)
T 3g2f_A 18 LELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEY 93 (336)
T ss_dssp EEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEECC
T ss_pred eeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEEec
Confidence 37899999999999987 68999999986532 3344445444 556899999999975542 23457899999
Q ss_pred cCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcC---------CCCCeeecCCCCCCeeecCCCceEEeecc
Q 005749 456 FPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTG---------HEIPITHGNVRSKNVLVDDFFVSRLTEFG 526 (679)
Q Consensus 456 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~---------~~~~ivHrDlkp~NILl~~~~~~kl~DFG 526 (679)
+++|+|.+++... ..++..+++|+.|+++||+|||+. + |+||||||+|||++.++.+||+|||
T Consensus 94 ~~~g~L~~~l~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~kL~DFG 165 (336)
T 3g2f_A 94 YPNGSLXKYLSLH-----TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTCVISDFG 165 (336)
T ss_dssp CTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCEEECCCT
T ss_pred CCCCcHHHHHhhc-----ccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcEEEeecc
Confidence 9999999999753 358999999999999999999998 6 9999999999999999999999999
Q ss_pred cccccCccc-------ccchhcccccccccccccccc-------cCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccc
Q 005749 527 LDQLMVPAV-------ADEMVALAKADGYKAPELQRM-------KKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVD 592 (679)
Q Consensus 527 la~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~-------~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~ 592 (679)
+++.+.... ........||+.|+|||++.+ ..++.++|||||||++|||++|..|+..........
T Consensus 166 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~ 245 (336)
T 3g2f_A 166 LSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQ 245 (336)
T ss_dssp TCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCC
T ss_pred ceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHH
Confidence 998764321 112234569999999999876 456789999999999999999987764433221111
Q ss_pred hhHH-----------HHHHhhcccccccchHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCCC-
Q 005749 593 LPSI-----------VKVAVLEETTMEVFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRPR- 660 (679)
Q Consensus 593 l~~~-----------~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~- 660 (679)
.... ........... +.+.. ..........++.+++.+||+.||++|||++|+++.|+++...
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~ 320 (336)
T 3g2f_A 246 MAFQTEVGNHPTFEDMQVLVSREKQR----PKFPE-AWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIW 320 (336)
T ss_dssp CTTHHHHCSSCCHHHHHHHHTTSCCC----CCCCT-TCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCC
T ss_pred HhhhcccCCCchHHHHHhhhcccccC----CCCCc-ccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHH
Confidence 1000 00000000000 00000 0011223556788999999999999999999999999998743
Q ss_pred CCCCCCCC
Q 005749 661 NRSALYSP 668 (679)
Q Consensus 661 ~~~~~~~~ 668 (679)
.+.....|
T Consensus 321 ~~~~~~~~ 328 (336)
T 3g2f_A 321 ERNKSVSP 328 (336)
T ss_dssp CC------
T ss_pred HhcccCCC
Confidence 33333333
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=341.38 Aligned_cols=242 Identities=20% Similarity=0.300 Sum_probs=194.4
Q ss_pred cCccccCCceEEEEEEe-CCCCEEEEEEcccCc---ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecC
Q 005749 382 GQVIEKTTYGTAYKAKL-ADGATIALRLLREGS---CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFP 457 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~ 457 (679)
.+.||+|+||.||+|+. .+++.||+|++.... ....+.+.+|++++++++||||+++++++.+ .+..++||||++
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~ 92 (279)
T 3fdn_A 14 GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD-ATRVYLILEYAP 92 (279)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEEEEECCCT
T ss_pred eeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEec-CCEEEEEEecCC
Confidence 37899999999999984 567899999986532 2234578899999999999999999999987 678999999999
Q ss_pred CCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCccccc
Q 005749 458 SRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVAD 537 (679)
Q Consensus 458 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 537 (679)
+|+|.+++... ..+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++......
T Consensus 93 ~~~l~~~l~~~----~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~--- 162 (279)
T 3fdn_A 93 LGTVYRELQKL----SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--- 162 (279)
T ss_dssp TEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC------
T ss_pred CCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCcc---
Confidence 99999999764 34899999999999999999999988 999999999999999999999999998754322
Q ss_pred chhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhc
Q 005749 538 EMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKG 617 (679)
Q Consensus 538 ~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~ 617 (679)
......|++.|+|||.+.+..++.++||||||+++|||++|+.||...... ..... +...
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~--------------~~~~ 222 (279)
T 3fdn_A 163 RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ------ETYKR--------------ISRV 222 (279)
T ss_dssp -----CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHH--------------HHHT
T ss_pred cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHH------HHHHH--------------HHhC
Confidence 223457899999999999889999999999999999999999999543211 11110 0111
Q ss_pred CCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 005749 618 IRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQL 654 (679)
Q Consensus 618 ~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L 654 (679)
...........+.+++.+||+.||++|||++|+++.-
T Consensus 223 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~ 259 (279)
T 3fdn_A 223 EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHP 259 (279)
T ss_dssp CCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCH
T ss_pred CCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCc
Confidence 1111112234567899999999999999999999864
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=366.02 Aligned_cols=258 Identities=15% Similarity=0.170 Sum_probs=189.7
Q ss_pred cCccccCCceEEEEEE-eCCCCEEEEEEcccCc--ccCcccHHHHHHHHhccCCCCCccceEEeeCCC-----CceEEEE
Q 005749 382 GQVIEKTTYGTAYKAK-LADGATIALRLLREGS--CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKR-----GEKLLIY 453 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~-----~~~~lv~ 453 (679)
.+.||+|+||+||+|+ ..+++.||||++.... ....+.+.+|+++++.++|||||++++++.... ...++||
T Consensus 67 ~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~ 146 (464)
T 3ttj_A 67 LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVM 146 (464)
T ss_dssp EEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEE
T ss_pred EEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEEEEE
Confidence 3789999999999998 5568999999997542 233557889999999999999999999997532 4579999
Q ss_pred EecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCc
Q 005749 454 DYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVP 533 (679)
Q Consensus 454 ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 533 (679)
|||++ +|.+.+.. .+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 147 E~~~~-~l~~~~~~------~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 216 (464)
T 3ttj_A 147 ELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 216 (464)
T ss_dssp ECCSE-EHHHHHTS------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC-----
T ss_pred eCCCC-CHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEeeeecCC
Confidence 99976 57776643 3899999999999999999999998 99999999999999999999999999987643
Q ss_pred ccccchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHh------------
Q 005749 534 AVADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAV------------ 601 (679)
Q Consensus 534 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~------------ 601 (679)
. .......||+.|+|||++.+..|+.++||||+||++|||++|+.||.+....+ .+...+...-
T Consensus 217 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~--~~~~i~~~lg~p~~~~~~~~~~ 292 (464)
T 3ttj_A 217 S--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID--QWNKVIEQLGTPCPEFMKKLQP 292 (464)
T ss_dssp C--CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCSCCHHHHTTSCH
T ss_pred C--cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhcCCCCHHHHHHcch
Confidence 2 22345689999999999999999999999999999999999999996543211 1111111000
Q ss_pred ------hcc-cccccchHhhh-hc----CCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 602 ------LEE-TTMEVFDMEIM-KG----IRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 602 ------~~~-~~~~~~~~~i~-~~----~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
... ......-+... .. .........+++.+++.+||+.||++|||++|++++
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 293 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp HHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000 00000000000 00 000011224678899999999999999999999875
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-41 Score=350.52 Aligned_cols=265 Identities=22% Similarity=0.327 Sum_probs=202.3
Q ss_pred cCccccCCceEEEEEEeC-----CCCEEEEEEcccCcc-cCcccHHHHHHHHhccCCCCCccceEEeeCC-CCceEEEEE
Q 005749 382 GQVIEKTTYGTAYKAKLA-----DGATIALRLLREGSC-KDRSSCLPVIRQLGKVRHENLIPLRAFYQGK-RGEKLLIYD 454 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~-----~~~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~-~~~~~lv~e 454 (679)
.+.||+|+||+||++++. +++.||||+++.... ...+.+.+|++++++++||||+++++++.+. ....++|||
T Consensus 36 ~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 115 (318)
T 3lxp_A 36 IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVME 115 (318)
T ss_dssp EEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEEEC
T ss_pred hheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEEEe
Confidence 378999999999998643 688999999976532 3356789999999999999999999999863 356899999
Q ss_pred ecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcc
Q 005749 455 YFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPA 534 (679)
Q Consensus 455 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 534 (679)
|+++|+|.+++... .+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 116 ~~~~~~L~~~l~~~-----~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 187 (318)
T 3lxp_A 116 YVPLGSLRDYLPRH-----SIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 187 (318)
T ss_dssp CCTTCBHHHHGGGS-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECCTT
T ss_pred cccCCcHHHHHhhC-----CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccccccccc
Confidence 99999999999753 3899999999999999999999988 999999999999999999999999999876443
Q ss_pred cc--cchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcc-cccccch
Q 005749 535 VA--DEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEE-TTMEVFD 611 (679)
Q Consensus 535 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~-~~~~~~~ 611 (679)
.. .......++..|+|||.+.+..++.++||||||+++|||++|+.||...... ..... ..... .....+.
T Consensus 188 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~----~~~~~--~~~~~~~~~~~~~ 261 (318)
T 3lxp_A 188 HEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTK----FLELI--GIAQGQMTVLRLT 261 (318)
T ss_dssp CSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH----HHHHH--CSCCHHHHHHHHH
T ss_pred ccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchh----hhhhh--cccccchhHHHHH
Confidence 21 1223456788899999999888999999999999999999999998432110 00000 00000 0000001
Q ss_pred HhhhhcCC-CChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCCC
Q 005749 612 MEIMKGIR-SPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRPR 660 (679)
Q Consensus 612 ~~i~~~~~-~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 660 (679)
..+..+.. ........++.+++.+||+.||++|||++|+++.|+++...
T Consensus 262 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 311 (318)
T 3lxp_A 262 ELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEK 311 (318)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHh
Confidence 11111111 11223345778899999999999999999999999988643
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-40 Score=356.57 Aligned_cols=242 Identities=20% Similarity=0.299 Sum_probs=186.4
Q ss_pred cCccccCCceEEEEEE-eCCCCEEEEEEcccCc--------ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEE
Q 005749 382 GQVIEKTTYGTAYKAK-LADGATIALRLLREGS--------CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLI 452 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~--------~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv 452 (679)
.+.||+|+||.||+|+ ..+++.||||++.... ......+.+|++++++++|||||++++++.. +..++|
T Consensus 140 ~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~--~~~~lv 217 (419)
T 3i6u_A 140 SKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA--EDYYIV 217 (419)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES--SEEEEE
T ss_pred EeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec--CceEEE
Confidence 4789999999999999 4568999999986532 1223468999999999999999999999865 568999
Q ss_pred EEecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCC---CceEEeeccccc
Q 005749 453 YDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDF---FVSRLTEFGLDQ 529 (679)
Q Consensus 453 ~ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~---~~~kl~DFGla~ 529 (679)
|||+++|+|.+++.. ...+++..++.++.|++.||+|||+++ |+||||||+|||++.+ +.+||+|||+++
T Consensus 218 ~e~~~~g~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~ 290 (419)
T 3i6u_A 218 LELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSK 290 (419)
T ss_dssp EECCTTCBGGGGTSS----SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEECCSSTTT
T ss_pred EEcCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEeecccce
Confidence 999999999998875 345899999999999999999999988 9999999999999754 459999999998
Q ss_pred ccCcccccchhcccccccccccccccc---cCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccc
Q 005749 530 LMVPAVADEMVALAKADGYKAPELQRM---KKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETT 606 (679)
Q Consensus 530 ~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 606 (679)
..... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... ..+..
T Consensus 291 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~--~~~~~----------- 355 (419)
T 3i6u_A 291 ILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ--VSLKD----------- 355 (419)
T ss_dssp SCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSS--CCHHH-----------
T ss_pred ecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcch--HHHHH-----------
Confidence 76432 22345679999999999863 56888999999999999999999999543322 11111
Q ss_pred cccchHhhhhcCCCChHH----HHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 607 MEVFDMEIMKGIRSPMEE----GLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 607 ~~~~~~~i~~~~~~~~~~----~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
.+..+.....++ ....+.+++.+||+.||++|||++|++++
T Consensus 356 ------~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 356 ------QITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp ------HHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ------HHhcCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 111111111111 23567789999999999999999999874
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=341.85 Aligned_cols=246 Identities=25% Similarity=0.394 Sum_probs=193.1
Q ss_pred cCccccCCceEEEEEEeCCCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCCh
Q 005749 382 GQVIEKTTYGTAYKAKLADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRTL 461 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gsL 461 (679)
.+.||+|+||.||+|+.. |+.||||.++... ..+.+.+|++++++++||||+++++++....+..++||||+++|+|
T Consensus 26 ~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L 102 (278)
T 1byg_A 26 LQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSL 102 (278)
T ss_dssp EEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEH
T ss_pred EeEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCCH
Confidence 478999999999999874 8899999997542 4567899999999999999999999987655678999999999999
Q ss_pred HHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccchhc
Q 005749 462 HDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVA 541 (679)
Q Consensus 462 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 541 (679)
.+++.... ...+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++..... ...
T Consensus 103 ~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~----~~~ 173 (278)
T 1byg_A 103 VDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----QDT 173 (278)
T ss_dssp HHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC--------------
T ss_pred HHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccccccc----ccC
Confidence 99997642 223789999999999999999999988 999999999999999999999999998865322 123
Q ss_pred ccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcCC-
Q 005749 542 LAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIR- 619 (679)
Q Consensus 542 ~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~- 619 (679)
..++..|+|||.+.+..++.++||||||+++|||++ |+.||...... .. .. .+..+..
T Consensus 174 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~---~~---~~--------------~~~~~~~~ 233 (278)
T 1byg_A 174 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DV---VP--------------RVEKGYKM 233 (278)
T ss_dssp --CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG---GH---HH--------------HHTTTCCC
T ss_pred CCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH---HH---HH--------------HHhcCCCC
Confidence 357888999999988889999999999999999998 99998543221 11 11 1111111
Q ss_pred CChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCC
Q 005749 620 SPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRP 659 (679)
Q Consensus 620 ~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 659 (679)
.......+.+.+++.+||+.||++|||+.|+++.|+++..
T Consensus 234 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~ 273 (278)
T 1byg_A 234 DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 273 (278)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHh
Confidence 1112223567789999999999999999999999998854
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=340.24 Aligned_cols=248 Identities=16% Similarity=0.258 Sum_probs=192.6
Q ss_pred cCccccCCceEEEEEEe-CCCCEEEEEEcccCc-ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCC
Q 005749 382 GQVIEKTTYGTAYKAKL-ADGATIALRLLREGS-CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSR 459 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~g 459 (679)
.+.||+|+||.||+|+. .++..||+|++.... ....+.+.+|++++++++||||+++++++.+ .+..++||||+++|
T Consensus 27 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~e~~~~~ 105 (285)
T 3is5_A 27 KRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFED-YHNMYIVMETCEGG 105 (285)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-SSEEEEEECCCSCC
T ss_pred cceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheec-CCeEEEEEEeCCCC
Confidence 47899999999999994 568999999987653 3345778999999999999999999999987 67899999999999
Q ss_pred ChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee---cCCCceEEeecccccccCcccc
Q 005749 460 TLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLV---DDFFVSRLTEFGLDQLMVPAVA 536 (679)
Q Consensus 460 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl---~~~~~~kl~DFGla~~~~~~~~ 536 (679)
+|.+++.........+++..++.|+.|++.||+|||+++ |+||||||+||++ +.++.+||+|||+++.....
T Consensus 106 ~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~-- 180 (285)
T 3is5_A 106 ELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD-- 180 (285)
T ss_dssp BHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC------
T ss_pred cHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceecCCc--
Confidence 999998754322456999999999999999999999988 9999999999999 45688999999999876432
Q ss_pred cchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhh
Q 005749 537 DEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMK 616 (679)
Q Consensus 537 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~ 616 (679)
.......||+.|+|||.+. ..++.++||||||+++|||++|+.||.+.... ............
T Consensus 181 ~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~------~~~~~~~~~~~~---------- 243 (285)
T 3is5_A 181 EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLE------EVQQKATYKEPN---------- 243 (285)
T ss_dssp ------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCCCC----------
T ss_pred ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHH------HHHhhhccCCcc----------
Confidence 2234557899999999876 56899999999999999999999999543211 111111000000
Q ss_pred cCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 617 GIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 617 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
.........+++.+++.+||+.||++|||+.|+++.
T Consensus 244 -~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 244 -YAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp -CCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred -cccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000123567789999999999999999999863
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=367.70 Aligned_cols=249 Identities=17% Similarity=0.237 Sum_probs=200.1
Q ss_pred CccccCCceEEEEEEe-CCCCEEEEEEcccCc---ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCC
Q 005749 383 QVIEKTTYGTAYKAKL-ADGATIALRLLREGS---CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPS 458 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~ 458 (679)
++||+|+||.||+|+. .+|+.||+|++.... ....+.+.+|++++++++|||||++++++.+ .+..|+||||+++
T Consensus 191 ~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~-~~~l~lVmE~~~g 269 (543)
T 3c4z_A 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFET-KTDLCLVMTIMNG 269 (543)
T ss_dssp EEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEEEECCCTT
T ss_pred EEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEee-CCEEEEEEEeccC
Confidence 5799999999999996 469999999996542 2334578899999999999999999999987 6789999999999
Q ss_pred CChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccc
Q 005749 459 RTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADE 538 (679)
Q Consensus 459 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 538 (679)
|+|.+++.........+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+.... ..
T Consensus 270 g~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~-~~ 345 (543)
T 3c4z_A 270 GDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ-TK 345 (543)
T ss_dssp CBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCTTC-CC
T ss_pred CCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeeccCCC-cc
Confidence 9999999765433456999999999999999999999988 9999999999999999999999999998764332 12
Q ss_pred hhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcC
Q 005749 539 MVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGI 618 (679)
Q Consensus 539 ~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~ 618 (679)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+..... ......+. +....
T Consensus 346 ~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~--~~~~~~~~--------------i~~~~ 409 (543)
T 3c4z_A 346 TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV--ENKELKQR--------------VLEQA 409 (543)
T ss_dssp BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCC--CHHHHHHH--------------HHHCC
T ss_pred cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccch--hHHHHHHH--------------Hhhcc
Confidence 234589999999999999999999999999999999999999996543211 11111111 11111
Q ss_pred CCChHHHHHHHHHHHHhccCcCCCCCCCH-----HHHHH
Q 005749 619 RSPMEEGLVQALKLAMGCCAPVASVRPTM-----DEVVK 652 (679)
Q Consensus 619 ~~~~~~~~~~~~~l~~~cl~~dP~~RPs~-----~evl~ 652 (679)
....+.....+.+++.+||+.||++||++ +|+++
T Consensus 410 ~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 410 VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred cCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 11112234567789999999999999975 56654
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=350.59 Aligned_cols=263 Identities=19% Similarity=0.270 Sum_probs=191.6
Q ss_pred CccccCCceEEEEEEe-CCCCEEEEEEcccCcc-cCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCC
Q 005749 383 QVIEKTTYGTAYKAKL-ADGATIALRLLREGSC-KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRT 460 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gs 460 (679)
+.||+|+||+||+|+. .+++.||+|+++.... .....+.+|++++++++||||+++++++.+ .+..++||||++ |+
T Consensus 8 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~-~~ 85 (324)
T 3mtl_A 8 DKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHT-EKSLTLVFEYLD-KD 85 (324)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEEC-SSCEEEEEECCS-EE
T ss_pred EEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEee-CCEEEEEecccc-cC
Confidence 6899999999999995 4799999999975432 233466789999999999999999999987 678999999997 59
Q ss_pred hHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccchh
Q 005749 461 LHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMV 540 (679)
Q Consensus 461 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 540 (679)
|.+++... ...+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++..... .....
T Consensus 86 l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~-~~~~~ 158 (324)
T 3mtl_A 86 LKQYLDDC---GNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIP-TKTYD 158 (324)
T ss_dssp HHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC---------
T ss_pred HHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCC-ccccc
Confidence 99988764 345899999999999999999999988 999999999999999999999999999865432 22233
Q ss_pred cccccccccccccccc-cCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhh---cccccccchHhhhh
Q 005749 541 ALAKADGYKAPELQRM-KKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVL---EETTMEVFDMEIMK 616 (679)
Q Consensus 541 ~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~---~~~~~~~~~~~i~~ 616 (679)
...||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+....+ ....+..... ...+..........
T Consensus 159 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (324)
T 3mtl_A 159 NEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE---QLHFIFRILGTPTEETWPGILSNEEFK 235 (324)
T ss_dssp ----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCTTTSTTGGGCHHHH
T ss_pred cccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCChHhchhhhcchhhc
Confidence 4578999999999876 568999999999999999999999996543221 1111111111 00111111000000
Q ss_pred cC-----C-CC----hHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH--HHhh
Q 005749 617 GI-----R-SP----MEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ--LEEN 657 (679)
Q Consensus 617 ~~-----~-~~----~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~--L~~~ 657 (679)
.. . .. .+....++.+++.+||+.||++|||++|+++. +.++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 288 (324)
T 3mtl_A 236 TYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSL 288 (324)
T ss_dssp HTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGG
T ss_pred ccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhc
Confidence 00 0 00 01123567789999999999999999999884 4444
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=357.40 Aligned_cols=260 Identities=20% Similarity=0.334 Sum_probs=185.5
Q ss_pred cCccccCCceEEEEEE-eCCCCEEEEEEcccCc--ccCcccHHHHHHHHhccC-CCCCccceEEeeCC-CCceEEEEEec
Q 005749 382 GQVIEKTTYGTAYKAK-LADGATIALRLLREGS--CKDRSSCLPVIRQLGKVR-HENLIPLRAFYQGK-RGEKLLIYDYF 456 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~-H~nIv~l~~~~~~~-~~~~~lv~ey~ 456 (679)
.+.||+|+||.||+|+ ..+|+.||||++.... ....+.+.+|+.++.+++ |||||++++++... ....++|||||
T Consensus 14 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~ 93 (388)
T 3oz6_A 14 VKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYM 93 (388)
T ss_dssp EEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEEECC
T ss_pred EEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEeccc
Confidence 3789999999999999 4679999999986542 233456789999999997 99999999999753 34689999999
Q ss_pred CCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcc--
Q 005749 457 PSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPA-- 534 (679)
Q Consensus 457 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~-- 534 (679)
+ |+|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+|+.+...
T Consensus 94 ~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 164 (388)
T 3oz6_A 94 E-TDLHAVIRA-----NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRR 164 (388)
T ss_dssp S-EEHHHHHHH-----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEESSSCCC
T ss_pred C-cCHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCccccccccccc
Confidence 7 599999875 35899999999999999999999988 999999999999999999999999999865321
Q ss_pred ------------------cccchhcccccccccccccccc-cCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhH
Q 005749 535 ------------------VADEMVALAKADGYKAPELQRM-KKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPS 595 (679)
Q Consensus 535 ------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~ 595 (679)
.........||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+....+ .+..
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~--~~~~ 242 (388)
T 3oz6_A 165 VTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN--QLER 242 (388)
T ss_dssp CCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHH
T ss_pred ccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHH
Confidence 0112344689999999999876 678999999999999999999999996543211 1111
Q ss_pred HHHHHhhcccc------cccchHh----hhh-------cCCCChH-------------HHHHHHHHHHHhccCcCCCCCC
Q 005749 596 IVKVAVLEETT------MEVFDME----IMK-------GIRSPME-------------EGLVQALKLAMGCCAPVASVRP 645 (679)
Q Consensus 596 ~~~~~~~~~~~------~~~~~~~----i~~-------~~~~~~~-------------~~~~~~~~l~~~cl~~dP~~RP 645 (679)
.... ...... ...+... +.. ......+ ...+++.+++.+||+.||++||
T Consensus 243 i~~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~ 321 (388)
T 3oz6_A 243 IIGV-IDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRI 321 (388)
T ss_dssp HHHH-HCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSC
T ss_pred HHHh-cCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCC
Confidence 1110 000000 0000000 000 0000000 1235678999999999999999
Q ss_pred CHHHHHHH
Q 005749 646 TMDEVVKQ 653 (679)
Q Consensus 646 s~~evl~~ 653 (679)
|++|++++
T Consensus 322 t~~e~l~H 329 (388)
T 3oz6_A 322 SANDALKH 329 (388)
T ss_dssp CHHHHTTS
T ss_pred CHHHHhCC
Confidence 99999887
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=348.55 Aligned_cols=254 Identities=23% Similarity=0.343 Sum_probs=199.2
Q ss_pred cCccccCCceEEEEEEe-CCCCEE--EEEEcccC-cccCcccHHHHHHHHhcc-CCCCCccceEEeeCCCCceEEEEEec
Q 005749 382 GQVIEKTTYGTAYKAKL-ADGATI--ALRLLREG-SCKDRSSCLPVIRQLGKV-RHENLIPLRAFYQGKRGEKLLIYDYF 456 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~-~~~~~v--AvK~~~~~-~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~~lv~ey~ 456 (679)
.+.||+|+||.||+|+. .++..+ |+|.++.. .....+.+.+|++++.++ +||||+++++++.+ .+..++||||+
T Consensus 30 ~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-~~~~~lv~e~~ 108 (327)
T 1fvr_A 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-RGYLYLAIEYA 108 (327)
T ss_dssp EEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE-TTEEEEEECCC
T ss_pred eeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeee-CCceEEEEecC
Confidence 47899999999999994 456644 99998754 234566799999999999 89999999999987 67899999999
Q ss_pred CCCChHHHhhccc------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEee
Q 005749 457 PSRTLHDLLHDTI------------AGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTE 524 (679)
Q Consensus 457 ~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~D 524 (679)
++|+|.+++.... .....+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|
T Consensus 109 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kL~D 185 (327)
T 1fvr_A 109 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIAD 185 (327)
T ss_dssp TTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECC
T ss_pred CCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeEEEcc
Confidence 9999999997642 11346899999999999999999999988 99999999999999999999999
Q ss_pred cccccccCcccccchhcccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHHhhc
Q 005749 525 FGLDQLMVPAVADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAVLE 603 (679)
Q Consensus 525 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~~~~ 603 (679)
||+++..... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||.+.... ......
T Consensus 186 fg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~------~~~~~~--- 254 (327)
T 1fvr_A 186 FGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA------ELYEKL--- 254 (327)
T ss_dssp TTCEESSCEE--CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHG---
T ss_pred cCcCcccccc--ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH------HHHHHh---
Confidence 9998754221 12233456788999999988889999999999999999998 99999543211 111111
Q ss_pred ccccccchHhhhhcCC-CChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCCCC
Q 005749 604 ETTMEVFDMEIMKGIR-SPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRPRN 661 (679)
Q Consensus 604 ~~~~~~~~~~i~~~~~-~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 661 (679)
..+.. ........++.+++.+||+.||++|||++|+++.|+++....
T Consensus 255 -----------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 302 (327)
T 1fvr_A 255 -----------PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 302 (327)
T ss_dssp -----------GGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred -----------hcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhh
Confidence 11111 111122356778999999999999999999999999886544
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=351.72 Aligned_cols=257 Identities=19% Similarity=0.255 Sum_probs=186.0
Q ss_pred cCccccCCceEEEEEEe-CCCCEEEEEEcccCcccCcccHHHHHHHHhccC-CCCCccceEEee-------CCCCceEEE
Q 005749 382 GQVIEKTTYGTAYKAKL-ADGATIALRLLREGSCKDRSSCLPVIRQLGKVR-HENLIPLRAFYQ-------GKRGEKLLI 452 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~~~~~-------~~~~~~~lv 452 (679)
.+.||+|+||.||+|+. .+++.||||++........+.+.+|+.++.++. ||||+++++++. ......++|
T Consensus 33 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~lv 112 (337)
T 3ll6_A 33 RRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLL 112 (337)
T ss_dssp EEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEEE
T ss_pred EEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCceEEEE
Confidence 47899999999999994 579999999987655455667899999999996 999999999984 224457999
Q ss_pred EEecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccC
Q 005749 453 YDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMV 532 (679)
Q Consensus 453 ~ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 532 (679)
|||+. |+|.+++..... ...+++..++.|+.||+.||+|||+++ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 113 ~e~~~-g~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 189 (337)
T 3ll6_A 113 TELCK-GQLVEFLKKMES-RGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFGSATTIS 189 (337)
T ss_dssp EECCS-EEHHHHHHHHHT-TCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCTTCBCCS
T ss_pred EEecC-CCHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCccceecc
Confidence 99996 699999875332 345999999999999999999999865 359999999999999999999999999998764
Q ss_pred ccccc-----------chhcccccccccccccc---cccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHH
Q 005749 533 PAVAD-----------EMVALAKADGYKAPELQ---RMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVK 598 (679)
Q Consensus 533 ~~~~~-----------~~~~~~gt~~y~aPE~~---~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~ 598 (679)
..... ......||+.|+|||++ .+..++.++|||||||++|||++|+.||........ ..
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~------~~ 263 (337)
T 3ll6_A 190 HYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRI------VN 263 (337)
T ss_dssp SCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----------------
T ss_pred ccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHh------hc
Confidence 32211 11244689999999998 566789999999999999999999999954322110 00
Q ss_pred HHhhcccccccchHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCCCCCC
Q 005749 599 VAVLEETTMEVFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRPRNRS 663 (679)
Q Consensus 599 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~ 663 (679)
.... ..........+.+++.+||+.||++|||+.|+++.|+++......
T Consensus 264 -------------~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~ 312 (337)
T 3ll6_A 264 -------------GKYS---IPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNV 312 (337)
T ss_dssp ---------------CC---CCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTC
T ss_pred -------------Cccc---CCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCC
Confidence 0000 000111123466799999999999999999999999988654433
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=357.07 Aligned_cols=271 Identities=16% Similarity=0.213 Sum_probs=207.1
Q ss_pred cCccccCCceEEEEEEeC-CCCEEEEEEcccCc-ccCcccHHHHHHHHhccCCCCCccceEEeeCCC-CceEEEEEecCC
Q 005749 382 GQVIEKTTYGTAYKAKLA-DGATIALRLLREGS-CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKR-GEKLLIYDYFPS 458 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~-~~~~lv~ey~~~ 458 (679)
.++||+|+||+||+|+.. +|+.||||+++... ....+.+.+|++++++++|||||++++++.... ...++||||+++
T Consensus 14 ~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~ 93 (396)
T 4eut_A 14 SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPC 93 (396)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECCCTT
T ss_pred EEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEecCCC
Confidence 378999999999999954 59999999997643 234567889999999999999999999988632 367999999999
Q ss_pred CChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee----cCCCceEEeecccccccCcc
Q 005749 459 RTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLV----DDFFVSRLTEFGLDQLMVPA 534 (679)
Q Consensus 459 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl----~~~~~~kl~DFGla~~~~~~ 534 (679)
|+|.+++..... ...+++..++.++.|++.||+|||+++ |+||||||+|||+ +.++.+||+|||+++.....
T Consensus 94 g~L~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~ 169 (396)
T 4eut_A 94 GSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD 169 (396)
T ss_dssp EEHHHHTTSGGG-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCCG
T ss_pred CCHHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCceEccCC
Confidence 999999986533 234899999999999999999999988 9999999999999 78888999999999876433
Q ss_pred cccchhcccccccccccccccc--------cCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcc--
Q 005749 535 VADEMVALAKADGYKAPELQRM--------KKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEE-- 604 (679)
Q Consensus 535 ~~~~~~~~~gt~~y~aPE~~~~--------~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~-- 604 (679)
. ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......... .+.........
T Consensus 170 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~--~~~~~~~~~~~p~ 245 (396)
T 4eut_A 170 E--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN--KEVMYKIITGKPS 245 (396)
T ss_dssp G--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTC--HHHHHHHHHSCCT
T ss_pred C--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccch--HHHHHHHhcCCCc
Confidence 2 2334579999999998864 56788999999999999999999999643322111 11111111111
Q ss_pred -ccccc---------chHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCCCC
Q 005749 605 -TTMEV---------FDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRPRN 661 (679)
Q Consensus 605 -~~~~~---------~~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 661 (679)
..... +...+. ............+.+++.+||+.||++||+++|+++.++++....
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~-~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~~ 311 (396)
T 4eut_A 246 GAISGVQKAENGPIDWSGDMP-VSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRM 311 (396)
T ss_dssp TCCEEEECSTTCCEEEESSCC-TTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTCE
T ss_pred ccchhheeccCCCcccCccCC-cccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhce
Confidence 00000 000000 000112445566778999999999999999999999999987653
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=344.99 Aligned_cols=255 Identities=19% Similarity=0.303 Sum_probs=191.5
Q ss_pred cCccccCCceEEEEEEeC----CCCEEEEEEcccCcc--cCcccHHHHHHHHhccCCCCCccceEEeeCCCC----ceEE
Q 005749 382 GQVIEKTTYGTAYKAKLA----DGATIALRLLREGSC--KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRG----EKLL 451 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~----~~~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~----~~~l 451 (679)
.+.||+|+||.||+|+.. ++..||+|.++.... ...+.+.+|++++++++||||+++++++.+... ..++
T Consensus 39 ~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 118 (313)
T 3brb_A 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMV 118 (313)
T ss_dssp EEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------CEEE
T ss_pred ccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCcccEE
Confidence 478999999999999843 345899999975432 234578999999999999999999999986322 3599
Q ss_pred EEEecCCCChHHHhhccc--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeeccccc
Q 005749 452 IYDYFPSRTLHDLLHDTI--AGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQ 529 (679)
Q Consensus 452 v~ey~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 529 (679)
||||+++|+|.+++.... .....+++..++.++.|+++||+|||+++ |+||||||+||+++.++.+||+|||+++
T Consensus 119 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kl~Dfg~~~ 195 (313)
T 3brb_A 119 ILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVCVADFGLSK 195 (313)
T ss_dssp EEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCEEECSCSCC-
T ss_pred EEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEEeecCcce
Confidence 999999999999985432 22456999999999999999999999988 9999999999999999999999999998
Q ss_pred ccCcccc-cchhcccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHHhhccccc
Q 005749 530 LMVPAVA-DEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAVLEETTM 607 (679)
Q Consensus 530 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 607 (679)
....... .......+++.|+|||.+.+..++.++||||||+++|||++ |..||...... .+.. .
T Consensus 196 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~---~-------- 261 (313)
T 3brb_A 196 KIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH---EMYD---Y-------- 261 (313)
T ss_dssp ---------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GHHH---H--------
T ss_pred ecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH---HHHH---H--------
Confidence 7643321 12233457788999999998899999999999999999999 88898543221 1111 1
Q ss_pred ccchHhhhhcC-CCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCC
Q 005749 608 EVFDMEIMKGI-RSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRP 659 (679)
Q Consensus 608 ~~~~~~i~~~~-~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 659 (679)
+..+. ..........+.+++.+||+.||++|||++++++.|+++..
T Consensus 262 ------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~ 308 (313)
T 3brb_A 262 ------LLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLE 308 (313)
T ss_dssp ------HHTTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------HHcCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 11111 11112233567889999999999999999999999998753
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=353.22 Aligned_cols=243 Identities=23% Similarity=0.324 Sum_probs=194.5
Q ss_pred cCccccCCceEEEEEE-eCCCCEEEEEEcccCcc---cCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecC
Q 005749 382 GQVIEKTTYGTAYKAK-LADGATIALRLLREGSC---KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFP 457 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~---~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~ 457 (679)
.+.||+|+||.||+|+ ..+|+.||||++..... ...+.+.+|++++++++|||||++++++.+ .+..++||||+.
T Consensus 59 ~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~~lv~e~~~ 137 (348)
T 1u5q_A 59 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-EHTAWLVMEYCL 137 (348)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEEEEECCS
T ss_pred eeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-CCeEEEEEecCC
Confidence 3689999999999999 46799999999975432 223568899999999999999999999987 678999999997
Q ss_pred CCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCccccc
Q 005749 458 SRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVAD 537 (679)
Q Consensus 458 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 537 (679)
|+|.+++... ...+++..++.++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 138 -g~l~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~--- 207 (348)
T 1u5q_A 138 -GSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--- 207 (348)
T ss_dssp -EEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---
T ss_pred -CCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCCC---
Confidence 6888888653 346899999999999999999999988 999999999999999999999999999876432
Q ss_pred chhccccccccccccccc---ccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhh
Q 005749 538 EMVALAKADGYKAPELQR---MKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEI 614 (679)
Q Consensus 538 ~~~~~~gt~~y~aPE~~~---~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i 614 (679)
....||+.|+|||++. ...++.++|||||||++|||++|+.||..... ............ . .
T Consensus 208 --~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~------~~~~~~~~~~~~-~-----~- 272 (348)
T 1u5q_A 208 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQNES-P-----A- 272 (348)
T ss_dssp --CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHSCC-C-----C-
T ss_pred --CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHHhcCC-C-----C-
Confidence 2457899999999874 56789999999999999999999999854321 111111111100 0 0
Q ss_pred hhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHH
Q 005749 615 MKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLE 655 (679)
Q Consensus 615 ~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~ 655 (679)
.........+.+++.+||+.||++|||++|+++..-
T Consensus 273 -----~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~ 308 (348)
T 1u5q_A 273 -----LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 308 (348)
T ss_dssp -----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHH
T ss_pred -----CCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChh
Confidence 001112345678999999999999999999987644
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=347.10 Aligned_cols=259 Identities=21% Similarity=0.349 Sum_probs=191.4
Q ss_pred CccccCCceEEEEEEe-CCCCEEEEEEcccCccc--CcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCC
Q 005749 383 QVIEKTTYGTAYKAKL-ADGATIALRLLREGSCK--DRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSR 459 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~--~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~g 459 (679)
+.||+|+||+||+|+. .+|+.||+|++...... ..+.+.+|++++++++||||+++++++.+ .+..++||||++++
T Consensus 9 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~ 87 (311)
T 4agu_A 9 GKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRR-KRRLHLVFEYCDHT 87 (311)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEEEEECCSEE
T ss_pred eEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeec-CCeEEEEEEeCCCc
Confidence 6899999999999995 45999999998654322 24568899999999999999999999987 67899999999999
Q ss_pred ChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccch
Q 005749 460 TLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEM 539 (679)
Q Consensus 460 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 539 (679)
+|.+++... ..+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++...... ...
T Consensus 88 ~l~~~~~~~----~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~ 159 (311)
T 4agu_A 88 VLHELDRYQ----RGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPS-DYY 159 (311)
T ss_dssp HHHHHHHTS----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred hHHHHHhhh----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc-ccc
Confidence 999988753 45899999999999999999999988 9999999999999999999999999998764322 223
Q ss_pred hcccccccccccccccc-cCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccc--cccch-Hhhh
Q 005749 540 VALAKADGYKAPELQRM-KKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETT--MEVFD-MEIM 615 (679)
Q Consensus 540 ~~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~--~~~~~-~~i~ 615 (679)
....||..|+|||++.+ ..++.++||||+|+++|||++|+.||.+....+.. ..+......... ...+. ....
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 236 (311)
T 4agu_A 160 DDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQL---YLIRKTLGDLIPRHQQVFSTNQYF 236 (311)
T ss_dssp ------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCSCCHHHHHHHHTCGGG
T ss_pred CCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHhccccccccccccccccc
Confidence 34578999999999875 56899999999999999999999999654322111 111111000000 00000 0000
Q ss_pred hcCC-------CCh----HHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 616 KGIR-------SPM----EEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 616 ~~~~-------~~~----~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
.+.. ... +.....+.+++.+||+.||++|||++|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 237 SGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp TTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred ccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0000 000 1223457789999999999999999999875
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=350.68 Aligned_cols=261 Identities=15% Similarity=0.218 Sum_probs=194.3
Q ss_pred cCccccCCceEEEEEEeC----CCCEEEEEEcccCccc-----------CcccHHHHHHHHhccCCCCCccceEEeeCC-
Q 005749 382 GQVIEKTTYGTAYKAKLA----DGATIALRLLREGSCK-----------DRSSCLPVIRQLGKVRHENLIPLRAFYQGK- 445 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~----~~~~vAvK~~~~~~~~-----------~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~- 445 (679)
.+.||+|+||.||+|+.. ++..||+|++...... ..+.+.+|+..+..++||||+++++++...
T Consensus 42 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~~~~~ 121 (345)
T 2v62_A 42 GKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEF 121 (345)
T ss_dssp EEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEEEEES
T ss_pred EeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeeccccccc
Confidence 478999999999999964 6789999998754321 223467888899999999999999998752
Q ss_pred --CCceEEEEEecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCC--ceE
Q 005749 446 --RGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFF--VSR 521 (679)
Q Consensus 446 --~~~~~lv~ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~--~~k 521 (679)
....++||||+ +++|.+++... ..+++..++.|+.||+.||+|||+++ |+||||||+|||++.++ .+|
T Consensus 122 ~~~~~~~lv~e~~-~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~k 193 (345)
T 2v62_A 122 KGRSYRFMVMERL-GIDLQKISGQN----GTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVY 193 (345)
T ss_dssp SSCEEEEEEEECE-EEEHHHHCBGG----GBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSSTTSEE
T ss_pred CCCcEEEEEEecc-CCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCCCCcEE
Confidence 46789999999 99999999864 26899999999999999999999988 99999999999999887 999
Q ss_pred EeecccccccCccccc------chhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhH
Q 005749 522 LTEFGLDQLMVPAVAD------EMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPS 595 (679)
Q Consensus 522 l~DFGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~ 595 (679)
|+|||+++.+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+..... ... .
T Consensus 194 L~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~-~~~-~ 271 (345)
T 2v62_A 194 LADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP-VAV-Q 271 (345)
T ss_dssp ECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH-HHH-H
T ss_pred EEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc-HHH-H
Confidence 9999999876433211 1244578999999999998899999999999999999999999995322211 111 1
Q ss_pred HHHHHhhcccccccchHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCC
Q 005749 596 IVKVAVLEETTMEVFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRP 659 (679)
Q Consensus 596 ~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 659 (679)
........ .+...+... .+......++.+++.+||+.||++||++++|++.|++...
T Consensus 272 ~~~~~~~~-----~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 272 TAKTNLLD-----ELPQSVLKW--APSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp HHHHHHHH-----TTTHHHHHH--SCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred HHHHhhcc-----cccHHHHhh--ccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 11111000 001111100 0000223467789999999999999999999999998754
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=353.51 Aligned_cols=261 Identities=17% Similarity=0.141 Sum_probs=200.1
Q ss_pred cCccccCCceEEEEEEeC---------CCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCcc---------------
Q 005749 382 GQVIEKTTYGTAYKAKLA---------DGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIP--------------- 437 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~---------~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~--------------- 437 (679)
.+.||+|+||.||+|+.. +++.||+|.+... +.+.+|++++++++|||||+
T Consensus 47 ~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~~ 121 (352)
T 2jii_A 47 KSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPT 121 (352)
T ss_dssp EEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCCC
T ss_pred EEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCccCccc
Confidence 378999999999999965 3889999998753 57899999999999999988
Q ss_pred ceEEeeCCCCceEEEEEecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCC
Q 005749 438 LRAFYQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDF 517 (679)
Q Consensus 438 l~~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~ 517 (679)
+++++....+..++||||+ +++|.+++.... ...+++..++.|+.||+.||+|||+++ |+||||||+|||++.+
T Consensus 122 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIl~~~~ 195 (352)
T 2jii_A 122 CMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP--KHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPE 195 (352)
T ss_dssp CCEEEEETTTEEEEEEECC-CEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGEEEETT
T ss_pred hhhccccCCcEEEEEecCC-CcCHHHHHHhCC--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEEcCC
Confidence 5666665467889999999 999999998642 245999999999999999999999988 9999999999999999
Q ss_pred C--ceEEeecccccccCccccc------chhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCc
Q 005749 518 F--VSRLTEFGLDQLMVPAVAD------EMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGE 589 (679)
Q Consensus 518 ~--~~kl~DFGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~ 589 (679)
+ .+||+|||+++.+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 196 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 275 (352)
T 2jii_A 196 DQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNT 275 (352)
T ss_dssp EEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred CCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcCH
Confidence 8 9999999999876543211 1133478999999999998899999999999999999999999995433211
Q ss_pred ccchhHHHHHHhhcccccccchHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCCCCC
Q 005749 590 FVDLPSIVKVAVLEETTMEVFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRPRNR 662 (679)
Q Consensus 590 ~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 662 (679)
..+......... ......+.. ........++.+++.+||+.||++|||++|+++.|+++.....
T Consensus 276 -~~~~~~~~~~~~--~~~~~~~~~------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 339 (352)
T 2jii_A 276 -EDIMKQKQKFVD--KPGPFVGPC------GHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLR 339 (352)
T ss_dssp -HHHHHHHHHHHH--SCCCEECTT------SCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred -HHHHHHHHhccC--Chhhhhhhc------cccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcC
Confidence 111111111100 000000000 0000113567789999999999999999999999999875443
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=335.85 Aligned_cols=246 Identities=17% Similarity=0.269 Sum_probs=198.8
Q ss_pred cCccccCCceEEEEEEeC-CCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeC---------------C
Q 005749 382 GQVIEKTTYGTAYKAKLA-DGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQG---------------K 445 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~---------------~ 445 (679)
.+.||+|+||.||+|+.. +++.||+|+++.. .+.+.+|++++++++||||+++++++.. .
T Consensus 16 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 91 (284)
T 2a19_B 16 IELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN----NEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSK 91 (284)
T ss_dssp EEEEECSSSCCEEEEEETTTCCEEEEEEEECC----SGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CCE
T ss_pred eeeeccCCceEEEEEEEcCCCeEEEEEEeccc----cHHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccccccC
Confidence 478999999999999964 7999999998753 3578899999999999999999998753 1
Q ss_pred CCceEEEEEecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeec
Q 005749 446 RGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEF 525 (679)
Q Consensus 446 ~~~~~lv~ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 525 (679)
....++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+++ |+||||||+||++++++.+||+||
T Consensus 92 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Df 166 (284)
T 2a19_B 92 TKCLFIQMEFCDKGTLEQWIEKRR--GEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDF 166 (284)
T ss_dssp EEEEEEEECCCCSCBHHHHHHHGG--GSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCC
T ss_pred cceEEEEEeccCCCCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCCEEECcc
Confidence 245799999999999999997643 245899999999999999999999988 999999999999999999999999
Q ss_pred ccccccCcccccchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhccc
Q 005749 526 GLDQLMVPAVADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEET 605 (679)
Q Consensus 526 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~ 605 (679)
|+++...... ......|++.|+|||.+.+..++.++||||||+++|||++|..|+.. ....... .
T Consensus 167 g~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~--------~~~~~~~-~---- 231 (284)
T 2a19_B 167 GLVTSLKNDG--KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE--------TSKFFTD-L---- 231 (284)
T ss_dssp TTCEESSCCS--CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH--------HHHHHHH-H----
T ss_pred hhheeccccc--cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh--------HHHHHHH-h----
Confidence 9998764332 22345689999999999988999999999999999999999988621 1111110 0
Q ss_pred ccccchHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCCCCC
Q 005749 606 TMEVFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRPRNR 662 (679)
Q Consensus 606 ~~~~~~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 662 (679)
..+.. .......+.+++.+||+.||++|||+.|+++.|+.+....+
T Consensus 232 ---------~~~~~--~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~ 277 (284)
T 2a19_B 232 ---------RDGII--SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE 277 (284)
T ss_dssp ---------HTTCC--CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred ---------hcccc--cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence 11100 01112446689999999999999999999999999876544
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=342.77 Aligned_cols=261 Identities=20% Similarity=0.247 Sum_probs=194.9
Q ss_pred CccccCCceEEEEEE-eCCCCEEEEEEcccCcc-----cCcccHHHHHHHHhccC---CCCCccceEEeeCCCC----ce
Q 005749 383 QVIEKTTYGTAYKAK-LADGATIALRLLREGSC-----KDRSSCLPVIRQLGKVR---HENLIPLRAFYQGKRG----EK 449 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~-----~~~~~~~~Ei~~l~~l~---H~nIv~l~~~~~~~~~----~~ 449 (679)
+.||+|+||+||+|+ ..+++.||||+++.... .....+.+|++++++++ ||||+++++++..... ..
T Consensus 15 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~~~~~ 94 (308)
T 3g33_A 15 AEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKV 94 (308)
T ss_dssp EEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSSEEEE
T ss_pred EEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCCceeE
Confidence 789999999999999 46799999999864321 22346788888887775 9999999999876332 47
Q ss_pred EEEEEecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeeccccc
Q 005749 450 LLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQ 529 (679)
Q Consensus 450 ~lv~ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 529 (679)
++||||+. |+|.+++.... ...+++..++.|+.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 95 ~lv~e~~~-~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 168 (308)
T 3g33_A 95 TLVFEHVD-QDLRTYLDKAP--PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLAR 168 (308)
T ss_dssp EEEEECCC-CBHHHHHHTCC--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEECSCSCTT
T ss_pred EEEehhhh-cCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEEeeCcccc
Confidence 99999997 59999998643 234899999999999999999999998 9999999999999999999999999998
Q ss_pred ccCcccccchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHh--hccccc
Q 005749 530 LMVPAVADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAV--LEETTM 607 (679)
Q Consensus 530 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~--~~~~~~ 607 (679)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+ .+........ ....+.
T Consensus 169 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~i~~~~~~~~~~~~~ 244 (308)
T 3g33_A 169 IYSYQ--MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD--QLGKIFDLIGLPPEDDWP 244 (308)
T ss_dssp TSTTC--CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHH--HHHHHHHHHCCCCTTTSC
T ss_pred ccCCC--cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCChhhcc
Confidence 76432 22345678999999999998999999999999999999999999995533211 1111111110 000000
Q ss_pred ccc---hHhhhhcCCCCh----HHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 608 EVF---DMEIMKGIRSPM----EEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 608 ~~~---~~~i~~~~~~~~----~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
... ............ ++....+.+++.+||+.||++|||+.|++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 245 RDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp SSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred chhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 000 000000000000 1123567789999999999999999999864
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=350.25 Aligned_cols=246 Identities=17% Similarity=0.234 Sum_probs=193.7
Q ss_pred cCccccCCceEEEEEEe-CCCCEEEEEEcccCcccCcccHHHHHHHHhcc-CCCCCccceEEeeCCCCceEEEEEecCCC
Q 005749 382 GQVIEKTTYGTAYKAKL-ADGATIALRLLREGSCKDRSSCLPVIRQLGKV-RHENLIPLRAFYQGKRGEKLLIYDYFPSR 459 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~~lv~ey~~~g 459 (679)
.+.||+|+||.||+|+. .+|+.||||+++... ....+|++++.++ +|||||++++++.+ .+..++||||+++|
T Consensus 27 ~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~----~~~~~E~~~l~~~~~hp~iv~~~~~~~~-~~~~~lv~E~~~gg 101 (342)
T 2qr7_A 27 KEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK----RDPTEEIEILLRYGQHPNIITLKDVYDD-GKYVYVVTELMKGG 101 (342)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEETTT----CCCHHHHHHHHHHTTSTTBCCEEEEEEC-SSEEEEEECCCCSC
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEccc----CChHHHHHHHHHhcCCCCcCeEEEEEEc-CCEEEEEEeCCCCC
Confidence 47899999999999995 468999999997642 3457899999888 79999999999987 68899999999999
Q ss_pred ChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCC----CceEEeecccccccCccc
Q 005749 460 TLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDF----FVSRLTEFGLDQLMVPAV 535 (679)
Q Consensus 460 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~----~~~kl~DFGla~~~~~~~ 535 (679)
+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||+.++ +.+||+|||+++......
T Consensus 102 ~L~~~i~~~----~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~ 174 (342)
T 2qr7_A 102 ELLDKILRQ----KFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN 174 (342)
T ss_dssp BHHHHHHTC----TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTT
T ss_pred cHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCC
Confidence 999999763 45899999999999999999999998 9999999999998543 359999999998764332
Q ss_pred ccchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhh
Q 005749 536 ADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIM 615 (679)
Q Consensus 536 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~ 615 (679)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||......... +.......... . ..
T Consensus 175 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~---~~~~~i~~~~~-~------~~ 243 (342)
T 2qr7_A 175 -GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPE---EILARIGSGKF-S------LS 243 (342)
T ss_dssp -CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHH---HHHHHHHHCCC-C------CC
T ss_pred -CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHH---HHHHHHccCCc-c------cC
Confidence 2234567899999999998888999999999999999999999999643222111 11111110000 0 00
Q ss_pred hcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 616 KGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 616 ~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
. ........++.+++.+||..||++||++.|++++
T Consensus 244 ~---~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 244 G---GYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp S---TTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred c---cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0 0011223567789999999999999999999875
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=369.41 Aligned_cols=247 Identities=21% Similarity=0.248 Sum_probs=199.9
Q ss_pred CccccCCceEEEEEEe-CCCCEEEEEEcccCc---ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCC
Q 005749 383 QVIEKTTYGTAYKAKL-ADGATIALRLLREGS---CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPS 458 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~ 458 (679)
++||+|+||.||+|+. .+|+.||+|++.... ......+.+|+++|++++|||||++++++.+ .+..++||||+++
T Consensus 190 ~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~-~~~l~lVmEy~~g 268 (576)
T 2acx_A 190 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET-KDALCLVLTLMNG 268 (576)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEEEECCCCS
T ss_pred EEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEee-CCEEEEEEEcCCC
Confidence 6899999999999995 579999999996532 2344568899999999999999999999987 6789999999999
Q ss_pred CChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccc
Q 005749 459 RTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADE 538 (679)
Q Consensus 459 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 538 (679)
|+|.+++.... ...+++..++.|+.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...... .
T Consensus 269 g~L~~~l~~~~--~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~--~ 341 (576)
T 2acx_A 269 GDLKFHIYHMG--QAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ--T 341 (576)
T ss_dssp CBHHHHHHSSS--SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCTTC--C
T ss_pred CcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceecccCc--c
Confidence 99999997642 234899999999999999999999988 9999999999999999999999999998764332 2
Q ss_pred hhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcC
Q 005749 539 MVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGI 618 (679)
Q Consensus 539 ~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~ 618 (679)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+..... ........ +....
T Consensus 342 ~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~--~~~~i~~~--------------i~~~~ 405 (576)
T 2acx_A 342 IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI--KREEVERL--------------VKEVP 405 (576)
T ss_dssp EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCC--CHHHHHHH--------------HHHCC
T ss_pred ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccch--hHHHHHHH--------------hhccc
Confidence 234589999999999998889999999999999999999999996543221 11111111 11111
Q ss_pred CCChHHHHHHHHHHHHhccCcCCCCCC-----CHHHHHHH
Q 005749 619 RSPMEEGLVQALKLAMGCCAPVASVRP-----TMDEVVKQ 653 (679)
Q Consensus 619 ~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~evl~~ 653 (679)
........+++.+++.+||+.||++|| +++||+++
T Consensus 406 ~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 406 EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred ccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 111122235677899999999999999 78888764
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=350.37 Aligned_cols=255 Identities=20% Similarity=0.322 Sum_probs=201.5
Q ss_pred cCccccCCceEEEEEEeC-CC-----CEEEEEEcccCcc-cCcccHHHHHHHHhcc-CCCCCccceEEeeCCCCceEEEE
Q 005749 382 GQVIEKTTYGTAYKAKLA-DG-----ATIALRLLREGSC-KDRSSCLPVIRQLGKV-RHENLIPLRAFYQGKRGEKLLIY 453 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~-~~-----~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~~lv~ 453 (679)
.+.||+|+||.||+|+.. ++ ..||+|.++.... ...+.+.+|+++++++ +||||+++++++.+ .+..++||
T Consensus 51 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-~~~~~lv~ 129 (333)
T 2i1m_A 51 GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH-GGPVLVIT 129 (333)
T ss_dssp EEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSSCEEEE
T ss_pred eeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec-CCceEEEE
Confidence 478999999999999953 23 4799999976532 3356789999999999 89999999999987 67899999
Q ss_pred EecCCCChHHHhhcccC----------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEe
Q 005749 454 DYFPSRTLHDLLHDTIA----------GKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLT 523 (679)
Q Consensus 454 ey~~~gsL~~~l~~~~~----------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~ 523 (679)
||+++|+|.+++..... ....+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+
T Consensus 130 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~ 206 (333)
T 2i1m_A 130 EYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIG 206 (333)
T ss_dssp ECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEEGGGEEEBC
T ss_pred ecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEECCCCeEEEC
Confidence 99999999999975421 1235899999999999999999999988 9999999999999999999999
Q ss_pred ecccccccCccccc-chhcccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHHh
Q 005749 524 EFGLDQLMVPAVAD-EMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAV 601 (679)
Q Consensus 524 DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~~ 601 (679)
|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||++ |..||.+..... .......
T Consensus 207 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--~~~~~~~--- 281 (333)
T 2i1m_A 207 DFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS--KFYKLVK--- 281 (333)
T ss_dssp CCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH--HHHHHHH---
T ss_pred ccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH--HHHHHHh---
Confidence 99999865433221 1223456788999999988899999999999999999998 899985433221 1111111
Q ss_pred hcccccccchHhhhhcCCC-ChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCC
Q 005749 602 LEETTMEVFDMEIMKGIRS-PMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRP 659 (679)
Q Consensus 602 ~~~~~~~~~~~~i~~~~~~-~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 659 (679)
.+... ........+.+++.+||+.||++|||+.|+++.|+++..
T Consensus 282 --------------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~ 326 (333)
T 2i1m_A 282 --------------DGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ 326 (333)
T ss_dssp --------------HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --------------cCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHH
Confidence 11100 011123467789999999999999999999999998753
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=341.00 Aligned_cols=247 Identities=18% Similarity=0.275 Sum_probs=195.6
Q ss_pred CccccCCceEEEEEEe---CCCCEEEEEEcccCccc--CcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecC
Q 005749 383 QVIEKTTYGTAYKAKL---ADGATIALRLLREGSCK--DRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFP 457 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~---~~~~~vAvK~~~~~~~~--~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~ 457 (679)
+.||+|+||.||+|+. .+++.||||+++..... ..+.+.+|++++++++||||+++++++. .+..++||||++
T Consensus 23 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~lv~e~~~ 100 (291)
T 1xbb_A 23 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE--AESWMLVMEMAE 100 (291)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE--SSSEEEEEECCT
T ss_pred CccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEC--CCCcEEEEEeCC
Confidence 3899999999999963 34678999999765322 2467899999999999999999999995 467899999999
Q ss_pred CCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCccccc
Q 005749 458 SRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVAD 537 (679)
Q Consensus 458 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 537 (679)
+++|.+++... ..+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++........
T Consensus 101 ~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 173 (291)
T 1xbb_A 101 LGPLNKYLQQN----RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 173 (291)
T ss_dssp TEEHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE
T ss_pred CCCHHHHHHhC----cCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCc
Confidence 99999999863 45899999999999999999999988 999999999999999999999999999876433221
Q ss_pred --chhcccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHHhhcccccccchHhh
Q 005749 538 --EMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEI 614 (679)
Q Consensus 538 --~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i 614 (679)
......+++.|+|||.+.+..++.++||||||+++|||++ |+.||.+.... .+ ... +
T Consensus 174 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~---~~~--------------~ 233 (291)
T 1xbb_A 174 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---EV---TAM--------------L 233 (291)
T ss_dssp EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HH---HHH--------------H
T ss_pred ccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH---HH---HHH--------------H
Confidence 1223346788999999988889999999999999999999 99999543221 11 110 0
Q ss_pred hhcCC-CChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhC
Q 005749 615 MKGIR-SPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENR 658 (679)
Q Consensus 615 ~~~~~-~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 658 (679)
..+.. .........+.+++.+||+.||++||++.|+++.|+++.
T Consensus 234 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 278 (291)
T 1xbb_A 234 EKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 278 (291)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred HcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11111 111122356778999999999999999999999999874
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-40 Score=338.31 Aligned_cols=249 Identities=18% Similarity=0.243 Sum_probs=200.0
Q ss_pred cCccccCCceEEEEEEe-CCCCEEEEEEcccCc---ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecC
Q 005749 382 GQVIEKTTYGTAYKAKL-ADGATIALRLLREGS---CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFP 457 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~ 457 (679)
.+.||+|+||.||+|+. .+++.||+|++.... ....+.+.+|++++++++||||+++++++.+ .+..++||||++
T Consensus 19 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~ 97 (284)
T 2vgo_A 19 GRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHD-RKRIYLMLEFAP 97 (284)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-SSEEEEEECCCT
T ss_pred eheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEc-CCEEEEEEEeCC
Confidence 47899999999999995 468899999986532 2234578999999999999999999999987 678999999999
Q ss_pred CCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCccccc
Q 005749 458 SRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVAD 537 (679)
Q Consensus 458 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 537 (679)
+|+|.+++... ..+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++......
T Consensus 98 ~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~--- 167 (284)
T 2vgo_A 98 RGELYKELQKH----GRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSL--- 167 (284)
T ss_dssp TEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSSS---
T ss_pred CCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCccc---
Confidence 99999999764 35899999999999999999999988 999999999999999999999999998765322
Q ss_pred chhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhc
Q 005749 538 EMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKG 617 (679)
Q Consensus 538 ~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~ 617 (679)
......|++.|+|||++.+..++.++||||||+++|||++|+.||...... ..... +...
T Consensus 168 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~--------------~~~~ 227 (284)
T 2vgo_A 168 RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT------ETHRR--------------IVNV 227 (284)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHH--------------HHTT
T ss_pred ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHh------HHHHH--------------Hhcc
Confidence 123457899999999999888999999999999999999999999543211 11110 0111
Q ss_pred CCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH--HHhhCCCC
Q 005749 618 IRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ--LEENRPRN 661 (679)
Q Consensus 618 ~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~--L~~~~~~~ 661 (679)
.....+.....+.+++.+||+.||++||+++|+++. ++....+.
T Consensus 228 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~~~~ 273 (284)
T 2vgo_A 228 DLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSRRV 273 (284)
T ss_dssp CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHCCCC
T ss_pred ccCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhcccc
Confidence 111111223466789999999999999999999974 45444333
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=340.08 Aligned_cols=248 Identities=21% Similarity=0.313 Sum_probs=194.5
Q ss_pred CccccCCceEEEEEE-eCCCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCCh
Q 005749 383 QVIEKTTYGTAYKAK-LADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRTL 461 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gsL 461 (679)
.+||+|+||.||+|+ ..+++.||||.+........+.+.+|++++++++||||+++++++.. .+..++||||+++++|
T Consensus 28 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~L 106 (295)
T 2clq_A 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSE-NGFIKIFMEQVPGGSL 106 (295)
T ss_dssp CEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEE-TTEEEEEEECCSEEEH
T ss_pred EEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEe-CCcEEEEEEeCCCCCH
Confidence 589999999999999 46789999999987655556789999999999999999999999987 6789999999999999
Q ss_pred HHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecC-CCceEEeecccccccCcccccchh
Q 005749 462 HDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDD-FFVSRLTEFGLDQLMVPAVADEMV 540 (679)
Q Consensus 462 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~-~~~~kl~DFGla~~~~~~~~~~~~ 540 (679)
.+++..... ...+++..+..++.|++.||+|||+++ |+||||||+||+++. ++.+||+|||+++...... ....
T Consensus 107 ~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~-~~~~ 181 (295)
T 2clq_A 107 SALLRSKWG-PLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN-PCTE 181 (295)
T ss_dssp HHHHHHTTC-CCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC------C
T ss_pred HHHHHhhcc-CCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCC-Cccc
Confidence 999976422 345779999999999999999999988 999999999999997 8999999999998764321 1223
Q ss_pred cccccccccccccccccC--CCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcC
Q 005749 541 ALAKADGYKAPELQRMKK--CSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGI 618 (679)
Q Consensus 541 ~~~gt~~y~aPE~~~~~~--~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~ 618 (679)
...|++.|+|||++.+.. ++.++||||||+++|||++|+.||....... ....... .....
T Consensus 182 ~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~~~~~~-------------~~~~~ 244 (295)
T 2clq_A 182 TFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQ----AAMFKVG-------------MFKVH 244 (295)
T ss_dssp CCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHH----HHHHHHH-------------HHCCC
T ss_pred ccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchh----HHHHhhc-------------ccccc
Confidence 457899999999987643 8899999999999999999999984321110 0000000 00000
Q ss_pred CCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 619 RSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 619 ~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
.........++.+++.+||+.||++||+++|+++.
T Consensus 245 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 245 PEIPESMSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp CCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred ccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 01111223567789999999999999999999864
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-40 Score=349.89 Aligned_cols=191 Identities=18% Similarity=0.285 Sum_probs=166.9
Q ss_pred CccccCCceEEEEEEe-CCCCEEEEEEcccCcccCcccHHHHHHHHhccC-----CCCCccceEEeeCCCCceEEEEEec
Q 005749 383 QVIEKTTYGTAYKAKL-ADGATIALRLLREGSCKDRSSCLPVIRQLGKVR-----HENLIPLRAFYQGKRGEKLLIYDYF 456 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~-----H~nIv~l~~~~~~~~~~~~lv~ey~ 456 (679)
+.||+|+||+||+|+. .+++.||||+++... ...+.+..|++++++++ |||||++++++.. .+..++||||+
T Consensus 41 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~-~~~~~lv~e~~ 118 (360)
T 3llt_A 41 RKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK-KYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMY-YDHMCLIFEPL 118 (360)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEECSCH-HHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEE-TTEEEEEECCC
T ss_pred EEEcccCCeEEEEEEECCCCeEEEEEEeccch-hhhhhhHHHHHHHHHhcccCCCCCCeecccceeeE-CCeeEEEEcCC
Confidence 7899999999999995 578999999997532 23456788999999986 9999999999987 67899999999
Q ss_pred CCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecC--------------------
Q 005749 457 PSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDD-------------------- 516 (679)
Q Consensus 457 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~-------------------- 516 (679)
+++|.+++.... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.
T Consensus 119 -~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~ 192 (360)
T 3llt_A 119 -GPSLYEIITRNN--YNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQ 192 (360)
T ss_dssp -CCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEE
T ss_pred -CCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccccccccccchhccccccccc
Confidence 889999998643 235899999999999999999999988 999999999999975
Q ss_pred -----CCceEEeecccccccCcccccchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 005749 517 -----FFVSRLTEFGLDQLMVPAVADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSG 585 (679)
Q Consensus 517 -----~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~ 585 (679)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 193 ~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 262 (360)
T 3llt_A 193 IYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTH 262 (360)
T ss_dssp EEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCC
Confidence 789999999999865322 23457899999999999999999999999999999999999999653
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-40 Score=344.65 Aligned_cols=263 Identities=19% Similarity=0.295 Sum_probs=202.8
Q ss_pred cCccccCCceEEEEEEe-----CCCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCC-CCceEEEEEe
Q 005749 382 GQVIEKTTYGTAYKAKL-----ADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGK-RGEKLLIYDY 455 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~-----~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~-~~~~~lv~ey 455 (679)
.+.||+|+||.||+|++ .+++.||||++........+.+.+|++++++++||||+++++++... ....++||||
T Consensus 46 ~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~ 125 (326)
T 2w1i_A 46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEY 125 (326)
T ss_dssp EEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEEECC
T ss_pred eeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEEEEC
Confidence 47899999999999984 46889999999876555566899999999999999999999998763 2368999999
Q ss_pred cCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCccc
Q 005749 456 FPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAV 535 (679)
Q Consensus 456 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 535 (679)
+++++|.+++... ...+++..++.++.|+++||+|||+++ |+||||||+||+++.++.+||+|||+++......
T Consensus 126 ~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~ 199 (326)
T 2w1i_A 126 LPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 199 (326)
T ss_dssp CTTCBHHHHHHHS---TTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECCSSC
T ss_pred CCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhhccccc
Confidence 9999999999864 345899999999999999999999988 9999999999999999999999999998764332
Q ss_pred cc--chhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccc----c
Q 005749 536 AD--EMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTME----V 609 (679)
Q Consensus 536 ~~--~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~----~ 609 (679)
.. ......++..|+|||.+.+..++.++||||||+++|||++|..|+.... ..+.... ......+ .
T Consensus 200 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~-------~~~~~~~-~~~~~~~~~~~~ 271 (326)
T 2w1i_A 200 EYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPP-------AEFMRMI-GNDKQGQMIVFH 271 (326)
T ss_dssp SEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHH-------HHHHHHH-CTTCCTHHHHHH
T ss_pred cccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCH-------HHHHHhh-ccccchhhhHHH
Confidence 21 1223456778999999988889999999999999999999999873210 0000000 0000000 0
Q ss_pred chHhhhhcCC-CChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhC
Q 005749 610 FDMEIMKGIR-SPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENR 658 (679)
Q Consensus 610 ~~~~i~~~~~-~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 658 (679)
+...+..+.+ +.......++.+++.+||+.||++|||+.|+++.|+++.
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~ 321 (326)
T 2w1i_A 272 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 321 (326)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 0011111111 112223456788999999999999999999999999875
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=349.17 Aligned_cols=246 Identities=15% Similarity=0.170 Sum_probs=188.8
Q ss_pred cCccccCCceEEEEEEeCCCCEEEEEEcccCcc--cCcccHHHHHHHHhccCC--CCCccceEEeeCCCCceEEEEEecC
Q 005749 382 GQVIEKTTYGTAYKAKLADGATIALRLLREGSC--KDRSSCLPVIRQLGKVRH--ENLIPLRAFYQGKRGEKLLIYDYFP 457 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~~~~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~H--~nIv~l~~~~~~~~~~~~lv~ey~~ 457 (679)
.+.||+|+||.||+|+..+++.||||++..... ...+.+.+|++++.+++| |||+++++++.+ .+..++||| +.
T Consensus 14 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~-~~~~~lv~e-~~ 91 (343)
T 3dbq_A 14 LKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT-DQYIYMVME-CG 91 (343)
T ss_dssp EEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-SSEEEEEEC-CC
T ss_pred EEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEee-CCEEEEEEe-CC
Confidence 378999999999999988899999999875432 234678999999999986 999999999987 678999999 45
Q ss_pred CCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCccccc
Q 005749 458 SRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVAD 537 (679)
Q Consensus 458 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 537 (679)
+|+|.+++... ..+++..++.|+.|++.||+|||+++ |+||||||+|||++ ++.+||+|||+++........
T Consensus 92 ~~~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~ 163 (343)
T 3dbq_A 92 NIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS 163 (343)
T ss_dssp SEEHHHHHHHS----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC------
T ss_pred CCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCccccc
Confidence 78999999863 45899999999999999999999988 99999999999997 578999999999876443222
Q ss_pred -chhcccccccccccccccc-----------cCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhccc
Q 005749 538 -EMVALAKADGYKAPELQRM-----------KKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEET 605 (679)
Q Consensus 538 -~~~~~~gt~~y~aPE~~~~-----------~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~ 605 (679)
......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ...........
T Consensus 164 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~~~~~~~~~~-- 236 (343)
T 3dbq_A 164 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QISKLHAIIDP-- 236 (343)
T ss_dssp ------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS-----HHHHHHHHHCT--
T ss_pred ccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh-----HHHHHHHHhcC--
Confidence 2235579999999999864 6789999999999999999999999954221 11111111100
Q ss_pred ccccchHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 005749 606 TMEVFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQL 654 (679)
Q Consensus 606 ~~~~~~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L 654 (679)
.... ........++.+++.+||+.||++|||+.|+++..
T Consensus 237 -------~~~~---~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp 275 (343)
T 3dbq_A 237 -------NHEI---EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 275 (343)
T ss_dssp -------TSCC---CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred -------Cccc---CCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCc
Confidence 0000 00011124567899999999999999999998763
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=343.80 Aligned_cols=260 Identities=23% Similarity=0.284 Sum_probs=200.2
Q ss_pred cCccccCCceEEEEEEeCCCCEEEEEEcccCcccCcccHHHHHHHHhc--cCCCCCccceEEeeCCC---CceEEEEEec
Q 005749 382 GQVIEKTTYGTAYKAKLADGATIALRLLREGSCKDRSSCLPVIRQLGK--VRHENLIPLRAFYQGKR---GEKLLIYDYF 456 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~--l~H~nIv~l~~~~~~~~---~~~~lv~ey~ 456 (679)
.+.||+|+||.||+|+. +|+.||||++... ..+.+.+|++++.. ++||||+++++++.... ...++||||+
T Consensus 47 ~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~ 122 (342)
T 1b6c_B 47 QESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYH 122 (342)
T ss_dssp EEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEECCC
T ss_pred EeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEEeec
Confidence 47899999999999998 5899999998653 34567889998887 79999999999998743 2789999999
Q ss_pred CCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHh--------cCCCCCeeecCCCCCCeeecCCCceEEeecccc
Q 005749 457 PSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLH--------TGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLD 528 (679)
Q Consensus 457 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH--------~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 528 (679)
++|+|.+++.. ..+++..++.++.|++.||+||| +.+ |+||||||+|||++.++.+||+|||++
T Consensus 123 ~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~ 194 (342)
T 1b6c_B 123 EHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGTCCIADLGLA 194 (342)
T ss_dssp TTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred CCCcHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCCCCEEEEECCCc
Confidence 99999999975 24899999999999999999999 666 999999999999999999999999999
Q ss_pred cccCccccc---chhccccccccccccccccc------CCCCcchhHHHHHHHHHHHhC----------CCCCCCCCCCc
Q 005749 529 QLMVPAVAD---EMVALAKADGYKAPELQRMK------KCSSRTDVYAFGILLLEILIG----------KKPGKSGRNGE 589 (679)
Q Consensus 529 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~k~DV~S~Gvvl~El~tg----------~~p~~~~~~~~ 589 (679)
+........ ......||+.|+|||++.+. .++.++|||||||++|||++| +.||......+
T Consensus 195 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~ 274 (342)
T 1b6c_B 195 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 274 (342)
T ss_dssp EEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS
T ss_pred eeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCc
Confidence 865433211 22345789999999998765 234689999999999999999 67775433221
Q ss_pred ccchhHHHHHHhhcccccccchHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCCCC
Q 005749 590 FVDLPSIVKVAVLEETTMEVFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRPRN 661 (679)
Q Consensus 590 ~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 661 (679)
.....+....... .....+... ....+....+.+++.+||+.||++|||+.||++.|+++....
T Consensus 275 -~~~~~~~~~~~~~-~~~~~~~~~------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~ 338 (342)
T 1b6c_B 275 -PSVEEMRKVVCEQ-KLRPNIPNR------WQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 338 (342)
T ss_dssp -CCHHHHHHHHTTS-CCCCCCCGG------GGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred -ccHHHHHHHHHHH-HhCCCCccc------ccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHh
Confidence 1112222211111 000000000 012245567889999999999999999999999999986544
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=361.79 Aligned_cols=238 Identities=15% Similarity=0.148 Sum_probs=183.8
Q ss_pred cCccccCCceEEEEEE-eCCCCEEEEEEcccCc---ccCcccHHHHH---HHHhccCCCCCccce-------EEeeCCCC
Q 005749 382 GQVIEKTTYGTAYKAK-LADGATIALRLLREGS---CKDRSSCLPVI---RQLGKVRHENLIPLR-------AFYQGKRG 447 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~---~~~~~~~~~Ei---~~l~~l~H~nIv~l~-------~~~~~~~~ 447 (679)
.+.||+|+||.||+|+ ..+|+.||||++.... ....+.+.+|+ +++++++|||||+++ +++.+.+.
T Consensus 78 ~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 157 (377)
T 3byv_A 78 GTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQK 157 (377)
T ss_dssp EEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTS
T ss_pred cceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccCC
Confidence 3789999999999999 4679999999997532 23346788999 555666899999998 66654211
Q ss_pred ----------------ceEEEEEecCCCChHHHhhcccC---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCC
Q 005749 448 ----------------EKLLIYDYFPSRTLHDLLHDTIA---GKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVR 508 (679)
Q Consensus 448 ----------------~~~lv~ey~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlk 508 (679)
..++||||+ +|+|.+++..... ....+++..++.|+.||+.||+|||+++ |+|||||
T Consensus 158 ~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDik 233 (377)
T 3byv_A 158 KKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLR 233 (377)
T ss_dssp CSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---EECSCCC
T ss_pred ccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCC
Confidence 378999999 6799999986421 1123456888999999999999999998 9999999
Q ss_pred CCCeeecCCCceEEeecccccccCcccccchhccccccccccccccccc-----------CCCCcchhHHHHHHHHHHHh
Q 005749 509 SKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKADGYKAPELQRMK-----------KCSSRTDVYAFGILLLEILI 577 (679)
Q Consensus 509 p~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~k~DV~S~Gvvl~El~t 577 (679)
|+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||++|||++
T Consensus 234 p~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~ellt 308 (377)
T 3byv_A 234 PVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWC 308 (377)
T ss_dssp GGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHH
T ss_pred HHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHH
Confidence 9999999999999999999986422 2234567 899999999877 89999999999999999999
Q ss_pred CCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHH
Q 005749 578 GKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVK 652 (679)
Q Consensus 578 g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 652 (679)
|+.||.+....+... .+.... . ...+++.+++.+||+.||++|||+.|+++
T Consensus 309 g~~Pf~~~~~~~~~~--------------------~~~~~~-~---~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 309 ADLPITKDAALGGSE--------------------WIFRSC-K---NIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp SSCCC------CCSG--------------------GGGSSC-C---CCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred CCCCCcccccccchh--------------------hhhhhc-c---CCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 999995433221110 011110 1 11246778999999999999999999986
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=332.81 Aligned_cols=251 Identities=18% Similarity=0.297 Sum_probs=197.0
Q ss_pred cCccccCCceEEEEEEeC-CCCEEEEEEcccCccc------CcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEE
Q 005749 382 GQVIEKTTYGTAYKAKLA-DGATIALRLLREGSCK------DRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYD 454 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~------~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~e 454 (679)
.+.||+|+||.||+|+.. +++.||+|.++..... ..+.+.+|++++++++||||+++++++.+ .+..++|||
T Consensus 10 ~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e 88 (283)
T 3bhy_A 10 GEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFEN-KTDVVLILE 88 (283)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEEEEE
T ss_pred HHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecC-CCeEEEEEe
Confidence 478999999999999964 6999999998754321 24578999999999999999999999987 678999999
Q ss_pred ecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCC----ceEEeecccccc
Q 005749 455 YFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFF----VSRLTEFGLDQL 530 (679)
Q Consensus 455 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~----~~kl~DFGla~~ 530 (679)
|+++++|.+++... ..+++..++.++.|++.||+|||+++ |+||||||+||+++.++ .+||+|||+++.
T Consensus 89 ~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~ 161 (283)
T 3bhy_A 89 LVSGGELFDFLAEK----ESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK 161 (283)
T ss_dssp CCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred ecCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEeccccee
Confidence 99999999999763 45899999999999999999999988 99999999999999877 899999999987
Q ss_pred cCcccccchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccc
Q 005749 531 MVPAVADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVF 610 (679)
Q Consensus 531 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 610 (679)
..... ......|++.|+|||++.+..++.++||||||+++|||++|+.||.+.... ....... .. ...+
T Consensus 162 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~-~~--~~~~ 230 (283)
T 3bhy_A 162 IEAGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ------ETLTNIS-AV--NYDF 230 (283)
T ss_dssp CC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHH-TT--CCCC
T ss_pred ccCCC--cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH------HHHHHhH-hc--ccCC
Confidence 64322 223456899999999999889999999999999999999999999543211 1111000 00 0000
Q ss_pred hHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH--HHhhC
Q 005749 611 DMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ--LEENR 658 (679)
Q Consensus 611 ~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~--L~~~~ 658 (679)
..... ......+.+++.+||+.||++|||+.|+++. ++++.
T Consensus 231 ~~~~~-------~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 273 (283)
T 3bhy_A 231 DEEYF-------SNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIR 273 (283)
T ss_dssp CHHHH-------TTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred cchhc-------ccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHH
Confidence 11111 1113457789999999999999999999984 45543
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=348.87 Aligned_cols=247 Identities=12% Similarity=0.163 Sum_probs=196.6
Q ss_pred CccccCCceEEEEEE------eCCCCEEEEEEcccCcccCcccHHHHHHHHhccC---CCCCccceEEeeCCCCceEEEE
Q 005749 383 QVIEKTTYGTAYKAK------LADGATIALRLLREGSCKDRSSCLPVIRQLGKVR---HENLIPLRAFYQGKRGEKLLIY 453 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~------~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~---H~nIv~l~~~~~~~~~~~~lv~ 453 (679)
+.||+|+||+||+|+ ..+++.||||+++.. ...++.+|++++.+++ |+||+++++++.. .+..++||
T Consensus 71 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~-~~~~~lv~ 146 (365)
T 3e7e_A 71 HLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLF-QNGSVLVG 146 (365)
T ss_dssp EEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC-SSCEEEEE
T ss_pred EEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeec-CCCcEEEE
Confidence 689999999999993 556899999999764 3456788888888886 9999999999987 67899999
Q ss_pred EecCCCChHHHhhcccC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecC-----------CCceE
Q 005749 454 DYFPSRTLHDLLHDTIA-GKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDD-----------FFVSR 521 (679)
Q Consensus 454 ey~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~-----------~~~~k 521 (679)
|||++|+|.+++..... ....+++..++.|+.||++||+|||+++ |+||||||+|||++. ++.+|
T Consensus 147 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~~~~~~~~k 223 (365)
T 3e7e_A 147 ELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDEDDLSAGLA 223 (365)
T ss_dssp CCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC------CTTEE
T ss_pred eccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCccccccccCCEE
Confidence 99999999999975332 2456999999999999999999999988 999999999999998 89999
Q ss_pred EeecccccccCcc-cccchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHH
Q 005749 522 LTEFGLDQLMVPA-VADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVA 600 (679)
Q Consensus 522 l~DFGla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~ 600 (679)
|+|||+|+.+... .........||+.|+|||++.+..++.++|||||||++|||++|+.||.........
T Consensus 224 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~--------- 294 (365)
T 3e7e_A 224 LIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK--------- 294 (365)
T ss_dssp ECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE---------
T ss_pred EeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCcee---------
Confidence 9999999765321 122334567999999999999999999999999999999999999998433221100
Q ss_pred hhcccccccchHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCC-CCHHHHHHHHHhhCCC
Q 005749 601 VLEETTMEVFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVR-PTMDEVVKQLEENRPR 660 (679)
Q Consensus 601 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~R-Ps~~evl~~L~~~~~~ 660 (679)
.... ... .+. .....+++..|++.+|.+| |+++++.+.|++....
T Consensus 295 -----~~~~-----~~~--~~~---~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~ 340 (365)
T 3e7e_A 295 -----PEGL-----FRR--LPH---LDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ 340 (365)
T ss_dssp -----ECSC-----CTT--CSS---HHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred -----echh-----ccc--cCc---HHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence 0000 011 112 2344468888999999998 6788888888877543
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=360.00 Aligned_cols=189 Identities=19% Similarity=0.292 Sum_probs=148.9
Q ss_pred cCccccCCceEEEEEE-eCCCCEEEEEEcccCcc--cCcccHHHHHHHHhccCCCCCccceEEeeCC----CCceEEEEE
Q 005749 382 GQVIEKTTYGTAYKAK-LADGATIALRLLREGSC--KDRSSCLPVIRQLGKVRHENLIPLRAFYQGK----RGEKLLIYD 454 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~----~~~~~lv~e 454 (679)
.++||+|+||+||+|+ ..+++.||||++..... ...+.+.+|+++|++++|||||++++++... ....|+|||
T Consensus 58 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e 137 (458)
T 3rp9_A 58 RHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLE 137 (458)
T ss_dssp CCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEEC
T ss_pred eeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEEEEe
Confidence 4789999999999999 45799999999865422 2345788999999999999999999998542 256899999
Q ss_pred ecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcc
Q 005749 455 YFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPA 534 (679)
Q Consensus 455 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 534 (679)
|+. |+|.+++.. ...+++..++.|+.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 138 ~~~-~~L~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 209 (458)
T 3rp9_A 138 IAD-SDFKKLFRT----PVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYP 209 (458)
T ss_dssp CCS-EEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBCTTSC
T ss_pred ccc-cchhhhccc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccchhccCc
Confidence 985 699999976 345999999999999999999999988 999999999999999999999999999876422
Q ss_pred cc--------------------------cchhcccccccccccccc-cccCCCCcchhHHHHHHHHHHHhC
Q 005749 535 VA--------------------------DEMVALAKADGYKAPELQ-RMKKCSSRTDVYAFGILLLEILIG 578 (679)
Q Consensus 535 ~~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~k~DV~S~Gvvl~El~tg 578 (679)
.. ......+||+.|+|||++ ....++.++|||||||++|||++|
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 210 ENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp TTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred cccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 11 123456789999999976 456799999999999999999993
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-40 Score=339.73 Aligned_cols=244 Identities=18% Similarity=0.263 Sum_probs=197.8
Q ss_pred cCccccCCceEEEEEEeC-CCCEEEEEEcccCcc---cCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecC
Q 005749 382 GQVIEKTTYGTAYKAKLA-DGATIALRLLREGSC---KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFP 457 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~---~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~ 457 (679)
.+.||+|+||.||+|+.. +++.||+|++..... ...+.+.+|++++++++||||+++++++.+ .+..++||||++
T Consensus 20 ~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~ 98 (294)
T 2rku_A 20 GRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED-NDFVFVVLELCR 98 (294)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC-SSEEEEEEECCT
T ss_pred EEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeecc-CCEEEEEEecCC
Confidence 478999999999999954 588999999865422 234578899999999999999999999987 678999999999
Q ss_pred CCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCccccc
Q 005749 458 SRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVAD 537 (679)
Q Consensus 458 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 537 (679)
+++|.+++... ..+++..++.++.|+++||+|||+++ |+||||||+||+++.++.+||+|||+++...... .
T Consensus 99 ~~~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~-~ 170 (294)
T 2rku_A 99 RRSLLELHKRR----KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG-E 170 (294)
T ss_dssp TCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCSTT-C
T ss_pred CCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceecccCc-c
Confidence 99999998763 45899999999999999999999988 9999999999999999999999999998754321 2
Q ss_pred chhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhc
Q 005749 538 EMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKG 617 (679)
Q Consensus 538 ~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~ 617 (679)
......|++.|+|||.+.+..++.++||||||+++|||++|+.||...... +..... ...
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~--------------~~~ 230 (294)
T 2rku_A 171 RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK------ETYLRI--------------KKN 230 (294)
T ss_dssp CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHH--------------HTT
T ss_pred ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHH--------------hhc
Confidence 223457899999999999888999999999999999999999999543211 111100 011
Q ss_pred CCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 005749 618 IRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQL 654 (679)
Q Consensus 618 ~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L 654 (679)
...........+.+++.+||+.||++|||++|+++.-
T Consensus 231 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~ 267 (294)
T 2rku_A 231 EYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDE 267 (294)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred cCCCccccCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence 0011112234567899999999999999999999853
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=346.73 Aligned_cols=248 Identities=18% Similarity=0.280 Sum_probs=194.4
Q ss_pred cCccccCCceEEEEEEe-CCCCEEEEEEcccCcc--cCcccHHHHHHHHhccC-CCCCccceEEeeCCCCceEEEEEecC
Q 005749 382 GQVIEKTTYGTAYKAKL-ADGATIALRLLREGSC--KDRSSCLPVIRQLGKVR-HENLIPLRAFYQGKRGEKLLIYDYFP 457 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~-H~nIv~l~~~~~~~~~~~~lv~ey~~ 457 (679)
++.||+|+||.||+|+. .+++.||+|+++.... .....+.+|+.++.+++ ||||+++++++.+ .+..++||||++
T Consensus 34 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~-~~~~~lv~e~~~ 112 (327)
T 3lm5_A 34 SKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYEN-TSEIILILEYAA 112 (327)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-SSEEEEEEECCT
T ss_pred cceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEe-CCeEEEEEEecC
Confidence 47899999999999995 4699999999876432 33567899999999994 6999999999987 678999999999
Q ss_pred CCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecC---CCceEEeecccccccCcc
Q 005749 458 SRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDD---FFVSRLTEFGLDQLMVPA 534 (679)
Q Consensus 458 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~---~~~~kl~DFGla~~~~~~ 534 (679)
+|+|.+++.... ...+++..++.++.|++.||+|||+++ |+||||||+||+++. ++.+||+|||+++.....
T Consensus 113 ~~~L~~~~~~~~--~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~ 187 (327)
T 3lm5_A 113 GGEIFSLCLPEL--AEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA 187 (327)
T ss_dssp TEEGGGGGSSCC---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEECCGGGCEEC---
T ss_pred CCcHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEEeeCccccccCCc
Confidence 999999986532 346899999999999999999999988 999999999999997 789999999999876432
Q ss_pred cccchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhh
Q 005749 535 VADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEI 614 (679)
Q Consensus 535 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i 614 (679)
.......||+.|+|||++.+..++.++||||||+++|||++|+.||......+ ....... .. .. .
T Consensus 188 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------~~~~i~~-~~-~~-~---- 252 (327)
T 3lm5_A 188 --CELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQE------TYLNISQ-VN-VD-Y---- 252 (327)
T ss_dssp --------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHH-TC-CC-C----
T ss_pred --cccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH------HHHHHHh-cc-cc-c----
Confidence 22334579999999999999999999999999999999999999995432211 0000000 00 00 0
Q ss_pred hhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 615 MKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 615 ~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
...........+.+++.+||+.||++|||++|+++.
T Consensus 253 ---~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 253 ---SEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp ---CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred ---CchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 001111223567789999999999999999999876
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-40 Score=353.30 Aligned_cols=245 Identities=16% Similarity=0.175 Sum_probs=189.5
Q ss_pred cCccccCCceEEEEEEeCCCCEEEEEEcccCcc--cCcccHHHHHHHHhccC--CCCCccceEEeeCCCCceEEEEEecC
Q 005749 382 GQVIEKTTYGTAYKAKLADGATIALRLLREGSC--KDRSSCLPVIRQLGKVR--HENLIPLRAFYQGKRGEKLLIYDYFP 457 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~~~~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~--H~nIv~l~~~~~~~~~~~~lv~ey~~ 457 (679)
.+.||+|+||.||+|+..+++.||||++..... ...+.+.+|++++.+++ |||||++++++.. .+..++||| +.
T Consensus 61 ~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~-~~~~~lv~E-~~ 138 (390)
T 2zmd_A 61 LKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT-DQYIYMVME-CG 138 (390)
T ss_dssp EEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-SSEEEEEEE-CC
T ss_pred EEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEec-CCEEEEEEe-cC
Confidence 378999999999999988899999999875432 23467899999999996 5999999999987 678999999 56
Q ss_pred CCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCccccc
Q 005749 458 SRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVAD 537 (679)
Q Consensus 458 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 537 (679)
+++|.+++... ..+++..++.|+.||+.||+|||+++ |+||||||+|||++ ++.+||+|||+++.+......
T Consensus 139 ~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~ 210 (390)
T 2zmd_A 139 NIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS 210 (390)
T ss_dssp SEEHHHHHHHC----SSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC------
T ss_pred CCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccCCCcc
Confidence 78999999863 45899999999999999999999988 99999999999996 589999999999876433221
Q ss_pred -chhcccccccccccccccc-----------cCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhccc
Q 005749 538 -EMVALAKADGYKAPELQRM-----------KKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEET 605 (679)
Q Consensus 538 -~~~~~~gt~~y~aPE~~~~-----------~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~ 605 (679)
......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ...........
T Consensus 211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~-----~~~~~~~~~~~-- 283 (390)
T 2zmd_A 211 VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QISKLHAIIDP-- 283 (390)
T ss_dssp ---CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC-----HHHHHHHHHCT--
T ss_pred ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH-----HHHHHHHHhCc--
Confidence 2235579999999998864 4689999999999999999999999954321 11111111100
Q ss_pred ccccchHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 606 TMEVFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 606 ~~~~~~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
.... ........++.+++.+||+.||++|||+.|+++.
T Consensus 284 -------~~~~---~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 284 -------NHEI---EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp -------TSCC---CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred -------cccC---CCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 0000 0000112456789999999999999999999875
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-40 Score=340.49 Aligned_cols=245 Identities=20% Similarity=0.289 Sum_probs=195.3
Q ss_pred cCccccCCceEEEEEEe-CCCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCC
Q 005749 382 GQVIEKTTYGTAYKAKL-ADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRT 460 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gs 460 (679)
.+.||+|+||.||+|+. .+|+.||+|.++.......+.+.+|++++++++||||+++++++.+ .+..++||||+++++
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~ 92 (304)
T 2jam_A 14 MEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYES-TTHYYLVMQLVSGGE 92 (304)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEEEECCCCSCB
T ss_pred eeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhccc-CCEEEEEEEcCCCcc
Confidence 47899999999999995 4799999999986554455678999999999999999999999987 678999999999999
Q ss_pred hHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee---cCCCceEEeecccccccCccccc
Q 005749 461 LHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLV---DDFFVSRLTEFGLDQLMVPAVAD 537 (679)
Q Consensus 461 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl---~~~~~~kl~DFGla~~~~~~~~~ 537 (679)
|.+++... ..+++..++.++.|++.||+|||+++ |+||||||+||++ ++++.+||+|||+++.....
T Consensus 93 L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~--- 162 (304)
T 2jam_A 93 LFDRILER----GVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG--- 162 (304)
T ss_dssp HHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB---
T ss_pred HHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC---
Confidence 99998763 35899999999999999999999988 9999999999999 78899999999999865322
Q ss_pred chhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhc
Q 005749 538 EMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKG 617 (679)
Q Consensus 538 ~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~ 617 (679)
......|++.|+|||.+.+..++.++||||+|+++|||++|+.||...... ........ .. .. +.
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~i~~-~~-~~-~~------ 227 (304)
T 2jam_A 163 IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES------KLFEKIKE-GY-YE-FE------ 227 (304)
T ss_dssp TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHH-CC-CC-CC------
T ss_pred ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHHc-CC-CC-CC------
Confidence 223446899999999999889999999999999999999999999543211 11111100 00 00 00
Q ss_pred CCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 618 IRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 618 ~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
.+........+.+++.+||+.||++|||++|+++.
T Consensus 228 -~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 228 -SPFWDDISESAKDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp -TTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred -ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 00111223567789999999999999999999874
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=346.73 Aligned_cols=243 Identities=18% Similarity=0.265 Sum_probs=197.6
Q ss_pred cCccccCCceEEEEEEe-CCCCEEEEEEcccCcc---cCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecC
Q 005749 382 GQVIEKTTYGTAYKAKL-ADGATIALRLLREGSC---KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFP 457 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~---~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~ 457 (679)
.+.||+|+||.||+|+. .+++.||+|++..... ...+.+.+|++++++++||||+++++++.+ .+..++||||++
T Consensus 46 ~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~ 124 (335)
T 2owb_A 46 GRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED-NDFVFVVLELCR 124 (335)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC-SSEEEEEECCCT
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-CCeEEEEEecCC
Confidence 47899999999999995 4588999999875422 234678899999999999999999999997 678999999999
Q ss_pred CCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCccccc
Q 005749 458 SRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVAD 537 (679)
Q Consensus 458 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 537 (679)
+++|.+++... ..+++.+++.++.|+++||+|||+++ |+||||||+||+++.++.+||+|||+++...... .
T Consensus 125 ~~~L~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~-~ 196 (335)
T 2owb_A 125 RRSLLELHKRR----KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG-E 196 (335)
T ss_dssp TCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCSTT-C
T ss_pred CCCHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecccCc-c
Confidence 99999998763 45899999999999999999999988 9999999999999999999999999998764321 2
Q ss_pred chhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhc
Q 005749 538 EMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKG 617 (679)
Q Consensus 538 ~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~ 617 (679)
......|+..|+|||++.+..++.++||||||+++|||++|+.||...... +..... ...
T Consensus 197 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~~--------------~~~ 256 (335)
T 2owb_A 197 RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK------ETYLRI--------------KKN 256 (335)
T ss_dssp CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHH--------------HHT
T ss_pred cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHH------HHHHHH--------------hcC
Confidence 223457899999999999888999999999999999999999999543211 111100 011
Q ss_pred CCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 618 IRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 618 ~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
...........+.+++.+||+.||++|||++|+++.
T Consensus 257 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 257 EYSIPKHINPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 001111123456789999999999999999999975
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=341.79 Aligned_cols=254 Identities=16% Similarity=0.211 Sum_probs=198.0
Q ss_pred CccccCCceEEEEEEe-CCCCEEEEEEcccCcc--cCcccHHHHHHHHhccCCCCCccceEEeeC-CCCceEEEEEecCC
Q 005749 383 QVIEKTTYGTAYKAKL-ADGATIALRLLREGSC--KDRSSCLPVIRQLGKVRHENLIPLRAFYQG-KRGEKLLIYDYFPS 458 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~-~~~~~~lv~ey~~~ 458 (679)
+.||+|+||.||+|+. .+++.||+|.+..... ...+.+.+|++++++++||||+++++++.+ ..+..++||||+++
T Consensus 12 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~ 91 (279)
T 2w5a_A 12 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEG 91 (279)
T ss_dssp EEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEECCTT
T ss_pred hhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeCCCC
Confidence 7899999999999995 4799999999975432 334678999999999999999999998753 24678999999999
Q ss_pred CChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCC--CCCeeecCCCCCCeeecCCCceEEeecccccccCcccc
Q 005749 459 RTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGH--EIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVA 536 (679)
Q Consensus 459 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~--~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 536 (679)
++|.+++.........+++..++.++.|++.||+|||+.+ ..+|+||||||+||+++.++.+||+|||+++......
T Consensus 92 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~~~~~- 170 (279)
T 2w5a_A 92 GDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT- 170 (279)
T ss_dssp EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHHHC---C-
T ss_pred CCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchheeecccc-
Confidence 9999999865443456999999999999999999999865 2349999999999999999999999999998764321
Q ss_pred cchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhh
Q 005749 537 DEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMK 616 (679)
Q Consensus 537 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~ 616 (679)
.......|+..|+|||.+.+..++.++||||||+++|||++|+.||..... ..+ ... +..
T Consensus 171 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~---~~~--------------i~~ 230 (279)
T 2w5a_A 171 SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ---KEL---AGK--------------IRE 230 (279)
T ss_dssp HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHH---HHH--------------HHH
T ss_pred ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH---HHH---HHH--------------Hhh
Confidence 122345689999999999988899999999999999999999999954321 111 111 111
Q ss_pred cCC-CChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhh
Q 005749 617 GIR-SPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEEN 657 (679)
Q Consensus 617 ~~~-~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 657 (679)
+.. ........++.+++.+||+.||++||+++|+++.+...
T Consensus 231 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~ 272 (279)
T 2w5a_A 231 GKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLIL 272 (279)
T ss_dssp TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCC
T ss_pred cccccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhh
Confidence 111 11112235677899999999999999999999876543
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=333.55 Aligned_cols=247 Identities=19% Similarity=0.255 Sum_probs=197.2
Q ss_pred cCccccCCceEEEEEEe-CCCCEEEEEEcccCcc-cCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCC
Q 005749 382 GQVIEKTTYGTAYKAKL-ADGATIALRLLREGSC-KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSR 459 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~g 459 (679)
.+.||+|+||.||+|+. .+++.||||++..... ...+.+.+|++++++++||||+++++++.+ .+..++||||++++
T Consensus 12 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~ 90 (276)
T 2yex_A 12 VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE-GNIQYLFLEYCSGG 90 (276)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-TTEEEEEEECCTTE
T ss_pred EEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEc-CCEEEEEEEecCCC
Confidence 47899999999999995 4799999999875432 334678999999999999999999999987 67899999999999
Q ss_pred ChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccc-cc
Q 005749 460 TLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVA-DE 538 (679)
Q Consensus 460 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~-~~ 538 (679)
+|.+++.. ...+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++........ ..
T Consensus 91 ~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 163 (276)
T 2yex_A 91 ELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 163 (276)
T ss_dssp EGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred cHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhc
Confidence 99999875 345899999999999999999999988 99999999999999999999999999986533221 12
Q ss_pred hhcccccccccccccccccCC-CCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhc
Q 005749 539 MVALAKADGYKAPELQRMKKC-SSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKG 617 (679)
Q Consensus 539 ~~~~~gt~~y~aPE~~~~~~~-~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~ 617 (679)
.....|+..|+|||.+.+..+ +.++||||||+++|||++|+.||....... .....+.. .. .
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~----~~------------~ 226 (276)
T 2yex_A 164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWKE----KK------------T 226 (276)
T ss_dssp BCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTS-HHHHHHHT----TC------------T
T ss_pred ccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH-HHHHHhhh----cc------------c
Confidence 334578999999999987665 779999999999999999999996543221 11111110 00 0
Q ss_pred CCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 618 IRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 618 ~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
...........+.+++.+||+.||++|||++|+++.
T Consensus 227 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 227 YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 001111223566789999999999999999999763
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=335.59 Aligned_cols=245 Identities=19% Similarity=0.247 Sum_probs=196.2
Q ss_pred CccccCCceEEEEEEe-CCCCEEEEEEcccCcc--cCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCC
Q 005749 383 QVIEKTTYGTAYKAKL-ADGATIALRLLREGSC--KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSR 459 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~g 459 (679)
+.||+|+||.||+|+. .+++.||+|++..... ...+.+.+|++++++++||||+++++++.+ .+..++||||++++
T Consensus 12 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e~~~~~ 90 (284)
T 3kk8_A 12 EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE-ESFHYLVFDLVTGG 90 (284)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEEEECCCCSC
T ss_pred hhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEc-CCEEEEEEecCCCC
Confidence 6899999999999994 5689999999875432 234568899999999999999999999987 67889999999999
Q ss_pred ChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCc---eEEeecccccccCcccc
Q 005749 460 TLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFV---SRLTEFGLDQLMVPAVA 536 (679)
Q Consensus 460 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~---~kl~DFGla~~~~~~~~ 536 (679)
+|.+.+... ..+++..+..++.|++.||+|||+++ |+||||||+||+++.++. +||+|||++.......
T Consensus 91 ~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~- 162 (284)
T 3kk8_A 91 ELFEDIVAR----EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE- 162 (284)
T ss_dssp BHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSC-
T ss_pred CHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCc-
Confidence 999988764 45899999999999999999999988 999999999999986655 9999999997664322
Q ss_pred cchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhh
Q 005749 537 DEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMK 616 (679)
Q Consensus 537 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~ 616 (679)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||.+.... ........... ..
T Consensus 163 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~------~~~~~~~~~~~--~~------- 226 (284)
T 3kk8_A 163 -AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH------RLYAQIKAGAY--DY------- 226 (284)
T ss_dssp -BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHTCC--CC-------
T ss_pred -cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh------HHHHHHHhccc--cC-------
Confidence 223457899999999999989999999999999999999999999543211 11111000000 00
Q ss_pred cCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 617 GIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 617 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
..+......+++.+++.+||+.||++|||++|+++.
T Consensus 227 -~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 227 -PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp -CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred -CchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 000011223567789999999999999999999985
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=355.95 Aligned_cols=257 Identities=25% Similarity=0.301 Sum_probs=190.8
Q ss_pred cCccccCCceEEEEEEe-CCCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCC-----CCceEEEEEe
Q 005749 382 GQVIEKTTYGTAYKAKL-ADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGK-----RGEKLLIYDY 455 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~-----~~~~~lv~ey 455 (679)
.++||+|+||.||+|+. .+|+.||||++... ...+.+|+++|++++|||||+++++|... ....++||||
T Consensus 59 ~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~ 134 (420)
T 1j1b_A 59 TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD----KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDY 134 (420)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEECC----TTSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEEC
T ss_pred eeEEeeCCCEEEEEEEECCCCcEEEEEEeccc----chhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehhc
Confidence 37899999999999996 46999999998653 23345799999999999999999988542 1236799999
Q ss_pred cCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCC-CceEEeecccccccCcc
Q 005749 456 FPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDF-FVSRLTEFGLDQLMVPA 534 (679)
Q Consensus 456 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~-~~~kl~DFGla~~~~~~ 534 (679)
+++ ++.+.+.........+++..++.++.||++||+|||+++ |+||||||+|||++.+ +.+||+|||+++.+...
T Consensus 135 ~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~ 210 (420)
T 1j1b_A 135 VPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 210 (420)
T ss_dssp CCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred ccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhhhcccC
Confidence 986 777776643333567999999999999999999999988 9999999999999965 67899999999876432
Q ss_pred cccchhccccccccccccccccc-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhh---------cc
Q 005749 535 VADEMVALAKADGYKAPELQRMK-KCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVL---------EE 604 (679)
Q Consensus 535 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~---------~~ 604 (679)
. ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.... ..+..+++..-. ..
T Consensus 211 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~--~~l~~i~~~lg~p~~~~~~~~~~ 286 (420)
T 1j1b_A 211 E--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV--DQLVEIIKVLGTPTREQIREMNP 286 (420)
T ss_dssp C--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHHHCSCCHHHHHHHCS
T ss_pred C--CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCCHHHHHhhCh
Confidence 2 22345789999999998764 7999999999999999999999999654321 122222221100 00
Q ss_pred cccccchHhhhhcCCCCh-----HHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 605 TTMEVFDMEIMKGIRSPM-----EEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 605 ~~~~~~~~~i~~~~~~~~-----~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
...+...+.+. ..+. +...+++.+++.+||+.||++||++.|++++
T Consensus 287 ~~~~~~~p~~~---~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 287 NYTEFKFPQIK---AHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp CCCCCCCCCCC---CCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhhhccCccC---CCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 00000000000 0000 1123578899999999999999999999875
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=346.99 Aligned_cols=260 Identities=17% Similarity=0.234 Sum_probs=186.5
Q ss_pred cCccccCCceEEEEEE-eCCCCEEEEEEcccCcc--cCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCC
Q 005749 382 GQVIEKTTYGTAYKAK-LADGATIALRLLREGSC--KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPS 458 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~ 458 (679)
.+.||+|+||+||+|+ ..+++.||||+++.... ...+.+.+|++++++++|||||++++++.+ .+..++||||+++
T Consensus 39 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~ 117 (329)
T 3gbz_A 39 ITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHH-NHRLHLIFEYAEN 117 (329)
T ss_dssp EEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEE-TTEEEEEEECCSE
T ss_pred EEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEec-CCEEEEEEecCCC
Confidence 3789999999999999 55799999999975432 234578899999999999999999999987 6889999999985
Q ss_pred CChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee-----cCCCceEEeecccccccCc
Q 005749 459 RTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLV-----DDFFVSRLTEFGLDQLMVP 533 (679)
Q Consensus 459 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl-----~~~~~~kl~DFGla~~~~~ 533 (679)
+|.+++... ..+++..++.|+.|++.||+|||+++ |+||||||+|||+ ++++.+||+|||+++....
T Consensus 118 -~L~~~~~~~----~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~ 189 (329)
T 3gbz_A 118 -DLKKYMDKN----PDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGI 189 (329)
T ss_dssp -EHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC-
T ss_pred -CHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCCccccCC
Confidence 999999763 45899999999999999999999988 9999999999999 4556699999999986543
Q ss_pred ccccchhccccccccccccccccc-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHh-hcc-ccccc-
Q 005749 534 AVADEMVALAKADGYKAPELQRMK-KCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAV-LEE-TTMEV- 609 (679)
Q Consensus 534 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~-~~~-~~~~~- 609 (679)
. ........||..|+|||++.+. .++.++|||||||++|||++|+.||.+.... ..+........ ... .....
T Consensus 190 ~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 266 (329)
T 3gbz_A 190 P-IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEI--DQLFKIFEVLGLPDDTTWPGVT 266 (329)
T ss_dssp -----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHHHCCCCTTTSTTGG
T ss_pred c-ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHH--HHHHHHHHHhCCCchhhhhhhh
Confidence 2 2223445689999999998864 4899999999999999999999999553221 11111111100 000 00000
Q ss_pred ----chHhhhhcCCCChHH-----HHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 610 ----FDMEIMKGIRSPMEE-----GLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 610 ----~~~~i~~~~~~~~~~-----~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
+.............. ...++.+++.+||+.||++|||++|+++.
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 319 (329)
T 3gbz_A 267 ALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319 (329)
T ss_dssp GSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence 000000000001111 22567799999999999999999999863
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=351.36 Aligned_cols=259 Identities=19% Similarity=0.256 Sum_probs=191.6
Q ss_pred cCccccCCceEEEEEE-eCCCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCC---------------
Q 005749 382 GQVIEKTTYGTAYKAK-LADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGK--------------- 445 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~--------------- 445 (679)
.+.||+|+||+||+|+ ..+|+.||||++... .....+|+++++.++|||||++++++...
T Consensus 12 ~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~----~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~ 87 (383)
T 3eb0_A 12 GKTLGTGSFGIVCEVFDIESGKRFALKKVLQD----PRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHN 87 (383)
T ss_dssp EEEEECC-CEEEEEEEETTTCCEEEEEEEECC----TTSCCHHHHHHTTCCCTTBCCEEEEEEEC---------------
T ss_pred EEEEEeccCEEEEEEEECCCCCEEEEEEEecC----cchHHHHHHHHHHcCCCCccchhheeeecCcccccccccccccc
Confidence 3789999999999999 467999999998653 23345899999999999999999998542
Q ss_pred ----------------------CCceEEEEEecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCee
Q 005749 446 ----------------------RGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPIT 503 (679)
Q Consensus 446 ----------------------~~~~~lv~ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iv 503 (679)
....++||||++ |+|.+.+.........+++..++.++.|+++||+|||+++ |+
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---i~ 163 (383)
T 3eb0_A 88 KLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG---IC 163 (383)
T ss_dssp ----------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EE
T ss_pred cccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCc---Cc
Confidence 223789999998 5888888764433567999999999999999999999988 99
Q ss_pred ecCCCCCCeeec-CCCceEEeecccccccCcccccchhccccccccccccccccc-CCCCcchhHHHHHHHHHHHhCCCC
Q 005749 504 HGNVRSKNVLVD-DFFVSRLTEFGLDQLMVPAVADEMVALAKADGYKAPELQRMK-KCSSRTDVYAFGILLLEILIGKKP 581 (679)
Q Consensus 504 HrDlkp~NILl~-~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~S~Gvvl~El~tg~~p 581 (679)
||||||+|||++ .++.+||+|||+++...... ......+|+.|+|||++.+. .++.++||||+||++|||++|+.|
T Consensus 164 H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~p 241 (383)
T 3eb0_A 164 HRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE--PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPL 241 (383)
T ss_dssp CSCCCGGGEEEETTTTEEEECCCTTCEECCTTS--CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred cCccCHHHEEEcCCCCcEEEEECCCCcccCCCC--CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCC
Confidence 999999999998 68999999999998764332 23355789999999988764 489999999999999999999999
Q ss_pred CCCCCCCcccchhHHHHHHhhcccccccc--hHh-----hhhcCCCC-----hHHHHHHHHHHHHhccCcCCCCCCCHHH
Q 005749 582 GKSGRNGEFVDLPSIVKVAVLEETTMEVF--DME-----IMKGIRSP-----MEEGLVQALKLAMGCCAPVASVRPTMDE 649 (679)
Q Consensus 582 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~--~~~-----i~~~~~~~-----~~~~~~~~~~l~~~cl~~dP~~RPs~~e 649 (679)
|.+.... ..+...+...- ........ ++. ........ ......++.+++.+||+.||++|||+.|
T Consensus 242 f~~~~~~--~~~~~i~~~~g-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e 318 (383)
T 3eb0_A 242 FSGETSI--DQLVRIIQIMG-TPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYE 318 (383)
T ss_dssp SCCSSHH--HHHHHHHHHHC-CCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred CCCCChH--HHHHHHHHHhC-CCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHH
Confidence 9654321 11112211110 00000000 000 00000000 0112345789999999999999999999
Q ss_pred HHHH
Q 005749 650 VVKQ 653 (679)
Q Consensus 650 vl~~ 653 (679)
++++
T Consensus 319 ~l~h 322 (383)
T 3eb0_A 319 AMAH 322 (383)
T ss_dssp HHTS
T ss_pred HhcC
Confidence 9864
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=346.06 Aligned_cols=263 Identities=21% Similarity=0.301 Sum_probs=195.8
Q ss_pred cCccccCCceEEEEEEe-CCCCEEEEEEcccCcc--cCcccHHHHHHHHhccCCCCCccceEEeeCC-------CCceEE
Q 005749 382 GQVIEKTTYGTAYKAKL-ADGATIALRLLREGSC--KDRSSCLPVIRQLGKVRHENLIPLRAFYQGK-------RGEKLL 451 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~-------~~~~~l 451 (679)
.+.||+|+||.||+|+. .+|+.||||++..... .....+.+|++++++++||||+++++++... .+..++
T Consensus 22 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~l 101 (351)
T 3mi9_A 22 LAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYL 101 (351)
T ss_dssp EEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CEEEE
T ss_pred EEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCceEEE
Confidence 37899999999999995 6799999999865532 2345788999999999999999999998763 346899
Q ss_pred EEEecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeeccccccc
Q 005749 452 IYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLM 531 (679)
Q Consensus 452 v~ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 531 (679)
||||+++ +|.+.+... ...+++..++.|+.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.+
T Consensus 102 v~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 174 (351)
T 3mi9_A 102 VFDFCEH-DLAGLLSNV---LVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAF 174 (351)
T ss_dssp EEECCSE-EHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEeccCC-CHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccchhcccc
Confidence 9999985 788877654 345899999999999999999999988 999999999999999999999999999876
Q ss_pred Cccc---ccchhcccccccccccccccc-cCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHH--hhccc
Q 005749 532 VPAV---ADEMVALAKADGYKAPELQRM-KKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVA--VLEET 605 (679)
Q Consensus 532 ~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~--~~~~~ 605 (679)
.... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+....+. +....... .....
T Consensus 175 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~~i~~~~~~~~~~~ 252 (351)
T 3mi9_A 175 SLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQ--LALISQLCGSITPEV 252 (351)
T ss_dssp CCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCCCCTTT
T ss_pred cccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHHHhCCCChhh
Confidence 4221 122344578999999998875 4589999999999999999999999965332111 11111100 00000
Q ss_pred ccccchHhh------hhcCCCChHHH------HHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 606 TMEVFDMEI------MKGIRSPMEEG------LVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 606 ~~~~~~~~i------~~~~~~~~~~~------~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
....-.... ........... .+.+.+++.+||+.||++|||++|+++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 253 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp STTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 000000000 00111111222 2457789999999999999999999885
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-40 Score=344.73 Aligned_cols=255 Identities=19% Similarity=0.281 Sum_probs=196.9
Q ss_pred cCccccCCceEEEEEEe------CCCCEEEEEEcccCc-ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEE
Q 005749 382 GQVIEKTTYGTAYKAKL------ADGATIALRLLREGS-CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYD 454 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~------~~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~e 454 (679)
.+.||+|+||.||+|+. .+++.||||.+.... ......+.+|+.++++++||||+++++++.. .+..++|||
T Consensus 35 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e 113 (327)
T 2yfx_A 35 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ-SLPRFILME 113 (327)
T ss_dssp EEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSSCEEEEE
T ss_pred EEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC-CCCcEEEEe
Confidence 37899999999999984 347799999997542 2345578999999999999999999999987 678899999
Q ss_pred ecCCCChHHHhhcccCC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecC---CCceEEeecccc
Q 005749 455 YFPSRTLHDLLHDTIAG---KPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDD---FFVSRLTEFGLD 528 (679)
Q Consensus 455 y~~~gsL~~~l~~~~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~---~~~~kl~DFGla 528 (679)
|+++|+|.+++...... ...+++..++.++.|++.||+|||+++ |+||||||+|||++. +..+||+|||++
T Consensus 114 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~ 190 (327)
T 2yfx_A 114 LMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMA 190 (327)
T ss_dssp CCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECCCHHH
T ss_pred cCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEECccccc
Confidence 99999999999865321 245899999999999999999999988 999999999999984 456999999998
Q ss_pred cccCcccc-cchhcccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHHhhcccc
Q 005749 529 QLMVPAVA-DEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAVLEETT 606 (679)
Q Consensus 529 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 606 (679)
+....... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||...... ........
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~------~~~~~~~~---- 260 (327)
T 2yfx_A 191 RDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ------EVLEFVTS---- 260 (327)
T ss_dssp HHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH------HHHHHHHT----
T ss_pred cccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH------HHHHHHhc----
Confidence 75432211 12233467889999999988899999999999999999998 99998543211 11111100
Q ss_pred cccchHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCC
Q 005749 607 MEVFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRP 659 (679)
Q Consensus 607 ~~~~~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 659 (679)
.............+.+++.+||+.||++||++.|+++.|+.+..
T Consensus 261 ---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 304 (327)
T 2yfx_A 261 ---------GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304 (327)
T ss_dssp ---------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---------CCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence 00011112223567789999999999999999999999998754
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=348.28 Aligned_cols=256 Identities=23% Similarity=0.319 Sum_probs=188.8
Q ss_pred CccccCCceEEEEEEe-CCCCEEEEEEcccCcc--cCcccHHHHHHHHhccCCCCCccceEEeeCCC-----CceEEEEE
Q 005749 383 QVIEKTTYGTAYKAKL-ADGATIALRLLREGSC--KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKR-----GEKLLIYD 454 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~-----~~~~lv~e 454 (679)
+.||+|+||.||+|+. .+|+.||||++..... ...+.+.+|++++++++||||+++++++.... ...++|||
T Consensus 31 ~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~e 110 (367)
T 1cm8_A 31 QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMP 110 (367)
T ss_dssp EEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEE
T ss_pred EEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEEEEEe
Confidence 6899999999999995 6799999999965422 22456889999999999999999999987632 34699999
Q ss_pred ecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcc
Q 005749 455 YFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPA 534 (679)
Q Consensus 455 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 534 (679)
|+ +++|.+++.. ..+++..+..++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 111 ~~-~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 181 (367)
T 1cm8_A 111 FM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSE 181 (367)
T ss_dssp CC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCSS
T ss_pred cC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeecccccccc
Confidence 99 7899999975 34899999999999999999999988 999999999999999999999999999875322
Q ss_pred cccchhcccccccccccccccc-cCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhh--ccccccc--
Q 005749 535 VADEMVALAKADGYKAPELQRM-KKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVL--EETTMEV-- 609 (679)
Q Consensus 535 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~--~~~~~~~-- 609 (679)
.....+|+.|+|||++.+ ..++.++||||+||++|||++|+.||.+....+ .+......... .+....+
T Consensus 182 ----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~l~~i~~~~g~~~~~~~~~~~~ 255 (367)
T 1cm8_A 182 ----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD--QLKEIMKVTGTPPAEFVQRLQS 255 (367)
T ss_dssp ----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCCCCHHHHHTCSC
T ss_pred ----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhcCCCCHHHHHHhhh
Confidence 345578999999999876 679999999999999999999999996543211 11111111000 0000000
Q ss_pred -chHhhhhcC----C----CChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 610 -FDMEIMKGI----R----SPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 610 -~~~~i~~~~----~----~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
......... . ...+...+.+.+++.+||+.||++|||++|++++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 256 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp HHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 000000000 0 0011224567899999999999999999999985
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=353.06 Aligned_cols=275 Identities=20% Similarity=0.298 Sum_probs=187.6
Q ss_pred cHHHHHHhhcCccccCCceEEEEEEeC---CCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeC-CCCc
Q 005749 373 TLEDVLNATGQVIEKTTYGTAYKAKLA---DGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQG-KRGE 448 (679)
Q Consensus 373 ~~~~l~~~~~~~ig~G~~g~Vy~~~~~---~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~-~~~~ 448 (679)
.+++.....+++||+|+||+||+|+.. +++.||||++.... ..+.+.+|++++++++|||||++++++.. ....
T Consensus 17 ~~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 94 (405)
T 3rgf_A 17 RVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRK 94 (405)
T ss_dssp CHHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTE
T ss_pred hhhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCe
Confidence 455665556789999999999999965 57899999997532 34578899999999999999999999853 2567
Q ss_pred eEEEEEecCCCChHHHhhcccC-----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee----cCCCc
Q 005749 449 KLLIYDYFPSRTLHDLLHDTIA-----GKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLV----DDFFV 519 (679)
Q Consensus 449 ~~lv~ey~~~gsL~~~l~~~~~-----~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl----~~~~~ 519 (679)
.++||||+.+ +|.+++..... ....+++..++.|+.||+.||+|||+++ |+||||||+|||+ +.++.
T Consensus 95 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~ 170 (405)
T 3rgf_A 95 VWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGR 170 (405)
T ss_dssp EEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTC
T ss_pred EEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCc
Confidence 8999999975 88888764321 1234899999999999999999999988 9999999999999 77899
Q ss_pred eEEeecccccccCcccc--cchhcccccccccccccccc-cCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCc-------
Q 005749 520 SRLTEFGLDQLMVPAVA--DEMVALAKADGYKAPELQRM-KKCSSRTDVYAFGILLLEILIGKKPGKSGRNGE------- 589 (679)
Q Consensus 520 ~kl~DFGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~------- 589 (679)
+||+|||+++....... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.....
T Consensus 171 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~ 250 (405)
T 3rgf_A 171 VKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYH 250 (405)
T ss_dssp EEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCC
T ss_pred EEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccch
Confidence 99999999987643211 22345678999999999886 458999999999999999999999996543311
Q ss_pred ccchhHHHHHHh-hc-ccccccc---h-HhhhhcC-----C-CChHH--------HHHHHHHHHHhccCcCCCCCCCHHH
Q 005749 590 FVDLPSIVKVAV-LE-ETTMEVF---D-MEIMKGI-----R-SPMEE--------GLVQALKLAMGCCAPVASVRPTMDE 649 (679)
Q Consensus 590 ~~~l~~~~~~~~-~~-~~~~~~~---~-~~i~~~~-----~-~~~~~--------~~~~~~~l~~~cl~~dP~~RPs~~e 649 (679)
...+...+...- .. ..+.... + ....... . ..... ....+.+++.+||+.||++|||++|
T Consensus 251 ~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e 330 (405)
T 3rgf_A 251 HDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQ 330 (405)
T ss_dssp HHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHH
T ss_pred HHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHH
Confidence 011111111100 00 0000000 0 0000000 0 00000 0246778999999999999999999
Q ss_pred HHHH
Q 005749 650 VVKQ 653 (679)
Q Consensus 650 vl~~ 653 (679)
++++
T Consensus 331 ~L~h 334 (405)
T 3rgf_A 331 AMQD 334 (405)
T ss_dssp HHTS
T ss_pred HhcC
Confidence 9986
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=337.59 Aligned_cols=244 Identities=18% Similarity=0.276 Sum_probs=198.5
Q ss_pred cCccccCCceEEEEEEe-CCCCEEEEEEcccCc-ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCC
Q 005749 382 GQVIEKTTYGTAYKAKL-ADGATIALRLLREGS-CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSR 459 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~g 459 (679)
.+.||+|+||.||+|+. .+++.||+|++.... ....+.+.+|++++++++||||+++++++.+ .+..++||||++++
T Consensus 27 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~ 105 (303)
T 3a7i_A 27 LEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK-DTKLWIIMEYLGGG 105 (303)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEEEEECCTTE
T ss_pred hhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec-CCeEEEEEEeCCCC
Confidence 37899999999999984 579999999997653 3345779999999999999999999999987 67899999999999
Q ss_pred ChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccch
Q 005749 460 TLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEM 539 (679)
Q Consensus 460 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 539 (679)
+|.+++.. ..+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++....... ...
T Consensus 106 ~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~ 176 (303)
T 3a7i_A 106 SALDLLEP-----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-IKR 176 (303)
T ss_dssp EHHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTB-CCB
T ss_pred cHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCccc-ccc
Confidence 99999864 35899999999999999999999988 9999999999999999999999999998764332 122
Q ss_pred hcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcCC
Q 005749 540 VALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIR 619 (679)
Q Consensus 540 ~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~ 619 (679)
....|++.|+|||++.+..++.++||||||+++|||++|+.||...... ..... ..... ..
T Consensus 177 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~-~~~~~------------~~ 237 (303)
T 3a7i_A 177 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM------KVLFL-IPKNN------------PP 237 (303)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHH-HHHSC------------CC
T ss_pred CccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH------HHHHH-hhcCC------------CC
Confidence 3457899999999999889999999999999999999999998532211 11110 00000 00
Q ss_pred CChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 005749 620 SPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQL 654 (679)
Q Consensus 620 ~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L 654 (679)
.........+.+++.+||+.||++|||++|+++..
T Consensus 238 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~ 272 (303)
T 3a7i_A 238 TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHK 272 (303)
T ss_dssp CCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred CCccccCHHHHHHHHHHcCCChhhCcCHHHHhhCh
Confidence 00111234577899999999999999999999864
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=336.32 Aligned_cols=240 Identities=15% Similarity=0.234 Sum_probs=191.6
Q ss_pred cCccccCCceEEEEEEeC-CCCEEEEEEcccCcc--cCcccHHHHHHHHhcc-CCCCCccceEEeeCCCCceEEEEEecC
Q 005749 382 GQVIEKTTYGTAYKAKLA-DGATIALRLLREGSC--KDRSSCLPVIRQLGKV-RHENLIPLRAFYQGKRGEKLLIYDYFP 457 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~~lv~ey~~ 457 (679)
.+.||+|+||.||+|+.. +++.||+|+++.... .....+.+|+..+.++ +||||+++++++.+ .+..++||||++
T Consensus 16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~-~~~~~lv~e~~~ 94 (289)
T 1x8b_A 16 LEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAE-DDHMLIQNEYCN 94 (289)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEE-TTEEEEEEECCT
T ss_pred hhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeec-CCeEEEEEEecC
Confidence 478999999999999954 799999999876432 2345788999999999 99999999999987 678999999999
Q ss_pred CCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCC-------------------C
Q 005749 458 SRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDF-------------------F 518 (679)
Q Consensus 458 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~-------------------~ 518 (679)
+|+|.+++.........+++..++.|+.|++.||+|||+++ |+||||||+||+++.+ .
T Consensus 95 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~ 171 (289)
T 1x8b_A 95 GGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKV 171 (289)
T ss_dssp TCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC--------------------CC
T ss_pred CCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccccccccccCCce
Confidence 99999999865332356899999999999999999999988 9999999999999844 4
Q ss_pred ceEEeecccccccCcccccchhccccccccccccccccc-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHH
Q 005749 519 VSRLTEFGLDQLMVPAVADEMVALAKADGYKAPELQRMK-KCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIV 597 (679)
Q Consensus 519 ~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~ 597 (679)
.+||+|||.+...... ....||..|+|||.+.+. .+++++|||||||++|||++|.+|+.... .+.
T Consensus 172 ~~kl~Dfg~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~--------~~~ 238 (289)
T 1x8b_A 172 MFKIGDLGHVTRISSP-----QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD--------QWH 238 (289)
T ss_dssp CEEECCCTTCEETTCS-----CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH--------HHH
T ss_pred EEEEcccccccccCCc-----cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh--------HHH
Confidence 7999999999876432 233589999999998765 56789999999999999999998763210 010
Q ss_pred HHHhhcccccccchHhhhhcCCC-ChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 598 KVAVLEETTMEVFDMEIMKGIRS-PMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 598 ~~~~~~~~~~~~~~~~i~~~~~~-~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
. +..+..+ ........+.+++.+||+.||++|||+.|+++.
T Consensus 239 ~---------------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 239 E---------------IRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp H---------------HHTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred H---------------HHcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 0 0111111 111223567789999999999999999999864
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=374.82 Aligned_cols=242 Identities=18% Similarity=0.245 Sum_probs=198.1
Q ss_pred cCccccCCceEEEEEEe-CCCCEEEEEEcccC---cccCcccHHHHHHHHhcc-CCCCCccceEEeeCCCCceEEEEEec
Q 005749 382 GQVIEKTTYGTAYKAKL-ADGATIALRLLREG---SCKDRSSCLPVIRQLGKV-RHENLIPLRAFYQGKRGEKLLIYDYF 456 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~~lv~ey~ 456 (679)
.++||+|+||.||+|+. .+++.||||+++.. .....+.+..|.+++..+ +||||+++++++.+ .+..|+||||+
T Consensus 346 ~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~-~~~~~lV~E~~ 424 (674)
T 3pfq_A 346 LMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT-MDRLYFVMEYV 424 (674)
T ss_dssp EEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBC-SSEEEEEEECC
T ss_pred EEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEe-CCEEEEEEeCc
Confidence 36899999999999994 56889999999753 234456788999999988 79999999999987 67899999999
Q ss_pred CCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccc
Q 005749 457 PSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVA 536 (679)
Q Consensus 457 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 536 (679)
++|+|.+++... ..+++..++.|+.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..... .
T Consensus 425 ~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~-~ 496 (674)
T 3pfq_A 425 NGGDLMYHIQQV----GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD-G 496 (674)
T ss_dssp CSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEECCCT-T
T ss_pred CCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeeccccC-C
Confidence 999999999864 35899999999999999999999988 999999999999999999999999999864322 2
Q ss_pred cchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhh
Q 005749 537 DEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMK 616 (679)
Q Consensus 537 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~ 616 (679)
......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.... +... .+..
T Consensus 497 ~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~------~~~~--------------~i~~ 556 (674)
T 3pfq_A 497 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED------ELFQ--------------SIME 556 (674)
T ss_dssp CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHH--------------HHHS
T ss_pred cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHH------HHHH--------------HHHh
Confidence 2344568999999999999999999999999999999999999999543221 1111 1111
Q ss_pred cCCCChHHHHHHHHHHHHhccCcCCCCCCCH-----HHHHH
Q 005749 617 GIRSPMEEGLVQALKLAMGCCAPVASVRPTM-----DEVVK 652 (679)
Q Consensus 617 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~-----~evl~ 652 (679)
+..........++.+++.+||+.||++||++ +||++
T Consensus 557 ~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 557 HNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp SCCCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred CCCCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 1111122234567889999999999999997 66664
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=353.44 Aligned_cols=256 Identities=14% Similarity=0.187 Sum_probs=199.3
Q ss_pred cCccccCCceEEEEEE-eCCCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCC
Q 005749 382 GQVIEKTTYGTAYKAK-LADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRT 460 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gs 460 (679)
.+.||+|+||.||+|+ ..+++.||||++.... ..+++.+|++++..++|++++..+.++....+..++||||+ +++
T Consensus 12 ~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g~s 88 (483)
T 3sv0_A 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPS 88 (483)
T ss_dssp CCCCEECSSCEEEEEEETTTCCEEEEEEEETTC--SSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-CCB
T ss_pred EEEEeeCCCEEEEEEEECCCCcEEEEEEecccc--ccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-CCC
Confidence 4789999999999999 4679999999876543 34578999999999988665555554444467889999999 889
Q ss_pred hHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee---cCCCceEEeecccccccCccccc
Q 005749 461 LHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLV---DDFFVSRLTEFGLDQLMVPAVAD 537 (679)
Q Consensus 461 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl---~~~~~~kl~DFGla~~~~~~~~~ 537 (679)
|.+++... ...+++..++.|+.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||+++.+......
T Consensus 89 L~~ll~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (483)
T 3sv0_A 89 LEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (483)
T ss_dssp HHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTC
T ss_pred HHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceeccCCccc
Confidence 99999753 345999999999999999999999988 9999999999999 68899999999999876443221
Q ss_pred ------chhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccch
Q 005749 538 ------EMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFD 611 (679)
Q Consensus 538 ------~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 611 (679)
......||..|+|||++.+..++.++|||||||++|||++|+.||.+............+..... ....
T Consensus 163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~----~~~~- 237 (483)
T 3sv0_A 163 QHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV----ATSI- 237 (483)
T ss_dssp CBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHH----HSCH-
T ss_pred cccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccc----cccH-
Confidence 12256799999999999999999999999999999999999999966544322211111110000 0000
Q ss_pred HhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhC
Q 005749 612 MEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENR 658 (679)
Q Consensus 612 ~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 658 (679)
..+.. ....++.+++.+||+.||++||++++|++.|+++.
T Consensus 238 ~~l~~-------~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~ 277 (483)
T 3sv0_A 238 EALCR-------GYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLF 277 (483)
T ss_dssp HHHHT-------TSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred HHHhc-------CCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 01111 11256788999999999999999999999998873
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-39 Score=343.04 Aligned_cols=241 Identities=21% Similarity=0.357 Sum_probs=194.9
Q ss_pred CccccCCceEEEEEEeC-CCCEEEEEEcccCccc--------CcccHHHHHHHHhcc-CCCCCccceEEeeCCCCceEEE
Q 005749 383 QVIEKTTYGTAYKAKLA-DGATIALRLLREGSCK--------DRSSCLPVIRQLGKV-RHENLIPLRAFYQGKRGEKLLI 452 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~--------~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~~lv 452 (679)
+.||+|+||.||+|+.. +|+.||||+++..... ..+.+.+|++++.++ +||||+++++++.. .+..++|
T Consensus 100 ~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-~~~~~lv 178 (365)
T 2y7j_A 100 DVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYES-SSFMFLV 178 (365)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEB-SSEEEEE
T ss_pred eEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEee-CCEEEEE
Confidence 78999999999999964 7999999998764321 134678999999999 79999999999987 6889999
Q ss_pred EEecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccC
Q 005749 453 YDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMV 532 (679)
Q Consensus 453 ~ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 532 (679)
|||+++++|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+||++++++.+||+|||++..+.
T Consensus 179 ~e~~~g~~L~~~l~~~----~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~ 251 (365)
T 2y7j_A 179 FDLMRKGELFDYLTEK----VALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLE 251 (365)
T ss_dssp ECCCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEEecCcccccC
Confidence 9999999999999763 45899999999999999999999988 9999999999999999999999999998764
Q ss_pred cccccchhcccccccccccccccc------cCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccc
Q 005749 533 PAVADEMVALAKADGYKAPELQRM------KKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETT 606 (679)
Q Consensus 533 ~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 606 (679)
... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... .....
T Consensus 252 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~------~~~~~------- 316 (365)
T 2y7j_A 252 PGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI------LMLRM------- 316 (365)
T ss_dssp TTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHH-------
T ss_pred CCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH------HHHHH-------
Confidence 332 2345679999999998763 35889999999999999999999999543211 11110
Q ss_pred cccchHhhhhcCCCCh-H---HHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 607 MEVFDMEIMKGIRSPM-E---EGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 607 ~~~~~~~i~~~~~~~~-~---~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
+..+..... + .....+.+++.+||+.||++|||++|+++.
T Consensus 317 -------i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 317 -------IMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp -------HHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred -------HHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 011111111 1 113457789999999999999999999873
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=334.78 Aligned_cols=245 Identities=20% Similarity=0.310 Sum_probs=192.9
Q ss_pred CccccCCceEEEEEEe-CCCCEEEEEEcccCc--ccCcccHHHHHHHHhccCCCCCccceEEeeCC---CCceEEEEEec
Q 005749 383 QVIEKTTYGTAYKAKL-ADGATIALRLLREGS--CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGK---RGEKLLIYDYF 456 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~---~~~~~lv~ey~ 456 (679)
+.||+|+||.||+|+. .++..||+|.+.... ....+.+.+|++++++++||||+++++++... ....++||||+
T Consensus 32 ~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~ 111 (290)
T 1t4h_A 32 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELM 111 (290)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECC
T ss_pred eeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEEEec
Confidence 6799999999999994 568899999987543 23356789999999999999999999988642 35689999999
Q ss_pred CCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeec-CCCceEEeecccccccCccc
Q 005749 457 PSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVD-DFFVSRLTEFGLDQLMVPAV 535 (679)
Q Consensus 457 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~-~~~~~kl~DFGla~~~~~~~ 535 (679)
++|+|.+++... ..+++..++.++.|++.||+|||+.+ .+|+||||||+||+++ +++.+||+|||++......
T Consensus 112 ~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~- 185 (290)
T 1t4h_A 112 TSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS- 185 (290)
T ss_dssp CSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT-
T ss_pred CCCCHHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCccccccc-
Confidence 999999999763 45899999999999999999999875 3599999999999998 7899999999999765332
Q ss_pred ccchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhh
Q 005749 536 ADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIM 615 (679)
Q Consensus 536 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~ 615 (679)
......||+.|+|||++. +.++.++||||+|+++|||++|+.||...... ......... ..... ..
T Consensus 186 --~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-----~~~~~~~~~-~~~~~----~~- 251 (290)
T 1t4h_A 186 --FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNA-----AQIYRRVTS-GVKPA----SF- 251 (290)
T ss_dssp --SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-----HHHHHHHTT-TCCCG----GG-
T ss_pred --ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcH-----HHHHHHHhc-cCCcc----cc-
Confidence 223456899999999876 46999999999999999999999999543221 111111111 00000 00
Q ss_pred hcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 616 KGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 616 ~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
.....+++.+++.+||+.||++|||++|+++.
T Consensus 252 ------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 252 ------DKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp ------GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ------CCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 01112467789999999999999999999864
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=333.40 Aligned_cols=242 Identities=19% Similarity=0.310 Sum_probs=188.9
Q ss_pred cCccccCCceEEEEEEeC-CCCEEEEEEcccCc---ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecC
Q 005749 382 GQVIEKTTYGTAYKAKLA-DGATIALRLLREGS---CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFP 457 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~ 457 (679)
.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|++++++++||||+++++++.. .+..++||||++
T Consensus 16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~ 94 (276)
T 2h6d_A 16 GDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIST-PTDFFMVMEYVS 94 (276)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-SSEEEEEEECCC
T ss_pred EeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEec-CCeEEEEEeccC
Confidence 378999999999999964 79999999986542 2335578899999999999999999999987 678999999999
Q ss_pred CCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCccccc
Q 005749 458 SRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVAD 537 (679)
Q Consensus 458 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 537 (679)
+++|.+++... ..+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++.......
T Consensus 95 ~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~-- 165 (276)
T 2h6d_A 95 GGELFDYICKH----GRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE-- 165 (276)
T ss_dssp SCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC----
T ss_pred CCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCCCc--
Confidence 99999999764 34899999999999999999999988 9999999999999999999999999998764322
Q ss_pred chhcccccccccccccccccCC-CCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhh
Q 005749 538 EMVALAKADGYKAPELQRMKKC-SSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMK 616 (679)
Q Consensus 538 ~~~~~~gt~~y~aPE~~~~~~~-~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~ 616 (679)
......+++.|+|||.+.+..+ +.++||||||+++|||++|+.||..... ...... +..
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~~~~--------------~~~ 225 (276)
T 2h6d_A 166 FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV------PTLFKK--------------IRG 225 (276)
T ss_dssp -----------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHH--------------HHH
T ss_pred ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH------HHHHHH--------------hhc
Confidence 2234568899999999987765 6899999999999999999999954221 111111 111
Q ss_pred cCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 617 GIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 617 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
+...........+.+++.+||+.||++|||++|+++.
T Consensus 226 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 226 GVFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred CcccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 1111111123456789999999999999999999985
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=345.48 Aligned_cols=262 Identities=23% Similarity=0.298 Sum_probs=194.4
Q ss_pred cCccccCCceEEEEEEe-CCCCEEEEEEcccCcc-----cCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEe
Q 005749 382 GQVIEKTTYGTAYKAKL-ADGATIALRLLREGSC-----KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDY 455 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~-----~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey 455 (679)
.+.||+|+||.||+|+. .+|+.||||+++.... ...+.+.+|++++++++||||+++++++.+ .+..++||||
T Consensus 15 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~ 93 (346)
T 1ua2_A 15 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH-KSNISLVFDF 93 (346)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC-TTCCEEEEEC
T ss_pred EeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEee-CCceEEEEEc
Confidence 37899999999999995 5699999999975422 123568899999999999999999999987 6789999999
Q ss_pred cCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCccc
Q 005749 456 FPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAV 535 (679)
Q Consensus 456 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 535 (679)
+++ +|.+++... ...+++..++.++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 94 ~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 166 (346)
T 1ua2_A 94 MET-DLEVIIKDN---SLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 166 (346)
T ss_dssp CSE-EHHHHHTTC---CSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred CCC-CHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccceeccCCc
Confidence 986 899888754 345889999999999999999999988 9999999999999999999999999998764322
Q ss_pred ccchhccccccccccccccccc-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhh--cccccccc--
Q 005749 536 ADEMVALAKADGYKAPELQRMK-KCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVL--EETTMEVF-- 610 (679)
Q Consensus 536 ~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~--~~~~~~~~-- 610 (679)
.......||+.|+|||++.+. .++.++|||||||++|||++|..||.+.... ..+......... ...+.+..
T Consensus 167 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~~ 243 (346)
T 1ua2_A 167 -RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL--DQLTRIFETLGTPTEEQWPDMCSL 243 (346)
T ss_dssp -CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHHHCCCCTTTSSSTTSS
T ss_pred -ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHH--HHHHHHHHHcCCCChhhhhhhccC
Confidence 223445789999999998754 5899999999999999999999998543221 111111111100 00000000
Q ss_pred -hHhhhhcCCC-Ch----HHHHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 005749 611 -DMEIMKGIRS-PM----EEGLVQALKLAMGCCAPVASVRPTMDEVVKQL 654 (679)
Q Consensus 611 -~~~i~~~~~~-~~----~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L 654 (679)
+......... +. .....++.+++.+||+.||++|||++|++++-
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~ 293 (346)
T 1ua2_A 244 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK 293 (346)
T ss_dssp TTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSG
T ss_pred cccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcCh
Confidence 0000000000 00 11235678999999999999999999999863
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-39 Score=335.84 Aligned_cols=241 Identities=19% Similarity=0.273 Sum_probs=190.2
Q ss_pred cCccccCCceEEEEEEe-CCCCEEEEEEcccCc--------ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEE
Q 005749 382 GQVIEKTTYGTAYKAKL-ADGATIALRLLREGS--------CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLI 452 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~--------~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv 452 (679)
.+.||+|+||.||+|+. .+++.||||++.... ......+.+|++++++++||||+++++++.. +..++|
T Consensus 15 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~lv 92 (322)
T 2ycf_A 15 SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA--EDYYIV 92 (322)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES--SSEEEE
T ss_pred eeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC--CceEEE
Confidence 47899999999999995 568899999986532 1223568999999999999999999999876 358999
Q ss_pred EEecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCc---eEEeeccccc
Q 005749 453 YDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFV---SRLTEFGLDQ 529 (679)
Q Consensus 453 ~ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~---~kl~DFGla~ 529 (679)
|||+++++|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+||+++.++. +||+|||+++
T Consensus 93 ~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~ 165 (322)
T 2ycf_A 93 LELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSK 165 (322)
T ss_dssp EECCTTEETHHHHST----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECCCTTCE
T ss_pred EecCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEccCccce
Confidence 999999999999875 345899999999999999999999988 999999999999987654 9999999998
Q ss_pred ccCcccccchhccccccccccccccc---ccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccc
Q 005749 530 LMVPAVADEMVALAKADGYKAPELQR---MKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETT 606 (679)
Q Consensus 530 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 606 (679)
..... .......||+.|+|||++. ...++.++|||||||++|||++|+.||....... .+...+
T Consensus 166 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~--------- 232 (322)
T 2ycf_A 166 ILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKDQI--------- 232 (322)
T ss_dssp ECCCC--HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS--CHHHHH---------
T ss_pred ecccc--cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH--HHHHHH---------
Confidence 76432 1223456899999999864 4678999999999999999999999995433221 111111
Q ss_pred cccchHhhhhcCCCChH----HHHHHHHHHHHhccCcCCCCCCCHHHHHH
Q 005749 607 MEVFDMEIMKGIRSPME----EGLVQALKLAMGCCAPVASVRPTMDEVVK 652 (679)
Q Consensus 607 ~~~~~~~i~~~~~~~~~----~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 652 (679)
..+.....+ .....+.+++.+||+.||++||+++|+++
T Consensus 233 --------~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 233 --------TSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp --------HHTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred --------HhCccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 111111111 12356778999999999999999999985
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=358.97 Aligned_cols=245 Identities=20% Similarity=0.290 Sum_probs=195.3
Q ss_pred cCccccCCceEEEEEEe-CCCCEEEEEEcccCc--ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCC
Q 005749 382 GQVIEKTTYGTAYKAKL-ADGATIALRLLREGS--CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPS 458 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~ 458 (679)
.+.||+|+||+||+|+. .+++.||||++.... ....+.+.+|++++++++|||||++++++.+ .+..++|||||++
T Consensus 27 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~~lv~e~~~~ 105 (486)
T 3mwu_A 27 VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED-SSSFYIVGELYTG 105 (486)
T ss_dssp EEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEEEECCCCS
T ss_pred eEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEc-CCEEEEEEEcCCC
Confidence 47899999999999995 479999999986532 2345678999999999999999999999997 6889999999999
Q ss_pred CChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeec---CCCceEEeecccccccCccc
Q 005749 459 RTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVD---DFFVSRLTEFGLDQLMVPAV 535 (679)
Q Consensus 459 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~---~~~~~kl~DFGla~~~~~~~ 535 (679)
|+|.+.+... ..+++..++.|+.|++.||+|||+++ |+||||||+|||++ .++.+||+|||+++.....
T Consensus 106 ~~L~~~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~- 177 (486)
T 3mwu_A 106 GELFDEIIKR----KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN- 177 (486)
T ss_dssp CBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC-
T ss_pred CcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC-
Confidence 9999988764 35899999999999999999999988 99999999999995 4567999999999876433
Q ss_pred ccchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhh
Q 005749 536 ADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIM 615 (679)
Q Consensus 536 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~ 615 (679)
.......||+.|+|||++.+ .++.++||||+||++|||++|+.||.+.... ............ ++
T Consensus 178 -~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~~~i~~~~~~---~~---- 242 (486)
T 3mwu_A 178 -TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY------DILKRVETGKYA---FD---- 242 (486)
T ss_dssp -----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHTCCC---SC----
T ss_pred -CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCCC---CC----
Confidence 22345679999999999875 5999999999999999999999999543221 111111000000 00
Q ss_pred hcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 616 KGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 616 ~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
.+......+++.+++.+||+.||++|||+.|+++.
T Consensus 243 ---~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 243 ---LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp ---SGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred ---CcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00111223567789999999999999999999986
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=352.94 Aligned_cols=193 Identities=18% Similarity=0.294 Sum_probs=161.1
Q ss_pred cCccccCCceEEEEEE-eCCCCEEEEEEcccCcc--cCcccHHHHHHHHhccCCCCCccceEEeeCCC----CceEEEEE
Q 005749 382 GQVIEKTTYGTAYKAK-LADGATIALRLLREGSC--KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKR----GEKLLIYD 454 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~----~~~~lv~e 454 (679)
.+.||+|+||.||+|+ ..+++.||||+++.... ...+.+.+|++++++++|||||++++++.... ...|+|||
T Consensus 31 ~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e 110 (432)
T 3n9x_A 31 KHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLE 110 (432)
T ss_dssp EEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEEE
T ss_pred EEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEEEEe
Confidence 3789999999999999 45688999999975422 23467899999999999999999999987632 57899999
Q ss_pred ecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcc
Q 005749 455 YFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPA 534 (679)
Q Consensus 455 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 534 (679)
|+. |+|.+++.. ...+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 111 ~~~-~~L~~~~~~----~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 182 (432)
T 3n9x_A 111 IAD-SDLKKLFKT----PIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSE 182 (432)
T ss_dssp CCS-EEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC---
T ss_pred cCC-cCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCccccccc
Confidence 996 599999976 345999999999999999999999998 999999999999999999999999999876432
Q ss_pred cc---------------------cchhcccccccccccccc-cccCCCCcchhHHHHHHHHHHHhCCCCC
Q 005749 535 VA---------------------DEMVALAKADGYKAPELQ-RMKKCSSRTDVYAFGILLLEILIGKKPG 582 (679)
Q Consensus 535 ~~---------------------~~~~~~~gt~~y~aPE~~-~~~~~~~k~DV~S~Gvvl~El~tg~~p~ 582 (679)
.. .......||+.|+|||++ ....++.++||||+||++|||++|..||
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 183 KDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp ----------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred ccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 21 123566899999999986 4567999999999999999999865554
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=371.71 Aligned_cols=250 Identities=22% Similarity=0.312 Sum_probs=197.8
Q ss_pred cCccccCCceEEEEEEeCC----CCEEEEEEcccCcc-cCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEec
Q 005749 382 GQVIEKTTYGTAYKAKLAD----GATIALRLLREGSC-KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYF 456 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~~----~~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~ 456 (679)
.+.||+|+||.||+|+... +..||+|.++.... ...+.+.+|+.++++++|||||++++++.+ +..++||||+
T Consensus 395 ~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~~~~lv~E~~ 472 (656)
T 2j0j_A 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE--NPVWIIMELC 472 (656)
T ss_dssp EEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSCEEEEECC
T ss_pred eeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec--CceEEEEEcC
Confidence 4789999999999998642 45799999876432 234678999999999999999999999854 5789999999
Q ss_pred CCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccc
Q 005749 457 PSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVA 536 (679)
Q Consensus 457 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 536 (679)
++|+|.+++... ...+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 473 ~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~ 546 (656)
T 2j0j_A 473 TLGELRSFLQVR---KFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY 546 (656)
T ss_dssp TTCBHHHHHHHT---TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCSCCC---
T ss_pred CCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCeecCCCcc
Confidence 999999999764 345899999999999999999999988 99999999999999999999999999987754433
Q ss_pred cchhcccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhh
Q 005749 537 DEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIM 615 (679)
Q Consensus 537 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~ 615 (679)
.......+++.|+|||++.+..++.++|||||||++|||++ |..||.+.... +.... +.
T Consensus 547 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~------~~~~~--------------i~ 606 (656)
T 2j0j_A 547 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN------DVIGR--------------IE 606 (656)
T ss_dssp -------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHH--------------HH
T ss_pred eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH------HHHHH--------------HH
Confidence 33334567789999999998899999999999999999997 99998543221 11111 11
Q ss_pred hcCC-CChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCC
Q 005749 616 KGIR-SPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRP 659 (679)
Q Consensus 616 ~~~~-~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 659 (679)
.+.+ +..+...+.+.+++.+||+.||++|||+.|+++.|+++..
T Consensus 607 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~ 651 (656)
T 2j0j_A 607 NGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 651 (656)
T ss_dssp HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCCCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 1111 1112223567789999999999999999999999998753
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=338.39 Aligned_cols=246 Identities=17% Similarity=0.256 Sum_probs=191.0
Q ss_pred CccccCCceEEEEEEeC-CCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCCh
Q 005749 383 QVIEKTTYGTAYKAKLA-DGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRTL 461 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gsL 461 (679)
+.||+|+||.||+|+.. +++.||+|++........+.+.+|++++++++||||+++++++.. .+..++||||+++++|
T Consensus 25 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~l 103 (302)
T 2j7t_A 25 GELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYH-DGKLWIMIEFCPGGAV 103 (302)
T ss_dssp EEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-C-CEEEEEECCTTEEH
T ss_pred ceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeee-CCeEEEEEEeCCCCcH
Confidence 67999999999999964 589999999987666667789999999999999999999999987 6789999999999999
Q ss_pred HHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccchhc
Q 005749 462 HDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVA 541 (679)
Q Consensus 462 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 541 (679)
.+++... ...+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++...... ......
T Consensus 104 ~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~ 176 (302)
T 2j7t_A 104 DAIMLEL---DRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT-LQKRDS 176 (302)
T ss_dssp HHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH-HHC---
T ss_pred HHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCcccccc-cccccc
Confidence 9998754 345899999999999999999999988 999999999999999999999999987643211 112234
Q ss_pred ccccccccccccc-----cccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhh
Q 005749 542 LAKADGYKAPELQ-----RMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMK 616 (679)
Q Consensus 542 ~~gt~~y~aPE~~-----~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~ 616 (679)
..|+..|+|||++ ....++.++||||||+++|||++|+.||...... .......... ....
T Consensus 177 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~-~~~~------- 242 (302)
T 2j7t_A 177 FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM------RVLLKIAKSD-PPTL------- 242 (302)
T ss_dssp --CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHSC-CCCC-------
T ss_pred ccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHH------HHHHHHhccC-Cccc-------
Confidence 5789999999987 3567899999999999999999999998543211 1111110000 0000
Q ss_pred cCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 617 GIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 617 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
.........+.+++.+||+.||++|||+.|+++.
T Consensus 243 ---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 243 ---LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp ---SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred ---CCccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 0111223467789999999999999999999763
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=345.77 Aligned_cols=259 Identities=16% Similarity=0.187 Sum_probs=186.0
Q ss_pred cCccccCCceEEEEEE-eCCCCEEEEEEcccCcc--cCcccHHHHHHHHhccCCCCCccceEEeeCCC-----CceEEEE
Q 005749 382 GQVIEKTTYGTAYKAK-LADGATIALRLLREGSC--KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKR-----GEKLLIY 453 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~-----~~~~lv~ 453 (679)
.+.||+|+||.||+|+ ..+++.||||++..... ...+.+.+|+++++.++||||+++++++.... ...++||
T Consensus 30 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv~ 109 (371)
T 2xrw_A 30 LKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVM 109 (371)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEEEE
T ss_pred eeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceEEEE
Confidence 3789999999999999 45689999999975422 23456889999999999999999999987632 2689999
Q ss_pred EecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCc
Q 005749 454 DYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVP 533 (679)
Q Consensus 454 ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 533 (679)
||+++ +|.+++.. .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 110 e~~~~-~l~~~~~~------~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 179 (371)
T 2xrw_A 110 ELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 179 (371)
T ss_dssp ECCSE-EHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC------
T ss_pred EcCCC-CHHHHHhh------ccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeeccccccc
Confidence 99975 78888853 3889999999999999999999988 99999999999999999999999999986533
Q ss_pred ccccchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHH---------------
Q 005749 534 AVADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVK--------------- 598 (679)
Q Consensus 534 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~--------------- 598 (679)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+ .+.....
T Consensus 180 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~i~~~~~~~~~~~~~~~~~ 255 (371)
T 2xrw_A 180 S--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID--QWNKVIEQLGTPCPEFMKKLQP 255 (371)
T ss_dssp ------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHC-CCCCCHHHHTTSCH
T ss_pred c--cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCCHHHHHHhhh
Confidence 2 12334578999999999999899999999999999999999999996543211 0000000
Q ss_pred ---HHhhcccc--cccchHhhhhcCCC----ChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 005749 599 ---VAVLEETT--MEVFDMEIMKGIRS----PMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQL 654 (679)
Q Consensus 599 ---~~~~~~~~--~~~~~~~i~~~~~~----~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L 654 (679)
........ ...+.........+ .......++.+++.+||+.||++|||++|+++.-
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 320 (371)
T 2xrw_A 256 TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 320 (371)
T ss_dssp HHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred HHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCc
Confidence 00000000 00000000000000 0112246788999999999999999999999863
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-40 Score=349.72 Aligned_cols=259 Identities=15% Similarity=0.246 Sum_probs=196.7
Q ss_pred CccccCCceEEEEEEe-CCCCEEEEEEcccCc-ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCC
Q 005749 383 QVIEKTTYGTAYKAKL-ADGATIALRLLREGS-CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRT 460 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gs 460 (679)
+.||+|+||.||+|+. .+++.||+|+++... ....+.+.+|++++++++||||+++++++.+ .+..++||||+++|+
T Consensus 39 ~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~ 117 (360)
T 3eqc_A 39 SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-DGEISICMEHMDGGS 117 (360)
T ss_dssp EEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEE-TTEEEEEECCCTTCB
T ss_pred eeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEE-CCEEEEEEECCCCCC
Confidence 6899999999999995 478999999997642 2334678999999999999999999999987 678999999999999
Q ss_pred hHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccch
Q 005749 461 LHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTG-HEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEM 539 (679)
Q Consensus 461 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~-~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 539 (679)
|.+++... ..+++..+..++.|++.||+|||+. + |+||||||+||+++.++.+||+|||+++..... ..
T Consensus 118 L~~~l~~~----~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---~~ 187 (360)
T 3eqc_A 118 LDQVLKKA----GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MA 187 (360)
T ss_dssp HHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH---C-
T ss_pred HHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCcccccc---cc
Confidence 99999864 3589999999999999999999985 6 999999999999999999999999998755322 22
Q ss_pred hcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHH----------------------
Q 005749 540 VALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIV---------------------- 597 (679)
Q Consensus 540 ~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~---------------------- 597 (679)
....||+.|+|||++.+..++.++|||||||++|||++|+.||......+........
T Consensus 188 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (360)
T 3eqc_A 188 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKF 267 (360)
T ss_dssp ---CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------------
T ss_pred cCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCccccc
Confidence 3457899999999999999999999999999999999999999653321100000000
Q ss_pred -HHHhhcccccccchHhhhhcCCCC--hHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 598 -KVAVLEETTMEVFDMEIMKGIRSP--MEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 598 -~~~~~~~~~~~~~~~~i~~~~~~~--~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
..........+..+.. ....... ......++.+++.+||+.||++|||++|++++
T Consensus 268 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 325 (360)
T 3eqc_A 268 GMDSRPPMAIFELLDYI-VNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325 (360)
T ss_dssp ------CCCHHHHHHHH-HHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred ccCCCCcccchhhhhHH-hccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 0000000000111111 1111111 11123567889999999999999999999875
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=360.84 Aligned_cols=245 Identities=20% Similarity=0.324 Sum_probs=197.3
Q ss_pred cCccccCCceEEEEEEe-CCCCEEEEEEcccCc---ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecC
Q 005749 382 GQVIEKTTYGTAYKAKL-ADGATIALRLLREGS---CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFP 457 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~ 457 (679)
.++||+|+||.||+|+. .+|+.||||++.... ....+.+.+|++++++++|||||++++++.+ .+..++||||+.
T Consensus 31 ~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~~lv~e~~~ 109 (484)
T 3nyv_A 31 QRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFED-KGYFYLVGEVYT 109 (484)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEEEEECCCC
T ss_pred eeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEe-CCEEEEEEecCC
Confidence 47899999999999995 479999999986543 2345678999999999999999999999997 688999999999
Q ss_pred CCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee---cCCCceEEeecccccccCcc
Q 005749 458 SRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLV---DDFFVSRLTEFGLDQLMVPA 534 (679)
Q Consensus 458 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl---~~~~~~kl~DFGla~~~~~~ 534 (679)
+|+|.+++... ..+++..++.|+.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||+++.....
T Consensus 110 ~~~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~ 182 (484)
T 3nyv_A 110 GGELFDEIISR----KRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS 182 (484)
T ss_dssp SCBHHHHHHTC----SCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCC
T ss_pred CCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccc
Confidence 99999998763 45899999999999999999999988 9999999999999 56789999999999876433
Q ss_pred cccchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhh
Q 005749 535 VADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEI 614 (679)
Q Consensus 535 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i 614 (679)
.......||+.|+|||++.+ .++.++||||+||++|||++|+.||.+.... .+...+. ...... .
T Consensus 183 --~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~i~---~~~~~~---~--- 247 (484)
T 3nyv_A 183 --KKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEY---DILKKVE---KGKYTF---E--- 247 (484)
T ss_dssp --CSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHH---HCCCCC---C---
T ss_pred --cccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH---HHHHHHH---cCCCCC---C---
Confidence 23345579999999999875 6999999999999999999999999543221 1111110 000000 0
Q ss_pred hhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 615 MKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 615 ~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
.+......+.+.+++.+||+.||++|||++|++++
T Consensus 248 ----~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 248 ----LPQWKKVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp ----SGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ----CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 00111223567789999999999999999999975
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-40 Score=345.48 Aligned_cols=259 Identities=22% Similarity=0.331 Sum_probs=192.0
Q ss_pred cCccccCCceEEEEEEe-CCCCEEEEEEcccCccc--CcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCC
Q 005749 382 GQVIEKTTYGTAYKAKL-ADGATIALRLLREGSCK--DRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPS 458 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~--~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~ 458 (679)
.+.||+|+||.||+|+. .+|+.||||++...... ..+.+.+|++++++++||||+++++++.+ .+..++||||+++
T Consensus 30 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~ 108 (331)
T 4aaa_A 30 LGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKK-KKRWYLVFEFVDH 108 (331)
T ss_dssp EEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEEEEECCSE
T ss_pred eeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeec-CCEEEEEEecCCc
Confidence 37899999999999995 45999999998654322 23457899999999999999999999987 6789999999999
Q ss_pred CChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccc
Q 005749 459 RTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADE 538 (679)
Q Consensus 459 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 538 (679)
++|.+++.. ...+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++...... ..
T Consensus 109 ~~l~~~~~~----~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 180 (331)
T 4aaa_A 109 TILDDLELF----PNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-EV 180 (331)
T ss_dssp EHHHHHHHS----TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC----------
T ss_pred chHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCCc-cc
Confidence 999888764 245899999999999999999999988 9999999999999999999999999998654321 22
Q ss_pred hhccccccccccccccccc-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHH----------hh-cccc
Q 005749 539 MVALAKADGYKAPELQRMK-KCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVA----------VL-EETT 606 (679)
Q Consensus 539 ~~~~~gt~~y~aPE~~~~~-~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~----------~~-~~~~ 606 (679)
.....|+..|+|||++.+. .++.++||||+||++|||++|+.||......+ .+....... +. ....
T Consensus 181 ~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (331)
T 4aaa_A 181 YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDID--QLYHIMMCLGNLIPRHQELFNKNPVF 258 (331)
T ss_dssp ---CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCSCCHHHHHHHHHCGGG
T ss_pred cCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHH--HHHHHHHHhCCCChhhhhHhhhcccc
Confidence 3345789999999998865 68999999999999999999999995543211 111111100 00 0000
Q ss_pred cccchHhhhhcCCCCh----HHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 607 MEVFDMEIMKGIRSPM----EEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 607 ~~~~~~~i~~~~~~~~----~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
.....+.+.. ..+. +.....+.+++.+||+.||++|||++|+++.
T Consensus 259 ~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 259 AGVRLPEIKE--REPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp TTCCCCCCSS--CCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ccccCccccc--cchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0000000000 0011 1123567899999999999999999999875
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=358.47 Aligned_cols=245 Identities=20% Similarity=0.320 Sum_probs=191.9
Q ss_pred cCccccCCceEEEEEEe-CCCCEEEEEEcccCc--ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCC
Q 005749 382 GQVIEKTTYGTAYKAKL-ADGATIALRLLREGS--CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPS 458 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~ 458 (679)
.+.||+|+||+||+|+. .++..||+|+++... ....+.+.+|+++++.++|||||+++++|.+ .+..++|||||++
T Consensus 42 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~~lv~e~~~~ 120 (494)
T 3lij_A 42 VKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFED-KRNYYLVMECYKG 120 (494)
T ss_dssp EEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEEEEEECCCS
T ss_pred eeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEe-CCEEEEEEecCCC
Confidence 47899999999999995 478999999997653 2345678999999999999999999999997 6789999999999
Q ss_pred CChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCC---CceEEeecccccccCccc
Q 005749 459 RTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDF---FVSRLTEFGLDQLMVPAV 535 (679)
Q Consensus 459 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~---~~~kl~DFGla~~~~~~~ 535 (679)
|+|.+++... ..+++..++.|+.||+.||+|||+++ |+||||||+|||++.. +.+||+|||+++.....
T Consensus 121 g~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~- 192 (494)
T 3lij_A 121 GELFDEIIHR----MKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ- 192 (494)
T ss_dssp CBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT-
T ss_pred CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC-
Confidence 9999988764 45899999999999999999999988 9999999999999764 55999999999876433
Q ss_pred ccchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhh
Q 005749 536 ADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIM 615 (679)
Q Consensus 536 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~ 615 (679)
.......||+.|+|||++. ..++.++||||+||++|||++|+.||.+.... ........... . ++.
T Consensus 193 -~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~~~i~~~~~--~-~~~--- 258 (494)
T 3lij_A 193 -KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ------EILRKVEKGKY--T-FDS--- 258 (494)
T ss_dssp -BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHTCC--C-CCS---
T ss_pred -ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCC--C-CCc---
Confidence 2234567999999999886 56999999999999999999999999543221 11111100000 0 000
Q ss_pred hcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 616 KGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 616 ~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
+......+.+.+++.+||+.||++|||+.|++++
T Consensus 259 ----~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 259 ----PEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp ----GGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred ----hhcccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 0011223567789999999999999999999865
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-39 Score=334.08 Aligned_cols=246 Identities=17% Similarity=0.274 Sum_probs=192.3
Q ss_pred cCccccCCceEEEEEEe-CCCCEEEEEEcccCc----ccCcccHHHHHHHHhccCCCCCccceEEeeC-CCCceEEEEEe
Q 005749 382 GQVIEKTTYGTAYKAKL-ADGATIALRLLREGS----CKDRSSCLPVIRQLGKVRHENLIPLRAFYQG-KRGEKLLIYDY 455 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~----~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~-~~~~~~lv~ey 455 (679)
.+.||+|+||.||+|+. .+++.||+|+++... ....+.+.+|++++++++||||+++++++.. ..+..++||||
T Consensus 10 ~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~ 89 (305)
T 2wtk_C 10 GDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEY 89 (305)
T ss_dssp CCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEEEEC
T ss_pred eeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEEehh
Confidence 47899999999999995 568999999997542 2335678999999999999999999999853 24578999999
Q ss_pred cCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCccc
Q 005749 456 FPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAV 535 (679)
Q Consensus 456 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 535 (679)
++++ |.+++.... ...+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++......
T Consensus 90 ~~~~-l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~ 163 (305)
T 2wtk_C 90 CVCG-MQEMLDSVP--EKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFA 163 (305)
T ss_dssp CSEE-HHHHHHHST--TCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECCTTC
T ss_pred ccCC-HHHHHHhCc--ccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccccCccc
Confidence 9876 777776543 345899999999999999999999988 9999999999999999999999999998764321
Q ss_pred -ccchhcccccccccccccccccC--CCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchH
Q 005749 536 -ADEMVALAKADGYKAPELQRMKK--CSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDM 612 (679)
Q Consensus 536 -~~~~~~~~gt~~y~aPE~~~~~~--~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 612 (679)
........|+..|+|||++.+.. ++.++||||||+++|||++|+.||.+... ......
T Consensus 164 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~------------- 224 (305)
T 2wtk_C 164 ADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI------YKLFEN------------- 224 (305)
T ss_dssp SSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHH-------------
T ss_pred cccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH------HHHHHH-------------
Confidence 12223456899999999987644 37799999999999999999999954221 111111
Q ss_pred hhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 613 EIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 613 ~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
+..+...........+.+++.+||+.||++|||++|+++.
T Consensus 225 -i~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 225 -IGKGSYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp -HHHCCCCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred -HhcCCCCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1111111111223566789999999999999999999975
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=336.12 Aligned_cols=254 Identities=18% Similarity=0.278 Sum_probs=190.5
Q ss_pred cCccccCCceEEEEEEeC--CCC--EEEEEEcccCc---ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEE
Q 005749 382 GQVIEKTTYGTAYKAKLA--DGA--TIALRLLREGS---CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYD 454 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~--~~~--~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~e 454 (679)
.+.||+|+||+||+|+.. +++ .||||+++... ....+.+.+|++++++++||||+++++++.+ +..++|||
T Consensus 23 ~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~v~e 100 (291)
T 1u46_A 23 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT--PPMKMVTE 100 (291)
T ss_dssp EEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSCEEEEE
T ss_pred eeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcc--CCceeeEe
Confidence 378999999999999853 333 68999987642 2234678999999999999999999999986 34899999
Q ss_pred ecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcc
Q 005749 455 YFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPA 534 (679)
Q Consensus 455 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 534 (679)
|+++++|.+++... ...+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++.....
T Consensus 101 ~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 174 (291)
T 1u46_A 101 LAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQN 174 (291)
T ss_dssp CCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECCC-
T ss_pred cccCCCHHHHHHhc---cCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccccccccc
Confidence 99999999999764 245899999999999999999999988 999999999999999999999999999876433
Q ss_pred ccc--chhcccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHHhhcccccccch
Q 005749 535 VAD--EMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFD 611 (679)
Q Consensus 535 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 611 (679)
... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||.+.... ...........
T Consensus 175 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~~~~~~~~~~~------ 242 (291)
T 1u46_A 175 DDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS------QILHKIDKEGE------ 242 (291)
T ss_dssp CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHHHTSCC------
T ss_pred ccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH------HHHHHHHccCC------
Confidence 221 1233457788999999988889999999999999999999 99999543211 11111111000
Q ss_pred HhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCCCC
Q 005749 612 MEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRPRN 661 (679)
Q Consensus 612 ~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 661 (679)
..+.......++.+++.+||+.||++|||+.++++.|+++.+..
T Consensus 243 ------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 286 (291)
T 1u46_A 243 ------RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTD 286 (291)
T ss_dssp ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred ------CCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCccc
Confidence 00111122356778999999999999999999999999987543
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-39 Score=356.97 Aligned_cols=241 Identities=20% Similarity=0.289 Sum_probs=193.2
Q ss_pred cCccccCCceEEEEEEe-CCCCEEEEEEcccCcc-------------cCcccHHHHHHHHhccCCCCCccceEEeeCCCC
Q 005749 382 GQVIEKTTYGTAYKAKL-ADGATIALRLLREGSC-------------KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRG 447 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~-------------~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~ 447 (679)
.+.||+|+||+||+|+. .+++.||+|++..... ...+.+.+|++++++++|||||++++++.+ .+
T Consensus 41 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~ 119 (504)
T 3q5i_A 41 VRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFED-KK 119 (504)
T ss_dssp EEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEEC-SS
T ss_pred EeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc-CC
Confidence 37899999999999995 5688999999875421 224568899999999999999999999997 68
Q ss_pred ceEEEEEecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCC---ceEEee
Q 005749 448 EKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFF---VSRLTE 524 (679)
Q Consensus 448 ~~~lv~ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~---~~kl~D 524 (679)
..++|||||++|+|.+++... ..+++..++.|+.||+.||+|||+++ |+||||||+|||++.++ .+||+|
T Consensus 120 ~~~lv~e~~~gg~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~D 192 (504)
T 3q5i_A 120 YFYLVTEFYEGGELFEQIINR----HKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVD 192 (504)
T ss_dssp EEEEEEECCTTCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSSEEECC
T ss_pred EEEEEEecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCccEEEEE
Confidence 899999999999999998764 45899999999999999999999988 99999999999998775 699999
Q ss_pred cccccccCcccccchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcc
Q 005749 525 FGLDQLMVPAVADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEE 604 (679)
Q Consensus 525 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~ 604 (679)
||+++..... .......||+.|+|||++. +.++.++||||+||++|||++|+.||.+.... .....
T Consensus 193 fg~a~~~~~~--~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~~~----- 258 (504)
T 3q5i_A 193 FGLSSFFSKD--YKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ------DIIKK----- 258 (504)
T ss_dssp CTTCEECCTT--SCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHH-----
T ss_pred CCCCEEcCCC--CccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH------HHHHH-----
Confidence 9999876433 2234567999999999987 56899999999999999999999999543221 11111
Q ss_pred cccccchHhhhhcCCCChH----HHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 605 TTMEVFDMEIMKGIRSPME----EGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 605 ~~~~~~~~~i~~~~~~~~~----~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
+..+...... ....++.+++.+||+.||++|||++|+++.
T Consensus 259 ---------i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 259 ---------VEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp ---------HHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ---------HHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 1111111111 123567889999999999999999999875
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=352.78 Aligned_cols=193 Identities=20% Similarity=0.274 Sum_probs=165.9
Q ss_pred cCccccCCceEEEEEEe-CCCCEEEEEEcccCcccCcccHHHHHHHHhcc------CCCCCccceEEeeCCCCceEEEEE
Q 005749 382 GQVIEKTTYGTAYKAKL-ADGATIALRLLREGSCKDRSSCLPVIRQLGKV------RHENLIPLRAFYQGKRGEKLLIYD 454 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l------~H~nIv~l~~~~~~~~~~~~lv~e 454 (679)
.+.||+|+||.||+|+. .+++.||||+++... ...+.+.+|+++++.+ +|+||+++++++.. .+..++|||
T Consensus 102 ~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~-~~~~~lv~e 179 (429)
T 3kvw_A 102 LKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF-RNHICMTFE 179 (429)
T ss_dssp EEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE-TTEEEEEEC
T ss_pred EEEcccCccEEEEEEEECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc-CCeEEEEEe
Confidence 37899999999999984 568999999997532 2245678888888877 57799999999987 688999999
Q ss_pred ecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCc--eEEeecccccccC
Q 005749 455 YFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFV--SRLTEFGLDQLMV 532 (679)
Q Consensus 455 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~--~kl~DFGla~~~~ 532 (679)
|+. ++|.+++.... ...+++..++.|+.||+.||+|||+++ |+||||||+|||++.++. +||+|||+++...
T Consensus 180 ~~~-~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~ 253 (429)
T 3kvw_A 180 LLS-MNLYELIKKNK--FQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH 253 (429)
T ss_dssp CCC-CBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTTCEETT
T ss_pred ccC-CCHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecccceecC
Confidence 996 59999987643 244899999999999999999999988 999999999999999887 9999999997643
Q ss_pred cccccchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 005749 533 PAVADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGR 586 (679)
Q Consensus 533 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~ 586 (679)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+..
T Consensus 254 ~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 254 Q----RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp C----CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred C----cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 2 2334578999999999999999999999999999999999999996543
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-39 Score=341.76 Aligned_cols=259 Identities=19% Similarity=0.257 Sum_probs=195.0
Q ss_pred CccccCCceEEEEEEe-CCCCEEEEEEcccCcc-cCcccHHHHHHHHhccCCCCCccceEEeeCCC----CceEEEEEec
Q 005749 383 QVIEKTTYGTAYKAKL-ADGATIALRLLREGSC-KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKR----GEKLLIYDYF 456 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~----~~~~lv~ey~ 456 (679)
+.||+|+||.||+|+. .+++.||||++..... ...+.+.+|++++.+++||||+++++++.... ...++||||+
T Consensus 33 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~ 112 (364)
T 3qyz_A 33 SYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 112 (364)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECC
T ss_pred EEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEEEccc
Confidence 7899999999999994 5788999999975432 23467889999999999999999999987532 4689999999
Q ss_pred CCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccc
Q 005749 457 PSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVA 536 (679)
Q Consensus 457 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 536 (679)
. |+|.+++.. ..+++..++.|+.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 113 ~-~~L~~~l~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 183 (364)
T 3qyz_A 113 E-TDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 183 (364)
T ss_dssp S-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCGGGC
T ss_pred C-cCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEecCCCCC
Confidence 7 499999875 34899999999999999999999988 99999999999999999999999999987643322
Q ss_pred c--chhcccccccccccccccc-cCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhccc---ccccc
Q 005749 537 D--EMVALAKADGYKAPELQRM-KKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEET---TMEVF 610 (679)
Q Consensus 537 ~--~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~---~~~~~ 610 (679)
. ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+....+. +..... ...... .....
T Consensus 184 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~~i~~-~~~~~~~~~~~~~~ 260 (364)
T 3qyz_A 184 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ--LNHILG-ILGSPSQEDLNCII 260 (364)
T ss_dssp BCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGH--HHHHHH-HHCSCCHHHHHTCC
T ss_pred ccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHH--HHHHHH-HhCCCCHHHHHHhh
Confidence 1 1244579999999998654 4589999999999999999999999965433221 111111 000000 00000
Q ss_pred h---Hhh----hhcCCCCh----HHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 611 D---MEI----MKGIRSPM----EEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 611 ~---~~i----~~~~~~~~----~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
+ ... ......+. +....++.+++.+||+.||++|||++|+++.
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 261 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 000 00000001 1123567899999999999999999999875
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=333.65 Aligned_cols=256 Identities=19% Similarity=0.276 Sum_probs=194.6
Q ss_pred cCccccCCceEEEEEE-eCCCCEEEEEEcccCcccCcccHHHHHHHHhccC-CCCCccceEEeeCC-CCceEEEEEecCC
Q 005749 382 GQVIEKTTYGTAYKAK-LADGATIALRLLREGSCKDRSSCLPVIRQLGKVR-HENLIPLRAFYQGK-RGEKLLIYDYFPS 458 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~~~~~~~-~~~~~lv~ey~~~ 458 (679)
.+.||+|+||.||+|+ ..+++.||||+++.. ..+.+.+|++++++++ ||||+++++++.+. ....++||||+++
T Consensus 41 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~ 117 (330)
T 3nsz_A 41 VRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNN 117 (330)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCC
T ss_pred EEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEeccCc
Confidence 3789999999999998 567999999998753 3567899999999997 99999999999863 4568999999999
Q ss_pred CChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCC-ceEEeecccccccCccccc
Q 005749 459 RTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFF-VSRLTEFGLDQLMVPAVAD 537 (679)
Q Consensus 459 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~-~~kl~DFGla~~~~~~~~~ 537 (679)
++|.+++.. +++..++.++.|++.||+|||+++ |+||||||+|||++.++ .+||+|||+++......
T Consensus 118 ~~l~~~~~~-------~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~-- 185 (330)
T 3nsz_A 118 TDFKQLYQT-------LTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ-- 185 (330)
T ss_dssp CCHHHHGGG-------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC--
T ss_pred hhHHHHHHh-------CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC--
Confidence 999999853 789999999999999999999988 99999999999999776 89999999998764332
Q ss_pred chhcccccccccccccccc-cCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcc----------cc
Q 005749 538 EMVALAKADGYKAPELQRM-KKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEE----------TT 606 (679)
Q Consensus 538 ~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~----------~~ 606 (679)
......++..|+|||.+.+ ..++.++|||||||++|||++|+.||...... ...+.......-... ..
T Consensus 186 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~ 264 (330)
T 3nsz_A 186 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN-YDQLVRIAKVLGTEDLYDYIDKYNIEL 264 (330)
T ss_dssp CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH-HHHHHHHHHHHCHHHHHHHHHHTTCCC
T ss_pred ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCch-HHHHHHHHHhcCCchhhhHHHHhcccc
Confidence 2334578899999999876 67899999999999999999999999543221 111111111110000 00
Q ss_pred cccchHhhhhc--------C-CCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 607 MEVFDMEIMKG--------I-RSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 607 ~~~~~~~i~~~--------~-~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
...+....... . ........+++.+++.+||+.||++|||++|++++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 265 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp CTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 00000000000 0 00011124677899999999999999999999874
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=336.58 Aligned_cols=247 Identities=20% Similarity=0.315 Sum_probs=180.2
Q ss_pred CccccCCceEEEEEEe-CCCCEEEEEEcccCcc-cC-cccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCC
Q 005749 383 QVIEKTTYGTAYKAKL-ADGATIALRLLREGSC-KD-RSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSR 459 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~-~~-~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~g 459 (679)
+.||+|+||.||+|+. .+|+.||+|+++.... .. .+.+..+...++.++||||+++++++.+ .+..++||||+++
T Consensus 13 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~-~~~~~lv~e~~~~- 90 (290)
T 3fme_A 13 MELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFR-EGDVWICMELMDT- 90 (290)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSSEEEEEECCSE-
T ss_pred HhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeec-cCCEEEEEehhcc-
Confidence 7899999999999994 6799999999976422 11 2234444555788899999999999997 6789999999974
Q ss_pred ChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccc
Q 005749 460 TLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTG-HEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADE 538 (679)
Q Consensus 460 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~-~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 538 (679)
+|.+++.........+++..++.|+.|++.||+|||++ + |+||||||+||+++.++.+||+|||+++...... .
T Consensus 91 ~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~ 165 (290)
T 3fme_A 91 SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDV--A 165 (290)
T ss_dssp EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC-------------
T ss_pred chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCcccccccc--c
Confidence 99888875433356799999999999999999999997 7 9999999999999999999999999998764332 2
Q ss_pred hhcccccccccccccc----cccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhh
Q 005749 539 MVALAKADGYKAPELQ----RMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEI 614 (679)
Q Consensus 539 ~~~~~gt~~y~aPE~~----~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i 614 (679)
.....||+.|+|||.+ .+..++.++||||||+++|||++|+.||...... . ...........
T Consensus 166 ~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~----~~~~~~~~~~~--------- 231 (290)
T 3fme_A 166 KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP-F----QQLKQVVEEPS--------- 231 (290)
T ss_dssp ----CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCH-H----HHHHHHHHSCC---------
T ss_pred ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCch-H----HHHHHHhccCC---------
Confidence 2334689999999996 4567899999999999999999999999542211 1 11111111000
Q ss_pred hhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 615 MKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 615 ~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
...+......++.+++.+||+.||++|||+.|+++.
T Consensus 232 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h 267 (290)
T 3fme_A 232 ---PQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQH 267 (290)
T ss_dssp ---CCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred ---CCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence 001111223567789999999999999999999873
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=339.46 Aligned_cols=253 Identities=25% Similarity=0.298 Sum_probs=192.4
Q ss_pred cCccccCCceEEEEEEeCCCCEEEEEEcccCc--ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCC
Q 005749 382 GQVIEKTTYGTAYKAKLADGATIALRLLREGS--CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSR 459 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~g 459 (679)
.+.||+|+||.||+|+..+ .||+|+++... ....+.+.+|++++++++||||+++++++.+ .+..++||||++++
T Consensus 38 ~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~iv~e~~~~~ 114 (319)
T 2y4i_B 38 GELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMS-PPHLAIITSLCKGR 114 (319)
T ss_dssp CCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEEC-SSCEEEECBCCCSE
T ss_pred eeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEec-CCceEEEeecccCC
Confidence 4899999999999999753 59999987543 2345678899999999999999999999997 67899999999999
Q ss_pred ChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCccc----
Q 005749 460 TLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAV---- 535 (679)
Q Consensus 460 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~---- 535 (679)
+|.+++... ...+++..++.++.|++.||+|||+++ |+||||||+||+++ ++.+||+|||+++......
T Consensus 115 ~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~ 187 (319)
T 2y4i_B 115 TLYSVVRDA---KIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRR 187 (319)
T ss_dssp EHHHHTTSS---CCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC----------
T ss_pred cHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCcccccccccccc
Confidence 999999764 345899999999999999999999988 99999999999998 6799999999987653211
Q ss_pred ccchhcccccccccccccccc---------cCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccc
Q 005749 536 ADEMVALAKADGYKAPELQRM---------KKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETT 606 (679)
Q Consensus 536 ~~~~~~~~gt~~y~aPE~~~~---------~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 606 (679)
........|+..|+|||.+.. ..++.++||||||+++|||++|+.||...... ...... .....
T Consensus 188 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~-~~~~~ 260 (319)
T 2y4i_B 188 EDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE------AIIWQM-GTGMK 260 (319)
T ss_dssp CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH------HHHHHH-HTTCC
T ss_pred ccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHh-ccCCC
Confidence 112233468899999998864 35788999999999999999999999543211 111110 00000
Q ss_pred cccchHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCCCCC
Q 005749 607 MEVFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRPRNR 662 (679)
Q Consensus 607 ~~~~~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 662 (679)
. . ........++.+++.+||+.||++|||++|+++.|+++....+
T Consensus 261 ~-----~------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~ 305 (319)
T 2y4i_B 261 P-----N------LSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNR 305 (319)
T ss_dssp C-----C------CCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-----
T ss_pred C-----C------CCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhc
Confidence 0 0 0000112356789999999999999999999999999876543
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=345.02 Aligned_cols=261 Identities=15% Similarity=0.206 Sum_probs=196.4
Q ss_pred cCccccCCceEEEEEE-eCCCCEEEEEEcccCcccCcccHHHHHHHHhccC--------CCCCccceEEeeC---CCCce
Q 005749 382 GQVIEKTTYGTAYKAK-LADGATIALRLLREGSCKDRSSCLPVIRQLGKVR--------HENLIPLRAFYQG---KRGEK 449 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~--------H~nIv~l~~~~~~---~~~~~ 449 (679)
.+.||+|+||+||+|+ ..+++.||||+++... ...+.+.+|++++++++ |+||+++++++.. .....
T Consensus 42 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~ 120 (397)
T 1wak_A 42 IRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE-HYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHI 120 (397)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTEEEE
T ss_pred EEEeeecCCeeEEEEEecCCCeEEEEEEEecCC-cchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCCceE
Confidence 3789999999999998 5668999999997532 23467889999999986 7889999998872 24578
Q ss_pred EEEEEecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCeeecCCCCCCeeecCCC----------
Q 005749 450 LLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTG-HEIPITHGNVRSKNVLVDDFF---------- 518 (679)
Q Consensus 450 ~lv~ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~-~~~~ivHrDlkp~NILl~~~~---------- 518 (679)
++||||+ +++|.+.+.... ...+++..++.|+.||+.||+|||++ + |+||||||+|||++.++
T Consensus 121 ~lv~e~~-~~~l~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~~~~~~~ 194 (397)
T 1wak_A 121 CMVFEVL-GHHLLKWIIKSN--YQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRRLAAEA 194 (397)
T ss_dssp EEEECCC-CCBHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHHHHHHHH
T ss_pred EEEEecc-CccHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhhhhhhhh
Confidence 9999999 557766665432 24589999999999999999999997 7 99999999999999775
Q ss_pred ---------------------------------------ceEEeecccccccCcccccchhcccccccccccccccccCC
Q 005749 519 ---------------------------------------VSRLTEFGLDQLMVPAVADEMVALAKADGYKAPELQRMKKC 559 (679)
Q Consensus 519 ---------------------------------------~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 559 (679)
.+||+|||+++..... .....||+.|+|||++.+..+
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~ 270 (397)
T 1wak_A 195 TEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVLIGSGY 270 (397)
T ss_dssp C---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHHHTSCC
T ss_pred HHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhhcCCCC
Confidence 7999999999876432 234578999999999999899
Q ss_pred CCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhh--cc----------cccccchH---------------
Q 005749 560 SSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVL--EE----------TTMEVFDM--------------- 612 (679)
Q Consensus 560 ~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~--~~----------~~~~~~~~--------------- 612 (679)
+.++|||||||++|||++|+.||......+...-......... .. ...+.+..
T Consensus 271 ~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (397)
T 1wak_A 271 NTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGL 350 (397)
T ss_dssp CTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCH
T ss_pred CcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcch
Confidence 9999999999999999999999966544332211111111100 00 00000000
Q ss_pred -hhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 613 -EIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 613 -~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
................+.+++.+||+.||++|||++|++++
T Consensus 351 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 351 FEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp HHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred hHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 00111112234556778899999999999999999999863
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=349.44 Aligned_cols=264 Identities=20% Similarity=0.285 Sum_probs=191.3
Q ss_pred cCccccCCceEEEEEEeCCCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCCC-----CceEEEEEec
Q 005749 382 GQVIEKTTYGTAYKAKLADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKR-----GEKLLIYDYF 456 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~-----~~~~lv~ey~ 456 (679)
.++||+|+||+||+|+..++..||+|++.... ....+|+++++.++|||||+++++|.... ...++||||+
T Consensus 45 ~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~----~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~ 120 (394)
T 4e7w_A 45 CKVIGNGSFGVVFQAKLVESDEVAIKKVLQDK----RFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYV 120 (394)
T ss_dssp EEEEEEETTEEEEEEEETTTEEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEECC
T ss_pred eEEEeeCCCeEEEEEEECCCCeEEEEEEecCc----chHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEeecc
Confidence 37899999999999998777779999886532 23347999999999999999999986422 2378999999
Q ss_pred CCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeec-CCCceEEeecccccccCccc
Q 005749 457 PSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVD-DFFVSRLTEFGLDQLMVPAV 535 (679)
Q Consensus 457 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~-~~~~~kl~DFGla~~~~~~~ 535 (679)
+++ +.+.+.........+++..++.++.|+++||+|||+++ |+||||||+|||++ .++.+||+|||+++......
T Consensus 121 ~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~ 196 (394)
T 4e7w_A 121 PET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGE 196 (394)
T ss_dssp SEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred Ccc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCC
Confidence 874 44444332222456999999999999999999999988 99999999999999 78999999999998764332
Q ss_pred ccchhccccccccccccccccc-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhc-ccccccchHh
Q 005749 536 ADEMVALAKADGYKAPELQRMK-KCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLE-ETTMEVFDME 613 (679)
Q Consensus 536 ~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~-~~~~~~~~~~ 613 (679)
......+|+.|+|||++.+. .++.++||||+||++|||++|+.||.+.... ..+....+..-.. ........+.
T Consensus 197 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~--~~l~~i~~~~g~p~~~~~~~~~~~ 272 (394)
T 4e7w_A 197 --PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGI--DQLVEIIKVLGTPSREQIKTMNPN 272 (394)
T ss_dssp --CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHHHCCCCHHHHHHHCGG
T ss_pred --CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCCHHHHHhhChh
Confidence 22355789999999988754 5899999999999999999999999654321 1122221110000 0000000000
Q ss_pred hhh-----cCCCChH-----HHHHHHHHHHHhccCcCCCCCCCHHHHHHH--HHhh
Q 005749 614 IMK-----GIRSPME-----EGLVQALKLAMGCCAPVASVRPTMDEVVKQ--LEEN 657 (679)
Q Consensus 614 i~~-----~~~~~~~-----~~~~~~~~l~~~cl~~dP~~RPs~~evl~~--L~~~ 657 (679)
... ....+.. ...+++.+++.+||+.||++|||+.|++++ ++++
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 328 (394)
T 4e7w_A 273 YMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDEL 328 (394)
T ss_dssp GSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTT
T ss_pred hhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhh
Confidence 000 0000111 123578899999999999999999999875 4444
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=342.51 Aligned_cols=257 Identities=13% Similarity=0.192 Sum_probs=196.4
Q ss_pred cCccccCCceEEEEEEeCCCCEEEEEEcccCcccCc-----------------ccHHHHHHHHhccCCCCCccceEEeeC
Q 005749 382 GQVIEKTTYGTAYKAKLADGATIALRLLREGSCKDR-----------------SSCLPVIRQLGKVRHENLIPLRAFYQG 444 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~-----------------~~~~~Ei~~l~~l~H~nIv~l~~~~~~ 444 (679)
.+.||+|+||.||+|+. +|+.||||++........ +.+.+|++++++++||||+++++++.+
T Consensus 36 ~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 114 (348)
T 2pml_X 36 IRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITN 114 (348)
T ss_dssp EEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSEEEES
T ss_pred EEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEEEEee
Confidence 37899999999999999 899999999875422111 678999999999999999999999998
Q ss_pred CCCceEEEEEecCCCChHHH------hhcccCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeeecCCCCCCeeecCC
Q 005749 445 KRGEKLLIYDYFPSRTLHDL------LHDTIAGKPVLNWARRHKIALGIARGLAYLHT-GHEIPITHGNVRSKNVLVDDF 517 (679)
Q Consensus 445 ~~~~~~lv~ey~~~gsL~~~------l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~-~~~~~ivHrDlkp~NILl~~~ 517 (679)
.+..++||||+++|+|.++ +.... ...+++..++.++.|++.||+|||+ ++ |+||||||+||+++.+
T Consensus 115 -~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil~~~~ 188 (348)
T 2pml_X 115 -YDEVYIIYEYMENDSILKFDEYFFVLDKNY--TCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNILMDKN 188 (348)
T ss_dssp -SSEEEEEEECCTTCBSSEESSSEESSCSSS--CCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEEECTT
T ss_pred -CCeEEEEEeccCCCcHHHHHHHhhhhhhcc--ccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEEEcCC
Confidence 6789999999999999998 54321 3569999999999999999999998 77 9999999999999999
Q ss_pred CceEEeecccccccCcccccchhccccccccccccccccc-CCCC-cchhHHHHHHHHHHHhCCCCCCCCCCCcccchhH
Q 005749 518 FVSRLTEFGLDQLMVPAVADEMVALAKADGYKAPELQRMK-KCSS-RTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPS 595 (679)
Q Consensus 518 ~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~ 595 (679)
+.+||+|||+++..... ......|+..|+|||.+.+. .++. ++||||||+++|||++|+.||...... ..
T Consensus 189 ~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~ 260 (348)
T 2pml_X 189 GRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL-----VE 260 (348)
T ss_dssp SCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS-----HH
T ss_pred CcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH-----HH
Confidence 99999999999875432 23455789999999999876 5666 999999999999999999999654331 11
Q ss_pred HHHHHhhcccccc-----cchHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 596 IVKVAVLEETTME-----VFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 596 ~~~~~~~~~~~~~-----~~~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
............. ...+................+.+++.+||+.||++|||++|+++.
T Consensus 261 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 261 LFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp HHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1111111000000 000000000000002223567789999999999999999999874
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-39 Score=334.35 Aligned_cols=245 Identities=16% Similarity=0.244 Sum_probs=193.7
Q ss_pred cCccccCCceEEEEEEeC-CCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCC
Q 005749 382 GQVIEKTTYGTAYKAKLA-DGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRT 460 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gs 460 (679)
.+.||+|+||.||+|+.. +|+.||+|.+... ...+.+.+|++++.+++||||+++++++.. .+..++||||+++++
T Consensus 34 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~ 110 (314)
T 3com_A 34 LEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYFK-NTDLWIVMEYCGAGS 110 (314)
T ss_dssp EEECC----CEEEEEEETTTCCEEEEEEEETT--SCCHHHHHHHHHHHTCCCTTBCCEEEEEEE-TTEEEEEEECCTTEE
T ss_pred heeeccCCCeEEEEEEECCCCCEEEEEecCch--HHHHHHHHHHHHHHhCCCCCCccEEEEEEe-CCEEEEEeecCCCCC
Confidence 368999999999999954 5999999999764 245678999999999999999999999987 678999999999999
Q ss_pred hHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccchh
Q 005749 461 LHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMV 540 (679)
Q Consensus 461 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 540 (679)
|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++....... ....
T Consensus 111 L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~-~~~~ 183 (314)
T 3com_A 111 VSDIIRLR---NKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM-AKRN 183 (314)
T ss_dssp HHHHHHHH---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTTB-SCBC
T ss_pred HHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhhc-cccC
Confidence 99999743 345899999999999999999999988 9999999999999999999999999997664322 2233
Q ss_pred cccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcCCC
Q 005749 541 ALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIRS 620 (679)
Q Consensus 541 ~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~~ 620 (679)
...|+..|+|||.+.+..++.++||||||+++|||++|+.||...... ...... ........ .
T Consensus 184 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~-~~~~~~~~----------~ 246 (314)
T 3com_A 184 TVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPM------RAIFMI-PTNPPPTF----------R 246 (314)
T ss_dssp CCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHH-HHSCCCCC----------S
T ss_pred ccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH------HHHHHH-hcCCCccc----------C
Confidence 457899999999999888999999999999999999999999542211 111000 00000000 0
Q ss_pred ChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 621 PMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 621 ~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
........+.+++.+||+.||++|||+.|+++.
T Consensus 247 ~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 247 KPELWSDNFTDFVKQCLVKSPEQRATATQLLQH 279 (314)
T ss_dssp SGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred CcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 011123567789999999999999999999874
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=349.23 Aligned_cols=249 Identities=10% Similarity=-0.034 Sum_probs=175.3
Q ss_pred cCccccCCceEEEEEEe-CCCCEEEEEEcccCcc---cCcccHHHHHHHHhcc--CCCCCccce-------EEeeCCC--
Q 005749 382 GQVIEKTTYGTAYKAKL-ADGATIALRLLREGSC---KDRSSCLPVIRQLGKV--RHENLIPLR-------AFYQGKR-- 446 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~---~~~~~~~~Ei~~l~~l--~H~nIv~l~-------~~~~~~~-- 446 (679)
.+.||+|+||.||+|+. .+|+.||||+++.... ...+.+.+|++++..+ +|||||+++ +++....
T Consensus 67 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~~~~ 146 (371)
T 3q60_A 67 VEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQP 146 (371)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEETTSC
T ss_pred eeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecCCCC
Confidence 47899999999999994 5799999999987542 2344677785544444 699988754 4443211
Q ss_pred --------------CceEEEEEecCCCChHHHhhcccCCCCCCCHHHH------HHHHHHHHHHHHHHhcCCCCCeeecC
Q 005749 447 --------------GEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARR------HKIALGIARGLAYLHTGHEIPITHGN 506 (679)
Q Consensus 447 --------------~~~~lv~ey~~~gsL~~~l~~~~~~~~~l~~~~~------~~i~~~ia~gL~~LH~~~~~~ivHrD 506 (679)
...++|||||+ |+|.+++.... ..+.+..+ +.++.||++||+|||+++ |+|||
T Consensus 147 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~---~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~---ivHrD 219 (371)
T 3q60_A 147 PFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD---FVYVFRGDEGILALHILTAQLIRLAANLQSKG---LVHGH 219 (371)
T ss_dssp SSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH---HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---EEETT
T ss_pred CeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc---cccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---CccCc
Confidence 34799999999 89999998642 23455556 788899999999999988 99999
Q ss_pred CCCCCeeecCCCceEEeecccccccCcccccchhcccccccccccccccc--cCCCCcchhHHHHHHHHHHHhCCCCCCC
Q 005749 507 VRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKADGYKAPELQRM--KKCSSRTDVYAFGILLLEILIGKKPGKS 584 (679)
Q Consensus 507 lkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~k~DV~S~Gvvl~El~tg~~p~~~ 584 (679)
|||+|||++.++.+||+|||+++...... ....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 220 ikp~NIll~~~~~~kL~DFG~a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~ 295 (371)
T 3q60_A 220 FTPDNLFIMPDGRLMLGDVSALWKVGTRG----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGL 295 (371)
T ss_dssp CSGGGEEECTTSCEEECCGGGEEETTCEE----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTB
T ss_pred CCHHHEEECCCCCEEEEecceeeecCCCc----cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999998663221 13456699999999987 7799999999999999999999999965
Q ss_pred CCCCcccchhHHHHHHhhcccccccchHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHH
Q 005749 585 GRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVK 652 (679)
Q Consensus 585 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 652 (679)
......... ............. ..+..+.....+.+++.+||+.||++|||+.|+++
T Consensus 296 ~~~~~~~~~--------~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 296 VTPGIKGSW--------KRPSLRVPGTDSL---AFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp CCTTCTTCC--------CBCCTTSCCCCSC---CCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred cCcccccch--------hhhhhhhcccccc---chhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 533211100 0000000000000 00111122356778999999999999999999975
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=334.15 Aligned_cols=258 Identities=16% Similarity=0.268 Sum_probs=178.4
Q ss_pred cCccccCCceEEEEEE-eCCCCEEEEEEcccCc-ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCC
Q 005749 382 GQVIEKTTYGTAYKAK-LADGATIALRLLREGS-CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSR 459 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~g 459 (679)
.+.||+|+||.||+|+ ..+++.||||.+.... ....+.+.+|++++.+++||||+++++++.. .+..++||||++++
T Consensus 20 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~ 98 (303)
T 2vwi_A 20 QEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVV-KDELWLVMKLLSGG 98 (303)
T ss_dssp EEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEES-SSCEEEEEECCTTC
T ss_pred hheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEee-cCCcEEEehhccCC
Confidence 3789999999999999 4578999999987543 2345678899999999999999999999987 67899999999999
Q ss_pred ChHHHhhccc----CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCccc
Q 005749 460 TLHDLLHDTI----AGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAV 535 (679)
Q Consensus 460 sL~~~l~~~~----~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 535 (679)
+|.+++.... .....+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++......
T Consensus 99 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 175 (303)
T 2vwi_A 99 SVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGG 175 (303)
T ss_dssp BHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHHHHCC---
T ss_pred chHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccchheeccCC
Confidence 9999987421 11345899999999999999999999988 9999999999999999999999999987654321
Q ss_pred c----cchhcccccccccccccccc-cCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccc
Q 005749 536 A----DEMVALAKADGYKAPELQRM-KKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVF 610 (679)
Q Consensus 536 ~----~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 610 (679)
. .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+ ......... .....
T Consensus 176 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~~~~~~~~-~~~~~ 248 (303)
T 2vwi_A 176 DITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK------VLMLTLQND-PPSLE 248 (303)
T ss_dssp ------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGG------HHHHHHTSS-CCCTT
T ss_pred CccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhh------HHHHHhccC-CCccc
Confidence 1 11234568999999999875 568999999999999999999999995533211 111111110 00000
Q ss_pred hHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 611 DMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 611 ~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
. .... .........++.+++.+||+.||++|||+.|+++.
T Consensus 249 ~-~~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 249 T-GVQD--KEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp C--------CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred c-cccc--chhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 0 0000 00001122467789999999999999999999874
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=344.15 Aligned_cols=256 Identities=18% Similarity=0.281 Sum_probs=177.3
Q ss_pred CccccCCceEEEEEE-eCCCCEEEEEEcccCcc--cCcccHHHHHHHHhccCCCCCccceEEeeCC-----CCceEEEEE
Q 005749 383 QVIEKTTYGTAYKAK-LADGATIALRLLREGSC--KDRSSCLPVIRQLGKVRHENLIPLRAFYQGK-----RGEKLLIYD 454 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~-----~~~~~lv~e 454 (679)
+.||+|+||.||+|+ ..+|+.||||++..... ...+.+.+|+++++.++||||+++++++... ....++|+|
T Consensus 35 ~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~e 114 (367)
T 2fst_X 35 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTH 114 (367)
T ss_dssp EECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEE
T ss_pred eEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEEEec
Confidence 789999999999999 56799999999975422 2345788999999999999999999998752 246799999
Q ss_pred ecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcc
Q 005749 455 YFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPA 534 (679)
Q Consensus 455 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 534 (679)
|+ +++|.+++.. ..+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 115 ~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~- 184 (367)
T 2fst_X 115 LM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTAD- 184 (367)
T ss_dssp CC-CEECC----------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC----------
T ss_pred cc-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeeccccccccc-
Confidence 99 6799998864 35899999999999999999999988 99999999999999999999999999986532
Q ss_pred cccchhcccccccccccccccc-cCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhh--cccccccch
Q 005749 535 VADEMVALAKADGYKAPELQRM-KKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVL--EETTMEVFD 611 (679)
Q Consensus 535 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~--~~~~~~~~~ 611 (679)
......||..|+|||++.+ ..++.++||||+||++|||++|+.||.+....+ .+.......-. .+....+..
T Consensus 185 ---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~l~~i~~~~g~p~~~~~~~~~~ 259 (367)
T 2fst_X 185 ---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID--QLKLILRLVGTPGAELLKKISS 259 (367)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCSCCHHHHTTCCC
T ss_pred ---cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCCHHHHHHhhh
Confidence 2345678999999999876 678999999999999999999999996543211 11111111000 000000000
Q ss_pred ---HhhhhcC----CCChH----HHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 612 ---MEIMKGI----RSPME----EGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 612 ---~~i~~~~----~~~~~----~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
....... ..... ...+.+.+++.+||+.||++|||++|+++.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 260 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 0000000 00111 113567899999999999999999999875
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-39 Score=341.46 Aligned_cols=259 Identities=18% Similarity=0.236 Sum_probs=187.1
Q ss_pred CccccCCceEEEEEEeCCCCEEEEEEcccCcccC-----------cccHHHHHHHHhccCCCCCccceEEeeCC----CC
Q 005749 383 QVIEKTTYGTAYKAKLADGATIALRLLREGSCKD-----------RSSCLPVIRQLGKVRHENLIPLRAFYQGK----RG 447 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~-----------~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~----~~ 447 (679)
+.||+|+||.||+|+..+|+.||||++....... .+.+.+|++++++++||||+++++++... ..
T Consensus 28 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 107 (362)
T 3pg1_A 28 RFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMH 107 (362)
T ss_dssp EEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEECCTTTCC
T ss_pred EEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEeccCCCcc
Confidence 6899999999999998889999999986543221 15689999999999999999999998542 33
Q ss_pred ceEEEEEecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeeccc
Q 005749 448 EKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGL 527 (679)
Q Consensus 448 ~~~lv~ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 527 (679)
..++||||++ |+|.+++... ...+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+
T Consensus 108 ~~~lv~e~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 180 (362)
T 3pg1_A 108 KLYLVTELMR-TDLAQVIHDQ---RIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNL 180 (362)
T ss_dssp EEEEEEECCS-EEHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCTTC
T ss_pred eEEEEEccCC-CCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEEEcCCCCEEEEecCc
Confidence 6799999998 5898888753 346899999999999999999999988 99999999999999999999999999
Q ss_pred ccccCcccccchhcccccccccccccccc-cCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccc
Q 005749 528 DQLMVPAVADEMVALAKADGYKAPELQRM-KKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETT 606 (679)
Q Consensus 528 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 606 (679)
++..... .......+|+.|+|||++.+ ..++.++|||||||++|||++|+.||.+....+ .+....... .....
T Consensus 181 ~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~i~~~~-~~~~~ 255 (362)
T 3pg1_A 181 AREDTAD--ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYN--QLNKIVEVV-GTPKI 255 (362)
T ss_dssp -----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHH-CCCCH
T ss_pred ccccccc--cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHc-CCCCh
Confidence 9854332 22334578899999998876 678999999999999999999999996543211 111111100 00000
Q ss_pred cc-------cchHhhhh---cCCC-C----hHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 607 ME-------VFDMEIMK---GIRS-P----MEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 607 ~~-------~~~~~i~~---~~~~-~----~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
.. .....+.. .... . .+...+.+.+++.+||+.||++|||++|++++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 256 EDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp HHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 00 00000000 0000 0 01123567789999999999999999999875
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=339.15 Aligned_cols=261 Identities=13% Similarity=0.205 Sum_probs=194.2
Q ss_pred cCccccCCceEEEEEEe-CCCCEEEEEEcccCcccCcccHHHHHHHHhccC-----------CCCCccceEEeeCCC---
Q 005749 382 GQVIEKTTYGTAYKAKL-ADGATIALRLLREGSCKDRSSCLPVIRQLGKVR-----------HENLIPLRAFYQGKR--- 446 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~-----------H~nIv~l~~~~~~~~--- 446 (679)
.+.||+|+||+||+|+. .+++.||||++.... ...+.+.+|++++++++ ||||+++++++....
T Consensus 24 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 102 (373)
T 1q8y_A 24 VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNG 102 (373)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTE
T ss_pred EEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccCCCC
Confidence 37899999999999994 679999999997532 23456889999999886 899999999987521
Q ss_pred CceEEEEEecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCeeecCCCCCCeeec------CCCc
Q 005749 447 GEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTG-HEIPITHGNVRSKNVLVD------DFFV 519 (679)
Q Consensus 447 ~~~~lv~ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~-~~~~ivHrDlkp~NILl~------~~~~ 519 (679)
...++||||+ +++|.+++.... ...+++..++.|+.||+.||+|||++ + |+||||||+|||++ ..+.
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~~~~~~ 176 (373)
T 1q8y_A 103 VHVVMVFEVL-GENLLALIKKYE--HRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENLIQ 176 (373)
T ss_dssp EEEEEEECCC-CEEHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTEEE
T ss_pred ceEEEEEecC-CCCHHHHHHHhh--ccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCCcCcce
Confidence 2689999999 889999998643 24489999999999999999999997 7 99999999999994 4458
Q ss_pred eEEeecccccccCcccccchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHH
Q 005749 520 SRLTEFGLDQLMVPAVADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKV 599 (679)
Q Consensus 520 ~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~ 599 (679)
+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.................
T Consensus 177 ~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 252 (373)
T 1q8y_A 177 IKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 252 (373)
T ss_dssp EEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHH
T ss_pred EEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHH
Confidence 999999999866432 2345789999999999998999999999999999999999999965433221111111110
Q ss_pred Hhh-cccccc-----------cc----------------hHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHH
Q 005749 600 AVL-EETTME-----------VF----------------DMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVV 651 (679)
Q Consensus 600 ~~~-~~~~~~-----------~~----------------~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl 651 (679)
... ...... .+ ...+.............++.+++.+||+.||++|||++|++
T Consensus 253 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell 332 (373)
T 1q8y_A 253 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLV 332 (373)
T ss_dssp HHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHH
T ss_pred HHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHh
Confidence 000 000000 00 00111112223345667888999999999999999999999
Q ss_pred HH
Q 005749 652 KQ 653 (679)
Q Consensus 652 ~~ 653 (679)
+.
T Consensus 333 ~h 334 (373)
T 1q8y_A 333 NH 334 (373)
T ss_dssp TC
T ss_pred hC
Confidence 85
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=338.72 Aligned_cols=268 Identities=19% Similarity=0.281 Sum_probs=185.5
Q ss_pred cCccccCCceEEEEEEe-CCCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCCCC------ceEEEEE
Q 005749 382 GQVIEKTTYGTAYKAKL-ADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRG------EKLLIYD 454 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~------~~~lv~e 454 (679)
.+.||+|+||.||+|+. .+|+.||||++... ......+.+|++.+..++|||||++++++..... ..++|||
T Consensus 28 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e 106 (360)
T 3e3p_A 28 ERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD-PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVME 106 (360)
T ss_dssp C----------CEEEEETTTCCEEEEEEEECC-TTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEEEEE
T ss_pred EEEEecCCCeEEEEEEECCCCCEEEEEEEecC-ccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEEEee
Confidence 47899999999999995 56999999998653 2334567888899999999999999999865211 2789999
Q ss_pred ecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHh--cCCCCCeeecCCCCCCeeecC-CCceEEeeccccccc
Q 005749 455 YFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLH--TGHEIPITHGNVRSKNVLVDD-FFVSRLTEFGLDQLM 531 (679)
Q Consensus 455 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH--~~~~~~ivHrDlkp~NILl~~-~~~~kl~DFGla~~~ 531 (679)
|+++ +|.+.+.........+++..+..++.|++.||.||| +.+ |+||||||+|||++. ++.+||+|||+++..
T Consensus 107 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~ 182 (360)
T 3e3p_A 107 YVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTLKLCDFGSAKKL 182 (360)
T ss_dssp CCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEEEECCCTTCBCC
T ss_pred cccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcEEEeeCCCceec
Confidence 9986 666555543333566899999999999999999999 777 999999999999997 899999999999876
Q ss_pred Ccccccchhccccccccccccccccc-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcc-cc---
Q 005749 532 VPAVADEMVALAKADGYKAPELQRMK-KCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEE-TT--- 606 (679)
Q Consensus 532 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~-~~--- 606 (679)
.... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.... ..+..+.+...... ..
T Consensus 183 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~ 258 (360)
T 3e3p_A 183 SPSE--PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA--GQLHEIVRVLGCPSREVLRK 258 (360)
T ss_dssp CTTS--CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHHHCCCCHHHHHH
T ss_pred CCCC--CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChH--HHHHHHHHHcCCCCHHHHHh
Confidence 4332 22345789999999988654 4899999999999999999999999653321 11111111100000 00
Q ss_pred --cccchHhhhhcC--------CCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH--HHhhC
Q 005749 607 --MEVFDMEIMKGI--------RSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ--LEENR 658 (679)
Q Consensus 607 --~~~~~~~i~~~~--------~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~--L~~~~ 658 (679)
....+....... .........++.+++.+||+.||++|||+.|++++ +++..
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 322 (360)
T 3e3p_A 259 LNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELH 322 (360)
T ss_dssp HCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGG
T ss_pred cccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccC
Confidence 000000000000 00111234678899999999999999999999976 45543
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=333.69 Aligned_cols=258 Identities=16% Similarity=0.262 Sum_probs=186.9
Q ss_pred CccccCCceEEEEEEeC-CCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeC-------------CCCc
Q 005749 383 QVIEKTTYGTAYKAKLA-DGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQG-------------KRGE 448 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~-------------~~~~ 448 (679)
+.||+|+||.||+|+.. +++.||+|++........+.+.+|++++++++||||+++++++.. ....
T Consensus 17 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~ 96 (320)
T 2i6l_A 17 KPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNS 96 (320)
T ss_dssp EECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCSCSE
T ss_pred EEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccccccCc
Confidence 78999999999999954 589999999976554556788999999999999999999998743 1357
Q ss_pred eEEEEEecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeec-CCCceEEeeccc
Q 005749 449 KLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVD-DFFVSRLTEFGL 527 (679)
Q Consensus 449 ~~lv~ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~-~~~~~kl~DFGl 527 (679)
.++||||++ |+|.+++.. ..+++..++.++.|++.||+|||+++ |+||||||+||+++ +++.+||+|||+
T Consensus 97 ~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl~Dfg~ 167 (320)
T 2i6l_A 97 VYIVQEYME-TDLANVLEQ-----GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGL 167 (320)
T ss_dssp EEEEEECCS-EEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEEECCCTT
T ss_pred eeEEeeccC-CCHHHHhhc-----CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEEEccCcc
Confidence 899999998 599999864 35899999999999999999999988 99999999999997 567999999999
Q ss_pred ccccCcccc--cchhcccccccccccccccc-cCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcc
Q 005749 528 DQLMVPAVA--DEMVALAKADGYKAPELQRM-KKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEE 604 (679)
Q Consensus 528 a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~ 604 (679)
++....... .......++..|+|||.+.. ..++.++||||||+++|||++|+.||.+....+ .+..... .....
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~--~~~~~~~-~~~~~ 244 (320)
T 2i6l_A 168 ARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELE--QMQLILE-SIPVV 244 (320)
T ss_dssp CBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHH-HSCCC
T ss_pred ccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHH--HHHHHHH-hcCCC
Confidence 987643211 11234467889999998765 678999999999999999999999996543211 1111110 00000
Q ss_pred ----------cccccchHhhhhcCCCChH----HHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 605 ----------TTMEVFDMEIMKGIRSPME----EGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 605 ----------~~~~~~~~~i~~~~~~~~~----~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
.......... .....+.. ....++.+++.+||+.||++|||++|+++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 245 HEEDRQELLSVIPVYIRNDM-TEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp CHHHHHHHHTTSCHHHHHHT-TSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred chhhhhhhhhcCcccccccc-cCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 0000000000 00001111 123567889999999999999999999874
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=329.29 Aligned_cols=246 Identities=18% Similarity=0.283 Sum_probs=195.1
Q ss_pred cCccccCCceEEEEEEe-CCCCEEEEEEcccCcc---------cCcccHHHHHHHHhccC-CCCCccceEEeeCCCCceE
Q 005749 382 GQVIEKTTYGTAYKAKL-ADGATIALRLLREGSC---------KDRSSCLPVIRQLGKVR-HENLIPLRAFYQGKRGEKL 450 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~---------~~~~~~~~Ei~~l~~l~-H~nIv~l~~~~~~~~~~~~ 450 (679)
.+.||+|+||.||+|+. .+|+.||||+++.... ...+.+.+|++++++++ ||||+++++++.. .+..+
T Consensus 22 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~-~~~~~ 100 (298)
T 1phk_A 22 KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET-NTFFF 100 (298)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC-SSEEE
T ss_pred eeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc-CCeEE
Confidence 37899999999999995 4689999999975431 12356789999999996 9999999999987 68899
Q ss_pred EEEEecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccc
Q 005749 451 LIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQL 530 (679)
Q Consensus 451 lv~ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 530 (679)
+||||+++++|.+++... ..+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++.
T Consensus 101 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 173 (298)
T 1phk_A 101 LVFDLMKKGELFDYLTEK----VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQ 173 (298)
T ss_dssp EEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEeccCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEecccchhh
Confidence 999999999999999863 45899999999999999999999988 99999999999999999999999999987
Q ss_pred cCcccccchhccccccccccccccc------ccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcc
Q 005749 531 MVPAVADEMVALAKADGYKAPELQR------MKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEE 604 (679)
Q Consensus 531 ~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~ 604 (679)
..... ......+++.|+|||++. ...++.++||||||+++|||++|+.||...... ..........
T Consensus 174 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~~ 245 (298)
T 1phk_A 174 LDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM------LMLRMIMSGN 245 (298)
T ss_dssp CCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHTC
T ss_pred cCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHH------HHHHHHhcCC
Confidence 64322 223457899999999875 456889999999999999999999999543211 1111110000
Q ss_pred cccccchHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 605 TTMEVFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 605 ~~~~~~~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
. .. ..+........+.+++.+||+.||++|||+.|+++.
T Consensus 246 ~--~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (298)
T 1phk_A 246 Y--QF--------GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 284 (298)
T ss_dssp C--CC--------CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred c--cc--------CcccccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence 0 00 001112234567789999999999999999999863
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=334.36 Aligned_cols=247 Identities=19% Similarity=0.291 Sum_probs=188.9
Q ss_pred cCccccCCceEEEEEEe-CCCCEEEEEEcccCcccCcccHHHHHHHHhcc-CCCCCccceEEeeCC-----CCceEEEEE
Q 005749 382 GQVIEKTTYGTAYKAKL-ADGATIALRLLREGSCKDRSSCLPVIRQLGKV-RHENLIPLRAFYQGK-----RGEKLLIYD 454 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~-----~~~~~lv~e 454 (679)
.+.||+|+||.||+|+. .+++.||||++.... ...+.+.+|++++.++ +||||+++++++... .+..++|||
T Consensus 29 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e 107 (326)
T 2x7f_A 29 VELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVME 107 (326)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEEE
T ss_pred EEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEEE
Confidence 37899999999999995 579999999987543 3456789999999999 899999999998753 357899999
Q ss_pred ecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcc
Q 005749 455 YFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPA 534 (679)
Q Consensus 455 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 534 (679)
|+++|+|.+++.... ...+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++......
T Consensus 108 ~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 182 (326)
T 2x7f_A 108 FCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT 182 (326)
T ss_dssp CCTTEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCTTTC-----
T ss_pred cCCCCcHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEEeeCcCceecCcC
Confidence 999999999998643 245899999999999999999999988 999999999999999999999999999875432
Q ss_pred cccchhccccccccccccccc-----ccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhccccccc
Q 005749 535 VADEMVALAKADGYKAPELQR-----MKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEV 609 (679)
Q Consensus 535 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 609 (679)
. .......|++.|+|||++. ...++.++|||||||++|||++|+.||.+.... ...... .......
T Consensus 183 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~-~~~~~~~- 253 (326)
T 2x7f_A 183 V-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM------RALFLI-PRNPAPR- 253 (326)
T ss_dssp ---------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHH-HHSCCCC-
T ss_pred c-cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH------HHHHHh-hcCcccc-
Confidence 1 1223457899999999986 567899999999999999999999999443211 000000 0000000
Q ss_pred chHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 610 FDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 610 ~~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
.........+.+++.+||..||++||+++|+++.
T Consensus 254 ----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 254 ----------LKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp ----------CSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred ----------CCccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0011123467789999999999999999999884
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=339.03 Aligned_cols=255 Identities=19% Similarity=0.270 Sum_probs=189.2
Q ss_pred cCccccCCceEEEEEE-eCCCCEEEEEEcccCcc--cCcccHHHHHHHHhccCCCCCccceEEeeCCCCc------eEEE
Q 005749 382 GQVIEKTTYGTAYKAK-LADGATIALRLLREGSC--KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGE------KLLI 452 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~------~~lv 452 (679)
.+.||+|+||.||+|+ ..+|+.||||++..... ...+.+.+|++++++++||||+++++++... +. .++|
T Consensus 47 ~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~~~~~~~lv 125 (371)
T 4exu_A 47 PTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPA-SSLRNFYDFYLV 125 (371)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSC-SSSTTCCCCEEE
T ss_pred EeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheecc-CCcccceeEEEE
Confidence 3789999999999999 45799999999976432 2246788999999999999999999999863 33 3999
Q ss_pred EEecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccC
Q 005749 453 YDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMV 532 (679)
Q Consensus 453 ~ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 532 (679)
|||+. ++|.+++.. .+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 126 ~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 195 (371)
T 4exu_A 126 MPFMQ-TDLQKIMGM------EFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHAD 195 (371)
T ss_dssp EECCC-EEHHHHTTS------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC----
T ss_pred Ecccc-ccHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCcccccc
Confidence 99997 588888743 3899999999999999999999988 9999999999999999999999999998653
Q ss_pred cccccchhcccccccccccccccc-cCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhc--ccccc-
Q 005749 533 PAVADEMVALAKADGYKAPELQRM-KKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLE--ETTME- 608 (679)
Q Consensus 533 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~--~~~~~- 608 (679)
. ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+....+ .+.......-.. +....
T Consensus 196 ~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~i~~~~~~~~~~~~~~~ 269 (371)
T 4exu_A 196 A----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD--QLTQILKVTGVPGTEFVQKL 269 (371)
T ss_dssp --------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCCCCHHHHTTC
T ss_pred c----CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhCCCcHHHHHHh
Confidence 2 2334578999999999886 678999999999999999999999996533211 111111100000 00000
Q ss_pred --c----chHhhhhcCCCCh----HHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 609 --V----FDMEIMKGIRSPM----EEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 609 --~----~~~~i~~~~~~~~----~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
. +...+........ +...+.+.+++.+||+.||++|||++|+++.
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 270 NDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp SCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 0 0000000000111 1124577899999999999999999999876
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=334.42 Aligned_cols=256 Identities=15% Similarity=0.263 Sum_probs=195.4
Q ss_pred CccccCCceEEEEEEe--CCCCEEEEEEcccCcccCcccHHHHHHHHhccCCCC------CccceEEeeCCCCceEEEEE
Q 005749 383 QVIEKTTYGTAYKAKL--ADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHEN------LIPLRAFYQGKRGEKLLIYD 454 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~--~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~n------Iv~l~~~~~~~~~~~~lv~e 454 (679)
+.||+|+||.||+|+. .+++.||||+++... ...+.+.+|+++++.++|+| |+++++++.. .+..++|||
T Consensus 20 ~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~-~~~~~lv~e 97 (339)
T 1z57_A 20 DTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEH-HGHICIVFE 97 (339)
T ss_dssp EEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEE-TTEEEEEEE
T ss_pred EEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeeccccc-CCcEEEEEc
Confidence 7899999999999985 368899999997532 23467889999999997765 9999999987 679999999
Q ss_pred ecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecC------------------
Q 005749 455 YFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDD------------------ 516 (679)
Q Consensus 455 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~------------------ 516 (679)
|+ +++|.+++.... ...+++..++.++.|++.||+|||+++ |+||||||+|||++.
T Consensus 98 ~~-~~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~ 171 (339)
T 1z57_A 98 LL-GLSTYDFIKENG--FLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRDERTL 171 (339)
T ss_dssp CC-CCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----CEEEEE
T ss_pred CC-CCCHHHHHHhcC--CCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCccccccccc
Confidence 99 889999997642 245899999999999999999999988 999999999999987
Q ss_pred -CCceEEeecccccccCcccccchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhH
Q 005749 517 -FFVSRLTEFGLDQLMVPAVADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPS 595 (679)
Q Consensus 517 -~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~ 595 (679)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. .
T Consensus 172 ~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~---~ 244 (339)
T 1z57_A 172 INPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHL---A 244 (339)
T ss_dssp SCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHH---H
T ss_pred cCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHH---H
Confidence 668999999999864322 23457899999999999889999999999999999999999999654322111 1
Q ss_pred HHHHHhhc--------ccccccch-------------Hhh------hhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHH
Q 005749 596 IVKVAVLE--------ETTMEVFD-------------MEI------MKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMD 648 (679)
Q Consensus 596 ~~~~~~~~--------~~~~~~~~-------------~~i------~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ 648 (679)
.+...... ......+. ..+ ............+++.+++.+||+.||++|||++
T Consensus 245 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ 324 (339)
T 1z57_A 245 MMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLR 324 (339)
T ss_dssp HHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHH
T ss_pred HHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHH
Confidence 11110000 00000000 000 0000111234456788999999999999999999
Q ss_pred HHHHH
Q 005749 649 EVVKQ 653 (679)
Q Consensus 649 evl~~ 653 (679)
|+++.
T Consensus 325 ell~h 329 (339)
T 1z57_A 325 EALKH 329 (339)
T ss_dssp HHTTS
T ss_pred HHhcC
Confidence 99864
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=332.46 Aligned_cols=262 Identities=18% Similarity=0.258 Sum_probs=195.6
Q ss_pred cCccccCCceEEEEEEe--CCCCEEEEEEcccCcc--cCcccHHHHHHHHhcc---CCCCCccceEEeeC----CCCceE
Q 005749 382 GQVIEKTTYGTAYKAKL--ADGATIALRLLREGSC--KDRSSCLPVIRQLGKV---RHENLIPLRAFYQG----KRGEKL 450 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~--~~~~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l---~H~nIv~l~~~~~~----~~~~~~ 450 (679)
.+.||+|+||.||+|+. .+|+.||+|+++.... .....+.+|+++++.+ +||||+++++++.. .....+
T Consensus 16 ~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~ 95 (326)
T 1blx_A 16 VAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLT 95 (326)
T ss_dssp EEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEE
T ss_pred eeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCceEE
Confidence 37899999999999996 4688999999875432 2345788899888777 89999999999872 246789
Q ss_pred EEEEecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccc
Q 005749 451 LIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQL 530 (679)
Q Consensus 451 lv~ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 530 (679)
+||||+. |+|.+++.... ...+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++.
T Consensus 96 lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~ 169 (326)
T 1blx_A 96 LVFEHVD-QDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARI 169 (326)
T ss_dssp EEEECCS-CBHHHHHHHSC--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSCCSCCC
T ss_pred EEEecCC-CCHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEecCccccc
Confidence 9999998 59999997643 234899999999999999999999988 99999999999999999999999999987
Q ss_pred cCcccccchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhh--cccccc
Q 005749 531 MVPAVADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVL--EETTME 608 (679)
Q Consensus 531 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~--~~~~~~ 608 (679)
.... .......|+..|+|||++.+..++.++|||||||++|||++|+.||.+....+ .+......... ......
T Consensus 170 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~i~~~~~~~~~~~~~~ 245 (326)
T 1blx_A 170 YSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD--QLGKILDVIGLPGEEDWPR 245 (326)
T ss_dssp CCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCCCCGGGSCT
T ss_pred ccCC--CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHH--HHHHHHHHcCCCCcccCcc
Confidence 6432 22345678999999999998899999999999999999999999996543211 11111111000 000000
Q ss_pred cc---hHhhhhcCCC----ChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 609 VF---DMEIMKGIRS----PMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 609 ~~---~~~i~~~~~~----~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
.. .......... ..+.....+.+++.+||+.||++|||+.|+++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 246 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp TCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 00 0000000000 001123456789999999999999999999964
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=325.36 Aligned_cols=245 Identities=20% Similarity=0.297 Sum_probs=193.7
Q ss_pred cCccccCCceEEEEEEeC-CCCEEEEEEcccCc--ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCC
Q 005749 382 GQVIEKTTYGTAYKAKLA-DGATIALRLLREGS--CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPS 458 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~ 458 (679)
.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+ .+..++||||+++
T Consensus 27 ~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~ 105 (287)
T 2wei_A 27 VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED-SSSFYIVGELYTG 105 (287)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-SSEEEEEECCCCS
T ss_pred eEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeC-CCeEEEEEEccCC
Confidence 478999999999999954 79999999986543 2345678999999999999999999999987 6789999999999
Q ss_pred CChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCC---CceEEeecccccccCccc
Q 005749 459 RTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDF---FVSRLTEFGLDQLMVPAV 535 (679)
Q Consensus 459 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~---~~~kl~DFGla~~~~~~~ 535 (679)
++|.+++... ..+++..++.++.|++.||+|||+++ |+||||||+||+++.+ +.+||+|||+++......
T Consensus 106 ~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~ 178 (287)
T 2wei_A 106 GELFDEIIKR----KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT 178 (287)
T ss_dssp CBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCS
T ss_pred CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcceeecCCC
Confidence 9999988763 35899999999999999999999988 9999999999999754 479999999998654322
Q ss_pred ccchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhh
Q 005749 536 ADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIM 615 (679)
Q Consensus 536 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~ 615 (679)
......+++.|+|||.+.+ .++.++||||||+++|||++|+.||.+.... ........... . ++.
T Consensus 179 --~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~~~-~--~~~--- 243 (287)
T 2wei_A 179 --KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY------DILKRVETGKY-A--FDL--- 243 (287)
T ss_dssp --SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCCC-C--CCS---
T ss_pred --ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH------HHHHHHHcCCC-C--CCc---
Confidence 1233457889999998875 5899999999999999999999999543211 11111100000 0 000
Q ss_pred hcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 616 KGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 616 ~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
+.......++.+++.+||+.||++|||+.|+++.
T Consensus 244 ----~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 244 ----PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp ----GGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred ----hhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence 0001223567789999999999999999999984
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=344.98 Aligned_cols=248 Identities=20% Similarity=0.234 Sum_probs=182.4
Q ss_pred cCccccCCceEEEEEEeCCCCEEEEEEcccCcccCcccHHHHHHHHhcc-CCCCCccceEEeeCCCCceEEEEEecCCCC
Q 005749 382 GQVIEKTTYGTAYKAKLADGATIALRLLREGSCKDRSSCLPVIRQLGKV-RHENLIPLRAFYQGKRGEKLLIYDYFPSRT 460 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~~lv~ey~~~gs 460 (679)
.++||+|+||+||.+...+|+.||||++... ..+.+.+|++++.++ +|||||++++++.+ .+..++|||||. |+
T Consensus 20 ~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~-~~~~~lv~E~~~-gs 94 (434)
T 2rio_A 20 EKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETT-DRFLYIALELCN-LN 94 (434)
T ss_dssp EEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEEC-SSEEEEEECCCS-EE
T ss_pred cCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEec-CCeEEEEEecCC-CC
Confidence 3789999999998777778999999998653 234678999999987 89999999999987 678999999996 69
Q ss_pred hHHHhhcccCCCCC---CCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCC-------------CceEEee
Q 005749 461 LHDLLHDTIAGKPV---LNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDF-------------FVSRLTE 524 (679)
Q Consensus 461 L~~~l~~~~~~~~~---l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~-------------~~~kl~D 524 (679)
|.+++......... .++..++.|+.||+.||+|||+++ |+||||||+|||++.+ +.+||+|
T Consensus 95 L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~D 171 (434)
T 2rio_A 95 LQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISD 171 (434)
T ss_dssp HHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECC
T ss_pred HHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEEEEcc
Confidence 99999864321111 133356789999999999999988 9999999999999754 4899999
Q ss_pred cccccccCccccc---chhcccccccccccccccc-------cCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccch
Q 005749 525 FGLDQLMVPAVAD---EMVALAKADGYKAPELQRM-------KKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDL 593 (679)
Q Consensus 525 FGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l 593 (679)
||+++........ ......||+.|+|||++.+ ..++.++|||||||++|||++ |+.||.+....+
T Consensus 172 FG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~---- 247 (434)
T 2rio_A 172 FGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE---- 247 (434)
T ss_dssp CTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH----
T ss_pred cccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH----
Confidence 9999876543221 1234579999999999865 568999999999999999998 999984432110
Q ss_pred hHHHHHHhhcccccccchHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHH
Q 005749 594 PSIVKVAVLEETTMEVFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVK 652 (679)
Q Consensus 594 ~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 652 (679)
..+..... .... . ..........++.+++.+||+.||++|||+.||++
T Consensus 248 ~~i~~~~~---~~~~------~--~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 248 SNIIRGIF---SLDE------M--KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp HHHHHTCC---CCCC------C--TTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHhcCCC---Cccc------c--cccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 11111000 0000 0 00112344567889999999999999999999986
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=329.42 Aligned_cols=260 Identities=19% Similarity=0.272 Sum_probs=192.2
Q ss_pred cCccccCCceEEEEEEe-CCCCEEEEEEcccCcc-cCcccHHHHHHHHhccCCCCCccceEEeeCC----CCceEEEEEe
Q 005749 382 GQVIEKTTYGTAYKAKL-ADGATIALRLLREGSC-KDRSSCLPVIRQLGKVRHENLIPLRAFYQGK----RGEKLLIYDY 455 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~----~~~~~lv~ey 455 (679)
.+.||+|+||.||+|+. .+|+.||||++..... .....+.+|++++++++||||+++++++... ....++||||
T Consensus 16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~ 95 (353)
T 2b9h_A 16 KSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQEL 95 (353)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEECC
T ss_pred eeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEEEec
Confidence 37899999999999995 4689999999975432 2345678999999999999999999988753 2678999999
Q ss_pred cCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCccc
Q 005749 456 FPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAV 535 (679)
Q Consensus 456 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 535 (679)
+. |+|.+++.. ..+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 96 ~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 166 (353)
T 2b9h_A 96 MQ-TDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESA 166 (353)
T ss_dssp CS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred cC-ccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEeccccccccccc
Confidence 97 599999875 34899999999999999999999988 9999999999999999999999999998764321
Q ss_pred cc---------chhcccccccccccccccc-cCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcc-
Q 005749 536 AD---------EMVALAKADGYKAPELQRM-KKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEE- 604 (679)
Q Consensus 536 ~~---------~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~- 604 (679)
.. ......||+.|+|||++.. ..++.++|||||||++|||++|+.||.+....+ .+..... .....
T Consensus 167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~~-~~~~~~ 243 (353)
T 2b9h_A 167 ADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRH--QLLLIFG-IIGTPH 243 (353)
T ss_dssp -------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHH-HHCCCC
T ss_pred ccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHH--HHHHHHH-HhCCCc
Confidence 11 1223578999999998764 678999999999999999999999996543211 0111110 00000
Q ss_pred ---cccccchH---hhhhcC----CCCh----HHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 605 ---TTMEVFDM---EIMKGI----RSPM----EEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 605 ---~~~~~~~~---~i~~~~----~~~~----~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
........ ...... .... +...+++.+++.+||+.||++|||++|+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 244 SDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp STTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00000000 000000 0000 1223567789999999999999999999874
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=331.66 Aligned_cols=235 Identities=19% Similarity=0.329 Sum_probs=191.7
Q ss_pred cCccccCCceEEEEEE-eCCCCEEEEEEcccCccc------CcccHHHHHHHHhccC--CCCCccceEEeeCCCCceEEE
Q 005749 382 GQVIEKTTYGTAYKAK-LADGATIALRLLREGSCK------DRSSCLPVIRQLGKVR--HENLIPLRAFYQGKRGEKLLI 452 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~------~~~~~~~Ei~~l~~l~--H~nIv~l~~~~~~~~~~~~lv 452 (679)
.+.||+|+||.||+|+ ..+++.||||+++..... ..+.+.+|++++++++ |+||+++++++.. .+..++|
T Consensus 48 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~-~~~~~lv 126 (320)
T 3a99_A 48 GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER-PDSFVLI 126 (320)
T ss_dssp EEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC-SSEEEEE
T ss_pred EEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec-CCcEEEE
Confidence 3789999999999998 567899999999764322 3457889999999996 5999999999997 6789999
Q ss_pred EEecCC-CChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeec-CCCceEEeecccccc
Q 005749 453 YDYFPS-RTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVD-DFFVSRLTEFGLDQL 530 (679)
Q Consensus 453 ~ey~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~-~~~~~kl~DFGla~~ 530 (679)
|||+.+ ++|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++ +++.+||+|||+++.
T Consensus 127 ~e~~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~ 199 (320)
T 3a99_A 127 LERPEPVQDLFDFITER----GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGAL 199 (320)
T ss_dssp EECCSSEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEcCCCCccHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEeeCccccc
Confidence 999976 8999999763 45899999999999999999999988 99999999999999 789999999999987
Q ss_pred cCcccccchhcccccccccccccccccCC-CCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhccccccc
Q 005749 531 MVPAVADEMVALAKADGYKAPELQRMKKC-SSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEV 609 (679)
Q Consensus 531 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 609 (679)
.... ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||.... ...
T Consensus 200 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~--------~~~------------ 256 (320)
T 3a99_A 200 LKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--------EII------------ 256 (320)
T ss_dssp CCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--------HHH------------
T ss_pred cccc---cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh--------hhh------------
Confidence 6432 2234568999999999886665 678999999999999999999984310 000
Q ss_pred chHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 610 FDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 610 ~~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
.+..........++.+++.+||+.||++|||++|+++.
T Consensus 257 ------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 257 ------RGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp ------HCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ------cccccccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000011122456789999999999999999999874
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=335.39 Aligned_cols=256 Identities=18% Similarity=0.269 Sum_probs=189.5
Q ss_pred cCccccCCceEEEEEEe-CCCCEEEEEEcccCcc--cCcccHHHHHHHHhccCCCCCccceEEeeCCCC-----ceEEEE
Q 005749 382 GQVIEKTTYGTAYKAKL-ADGATIALRLLREGSC--KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRG-----EKLLIY 453 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~-----~~~lv~ 453 (679)
.+.||+|+||.||+|+. .+|+.||||++..... ...+.+.+|+.++++++||||+++++++..... ..++||
T Consensus 29 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~ 108 (353)
T 3coi_A 29 PTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVM 108 (353)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEE
T ss_pred eeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEEEEe
Confidence 37899999999999995 5699999999976432 224578899999999999999999999986322 359999
Q ss_pred EecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCc
Q 005749 454 DYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVP 533 (679)
Q Consensus 454 ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 533 (679)
||+. ++|.+++.. .+++..++.++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++....
T Consensus 109 e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 178 (353)
T 3coi_A 109 PFMQ-TDLQKIMGL------KFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADA 178 (353)
T ss_dssp ECCS-EEGGGTTTS------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCTTC---
T ss_pred cccc-CCHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccccCCCC
Confidence 9997 588887743 3899999999999999999999988 99999999999999999999999999986532
Q ss_pred ccccchhcccccccccccccccc-cCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhh--cccccccc
Q 005749 534 AVADEMVALAKADGYKAPELQRM-KKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVL--EETTMEVF 610 (679)
Q Consensus 534 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~--~~~~~~~~ 610 (679)
. .....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||.+....+ .+.......-. .+......
T Consensus 179 ~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~--~~~~i~~~~~~~~~~~~~~~~ 252 (353)
T 3coi_A 179 E----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD--QLTQILKVTGVPGTEFVQKLN 252 (353)
T ss_dssp ---------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHH--HHHHHHHHHCBCCHHHHTTCS
T ss_pred C----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCCHHHHHHHh
Confidence 2 234578999999998876 678999999999999999999999996533211 11111110000 00000000
Q ss_pred h---Hhhhhc--------CCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 611 D---MEIMKG--------IRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 611 ~---~~i~~~--------~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
+ ...... .....+....++.+++.+||+.||++|||++|+++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 253 DKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp CHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0 000000 001112334677889999999999999999999875
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=327.01 Aligned_cols=247 Identities=19% Similarity=0.304 Sum_probs=184.9
Q ss_pred cCccccCCceEEEEEEe-CCCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCC------------CCc
Q 005749 382 GQVIEKTTYGTAYKAKL-ADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGK------------RGE 448 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~------------~~~ 448 (679)
.+.||+|+||.||+|+. .+++.||||++... ....+.+.+|++++++++||||+++++++.+. .+.
T Consensus 11 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 89 (303)
T 1zy4_A 11 IAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKST 89 (303)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------CEEE
T ss_pred hheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccccCCc
Confidence 47899999999999995 57999999998653 23346789999999999999999999987642 346
Q ss_pred eEEEEEecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccc
Q 005749 449 KLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLD 528 (679)
Q Consensus 449 ~~lv~ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 528 (679)
.++||||+++|+|.+++... ...+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~ 163 (303)
T 1zy4_A 90 LFIQMEYCENGTLYDLIHSE---NLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLA 163 (303)
T ss_dssp EEEEEECCCSCBHHHHHHHS---CGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCCC
T ss_pred eEEEEecCCCCCHHHhhhcc---ccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEeeCcch
Confidence 79999999999999999753 345788999999999999999999988 999999999999999999999999999
Q ss_pred cccCccc-------------ccchhccccccccccccccccc-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchh
Q 005749 529 QLMVPAV-------------ADEMVALAKADGYKAPELQRMK-KCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLP 594 (679)
Q Consensus 529 ~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~ 594 (679)
+...... ........|+..|+|||++.+. .++.++|||||||++|||++ ||... ....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~-----~~~~ 235 (303)
T 1zy4_A 164 KNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG-----MERV 235 (303)
T ss_dssp SCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH-----HHHH
T ss_pred hhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc-----hhHH
Confidence 8754221 1122345688999999998754 68999999999999999998 54211 0111
Q ss_pred HHHHHHhhcccccccchHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 595 SIVKVAVLEETTMEVFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 595 ~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
...... ... ...+. . .........+.+++.+||+.||++|||++|+++.
T Consensus 236 ~~~~~~-~~~--~~~~~----~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 236 NILKKL-RSV--SIEFP----P---DFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp HHHHHH-HST--TCCCC----T---TCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred HHHHhc-ccc--ccccC----c---cccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 111110 000 00000 0 0111223456789999999999999999999874
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-38 Score=336.92 Aligned_cols=194 Identities=19% Similarity=0.308 Sum_probs=162.8
Q ss_pred cCccccCCceEEEEEEe-CCCCEEEEEEcccCcccCcccHHHHHHHHhccC-CC-----CCccceEEeeCCCCceEEEEE
Q 005749 382 GQVIEKTTYGTAYKAKL-ADGATIALRLLREGSCKDRSSCLPVIRQLGKVR-HE-----NLIPLRAFYQGKRGEKLLIYD 454 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~-H~-----nIv~l~~~~~~~~~~~~lv~e 454 (679)
.+.||+|+||+||+|+. .+++.||||+++... ...+++.+|++++..++ |+ +|+++++++.. .+..++|||
T Consensus 59 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~-~~~~~lv~e 136 (382)
T 2vx3_A 59 DSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF-RNHLCLVFE 136 (382)
T ss_dssp EEEEEEETTEEEEEEEETTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE-TTEEEEEEE
T ss_pred EEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc-CCceEEEEe
Confidence 37899999999999994 468899999997532 22456778899988885 44 49999999987 689999999
Q ss_pred ecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeec--CCCceEEeecccccccC
Q 005749 455 YFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVD--DFFVSRLTEFGLDQLMV 532 (679)
Q Consensus 455 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~--~~~~~kl~DFGla~~~~ 532 (679)
|++ |+|.+++.... ...+++..++.++.|++.||+|||++ ..+|+||||||+|||++ .++.+||+|||+++...
T Consensus 137 ~~~-~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~ 212 (382)
T 2vx3_A 137 MLS-YNLYDLLRNTN--FRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG 212 (382)
T ss_dssp CCC-CBHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTCEETT
T ss_pred cCC-CCHHHHHhhcC--cCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCceecc
Confidence 996 49999998643 23589999999999999999999963 13499999999999994 57889999999998763
Q ss_pred cccccchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 005749 533 PAVADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSG 585 (679)
Q Consensus 533 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~ 585 (679)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+.
T Consensus 213 ~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~ 261 (382)
T 2vx3_A 213 QR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA 261 (382)
T ss_dssp CC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 32 23457899999999999989999999999999999999999999654
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=328.49 Aligned_cols=235 Identities=20% Similarity=0.378 Sum_probs=187.5
Q ss_pred cCccccCCceEEEEEE-eCCCCEEEEEEcccCcc------cCcccHHHHHHHHhcc----CCCCCccceEEeeCCCCceE
Q 005749 382 GQVIEKTTYGTAYKAK-LADGATIALRLLREGSC------KDRSSCLPVIRQLGKV----RHENLIPLRAFYQGKRGEKL 450 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~------~~~~~~~~Ei~~l~~l----~H~nIv~l~~~~~~~~~~~~ 450 (679)
.+.||+|+||.||+|+ ..+++.||||+++.... .....+.+|++++.++ +||||+++++++.. .+..+
T Consensus 36 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~-~~~~~ 114 (312)
T 2iwi_A 36 GPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFET-QEGFM 114 (312)
T ss_dssp EEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC------CE
T ss_pred eeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEec-CCeEE
Confidence 4789999999999998 46789999999975432 2345678899999999 89999999999987 67889
Q ss_pred EEEEe-cCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeec-CCCceEEeecccc
Q 005749 451 LIYDY-FPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVD-DFFVSRLTEFGLD 528 (679)
Q Consensus 451 lv~ey-~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~-~~~~~kl~DFGla 528 (679)
+|||| +.+++|.+++... ..+++..++.++.|++.||+|||+++ |+||||||+||+++ +++.+||+|||++
T Consensus 115 ~v~e~~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl~dfg~~ 187 (312)
T 2iwi_A 115 LVLERPLPAQDLFDYITEK----GPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSG 187 (312)
T ss_dssp EEEECCSSEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEEECCCSSC
T ss_pred EEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEEEEEcchh
Confidence 99999 7899999999863 35899999999999999999999988 99999999999999 8899999999999
Q ss_pred cccCcccccchhcccccccccccccccccCC-CCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhccccc
Q 005749 529 QLMVPAVADEMVALAKADGYKAPELQRMKKC-SSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTM 607 (679)
Q Consensus 529 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 607 (679)
+..... ......|+..|+|||++.+..+ +.++||||||+++|||++|+.||.... ...
T Consensus 188 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--------~~~---------- 246 (312)
T 2iwi_A 188 ALLHDE---PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ--------EIL---------- 246 (312)
T ss_dssp EECCSS---CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--------HHH----------
T ss_pred hhcccC---cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH--------HHh----------
Confidence 876433 2234568999999999876665 458999999999999999999984210 000
Q ss_pred ccchHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 608 EVFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 608 ~~~~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
.............+.+++.+||+.||++|||++|+++.
T Consensus 247 --------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 247 --------EAELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp --------HTCCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred --------hhccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00001111223456789999999999999999999875
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-38 Score=332.46 Aligned_cols=247 Identities=17% Similarity=0.220 Sum_probs=168.2
Q ss_pred cCccccCCceEEEEEEeC-CCCEEEEEEcccCcccCcccHHHHHH-HHhccCCCCCccceEEeeCC---CCceEEEEEec
Q 005749 382 GQVIEKTTYGTAYKAKLA-DGATIALRLLREGSCKDRSSCLPVIR-QLGKVRHENLIPLRAFYQGK---RGEKLLIYDYF 456 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~-~l~~l~H~nIv~l~~~~~~~---~~~~~lv~ey~ 456 (679)
+++||+|+||.||+|+.. +|+.||||++... ....+|+. .+..++||||+++++++... ....++||||+
T Consensus 34 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~ 108 (336)
T 3fhr_A 34 KQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECM 108 (336)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEESS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECC
T ss_pred ceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEecc
Confidence 467999999999999954 7999999998652 22333433 45667999999999998751 33579999999
Q ss_pred CCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecC---CCceEEeecccccccCc
Q 005749 457 PSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDD---FFVSRLTEFGLDQLMVP 533 (679)
Q Consensus 457 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~---~~~~kl~DFGla~~~~~ 533 (679)
++|+|.+++.... ...+++.+++.++.|++.||+|||+++ |+||||||+||+++. ++.+||+|||+++....
T Consensus 109 ~gg~L~~~l~~~~--~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~ 183 (336)
T 3fhr_A 109 EGGELFSRIQERG--DQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ 183 (336)
T ss_dssp TTEEHHHHHHTC---CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEEC--
T ss_pred CCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEeccccceeccc
Confidence 9999999998643 346999999999999999999999988 999999999999976 45599999999986542
Q ss_pred ccccchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHh
Q 005749 534 AVADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDME 613 (679)
Q Consensus 534 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 613 (679)
. ......+|+.|+|||++.+..++.++||||||+++|||++|+.||........... ... .....
T Consensus 184 ~---~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~---~~~---------~~~~~ 248 (336)
T 3fhr_A 184 N---ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPG---MKR---------RIRLG 248 (336)
T ss_dssp -----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------------------
T ss_pred c---ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhh---HHH---------hhhcc
Confidence 2 22345689999999999888899999999999999999999999955432211000 000 00000
Q ss_pred hhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 614 IMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 614 i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
......+.......++.+++.+||+.||++|||++|+++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 288 (336)
T 3fhr_A 249 QYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNH 288 (336)
T ss_dssp --CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred ccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0000001111234567789999999999999999999985
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=331.56 Aligned_cols=251 Identities=19% Similarity=0.246 Sum_probs=172.7
Q ss_pred cCccccCCceEEEEEEe-CCCCEEEEEEcccCcc-cCcccHHHHHH-HHhccCCCCCccceEEeeCCCCceEEEEEecCC
Q 005749 382 GQVIEKTTYGTAYKAKL-ADGATIALRLLREGSC-KDRSSCLPVIR-QLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPS 458 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~-~~~~~~~~Ei~-~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~ 458 (679)
.+.||+|+||.||+|+. .+|+.||||+++.... .....+..|+. +++.++||||+++++++.. .+..++||||+++
T Consensus 27 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~-~~~~~lv~e~~~~ 105 (327)
T 3aln_A 27 LGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFR-EGDCWICMELMST 105 (327)
T ss_dssp -CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEEC-SSEEEEEECCCSE
T ss_pred hheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEe-CCceEEEEeecCC
Confidence 37899999999999995 5799999999976432 23345666666 6777899999999999987 6789999999985
Q ss_pred CChHHHhhccc-CCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCeeecCCCCCCeeecCCCceEEeecccccccCcccc
Q 005749 459 RTLHDLLHDTI-AGKPVLNWARRHKIALGIARGLAYLHTG-HEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVA 536 (679)
Q Consensus 459 gsL~~~l~~~~-~~~~~l~~~~~~~i~~~ia~gL~~LH~~-~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 536 (679)
+|.+++.... .....+++..+..++.|++.||+|||+. + |+||||||+||+++.++.+||+|||+++......
T Consensus 106 -~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~- 180 (327)
T 3aln_A 106 -SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSI- 180 (327)
T ss_dssp -EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC------
T ss_pred -ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceeccccc-
Confidence 8888776321 1135689999999999999999999997 7 9999999999999999999999999998764322
Q ss_pred cchhcccccccccccccc----cccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchH
Q 005749 537 DEMVALAKADGYKAPELQ----RMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDM 612 (679)
Q Consensus 537 ~~~~~~~gt~~y~aPE~~----~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 612 (679)
......||+.|+|||++ .+..++.++||||||+++|||++|+.||....... ..+ .. . .....+
T Consensus 181 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~--------~~-~-~~~~~~ 248 (327)
T 3aln_A 181 -AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF-DQL--------TQ-V-VKGDPP 248 (327)
T ss_dssp --------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC----------------CC-C-CCSCCC
T ss_pred -ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH-HHH--------HH-H-hcCCCC
Confidence 12334689999999998 45678999999999999999999999995432110 000 00 0 000000
Q ss_pred hhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 613 EIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 613 ~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
.+.. .........+.+++.+||+.||++|||+.|+++.
T Consensus 249 ~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 249 QLSN---SEEREFSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp CCCC---CSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred CCCC---cccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 0000 0011223567789999999999999999999774
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-38 Score=327.06 Aligned_cols=245 Identities=16% Similarity=0.188 Sum_probs=187.3
Q ss_pred CccccCCceEEEEEEeCCCCEEEEEEcccCcc--cCcccHHHHHHHHhccC--CCCCccceEEeeCCCCceEEEEEecCC
Q 005749 383 QVIEKTTYGTAYKAKLADGATIALRLLREGSC--KDRSSCLPVIRQLGKVR--HENLIPLRAFYQGKRGEKLLIYDYFPS 458 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~~~~~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~--H~nIv~l~~~~~~~~~~~~lv~ey~~~ 458 (679)
+.||+|+||.||+|+..+++.||||++..... ...+.+.+|++++.+++ ||||+++++++.. .+..++||| +.+
T Consensus 34 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~-~~~~~lv~e-~~~ 111 (313)
T 3cek_A 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT-DQYIYMVME-CGN 111 (313)
T ss_dssp EEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEEC-SSEEEEEEC-CCS
T ss_pred EEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeec-CCEEEEEEe-cCC
Confidence 78999999999999988899999999975432 23467899999999997 5999999999987 678999999 567
Q ss_pred CChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCccccc-
Q 005749 459 RTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVAD- 537 (679)
Q Consensus 459 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~- 537 (679)
++|.+++... ..+++..++.++.|+++||+|||+++ |+||||||+||++++ +.+||+|||+++........
T Consensus 112 ~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~~~ 183 (313)
T 3cek_A 112 IDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSV 183 (313)
T ss_dssp EEHHHHHHHC----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSSSCC--------
T ss_pred CcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeeccccccccCccccc
Confidence 8999999863 45899999999999999999999988 999999999999975 89999999999876433221
Q ss_pred chhcccccccccccccccc-----------cCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccc
Q 005749 538 EMVALAKADGYKAPELQRM-----------KKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETT 606 (679)
Q Consensus 538 ~~~~~~gt~~y~aPE~~~~-----------~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 606 (679)
......|++.|+|||.+.+ ..++.++||||||+++|||++|+.||...... ..........
T Consensus 184 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-----~~~~~~~~~~--- 255 (313)
T 3cek_A 184 VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----ISKLHAIIDP--- 255 (313)
T ss_dssp ------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-----HHHHHHHHCT---
T ss_pred cccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH-----HHHHHHHHhc---
Confidence 1234568999999999865 46888999999999999999999999543211 1111111100
Q ss_pred cccchHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHH
Q 005749 607 MEVFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQL 654 (679)
Q Consensus 607 ~~~~~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L 654 (679)
.... ........++.+++.+||+.||++||+++|+++.-
T Consensus 256 ------~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~ 294 (313)
T 3cek_A 256 ------NHEI---EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 294 (313)
T ss_dssp ------TSCC---CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred ------cccc---CCcccchHHHHHHHHHHccCCcccCcCHHHHhcCc
Confidence 0000 00011124567899999999999999999999764
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-38 Score=341.04 Aligned_cols=243 Identities=17% Similarity=0.209 Sum_probs=181.3
Q ss_pred cCccccCCceEEEEEEeCCCCEEEEEEcccCcccCcccHHHHHHHHhcc-CCCCCccceEEeeCCCCceEEEEEecCCCC
Q 005749 382 GQVIEKTTYGTAYKAKLADGATIALRLLREGSCKDRSSCLPVIRQLGKV-RHENLIPLRAFYQGKRGEKLLIYDYFPSRT 460 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~~lv~ey~~~gs 460 (679)
.++||+|+||+||.....+++.||||++... ..+.+.+|+++++++ +|||||++++++.+ ....++|||||. |+
T Consensus 29 ~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~-~~~~~lv~E~~~-g~ 103 (432)
T 3p23_A 29 KDVLGHGAEGTIVYRGMFDNRDVAVKRILPE---CFSFADREVQLLRESDEHPNVIRYFCTEKD-RQFQYIAIELCA-AT 103 (432)
T ss_dssp EEEEEECGGGCEEEEEESSSSEEEEEEECTT---TEEECHHHHHHHHHSCCCTTBCCEEEEEEE-TTEEEEEEECCS-EE
T ss_pred CCeeecCcCEEEEEEEEeCCeEEEEEEECHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEec-CCEEEEEEECCC-CC
Confidence 3789999999976655668999999998653 345678999999999 79999999999987 678999999996 59
Q ss_pred hHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecC-----CCceEEeecccccccCccc
Q 005749 461 LHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDD-----FFVSRLTEFGLDQLMVPAV 535 (679)
Q Consensus 461 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~-----~~~~kl~DFGla~~~~~~~ 535 (679)
|.+++.... ..+.+..++.++.||+.||+|||+++ |+||||||+|||++. ...+||+|||+++......
T Consensus 104 L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~ 177 (432)
T 3p23_A 104 LQEYVEQKD---FAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGR 177 (432)
T ss_dssp HHHHHHSSS---CCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC----
T ss_pred HHHHHHhcC---CCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCC
Confidence 999998643 23445566789999999999999988 999999999999943 3468899999998764332
Q ss_pred c--cchhccccccccccccccc---ccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHHhhccccccc
Q 005749 536 A--DEMVALAKADGYKAPELQR---MKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAVLEETTMEV 609 (679)
Q Consensus 536 ~--~~~~~~~gt~~y~aPE~~~---~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 609 (679)
. .......||+.|+|||++. ...++.++|||||||++|||++ |..||...... .......... ..
T Consensus 178 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~-------~~~~~~~~~~-~~- 248 (432)
T 3p23_A 178 HSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR-------QANILLGACS-LD- 248 (432)
T ss_dssp --------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH-------HHHHHTTCCC-CT-
T ss_pred cceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH-------HHHHHhccCC-cc-
Confidence 1 2234567999999999987 4567889999999999999999 88898432111 1111110000 00
Q ss_pred chHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHH
Q 005749 610 FDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVK 652 (679)
Q Consensus 610 ~~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 652 (679)
...+.......+.+++.+||+.||++|||++||++
T Consensus 249 --------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 249 --------CLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp --------TSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --------ccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 00111223445678999999999999999999984
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-38 Score=332.60 Aligned_cols=257 Identities=17% Similarity=0.249 Sum_probs=192.9
Q ss_pred cCccccCCceEEEEEEeC-CC-CEEEEEEcccCcccCcccHHHHHHHHhccCCCC------CccceEEeeCCCCceEEEE
Q 005749 382 GQVIEKTTYGTAYKAKLA-DG-ATIALRLLREGSCKDRSSCLPVIRQLGKVRHEN------LIPLRAFYQGKRGEKLLIY 453 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~-~~-~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~n------Iv~l~~~~~~~~~~~~lv~ 453 (679)
.+.||+|+||.||+|+.. ++ +.||+|+++... ...+.+.+|++++++++|++ ++.+++++.. .+..++||
T Consensus 24 ~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~-~~~~~lv~ 101 (355)
T 2eu9_A 24 VGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG-KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF-HGHMCIAF 101 (355)
T ss_dssp EEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE-TTEEEEEE
T ss_pred EEEeeccCCeEEEEEEecCCCceEEEEEEEcccc-cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee-CCeEEEEE
Confidence 378999999999999953 44 689999997532 23467889999999998776 8899998887 67899999
Q ss_pred EecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee-------------------
Q 005749 454 DYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLV------------------- 514 (679)
Q Consensus 454 ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl------------------- 514 (679)
||+ ++++.+++.... ...+++..++.|+.||+.||+|||+++ |+||||||+|||+
T Consensus 102 e~~-~~~l~~~l~~~~--~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~ 175 (355)
T 2eu9_A 102 ELL-GKNTFEFLKENN--FQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCEEKS 175 (355)
T ss_dssp ECC-CCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CCCEEE
T ss_pred ecc-CCChHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccccccccc
Confidence 999 567777776532 245899999999999999999999988 9999999999999
Q ss_pred cCCCceEEeecccccccCcccccchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchh
Q 005749 515 DDFFVSRLTEFGLDQLMVPAVADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLP 594 (679)
Q Consensus 515 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~ 594 (679)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+..
T Consensus 176 ~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~--- 248 (355)
T 2eu9_A 176 VKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHL--- 248 (355)
T ss_dssp ESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---
T ss_pred cCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHH---
Confidence 67789999999999864322 23457899999999999889999999999999999999999999654322111
Q ss_pred HHHHHHhhc--------cccccc------------chHh-hh------hcCCCChHHHHHHHHHHHHhccCcCCCCCCCH
Q 005749 595 SIVKVAVLE--------ETTMEV------------FDME-IM------KGIRSPMEEGLVQALKLAMGCCAPVASVRPTM 647 (679)
Q Consensus 595 ~~~~~~~~~--------~~~~~~------------~~~~-i~------~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~ 647 (679)
..+...... ...... .+.. .. ............++.+++.+||+.||++|||+
T Consensus 249 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~ 328 (355)
T 2eu9_A 249 VMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITL 328 (355)
T ss_dssp HHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCH
T ss_pred HHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCH
Confidence 111110000 000000 0000 00 00011122345678899999999999999999
Q ss_pred HHHHHH
Q 005749 648 DEVVKQ 653 (679)
Q Consensus 648 ~evl~~ 653 (679)
+|+++.
T Consensus 329 ~e~l~h 334 (355)
T 2eu9_A 329 AEALLH 334 (355)
T ss_dssp HHHTTS
T ss_pred HHHhcC
Confidence 999864
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-37 Score=320.86 Aligned_cols=246 Identities=18% Similarity=0.247 Sum_probs=171.4
Q ss_pred cCccccCCceEEEEEEe-CCCCEEEEEEcccCccc-C-cccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCC
Q 005749 382 GQVIEKTTYGTAYKAKL-ADGATIALRLLREGSCK-D-RSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPS 458 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~-~-~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~ 458 (679)
.+.||+|+||.||+|+. .+|+.||||++...... . .+.+..+..+++.++||||+++++++.+ .+..++||||+ +
T Consensus 30 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~-~~~~~lv~e~~-~ 107 (318)
T 2dyl_A 30 LGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFIT-NTDVFIAMELM-G 107 (318)
T ss_dssp EEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-SSEEEEEECCC-S
T ss_pred cceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEec-CCcEEEEEecc-C
Confidence 36899999999999995 47999999999764321 1 2233444556788899999999999987 67899999999 4
Q ss_pred CChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCeeecCCCCCCeeecCCCceEEeecccccccCccccc
Q 005749 459 RTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTG-HEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVAD 537 (679)
Q Consensus 459 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~-~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 537 (679)
+.+..+.... ...+++..++.++.|+++||+|||++ + |+||||||+||+++.++.+||+|||+++......
T Consensus 108 ~~~~~l~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-- 179 (318)
T 2dyl_A 108 TCAEKLKKRM---QGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK-- 179 (318)
T ss_dssp EEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred CcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccCCc--
Confidence 4555555432 34589999999999999999999985 7 9999999999999999999999999997654322
Q ss_pred chhccccccccccccccc-----ccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchH
Q 005749 538 EMVALAKADGYKAPELQR-----MKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDM 612 (679)
Q Consensus 538 ~~~~~~gt~~y~aPE~~~-----~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 612 (679)
......+++.|+|||++. ...++.++||||||+++|||++|+.||...... ............ .
T Consensus 180 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~~~~~~~~-~----- 248 (318)
T 2dyl_A 180 AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD-----FEVLTKVLQEEP-P----- 248 (318)
T ss_dssp -------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH-----HHHHHHHHHSCC-C-----
T ss_pred cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc-----HHHHHHHhccCC-C-----
Confidence 223456899999999984 456899999999999999999999999542211 111111111100 0
Q ss_pred hhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 613 EIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 613 ~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
. .+.......++.+++.+||+.||++||+++|+++.
T Consensus 249 ~-----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 249 L-----LPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp C-----CCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred C-----CCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 0 00001123467789999999999999999999874
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=314.18 Aligned_cols=244 Identities=10% Similarity=0.071 Sum_probs=177.0
Q ss_pred CccccCCceEEEEEEe-CCCCEEEEEEcccCcccC---cccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCC
Q 005749 383 QVIEKTTYGTAYKAKL-ADGATIALRLLREGSCKD---RSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPS 458 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~---~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~ 458 (679)
+.||+|+||.||+|+. .+++.||||+++...... .+.+.+|++++.+++||||+++++++.+ .+..|+||||+++
T Consensus 37 ~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~e~~~g 115 (286)
T 3uqc_A 37 IFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHT-RAGGLVVAEWIRG 115 (286)
T ss_dssp EEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-TTEEEEEEECCCE
T ss_pred EEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEE-CCcEEEEEEecCC
Confidence 6899999999999995 458999999998654322 3678999999999999999999999987 6789999999999
Q ss_pred CChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccc
Q 005749 459 RTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADE 538 (679)
Q Consensus 459 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 538 (679)
++|.++++.. ....++.+|+.|++.||+|||+++ |+||||||+|||+++++.+||+++|
T Consensus 116 ~~L~~~l~~~------~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~------------ 174 (286)
T 3uqc_A 116 GSLQEVADTS------PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA------------ 174 (286)
T ss_dssp EEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC------------
T ss_pred CCHHHHHhcC------CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc------------
Confidence 9999999542 355678899999999999999998 9999999999999999999998543
Q ss_pred hhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcC
Q 005749 539 MVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGI 618 (679)
Q Consensus 539 ~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~ 618 (679)
|++| ++.++|||||||++|||++|+.||.+....+..... ..........+....
T Consensus 175 ---------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~-------~~~~~~~~~~~~~~~-- 229 (286)
T 3uqc_A 175 ---------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA-------ERDTAGQPIEPADID-- 229 (286)
T ss_dssp ---------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC-------CBCTTSCBCCHHHHC--
T ss_pred ---------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH-------HHHhccCCCChhhcc--
Confidence 3333 688999999999999999999999664432211000 000000000000000
Q ss_pred CCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCCCCCC-CCCCCccccccCCCC
Q 005749 619 RSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRPRNRS-ALYSPTETRSEIGTP 678 (679)
Q Consensus 619 ~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~-~~~~~~~~~~~~~~~ 678 (679)
+....++.+++.+||+.||++| |+.|+++.|+++...... ....|.+.++.++.|
T Consensus 230 ----~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~~~~~~~p~~~~~~~~~p 285 (286)
T 3uqc_A 230 ----RDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVADRTEVLGPIDEAPVSAAP 285 (286)
T ss_dssp ----TTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--------------------
T ss_pred ----cCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCCccCCCCCCCCCCcccCC
Confidence 1122457789999999999999 999999999998765443 333344444555544
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-37 Score=346.22 Aligned_cols=270 Identities=16% Similarity=0.162 Sum_probs=199.9
Q ss_pred hcCccccCCceEEEEEEe-CCCCEEEEEEcccCc-ccCcccHHHHHHHHhccCCCCCccceEEeeC-----CCCceEEEE
Q 005749 381 TGQVIEKTTYGTAYKAKL-ADGATIALRLLREGS-CKDRSSCLPVIRQLGKVRHENLIPLRAFYQG-----KRGEKLLIY 453 (679)
Q Consensus 381 ~~~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~-----~~~~~~lv~ 453 (679)
..+.||+|+||.||+|+. .+|+.||||+++... ....+.+.+|++++++++|||||++++++.. ..+..++||
T Consensus 18 i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~LVm 97 (676)
T 3qa8_A 18 MKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAM 97 (676)
T ss_dssp CCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCCCEE
T ss_pred EEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEEEEE
Confidence 348999999999999995 569999999987642 2335678999999999999999999998754 246779999
Q ss_pred EecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCc---eEEeecccccc
Q 005749 454 DYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFV---SRLTEFGLDQL 530 (679)
Q Consensus 454 ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~---~kl~DFGla~~ 530 (679)
||+++|+|.+++..... ...+++..++.|+.|++.||+|||+.+ |+||||||+||+++.++. +||+|||+++.
T Consensus 98 Ey~~ggsL~~~L~~~~~-~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~ 173 (676)
T 3qa8_A 98 EYCEGGDLRKYLNQFEN-CCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE 173 (676)
T ss_dssp ECCSSCBHHHHHHSSSC-TTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCCCCCB
T ss_pred EeCCCCCHHHHHHhccc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEcccccccc
Confidence 99999999999986432 335889999999999999999999988 999999999999997664 99999999987
Q ss_pred cCcccccchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcc----cc
Q 005749 531 MVPAVADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEE----TT 606 (679)
Q Consensus 531 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~----~~ 606 (679)
..... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||...... ..|........ ..
T Consensus 174 ~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~-----~~~~~~i~~~~~~~~~~ 246 (676)
T 3qa8_A 174 LDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP-----VQWHGKVREKSNEHIVV 246 (676)
T ss_dssp TTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH-----HHSSTTCC------CCS
T ss_pred ccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch-----hhhhhhhhcccchhhhh
Confidence 64332 224457899999999999999999999999999999999999999543110 00000000000 00
Q ss_pred cccchHhhh--hc---CCCChHHHHHHHHHHHHhccCcCCCCCCCHHH-----HHHHHHhhCCCC
Q 005749 607 MEVFDMEIM--KG---IRSPMEEGLVQALKLAMGCCAPVASVRPTMDE-----VVKQLEENRPRN 661 (679)
Q Consensus 607 ~~~~~~~i~--~~---~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~e-----vl~~L~~~~~~~ 661 (679)
.+.....+. .. ...........+.+++.+||+.||++|||++| ..+.++++....
T Consensus 247 ~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~k 311 (676)
T 3qa8_A 247 YDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSLK 311 (676)
T ss_dssp CCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCCC
T ss_pred hhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhcc
Confidence 000000000 00 00112234567788999999999999999988 556677766544
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-36 Score=348.46 Aligned_cols=233 Identities=18% Similarity=0.239 Sum_probs=184.9
Q ss_pred CccccCCceEEEEEEeC--CCCEEEEEEcccCcc-cCcccHHHHHHHHhccCCCCCccceEEeeCCCCc----eEEEEEe
Q 005749 383 QVIEKTTYGTAYKAKLA--DGATIALRLLREGSC-KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGE----KLLIYDY 455 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~~--~~~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~----~~lv~ey 455 (679)
+.||+|+||.||+|+.. +|+.||||++..... ...+.+.+|++++.+++|||||++++++...... .|+||||
T Consensus 86 ~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~E~ 165 (681)
T 2pzi_A 86 GCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEY 165 (681)
T ss_dssp EEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEEEEEC
T ss_pred EEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEEEEEe
Confidence 68999999999999964 689999999875432 3345788999999999999999999999863221 6999999
Q ss_pred cCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCccc
Q 005749 456 FPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAV 535 (679)
Q Consensus 456 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 535 (679)
+++++|.+++.. .+++.+++.|+.||+.||+|||+++ |+||||||+|||++.+ .+||+|||+++.....
T Consensus 166 ~~g~~L~~~~~~------~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~- 234 (681)
T 2pzi_A 166 VGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF- 234 (681)
T ss_dssp CCCEECC----C------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCEETTCC-
T ss_pred CCCCcHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccchhcccC-
Confidence 999999987753 4899999999999999999999988 9999999999999986 8999999999876432
Q ss_pred ccchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhh
Q 005749 536 ADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIM 615 (679)
Q Consensus 536 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~ 615 (679)
....||+.|+|||++.+. ++.++|||||||++|||++|..|+.+...... .
T Consensus 235 ----~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~----------------~-------- 285 (681)
T 2pzi_A 235 ----GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDGL----------------P-------- 285 (681)
T ss_dssp ----SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSSC----------------C--------
T ss_pred ----CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccccc----------------c--------
Confidence 345799999999988755 48899999999999999999988743211100 0
Q ss_pred hcCCCChHHHHHHHHHHHHhccCcCCCCCCC-HHHHHHHHHhh
Q 005749 616 KGIRSPMEEGLVQALKLAMGCCAPVASVRPT-MDEVVKQLEEN 657 (679)
Q Consensus 616 ~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs-~~evl~~L~~~ 657 (679)
. ..+.....+.+.+++.+||+.||++||+ ++++.+.|..+
T Consensus 286 ~--~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 286 E--DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp T--TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred c--cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 0 0111122356778999999999999995 56666666554
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-36 Score=325.50 Aligned_cols=238 Identities=14% Similarity=0.094 Sum_probs=176.0
Q ss_pred cCccccCCceEEEEEE-eCCCCEEEEEEcccCcc---cCcccHHHHHHHHhccCC-CCCccc---------eEEe-----
Q 005749 382 GQVIEKTTYGTAYKAK-LADGATIALRLLREGSC---KDRSSCLPVIRQLGKVRH-ENLIPL---------RAFY----- 442 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~---~~~~~~~~Ei~~l~~l~H-~nIv~l---------~~~~----- 442 (679)
+++||+|+||+||+|+ ..+|+.||||+++.... ...+.+.+|+.+++.++| +|.... ...+
T Consensus 83 ~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (413)
T 3dzo_A 83 GTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQK 162 (413)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC-
T ss_pred ecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCC
Confidence 4789999999999999 66799999999874332 335678999999999987 322111 1111
Q ss_pred -------eCC----CCceEEEEEecCCCChHHHhhcc---cCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCC
Q 005749 443 -------QGK----RGEKLLIYDYFPSRTLHDLLHDT---IAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVR 508 (679)
Q Consensus 443 -------~~~----~~~~~lv~ey~~~gsL~~~l~~~---~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlk 508 (679)
... ....+++|+++ +++|.+++... ......+++..++.|+.|+++||+|||+++ |+|||||
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---iiHrDiK 238 (413)
T 3dzo_A 163 KKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLR 238 (413)
T ss_dssp --------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EECSCCC
T ss_pred CccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcc
Confidence 110 12356667765 67999988521 112345889999999999999999999988 9999999
Q ss_pred CCCeeecCCCceEEeecccccccCcccccchhcccccccccccccc----------cccCCCCcchhHHHHHHHHHHHhC
Q 005749 509 SKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKADGYKAPELQ----------RMKKCSSRTDVYAFGILLLEILIG 578 (679)
Q Consensus 509 p~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~k~DV~S~Gvvl~El~tg 578 (679)
|+|||++.++.+||+|||+++..... .....| +.|+|||++ ....++.++|||||||++|||++|
T Consensus 239 p~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg 313 (413)
T 3dzo_A 239 PVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCA 313 (413)
T ss_dssp GGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHS
T ss_pred cceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHC
Confidence 99999999999999999998865332 344567 899999998 556688999999999999999999
Q ss_pred CCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHH
Q 005749 579 KKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVK 652 (679)
Q Consensus 579 ~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 652 (679)
+.||......+. .... ..... .. ..++.+++.+||+.||++||++.|+++
T Consensus 314 ~~Pf~~~~~~~~-------------------~~~~-~~~~~-~~---~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 314 DLPNTDDAALGG-------------------SEWI-FRSCK-NI---PQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp SCCCCTTGGGSC-------------------SGGG-GSSCC-CC---CHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCCCcchhhh-------------------HHHH-Hhhcc-cC---CHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 999954322111 1111 11111 11 255778999999999999999776643
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=306.16 Aligned_cols=223 Identities=18% Similarity=0.251 Sum_probs=174.0
Q ss_pred cCccccCCceEEEEEEe-CCCCEEEEEEcccCcccCcccHHHHHHHH-hccCCCCCccceEEeeC---CCCceEEEEEec
Q 005749 382 GQVIEKTTYGTAYKAKL-ADGATIALRLLREGSCKDRSSCLPVIRQL-GKVRHENLIPLRAFYQG---KRGEKLLIYDYF 456 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l-~~l~H~nIv~l~~~~~~---~~~~~~lv~ey~ 456 (679)
+++||+|+||.||+|+. .+++.||+|+++. ...+.+|++++ +..+||||+++++++.. .....++||||+
T Consensus 23 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~ 97 (299)
T 3m2w_A 23 SQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECL 97 (299)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCC
T ss_pred CcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeec
Confidence 36799999999999994 6799999999864 34678899988 55699999999998864 245689999999
Q ss_pred CCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecC---CCceEEeecccccccCc
Q 005749 457 PSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDD---FFVSRLTEFGLDQLMVP 533 (679)
Q Consensus 457 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~---~~~~kl~DFGla~~~~~ 533 (679)
++|+|.+++.... ...+++..++.++.|++.||+|||+++ |+||||||+||+++. ++.+||+|||+++...
T Consensus 98 ~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~- 171 (299)
T 3m2w_A 98 DGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT- 171 (299)
T ss_dssp CSCBHHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECT-
T ss_pred CCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEeccccccccc-
Confidence 9999999998643 346899999999999999999999988 999999999999998 7899999999986432
Q ss_pred ccccchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHh
Q 005749 534 AVADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDME 613 (679)
Q Consensus 534 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 613 (679)
+..++.++|||||||++|||++|+.||.+........ .. .. .
T Consensus 172 ----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~-----------~~-~~----~ 213 (299)
T 3m2w_A 172 ----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP-----------GM-KT----R 213 (299)
T ss_dssp ----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------C-----------CS-CC----S
T ss_pred ----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhH-----------HH-HH----H
Confidence 1346789999999999999999999995433211000 00 00 0
Q ss_pred hhhcCC-CCh---HHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 614 IMKGIR-SPM---EEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 614 i~~~~~-~~~---~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
+..+.. .+. .....++.+++.+||+.||++|||++|+++.
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 214 IRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp SCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 000000 111 1123567789999999999999999999985
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=314.00 Aligned_cols=236 Identities=12% Similarity=0.110 Sum_probs=176.9
Q ss_pred hcCccccCCceEEEEEEeCCCCEEEEEEcccCcc--------cCcccHHHHHHHHhccC---------CCCCccceEEee
Q 005749 381 TGQVIEKTTYGTAYKAKLADGATIALRLLREGSC--------KDRSSCLPVIRQLGKVR---------HENLIPLRAFYQ 443 (679)
Q Consensus 381 ~~~~ig~G~~g~Vy~~~~~~~~~vAvK~~~~~~~--------~~~~~~~~Ei~~l~~l~---------H~nIv~l~~~~~ 443 (679)
..+.||+|+||+||+|+. +|+.||||+++.... ...+.+.+|++++++++ |||||++.+++.
T Consensus 24 ~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~~~ 102 (336)
T 2vuw_A 24 RCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHC 102 (336)
T ss_dssp TCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEEEE
T ss_pred heeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhcceeE
Confidence 358999999999999998 689999999976532 12367899999999886 777776666542
Q ss_pred -----------------C------------CCCceEEEEEecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHH
Q 005749 444 -----------------G------------KRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYL 494 (679)
Q Consensus 444 -----------------~------------~~~~~~lv~ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~L 494 (679)
+ ..+..++|||||++|++.+.+.. ..+++..++.|+.||+.||+||
T Consensus 103 ~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-----~~~~~~~~~~i~~qi~~aL~~l 177 (336)
T 2vuw_A 103 VQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----KLSSLATAKSILHQLTASLAVA 177 (336)
T ss_dssp EESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-----TCCCHHHHHHHHHHHHHHHHHH
T ss_pred ecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-----cCCCHHHHHHHHHHHHHHHHHH
Confidence 1 15689999999999977666643 3489999999999999999999
Q ss_pred h-cCCCCCeeecCCCCCCeeecCCC--------------------ceEEeecccccccCcccccchhccccccccccccc
Q 005749 495 H-TGHEIPITHGNVRSKNVLVDDFF--------------------VSRLTEFGLDQLMVPAVADEMVALAKADGYKAPEL 553 (679)
Q Consensus 495 H-~~~~~~ivHrDlkp~NILl~~~~--------------------~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~ 553 (679)
| +++ |+||||||+|||++.++ .+||+|||+|+..... ...||+.|+|||+
T Consensus 178 H~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y~aPE~ 248 (336)
T 2vuw_A 178 EASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVSMDEDL 248 (336)
T ss_dssp HHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCTTCSGG
T ss_pred HHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeecccChhh
Confidence 9 888 99999999999999887 8999999999865322 3479999999999
Q ss_pred ccccCCCCcchhHHHHHH-HHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhc-CCC-ChHHHHHHHH
Q 005749 554 QRMKKCSSRTDVYAFGIL-LLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKG-IRS-PMEEGLVQAL 630 (679)
Q Consensus 554 ~~~~~~~~k~DV~S~Gvv-l~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~-~~~-~~~~~~~~~~ 630 (679)
+.+.. +.++||||++++ .+++++|..||.. ..|....... ......... ... ..+...+++.
T Consensus 249 ~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~---------~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~s~~~~ 313 (336)
T 2vuw_A 249 FTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN---------VLWLHYLTDK-----MLKQMTFKTKCNTPAMKQIKRKIQ 313 (336)
T ss_dssp GCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH---------HHHHHHHHHH-----HHHTCCCSSCCCSHHHHHHHHHHH
T ss_pred hcCCC-ccceehhhhhCCCCcccccccCCCcc---------hhhhhHHHHh-----hhhhhccCcccchhhhhhcCHHHH
Confidence 98766 889999998777 7778889999721 1111111000 000000000 001 1234557788
Q ss_pred HHHHhccCcCCCCCCCHHHHH
Q 005749 631 KLAMGCCAPVASVRPTMDEVV 651 (679)
Q Consensus 631 ~l~~~cl~~dP~~RPs~~evl 651 (679)
+++.+||+.| |++|++
T Consensus 314 dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 314 EFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHGGGSS-----SHHHHH
T ss_pred HHHHHHhccC-----CHHHHH
Confidence 9999999976 999988
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-31 Score=278.94 Aligned_cols=259 Identities=28% Similarity=0.460 Sum_probs=153.0
Q ss_pred CCChHHHHHHHHHHHhhCCCCCCcccCCCCCCCCCCcc--cccceeecCC--CCC--cccCCCCCCc-------cccc--
Q 005749 27 ASASSDVELLLGKIKSSLQGDDENLLLSSWNISVPLCQ--WRGLKWISTN--GSP--LSCSDISLPQ-------WANL-- 91 (679)
Q Consensus 27 ~~~~~~~~~ll~~~k~~~~~~~~~~~l~~W~~~~~~C~--w~Gv~c~~~~--~~~--l~c~~~~~~~-------~~~l-- 91 (679)
.|.++|+.||+ +||+++.+ +. .+++|+.+++||. |.||+|+..+ ++. ++.+...... +.++
T Consensus 2 ~c~~~~~~aL~-~~k~~~~~--~~-~l~~W~~~~~~C~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~~l~~l~~ 77 (313)
T 1ogq_A 2 LCNPQDKQALL-QIKKDLGN--PT-TLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPY 77 (313)
T ss_dssp CSCHHHHHHHH-HHHHHTTC--CG-GGTTCCTTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTT
T ss_pred CCCHHHHHHHH-HHHHhcCC--cc-cccCCCCCCCCCcCCCcceEeCCCCCCceEEEEECCCCCccCCcccChhHhCCCC
Confidence 36678889998 99999964 44 7999998889999 9999997654 332 2222211110 1110
Q ss_pred ----ccc------------CCCCccEEEEEcCCCCCcccCCccccCCCCCCeeecccCcccccCCcccCCCCCCCEEEcc
Q 005749 92 ----SLY------------KDSSIHLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLS 155 (679)
Q Consensus 92 ----~~~------------~~~~~~l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls 155 (679)
.+. .....+++.|+|++|+++|.+|..|+++++|++|+|++|.|+|.+|..++.+++|++|+|+
T Consensus 78 L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 157 (313)
T 1ogq_A 78 LNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFD 157 (313)
T ss_dssp CSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECC
T ss_pred CCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECc
Confidence 000 0112244455555555555555555555555555555555555555555555555555555
Q ss_pred CCCCCCcChhhHHhhcccCcEEEccCCCCcccCCCCCC------------------C--CCCCCCccEEEccCccccccc
Q 005749 156 ANLFTGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPAL------------------P--NSTCSDLQYLDLGSNKFSGSF 215 (679)
Q Consensus 156 ~N~l~g~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~------------------~--~~~~~~L~~L~l~~N~l~g~~ 215 (679)
+|.++|.+|..+..+.++|+.|+|++|++++.+|..+. + ...+++|++|+|++|++++.+
T Consensus 158 ~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 237 (313)
T 1ogq_A 158 GNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDL 237 (313)
T ss_dssp SSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBG
T ss_pred CCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCcccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeec
Confidence 55555555555544422555555555555554443210 0 012345555555555555544
Q ss_pred cccccCCCCCCEEEccCCcccccCCcccccc-ccCEEEccCCcCCCCCCCccc-CCCCcccccCCCCCCCCCCCCCCC
Q 005749 216 PEFVTRFEALKELDISNNLFSGSIPEGLTRL-SLEKLNLSHNNFSGVLPVFSE-SKFGAEVFEGNSPALCGFPLRDCS 291 (679)
Q Consensus 216 p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l-~L~~l~ls~N~l~g~ip~~~~-~~~~~~~~~~n~~~~c~~p~~~c~ 291 (679)
|. +..+++|++|+|++|+++|.+|..+..+ +|+.|+|++|+|+|.+|.... ..+....+.+| +.+||.|...|.
T Consensus 238 ~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~~~l~~L~~l~l~~N-~~lc~~p~~~C~ 313 (313)
T 1ogq_A 238 GK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANN-KCLCGSPLPACT 313 (313)
T ss_dssp GG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSS-SEEESTTSSCCC
T ss_pred Cc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCCccccccChHHhcCC-CCccCCCCCCCC
Confidence 44 5566777777777777777778777776 588888888888888887521 22334456677 889999887773
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.3e-30 Score=291.41 Aligned_cols=186 Identities=17% Similarity=0.060 Sum_probs=131.6
Q ss_pred CccccCCceEEEEEE-eCCCCEEEEEEcccCcc----------cCcccHHHHHHHHhcc-CCCCCccceEEeeCCCCceE
Q 005749 383 QVIEKTTYGTAYKAK-LADGATIALRLLREGSC----------KDRSSCLPVIRQLGKV-RHENLIPLRAFYQGKRGEKL 450 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~----------~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~~ 450 (679)
...+.|+.|.++.++ +..|+.+|+|.+..... ...++|.+|+++|+++ .|+||+++++++.+ ++..|
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed-~~~~y 318 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGEN-AQSGW 318 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEEC-SSEEE
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEE-CCEEE
Confidence 456677788777766 55699999999965421 2235699999999999 79999999999998 78999
Q ss_pred EEEEecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccc
Q 005749 451 LIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQL 530 (679)
Q Consensus 451 lv~ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 530 (679)
|||||++|++|.+++... .+++.. +|+.||+.||+|+|+++ ||||||||+|||+++++.+||+|||+|+.
T Consensus 319 LVMEyv~G~~L~d~i~~~----~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~ 388 (569)
T 4azs_A 319 LVMEKLPGRLLSDMLAAG----EEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVT 388 (569)
T ss_dssp EEEECCCSEEHHHHHHTT----CCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEES
T ss_pred EEEecCCCCcHHHHHHhC----CCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCee
Confidence 999999999999999863 346654 58999999999999999 99999999999999999999999999987
Q ss_pred cCcccccchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCC
Q 005749 531 MVPAVADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKP 581 (679)
Q Consensus 531 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p 581 (679)
.... .......+||++|||||++.+ .+..++|+||+|++++++.++..+
T Consensus 389 ~~~~-~~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 389 TPQD-CSWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp CC----CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred CCCC-CccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 6443 233455689999999999875 467789999999998877655433
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.9e-27 Score=278.66 Aligned_cols=229 Identities=29% Similarity=0.419 Sum_probs=165.0
Q ss_pred CCCCChHHHHHHHHHHHhhCCCCCCcccCCCCCCCCCCcccccceeecCCCCC--cccCCCCCCc--------ccc---c
Q 005749 25 SPASASSDVELLLGKIKSSLQGDDENLLLSSWNISVPLCQWRGLKWISTNGSP--LSCSDISLPQ--------WAN---L 91 (679)
Q Consensus 25 ~~~~~~~~~~~ll~~~k~~~~~~~~~~~l~~W~~~~~~C~w~Gv~c~~~~~~~--l~c~~~~~~~--------~~~---l 91 (679)
+.++.++|++||+ +||+++.+ +. .+++|+.+++||+|.||+|+ +|++ ++.+...... +.+ +
T Consensus 6 ~~~~~~~~~~all-~~k~~~~~--~~-~l~~W~~~~~~C~w~gv~C~--~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L 79 (768)
T 3rgz_A 6 PSQSLYREIHQLI-SFKDVLPD--KN-LLPDWSSNKNPCTFDGVTCR--DDKVTSIDLSSKPLNVGFSAVSSSLLSLTGL 79 (768)
T ss_dssp --CCHHHHHHHHH-HHHTTCSC--TT-SSTTCCTTSCGGGSTTEEEE--TTEEEEEECTTSCCCEEHHHHHHHTTTCTTC
T ss_pred cccCCHHHHHHHH-HHHhhCCC--cc-cccCCCCCCCCcCCcceEEC--CCcEEEEECCCCCcCCccCccChhHhccCcc
Confidence 3445678899999 99999974 55 89999988899999999997 4543 2222211110 000 0
Q ss_pred c-------------ccCCCCccEEEEEcCCCCCcccCCc--cccCCCCCCeeecccCcccccCCccc-CCCCCCCEEEcc
Q 005749 92 S-------------LYKDSSIHLLSIQLPSANLTGSLPR--ELGEFSMLQSLYLNVNSLKGTIPFEL-GYSSSLSEIDLS 155 (679)
Q Consensus 92 ~-------------~~~~~~~~l~~l~l~~n~l~g~ip~--~l~~l~~L~~L~L~~N~l~g~ip~~l-~~l~~L~~L~Ls 155 (679)
. .......+++.|+|++|+++|.+|. .++++++|++|+|++|.+++.+|..+ .++++|++|||+
T Consensus 80 ~~l~~~~~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls 159 (768)
T 3rgz_A 80 ESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLS 159 (768)
T ss_dssp CEEECTTSCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECC
T ss_pred cccCCcCCCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECC
Confidence 0 1122345799999999999999999 99999999999999999999999876 889999999999
Q ss_pred CCCCCCcChhhH--HhhcccCcEEEccCCCCcccCCCCCCCCCCCCCccEEEccCccccccccccccCCCCCCEEEccCC
Q 005749 156 ANLFTGVLAPSI--WNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNN 233 (679)
Q Consensus 156 ~N~l~g~~p~~~--~~~~~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N 233 (679)
+|.+++..|..+ ...+++|++|+|++|++++.+|. ..+++|++|+|++|++++.+|. ++.+++|++|++++|
T Consensus 160 ~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~-----~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n 233 (768)
T 3rgz_A 160 ANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDV-----SRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGN 233 (768)
T ss_dssp SSCCEEETHHHHHHTTCCTTCCEEECCSSEEESCCBC-----TTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEEECCSS
T ss_pred CCccCCcCChhhhhhccCCCCCEEECCCCcccccCCc-----ccCCcCCEEECcCCcCCCCCcc-cccCCCCCEEECcCC
Confidence 999998877652 23347788888888887765543 3456677777777777666665 666677777777777
Q ss_pred cccccCCcccccc-ccCEEEccCCcCCCCCCCc
Q 005749 234 LFSGSIPEGLTRL-SLEKLNLSHNNFSGVLPVF 265 (679)
Q Consensus 234 ~l~g~~p~~~~~l-~L~~l~ls~N~l~g~ip~~ 265 (679)
++++.+|..+..+ +|+.|++++|+++|.+|..
T Consensus 234 ~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~ 266 (768)
T 3rgz_A 234 KLSGDFSRAISTCTELKLLNISSNQFVGPIPPL 266 (768)
T ss_dssp CCCSCHHHHTTTCSSCCEEECCSSCCEESCCCC
T ss_pred cCCCcccHHHhcCCCCCEEECCCCcccCccCcc
Confidence 7766666666655 4666666666666666553
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.3e-27 Score=264.25 Aligned_cols=182 Identities=16% Similarity=0.180 Sum_probs=145.2
Q ss_pred cCccccCCceEEEEEEeCCCCEEEEEEcccCcccC--------cccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEE
Q 005749 382 GQVIEKTTYGTAYKAKLADGATIALRLLREGSCKD--------RSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIY 453 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~--------~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ 453 (679)
.++||+|+||.||+|+. .++.+|+|+........ .+.+.+|++++++++||||+++..++.. .++.++||
T Consensus 341 ~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~-~~~~~lVm 418 (540)
T 3en9_A 341 EHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVD-LDNKRIMM 418 (540)
T ss_dssp -------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEE-TTTTEEEE
T ss_pred CCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEe-CCccEEEE
Confidence 47899999999999964 47888999865432111 2457999999999999999966665555 56789999
Q ss_pred EecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCc
Q 005749 454 DYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVP 533 (679)
Q Consensus 454 ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 533 (679)
||+++++|.+++.. ++.|+.|+++||+|||+++ |+||||||+|||+++ .+||+|||+++....
T Consensus 419 E~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 419 SYINGKLAKDVIED------------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNL 481 (540)
T ss_dssp ECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred ECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence 99999999999864 4589999999999999988 999999999999998 999999999998754
Q ss_pred ccccc------hhcccccccccccccccc--cCCCCcchhHHHHHHHHHHHhCCCCC
Q 005749 534 AVADE------MVALAKADGYKAPELQRM--KKCSSRTDVYAFGILLLEILIGKKPG 582 (679)
Q Consensus 534 ~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~k~DV~S~Gvvl~El~tg~~p~ 582 (679)
..... .....||+.|||||++.. ..|+.++|+||..+-..|-+.++.+|
T Consensus 482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 32211 235679999999999986 56888899999999998988888776
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=6.2e-26 Score=265.87 Aligned_cols=190 Identities=36% Similarity=0.611 Sum_probs=143.1
Q ss_pred cEEEEEcCCCCCcccCCccccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhh---------
Q 005749 100 HLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNL--------- 170 (679)
Q Consensus 100 ~l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~--------- 170 (679)
+++.|+|++|.++|.+|..++.+++|++|+|++|.++|.+|..++.+++|+.|||++|.++|.+|..++..
T Consensus 491 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~ 570 (768)
T 3rgz_A 491 NLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFI 570 (768)
T ss_dssp TCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTT
T ss_pred CCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhcc
Confidence 56666666666666666666666777777777777766677666667777777777777766666544321
Q ss_pred ------------------------------------------------------------cccCcEEEccCCCCcccCCC
Q 005749 171 ------------------------------------------------------------CDRLVSLRLHGNSLTAALPE 190 (679)
Q Consensus 171 ------------------------------------------------------------~~~L~~L~Ls~N~l~~~~p~ 190 (679)
+++|+.|||++|+++|.+|.
T Consensus 571 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~ 650 (768)
T 3rgz_A 571 AGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPK 650 (768)
T ss_dssp CSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCG
T ss_pred ccccccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCCH
Confidence 13566777777777777765
Q ss_pred CCCCCCCCCCccEEEccCccccccccccccCCCCCCEEEccCCcccccCCcccccc-ccCEEEccCCcCCCCCCCcc-cC
Q 005749 191 PALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRL-SLEKLNLSHNNFSGVLPVFS-ES 268 (679)
Q Consensus 191 ~~~~~~~~~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l-~L~~l~ls~N~l~g~ip~~~-~~ 268 (679)
.+ ..+++|++|+|++|+++|.+|..++.+++|+.|||++|+++|.+|..+..+ +|+.||+++|+|+|.||... ..
T Consensus 651 ~l---~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~~~~~ 727 (768)
T 3rgz_A 651 EI---GSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFE 727 (768)
T ss_dssp GG---GGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSSSSGG
T ss_pred HH---hccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCchhhc
Confidence 43 457788888888888888888888888889999999999998888888887 58999999999999998753 34
Q ss_pred CCCcccccCCCCCCCCCCCCCCCCC
Q 005749 269 KFGAEVFEGNSPALCGFPLRDCSGN 293 (679)
Q Consensus 269 ~~~~~~~~~n~~~~c~~p~~~c~~~ 293 (679)
.+....|.|| +.+||.|..+|...
T Consensus 728 ~~~~~~~~gN-~~Lcg~~l~~C~~~ 751 (768)
T 3rgz_A 728 TFPPAKFLNN-PGLCGYPLPRCDPS 751 (768)
T ss_dssp GSCGGGGCSC-TEEESTTSCCCCSC
T ss_pred cCCHHHhcCC-chhcCCCCcCCCCC
Confidence 5677788999 89999999889754
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.92 E-value=7.6e-26 Score=259.31 Aligned_cols=205 Identities=20% Similarity=0.321 Sum_probs=168.1
Q ss_pred CCChHHHHHHHHHHHhhCCCCC------CcccCCCCCCCCCCccc---ccceeecCCCCCcccCCCCCCccccccccCCC
Q 005749 27 ASASSDVELLLGKIKSSLQGDD------ENLLLSSWNISVPLCQW---RGLKWISTNGSPLSCSDISLPQWANLSLYKDS 97 (679)
Q Consensus 27 ~~~~~~~~~ll~~~k~~~~~~~------~~~~l~~W~~~~~~C~w---~Gv~c~~~~~~~l~c~~~~~~~~~~l~~~~~~ 97 (679)
+....|+.||. .+++++.... +.....+|+.++++|.| .||+| +..+
T Consensus 26 ~~~~~d~~aL~-~~~~~~~~~~w~~~~~~~~~~~~W~~~~~~c~w~~~~GV~C----------~~~~------------- 81 (636)
T 4eco_A 26 AEYIKDYLALK-EIWDALNGKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSL----------NSNG------------- 81 (636)
T ss_dssp CHHHHHHHHHH-HHHHHTTGGGCCCCC------CCCCCSSCGGGTTCCTTEEE----------CTTC-------------
T ss_pred hhHHHHHHHHH-HHHHHcCCCCcccCCcCCccCCCCCCCCCcccccCCCCeEE----------cCCC-------------
Confidence 33446888988 9999986421 11234589988899999 99995 3221
Q ss_pred CccEEEEEcCCCCCcccCCccccCCCCCCeeecccC--------------------------------------------
Q 005749 98 SIHLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVN-------------------------------------------- 133 (679)
Q Consensus 98 ~~~l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N-------------------------------------------- 133 (679)
+|+.|+|+++++.|.+|++|++|++|++|+|++|
T Consensus 82 --~V~~L~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~ 159 (636)
T 4eco_A 82 --RVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFS 159 (636)
T ss_dssp --CEEEEECTTSCCEEEECGGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSC
T ss_pred --CEEEEEecCcccCCcCChHHhcCccceEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHH
Confidence 4899999999999999999999999999999888
Q ss_pred ----------------------------------cccccCCcccCCCCCCCEEEccCCCCCCc-----------------
Q 005749 134 ----------------------------------SLKGTIPFELGYSSSLSEIDLSANLFTGV----------------- 162 (679)
Q Consensus 134 ----------------------------------~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~----------------- 162 (679)
+|+| ||..++++++|++|+|++|.|+|.
T Consensus 160 ~~~~~l~~~~l~~~~~~~~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ 238 (636)
T 4eco_A 160 DLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQY 238 (636)
T ss_dssp HHHHHHHHHCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHH
T ss_pred HHHHHHhhcCccccccccccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhccc
Confidence 4456 888899999999999999999985
Q ss_pred ChhhHH--hhcccCcEEEccCCCCcccCCCCCCCCCCCCCccEEEccCcc-ccc-cccccccCC------CCCCEEEccC
Q 005749 163 LAPSIW--NLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNK-FSG-SFPEFVTRF------EALKELDISN 232 (679)
Q Consensus 163 ~p~~~~--~~~~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~l~~N~-l~g-~~p~~~~~l------~~L~~L~ls~ 232 (679)
+|+.+. ++ ++|++|+|++|++.+.+|..+ ..+++|++|+|++|+ ++| .+|..++.+ ++|+.|++++
T Consensus 239 ip~~l~~~~l-~~L~~L~L~~n~l~~~~p~~l---~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~ 314 (636)
T 4eco_A 239 KTEDLKWDNL-KDLTDVEVYNCPNLTKLPTFL---KALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGY 314 (636)
T ss_dssp TTSCCCGGGC-TTCCEEEEECCTTCSSCCTTT---TTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCS
T ss_pred Cchhhhhccc-CCCCEEEecCCcCCccChHHH---hcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCC
Confidence 788776 65 889999999999999888654 467889999999998 988 889888876 8999999999
Q ss_pred CcccccCCc--ccccc-ccCEEEccCCcCCCCCC
Q 005749 233 NLFSGSIPE--GLTRL-SLEKLNLSHNNFSGVLP 263 (679)
Q Consensus 233 N~l~g~~p~--~~~~l-~L~~l~ls~N~l~g~ip 263 (679)
|+++ .+|. .+..+ +|+.|++++|+++|.+|
T Consensus 315 n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip 347 (636)
T 4eco_A 315 NNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP 347 (636)
T ss_dssp SCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC
T ss_pred CcCC-ccCchhhhccCCCCCEEeCcCCcCccchh
Confidence 9998 7888 78777 68999999999998888
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.8e-25 Score=235.05 Aligned_cols=216 Identities=23% Similarity=0.313 Sum_probs=108.8
Q ss_pred CCCCChHHHHHHHHHHHhhCCCCCCcccCCCC----CCCCCCcccccceeecCCCCCcccCCCCCCccccccccCCCCcc
Q 005749 25 SPASASSDVELLLGKIKSSLQGDDENLLLSSW----NISVPLCQWRGLKWISTNGSPLSCSDISLPQWANLSLYKDSSIH 100 (679)
Q Consensus 25 ~~~~~~~~~~~ll~~~k~~~~~~~~~~~l~~W----~~~~~~C~w~Gv~c~~~~~~~l~c~~~~~~~~~~l~~~~~~~~~ 100 (679)
..++..+|..+|+ +||..+.. ++.+.+++| +.+.++|.|.|+.|...... +. . ....+
T Consensus 21 ~~~~~~~~~~aLl-~~k~~~~~-~~~~~~~~w~~~~~~~~~~~~~~g~~~~~~~~~-l~--~-------------~~~~~ 82 (328)
T 4fcg_A 21 GSTALRPYHDVLS-QWQRHYNA-DRNRWHSAWRQANSNNPQIETRTGRALKATADL-LE--D-------------ATQPG 82 (328)
T ss_dssp --CCCCCHHHHHH-HHHHHHHH-CCTTHHHHHHHHTTTCTTSCCSHHHHHHHHHHH-HH--H-------------HTSTT
T ss_pred ccccCchHHHHHH-HHHHhccC-CchhhhhhhcccccccccccccCCcchhhhHHH-Hh--c-------------ccccc
Confidence 3445667888998 99998854 355567889 44568999999996321000 00 0 00112
Q ss_pred EEEEEcCCCCCcccCCccccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEEcc
Q 005749 101 LLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLH 180 (679)
Q Consensus 101 l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls 180 (679)
++.|+|++|++. .+|+.++++++|++|+|++|.|+ .+|..++.+++|++|+|++|.++ .+|+.+..+ ++|++|+|+
T Consensus 83 l~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l-~~L~~L~L~ 158 (328)
T 4fcg_A 83 RVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASL-NRLRELSIR 158 (328)
T ss_dssp CCEEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGC-TTCCEEEEE
T ss_pred eeEEEccCCCch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcC-cCCCEEECC
Confidence 445555555554 44555555555555555555555 45555555555555555555554 344444333 455555555
Q ss_pred CCCCcccCCCCCCC------CCCCCCccEEEccCccccccccccccCCCCCCEEEccCCcccccCCcccccc-ccCEEEc
Q 005749 181 GNSLTAALPEPALP------NSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRL-SLEKLNL 253 (679)
Q Consensus 181 ~N~l~~~~p~~~~~------~~~~~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l-~L~~l~l 253 (679)
+|++.+.+|..... ...+++|++|+|++|+++ .+|..++.+++|+.|+|++|++++ +|..+..+ +|+.|+|
T Consensus 159 ~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~L 236 (328)
T 4fcg_A 159 ACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDL 236 (328)
T ss_dssp EETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC-CCGGGGGCTTCCEEEC
T ss_pred CCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc-CchhhccCCCCCEEEC
Confidence 55544444432200 011344555555555544 444444445555555555555442 33334333 3445555
Q ss_pred cCCcCCCCCCC
Q 005749 254 SHNNFSGVLPV 264 (679)
Q Consensus 254 s~N~l~g~ip~ 264 (679)
++|++.+.+|.
T Consensus 237 s~n~~~~~~p~ 247 (328)
T 4fcg_A 237 RGCTALRNYPP 247 (328)
T ss_dssp TTCTTCCBCCC
T ss_pred cCCcchhhhHH
Confidence 55544444443
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.92 E-value=2.1e-25 Score=261.05 Aligned_cols=199 Identities=22% Similarity=0.329 Sum_probs=144.1
Q ss_pred CCCChHHHHHHHHHHHhhCCCCCCcccCCCCCCCC-----CC--ccc------------ccceeecCCCCCcccCCCCCC
Q 005749 26 PASASSDVELLLGKIKSSLQGDDENLLLSSWNISV-----PL--CQW------------RGLKWISTNGSPLSCSDISLP 86 (679)
Q Consensus 26 ~~~~~~~~~~ll~~~k~~~~~~~~~~~l~~W~~~~-----~~--C~w------------~Gv~c~~~~~~~l~c~~~~~~ 86 (679)
++....|+.||+ +||+++.+ + +|+.+. +| |+| .||+|+. ++
T Consensus 264 ~~~~~~d~~ALl-~~k~~l~~--~-----~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~-~~----------- 323 (876)
T 4ecn_A 264 TAEYIKDYKALK-AIWEALDG--K-----NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDN-NG----------- 323 (876)
T ss_dssp CCHHHHHHHHHH-HHHHHTTG--G-----GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECT-TS-----------
T ss_pred cccchHHHHHHH-HHHHHcCC--C-----CCCcCCCcccccCCccccccccccccccCcCceEecC-CC-----------
Confidence 344557889998 99999964 3 897654 56 999 9999643 11
Q ss_pred ccccccccCCCCccEEEEEcCCCCCcccCCccccCCCCCCeeec-ccCccccc---------------------------
Q 005749 87 QWANLSLYKDSSIHLLSIQLPSANLTGSLPRELGEFSMLQSLYL-NVNSLKGT--------------------------- 138 (679)
Q Consensus 87 ~~~~l~~~~~~~~~l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L-~~N~l~g~--------------------------- 138 (679)
+|+.|+|++|++.|.+|++|++|++|++|+| ++|.++|.
T Consensus 324 -------------~V~~L~Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~ 390 (876)
T 4ecn_A 324 -------------RVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKM 390 (876)
T ss_dssp -------------CEEEEECTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHH
T ss_pred -------------CEEEEECccCCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhh
Confidence 4778888888888888888888888888888 66655554
Q ss_pred -------------------------------------------------CCcccCCCCCCCEEEccCCCCCC--------
Q 005749 139 -------------------------------------------------IPFELGYSSSLSEIDLSANLFTG-------- 161 (679)
Q Consensus 139 -------------------------------------------------ip~~l~~l~~L~~L~Ls~N~l~g-------- 161 (679)
||..++++++|++|+|++|.|+|
T Consensus 391 ~l~~~~~~~~s~l~~~~l~~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~ 470 (876)
T 4ecn_A 391 FLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWE 470 (876)
T ss_dssp HTCCCGGGGSCHHHHHHHHTCTTSCCCCCCCCCCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCS
T ss_pred hhccCcchhhhHHHHHHhhhCccccccccccccchhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCccccccc
Confidence 67777777778888888887777
Q ss_pred ---------cChhhHH--hhcccCcEEEccCCCCcccCCCCCCCCCCCCCccEEEccCcc-ccc-cccccccCCC-----
Q 005749 162 ---------VLAPSIW--NLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNK-FSG-SFPEFVTRFE----- 223 (679)
Q Consensus 162 ---------~~p~~~~--~~~~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~l~~N~-l~g-~~p~~~~~l~----- 223 (679)
.+|+.+. ++ ++|+.|+|++|++.+.+|..+ ..+++|++|+|++|+ ++| .+|..+++++
T Consensus 471 ~~s~n~~~g~iP~~l~f~~L-~~L~~L~Ls~N~l~~~iP~~l---~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~ 546 (876)
T 4ecn_A 471 DANSDYAKQYENEELSWSNL-KDLTDVELYNCPNMTQLPDFL---YDLPELQSLNIACNRGISAAQLKADWTRLADDEDT 546 (876)
T ss_dssp CTTSHHHHHHTTSCCCGGGC-TTCCEEEEESCTTCCSCCGGG---GGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTT
T ss_pred ccccccccccCChhhhhccC-CCCCEEECcCCCCCccChHHH---hCCCCCCEEECcCCCCcccccchHHHHhhhhcccc
Confidence 3666654 43 777888888777777777433 456677777777776 777 6776665554
Q ss_pred --CCCEEEccCCcccccCCc--ccccc-ccCEEEccCCcCCCCCC
Q 005749 224 --ALKELDISNNLFSGSIPE--GLTRL-SLEKLNLSHNNFSGVLP 263 (679)
Q Consensus 224 --~L~~L~ls~N~l~g~~p~--~~~~l-~L~~l~ls~N~l~g~ip 263 (679)
+|+.|+|++|+|+ .+|. .+..+ +|+.|+|++|+++ .+|
T Consensus 547 l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp 589 (876)
T 4ecn_A 547 GPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLE 589 (876)
T ss_dssp TTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCC
T ss_pred cCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cch
Confidence 7777777777777 6776 66666 5777777777777 666
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=1.8e-23 Score=214.74 Aligned_cols=152 Identities=13% Similarity=0.166 Sum_probs=120.7
Q ss_pred cCccccCCceEEEEEEeCCCCEEEEEEcccCccc------------------CcccHHHHHHHHhccCCCCCccceEEee
Q 005749 382 GQVIEKTTYGTAYKAKLADGATIALRLLREGSCK------------------DRSSCLPVIRQLGKVRHENLIPLRAFYQ 443 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~------------------~~~~~~~Ei~~l~~l~H~nIv~l~~~~~ 443 (679)
++.||+|+||.||+|+..+|+.||+|.++..... ....+.+|++++++++ | +++.+++.
T Consensus 95 ~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~~~ 171 (282)
T 1zar_A 95 GKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKVYA 171 (282)
T ss_dssp EEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCEEE
T ss_pred cCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeEEe
Confidence 4789999999999999977999999999653211 1345889999999999 5 67777665
Q ss_pred CCCCceEEEEEecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEe
Q 005749 444 GKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLT 523 (679)
Q Consensus 444 ~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~ 523 (679)
. +..++||||+++|+|.+ +.. .....++.|++.||+|||+.+ |+||||||+|||++ ++.+||+
T Consensus 172 ~--~~~~lvmE~~~g~~L~~-l~~----------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl~-~~~vkl~ 234 (282)
T 1zar_A 172 W--EGNAVLMELIDAKELYR-VRV----------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS-EEGIWII 234 (282)
T ss_dssp E--ETTEEEEECCCCEEGGG-CCC----------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE-TTEEEEC
T ss_pred c--cceEEEEEecCCCcHHH-cch----------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEEE-CCcEEEE
Confidence 3 56799999999999998 432 123479999999999999988 99999999999999 9999999
Q ss_pred ecccccccCcccccchhcccccccccccccccc----------cCCCCcchhHH
Q 005749 524 EFGLDQLMVPAVADEMVALAKADGYKAPELQRM----------KKCSSRTDVYA 567 (679)
Q Consensus 524 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~----------~~~~~k~DV~S 567 (679)
|||+|+.. ..|+|||++.. ..|+.++|+|.
T Consensus 235 DFG~a~~~--------------~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~ 274 (282)
T 1zar_A 235 DFPQSVEV--------------GEEGWREILERDVRNIITYFSRTYRTEKDINS 274 (282)
T ss_dssp CCTTCEET--------------TSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred ECCCCeEC--------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence 99998632 33788887753 34555566654
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.88 E-value=1.6e-21 Score=198.98 Aligned_cols=216 Identities=22% Similarity=0.288 Sum_probs=166.1
Q ss_pred CCCcccccceeecCC-CCCcccCCCCCCccccccccCCCCccEEEEEcCCCCCcccCCccccCCCCCCeeecccCccccc
Q 005749 60 VPLCQWRGLKWISTN-GSPLSCSDISLPQWANLSLYKDSSIHLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGT 138 (679)
Q Consensus 60 ~~~C~w~Gv~c~~~~-~~~l~c~~~~~~~~~~l~~~~~~~~~l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ 138 (679)
.+.|.|.|+.|.... ...++|+......+. . .-..+++.|+|++|++++..+..|+++++|++|+|++|.|+..
T Consensus 2 ~~~C~~~~~~C~c~~~~~~l~~~~~~l~~ip---~--~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i 76 (270)
T 2o6q_A 2 EALCKKDGGVCSCNNNKNSVDCSSKKLTAIP---S--NIPADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTL 76 (270)
T ss_dssp CCCBGGGTCSBEEETTTTEEECTTSCCSSCC---S--CCCTTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCC
T ss_pred CccCCCCCCCCEeCCCCCEEEccCCCCCccC---C--CCCCCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCee
Confidence 378999999997654 345778765433221 1 1123589999999999977777899999999999999999954
Q ss_pred CCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEEccCCCCcccCCCCCCCCCCCCCccEEEccCcccccccccc
Q 005749 139 IPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEF 218 (679)
Q Consensus 139 ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~l~~N~l~g~~p~~ 218 (679)
.+..+..+++|++|+|++|.+++.. +..+..+++|++|+|++|++++..+..+ ..+++|++|+|++|++++..+..
T Consensus 77 ~~~~~~~l~~L~~L~l~~n~l~~~~-~~~~~~l~~L~~L~l~~n~l~~~~~~~~---~~l~~L~~L~Ls~n~l~~~~~~~ 152 (270)
T 2o6q_A 77 PAGIFKELKNLETLWVTDNKLQALP-IGVFDQLVNLAELRLDRNQLKSLPPRVF---DSLTKLTYLSLGYNELQSLPKGV 152 (270)
T ss_dssp CTTTTSSCTTCCEEECCSSCCCCCC-TTTTTTCSSCCEEECCSSCCCCCCTTTT---TTCTTCCEEECCSSCCCCCCTTT
T ss_pred ChhhhcCCCCCCEEECCCCcCCcCC-HhHcccccCCCEEECCCCccCeeCHHHh---CcCcCCCEEECCCCcCCccCHhH
Confidence 4445688999999999999999754 4444445899999999999997655432 46789999999999999766667
Q ss_pred ccCCCCCCEEEccCCcccccCCcccccc-ccCEEEccCCcCCCCCCCccc--CCCCcccccCCCCCCCCC
Q 005749 219 VTRFEALKELDISNNLFSGSIPEGLTRL-SLEKLNLSHNNFSGVLPVFSE--SKFGAEVFEGNSPALCGF 285 (679)
Q Consensus 219 ~~~l~~L~~L~ls~N~l~g~~p~~~~~l-~L~~l~ls~N~l~g~ip~~~~--~~~~~~~~~~n~~~~c~~ 285 (679)
+..+++|+.|+|++|++++..+..+..+ +|+.|+|++|++++..+.... .......+.+| +..|.+
T Consensus 153 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N-~~~c~c 221 (270)
T 2o6q_A 153 FDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN-PWDCTC 221 (270)
T ss_dssp TTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSS-CBCCSS
T ss_pred ccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCC-CeeCCC
Confidence 8999999999999999997767677776 699999999999976554322 22233344566 666644
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.87 E-value=7.4e-22 Score=199.29 Aligned_cols=193 Identities=18% Similarity=0.170 Sum_probs=156.1
Q ss_pred CCcccccceeecCCCCCcccCCCCCCccccccccCCCCccEEEEEcCCCCCcccCCccccCCCCCCeeecccCcccccCC
Q 005749 61 PLCQWRGLKWISTNGSPLSCSDISLPQWANLSLYKDSSIHLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIP 140 (679)
Q Consensus 61 ~~C~w~Gv~c~~~~~~~l~c~~~~~~~~~~l~~~~~~~~~l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip 140 (679)
+||.|.|++|... ...++|+......+. .. -..+++.|+|++|++.+..|..|+++++|++|+|++|.|++..|
T Consensus 3 ~Cp~~~gC~C~~~-~~~l~~~~~~l~~~p---~~--~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 76 (251)
T 3m19_A 3 TCETVTGCTCNEG-KKEVDCQGKSLDSVP---SG--IPADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSA 76 (251)
T ss_dssp -CHHHHSSEEEGG-GTEEECTTCCCSSCC---SC--CCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCT
T ss_pred cCCCCCceEcCCC-CeEEecCCCCccccC---CC--CCCCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCH
Confidence 5889999998532 234667654432211 11 12368999999999999888899999999999999999998888
Q ss_pred cccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEEccCCCCcccCCCCCCCCCCCCCccEEEccCcccccccccccc
Q 005749 141 FELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVT 220 (679)
Q Consensus 141 ~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~l~~N~l~g~~p~~~~ 220 (679)
..+..+++|++|+|++|++++..+..+.. +++|+.|+|++|+|++..+. .+ ..+++|++|+|++|+|++..+..++
T Consensus 77 ~~~~~l~~L~~L~L~~n~l~~~~~~~~~~-l~~L~~L~L~~N~l~~~~~~-~~--~~l~~L~~L~Ls~N~l~~~~~~~~~ 152 (251)
T 3m19_A 77 GVFDDLTELGTLGLANNQLASLPLGVFDH-LTQLDKLYLGGNQLKSLPSG-VF--DRLTKLKELRLNTNQLQSIPAGAFD 152 (251)
T ss_dssp TTTTTCTTCCEEECTTSCCCCCCTTTTTT-CTTCCEEECCSSCCCCCCTT-TT--TTCTTCCEEECCSSCCCCCCTTTTT
T ss_pred hHhccCCcCCEEECCCCcccccChhHhcc-cCCCCEEEcCCCcCCCcChh-Hh--ccCCcccEEECcCCcCCccCHHHcC
Confidence 88999999999999999999755444444 58999999999999965443 22 4578999999999999977777899
Q ss_pred CCCCCCEEEccCCcccccCCcccccc-ccCEEEccCCcCCCCCC
Q 005749 221 RFEALKELDISNNLFSGSIPEGLTRL-SLEKLNLSHNNFSGVLP 263 (679)
Q Consensus 221 ~l~~L~~L~ls~N~l~g~~p~~~~~l-~L~~l~ls~N~l~g~ip 263 (679)
.+++|+.|+|++|+|++..|..+..+ +|+.|+|++|.|++..+
T Consensus 153 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~ 196 (251)
T 3m19_A 153 KLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCSRC 196 (251)
T ss_dssp TCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTTST
T ss_pred cCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCCcc
Confidence 99999999999999998777778777 69999999999988744
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.87 E-value=2e-22 Score=210.33 Aligned_cols=163 Identities=26% Similarity=0.440 Sum_probs=150.6
Q ss_pred cEEEEEcCCCCCcc--cCCccccCCCCCCeeeccc-CcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcE
Q 005749 100 HLLSIQLPSANLTG--SLPRELGEFSMLQSLYLNV-NSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVS 176 (679)
Q Consensus 100 ~l~~l~l~~n~l~g--~ip~~l~~l~~L~~L~L~~-N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~ 176 (679)
+|+.|+|++|++.| .+|+.|+++++|++|+|++ |.+.|.+|..++++++|++|+|++|.+++.+|..+..+ ++|++
T Consensus 51 ~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l-~~L~~ 129 (313)
T 1ogq_A 51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQI-KTLVT 129 (313)
T ss_dssp CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGC-TTCCE
T ss_pred eEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCC-CCCCE
Confidence 69999999999999 9999999999999999995 99999999999999999999999999999998888775 89999
Q ss_pred EEccCCCCcccCCCCCCCCCCCCCccEEEccCccccccccccccCCC-CCCEEEccCCcccccCCccccccccCEEEccC
Q 005749 177 LRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFE-ALKELDISNNLFSGSIPEGLTRLSLEKLNLSH 255 (679)
Q Consensus 177 L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~l~~N~l~g~~p~~~~~l~-~L~~L~ls~N~l~g~~p~~~~~l~L~~l~ls~ 255 (679)
|+|++|++++.+|..+ ..+++|++|+|++|+++|.+|..++.++ +|+.|++++|+++|.+|..+..++|+.|++++
T Consensus 130 L~Ls~N~l~~~~p~~~---~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~L~~L~Ls~ 206 (313)
T 1ogq_A 130 LDFSYNALSGTLPPSI---SSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSR 206 (313)
T ss_dssp EECCSSEEESCCCGGG---GGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEECCS
T ss_pred EeCCCCccCCcCChHH---hcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCcccEEECcC
Confidence 9999999998887644 4678999999999999999999999998 99999999999999999999988999999999
Q ss_pred CcCCCCCCCcc
Q 005749 256 NNFSGVLPVFS 266 (679)
Q Consensus 256 N~l~g~ip~~~ 266 (679)
|.+++.+|...
T Consensus 207 N~l~~~~~~~~ 217 (313)
T 1ogq_A 207 NMLEGDASVLF 217 (313)
T ss_dssp SEEEECCGGGC
T ss_pred CcccCcCCHHH
Confidence 99999887643
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.83 E-value=1.1e-20 Score=184.76 Aligned_cols=157 Identities=20% Similarity=0.214 Sum_probs=133.4
Q ss_pred cEEEEEcCCCCCcccCCccccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEEc
Q 005749 100 HLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRL 179 (679)
Q Consensus 100 ~l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~L 179 (679)
+++.|+|++|++++..+..++.+++|++|+|++|+|++..+..+..+++|++|+|++|++++..+..+.. +++|++|+|
T Consensus 29 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~-l~~L~~L~L 107 (208)
T 2o6s_A 29 QTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDK-LTQLKELAL 107 (208)
T ss_dssp TCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTT-CTTCCEEEC
T ss_pred CCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcC-ccCCCEEEc
Confidence 6899999999999766667899999999999999999665566789999999999999999754433444 589999999
Q ss_pred cCCCCcccCCCCCCCCCCCCCccEEEccCccccccccccccCCCCCCEEEccCCcccccCCccccccccCEEEccCCcCC
Q 005749 180 HGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRLSLEKLNLSHNNFS 259 (679)
Q Consensus 180 s~N~l~~~~p~~~~~~~~~~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~L~~l~ls~N~l~ 259 (679)
++|++++..+.. + ..+++|++|+|++|++++..+..+..+++|+.|++++|.+.+..| +|+.|+++.|+++
T Consensus 108 ~~N~l~~~~~~~-~--~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~------~l~~L~~~~n~~~ 178 (208)
T 2o6s_A 108 NTNQLQSLPDGV-F--DKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP------GIRYLSEWINKHS 178 (208)
T ss_dssp CSSCCCCCCTTT-T--TTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCCCTT------TTHHHHHHHHHCT
T ss_pred CCCcCcccCHhH-h--ccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeecCCC------CHHHHHHHHHhCC
Confidence 999999755432 2 467899999999999997767778999999999999999987654 4788999999999
Q ss_pred CCCCCcc
Q 005749 260 GVLPVFS 266 (679)
Q Consensus 260 g~ip~~~ 266 (679)
|.+|...
T Consensus 179 g~ip~~~ 185 (208)
T 2o6s_A 179 GVVRNSA 185 (208)
T ss_dssp TTBBCTT
T ss_pred ceeeccC
Confidence 9999754
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.82 E-value=2.2e-20 Score=196.17 Aligned_cols=158 Identities=23% Similarity=0.316 Sum_probs=74.9
Q ss_pred cEEEEEcCCCCCcccCCccccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHh--------hc
Q 005749 100 HLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWN--------LC 171 (679)
Q Consensus 100 ~l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~--------~~ 171 (679)
+++.|+|++|+++ .+|..++++++|++|+|++|.|+ .+|..++++++|++|+|++|++.+.+|..+.. .+
T Consensus 105 ~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~~l 182 (328)
T 4fcg_A 105 HLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGL 182 (328)
T ss_dssp TCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCCEEES
T ss_pred CCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccchhhhccC
Confidence 3445555555555 45555555555555555555555 44555555555555555555554444443321 12
Q ss_pred ccCcEEEccCCCCcccCCCCCCCCCCCCCccEEEccCccccccccccccCCCCCCEEEccCCcccccCCcccccc-ccCE
Q 005749 172 DRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRL-SLEK 250 (679)
Q Consensus 172 ~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l-~L~~ 250 (679)
++|+.|+|++|+++ .+|..+ ..+++|++|+|++|++++ +|..++.+++|+.|+|++|++.+.+|..+..+ +|+.
T Consensus 183 ~~L~~L~L~~n~l~-~lp~~l---~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~ 257 (328)
T 4fcg_A 183 VNLQSLRLEWTGIR-SLPASI---ANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKR 257 (328)
T ss_dssp TTCCEEEEEEECCC-CCCGGG---GGCTTCCEEEEESSCCCC-CCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCE
T ss_pred CCCCEEECcCCCcC-cchHhh---cCCCCCCEEEccCCCCCc-CchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCE
Confidence 44555555555544 333221 233444444444444442 33344444444444444444444444444444 3444
Q ss_pred EEccCCcCCCCCCC
Q 005749 251 LNLSHNNFSGVLPV 264 (679)
Q Consensus 251 l~ls~N~l~g~ip~ 264 (679)
|+|++|++.+.+|.
T Consensus 258 L~L~~n~~~~~~p~ 271 (328)
T 4fcg_A 258 LILKDCSNLLTLPL 271 (328)
T ss_dssp EECTTCTTCCBCCT
T ss_pred EECCCCCchhhcch
Confidence 44444444444443
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.81 E-value=1.8e-19 Score=179.12 Aligned_cols=167 Identities=23% Similarity=0.253 Sum_probs=101.5
Q ss_pred CCCCCCCCCCcccccceeecCCCCCcccCCCCCCccccccccCCCCccEEEEEcCCCCCcccCCccccCCCCCCeeeccc
Q 005749 53 LSSWNISVPLCQWRGLKWISTNGSPLSCSDISLPQWANLSLYKDSSIHLLSIQLPSANLTGSLPRELGEFSMLQSLYLNV 132 (679)
Q Consensus 53 l~~W~~~~~~C~w~Gv~c~~~~~~~l~c~~~~~~~~~~l~~~~~~~~~l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~ 132 (679)
..-|..+...|+|.+|. |+.... +.+|..+. ++|++|+|++
T Consensus 9 ~~~~~~~~~~Cs~~~v~----------c~~~~l---------------------------~~ip~~~~--~~L~~L~Ls~ 49 (229)
T 3e6j_A 9 HSAACPSQCSCSGTTVD----------CRSKRH---------------------------ASVPAGIP--TNAQILYLHD 49 (229)
T ss_dssp --CCCCTTCEEETTEEE----------CTTSCC---------------------------SSCCSCCC--TTCSEEECCS
T ss_pred hhccCCCCCEEeCCEeE----------ccCCCc---------------------------CccCCCCC--CCCCEEEcCC
Confidence 34566677899999999 543221 13343332 5666666666
Q ss_pred CcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEEccCCCCcccCCCCCCCCCCCCCccEEEccCcccc
Q 005749 133 NSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFS 212 (679)
Q Consensus 133 N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~l~~N~l~ 212 (679)
|.|++..|..+..+++|++|+|++|+|++ +|+..+..+++|+.|+|++|+|++..+. .+ ..+++|++|+|++|+|+
T Consensus 50 n~i~~~~~~~~~~l~~L~~L~L~~N~l~~-i~~~~~~~l~~L~~L~Ls~N~l~~l~~~-~~--~~l~~L~~L~Ls~N~l~ 125 (229)
T 3e6j_A 50 NQITKLEPGVFDSLINLKELYLGSNQLGA-LPVGVFDSLTQLTVLDLGTNQLTVLPSA-VF--DRLVHLKELFMCCNKLT 125 (229)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSCCCCCCTT-TT--TTCTTCCEEECCSSCCC
T ss_pred CccCccCHHHhhCccCCcEEECCCCCCCC-cChhhcccCCCcCEEECCCCcCCccChh-Hh--CcchhhCeEeccCCccc
Confidence 66666556666666666666666666654 3333333346666666666666644332 11 24566777777777776
Q ss_pred ccccccccCCCCCCEEEccCCcccccCCcccccc-ccCEEEccCCcCCCCCC
Q 005749 213 GSFPEFVTRFEALKELDISNNLFSGSIPEGLTRL-SLEKLNLSHNNFSGVLP 263 (679)
Q Consensus 213 g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l-~L~~l~ls~N~l~g~ip 263 (679)
.+|..+..+++|+.|+|++|+|++..+..+..+ +|+.|+|++|.+++..+
T Consensus 126 -~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 176 (229)
T 3e6j_A 126 -ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCECR 176 (229)
T ss_dssp -SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTBG
T ss_pred -ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCcc
Confidence 566666777777777777777765544555555 57777777777665544
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.81 E-value=1.5e-19 Score=184.53 Aligned_cols=161 Identities=21% Similarity=0.204 Sum_probs=136.2
Q ss_pred ccEEEEEcCCCCCcccCCccccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEE
Q 005749 99 IHLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLR 178 (679)
Q Consensus 99 ~~l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~ 178 (679)
.+++.|+|++|++.+ + +.++.+++|++|+|++|.|++..|..++.+++|++|+|++|++++..+..+.. +++|++|+
T Consensus 63 ~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~-l~~L~~L~ 139 (272)
T 3rfs_A 63 PNVRYLALGGNKLHD-I-SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDK-LTNLTYLN 139 (272)
T ss_dssp TTCCEEECTTSCCCC-C-GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTT-CTTCCEEE
T ss_pred CCCcEEECCCCCCCC-c-hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhcc-CCCCCEEE
Confidence 358899999999987 3 48999999999999999999777777899999999999999999765444444 48999999
Q ss_pred ccCCCCcccCCCCCCCCCCCCCccEEEccCccccccccccccCCCCCCEEEccCCcccccCCcccccc-ccCEEEccCCc
Q 005749 179 LHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRL-SLEKLNLSHNN 257 (679)
Q Consensus 179 Ls~N~l~~~~p~~~~~~~~~~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l-~L~~l~ls~N~ 257 (679)
|++|++++..+..+ ..+++|++|++++|++++..|..++.+++|+.|++++|++++..|..+..+ +|+.|++++|.
T Consensus 140 L~~n~l~~~~~~~~---~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~ 216 (272)
T 3rfs_A 140 LAHNQLQSLPKGVF---DKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNP 216 (272)
T ss_dssp CCSSCCCCCCTTTT---TTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSC
T ss_pred CCCCccCccCHHHh---ccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCC
Confidence 99999996555322 467899999999999998777778999999999999999998877777777 69999999999
Q ss_pred CCCCCCCc
Q 005749 258 FSGVLPVF 265 (679)
Q Consensus 258 l~g~ip~~ 265 (679)
+++..|..
T Consensus 217 ~~~~~~~l 224 (272)
T 3rfs_A 217 WDCTCPGI 224 (272)
T ss_dssp BCCCTTTT
T ss_pred ccccCcHH
Confidence 99988854
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=1.1e-18 Score=179.27 Aligned_cols=160 Identities=23% Similarity=0.224 Sum_probs=75.6
Q ss_pred cEEEEEcCCCCCcccCCccccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCC-CCCcChhhHHhhcccCcEEE
Q 005749 100 HLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANL-FTGVLAPSIWNLCDRLVSLR 178 (679)
Q Consensus 100 ~l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~-l~g~~p~~~~~~~~~L~~L~ 178 (679)
+++.|+|++|++++..+..|+.+++|++|+|++|.+++..|..+..+++|++|+|++|. +++..|..+.. +++|++|+
T Consensus 33 ~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~-l~~L~~L~ 111 (285)
T 1ozn_A 33 ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHG-LGRLHTLH 111 (285)
T ss_dssp TCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTT-CTTCCEEE
T ss_pred CceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcC-CcCCCEEE
Confidence 34555555555554444445555555555555555554445555555555555555554 33322323322 24555555
Q ss_pred ccCCCCcccCCCCCCCCCCCCCccEEEccCccccccccccccCCCCCCEEEccCCcccccCCcccccc-ccCEEEccCCc
Q 005749 179 LHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRL-SLEKLNLSHNN 257 (679)
Q Consensus 179 Ls~N~l~~~~p~~~~~~~~~~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l-~L~~l~ls~N~ 257 (679)
|++|++++..|..+ ..+++|++|++++|++++..+..++.+++|+.|+|++|++++..+..+..+ +|+.|++++|.
T Consensus 112 l~~n~l~~~~~~~~---~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~ 188 (285)
T 1ozn_A 112 LDRCGLQELGPGLF---RGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNR 188 (285)
T ss_dssp CTTSCCCCCCTTTT---TTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred CCCCcCCEECHhHh---hCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCc
Confidence 55555554333211 234445555555555544333344445555555555555543333334333 34555555555
Q ss_pred CCCCCC
Q 005749 258 FSGVLP 263 (679)
Q Consensus 258 l~g~ip 263 (679)
+++..|
T Consensus 189 l~~~~~ 194 (285)
T 1ozn_A 189 VAHVHP 194 (285)
T ss_dssp CCEECT
T ss_pred ccccCH
Confidence 544443
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=6.8e-19 Score=180.91 Aligned_cols=163 Identities=21% Similarity=0.169 Sum_probs=143.2
Q ss_pred CccEEEEEcCCCCCcccCCccccCCCCCCeeecccCc-ccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcE
Q 005749 98 SIHLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNS-LKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVS 176 (679)
Q Consensus 98 ~~~l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~-l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~ 176 (679)
..+++.|+|++|.+++..|..++.+++|++|+|++|. +++..|..+..+++|++|+|++|.+++..|..+.. +++|++
T Consensus 55 ~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~-l~~L~~ 133 (285)
T 1ozn_A 55 CRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRG-LAALQY 133 (285)
T ss_dssp CTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTT-CTTCCE
T ss_pred CCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhC-CcCCCE
Confidence 4579999999999999889999999999999999998 87666888999999999999999999876655555 489999
Q ss_pred EEccCCCCcccCCCCCCCCCCCCCccEEEccCccccccccccccCCCCCCEEEccCCcccccCCcccccc-ccCEEEccC
Q 005749 177 LRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRL-SLEKLNLSH 255 (679)
Q Consensus 177 L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l-~L~~l~ls~ 255 (679)
|+|++|++++..+..+ ..+++|++|+|++|++++..+..+..+++|+.|++++|++++..|..+..+ +|+.|++++
T Consensus 134 L~l~~n~l~~~~~~~~---~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 210 (285)
T 1ozn_A 134 LYLQDNALQALPDDTF---RDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFA 210 (285)
T ss_dssp EECCSSCCCCCCTTTT---TTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred EECCCCcccccCHhHh---ccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCC
Confidence 9999999997554322 467899999999999997666779999999999999999999989999887 699999999
Q ss_pred CcCCCCCCC
Q 005749 256 NNFSGVLPV 264 (679)
Q Consensus 256 N~l~g~ip~ 264 (679)
|++++..|.
T Consensus 211 n~l~~~~~~ 219 (285)
T 1ozn_A 211 NNLSALPTE 219 (285)
T ss_dssp SCCSCCCHH
T ss_pred CcCCcCCHH
Confidence 999986654
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.79 E-value=1.7e-18 Score=178.43 Aligned_cols=178 Identities=24% Similarity=0.236 Sum_probs=143.6
Q ss_pred ccEEEEEcCCCCCcccCCccccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEE
Q 005749 99 IHLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLR 178 (679)
Q Consensus 99 ~~l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~ 178 (679)
.+++.|+|++|++++..|..|..+++|++|+|++|.|++ +|.. +.+++|++|+|++|+++ .+|..+..+ ++|+.|+
T Consensus 31 ~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~-~~l~~L~~L~Ls~N~l~-~l~~~~~~l-~~L~~L~ 106 (290)
T 1p9a_G 31 KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQVD-GTLPVLGTLDLSHNQLQ-SLPLLGQTL-PALTVLD 106 (290)
T ss_dssp TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE-EECC-SCCTTCCEEECCSSCCS-SCCCCTTTC-TTCCEEE
T ss_pred CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCc-ccCC-CCCCcCCEEECCCCcCC-cCchhhccC-CCCCEEE
Confidence 368899999999999889999999999999999999996 4443 78999999999999998 466655554 8999999
Q ss_pred ccCCCCcccCCCCCCCCCCCCCccEEEccCccccccccccccCCCCCCEEEccCCcccccCCcccccc-ccCEEEccCCc
Q 005749 179 LHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRL-SLEKLNLSHNN 257 (679)
Q Consensus 179 Ls~N~l~~~~p~~~~~~~~~~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l-~L~~l~ls~N~ 257 (679)
|++|+|++..|..+ ..+++|++|+|++|+|++..+..|..+++|+.|+|++|+|++..+..+..+ +|+.|+|++|+
T Consensus 107 l~~N~l~~l~~~~~---~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~ 183 (290)
T 1p9a_G 107 VSFNRLTSLPLGAL---RGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENS 183 (290)
T ss_dssp CCSSCCCCCCSSTT---TTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSC
T ss_pred CCCCcCcccCHHHH---cCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCc
Confidence 99999997655432 467899999999999997777778999999999999999996555556666 69999999999
Q ss_pred CCCCCCCcccCC--CCcccccCCCCCCCCC
Q 005749 258 FSGVLPVFSESK--FGAEVFEGNSPALCGF 285 (679)
Q Consensus 258 l~g~ip~~~~~~--~~~~~~~~n~~~~c~~ 285 (679)
|+ .+|...... .....+.+| |..|.+
T Consensus 184 l~-~ip~~~~~~~~L~~l~L~~N-p~~C~c 211 (290)
T 1p9a_G 184 LY-TIPKGFFGSHLLPFAFLHGN-PWLCNC 211 (290)
T ss_dssp CC-CCCTTTTTTCCCSEEECCSC-CBCCSG
T ss_pred CC-ccChhhcccccCCeEEeCCC-CccCcC
Confidence 99 455543221 222334455 676643
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.78 E-value=9.9e-19 Score=185.51 Aligned_cols=188 Identities=23% Similarity=0.256 Sum_probs=146.3
Q ss_pred CCCCCCCCcccccceeecCCCCCcccCCCCCCccccccccCCCCccEEEEEcCCCCCcccCCccccCCCCCCeeecccCc
Q 005749 55 SWNISVPLCQWRGLKWISTNGSPLSCSDISLPQWANLSLYKDSSIHLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNS 134 (679)
Q Consensus 55 ~W~~~~~~C~w~Gv~c~~~~~~~l~c~~~~~~~~~~l~~~~~~~~~l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~ 134 (679)
.|.....+|.|.|+ |+.. ..... .+.. .-..+++.|+|++|++++..+..++++++|++|+|++|.
T Consensus 22 ~~~~~~~~C~~~~~-c~~~--------~~~l~---~iP~--~~~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~ 87 (353)
T 2z80_A 22 SSNQASLSCDRNGI-CKGS--------SGSLN---SIPS--GLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNG 87 (353)
T ss_dssp -----CCEECTTSE-EECC--------STTCS---SCCT--TCCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSC
T ss_pred CCCccCCCCCCCeE-eeCC--------CCCcc---cccc--cccccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCc
Confidence 35555678999998 5432 22111 1111 011368999999999997666689999999999999999
Q ss_pred ccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEEccCCCCcccCCC-CCCCCCCCCCccEEEccCcc-cc
Q 005749 135 LKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNSLTAALPE-PALPNSTCSDLQYLDLGSNK-FS 212 (679)
Q Consensus 135 l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~-~~~~~~~~~~L~~L~l~~N~-l~ 212 (679)
+++..|..++++++|++|+|++|.+++. |+..+..+++|++|+|++|++++ +|. ..+ ..+++|++|++++|+ ++
T Consensus 88 l~~~~~~~~~~l~~L~~L~Ls~n~l~~~-~~~~~~~l~~L~~L~L~~n~l~~-l~~~~~~--~~l~~L~~L~l~~n~~~~ 163 (353)
T 2z80_A 88 INTIEEDSFSSLGSLEHLDLSYNYLSNL-SSSWFKPLSSLTFLNLLGNPYKT-LGETSLF--SHLTKLQILRVGNMDTFT 163 (353)
T ss_dssp CCEECTTTTTTCTTCCEEECCSSCCSSC-CHHHHTTCTTCSEEECTTCCCSS-SCSSCSC--TTCTTCCEEEEEESSSCC
T ss_pred cCccCHhhcCCCCCCCEEECCCCcCCcC-CHhHhCCCccCCEEECCCCCCcc-cCchhhh--ccCCCCcEEECCCCcccc
Confidence 9988888899999999999999999974 45534445899999999999995 443 222 467899999999994 77
Q ss_pred ccccccccCCCCCCEEEccCCcccccCCcccccc-ccCEEEccCCcCCC
Q 005749 213 GSFPEFVTRFEALKELDISNNLFSGSIPEGLTRL-SLEKLNLSHNNFSG 260 (679)
Q Consensus 213 g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l-~L~~l~ls~N~l~g 260 (679)
+..|..+..+++|+.|++++|++++..|..+..+ +|+.|++++|.++.
T Consensus 164 ~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~ 212 (353)
T 2z80_A 164 KIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHIL 212 (353)
T ss_dssp EECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTT
T ss_pred ccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCcccc
Confidence 6667789999999999999999999889988887 69999999999854
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=2.6e-19 Score=181.28 Aligned_cols=135 Identities=16% Similarity=0.215 Sum_probs=103.7
Q ss_pred cCccccCCceEEEEEEe-CCCCE--EEEEEcccCcccC------------------------cccHHHHHHHHhccCCCC
Q 005749 382 GQVIEKTTYGTAYKAKL-ADGAT--IALRLLREGSCKD------------------------RSSCLPVIRQLGKVRHEN 434 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~-~~~~~--vAvK~~~~~~~~~------------------------~~~~~~Ei~~l~~l~H~n 434 (679)
.+.||+|+||.||+|+. .+|+. ||||+++...... ...+.+|++++.+++|++
T Consensus 52 ~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 131 (258)
T 1zth_A 52 GGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKEAG 131 (258)
T ss_dssp EEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHhCC
Confidence 46899999999999996 78989 9999875432110 125789999999999987
Q ss_pred CccceEEeeCCCCceEEEEEecCC-C----ChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHh-cCCCCCeeecCCC
Q 005749 435 LIPLRAFYQGKRGEKLLIYDYFPS-R----TLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLH-TGHEIPITHGNVR 508 (679)
Q Consensus 435 Iv~l~~~~~~~~~~~~lv~ey~~~-g----sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH-~~~~~~ivHrDlk 508 (679)
+....-+.. +..++||||+.+ | +|.++... .++..+..++.|++.||.||| +.+ |+|||||
T Consensus 132 i~~p~~~~~---~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~g---ivHrDlk 198 (258)
T 1zth_A 132 VSVPQPYTY---MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQEAE---LVHADLS 198 (258)
T ss_dssp CCCCCEEEE---ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHTSC---EECSSCS
T ss_pred CCCCeEEEc---CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHHCC---EEeCCCC
Confidence 532222221 357899999942 4 66665432 224456789999999999999 887 9999999
Q ss_pred CCCeeecCCCceEEeeccccccc
Q 005749 509 SKNVLVDDFFVSRLTEFGLDQLM 531 (679)
Q Consensus 509 p~NILl~~~~~~kl~DFGla~~~ 531 (679)
|+|||+++ .++|+|||+|...
T Consensus 199 p~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 199 EYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp TTSEEESS--SEEECCCTTCEET
T ss_pred HHHEEEcC--cEEEEECcccccC
Confidence 99999998 9999999999754
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.78 E-value=2.7e-18 Score=188.55 Aligned_cols=161 Identities=24% Similarity=0.198 Sum_probs=91.9
Q ss_pred ccEEEEEcCCCCCcccCCccccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHh---------
Q 005749 99 IHLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWN--------- 169 (679)
Q Consensus 99 ~~l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~--------- 169 (679)
.+|+.|+|++|++++..|..|..+++|++|+|++|.|++..+..+..+++|++|+|++|.+++..+..+..
T Consensus 99 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l 178 (452)
T 3zyi_A 99 HHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDL 178 (452)
T ss_dssp TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEEC
T ss_pred CCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeC
Confidence 34556666666666555556666666666666666666444444555666666666666655322211111
Q ss_pred ---------------hcccCcEEEccCCCCcccCCCCCCCCCCCCCccEEEccCccccccccccccCCCCCCEEEccCCc
Q 005749 170 ---------------LCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNL 234 (679)
Q Consensus 170 ---------------~~~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~ 234 (679)
.+++|+.|+|++|++++. |. ...+++|++|+|++|++++..|..|..+++|+.|+|++|+
T Consensus 179 ~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~-~~----~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~ 253 (452)
T 3zyi_A 179 GELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM-PN----LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQ 253 (452)
T ss_dssp CCCTTCCEECTTTTTTCTTCCEEECTTSCCSSC-CC----CTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSC
T ss_pred CCCCCccccChhhccCCCCCCEEECCCCccccc-cc----ccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCc
Confidence 112333333333333321 11 1234566677777777776667777777777777777777
Q ss_pred ccccCCcccccc-ccCEEEccCCcCCCCCCC
Q 005749 235 FSGSIPEGLTRL-SLEKLNLSHNNFSGVLPV 264 (679)
Q Consensus 235 l~g~~p~~~~~l-~L~~l~ls~N~l~g~ip~ 264 (679)
+++..|..+..+ +|+.|+|++|+|++..+.
T Consensus 254 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 284 (452)
T 3zyi_A 254 VSLIERNAFDGLASLVELNLAHNNLSSLPHD 284 (452)
T ss_dssp CCEECTTTTTTCTTCCEEECCSSCCSCCCTT
T ss_pred CceECHHHhcCCCCCCEEECCCCcCCccChH
Confidence 776666666665 577777777777755444
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.77 E-value=4.3e-18 Score=171.55 Aligned_cols=158 Identities=21% Similarity=0.210 Sum_probs=135.5
Q ss_pred EEEEEcCCCCCcccCCccccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEEcc
Q 005749 101 LLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLH 180 (679)
Q Consensus 101 l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls 180 (679)
...+++++++++ .+|..+. ++|+.|+|++|.+++..|..+..+++|++|+|++|.+++..+..+.. +++|+.|+|+
T Consensus 16 ~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~-l~~L~~L~L~ 91 (251)
T 3m19_A 16 KKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDD-LTELGTLGLA 91 (251)
T ss_dssp GTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTT-CTTCCEEECT
T ss_pred CeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhcc-CCcCCEEECC
Confidence 456888999887 6887765 69999999999999888888999999999999999999876555555 4899999999
Q ss_pred CCCCcccCCCCCCCCCCCCCccEEEccCccccccccccccCCCCCCEEEccCCcccccCCcccccc-ccCEEEccCCcCC
Q 005749 181 GNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRL-SLEKLNLSHNNFS 259 (679)
Q Consensus 181 ~N~l~~~~p~~~~~~~~~~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l-~L~~l~ls~N~l~ 259 (679)
+|++++..+..+ ..+++|++|+|++|+|++..+..+..+++|+.|+|++|+|++..|..+..+ +|+.|+|++|+|+
T Consensus 92 ~n~l~~~~~~~~---~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 168 (251)
T 3m19_A 92 NNQLASLPLGVF---DHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQ 168 (251)
T ss_dssp TSCCCCCCTTTT---TTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCS
T ss_pred CCcccccChhHh---cccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCC
Confidence 999997655432 467899999999999997777778999999999999999997777678777 6999999999999
Q ss_pred CCCCCc
Q 005749 260 GVLPVF 265 (679)
Q Consensus 260 g~ip~~ 265 (679)
+..|..
T Consensus 169 ~~~~~~ 174 (251)
T 3m19_A 169 SVPHGA 174 (251)
T ss_dssp CCCTTT
T ss_pred ccCHHH
Confidence 877744
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.77 E-value=4.1e-19 Score=203.38 Aligned_cols=162 Identities=17% Similarity=0.258 Sum_probs=146.8
Q ss_pred CccEEEEEcCCCCCccc-----------------CCcccc--CCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCC
Q 005749 98 SIHLLSIQLPSANLTGS-----------------LPRELG--EFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANL 158 (679)
Q Consensus 98 ~~~l~~l~l~~n~l~g~-----------------ip~~l~--~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~ 158 (679)
..+++.|+|++|+++|. +|++++ ++++|++|+|++|.+.|.+|..++++++|++|+|++|+
T Consensus 205 l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~ 284 (636)
T 4eco_A 205 LTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNR 284 (636)
T ss_dssp CTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCT
T ss_pred ccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCC
Confidence 45789999999999997 999999 99999999999999999999999999999999999998
Q ss_pred -CCC-cChhhHHhh-----cccCcEEEccCCCCcccCCC--CCCCCCCCCCccEEEccCccccccccccccCCCCCCEEE
Q 005749 159 -FTG-VLAPSIWNL-----CDRLVSLRLHGNSLTAALPE--PALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELD 229 (679)
Q Consensus 159 -l~g-~~p~~~~~~-----~~~L~~L~Ls~N~l~~~~p~--~~~~~~~~~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ 229 (679)
++| .+|..+..+ +++|+.|+|++|+++ .+|. .+ ..+++|++|++++|+++|.+| .++.+++|+.|+
T Consensus 285 ~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l---~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~ 359 (636)
T 4eco_A 285 GISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSL---QKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLN 359 (636)
T ss_dssp TSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHH---TTCTTCCEEECCSCCCEEECC-CCEEEEEESEEE
T ss_pred CCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhh---ccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEE
Confidence 999 899888774 379999999999999 6775 33 467899999999999999999 899999999999
Q ss_pred ccCCcccccCCcccccc-c-cCEEEccCCcCCCCCCCcc
Q 005749 230 ISNNLFSGSIPEGLTRL-S-LEKLNLSHNNFSGVLPVFS 266 (679)
Q Consensus 230 ls~N~l~g~~p~~~~~l-~-L~~l~ls~N~l~g~ip~~~ 266 (679)
+++|+++ .+|..+..+ + |+.|++++|+++ .+|...
T Consensus 360 L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~ 396 (636)
T 4eco_A 360 LAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YIPNIF 396 (636)
T ss_dssp CCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SCCSCC
T ss_pred CCCCccc-cccHhhhhhcccCcEEEccCCcCc-ccchhh
Confidence 9999999 889888887 6 999999999999 777643
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.77 E-value=1.8e-18 Score=179.54 Aligned_cols=161 Identities=24% Similarity=0.287 Sum_probs=90.6
Q ss_pred ccEEEEEcCCCCCc--ccCCccccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcE
Q 005749 99 IHLLSIQLPSANLT--GSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVS 176 (679)
Q Consensus 99 ~~l~~l~l~~n~l~--g~ip~~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~ 176 (679)
.+++.|+|++|.++ |.+|..+..+++|++|+|++|.++ .+|..+..+++|++|+|++|.+++..+...+..+++|++
T Consensus 52 ~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~ 130 (306)
T 2z66_A 52 TQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIY 130 (306)
T ss_dssp TTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECCSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCE
T ss_pred ccCCEEECCCCccCcccCcccccccccccCEEECCCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCE
Confidence 35566666666655 333555555666666666666665 355556666666666666666655433122222356666
Q ss_pred EEccCCCCcccCCCCCCCCCCCCCccEEEccCccccc-cccccccCCCCCCEEEccCCcccccCCcccccc-ccCEEEcc
Q 005749 177 LRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSG-SFPEFVTRFEALKELDISNNLFSGSIPEGLTRL-SLEKLNLS 254 (679)
Q Consensus 177 L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~l~~N~l~g-~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l-~L~~l~ls 254 (679)
|+|++|.+++..|..+ ..+++|++|++++|++++ .+|..+..+++|+.|++++|++++..|..+..+ +|+.|+|+
T Consensus 131 L~l~~n~l~~~~~~~~---~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~ 207 (306)
T 2z66_A 131 LDISHTHTRVAFNGIF---NGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMS 207 (306)
T ss_dssp EECTTSCCEECSTTTT---TTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECT
T ss_pred EECCCCcCCccchhhc---ccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECC
Confidence 6666666665444322 234566666666666654 455556666666666666666665555555554 46666666
Q ss_pred CCcCCCCCC
Q 005749 255 HNNFSGVLP 263 (679)
Q Consensus 255 ~N~l~g~ip 263 (679)
+|++++..+
T Consensus 208 ~N~l~~~~~ 216 (306)
T 2z66_A 208 HNNFFSLDT 216 (306)
T ss_dssp TSCCSBCCS
T ss_pred CCccCccCh
Confidence 666655433
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.77 E-value=1.7e-18 Score=171.00 Aligned_cols=152 Identities=20% Similarity=0.196 Sum_probs=77.6
Q ss_pred EcCCCCCcccCCccccCCCCCCeeecccCcccccCCc-ccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEEccCCC
Q 005749 105 QLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPF-ELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNS 183 (679)
Q Consensus 105 ~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip~-~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N~ 183 (679)
++++|+++ .||..+. ..+++|+|++|+|++..|. .+..+++|++|+|++|.+++..+..+..+ ++|+.|+|++|+
T Consensus 17 ~~s~n~l~-~iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l-~~L~~L~Ls~N~ 92 (220)
T 2v70_A 17 DCSNQKLN-KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGA-SGVNEILLTSNR 92 (220)
T ss_dssp ECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTC-TTCCEEECCSSC
T ss_pred EeCCCCcc-cCccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCC-CCCCEEECCCCc
Confidence 34444443 2444332 2345555555555544332 24555555555555555554433333332 555555555555
Q ss_pred CcccCCCCCCCCCCCCCccEEEccCccccccccccccCCCCCCEEEccCCcccccCCcccccc-ccCEEEccCCcCCCCC
Q 005749 184 LTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRL-SLEKLNLSHNNFSGVL 262 (679)
Q Consensus 184 l~~~~p~~~~~~~~~~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l-~L~~l~ls~N~l~g~i 262 (679)
+++..+..+ ..+++|++|+|++|+|++..|..|..+++|+.|+|++|+|++..|..+..+ +|+.|+|++|.|++..
T Consensus 93 l~~~~~~~~---~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c 169 (220)
T 2v70_A 93 LENVQHKMF---KGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNC 169 (220)
T ss_dssp CCCCCGGGG---TTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSG
T ss_pred cCccCHhHh---cCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCC
Confidence 554333211 234555556666666555555555566666666666666665555555555 4666666666665544
Q ss_pred C
Q 005749 263 P 263 (679)
Q Consensus 263 p 263 (679)
+
T Consensus 170 ~ 170 (220)
T 2v70_A 170 Y 170 (220)
T ss_dssp G
T ss_pred c
Confidence 3
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=7.3e-19 Score=193.02 Aligned_cols=164 Identities=19% Similarity=0.139 Sum_probs=140.8
Q ss_pred ccEEEEEcCCCCCcccCCccccCCCCCCeeecccCcccccCC-cccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEE
Q 005749 99 IHLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIP-FELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSL 177 (679)
Q Consensus 99 ~~l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip-~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L 177 (679)
.+++.|+|++|++++..|..|+++++|++|+|++|.+.+.+| ..+..+++|++|||++|.+++..|..+..+ ++|++|
T Consensus 30 ~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l-~~L~~L 108 (455)
T 3v47_A 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGL-ANLEVL 108 (455)
T ss_dssp TTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEECTTTTTTC-TTCCEE
T ss_pred CccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCccCccChhhccCc-ccCCEE
Confidence 468999999999999889999999999999999999987775 568999999999999999998877777665 899999
Q ss_pred EccCCCCcccCCCCCCCCCCCCCccEEEccCcccccccccc-ccCCCCCCEEEccCCcccccCCcccccc---ccCEEEc
Q 005749 178 RLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEF-VTRFEALKELDISNNLFSGSIPEGLTRL---SLEKLNL 253 (679)
Q Consensus 178 ~Ls~N~l~~~~p~~~~~~~~~~~L~~L~l~~N~l~g~~p~~-~~~l~~L~~L~ls~N~l~g~~p~~~~~l---~L~~l~l 253 (679)
+|++|++++.+|... ....+++|++|+|++|++++..|.. +..+++|++|++++|++++..|..+..+ +++.|++
T Consensus 109 ~L~~n~l~~~~~~~~-~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l 187 (455)
T 3v47_A 109 TLTQCNLDGAVLSGN-FFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRL 187 (455)
T ss_dssp ECTTSCCBTHHHHSS-TTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEEC
T ss_pred eCCCCCCCccccCcc-cccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccccChhhhhcccccccccccc
Confidence 999999998554321 1246789999999999999887876 8999999999999999999888887765 5788888
Q ss_pred cCCcCCCCCCC
Q 005749 254 SHNNFSGVLPV 264 (679)
Q Consensus 254 s~N~l~g~ip~ 264 (679)
++|.+++..+.
T Consensus 188 ~~n~l~~~~~~ 198 (455)
T 3v47_A 188 SSITLQDMNEY 198 (455)
T ss_dssp TTCBCTTCSTT
T ss_pred ccCcccccchh
Confidence 88888775543
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.77 E-value=6.6e-18 Score=172.36 Aligned_cols=176 Identities=20% Similarity=0.223 Sum_probs=141.7
Q ss_pred cEEEEEcCCCCCcccCCccccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEEc
Q 005749 100 HLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRL 179 (679)
Q Consensus 100 ~l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~L 179 (679)
+++.|++.+|.+.. + +.++.+++|++|+|++|.+++ + ..++.+++|++|+|++|.+++..+..+.. +++|++|+|
T Consensus 42 ~L~~L~l~~~~i~~-~-~~l~~l~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~L~~n~l~~~~~~~~~~-l~~L~~L~L 116 (272)
T 3rfs_A 42 SIDQIIANNSDIKS-V-QGIQYLPNVRYLALGGNKLHD-I-SALKELTNLTYLILTGNQLQSLPNGVFDK-LTNLKELVL 116 (272)
T ss_dssp TCCEEECTTSCCCC-C-TTGGGCTTCCEEECTTSCCCC-C-GGGTTCTTCCEEECTTSCCCCCCTTTTTT-CTTCCEEEC
T ss_pred ceeeeeeCCCCccc-c-cccccCCCCcEEECCCCCCCC-c-hhhcCCCCCCEEECCCCccCccChhHhcC-CcCCCEEEC
Confidence 48889999998873 3 368999999999999999996 4 47899999999999999999765444444 589999999
Q ss_pred cCCCCcccCCCCCCCCCCCCCccEEEccCccccccccccccCCCCCCEEEccCCcccccCCcccccc-ccCEEEccCCcC
Q 005749 180 HGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRL-SLEKLNLSHNNF 258 (679)
Q Consensus 180 s~N~l~~~~p~~~~~~~~~~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l-~L~~l~ls~N~l 258 (679)
++|++++..+..+ ..+++|++|+|++|++++..|..++.+++|+.|++++|++++..|..+..+ +|+.|++++|++
T Consensus 117 ~~n~l~~~~~~~~---~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l 193 (272)
T 3rfs_A 117 VENQLQSLPDGVF---DKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQL 193 (272)
T ss_dssp TTSCCCCCCTTTT---TTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred CCCcCCccCHHHh---ccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcC
Confidence 9999997655322 467899999999999998777778999999999999999998777777776 799999999999
Q ss_pred CCCCCCccc--CCCCcccccCCCCCCCC
Q 005749 259 SGVLPVFSE--SKFGAEVFEGNSPALCG 284 (679)
Q Consensus 259 ~g~ip~~~~--~~~~~~~~~~n~~~~c~ 284 (679)
++..|.... .......+.+| +..|.
T Consensus 194 ~~~~~~~~~~l~~L~~L~l~~N-~~~~~ 220 (272)
T 3rfs_A 194 KSVPDGVFDRLTSLQYIWLHDN-PWDCT 220 (272)
T ss_dssp SCCCTTTTTTCTTCCEEECCSS-CBCCC
T ss_pred CccCHHHHhCCcCCCEEEccCC-Ccccc
Confidence 998775432 22233334455 44444
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=3.8e-18 Score=174.47 Aligned_cols=161 Identities=21% Similarity=0.197 Sum_probs=124.1
Q ss_pred cEEEEEcCCCCCcccCCccccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEEc
Q 005749 100 HLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRL 179 (679)
Q Consensus 100 ~l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~L 179 (679)
+++.|+|++|++++..+..++++++|++|+|++|.+++..+..+..+++|++|+|++|.+++..+..+..+ ++|+.|++
T Consensus 29 ~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l-~~L~~L~l 107 (276)
T 2z62_A 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGL-SSLQKLVA 107 (276)
T ss_dssp TCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTC-TTCCEEEC
T ss_pred CccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCC-ccccEEEC
Confidence 57888899998887777788889999999999998887666678888899999999998887655555554 88999999
Q ss_pred cCCCCcccCCCCCCCCCCCCCccEEEccCccccc-cccccccCCCCCCEEEccCCcccccCCcccccc-ccC----EEEc
Q 005749 180 HGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSG-SFPEFVTRFEALKELDISNNLFSGSIPEGLTRL-SLE----KLNL 253 (679)
Q Consensus 180 s~N~l~~~~p~~~~~~~~~~~L~~L~l~~N~l~g-~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l-~L~----~l~l 253 (679)
++|++++..+.. ...+++|++|++++|++++ .+|..++.+++|+.|++++|++++..+..+..+ +|+ .|++
T Consensus 108 ~~n~l~~~~~~~---~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~l 184 (276)
T 2z62_A 108 VETNLASLENFP---IGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDL 184 (276)
T ss_dssp TTSCCCCSTTCC---CTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEEC
T ss_pred CCCCccccCchh---cccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeec
Confidence 999888754432 2467788888888888876 368888888888888888888887666655544 344 6777
Q ss_pred cCCcCCCCCCC
Q 005749 254 SHNNFSGVLPV 264 (679)
Q Consensus 254 s~N~l~g~ip~ 264 (679)
++|.+++..+.
T Consensus 185 s~n~l~~~~~~ 195 (276)
T 2z62_A 185 SLNPMNFIQPG 195 (276)
T ss_dssp CSSCCCEECTT
T ss_pred CCCcccccCcc
Confidence 77777655443
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=3e-18 Score=175.21 Aligned_cols=183 Identities=21% Similarity=0.210 Sum_probs=148.3
Q ss_pred CccEEEEEcCCCCCcccCCccccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEE
Q 005749 98 SIHLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSL 177 (679)
Q Consensus 98 ~~~l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L 177 (679)
..+++.|+|++|.+.+..+..++.+++|++|+|++|.+++..|..+..+++|++|+|++|.+++..+..+.. +++|+.|
T Consensus 51 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~-l~~L~~L 129 (276)
T 2z62_A 51 FPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGH-LKTLKEL 129 (276)
T ss_dssp CTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTT-CTTCCEE
T ss_pred ccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECCCCCccccCchhccc-CCCCCEE
Confidence 457999999999999877889999999999999999999888888999999999999999999865545555 4899999
Q ss_pred EccCCCCccc-CCCCCCCCCCCCCccEEEccCccccccccccccCCCCCC----EEEccCCcccccCCccccccccCEEE
Q 005749 178 RLHGNSLTAA-LPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALK----ELDISNNLFSGSIPEGLTRLSLEKLN 252 (679)
Q Consensus 178 ~Ls~N~l~~~-~p~~~~~~~~~~~L~~L~l~~N~l~g~~p~~~~~l~~L~----~L~ls~N~l~g~~p~~~~~l~L~~l~ 252 (679)
+|++|++++. +|..+ ..+++|++|+|++|++++..+..+..+++|+ .|++++|++++..+..+...+|+.|+
T Consensus 130 ~l~~n~l~~~~l~~~~---~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~~~~L~~L~ 206 (276)
T 2z62_A 130 NVAHNLIQSFKLPEYF---SNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLKELA 206 (276)
T ss_dssp ECCSSCCCCCCCCGGG---GGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSCCCEECTTSSCSCCEEEEE
T ss_pred ECcCCccceecCchhh---ccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCcccccCccccCCCcccEEE
Confidence 9999999873 45432 4678999999999999987777787777777 89999999998777777666899999
Q ss_pred ccCCcCCCCCCCccc--CCCCcccccCCCCCCCCC
Q 005749 253 LSHNNFSGVLPVFSE--SKFGAEVFEGNSPALCGF 285 (679)
Q Consensus 253 ls~N~l~g~ip~~~~--~~~~~~~~~~n~~~~c~~ 285 (679)
+++|++++..+.... .......+.+| +..|.+
T Consensus 207 L~~n~l~~~~~~~~~~l~~L~~L~l~~N-~~~c~c 240 (276)
T 2z62_A 207 LDTNQLKSVPDGIFDRLTSLQKIWLHTN-PWDCSC 240 (276)
T ss_dssp CCSSCCSCCCTTTTTTCCSCCEEECCSS-CBCCCT
T ss_pred CCCCceeecCHhHhcccccccEEEccCC-cccccC
Confidence 999999976654322 22233334455 556644
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=3.4e-18 Score=192.42 Aligned_cols=157 Identities=20% Similarity=0.190 Sum_probs=136.6
Q ss_pred ccEEEEEcCCCCCcccCCccccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEE
Q 005749 99 IHLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLR 178 (679)
Q Consensus 99 ~~l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~ 178 (679)
.+++.|+|++|++++..|..|+++++|++|+|++|++++..|..++.+++|++|||++|.+++..|..+..+ ++|++|+
T Consensus 26 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l-~~L~~L~ 104 (549)
T 2z81_A 26 AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPL-SSLKYLN 104 (549)
T ss_dssp TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTC-TTCCEEE
T ss_pred CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccC-CCCcEEE
Confidence 368999999999999989999999999999999999998888899999999999999999998766556654 8999999
Q ss_pred ccCCCCccc-CCCCCCCCCCCCCccEEEccCcccccccc-ccccCCCCCCEEEccCCcccccCCcccccc-ccCEEEccC
Q 005749 179 LHGNSLTAA-LPEPALPNSTCSDLQYLDLGSNKFSGSFP-EFVTRFEALKELDISNNLFSGSIPEGLTRL-SLEKLNLSH 255 (679)
Q Consensus 179 Ls~N~l~~~-~p~~~~~~~~~~~L~~L~l~~N~l~g~~p-~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l-~L~~l~ls~ 255 (679)
|++|++++. +|..+ ..+++|++|++++|++.+.+| ..+.++++|+.|++++|++++.+|..+..+ +|+.|++++
T Consensus 105 Ls~n~l~~~~~~~~~---~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~ 181 (549)
T 2z81_A 105 LMGNPYQTLGVTSLF---PNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHL 181 (549)
T ss_dssp CTTCCCSSSCSSCSC---TTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEEC
T ss_pred CCCCcccccchhhhh---hccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccccChhhhhccccCceEeccc
Confidence 999999863 33322 468899999999999666666 579999999999999999999999988877 588888888
Q ss_pred CcCC
Q 005749 256 NNFS 259 (679)
Q Consensus 256 N~l~ 259 (679)
|.+.
T Consensus 182 n~~~ 185 (549)
T 2z81_A 182 SESA 185 (549)
T ss_dssp SBST
T ss_pred Cccc
Confidence 8764
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.76 E-value=2.9e-18 Score=178.04 Aligned_cols=163 Identities=20% Similarity=0.193 Sum_probs=142.1
Q ss_pred ccEEEEEcCCCCCcccCCccccCCCCCCeeecccCcccccCC-cccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEE
Q 005749 99 IHLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIP-FELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSL 177 (679)
Q Consensus 99 ~~l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip-~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L 177 (679)
.+++.|+|++|.+. .+|..+..+++|++|+|++|.+++..+ ..+..+++|++|+|++|.+++..+..+..+ ++|+.|
T Consensus 78 ~~L~~L~Ls~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l-~~L~~L 155 (306)
T 2z66_A 78 TSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGL-SSLEVL 155 (306)
T ss_dssp SCCCEEECCSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTC-TTCCEE
T ss_pred cccCEEECCCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccC-cCCCEE
Confidence 47889999999988 588889999999999999999996554 578999999999999999998776655554 899999
Q ss_pred EccCCCCcc-cCCCCCCCCCCCCCccEEEccCccccccccccccCCCCCCEEEccCCcccccCCcccccc-ccCEEEccC
Q 005749 178 RLHGNSLTA-ALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRL-SLEKLNLSH 255 (679)
Q Consensus 178 ~Ls~N~l~~-~~p~~~~~~~~~~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l-~L~~l~ls~ 255 (679)
+|++|.+++ .+|... ..+++|++|+|++|++++..|..+..+++|+.|+|++|++++..+..+..+ +|+.|++++
T Consensus 156 ~l~~n~l~~~~~~~~~---~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 232 (306)
T 2z66_A 156 KMAGNSFQENFLPDIF---TELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSL 232 (306)
T ss_dssp ECTTCEEGGGEECSCC---TTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTT
T ss_pred ECCCCccccccchhHH---hhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCC
Confidence 999999987 455433 467899999999999998889999999999999999999998777677766 699999999
Q ss_pred CcCCCCCCCcc
Q 005749 256 NNFSGVLPVFS 266 (679)
Q Consensus 256 N~l~g~ip~~~ 266 (679)
|++++.+|...
T Consensus 233 N~l~~~~~~~~ 243 (306)
T 2z66_A 233 NHIMTSKKQEL 243 (306)
T ss_dssp SCCCBCSSSSC
T ss_pred CCCcccCHHHH
Confidence 99999888654
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.75 E-value=5.9e-18 Score=167.01 Aligned_cols=133 Identities=24% Similarity=0.297 Sum_probs=64.2
Q ss_pred CCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEEccCCCCcccCCCCCCCCCCCCCcc
Q 005749 123 SMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQ 202 (679)
Q Consensus 123 ~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~ 202 (679)
++|+.|+|++|+|++..|..+..+++|++|+|++|++++..|..+.++ ++|++|+|++|+|+.. |...+ ..+++|+
T Consensus 32 ~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l-~~L~~L~Ls~N~l~~l-~~~~f--~~l~~L~ 107 (220)
T 2v9t_B 32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGL-RSLNSLVLYGNKITEL-PKSLF--EGLFSLQ 107 (220)
T ss_dssp TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTC-SSCCEEECCSSCCCCC-CTTTT--TTCTTCC
T ss_pred cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCC-cCCCEEECCCCcCCcc-CHhHc--cCCCCCC
Confidence 344555555555554333344445555555555555544433333332 4455555555555432 22211 2344555
Q ss_pred EEEccCccccccccccccCCCCCCEEEccCCcccccCCcccccc-ccCEEEccCCcCC
Q 005749 203 YLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRL-SLEKLNLSHNNFS 259 (679)
Q Consensus 203 ~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l-~L~~l~ls~N~l~ 259 (679)
+|+|++|+|++..|..|..+++|+.|+|++|+|++..+..+..+ +|+.|+|++|.|+
T Consensus 108 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 165 (220)
T 2v9t_B 108 LLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFI 165 (220)
T ss_dssp EEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEE
T ss_pred EEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcC
Confidence 55555555555445555555555555555555554444444444 3555555555543
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.75 E-value=7.4e-18 Score=191.65 Aligned_cols=111 Identities=19% Similarity=0.257 Sum_probs=77.6
Q ss_pred ccEEEEEcCCCCCcccCCccccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEE
Q 005749 99 IHLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLR 178 (679)
Q Consensus 99 ~~l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~ 178 (679)
.+|+.|+|++|++++..|..|+.+++|++|+|++|.|++..|..++++++|++|+|++|.|++ +|+.++..+++|+.|+
T Consensus 75 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-l~~~~~~~l~~L~~L~ 153 (597)
T 3oja_B 75 RQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSS-LPRGIFHNTPKLTTLS 153 (597)
T ss_dssp CCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEE
T ss_pred CCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCC-CCHHHhccCCCCCEEE
Confidence 357778888888777777778888888888888888877666667778888888888888775 4444433347788888
Q ss_pred ccCCCCcccCCCCCCCCCCCCCccEEEccCccccc
Q 005749 179 LHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSG 213 (679)
Q Consensus 179 Ls~N~l~~~~p~~~~~~~~~~~L~~L~l~~N~l~g 213 (679)
|++|.+++.+|..+ ..+++|++|+|++|++++
T Consensus 154 Ls~N~l~~~~~~~~---~~l~~L~~L~L~~N~l~~ 185 (597)
T 3oja_B 154 MSNNNLERIEDDTF---QATTSLQNLQLSSNRLTH 185 (597)
T ss_dssp CCSSCCCBCCTTTT---TTCTTCCEEECTTSCCSB
T ss_pred eeCCcCCCCChhhh---hcCCcCcEEECcCCCCCC
Confidence 88887776655432 345566666666666654
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.75 E-value=8.6e-18 Score=165.83 Aligned_cols=137 Identities=18% Similarity=0.176 Sum_probs=120.9
Q ss_pred cEEEEEcCCCCCcccCCc-cccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEE
Q 005749 100 HLLSIQLPSANLTGSLPR-ELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLR 178 (679)
Q Consensus 100 ~l~~l~l~~n~l~g~ip~-~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~ 178 (679)
.++.|+|++|++++..|. .|+.+++|++|+|++|.|++..|..+..+++|++|+|++|.+++..+..+.. +++|+.|+
T Consensus 33 ~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~-l~~L~~L~ 111 (220)
T 2v70_A 33 YTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKG-LESLKTLM 111 (220)
T ss_dssp TCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTT-CSSCCEEE
T ss_pred CCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcC-CcCCCEEE
Confidence 367899999999988664 5899999999999999999877778999999999999999999866555555 58999999
Q ss_pred ccCCCCcccCCCCCCCCCCCCCccEEEccCccccccccccccCCCCCCEEEccCCcccccCC
Q 005749 179 LHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIP 240 (679)
Q Consensus 179 Ls~N~l~~~~p~~~~~~~~~~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p 240 (679)
|++|+|++..|..+ ..+++|++|+|++|+|++..|..|..+++|+.|+|++|.+++..+
T Consensus 112 Ls~N~l~~~~~~~~---~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 170 (220)
T 2v70_A 112 LRSNRITCVGNDSF---IGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCY 170 (220)
T ss_dssp CTTSCCCCBCTTSS---TTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred CCCCcCCeECHhHc---CCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCc
Confidence 99999998777543 467899999999999999889999999999999999999987544
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.75 E-value=7.4e-18 Score=192.56 Aligned_cols=203 Identities=20% Similarity=0.193 Sum_probs=147.1
Q ss_pred cccCCCCCCCCCCcccccceeecCCCCCcccCCCCCCccc-cccccCCCCccEEEEEcCCCCCcccCCccccCCCCCCee
Q 005749 50 NLLLSSWNISVPLCQWRGLKWISTNGSPLSCSDISLPQWA-NLSLYKDSSIHLLSIQLPSANLTGSLPRELGEFSMLQSL 128 (679)
Q Consensus 50 ~~~l~~W~~~~~~C~w~Gv~c~~~~~~~l~c~~~~~~~~~-~l~~~~~~~~~l~~l~l~~n~l~g~ip~~l~~l~~L~~L 128 (679)
...+++|+.+. |..|....|... ...++|+..+...+. ++ ...++.|+|++|++++..|..|.++++|++|
T Consensus 10 ~~~~~~~~~~~-p~~~~~c~~~~~-~~~~~c~~~~l~~vP~~l------p~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L 81 (635)
T 4g8a_A 10 DDKLAAANSSI-PESWEPCVEVVP-NITYQCMELNFYKIPDNL------PFSTKNLDLSFNPLRHLGSYSFFSFPELQVL 81 (635)
T ss_dssp ----------------CCSEEEET-TTEEECTTSCCSSCCSSS------CTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred cchhhcccCCC-CCCCCCccccCC-CCEEECCCCCcCccCCCC------CcCCCEEEeeCCCCCCCCHHHHhCCCCCCEE
Confidence 34567776543 333544333222 122457654432221 11 1358999999999998777899999999999
Q ss_pred ecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEEccCCCCcccCCCCCCCCCCCCCccEEEccC
Q 005749 129 YLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGS 208 (679)
Q Consensus 129 ~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~l~~ 208 (679)
+|++|+|++..|..+.++++|++|+|++|+|++..+..+.+ +++|++|+|++|++++..+.. + ..+++|++|+|++
T Consensus 82 ~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~-L~~L~~L~Ls~N~l~~l~~~~-~--~~L~~L~~L~Ls~ 157 (635)
T 4g8a_A 82 DLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSG-LSSLQKLVAVETNLASLENFP-I--GHLKTLKELNVAH 157 (635)
T ss_dssp ECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTT-CTTCCEEECTTSCCCCSTTCC-C--TTCTTCCEEECCS
T ss_pred ECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcC-CCCCCEEECCCCcCCCCChhh-h--hcCcccCeecccc
Confidence 99999999777778999999999999999999754444444 599999999999999754432 2 5788999999999
Q ss_pred ccccc-cccccccCCCCCCEEEccCCcccccCCcccccc-----ccCEEEccCCcCCCCCCC
Q 005749 209 NKFSG-SFPEFVTRFEALKELDISNNLFSGSIPEGLTRL-----SLEKLNLSHNNFSGVLPV 264 (679)
Q Consensus 209 N~l~g-~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l-----~L~~l~ls~N~l~g~ip~ 264 (679)
|++++ .+|..++.+++|++|++++|+|++..|..+..+ ....++++.|.++...|.
T Consensus 158 N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n~l~~i~~~ 219 (635)
T 4g8a_A 158 NLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPG 219 (635)
T ss_dssp SCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTT
T ss_pred CccccCCCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhcccCcccccCcc
Confidence 99975 578899999999999999999998888877655 245799999999876554
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.75 E-value=2.7e-18 Score=178.95 Aligned_cols=161 Identities=21% Similarity=0.175 Sum_probs=126.4
Q ss_pred CccEEEEEcCCCCCcccCCccccCC-----CCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcC--hhhH-Hh
Q 005749 98 SIHLLSIQLPSANLTGSLPRELGEF-----SMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVL--APSI-WN 169 (679)
Q Consensus 98 ~~~l~~l~l~~n~l~g~ip~~l~~l-----~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~--p~~~-~~ 169 (679)
..+++.|+|++|.+++. |..++.+ ++|++|+|++|+|++..|..++.+++|++|||++|++.|.+ |+.+ ..
T Consensus 120 l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~ 198 (312)
T 1wwl_A 120 GPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPL 198 (312)
T ss_dssp SCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHSCTT
T ss_pred CCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHHHhc
Confidence 45688999999999887 8888877 89999999999999877788999999999999999988752 3333 13
Q ss_pred hcccCcEEEccCCCCccc--CCCCCCCCCCCCCccEEEccCcccccccc-ccccCCCCCCEEEccCCcccccCCcccccc
Q 005749 170 LCDRLVSLRLHGNSLTAA--LPEPALPNSTCSDLQYLDLGSNKFSGSFP-EFVTRFEALKELDISNNLFSGSIPEGLTRL 246 (679)
Q Consensus 170 ~~~~L~~L~Ls~N~l~~~--~p~~~~~~~~~~~L~~L~l~~N~l~g~~p-~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l 246 (679)
.+++|+.|+|++|++++. ++...+ ..+++|++|+|++|++++.+| ..+..+++|+.|+|++|+|+ .+|..+. .
T Consensus 199 ~l~~L~~L~L~~N~l~~~~~~~~~~~--~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~~-~ 274 (312)
T 1wwl_A 199 KFPTLQVLALRNAGMETPSGVCSALA--AARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP-A 274 (312)
T ss_dssp SCTTCCEEECTTSCCCCHHHHHHHHH--HTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSCC-S
T ss_pred cCCCCCEEECCCCcCcchHHHHHHHH--hcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhcc-C
Confidence 348899999999998842 111110 245789999999999998775 45667889999999999998 7887776 5
Q ss_pred ccCEEEccCCcCCCCCCC
Q 005749 247 SLEKLNLSHNNFSGVLPV 264 (679)
Q Consensus 247 ~L~~l~ls~N~l~g~ip~ 264 (679)
+|+.|+|++|+|++. |.
T Consensus 275 ~L~~L~Ls~N~l~~~-p~ 291 (312)
T 1wwl_A 275 KLSVLDLSYNRLDRN-PS 291 (312)
T ss_dssp EEEEEECCSSCCCSC-CC
T ss_pred CceEEECCCCCCCCC-hh
Confidence 689999999999887 54
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.75 E-value=1.7e-17 Score=169.03 Aligned_cols=162 Identities=19% Similarity=0.184 Sum_probs=136.7
Q ss_pred CccEEEEEcCCCCCcccCCccccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEE
Q 005749 98 SIHLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSL 177 (679)
Q Consensus 98 ~~~l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L 177 (679)
..+|+.|+|++|++++..+..+..+++|++|+|++|.+++..+..+..+++|++|+|++|.+++..+..+.. +++|+.|
T Consensus 60 l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~-l~~L~~L 138 (270)
T 2o6q_A 60 LTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDS-LTKLTYL 138 (270)
T ss_dssp CTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTT-CTTCCEE
T ss_pred CCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCc-CcCCCEE
Confidence 457999999999998555556789999999999999999766667899999999999999999865544444 5899999
Q ss_pred EccCCCCcccCCCCCCCCCCCCCccEEEccCccccccccccccCCCCCCEEEccCCcccccCCcccccc-ccCEEEccCC
Q 005749 178 RLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRL-SLEKLNLSHN 256 (679)
Q Consensus 178 ~Ls~N~l~~~~p~~~~~~~~~~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l-~L~~l~ls~N 256 (679)
+|++|++++..+. .+ ..+++|++|+|++|++++..+..|..+++|+.|+|++|++++..+..+..+ +|+.|+|++|
T Consensus 139 ~Ls~n~l~~~~~~-~~--~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N 215 (270)
T 2o6q_A 139 SLGYNELQSLPKG-VF--DKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215 (270)
T ss_dssp ECCSSCCCCCCTT-TT--TTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSS
T ss_pred ECCCCcCCccCHh-Hc--cCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCC
Confidence 9999999965443 22 467899999999999997777779999999999999999997666667766 6999999999
Q ss_pred cCCCCCC
Q 005749 257 NFSGVLP 263 (679)
Q Consensus 257 ~l~g~ip 263 (679)
.+...-+
T Consensus 216 ~~~c~c~ 222 (270)
T 2o6q_A 216 PWDCTCN 222 (270)
T ss_dssp CBCCSSS
T ss_pred CeeCCCc
Confidence 9987654
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.75 E-value=6.8e-19 Score=183.49 Aligned_cols=161 Identities=19% Similarity=0.159 Sum_probs=71.6
Q ss_pred cEEEEEcCCCCCcccCCccc--cCCCCCCeeecccCcccccCCcccCCC-----CCCCEEEccCCCCCCcChhhHHhhcc
Q 005749 100 HLLSIQLPSANLTGSLPREL--GEFSMLQSLYLNVNSLKGTIPFELGYS-----SSLSEIDLSANLFTGVLAPSIWNLCD 172 (679)
Q Consensus 100 ~l~~l~l~~n~l~g~ip~~l--~~l~~L~~L~L~~N~l~g~ip~~l~~l-----~~L~~L~Ls~N~l~g~~p~~~~~~~~ 172 (679)
+++.|+|++|+++|.+|..+ +.+++|++|+|++|.|++. |..++.+ ++|++|+|++|++++..|..+..+ +
T Consensus 96 ~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l-~ 173 (312)
T 1wwl_A 96 GLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVF-P 173 (312)
T ss_dssp CCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCC-S
T ss_pred CccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccC-C
Confidence 34445555555555555443 4455555555555555443 4444433 455555555555544333333332 4
Q ss_pred cCcEEEccCCCCcccCC--CCCCCCCCCCCccEEEccCccccc--ccc-ccccCCCCCCEEEccCCcccccCCc-ccccc
Q 005749 173 RLVSLRLHGNSLTAALP--EPALPNSTCSDLQYLDLGSNKFSG--SFP-EFVTRFEALKELDISNNLFSGSIPE-GLTRL 246 (679)
Q Consensus 173 ~L~~L~Ls~N~l~~~~p--~~~~~~~~~~~L~~L~l~~N~l~g--~~p-~~~~~l~~L~~L~ls~N~l~g~~p~-~~~~l 246 (679)
+|+.|+|++|++.+.++ ... ....+++|++|+|++|++++ .++ ..+..+++|+.|+|++|++++.+|. .+..+
T Consensus 174 ~L~~L~Ls~N~l~~~~~~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l 252 (312)
T 1wwl_A 174 ALSTLDLSDNPELGERGLISAL-CPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWP 252 (312)
T ss_dssp SCCEEECCSCTTCHHHHHHHHS-CTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCC
T ss_pred CCCEEECCCCCcCcchHHHHHH-HhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhc
Confidence 45555555555443211 000 01233455555555555541 111 2223445555555555555544432 22222
Q ss_pred -ccCEEEccCCcCCCCCCC
Q 005749 247 -SLEKLNLSHNNFSGVLPV 264 (679)
Q Consensus 247 -~L~~l~ls~N~l~g~ip~ 264 (679)
+|+.|+|++|+|+ .+|.
T Consensus 253 ~~L~~L~Ls~N~l~-~ip~ 270 (312)
T 1wwl_A 253 SQLNSLNLSFTGLK-QVPK 270 (312)
T ss_dssp TTCCEEECTTSCCS-SCCS
T ss_pred CCCCEEECCCCccC-hhhh
Confidence 3555555555555 3443
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.75 E-value=2.4e-18 Score=201.40 Aligned_cols=160 Identities=21% Similarity=0.239 Sum_probs=143.3
Q ss_pred CccEEEEEcCCCCCcc-----------------cCCcccc--CCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCC
Q 005749 98 SIHLLSIQLPSANLTG-----------------SLPRELG--EFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANL 158 (679)
Q Consensus 98 ~~~l~~l~l~~n~l~g-----------------~ip~~l~--~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~ 158 (679)
..+|+.|+|++|+++| .+|++++ +|++|++|+|++|.+.|.+|..++++++|++|+|++|+
T Consensus 447 L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~ 526 (876)
T 4ecn_A 447 LTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNR 526 (876)
T ss_dssp CTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCT
T ss_pred CCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCC
Confidence 3578999999999999 5999988 99999999999999999999999999999999999998
Q ss_pred -CCC-cChhhHHhhc------ccCcEEEccCCCCcccCCC--CCCCCCCCCCccEEEccCccccccccccccCCCCCCEE
Q 005749 159 -FTG-VLAPSIWNLC------DRLVSLRLHGNSLTAALPE--PALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKEL 228 (679)
Q Consensus 159 -l~g-~~p~~~~~~~------~~L~~L~Ls~N~l~~~~p~--~~~~~~~~~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L 228 (679)
|+| .+|..+..+. ++|+.|+|++|+++ .+|. .+ ..+++|++|+|++|+++ .+| .++.+++|+.|
T Consensus 527 ~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l---~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L 600 (876)
T 4ecn_A 527 GISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASL---QKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDL 600 (876)
T ss_dssp TSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHH---TTCTTCCEEECTTSCCC-BCC-CCCTTSEESEE
T ss_pred CcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhh---hcCCCCCEEECCCCCcc-cch-hhcCCCcceEE
Confidence 999 8888887651 38999999999999 6775 33 46789999999999999 889 89999999999
Q ss_pred EccCCcccccCCcccccc-c-cCEEEccCCcCCCCCCCc
Q 005749 229 DISNNLFSGSIPEGLTRL-S-LEKLNLSHNNFSGVLPVF 265 (679)
Q Consensus 229 ~ls~N~l~g~~p~~~~~l-~-L~~l~ls~N~l~g~ip~~ 265 (679)
+|++|+++ .+|..+..+ + |+.|+|++|+|+ .+|..
T Consensus 601 ~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~ 637 (876)
T 4ecn_A 601 KLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNI 637 (876)
T ss_dssp ECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCSC
T ss_pred ECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCchh
Confidence 99999999 889888877 5 999999999999 77754
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.74 E-value=3.2e-18 Score=187.91 Aligned_cols=136 Identities=21% Similarity=0.247 Sum_probs=65.1
Q ss_pred CCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEEccCCCCcccCCCCCCCCCCCCCccE
Q 005749 124 MLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQY 203 (679)
Q Consensus 124 ~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~ 203 (679)
+|++|+|++|.+++.+|..++.+++|++|+|++|.+++..|..+..+ ++|+.|+|++|++++..|..+ ..+++|++
T Consensus 276 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l-~~L~~L~Ls~N~l~~~~~~~~---~~l~~L~~ 351 (455)
T 3v47_A 276 GVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGL-THLLKLNLSQNFLGSIDSRMF---ENLDKLEV 351 (455)
T ss_dssp CCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTC-TTCCEEECCSSCCCEECGGGG---TTCTTCCE
T ss_pred CceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCc-ccCCEEECCCCccCCcChhHh---cCcccCCE
Confidence 45555555555554445455555555555555555554433333332 455555555555544333221 23445555
Q ss_pred EEccCccccccccccccCCCCCCEEEccCCcccccCCcccccc-ccCEEEccCCcCCCCCC
Q 005749 204 LDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRL-SLEKLNLSHNNFSGVLP 263 (679)
Q Consensus 204 L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l-~L~~l~ls~N~l~g~ip 263 (679)
|+|++|++++..|..+..+++|++|+|++|+|++..+..+..+ +|+.|++++|++++.+|
T Consensus 352 L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 412 (455)
T 3v47_A 352 LDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 412 (455)
T ss_dssp EECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred EECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCC
Confidence 5555555554445555555555555555555554333333333 35555555555555544
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.74 E-value=1.5e-17 Score=181.98 Aligned_cols=181 Identities=22% Similarity=0.206 Sum_probs=119.5
Q ss_pred ccEEEEEcCCCCCcccCCccccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhH-----------
Q 005749 99 IHLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSI----------- 167 (679)
Q Consensus 99 ~~l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~----------- 167 (679)
.+|+.|+|++|++.+..+..|..+++|++|+|++|+|++..+..+..+++|++|+|++|.+++..+..+
T Consensus 88 ~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l 167 (440)
T 3zyj_A 88 RHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDL 167 (440)
T ss_dssp SSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEEC
T ss_pred CCCCEEECCCCcCCccChhhccCCccCCEEECCCCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCC
Confidence 467777777777776666777777777777777777775444457777777777777777764332222
Q ss_pred -------------HhhcccCcEEEccCCCCcccCCCCCCCCCCCCCccEEEccCccccccccccccCCCCCCEEEccCCc
Q 005749 168 -------------WNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNL 234 (679)
Q Consensus 168 -------------~~~~~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~ 234 (679)
+..+++|+.|+|++|+++. +|. ...+++|++|+|++|++++..|..|..+++|+.|+|++|+
T Consensus 168 ~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~-~~~----~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~ 242 (440)
T 3zyj_A 168 GELKRLSYISEGAFEGLSNLRYLNLAMCNLRE-IPN----LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQ 242 (440)
T ss_dssp CCCTTCCEECTTTTTTCSSCCEEECTTSCCSS-CCC----CTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred CCCCCcceeCcchhhcccccCeecCCCCcCcc-ccc----cCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCc
Confidence 2223455555555555552 221 1345678888888888887777888888888888888888
Q ss_pred ccccCCcccccc-ccCEEEccCCcCCCCCCCccc--CCCCcccccCCCCCCCCC
Q 005749 235 FSGSIPEGLTRL-SLEKLNLSHNNFSGVLPVFSE--SKFGAEVFEGNSPALCGF 285 (679)
Q Consensus 235 l~g~~p~~~~~l-~L~~l~ls~N~l~g~ip~~~~--~~~~~~~~~~n~~~~c~~ 285 (679)
+++..|..+..+ +|+.|+|++|+|++..+.... .......+.+| |..|.+
T Consensus 243 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N-p~~CdC 295 (440)
T 3zyj_A 243 IQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHN-PWNCNC 295 (440)
T ss_dssp CCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSS-CEECSS
T ss_pred eeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCC-CccCCC
Confidence 887777777776 688888888888866554322 12222334455 666654
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.74 E-value=3.6e-18 Score=191.16 Aligned_cols=179 Identities=26% Similarity=0.314 Sum_probs=122.4
Q ss_pred CCCCCCCCCCc-----ccccc-eeecCCCCCcccCCCCCCccccccccCCCCccEEEEEcCCCCCcccCCccccCCCCCC
Q 005749 53 LSSWNISVPLC-----QWRGL-KWISTNGSPLSCSDISLPQWANLSLYKDSSIHLLSIQLPSANLTGSLPRELGEFSMLQ 126 (679)
Q Consensus 53 l~~W~~~~~~C-----~w~Gv-~c~~~~~~~l~c~~~~~~~~~~l~~~~~~~~~l~~l~l~~n~l~g~ip~~l~~l~~L~ 126 (679)
+.+|..+.++| .|.|+ .|...+-..++++...... +.... ..+++.|+|++|+++ .|| +.+++|+
T Consensus 33 l~~W~~~~~~~~~~~~~~~~l~~C~~~~L~~L~Ls~n~L~~---lp~~l--~~~L~~L~Ls~N~l~-~ip---~~l~~L~ 103 (571)
T 3cvr_A 33 WDKWEKQALPGENRNEAVSLLKECLINQFSELQLNRLNLSS---LPDNL--PPQITVLEITQNALI-SLP---ELPASLE 103 (571)
T ss_dssp HHHHHTTCCTTCCHHHHHHHHHHHHHTTCSEEECCSSCCSC---CCSCC--CTTCSEEECCSSCCS-CCC---CCCTTCC
T ss_pred HHHHhccCCccccccchhhhccccccCCccEEEeCCCCCCc---cCHhH--cCCCCEEECcCCCCc-ccc---cccCCCC
Confidence 45676666778 79999 6765555556665443222 11111 245788888888887 677 4578888
Q ss_pred eeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEEccCCCCcccCCCCCCCCCCCCCccEEEc
Q 005749 127 SLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDL 206 (679)
Q Consensus 127 ~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~l 206 (679)
+|+|++|+|++ +|. +.. +|++|+|++|.|++ +|+ .+++|+.|+|++|+|++ +|. .+++|++|+|
T Consensus 104 ~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~----~l~~L~~L~Ls~N~l~~-lp~------~l~~L~~L~L 167 (571)
T 3cvr_A 104 YLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE----LPALLEYINADNNQLTM-LPE------LPTSLEVLSV 167 (571)
T ss_dssp EEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC----CCTTCCEEECCSSCCSC-CCC------CCTTCCEEEC
T ss_pred EEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC----cCccccEEeCCCCccCc-CCC------cCCCcCEEEC
Confidence 88888888886 777 554 78888888888887 554 34778888888888876 443 3457888888
Q ss_pred cCccccccccccccCCCCCCEEEccCCcccccCCcccccccc-------CEEEccCCcCCCCCCC
Q 005749 207 GSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRLSL-------EKLNLSHNNFSGVLPV 264 (679)
Q Consensus 207 ~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~L-------~~l~ls~N~l~g~ip~ 264 (679)
++|+|++ +|. +. ++|+.|+|++|+|+ .+|. +.. +| +.|+|++|+|+. ||.
T Consensus 168 s~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~lp~-~~~-~L~~~~~~L~~L~Ls~N~l~~-lp~ 224 (571)
T 3cvr_A 168 RNNQLTF-LPE-LP--ESLEALDVSTNLLE-SLPA-VPV-RNHHSEETEIFFRCRENRITH-IPE 224 (571)
T ss_dssp CSSCCSC-CCC-CC--TTCCEEECCSSCCS-SCCC-CC---------CCEEEECCSSCCCC-CCG
T ss_pred CCCCCCC-cch-hh--CCCCEEECcCCCCC-chhh-HHH-hhhcccccceEEecCCCccee-cCH
Confidence 8888875 666 54 77888888888887 5666 444 56 778888887774 554
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.74 E-value=1.7e-17 Score=163.67 Aligned_cols=135 Identities=19% Similarity=0.216 Sum_probs=120.4
Q ss_pred ccEEEEEcCCCCCcccCCccccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEE
Q 005749 99 IHLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLR 178 (679)
Q Consensus 99 ~~l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~ 178 (679)
.+++.|+|++|++++..+..|..+++|++|+|++|.|++..|..+..+++|++|+|++|.|++ +|+..+..+++|+.|+
T Consensus 32 ~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~f~~l~~L~~L~ 110 (220)
T 2v9t_B 32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITE-LPKSLFEGLFSLQLLL 110 (220)
T ss_dssp TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCCC-CCTTTTTTCTTCCEEE
T ss_pred cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCc-cCHhHccCCCCCCEEE
Confidence 368999999999998777799999999999999999998889999999999999999999995 5565555559999999
Q ss_pred ccCCCCcccCCCCCCCCCCCCCccEEEccCccccccccccccCCCCCCEEEccCCcccc
Q 005749 179 LHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSG 237 (679)
Q Consensus 179 Ls~N~l~~~~p~~~~~~~~~~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g 237 (679)
|++|++++..|..+ ..+++|++|+|++|+|++..+..+..+++|+.|+|++|.+..
T Consensus 111 L~~N~l~~~~~~~~---~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c 166 (220)
T 2v9t_B 111 LNANKINCLRVDAF---QDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFIC 166 (220)
T ss_dssp CCSSCCCCCCTTTT---TTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred CCCCCCCEeCHHHc---CCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCC
Confidence 99999998766543 467899999999999998877889999999999999999974
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=8.1e-18 Score=191.71 Aligned_cols=160 Identities=18% Similarity=0.124 Sum_probs=82.2
Q ss_pred ccEEEEEcCCCCCccc--CCccccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcE
Q 005749 99 IHLLSIQLPSANLTGS--LPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVS 176 (679)
Q Consensus 99 ~~l~~l~l~~n~l~g~--ip~~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~ 176 (679)
.+++.|+|++|.+++. +|..++.+++|++|+|++|.+++ +|..+..+++|++|+|++|.+++..|...+..+++|+.
T Consensus 350 ~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~ 428 (606)
T 3vq2_A 350 PSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLY 428 (606)
T ss_dssp TTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEE-ECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCE
T ss_pred CCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCcccc-chhhccCCCCCCeeECCCCccCCccChhhhhccccCCE
Confidence 4566666666666654 35556666666666666666553 44555555555555555555555444222222355555
Q ss_pred EEccCCCCcccCCCCCC----------------------CCCCCCCccEEEccCccccccccccccCCCCCCEEEccCCc
Q 005749 177 LRLHGNSLTAALPEPAL----------------------PNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNL 234 (679)
Q Consensus 177 L~Ls~N~l~~~~p~~~~----------------------~~~~~~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~ 234 (679)
|++++|++++.+|..+. ....+++|++|+|++|++++..|..++.+++|+.|+|++|+
T Consensus 429 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~ 508 (606)
T 3vq2_A 429 LDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNN 508 (606)
T ss_dssp EECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred EECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCc
Confidence 55555555554443220 00234445555555555554444445555555555555555
Q ss_pred ccccCCcccccc-ccCEEEccCCcCC
Q 005749 235 FSGSIPEGLTRL-SLEKLNLSHNNFS 259 (679)
Q Consensus 235 l~g~~p~~~~~l-~L~~l~ls~N~l~ 259 (679)
+++.+|..+..+ +|+.|+|++|+|+
T Consensus 509 l~~~~~~~~~~l~~L~~L~l~~N~l~ 534 (606)
T 3vq2_A 509 LLFLDSSHYNQLYSLSTLDCSFNRIE 534 (606)
T ss_dssp CSCEEGGGTTTCTTCCEEECTTSCCC
T ss_pred CCCcCHHHccCCCcCCEEECCCCcCc
Confidence 554445444444 3555555555555
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=1.8e-17 Score=188.80 Aligned_cols=163 Identities=20% Similarity=0.140 Sum_probs=144.8
Q ss_pred ccEEEEEcCCCCCcccCCccccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEE
Q 005749 99 IHLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLR 178 (679)
Q Consensus 99 ~~l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~ 178 (679)
.+++.|+|++|++++..|..|+++++|++|+|++|.+++..|..++++++|++|+|++|.+++..|..+.++ ++|++|+
T Consensus 32 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l-~~L~~L~ 110 (606)
T 3vq2_A 32 SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGL-TSLENLV 110 (606)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTC-TTCCEEE
T ss_pred CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCc-ccCCEEE
Confidence 468999999999999888899999999999999999998888899999999999999999998777777665 8999999
Q ss_pred ccCCCCcccCCCCCCCCCCCCCccEEEccCccccc-cccccccCCCCCCEEEccCCcccccCCccccccc-----cCEEE
Q 005749 179 LHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSG-SFPEFVTRFEALKELDISNNLFSGSIPEGLTRLS-----LEKLN 252 (679)
Q Consensus 179 Ls~N~l~~~~p~~~~~~~~~~~L~~L~l~~N~l~g-~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~-----L~~l~ 252 (679)
|++|++++..|..+ ..+++|++|++++|++++ .+|..++++++|++|++++|++++..|..+..+. +..|+
T Consensus 111 L~~n~l~~~~~~~~---~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~ 187 (606)
T 3vq2_A 111 AVETKLASLESFPI---GQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLD 187 (606)
T ss_dssp CTTSCCCCSSSSCC---TTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCEEE
T ss_pred ccCCcccccccccc---CCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChhhhhhhhccccccceee
Confidence 99999997665442 578899999999999986 6899999999999999999999998888887762 45899
Q ss_pred ccCCcCCCCCCCc
Q 005749 253 LSHNNFSGVLPVF 265 (679)
Q Consensus 253 ls~N~l~g~ip~~ 265 (679)
+++|.+++..+..
T Consensus 188 l~~n~l~~~~~~~ 200 (606)
T 3vq2_A 188 MSLNPIDFIQDQA 200 (606)
T ss_dssp CTTCCCCEECTTT
T ss_pred ccCCCcceeCccc
Confidence 9999998766543
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.73 E-value=3.3e-18 Score=178.05 Aligned_cols=175 Identities=19% Similarity=0.175 Sum_probs=132.9
Q ss_pred cEEEEEcCCCCCcccCCccc--cCCCCCCeeecccCcccccCC----cccCCCCCCCEEEccCCCCCCcChhhHHhhccc
Q 005749 100 HLLSIQLPSANLTGSLPREL--GEFSMLQSLYLNVNSLKGTIP----FELGYSSSLSEIDLSANLFTGVLAPSIWNLCDR 173 (679)
Q Consensus 100 ~l~~l~l~~n~l~g~ip~~l--~~l~~L~~L~L~~N~l~g~ip----~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~ 173 (679)
+++.|+|++|++.+.+|..+ +.+++|++|+|++|.+++..| ..+..+++|++|+|++|.+++..|..+.. +++
T Consensus 92 ~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~-l~~ 170 (310)
T 4glp_A 92 RLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRA-FPA 170 (310)
T ss_dssp CCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCC-CTT
T ss_pred ceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhcc-CCC
Confidence 48899999999999999988 999999999999999998766 34567899999999999998766555555 489
Q ss_pred CcEEEccCCCCccc--CCCCCCCCCCCCCccEEEccCccccccccc----cccCCCCCCEEEccCCcccccCCcccccc-
Q 005749 174 LVSLRLHGNSLTAA--LPEPALPNSTCSDLQYLDLGSNKFSGSFPE----FVTRFEALKELDISNNLFSGSIPEGLTRL- 246 (679)
Q Consensus 174 L~~L~Ls~N~l~~~--~p~~~~~~~~~~~L~~L~l~~N~l~g~~p~----~~~~l~~L~~L~ls~N~l~g~~p~~~~~l- 246 (679)
|++|+|++|++.+. ++.... ...+++|++|+|++|+++ .+|. .++.+++|++|||++|+|++.+|..+..+
T Consensus 171 L~~L~Ls~N~l~~~~~~~~~~~-~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~ 248 (310)
T 4glp_A 171 LTSLDLSDNPGLGERGLMAALC-PHKFPAIQNLALRNTGME-TPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCM 248 (310)
T ss_dssp CCEEECCSCTTCHHHHHHTTSC-TTSSCCCCSCBCCSSCCC-CHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCC
T ss_pred CCEEECCCCCCccchhhhHHHh-hhcCCCCCEEECCCCCCC-chHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhcc
Confidence 99999999998752 221111 135678899999999887 3333 35678889999999999988777777665
Q ss_pred ---ccCEEEccCCcCCCCCCCcccCCCCcccccCC
Q 005749 247 ---SLEKLNLSHNNFSGVLPVFSESKFGAEVFEGN 278 (679)
Q Consensus 247 ---~L~~l~ls~N~l~g~ip~~~~~~~~~~~~~~n 278 (679)
+|+.|+|++|+|+ .+|.........-.+.+|
T Consensus 249 ~~~~L~~L~Ls~N~l~-~lp~~~~~~L~~L~Ls~N 282 (310)
T 4glp_A 249 WSSALNSLNLSFAGLE-QVPKGLPAKLRVLDLSSN 282 (310)
T ss_dssp CCTTCCCEECCSSCCC-SCCSCCCSCCSCEECCSC
T ss_pred CcCcCCEEECCCCCCC-chhhhhcCCCCEEECCCC
Confidence 6888999999988 566544333333333344
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=1.2e-17 Score=190.31 Aligned_cols=163 Identities=25% Similarity=0.233 Sum_probs=85.3
Q ss_pred cEEEEEcCCCCCcccCCccccCCCCCCeeecccCcccccCCcc-cCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEE
Q 005749 100 HLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFE-LGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLR 178 (679)
Q Consensus 100 ~l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip~~-l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~ 178 (679)
+++.|+|++|.+.+..|..++.+++|++|+|++|.+++..|.. +..+++|++|+|++|.+++..|..+..+ ++|+.|+
T Consensus 377 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l-~~L~~L~ 455 (606)
T 3t6q_A 377 HLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGL-PALQHLN 455 (606)
T ss_dssp TCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTC-TTCCEEE
T ss_pred CCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCC-CCCCEEE
Confidence 4455555555555555555555555555555555555444333 4555555555555555554443333332 5555555
Q ss_pred ccCCCCcccCCCCCCCCCCCCCccEEEccCccccccccccccCCCCCCEEEccCCcccccCCcccccc-ccCEEEccCCc
Q 005749 179 LHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRL-SLEKLNLSHNN 257 (679)
Q Consensus 179 Ls~N~l~~~~p~~~~~~~~~~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l-~L~~l~ls~N~ 257 (679)
|++|++++...........+++|++|+|++|++++..|..++.+++|+.|+|++|++++.+|..+..+ .| .|++++|+
T Consensus 456 L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~ 534 (606)
T 3t6q_A 456 LQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNH 534 (606)
T ss_dssp CTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSC
T ss_pred CCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCc
Confidence 55555554211100011234556666666666665555566666666666666666666556555555 35 66666666
Q ss_pred CCCCCCC
Q 005749 258 FSGVLPV 264 (679)
Q Consensus 258 l~g~ip~ 264 (679)
+++.+|.
T Consensus 535 l~~~~~~ 541 (606)
T 3t6q_A 535 ISIILPS 541 (606)
T ss_dssp CCCCCGG
T ss_pred ccccCHh
Confidence 6655554
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.73 E-value=4.5e-17 Score=159.06 Aligned_cols=140 Identities=22% Similarity=0.241 Sum_probs=118.5
Q ss_pred CCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEEccCCCCcccCCCCCCCCCCCCCc
Q 005749 122 FSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDL 201 (679)
Q Consensus 122 l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L 201 (679)
.++|++|+|++|.|++..+..+..+++|++|+|++|++++. |+..+..+++|++|+|++|++++..+. .+ ..+++|
T Consensus 27 ~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~-~~~~~~~l~~L~~L~Ls~n~l~~~~~~-~~--~~l~~L 102 (208)
T 2o6s_A 27 PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSL-PNGVFNKLTSLTYLNLSTNQLQSLPNG-VF--DKLTQL 102 (208)
T ss_dssp CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCC-CTTTTTTCTTCCEEECCSSCCCCCCTT-TT--TTCTTC
T ss_pred CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCcc-ChhhcCCCCCcCEEECCCCcCCccCHh-Hh--cCccCC
Confidence 46899999999999976666688999999999999999965 444444458999999999999965443 22 467899
Q ss_pred cEEEccCccccccccccccCCCCCCEEEccCCcccccCCcccccc-ccCEEEccCCcCCCCCCCc
Q 005749 202 QYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRL-SLEKLNLSHNNFSGVLPVF 265 (679)
Q Consensus 202 ~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l-~L~~l~ls~N~l~g~ip~~ 265 (679)
++|+|++|++++..+..+..+++|+.|++++|++++..+..+..+ +|+.|++++|.+++..|..
T Consensus 103 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~l 167 (208)
T 2o6s_A 103 KELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCPGI 167 (208)
T ss_dssp CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCCCTTTT
T ss_pred CEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeecCCCCH
Confidence 999999999997777778999999999999999997666667766 6999999999999988854
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.73 E-value=1.7e-17 Score=183.42 Aligned_cols=161 Identities=19% Similarity=0.219 Sum_probs=131.4
Q ss_pred cEEEEEcCCCCCcccCCccccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEEc
Q 005749 100 HLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRL 179 (679)
Q Consensus 100 ~l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~L 179 (679)
+++.|+|++|++++..|..|.++++|++|+|++|.+++..|..+.++++|++|+|++|.+++. |+..+..+++|+.|+|
T Consensus 33 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~L 111 (477)
T 2id5_A 33 ETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLI-PLGVFTGLSNLTKLDI 111 (477)
T ss_dssp TCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSC-CTTSSTTCTTCCEEEC
T ss_pred CCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCcc-CcccccCCCCCCEEEC
Confidence 578899999999888888899999999999999999988888899999999999999998864 4443333588999999
Q ss_pred cCCCCcccCCCCCCCCCCCCCccEEEccCccccccccccccCCCCCCEEEccCCcccccCCcccccc-ccCEEEccCCcC
Q 005749 180 HGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRL-SLEKLNLSHNNF 258 (679)
Q Consensus 180 s~N~l~~~~p~~~~~~~~~~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l-~L~~l~ls~N~l 258 (679)
++|++++..|..+ ..+++|++|+|++|++++..|..|..+++|+.|+|++|++++..+..+..+ +|+.|+|++|.+
T Consensus 112 s~n~i~~~~~~~~---~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i 188 (477)
T 2id5_A 112 SENKIVILLDYMF---QDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNI 188 (477)
T ss_dssp TTSCCCEECTTTT---TTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCC
T ss_pred CCCccccCChhHc---cccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcC
Confidence 9999987766543 467789999999999888878888888899999999998886655566666 688888888888
Q ss_pred CCCCCC
Q 005749 259 SGVLPV 264 (679)
Q Consensus 259 ~g~ip~ 264 (679)
++..+.
T Consensus 189 ~~~~~~ 194 (477)
T 2id5_A 189 NAIRDY 194 (477)
T ss_dssp CEECTT
T ss_pred cEeChh
Confidence 876553
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.72 E-value=5.4e-18 Score=187.71 Aligned_cols=159 Identities=23% Similarity=0.247 Sum_probs=94.0
Q ss_pred cEEEEEcCCCCCcccCCccccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhh-------------
Q 005749 100 HLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPS------------- 166 (679)
Q Consensus 100 ~l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~------------- 166 (679)
+|+.|+|++|++++..|..|+.+++|++|+|++|.|++.+| ++.+++|++|||++|.|++..+..
T Consensus 35 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~~~~L~~L~L~~N~l~ 112 (487)
T 3oja_A 35 NVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNIS 112 (487)
T ss_dssp GCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEECTTCCEEECCSSCCC
T ss_pred CccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCCCCCcCEEECcCCcCC
Confidence 57777777777777666777777777777777777776555 777777777777777766532110
Q ss_pred --HHhhcccCcEEEccCCCCcccCCCCCCCCCCCCCccEEEccCcccccccccccc-CCCCCCEEEccCCcccccCCccc
Q 005749 167 --IWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVT-RFEALKELDISNNLFSGSIPEGL 243 (679)
Q Consensus 167 --~~~~~~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~l~~N~l~g~~p~~~~-~l~~L~~L~ls~N~l~g~~p~~~ 243 (679)
....+++|+.|+|++|++++..|..+ ..+++|++|+|++|++++.+|..+. .+++|+.|+|++|.|++. |...
T Consensus 113 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~---~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~-~~~~ 188 (487)
T 3oja_A 113 RVSCSRGQGKKNIYLANNKITMLRDLDE---GCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KGQV 188 (487)
T ss_dssp CEEECCCSSCEEEECCSSCCCSGGGBCG---GGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-ECCC
T ss_pred CCCccccCCCCEEECCCCCCCCCCchhh---cCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccc-cccc
Confidence 00012345555555555554433221 2345666666666666665555554 566666666666666644 2222
Q ss_pred cccccCEEEccCCcCCCCCCC
Q 005749 244 TRLSLEKLNLSHNNFSGVLPV 264 (679)
Q Consensus 244 ~~l~L~~l~ls~N~l~g~ip~ 264 (679)
...+|+.|+|++|.|++..|.
T Consensus 189 ~l~~L~~L~Ls~N~l~~~~~~ 209 (487)
T 3oja_A 189 VFAKLKTLDLSSNKLAFMGPE 209 (487)
T ss_dssp CCTTCCEEECCSSCCCEECGG
T ss_pred cCCCCCEEECCCCCCCCCCHh
Confidence 222466666666666665544
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.72 E-value=1.2e-16 Score=167.83 Aligned_cols=161 Identities=22% Similarity=0.301 Sum_probs=94.4
Q ss_pred ccEEEEEcCCCCCcccCCccccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEE
Q 005749 99 IHLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLR 178 (679)
Q Consensus 99 ~~l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~ 178 (679)
.+++.|+|++|++++..|..++.+++|++|+|++|.|+ .+|..+. ++|++|++++|.+++..+..+.. +++|+.|+
T Consensus 76 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~-l~~L~~L~ 151 (330)
T 1xku_A 76 KNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNG-LNQMIVVE 151 (330)
T ss_dssp TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTT-CTTCCEEE
T ss_pred CCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCCcCC-ccChhhc--ccccEEECCCCcccccCHhHhcC-CccccEEE
Confidence 45677777777777666777777777777777777776 4555443 45666666666665543333333 36666666
Q ss_pred ccCCCCcc--cCCCCC------------------CCCCCCCCccEEEccCccccccccccccCCCCCCEEEccCCccccc
Q 005749 179 LHGNSLTA--ALPEPA------------------LPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGS 238 (679)
Q Consensus 179 Ls~N~l~~--~~p~~~------------------~~~~~~~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ 238 (679)
|++|.++. ..+... +|....++|++|++++|++++..|..+..+++|+.|++++|++++.
T Consensus 152 l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~l~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~ 231 (330)
T 1xku_A 152 LGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAV 231 (330)
T ss_dssp CCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCSCCSSCCTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEE
T ss_pred CCCCcCCccCcChhhccCCCCcCEEECCCCccccCCccccccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCcee
Confidence 66666642 222110 1111124566666666666655566666666666666666666665
Q ss_pred CCcccccc-ccCEEEccCCcCCCCCCC
Q 005749 239 IPEGLTRL-SLEKLNLSHNNFSGVLPV 264 (679)
Q Consensus 239 ~p~~~~~l-~L~~l~ls~N~l~g~ip~ 264 (679)
.|..+..+ +|+.|+|++|+++ .+|.
T Consensus 232 ~~~~~~~l~~L~~L~L~~N~l~-~lp~ 257 (330)
T 1xku_A 232 DNGSLANTPHLRELHLNNNKLV-KVPG 257 (330)
T ss_dssp CTTTGGGSTTCCEEECCSSCCS-SCCT
T ss_pred ChhhccCCCCCCEEECCCCcCc-cCCh
Confidence 55555555 4666666666666 4443
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.72 E-value=1.8e-17 Score=196.07 Aligned_cols=85 Identities=24% Similarity=0.271 Sum_probs=57.3
Q ss_pred CCCccEEEccCccccccccccccCCCCCCEEEccCCcccccCCccccccccCEEEccCCcCCCCCCCcccCCCCcccccC
Q 005749 198 CSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRLSLEKLNLSHNNFSGVLPVFSESKFGAEVFEG 277 (679)
Q Consensus 198 ~~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~L~~l~ls~N~l~g~ip~~~~~~~~~~~~~~ 277 (679)
+++|++|+|++|+|++..|..+..+++|+.|+|++|+|++..|..+. .+|+.|+|++|+|++.+|.... ......+.+
T Consensus 479 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~-~~L~~L~Ls~N~l~~~~~~~~~-~L~~l~l~~ 556 (844)
T 3j0a_A 479 LSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP-ANLEILDISRNQLLAPNPDVFV-SLSVLDITH 556 (844)
T ss_dssp BCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC-SCCCEEEEEEECCCCCCSCCCS-SCCEEEEEE
T ss_pred cccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh-ccccEEECCCCcCCCCChhHhC-CcCEEEecC
Confidence 45677777777777766677777788888888888888765555444 4688888888888888776532 333334445
Q ss_pred CCCCCCCC
Q 005749 278 NSPALCGF 285 (679)
Q Consensus 278 n~~~~c~~ 285 (679)
| |..|.+
T Consensus 557 N-p~~C~c 563 (844)
T 3j0a_A 557 N-KFICEC 563 (844)
T ss_dssp E-CCCCSS
T ss_pred C-Cccccc
Confidence 5 666643
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.72 E-value=1.5e-17 Score=176.98 Aligned_cols=157 Identities=22% Similarity=0.162 Sum_probs=101.9
Q ss_pred cEEEEEcCCCCCcccCCcccc-CCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEE
Q 005749 100 HLLSIQLPSANLTGSLPRELG-EFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLR 178 (679)
Q Consensus 100 ~l~~l~l~~n~l~g~ip~~l~-~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~ 178 (679)
.++.|+|++|++++..+..+. .+++|++|+|++|+|++..|..+.++++|++|||++|+|++..+..+.. +++|+.|+
T Consensus 40 ~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~-l~~L~~L~ 118 (361)
T 2xot_A 40 YTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSD-LQALEVLL 118 (361)
T ss_dssp TCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTT-CTTCCEEE
T ss_pred CCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCC-CcCCCEEE
Confidence 356677777777766666666 7777777777777777666666777777777777777777544333333 47777777
Q ss_pred ccCCCCcccCCCCCCCCCCCCCccEEEccCccccccccccc---cCCCCCCEEEccCCcccccCCccccccc---cCEEE
Q 005749 179 LHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFV---TRFEALKELDISNNLFSGSIPEGLTRLS---LEKLN 252 (679)
Q Consensus 179 Ls~N~l~~~~p~~~~~~~~~~~L~~L~l~~N~l~g~~p~~~---~~l~~L~~L~ls~N~l~g~~p~~~~~l~---L~~l~ 252 (679)
|++|+|++..|..+ ..+++|++|+|++|+|++..+..+ ..+++|+.|+|++|+|++..+..+..+. ++.|+
T Consensus 119 L~~N~i~~~~~~~~---~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~ 195 (361)
T 2xot_A 119 LYNNHIVVVDRNAF---EDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLY 195 (361)
T ss_dssp CCSSCCCEECTTTT---TTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEE
T ss_pred CCCCcccEECHHHh---CCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEE
Confidence 77777776544332 356677777777777774322333 4577777777777777744334444442 46677
Q ss_pred ccCCcCCC
Q 005749 253 LSHNNFSG 260 (679)
Q Consensus 253 ls~N~l~g 260 (679)
|++|.+..
T Consensus 196 l~~N~~~C 203 (361)
T 2xot_A 196 LHNNPLEC 203 (361)
T ss_dssp CCSSCEEC
T ss_pred ecCCCccC
Confidence 77776653
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.71 E-value=5.4e-17 Score=167.21 Aligned_cols=156 Identities=25% Similarity=0.305 Sum_probs=132.2
Q ss_pred CccEEEEEcCCCCCcccCCccccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEE
Q 005749 98 SIHLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSL 177 (679)
Q Consensus 98 ~~~l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L 177 (679)
..+++.|+|++|++++.-+ . +.+++|++|+|++|.|+ .+|..+..+++|++|+|++|++++..|..+.. +++|+.|
T Consensus 54 l~~L~~L~L~~n~l~~~~~-~-~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~-l~~L~~L 129 (290)
T 1p9a_G 54 YTRLTQLNLDRAELTKLQV-D-GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRG-LGELQEL 129 (290)
T ss_dssp CTTCCEEECTTSCCCEEEC-C-SCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTT-CTTCCEE
T ss_pred CCCCCEEECCCCccCcccC-C-CCCCcCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcC-CCCCCEE
Confidence 4579999999999986433 3 89999999999999998 79999999999999999999999765555555 4899999
Q ss_pred EccCCCCcccCCCCCCCCCCCCCccEEEccCccccccccccccCCCCCCEEEccCCcccccCCcccccc-ccCEEEccCC
Q 005749 178 RLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRL-SLEKLNLSHN 256 (679)
Q Consensus 178 ~Ls~N~l~~~~p~~~~~~~~~~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l-~L~~l~ls~N 256 (679)
+|++|++++..+ ..+ ..+++|++|+|++|+|++..+..+..+++|+.|+|++|+|+ .+|..+... +|+.|+|++|
T Consensus 130 ~L~~N~l~~~~~-~~~--~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~N 205 (290)
T 1p9a_G 130 YLKGNELKTLPP-GLL--TPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205 (290)
T ss_dssp ECTTSCCCCCCT-TTT--TTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSC
T ss_pred ECCCCCCCccCh-hhc--ccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCC
Confidence 999999996544 333 45789999999999999665667789999999999999999 677776655 7999999999
Q ss_pred cCCCC
Q 005749 257 NFSGV 261 (679)
Q Consensus 257 ~l~g~ 261 (679)
.+...
T Consensus 206 p~~C~ 210 (290)
T 1p9a_G 206 PWLCN 210 (290)
T ss_dssp CBCCS
T ss_pred CccCc
Confidence 98754
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.71 E-value=3e-17 Score=185.30 Aligned_cols=177 Identities=23% Similarity=0.242 Sum_probs=143.3
Q ss_pred cEEEEEcCCCCCcccCCccc-----------------------------------------------------cCCCCCC
Q 005749 100 HLLSIQLPSANLTGSLPREL-----------------------------------------------------GEFSMLQ 126 (679)
Q Consensus 100 ~l~~l~l~~n~l~g~ip~~l-----------------------------------------------------~~l~~L~ 126 (679)
+++.|++++|.++|.+|..+ +.+++|+
T Consensus 277 ~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~l~~L~ 356 (562)
T 3a79_B 277 PVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFT 356 (562)
T ss_dssp SEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCCSSCHHHHHHHHHTCCCSEEEEESSCCCCCCCCSSCCCCC
T ss_pred cccEEEEeccEeeccccchhhhcccccchheehhhcccceeecChhhhhhhhccCcceEEEccCCCcccccCccCCCCce
Confidence 78999999999999888766 7789999
Q ss_pred eeecccCcccccCCcccCCCCCCCEEEccCCCCCCc--ChhhHHhhcccCcEEEccCCCCcccCCCCCCCCCCCCCccEE
Q 005749 127 SLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGV--LAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYL 204 (679)
Q Consensus 127 ~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~--~p~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L 204 (679)
+|+|++|.+++.+|..++.+++|++|+|++|++++. +|..+.. +++|+.|+|++|++++.+|...+ ..+++|++|
T Consensus 357 ~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~-l~~L~~L~l~~N~l~~~~~~~~~--~~l~~L~~L 433 (562)
T 3a79_B 357 FLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKN-MSSLETLDVSLNSLNSHAYDRTC--AWAESILVL 433 (562)
T ss_dssp EEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTT-CTTCCEEECTTSCCBSCCSSCCC--CCCTTCCEE
T ss_pred EEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcC-CCCCCEEECCCCcCCCccChhhh--cCcccCCEE
Confidence 999999999999999999999999999999999974 2333444 48999999999999987776543 457899999
Q ss_pred EccCccccccccccccCCCCCCEEEccCCcccccCCcccccc-ccCEEEccCCcCCCCCCCccc---CCCCcccccCCCC
Q 005749 205 DLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRL-SLEKLNLSHNNFSGVLPVFSE---SKFGAEVFEGNSP 280 (679)
Q Consensus 205 ~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l-~L~~l~ls~N~l~g~ip~~~~---~~~~~~~~~~n~~ 280 (679)
++++|++++.+|..+. ++|+.|+|++|+|+ .+|..+..+ +|+.|+|++|+|++ +|.... .......+.+| +
T Consensus 434 ~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~-l~~~~~~~l~~L~~L~l~~N-~ 508 (562)
T 3a79_B 434 NLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKS-VPDGVFDRLTSLQYIWLHDN-P 508 (562)
T ss_dssp ECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCCC-CCTTSTTTCTTCCCEECCSC-C
T ss_pred ECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCCC-CCHHHHhcCCCCCEEEecCC-C
Confidence 9999999988887654 79999999999998 788877776 69999999999994 565311 12223334455 5
Q ss_pred CCCC
Q 005749 281 ALCG 284 (679)
Q Consensus 281 ~~c~ 284 (679)
..|.
T Consensus 509 ~~c~ 512 (562)
T 3a79_B 509 WDCT 512 (562)
T ss_dssp BCCC
T ss_pred cCCC
Confidence 5554
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.71 E-value=4.6e-17 Score=175.06 Aligned_cols=133 Identities=18% Similarity=0.273 Sum_probs=72.0
Q ss_pred cEEEEEcCCCCCcccCCc-cccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEE
Q 005749 100 HLLSIQLPSANLTGSLPR-ELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLR 178 (679)
Q Consensus 100 ~l~~l~l~~n~l~g~ip~-~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~ 178 (679)
+++.|++.+|.+.. +|+ .+..+++|++|+|++|.+++..|..+..+++|++|+|++|.+++..|..+.. +++|++|+
T Consensus 46 ~l~~l~l~~~~l~~-l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~-l~~L~~L~ 123 (390)
T 3o6n_A 46 NQKIVTFKNSTMRK-LPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQN-VPLLTVLV 123 (390)
T ss_dssp CCSEEEEESCEESE-ECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTT-CTTCCEEE
T ss_pred CceEEEecCCchhh-CChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcC-CCCCCEEE
Confidence 34555555555443 333 3455666666666666665544445566666666666666665543333333 25566666
Q ss_pred ccCCCCcccCCCCCCCCCCCCCccEEEccCccccccccccccCCCCCCEEEccCCcccc
Q 005749 179 LHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSG 237 (679)
Q Consensus 179 Ls~N~l~~~~p~~~~~~~~~~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g 237 (679)
|++|+++. +|...+ ..+++|++|++++|++++..|..+..+++|+.|++++|++++
T Consensus 124 L~~n~l~~-l~~~~~--~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 179 (390)
T 3o6n_A 124 LERNDLSS-LPRGIF--HNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH 179 (390)
T ss_dssp CCSSCCCC-CCTTTT--TTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSB
T ss_pred CCCCccCc-CCHHHh--cCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCc
Confidence 66666653 222221 234556666666666655555555566666666666666553
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.71 E-value=2.9e-17 Score=183.51 Aligned_cols=139 Identities=23% Similarity=0.280 Sum_probs=115.9
Q ss_pred cCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCC--cChhhHHhhcccCcEEEccCCCCcccCCCCCCCCCC
Q 005749 120 GEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTG--VLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNST 197 (679)
Q Consensus 120 ~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g--~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~~~~ 197 (679)
+.+++|++|+|++|.+++.+|..++.+++|++|+|++|++++ .+|..+..+ ++|+.|+|++|++++.+|...+ ..
T Consensus 321 ~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l-~~L~~L~Ls~N~l~~~l~~~~~--~~ 397 (520)
T 2z7x_B 321 SKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQM-KSLQQLDISQNSVSYDEKKGDC--SW 397 (520)
T ss_dssp SSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTC-TTCCEEECCSSCCBCCGGGCSC--CC
T ss_pred hhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhC-CCCCEEECCCCcCCcccccchh--cc
Confidence 678899999999999998899999999999999999999987 444555554 8999999999999986665433 35
Q ss_pred CCCccEEEccCccccccccccccCCCCCCEEEccCCcccccCCcccccc-ccCEEEccCCcCCCCCCCc
Q 005749 198 CSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRL-SLEKLNLSHNNFSGVLPVF 265 (679)
Q Consensus 198 ~~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l-~L~~l~ls~N~l~g~ip~~ 265 (679)
+++|++|++++|++++.+|..+. ++|+.|++++|+++ .+|..+..+ +|+.|++++|+|+. +|..
T Consensus 398 l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~-l~~~ 462 (520)
T 2z7x_B 398 TKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKS-VPDG 462 (520)
T ss_dssp CTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CCTT
T ss_pred CccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCc-cCHH
Confidence 67899999999999988887664 78999999999998 788877766 69999999999994 5653
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.70 E-value=1.3e-18 Score=201.57 Aligned_cols=226 Identities=19% Similarity=0.094 Sum_probs=132.4
Q ss_pred hHHHHHHHHHHHhhCCCCCCcccCCCCCC-CCCCcccccceeecCCCCCcccCCCCCCcc--ccccccCCCCccEEEEEc
Q 005749 30 SSDVELLLGKIKSSLQGDDENLLLSSWNI-SVPLCQWRGLKWISTNGSPLSCSDISLPQW--ANLSLYKDSSIHLLSIQL 106 (679)
Q Consensus 30 ~~~~~~ll~~~k~~~~~~~~~~~l~~W~~-~~~~C~w~Gv~c~~~~~~~l~c~~~~~~~~--~~l~~~~~~~~~l~~l~l 106 (679)
..+..+++ .+...+.. +....-..|.. .++.+.|.++.+....-..++......... ..+.........+..+++
T Consensus 131 ~~~~~~l~-~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~l~L~~n~~~~~~~~~l~~l~Ls~~~i~~~~~ 208 (727)
T 4b8c_D 131 DCTKQALM-EMADTLTD-SKTAKKQQPTGDSTPSGTATNSAVSTPLTPKIELFANGKDEANQALLQHKKLSQYSIDEDDD 208 (727)
T ss_dssp -CCCHHHH-HHHHHHHH-HHTTC---------------------------------------------------------
T ss_pred ccchhhhh-hhhhhccc-ccCcccCCCcCCCCccccCCCceecCCccceEEeeCCCCCcchhhHhhcCccCcccccCccc
Confidence 34556666 66665432 01122335643 335677988874433222222211110000 000000011112333344
Q ss_pred CCCCCcccCCccccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEEccCCCCcc
Q 005749 107 PSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNSLTA 186 (679)
Q Consensus 107 ~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N~l~~ 186 (679)
..|++. ..|..+..+++|+.|+|++|.|. .+|..++++++|++|+|++|.|+ .+|+.+..+ ++|+.|+|++|+|+
T Consensus 209 ~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l-~~L~~L~Ls~N~l~- 283 (727)
T 4b8c_D 209 IENRMV-MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNL-SNLRVLDLSHNRLT- 283 (727)
T ss_dssp --------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGG-TTCCEEECTTSCCS-
T ss_pred ccccee-cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCC-CCCCEEeCcCCcCC-
Confidence 444444 45778999999999999999998 89999999999999999999999 788888765 89999999999999
Q ss_pred cCCCCCCCCCCCCCccEEEccCccccccccccccCCCCCCEEEccCCcccccCCccccccc--cCEEEccCCcCCCCCCC
Q 005749 187 ALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRLS--LEKLNLSHNNFSGVLPV 264 (679)
Q Consensus 187 ~~p~~~~~~~~~~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~--L~~l~ls~N~l~g~ip~ 264 (679)
.+|..+ ..+++|++|+|++|.|+ .+|..|+.+++|+.|+|++|.|+|.+|..+..++ +..++|++|.++|.+|.
T Consensus 284 ~lp~~~---~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~ 359 (727)
T 4b8c_D 284 SLPAEL---GSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPH 359 (727)
T ss_dssp SCCSSG---GGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCC
T ss_pred ccChhh---cCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCcc
Confidence 667654 56889999999999997 8899999999999999999999999999887653 34578999999999997
Q ss_pred cc
Q 005749 265 FS 266 (679)
Q Consensus 265 ~~ 266 (679)
..
T Consensus 360 ~l 361 (727)
T 4b8c_D 360 ER 361 (727)
T ss_dssp C-
T ss_pred cc
Confidence 54
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.70 E-value=2.4e-17 Score=184.28 Aligned_cols=161 Identities=30% Similarity=0.399 Sum_probs=142.2
Q ss_pred CCccEEEEEcCCCCCcccCCccccCCCCCCeeecccCcccc--cCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccC
Q 005749 97 SSIHLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKG--TIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRL 174 (679)
Q Consensus 97 ~~~~l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g--~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L 174 (679)
...+++.|+|++|.+++.+|..++.+++|++|+|++|++++ .+|..++.+++|++|||++|.+++.+|...+..+++|
T Consensus 322 ~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L 401 (520)
T 2z7x_B 322 KISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSL 401 (520)
T ss_dssp SCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTC
T ss_pred hCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccC
Confidence 34578999999999999999999999999999999999997 6778899999999999999999987777655556899
Q ss_pred cEEEccCCCCcccCCCCCCCCCCCCCccEEEccCccccccccccccCCCCCCEEEccCCcccccCCcc-cccc-ccCEEE
Q 005749 175 VSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEG-LTRL-SLEKLN 252 (679)
Q Consensus 175 ~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~-~~~l-~L~~l~ 252 (679)
+.|+|++|++++.+|... .++|++|++++|+++ .+|..+..+++|+.|+|++|+|+ .+|.. +..+ +|+.|+
T Consensus 402 ~~L~Ls~N~l~~~~~~~l-----~~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~ 474 (520)
T 2z7x_B 402 LSLNMSSNILTDTIFRCL-----PPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIW 474 (520)
T ss_dssp CEEECCSSCCCGGGGGSC-----CTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEE
T ss_pred CEEECcCCCCCcchhhhh-----cccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCC-ccCHHHhccCCcccEEE
Confidence 999999999998877543 158999999999999 89998889999999999999999 56665 6666 699999
Q ss_pred ccCCcCCCCCCC
Q 005749 253 LSHNNFSGVLPV 264 (679)
Q Consensus 253 ls~N~l~g~ip~ 264 (679)
+++|.+++..+.
T Consensus 475 l~~N~~~c~c~~ 486 (520)
T 2z7x_B 475 LHTNPWDCSCPR 486 (520)
T ss_dssp CCSSCBCCCHHH
T ss_pred CcCCCCcccCCc
Confidence 999999987653
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.70 E-value=2e-17 Score=172.16 Aligned_cols=162 Identities=20% Similarity=0.183 Sum_probs=113.8
Q ss_pred CccEEEEEcCCCCCcccCC----ccccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCc--ChhhH-Hhh
Q 005749 98 SIHLLSIQLPSANLTGSLP----RELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGV--LAPSI-WNL 170 (679)
Q Consensus 98 ~~~l~~l~l~~n~l~g~ip----~~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~--~p~~~-~~~ 170 (679)
..+++.|+|++|.+++.+| ..+..+++|++|+|++|.|++..|..++.+++|++|||++|++.+. ++... ...
T Consensus 116 ~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~ 195 (310)
T 4glp_A 116 GLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHK 195 (310)
T ss_dssp CBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTS
T ss_pred CCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhc
Confidence 4467788888888887665 3456788888888888888877777888888888888888887653 22222 123
Q ss_pred cccCcEEEccCCCCcccCCCCCCCCCCCCCccEEEccCccccccccccccCC---CCCCEEEccCCcccccCCccccccc
Q 005749 171 CDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRF---EALKELDISNNLFSGSIPEGLTRLS 247 (679)
Q Consensus 171 ~~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~l~~N~l~g~~p~~~~~l---~~L~~L~ls~N~l~g~~p~~~~~l~ 247 (679)
+++|++|+|++|+++...+....-...+++|++|+|++|++++.+|..+..+ ++|+.|+|++|+|+ .+|..+. .+
T Consensus 196 l~~L~~L~Ls~N~l~~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~-~~ 273 (310)
T 4glp_A 196 FPAIQNLALRNTGMETPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP-AK 273 (310)
T ss_dssp SCCCCSCBCCSSCCCCHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC-SC
T ss_pred CCCCCEEECCCCCCCchHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc-CC
Confidence 4778888888888863211000000235678888888888887777777766 58888888888888 6677664 36
Q ss_pred cCEEEccCCcCCCC
Q 005749 248 LEKLNLSHNNFSGV 261 (679)
Q Consensus 248 L~~l~ls~N~l~g~ 261 (679)
|+.|+|++|+|++.
T Consensus 274 L~~L~Ls~N~l~~~ 287 (310)
T 4glp_A 274 LRVLDLSSNRLNRA 287 (310)
T ss_dssp CSCEECCSCCCCSC
T ss_pred CCEEECCCCcCCCC
Confidence 88888888888873
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.70 E-value=6.6e-17 Score=186.79 Aligned_cols=163 Identities=25% Similarity=0.267 Sum_probs=142.0
Q ss_pred ccEEEEEcCCCCCcccCCccccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEE
Q 005749 99 IHLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLR 178 (679)
Q Consensus 99 ~~l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~ 178 (679)
.+++.|+|++|++++..+..|+++++|++|+|++|.+++..|..++++++|++|+|++|.+++..+..+.. +++|++|+
T Consensus 25 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~-l~~L~~L~ 103 (680)
T 1ziw_A 25 TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAF-CTNLTELH 103 (680)
T ss_dssp TTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTT-CTTCSEEE
T ss_pred CCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhcc-CCCCCEEE
Confidence 46899999999999877788999999999999999999988999999999999999999999654334555 58999999
Q ss_pred ccCCCCcccCCCCCCCCCCCCCccEEEccCccccccccccccCCCCCCEEEccCCcccccCCccccc---cccCEEEccC
Q 005749 179 LHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTR---LSLEKLNLSH 255 (679)
Q Consensus 179 Ls~N~l~~~~p~~~~~~~~~~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~---l~L~~l~ls~ 255 (679)
|++|++++..|..+ ..+++|++|+|++|++++..|..++++++|++|++++|++++..|..+.. .+|+.|++++
T Consensus 104 L~~n~l~~~~~~~~---~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L~~ 180 (680)
T 1ziw_A 104 LMSNSIQKIKNNPF---VKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSS 180 (680)
T ss_dssp CCSSCCCCCCSCTT---TTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEESEEECTT
T ss_pred CCCCccCccChhHc---cccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHHHhhccccccccEEECCC
Confidence 99999987655433 56889999999999999998999999999999999999999877765543 2699999999
Q ss_pred CcCCCCCCCc
Q 005749 256 NNFSGVLPVF 265 (679)
Q Consensus 256 N~l~g~ip~~ 265 (679)
|++++..|..
T Consensus 181 n~l~~~~~~~ 190 (680)
T 1ziw_A 181 NQIKEFSPGC 190 (680)
T ss_dssp CCCCCBCTTG
T ss_pred CcccccChhh
Confidence 9999987754
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.69 E-value=6.2e-17 Score=170.10 Aligned_cols=155 Identities=21% Similarity=0.329 Sum_probs=110.3
Q ss_pred cEEEEEcCCCCCcccCCccccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEEc
Q 005749 100 HLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRL 179 (679)
Q Consensus 100 ~l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~L 179 (679)
+++.|+|++|++.+..|..|+++++|++|+|++|.+++..|..++++++|++|+|++|.++ .+|..++ ++|++|++
T Consensus 55 ~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~---~~L~~L~l 130 (332)
T 2ft3_A 55 DTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNLP---SSLVELRI 130 (332)
T ss_dssp TCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSSCCC-SCCSSCC---TTCCEEEC
T ss_pred CCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCCcCC-ccCcccc---ccCCEEEC
Confidence 5777888888888777777888888888888888888777778888888888888888887 3555443 57888888
Q ss_pred cCCCCcccCCCCCCCCCCCCCccEEEccCcccc--ccccccccCCCCCCEEEccCCcccccCCccccccccCEEEccCCc
Q 005749 180 HGNSLTAALPEPALPNSTCSDLQYLDLGSNKFS--GSFPEFVTRFEALKELDISNNLFSGSIPEGLTRLSLEKLNLSHNN 257 (679)
Q Consensus 180 s~N~l~~~~p~~~~~~~~~~~L~~L~l~~N~l~--g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~L~~l~ls~N~ 257 (679)
++|++++..+. .+ ..+++|++|++++|.++ +..|..+..+ +|+.|++++|++++ +|..+. -+|+.|++++|.
T Consensus 131 ~~n~i~~~~~~-~~--~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~-l~~~~~-~~L~~L~l~~n~ 204 (332)
T 2ft3_A 131 HDNRIRKVPKG-VF--SGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTG-IPKDLP-ETLNELHLDHNK 204 (332)
T ss_dssp CSSCCCCCCSG-GG--SSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSS-CCSSSC-SSCSCCBCCSSC
T ss_pred CCCccCccCHh-Hh--CCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCc-cCcccc-CCCCEEECCCCc
Confidence 88888754332 11 35677888888888775 3556666666 77777777777764 555443 256777777777
Q ss_pred CCCCCCC
Q 005749 258 FSGVLPV 264 (679)
Q Consensus 258 l~g~ip~ 264 (679)
+++..|.
T Consensus 205 i~~~~~~ 211 (332)
T 2ft3_A 205 IQAIELE 211 (332)
T ss_dssp CCCCCTT
T ss_pred CCccCHH
Confidence 7766544
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.69 E-value=1e-16 Score=175.23 Aligned_cols=158 Identities=21% Similarity=0.230 Sum_probs=106.5
Q ss_pred ccEEEEEcCCCCCcccCCccccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEE
Q 005749 99 IHLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLR 178 (679)
Q Consensus 99 ~~l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~ 178 (679)
.+++.|+|++|++.+..+..|+++++|++|+|++|.|++..|..+.++++|++|+|++|++++..+..+.. +++|+.|+
T Consensus 64 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~-l~~L~~L~ 142 (440)
T 3zyj_A 64 TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVY-LSKLKELW 142 (440)
T ss_dssp TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCCSSCCTTTSCS-CSSCCEEE
T ss_pred CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcCCeeCHhHhhc-cccCceee
Confidence 35888999999999988899999999999999999999877788999999999999999999654434444 58999999
Q ss_pred ccCCCCcccCCCCCCCCCCCCCccEEEccCccccccccc-cccCCCCCCEEEccCCcccccCCcccccc-ccCEEEccCC
Q 005749 179 LHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPE-FVTRFEALKELDISNNLFSGSIPEGLTRL-SLEKLNLSHN 256 (679)
Q Consensus 179 Ls~N~l~~~~p~~~~~~~~~~~L~~L~l~~N~l~g~~p~-~~~~l~~L~~L~ls~N~l~g~~p~~~~~l-~L~~l~ls~N 256 (679)
|++|+++...+..+ ..+++|++|+|++|+..+.+|. .|..+++|+.|+|++|+++ .+|. +..+ +|+.|+|++|
T Consensus 143 L~~N~i~~~~~~~~---~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~~~-~~~l~~L~~L~Ls~N 217 (440)
T 3zyj_A 143 LRNNPIESIPSYAF---NRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPN-LTPLIKLDELDLSGN 217 (440)
T ss_dssp CCSCCCCEECTTTT---TTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS-SCCC-CTTCSSCCEEECTTS
T ss_pred CCCCcccccCHHHh---hhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc-cccc-cCCCcccCEEECCCC
Confidence 99999996544322 2344555555554322222222 3444444444444444444 2332 2222 3444444444
Q ss_pred cCCCCC
Q 005749 257 NFSGVL 262 (679)
Q Consensus 257 ~l~g~i 262 (679)
+|++..
T Consensus 218 ~l~~~~ 223 (440)
T 3zyj_A 218 HLSAIR 223 (440)
T ss_dssp CCCEEC
T ss_pred ccCccC
Confidence 444433
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.69 E-value=6.7e-17 Score=191.20 Aligned_cols=163 Identities=20% Similarity=0.152 Sum_probs=115.3
Q ss_pred cEEEEEcCCCCCcccCCccccCCCCCCeeecccCcccccC-CcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEE
Q 005749 100 HLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTI-PFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLR 178 (679)
Q Consensus 100 ~l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~i-p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~ 178 (679)
+++.|+|++|.+++..|..|+++++|++|+|++|.+.+.+ |..+.++++|++|+|++|.+++..|..+.++ ++|++|+
T Consensus 25 ~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l-~~L~~L~ 103 (844)
T 3j0a_A 25 TTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGL-FHLFELR 103 (844)
T ss_dssp TCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSC-SSCCCEE
T ss_pred CcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCC-cccCEee
Confidence 5777788888887777777888888888888887666666 5667778888888888888877666665554 7788888
Q ss_pred ccCCCCcccCCCCCCCCCCCCCccEEEccCcccccccc-ccccCCCCCCEEEccCCcccccCCcccccc---ccCEEEcc
Q 005749 179 LHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFP-EFVTRFEALKELDISNNLFSGSIPEGLTRL---SLEKLNLS 254 (679)
Q Consensus 179 Ls~N~l~~~~p~~~~~~~~~~~L~~L~l~~N~l~g~~p-~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l---~L~~l~ls 254 (679)
|++|.+++.+|... ....+++|++|+|++|++++..| ..++++++|++|+|++|++++..|..+..+ +|+.|+++
T Consensus 104 Ls~n~l~~~~~~~~-~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~~~L~~L~L~ 182 (844)
T 3j0a_A 104 LYFCGLSDAVLKDG-YFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLA 182 (844)
T ss_dssp CTTCCCSSCCSTTC-CCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHHHCSSCCCEEC
T ss_pred CcCCCCCcccccCc-cccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccccCCccceEECC
Confidence 88888777555421 12456778888888887776544 467777888888888887777666666543 46666666
Q ss_pred CCcCCCCCCC
Q 005749 255 HNNFSGVLPV 264 (679)
Q Consensus 255 ~N~l~g~ip~ 264 (679)
+|.+++.+|.
T Consensus 183 ~n~l~~~~~~ 192 (844)
T 3j0a_A 183 ANSLYSRVSV 192 (844)
T ss_dssp CSBSCCCCCC
T ss_pred CCcccccccc
Confidence 6666665554
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.69 E-value=8.9e-17 Score=177.61 Aligned_cols=166 Identities=22% Similarity=0.181 Sum_probs=144.6
Q ss_pred CCccEEEEEcCCCCCcccCCccccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcE
Q 005749 97 SSIHLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVS 176 (679)
Q Consensus 97 ~~~~l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~ 176 (679)
...+|+.|+|++|.+++..|..|+++++|++|+|++|.|++..+..+.++++|++|+|++|.+++..|..+..+ ++|+.
T Consensus 54 ~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l-~~L~~ 132 (477)
T 2id5_A 54 SFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDL-YNLKS 132 (477)
T ss_dssp TCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTC-TTCCE
T ss_pred CCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEECCCCccccCChhHcccc-ccCCE
Confidence 34579999999999999999999999999999999999996555568999999999999999998776666554 89999
Q ss_pred EEccCCCCcccCCCCCCCCCCCCCccEEEccCccccccccccccCCCCCCEEEccCCcccccCCcccccc-ccCEEEccC
Q 005749 177 LRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRL-SLEKLNLSH 255 (679)
Q Consensus 177 L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l-~L~~l~ls~ 255 (679)
|+|++|++++..|..+ ..+++|++|+|++|++++..+..+..+++|+.|+|++|++++..+..+..+ +|+.|++++
T Consensus 133 L~l~~n~l~~~~~~~~---~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~ 209 (477)
T 2id5_A 133 LEVGDNDLVYISHRAF---SGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISH 209 (477)
T ss_dssp EEECCTTCCEECTTSS---TTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEEC
T ss_pred EECCCCccceeChhhc---cCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCC
Confidence 9999999998766543 467899999999999997767789999999999999999998878778777 699999999
Q ss_pred CcCCCCCCCcc
Q 005749 256 NNFSGVLPVFS 266 (679)
Q Consensus 256 N~l~g~ip~~~ 266 (679)
|++.+.+|...
T Consensus 210 ~~~~~~~~~~~ 220 (477)
T 2id5_A 210 WPYLDTMTPNC 220 (477)
T ss_dssp CTTCCEECTTT
T ss_pred CccccccCccc
Confidence 99888887643
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.69 E-value=8.4e-17 Score=183.28 Aligned_cols=163 Identities=20% Similarity=0.119 Sum_probs=141.0
Q ss_pred cEEEEEcCCCCCcccCCccccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEEc
Q 005749 100 HLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRL 179 (679)
Q Consensus 100 ~l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~L 179 (679)
+++.|+|++|++++..|..|+++++|++|+|++|.+++..|..++++++|++|+|++|.+++..|..+..+ ++|++|+|
T Consensus 34 ~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l-~~L~~L~L 112 (606)
T 3t6q_A 34 STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGP-KALKHLFF 112 (606)
T ss_dssp TCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSC-TTCCEEEC
T ss_pred cCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhccc-ccccEeec
Confidence 58999999999999889999999999999999999998889999999999999999999998777776665 89999999
Q ss_pred cCCCCcccCCCCCCCCCCCCCccEEEccCccccccccccccCCCCCCEEEccCCcccccCCcccccc-ccC--EEEccCC
Q 005749 180 HGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRL-SLE--KLNLSHN 256 (679)
Q Consensus 180 s~N~l~~~~p~~~~~~~~~~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l-~L~--~l~ls~N 256 (679)
++|++++..|... ..+++|++|++++|++++..+..+..+++|+.|++++|++++..|..+..+ +|+ .|++++|
T Consensus 113 ~~n~i~~l~~~~~---~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~l~L~l~~n 189 (606)
T 3t6q_A 113 IQTGISSIDFIPL---HNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGN 189 (606)
T ss_dssp TTSCCSCGGGSCC---TTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHHHHTTTTCCSEEEECTTC
T ss_pred cccCcccCCcchh---ccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhhhhhhcccceeEEecCCC
Confidence 9999997544332 578899999999999997433344459999999999999998888877777 577 8999999
Q ss_pred cCCCCCCCcc
Q 005749 257 NFSGVLPVFS 266 (679)
Q Consensus 257 ~l~g~ip~~~ 266 (679)
.+++..|...
T Consensus 190 ~l~~~~~~~~ 199 (606)
T 3t6q_A 190 DIAGIEPGAF 199 (606)
T ss_dssp CCCEECTTTT
T ss_pred ccCccChhHh
Confidence 9999887653
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.69 E-value=1.3e-16 Score=153.93 Aligned_cols=132 Identities=20% Similarity=0.270 Sum_probs=93.5
Q ss_pred EEEEcCCCCCcccCCccccCCCCCCeeecccCcccccCCc-ccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEEcc
Q 005749 102 LSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPF-ELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLH 180 (679)
Q Consensus 102 ~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip~-~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls 180 (679)
+.+++++|++ +.+|..+.. +|++|+|++|+|++..|. .++.+++|++|+|++|+|++..|..+..+ ++|+.|+|+
T Consensus 11 ~~l~~s~~~l-~~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l-~~L~~L~Ls 86 (192)
T 1w8a_A 11 TTVDCTGRGL-KEIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGA-SHIQELQLG 86 (192)
T ss_dssp TEEECTTSCC-SSCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTC-TTCCEEECC
T ss_pred CEEEcCCCCc-CcCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCc-ccCCEEECC
Confidence 4567777777 467766544 788888888888755543 37778888888888888887666665554 778888888
Q ss_pred CCCCcccCCCCCCCCCCCCCccEEEccCccccccccccccCCCCCCEEEccCCcccccCC
Q 005749 181 GNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIP 240 (679)
Q Consensus 181 ~N~l~~~~p~~~~~~~~~~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p 240 (679)
+|+|++..|..+ ..+++|++|+|++|+|++.+|..+..+++|+.|+|++|.+++..+
T Consensus 87 ~N~l~~~~~~~~---~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 143 (192)
T 1w8a_A 87 ENKIKEISNKMF---LGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH 143 (192)
T ss_dssp SCCCCEECSSSS---TTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred CCcCCccCHHHh---cCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCc
Confidence 887776655422 345677777777777777777777777777777777777776544
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.69 E-value=4.2e-17 Score=184.10 Aligned_cols=160 Identities=27% Similarity=0.368 Sum_probs=141.3
Q ss_pred CccEEEEEcCCCCCcccCCccccCCCCCCeeecccCcccc--cCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCc
Q 005749 98 SIHLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKG--TIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLV 175 (679)
Q Consensus 98 ~~~l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g--~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~ 175 (679)
..+++.|+|++|.+++.+|..++.+++|++|+|++|+|++ .+|..++.+++|++|+|++|.+++.+|...+..+++|+
T Consensus 352 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~ 431 (562)
T 3a79_B 352 PSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESIL 431 (562)
T ss_dssp CCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCC
T ss_pred CCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCC
Confidence 4578999999999999999999999999999999999996 45677899999999999999999877776555568999
Q ss_pred EEEccCCCCcccCCCCCCCCCCCCCccEEEccCccccccccccccCCCCCCEEEccCCcccccCCcc-cccc-ccCEEEc
Q 005749 176 SLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEG-LTRL-SLEKLNL 253 (679)
Q Consensus 176 ~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~-~~~l-~L~~l~l 253 (679)
.|+|++|++++.+|... .++|++|+|++|+++ .+|..+..+++|+.|+|++|+|+ .+|.. +..+ +|+.|++
T Consensus 432 ~L~l~~n~l~~~~~~~l-----~~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l 504 (562)
T 3a79_B 432 VLNLSSNMLTGSVFRCL-----PPKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWL 504 (562)
T ss_dssp EEECCSSCCCGGGGSSC-----CTTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCC-CCCTTSTTTCTTCCCEEC
T ss_pred EEECCCCCCCcchhhhh-----cCcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCC-CCCHHHHhcCCCCCEEEe
Confidence 99999999998877532 158999999999999 78888889999999999999999 56665 6666 6999999
Q ss_pred cCCcCCCCCCC
Q 005749 254 SHNNFSGVLPV 264 (679)
Q Consensus 254 s~N~l~g~ip~ 264 (679)
++|.+++..|.
T Consensus 505 ~~N~~~c~c~~ 515 (562)
T 3a79_B 505 HDNPWDCTCPG 515 (562)
T ss_dssp CSCCBCCCHHH
T ss_pred cCCCcCCCcch
Confidence 99999998764
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.69 E-value=6.8e-17 Score=182.49 Aligned_cols=184 Identities=20% Similarity=0.214 Sum_probs=145.8
Q ss_pred CccEEEEEcCCCCCcccC--CccccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCc
Q 005749 98 SIHLLSIQLPSANLTGSL--PRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLV 175 (679)
Q Consensus 98 ~~~l~~l~l~~n~l~g~i--p~~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~ 175 (679)
..+++.|++++|++++.. |..+..+++|++|+|++|.+++ +|..+..+++|++|+|++|.+++..|...+..+++|+
T Consensus 346 ~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~ 424 (570)
T 2z63_A 346 LPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLI 424 (570)
T ss_dssp CTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEE-EEEEEETCTTCCEEECTTSEEESCTTSCTTTTCTTCC
T ss_pred CCCCCEEeCcCCccCccccccccccccCccCEEECCCCcccc-ccccccccCCCCEEEccCCccccccchhhhhcCCCCC
Confidence 356888999999888654 7788899999999999999985 4445889999999999999998876644444458999
Q ss_pred EEEccCCCCcccCCCCCCCCCCCCCccEEEccCcccc-ccccccccCCCCCCEEEccCCcccccCCcccccc-ccCEEEc
Q 005749 176 SLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFS-GSFPEFVTRFEALKELDISNNLFSGSIPEGLTRL-SLEKLNL 253 (679)
Q Consensus 176 ~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~l~~N~l~-g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l-~L~~l~l 253 (679)
.|++++|.+++.+|..+ ..+++|++|++++|+++ +.+|..+..+++|+.|++++|++++..|..+..+ +|+.|++
T Consensus 425 ~L~l~~n~l~~~~~~~~---~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 501 (570)
T 2z63_A 425 YLDISHTHTRVAFNGIF---NGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNM 501 (570)
T ss_dssp EEECTTSCCEECCTTTT---TTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred EEeCcCCcccccchhhh---hcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeC
Confidence 99999999998776543 46789999999999998 6889999999999999999999998889888877 6999999
Q ss_pred cCCcCCCCCCCccc--CCCCcccccCCCCCCCCCC
Q 005749 254 SHNNFSGVLPVFSE--SKFGAEVFEGNSPALCGFP 286 (679)
Q Consensus 254 s~N~l~g~ip~~~~--~~~~~~~~~~n~~~~c~~p 286 (679)
++|++++..|.... .......+.+| +..|.+|
T Consensus 502 ~~n~l~~~~~~~~~~l~~L~~L~l~~N-~~~~~~~ 535 (570)
T 2z63_A 502 ASNQLKSVPDGIFDRLTSLQKIWLHTN-PWDCSCP 535 (570)
T ss_dssp CSSCCSCCCTTTTTTCTTCCEEECCSS-CBCCCTT
T ss_pred CCCcCCCCCHHHhhcccCCcEEEecCC-cccCCCc
Confidence 99999988775432 12223334455 5555433
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.69 E-value=1.5e-16 Score=183.78 Aligned_cols=186 Identities=23% Similarity=0.218 Sum_probs=131.3
Q ss_pred CccEEEEEcCCCCCcccCC-ccccCCCCCCeeecccCccc--------------------------ccCCcccCCCCCCC
Q 005749 98 SIHLLSIQLPSANLTGSLP-RELGEFSMLQSLYLNVNSLK--------------------------GTIPFELGYSSSLS 150 (679)
Q Consensus 98 ~~~l~~l~l~~n~l~g~ip-~~l~~l~~L~~L~L~~N~l~--------------------------g~ip~~l~~l~~L~ 150 (679)
..+++.|+|++|.+.+.+| ..+..+++|++|+|++|.++ +.+|..+..+++|+
T Consensus 404 l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~ 483 (680)
T 1ziw_A 404 LGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLT 483 (680)
T ss_dssp CTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCC
T ss_pred CCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCCC
Confidence 3467778888888877776 46777777777777777655 34566677788888
Q ss_pred EEEccCCCCCCcChhhHHhhcccCcEEEccCCCCcccCCCCCCC------CCCCCCccEEEccCccccccccccccCCCC
Q 005749 151 EIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALP------NSTCSDLQYLDLGSNKFSGSFPEFVTRFEA 224 (679)
Q Consensus 151 ~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~------~~~~~~L~~L~l~~N~l~g~~p~~~~~l~~ 224 (679)
+|+|++|++++..+..+.. +++|+.|+|++|++++..+. .+| ...+++|++|+|++|+++...+..|..+++
T Consensus 484 ~L~Ls~N~l~~i~~~~~~~-l~~L~~L~Ls~N~l~~~~~~-~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~ 561 (680)
T 1ziw_A 484 ILDLSNNNIANINDDMLEG-LEKLEILDLQHNNLARLWKH-ANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFE 561 (680)
T ss_dssp EEECCSSCCCCCCTTTTTT-CTTCCEEECCSSCCGGGGST-TSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTT
T ss_pred EEECCCCCCCcCChhhhcc-ccccCEEeCCCCCccccchh-hccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccC
Confidence 8888888888654433444 47888888888888764321 111 245788999999999998433346888999
Q ss_pred CCEEEccCCcccccCCcccccc-ccCEEEccCCcCCCCCCCccc---CCCCcccccCCCCCCCCCC
Q 005749 225 LKELDISNNLFSGSIPEGLTRL-SLEKLNLSHNNFSGVLPVFSE---SKFGAEVFEGNSPALCGFP 286 (679)
Q Consensus 225 L~~L~ls~N~l~g~~p~~~~~l-~L~~l~ls~N~l~g~ip~~~~---~~~~~~~~~~n~~~~c~~p 286 (679)
|+.|+|++|+|++..+..+..+ +|+.|+|++|+|++..|.... .......+.+| |..|.++
T Consensus 562 L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N-~~~c~c~ 626 (680)
T 1ziw_A 562 LKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFN-PFDCTCE 626 (680)
T ss_dssp CCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTC-CCCBCCC
T ss_pred cceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCC-CcccCCc
Confidence 9999999999986555556665 699999999999987765321 33344455567 8888765
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.68 E-value=9.9e-17 Score=160.24 Aligned_cols=158 Identities=13% Similarity=0.173 Sum_probs=121.9
Q ss_pred cEEEEEcCCCCCcccCCccccCCCCCCeeecccCc-ccccCCcccCCCCCCCEEEccC-CCCCCcChhhHHhhcccCcEE
Q 005749 100 HLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNS-LKGTIPFELGYSSSLSEIDLSA-NLFTGVLAPSIWNLCDRLVSL 177 (679)
Q Consensus 100 ~l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~-l~g~ip~~l~~l~~L~~L~Ls~-N~l~g~~p~~~~~~~~~L~~L 177 (679)
+++.|+|++|++++..+..++.+++|++|+|++|. +++..+..+.++++|++|+|++ |.+++..+..+.. +++|+.|
T Consensus 32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~-l~~L~~L 110 (239)
T 2xwt_C 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKE-LPLLKFL 110 (239)
T ss_dssp TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEEC-CTTCCEE
T ss_pred cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCC-CCCCCEE
Confidence 58889999999887777788899999999999997 8765555788899999999998 8888654334434 4889999
Q ss_pred EccCCCCcccCCCCCCCCCCCCCcc---EEEccCc-cccccccccccCCCCCC-EEEccCCcccccCCccc-cccccCEE
Q 005749 178 RLHGNSLTAALPEPALPNSTCSDLQ---YLDLGSN-KFSGSFPEFVTRFEALK-ELDISNNLFSGSIPEGL-TRLSLEKL 251 (679)
Q Consensus 178 ~Ls~N~l~~~~p~~~~~~~~~~~L~---~L~l~~N-~l~g~~p~~~~~l~~L~-~L~ls~N~l~g~~p~~~-~~l~L~~l 251 (679)
+|++|++++ +|. + ..+++|+ +|++++| ++++..+..|..+++|+ .|++++|+++ .+|... ...+|+.|
T Consensus 111 ~l~~n~l~~-lp~-~---~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~-~i~~~~~~~~~L~~L 184 (239)
T 2xwt_C 111 GIFNTGLKM-FPD-L---TKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAV 184 (239)
T ss_dssp EEEEECCCS-CCC-C---TTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC-EECTTTTTTCEEEEE
T ss_pred eCCCCCCcc-ccc-c---ccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc-ccCHhhcCCCCCCEE
Confidence 999999987 554 2 3455666 9999999 88866666788889999 9999999988 555543 33368899
Q ss_pred EccCCc-CCCCCCC
Q 005749 252 NLSHNN-FSGVLPV 264 (679)
Q Consensus 252 ~ls~N~-l~g~ip~ 264 (679)
++++|. +++..|.
T Consensus 185 ~L~~n~~l~~i~~~ 198 (239)
T 2xwt_C 185 YLNKNKYLTVIDKD 198 (239)
T ss_dssp ECTTCTTCCEECTT
T ss_pred EcCCCCCcccCCHH
Confidence 999994 8754443
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.68 E-value=1e-16 Score=154.55 Aligned_cols=133 Identities=27% Similarity=0.361 Sum_probs=89.1
Q ss_pred CeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEEccCCCCcccCCCCCCCCCCCCCccEEE
Q 005749 126 QSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLD 205 (679)
Q Consensus 126 ~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~ 205 (679)
++|++++|+|+ .+|..+.. +|++|+|++|++++..+...+..+++|+.|+|++|+|++..|..+ ..+++|++|+
T Consensus 11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~---~~l~~L~~L~ 84 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAF---EGASHIQELQ 84 (192)
T ss_dssp TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTT---TTCTTCCEEE
T ss_pred CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHc---CCcccCCEEE
Confidence 56777777775 56665543 677777777777765443333334677777777777776655433 3456777777
Q ss_pred ccCccccccccccccCCCCCCEEEccCCcccccCCcccccc-ccCEEEccCCcCCCCCCC
Q 005749 206 LGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRL-SLEKLNLSHNNFSGVLPV 264 (679)
Q Consensus 206 l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l-~L~~l~ls~N~l~g~ip~ 264 (679)
|++|+|++..|..|..+++|++|+|++|+|++.+|..+..+ +|+.|+|++|.|++..+.
T Consensus 85 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l 144 (192)
T 1w8a_A 85 LGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHL 144 (192)
T ss_dssp CCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGG
T ss_pred CCCCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcc
Confidence 77777776666667777777777777777777777766666 577777777777776553
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.68 E-value=5e-17 Score=157.39 Aligned_cols=150 Identities=18% Similarity=0.181 Sum_probs=119.2
Q ss_pred cEEEEEcCCCCCcccCCccccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEEc
Q 005749 100 HLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRL 179 (679)
Q Consensus 100 ~l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~L 179 (679)
+++.|++++|++. .+| .+..+++|++|+|++|.++ .+..+..+++|++|+|++|.+++..|..+..+ ++|+.|+|
T Consensus 45 ~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l-~~L~~L~L 119 (197)
T 4ezg_A 45 SLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGL-TSLTLLDI 119 (197)
T ss_dssp TCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTC-TTCCEEEC
T ss_pred CccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCC-CCCCEEEe
Confidence 4788999999988 677 7899999999999999775 34578889999999999999988666666664 89999999
Q ss_pred cCCCCcccCCCCCCCCCCCCCccEEEccCccccccccccccCCCCCCEEEccCCcccccCCcccccc-ccCEEEccCCcC
Q 005749 180 HGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRL-SLEKLNLSHNNF 258 (679)
Q Consensus 180 s~N~l~~~~p~~~~~~~~~~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l-~L~~l~ls~N~l 258 (679)
++|++++..|... ..+++|++|++++|++.+.+| .+..+++|+.|++++|++++ ++ .+..+ +|+.|++++|++
T Consensus 120 s~n~i~~~~~~~l---~~l~~L~~L~L~~n~~i~~~~-~l~~l~~L~~L~l~~n~i~~-~~-~l~~l~~L~~L~l~~N~i 193 (197)
T 4ezg_A 120 SHSAHDDSILTKI---NTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVHD-YR-GIEDFPKLNQLYAFSQTI 193 (197)
T ss_dssp CSSBCBGGGHHHH---TTCSSCCEEECCSCTBCCCCG-GGGGCSSCCEEECTTBCCCC-CT-TGGGCSSCCEEEECBC--
T ss_pred cCCccCcHhHHHH---hhCCCCCEEEccCCCCccccH-hhcCCCCCCEEECCCCCCcC-hH-HhccCCCCCEEEeeCccc
Confidence 9999987555432 457889999999998434666 68889999999999999985 44 45555 699999999988
Q ss_pred CC
Q 005749 259 SG 260 (679)
Q Consensus 259 ~g 260 (679)
.+
T Consensus 194 ~~ 195 (197)
T 4ezg_A 194 GG 195 (197)
T ss_dssp --
T ss_pred CC
Confidence 65
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.68 E-value=3.6e-17 Score=181.11 Aligned_cols=151 Identities=19% Similarity=0.120 Sum_probs=102.9
Q ss_pred ccEEEEEcCCCCCcccCCccccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEE
Q 005749 99 IHLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLR 178 (679)
Q Consensus 99 ~~l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~ 178 (679)
.+|+.|+|++|.+++.. ..++|++|+|++|.|++..+. .+++|+.|+|++|.+++..|..+..+ ++|+.|+
T Consensus 80 ~~L~~L~Ls~N~l~~l~-----~~~~L~~L~L~~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l-~~L~~L~ 150 (487)
T 3oja_A 80 STLRTLDLNNNYVQELL-----VGPSIETLHAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCR-SRVQYLD 150 (487)
T ss_dssp TTCCEEECCSSEEEEEE-----ECTTCCEEECCSSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGG-SSEEEEE
T ss_pred CCCCEEEecCCcCCCCC-----CCCCcCEEECcCCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCC-CCCCEEE
Confidence 45778888888777432 237788888888888765443 35677888888888877666555554 7788888
Q ss_pred ccCCCCcccCCCCCCCCCCCCCccEEEccCccccccccccccCCCCCCEEEccCCcccccCCcccccc-ccCEEEccCCc
Q 005749 179 LHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRL-SLEKLNLSHNN 257 (679)
Q Consensus 179 Ls~N~l~~~~p~~~~~~~~~~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l-~L~~l~ls~N~ 257 (679)
|++|.+++.+|..+. ..+++|++|+|++|.|++. |. +..+++|+.|+|++|+|++.+|. +..+ +|+.|+|++|.
T Consensus 151 Ls~N~l~~~~~~~l~--~~l~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~~~~~~-~~~l~~L~~L~Ls~N~ 225 (487)
T 3oja_A 151 LKLNEIDTVNFAELA--ASSDTLEHLNLQYNFIYDV-KG-QVVFAKLKTLDLSSNKLAFMGPE-FQSAAGVTWISLRNNK 225 (487)
T ss_dssp CTTSCCCEEEGGGGG--GGTTTCCEEECTTSCCCEE-EC-CCCCTTCCEEECCSSCCCEECGG-GGGGTTCSEEECTTSC
T ss_pred CCCCCCCCcChHHHh--hhCCcccEEecCCCccccc-cc-cccCCCCCEEECCCCCCCCCCHh-HcCCCCccEEEecCCc
Confidence 888888776554331 1456788888888888755 22 33577788888888888764443 5555 57888888888
Q ss_pred CCCCCCC
Q 005749 258 FSGVLPV 264 (679)
Q Consensus 258 l~g~ip~ 264 (679)
|++ +|.
T Consensus 226 l~~-lp~ 231 (487)
T 3oja_A 226 LVL-IEK 231 (487)
T ss_dssp CCE-ECT
T ss_pred Ccc-cch
Confidence 876 443
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.67 E-value=2.1e-16 Score=179.65 Aligned_cols=160 Identities=19% Similarity=0.265 Sum_probs=119.5
Q ss_pred CccEEEEEcCCCCCcccCCccccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEE
Q 005749 98 SIHLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSL 177 (679)
Q Consensus 98 ~~~l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L 177 (679)
..+|+.|+|++|.+++..|..|+.+++|++|+|++|.|++..|..++++++|++|+|++|.+++..|..+..+ ++|+.|
T Consensus 98 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l-~~L~~L 176 (597)
T 3oja_B 98 AHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQAT-TSLQNL 176 (597)
T ss_dssp CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTC-TTCCEE
T ss_pred CCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcC-CcCcEE
Confidence 4578999999999999888889999999999999999995444456899999999999999998776666554 899999
Q ss_pred EccCCCCcccCCCCCCCC-----------------------------------CCCCCccEEEccCccccccccccccCC
Q 005749 178 RLHGNSLTAALPEPALPN-----------------------------------STCSDLQYLDLGSNKFSGSFPEFVTRF 222 (679)
Q Consensus 178 ~Ls~N~l~~~~p~~~~~~-----------------------------------~~~~~L~~L~l~~N~l~g~~p~~~~~l 222 (679)
+|++|.+++..+. .++. ...++|+.|+|++|++++ +..++.+
T Consensus 177 ~L~~N~l~~~~~~-~l~~L~~L~l~~n~l~~l~~~~~L~~L~ls~n~l~~~~~~~~~~L~~L~L~~n~l~~--~~~l~~l 253 (597)
T 3oja_B 177 QLSSNRLTHVDLS-LIPSLFHANVSYNLLSTLAIPIAVEELDASHNSINVVRGPVNVELTILKLQHNNLTD--TAWLLNY 253 (597)
T ss_dssp ECTTSCCSBCCGG-GCTTCSEEECCSSCCSEEECCTTCSEEECCSSCCCEEECSCCSCCCEEECCSSCCCC--CGGGGGC
T ss_pred ECcCCCCCCcChh-hhhhhhhhhcccCccccccCCchhheeeccCCcccccccccCCCCCEEECCCCCCCC--ChhhccC
Confidence 9999999864211 1110 011245566666666654 3556777
Q ss_pred CCCCEEEccCCcccccCCcccccc-ccCEEEccCCcCCCC
Q 005749 223 EALKELDISNNLFSGSIPEGLTRL-SLEKLNLSHNNFSGV 261 (679)
Q Consensus 223 ~~L~~L~ls~N~l~g~~p~~~~~l-~L~~l~ls~N~l~g~ 261 (679)
++|+.|+|++|.+++.+|..+..+ +|+.|+|++|.+++.
T Consensus 254 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l 293 (597)
T 3oja_B 254 PGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVAL 293 (597)
T ss_dssp TTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCEE
T ss_pred CCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCCC
Confidence 777777777777777777777666 577777777777763
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.67 E-value=1.7e-16 Score=179.23 Aligned_cols=163 Identities=20% Similarity=0.169 Sum_probs=143.3
Q ss_pred cEEEEEcCCCCCcccCCccccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEEc
Q 005749 100 HLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRL 179 (679)
Q Consensus 100 ~l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~L 179 (679)
+++.|+|++|++++..+..|.++++|++|+|++|.+++..|..++++++|++|+|++|.+++..|..+.+ +++|++|+|
T Consensus 29 ~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~-l~~L~~L~L 107 (570)
T 2z63_A 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSG-LSSLQKLVA 107 (570)
T ss_dssp SCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTT-CTTCCEEEC
T ss_pred cccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcC-ccccccccc
Confidence 5889999999999888889999999999999999999877888999999999999999999866566655 489999999
Q ss_pred cCCCCcccCCCCCCCCCCCCCccEEEccCccccc-cccccccCCCCCCEEEccCCcccccCCcccccc-cc----CEEEc
Q 005749 180 HGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSG-SFPEFVTRFEALKELDISNNLFSGSIPEGLTRL-SL----EKLNL 253 (679)
Q Consensus 180 s~N~l~~~~p~~~~~~~~~~~L~~L~l~~N~l~g-~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l-~L----~~l~l 253 (679)
++|++++..+.. ...+++|++|++++|++++ .+|..++++++|+.|++++|++++..|..+..+ +| ..|++
T Consensus 108 ~~n~l~~l~~~~---~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l 184 (570)
T 2z63_A 108 VETNLASLENFP---IGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDL 184 (570)
T ss_dssp TTSCCCCSTTCS---CTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEEC
T ss_pred cccccccCCCcc---ccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccchhhhhccc
Confidence 999999754422 3578999999999999997 579999999999999999999998888877766 46 89999
Q ss_pred cCCcCCCCCCCcc
Q 005749 254 SHNNFSGVLPVFS 266 (679)
Q Consensus 254 s~N~l~g~ip~~~ 266 (679)
++|.+++..|...
T Consensus 185 ~~n~l~~~~~~~~ 197 (570)
T 2z63_A 185 SLNPMNFIQPGAF 197 (570)
T ss_dssp TTCCCCEECTTTT
T ss_pred CCCCceecCHHHh
Confidence 9999998877543
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.67 E-value=2.6e-16 Score=156.24 Aligned_cols=136 Identities=21% Similarity=0.213 Sum_probs=117.9
Q ss_pred cEEEEEcCCCCCcccCCccccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEEc
Q 005749 100 HLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRL 179 (679)
Q Consensus 100 ~l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~L 179 (679)
+++.|+|++|++++..|..|+.+++|++|+|++|+|++..+..+..+++|++|+|++|+|++.. +..+..+++|+.|+|
T Consensus 41 ~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~-~~~~~~l~~L~~L~L 119 (229)
T 3e6j_A 41 NAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLP-SAVFDRLVHLKELFM 119 (229)
T ss_dssp TCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCC-TTTTTTCTTCCEEEC
T ss_pred CCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCCccC-hhHhCcchhhCeEec
Confidence 5889999999999999999999999999999999998555556789999999999999999754 444444589999999
Q ss_pred cCCCCcccCCCCCCCCCCCCCccEEEccCccccccccccccCCCCCCEEEccCCcccccCC
Q 005749 180 HGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIP 240 (679)
Q Consensus 180 s~N~l~~~~p~~~~~~~~~~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p 240 (679)
++|+|+ .+|... ..+++|++|+|++|+|++..+..+..+++|+.|+|++|.+++..+
T Consensus 120 s~N~l~-~lp~~~---~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 176 (229)
T 3e6j_A 120 CCNKLT-ELPRGI---ERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCECR 176 (229)
T ss_dssp CSSCCC-SCCTTG---GGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTBG
T ss_pred cCCccc-ccCccc---ccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCcc
Confidence 999999 566543 467899999999999997766789999999999999999987654
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.67 E-value=5.5e-17 Score=169.40 Aligned_cols=147 Identities=22% Similarity=0.193 Sum_probs=87.0
Q ss_pred cEEEEEcCCCCCcccCCccccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEEc
Q 005749 100 HLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRL 179 (679)
Q Consensus 100 ~l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~L 179 (679)
+++.|+|++|++++..|..|+.+++|++|+|++|.+++..| +..+++|++|+|++|.+++..+ .++|+.|++
T Consensus 35 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~l~~l~~------~~~L~~L~l 106 (317)
T 3o53_A 35 NVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLV------GPSIETLHA 106 (317)
T ss_dssp GCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSSEEEEEEE------CTTCCEEEC
T ss_pred CCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcCCccccccC------CCCcCEEEC
Confidence 57788888888887777778888888888888888876554 7778888888888887775321 145666666
Q ss_pred cCCCCcccCCCCCCCCCCCCCccEEEccCccccccccccccCCCCCCEEEccCCcccccCCcccc-cc-ccCEEEccCCc
Q 005749 180 HGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLT-RL-SLEKLNLSHNN 257 (679)
Q Consensus 180 s~N~l~~~~p~~~~~~~~~~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~-~l-~L~~l~ls~N~ 257 (679)
++|++++..+. .+++|++|++++|++++..|..++.+++|+.|++++|++++..|..+. .+ +|+.|+|++|.
T Consensus 107 ~~n~l~~~~~~------~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~ 180 (317)
T 3o53_A 107 ANNNISRVSCS------RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNF 180 (317)
T ss_dssp CSSCCSEEEEC------CCSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSC
T ss_pred CCCccCCcCcc------ccCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCc
Confidence 66666544332 123455555555555444444444444555555555555444333332 22 34444444444
Q ss_pred CCC
Q 005749 258 FSG 260 (679)
Q Consensus 258 l~g 260 (679)
+++
T Consensus 181 l~~ 183 (317)
T 3o53_A 181 IYD 183 (317)
T ss_dssp CCE
T ss_pred Ccc
Confidence 443
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.67 E-value=3.2e-16 Score=166.69 Aligned_cols=153 Identities=22% Similarity=0.133 Sum_probs=124.2
Q ss_pred EEEcCCCCCcccCCccccCCCCCCeeecccCcccccCCcccC-CCCCCCEEEccCCCCCCcChhhHHhhcccCcEEEccC
Q 005749 103 SIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELG-YSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHG 181 (679)
Q Consensus 103 ~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip~~l~-~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~ 181 (679)
.+++++++++ .+|..+. +.|+.|+|++|+|++..+..+. ++++|++|+|++|+|++..+..+.. +++|+.|+|++
T Consensus 22 ~l~c~~~~l~-~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~-l~~L~~L~Ls~ 97 (361)
T 2xot_A 22 ILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVP-VPNLRYLDLSS 97 (361)
T ss_dssp EEECCSSCCS-SCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTT-CTTCCEEECCS
T ss_pred EEEeCCCCcC-ccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccC-CCCCCEEECCC
Confidence 3456667766 4777654 4689999999999987777776 8999999999999999766555555 48999999999
Q ss_pred CCCcccCCCCCCCCCCCCCccEEEccCccccccccccccCCCCCCEEEccCCcccccCCccc---ccc-ccCEEEccCCc
Q 005749 182 NSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGL---TRL-SLEKLNLSHNN 257 (679)
Q Consensus 182 N~l~~~~p~~~~~~~~~~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~---~~l-~L~~l~ls~N~ 257 (679)
|+|++..+..+ ..+++|++|+|++|+|++..|..|..+++|+.|+|++|+|++..+..+ ..+ +|+.|+|++|+
T Consensus 98 N~l~~~~~~~~---~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~ 174 (361)
T 2xot_A 98 NHLHTLDEFLF---SDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNK 174 (361)
T ss_dssp SCCCEECTTTT---TTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSC
T ss_pred CcCCcCCHHHh---CCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCC
Confidence 99997655332 467899999999999998889999999999999999999996444444 334 69999999999
Q ss_pred CCCCC
Q 005749 258 FSGVL 262 (679)
Q Consensus 258 l~g~i 262 (679)
|++..
T Consensus 175 l~~l~ 179 (361)
T 2xot_A 175 LKKLP 179 (361)
T ss_dssp CCCCC
T ss_pred CCccC
Confidence 99644
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.66 E-value=2.6e-16 Score=157.19 Aligned_cols=160 Identities=13% Similarity=0.074 Sum_probs=131.7
Q ss_pred CCccEEEEEcCCCC-CcccCCccccCCCCCCeeeccc-CcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccC
Q 005749 97 SSIHLLSIQLPSAN-LTGSLPRELGEFSMLQSLYLNV-NSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRL 174 (679)
Q Consensus 97 ~~~~l~~l~l~~n~-l~g~ip~~l~~l~~L~~L~L~~-N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L 174 (679)
...+++.|+|++|+ +++..+..|+.+++|++|+|++ |.|++..|..+.++++|++|+|++|.+++ +|. +.. +++|
T Consensus 53 ~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~-lp~-~~~-l~~L 129 (239)
T 2xwt_C 53 NLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPD-LTK-VYST 129 (239)
T ss_dssp TCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEEEEEECCCS-CCC-CTT-CCBC
T ss_pred CCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCcc-ccc-ccc-cccc
Confidence 34579999999998 6655555899999999999999 99997666788999999999999999998 554 444 4788
Q ss_pred c---EEEccCC-CCcccCCCCCCCCCCCCCcc-EEEccCccccccccccccCCCCCCEEEccCCc-ccccCCcccccc--
Q 005749 175 V---SLRLHGN-SLTAALPEPALPNSTCSDLQ-YLDLGSNKFSGSFPEFVTRFEALKELDISNNL-FSGSIPEGLTRL-- 246 (679)
Q Consensus 175 ~---~L~Ls~N-~l~~~~p~~~~~~~~~~~L~-~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~-l~g~~p~~~~~l-- 246 (679)
+ .|++++| ++++..+. .+ ..+++|+ +|++++|+++ .+|......++|+.|++++|+ +++..+..+..+
T Consensus 130 ~~L~~L~l~~N~~l~~i~~~-~~--~~l~~L~~~L~l~~n~l~-~i~~~~~~~~~L~~L~L~~n~~l~~i~~~~~~~l~~ 205 (239)
T 2xwt_C 130 DIFFILEITDNPYMTSIPVN-AF--QGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYS 205 (239)
T ss_dssp CSEEEEEEESCTTCCEECTT-TT--TTTBSSEEEEECCSCCCC-EECTTTTTTCEEEEEECTTCTTCCEECTTTTTTCSB
T ss_pred ccccEEECCCCcchhhcCcc-cc--cchhcceeEEEcCCCCCc-ccCHhhcCCCCCCEEEcCCCCCcccCCHHHhhcccc
Confidence 8 9999999 99875443 22 4678999 9999999999 677655455899999999995 997667777776
Q ss_pred ccCEEEccCCcCCCCCC
Q 005749 247 SLEKLNLSHNNFSGVLP 263 (679)
Q Consensus 247 ~L~~l~ls~N~l~g~ip 263 (679)
+|+.|++++|+|++..+
T Consensus 206 ~L~~L~l~~N~l~~l~~ 222 (239)
T 2xwt_C 206 GPSLLDVSQTSVTALPS 222 (239)
T ss_dssp CCSEEECTTCCCCCCCC
T ss_pred CCcEEECCCCccccCCh
Confidence 69999999999985433
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.66 E-value=5.8e-16 Score=166.44 Aligned_cols=111 Identities=19% Similarity=0.257 Sum_probs=81.3
Q ss_pred ccEEEEEcCCCCCcccCCccccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEE
Q 005749 99 IHLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLR 178 (679)
Q Consensus 99 ~~l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~ 178 (679)
.+++.|+|++|.+.+..|..|+.+++|++|+|++|.+++..|..++.+++|++|+|++|.++. +|+.++..+++|++|+
T Consensus 69 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-l~~~~~~~l~~L~~L~ 147 (390)
T 3o6n_A 69 RQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSS-LPRGIFHNTPKLTTLS 147 (390)
T ss_dssp CCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEE
T ss_pred ccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCc-CCHHHhcCCCCCcEEE
Confidence 467788888888877767788888888888888888887667777888888888888888874 4555444447888888
Q ss_pred ccCCCCcccCCCCCCCCCCCCCccEEEccCccccc
Q 005749 179 LHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSG 213 (679)
Q Consensus 179 Ls~N~l~~~~p~~~~~~~~~~~L~~L~l~~N~l~g 213 (679)
|++|++++..|..+ ..+++|++|++++|++++
T Consensus 148 L~~n~l~~~~~~~~---~~l~~L~~L~l~~n~l~~ 179 (390)
T 3o6n_A 148 MSNNNLERIEDDTF---QATTSLQNLQLSSNRLTH 179 (390)
T ss_dssp CCSSCCCBCCTTTT---SSCTTCCEEECCSSCCSB
T ss_pred CCCCccCccChhhc---cCCCCCCEEECCCCcCCc
Confidence 88888876555322 345666777777666664
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.66 E-value=3.7e-16 Score=163.97 Aligned_cols=155 Identities=21% Similarity=0.243 Sum_probs=104.3
Q ss_pred EEEEcCCCCCcccCCccccCCCCCCeeecccCccc--ccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEEc
Q 005749 102 LSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLK--GTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRL 179 (679)
Q Consensus 102 ~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~--g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~L 179 (679)
+.|++++|.+.+..+..++++++|++|+|++|.++ |..|..+..+++|++|++++|.++. +|..+. ++|+.|+|
T Consensus 124 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~-l~~~~~---~~L~~L~l 199 (330)
T 1xku_A 124 QELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT-IPQGLP---PSLTELHL 199 (330)
T ss_dssp CEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS-CCSSCC---TTCSEEEC
T ss_pred cEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCcccc-CCcccc---ccCCEEEC
Confidence 33334444444333334455555555555555553 2444455555555555555555553 333221 45666666
Q ss_pred cCCCCcccCCCCCCCCCCCCCccEEEccCccccccccccccCCCCCCEEEccCCcccccCCcccccc-ccCEEEccCCcC
Q 005749 180 HGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRL-SLEKLNLSHNNF 258 (679)
Q Consensus 180 s~N~l~~~~p~~~~~~~~~~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l-~L~~l~ls~N~l 258 (679)
++|++++..|..+ ..+++|++|+|++|++++..+..+..+++|+.|+|++|+++ .+|..+..+ +|+.|++++|+|
T Consensus 200 ~~n~l~~~~~~~~---~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i 275 (330)
T 1xku_A 200 DGNKITKVDAASL---KGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNI 275 (330)
T ss_dssp TTSCCCEECTGGG---TTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCC
T ss_pred CCCcCCccCHHHh---cCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcC
Confidence 6666665544322 45789999999999999888888999999999999999998 788888777 699999999999
Q ss_pred CCCCCC
Q 005749 259 SGVLPV 264 (679)
Q Consensus 259 ~g~ip~ 264 (679)
++..+.
T Consensus 276 ~~~~~~ 281 (330)
T 1xku_A 276 SAIGSN 281 (330)
T ss_dssp CCCCTT
T ss_pred CccChh
Confidence 976554
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.65 E-value=4.6e-16 Score=163.40 Aligned_cols=163 Identities=25% Similarity=0.340 Sum_probs=118.5
Q ss_pred CCccEEEEEcCCCCCcccCCccccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcE
Q 005749 97 SSIHLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVS 176 (679)
Q Consensus 97 ~~~~l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~ 176 (679)
...+++.|+|++|++++..|..|+++++|++|+|++|.++ .+|..+. ++|++|+|++|.+++.. +..+..+++|+.
T Consensus 76 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~-~~~~~~l~~L~~ 151 (332)
T 2ft3_A 76 GLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNLP--SSLVELRIHDNRIRKVP-KGVFSGLRNMNC 151 (332)
T ss_dssp TCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSSCCC-SCCSSCC--TTCCEEECCSSCCCCCC-SGGGSSCSSCCE
T ss_pred CCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCCcCC-ccCcccc--ccCCEEECCCCccCccC-HhHhCCCccCCE
Confidence 3457999999999999988999999999999999999998 7887776 89999999999998654 443344589999
Q ss_pred EEccCCCCcc--cCCCCC-----------------CCCCCCCCccEEEccCccccccccccccCCCCCCEEEccCCcccc
Q 005749 177 LRLHGNSLTA--ALPEPA-----------------LPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSG 237 (679)
Q Consensus 177 L~Ls~N~l~~--~~p~~~-----------------~~~~~~~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g 237 (679)
|++++|.++. ..|... +|....++|++|++++|++++..|..+..+++|+.|++++|++++
T Consensus 152 L~l~~n~l~~~~~~~~~~~~l~L~~L~l~~n~l~~l~~~~~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~ 231 (332)
T 2ft3_A 152 IEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTGIPKDLPETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRM 231 (332)
T ss_dssp EECCSCCCBGGGSCTTSSCSCCCSCCBCCSSBCSSCCSSSCSSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCC
T ss_pred EECCCCccccCCCCcccccCCccCEEECcCCCCCccCccccCCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCc
Confidence 9999999863 333211 111112456666667777666555666777777777777777776
Q ss_pred cCCcccccc-ccCEEEccCCcCCCCCCC
Q 005749 238 SIPEGLTRL-SLEKLNLSHNNFSGVLPV 264 (679)
Q Consensus 238 ~~p~~~~~l-~L~~l~ls~N~l~g~ip~ 264 (679)
..|..+..+ +|+.|+|++|+++ .+|.
T Consensus 232 ~~~~~~~~l~~L~~L~L~~N~l~-~lp~ 258 (332)
T 2ft3_A 232 IENGSLSFLPTLRELHLDNNKLS-RVPA 258 (332)
T ss_dssp CCTTGGGGCTTCCEEECCSSCCC-BCCT
T ss_pred CChhHhhCCCCCCEEECCCCcCe-ecCh
Confidence 555556555 5777777777776 4454
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.65 E-value=1e-16 Score=170.02 Aligned_cols=162 Identities=17% Similarity=0.183 Sum_probs=134.2
Q ss_pred CccEEEEEcCCCCCcccCCccccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChh-hHHhhcccCcE
Q 005749 98 SIHLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAP-SIWNLCDRLVS 176 (679)
Q Consensus 98 ~~~l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~~~~~~L~~ 176 (679)
..+++.|+|++|++++..|..|+++++|++|+|++|.|++..+..++.+++|++|+|++|.+++ +|. ..+..+++|+.
T Consensus 75 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-l~~~~~~~~l~~L~~ 153 (353)
T 2z80_A 75 CVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKT-LGETSLFSHLTKLQI 153 (353)
T ss_dssp CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSS-SCSSCSCTTCTTCCE
T ss_pred CCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcc-cCchhhhccCCCCcE
Confidence 4579999999999999888899999999999999999995444448999999999999999996 444 33444589999
Q ss_pred EEccCCC-CcccCCCCCCCCCCCCCccEEEccCccccccccccccCCCCCCEEEccCCcccccCCccc-ccc-ccCEEEc
Q 005749 177 LRLHGNS-LTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGL-TRL-SLEKLNL 253 (679)
Q Consensus 177 L~Ls~N~-l~~~~p~~~~~~~~~~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~-~~l-~L~~l~l 253 (679)
|++++|+ +++..|.. + ..+++|++|++++|++++..|..+..+++|++|++++|+++ .+|..+ ..+ +|+.|++
T Consensus 154 L~l~~n~~~~~~~~~~-~--~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~-~~~~~~~~~~~~L~~L~L 229 (353)
T 2z80_A 154 LRVGNMDTFTKIQRKD-F--AGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLEL 229 (353)
T ss_dssp EEEEESSSCCEECTTT-T--TTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCST-THHHHHHHHTTTEEEEEE
T ss_pred EECCCCccccccCHHH-c--cCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccc-cchhhhhhhcccccEEEC
Confidence 9999995 66544433 2 46789999999999999998999999999999999999996 445443 333 6999999
Q ss_pred cCCcCCCCCCC
Q 005749 254 SHNNFSGVLPV 264 (679)
Q Consensus 254 s~N~l~g~ip~ 264 (679)
++|.+++..+.
T Consensus 230 ~~n~l~~~~~~ 240 (353)
T 2z80_A 230 RDTDLDTFHFS 240 (353)
T ss_dssp ESCBCTTCCCC
T ss_pred CCCcccccccc
Confidence 99999986543
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.65 E-value=3.1e-16 Score=147.61 Aligned_cols=138 Identities=21% Similarity=0.146 Sum_probs=112.6
Q ss_pred ccEEEEEcCCCCCc-ccCCccccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEE
Q 005749 99 IHLLSIQLPSANLT-GSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSL 177 (679)
Q Consensus 99 ~~l~~l~l~~n~l~-g~ip~~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L 177 (679)
.+++.|+|++|+++ |.+|..+..+++|++|+|++|.|++. ..+..+++|++|+|++|.+++.+|..+.. +++|+.|
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~-l~~L~~L 100 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEK-LPNLTHL 100 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHH-CTTCCEE
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhh-CCCCCEE
Confidence 35899999999998 89999999999999999999999965 77899999999999999999876655444 4899999
Q ss_pred EccCCCCcccCCCCCCCCCCCCCccEEEccCcccccccc---ccccCCCCCCEEEccCCcccccCCcc
Q 005749 178 RLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFP---EFVTRFEALKELDISNNLFSGSIPEG 242 (679)
Q Consensus 178 ~Ls~N~l~~~~p~~~~~~~~~~~L~~L~l~~N~l~g~~p---~~~~~l~~L~~L~ls~N~l~g~~p~~ 242 (679)
+|++|++++..+... ...+++|++|++++|.+++..+ ..+..+++|+.|++++|.+. .+|..
T Consensus 101 ~Ls~N~l~~~~~~~~--l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~-~~~~~ 165 (168)
T 2ell_A 101 NLSGNKLKDISTLEP--LKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ-EAPDS 165 (168)
T ss_dssp ECBSSSCCSSGGGGG--GSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC-BCCSS
T ss_pred eccCCccCcchhHHH--HhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh-hcccc
Confidence 999999987432111 1457789999999999986544 47888999999999999886 44543
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.64 E-value=3.4e-16 Score=163.41 Aligned_cols=150 Identities=21% Similarity=0.206 Sum_probs=78.2
Q ss_pred cEEEEEcCCCCCcccCCccccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEEc
Q 005749 100 HLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRL 179 (679)
Q Consensus 100 ~l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~L 179 (679)
+++.|++++|++++..+. .+++|++|+|++|.+++..|..++.+++|++|+|++|.+++..+..+...+++|+.|+|
T Consensus 100 ~L~~L~l~~n~l~~~~~~---~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L 176 (317)
T 3o53_A 100 SIETLHAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNL 176 (317)
T ss_dssp TCCEEECCSSCCSEEEEC---CCSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEEC
T ss_pred CcCEEECCCCccCCcCcc---ccCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEEC
Confidence 344455555555443322 24555555566665555445455555556666666666555444444333355666666
Q ss_pred cCCCCcccCCCCCCCCCCCCCccEEEccCccccccccccccCCCCCCEEEccCCcccccCCcccccc-ccCEEEccCCcC
Q 005749 180 HGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRL-SLEKLNLSHNNF 258 (679)
Q Consensus 180 s~N~l~~~~p~~~~~~~~~~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l-~L~~l~ls~N~l 258 (679)
++|++++..+. ..+++|++|+|++|++++ +|..+..+++|+.|+|++|+|+ .+|..+..+ +|+.|++++|.+
T Consensus 177 ~~N~l~~~~~~-----~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~ 249 (317)
T 3o53_A 177 QYNFIYDVKGQ-----VVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGF 249 (317)
T ss_dssp TTSCCCEEECC-----CCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCC
T ss_pred CCCcCcccccc-----cccccCCEEECCCCcCCc-chhhhcccCcccEEECcCCccc-chhhHhhcCCCCCEEEccCCCc
Confidence 66655543111 124455666666666553 3334555556666666666655 345444444 455666666655
Q ss_pred C
Q 005749 259 S 259 (679)
Q Consensus 259 ~ 259 (679)
+
T Consensus 250 ~ 250 (317)
T 3o53_A 250 H 250 (317)
T ss_dssp B
T ss_pred c
Confidence 5
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.64 E-value=3.2e-16 Score=175.41 Aligned_cols=143 Identities=29% Similarity=0.341 Sum_probs=123.2
Q ss_pred CccEEEEEcCCCCCcccCCccccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEE
Q 005749 98 SIHLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSL 177 (679)
Q Consensus 98 ~~~l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L 177 (679)
..+++.|+|++|++++ ||. +.. +|++|+|++|.|++ +|. .+++|++|+|++|.|++ +|. .+++|+.|
T Consensus 99 l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~----~l~~L~~L 165 (571)
T 3cvr_A 99 PASLEYLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPE----LPTSLEVL 165 (571)
T ss_dssp CTTCCEEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC----CCTTCCEE
T ss_pred cCCCCEEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCC----cCCCcCEE
Confidence 3579999999999998 888 766 99999999999997 887 68999999999999997 655 35899999
Q ss_pred EccCCCCcccCCCCCCCCCCCCCccEEEccCccccccccccccCCCCC-------CEEEccCCcccccCCcccccc-ccC
Q 005749 178 RLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEAL-------KELDISNNLFSGSIPEGLTRL-SLE 249 (679)
Q Consensus 178 ~Ls~N~l~~~~p~~~~~~~~~~~L~~L~l~~N~l~g~~p~~~~~l~~L-------~~L~ls~N~l~g~~p~~~~~l-~L~ 249 (679)
+|++|+|++ +|. +. ++|++|+|++|+|+ .+|. +.. +| +.|+|++|+|+ .+|..+..+ +|+
T Consensus 166 ~Ls~N~L~~-lp~--l~----~~L~~L~Ls~N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~ 233 (571)
T 3cvr_A 166 SVRNNQLTF-LPE--LP----ESLEALDVSTNLLE-SLPA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTC 233 (571)
T ss_dssp ECCSSCCSC-CCC--CC----TTCCEEECCSSCCS-SCCC-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTE
T ss_pred ECCCCCCCC-cch--hh----CCCCEEECcCCCCC-chhh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCC
Confidence 999999998 665 32 78999999999999 7887 654 77 99999999999 688888777 699
Q ss_pred EEEccCCcCCCCCCCc
Q 005749 250 KLNLSHNNFSGVLPVF 265 (679)
Q Consensus 250 ~l~ls~N~l~g~ip~~ 265 (679)
.|+|++|.|++.+|..
T Consensus 234 ~L~L~~N~l~~~~p~~ 249 (571)
T 3cvr_A 234 TIILEDNPLSSRIRES 249 (571)
T ss_dssp EEECCSSSCCHHHHHH
T ss_pred EEEeeCCcCCCcCHHH
Confidence 9999999999998864
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.64 E-value=9.7e-16 Score=159.24 Aligned_cols=149 Identities=27% Similarity=0.416 Sum_probs=115.1
Q ss_pred ccEEEEEcCCCCCcccCCccccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEE
Q 005749 99 IHLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLR 178 (679)
Q Consensus 99 ~~l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~ 178 (679)
.+++.|+|++|++.+. ++ ++.+++|++|+|++|.+++ +| .+..+++|++|+|++|.+++. ++ +.. +++|+.|+
T Consensus 63 ~~L~~L~L~~n~i~~~-~~-~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~l~~n~l~~~-~~-l~~-l~~L~~L~ 135 (308)
T 1h6u_A 63 NNLIGLELKDNQITDL-AP-LKNLTKITELELSGNPLKN-VS-AIAGLQSIKTLDLTSTQITDV-TP-LAG-LSNLQVLY 135 (308)
T ss_dssp TTCCEEECCSSCCCCC-GG-GTTCCSCCEEECCSCCCSC-CG-GGTTCTTCCEEECTTSCCCCC-GG-GTT-CTTCCEEE
T ss_pred CCCCEEEccCCcCCCC-hh-HccCCCCCEEEccCCcCCC-ch-hhcCCCCCCEEECCCCCCCCc-hh-hcC-CCCCCEEE
Confidence 3588888988888754 43 8888999999999998885 44 688888999999999988874 33 444 48899999
Q ss_pred ccCCCCcccCCCCCCCCCCCCCccEEEccCccccccccccccCCCCCCEEEccCCcccccCCcccccc-ccCEEEccCCc
Q 005749 179 LHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRL-SLEKLNLSHNN 257 (679)
Q Consensus 179 Ls~N~l~~~~p~~~~~~~~~~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l-~L~~l~ls~N~ 257 (679)
|++|++++..+ ...+++|++|+|++|++++ ++. +..+++|+.|++++|++++..+ +..+ +|+.|+|++|+
T Consensus 136 l~~n~l~~~~~-----l~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~ 206 (308)
T 1h6u_A 136 LDLNQITNISP-----LAGLTNLQYLSIGNAQVSD-LTP-LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQ 206 (308)
T ss_dssp CCSSCCCCCGG-----GGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSC
T ss_pred CCCCccCcCcc-----ccCCCCccEEEccCCcCCC-Chh-hcCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCc
Confidence 99998886543 2467788999999998885 343 7888889999999998885443 4455 68889999998
Q ss_pred CCCCCC
Q 005749 258 FSGVLP 263 (679)
Q Consensus 258 l~g~ip 263 (679)
+++..|
T Consensus 207 l~~~~~ 212 (308)
T 1h6u_A 207 ISDVSP 212 (308)
T ss_dssp CCBCGG
T ss_pred cCcccc
Confidence 887665
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.63 E-value=7e-16 Score=169.28 Aligned_cols=158 Identities=21% Similarity=0.194 Sum_probs=126.1
Q ss_pred CccEEEEEcCCCCCcccCCccccCCCCCCeeecccCcccccCCc-------------------------ccCCCCCCCEE
Q 005749 98 SIHLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPF-------------------------ELGYSSSLSEI 152 (679)
Q Consensus 98 ~~~l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip~-------------------------~l~~l~~L~~L 152 (679)
..+|+.|+|++|++++..+..++.+++|++|+|++|.|++..+. .+..+++|++|
T Consensus 122 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L 201 (452)
T 3zyi_A 122 LASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYL 201 (452)
T ss_dssp CTTCCEEECCSSCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEE
T ss_pred cccCCEEECCCCcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEE
Confidence 34677888888888765556677888888888888877743332 35567778888
Q ss_pred EccCCCCCCcChhhHHhhcccCcEEEccCCCCcccCCCCCCCCCCCCCccEEEccCccccccccccccCCCCCCEEEccC
Q 005749 153 DLSANLFTGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISN 232 (679)
Q Consensus 153 ~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~ 232 (679)
+|++|++++. +.+.. +++|+.|+|++|++++..|..+ ..+++|++|+|++|++++..|..|..+++|+.|+|++
T Consensus 202 ~L~~n~l~~~--~~~~~-l~~L~~L~Ls~N~l~~~~~~~~---~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 275 (452)
T 3zyi_A 202 NLGMCNIKDM--PNLTP-LVGLEELEMSGNHFPEIRPGSF---HGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAH 275 (452)
T ss_dssp ECTTSCCSSC--CCCTT-CTTCCEEECTTSCCSEECGGGG---TTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCS
T ss_pred ECCCCccccc--ccccc-cccccEEECcCCcCcccCcccc---cCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCC
Confidence 8888888864 34544 4899999999999998766543 4678999999999999998899999999999999999
Q ss_pred CcccccCCcccccc-ccCEEEccCCcCCCC
Q 005749 233 NLFSGSIPEGLTRL-SLEKLNLSHNNFSGV 261 (679)
Q Consensus 233 N~l~g~~p~~~~~l-~L~~l~ls~N~l~g~ 261 (679)
|+|++..+..+..+ +|+.|+|++|.+...
T Consensus 276 N~l~~~~~~~~~~l~~L~~L~L~~Np~~Cd 305 (452)
T 3zyi_A 276 NNLSSLPHDLFTPLRYLVELHLHHNPWNCD 305 (452)
T ss_dssp SCCSCCCTTSSTTCTTCCEEECCSSCEECS
T ss_pred CcCCccChHHhccccCCCEEEccCCCcCCC
Confidence 99997777777776 699999999987644
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.63 E-value=2.4e-16 Score=177.19 Aligned_cols=161 Identities=17% Similarity=0.166 Sum_probs=138.2
Q ss_pred CCccEEEEEcCCCCCcccCCccccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCc-ChhhHHhhcccCc
Q 005749 97 SSIHLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGV-LAPSIWNLCDRLV 175 (679)
Q Consensus 97 ~~~~l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~-~p~~~~~~~~~L~ 175 (679)
...+++.|+|++|++++..|..|+.+++|++|+|++|.|++..|..++++++|++|+|++|.+++. +|+.+.. +++|+
T Consensus 48 ~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~-l~~L~ 126 (549)
T 2z81_A 48 ACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPN-LTNLQ 126 (549)
T ss_dssp SCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTT-CTTCC
T ss_pred cCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhc-cCCcc
Confidence 345799999999999998889999999999999999999987777799999999999999999973 4555555 48999
Q ss_pred EEEccCCCCcccCCCCCCCCCCCCCccEEEccCccccccccccccCCCCCCEEEccCCcccccCCccc-ccc-ccCEEEc
Q 005749 176 SLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGL-TRL-SLEKLNL 253 (679)
Q Consensus 176 ~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~-~~l-~L~~l~l 253 (679)
.|+|++|++.+.+|...+ ..+++|++|++++|++++.+|..++.+++|+.|++++|.+. .+|..+ ..+ +|+.|++
T Consensus 127 ~L~L~~n~~~~~~~~~~~--~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~-~~~~~~~~~l~~L~~L~L 203 (549)
T 2z81_A 127 TLRIGNVETFSEIRRIDF--AGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESA-FLLEIFADILSSVRYLEL 203 (549)
T ss_dssp EEEEEESSSCCEECTTTT--TTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSBST-THHHHHHHSTTTBSEEEE
T ss_pred EEECCCCccccccCHhhh--hcccccCeeeccCCcccccChhhhhccccCceEecccCccc-ccchhhHhhcccccEEEc
Confidence 999999996666664433 46889999999999999999999999999999999999986 455543 234 6999999
Q ss_pred cCCcCCCC
Q 005749 254 SHNNFSGV 261 (679)
Q Consensus 254 s~N~l~g~ 261 (679)
++|++++.
T Consensus 204 ~~n~l~~~ 211 (549)
T 2z81_A 204 RDTNLARF 211 (549)
T ss_dssp ESCBCTTC
T ss_pred cCCccccc
Confidence 99999985
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.63 E-value=1.2e-16 Score=168.53 Aligned_cols=134 Identities=12% Similarity=0.113 Sum_probs=94.8
Q ss_pred cCccccCCceEEEEEEeCCCCEEEEEEcccCccc-----Cc---------ccH--------HHHHHHHhccCCCCCccce
Q 005749 382 GQVIEKTTYGTAYKAKLADGATIALRLLREGSCK-----DR---------SSC--------LPVIRQLGKVRHENLIPLR 439 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~-----~~---------~~~--------~~Ei~~l~~l~H~nIv~l~ 439 (679)
+..||+|+||.||+|+..+|+.||||+++..... .. ... .+|...|.++.+..+....
T Consensus 100 ~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~vp~ 179 (397)
T 4gyi_A 100 GSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFPVPE 179 (397)
T ss_dssp EEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCSCCC
T ss_pred cCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCCCCe
Confidence 5789999999999999889999999997643110 00 011 2345555555443332111
Q ss_pred EEeeCCCCceEEEEEecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCC-
Q 005749 440 AFYQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFF- 518 (679)
Q Consensus 440 ~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~- 518 (679)
-+.. ...++||||+++++|.++... .....++.|++.+|.|||+++ ||||||||.|||+++++
T Consensus 180 p~~~---~~~~LVME~i~G~~L~~l~~~----------~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~~dgd 243 (397)
T 4gyi_A 180 PIAQ---SRHTIVMSLVDALPMRQVSSV----------PDPASLYADLIALILRLAKHG---LIHGDFNEFNILIREEKD 243 (397)
T ss_dssp EEEE---ETTEEEEECCSCEEGGGCCCC----------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEEEEEC
T ss_pred eeec---cCceEEEEecCCccHhhhccc----------HHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeCCCC
Confidence 1111 134799999999888765421 123568899999999999988 99999999999998876
Q ss_pred ---------ceEEeeccccccc
Q 005749 519 ---------VSRLTEFGLDQLM 531 (679)
Q Consensus 519 ---------~~kl~DFGla~~~ 531 (679)
.+.|+||+-+...
T Consensus 244 ~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 244 AEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp SSCTTSEEEEEEECCCTTCEET
T ss_pred cccccccccceEEEEeCCcccC
Confidence 4899999976543
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.62 E-value=2.1e-15 Score=156.69 Aligned_cols=148 Identities=24% Similarity=0.328 Sum_probs=125.7
Q ss_pred cEEEEEcCCCCCcccCCccccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEEc
Q 005749 100 HLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRL 179 (679)
Q Consensus 100 ~l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~L 179 (679)
+++.|++++|++.. +| .+..+++|++|+|++|.+++ +|. +..+++|++|+|++|.+++. +.+..+ ++|+.|+|
T Consensus 42 ~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~-~~~-~~~l~~L~~L~L~~n~l~~~--~~~~~l-~~L~~L~l 114 (308)
T 1h6u_A 42 GITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITD-LAP-LKNLTKITELELSGNPLKNV--SAIAGL-QSIKTLDL 114 (308)
T ss_dssp TCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCC-CGG-GTTCCSCCEEECCSCCCSCC--GGGTTC-TTCCEEEC
T ss_pred CcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCC-Chh-HccCCCCCEEEccCCcCCCc--hhhcCC-CCCCEEEC
Confidence 58899999999874 55 69999999999999999995 554 99999999999999999974 455554 89999999
Q ss_pred cCCCCcccCCCCCCCCCCCCCccEEEccCccccccccccccCCCCCCEEEccCCcccccCCcccccc-ccCEEEccCCcC
Q 005749 180 HGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRL-SLEKLNLSHNNF 258 (679)
Q Consensus 180 s~N~l~~~~p~~~~~~~~~~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l-~L~~l~ls~N~l 258 (679)
++|++++..+ ...+++|++|++++|++++..+ ++.+++|+.|++++|++++. |. +..+ +|+.|++++|++
T Consensus 115 ~~n~l~~~~~-----l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~-~~-l~~l~~L~~L~l~~n~l 185 (308)
T 1h6u_A 115 TSTQITDVTP-----LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDL-TP-LANLSKLTTLKADDNKI 185 (308)
T ss_dssp TTSCCCCCGG-----GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCC
T ss_pred CCCCCCCchh-----hcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCC-hh-hcCCCCCCEEECCCCcc
Confidence 9999997432 2568899999999999996543 88999999999999999964 43 6666 699999999999
Q ss_pred CCCCC
Q 005749 259 SGVLP 263 (679)
Q Consensus 259 ~g~ip 263 (679)
++..|
T Consensus 186 ~~~~~ 190 (308)
T 1h6u_A 186 SDISP 190 (308)
T ss_dssp CCCGG
T ss_pred CcChh
Confidence 98665
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.62 E-value=6.4e-16 Score=142.29 Aligned_cols=128 Identities=23% Similarity=0.203 Sum_probs=103.1
Q ss_pred ccEEEEEcCCCCCc-ccCCccccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEE
Q 005749 99 IHLLSIQLPSANLT-GSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSL 177 (679)
Q Consensus 99 ~~l~~l~l~~n~l~-g~ip~~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L 177 (679)
.+++.|++++|+++ +.+|..++.+++|++|+|++|.|++. ..++.+++|++|+|++|.+++.+|..+..+ ++|+.|
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l-~~L~~L 93 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKC-PNLTHL 93 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHC-TTCCEE
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhC-CCCCEE
Confidence 35889999999998 89999999999999999999999965 778899999999999999998776655444 889999
Q ss_pred EccCCCCcccC-CCCCCCCCCCCCccEEEccCcccccccc---ccccCCCCCCEEEccC
Q 005749 178 RLHGNSLTAAL-PEPALPNSTCSDLQYLDLGSNKFSGSFP---EFVTRFEALKELDISN 232 (679)
Q Consensus 178 ~Ls~N~l~~~~-p~~~~~~~~~~~L~~L~l~~N~l~g~~p---~~~~~l~~L~~L~ls~ 232 (679)
++++|++++.. +... ..+++|++|++++|++++..+ ..+..+++|+.||+++
T Consensus 94 ~ls~N~i~~~~~~~~~---~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d 149 (149)
T 2je0_A 94 NLSGNKIKDLSTIEPL---KKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD 149 (149)
T ss_dssp ECTTSCCCSHHHHGGG---GGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred ECCCCcCCChHHHHHH---hhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence 99999988632 1211 456788888888888886554 4677888888888763
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.62 E-value=1.9e-15 Score=155.73 Aligned_cols=145 Identities=26% Similarity=0.346 Sum_probs=88.1
Q ss_pred cEEEEEcCCCCCcccCCccccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEEc
Q 005749 100 HLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRL 179 (679)
Q Consensus 100 ~l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~L 179 (679)
+++.|+|++|++++..| ++.+++|++|+|++|.+++ +| .+..+++|++|+|++|.+++. +.+..+ ++|+.|+|
T Consensus 69 ~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~L~~n~i~~~--~~l~~l-~~L~~L~l 141 (291)
T 1h6t_A 69 NVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGISDI--NGLVHL-PQLESLYL 141 (291)
T ss_dssp TCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCCCC--GGGGGC-TTCCEEEC
T ss_pred CCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-Ch-hhccCCCCCEEECCCCcCCCC--hhhcCC-CCCCEEEc
Confidence 46666676666665333 6666777777777776664 33 366666777777777766653 334333 66777777
Q ss_pred cCCCCcccCCCCCCCCCCCCCccEEEccCccccccccccccCCCCCCEEEccCCcccccCCcccccc-ccCEEEccCCcC
Q 005749 180 HGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRL-SLEKLNLSHNNF 258 (679)
Q Consensus 180 s~N~l~~~~p~~~~~~~~~~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l-~L~~l~ls~N~l 258 (679)
++|++++. + ....+++|++|++++|++++..| +..+++|+.|++++|++++ +|. +..+ +|+.|++++|.+
T Consensus 142 ~~n~l~~~-~----~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~~-l~~-l~~l~~L~~L~l~~n~i 212 (291)
T 1h6t_A 142 GNNKITDI-T----VLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD-LRA-LAGLKNLDVLELFSQEC 212 (291)
T ss_dssp CSSCCCCC-G----GGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCB-CGG-GTTCTTCSEEEEEEEEE
T ss_pred cCCcCCcc-h----hhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcCCC-Chh-hccCCCCCEEECcCCcc
Confidence 77766653 1 11345666777777776665433 6666677777777776664 333 4444 466777777666
Q ss_pred CC
Q 005749 259 SG 260 (679)
Q Consensus 259 ~g 260 (679)
+.
T Consensus 213 ~~ 214 (291)
T 1h6t_A 213 LN 214 (291)
T ss_dssp EC
T ss_pred cC
Confidence 54
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.61 E-value=2e-15 Score=155.52 Aligned_cols=146 Identities=25% Similarity=0.339 Sum_probs=124.1
Q ss_pred cEEEEEcCCCCCcccCCccccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEEc
Q 005749 100 HLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRL 179 (679)
Q Consensus 100 ~l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~L 179 (679)
+++.|++++|++.. +| .++.+++|++|+|++|.+++. +. +..+++|++|+|++|.+++. +.+.. +++|+.|+|
T Consensus 47 ~L~~L~l~~~~i~~-~~-~~~~l~~L~~L~L~~n~l~~~-~~-l~~l~~L~~L~l~~n~l~~~--~~l~~-l~~L~~L~L 119 (291)
T 1h6t_A 47 SIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDI-KP-LANLKNLGWLFLDENKVKDL--SSLKD-LKKLKSLSL 119 (291)
T ss_dssp TCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCCG--GGGTT-CTTCCEEEC
T ss_pred cccEEEccCCCccc-Ch-hHhcCCCCCEEEccCCccCCC-cc-cccCCCCCEEECCCCcCCCC--hhhcc-CCCCCEEEC
Confidence 48889999999874 44 589999999999999999964 44 99999999999999999973 44555 489999999
Q ss_pred cCCCCcccCCCCCCCCCCCCCccEEEccCccccccccccccCCCCCCEEEccCCcccccCCcccccc-ccCEEEccCCcC
Q 005749 180 HGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRL-SLEKLNLSHNNF 258 (679)
Q Consensus 180 s~N~l~~~~p~~~~~~~~~~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l-~L~~l~ls~N~l 258 (679)
++|++++. +. ...+++|++|++++|++++. ..++.+++|+.|++++|++++..| +..+ +|+.|++++|.|
T Consensus 120 ~~n~i~~~-~~----l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i 190 (291)
T 1h6t_A 120 EHNGISDI-NG----LVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHI 190 (291)
T ss_dssp TTSCCCCC-GG----GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCC
T ss_pred CCCcCCCC-hh----hcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcC
Confidence 99999974 21 24678999999999999964 678999999999999999997655 6666 699999999999
Q ss_pred CCC
Q 005749 259 SGV 261 (679)
Q Consensus 259 ~g~ 261 (679)
++.
T Consensus 191 ~~l 193 (291)
T 1h6t_A 191 SDL 193 (291)
T ss_dssp CBC
T ss_pred CCC
Confidence 874
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.61 E-value=1.8e-15 Score=153.50 Aligned_cols=145 Identities=22% Similarity=0.288 Sum_probs=114.8
Q ss_pred cEEEEEcCCCCCcccCCccccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEEc
Q 005749 100 HLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRL 179 (679)
Q Consensus 100 ~l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~L 179 (679)
+++.|++++|+++ .+| .++.+++|++|+|++|.|++ +|. +..+++|++|+|++|++++. |+ +.. ++|+.|+|
T Consensus 42 ~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~-~~~-l~~l~~L~~L~L~~N~l~~l-~~-~~~--~~L~~L~L 113 (263)
T 1xeu_A 42 GVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISD-LSP-LKDLTKLEELSVNRNRLKNL-NG-IPS--ACLSRLFL 113 (263)
T ss_dssp TCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCC-CGG-GTTCSSCCEEECCSSCCSCC-TT-CCC--SSCCEEEC
T ss_pred cCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCC-Chh-hccCCCCCEEECCCCccCCc-Cc-ccc--CcccEEEc
Confidence 4788889988887 466 78889999999999999985 444 88899999999999999873 33 222 68999999
Q ss_pred cCCCCcccCCCCCCCCCCCCCccEEEccCccccccccccccCCCCCCEEEccCCcccccCCcccccc-ccCEEEccCCcC
Q 005749 180 HGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRL-SLEKLNLSHNNF 258 (679)
Q Consensus 180 s~N~l~~~~p~~~~~~~~~~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l-~L~~l~ls~N~l 258 (679)
++|++++. +. ...+++|++|+|++|++++. | .++.+++|+.|++++|++++. ..+..+ +|+.|++++|.+
T Consensus 114 ~~N~l~~~-~~----l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~~ 184 (263)
T 1xeu_A 114 DNNELRDT-DS----LIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKC 184 (263)
T ss_dssp CSSCCSBS-GG----GTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEEEEEEE
T ss_pred cCCccCCC-hh----hcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcCcch--HHhccCCCCCEEeCCCCcc
Confidence 99999874 31 24678899999999999854 4 688889999999999999865 445555 689999999988
Q ss_pred CCC
Q 005749 259 SGV 261 (679)
Q Consensus 259 ~g~ 261 (679)
++.
T Consensus 185 ~~~ 187 (263)
T 1xeu_A 185 VNE 187 (263)
T ss_dssp ECC
T ss_pred cCC
Confidence 766
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.60 E-value=2e-15 Score=172.30 Aligned_cols=183 Identities=19% Similarity=0.181 Sum_probs=145.1
Q ss_pred ccEEEEEcCCCCCcccCCccccCCCCCCeeecccCcccccCCc-ccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEE
Q 005749 99 IHLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPF-ELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSL 177 (679)
Q Consensus 99 ~~l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip~-~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L 177 (679)
.++..+++..+...+ ++..+..+++|+.++++.|++....+. .+.++.+|+.++++.|.+.+..+..+.. +++|+.|
T Consensus 397 ~~L~~L~~~~~~~~~-~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~-~~~L~~L 474 (635)
T 4g8a_A 397 ISLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNG-LSSLEVL 474 (635)
T ss_dssp SCCCEEECCSCSEEE-ECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTT-CTTCCEE
T ss_pred hhhhhhhcccccccc-ccccccccccccchhhhhcccccccccccccccccccccccccccccccccccccc-chhhhhh
Confidence 467788888888765 556788999999999999988766554 4678899999999999999766554444 5899999
Q ss_pred EccCCCCcccCCCCCCCCCCCCCccEEEccCccccccccccccCCCCCCEEEccCCcccccCCcccccc-ccCEEEccCC
Q 005749 178 RLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRL-SLEKLNLSHN 256 (679)
Q Consensus 178 ~Ls~N~l~~~~p~~~~~~~~~~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l-~L~~l~ls~N 256 (679)
+|++|++...+++..+ ..+++|++|+|++|+|++..|..|.++++|+.|+|++|+|++..|..+..+ +|+.|+|++|
T Consensus 475 ~Ls~N~~~~~~~~~~~--~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N 552 (635)
T 4g8a_A 475 KMAGNSFQENFLPDIF--TELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLN 552 (635)
T ss_dssp ECTTCEEGGGEECSCC--TTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTS
T ss_pred hhhhcccccccCchhh--hhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCC
Confidence 9999986544332232 467899999999999999889999999999999999999998888888877 6999999999
Q ss_pred cCCCCCCCcccC---CCCcccccCCCCCCCCCC
Q 005749 257 NFSGVLPVFSES---KFGAEVFEGNSPALCGFP 286 (679)
Q Consensus 257 ~l~g~ip~~~~~---~~~~~~~~~n~~~~c~~p 286 (679)
+|++.+|..... ......+.+| |..|.+.
T Consensus 553 ~l~~~~~~~l~~l~~~L~~L~L~~N-p~~C~C~ 584 (635)
T 4g8a_A 553 HIMTSKKQELQHFPSSLAFLNLTQN-DFACTCE 584 (635)
T ss_dssp CCCBCCSSCTTCCCTTCCEEECTTC-CBCCSGG
T ss_pred cCCCCCHHHHHhhhCcCCEEEeeCC-CCcccCC
Confidence 999998875432 2233334566 8888653
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.60 E-value=5e-15 Score=167.45 Aligned_cols=147 Identities=26% Similarity=0.332 Sum_probs=126.5
Q ss_pred ccEEEEEcCCCCCcccCCccccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEE
Q 005749 99 IHLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLR 178 (679)
Q Consensus 99 ~~l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~ 178 (679)
.+|+.|+|++|.+.+..| ++.|++|+.|+|++|.|++ +| .+..+++|++|+|++|.|++. +.+..+ ++|+.|+
T Consensus 65 ~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~l--~~l~~l-~~L~~L~ 137 (605)
T 1m9s_A 65 PNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKD-LS-SLKDLKKLKSLSLEHNGISDI--NGLVHL-PQLESLY 137 (605)
T ss_dssp TTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCC-CT-TSTTCTTCCEEECTTSCCCCC--GGGGGC-TTCSEEE
T ss_pred CCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCC-Ch-hhccCCCCCEEEecCCCCCCC--ccccCC-CccCEEE
Confidence 468999999999997555 9999999999999999985 45 799999999999999999974 455554 8999999
Q ss_pred ccCCCCcccCCCCCCCCCCCCCccEEEccCccccccccccccCCCCCCEEEccCCcccccCCcccccc-ccCEEEccCCc
Q 005749 179 LHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRL-SLEKLNLSHNN 257 (679)
Q Consensus 179 Ls~N~l~~~~p~~~~~~~~~~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l-~L~~l~ls~N~ 257 (679)
|++|+|++. + ....+++|+.|+|++|+|++..| +..+++|+.|+|++|+|++ +| .+..+ +|+.|+|++|.
T Consensus 138 Ls~N~l~~l-~----~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~L~~N~ 208 (605)
T 1m9s_A 138 LGNNKITDI-T----VLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFSQE 208 (605)
T ss_dssp CCSSCCCCC-G----GGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEECCSEE
T ss_pred CCCCccCCc-h----hhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCCCCC-Ch-HHccCCCCCEEEccCCc
Confidence 999999975 2 12468899999999999998766 8999999999999999986 44 45666 69999999999
Q ss_pred CCCC
Q 005749 258 FSGV 261 (679)
Q Consensus 258 l~g~ 261 (679)
+++.
T Consensus 209 l~~~ 212 (605)
T 1m9s_A 209 CLNK 212 (605)
T ss_dssp EECC
T ss_pred CcCC
Confidence 9875
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.59 E-value=4.1e-15 Score=143.83 Aligned_cols=136 Identities=18% Similarity=0.235 Sum_probs=115.8
Q ss_pred cccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEEccCCCCcccCCCCCCCCCC
Q 005749 118 ELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNST 197 (679)
Q Consensus 118 ~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~~~~ 197 (679)
..+.+++|++|+|++|.++ .+| .+..+++|++|+|++|.++.. +.+.. +++|++|+|++|++++..|..+ ..
T Consensus 39 ~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~~~--~~l~~-l~~L~~L~l~~n~l~~~~~~~l---~~ 110 (197)
T 4ezg_A 39 TEAQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHATNY--NPISG-LSNLERLRIMGKDVTSDKIPNL---SG 110 (197)
T ss_dssp BHHHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCSCC--GGGTT-CTTCCEEEEECTTCBGGGSCCC---TT
T ss_pred ChhhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCCcc--hhhhc-CCCCCEEEeECCccCcccChhh---cC
Confidence 3478899999999999999 778 789999999999999987643 45555 4899999999999998666543 46
Q ss_pred CCCccEEEccCccccccccccccCCCCCCEEEccCCcccccCCcccccc-ccCEEEccCCcCCCCC
Q 005749 198 CSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRL-SLEKLNLSHNNFSGVL 262 (679)
Q Consensus 198 ~~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l-~L~~l~ls~N~l~g~i 262 (679)
+++|++|+|++|++++..|..++.+++|+.|++++|++.+.+| .+..+ +|+.|++++|.+++..
T Consensus 111 l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~~-~l~~l~~L~~L~l~~n~i~~~~ 175 (197)
T 4ezg_A 111 LTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVHDYR 175 (197)
T ss_dssp CTTCCEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCCCG-GGGGCSSCCEEECTTBCCCCCT
T ss_pred CCCCCEEEecCCccCcHhHHHHhhCCCCCEEEccCCCCccccH-hhcCCCCCCEEECCCCCCcChH
Confidence 8899999999999999889999999999999999998444666 46666 6999999999998743
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.58 E-value=4.9e-15 Score=167.82 Aligned_cols=117 Identities=26% Similarity=0.414 Sum_probs=67.6
Q ss_pred cCCCCCCCCCCcccccc--------eeecCCCCCcccCCCCCCccccccccCCCCccEEEEEcCCCCCcccCCccccCCC
Q 005749 52 LLSSWNISVPLCQWRGL--------KWISTNGSPLSCSDISLPQWANLSLYKDSSIHLLSIQLPSANLTGSLPRELGEFS 123 (679)
Q Consensus 52 ~l~~W~~~~~~C~w~Gv--------~c~~~~~~~l~c~~~~~~~~~~l~~~~~~~~~l~~l~l~~n~l~g~ip~~l~~l~ 123 (679)
..+.|..+.++|.|+|. .|...+...++|+......+ ... -..+++.|+|++|+++ .||. .++
T Consensus 11 ~w~~W~~~~~~~~~~~r~~~~~~~~~c~~~~l~~L~ls~n~L~~l---p~~--l~~~L~~L~L~~N~l~-~lp~---~l~ 81 (622)
T 3g06_A 11 VWSAWRRAAPAEESRGRAAVVQKMRACLNNGNAVLNVGESGLTTL---PDC--LPAHITTLVIPDNNLT-SLPA---LPP 81 (622)
T ss_dssp HHHHHHHTCCGGGHHHHHHHHHHHHHHHHHCCCEEECCSSCCSCC---CSC--CCTTCSEEEECSCCCS-CCCC---CCT
T ss_pred HHHHHHhcCCcchhccccccCcccccccCCCCcEEEecCCCcCcc---Chh--hCCCCcEEEecCCCCC-CCCC---cCC
Confidence 45668777789999774 23333344555654433211 110 1135777777777776 4665 467
Q ss_pred CCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEEccCCCCcc
Q 005749 124 MLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNSLTA 186 (679)
Q Consensus 124 ~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N~l~~ 186 (679)
+|++|+|++|+|+ .+|. .+++|++|+|++|.+++. |. .+++|+.|+|++|++++
T Consensus 82 ~L~~L~Ls~N~l~-~lp~---~l~~L~~L~Ls~N~l~~l-~~----~l~~L~~L~L~~N~l~~ 135 (622)
T 3g06_A 82 ELRTLEVSGNQLT-SLPV---LPPGLLELSIFSNPLTHL-PA----LPSGLCKLWIFGNQLTS 135 (622)
T ss_dssp TCCEEEECSCCCS-CCCC---CCTTCCEEEECSCCCCCC-CC----CCTTCCEEECCSSCCSC
T ss_pred CCCEEEcCCCcCC-cCCC---CCCCCCEEECcCCcCCCC-CC----CCCCcCEEECCCCCCCc
Confidence 7777777777776 4655 456667777777766653 22 12455555555555553
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.58 E-value=8.9e-15 Score=141.00 Aligned_cols=125 Identities=27% Similarity=0.336 Sum_probs=82.6
Q ss_pred EEcCCCCCcccCCccccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEEccCCC
Q 005749 104 IQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNS 183 (679)
Q Consensus 104 l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N~ 183 (679)
+++++|+++ .+|..+. ++|++|+|++|.|+ .+|..+.++++|++|+|++|.+++..+..+.++ ++|+.|+|++|+
T Consensus 15 l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l-~~L~~L~Ls~N~ 89 (193)
T 2wfh_A 15 VRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNM-TQLLTLILSYNR 89 (193)
T ss_dssp EECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTC-TTCCEEECCSSC
T ss_pred EEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCC-CCCCEEECCCCc
Confidence 455556555 5665543 57788888888887 677777777888888888888776544444443 677777777777
Q ss_pred CcccCCCCCCCCCCCCCccEEEccCccccccccccccCCCCCCEEEccCCccc
Q 005749 184 LTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFS 236 (679)
Q Consensus 184 l~~~~p~~~~~~~~~~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~ 236 (679)
|++..|..+ ..+++|++|+|++|+|++..+..|..+++|+.|+|++|.+.
T Consensus 90 l~~i~~~~f---~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 139 (193)
T 2wfh_A 90 LRCIPPRTF---DGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLY 139 (193)
T ss_dssp CCBCCTTTT---TTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEE
T ss_pred cCEeCHHHh---CCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCee
Confidence 776544322 34566777777777776544445666777777777777665
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.58 E-value=9.1e-15 Score=138.76 Aligned_cols=114 Identities=21% Similarity=0.227 Sum_probs=73.3
Q ss_pred CCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEEccCCCCcccCCCCCCCCCCCCCcc
Q 005749 123 SMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQ 202 (679)
Q Consensus 123 ~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~ 202 (679)
++|++|+|++|+|++..+..++.+++|++|+|++|.+++..+..+.. +++|+.|+|++|++++..+.. + ..+++|+
T Consensus 28 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~-l~~L~~L~l~~N~l~~~~~~~-~--~~l~~L~ 103 (177)
T 2o6r_A 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDK-LTKLTILYLHENKLQSLPNGV-F--DKLTQLK 103 (177)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTT-CTTCCEEECCSSCCCCCCTTT-T--TTCTTCC
T ss_pred CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccC-CCccCEEECCCCCccccCHHH-h--hCCcccC
Confidence 57778888888877655555677777888888888777543332333 367777777777777543321 1 2455677
Q ss_pred EEEccCccccccccccccCCCCCCEEEccCCcccccCC
Q 005749 203 YLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIP 240 (679)
Q Consensus 203 ~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p 240 (679)
+|+|++|++++..+..+..+++|+.|++++|.+++..|
T Consensus 104 ~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 104 ELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp EEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred EEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 77777777765444445667777777777777765544
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.58 E-value=9.4e-15 Score=138.64 Aligned_cols=133 Identities=22% Similarity=0.265 Sum_probs=109.3
Q ss_pred CCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEEccCCCCcccCCCCCCCCCCCCCccEE
Q 005749 125 LQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYL 204 (679)
Q Consensus 125 L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L 204 (679)
.+.+++++|+++ .+|..+ .++|++|+|++|++++..+..+.. +++|++|+|++|++++..+. .+ ..+++|++|
T Consensus 9 ~~~l~~~~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~-l~~L~~L~l~~n~l~~~~~~-~~--~~l~~L~~L 81 (177)
T 2o6r_A 9 GTEIRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDK-LTQLTKLSLSQNQIQSLPDG-VF--DKLTKLTIL 81 (177)
T ss_dssp TTEEECCSSCCS-SCCTTC--CTTCSEEECCSSCCCCCCTTTTTT-CTTCSEEECCSSCCCCCCTT-TT--TTCTTCCEE
T ss_pred CCEEEecCCCCc-cCCCCC--CCCCcEEEeCCCcccEeCHHHhcC-cccccEEECCCCcceEeChh-Hc--cCCCccCEE
Confidence 467889999998 677655 379999999999999754434444 58999999999999965443 22 467899999
Q ss_pred EccCccccccccccccCCCCCCEEEccCCcccccCCcccccc-ccCEEEccCCcCCCCCCC
Q 005749 205 DLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRL-SLEKLNLSHNNFSGVLPV 264 (679)
Q Consensus 205 ~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l-~L~~l~ls~N~l~g~ip~ 264 (679)
+|++|++++..+..+..+++|+.|++++|+|++..+..+..+ +|+.|+|++|.+++..|.
T Consensus 82 ~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~ 142 (177)
T 2o6r_A 82 YLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 142 (177)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHHH
T ss_pred ECCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCcc
Confidence 999999998777778999999999999999996655556666 699999999999998773
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.58 E-value=1.5e-15 Score=142.91 Aligned_cols=135 Identities=21% Similarity=0.145 Sum_probs=113.3
Q ss_pred cCCCCCCeeecccCccc-ccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEEccCCCCcccCCCCCCCCCCC
Q 005749 120 GEFSMLQSLYLNVNSLK-GTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTC 198 (679)
Q Consensus 120 ~~l~~L~~L~L~~N~l~-g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~~~~~ 198 (679)
...++|++|+|++|.++ |.+|..+..+++|++|+|++|.+++. ..+.. +++|+.|+|++|++++.+|... ..+
T Consensus 21 ~~~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~-l~~L~~L~Ls~N~l~~~~~~~~---~~l 94 (168)
T 2ell_A 21 RTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPK-LPKLKKLELSENRIFGGLDMLA---EKL 94 (168)
T ss_dssp SCTTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCC-CSSCCEEEEESCCCCSCCCHHH---HHC
T ss_pred CCcccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhcc-CCCCCEEECcCCcCchHHHHHH---hhC
Confidence 34588999999999998 88999999999999999999999976 45555 4899999999999998655322 247
Q ss_pred CCccEEEccCcccccc-ccccccCCCCCCEEEccCCcccccCC---cccccc-ccCEEEccCCcCCC
Q 005749 199 SDLQYLDLGSNKFSGS-FPEFVTRFEALKELDISNNLFSGSIP---EGLTRL-SLEKLNLSHNNFSG 260 (679)
Q Consensus 199 ~~L~~L~l~~N~l~g~-~p~~~~~l~~L~~L~ls~N~l~g~~p---~~~~~l-~L~~l~ls~N~l~g 260 (679)
++|++|+|++|++++. .+..+..+++|+.|++++|.+++..+ ..+..+ +|+.|++++|.+..
T Consensus 95 ~~L~~L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~~ 161 (168)
T 2ell_A 95 PNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQE 161 (168)
T ss_dssp TTCCEEECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSCB
T ss_pred CCCCEEeccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChhh
Confidence 8999999999999963 23789999999999999999996555 366666 69999999998764
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.58 E-value=8.7e-16 Score=141.42 Aligned_cols=129 Identities=22% Similarity=0.205 Sum_probs=107.6
Q ss_pred CCCCCCeeecccCccc-ccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEEccCCCCcccCCCCCCCCCCCC
Q 005749 121 EFSMLQSLYLNVNSLK-GTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTCS 199 (679)
Q Consensus 121 ~l~~L~~L~L~~N~l~-g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~~~~~~ 199 (679)
..++|+.|+|++|.++ |.+|..+..+++|++|+|++|.+++. +.+.. +++|+.|+|++|++++.+|... ..++
T Consensus 15 ~~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~-l~~L~~L~Ls~n~i~~~~~~~~---~~l~ 88 (149)
T 2je0_A 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPK-LNKLKKLELSDNRVSGGLEVLA---EKCP 88 (149)
T ss_dssp CGGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCC-CTTCCEEECCSSCCCSCTHHHH---HHCT
T ss_pred CCccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhc-CCCCCEEECCCCcccchHHHHh---hhCC
Confidence 4578999999999999 89999999999999999999999976 45545 4899999999999998655422 2478
Q ss_pred CccEEEccCcccccc-ccccccCCCCCCEEEccCCcccccCC---cccccc-ccCEEEccC
Q 005749 200 DLQYLDLGSNKFSGS-FPEFVTRFEALKELDISNNLFSGSIP---EGLTRL-SLEKLNLSH 255 (679)
Q Consensus 200 ~L~~L~l~~N~l~g~-~p~~~~~l~~L~~L~ls~N~l~g~~p---~~~~~l-~L~~l~ls~ 255 (679)
+|++|++++|++++. .|..++.+++|+.|++++|++++..+ ..+..+ +|+.|++++
T Consensus 89 ~L~~L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d 149 (149)
T 2je0_A 89 NLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD 149 (149)
T ss_dssp TCCEEECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred CCCEEECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence 999999999999973 45889999999999999999997655 356665 688888764
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.57 E-value=3.3e-17 Score=184.15 Aligned_cols=156 Identities=25% Similarity=0.191 Sum_probs=104.9
Q ss_pred ccEEEEEcCCCCCcccCCccccCCCCCCeeecccCc-------------ccccCCcccCCCC------------------
Q 005749 99 IHLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNS-------------LKGTIPFELGYSS------------------ 147 (679)
Q Consensus 99 ~~l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~-------------l~g~ip~~l~~l~------------------ 147 (679)
.++..|+|++|.+. .||++|++|++|+.|++++|. +.|.+|..+++++
T Consensus 349 ~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~~L~~ 427 (567)
T 1dce_A 349 EQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRS 427 (567)
T ss_dssp TTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHHHHHH
T ss_pred ccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcccchhhh
Confidence 34566777877775 788888888888888887764 4555554443322
Q ss_pred --------------CCCEEEccCCCCCCcChhhHHhhcccCcEEEccCCCCcccCCCCCCCCCCCCCccEEEccCccccc
Q 005749 148 --------------SLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSG 213 (679)
Q Consensus 148 --------------~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~l~~N~l~g 213 (679)
.|+.|+|++|.|++ +|. +..+ ++|+.|+|++|+|+ .+|..+ ..+++|++|+|++|+|++
T Consensus 428 l~l~~n~i~~l~~~~L~~L~Ls~n~l~~-lp~-~~~l-~~L~~L~Ls~N~l~-~lp~~~---~~l~~L~~L~Ls~N~l~~ 500 (567)
T 1dce_A 428 KFLLENSVLKMEYADVRVLHLAHKDLTV-LCH-LEQL-LLVTHLDLSHNRLR-ALPPAL---AALRCLEVLQASDNALEN 500 (567)
T ss_dssp HHHHHHHHHHHHHTTCSEEECTTSCCSS-CCC-GGGG-TTCCEEECCSSCCC-CCCGGG---GGCTTCCEEECCSSCCCC
T ss_pred hhhhcccccccCccCceEEEecCCCCCC-CcC-cccc-ccCcEeecCccccc-ccchhh---hcCCCCCEEECCCCCCCC
Confidence 46667777777776 443 4443 67777777777777 455432 356677777777777775
Q ss_pred cccccccCCCCCCEEEccCCcccccC-Ccccccc-ccCEEEccCCcCCCCCCC
Q 005749 214 SFPEFVTRFEALKELDISNNLFSGSI-PEGLTRL-SLEKLNLSHNNFSGVLPV 264 (679)
Q Consensus 214 ~~p~~~~~l~~L~~L~ls~N~l~g~~-p~~~~~l-~L~~l~ls~N~l~g~ip~ 264 (679)
+| .++.+++|+.|+|++|+|++.+ |..+..+ +|+.|+|++|+|++.+|.
T Consensus 501 -lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~ 551 (567)
T 1dce_A 501 -VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGI 551 (567)
T ss_dssp -CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSC
T ss_pred -Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccH
Confidence 56 6777777777777777777665 6666666 577777777777766553
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.57 E-value=1.5e-14 Score=139.51 Aligned_cols=128 Identities=20% Similarity=0.254 Sum_probs=109.7
Q ss_pred CeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEEccCCCCcccCCCCCCCCCCCCCccEEE
Q 005749 126 QSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLD 205 (679)
Q Consensus 126 ~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~ 205 (679)
+++++++|.|+ .+|..+. ++|++|+|++|+|+ .+|..+..+ ++|+.|+|++|+|++..+..+ ..+++|++|+
T Consensus 13 ~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l-~~L~~L~Ls~N~i~~i~~~~f---~~l~~L~~L~ 84 (193)
T 2wfh_A 13 TVVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNY-KHLTLIDLSNNRISTLSNQSF---SNMTQLLTLI 84 (193)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGC-TTCCEEECCSSCCCCCCTTTT---TTCTTCCEEE
T ss_pred CEEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcc-cCCCEEECCCCcCCEeCHhHc---cCCCCCCEEE
Confidence 58999999998 7887764 68999999999998 567666554 899999999999997655433 4678999999
Q ss_pred ccCccccccccccccCCCCCCEEEccCCcccccCCcccccc-ccCEEEccCCcCCCC
Q 005749 206 LGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRL-SLEKLNLSHNNFSGV 261 (679)
Q Consensus 206 l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l-~L~~l~ls~N~l~g~ 261 (679)
|++|+|++..|..|..+++|+.|+|++|+|++..+..+..+ +|+.|+|++|.+...
T Consensus 85 Ls~N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~ 141 (193)
T 2wfh_A 85 LSYNRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCD 141 (193)
T ss_dssp CCSSCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECS
T ss_pred CCCCccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecC
Confidence 99999998888899999999999999999996666667777 699999999988754
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.56 E-value=6e-15 Score=166.81 Aligned_cols=146 Identities=25% Similarity=0.360 Sum_probs=124.6
Q ss_pred cEEEEEcCCCCCcccCCccccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEEc
Q 005749 100 HLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRL 179 (679)
Q Consensus 100 ~l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~L 179 (679)
+|+.|+|++|++.. +| .|+.|++|+.|+|++|.|++..| +..+++|+.|+|++|.|++. +.+.. +++|+.|+|
T Consensus 44 ~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l--~~l~~-l~~L~~L~L 116 (605)
T 1m9s_A 44 SIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKDL--SSLKD-LKKLKSLSL 116 (605)
T ss_dssp TCCCCBCTTCCCCC-CT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCC--TTSTT-CTTCCEEEC
T ss_pred CCCEEECcCCCCCC-Ch-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCCC--hhhcc-CCCCCEEEe
Confidence 47778888888864 44 69999999999999999997544 89999999999999999974 35555 489999999
Q ss_pred cCCCCcccCCCCCCCCCCCCCccEEEccCccccccccccccCCCCCCEEEccCCcccccCCcccccc-ccCEEEccCCcC
Q 005749 180 HGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRL-SLEKLNLSHNNF 258 (679)
Q Consensus 180 s~N~l~~~~p~~~~~~~~~~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l-~L~~l~ls~N~l 258 (679)
++|+|++. +. ...+++|+.|+|++|+|++. ..++.+++|+.|+|++|+|++..| +..+ +|+.|+|++|+|
T Consensus 117 s~N~l~~l-~~----l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i 187 (605)
T 1m9s_A 117 EHNGISDI-NG----LVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHI 187 (605)
T ss_dssp TTSCCCCC-GG----GGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCC
T ss_pred cCCCCCCC-cc----ccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCCC
Confidence 99999973 31 24688999999999999965 678999999999999999998766 6666 699999999999
Q ss_pred CCC
Q 005749 259 SGV 261 (679)
Q Consensus 259 ~g~ 261 (679)
++.
T Consensus 188 ~~l 190 (605)
T 1m9s_A 188 SDL 190 (605)
T ss_dssp CBC
T ss_pred CCC
Confidence 985
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.56 E-value=5.6e-16 Score=179.48 Aligned_cols=153 Identities=22% Similarity=0.267 Sum_probs=120.5
Q ss_pred ccEEEEEcCCCCCcccCCccccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEE
Q 005749 99 IHLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLR 178 (679)
Q Consensus 99 ~~l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~ 178 (679)
..|+.|+|++|.+. .||..+..|++|++|+|++|.|+ .+|..++++++|++|||++|.|+ .+|..+..+ ++|++|+
T Consensus 224 ~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l-~~L~~L~ 299 (727)
T 4b8c_D 224 QLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSC-FQLKYFY 299 (727)
T ss_dssp CCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGG-TTCSEEE
T ss_pred CCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCC-CCCCEEE
Confidence 46889999999998 89999999999999999999999 89999999999999999999999 678888775 8999999
Q ss_pred ccCCCCcccCCCCCCCCCCCCCccEEEccCccccccccccccCCCC-CCEEEccCCcccccCCccccccccCEEEccCC-
Q 005749 179 LHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEA-LKELDISNNLFSGSIPEGLTRLSLEKLNLSHN- 256 (679)
Q Consensus 179 Ls~N~l~~~~p~~~~~~~~~~~L~~L~l~~N~l~g~~p~~~~~l~~-L~~L~ls~N~l~g~~p~~~~~l~L~~l~ls~N- 256 (679)
|++|.|+ .+|..+ ..+++|++|+|++|.|+|.+|..+..+.. +..|+|++|.++|.+|..+. .|++++|
T Consensus 300 L~~N~l~-~lp~~~---~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~l~-----~l~l~~n~ 370 (727)
T 4b8c_D 300 FFDNMVT-TLPWEF---GNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHERR-----FIEINTDG 370 (727)
T ss_dssp CCSSCCC-CCCSST---TSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC---------------
T ss_pred CCCCCCC-ccChhh---hcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCccccc-----eeEeeccc
Confidence 9999998 567653 57889999999999999999988765432 23478999999999998654 4566666
Q ss_pred ---cCCCCCCC
Q 005749 257 ---NFSGVLPV 264 (679)
Q Consensus 257 ---~l~g~ip~ 264 (679)
...|.+|.
T Consensus 371 ~~~~~~~~l~~ 381 (727)
T 4b8c_D 371 EPQREYDSLQQ 381 (727)
T ss_dssp -----------
T ss_pred ccccccCCccc
Confidence 34444443
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.56 E-value=4e-14 Score=155.26 Aligned_cols=142 Identities=21% Similarity=0.248 Sum_probs=75.1
Q ss_pred cEEEEEcCCCCCcccCCccccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEEc
Q 005749 100 HLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRL 179 (679)
Q Consensus 100 ~l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~L 179 (679)
+++.|+|++|.+++. | ++++++|++|+|++|.|++ +| ++.+++|++|+|++|++++. + +.. +++|+.|++
T Consensus 86 ~L~~L~Ls~N~l~~~-~--~~~l~~L~~L~L~~N~l~~-l~--~~~l~~L~~L~l~~N~l~~l-~--l~~-l~~L~~L~l 155 (457)
T 3bz5_A 86 NLTYLACDSNKLTNL-D--VTPLTKLTYLNCDTNKLTK-LD--VSQNPLLTYLNCARNTLTEI-D--VSH-NTQLTELDC 155 (457)
T ss_dssp TCSEEECCSSCCSCC-C--CTTCTTCCEEECCSSCCSC-CC--CTTCTTCCEEECTTSCCSCC-C--CTT-CTTCCEEEC
T ss_pred CCCEEECcCCCCcee-e--cCCCCcCCEEECCCCcCCe-ec--CCCCCcCCEEECCCCcccee-c--ccc-CCcCCEEEC
Confidence 455555555555542 2 5555555555555555553 33 45555555555555555542 1 222 244555555
Q ss_pred cCCCCcccCCCCCCCCCCCCCccEEEccCccccccccccccCCCCCCEEEccCCcccccCCcccccc-ccCEEEccCCcC
Q 005749 180 HGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRL-SLEKLNLSHNNF 258 (679)
Q Consensus 180 s~N~l~~~~p~~~~~~~~~~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l-~L~~l~ls~N~l 258 (679)
++|+..+.++ ...+++|++|++++|++++ +| ++.+++|+.|++++|++++. + +..+ +|+.|++++|+|
T Consensus 156 ~~n~~~~~~~-----~~~l~~L~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~-~--l~~l~~L~~L~Ls~N~l 224 (457)
T 3bz5_A 156 HLNKKITKLD-----VTPQTQLTTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNITKL-D--LNQNIQLTFLDCSSNKL 224 (457)
T ss_dssp TTCSCCCCCC-----CTTCTTCCEEECCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC-C--CTTCTTCSEEECCSSCC
T ss_pred CCCCcccccc-----cccCCcCCEEECCCCccce-ec--cccCCCCCEEECcCCcCCee-c--cccCCCCCEEECcCCcc
Confidence 5554333321 2345566666666666664 44 55666666666666666643 1 3333 466677777776
Q ss_pred CCCCC
Q 005749 259 SGVLP 263 (679)
Q Consensus 259 ~g~ip 263 (679)
++ +|
T Consensus 225 ~~-ip 228 (457)
T 3bz5_A 225 TE-ID 228 (457)
T ss_dssp SC-CC
T ss_pred cc-cC
Confidence 66 44
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.56 E-value=1.7e-15 Score=166.07 Aligned_cols=149 Identities=26% Similarity=0.300 Sum_probs=78.1
Q ss_pred ccEEEEEcCCCCCcccCCccccCCCCCCeeecccCcccccCCcccCCCCCC-------------CEEEccCCCCCCcChh
Q 005749 99 IHLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSL-------------SEIDLSANLFTGVLAP 165 (679)
Q Consensus 99 ~~l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L-------------~~L~Ls~N~l~g~~p~ 165 (679)
.+++.|++++|++ |.||++|++|++|++|+|++|.++|.+|..++++.+| ++|++++|.+++. |.
T Consensus 11 ~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~l-p~ 88 (454)
T 1jl5_A 11 TFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSSL-PE 88 (454)
T ss_dssp ------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSCC-CS
T ss_pred ccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCccccC-CC
Confidence 3588899999999 8999999999999999999999999999999887764 8888888888763 32
Q ss_pred hHHhhcccCcEEEccCCCCcccCCCCC---------------CCCCCCCCccEEEccCccccccccccccCCCCCCEEEc
Q 005749 166 SIWNLCDRLVSLRLHGNSLTAALPEPA---------------LPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDI 230 (679)
Q Consensus 166 ~~~~~~~~L~~L~Ls~N~l~~~~p~~~---------------~~~~~~~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l 230 (679)
..++|+.|++++|++++ +|... ++ ...++|++|++++|++++ +| .++.+++|++|++
T Consensus 89 ----~~~~L~~L~l~~n~l~~-lp~~~~~L~~L~l~~n~l~~l~-~~~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l 160 (454)
T 1jl5_A 89 ----LPPHLESLVASCNSLTE-LPELPQSLKSLLVDNNNLKALS-DLPPLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDV 160 (454)
T ss_dssp ----CCTTCSEEECCSSCCSS-CCCCCTTCCEEECCSSCCSCCC-SCCTTCCEEECCSSCCSS-CC-CCTTCTTCCEEEC
T ss_pred ----CcCCCCEEEccCCcCCc-cccccCCCcEEECCCCccCccc-CCCCCCCEEECcCCCCCC-Cc-ccCCCCCCCEEEC
Confidence 12567777777777776 44311 00 001345555555555553 44 3555555555555
Q ss_pred cCCcccccCCccccccccCEEEccCCcCCC
Q 005749 231 SNNLFSGSIPEGLTRLSLEKLNLSHNNFSG 260 (679)
Q Consensus 231 s~N~l~g~~p~~~~~l~L~~l~ls~N~l~g 260 (679)
++|++++ +|..+. +|+.|++++|++++
T Consensus 161 ~~N~l~~-lp~~~~--~L~~L~L~~n~l~~ 187 (454)
T 1jl5_A 161 DNNSLKK-LPDLPP--SLEFIAAGNNQLEE 187 (454)
T ss_dssp CSSCCSC-CCCCCT--TCCEEECCSSCCSS
T ss_pred CCCcCcc-cCCCcc--cccEEECcCCcCCc
Confidence 5555553 443322 35555555555554
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.56 E-value=1.7e-14 Score=158.94 Aligned_cols=147 Identities=27% Similarity=0.388 Sum_probs=82.6
Q ss_pred ccEEEEEcCCCCCcccCCccccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEE
Q 005749 99 IHLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLR 178 (679)
Q Consensus 99 ~~l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~ 178 (679)
.+++.|++++|.+.+..| ++.+++|+.|+|++|.+++ + +.+..+++|++|+|++|.+++..+ +.. +++|+.|+
T Consensus 199 ~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~l~~n~l~~~~~--~~~-l~~L~~L~ 271 (466)
T 1o6v_A 199 TNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD-I-GTLASLTNLTDLDLANNQISNLAP--LSG-LTKLTELK 271 (466)
T ss_dssp TTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCCCGG--GTT-CTTCSEEE
T ss_pred CCCCEEEecCCccccccc--ccccCCCCEEECCCCCccc-c-hhhhcCCCCCEEECCCCccccchh--hhc-CCCCCEEE
Confidence 356677777777766544 5666666666666666663 2 245566666666666666665432 333 35666666
Q ss_pred ccCCCCcccCCCCCCCCCCCCCccEEEccCccccccccccccCCCCCCEEEccCCcccccCCcccccc-ccCEEEccCCc
Q 005749 179 LHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRL-SLEKLNLSHNN 257 (679)
Q Consensus 179 Ls~N~l~~~~p~~~~~~~~~~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l-~L~~l~ls~N~ 257 (679)
+++|++++..+ ...+++|++|++++|++++..| ++.+++|+.|++++|++++..| +..+ +|+.|++++|+
T Consensus 272 l~~n~l~~~~~-----~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~ 342 (466)
T 1o6v_A 272 LGANQISNISP-----LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNK 342 (466)
T ss_dssp CCSSCCCCCGG-----GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSC
T ss_pred CCCCccCcccc-----ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCCCc
Confidence 66666665332 1234556666666666554322 4555555666666555554443 2233 35555555555
Q ss_pred CCCC
Q 005749 258 FSGV 261 (679)
Q Consensus 258 l~g~ 261 (679)
+++.
T Consensus 343 l~~~ 346 (466)
T 1o6v_A 343 VSDV 346 (466)
T ss_dssp CCCC
T ss_pred cCCc
Confidence 5543
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.55 E-value=2.7e-14 Score=156.50 Aligned_cols=143 Identities=30% Similarity=0.380 Sum_probs=100.1
Q ss_pred cEEEEEcCCCCCcccCCccccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEEc
Q 005749 100 HLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRL 179 (679)
Q Consensus 100 ~l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~L 179 (679)
+++.|+|++|++++ +| +++++++|++|++++|++++ +|..+ .+|++|+|++|.+++ +| .+.. +++|+.|++
T Consensus 132 ~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~-l~~L~~L~l 202 (454)
T 1jl5_A 132 LLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQN-LPFLTAIYA 202 (454)
T ss_dssp TCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTT-CTTCCEEEC
T ss_pred CCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccC-CCCCCEEEC
Confidence 57777777777775 66 57777778888888877774 66543 477777888777776 44 4444 377888888
Q ss_pred cCCCCcccCCCCCCCCCCCCCccEEEccCccccccccccccCCCCCCEEEccCCcccccCCccccccccCEEEccCCcCC
Q 005749 180 HGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRLSLEKLNLSHNNFS 259 (679)
Q Consensus 180 s~N~l~~~~p~~~~~~~~~~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~L~~l~ls~N~l~ 259 (679)
++|++++ +|.. ..+|++|++++|+++ .+|. ++.+++|+.|++++|++++ +|..+ .+|+.|++++|+++
T Consensus 203 ~~N~l~~-l~~~------~~~L~~L~l~~n~l~-~lp~-~~~l~~L~~L~l~~N~l~~-l~~~~--~~L~~L~l~~N~l~ 270 (454)
T 1jl5_A 203 DNNSLKK-LPDL------PLSLESIVAGNNILE-ELPE-LQNLPFLTTIYADNNLLKT-LPDLP--PSLEALNVRDNYLT 270 (454)
T ss_dssp CSSCCSS-CCCC------CTTCCEEECCSSCCS-SCCC-CTTCTTCCEEECCSSCCSS-CCSCC--TTCCEEECCSSCCS
T ss_pred CCCcCCc-CCCC------cCcccEEECcCCcCC-cccc-cCCCCCCCEEECCCCcCCc-ccccc--cccCEEECCCCccc
Confidence 8887775 3321 247888888888887 6674 7778888888888888874 55433 25778888888877
Q ss_pred CCCCC
Q 005749 260 GVLPV 264 (679)
Q Consensus 260 g~ip~ 264 (679)
+ +|.
T Consensus 271 ~-l~~ 274 (454)
T 1jl5_A 271 D-LPE 274 (454)
T ss_dssp C-CCC
T ss_pred c-cCc
Confidence 6 443
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.55 E-value=1.8e-14 Score=152.11 Aligned_cols=156 Identities=26% Similarity=0.330 Sum_probs=77.2
Q ss_pred ccEEEEEcCCCCCcccCCccccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEE
Q 005749 99 IHLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLR 178 (679)
Q Consensus 99 ~~l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~ 178 (679)
.+++.|++++|.+.+..+ ++.+++|++|++++|.+++ ++. +..+++|+.|++++|.+++..+ +.. +++|+.|+
T Consensus 155 ~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l~~-~~~-~~~l~~L~~L~l~~n~l~~~~~--~~~-~~~L~~L~ 227 (347)
T 4fmz_A 155 TGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIED-ISP-LASLTSLHYFTAYVNQITDITP--VAN-MTRLNSLK 227 (347)
T ss_dssp TTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTSCCCC-CGG-GGGCTTCCEEECCSSCCCCCGG--GGG-CTTCCEEE
T ss_pred CCCcEEEecCCCcCCchh--hccCCCCCEEEccCCcccc-ccc-ccCCCccceeecccCCCCCCch--hhc-CCcCCEEE
Confidence 356667777766654333 6666677777777766663 332 4555555555555555554322 222 24555555
Q ss_pred ccCCCCcccCCCCC-----------------CCCCCCCCccEEEccCccccccccccccCCCCCCEEEccCCcccccCCc
Q 005749 179 LHGNSLTAALPEPA-----------------LPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPE 241 (679)
Q Consensus 179 Ls~N~l~~~~p~~~-----------------~~~~~~~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~ 241 (679)
+++|++++..+-.. -....+++|++|++++|++++. +.+..+++|+.|++++|++++..|.
T Consensus 228 l~~n~l~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~ 305 (347)
T 4fmz_A 228 IGNNKITDLSPLANLSQLTWLEIGTNQISDINAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDME 305 (347)
T ss_dssp CCSSCCCCCGGGTTCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHH
T ss_pred ccCCccCCCcchhcCCCCCEEECCCCccCCChhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChh
Confidence 55555554322000 0012334455555555554432 2344455555555555555544444
Q ss_pred ccccc-ccCEEEccCCcCCCCCC
Q 005749 242 GLTRL-SLEKLNLSHNNFSGVLP 263 (679)
Q Consensus 242 ~~~~l-~L~~l~ls~N~l~g~ip 263 (679)
.+..+ +|+.|++++|++++..|
T Consensus 306 ~l~~l~~L~~L~L~~n~l~~~~~ 328 (347)
T 4fmz_A 306 VIGGLTNLTTLFLSQNHITDIRP 328 (347)
T ss_dssp HHHTCTTCSEEECCSSSCCCCGG
T ss_pred HhhccccCCEEEccCCccccccC
Confidence 44443 35555555555554444
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.55 E-value=1.5e-14 Score=159.33 Aligned_cols=149 Identities=29% Similarity=0.382 Sum_probs=121.9
Q ss_pred ccEEEEEcCCCCCcccCCccccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEE
Q 005749 99 IHLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLR 178 (679)
Q Consensus 99 ~~l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~ 178 (679)
.+++.|++++|.+.+. +.+..+++|++|+|++|.+++..| +..+++|++|+|++|.+++.. + +.. +++|+.|+
T Consensus 221 ~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~-~-~~~-l~~L~~L~ 293 (466)
T 1o6v_A 221 TNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNIS-P-LAG-LTALTNLE 293 (466)
T ss_dssp TTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCG-G-GTT-CTTCSEEE
T ss_pred CCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCccc-c-ccC-CCccCeEE
Confidence 4688999999998763 468889999999999999987554 888999999999999998753 3 444 48899999
Q ss_pred ccCCCCcccCCCCCCCCCCCCCccEEEccCccccccccccccCCCCCCEEEccCCcccccCCcccccc-ccCEEEccCCc
Q 005749 179 LHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRL-SLEKLNLSHNN 257 (679)
Q Consensus 179 Ls~N~l~~~~p~~~~~~~~~~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l-~L~~l~ls~N~ 257 (679)
|++|++++..| ...+++|++|++++|++++..| +..+++|+.|++++|++++. + .+..+ +|+.|++++|+
T Consensus 294 L~~n~l~~~~~-----~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~-~-~l~~l~~L~~L~l~~n~ 364 (466)
T 1o6v_A 294 LNENQLEDISP-----ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV-S-SLANLTNINWLSAGHNQ 364 (466)
T ss_dssp CCSSCCSCCGG-----GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSC
T ss_pred cCCCcccCchh-----hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCCc-h-hhccCCCCCEEeCCCCc
Confidence 99999987544 2467889999999999987665 77889999999999999864 3 45555 69999999999
Q ss_pred CCCCCC
Q 005749 258 FSGVLP 263 (679)
Q Consensus 258 l~g~ip 263 (679)
+++.+|
T Consensus 365 l~~~~~ 370 (466)
T 1o6v_A 365 ISDLTP 370 (466)
T ss_dssp CCBCGG
T ss_pred cCccch
Confidence 998887
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.55 E-value=2.4e-14 Score=157.06 Aligned_cols=146 Identities=23% Similarity=0.204 Sum_probs=120.9
Q ss_pred CCccEEEEEcCCCCCcccCCccccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcE
Q 005749 97 SSIHLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVS 176 (679)
Q Consensus 97 ~~~~l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~ 176 (679)
...+++.|+|++|++++ +| ++.+++|++|+|++|.|++ +| ++.+++|++|++++|.+.+.++ +.. +++|+.
T Consensus 104 ~l~~L~~L~L~~N~l~~-l~--~~~l~~L~~L~l~~N~l~~-l~--l~~l~~L~~L~l~~n~~~~~~~--~~~-l~~L~~ 174 (457)
T 3bz5_A 104 PLTKLTYLNCDTNKLTK-LD--VSQNPLLTYLNCARNTLTE-ID--VSHNTQLTELDCHLNKKITKLD--VTP-QTQLTT 174 (457)
T ss_dssp TCTTCCEEECCSSCCSC-CC--CTTCTTCCEEECTTSCCSC-CC--CTTCTTCCEEECTTCSCCCCCC--CTT-CTTCCE
T ss_pred CCCcCCEEECCCCcCCe-ec--CCCCCcCCEEECCCCccce-ec--cccCCcCCEEECCCCCcccccc--ccc-CCcCCE
Confidence 34578999999999997 55 8999999999999999997 44 8889999999999997776663 444 489999
Q ss_pred EEccCCCCcccCCCCCCCCCCCCCccEEEccCccccccccccccCCCCCCEEEccCCcccccCCcccccc-ccCEEEccC
Q 005749 177 LRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRL-SLEKLNLSH 255 (679)
Q Consensus 177 L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l-~L~~l~ls~ 255 (679)
|++++|++++ +| ...+++|+.|++++|++++. .++.+++|+.|++++|++++ +| +..+ +|+.|++++
T Consensus 175 L~ls~n~l~~-l~-----l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~ 242 (457)
T 3bz5_A 175 LDCSFNKITE-LD-----VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSV 242 (457)
T ss_dssp EECCSSCCCC-CC-----CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCS
T ss_pred EECCCCccce-ec-----cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeC
Confidence 9999999997 33 24678899999999999864 37888999999999999987 66 5555 699999999
Q ss_pred CcCCCCCC
Q 005749 256 NNFSGVLP 263 (679)
Q Consensus 256 N~l~g~ip 263 (679)
|+|++..+
T Consensus 243 N~l~~~~~ 250 (457)
T 3bz5_A 243 NPLTELDV 250 (457)
T ss_dssp SCCSCCCC
T ss_pred CcCCCcCH
Confidence 99998644
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.55 E-value=7.5e-15 Score=148.84 Aligned_cols=145 Identities=21% Similarity=0.275 Sum_probs=120.9
Q ss_pred cEEEEEcCCCCCcccCCccccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEEc
Q 005749 100 HLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRL 179 (679)
Q Consensus 100 ~l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~L 179 (679)
+++.+++..+++++.. .+..+++|++|+|++|.|+ .+| .+..+++|++|+|++|++++.. + +.. +++|+.|+|
T Consensus 20 ~l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~~-~-l~~-l~~L~~L~L 92 (263)
T 1xeu_A 20 NAVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDLS-P-LKD-LTKLEELSV 92 (263)
T ss_dssp HHHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCG-G-GTT-CSSCCEEEC
T ss_pred HHHHHHhcCCCccccc--chhhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCCh-h-hcc-CCCCCEEEC
Confidence 3556678888887543 6889999999999999998 577 7889999999999999999754 4 555 589999999
Q ss_pred cCCCCcccCCCCCCCCCCCCCccEEEccCccccccccccccCCCCCCEEEccCCcccccCCcccccc-ccCEEEccCCcC
Q 005749 180 HGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRL-SLEKLNLSHNNF 258 (679)
Q Consensus 180 s~N~l~~~~p~~~~~~~~~~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l-~L~~l~ls~N~l 258 (679)
++|++++. |... . ++|++|+|++|++++ +| .+..+++|+.|++++|++++. | .+..+ +|+.|++++|++
T Consensus 93 ~~N~l~~l-~~~~----~-~~L~~L~L~~N~l~~-~~-~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i 162 (263)
T 1xeu_A 93 NRNRLKNL-NGIP----S-ACLSRLFLDNNELRD-TD-SLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEI 162 (263)
T ss_dssp CSSCCSCC-TTCC----C-SSCCEEECCSSCCSB-SG-GGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCC
T ss_pred CCCccCCc-Cccc----c-CcccEEEccCCccCC-Ch-hhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcC
Confidence 99999974 3221 2 789999999999996 44 589999999999999999964 4 46666 699999999999
Q ss_pred CCC
Q 005749 259 SGV 261 (679)
Q Consensus 259 ~g~ 261 (679)
++.
T Consensus 163 ~~~ 165 (263)
T 1xeu_A 163 TNT 165 (263)
T ss_dssp CBC
T ss_pred cch
Confidence 987
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.54 E-value=1.2e-14 Score=153.30 Aligned_cols=146 Identities=18% Similarity=0.264 Sum_probs=111.8
Q ss_pred cEEEEEcCCCCCcccCCccccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEEc
Q 005749 100 HLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRL 179 (679)
Q Consensus 100 ~l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~L 179 (679)
+++.|++++|.+.+..+ ++.+++|++|+|++|.+++ +|. +..+++|++|+|++|.+++. +.+.. +++|+.|++
T Consensus 200 ~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~-~~~-~~~l~~L~~L~l~~n~l~~~--~~~~~-l~~L~~L~l 272 (347)
T 4fmz_A 200 SLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITD-LSP-LANLSQLTWLEIGTNQISDI--NAVKD-LTKLKMLNV 272 (347)
T ss_dssp TCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCCC--GGGTT-CTTCCEEEC
T ss_pred ccceeecccCCCCCCch--hhcCCcCCEEEccCCccCC-Ccc-hhcCCCCCEEECCCCccCCC--hhHhc-CCCcCEEEc
Confidence 34555555555554333 7778888888888888875 343 77888888888888888864 34444 478999999
Q ss_pred cCCCCcccCCCCCCCCCCCCCccEEEccCccccccccccccCCCCCCEEEccCCcccccCCcccccc-ccCEEEccCCcC
Q 005749 180 HGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRL-SLEKLNLSHNNF 258 (679)
Q Consensus 180 s~N~l~~~~p~~~~~~~~~~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l-~L~~l~ls~N~l 258 (679)
++|++++. +. ...+++|++|++++|++++..|..++.+++|+.|++++|++++..| +..+ +|+.|++++|.|
T Consensus 273 ~~n~l~~~-~~----~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i 345 (347)
T 4fmz_A 273 GSNQISDI-SV----LNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVI 345 (347)
T ss_dssp CSSCCCCC-GG----GGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG--GGGCTTCSEESSSCC--
T ss_pred cCCccCCC-hh----hcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccC--hhhhhccceeehhhhcc
Confidence 99988864 21 2467899999999999999999999999999999999999997766 5555 699999999998
Q ss_pred C
Q 005749 259 S 259 (679)
Q Consensus 259 ~ 259 (679)
+
T Consensus 346 ~ 346 (347)
T 4fmz_A 346 K 346 (347)
T ss_dssp -
T ss_pred c
Confidence 6
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.54 E-value=6.7e-16 Score=165.76 Aligned_cols=158 Identities=22% Similarity=0.325 Sum_probs=90.9
Q ss_pred ccEEEEEcCCCCCcc----cCCccccCCCCCCeeecccCcccccCCccc----CCC---------CCCCEEEccCCCCC-
Q 005749 99 IHLLSIQLPSANLTG----SLPRELGEFSMLQSLYLNVNSLKGTIPFEL----GYS---------SSLSEIDLSANLFT- 160 (679)
Q Consensus 99 ~~l~~l~l~~n~l~g----~ip~~l~~l~~L~~L~L~~N~l~g~ip~~l----~~l---------~~L~~L~Ls~N~l~- 160 (679)
.+|+.|+|++|.+.+ .+|..+..+++|++|+|++|.|++..+..+ ..+ ++|++|+|++|+++
T Consensus 94 ~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~ 173 (386)
T 2ca6_A 94 PKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLEN 173 (386)
T ss_dssp TTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTG
T ss_pred CcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCc
Confidence 456666666666665 456666666666666666666653322222 222 66666666666665
Q ss_pred CcCh---hhHHhhcccCcEEEccCCCCc--c---cCCCCCCCCCCCCCccEEEccCcccc----ccccccccCCCCCCEE
Q 005749 161 GVLA---PSIWNLCDRLVSLRLHGNSLT--A---ALPEPALPNSTCSDLQYLDLGSNKFS----GSFPEFVTRFEALKEL 228 (679)
Q Consensus 161 g~~p---~~~~~~~~~L~~L~Ls~N~l~--~---~~p~~~~~~~~~~~L~~L~l~~N~l~----g~~p~~~~~l~~L~~L 228 (679)
+.++ ..+.. +++|+.|+|++|+++ | .+|... ..+++|++|+|++|+++ +.+|..+..+++|+.|
T Consensus 174 ~~~~~l~~~l~~-~~~L~~L~L~~n~l~~~g~~~l~~~~l---~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L 249 (386)
T 2ca6_A 174 GSMKEWAKTFQS-HRLLHTVKMVQNGIRPEGIEHLLLEGL---AYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLREL 249 (386)
T ss_dssp GGHHHHHHHHHH-CTTCCEEECCSSCCCHHHHHHHHHTTG---GGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEE
T ss_pred HHHHHHHHHHHh-CCCcCEEECcCCCCCHhHHHHHHHHHh---hcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEE
Confidence 2222 12222 356666666666665 2 122111 24556777777777765 4566666667777777
Q ss_pred EccCCccccc----CCccccc--c-ccCEEEccCCcCCC
Q 005749 229 DISNNLFSGS----IPEGLTR--L-SLEKLNLSHNNFSG 260 (679)
Q Consensus 229 ~ls~N~l~g~----~p~~~~~--l-~L~~l~ls~N~l~g 260 (679)
+|++|++++. +|..+.. + +|+.|+|++|.+++
T Consensus 250 ~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~ 288 (386)
T 2ca6_A 250 GLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIEL 288 (386)
T ss_dssp ECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBH
T ss_pred ECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCH
Confidence 7777776654 4444421 2 46777777777766
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.54 E-value=2e-14 Score=152.06 Aligned_cols=159 Identities=14% Similarity=0.117 Sum_probs=110.1
Q ss_pred cEEEEEcCCCCCcccCCccccCCCCCCeeecccCcccccCCc-ccCCCCCCCE-EEccCCCCCCcChhhHHhhcccCcEE
Q 005749 100 HLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPF-ELGYSSSLSE-IDLSANLFTGVLAPSIWNLCDRLVSL 177 (679)
Q Consensus 100 ~l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip~-~l~~l~~L~~-L~Ls~N~l~g~~p~~~~~~~~~L~~L 177 (679)
+++.|+|++|+++..-+..|++|++|++|+|++|.+.+.+|. .+.++++|.+ +++++|++++..|..+.. +++|++|
T Consensus 31 ~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~-l~~L~~L 109 (350)
T 4ay9_X 31 NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQN-LPNLQYL 109 (350)
T ss_dssp TCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTCCEECTTSBCC-CTTCCEE
T ss_pred CCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCcccccCchhhhh-ccccccc
Confidence 578899999998843334689999999999999998777775 4577877764 666778888654444434 4889999
Q ss_pred EccCCCCcccCCCCCCCC----------------------C-CCCCccEEEccCccccccccccccCCCCCCEEEccC-C
Q 005749 178 RLHGNSLTAALPEPALPN----------------------S-TCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISN-N 233 (679)
Q Consensus 178 ~Ls~N~l~~~~p~~~~~~----------------------~-~~~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~-N 233 (679)
++++|++++..+...... . ....+++|+|++|+|+ .+|.......+|+.|++++ |
T Consensus 110 ~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~-~i~~~~f~~~~L~~l~l~~~n 188 (350)
T 4ay9_X 110 LISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNN 188 (350)
T ss_dssp EEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC-EECTTSSTTEEEEEEECTTCT
T ss_pred cccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhcccccccc-CCChhhccccchhHHhhccCC
Confidence 999998886544321110 0 1135777888888887 4555555566788888875 4
Q ss_pred cccccCCc-ccccc-ccCEEEccCCcCCCC
Q 005749 234 LFSGSIPE-GLTRL-SLEKLNLSHNNFSGV 261 (679)
Q Consensus 234 ~l~g~~p~-~~~~l-~L~~l~ls~N~l~g~ 261 (679)
.++ .+|. .+..+ +|+.|||++|+|+..
T Consensus 189 ~l~-~i~~~~f~~l~~L~~LdLs~N~l~~l 217 (350)
T 4ay9_X 189 NLE-ELPNDVFHGASGPVILDISRTRIHSL 217 (350)
T ss_dssp TCC-CCCTTTTTTEECCSEEECTTSCCCCC
T ss_pred ccc-CCCHHHhccCcccchhhcCCCCcCcc
Confidence 454 5554 45555 688888888888754
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.54 E-value=5.1e-16 Score=163.14 Aligned_cols=153 Identities=25% Similarity=0.320 Sum_probs=69.0
Q ss_pred cEEEEEcCCCCCccc-CCccccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCC-CCCCc-ChhhHHhhcccCcE
Q 005749 100 HLLSIQLPSANLTGS-LPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSAN-LFTGV-LAPSIWNLCDRLVS 176 (679)
Q Consensus 100 ~l~~l~l~~n~l~g~-ip~~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N-~l~g~-~p~~~~~~~~~L~~ 176 (679)
+++.|+|++|++++. +|..+..+++|++|+|++|.+++.+|..++.+++|++|+|++| .+++. ++..+ ..+++|+.
T Consensus 94 ~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~-~~~~~L~~ 172 (336)
T 2ast_B 94 RVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLL-SSCSRLDE 172 (336)
T ss_dssp CCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHH-HHCTTCCE
T ss_pred CCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHH-hcCCCCCE
Confidence 444555555554443 4444455555555555555554444444444555555555555 34432 22222 22245555
Q ss_pred EEccCC-CCccc-CCCCCCCCCCCC-CccEEEccCc--ccc-ccccccccCCCCCCEEEccCCc-ccccCCcccccc-cc
Q 005749 177 LRLHGN-SLTAA-LPEPALPNSTCS-DLQYLDLGSN--KFS-GSFPEFVTRFEALKELDISNNL-FSGSIPEGLTRL-SL 248 (679)
Q Consensus 177 L~Ls~N-~l~~~-~p~~~~~~~~~~-~L~~L~l~~N--~l~-g~~p~~~~~l~~L~~L~ls~N~-l~g~~p~~~~~l-~L 248 (679)
|+|++| .+++. ++... ..++ +|++|++++| .++ +.+|..+..+++|+.|++++|. +++..+..+..+ +|
T Consensus 173 L~l~~~~~l~~~~~~~~~---~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L 249 (336)
T 2ast_B 173 LNLSWCFDFTEKHVQVAV---AHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYL 249 (336)
T ss_dssp EECCCCTTCCHHHHHHHH---HHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTC
T ss_pred EcCCCCCCcChHHHHHHH---HhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCC
Confidence 555555 44432 11100 1233 4555555555 233 3344444445555555555555 444444444443 35
Q ss_pred CEEEccCC
Q 005749 249 EKLNLSHN 256 (679)
Q Consensus 249 ~~l~ls~N 256 (679)
+.|++++|
T Consensus 250 ~~L~l~~~ 257 (336)
T 2ast_B 250 QHLSLSRC 257 (336)
T ss_dssp CEEECTTC
T ss_pred CEeeCCCC
Confidence 55555555
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.53 E-value=1.7e-15 Score=159.13 Aligned_cols=162 Identities=18% Similarity=0.206 Sum_probs=134.9
Q ss_pred ccEEEEEcCCCCCcccCCccccCCCCCCeeecccCccccc-CCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEE
Q 005749 99 IHLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGT-IPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSL 177 (679)
Q Consensus 99 ~~l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~-ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L 177 (679)
.+++.|++++|.+.+.++. +..+++|++|+|++|.+++. +|..+..+++|++|+|++|.+++..+..+.. +++|++|
T Consensus 70 ~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~-~~~L~~L 147 (336)
T 2ast_B 70 QGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAK-NSNLVRL 147 (336)
T ss_dssp TTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTT-CTTCSEE
T ss_pred ccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhc-CCCCCEE
Confidence 3588999999999987765 67899999999999999976 8888999999999999999999887777766 5999999
Q ss_pred EccCC-CCccc-CCCCCCCCCCCCCccEEEccCc-ccccc-ccccccCCC-CCCEEEccCC--ccc-ccCCcccccc-cc
Q 005749 178 RLHGN-SLTAA-LPEPALPNSTCSDLQYLDLGSN-KFSGS-FPEFVTRFE-ALKELDISNN--LFS-GSIPEGLTRL-SL 248 (679)
Q Consensus 178 ~Ls~N-~l~~~-~p~~~~~~~~~~~L~~L~l~~N-~l~g~-~p~~~~~l~-~L~~L~ls~N--~l~-g~~p~~~~~l-~L 248 (679)
+|++| .+++. ++... ..+++|++|++++| ++++. ++..+..++ +|+.|++++| .++ +.+|..+..+ +|
T Consensus 148 ~L~~~~~l~~~~l~~~~---~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L 224 (336)
T 2ast_B 148 NLSGCSGFSEFALQTLL---SSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNL 224 (336)
T ss_dssp ECTTCBSCCHHHHHHHH---HHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTC
T ss_pred ECCCCCCCCHHHHHHHH---hcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCC
Confidence 99999 68752 33211 34789999999999 99865 788899999 9999999999 565 5667766666 69
Q ss_pred CEEEccCCc-CCCCCCCc
Q 005749 249 EKLNLSHNN-FSGVLPVF 265 (679)
Q Consensus 249 ~~l~ls~N~-l~g~ip~~ 265 (679)
+.|++++|. +++..+..
T Consensus 225 ~~L~l~~~~~l~~~~~~~ 242 (336)
T 2ast_B 225 VHLDLSDSVMLKNDCFQE 242 (336)
T ss_dssp SEEECTTCTTCCGGGGGG
T ss_pred CEEeCCCCCcCCHHHHHH
Confidence 999999999 77665543
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.52 E-value=1.7e-15 Score=162.51 Aligned_cols=164 Identities=20% Similarity=0.185 Sum_probs=131.7
Q ss_pred CccEEEEEcCCC---CCcccCCccc-------cCCCCCCeeecccCcccc----cCCcccCCCCCCCEEEccCCCCCCcC
Q 005749 98 SIHLLSIQLPSA---NLTGSLPREL-------GEFSMLQSLYLNVNSLKG----TIPFELGYSSSLSEIDLSANLFTGVL 163 (679)
Q Consensus 98 ~~~l~~l~l~~n---~l~g~ip~~l-------~~l~~L~~L~L~~N~l~g----~ip~~l~~l~~L~~L~Ls~N~l~g~~ 163 (679)
..+++.|+|++| ++++.+|..+ ..+++|++|+|++|.|++ .+|..+..+++|++|+|++|.+++..
T Consensus 59 ~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~ 138 (386)
T 2ca6_A 59 KKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQA 138 (386)
T ss_dssp CTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHH
T ss_pred CCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHH
Confidence 346889999985 6778888776 789999999999999997 58888999999999999999997544
Q ss_pred hhhHHhhc------------ccCcEEEccCCCCc-ccCCCCCCCCCCCCCccEEEccCcccc--c---cccccccCCCCC
Q 005749 164 APSIWNLC------------DRLVSLRLHGNSLT-AALPEPALPNSTCSDLQYLDLGSNKFS--G---SFPEFVTRFEAL 225 (679)
Q Consensus 164 p~~~~~~~------------~~L~~L~Ls~N~l~-~~~p~~~~~~~~~~~L~~L~l~~N~l~--g---~~p~~~~~l~~L 225 (679)
+..+...+ ++|+.|+|++|+++ +.+|...-....+++|++|+|++|+++ | .+|..+..+++|
T Consensus 139 ~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L 218 (386)
T 2ca6_A 139 GAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQEL 218 (386)
T ss_dssp HHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTC
T ss_pred HHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCc
Confidence 44443332 79999999999998 333310000124678999999999998 3 455588899999
Q ss_pred CEEEccCCccc----ccCCcccccc-ccCEEEccCCcCCCC
Q 005749 226 KELDISNNLFS----GSIPEGLTRL-SLEKLNLSHNNFSGV 261 (679)
Q Consensus 226 ~~L~ls~N~l~----g~~p~~~~~l-~L~~l~ls~N~l~g~ 261 (679)
+.|+|++|+++ +.+|..+..+ +|+.|+|++|.|++.
T Consensus 219 ~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~ 259 (386)
T 2ca6_A 219 KVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSAR 259 (386)
T ss_dssp CEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHH
T ss_pred cEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchh
Confidence 99999999997 6788877776 699999999999876
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.51 E-value=1.5e-16 Score=154.09 Aligned_cols=148 Identities=20% Similarity=0.276 Sum_probs=119.5
Q ss_pred EEEEEcCCCCCcccCCc------cccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccC
Q 005749 101 LLSIQLPSANLTGSLPR------ELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRL 174 (679)
Q Consensus 101 l~~l~l~~n~l~g~ip~------~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L 174 (679)
++.+++..+++.|.+|. .++.+++|++|+|++|.|++ +| .+..+++|++|+|++|.++ .+|..+.. +++|
T Consensus 20 l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~-~~~L 95 (198)
T 1ds9_A 20 VVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAV-ADTL 95 (198)
T ss_dssp CCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHH-HHHC
T ss_pred ccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhc-CCcC
Confidence 55667777788888777 89999999999999999996 88 8899999999999999999 46665544 4899
Q ss_pred cEEEccCCCCcccCCCCCCCCCCCCCccEEEccCcccccccc-ccccCCCCCCEEEccCCcccccCCcc----------c
Q 005749 175 VSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFP-EFVTRFEALKELDISNNLFSGSIPEG----------L 243 (679)
Q Consensus 175 ~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~l~~N~l~g~~p-~~~~~l~~L~~L~ls~N~l~g~~p~~----------~ 243 (679)
+.|+|++|++++. |. ...+++|++|++++|++++..+ ..+..+++|++|++++|.+++.+|.. +
T Consensus 96 ~~L~L~~N~l~~l-~~----~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~ 170 (198)
T 1ds9_A 96 EELWISYNQIASL-SG----IEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVV 170 (198)
T ss_dssp SEEEEEEEECCCH-HH----HHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHH
T ss_pred CEEECcCCcCCcC-Cc----cccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHHH
Confidence 9999999999973 31 1356789999999999985322 47889999999999999999887753 4
Q ss_pred ccc-ccCEEEccCCcCC
Q 005749 244 TRL-SLEKLNLSHNNFS 259 (679)
Q Consensus 244 ~~l-~L~~l~ls~N~l~ 259 (679)
..+ +|+.|| +|.++
T Consensus 171 ~~l~~L~~Ld--~~~i~ 185 (198)
T 1ds9_A 171 KRLPNLKKLD--GMPVD 185 (198)
T ss_dssp HHCSSCSEEC--CGGGT
T ss_pred HhCCCcEEEC--CcccC
Confidence 444 588776 56554
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.50 E-value=3.2e-15 Score=159.01 Aligned_cols=161 Identities=19% Similarity=0.177 Sum_probs=104.3
Q ss_pred cEEEEEcCCCCCcccCC----ccccCCC-CCCeeecccCcccccCCcccCCC-----CCCCEEEccCCCCCCcChhhHHh
Q 005749 100 HLLSIQLPSANLTGSLP----RELGEFS-MLQSLYLNVNSLKGTIPFELGYS-----SSLSEIDLSANLFTGVLAPSIWN 169 (679)
Q Consensus 100 ~l~~l~l~~n~l~g~ip----~~l~~l~-~L~~L~L~~N~l~g~ip~~l~~l-----~~L~~L~Ls~N~l~g~~p~~~~~ 169 (679)
+++.|+|++|++++.-+ ..+..++ +|++|+|++|.|++..+..+..+ ++|++|+|++|.+++..+..+..
T Consensus 23 ~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~ 102 (362)
T 3goz_A 23 GVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVK 102 (362)
T ss_dssp TCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHH
T ss_pred CceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHHH
Confidence 37777888887776555 5667777 78888888888776666666554 77888888888877666555444
Q ss_pred hc----ccCcEEEccCCCCcccCCCCCCC-CCC-CCCccEEEccCccccc----cccccccCCC-CCCEEEccCCccccc
Q 005749 170 LC----DRLVSLRLHGNSLTAALPEPALP-NST-CSDLQYLDLGSNKFSG----SFPEFVTRFE-ALKELDISNNLFSGS 238 (679)
Q Consensus 170 ~~----~~L~~L~Ls~N~l~~~~p~~~~~-~~~-~~~L~~L~l~~N~l~g----~~p~~~~~l~-~L~~L~ls~N~l~g~ 238 (679)
.+ ++|+.|+|++|++++..+..... ... +++|++|+|++|++++ .++..+..++ +|+.|+|++|++++.
T Consensus 103 ~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~ 182 (362)
T 3goz_A 103 TLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASK 182 (362)
T ss_dssp HHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGS
T ss_pred HHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCchh
Confidence 32 57788888888777543321100 001 2477788888887774 3344445555 778888888877765
Q ss_pred CCcccccc------ccCEEEccCCcCCC
Q 005749 239 IPEGLTRL------SLEKLNLSHNNFSG 260 (679)
Q Consensus 239 ~p~~~~~l------~L~~l~ls~N~l~g 260 (679)
.+..+... +|+.|+|++|.|++
T Consensus 183 ~~~~l~~~l~~~~~~L~~L~Ls~N~i~~ 210 (362)
T 3goz_A 183 NCAELAKFLASIPASVTSLDLSANLLGL 210 (362)
T ss_dssp CHHHHHHHHHTSCTTCCEEECTTSCGGG
T ss_pred hHHHHHHHHHhCCCCCCEEECCCCCCCh
Confidence 55443321 57778888887765
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.46 E-value=2.2e-13 Score=154.24 Aligned_cols=148 Identities=30% Similarity=0.338 Sum_probs=71.6
Q ss_pred cEEEEEcCCCCCcccCCccccCCCCCCeeecccCcccccCCcccC-----------------CCCCCCEEEccCCCCCCc
Q 005749 100 HLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELG-----------------YSSSLSEIDLSANLFTGV 162 (679)
Q Consensus 100 ~l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip~~l~-----------------~l~~L~~L~Ls~N~l~g~ 162 (679)
++..|+|++|++++ +|.. +++|++|+|++|.|++ +|..+. .+++|+.|+|++|.+++
T Consensus 122 ~L~~L~L~~N~l~~-lp~~---l~~L~~L~Ls~N~l~~-l~~~~~~L~~L~L~~N~l~~l~~~~~~L~~L~Ls~N~l~~- 195 (622)
T 3g06_A 122 GLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQLAS-LPALPSELCKLWAYNNQLTSLPMLPSGLQELSVSDNQLAS- 195 (622)
T ss_dssp TCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSC-CCCCCTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSC-
T ss_pred CcCEEECCCCCCCc-CCCC---CCCCCEEECcCCcCCC-cCCccCCCCEEECCCCCCCCCcccCCCCcEEECCCCCCCC-
Confidence 45555555555543 4432 2555555555555553 222221 12667777777777765
Q ss_pred ChhhHHhhcccCcEEEccCCCCcccCCCCC---------------CCCCCCCCccEEEccCccccccccccccCCCCCCE
Q 005749 163 LAPSIWNLCDRLVSLRLHGNSLTAALPEPA---------------LPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKE 227 (679)
Q Consensus 163 ~p~~~~~~~~~L~~L~Ls~N~l~~~~p~~~---------------~~~~~~~~L~~L~l~~N~l~g~~p~~~~~l~~L~~ 227 (679)
+|.. +++|+.|++++|.++. +|... +| ..+++|++|+|++|+|+ .+|. .+++|+.
T Consensus 196 l~~~----~~~L~~L~L~~N~l~~-l~~~~~~L~~L~Ls~N~L~~lp-~~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~ 265 (622)
T 3g06_A 196 LPTL----PSELYKLWAYNNRLTS-LPALPSGLKELIVSGNRLTSLP-VLPSELKELMVSGNRLT-SLPM---LPSGLLS 265 (622)
T ss_dssp CCCC----CTTCCEEECCSSCCSS-CCCCCTTCCEEECCSSCCSCCC-CCCTTCCEEECCSSCCS-CCCC---CCTTCCE
T ss_pred CCCc----cchhhEEECcCCcccc-cCCCCCCCCEEEccCCccCcCC-CCCCcCcEEECCCCCCC-cCCc---ccccCcE
Confidence 3321 1345555555554442 22100 00 12344555555555555 3443 3455555
Q ss_pred EEccCCcccccCCcccccc-ccCEEEccCCcCCCCCCC
Q 005749 228 LDISNNLFSGSIPEGLTRL-SLEKLNLSHNNFSGVLPV 264 (679)
Q Consensus 228 L~ls~N~l~g~~p~~~~~l-~L~~l~ls~N~l~g~ip~ 264 (679)
|+|++|+|+ .+|..+..+ +|+.|+|++|.|++.+|.
T Consensus 266 L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~ 302 (622)
T 3g06_A 266 LSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQ 302 (622)
T ss_dssp EECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHH
T ss_pred EeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHH
Confidence 555555555 445555544 355555555555555443
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.46 E-value=3.8e-14 Score=134.40 Aligned_cols=130 Identities=15% Similarity=0.204 Sum_probs=89.3
Q ss_pred ccEEEEEcCCCCCcccCCccccCCC-CCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEE
Q 005749 99 IHLLSIQLPSANLTGSLPRELGEFS-MLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSL 177 (679)
Q Consensus 99 ~~l~~l~l~~n~l~g~ip~~l~~l~-~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L 177 (679)
.+++.|+|++|+++ .+|. +..+. +|++|+|++|.|++. ..++.+++|++|+|++|.+++. |+.++..+++|+.|
T Consensus 19 ~~L~~L~l~~n~l~-~i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~-~~~~~~~l~~L~~L 93 (176)
T 1a9n_A 19 VRDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRI-GEGLDQALPDLTEL 93 (176)
T ss_dssp TSCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEE-CSCHHHHCTTCCEE
T ss_pred CCceEEEeeCCCCc-hhHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCccccc-CcchhhcCCCCCEE
Confidence 35788888888887 4543 55544 888888888888854 5677788888888888888754 44443444788888
Q ss_pred EccCCCCcccCCCCCCCCCCCCCccEEEccCcccccccccc----ccCCCCCCEEEccCCccc
Q 005749 178 RLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEF----VTRFEALKELDISNNLFS 236 (679)
Q Consensus 178 ~Ls~N~l~~~~p~~~~~~~~~~~L~~L~l~~N~l~g~~p~~----~~~l~~L~~L~ls~N~l~ 236 (679)
+|++|+++. +|.. -....+++|++|++++|.++ .+|.. +..+++|+.||+++|.+.
T Consensus 94 ~L~~N~i~~-~~~~-~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 94 ILTNNSLVE-LGDL-DPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp ECCSCCCCC-GGGG-GGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHH
T ss_pred ECCCCcCCc-chhh-HhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHH
Confidence 888888854 3320 01134667777888777776 45553 777777777777777765
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.46 E-value=1.2e-13 Score=130.82 Aligned_cols=133 Identities=17% Similarity=0.157 Sum_probs=108.6
Q ss_pred ccccCCCCCCeeecccCcccccCCcccCCC-CCCCEEEccCCCCCCcChhhHHhhcccCcEEEccCCCCcccCCCCCCCC
Q 005749 117 RELGEFSMLQSLYLNVNSLKGTIPFELGYS-SSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPN 195 (679)
Q Consensus 117 ~~l~~l~~L~~L~L~~N~l~g~ip~~l~~l-~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~~ 195 (679)
+.+..+++|+.|+|++|+|+ .+|. +..+ ++|++|||++|.+++. +.+.. +++|+.|+|++|++++..+. .+
T Consensus 13 ~~~~~~~~L~~L~l~~n~l~-~i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~-l~~L~~L~Ls~N~l~~~~~~-~~-- 84 (176)
T 1a9n_A 13 AQYTNAVRDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRKL--DGFPL-LRRLKTLLVNNNRICRIGEG-LD-- 84 (176)
T ss_dssp CEEECTTSCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCEE--CCCCC-CSSCCEEECCSSCCCEECSC-HH--
T ss_pred HhcCCcCCceEEEeeCCCCc-hhHH-hhhcCCCCCEEECCCCCCCcc--ccccc-CCCCCEEECCCCcccccCcc-hh--
Confidence 35678899999999999999 5665 4444 4999999999999975 45555 48999999999999975332 21
Q ss_pred CCCCCccEEEccCccccccccc--cccCCCCCCEEEccCCcccccCCcc----cccc-ccCEEEccCCcCC
Q 005749 196 STCSDLQYLDLGSNKFSGSFPE--FVTRFEALKELDISNNLFSGSIPEG----LTRL-SLEKLNLSHNNFS 259 (679)
Q Consensus 196 ~~~~~L~~L~l~~N~l~g~~p~--~~~~l~~L~~L~ls~N~l~g~~p~~----~~~l-~L~~l~ls~N~l~ 259 (679)
..+++|++|+|++|+++ .+|. .+..+++|+.|++++|.++ .+|.. +..+ +|+.||+++|.+.
T Consensus 85 ~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 85 QALPDLTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp HHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHH
T ss_pred hcCCCCCEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHH
Confidence 35789999999999996 6776 8899999999999999998 56664 5555 6999999999865
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.45 E-value=1.7e-14 Score=153.34 Aligned_cols=162 Identities=19% Similarity=0.179 Sum_probs=127.4
Q ss_pred EEEcCCCCCcccCCccccCCCCCCeeecccCcccccCC----cccCCCC-CCCEEEccCCCCCCcChhhHHhh----ccc
Q 005749 103 SIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIP----FELGYSS-SLSEIDLSANLFTGVLAPSIWNL----CDR 173 (679)
Q Consensus 103 ~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip----~~l~~l~-~L~~L~Ls~N~l~g~~p~~~~~~----~~~ 173 (679)
.+.|+.|+++|.+|..+...++|++|+|++|.|++..+ ..+..++ +|++|+|++|.+++..+..+... .++
T Consensus 2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~ 81 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81 (362)
T ss_dssp EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence 35789999999999988888889999999999997665 6777888 99999999999998777766654 278
Q ss_pred CcEEEccCCCCcccCCCCCCC-CCCC-CCccEEEccCcccccccccccc----C-CCCCCEEEccCCcccccCC----cc
Q 005749 174 LVSLRLHGNSLTAALPEPALP-NSTC-SDLQYLDLGSNKFSGSFPEFVT----R-FEALKELDISNNLFSGSIP----EG 242 (679)
Q Consensus 174 L~~L~Ls~N~l~~~~p~~~~~-~~~~-~~L~~L~l~~N~l~g~~p~~~~----~-l~~L~~L~ls~N~l~g~~p----~~ 242 (679)
|+.|+|++|++++..+..... ...+ ++|++|+|++|++++..+..+. . .++|++|+|++|++++..+ ..
T Consensus 82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~ 161 (362)
T 3goz_A 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQI 161 (362)
T ss_dssp CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHH
T ss_pred ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHH
Confidence 999999999999754431100 0122 6899999999999976665543 3 3699999999999985433 33
Q ss_pred cccc--ccCEEEccCCcCCCCCCC
Q 005749 243 LTRL--SLEKLNLSHNNFSGVLPV 264 (679)
Q Consensus 243 ~~~l--~L~~l~ls~N~l~g~ip~ 264 (679)
+... +|+.|+|++|++++..+.
T Consensus 162 l~~~~~~L~~L~Ls~n~l~~~~~~ 185 (362)
T 3goz_A 162 LAAIPANVNSLNLRGNNLASKNCA 185 (362)
T ss_dssp HHTSCTTCCEEECTTSCGGGSCHH
T ss_pred HhcCCccccEeeecCCCCchhhHH
Confidence 3332 699999999999877653
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.44 E-value=1.4e-13 Score=154.56 Aligned_cols=121 Identities=21% Similarity=0.174 Sum_probs=103.1
Q ss_pred CCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEEccCCCCcccCCCCCCCCCCCCCccE
Q 005749 124 MLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQY 203 (679)
Q Consensus 124 ~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~ 203 (679)
.|+.|+|++|.|++ +|. ++.+++|+.|+|++|.|+ .+|..+..+ ++|+.|+|++|+|++ +| .+ ..+++|++
T Consensus 442 ~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l-~~L~~L~Ls~N~l~~-lp-~l---~~l~~L~~ 512 (567)
T 1dce_A 442 DVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAAL-RCLEVLQASDNALEN-VD-GV---ANLPRLQE 512 (567)
T ss_dssp TCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGC-TTCCEEECCSSCCCC-CG-GG---TTCSSCCE
T ss_pred CceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcC-CCCCEEECCCCCCCC-Cc-cc---CCCCCCcE
Confidence 59999999999996 786 999999999999999999 678877765 899999999999997 55 22 56889999
Q ss_pred EEccCccccccc-cccccCCCCCCEEEccCCcccccCCcccc---cc-ccCEEEc
Q 005749 204 LDLGSNKFSGSF-PEFVTRFEALKELDISNNLFSGSIPEGLT---RL-SLEKLNL 253 (679)
Q Consensus 204 L~l~~N~l~g~~-p~~~~~l~~L~~L~ls~N~l~g~~p~~~~---~l-~L~~l~l 253 (679)
|+|++|+|++.. |..++.+++|+.|+|++|+|++.+|.... .+ +|+.||+
T Consensus 513 L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~l~~~lp~L~~L~l 567 (567)
T 1dce_A 513 LLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSILT 567 (567)
T ss_dssp EECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEEEC
T ss_pred EECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHHHHHHHCcccCccCC
Confidence 999999999877 99999999999999999999977654321 12 5788764
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.42 E-value=6.1e-13 Score=125.29 Aligned_cols=106 Identities=19% Similarity=0.212 Sum_probs=53.3
Q ss_pred CeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEEccCCCCcccCCCCCCCCCCCCCccEEE
Q 005749 126 QSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLD 205 (679)
Q Consensus 126 ~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~ 205 (679)
+.|++++|.|+ .+|..+. ++|++|+|++|+|++..|..+..+ ++|+.|+|++|+|++..+. .+ ..+++|++|+
T Consensus 12 ~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l-~~L~~L~Ls~N~l~~l~~~-~f--~~l~~L~~L~ 84 (170)
T 3g39_A 12 TTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRL-TQLTRLDLDNNQLTVLPAG-VF--DKLTQLTQLS 84 (170)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTC-TTCSEEECCSSCCCCCCTT-TT--TTCTTCCEEE
T ss_pred CEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCc-ccCCEEECCCCCcCccChh-hc--cCCCCCCEEE
Confidence 34455555554 3444332 445555555555554433333332 4455555555555533221 11 2345566666
Q ss_pred ccCccccccccccccCCCCCCEEEccCCccccc
Q 005749 206 LGSNKFSGSFPEFVTRFEALKELDISNNLFSGS 238 (679)
Q Consensus 206 l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ 238 (679)
|++|+|++..+..|..+++|+.|+|++|.++..
T Consensus 85 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~ 117 (170)
T 3g39_A 85 LNDNQLKSIPRGAFDNLKSLTHIWLLNNPWDCA 117 (170)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCBCTT
T ss_pred CCCCccCEeCHHHhcCCCCCCEEEeCCCCCCCC
Confidence 666666644444566666777777777766643
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.39 E-value=1.1e-12 Score=124.15 Aligned_cols=103 Identities=19% Similarity=0.299 Sum_probs=55.3
Q ss_pred EEEcCCCCCcccCCccccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEEccCC
Q 005749 103 SIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGN 182 (679)
Q Consensus 103 ~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N 182 (679)
.+++++|++ +.+|..+. ++|++|+|++|.|++..|..++.+++|++|+|++|+|++. |+..+.
T Consensus 16 ~l~~~~n~l-~~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i-~~~~~~------------- 78 (174)
T 2r9u_A 16 LVNCQNIRL-ASVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAI-PTGVFD------------- 78 (174)
T ss_dssp EEECCSSCC-SSCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCC-CTTTTT-------------
T ss_pred EEEeCCCCC-CccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCcc-ChhHhC-------------
Confidence 455555555 35555443 5566666666666655555555566666666666665542 232222
Q ss_pred CCcccCCCCCCCCCCCCCccEEEccCccccccccccccCCCCCCEEEccCCccc
Q 005749 183 SLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFS 236 (679)
Q Consensus 183 ~l~~~~p~~~~~~~~~~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~ 236 (679)
.+++|++|+|++|+|++..+..|..+++|+.|+|++|.+.
T Consensus 79 --------------~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~~~ 118 (174)
T 2r9u_A 79 --------------KLTQLTQLDLNDNHLKSIPRGAFDNLKSLTHIYLYNNPWD 118 (174)
T ss_dssp --------------TCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCBC
T ss_pred --------------CcchhhEEECCCCccceeCHHHhccccCCCEEEeCCCCcc
Confidence 2344555555555555333334556666666666666665
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.37 E-value=3e-15 Score=144.98 Aligned_cols=138 Identities=21% Similarity=0.217 Sum_probs=115.5
Q ss_pred cccCCCCCCeeecccCcccccCCc------ccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEEccCCCCcccCCCC
Q 005749 118 ELGEFSMLQSLYLNVNSLKGTIPF------ELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNSLTAALPEP 191 (679)
Q Consensus 118 ~l~~l~~L~~L~L~~N~l~g~ip~------~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~~ 191 (679)
.+....+++.++|+.|.|+|.+|. .+..+++|++|+|++|.+++ +| .+..+ ++|+.|+|++|+++ .+|..
T Consensus 13 ~~~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l-~~L~~L~l~~n~l~-~l~~~ 88 (198)
T 1ds9_A 13 IFEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGM-ENLRILSLGRNLIK-KIENL 88 (198)
T ss_dssp HHHHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHH-TTCCEEEEEEEEEC-SCSSH
T ss_pred HHHhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccC-CCCCEEECCCCCcc-cccch
Confidence 366788999999999999999987 89999999999999999998 55 66665 89999999999998 44532
Q ss_pred CCCCCCCCCccEEEccCccccccccccccCCCCCCEEEccCCcccccCC-cccccc-ccCEEEccCCcCCCCCCC
Q 005749 192 ALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIP-EGLTRL-SLEKLNLSHNNFSGVLPV 264 (679)
Q Consensus 192 ~~~~~~~~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p-~~~~~l-~L~~l~ls~N~l~g~ip~ 264 (679)
. ..+++|++|+|++|++++ +| .+..+++|+.|++++|++++..+ ..+..+ +|+.|++++|.+++.+|.
T Consensus 89 ~---~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~ 158 (198)
T 1ds9_A 89 D---AVADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKE 158 (198)
T ss_dssp H---HHHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHT
T ss_pred h---hcCCcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCcccccccc
Confidence 1 235789999999999996 56 68899999999999999985332 355555 699999999999988765
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.36 E-value=2.2e-12 Score=121.44 Aligned_cols=107 Identities=21% Similarity=0.274 Sum_probs=84.9
Q ss_pred EEEEcCCCCCcccCCccccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEEccC
Q 005749 102 LSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHG 181 (679)
Q Consensus 102 ~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~ 181 (679)
+.+++++|+++ .+|..+. ++|++|+|++|+|++..|..+..+++|++|+|++|+|++. |+..+..+++|+.|+|++
T Consensus 12 ~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l-~~~~f~~l~~L~~L~L~~ 87 (170)
T 3g39_A 12 TTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVL-PAGVFDKLTQLTQLSLND 87 (170)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCC-CTTTTTTCTTCCEEECCS
T ss_pred CEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCcc-ChhhccCCCCCCEEECCC
Confidence 34667777776 4777663 8899999999999988888899999999999999999965 444444458999999999
Q ss_pred CCCcccCCCCCCCCCCCCCccEEEccCccccccc
Q 005749 182 NSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSF 215 (679)
Q Consensus 182 N~l~~~~p~~~~~~~~~~~L~~L~l~~N~l~g~~ 215 (679)
|+|++..+..+ ..+++|++|+|++|.++...
T Consensus 88 N~l~~~~~~~~---~~l~~L~~L~L~~N~~~c~c 118 (170)
T 3g39_A 88 NQLKSIPRGAF---DNLKSLTHIWLLNNPWDCAC 118 (170)
T ss_dssp SCCCCCCTTTT---TTCTTCCEEECCSSCBCTTB
T ss_pred CccCEeCHHHh---cCCCCCCEEEeCCCCCCCCc
Confidence 99997554322 46789999999999998654
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.35 E-value=2.5e-12 Score=121.60 Aligned_cols=87 Identities=20% Similarity=0.253 Sum_probs=73.9
Q ss_pred ccEEEEEcCCCCCcccCCccccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEE
Q 005749 99 IHLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLR 178 (679)
Q Consensus 99 ~~l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~ 178 (679)
.+++.|+|++|++++..|..|+.+++|++|+|++|+|++..+..+..+++|++|||++|+|++. |+..+..+++|+.|+
T Consensus 33 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~l~~l-~~~~~~~l~~L~~L~ 111 (174)
T 2r9u_A 33 TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNHLKSI-PRGAFDNLKSLTHIY 111 (174)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCC-CTTTTTTCTTCSEEE
T ss_pred CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCcccee-CHHHhccccCCCEEE
Confidence 4689999999999999999999999999999999999975555578999999999999999975 444333348888888
Q ss_pred ccCCCCcc
Q 005749 179 LHGNSLTA 186 (679)
Q Consensus 179 Ls~N~l~~ 186 (679)
|++|.+..
T Consensus 112 L~~N~~~c 119 (174)
T 2r9u_A 112 LYNNPWDC 119 (174)
T ss_dssp CCSSCBCT
T ss_pred eCCCCccc
Confidence 88888874
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.34 E-value=2.2e-12 Score=136.32 Aligned_cols=148 Identities=18% Similarity=0.128 Sum_probs=109.4
Q ss_pred CCCCcccCCccccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCc-EEEccCCCCcc
Q 005749 108 SANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLV-SLRLHGNSLTA 186 (679)
Q Consensus 108 ~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~-~L~Ls~N~l~~ 186 (679)
+++++ .||..+ .++|++|+|++|+|+...+..+.++++|++|||++|.+.+.+|+..+..+++|+ .+.+++|+++.
T Consensus 18 ~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l~~ 94 (350)
T 4ay9_X 18 ESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLY 94 (350)
T ss_dssp STTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTCCE
T ss_pred CCCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCcccc
Confidence 34444 577666 468999999999999533456899999999999999998888876655456665 57778899997
Q ss_pred cCCCCCCCCCCCCCccEEEccCccccccccccccCCCCCCEEEccC-CcccccCCcccccc--ccCEEEccCCcCCCC
Q 005749 187 ALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISN-NLFSGSIPEGLTRL--SLEKLNLSHNNFSGV 261 (679)
Q Consensus 187 ~~p~~~~~~~~~~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~-N~l~g~~p~~~~~l--~L~~l~ls~N~l~g~ 261 (679)
..|..+ ..+++|++|++++|++++..+..+....++..|++++ |++....+..+..+ .++.|+|++|+|+..
T Consensus 95 l~~~~f---~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~~i 169 (350)
T 4ay9_X 95 INPEAF---QNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEI 169 (350)
T ss_dssp ECTTSB---CCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEE
T ss_pred cCchhh---hhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhccccccccCC
Confidence 666433 4678999999999999876665666666777888765 55654444445444 477788888888743
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.32 E-value=1.1e-13 Score=151.70 Aligned_cols=165 Identities=25% Similarity=0.198 Sum_probs=126.5
Q ss_pred ccEEEEEcCCCCCccc----CCccccCCCCCCeeecccCcccccC-----CcccCCCCCCCEEEccCCCCCCc----Chh
Q 005749 99 IHLLSIQLPSANLTGS----LPRELGEFSMLQSLYLNVNSLKGTI-----PFELGYSSSLSEIDLSANLFTGV----LAP 165 (679)
Q Consensus 99 ~~l~~l~l~~n~l~g~----ip~~l~~l~~L~~L~L~~N~l~g~i-----p~~l~~l~~L~~L~Ls~N~l~g~----~p~ 165 (679)
.+++.|+|++|++++. ++..+..+++|++|+|++|.+++.- +.....+++|++|+|++|.+++. ++.
T Consensus 199 ~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~ 278 (461)
T 1z7x_W 199 CQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCR 278 (461)
T ss_dssp CCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHH
T ss_pred CCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHH
Confidence 3799999999999874 7888899999999999999998642 22334689999999999999864 445
Q ss_pred hHHhhcccCcEEEccCCCCcccCCCCCCC--CCCCCCccEEEccCcccccc----ccccccCCCCCCEEEccCCcccccC
Q 005749 166 SIWNLCDRLVSLRLHGNSLTAALPEPALP--NSTCSDLQYLDLGSNKFSGS----FPEFVTRFEALKELDISNNLFSGSI 239 (679)
Q Consensus 166 ~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~--~~~~~~L~~L~l~~N~l~g~----~p~~~~~l~~L~~L~ls~N~l~g~~ 239 (679)
.+.. +++|+.|+|++|.+++..+..... ....++|++|+|++|.+++. +|..+..+++|+.|++++|++++..
T Consensus 279 ~l~~-~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~ 357 (461)
T 1z7x_W 279 VLRA-KESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAG 357 (461)
T ss_dssp HHHH-CTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHH
T ss_pred HHhh-CCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCcccccc
Confidence 5444 489999999999997532211000 01235899999999999865 6777888899999999999998765
Q ss_pred Cccccc------cccCEEEccCCcCCC----CCCC
Q 005749 240 PEGLTR------LSLEKLNLSHNNFSG----VLPV 264 (679)
Q Consensus 240 p~~~~~------l~L~~l~ls~N~l~g----~ip~ 264 (679)
+..+.. .+|+.|++++|.+++ .+|.
T Consensus 358 ~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~ 392 (461)
T 1z7x_W 358 VRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAA 392 (461)
T ss_dssp HHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHH
T ss_pred HHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHH
Confidence 554432 269999999999986 5554
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.29 E-value=2.7e-13 Score=148.76 Aligned_cols=158 Identities=20% Similarity=0.230 Sum_probs=77.4
Q ss_pred cEEEEEcCCCCCcccCCcc-ccCCCCCCeeecccCcccc----cCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcc--
Q 005749 100 HLLSIQLPSANLTGSLPRE-LGEFSMLQSLYLNVNSLKG----TIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCD-- 172 (679)
Q Consensus 100 ~l~~l~l~~n~l~g~ip~~-l~~l~~L~~L~L~~N~l~g----~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~-- 172 (679)
+++.|+|++|+++...... +..+++|++|+|++|.+++ .+|..+..+++|++|||++|.+++..+..+...++
T Consensus 4 ~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~ 83 (461)
T 1z7x_W 4 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 83 (461)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred cceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhhC
Confidence 3555666666555332222 4555666666666666553 24444555566666666666555433333333333
Q ss_pred --cCcEEEccCCCCcc----cCCCCCCCCCCCCCccEEEccCcccccccccccc-----CCCCCCEEEccCCcccccC--
Q 005749 173 --RLVSLRLHGNSLTA----ALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVT-----RFEALKELDISNNLFSGSI-- 239 (679)
Q Consensus 173 --~L~~L~Ls~N~l~~----~~p~~~~~~~~~~~L~~L~l~~N~l~g~~p~~~~-----~l~~L~~L~ls~N~l~g~~-- 239 (679)
+|++|+|++|+++. .++... ..+++|++|+|++|.+++..+..+. ..++|+.|++++|++++..
T Consensus 84 ~~~L~~L~L~~n~i~~~~~~~l~~~l---~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~ 160 (461)
T 1z7x_W 84 SCKIQKLSLQNCCLTGAGCGVLSSTL---RTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCE 160 (461)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHT---TSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHH
T ss_pred CCceeEEEccCCCCCHHHHHHHHHHH---ccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHH
Confidence 46666666665552 222211 2344566666666655543332222 1345556666666555422
Q ss_pred --Ccccccc-ccCEEEccCCcCCC
Q 005749 240 --PEGLTRL-SLEKLNLSHNNFSG 260 (679)
Q Consensus 240 --p~~~~~l-~L~~l~ls~N~l~g 260 (679)
+..+..+ +|+.|++++|.++.
T Consensus 161 ~l~~~l~~~~~L~~L~L~~n~i~~ 184 (461)
T 1z7x_W 161 PLASVLRAKPDFKELTVSNNDINE 184 (461)
T ss_dssp HHHHHHHHCTTCCEEECCSSBCHH
T ss_pred HHHHHHhhCCCCCEEECcCCCcch
Confidence 2222222 45555555555543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.22 E-value=4.5e-11 Score=120.66 Aligned_cols=136 Identities=15% Similarity=0.101 Sum_probs=106.1
Q ss_pred CccccCCceEEEEEEeCCCCEEEEEEcccCcccCcccHHHHHHHHhccC-CCCCccceEEeeCCCCceEEEEEecCCCCh
Q 005749 383 QVIEKTTYGTAYKAKLADGATIALRLLREGSCKDRSSCLPVIRQLGKVR-HENLIPLRAFYQGKRGEKLLIYDYFPSRTL 461 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~~~~~~~~~~~~lv~ey~~~gsL 461 (679)
..++.|+.+.||++... ++.+++|............+.+|+++++.+. |..+.++++++.+ .+..++||||++|.+|
T Consensus 20 ~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~-~~~~~lv~e~i~G~~l 97 (263)
T 3tm0_A 20 KDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERH-DGWSNLLMSEADGVLC 97 (263)
T ss_dssp ECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE-TTEEEEEEECCSSEEH
T ss_pred eeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEec-CCceEEEEEecCCeeh
Confidence 45667788899999854 6899999987543334567999999999985 6677789988876 6788999999999998
Q ss_pred HHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-------------------------------------------
Q 005749 462 HDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGH------------------------------------------- 498 (679)
Q Consensus 462 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~------------------------------------------- 498 (679)
.+.+.. ......++.+++++|+.||+..
T Consensus 98 ~~~~~~---------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (263)
T 3tm0_A 98 SEEYED---------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPR 168 (263)
T ss_dssp HHHCCT---------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHH
T ss_pred hhccCC---------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHH
Confidence 876421 1123478899999999999811
Q ss_pred -------------CCCeeecCCCCCCeeecCCCceEEeeccccc
Q 005749 499 -------------EIPITHGNVRSKNVLVDDFFVSRLTEFGLDQ 529 (679)
Q Consensus 499 -------------~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 529 (679)
...++|+|++|.||+++++..+.|.||+.+.
T Consensus 169 ~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 169 ELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1348999999999999876666799998764
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.22 E-value=2.3e-11 Score=128.21 Aligned_cols=97 Identities=23% Similarity=0.153 Sum_probs=75.8
Q ss_pred CCcccCCccccCCCCCCeeeccc-CcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEEccCCCCcccC
Q 005749 110 NLTGSLPRELGEFSMLQSLYLNV-NSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNSLTAAL 188 (679)
Q Consensus 110 ~l~g~ip~~l~~l~~L~~L~L~~-N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N~l~~~~ 188 (679)
+|+ .||. |+.+++|+.|+|++ |.|++..|..++++++|++|||++|+|++..|..+.++ ++|+.|+|++|+|++.+
T Consensus 20 ~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l-~~L~~L~l~~N~l~~~~ 96 (347)
T 2ifg_A 20 ALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFT-PRLSRLNLSFNALESLS 96 (347)
T ss_dssp CCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSC-SCCCEEECCSSCCSCCC
T ss_pred CCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCC-cCCCEEeCCCCccceeC
Confidence 455 4888 99999999999996 99998777889999999999999999998766555554 88999999999998644
Q ss_pred CCCCCCCCCCCCccEEEccCccccc
Q 005749 189 PEPALPNSTCSDLQYLDLGSNKFSG 213 (679)
Q Consensus 189 p~~~~~~~~~~~L~~L~l~~N~l~g 213 (679)
+ ..+. .+ +|++|+|.+|.|..
T Consensus 97 ~-~~~~--~~-~L~~l~l~~N~~~c 117 (347)
T 2ifg_A 97 W-KTVQ--GL-SLQELVLSGNPLHC 117 (347)
T ss_dssp S-TTTC--SC-CCCEEECCSSCCCC
T ss_pred H-HHcc--cC-CceEEEeeCCCccC
Confidence 3 3321 22 27777777777763
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.18 E-value=3.1e-11 Score=127.21 Aligned_cols=103 Identities=19% Similarity=0.222 Sum_probs=66.7
Q ss_pred eeecccC-cccccCCcccCCCCCCCEEEccC-CCCCCcChhhHHhhcccCcEEEccCCCCcccCCCCCCCCCCCCCccEE
Q 005749 127 SLYLNVN-SLKGTIPFELGYSSSLSEIDLSA-NLFTGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYL 204 (679)
Q Consensus 127 ~L~L~~N-~l~g~ip~~l~~l~~L~~L~Ls~-N~l~g~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L 204 (679)
.+++++| +|+ .||. +..+++|++|+|++ |+|++..+..+..+ ++|+.|+|++|+|++.+|..+ ..+++|++|
T Consensus 12 ~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l-~~L~~L~l~~N~l~~~~~~~~---~~l~~L~~L 85 (347)
T 2ifg_A 12 GLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGL-GELRNLTIVKSGLRFVAPDAF---HFTPRLSRL 85 (347)
T ss_dssp CEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSC-CCCSEEECCSSCCCEECTTGG---GSCSCCCEE
T ss_pred EEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccc-cCCCEEECCCCccceeCHHHh---cCCcCCCEE
Confidence 4688887 888 4888 88888888888885 88887655444443 677777777777776544322 345566666
Q ss_pred EccCccccccccccccCCCCCCEEEccCCccc
Q 005749 205 DLGSNKFSGSFPEFVTRFEALKELDISNNLFS 236 (679)
Q Consensus 205 ~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~ 236 (679)
+|++|+|++..+..+..++ |+.|+|++|.|.
T Consensus 86 ~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~~~ 116 (347)
T 2ifg_A 86 NLSFNALESLSWKTVQGLS-LQELVLSGNPLH 116 (347)
T ss_dssp ECCSSCCSCCCSTTTCSCC-CCEEECCSSCCC
T ss_pred eCCCCccceeCHHHcccCC-ceEEEeeCCCcc
Confidence 6666666644333444443 666666666654
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.15 E-value=1.3e-12 Score=139.02 Aligned_cols=161 Identities=20% Similarity=0.172 Sum_probs=115.4
Q ss_pred cEEEEEcCCCCCcccCCccccCC-----CCCCeeecccCcccccCCccc-CCCCCCCEEEccCCCCCCcChhhHHhh---
Q 005749 100 HLLSIQLPSANLTGSLPRELGEF-----SMLQSLYLNVNSLKGTIPFEL-GYSSSLSEIDLSANLFTGVLAPSIWNL--- 170 (679)
Q Consensus 100 ~l~~l~l~~n~l~g~ip~~l~~l-----~~L~~L~L~~N~l~g~ip~~l-~~l~~L~~L~Ls~N~l~g~~p~~~~~~--- 170 (679)
+++.|+|++|+++..-...|..+ ++|+.|+|++|.|+..-...+ ..+++|++|||++|.|+......+...
T Consensus 73 ~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~ 152 (372)
T 3un9_A 73 SLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLH 152 (372)
T ss_dssp TCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHS
T ss_pred hCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHh
Confidence 58899999999986544444333 799999999999975433333 345689999999999986543444332
Q ss_pred -cccCcEEEccCCCCcccCCCCCCC--CCCCCCccEEEccCcccccc----ccccccCCCCCCEEEccCCcccccC----
Q 005749 171 -CDRLVSLRLHGNSLTAALPEPALP--NSTCSDLQYLDLGSNKFSGS----FPEFVTRFEALKELDISNNLFSGSI---- 239 (679)
Q Consensus 171 -~~~L~~L~Ls~N~l~~~~p~~~~~--~~~~~~L~~L~l~~N~l~g~----~p~~~~~l~~L~~L~ls~N~l~g~~---- 239 (679)
.++|+.|+|++|.|+..-.. .+. ...+++|++|+|++|+|+.. ++..+...++|+.|+|++|+|++.-
T Consensus 153 ~~~~L~~L~Ls~n~l~~~~~~-~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l 231 (372)
T 3un9_A 153 DQCQITTLRLSNNPLTAAGVA-VLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALAL 231 (372)
T ss_dssp TTCCCCEEECCSSCCHHHHHH-HHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHH
T ss_pred cCCccceeeCCCCCCChHHHH-HHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHH
Confidence 26799999999999752110 000 01356899999999999853 4566778889999999999998532
Q ss_pred Ccccccc-ccCEEEccCCcCCCC
Q 005749 240 PEGLTRL-SLEKLNLSHNNFSGV 261 (679)
Q Consensus 240 p~~~~~l-~L~~l~ls~N~l~g~ 261 (679)
+..+... +|+.|+|++|.|+..
T Consensus 232 ~~~L~~~~~L~~L~Ls~N~i~~~ 254 (372)
T 3un9_A 232 ARAAREHPSLELLHLYFNELSSE 254 (372)
T ss_dssp HHHHHHCSSCCEEECTTSSCCHH
T ss_pred HHHHHhCCCCCEEeccCCCCCHH
Confidence 3333222 699999999998754
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.11 E-value=3.3e-10 Score=113.85 Aligned_cols=129 Identities=14% Similarity=0.162 Sum_probs=98.1
Q ss_pred ccCCceEEEEEEeCCCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCC--ccceEEeeCCCCceEEEEEecCCCChHH
Q 005749 386 EKTTYGTAYKAKLADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENL--IPLRAFYQGKRGEKLLIYDYFPSRTLHD 463 (679)
Q Consensus 386 g~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nI--v~l~~~~~~~~~~~~lv~ey~~~gsL~~ 463 (679)
+.|..+.||++...+|..+++|..... ....+.+|+++++.+++.++ .+++++... .+..++||||++|.+|.
T Consensus 29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~-~~~~~~v~e~i~G~~l~- 103 (264)
T 1nd4_A 29 IGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTE-AGRDWLLLGEVPGQDLL- 103 (264)
T ss_dssp CTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEEC-SSCEEEEEECCSSEETT-
T ss_pred cCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccC-CCCCEEEEEecCCcccC-
Confidence 356669999998877889999997653 34678899999999965554 457887766 56789999999998884
Q ss_pred HhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCC---------------------------------------------
Q 005749 464 LLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGH--------------------------------------------- 498 (679)
Q Consensus 464 ~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~--------------------------------------------- 498 (679)
... .+ ...++.++++.|..||+..
T Consensus 104 -~~~-------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (264)
T 1nd4_A 104 -SSH-------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA 172 (264)
T ss_dssp -TSC-------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred -cCc-------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHH
Confidence 211 11 2357788888888888743
Q ss_pred ----------CCCeeecCCCCCCeeecCCCceEEeecccccc
Q 005749 499 ----------EIPITHGNVRSKNVLVDDFFVSRLTEFGLDQL 530 (679)
Q Consensus 499 ----------~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 530 (679)
...++|+|++|.||+++++..++|.|||.+..
T Consensus 173 ~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 173 RLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 11299999999999998876678999998753
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.04 E-value=2.3e-11 Score=137.77 Aligned_cols=161 Identities=17% Similarity=0.161 Sum_probs=121.7
Q ss_pred CccEEEEEcCC-----------CCCccc-CCccccCCCCCCeeecccCcccccCCcccCC-CCCCCEEEcc----CCCCC
Q 005749 98 SIHLLSIQLPS-----------ANLTGS-LPRELGEFSMLQSLYLNVNSLKGTIPFELGY-SSSLSEIDLS----ANLFT 160 (679)
Q Consensus 98 ~~~l~~l~l~~-----------n~l~g~-ip~~l~~l~~L~~L~L~~N~l~g~ip~~l~~-l~~L~~L~Ls----~N~l~ 160 (679)
..+++.|+|.+ |.+++. ++.-+..+++|++|+|+.|.+++..+..++. +++|+.|+|+ .|.++
T Consensus 341 ~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~ 420 (592)
T 3ogk_B 341 CKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERIT 420 (592)
T ss_dssp CTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCS
T ss_pred CCCCCEEEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCcccc
Confidence 45699999993 566654 3334566999999999999999888877776 8999999996 78898
Q ss_pred Cc-----ChhhHHhhcccCcEEEccCC--CCcccCCCCCCCCCCCCCccEEEccCccccc-cccccccCCCCCCEEEccC
Q 005749 161 GV-----LAPSIWNLCDRLVSLRLHGN--SLTAALPEPALPNSTCSDLQYLDLGSNKFSG-SFPEFVTRFEALKELDISN 232 (679)
Q Consensus 161 g~-----~p~~~~~~~~~L~~L~Ls~N--~l~~~~p~~~~~~~~~~~L~~L~l~~N~l~g-~~p~~~~~l~~L~~L~ls~ 232 (679)
+. ++. +...+++|+.|+|+++ .+++..+.... ..+++|++|+|++|++++ .++..+..+++|+.|+|++
T Consensus 421 ~~p~~~~~~~-~~~~~~~L~~L~L~~~~~~l~~~~~~~~~--~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~ 497 (592)
T 3ogk_B 421 DLPLDNGVRS-LLIGCKKLRRFAFYLRQGGLTDLGLSYIG--QYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRG 497 (592)
T ss_dssp SCCCHHHHHH-HHHHCTTCCEEEEECCGGGCCHHHHHHHH--HSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEES
T ss_pred CchHHHHHHH-HHHhCCCCCEEEEecCCCCccHHHHHHHH--HhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccC
Confidence 74 322 2344589999999854 36644332111 236789999999999986 4566778899999999999
Q ss_pred CcccccC-Ccccccc-ccCEEEccCCcCCCC
Q 005749 233 NLFSGSI-PEGLTRL-SLEKLNLSHNNFSGV 261 (679)
Q Consensus 233 N~l~g~~-p~~~~~l-~L~~l~ls~N~l~g~ 261 (679)
|.|++.. +..+..+ +|+.|+|++|++++.
T Consensus 498 n~l~~~~~~~~~~~l~~L~~L~ls~n~it~~ 528 (592)
T 3ogk_B 498 CCFSERAIAAAVTKLPSLRYLWVQGYRASMT 528 (592)
T ss_dssp CCCBHHHHHHHHHHCSSCCEEEEESCBCCTT
T ss_pred CCCcHHHHHHHHHhcCccCeeECcCCcCCHH
Confidence 9997653 3333444 699999999999875
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.99 E-value=1.1e-09 Score=115.78 Aligned_cols=141 Identities=18% Similarity=0.224 Sum_probs=105.3
Q ss_pred CccccCCceEEEEEEeCCCCEEEEEEcc--cCc-ccCcccHHHHHHHHhccC--CCCCccceEEeeCCC--CceEEEEEe
Q 005749 383 QVIEKTTYGTAYKAKLADGATIALRLLR--EGS-CKDRSSCLPVIRQLGKVR--HENLIPLRAFYQGKR--GEKLLIYDY 455 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~~~~~~vAvK~~~--~~~-~~~~~~~~~Ei~~l~~l~--H~nIv~l~~~~~~~~--~~~~lv~ey 455 (679)
+.++.|.++.||+.+..+ ..+++|+.. ... ......+.+|+++++.++ +..+.++++++.+.. +..++||||
T Consensus 44 ~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~ 122 (359)
T 3dxp_A 44 EQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEF 122 (359)
T ss_dssp EECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEEC
T ss_pred EEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEe
Confidence 467889999999998764 578888876 432 123467899999999997 455778888877521 458999999
Q ss_pred cCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-------------------------------------
Q 005749 456 FPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGH------------------------------------- 498 (679)
Q Consensus 456 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~------------------------------------- 498 (679)
++|..+.+.. ...++..++..++.++++.|+.||+..
T Consensus 123 v~G~~l~~~~------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (359)
T 3dxp_A 123 VSGRVLWDQS------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA 196 (359)
T ss_dssp CCCBCCCCTT------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred cCCeecCCCc------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence 9998775421 123678888999999999999999731
Q ss_pred ------------------CCCeeecCCCCCCeeecCCCc--eEEeecccccc
Q 005749 499 ------------------EIPITHGNVRSKNVLVDDFFV--SRLTEFGLDQL 530 (679)
Q Consensus 499 ------------------~~~ivHrDlkp~NILl~~~~~--~kl~DFGla~~ 530 (679)
...++|+|+++.|||+++++. +.|.||+.+..
T Consensus 197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 245999999999999997753 68999998875
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=98.96 E-value=6.4e-11 Score=134.05 Aligned_cols=164 Identities=13% Similarity=0.038 Sum_probs=121.2
Q ss_pred CCccEEEEEcCCCCCc-ccCCccccCCCCCCeeecc-----------cCccccc-CCcccCCCCCCCEEEccCCCCCCcC
Q 005749 97 SSIHLLSIQLPSANLT-GSLPRELGEFSMLQSLYLN-----------VNSLKGT-IPFELGYSSSLSEIDLSANLFTGVL 163 (679)
Q Consensus 97 ~~~~l~~l~l~~n~l~-g~ip~~l~~l~~L~~L~L~-----------~N~l~g~-ip~~l~~l~~L~~L~Ls~N~l~g~~ 163 (679)
...+++.|+|. +++. +.++..+..+++|++|+|+ .|.+++. ++.....+++|++|+|+.|.+++..
T Consensus 316 ~~~~L~~L~L~-~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~ 394 (592)
T 3ogk_B 316 KCPNLEVLETR-NVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNES 394 (592)
T ss_dssp TCTTCCEEEEE-GGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHH
T ss_pred hCcCCCEEecc-CccCHHHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHH
Confidence 34578899998 5554 4456566789999999999 4777754 3333456899999999999999877
Q ss_pred hhhHHhhcccCcEEEcc----CCCCcccCCCCCCC--CCCCCCccEEEccCc--cccccccccccC-CCCCCEEEccCCc
Q 005749 164 APSIWNLCDRLVSLRLH----GNSLTAALPEPALP--NSTCSDLQYLDLGSN--KFSGSFPEFVTR-FEALKELDISNNL 234 (679)
Q Consensus 164 p~~~~~~~~~L~~L~Ls----~N~l~~~~p~~~~~--~~~~~~L~~L~l~~N--~l~g~~p~~~~~-l~~L~~L~ls~N~ 234 (679)
+..+...+++|+.|+|+ .|.+++.+.+..++ ...+++|++|+++.| .+++..+..++. +++|+.|+|++|+
T Consensus 395 ~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~ 474 (592)
T 3ogk_B 395 LESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVG 474 (592)
T ss_dssp HHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCC
T ss_pred HHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCC
Confidence 77777756899999996 77887632110000 124789999999853 477666665554 8999999999999
Q ss_pred ccc-cCCcccccc-ccCEEEccCCcCCCC
Q 005749 235 FSG-SIPEGLTRL-SLEKLNLSHNNFSGV 261 (679)
Q Consensus 235 l~g-~~p~~~~~l-~L~~l~ls~N~l~g~ 261 (679)
+++ .++..+..+ +|+.|+|++|.|++.
T Consensus 475 l~~~~~~~~~~~~~~L~~L~l~~n~l~~~ 503 (592)
T 3ogk_B 475 ESDEGLMEFSRGCPNLQKLEMRGCCFSER 503 (592)
T ss_dssp SSHHHHHHHHTCCTTCCEEEEESCCCBHH
T ss_pred CCHHHHHHHHhcCcccCeeeccCCCCcHH
Confidence 986 345444444 699999999998765
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.93 E-value=4.6e-11 Score=127.00 Aligned_cols=139 Identities=18% Similarity=0.158 Sum_probs=102.4
Q ss_pred CCCCCeeecccCcccccCCccc----C-CCCCCCEEEccCCCCCCcChhhHHhhcccCcEEEccCCCCcccCCCCCCC--
Q 005749 122 FSMLQSLYLNVNSLKGTIPFEL----G-YSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALP-- 194 (679)
Q Consensus 122 l~~L~~L~L~~N~l~g~ip~~l----~-~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~-- 194 (679)
+++|+.|+|++|.|+..-...+ . +.++|++|||++|.++..-...+...+++|+.|+|++|+|+.........
T Consensus 71 ~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L 150 (372)
T 3un9_A 71 LSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLL 150 (372)
T ss_dssp HTTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHH
T ss_pred HhhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHH
Confidence 4689999999999986433333 2 23799999999999986544555555679999999999997532111000
Q ss_pred CCCCCCccEEEccCccccc----cccccccCCCCCCEEEccCCccccc----CCcccccc-ccCEEEccCCcCCC
Q 005749 195 NSTCSDLQYLDLGSNKFSG----SFPEFVTRFEALKELDISNNLFSGS----IPEGLTRL-SLEKLNLSHNNFSG 260 (679)
Q Consensus 195 ~~~~~~L~~L~l~~N~l~g----~~p~~~~~l~~L~~L~ls~N~l~g~----~p~~~~~l-~L~~l~ls~N~l~g 260 (679)
....++|++|+|++|.|+. .++..+...++|++|+|++|+|++. ++..+... +|+.|+|++|.|+.
T Consensus 151 ~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~ 225 (372)
T 3un9_A 151 LHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGD 225 (372)
T ss_dssp HSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCH
T ss_pred HhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCH
Confidence 0124689999999999975 3556668899999999999999753 23444433 69999999999975
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=98.89 E-value=5e-09 Score=109.40 Aligned_cols=85 Identities=14% Similarity=0.146 Sum_probs=55.4
Q ss_pred cccCcEEEccCCCCcccCCCCCCCCCCCCCccEEEccCccccccccccccCCCCCC-EEEccCCcccccCCcccccc-cc
Q 005749 171 CDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALK-ELDISNNLFSGSIPEGLTRL-SL 248 (679)
Q Consensus 171 ~~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~l~~N~l~g~~p~~~~~l~~L~-~L~ls~N~l~g~~p~~~~~l-~L 248 (679)
+++|+.|+|++|+++. +|...+ ..|.+|+.|+|.+| ++..-+..|..+++|+ .+++.+ +++..-+..|..+ +|
T Consensus 225 ~~~L~~l~L~~n~i~~-I~~~aF--~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L 299 (329)
T 3sb4_A 225 MPNLVSLDISKTNATT-IPDFTF--AQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNL 299 (329)
T ss_dssp CTTCCEEECTTBCCCE-ECTTTT--TTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTE
T ss_pred cCCCeEEECCCCCcce-ecHhhh--hCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccC
Confidence 4677777777777763 444433 45677777777776 6544445677777777 777776 5654444556555 57
Q ss_pred CEEEccCCcCCC
Q 005749 249 EKLNLSHNNFSG 260 (679)
Q Consensus 249 ~~l~ls~N~l~g 260 (679)
+.|++++|+++.
T Consensus 300 ~~l~l~~n~i~~ 311 (329)
T 3sb4_A 300 RYVLATGDKITT 311 (329)
T ss_dssp EEEEECSSCCCE
T ss_pred CEEEeCCCccCc
Confidence 777777777653
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.87 E-value=9.5e-10 Score=113.58 Aligned_cols=184 Identities=14% Similarity=0.173 Sum_probs=120.3
Q ss_pred CccccCCceEEEEEEeCCCCEEEEEEcccCcccCcccHHHHHHHHhccC-CCCC--ccceEEeeCCC--CceEEEEEecC
Q 005749 383 QVIEKTTYGTAYKAKLADGATIALRLLREGSCKDRSSCLPVIRQLGKVR-HENL--IPLRAFYQGKR--GEKLLIYDYFP 457 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~-H~nI--v~l~~~~~~~~--~~~~lv~ey~~ 457 (679)
+.++.|....||+.. ..+++|+.... .....+.+|+++|+.+. +..+ .+++.+..... ...|+||||++
T Consensus 26 ~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~ 99 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK 99 (304)
T ss_dssp CEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred EecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence 468889999999863 56888886432 22457889999998884 3333 33444333211 23589999999
Q ss_pred CCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCC---------------------------------------
Q 005749 458 SRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGH--------------------------------------- 498 (679)
Q Consensus 458 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~--------------------------------------- 498 (679)
|.++.+.... .++..++..++.++++.|+.||+..
T Consensus 100 G~~l~~~~~~------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 100 GVPLTPLLLN------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp CEECCHHHHH------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred CeECCccccc------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 9888754322 2677788888889998888888611
Q ss_pred ----------------CCCeeecCCCCCCeeecC--CCceEEeecccccccCcccccchhccc---------------cc
Q 005749 499 ----------------EIPITHGNVRSKNVLVDD--FFVSRLTEFGLDQLMVPAVADEMVALA---------------KA 545 (679)
Q Consensus 499 ----------------~~~ivHrDlkp~NILl~~--~~~~kl~DFGla~~~~~~~~~~~~~~~---------------gt 545 (679)
.+.++|+|++|.||++++ ...+.|.||+.+....+.. ...... ..
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~--Dl~~~~~~~~~~~~~~~~~~l~~ 251 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN--DFISLMEDDEEYGMEFVSKILNH 251 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH--HHHTTCCTTTSCCHHHHHHHHHH
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH--HHHHHHhhccccCHHHHHHHHHH
Confidence 134799999999999998 5567899999886532210 000000 00
Q ss_pred ccccc-cccccccCCCCcchhHHHHHHHHHHHhCCCCC
Q 005749 546 DGYKA-PELQRMKKCSSRTDVYAFGILLLEILIGKKPG 582 (679)
Q Consensus 546 ~~y~a-PE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~ 582 (679)
+++.. |+.... .....+.|+++.++|++.+|..+|
T Consensus 252 Y~~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 252 YKHKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HTCSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred cCCCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 01111 222111 112368999999999999998876
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=98.72 E-value=4e-08 Score=102.50 Aligned_cols=101 Identities=15% Similarity=0.144 Sum_probs=82.5
Q ss_pred CCCCCEEEccCCCCCCcChhhHHhhcccCcEEEccCCCCcccCCCCCCCCCCCCCcc-EEEccCccccccccccccCCCC
Q 005749 146 SSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQ-YLDLGSNKFSGSFPEFVTRFEA 224 (679)
Q Consensus 146 l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~-~L~l~~N~l~g~~p~~~~~l~~ 224 (679)
+++|+.|+|++|+++ .||+..+..+++|+.|+|++| ++. ++...+ ..|.+|+ .+++.+ +++..-+..|..+++
T Consensus 225 ~~~L~~l~L~~n~i~-~I~~~aF~~~~~L~~l~l~~n-i~~-I~~~aF--~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~ 298 (329)
T 3sb4_A 225 MPNLVSLDISKTNAT-TIPDFTFAQKKYLLKIKLPHN-LKT-IGQRVF--SNCGRLAGTLELPA-SVTAIEFGAFMGCDN 298 (329)
T ss_dssp CTTCCEEECTTBCCC-EECTTTTTTCTTCCEEECCTT-CCE-ECTTTT--TTCTTCCEEEEECT-TCCEECTTTTTTCTT
T ss_pred cCCCeEEECCCCCcc-eecHhhhhCCCCCCEEECCcc-cce-ehHHHh--hCChhccEEEEEcc-cceEEchhhhhCCcc
Confidence 789999999999998 466666666799999999998 663 555544 5788999 999998 777555688999999
Q ss_pred CCEEEccCCcccccCCcccccc-ccCEEE
Q 005749 225 LKELDISNNLFSGSIPEGLTRL-SLEKLN 252 (679)
Q Consensus 225 L~~L~ls~N~l~g~~p~~~~~l-~L~~l~ 252 (679)
|+.|++++|+++..-+..|..+ +|+.+.
T Consensus 299 L~~l~l~~n~i~~I~~~aF~~~~~L~~ly 327 (329)
T 3sb4_A 299 LRYVLATGDKITTLGDELFGNGVPSKLIY 327 (329)
T ss_dssp EEEEEECSSCCCEECTTTTCTTCCCCEEE
T ss_pred CCEEEeCCCccCccchhhhcCCcchhhhc
Confidence 9999999999986656677766 687775
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.68 E-value=1.6e-08 Score=106.63 Aligned_cols=156 Identities=15% Similarity=0.217 Sum_probs=105.1
Q ss_pred cEEEEEcCCCCC---------cccCCccccCCCCCCeeecccCc-ccccCCcccCCCCCCCEEEccCCCCCCcChhhHHh
Q 005749 100 HLLSIQLPSANL---------TGSLPRELGEFSMLQSLYLNVNS-LKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWN 169 (679)
Q Consensus 100 ~l~~l~l~~n~l---------~g~ip~~l~~l~~L~~L~L~~N~-l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~ 169 (679)
+|+.|.+..+.. .+.++..+..+++|+.|+|++|. + .+|. +. +++|+.|+|..|.++......+..
T Consensus 140 ~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l--~l~~-~~-~~~L~~L~L~~~~l~~~~l~~l~~ 215 (362)
T 2ra8_A 140 HFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNL--SIGK-KP-RPNLKSLEIISGGLPDSVVEDILG 215 (362)
T ss_dssp TCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTC--BCCS-CB-CTTCSEEEEECSBCCHHHHHHHHH
T ss_pred hhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCc--eecc-cc-CCCCcEEEEecCCCChHHHHHHHH
Confidence 567777755433 23466677889999999999883 3 3444 43 889999999999886543333431
Q ss_pred -hcccCcEEEccC--CCCcccCCC----CCCCCCCCCCccEEEccCcccccccccccc---CCCCCCEEEccCCccccc-
Q 005749 170 -LCDRLVSLRLHG--NSLTAALPE----PALPNSTCSDLQYLDLGSNKFSGSFPEFVT---RFEALKELDISNNLFSGS- 238 (679)
Q Consensus 170 -~~~~L~~L~Ls~--N~l~~~~p~----~~~~~~~~~~L~~L~l~~N~l~g~~p~~~~---~l~~L~~L~ls~N~l~g~- 238 (679)
.+++|+.|+|+. |...+.... ..+....+++|++|+|.+|.+.+..+..+. .+++|+.|+|+.|.|++.
T Consensus 216 ~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G 295 (362)
T 2ra8_A 216 SDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEG 295 (362)
T ss_dssp SBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHH
T ss_pred ccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHH
Confidence 358999999863 322221100 011112467999999999999865544443 578999999999999864
Q ss_pred ---CCcccccc-ccCEEEccCCcCC
Q 005749 239 ---IPEGLTRL-SLEKLNLSHNNFS 259 (679)
Q Consensus 239 ---~p~~~~~l-~L~~l~ls~N~l~ 259 (679)
++..+..+ +|+.|+|++|.++
T Consensus 296 ~~~L~~~L~~l~~L~~L~L~~n~i~ 320 (362)
T 2ra8_A 296 ARLLLDHVDKIKHLKFINMKYNYLS 320 (362)
T ss_dssp HHHHHTTHHHHTTCSEEECCSBBCC
T ss_pred HHHHHhhcccCCcceEEECCCCcCC
Confidence 34333333 6999999999876
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.68 E-value=1.7e-09 Score=108.44 Aligned_cols=82 Identities=24% Similarity=0.269 Sum_probs=42.7
Q ss_pred CCCCCCCEEEccCCCCCC--cChhhHHhhcccCcEEEccCCCCcccCCCCCCCCCCCCCccEEEccCccccccccc----
Q 005749 144 GYSSSLSEIDLSANLFTG--VLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPE---- 217 (679)
Q Consensus 144 ~~l~~L~~L~Ls~N~l~g--~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~l~~N~l~g~~p~---- 217 (679)
.++++|+.|+|++|+|++ .+|..+.. +++|+.|+|++|+|++.-. .-....+ +|++|+|++|.+.+.+|.
T Consensus 167 ~~l~~L~~L~Ls~N~l~~l~~l~~~~~~-l~~L~~L~Ls~N~i~~~~~--l~~l~~l-~L~~L~L~~Npl~~~~~~~~~y 242 (267)
T 3rw6_A 167 ENIPELLSLNLSNNRLYRLDDMSSIVQK-APNLKILNLSGNELKSERE--LDKIKGL-KLEELWLDGNSLCDTFRDQSTY 242 (267)
T ss_dssp HHCTTCCEEECTTSCCCCCGGGTTHHHH-STTCCEEECTTSCCCSGGG--GGGGTTS-CCSEEECTTSTTGGGCSSHHHH
T ss_pred hhCCCCCEEECCCCCCCCCccchhHHhh-CCCCCEEECCCCccCCchh--hhhcccC-CcceEEccCCcCccccCcchhH
Confidence 345666666666666665 22222223 3666666666666664311 0000112 566666666666655542
Q ss_pred ---cccCCCCCCEEE
Q 005749 218 ---FVTRFEALKELD 229 (679)
Q Consensus 218 ---~~~~l~~L~~L~ 229 (679)
.+..+++|+.||
T Consensus 243 ~~~il~~~P~L~~LD 257 (267)
T 3rw6_A 243 ISAIRERFPKLLRLD 257 (267)
T ss_dssp HHHHHHHCTTCCEES
T ss_pred HHHHHHHCcccCeEC
Confidence 345566666665
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=98.60 E-value=3.9e-09 Score=119.33 Aligned_cols=162 Identities=15% Similarity=0.111 Sum_probs=109.4
Q ss_pred CccEEEEEcCCCCCccc-CCccccCCCCCCeeec---------ccCcccccCCcccC-CCCCCCEEEccCCCCCCcChhh
Q 005749 98 SIHLLSIQLPSANLTGS-LPRELGEFSMLQSLYL---------NVNSLKGTIPFELG-YSSSLSEIDLSANLFTGVLAPS 166 (679)
Q Consensus 98 ~~~l~~l~l~~n~l~g~-ip~~l~~l~~L~~L~L---------~~N~l~g~ip~~l~-~l~~L~~L~Ls~N~l~g~~p~~ 166 (679)
..+++.|++.+| +... ++.-...+++|++|+| +.|.+++.....+. .+++|+.|+++.|.+++..+..
T Consensus 313 ~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~ 391 (594)
T 2p1m_B 313 CPKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALIT 391 (594)
T ss_dssp CTTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHH
T ss_pred CCCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHH
Confidence 457889999887 4432 3333446899999988 44566644333333 4789999999999998766666
Q ss_pred HHhhcccCcEEEcc--C----CCCcccCCCCCCC--CCCCCCccEEEccCccccccccccccC-CCCCCEEEccCCcccc
Q 005749 167 IWNLCDRLVSLRLH--G----NSLTAALPEPALP--NSTCSDLQYLDLGSNKFSGSFPEFVTR-FEALKELDISNNLFSG 237 (679)
Q Consensus 167 ~~~~~~~L~~L~Ls--~----N~l~~~~p~~~~~--~~~~~~L~~L~l~~N~l~g~~p~~~~~-l~~L~~L~ls~N~l~g 237 (679)
+...+++|+.|+|+ + |++++...+..++ ...+++|+.|+|++ ++++..+..++. +++|+.|+|++|.+++
T Consensus 392 l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~ 470 (594)
T 2p1m_B 392 IARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSD 470 (594)
T ss_dssp HHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSH
T ss_pred HHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcH
Confidence 66556899999999 4 5565321110000 12467899999977 677665566655 8889999999999876
Q ss_pred cCCccc-ccc-ccCEEEccCCcCCCC
Q 005749 238 SIPEGL-TRL-SLEKLNLSHNNFSGV 261 (679)
Q Consensus 238 ~~p~~~-~~l-~L~~l~ls~N~l~g~ 261 (679)
..+..+ ..+ +|+.|+|++|.+++.
T Consensus 471 ~~~~~l~~~~~~L~~L~L~~n~~~~~ 496 (594)
T 2p1m_B 471 LGMHHVLSGCDSLRKLEIRDCPFGDK 496 (594)
T ss_dssp HHHHHHHHHCTTCCEEEEESCSCCHH
T ss_pred HHHHHHHhcCCCcCEEECcCCCCcHH
Confidence 554443 323 689999999988544
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=98.54 E-value=3.5e-09 Score=119.74 Aligned_cols=161 Identities=17% Similarity=0.160 Sum_probs=116.0
Q ss_pred ccEEEEEcCCCCCcccCC-ccccCCCCCCeeecccCcccc-cCCcccCCCCCCCEEEc---------cCCCCCCcChhhH
Q 005749 99 IHLLSIQLPSANLTGSLP-RELGEFSMLQSLYLNVNSLKG-TIPFELGYSSSLSEIDL---------SANLFTGVLAPSI 167 (679)
Q Consensus 99 ~~l~~l~l~~n~l~g~ip-~~l~~l~~L~~L~L~~N~l~g-~ip~~l~~l~~L~~L~L---------s~N~l~g~~p~~~ 167 (679)
.+++.|+|++|.+++... ..+..+++|++|+|++| ++. .++.....+++|++|+| +.|.+++.....+
T Consensus 289 ~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l 367 (594)
T 2p1m_B 289 SRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSV 367 (594)
T ss_dssp TTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHHHHHHH
T ss_pred CCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCcccccccCCCCCHHHHHHH
Confidence 579999999999876543 34678999999999998 543 23333346899999999 4466765444455
Q ss_pred HhhcccCcEEEccCCCCcccCCCCCCCCCCCCCccEEEcc--C----ccccc-----cccccccCCCCCCEEEccCCccc
Q 005749 168 WNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLG--S----NKFSG-----SFPEFVTRFEALKELDISNNLFS 236 (679)
Q Consensus 168 ~~~~~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~l~--~----N~l~g-----~~p~~~~~l~~L~~L~ls~N~l~ 236 (679)
...+++|+.|+++.|++++....... ..+++|+.|+++ + |++++ .++..+..+++|+.|+|++ +++
T Consensus 368 ~~~~~~L~~L~~~~~~l~~~~~~~l~--~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~ 444 (594)
T 2p1m_B 368 SMGCPKLESVLYFCRQMTNAALITIA--RNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLT 444 (594)
T ss_dssp HHHCTTCCEEEEEESCCCHHHHHHHH--HHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCC
T ss_pred HHhchhHHHHHHhcCCcCHHHHHHHH--hhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-ccc
Confidence 55468999999999999864332110 136789999999 4 66662 2334467889999999987 777
Q ss_pred ccCCccccc-c-ccCEEEccCCcCCCCCC
Q 005749 237 GSIPEGLTR-L-SLEKLNLSHNNFSGVLP 263 (679)
Q Consensus 237 g~~p~~~~~-l-~L~~l~ls~N~l~g~ip 263 (679)
+..+..+.. + +|+.|+|++|.+++..+
T Consensus 445 ~~~~~~l~~~~~~L~~L~L~~~~i~~~~~ 473 (594)
T 2p1m_B 445 DKVFEYIGTYAKKMEMLSVAFAGDSDLGM 473 (594)
T ss_dssp HHHHHHHHHHCTTCCEEEEESCCSSHHHH
T ss_pred HHHHHHHHHhchhccEeeccCCCCcHHHH
Confidence 655555544 3 69999999999876533
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.41 E-value=5.6e-08 Score=92.41 Aligned_cols=121 Identities=13% Similarity=0.116 Sum_probs=73.8
Q ss_pred ccCCccccCCCCCCeeecccC-ccccc----CCcccCCCCCCCEEEccCCCCCCcChhhHHhh---cccCcEEEccCCCC
Q 005749 113 GSLPRELGEFSMLQSLYLNVN-SLKGT----IPFELGYSSSLSEIDLSANLFTGVLAPSIWNL---CDRLVSLRLHGNSL 184 (679)
Q Consensus 113 g~ip~~l~~l~~L~~L~L~~N-~l~g~----ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~---~~~L~~L~Ls~N~l 184 (679)
..+...+...++|++|+|++| .|... +...+...++|++|||++|.+...-...+... .++|++|+|++|.|
T Consensus 26 ~~l~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i 105 (185)
T 1io0_A 26 ETLKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFI 105 (185)
T ss_dssp HHHHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCC
T ss_pred HHHHHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcC
Confidence 345556677888888898888 87632 44556667888899999988864311122211 25677888888777
Q ss_pred cccC----CCCCCCCCCCCCccEEEc--cCcccccc----ccccccCCCCCCEEEccCCccc
Q 005749 185 TAAL----PEPALPNSTCSDLQYLDL--GSNKFSGS----FPEFVTRFEALKELDISNNLFS 236 (679)
Q Consensus 185 ~~~~----p~~~~~~~~~~~L~~L~l--~~N~l~g~----~p~~~~~l~~L~~L~ls~N~l~ 236 (679)
+..- .... ...++|++|+| ++|.|+.. +...+...++|+.|+|++|.+.
T Consensus 106 ~~~g~~~l~~~L---~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 106 SGSGILALVEAL---QSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp CHHHHHHHHHGG---GGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred CHHHHHHHHHHH---HhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 6420 0000 12346777777 66766632 3334445566777777777664
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.37 E-value=3e-08 Score=104.48 Aligned_cols=157 Identities=15% Similarity=0.159 Sum_probs=104.0
Q ss_pred CccEEEEEcCCCCCcccCCccccCCCCCCeeecccCcccccCCcccC--CCCCCCEEEccC--CCCCCc-----ChhhHH
Q 005749 98 SIHLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELG--YSSSLSEIDLSA--NLFTGV-----LAPSIW 168 (679)
Q Consensus 98 ~~~l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip~~l~--~l~~L~~L~Ls~--N~l~g~-----~p~~~~ 168 (679)
..+|+.|+|.+|.- -.+++ + .+++|++|+|..|.++......+. .+++|++|+|+. |...|. +.+.+.
T Consensus 171 ~P~L~~L~L~g~~~-l~l~~-~-~~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~ 247 (362)
T 2ra8_A 171 MPLLNNLKIKGTNN-LSIGK-K-PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFS 247 (362)
T ss_dssp CTTCCEEEEECCBT-CBCCS-C-BCTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSC
T ss_pred CCCCcEEEEeCCCC-ceecc-c-cCCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHh
Confidence 45789999988731 13444 4 389999999999988754434443 789999999964 332221 111111
Q ss_pred -hhcccCcEEEccCCCCcccCCCCCCCCCCCCCccEEEccCcccccc----ccccccCCCCCCEEEccCCcccccCCccc
Q 005749 169 -NLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGS----FPEFVTRFEALKELDISNNLFSGSIPEGL 243 (679)
Q Consensus 169 -~~~~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~l~~N~l~g~----~p~~~~~l~~L~~L~ls~N~l~g~~p~~~ 243 (679)
..+++|+.|+|++|.++...+........+++|++|+|+.|++++. ++..+..+++|+.|+|++|.++...-..+
T Consensus 248 ~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~~~~~l 327 (362)
T 2ra8_A 248 KDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKEL 327 (362)
T ss_dssp TTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHHHHHHH
T ss_pred cCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHHHHHHH
Confidence 2247999999999999753321111112467999999999999864 44445567999999999999875432223
Q ss_pred cccccCEEEccCCc
Q 005749 244 TRLSLEKLNLSHNN 257 (679)
Q Consensus 244 ~~l~L~~l~ls~N~ 257 (679)
...-...++++.|+
T Consensus 328 ~~alg~~~~~~~~~ 341 (362)
T 2ra8_A 328 QKSLPMKIDVSDSQ 341 (362)
T ss_dssp HHHCCSEEECCSBC
T ss_pred HHHcCCEEEecCCc
Confidence 22113568998887
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.36 E-value=1.7e-06 Score=89.20 Aligned_cols=136 Identities=14% Similarity=0.110 Sum_probs=93.1
Q ss_pred CccccCCceEEEEEEeCCCCEEEEEEcccCcccCcccHHHHHHHHhccCCC---CCccceEEeeCCCCceEEEEEecCCC
Q 005749 383 QVIEKTTYGTAYKAKLADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHE---NLIPLRAFYQGKRGEKLLIYDYFPSR 459 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~---nIv~l~~~~~~~~~~~~lv~ey~~~g 459 (679)
+.++.|....||+. |..+++|+-.. ......+.+|.++|+.+.+. .+.+.+.+.....+..++||||++|.
T Consensus 25 ~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~ 98 (306)
T 3tdw_A 25 ESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ 98 (306)
T ss_dssp EEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred eecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence 45778888899987 56788888432 12245788999999999753 24456666643356789999999998
Q ss_pred ChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcC------------------------------------------
Q 005749 460 TLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTG------------------------------------------ 497 (679)
Q Consensus 460 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~------------------------------------------ 497 (679)
++.+.... .++..++..++.++++.|+.||+.
T Consensus 99 ~l~~~~~~------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 99 ILGEDGMA------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp ECHHHHHT------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred ECchhhhh------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 88763211 134445555555555555555542
Q ss_pred ---------------CCCCeeecCCCCCCeeecC---CCc-eEEeecccccc
Q 005749 498 ---------------HEIPITHGNVRSKNVLVDD---FFV-SRLTEFGLDQL 530 (679)
Q Consensus 498 ---------------~~~~ivHrDlkp~NILl~~---~~~-~kl~DFGla~~ 530 (679)
..+.++|+|+++.||++++ ++. +.|.||+.+..
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 1224699999999999997 455 48999998764
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.25 E-value=7.4e-07 Score=89.24 Aligned_cols=99 Identities=22% Similarity=0.252 Sum_probs=72.8
Q ss_pred EEcCCCC---CcccCCccccCCCCCCeeecccCcccc--cCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcc--cCcE
Q 005749 104 IQLPSAN---LTGSLPRELGEFSMLQSLYLNVNSLKG--TIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCD--RLVS 176 (679)
Q Consensus 104 l~l~~n~---l~g~ip~~l~~l~~L~~L~L~~N~l~g--~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~--~L~~ 176 (679)
++++.|. +.+.++....++++|+.|+|++|+|++ .+|..+..+++|+.|||++|+|++. ..+..+ . +|+.
T Consensus 148 l~l~~N~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l-~~l~L~~ 224 (267)
T 3rw6_A 148 IDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKI-KGLKLEE 224 (267)
T ss_dssp CCCCTTSHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGG-TTSCCSE
T ss_pred ccccCCHHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhc-ccCCcce
Confidence 5667774 233333333679999999999999998 6777788999999999999999986 334333 4 8999
Q ss_pred EEccCCCCcccCCCCC--C--CCCCCCCccEEE
Q 005749 177 LRLHGNSLTAALPEPA--L--PNSTCSDLQYLD 205 (679)
Q Consensus 177 L~Ls~N~l~~~~p~~~--~--~~~~~~~L~~L~ 205 (679)
|+|++|.+++.+|... . -...+++|+.||
T Consensus 225 L~L~~Npl~~~~~~~~~y~~~il~~~P~L~~LD 257 (267)
T 3rw6_A 225 LWLDGNSLCDTFRDQSTYISAIRERFPKLLRLD 257 (267)
T ss_dssp EECTTSTTGGGCSSHHHHHHHHHHHCTTCCEES
T ss_pred EEccCCcCccccCcchhHHHHHHHHCcccCeEC
Confidence 9999999998766310 0 012356888876
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.23 E-value=4.6e-06 Score=87.69 Aligned_cols=81 Identities=9% Similarity=0.004 Sum_probs=56.8
Q ss_pred Ccc-ccCCceEEEEEEeC-------CCCEEEEEEcccCc---ccCcccHHHHHHHHhccCC---CCCccceEEeeCCC--
Q 005749 383 QVI-EKTTYGTAYKAKLA-------DGATIALRLLREGS---CKDRSSCLPVIRQLGKVRH---ENLIPLRAFYQGKR-- 446 (679)
Q Consensus 383 ~~i-g~G~~g~Vy~~~~~-------~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H---~nIv~l~~~~~~~~-- 446 (679)
+.| +.|....+|+.... ++..+++|+..... ......+.+|+++++.+.. -.+.++++++.+..
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 456 77888999998764 26688888865432 1123678899999998853 24567777766521
Q ss_pred CceEEEEEecCCCChHH
Q 005749 447 GEKLLIYDYFPSRTLHD 463 (679)
Q Consensus 447 ~~~~lv~ey~~~gsL~~ 463 (679)
+..++||||++|..+.+
T Consensus 106 g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp SSCEEEEECCCCBCCCB
T ss_pred CCceEEEEecCCCChhh
Confidence 45789999999876653
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=98.14 E-value=1.3e-05 Score=85.64 Aligned_cols=149 Identities=15% Similarity=0.160 Sum_probs=83.5
Q ss_pred cEEEEEcCCCCCcccCCccccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEEc
Q 005749 100 HLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRL 179 (679)
Q Consensus 100 ~l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~L 179 (679)
+|+.+.|++ ++...-+..|.++++|+.++|++|+++ .||.....+++|+.++|..| ++ .|+...+..+++|+.++|
T Consensus 158 ~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~-~I~~~aF~~~~L~~l~lp~~-l~-~I~~~aF~~~~~L~~l~l 233 (401)
T 4fdw_A 158 TVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKIT-KLPASTFVYAGIEEVLLPVT-LK-EIGSQAFLKTSQLKTIEI 233 (401)
T ss_dssp CCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCS-EECTTTTTTCCCSEEECCTT-CC-EECTTTTTTCTTCCCEEC
T ss_pred CceEEEeCC-CccEehHHHhhCcccCCeeecCCCcce-EechhhEeecccCEEEeCCc-hh-eehhhHhhCCCCCCEEec
Confidence 456666664 444333345666777777777776666 34443333455555555533 33 222222333344444444
Q ss_pred cC---------------------CCCcccCCCCCCCCCCCCCccEEEccCcccc-----ccccccccCCCCCCEEEccCC
Q 005749 180 HG---------------------NSLTAALPEPALPNSTCSDLQYLDLGSNKFS-----GSFPEFVTRFEALKELDISNN 233 (679)
Q Consensus 180 s~---------------------N~l~~~~p~~~~~~~~~~~L~~L~l~~N~l~-----g~~p~~~~~l~~L~~L~ls~N 233 (679)
.+ |+++ .++...+ ..|++|+.+++.+|.+. ..-+..|..+++|+.++|. |
T Consensus 234 ~~~l~~I~~~aF~~~~L~~i~lp~~i~-~I~~~aF--~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~ 309 (401)
T 4fdw_A 234 PENVSTIGQEAFRESGITTVKLPNGVT-NIASRAF--YYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-E 309 (401)
T ss_dssp CTTCCEECTTTTTTCCCSEEEEETTCC-EECTTTT--TTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-T
T ss_pred CCCccCccccccccCCccEEEeCCCcc-EEChhHh--hCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-C
Confidence 33 2232 1222222 46788999988888765 2334568888888888888 4
Q ss_pred cccccCCcccccc-ccCEEEccCC
Q 005749 234 LFSGSIPEGLTRL-SLEKLNLSHN 256 (679)
Q Consensus 234 ~l~g~~p~~~~~l-~L~~l~ls~N 256 (679)
.++-.-...+..+ +|+.++|..|
T Consensus 310 ~i~~I~~~aF~~c~~L~~l~lp~~ 333 (401)
T 4fdw_A 310 SIRILGQGLLGGNRKVTQLTIPAN 333 (401)
T ss_dssp TCCEECTTTTTTCCSCCEEEECTT
T ss_pred ceEEEhhhhhcCCCCccEEEECcc
Confidence 4663334455554 6888888655
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.13 E-value=1.1e-05 Score=81.29 Aligned_cols=135 Identities=16% Similarity=0.172 Sum_probs=93.5
Q ss_pred ccccCCce-EEEEEEeC-CCCEEEEEEcccCcccCcccHHHHHHHHhccC-CCCCccceEEeeCCCCceEEEEEecCCCC
Q 005749 384 VIEKTTYG-TAYKAKLA-DGATIALRLLREGSCKDRSSCLPVIRQLGKVR-HENLIPLRAFYQGKRGEKLLIYDYFPSRT 460 (679)
Q Consensus 384 ~ig~G~~g-~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~~~~~~~~~~~~lv~ey~~~gs 460 (679)
.+..|..| .||+.... ++..+.+|+-... ....+.+|.+.|+.+. +--+-++++++.+ .+..++|||++++.+
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~-~~~~~lvme~l~G~~ 106 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRT-PDDAWLLTTAIPGKT 106 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEE-TTEEEEEEECCCSEE
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEE-CCeEEEEEEeeCCcc
Confidence 34445555 68988754 4678889986543 2346788999988874 2224567777776 578899999999988
Q ss_pred hHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCC------------------------------------------
Q 005749 461 LHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGH------------------------------------------ 498 (679)
Q Consensus 461 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~------------------------------------------ 498 (679)
+.+..... ......++.+++..|.-||+..
T Consensus 107 ~~~~~~~~--------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (272)
T 4gkh_A 107 AFQVLEEY--------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQ 178 (272)
T ss_dssp HHHHHHHC--------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHH
T ss_pred ccccccCC--------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHH
Confidence 87765421 1223345666666666666421
Q ss_pred -------------CCCeeecCCCCCCeeecCCCceEEeecccccc
Q 005749 499 -------------EIPITHGNVRSKNVLVDDFFVSRLTEFGLDQL 530 (679)
Q Consensus 499 -------------~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 530 (679)
.+.++|+|+.+.||++++++.+-|.||+.+..
T Consensus 179 ~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 179 VWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 11279999999999999887778999987753
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.08 E-value=1.4e-06 Score=82.72 Aligned_cols=121 Identities=15% Similarity=0.119 Sum_probs=82.8
Q ss_pred CCcccCCCCCCCEEEccCC-CCCCcChhhHHh---hcccCcEEEccCCCCcccCCCCCC-CCCCCCCccEEEccCccccc
Q 005749 139 IPFELGYSSSLSEIDLSAN-LFTGVLAPSIWN---LCDRLVSLRLHGNSLTAALPEPAL-PNSTCSDLQYLDLGSNKFSG 213 (679)
Q Consensus 139 ip~~l~~l~~L~~L~Ls~N-~l~g~~p~~~~~---~~~~L~~L~Ls~N~l~~~~p~~~~-~~~~~~~L~~L~l~~N~l~g 213 (679)
+...+...++|++|+|++| .+...--..+.. ..++|++|+|++|.++..--.... .....++|++|+|++|+|+.
T Consensus 28 l~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~ 107 (185)
T 1io0_A 28 LKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISG 107 (185)
T ss_dssp HHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCH
T ss_pred HHHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCH
Confidence 4445677899999999999 887431122222 136899999999999742100000 00123579999999999985
Q ss_pred c----ccccccCCCCCCEEEc--cCCcccccCCccccc-----cccCEEEccCCcCC
Q 005749 214 S----FPEFVTRFEALKELDI--SNNLFSGSIPEGLTR-----LSLEKLNLSHNNFS 259 (679)
Q Consensus 214 ~----~p~~~~~l~~L~~L~l--s~N~l~g~~p~~~~~-----l~L~~l~ls~N~l~ 259 (679)
. +...+...+.|++|+| ++|.|+..-...+.. -+|+.|+|++|.+.
T Consensus 108 ~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 108 SGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 3 5667778889999999 889997543222222 16999999999874
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=98.03 E-value=1.9e-05 Score=84.35 Aligned_cols=148 Identities=16% Similarity=0.159 Sum_probs=106.9
Q ss_pred cEEEEEcCCCCCcccCCccccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEEc
Q 005749 100 HLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRL 179 (679)
Q Consensus 100 ~l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~L 179 (679)
+++.+.|..+ ++..-...|.+ .+|+.++|.+ .++..-+..+.+|++|+.++|++|+++. ++...+.. .+|+.+.|
T Consensus 136 ~L~~i~l~~~-i~~I~~~aF~~-~~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~~-I~~~aF~~-~~L~~l~l 210 (401)
T 4fdw_A 136 QIAKVVLNEG-LKSIGDMAFFN-STVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKITK-LPASTFVY-AGIEEVLL 210 (401)
T ss_dssp CCSEEECCTT-CCEECTTTTTT-CCCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCSE-ECTTTTTT-CCCSEEEC
T ss_pred CccEEEeCCC-ccEECHHhcCC-CCceEEEeCC-CccEehHHHhhCcccCCeeecCCCcceE-echhhEee-cccCEEEe
Confidence 6888888765 55333346666 4799999996 6774445678899999999999999984 56666664 89999999
Q ss_pred cCCCCcccCCCCCCCCCCCCCccEEEccCccccccccccccCCCCCCEEEccCCcccccCCcccccc-ccCEEEccCCcC
Q 005749 180 HGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRL-SLEKLNLSHNNF 258 (679)
Q Consensus 180 s~N~l~~~~p~~~~~~~~~~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l-~L~~l~ls~N~l 258 (679)
.+| ++ .++...+ ..|.+|+.+++..| ++..-..+|.. .+|+.+.+ .|.++..-+..+..+ +|+.+++.+|.+
T Consensus 211 p~~-l~-~I~~~aF--~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~ 283 (401)
T 4fdw_A 211 PVT-LK-EIGSQAF--LKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTF 283 (401)
T ss_dssp CTT-CC-EECTTTT--TTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCC
T ss_pred CCc-hh-eehhhHh--hCCCCCCEEecCCC-ccCcccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCccc
Confidence 855 65 3444443 57889999999875 55333445665 78999998 455663445556655 699999988877
Q ss_pred C
Q 005749 259 S 259 (679)
Q Consensus 259 ~ 259 (679)
.
T Consensus 284 ~ 284 (401)
T 4fdw_A 284 N 284 (401)
T ss_dssp C
T ss_pred c
Confidence 5
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.83 E-value=6.8e-05 Score=80.00 Aligned_cols=74 Identities=5% Similarity=-0.056 Sum_probs=49.1
Q ss_pred CccccCCceEEEEEEeC-CCCEEEEEEcccCcc-------cCcccHHHHHHHHhccCC--CCCc-cceEEeeCCCCceEE
Q 005749 383 QVIEKTTYGTAYKAKLA-DGATIALRLLREGSC-------KDRSSCLPVIRQLGKVRH--ENLI-PLRAFYQGKRGEKLL 451 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~-------~~~~~~~~Ei~~l~~l~H--~nIv-~l~~~~~~~~~~~~l 451 (679)
+.||.|..+.||+++.. +++.++||....... ...+.+..|.++++.+.. +..+ +++.+ . .+..++
T Consensus 36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~-d--~~~~~l 112 (397)
T 2olc_A 36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS-D--TEMAVT 112 (397)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE-E--TTTTEE
T ss_pred EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE-c--CCccEE
Confidence 46899999999999854 478899998654211 123456889999888742 3444 45543 2 345689
Q ss_pred EEEecCCC
Q 005749 452 IYDYFPSR 459 (679)
Q Consensus 452 v~ey~~~g 459 (679)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.82 E-value=5.5e-05 Score=78.68 Aligned_cols=141 Identities=14% Similarity=0.212 Sum_probs=78.9
Q ss_pred ccccCCceEEEEEEeCCCCEEEEEEcccCcccCcccHHHHHHHHhccC-----CCCCccce-E-EeeCCCCceEEEEEec
Q 005749 384 VIEKTTYGTAYKAKLADGATIALRLLREGSCKDRSSCLPVIRQLGKVR-----HENLIPLR-A-FYQGKRGEKLLIYDYF 456 (679)
Q Consensus 384 ~ig~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~-----H~nIv~l~-~-~~~~~~~~~~lv~ey~ 456 (679)
.|+.|..+.||+....+| .+++|+.... .+....|++++..+. .|.++... | .+....+..++||||+
T Consensus 39 ~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i 113 (346)
T 2q83_A 39 VIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWI 113 (346)
T ss_dssp ECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECC
T ss_pred eccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEee
Confidence 455577889999987655 4889988752 233445666666553 24443311 1 1111145689999999
Q ss_pred CCCChH--------------HHhhcccCCC----------CCCCHHHHH-------------------------------
Q 005749 457 PSRTLH--------------DLLHDTIAGK----------PVLNWARRH------------------------------- 481 (679)
Q Consensus 457 ~~gsL~--------------~~l~~~~~~~----------~~l~~~~~~------------------------------- 481 (679)
+|..+. ..+|...... ..-.|....
T Consensus 114 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 193 (346)
T 2q83_A 114 EGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEID 193 (346)
T ss_dssp CCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHH
T ss_pred cCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHH
Confidence 986542 1122111100 012332210
Q ss_pred HHHHHHHHHHHHHhc--------C--CCCCeeecCCCCCCeeecCCCceEEeeccccc
Q 005749 482 KIALGIARGLAYLHT--------G--HEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQ 529 (679)
Q Consensus 482 ~i~~~ia~gL~~LH~--------~--~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 529 (679)
.+...+.+++++|+. . ....++|+|+++.|||++.++.+.|.||+.+.
T Consensus 194 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 194 GFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 111223445666653 0 23459999999999999888889999998764
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.62 E-value=0.00043 Score=70.18 Aligned_cols=74 Identities=12% Similarity=0.154 Sum_probs=54.1
Q ss_pred CccccCCceEEEEEEeCCCCEEEEEEcccCcccCcccHHHHHHHHhccCCC---CCccceEEeeCCCCceEEEEEecCCC
Q 005749 383 QVIEKTTYGTAYKAKLADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHE---NLIPLRAFYQGKRGEKLLIYDYFPSR 459 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~---nIv~l~~~~~~~~~~~~lv~ey~~~g 459 (679)
+.+|.|..+.||+.++.||+.|.+|+-..........|.+|.+.|+.+.-. -+.+++++ +.-++||||++.+
T Consensus 21 ~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~-----~~~~lv~e~l~~~ 95 (288)
T 3f7w_A 21 AERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW-----DDRTLAMEWVDER 95 (288)
T ss_dssp EEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE-----ETTEEEEECCCCC
T ss_pred EecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec-----cCceEEEEeeccc
Confidence 457889999999999999999999987654444445688999999888422 23344443 2347899999876
Q ss_pred Ch
Q 005749 460 TL 461 (679)
Q Consensus 460 sL 461 (679)
..
T Consensus 96 ~~ 97 (288)
T 3f7w_A 96 PP 97 (288)
T ss_dssp CC
T ss_pred CC
Confidence 53
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.58 E-value=0.00017 Score=77.47 Aligned_cols=77 Identities=8% Similarity=0.035 Sum_probs=47.7
Q ss_pred CCeeecCCCCCCeeecCCCceEEeecccccccCcccccchhccc--cccccccccccccc---CCCCcchhHHHHHHHHH
Q 005749 500 IPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALA--KADGYKAPELQRMK---KCSSRTDVYAFGILLLE 574 (679)
Q Consensus 500 ~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~---~~~~k~DV~S~Gvvl~E 574 (679)
..++|+|++|.|||+++++ +++.||+.+..-.+.. ...... -...|.+|+..... .-....++......+|+
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~--Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGF--DIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN 308 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHH--HHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHH--HHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence 3499999999999999876 9999999887543221 111111 11346666654311 11123556678888888
Q ss_pred HHhCC
Q 005749 575 ILIGK 579 (679)
Q Consensus 575 l~tg~ 579 (679)
.+.++
T Consensus 309 ~y~~~ 313 (420)
T 2pyw_A 309 LFNKR 313 (420)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 77653
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.48 E-value=0.00041 Score=71.21 Aligned_cols=138 Identities=16% Similarity=0.144 Sum_probs=89.5
Q ss_pred CccccCCceEEEEEEeCCCCEEEEEEcccCcccCcccHHHHHHHHhccC---CCCCccceEEeeCCCCceEEEEEecCCC
Q 005749 383 QVIEKTTYGTAYKAKLADGATIALRLLREGSCKDRSSCLPVIRQLGKVR---HENLIPLRAFYQGKRGEKLLIYDYFPSR 459 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~---H~nIv~l~~~~~~~~~~~~lv~ey~~~g 459 (679)
+.|+.|.+..+|+... ++..+++|+.... ....+..|.+.|+.+. ...+.+++++... .+..++||||+++.
T Consensus 42 ~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~-~g~~~lvme~l~G~ 116 (312)
T 3jr1_A 42 EKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNS-QGHSFLLLEALNKS 116 (312)
T ss_dssp EEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEEC-SSEEEEEEECCCCC
T ss_pred EEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeec-CCceEEEEEeccCC
Confidence 3578899999999986 4678888987542 2456889999998884 2557778887776 57899999999987
Q ss_pred ChHH-----------HhhcccC----C--------------CCCCCHHHHH---HHHH----------------HHHHH-
Q 005749 460 TLHD-----------LLHDTIA----G--------------KPVLNWARRH---KIAL----------------GIARG- 490 (679)
Q Consensus 460 sL~~-----------~l~~~~~----~--------------~~~l~~~~~~---~i~~----------------~ia~g- 490 (679)
.+.. .|+.... + ...-+|.... ++.. .+...
T Consensus 117 ~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l 196 (312)
T 3jr1_A 117 KNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIV 196 (312)
T ss_dssp CCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHH
T ss_pred CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHH
Confidence 6521 1222111 0 0012465321 1111 11111
Q ss_pred HHHHhc-CCCCCeeecCCCCCCeeecCCCceEEeecc
Q 005749 491 LAYLHT-GHEIPITHGNVRSKNVLVDDFFVSRLTEFG 526 (679)
Q Consensus 491 L~~LH~-~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 526 (679)
...|.. ...+.++|+|+.+.|++++.++ +.|.||.
T Consensus 197 ~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 197 ADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 223432 2245699999999999999887 8899974
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.13 E-value=0.0027 Score=65.61 Aligned_cols=141 Identities=12% Similarity=0.108 Sum_probs=74.2
Q ss_pred ccccCCceE-EEEEEeCCCCEEEEEEcccCcccCcccHHHHHHHHhccCCCC--CccceEEeeCCCCceEEEEEecCCCC
Q 005749 384 VIEKTTYGT-AYKAKLADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHEN--LIPLRAFYQGKRGEKLLIYDYFPSRT 460 (679)
Q Consensus 384 ~ig~G~~g~-Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~n--Iv~l~~~~~~~~~~~~lv~ey~~~gs 460 (679)
.++.|.... +|+....+|..+++|...... .+.+..|++++..+.... +.+++.+... .+ +++||++.+..
T Consensus 25 ~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~---~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~-~g--~ll~e~l~~~~ 98 (333)
T 3csv_A 25 PLAGDASSRRYQRLRSPTGAKAVLMDWSPEE---GGDTQPFVDLAQYLRNLDISAPEIYAEEHA-RG--LLLIEDLGDAL 98 (333)
T ss_dssp C--------CCEEEECTTCCEEEEEECCTTT---TCCSHHHHHHHHHHHHTTCBCCCEEEEETT-TT--EEEECCCCSCB
T ss_pred ECCCCCCCceEEEEEcCCCCeEEEEECCCCC---CccccHHHHHHHHHHhCCCCCCceeeecCC-CC--EEEEeeCCCcc
Confidence 344444443 667765446777777654421 145677888887774323 4456665332 23 78999998766
Q ss_pred hHHHhhccc---------------------C-CCCCCCHHHHH-------H-H------------HHHHHHHHHHHh---
Q 005749 461 LHDLLHDTI---------------------A-GKPVLNWARRH-------K-I------------ALGIARGLAYLH--- 495 (679)
Q Consensus 461 L~~~l~~~~---------------------~-~~~~l~~~~~~-------~-i------------~~~ia~gL~~LH--- 495 (679)
+.+.+.... . .-+.++..... . + ...+...++.+.
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 654432110 0 01112211100 0 0 001111222221
Q ss_pred cCCCCCeeecCCCCCCeeecCC----CceEEeecccccc
Q 005749 496 TGHEIPITHGNVRSKNVLVDDF----FVSRLTEFGLDQL 530 (679)
Q Consensus 496 ~~~~~~ivHrDlkp~NILl~~~----~~~kl~DFGla~~ 530 (679)
......++|+|+.+.||+++++ ..+.|.||+.+..
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 1123459999999999999874 6789999998764
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.03 E-value=0.0033 Score=63.98 Aligned_cols=70 Identities=9% Similarity=0.090 Sum_probs=44.7
Q ss_pred CccccCCceEEEEEEeCCCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCc-cceEEeeCCCCceEEEEEec-CCCC
Q 005749 383 QVIEKTTYGTAYKAKLADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLI-PLRAFYQGKRGEKLLIYDYF-PSRT 460 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv-~l~~~~~~~~~~~~lv~ey~-~~gs 460 (679)
+.|+.|....+|+. ..+++|+...... ......+|+++++.+....+. ++++++ .+.-++|+||+ ++.+
T Consensus 24 ~~l~gG~tN~~~~~-----~~~vlR~~~~~~~-~~~~r~~E~~~l~~l~~~g~~P~~~~~~---~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 24 LERLGGLTNLVFRA-----GDLCLRIPGKGTE-EYINRANEAVAAREAAKAGVSPEVLHVD---PATGVMVTRYIAGAQT 94 (301)
T ss_dssp EEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC---TTTCCEEEECCTTCEE
T ss_pred eEcCCcccccccee-----eeEEEECCCCCcc-ceeCHHHHHHHHHHHHHcCCCCceEEEE---CCCCEEEEeecCCCcc
Confidence 45778888999998 5688888765322 223456788888887544443 455443 23457899999 6544
Q ss_pred h
Q 005749 461 L 461 (679)
Q Consensus 461 L 461 (679)
+
T Consensus 95 l 95 (301)
T 3dxq_A 95 M 95 (301)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=96.99 E-value=0.00027 Score=65.59 Aligned_cols=59 Identities=7% Similarity=-0.019 Sum_probs=31.6
Q ss_pred CCCeeecccCcccccCCcccCCCCCCCEEEccCCC-CCCcChhhHHhh---cccCcEEEccCC
Q 005749 124 MLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANL-FTGVLAPSIWNL---CDRLVSLRLHGN 182 (679)
Q Consensus 124 ~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~-l~g~~p~~~~~~---~~~L~~L~Ls~N 182 (679)
+|+.|||+++.++..=-..+..+++|++|+|+++. ++..--..+... +++|++|+|+++
T Consensus 62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C 124 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISC 124 (176)
T ss_dssp CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESC
T ss_pred eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCC
Confidence 56777777776654322345667777777777764 543211122221 134666666554
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.86 E-value=0.0025 Score=65.47 Aligned_cols=143 Identities=13% Similarity=0.133 Sum_probs=78.9
Q ss_pred ccccCCceEEEEEEeCCCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCC--ccceEEe-----eCCCCceEEEEEec
Q 005749 384 VIEKTTYGTAYKAKLADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENL--IPLRAFY-----QGKRGEKLLIYDYF 456 (679)
Q Consensus 384 ~ig~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nI--v~l~~~~-----~~~~~~~~lv~ey~ 456 (679)
.|+.|....+|+....+| .+++|..... ...+.+..|++++..++...+ .+++... ....+..+++|+|+
T Consensus 29 ~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~l 105 (322)
T 2ppq_A 29 GIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFL 105 (322)
T ss_dssp EECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECC
T ss_pred ccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEeC
Confidence 456677789999987666 6778887652 134566778888877743222 2232210 00135678999999
Q ss_pred CCCChHH--------------HhhcccCC--CC------CCCHHHHHH------------HHHHHHHHHHHHhcC----C
Q 005749 457 PSRTLHD--------------LLHDTIAG--KP------VLNWARRHK------------IALGIARGLAYLHTG----H 498 (679)
Q Consensus 457 ~~gsL~~--------------~l~~~~~~--~~------~l~~~~~~~------------i~~~ia~gL~~LH~~----~ 498 (679)
+|..+.. .++..... .. ...|..... +...+.+.+++++.. .
T Consensus 106 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~~ 185 (322)
T 2ppq_A 106 EGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDL 185 (322)
T ss_dssp CCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSS
T ss_pred CCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcccC
Confidence 9865321 11211000 00 012332110 011234445555431 1
Q ss_pred CCCeeecCCCCCCeeecCCCceEEeeccccc
Q 005749 499 EIPITHGNVRSKNVLVDDFFVSRLTEFGLDQ 529 (679)
Q Consensus 499 ~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 529 (679)
...++|+|+++.|||++++..+.|.||+.+.
T Consensus 186 ~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 186 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred CcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 2358999999999999987666899998765
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.75 E-value=0.01 Score=61.05 Aligned_cols=141 Identities=11% Similarity=0.142 Sum_probs=80.2
Q ss_pred cccCCceEEEEEEeCCCCEEEEEEcccCcccCcccHHHHHHHHhccCCCC--CccceEE-----eeCCCCceEEEEEecC
Q 005749 385 IEKTTYGTAYKAKLADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHEN--LIPLRAF-----YQGKRGEKLLIYDYFP 457 (679)
Q Consensus 385 ig~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~n--Iv~l~~~-----~~~~~~~~~lv~ey~~ 457 (679)
++ |....||+....+|+.+++|...... ...+.+..|.+++..+.... +.+++.. ... .+..+++|||++
T Consensus 34 l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~-~g~~~~l~~~i~ 110 (328)
T 1zyl_A 34 LN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNH-QGFYFAVFPSVG 110 (328)
T ss_dssp EC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEE-TTEEEEEEECCC
T ss_pred ec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEE-CCEEEEEEEecC
Confidence 44 77779999887778889999986432 13456777888888774222 3344432 111 345688999998
Q ss_pred CCChH-----H------H---hhcccC-----CCCCCCHHHH----------------------HHHHHHHHHHHHHHhc
Q 005749 458 SRTLH-----D------L---LHDTIA-----GKPVLNWARR----------------------HKIALGIARGLAYLHT 496 (679)
Q Consensus 458 ~gsL~-----~------~---l~~~~~-----~~~~l~~~~~----------------------~~i~~~ia~gL~~LH~ 496 (679)
|..+. . . +|.... ....+++... ...+..+...++-+..
T Consensus 111 G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 190 (328)
T 1zyl_A 111 GRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWR 190 (328)
T ss_dssp CEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCC
T ss_pred CCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHhh
Confidence 75432 0 0 111100 0112232211 0111122222222211
Q ss_pred -CCCCCeeecCCCCCCeeecCCCceEEeecccccc
Q 005749 497 -GHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQL 530 (679)
Q Consensus 497 -~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 530 (679)
.....++|+|+++.|||++ + .+.+.||+.+..
T Consensus 191 ~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 191 EDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp SCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 1223489999999999999 4 899999987753
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.75 E-value=0.0019 Score=56.90 Aligned_cols=54 Identities=28% Similarity=0.261 Sum_probs=23.5
Q ss_pred EEcCCCCCc-ccCCccccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCC
Q 005749 104 IQLPSANLT-GSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLF 159 (679)
Q Consensus 104 l~l~~n~l~-g~ip~~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l 159 (679)
++-++++|+ ..+|..|. ++|++|+|++|+|+..-+..+..+++|+.|+|++|.+
T Consensus 13 v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~ 67 (130)
T 3rfe_A 13 VDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPW 67 (130)
T ss_dssp EECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCC
T ss_pred EEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCe
Confidence 344555554 34443221 2345555555555422222234444455555555544
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=96.74 E-value=0.00094 Score=61.95 Aligned_cols=83 Identities=11% Similarity=0.035 Sum_probs=58.9
Q ss_pred ccEEEEEcCCCCCcccCCccccCCCCCCeeecccCc-ccccCCcccCCC----CCCCEEEccCCC-CCCcChhhHHhhcc
Q 005749 99 IHLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNS-LKGTIPFELGYS----SSLSEIDLSANL-FTGVLAPSIWNLCD 172 (679)
Q Consensus 99 ~~l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~-l~g~ip~~l~~l----~~L~~L~Ls~N~-l~g~~p~~~~~~~~ 172 (679)
.+++.|+|+++.++..--..+..+++|++|+|+++. |+..-=..++.+ ++|++|||+++. +|..--..+.. ++
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~-~~ 139 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHH-FR 139 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGG-CT
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhc-CC
Confidence 369999999999875544567899999999999995 775333345543 479999999974 76421123333 46
Q ss_pred cCcEEEccCC
Q 005749 173 RLVSLRLHGN 182 (679)
Q Consensus 173 ~L~~L~Ls~N 182 (679)
+|+.|+|++.
T Consensus 140 ~L~~L~L~~c 149 (176)
T 3e4g_A 140 NLKYLFLSDL 149 (176)
T ss_dssp TCCEEEEESC
T ss_pred CCCEEECCCC
Confidence 7777777765
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.70 E-value=0.0043 Score=66.68 Aligned_cols=72 Identities=18% Similarity=0.265 Sum_probs=48.9
Q ss_pred CccccCCceEEEEEEeCC--------CCEEEEEEcccCcccCcccHHHHHHHHhccCCCCC-ccceEEeeCCCCceEEEE
Q 005749 383 QVIEKTTYGTAYKAKLAD--------GATIALRLLREGSCKDRSSCLPVIRQLGKVRHENL-IPLRAFYQGKRGEKLLIY 453 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~~~--------~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nI-v~l~~~~~~~~~~~~lv~ 453 (679)
+.|+.|....||+....+ +..+.+|+.... ...+.+.+|..+++.+...++ .++++.+.+ .+|+
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~-----g~v~ 151 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG-----GRLE 151 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT-----EEEE
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC-----CEEE
Confidence 356778888999998753 578999987432 111566789999988854444 456665432 2899
Q ss_pred EecCCCCh
Q 005749 454 DYFPSRTL 461 (679)
Q Consensus 454 ey~~~gsL 461 (679)
||+++.++
T Consensus 152 e~l~G~~l 159 (429)
T 1nw1_A 152 EYIPSRPL 159 (429)
T ss_dssp CCCCEEEC
T ss_pred EEeCCccc
Confidence 99986443
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.70 E-value=0.00056 Score=64.71 Aligned_cols=67 Identities=15% Similarity=0.059 Sum_probs=35.9
Q ss_pred cccCCCCCCeeecccC-ccccc----CCcccCCCCCCCEEEccCCCCCCcC----hhhHHhhcccCcEEEccCCCCc
Q 005749 118 ELGEFSMLQSLYLNVN-SLKGT----IPFELGYSSSLSEIDLSANLFTGVL----APSIWNLCDRLVSLRLHGNSLT 185 (679)
Q Consensus 118 ~l~~l~~L~~L~L~~N-~l~g~----ip~~l~~l~~L~~L~Ls~N~l~g~~----p~~~~~~~~~L~~L~Ls~N~l~ 185 (679)
-+.+-+.|+.|+|++| .|... +-..+..-+.|+.|+|++|.+...- ...+... +.|+.|+|++|.|+
T Consensus 36 ll~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N-~tL~~L~L~~N~Ig 111 (197)
T 1pgv_A 36 LREDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETS-PSLRVLNVESNFLT 111 (197)
T ss_dssp HHTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHC-SSCCEEECCSSBCC
T ss_pred HHhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcC-CccCeEecCCCcCC
Confidence 3344566777777764 65421 3334455566777777777775321 1112222 34556666655554
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=96.44 E-value=0.01 Score=62.82 Aligned_cols=131 Identities=17% Similarity=0.211 Sum_probs=73.0
Q ss_pred cccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEEccCCCCcccCCCCCCCCCC
Q 005749 118 ELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNST 197 (679)
Q Consensus 118 ~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~~~~ 197 (679)
.|..+++|+.+.+.++..+ .-...+.++++|+.+++.. .++ .++...+..+.+|+.++|..| ++ .|....+ ..
T Consensus 260 aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~~-~i~-~I~~~aF~~c~~L~~i~lp~~-v~-~I~~~aF--~~ 332 (394)
T 4gt6_A 260 AFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFSS-RIT-ELPESVFAGCISLKSIDIPEG-IT-QILDDAF--AG 332 (394)
T ss_dssp TTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECCT-TCC-EECTTTTTTCTTCCEEECCTT-CC-EECTTTT--TT
T ss_pred eeeecccccEEecccccce-ecCcccccccccccccCCC-ccc-ccCceeecCCCCcCEEEeCCc-cc-EehHhHh--hC
Confidence 4566777888877765443 2334466778888888863 344 345555555678888888654 43 2333333 46
Q ss_pred CCCccEEEccCccccccccccccCCCCCCEEEccCCcccccCCccccccccCEEEccCCcC
Q 005749 198 CSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRLSLEKLNLSHNNF 258 (679)
Q Consensus 198 ~~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~L~~l~ls~N~l 258 (679)
|.+|+.+.+..+ ++..-..+|.++++|+.+++.+|.... -.....-.|+.+.+..|.+
T Consensus 333 C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~~~--~~~~~~~~L~~i~i~~~~~ 390 (394)
T 4gt6_A 333 CEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRSQW--NAISTDSGLQNLPVAPGSI 390 (394)
T ss_dssp CTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHHHH--HTCBCCCCC----------
T ss_pred CCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCceeeh--hhhhccCCCCEEEeCCCCE
Confidence 778888888654 552334567788888888887776432 1122222566666666544
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.36 E-value=0.0015 Score=61.74 Aligned_cols=65 Identities=14% Similarity=0.187 Sum_probs=49.7
Q ss_pred CccEEEEEcCCC-CCcc----cCCccccCCCCCCeeecccCccccc----CCcccCCCCCCCEEEccCCCCCCc
Q 005749 98 SIHLLSIQLPSA-NLTG----SLPRELGEFSMLQSLYLNVNSLKGT----IPFELGYSSSLSEIDLSANLFTGV 162 (679)
Q Consensus 98 ~~~l~~l~l~~n-~l~g----~ip~~l~~l~~L~~L~L~~N~l~g~----ip~~l~~l~~L~~L~Ls~N~l~g~ 162 (679)
...++.|+|++| ++.. .|-..+..-+.|+.|+|++|.|... |-..+..-+.|++|+|++|.+...
T Consensus 40 n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~ 113 (197)
T 1pgv_A 40 DTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPE 113 (197)
T ss_dssp CSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHH
T ss_pred CCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHH
Confidence 446899999986 6642 2566778889999999999999743 333444557899999999999753
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.34 E-value=0.0099 Score=62.35 Aligned_cols=73 Identities=8% Similarity=0.105 Sum_probs=44.8
Q ss_pred CccccCCceEEEEEEeCC---------CCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCc-cceEEeeCCCCceEEE
Q 005749 383 QVIEKTTYGTAYKAKLAD---------GATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLI-PLRAFYQGKRGEKLLI 452 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~~~---------~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv-~l~~~~~~~~~~~~lv 452 (679)
+.++.|....+|+....+ +..+++|+...... ...+...|.++++.+...+++ ++++.. . -++|
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~---~--~~~v 112 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTF---N--GGRI 112 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEE---T--TEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEec---C--CcEE
Confidence 346667778899998654 26888888755321 122457888888888544444 565443 1 2689
Q ss_pred EEecCCCCh
Q 005749 453 YDYFPSRTL 461 (679)
Q Consensus 453 ~ey~~~gsL 461 (679)
|||++|..+
T Consensus 113 ~e~i~G~~l 121 (369)
T 3c5i_A 113 EEWLYGDPL 121 (369)
T ss_dssp EECCCSEEC
T ss_pred EEEecCCcC
Confidence 999987543
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.33 E-value=0.029 Score=53.35 Aligned_cols=103 Identities=15% Similarity=0.084 Sum_probs=67.1
Q ss_pred CChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccc
Q 005749 459 RTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADE 538 (679)
Q Consensus 459 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 538 (679)
-||.++|... +.++++.+++.++.|.+++|.-+-.+..+ ..+=+.|..|++..+|.+...+ +.+.
T Consensus 33 vSL~eIL~~~---~~PlsEEqaWALc~Qc~~~L~~~~~~~~~--~~~i~~~~~i~l~~dG~V~f~~-~~s~--------- 97 (229)
T 2yle_A 33 LSLEEILRLY---NQPINEEQAWAVCYQCCGSLRAAARRRQP--RHRVRSAAQIRVWRDGAVTLAP-AADD--------- 97 (229)
T ss_dssp EEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred ccHHHHHHHc---CCCcCHHHHHHHHHHHHHHHHhhhhcccC--CceecCCcceEEecCCceeccc-cccc---------
Confidence 3899999876 57899999999999999998776211101 1222446889999999887764 1111
Q ss_pred hhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCC
Q 005749 539 MVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKP 581 (679)
Q Consensus 539 ~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p 581 (679)
.....+.|||... ...+.+.=|||+|+++|.-+--..|
T Consensus 98 ----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 ----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp -------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred ----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 1122366888764 3456788999999999998854433
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.29 E-value=0.0059 Score=53.71 Aligned_cols=57 Identities=23% Similarity=0.276 Sum_probs=36.7
Q ss_pred cEEEccCCCCc-ccCCCCCCCCCCCCCccEEEccCccccccccccccCCCCCCEEEccCCccc
Q 005749 175 VSLRLHGNSLT-AALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFS 236 (679)
Q Consensus 175 ~~L~Ls~N~l~-~~~p~~~~~~~~~~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~ 236 (679)
..++.+++.|+ ..+|..+ ..+|++|+|++|+|+..-+..|..+++|+.|+|++|.+.
T Consensus 11 ~~v~Cs~~~L~~~~vP~~l-----p~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 11 TLVDCGRRGLTWASLPTAF-----PVDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp TEEECCSSCCCTTTSCSCC-----CTTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred CEEEeCCCCCccccCCCCC-----CcCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 35677777775 2344321 235777777777777544556677778888888877663
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.17 E-value=0.028 Score=60.70 Aligned_cols=73 Identities=15% Similarity=0.132 Sum_probs=47.4
Q ss_pred CccccCCceEEEEEEeCC-CCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCc-cceEEeeCCCCceEEEEEecCCCC
Q 005749 383 QVIEKTTYGTAYKAKLAD-GATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLI-PLRAFYQGKRGEKLLIYDYFPSRT 460 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv-~l~~~~~~~~~~~~lv~ey~~~gs 460 (679)
+.|+.|-...+|+....+ +..+++|+..... ...-+..+|..++..+...+++ ++++++. . .+||||+++.+
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~-~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~---G~v~e~I~G~~ 187 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKT-DEIINREREKKISCILYNKNIAKKIYVFFT--N---GRIEEFMDGYA 187 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-C-CSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T---EEEEECCCSEE
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCCh-hhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C---eEEEEeeCCcc
Confidence 456778888999999765 4788888864432 1222336899999988755554 5666653 2 25999998754
Q ss_pred h
Q 005749 461 L 461 (679)
Q Consensus 461 L 461 (679)
|
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.91 E-value=0.044 Score=56.65 Aligned_cols=68 Identities=13% Similarity=0.048 Sum_probs=43.2
Q ss_pred ccCCceEEEEEEeCCCCEEEEEEcccCcccCcccHHHHHHHHhccCC---CCCccceEE------eeCCCCceEEEEEec
Q 005749 386 EKTTYGTAYKAKLADGATIALRLLREGSCKDRSSCLPVIRQLGKVRH---ENLIPLRAF------YQGKRGEKLLIYDYF 456 (679)
Q Consensus 386 g~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H---~nIv~l~~~------~~~~~~~~~lv~ey~ 456 (679)
|.|....||+....+| .+++|+..... ...|++.+..+.. |.+.+.+.. ... .+..+++|+|+
T Consensus 32 G~g~~N~vy~v~~~~g-~~vLK~~~~~~------~~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~-~g~~~~l~~~i 103 (339)
T 3i1a_A 32 GADTNAFAYQADSESK-SYFIKLKYGYH------DEINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQL-KHFKIIAYPFI 103 (339)
T ss_dssp TSCSSCEEEEEECSSC-EEEEEEEECSS------CCHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEEC-SSEEEEEEECC
T ss_pred cCccccceEEEEeCCC-CEEEEEecCcc------chHHHHHHHHHHhcCCcccccceecCCCCEEEEE-CCEEEEEEecc
Confidence 3344678999998777 89999876532 1356666666632 224444432 112 45679999999
Q ss_pred CCCCh
Q 005749 457 PSRTL 461 (679)
Q Consensus 457 ~~gsL 461 (679)
+|..+
T Consensus 104 ~G~~~ 108 (339)
T 3i1a_A 104 HAPNG 108 (339)
T ss_dssp CCCBT
T ss_pred CCCcC
Confidence 98765
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=95.80 E-value=0.03 Score=58.87 Aligned_cols=140 Identities=15% Similarity=0.194 Sum_probs=80.6
Q ss_pred ccccCCceEEEEEEeC--------CCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCC-ccceEEeeCCCCceEEEEE
Q 005749 384 VIEKTTYGTAYKAKLA--------DGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENL-IPLRAFYQGKRGEKLLIYD 454 (679)
Q Consensus 384 ~ig~G~~g~Vy~~~~~--------~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nI-v~l~~~~~~~~~~~~lv~e 454 (679)
.+..|....+|+.... +++.+.+|+.... ........+|.++++.+.-..+ .++++++.+ + +|||
T Consensus 57 ~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~--g---~v~e 130 (379)
T 3feg_A 57 PVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE--G---RLEQ 130 (379)
T ss_dssp EC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT--E---EEEE
T ss_pred EcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC--c---cEEE
Confidence 4555667788998864 2478899886332 2234567789999988853333 456665542 2 9999
Q ss_pred ecCCCChHHH-----------------hhccc-CCCCCCC--HHHHHHHHHHHHH-------------------HHHHH-
Q 005749 455 YFPSRTLHDL-----------------LHDTI-AGKPVLN--WARRHKIALGIAR-------------------GLAYL- 494 (679)
Q Consensus 455 y~~~gsL~~~-----------------l~~~~-~~~~~l~--~~~~~~i~~~ia~-------------------gL~~L- 494 (679)
|++|.+|..- +|... ....... |.+..++..++.. .++.|
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 9998654311 11110 0011122 4555555544321 22333
Q ss_pred ---hcC-CCCCeeecCCCCCCeeecCC----CceEEeeccccc
Q 005749 495 ---HTG-HEIPITHGNVRSKNVLVDDF----FVSRLTEFGLDQ 529 (679)
Q Consensus 495 ---H~~-~~~~ivHrDlkp~NILl~~~----~~~kl~DFGla~ 529 (679)
... ....++|+|+.+.||+++++ +.+.+.||..+.
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 221 22358999999999999876 689999998765
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=95.53 E-value=0.062 Score=56.70 Aligned_cols=127 Identities=15% Similarity=0.190 Sum_probs=68.2
Q ss_pred ccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEEccCCCCcccCCCCCCCCCCC
Q 005749 119 LGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTC 198 (679)
Q Consensus 119 l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~~~~~ 198 (679)
+..+.+|+.+.+..|..+ .-...+..+..|+.+.+..+. ++...+..+.+|+.+.+.+| ++ .|++..+ ..|
T Consensus 249 f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~----i~~~~F~~~~~L~~i~l~~~-i~-~I~~~aF--~~c 319 (394)
T 4fs7_A 249 FYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVI----VPEKTFYGCSSLTEVKLLDS-VK-FIGEEAF--ESC 319 (394)
T ss_dssp TTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSE----ECTTTTTTCTTCCEEEECTT-CC-EECTTTT--TTC
T ss_pred ccccccceeEEcCCCcce-eeccccccccccceeccCcee----eccccccccccccccccccc-cc-eechhhh--cCC
Confidence 444555666665555433 223334555566665555443 22333333467777777654 33 2333332 456
Q ss_pred CCccEEEccCccccccccccccCCCCCCEEEccCCcccccCCcccccc-ccCEEEccCC
Q 005749 199 SDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRL-SLEKLNLSHN 256 (679)
Q Consensus 199 ~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l-~L~~l~ls~N 256 (679)
++|+.++|..+ ++..-..+|.++++|+.+++..| ++..-...+... +|+.+++..|
T Consensus 320 ~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~ 376 (394)
T 4fs7_A 320 TSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR 376 (394)
T ss_dssp TTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG
T ss_pred CCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC
Confidence 77777777543 54333456777777777777665 542223344444 5777777554
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=95.52 E-value=0.029 Score=59.31 Aligned_cols=127 Identities=17% Similarity=0.291 Sum_probs=80.0
Q ss_pred ccEEEEEcCCCCCcccCCccccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEE
Q 005749 99 IHLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLR 178 (679)
Q Consensus 99 ~~l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~ 178 (679)
..++.+.+..+-. ..-...+.++++|+.+.+. +.++..-...+.++.+|+.++|..| ++ .|....+..+.+|+.+.
T Consensus 265 ~~L~~i~lp~~~~-~I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~-~I~~~aF~~C~~L~~i~ 340 (394)
T 4gt6_A 265 AYLASVKMPDSVV-SIGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-IT-QILDDAFAGCEQLERIA 340 (394)
T ss_dssp SSCCEEECCTTCC-EECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CC-EECTTTTTTCTTCCEEE
T ss_pred ccccEEecccccc-eecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-cc-EehHhHhhCCCCCCEEE
Confidence 3456666654332 1223467889999999997 4566333345778999999999876 55 35555566678999999
Q ss_pred ccCCCCcccCCCCCCCCCCCCCccEEEccCccccccccccccCCCCCCEEEccCCccc
Q 005749 179 LHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFS 236 (679)
Q Consensus 179 Ls~N~l~~~~p~~~~~~~~~~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~ 236 (679)
|..+ ++ .++...+ ..|++|+.+++.+|.... ..+....+|+.+.+..|.+.
T Consensus 341 ip~s-v~-~I~~~aF--~~C~~L~~i~~~~~~~~~---~~~~~~~~L~~i~i~~~~~~ 391 (394)
T 4gt6_A 341 IPSS-VT-KIPESAF--SNCTALNNIEYSGSRSQW---NAISTDSGLQNLPVAPGSID 391 (394)
T ss_dssp ECTT-CC-BCCGGGG--TTCTTCCEEEESSCHHHH---HTCBCCCCC-----------
T ss_pred ECcc-cC-EEhHhHh--hCCCCCCEEEECCceeeh---hhhhccCCCCEEEeCCCCEE
Confidence 9765 55 3444333 579999999999987642 45677889999988777653
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=95.11 E-value=0.063 Score=56.21 Aligned_cols=133 Identities=13% Similarity=0.158 Sum_probs=83.0
Q ss_pred CccccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEEccCCCCcccCCCCCCCC
Q 005749 116 PRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPN 195 (679)
Q Consensus 116 p~~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~~ 195 (679)
...+....+|+.+.+..+ +...-...+.++.+|+.+.+..+ ++ .+....+..+.+|+.+.+..+ ++ .++...+
T Consensus 210 ~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~-~I~~~aF~~~~~l~~i~l~~~-i~-~i~~~aF-- 282 (379)
T 4h09_A 210 AYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VT-SIGSFLLQNCTALKTLNFYAK-VK-TVPYLLC-- 282 (379)
T ss_dssp TTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CC-EECTTTTTTCTTCCEEEECCC-CS-EECTTTT--
T ss_pred ecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-cc-EeCccccceeehhcccccccc-ce-ecccccc--
Confidence 345566778888887655 33233445667788888888766 44 234444454577888888654 33 2333332
Q ss_pred CCCCCccEEEccCccccccccccccCCCCCCEEEccCCcccccCCcccccc-ccCEEEccCC
Q 005749 196 STCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRL-SLEKLNLSHN 256 (679)
Q Consensus 196 ~~~~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l-~L~~l~ls~N 256 (679)
..|++|+.+.+.++.++..-...|.++.+|+.++|..+ ++-.-...+... +|+.+.+..|
T Consensus 283 ~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~ 343 (379)
T 4h09_A 283 SGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPKS 343 (379)
T ss_dssp TTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCTT
T ss_pred ccccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc
Confidence 46788888888888777444567888888888888654 542223345443 5776665443
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=94.79 E-value=0.12 Score=53.99 Aligned_cols=130 Identities=13% Similarity=0.188 Sum_probs=75.5
Q ss_pred ccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEEccCCCCcccCCCCCCCCCCC
Q 005749 119 LGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTC 198 (679)
Q Consensus 119 l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~~~~~ 198 (679)
+.....+..+.+..+.-. .....+..+.+|+.+.+..+- + .++...+..+..|+.+.+..+ ++ .+....+ ..|
T Consensus 190 ~~~~~~~~~~~~~~~~~~-i~~~~f~~~~~l~~i~~~~~~-~-~i~~~~f~~~~~L~~i~lp~~-v~-~I~~~aF--~~~ 262 (379)
T 4h09_A 190 YPAAKTGTEFTIPSTVKT-VTAYGFSYGKNLKKITITSGV-T-TLGDGAFYGMKALDEIAIPKN-VT-SIGSFLL--QNC 262 (379)
T ss_dssp CCTTCCCSEEECCTTCCE-ECTTTTTTCSSCSEEECCTTC-C-EECTTTTTTCSSCCEEEECTT-CC-EECTTTT--TTC
T ss_pred ccccccccccccccceeE-Eeecccccccccceeeeccce-e-EEccccccCCccceEEEcCCC-cc-EeCcccc--cee
Confidence 334445555554443322 334445567778888876552 2 233333344577888888765 43 2333222 456
Q ss_pred CCccEEEccCccccccccccccCCCCCCEEEccCCcccccCCcccccc-ccCEEEccCC
Q 005749 199 SDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRL-SLEKLNLSHN 256 (679)
Q Consensus 199 ~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l-~L~~l~ls~N 256 (679)
.+|+.+.+..+ +...-...|..+++|+.+.+.+|.++..-...+... +|+.++|..+
T Consensus 263 ~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~ 320 (379)
T 4h09_A 263 TALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA 320 (379)
T ss_dssp TTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT
T ss_pred ehhcccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc
Confidence 77888887644 442333467778888888888877763334455554 6888887654
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=94.76 E-value=0.086 Score=55.58 Aligned_cols=123 Identities=16% Similarity=0.189 Sum_probs=85.2
Q ss_pred cEEEEEcCCCCCcccCCccccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEEc
Q 005749 100 HLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRL 179 (679)
Q Consensus 100 ~l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~L 179 (679)
.+..+.+..+.. ..-...+..+..|+.+.+..+.+. ...+..+.+|+.+.+..| ++ .|+...+..+++|+.++|
T Consensus 254 ~l~~~~~~~~~~-~i~~~~F~~~~~l~~~~~~~~~i~---~~~F~~~~~L~~i~l~~~-i~-~I~~~aF~~c~~L~~i~l 327 (394)
T 4fs7_A 254 DLESISIQNNKL-RIGGSLFYNCSGLKKVIYGSVIVP---EKTFYGCSSLTEVKLLDS-VK-FIGEEAFESCTSLVSIDL 327 (394)
T ss_dssp SCCEEEECCTTC-EECSCTTTTCTTCCEEEECSSEEC---TTTTTTCTTCCEEEECTT-CC-EECTTTTTTCTTCCEECC
T ss_pred cceeEEcCCCcc-eeeccccccccccceeccCceeec---cccccccccccccccccc-cc-eechhhhcCCCCCCEEEe
Confidence 344555544432 223345778889999888776542 234677899999999876 54 355555655689999999
Q ss_pred cCCCCcccCCCCCCCCCCCCCccEEEccCccccccccccccCCCCCCEEEccCC
Q 005749 180 HGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNN 233 (679)
Q Consensus 180 s~N~l~~~~p~~~~~~~~~~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N 233 (679)
.++ ++ .++...+ ..|++|+.+.+..| ++..-..+|.++++|+.+++..|
T Consensus 328 p~~-v~-~I~~~aF--~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~ 376 (394)
T 4fs7_A 328 PYL-VE-EIGKRSF--RGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR 376 (394)
T ss_dssp CTT-CC-EECTTTT--TTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG
T ss_pred CCc-cc-EEhHHhc--cCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC
Confidence 755 55 3444443 57899999999877 66444567999999999999765
|
| >2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A | Back alignment and structure |
|---|
Probab=94.08 E-value=0.036 Score=36.74 Aligned_cols=26 Identities=31% Similarity=0.677 Sum_probs=19.2
Q ss_pred CCCCCCcchhhhhHHHHHHHHHHHHH
Q 005749 294 SRLSSGAIAGLVIGLMTGAVVFASLL 319 (679)
Q Consensus 294 ~~~s~~~i~~iv~~~~~~~~~~~~l~ 319 (679)
++++.+.++++++|.++++++++.++
T Consensus 6 ~~ls~GaIAGiVvG~v~gv~li~~l~ 31 (38)
T 2k1k_A 6 RGLTGGEIVAVIFGLLLGAALLLGIL 31 (38)
T ss_dssp TTCCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred CCCCCCceeeeehHHHHHHHHHHHHH
Confidence 45677889999999888766655544
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=93.64 E-value=0.35 Score=51.39 Aligned_cols=72 Identities=10% Similarity=0.082 Sum_probs=47.2
Q ss_pred ccccCCceEEEEEEeCC--------CCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCc-cceEEeeCCCCceEEEEE
Q 005749 384 VIEKTTYGTAYKAKLAD--------GATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLI-PLRAFYQGKRGEKLLIYD 454 (679)
Q Consensus 384 ~ig~G~~g~Vy~~~~~~--------~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv-~l~~~~~~~~~~~~lv~e 454 (679)
.+..|-...+|+....+ +..+++|+..... ...-+..+|.++++.+.-..++ ++++.+. -++|||
T Consensus 77 ~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~~-----~~~I~e 150 (424)
T 3mes_A 77 QIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADFP-----EGRIEE 150 (424)
T ss_dssp EECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET-----TEEEEE
T ss_pred EcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEcC-----CCEEEE
Confidence 45557777899988753 5788998865432 2233457899998888544443 4554322 268999
Q ss_pred ecCCCCh
Q 005749 455 YFPSRTL 461 (679)
Q Consensus 455 y~~~gsL 461 (679)
|++|..|
T Consensus 151 fI~G~~l 157 (424)
T 3mes_A 151 FIDGEPL 157 (424)
T ss_dssp CCCSEEC
T ss_pred EeCCccC
Confidence 9998654
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=86.01 E-value=0.098 Score=56.53 Aligned_cols=58 Identities=9% Similarity=-0.008 Sum_probs=16.5
Q ss_pred CccccCCceEEEEEEeCC-CCEEEE------EEcccCc--ccCcccHHHHHHHHhccCCCCCccceEEee
Q 005749 383 QVIEKTTYGTAYKAKLAD-GATIAL------RLLREGS--CKDRSSCLPVIRQLGKVRHENLIPLRAFYQ 443 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~~~-~~~vAv------K~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~ 443 (679)
+.+| ||.||+|.+.. ..+||| |..+... .+....|.+|..++.+.+|||+++.++|-.
T Consensus 148 ~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 148 EHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp TTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred ccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence 4555 99999999754 468898 7766532 233457889999999999999999988754
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=85.69 E-value=0.89 Score=30.96 Aligned_cols=7 Identities=43% Similarity=0.738 Sum_probs=3.5
Q ss_pred chhhhhH
Q 005749 301 IAGLVIG 307 (679)
Q Consensus 301 i~~iv~~ 307 (679)
+++.++|
T Consensus 14 Ia~~vVG 20 (44)
T 2jwa_A 14 IISAVVG 20 (44)
T ss_dssp HHHHHHH
T ss_pred hHHHHHH
Confidence 4445555
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=85.55 E-value=0.92 Score=30.95 Aligned_cols=7 Identities=14% Similarity=0.567 Sum_probs=2.7
Q ss_pred hhhHHHH
Q 005749 304 LVIGLMT 310 (679)
Q Consensus 304 iv~~~~~ 310 (679)
|++|++.
T Consensus 12 IA~gVVg 18 (44)
T 2l2t_A 12 IAAGVIG 18 (44)
T ss_dssp HHHHHHH
T ss_pred EEEeehH
Confidence 3333333
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=85.52 E-value=2.3 Score=44.73 Aligned_cols=29 Identities=17% Similarity=0.314 Sum_probs=24.1
Q ss_pred eeecCCCCCCeee------cCCCceEEeecccccc
Q 005749 502 ITHGNVRSKNVLV------DDFFVSRLTEFGLDQL 530 (679)
Q Consensus 502 ivHrDlkp~NILl------~~~~~~kl~DFGla~~ 530 (679)
++|+|+.+.|||+ +++..+++.||-.|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 5799999999999 4456799999987753
|
| >2k9y_A Ephrin type-A receptor 2; receptor tyrosine kinase, membrane protein, dimeric transmembrane domain, ephrin receptor, ATP-binding, glycoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=82.96 E-value=1.1 Score=30.07 Aligned_cols=27 Identities=15% Similarity=0.362 Sum_probs=12.9
Q ss_pred chhhhhHHHHHHHHHH-HHHHhhhhccc
Q 005749 301 IAGLVIGLMTGAVVFA-SLLIGYVQNKK 327 (679)
Q Consensus 301 i~~iv~~~~~~~~~~~-~l~~~~~~~~~ 327 (679)
..++++++++|+++++ ++.+.++.+||
T Consensus 12 ~~~I~~~vv~Gv~ll~~iv~~~~~~~rR 39 (41)
T 2k9y_A 12 NLAVIGGVAVGVVLLLVLAGVGFFIHRR 39 (41)
T ss_dssp STHHHHHHHHHHHHHHHHHHHHHSSSSS
T ss_pred eEEEEeehhHHHHHHHHHHHHheeEeee
Confidence 3455666666555544 33333444443
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=82.01 E-value=1.5 Score=29.92 Aligned_cols=18 Identities=33% Similarity=0.211 Sum_probs=9.3
Q ss_pred CcchhhhhHHHHHHHHHH
Q 005749 299 GAIAGLVIGLMTGAVVFA 316 (679)
Q Consensus 299 ~~i~~iv~~~~~~~~~~~ 316 (679)
..+++.++|.++++++++
T Consensus 10 ~aIA~gVVgGv~~v~ii~ 27 (44)
T 2l2t_A 10 PLIAAGVIGGLFILVIVG 27 (44)
T ss_dssp HHHHHHHHHHHHHHHHHH
T ss_pred ceEEEeehHHHHHHHHHH
Confidence 346666665555444444
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=80.91 E-value=4.5 Score=38.40 Aligned_cols=113 Identities=10% Similarity=0.046 Sum_probs=73.5
Q ss_pred CCCCCccceEEeeCCCCceEEEEEecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHH-HHhcCCCCCeeecCCCC
Q 005749 431 RHENLIPLRAFYQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLA-YLHTGHEIPITHGNVRS 509 (679)
Q Consensus 431 ~H~nIv~l~~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~-~LH~~~~~~ivHrDlkp 509 (679)
.||++ -..+-.+ .+.+.+.|+.-+++.=...++ .++...+++++..|+.-.. +++. -+|--+.|
T Consensus 48 ~~~~f--~~~I~~~-eD~~~i~y~~~~~~~~f~~i~-------~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P 112 (219)
T 4ano_A 48 VDPCI--VRDIDVS-EDEVKVVIKPPSSFLTFAAIR-------KTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCP 112 (219)
T ss_dssp SCSSS--EEEEEEC-SSEEEEEEECCTTCEEHHHHH-------TSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCG
T ss_pred cCCCC--CeEEEEe-CCEEEEEEEcCcccCcHHHHH-------hcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeC
Confidence 57877 2233333 567777777654432223333 2688899999999987666 5554 56888999
Q ss_pred CCeeecCCCceEEeecccccccCcccccchhcccccccccccccccccCCCCcchhH-HHHHHHHHHHhCCCCC
Q 005749 510 KNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKADGYKAPELQRMKKCSSRTDVY-AFGILLLEILIGKKPG 582 (679)
Q Consensus 510 ~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~-S~Gvvl~El~tg~~p~ 582 (679)
+||++|.++.+++.-.|+-..+ +|.-+ ...|.| .+=+++..++.++..|
T Consensus 113 ~NL~f~~~~~p~i~hRGi~~~l------------------pP~e~------~ee~fl~qyKali~all~~K~~F 162 (219)
T 4ano_A 113 ENLMFNRALEPFFLHVGVKESL------------------PPDEW------DDERLLREVKATVLALTEGEYRF 162 (219)
T ss_dssp GGEEECTTCCEEESCCEETTTB------------------SSCSC------CHHHHHHHHHHHHHHHTTCSSCH
T ss_pred ceEEEeCCCcEEEEEcCCcccC------------------CCCCC------CHHHHHHHHHHHHHHHHcCCCCH
Confidence 9999999999999988864433 22211 122222 3566777788887766
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 679 | ||||
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 5e-42 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-37 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-37 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 6e-37 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 7e-37 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 9e-37 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-36 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-34 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 6e-34 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 7e-34 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-33 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 6e-33 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 7e-33 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 8e-33 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 9e-33 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-31 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-30 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-30 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-30 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 9e-30 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-29 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 4e-29 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-28 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-28 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-28 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 4e-28 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 4e-28 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 5e-28 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 5e-28 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-27 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 5e-27 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-26 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-25 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 7e-25 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-24 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-24 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 4e-24 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 6e-22 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 7e-22 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-21 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-21 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-21 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 7e-21 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 8e-21 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-20 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-20 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-20 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-20 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-20 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 4e-20 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 6e-20 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-18 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-18 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 4e-18 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-17 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-16 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-04 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 8e-04 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 8e-16 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-15 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-15 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 7e-15 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-14 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 9e-13 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 1e-08 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 4e-07 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-12 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-07 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-07 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 4e-04 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-09 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 5e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.004 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 7e-04 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 6e-07 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 4e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 3e-05 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 4e-05 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 7e-04 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 0.003 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 0.004 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 4e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.003 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.004 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.004 |
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 5e-42
Identities = 59/276 (21%), Positives = 108/276 (39%), Gaps = 28/276 (10%)
Query: 382 GQVIEKTTYGTAYKAKLADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAF 441
+ + +G + +A++ L++GS + L + +++H+ L+ L A
Sbjct: 18 VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAV 76
Query: 442 YQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIP 501
+ +I +Y + +L D L L + +A IA G+A++ E
Sbjct: 77 VT--QEPIYIITEYMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIE---ERN 129
Query: 502 ITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKADGYKAPELQRMKKCSS 561
H ++R+ N+LV D ++ +FGL +L+ + APE +
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTI 189
Query: 562 RTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIRSP 621
++DV++FGILL EI+ + G T EV + +G R
Sbjct: 190 KSDVWSFGILLTEIVTHGRIPYPG------------------MTNPEVIQN-LERGYRMV 230
Query: 622 MEEGLVQALK-LAMGCCAPVASVRPTMDEVVKQLEE 656
+ + L L C RPT D + LE+
Sbjct: 231 RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 266
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (350), Expect = 1e-37
Identities = 61/276 (22%), Positives = 113/276 (40%), Gaps = 32/276 (11%)
Query: 382 GQVIEKTTYGTAYKAKLADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAF 441
Q I K +G G +A++ ++ + L + ++RH NL+ L
Sbjct: 12 LQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGV 68
Query: 442 YQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIP 501
++G ++ +Y +L D L G+ VL K +L + + YL
Sbjct: 69 IVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLE---GNN 123
Query: 502 ITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKADGYKAPELQRMKKCSS 561
H ++ ++NVLV + V+++++FGL + + + APE R KK S+
Sbjct: 124 FVHRDLAARNVLVSEDNVAKVSDFGLTKEA----SSTQDTGKLPVKWTAPEALREKKFST 179
Query: 562 RTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIRSP 621
++DV++FGILL EI + +V + KG +
Sbjct: 180 KSDVWSFGILLWEIYSFGRVPYPRIP------------------LKDVVPR-VEKGYKMD 220
Query: 622 MEEGLVQALK-LAMGCCAPVASVRPTMDEVVKQLEE 656
+G A+ + C A++RP+ ++ +QLE
Sbjct: 221 APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEH 256
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 2e-37
Identities = 49/276 (17%), Positives = 107/276 (38%), Gaps = 28/276 (10%)
Query: 382 GQVIEKTTYGTAYKAKLADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAF 441
+ + +G K +A+++++EGS + + + + + HE L+ L
Sbjct: 9 LKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE-FIEEAKVMMNLSHEKLVQLYGV 67
Query: 442 YQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIP 501
K+ +I +Y + L + L + + + ++ + + YL +
Sbjct: 68 CT-KQRPIFIITEYMANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESKQ--- 120
Query: 502 ITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKADGYKAPELQRMKKCSS 561
H ++ ++N LV+D V ++++FGL + ++ V + PE+ K SS
Sbjct: 121 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSS 180
Query: 562 RTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIRSP 621
++D++AFG+L+ EI K E + I +G+R
Sbjct: 181 KSDIWAFGVLMWEIYSLGKMPYERFT------------------NSETAEH-IAQGLRLY 221
Query: 622 MEEGLVQALK-LAMGCCAPVASVRPTMDEVVKQLEE 656
+ + + C A RPT ++ + +
Sbjct: 222 RPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 6e-37
Identities = 58/284 (20%), Positives = 111/284 (39%), Gaps = 36/284 (12%)
Query: 382 GQVIEKTTYGTAYKAKLADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAF 441
GQ I ++GT YK K + + + + + + + L K RH N++ +
Sbjct: 13 GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 442 YQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIP 501
+ ++ + +L+ LH + + IA A+G+ YLH
Sbjct: 73 STA--PQLAIVTQWCEGSSLYHHLHII---ETKFEMIKLIDIARQTAQGMDYLHAK---S 124
Query: 502 ITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMV-ALAKADGYKAPELQRMKKC- 559
I H +++S N+ + + ++ +FGL + L+ + + APE+ RM+
Sbjct: 125 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 184
Query: 560 --SSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKG 617
S ++DVYAFGI+L E++ G+ P + + +G
Sbjct: 185 PYSFQSDVYAFGIVLYELMTGQLP-------------------YSNINNRDQIIFMVGRG 225
Query: 618 IRSP----MEEGLVQALK-LAMGCCAPVASVRPTMDEVVKQLEE 656
SP + +A+K L C RP +++ +E
Sbjct: 226 YLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIEL 269
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (347), Expect = 7e-37
Identities = 64/296 (21%), Positives = 108/296 (36%), Gaps = 30/296 (10%)
Query: 382 GQVIEKTTYGTAYKAKLADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAF 441
+ I K +G ++ K G +A+++ + I Q +RHEN++ A
Sbjct: 8 QESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREA-EIYQTVMLRHENILGFIAA 65
Query: 442 YQGKRGEKL---LIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLH--- 495
G L+ DY +L D L+ + + K+AL A GLA+LH
Sbjct: 66 DNKDNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEGMIKLALSTASGLAHLHMEI 120
Query: 496 --TGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKADG---YKA 550
T + I H +++SKN+LV + + GL A +A G Y A
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 180
Query: 551 PEL------QRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEF----VDLPSIVKVA 600
PE+ + + R D+YA G++ EI G + + +
Sbjct: 181 PEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 240
Query: 601 VLEETTMEVFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEE 656
+ + + I +S E L K+ C + R T + K L +
Sbjct: 241 MRKVVCEQKLRPNIPNRWQSC--EALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 9e-37
Identities = 51/276 (18%), Positives = 105/276 (38%), Gaps = 28/276 (10%)
Query: 382 GQVIEKTTYGTAYKAKLADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAF 441
Q I +G + + +A++ +REG+ + + + K+ H L+ L
Sbjct: 10 VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED-FIEEAEVMMKLSHPKLVQLYGV 68
Query: 442 YQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIP 501
++ L++++ L D L + L + G+AYL E
Sbjct: 69 CL-EQAPICLVFEFMEHGCLSDYLRTQRGLFA---AETLLGMCLDVCEGMAYLE---EAC 121
Query: 502 ITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKADGYKAPELQRMKKCSS 561
+ H ++ ++N LV + V ++++FG+ + ++ + +PE+ + SS
Sbjct: 122 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 181
Query: 562 RTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIRSP 621
++DV++FG+L+ E+ K R+ EV + I G R
Sbjct: 182 KSDVWSFGVLMWEVFSEGKIPYENRS------------------NSEVVED-ISTGFRLY 222
Query: 622 MEEGLVQALK-LAMGCCAPVASVRPTMDEVVKQLEE 656
+ + C RP +++QL E
Sbjct: 223 KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAE 258
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 4e-36
Identities = 59/276 (21%), Positives = 108/276 (39%), Gaps = 28/276 (10%)
Query: 382 GQVIEKTTYGTAYKAKLADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAF 441
+ + +G + +A++ L+ G+ + L + + K+RHE L+ L A
Sbjct: 22 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAV 80
Query: 442 YQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIP 501
++ +Y +L D L L + +A IA G+AY+ +
Sbjct: 81 VS--EEPIYIVTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERMN--- 133
Query: 502 ITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKADGYKAPELQRMKKCSS 561
H ++R+ N+LV + V ++ +FGL +L+ + APE + +
Sbjct: 134 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 193
Query: 562 RTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIRSP 621
++DV++FGILL E+ + G EV D + +G R P
Sbjct: 194 KSDVWSFGILLTELTTKGRVPYPG------------------MVNREVLDQ-VERGYRMP 234
Query: 622 MEEGLVQALK-LAMGCCAPVASVRPTMDEVVKQLEE 656
++L L C RPT + + LE+
Sbjct: 235 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 270
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 3e-34
Identities = 55/284 (19%), Positives = 107/284 (37%), Gaps = 34/284 (11%)
Query: 382 GQVIEKTTYGTAYKAKLAD----GATIAL-RLLREGSCKDRSSCLPVIRQLGKVRHENLI 436
+VI + +G Y L D A+ L R + S L + H N++
Sbjct: 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 437 PLRAFYQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHT 496
L G L++ Y L + + + L +A+G+
Sbjct: 92 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGM---KF 145
Query: 497 GHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKADG---YKAPEL 553
H ++ ++N ++D+ F ++ +FGL + M D + A + A E
Sbjct: 146 LASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 205
Query: 554 QRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDME 613
+ +K ++++DV++FG+LL E++ P N T ++
Sbjct: 206 LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN------------------TFDITVY- 246
Query: 614 IMKGIRSPMEEGLVQALK-LAMGCCAPVASVRPTMDEVVKQLEE 656
+++G R E L + + C P A +RP+ E+V ++
Sbjct: 247 LLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 290
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 6e-34
Identities = 43/278 (15%), Positives = 99/278 (35%), Gaps = 28/278 (10%)
Query: 382 GQVIEKTTYGTAYKAK-LADGATIALRLLREGSC--KDRSSCLPVIRQLGKVRHENLIPL 438
I +YG K + +DG + + L GS ++ + + L +++H N++
Sbjct: 9 LYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRY 68
Query: 439 RAFYQGKRGEKL-LIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTG 497
+ L ++ +Y L ++ + L+ ++ + L H
Sbjct: 69 YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR 128
Query: 498 HEI--PITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKADGYKAPELQR 555
+ + H +++ NV +D +L +FGL +++ A Y +PE
Sbjct: 129 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD-TSFAKAFVGTPYYMSPEQMN 187
Query: 556 MKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIM 615
+ ++D+++ G LL E+ P + + E+ I
Sbjct: 188 RMSYNEKSDIWSLGCLLYELCALMPPFTA-------------------FSQKELAGK-IR 227
Query: 616 KGIRSPMEEGLVQALK-LAMGCCAPVASVRPTMDEVVK 652
+G + L + RP+++E+++
Sbjct: 228 EGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 7e-34
Identities = 49/294 (16%), Positives = 111/294 (37%), Gaps = 40/294 (13%)
Query: 370 EHLTLEDVLNATGQVIEKTTYGTAYKAKLA---DGATIALRLLREGSCK-DRSSCLPVIR 425
++L + D+ + +G+ + +A+++L++G+ K D + +
Sbjct: 8 DNLLIADI------ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 61
Query: 426 QLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIAL 485
+ ++ + ++ L Q + +L+ + LH L + + + ++
Sbjct: 62 IMHQLDNPYIVRLIGVCQAE--ALMLVMEMAGGGPLHKFLVGK---REEIPVSNVAELLH 116
Query: 486 GIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVP--AVADEMVALA 543
++ G+ YL H ++ ++NVL+ + +++++FGL + + + A
Sbjct: 117 QVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 173
Query: 544 KADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLE 603
+ APE +K SSR+DV+++G+ + E L + G
Sbjct: 174 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--------------- 218
Query: 604 ETTMEVFDMEIMKGIRSPMEEGLVQALK-LAMGCCAPVASVRPTMDEVVKQLEE 656
EV I +G R L L C RP V +++
Sbjct: 219 ---PEVMAF-IEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 268
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 128 bits (322), Expect = 1e-33
Identities = 56/277 (20%), Positives = 107/277 (38%), Gaps = 28/277 (10%)
Query: 382 GQVIEKTTYGTAYKAKLAD-GATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRA 440
+ YG Y+ T+A++ L+E + + L + +++H NL+ L
Sbjct: 22 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLG 80
Query: 441 FYQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEI 500
+ +I ++ L D L + + ++ +A I+ + YL +
Sbjct: 81 VCT-REPPFYIITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLE---KK 134
Query: 501 PITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKADGYKAPELQRMKKCS 560
H ++ ++N LV + + ++ +FGL +LM + APE K S
Sbjct: 135 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 194
Query: 561 SRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIRS 620
++DV+AFG+LL EI G + +V+++ + K R
Sbjct: 195 IKSDVWAFGVLLWEIATYGMSPYPGID------------------LSQVYEL-LEKDYRM 235
Query: 621 PMEEGLVQALK-LAMGCCAPVASVRPTMDEVVKQLEE 656
EG + + L C S RP+ E+ + E
Sbjct: 236 ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFET 272
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 126 bits (317), Expect = 6e-33
Identities = 63/308 (20%), Positives = 117/308 (37%), Gaps = 50/308 (16%)
Query: 373 TLEDVLNAT--------------GQVIEKTTYGTAYKAKLA----DGATIALRLLREG-S 413
T ED A QVI +G L +A++ L+ G +
Sbjct: 8 TFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT 67
Query: 414 CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKP 473
K R L +G+ H N+I L K ++I ++ + +L L
Sbjct: 68 EKQRRDFLSEASIMGQFDHPNVIHLEGVVT-KSTPVMIITEFMENGSLDSFLRQNDGQFT 126
Query: 474 VLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVP 533
+ + GIA G+ YL + H ++ ++N+LV+ V ++++FGL + +
Sbjct: 127 ---VIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180
Query: 534 AVADEMVALAKAD----GYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGE 589
+D A + APE + +K +S +DV+++GI++ E++ +
Sbjct: 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWD---- 236
Query: 590 FVDLPSIVKVAVLEETTMEVFDMEIMKGIRSPMEEGLVQALK-LAMGCCAPVASVRPTMD 648
T +V + I + R P AL L + C + RP
Sbjct: 237 --------------MTNQDVINA-IEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFG 281
Query: 649 EVVKQLEE 656
++V L++
Sbjct: 282 QIVNTLDK 289
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 126 bits (317), Expect = 7e-33
Identities = 56/304 (18%), Positives = 113/304 (37%), Gaps = 52/304 (17%)
Query: 382 GQVIEKTTYGTAYKAKL------ADGATIALRLLREGSCKD-RSSCLPVIRQLGKVRHEN 434
+ I + +G ++A+ +A+++L+E + D ++ + + + N
Sbjct: 18 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPN 77
Query: 435 LIPLRAFYQGKRGEKLLIYDYFPSRTLHDLLHD--------------------TIAGKPV 474
++ L L+++Y L++ L + G P
Sbjct: 78 IVKLLGVCA-VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 136
Query: 475 LNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPA 534
L+ A + IA +A G+AYL E H ++ ++N LV + V ++ +FGL + + A
Sbjct: 137 LSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 193
Query: 535 VADEMV-ALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDL 593
+ A + PE + ++ +DV+A+G++L EI G E
Sbjct: 194 DYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE---- 249
Query: 594 PSIVKVAVLEETTMEVFDMEIMKGIRSPMEEGLVQALK-LAMGCCAPVASVRPTMDEVVK 652
EV + G E L L C + + + RP+ + +
Sbjct: 250 --------------EVIYY-VRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294
Query: 653 QLEE 656
L+
Sbjct: 295 ILQR 298
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (315), Expect = 8e-33
Identities = 52/295 (17%), Positives = 106/295 (35%), Gaps = 42/295 (14%)
Query: 370 EHLTLEDVLNATGQVIEKTTYGTAYKAKLAD---GATIALRLLREGSC--KDRSSCLPVI 424
+ LTLED + + +GT K T+A+++L+ + + L
Sbjct: 6 KLLTLED------KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEA 59
Query: 425 RQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIA 484
+ ++ + ++ + + +L+ + L+ L + ++
Sbjct: 60 NVMQQLDNPYIVRMIGICE--AESWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELV 113
Query: 485 LGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAK 544
++ G+ YL + H ++ ++NVL+ +++++FGL + +
Sbjct: 114 HQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 170
Query: 545 A--DGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVL 602
+ APE K SS++DV++FG+L+ E + G G
Sbjct: 171 KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG-------------- 216
Query: 603 EETTMEVFDMEIMKGIRSPMEEGLVQALK-LAMGCCAPVASVRPTMDEVVKQLEE 656
EV M + KG R G + + L C RP V +L
Sbjct: 217 ----SEVTAM-LEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 9e-33
Identities = 45/296 (15%), Positives = 109/296 (36%), Gaps = 36/296 (12%)
Query: 383 QVIEKTTYGTAYKAK-LADGATIALRLLR-EGSCKDRSSCLPVIRQLGKVRHENLIPLRA 440
+ G +K G +A +L+ E R+ + ++ L + ++
Sbjct: 12 SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 71
Query: 441 FYQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEI 500
+ GE + ++ +L +L + K+++ + +GL YL +
Sbjct: 72 AFY-SDGEISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLR--EKH 124
Query: 501 PITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKADGYKAPELQRMKKCS 560
I H +V+ N+LV+ +L +FG+ ++ ++A+ V Y +PE + S
Sbjct: 125 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVG---TRSYMSPERLQGTHYS 181
Query: 561 SRTDVYAFGILLLEILIGKKP------------------GKSGRNGEFVDLPSIVKVAVL 602
++D+++ G+ L+E+ +G+ P G + P +
Sbjct: 182 VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYG 241
Query: 603 EETTMEVFDMEIMKGIRSPMEEGL------VQALKLAMGCCAPVASVRPTMDEVVK 652
++ + E++ I + L ++ C + R + +++
Sbjct: 242 MDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 3e-31
Identities = 61/284 (21%), Positives = 111/284 (39%), Gaps = 35/284 (12%)
Query: 382 GQVIEKTTYGTAYKAKLADG-----ATIALRLLREGSC-KDRSSCLPVIRQLGKVRHENL 435
+VI +G YK L +A++ L+ G K R L +G+ H N+
Sbjct: 12 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 71
Query: 436 IPLRAFYQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLH 495
I L K ++I +Y + L L + + + + GIA G+ Y
Sbjct: 72 IRLEGVIS-KYKPMMIITEYMENGALDKFLREK---DGEFSVLQLVGMLRGIAAGMKY-- 125
Query: 496 TGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMV--PAVADEMVALAKADGYKAPEL 553
+ H ++ ++N+LV+ V ++++FGL +++ P + APE
Sbjct: 126 -LANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEA 184
Query: 554 QRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDME 613
+K +S +DV++FGI++ E++ + + EV
Sbjct: 185 ISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS------------------NHEVMKA- 225
Query: 614 IMKGIRSPMEEGLVQALK-LAMGCCAPVASVRPTMDEVVKQLEE 656
I G R P A+ L M C + RP ++V L++
Sbjct: 226 INDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDK 269
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 1e-30
Identities = 59/293 (20%), Positives = 111/293 (37%), Gaps = 43/293 (14%)
Query: 382 GQVIEKTTYGTAYKAKLADGAT---IALRLLREGSCKD-RSSCLPVIRQLGKV-RHENLI 436
VI + +G KA++ A++ ++E + KD + L K+ H N+I
Sbjct: 15 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 74
Query: 437 PLRAFYQGKRGEKLLIYDYFPSRTLHDLLHDTI------------AGKPVLNWARRHKIA 484
L + RG L +Y P L D L + + L+ + A
Sbjct: 75 NLLGACE-HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 133
Query: 485 LGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAK 544
+ARG+ YL + H ++ ++N+LV + +V+++ +FGL + V M L
Sbjct: 134 ADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPV 190
Query: 545 ADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEE 604
+ A E ++ +DV+++G+LL EI+ G
Sbjct: 191 --RWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT----------------- 231
Query: 605 TTMEVFDMEIMKGIRSPMEEGLVQALK-LAMGCCAPVASVRPTMDEVVKQLEE 656
E+++ + +G R + L C RP+ +++ L
Sbjct: 232 -CAELYEK-LPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 282
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (296), Expect = 2e-30
Identities = 56/281 (19%), Positives = 96/281 (34%), Gaps = 33/281 (11%)
Query: 382 GQVIEKTTYGTAYKAKLAD----GATIALRLLREGSCKD-RSSCLPVIRQLGKVRHENLI 436
G+ I + +G ++ +A++ + + R L + + H +++
Sbjct: 12 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 71
Query: 437 PLRAFYQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHT 496
L +I + L L L+ A A ++ LAYL
Sbjct: 72 KLIGVIT--ENPVWIIMELCTLGELRSFLQVRKYS---LDLASLILYAYQLSTALAYLE- 125
Query: 497 GHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKADGYKAPELQRM 556
H ++ ++NVLV +L +FGL + M + + + APE
Sbjct: 126 --SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF 183
Query: 557 KKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMK 616
++ +S +DV+ FG+ + EIL+ G +V I
Sbjct: 184 RRFTSASDVWMFGVCMWEILMHGVKPFQGVK------------------NNDVIGR-IEN 224
Query: 617 GIRSPMEEGLVQALK-LAMGCCAPVASVRPTMDEVVKQLEE 656
G R PM L L C A S RP E+ QL
Sbjct: 225 GERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST 265
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (298), Expect = 3e-30
Identities = 50/299 (16%), Positives = 110/299 (36%), Gaps = 46/299 (15%)
Query: 382 GQVIEKTTYGTAYKAKLA------DGATIALRLLREGSC-KDRSSCLPVIRQLGKV-RHE 433
G+ + +G +A T+A+++L+ + +R + + ++ L + H
Sbjct: 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87
Query: 434 NLIPLRAFYQGKRGEKLLIYDYFPSRTLHDLLHD--------------TIAGKPVLNWAR 479
N++ L G L+I +Y L + L + L+
Sbjct: 88 NIVNLLGACT-IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146
Query: 480 RHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEM 539
+ +A+G+A+L + + H ++ ++N+L+ ++++ +FGL + + +
Sbjct: 147 LLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 203
Query: 540 VALAK-ADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVK 598
A+ + APE + +DV+++GI L E+ G
Sbjct: 204 KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP----------- 252
Query: 599 VAVLEETTMEVFDMEIMKGIRSPMEEGLVQALK-LAMGCCAPVASVRPTMDEVVKQLEE 656
F I +G R E + + C RPT ++V+ +E+
Sbjct: 253 -------VDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 117 bits (295), Expect = 9e-30
Identities = 49/278 (17%), Positives = 97/278 (34%), Gaps = 40/278 (14%)
Query: 383 QVIEKTTYGTAYKAK-LADGATIALRLLREGSCKDRSSCLPVIRQ---LGKVRHENLIPL 438
+ I ++G Y A+ + + +A++ + + +I++ L K+RH N I
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 439 RAFYQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGH 498
R Y + L+ +Y K L + G +GLAYL H
Sbjct: 81 RGCYL-REHTAWLVMEYCL----GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYL---H 132
Query: 499 EIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKADGYKAPEL---QR 555
+ H +V++ N+L+ + + +L +FG +M + + APE+
Sbjct: 133 SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM-----APANSFVGTPYWMAPEVILAMD 187
Query: 556 MKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIM 615
+ + DV++ GI +E+ K P + M
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKPP-------------------LFNMNAMSALYHIAQ 228
Query: 616 KGIRSPMEEGLVQALK-LAMGCCAPVASVRPTMDEVVK 652
+ + + C + RPT + ++K
Sbjct: 229 NESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (291), Expect = 4e-29
Identities = 55/303 (18%), Positives = 109/303 (35%), Gaps = 51/303 (16%)
Query: 382 GQVIEKTTYGTAYKA------KLADGATIALRLLREGSC-KDRSSCLPVIRQLGKV-RHE 433
G+V+ +G A K +A+++L+E + +R + + ++ + ++ HE
Sbjct: 42 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 101
Query: 434 NLIPLRAFYQGKRGEKLLIYDYFPSRTLHDLLH-------------------DTIAGKPV 474
N++ L G LI++Y L + L + V
Sbjct: 102 NIVNLLGACT-LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 160
Query: 475 LNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPA 534
L + A +A+G+ +L H ++ ++NVLV V ++ +FGL + ++
Sbjct: 161 LTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 217
Query: 535 VADEMVALAKAD-GYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDL 593
+ A+ + APE + ++DV+++GILL EI G
Sbjct: 218 SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP------ 271
Query: 594 PSIVKVAVLEETTMEVFDMEIMKGIRSPMEEGLVQALK-LAMGCCAPVASVRPTMDEVVK 652
F I G + + + + C A + RP+ +
Sbjct: 272 ------------VDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTS 319
Query: 653 QLE 655
L
Sbjct: 320 FLG 322
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (287), Expect = 4e-29
Identities = 49/285 (17%), Positives = 103/285 (36%), Gaps = 36/285 (12%)
Query: 382 GQVIEKTTYGTAYKAKL----ADGATIALRLLREGSCKDRSSCLPVIRQ---LGKVRHEN 434
+ + ++G + + ++A++ L+ + IR+ + + H N
Sbjct: 13 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 72
Query: 435 LIPLRAFYQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYL 494
LI L ++ + P +L D L + + A+ +A G+ YL
Sbjct: 73 LIRLYGVVL--TPPMKMVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYL 127
Query: 495 HTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKA--DGYKAPE 552
H ++ ++N+L+ + ++ +FGL + + ++ + + APE
Sbjct: 128 E---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 184
Query: 553 LQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDM 612
+ + S +D + FG+ L E+ + G NG ++
Sbjct: 185 SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG------------------SQILHK 226
Query: 613 EIMKGIRSPMEEGLVQALK-LAMGCCAPVASVRPTMDEVVKQLEE 656
+G R P E Q + + + C A RPT + L E
Sbjct: 227 IDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (284), Expect = 3e-28
Identities = 51/283 (18%), Positives = 99/283 (34%), Gaps = 35/283 (12%)
Query: 382 GQVIEKTTYGTAYKAK-LADGATIAL-----RLLREGSCKDRSSCLPVIRQLGKVRHENL 435
+V+ +GT YK + +G + + L S K L + V + ++
Sbjct: 14 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 73
Query: 436 IPLRAFYQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLH 495
L LI P LL K + + IA+G+ YL
Sbjct: 74 CRLLGICL--TSTVQLITQLMPF---GCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 128
Query: 496 TGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKAD-GYKAPELQ 554
+ H ++ ++NVLV ++T+FGL +L+ + K + A E
Sbjct: 129 DRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 185
Query: 555 RMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEI 614
+ + ++DV+++G+ + E++ G E+ + +
Sbjct: 186 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS------------------EISSI-L 226
Query: 615 MKGIRSPMEEGLVQALK-LAMGCCAPVASVRPTMDEVVKQLEE 656
KG R P + + + C A RP E++ + +
Sbjct: 227 EKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 269
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (280), Expect = 3e-28
Identities = 48/280 (17%), Positives = 100/280 (35%), Gaps = 37/280 (13%)
Query: 382 GQVIEKTTYGTAYKAKLAD-GATIALRLLREGSC--KDRSSCLPVIRQLGKVRHENLIPL 438
I + ++ T YK + +A L++ +R L ++H N++
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73
Query: 439 RAFYQG---KRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLH 495
++ + +L+ + S TL L V+ I +GL +LH
Sbjct: 74 YDSWESTVKGKKCIVLVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLH 129
Query: 496 TGHEIPITHGNVRSKNVLVDD-FFVSRLTEFGLDQLMVPAVADEMVALAKADGYKAPELQ 554
T PI H +++ N+ + ++ + GL L + A ++ + APE+
Sbjct: 130 T-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTP---EFMAPEMY 185
Query: 555 RMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEI 614
+K DVYAFG+ +LE+ + P E +
Sbjct: 186 E-EKYDESVDVYAFGMCMLEMATSEYP-------------------YSECQNAAQIYRRV 225
Query: 615 MKGIRSPMEEGLV--QALKLAMGCCAPVASVRPTMDEVVK 652
G++ + + + ++ GC R ++ +++
Sbjct: 226 TSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (282), Expect = 3e-28
Identities = 44/291 (15%), Positives = 99/291 (34%), Gaps = 41/291 (14%)
Query: 382 GQVIEKTTYGTAYKAK-LADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRA 440
+ +G YKA+ A +++ S ++ + I L H N++ L
Sbjct: 17 IGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLD 76
Query: 441 FYQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEI 500
+ ++ ++ + ++ + + L ++ + L YLH +
Sbjct: 77 AFY-YENNLWILIEFCAGGAVDAVMLEL---ERPLTESQIQVVCKQTLDALNYLH---DN 129
Query: 501 PITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKADGYKAPEL-----QR 555
I H ++++ N+L +L +FG+ + + + APE+ +
Sbjct: 130 KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRRDSFIGTPYWMAPEVVMCETSK 188
Query: 556 MKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIM 615
+ + DV++ GI L+E+ + P E M V ++I
Sbjct: 189 DRPYDYKADVWSLGITLIEMAEIEPPHH-------------------ELNPMRVL-LKIA 228
Query: 616 KGIRSPME--EGLVQALK-LAMGCCAPVASVRPTMDEVVK----QLEENRP 659
K + K C R T ++++ ++ N+P
Sbjct: 229 KSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKP 279
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (282), Expect = 4e-28
Identities = 44/290 (15%), Positives = 105/290 (36%), Gaps = 38/290 (13%)
Query: 382 GQVIEKTTYGTAYKAKL------ADGATIALRLLREGSC-KDRSSCLPVIRQLGKVRHEN 434
+ + + ++G Y+ +A++ + E + ++R L + + +
Sbjct: 25 SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 84
Query: 435 LIPLRAFYQGKRGEKLLIYDYFPSRTLHDLLH------DTIAGKPVLNWARRHKIALGIA 488
++ L L+I + L L + ++ ++A IA
Sbjct: 85 VVRLLGVVSQG-QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 143
Query: 489 RGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAK-ADG 547
G+AYL+ H ++ ++N +V + F ++ +FG+ + +
Sbjct: 144 DGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 200
Query: 548 YKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTM 607
+ +PE + ++ +DV++FG++L EI + G +
Sbjct: 201 WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS------------------NE 242
Query: 608 EVFDMEIMKGIRSPMEEGLVQALK-LAMGCCAPVASVRPTMDEVVKQLEE 656
+V +M+G + L L C +RP+ E++ ++E
Sbjct: 243 QVLRF-VMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 291
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (281), Expect = 4e-28
Identities = 56/298 (18%), Positives = 109/298 (36%), Gaps = 45/298 (15%)
Query: 382 GQVIEKTTYGTAYKAKL--------ADGATIALRLLR-EGSCKDRSSCLPVIRQLGKVRH 432
G+ + + +G A+ +A+++L+ + + KD S + + + +
Sbjct: 18 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 77
Query: 433 ENLIPLRAFYQGKRGEKLLIYDYFPSRTLHDLLH------------DTIAGKPVLNWARR 480
I + G +I +Y L + L + + L+
Sbjct: 78 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 137
Query: 481 HKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADE-M 539
A +ARG+ YL H ++ ++NVLV + V ++ +FGL + + +
Sbjct: 138 VSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 194
Query: 540 VALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKV 599
+ APE + + ++DV++FG+LL EI G E
Sbjct: 195 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE---------- 244
Query: 600 AVLEETTMEVFDMEIMKGIRSPMEEGLVQALK-LAMGCCAPVASVRPTMDEVVKQLEE 656
E+F + + +G R L + C V S RPT ++V+ L+
Sbjct: 245 --------ELFKL-LKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 293
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (280), Expect = 5e-28
Identities = 54/297 (18%), Positives = 109/297 (36%), Gaps = 43/297 (14%)
Query: 382 GQVIEKTTYGTAYKA------KLADGATIALRLLREGSC-KDRSSCLPVIRQLGKVRHEN 434
G+ + + +G +A K A T+A+++L+EG+ + + + ++ L + H
Sbjct: 18 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 77
Query: 435 LIPLRAFYQGKRGEKLLI-YDYFPSRTLHDLLHD------------TIAGKPVLNWARRH 481
+ K G L++ ++ L L K L
Sbjct: 78 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 137
Query: 482 KIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVA 541
+ +A+G+ +L H ++ ++N+L+ + V ++ +FGL + +
Sbjct: 138 CYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 194
Query: 542 LAKAD-GYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVA 600
A+ + APE + + ++DV++FG+LL EI G
Sbjct: 195 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK------------- 241
Query: 601 VLEETTMEVFDMEIMKGIRSPMEEGLVQALK-LAMGCCAPVASVRPTMDEVVKQLEE 656
E F + +G R + + + C S RPT E+V+ L
Sbjct: 242 -----IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 293
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (278), Expect = 5e-28
Identities = 51/275 (18%), Positives = 102/275 (37%), Gaps = 35/275 (12%)
Query: 382 GQVIEKTTYGTAYKAKL-ADGATIALRLLREGSCKDRSSCLPVIRQ---LGKVRHENLIP 437
G+ + K +G Y A+ +AL++L + + + R+ +RH N++
Sbjct: 11 GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILR 70
Query: 438 LRAFYQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTG 497
L ++ LI +Y P T++ L + R +A L+Y H+
Sbjct: 71 LYGYFH-DATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSK 125
Query: 498 HEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKADGYKAPELQRMK 557
+ H +++ +N+L+ ++ +FG + L Y PE+ +
Sbjct: 126 R---VIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRTTLCGTLDYLPPEMIEGR 179
Query: 558 KCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKG 617
+ D+++ G+L E L+GK P ++ T E + I +
Sbjct: 180 MHDEKVDLWSLGVLCYEFLVGKPPFEA-------------------NTYQETYKR-ISRV 219
Query: 618 IRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVK 652
+ + A L S RP + EV++
Sbjct: 220 EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 111 bits (278), Expect = 3e-27
Identities = 40/278 (14%), Positives = 94/278 (33%), Gaps = 36/278 (12%)
Query: 382 GQVIEKTTYGTAYKAK-LADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRA 440
+ + +G ++ A G A + + D+ + I+ + +RH L+ L
Sbjct: 31 HEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHD 90
Query: 441 FYQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEI 500
++ E ++IY++ L + + D ++ + + +GL ++H +
Sbjct: 91 AFEDD-NEMVMIYEFMSGGELFEKVADE---HNKMSEDEAVEYMRQVCKGLCHMHENN-- 144
Query: 501 PITHGNVRSKNVLVDDFFVSR--LTEFGLDQLMVPAVADEMVALAKADGYKAPELQRMKK 558
H +++ +N++ + L +FGL + P + + APE+ K
Sbjct: 145 -YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK--QSVKVTTGTAEFAAPEVAEGKP 201
Query: 559 CSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGI 618
TD+++ G+L +L G P E E +
Sbjct: 202 VGYYTDMWSVGVLSYILLSGLSPFGG-------------------ENDDETLRN-VKSCD 241
Query: 619 RSPMEEGLV----QALKLAMGCCAPVASVRPTMDEVVK 652
+ + + R T+ + ++
Sbjct: 242 WNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 279
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (273), Expect = 5e-27
Identities = 45/273 (16%), Positives = 105/273 (38%), Gaps = 32/273 (11%)
Query: 383 QVIEKTTYGTAYKAK-LADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAF 441
+ I + GT Y A +A G +A+R + + + I + + ++ N++
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 442 YQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIP 501
Y E ++ +Y +L D++ + ++ + + + L +LH+
Sbjct: 86 YL-VGDELWVVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLHSNQ--- 136
Query: 502 ITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKADGYKAPELQRMKKCSS 561
+ H +++S N+L+ +LT+FG + P + + + APE+ K
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-SKRSTMVGTPYWMAPEVVTRKAYGP 195
Query: 562 RTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGI-RS 620
+ D+++ GI+ +E++ G+ P +++ E + + G
Sbjct: 196 KVDIWSLGIMAIEMIEGEPP--------YLN-----------ENPLRALYLIATNGTPEL 236
Query: 621 PMEEGLVQALK-LAMGCCAPVASVRPTMDEVVK 652
E L + C R + E+++
Sbjct: 237 QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 109 bits (273), Expect = 2e-26
Identities = 46/278 (16%), Positives = 97/278 (34%), Gaps = 36/278 (12%)
Query: 382 GQVIEKTTYGTAYKAK-LADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRA 440
+ + +G ++ A G + + D+ + I + ++ H LI L
Sbjct: 34 LEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHD 93
Query: 441 FYQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEI 500
++ + E +LI ++ L D + A ++ A GL ++H E
Sbjct: 94 AFE-DKYEMVLILEFLSGGELFDRIA---AEDYKMSEAEVINYMRQACEGLKHMH---EH 146
Query: 501 PITHGNVRSKNVLVDDFFVSR--LTEFGLDQLMVPAVADEMVALAKADGYKAPELQRMKK 558
I H +++ +N++ + S + +FGL + P + + + APE+ +
Sbjct: 147 SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD--EIVKVTTATAEFAAPEIVDREP 204
Query: 559 CSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGI 618
TD++A G+L +L G P F E +E + +
Sbjct: 205 VGFYTDMWAIGVLGYVLLSGLSP--------FAG-----------EDDLETLQN-VKRCD 244
Query: 619 RSPMEEGLV----QALKLAMGCCAPVASVRPTMDEVVK 652
E+ +A R T+ + ++
Sbjct: 245 WEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (261), Expect = 1e-25
Identities = 52/275 (18%), Positives = 104/275 (37%), Gaps = 29/275 (10%)
Query: 382 GQVIEKTTYGTAYKAK-LADGATIALRLLREGSCKD-RSSCLPVIRQLGKVRHENLIPLR 439
Q + + YG A +A++++ D + I + HEN++
Sbjct: 10 VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 69
Query: 440 AFYQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHE 499
+ + L +Y L D + + + + G+ YL H
Sbjct: 70 GHRREG-NIQYLFLEYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYL---HG 121
Query: 500 IPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMV-ALAKADGYKAPE-LQRMK 557
I ITH +++ +N+L+D+ ++++FGL + + ++ + Y APE L+R +
Sbjct: 122 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 181
Query: 558 KCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKG 617
+ DV++ GI+L +L G+ P ++ E D + K
Sbjct: 182 FHAEPVDVWSCGIVLTAMLAGELPWDQP-----------------SDSCQEYSDWKEKKT 224
Query: 618 IRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVK 652
+P ++ L L S R T+ ++ K
Sbjct: 225 YLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (258), Expect = 7e-25
Identities = 48/278 (17%), Positives = 101/278 (36%), Gaps = 37/278 (13%)
Query: 382 GQVIEKTTYGTAYKAK-LADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRA 440
+ + + +G ++ + T + ++ D+ I L RH N++ L
Sbjct: 10 AEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHE 68
Query: 441 FYQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEI 500
++ E ++I+++ + + ++ LN + L +LH
Sbjct: 69 SFE-SMEELVMIFEFISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLH---SH 121
Query: 501 PITHGNVRSKNVLVD--DFFVSRLTEFGLDQLMVPAVADEMVALAKADGYKAPELQRMKK 558
I H ++R +N++ ++ EFG + + D L A Y APE+ +
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL--KPGDNFRLLFTAPEYYAPEVHQHDV 179
Query: 559 CSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGI 618
S+ TD+++ G L+ +L G P + ET ++ + IM
Sbjct: 180 VSTATDMWSLGTLVYVLLSGINPFLA-------------------ETNQQIIEN-IMNAE 219
Query: 619 RSPMEEGL----VQALKLAMGCCAPVASVRPTMDEVVK 652
+ EE ++A+ R T E ++
Sbjct: 220 YTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 102 bits (254), Expect = 2e-24
Identities = 47/277 (16%), Positives = 96/277 (34%), Gaps = 33/277 (11%)
Query: 382 GQVIEKTTYGTAYKAK-LADGATIALRLLREGSCKDRSSCLPV-IRQLGKVRHENLIPLR 439
V+ + A+ +A++ + + + + + + I L K++H N++ L
Sbjct: 14 RDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALD 73
Query: 440 AFYQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHE 499
Y+ G LI L D + + K ++ + + YLH
Sbjct: 74 DIYE-SGGHLYLIMQLVSGGELFDRIVE----KGFYTERDASRLIFQVLDAVKYLHDLGI 128
Query: 500 IPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKADGYKAPELQRMKKC 559
+ +D+ +++FGL ++ P + GY APE+ K
Sbjct: 129 VHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP--GSVLSTACGTPGYVAPEVLAQKPY 186
Query: 560 SSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKG-- 617
S D ++ G++ +L G P F D E ++F+ I+K
Sbjct: 187 SKAVDCWSIGVIAYILLCGYPP--------FYD-----------ENDAKLFEQ-ILKAEY 226
Query: 618 -IRSPMEEGLVQALK-LAMGCCAPVASVRPTMDEVVK 652
SP + + + K R T ++ ++
Sbjct: 227 EFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (252), Expect = 3e-24
Identities = 44/279 (15%), Positives = 101/279 (36%), Gaps = 33/279 (11%)
Query: 382 GQVIEKTTYGTAYKAK-LADGATIALRLLREGSCKDRSSCLPVIRQ---LGKVRHENLIP 437
G+++ + ++ T A+ LA A+++L + + V R+ + ++ H +
Sbjct: 13 GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 72
Query: 438 LRAFYQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTG 497
L +Q + Y + L + + A ++ L
Sbjct: 73 LYFTFQDD-EKLYFGLSYAKNGELLKYIRK----IGSFDETC---TRFYTAEIVSALEYL 124
Query: 498 HEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMV-ALAKADGYKAPELQRM 556
H I H +++ +N+L+++ ++T+FG +++ P + Y +PEL
Sbjct: 125 HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 184
Query: 557 KKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMK 616
K +D++A G ++ +++ G P ++ +F I+K
Sbjct: 185 KSACKSSDLWALGCIIYQLVAGLPPFRA-------------------GNEYLIFQK-IIK 224
Query: 617 GIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLE 655
E+ +A L A+ R +E+
Sbjct: 225 LEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGP 263
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 100 bits (249), Expect = 4e-24
Identities = 54/287 (18%), Positives = 110/287 (38%), Gaps = 39/287 (13%)
Query: 382 GQVIEKTTYGTAYKAK-LADGATIALRLLREGSCKDRSSCLPVIRQ---LGKVRHENLIP 437
G+++ + A+ L +A+++LR +D S L R+ + H ++
Sbjct: 12 GEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 71
Query: 438 LRAFYQGKRGEKLLIY---DYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYL 494
+ + + L Y +Y TL D++H + + R ++ + L +
Sbjct: 72 VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFS 127
Query: 495 HTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVAD--EMVALAKADGYKAPE 552
H + I H +V+ N+++ ++ +FG+ + + + + A+ Y +PE
Sbjct: 128 H---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 184
Query: 553 LQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDM 612
R +R+DVY+ G +L E+L G+ P F ++ + V
Sbjct: 185 QARGDSVDARSDVYSLGCVLYEVLTGEPP--------FTG-----------DSPVSVAYQ 225
Query: 613 EIMKGIRSPME--EGLVQALK-LAMGCCAPVASVRP-TMDEVVKQLE 655
+ + P EGL L + + A R T E+ L
Sbjct: 226 HVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV 272
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.2 bits (236), Expect = 6e-22
Identities = 44/280 (15%), Positives = 93/280 (33%), Gaps = 32/280 (11%)
Query: 381 TGQVIEKTTYGTAYKAK-LADGATIALRLLREGSCKDRSSCLPVIRQLGKV-RHENLIPL 438
T QV+ G + AL++L++ R + + + +++ +
Sbjct: 16 TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARRE-----VELHWRASQCPHIVRI 70
Query: 439 RAFYQGKRGEK---LLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLH 495
Y+ + L++ + L + D G +I I + YLH
Sbjct: 71 VDVYENLYAGRKCLLIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLH 128
Query: 496 TGHEIPITHGNVRSKNVLVDDFF---VSRLTEFGLDQLMVPAVADEMVALAKADGYKAPE 552
+ + I H +V+ +N+L + +LT+FG + + + Y APE
Sbjct: 129 SIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH--NSLTTPCYTPYYVAPE 183
Query: 553 LQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDM 612
+ +K D+++ G+++ +L G P S + M ++
Sbjct: 184 VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP-------GMKTRIRMGQYEF 236
Query: 613 EIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVK 652
+ E L + R T+ E +
Sbjct: 237 PNPEWSEVSEE-----VKMLIRNLLKTEPTQRMTITEFMN 271
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.3 bits (236), Expect = 7e-22
Identities = 47/290 (16%), Positives = 108/290 (37%), Gaps = 27/290 (9%)
Query: 382 GQVIEKTTYGTAYKAK-LADGATIALRLLREGSCK-DRSSCLPVIRQLGKVRHENLIPLR 439
I + YG A + +A++ + + L I+ L + RHEN+I +
Sbjct: 13 LSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 72
Query: 440 AFYQG---KRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHT 496
+ ++ + + + + L+ LL L+ I RGL Y+H+
Sbjct: 73 DIIRAPTIEQMKDVYLVTHLMGADLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHS 127
Query: 497 GHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKAD--GYKAPE-L 553
+ + H +++ N+L++ ++ +FGL ++ P Y+APE +
Sbjct: 128 AN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 184
Query: 554 QRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDME 613
K + D+++ G +L E+L + + ++ + + +E + +++
Sbjct: 185 LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 244
Query: 614 IMKGIRSPMEEGLV-----------QALKLAMGCCAPVASVRPTMDEVVK 652
+ S + V +AL L R +++ +
Sbjct: 245 ARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 94.8 bits (235), Expect = 1e-21
Identities = 45/218 (20%), Positives = 86/218 (39%), Gaps = 21/218 (9%)
Query: 372 LTLEDVLNATGQVIEKTTYGTAYKAKLAD-GATIALRLLREGSCKDRS------SCLPVI 424
LT+ D + ++I + +G Y + AD G A++ L + K + + ++
Sbjct: 1 LTMNDF--SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIML 58
Query: 425 RQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIA 484
+ ++ + + + I D LH L V + A A
Sbjct: 59 SLVSTGDCPFIVCMSYAFHTP-DKLSFILDLMNGGDLHYHLSQ----HGVFSEADMRFYA 113
Query: 485 LGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAK 544
I GL ++H + + +++ N+L+D+ R+++ GL + A
Sbjct: 114 AEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSK---KKPHASVG 167
Query: 545 ADGYKAPE-LQRMKKCSSRTDVYAFGILLLEILIGKKP 581
GY APE LQ+ S D ++ G +L ++L G P
Sbjct: 168 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 205
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.6 bits (232), Expect = 2e-21
Identities = 48/278 (17%), Positives = 99/278 (35%), Gaps = 36/278 (12%)
Query: 382 GQVIEKTTYGTAYKAK-LADGATIALRLLREGSCKDRSSCLPVIRQ----LGKVRHENLI 436
+++ K ++G + A+ A++ L++ + + H L
Sbjct: 7 HKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 66
Query: 437 PLRAFYQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHT 496
+ +Q + + +Y L + + +R A I GL +LH+
Sbjct: 67 HMFCTFQ-TKENLFFVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHS 121
Query: 497 GHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKADGYKAPELQRM 556
I + +++ N+L+D ++ +FG+ + + + Y APE+
Sbjct: 122 KG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD-AKTNTFCGTPDYIAPEILLG 177
Query: 557 KKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMK 616
+K + D ++FG+LL E+LIG+ P F + E+F M
Sbjct: 178 QKYNHSVDWWSFGVLLYEMLIGQSP--------FHG-----------QDEEELFHSIRMD 218
Query: 617 GIRSPMEEGLVQALK-LAMGCCAPVASVRPTMDEVVKQ 653
P L + K L + R + ++Q
Sbjct: 219 NPFYP--RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.6 bits (229), Expect = 3e-21
Identities = 50/299 (16%), Positives = 110/299 (36%), Gaps = 28/299 (9%)
Query: 382 GQVIEKTTYGTAYKAK--LADGATIALRLLREGSCKDRSSC-----LPVIRQLGKVRHEN 434
I + YG +KA+ G +AL+ +R + ++ + V+R L H N
Sbjct: 12 VAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPN 71
Query: 435 LIPLRAFYQGKRGEKL-LIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAY 493
++ L R ++ + F + +P + + + RGL +
Sbjct: 72 VVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDF 131
Query: 494 LHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKADGYKAPEL 553
LH+ + H +++ +N+LV +L +FGL ++ +A V + Y+APE+
Sbjct: 132 LHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTL--WYRAPEV 186
Query: 554 QRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGE-------FVDLPSIVKVAVLEETT 606
++ D+++ G + E+ K + + + + LP
Sbjct: 187 LLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALP 246
Query: 607 MEVFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEV--------VKQLEEN 657
+ F + + I + + L + C + R + +++ +EN
Sbjct: 247 RQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCKEN 305
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.5 bits (229), Expect = 7e-21
Identities = 58/288 (20%), Positives = 113/288 (39%), Gaps = 27/288 (9%)
Query: 382 GQVIEKTTYGTAYKAKLAD-GATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRA 440
+VI ++G Y+AKL D G +A++ + +D+ ++ + K+ H N++ LR
Sbjct: 25 TKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVRLRY 80
Query: 441 FYQGKRGEK-----LLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLH 495
F+ +K L+ DY P H + A + L + R LAY+H
Sbjct: 81 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQT-LPVIYVKLYMYQLFRSLAYIH 139
Query: 496 TGHEIPITHGNVR-SKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKADGYKAP-EL 553
+ I H +++ +L D V +L +FG + +V + V+ + Y+AP +
Sbjct: 140 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--GEPNVSYICSRYYRAPELI 194
Query: 554 QRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGE----FVDLPSIVKVAVLEETTMEV 609
+S DV++ G +L E+L+G+ + + + + E
Sbjct: 195 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY 254
Query: 610 FDMEIMKGIRSPMEEGLV-----QALKLAMGCCAPVASVRPTMDEVVK 652
+ + + P + +A+ L + R T E
Sbjct: 255 TEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 90.9 bits (225), Expect = 8e-21
Identities = 54/292 (18%), Positives = 101/292 (34%), Gaps = 51/292 (17%)
Query: 382 GQVIEKTTYGTAYKAK-LADGATIALRLLREGSCKD---------RSSCLPVIRQLGKVR 431
+++ + + A++++ R + L + L KV
Sbjct: 8 KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVS 67
Query: 432 -HENLIPLRAFYQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARG 490
H N+I L+ Y+ L++D L D L + K L+ KI +
Sbjct: 68 GHPNIIQLKDTYETNT-FFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEV 122
Query: 491 LAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKADGYKA 550
+ LH + I H +++ +N+L+DD +LT+FG + P +++ + Y A
Sbjct: 123 ICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDP--GEKLREVCGTPSYLA 177
Query: 551 PEL------QRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEE 604
PE+ D+++ G+++ +L G P
Sbjct: 178 PEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW-------------------HR 218
Query: 605 TTMEVFDMEIMKG---IRSPMEEGLVQALK-LAMGCCAPVASVRPTMDEVVK 652
M + M IM G SP + +K L R T +E +
Sbjct: 219 KQMLMLRM-IMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 91.1 bits (225), Expect = 1e-20
Identities = 38/285 (13%), Positives = 84/285 (29%), Gaps = 31/285 (10%)
Query: 382 GQVIEKTTYGTAYKAK-LADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRA 440
G+ I ++G Y +A G +A++L + ++ IP
Sbjct: 12 GRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK--TKHPQLHIESKIYKMMQGGVGIPTIR 69
Query: 441 FYQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEI 500
+ + +++ + L + +A + + Y+H
Sbjct: 70 WCGAEGDYNVMVMELLG----PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SK 122
Query: 501 PITHGNVRSKNVLV---DDFFVSRLTEFGLDQLMVPAVADEMVALAKAD------GYKAP 551
H +V+ N L+ + + +FGL + A + + + Y +
Sbjct: 123 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASI 182
Query: 552 ELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFD 611
+ S R D+ + G +L+ +G P + + K + E M
Sbjct: 183 NTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAAT-----KRQKYERISEKKMSTPI 237
Query: 612 MEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEE 656
+ KG S C + +P + +
Sbjct: 238 EVLCKGYPSEFAT-------YLNFCRSLRFDDKPDYSYLRQLFRN 275
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.7 bits (224), Expect = 1e-20
Identities = 48/282 (17%), Positives = 100/282 (35%), Gaps = 19/282 (6%)
Query: 383 QVIEKTTYGTAYKAK-LADGATIALRLLREGSCKD--RSSCLPVIRQLGKVRHENLIPLR 439
+ I + TYG YKA+ G +AL+ +R + + S+ + I L ++ H N++ L
Sbjct: 8 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67
Query: 440 AFYQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHE 499
KL + F + L + + + + +GLA+ H
Sbjct: 68 DVIH--TENKLYLVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCH---S 120
Query: 500 IPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKADGYKAPELQRMKKC 559
+ H +++ +N+L++ +L +FGL + V + L K
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 180
Query: 560 SSRTDVYAFGILLLEILIGKKPGKSGRNGE-----FVDLPSIVKVAVLEETTMEVFDMEI 614
S+ D+++ G + E++ + + F L + +V T+M +
Sbjct: 181 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 240
Query: 615 MKGIRSPMEEGLV----QALKLAMGCCAPVASVRPTMDEVVK 652
K R + + L + R + +
Sbjct: 241 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.2 bits (223), Expect = 1e-20
Identities = 45/286 (15%), Positives = 99/286 (34%), Gaps = 45/286 (15%)
Query: 382 GQVIEKTTYGTAYKAK-LADGATIALRLLREGSCKDRSSCLPV------IRQLGKVRHEN 434
G+ + + K + + G A + +++ K + + L +++H N
Sbjct: 15 GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 74
Query: 435 LIPLRAFYQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYL 494
+I L Y+ + + +LI + L D +A K L + I G+
Sbjct: 75 VITLHEVYE-NKTDVILILELVA----GGELFDFLAEKESLTEEEATEFLKQILNGV--- 126
Query: 495 HTGHEIPITHGNVRSKNVLVDDFFVSR----LTEFGLDQLMVPAVADEMVALAKADGYKA 550
+ H + I H +++ +N+++ D V + + +FGL + +E + + A
Sbjct: 127 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG--NEFKNIFGTPEFVA 184
Query: 551 PELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVF 610
PE+ + D+++ G++ +L G P L +T E
Sbjct: 185 PEIVNYEPLGLEADMWSIGVITYILLSGASP-------------------FLGDTKQETL 225
Query: 611 DMEIMKGIRSPMEEGL----VQALKLAMGCCAPVASVRPTMDEVVK 652
+ +E A R T+ + ++
Sbjct: 226 AN-VSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 89.9 bits (222), Expect = 2e-20
Identities = 52/281 (18%), Positives = 104/281 (37%), Gaps = 19/281 (6%)
Query: 383 QVIEKTTYGTAYKAKLADGATIALRLLREGSCKD--RSSCLPVIRQLGKVRHENLIPLRA 440
+ I + TYG YKA+ G T AL+ +R + S+ + I L +++H N++ L
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 441 FYQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEI 500
K+ +L++++ L + L L + G+AY H +
Sbjct: 68 VIHTKK-RLVLVFEHLDQDLKKLLDVC----EGGLESVTAKSFLLQLLNGIAYCH---DR 119
Query: 501 PITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKADGYKAPELQRMKKCS 560
+ H +++ +N+L++ ++ +FGL + V + L KK S
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYS 179
Query: 561 SRTDVYAFGILLLEILIGKKPGKSGRNGE-----FVDLPSIVKVAVLEETTMEVFDMEIM 615
+ D+++ G + E++ G + F L + T + +D
Sbjct: 180 TTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFT 239
Query: 616 KGIRSPMEEGLV----QALKLAMGCCAPVASVRPTMDEVVK 652
P E L + L + R T + ++
Sbjct: 240 VYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.9 bits (222), Expect = 2e-20
Identities = 49/284 (17%), Positives = 100/284 (35%), Gaps = 22/284 (7%)
Query: 383 QVIEKTTYGTAYKAK-LADGATIALRLLREGSCKDRSSCLPV-----IRQLGKVRHENLI 436
+ + + T YKA+ +A++ ++ G + + I+ L ++ H N+I
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 437 PLRAFYQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHT 496
L + + L++D+ + + + VL + L +GL YLH
Sbjct: 64 GLLDAFG-HKSNISLVFDFMETDLEVIIKDN----SLVLTPSHIKAYMLMTLQGLEYLH- 117
Query: 497 GHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKADGYKAPELQRM 556
+ I H +++ N+L+D+ V +L +FGL + + L
Sbjct: 118 --QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGA 175
Query: 557 KKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMK 616
+ D++A G +L E+L+ + + + EE ++ +
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV 235
Query: 617 GIRSPMEEGLV--------QALKLAMGCCAPVASVRPTMDEVVK 652
+S L L L G R T + +K
Sbjct: 236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 89.1 bits (220), Expect = 4e-20
Identities = 40/289 (13%), Positives = 85/289 (29%), Gaps = 37/289 (12%)
Query: 382 GQVIEKTTYGTAYKAK-LADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRA 440
G+ I + ++G ++ L + +A++ S D R + IP
Sbjct: 10 GRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIP-NV 66
Query: 441 FYQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEI 500
+Y G+ G ++ +L DLL + A + + +H E
Sbjct: 67 YYFGQEGLHNVLVIDLLGPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIH---EK 120
Query: 501 PITHGNVRSKNVLVDDFFVS-----RLTEFGLDQLMVPAVADEMVALAKADG------YK 549
+ + +++ N L+ + +FG+ + V + + + Y
Sbjct: 121 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM 180
Query: 550 APELQRMKKCSSRTDVYAFGILLLEILIGK--KPGKSGRNGEFVDLPSIVKVAVLEETTM 607
+ ++ S R D+ A G + + L G G + K + E
Sbjct: 181 SINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAAT-------NKQKYERIGEKKQ 233
Query: 608 EVFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEE 656
E+ G + P D + +
Sbjct: 234 STPLRELCAGFPEEFYK-------YMHYARNLAFDATPDYDYLQGLFSK 275
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 89.0 bits (220), Expect = 6e-20
Identities = 45/204 (22%), Positives = 79/204 (38%), Gaps = 16/204 (7%)
Query: 382 GQVIEKTTYGTAYKAK-LADGATIALRLLREG---SCKDRSSCLPVIRQLGKVRHENLIP 437
+ + ++G + + +G A+++L++ K L V H +I
Sbjct: 9 LRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIR 68
Query: 438 LRAFYQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTG 497
+ +Q + +I DY L LL A + L YLH
Sbjct: 69 MWGTFQ-DAQQIFMIMDYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLH-- 121
Query: 498 HEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKADGYKAPELQRMK 557
I + +++ +N+L+D ++T+FG V D L Y APE+ K
Sbjct: 122 -SKDIIYRDLKPENILLDKNGHIKITDFG----FAKYVPDVTYTLCGTPDYIAPEVVSTK 176
Query: 558 KCSSRTDVYAFGILLLEILIGKKP 581
+ D ++FGIL+ E+L G P
Sbjct: 177 PYNKSIDWWSFGILIYEMLAGYTP 200
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.8 bits (209), Expect = 1e-18
Identities = 48/282 (17%), Positives = 98/282 (34%), Gaps = 47/282 (16%)
Query: 382 GQVIEKTTYGTAYKAK-LADGATIALRLLREGSCKDRSSCLPVIRQLGKVR--------H 432
G ++ +G+ Y ++D +A++ + + D R +V
Sbjct: 9 GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 68
Query: 433 ENLIPLRAFYQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLA 492
+I L +++ + +LI + L D I + L + +
Sbjct: 69 SGVIRLLDWFE-RPDSFVLILERPEP---VQDLFDFITERGALQEELARSFFWQVLEAVR 124
Query: 493 YLHTGHEIPITHGNVRSKNVLVD-DFFVSRLTEFGLDQLMVPAVADEMVALAKADGYKAP 551
+ H + H +++ +N+L+D + +L +FG L+ V + Y P
Sbjct: 125 HCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDG---TRVYSPP 178
Query: 552 E-LQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVF 610
E ++ + V++ GILL +++ G P +
Sbjct: 179 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH-------------------------- 212
Query: 611 DMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVK 652
D EI++G + + L C A S RPT +E+
Sbjct: 213 DEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 254
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.2 bits (207), Expect = 2e-18
Identities = 49/283 (17%), Positives = 102/283 (36%), Gaps = 21/283 (7%)
Query: 383 QVIEKTTYGTAYKAK-LADGATIALRLLREGSCKD--RSSCLPVIRQLGKVRHENLIPLR 439
+ I + TYGT +KAK +AL+ +R + SS L I L +++H+N++ L
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 440 AFYQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHE 499
+ L+ DL + L+ + +GL + H+ +
Sbjct: 68 DVLHSDKKLTLVFEFCD-----QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN- 121
Query: 500 IPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKADGYKAPELQRMKKC 559
+ H +++ +N+L++ +L FGL + V + L K
Sbjct: 122 --VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLY 179
Query: 560 SSRTDVYAFGILLLEILIGKKPGKSGRNGE------FVDLPSIVKVAVLEETTMEVFDME 613
S+ D+++ G + E+ +P G + + F L + + T + +
Sbjct: 180 STSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY 239
Query: 614 IMKGIRSPMEEGLV----QALKLAMGCCAPVASVRPTMDEVVK 652
M + + + L R + +E ++
Sbjct: 240 PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 83.8 bits (206), Expect = 4e-18
Identities = 55/296 (18%), Positives = 109/296 (36%), Gaps = 33/296 (11%)
Query: 383 QVIEKTTYGTAYKAK-LADGATIALRLLREGSCKD--RSSCLPVIRQLGKVRHENLIPL- 438
I + T+G +KA+ G +AL+ + + K+ + L I+ L ++HEN++ L
Sbjct: 16 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75
Query: 439 ------RAFYQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLA 492
+ Y +G L++D+ HDL + ++ + GL
Sbjct: 76 EICRTKASPYNRCKGSIYLVFDFCE----HDLAGLLSNVLVKFTLSEIKRVMQMLLNGLY 131
Query: 493 YLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKADG---YK 549
Y+H I H ++++ NVL+ V +L +FGL + A + Y+
Sbjct: 132 YIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYR 188
Query: 550 APE-LQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTME 608
PE L + D++ G ++ E+ + + L S + ++ E
Sbjct: 189 PPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN 248
Query: 609 VFDMEIMKGIRSPMEEGLV------------QALKLAMGCCAPVASVRPTMDEVVK 652
V + E+ + + + AL L + R D+ +
Sbjct: 249 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 81.8 bits (201), Expect = 2e-17
Identities = 52/285 (18%), Positives = 100/285 (35%), Gaps = 23/285 (8%)
Query: 383 QVIEKTTYGTAYKAK-LADGATIALRLLREGSCKD--RSSCLPVIRQLGKVRHENLIPLR 439
Q + YG A GA +A++ L + +R L +RHEN+I L
Sbjct: 24 QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLL 83
Query: 440 AFYQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHE 499
+ D++ + L R + + +GL Y+H
Sbjct: 84 DVFT-PDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAG- 141
Query: 500 IPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKADGYKAPE-LQRMKK 558
I H +++ N+ V++ ++ +FGL + EM Y+APE + +
Sbjct: 142 --IIHRDLKPGNLAVNEDCELKILDFGLAR----QADSEMTGYVVTRWYRAPEVILNWMR 195
Query: 559 CSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDL-------PSIVKVAVLEETTMEVFD 611
+ D+++ G ++ E++ GK K + + + P V L+ + +
Sbjct: 196 YTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYM 255
Query: 612 MEIMKGIRSPMEEGLV----QALKLAMGCCAPVASVRPTMDEVVK 652
+ + + L A+ L A R T E +
Sbjct: 256 KGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 78.5 bits (192), Expect = 4e-16
Identities = 41/231 (17%), Positives = 68/231 (29%), Gaps = 42/231 (18%)
Query: 55 SWNISVPLCQWRGLKWISTNGSPLSCSDISLPQWANLSLYKDS---------SIHLLSIQ 105
+ + IS+N L +L + +L +
Sbjct: 166 TDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGILTNLDELS 225
Query: 106 LPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLA- 164
L L L + L L L N + P + L+E+ L AN + +
Sbjct: 226 LNGNQLKD--IGTLASLTNLTDLDLANNQISNLAPL--SGLTKLTELKLGANQISNISPL 281
Query: 165 ------------------PSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDL 206
S + L L L+ N+++ P +L LQ L
Sbjct: 282 AGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISPVSSLTK-----LQRLFF 336
Query: 207 GSNKFSGSFPEFVTRFEALKELDISNNLFSGSIP-EGLTRLSLEKLNLSHN 256
+NK S + + L +N S P LTR+ +L L+
Sbjct: 337 ANNKVSD--VSSLANLTNINWLSAGHNQISDLTPLANLTRI--TQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 41.1 bits (95), Expect = 4e-04
Identities = 14/77 (18%), Positives = 34/77 (44%), Gaps = 5/77 (6%)
Query: 194 PNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRLS-LEKLN 252
++ ++ LG + + + T + + L SI +G+ L+ L ++N
Sbjct: 17 TDTALAEKMKTVLGKTNVTDTVSQ--TDLDQVTTLQADRLGIK-SI-DGVEYLNNLTQIN 72
Query: 253 LSHNNFSGVLPVFSESK 269
S+N + + P+ + +K
Sbjct: 73 FSNNQLTDITPLKNLTK 89
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 40.0 bits (92), Expect = 8e-04
Identities = 16/120 (13%), Positives = 36/120 (30%), Gaps = 13/120 (10%)
Query: 49 ENLLLSSWNI----SVPLCQWRGLKWISTNGSPLSCSDISLPQWANLSLYKDSSIHLLSI 104
L L + I + ++ N +L L+LY ++ + +
Sbjct: 266 TELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISPV 325
Query: 105 ----QLPSANLTG---SLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSAN 157
+L S L + + L N + P L + ++++ L+
Sbjct: 326 SSLTKLQRLFFANNKVSDVSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 76.7 bits (188), Expect = 8e-16
Identities = 36/204 (17%), Positives = 76/204 (37%), Gaps = 13/204 (6%)
Query: 382 GQVIEKTTYGTAYKAK-LADGATIALRLLREGSCKDRSSCLPVIRQ---LGKVRHENLIP 437
+++ K T+G + A G A+++LR+ + + + L RH L
Sbjct: 10 LKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 69
Query: 438 LRAFYQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTG 497
L+ +Q + L ++ + V R I L
Sbjct: 70 LKYAFQTHDR-----LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSAL---EYL 121
Query: 498 HEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKADGYKAPELQRMK 557
H + + +++ +N+++D ++T+FGL + + M Y APE+
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-GATMKTFCGTPEYLAPEVLEDN 180
Query: 558 KCSSRTDVYAFGILLLEILIGKKP 581
D + G+++ E++ G+ P
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 76.0 bits (186), Expect = 1e-15
Identities = 40/210 (19%), Positives = 77/210 (36%), Gaps = 17/210 (8%)
Query: 382 GQVIEKTTYGTAYKAKLA----DGATIALRLLREGSCKDRSSCLPVIRQ----LGKVRHE 433
+V+ YG + + G A+++L++ + ++ R L +R
Sbjct: 29 LKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQS 88
Query: 434 NLIPLRAFYQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAY 493
+ + + LI DY L L + I L +
Sbjct: 89 PFLVTLHYAFQTETKLHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEH 144
Query: 494 LHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKADGYKAPEL 553
LH ++ I + +++ +N+L+D LT+FGL + V + Y AP++
Sbjct: 145 LH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDI 201
Query: 554 QRMKK--CSSRTDVYAFGILLLEILIGKKP 581
R D ++ G+L+ E+L G P
Sbjct: 202 VRGGDSGHDKAVDWWSLGVLMYELLTGASP 231
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 75.2 bits (184), Expect = 3e-15
Identities = 35/203 (17%), Positives = 69/203 (33%), Gaps = 16/203 (7%)
Query: 383 QVIEKTTYGTAYKAK-LADGATIALRLLREGSC---KDRSSCLPVIRQLGKVRHENLIPL 438
+ + ++G K G A+++L + K L R L V L+ L
Sbjct: 47 KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 439 RAFYQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGH 498
++ + + + A I YLH
Sbjct: 107 EFSFKDNS-----NLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH--- 158
Query: 499 EIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKADGYKAPELQRMKK 558
+ + + +++ +N+L+D ++T+FG + + L APE+ K
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTWTLCGTPEALAPEIILSKG 214
Query: 559 CSSRTDVYAFGILLLEILIGKKP 581
+ D +A G+L+ E+ G P
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPP 237
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 73.6 bits (179), Expect = 7e-15
Identities = 62/335 (18%), Positives = 106/335 (31%), Gaps = 101/335 (30%)
Query: 31 SDVELLLGKIKSSLQGDDENLLLSSWNISVPLCQ--WRGLKWISTNGSP------LSCSD 82
D + LL +IK L LSSW + C W G+ + + LS +
Sbjct: 6 QDKQALL-QIKKDLGNPT---TLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLN 61
Query: 83 IS-------------------LPQWANLSLYKDSSIH----LLSIQLPSANLTGSLPREL 119
+ + NL +I L + + N++G++P L
Sbjct: 62 LPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFL 121
Query: 120 GEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRL 179
+ L +L + N+L GT+P + +L I N +G + S + S+ +
Sbjct: 122 SQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTI 181
Query: 180 HGNSLTAALPEPALPNSTCSDL-------------------------------------- 201
N LT +P +
Sbjct: 182 SRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVG 241
Query: 202 -----QYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRLSLEKLNLSHN 256
LDL +N+ G+ P+ +T+ + L L++S N G IP+G + ++N
Sbjct: 242 LSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANN 301
Query: 257 NFSGVLPVFSESKFGAEVFEGNSPALCGFPLRDCS 291
LCG PL C+
Sbjct: 302 KC-----------------------LCGSPLPACT 313
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 72.2 bits (176), Expect = 3e-14
Identities = 45/284 (15%), Positives = 95/284 (33%), Gaps = 21/284 (7%)
Query: 383 QVIEKTTYGTAYKAK-LADGATIALRLLREG--SCKDRSSCLPVIRQLGKVRHENLIPLR 439
+ YG+ A G +A++ L S +R L ++HEN+I L
Sbjct: 24 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83
Query: 440 AFYQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHE 499
+ R + D + L + I L + I RGL Y+H+
Sbjct: 84 DVFTPARSLE-EFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD- 141
Query: 500 IPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVALAKADGYKAPELQRMKKC 559
I H +++ N+ V++ ++ +FGL + + + +
Sbjct: 142 --IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRW---YRAPEIMLNWMHY 196
Query: 560 SSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIR 619
+ D+++ G ++ E+L G+ + + + L + E ++ I+
Sbjct: 197 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 256
Query: 620 SPMEEGLV-----------QALKLAMGCCAPVASVRPTMDEVVK 652
S + + A+ L + R T + +
Sbjct: 257 SLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 67.1 bits (162), Expect = 9e-13
Identities = 29/161 (18%), Positives = 48/161 (29%), Gaps = 7/161 (4%)
Query: 100 HLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLF 159
L + L L + L L+L+ N + SL + L N
Sbjct: 130 ALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRV 189
Query: 160 TGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFV 219
V + +L P + LQYL L N +
Sbjct: 190 AHVHPHAFRDLGRL----MTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCD-CRAR 244
Query: 220 TRFEALKELDISNNLFSGSIPEGLTRLSLEKLNLSHNNFSG 260
+ L++ S++ S+P+ L L L+ N+ G
Sbjct: 245 PLWAWLQKFRGSSSEVPCSLPQRLAGRDL--KRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.8 bits (130), Expect = 1e-08
Identities = 35/164 (21%), Positives = 54/164 (32%), Gaps = 4/164 (2%)
Query: 100 HLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLF 159
L ++ L L P + LQ LYL N+L+ +L+ + L N
Sbjct: 106 RLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRI 165
Query: 160 TGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFV 219
+ V + L L L LH N + P L N S E +
Sbjct: 166 SSVPERAFRGL-HSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFA---NNLSALPTEAL 221
Query: 220 TRFEALKELDISNNLFSGSIPEGLTRLSLEKLNLSHNNFSGVLP 263
AL+ L +++N + L+K S + LP
Sbjct: 222 APLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLP 265
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.8 bits (117), Expect = 4e-07
Identities = 43/252 (17%), Positives = 79/252 (31%), Gaps = 11/252 (4%)
Query: 37 LGKIKSSLQGDDENLLLSSWNIS-VPLCQWRGLKWISTNGSPLSCSDISLPQWANLSLYK 95
L + + + + L IS VP +R + ++ + +
Sbjct: 23 LQAVPVGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAA-----FT 77
Query: 96 DSSIHLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLS 155
++ +A L P L +L+L+ L+ P ++L + L
Sbjct: 78 GLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQ 137
Query: 156 ANLFTGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSF 215
N + + L L LHGN +++ +PE A L L L N+ +
Sbjct: 138 DNALQALP-DDTFRDLGNLTHLFLHGNRISS-VPERAFRG--LHSLDRLLLHQNRVAHVH 193
Query: 216 PEFVTRFEALKELDISNNLFSG-SIPEGLTRLSLEKLNLSHNNFSGVLPVFSESKFGAEV 274
P L L + N S +L+ L L+ N + + +
Sbjct: 194 PHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKF 253
Query: 275 FEGNSPALCGFP 286
+S C P
Sbjct: 254 RGSSSEVPCSLP 265
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 67.0 bits (162), Expect = 1e-12
Identities = 36/223 (16%), Positives = 66/223 (29%), Gaps = 12/223 (5%)
Query: 74 NGSPLSCSDISLPQWANLSLYKDSSIHLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVN 133
+ + CSD+ L + KD + L + +T + L +L L N
Sbjct: 11 HLRVVQCSDLGLE-----KVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINN 65
Query: 134 SLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPAL 193
+ P L + LS N L + L + +
Sbjct: 66 KISKISPGAFAPLVKLERLYLSKNQLKE-LPEKMPKTLQELRVHENEITK----VRKSVF 120
Query: 194 PNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRLSLEKLNL 253
+ L K SG + L + I++ + +IP+GL SL +L+L
Sbjct: 121 NGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLPP-SLTELHL 178
Query: 254 SHNNFSGVLPVFSESKFGAEVFEGNSPALCGFPLRDCSGNSRL 296
N + V + + ++ + L
Sbjct: 179 DGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHL 221
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 51.6 bits (122), Expect = 1e-07
Identities = 31/198 (15%), Positives = 63/198 (31%), Gaps = 17/198 (8%)
Query: 70 WISTNGSPLSCSDISLPQWANLSLYKDSSIHLLSIQLPSANLTGSLPRELGEFSMLQSLY 129
+ L + + + + + ++ + +G L +
Sbjct: 97 KMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIR 156
Query: 130 LNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNSLTAALP 189
+ ++ TIP L SL+E+ L N T V A S+ L + L G S +
Sbjct: 157 IADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNN----LAKLGLSFNSISA 209
Query: 190 EPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEG------- 242
+ L+ L +N P + + ++ + + NN S +I
Sbjct: 210 VDNGSLANTPHLRELH-LNNNKLVKVPGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGY 267
Query: 243 -LTRLSLEKLNLSHNNFS 259
+ S ++L N
Sbjct: 268 NTKKASYSGVSLFSNPVQ 285
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 50.4 bits (119), Expect = 3e-07
Identities = 38/252 (15%), Positives = 73/252 (28%), Gaps = 64/252 (25%)
Query: 63 CQWRGLKWISTNGSP------LSCSDIS-LPQWANLSLYKDSSIHLLSIQLPSANLTGSL 115
C GL+ + + P L + I+ + +L +L ++ L + ++
Sbjct: 17 CSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLK-----NLHTLILINNKISKIS 71
Query: 116 PRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDL--------------------- 154
P L+ LYL+ N LK L +
Sbjct: 72 PGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVEL 131
Query: 155 -SANLFTGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSG 213
+ L + + + +L +R+ ++T +P L L L NK +
Sbjct: 132 GTNPLKSSGIENGAFQGMKKLSYIRIADTNITT------IPQGLPPSLTELHLDGNKITK 185
Query: 214 SFPEFVTRFEALKELDISNNLFSGSIPEGLTRLS------------------------LE 249
+ L +L +S N S L ++
Sbjct: 186 VDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQ 245
Query: 250 KLNLSHNNFSGV 261
+ L +NN S +
Sbjct: 246 VVYLHNNNISAI 257
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 40.8 bits (94), Expect = 4e-04
Identities = 30/185 (16%), Positives = 60/185 (32%), Gaps = 16/185 (8%)
Query: 42 SSLQGDDENLLLSSWNISVPLCQWRGLKWISTNGSPLSCSDISLPQWANLSLYKDSSIHL 101
L+ + + ++ L Q ++ + + + LS + + ++
Sbjct: 103 QELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNI 162
Query: 102 LSI-----------QLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLS 150
+I L +T L + L L L+ NS+ L + L
Sbjct: 163 TTIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLR 222
Query: 151 EIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNSLTAALPE---PALPNSTCSDLQYLDLG 207
E+ L+ N V P + + LH N+++A P N+ + + L
Sbjct: 223 ELHLNNNKLVKV--PGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLF 280
Query: 208 SNKFS 212
SN
Sbjct: 281 SNPVQ 285
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 55.9 bits (134), Expect = 1e-09
Identities = 19/160 (11%), Positives = 49/160 (30%), Gaps = 22/160 (13%)
Query: 378 LNATGQVIEKTTYGTAYKAKLADGATIALRLLREGSCKDRSSC----------LPVIRQL 427
++A G+++ + + ++ + G + + +
Sbjct: 1 VDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60
Query: 428 GKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGI 487
+ L L+ K Y + + L +L+ + + + I
Sbjct: 61 ARNEFRALQKLQGLAVPKV------YAWEGNAVLMELIDAKELYRVRVENPDE--VLDMI 112
Query: 488 ARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGL 527
+A + I HG++ NVLV + + + +F
Sbjct: 113 LEEVAKF---YHRGIVHGDLSQYNVLVSEEGI-WIIDFPQ 148
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 54.4 bits (129), Expect = 2e-08
Identities = 15/70 (21%), Positives = 29/70 (41%), Gaps = 7/70 (10%)
Query: 198 CSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRLSLEKLNLSHNN 257
L+ L++ +NK P R L+ L S N + +PE +L++L++ +N
Sbjct: 283 PPSLEELNVSNNKLI-ELPALPPR---LERLIASFNHLA-EVPELPQ--NLKQLHVEYNP 335
Query: 258 FSGVLPVFSE 267
+
Sbjct: 336 LREFPDIPES 345
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 50.2 bits (118), Expect = 5e-07
Identities = 22/104 (21%), Positives = 40/104 (38%), Gaps = 16/104 (15%)
Query: 129 YLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNSLTAAL 188
+N+ I SL E+++S N + L RL L N L +
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-----ELPALPPRLERLIASFNHLAE-V 319
Query: 189 PEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISN 232
PE +L+ L + N FP+ E++++L +++
Sbjct: 320 PE------LPQNLKQLHVEYNPLR-EFPDI---PESVEDLRMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 42.9 bits (99), Expect = 1e-04
Identities = 16/53 (30%), Positives = 24/53 (45%), Gaps = 3/53 (5%)
Query: 209 NKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRLSLEKLNLSHNNFSGV 261
N S +L+EL++SNN +P RL E+L S N+ + V
Sbjct: 270 NASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRL--ERLIASFNHLAEV 319
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 42.1 bits (97), Expect = 1e-04
Identities = 18/87 (20%), Positives = 30/87 (34%), Gaps = 16/87 (18%)
Query: 122 FSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHG 181
L+ L ++ N L +P L + S N + L L L +
Sbjct: 283 PPSLEELNVSNNKLI-ELPALPP---RLERLIASFNHLA-----EVPELPQNLKQLHVEY 333
Query: 182 NSLTAALPEPALPNSTCSDLQYLDLGS 208
N L P+ +P S ++ L + S
Sbjct: 334 NPLR-EFPD--IPES----VEDLRMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 37.5 bits (85), Expect = 0.004
Identities = 12/35 (34%), Positives = 18/35 (51%), Gaps = 3/35 (8%)
Query: 225 LKELDISNNLFSGSIPEGLTRLSLEKLNLSHNNFS 259
EL+++N S S+PE LE L S N+ +
Sbjct: 40 AHELELNNLGLS-SLPELPP--HLESLVASCNSLT 71
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.3 bits (123), Expect = 1e-07
Identities = 18/115 (15%), Positives = 36/115 (31%), Gaps = 21/115 (18%)
Query: 146 SSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPN--STCSDLQY 203
S + +D+ + + L + +RL LT A + + + L
Sbjct: 1 SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCK-DISSALRVNPALAE 59
Query: 204 LDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRLSLEKLNLSHNNF 258
L+L SN+ + L + S ++KL+L +
Sbjct: 60 LNLRSNELGDVGVH-----------CVLQGLQTPS-------CKIQKLSLQNCCL 96
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.3 bits (123), Expect = 1e-07
Identities = 13/67 (19%), Positives = 27/67 (40%), Gaps = 6/67 (8%)
Query: 200 DLQYLDLGSNKFSGS-FPEFVTRFEALKELDISNNLFSG----SIPEGLTRL-SLEKLNL 253
D+Q LD+ + S + + E + + + + + + + I L +L +LNL
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 254 SHNNFSG 260
N
Sbjct: 63 RSNELGD 69
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.9 bits (122), Expect = 1e-07
Identities = 19/76 (25%), Positives = 28/76 (36%), Gaps = 10/76 (13%)
Query: 198 CSDLQYLDLGSNKFSG----SFPEFVTRFEALKELDISNNLFSGSIPEGLTRL------S 247
S L+ L L S S + +L+ELD+SNN + L
Sbjct: 368 GSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCL 427
Query: 248 LEKLNLSHNNFSGVLP 263
LE+L L +S +
Sbjct: 428 LEQLVLYDIYWSEEME 443
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.7 bits (119), Expect = 4e-07
Identities = 16/97 (16%), Positives = 34/97 (35%), Gaps = 8/97 (8%)
Query: 165 PSIWNLCDRLVSLRLHGNSLTAALPEPALPN--STCSDLQYLDLGSNKFSGSFPEFVTRF 222
+ L L L ++ + +L L+ LDL +N + +
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCS-SLAATLLANHSLRELDLSNNCLGDAGILQLVES 420
Query: 223 -----EALKELDISNNLFSGSIPEGLTRLSLEKLNLS 254
L++L + + +S + + L L +K +L
Sbjct: 421 VRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLR 457
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.9 bits (96), Expect = 2e-04
Identities = 16/94 (17%), Positives = 34/94 (36%), Gaps = 9/94 (9%)
Query: 98 SIHLLSIQLPSANLTGS-LPRELGEFSMLQSLYLNVNSLKG----TIPFELGYSSSLSEI 152
S+ + S+ + L+ + L Q + L+ L I L + +L+E+
Sbjct: 1 SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 60
Query: 153 DLSANLFTGV----LAPSIWNLCDRLVSLRLHGN 182
+L +N V + + ++ L L
Sbjct: 61 NLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.3 bits (92), Expect = 7e-04
Identities = 17/77 (22%), Positives = 30/77 (38%), Gaps = 8/77 (10%)
Query: 122 FSMLQSLYLNVNSLKGT----IPFELGYSSSLSEIDLSANLFTG----VLAPSIWNLCDR 173
S+L+ L+L + + + L + SL E+DLS N L S+
Sbjct: 368 GSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCL 427
Query: 174 LVSLRLHGNSLTAALPE 190
L L L+ + + +
Sbjct: 428 LEQLVLYDIYWSEEMED 444
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.3 bits (116), Expect = 6e-07
Identities = 19/110 (17%), Positives = 44/110 (40%), Gaps = 10/110 (9%)
Query: 152 IDLSANLFTGVLAPSIWNLCDR-LVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNK 210
+DL+ L + +++ R + + L E + + +Q++DL ++
Sbjct: 5 LDLTGKNLHP---DVTGRLLSQGVIAFRCPRSFMDQPLAE----HFSPFRVQHMDLSNSV 57
Query: 211 FSG-SFPEFVTRFEALKELDISNNLFSGSIPEGLTRL-SLEKLNLSHNNF 258
+ +++ L+ L + S I L + +L +LNLS +
Sbjct: 58 IEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSG 107
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.6 bits (101), Expect = 4e-05
Identities = 7/59 (11%), Positives = 19/59 (32%), Gaps = 1/59 (1%)
Query: 202 QYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRLSLEKLNLSHNNFSG 260
Q LDL + + + + + E + ++ ++LS++
Sbjct: 3 QTLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEV 60
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 45.1 bits (106), Expect = 2e-06
Identities = 25/131 (19%), Positives = 46/131 (35%), Gaps = 14/131 (10%)
Query: 126 QSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNSLT 185
+ L+L L T+ L ++ +DLS N + P++ L L +
Sbjct: 1 RVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRAL-PPALAALR------CLEVLQAS 51
Query: 186 AALPEPALPNSTCSDLQYLDLGSNKF-SGSFPEFVTRFEALKELDISNNLFSG--SIPEG 242
E + LQ L L +N+ + + + L L++ N I E
Sbjct: 52 DNALENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQER 111
Query: 243 LTRL--SLEKL 251
L + S+ +
Sbjct: 112 LAEMLPSVSSI 122
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 42.0 bits (98), Expect = 3e-05
Identities = 23/109 (21%), Positives = 32/109 (29%), Gaps = 30/109 (27%)
Query: 177 LRLHGNSLTAALPEPALPN-STCSDLQYLDLGSNKFSGSFPEF----------------- 218
L L LT L + + +LDL N+ P
Sbjct: 3 LHLAHKDLTV------LCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALE 56
Query: 219 ----VTRFEALKELDISNN-LFSGSIPEGLTRL-SLEKLNLSHNNFSGV 261
V L+EL + NN L + + L L LNL N+
Sbjct: 57 NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.6 bits (101), Expect = 4e-05
Identities = 39/207 (18%), Positives = 64/207 (30%), Gaps = 21/207 (10%)
Query: 101 LLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFT 160
L + NLT +LP +L L+L+ N L L + L++++L T
Sbjct: 12 HLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT 68
Query: 161 GVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYL---------------- 204
+ + L SL L
Sbjct: 69 KLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQE 128
Query: 205 -DLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRL-SLEKLNLSHNNFSGVL 262
L N+ P +T L++L ++NN + L L +L+ L L N+ +
Sbjct: 129 LYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIP 188
Query: 263 PVFSESKFGAEVFEGNSPALCGFPLRD 289
F S F +P LC +
Sbjct: 189 KGFFGSHLLPFAFLHGNPWLCNCEILY 215
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.7 bits (91), Expect = 7e-04
Identities = 11/63 (17%), Positives = 19/63 (30%), Gaps = 6/63 (9%)
Query: 171 CDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDI 230
+ + +LTA LP D L L N + + L +L++
Sbjct: 9 VASHLEVNCDKRNLTA------LPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNL 62
Query: 231 SNN 233
Sbjct: 63 DRA 65
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.8 bits (86), Expect = 0.003
Identities = 11/64 (17%), Positives = 20/64 (31%), Gaps = 4/64 (6%)
Query: 196 STCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRL-SLEKLNLS 254
S + ++ + + P + + L +S NL L L +LNL
Sbjct: 7 SKVASHLEVNCDKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLD 63
Query: 255 HNNF 258
Sbjct: 64 RAEL 67
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.4 bits (85), Expect = 0.004
Identities = 8/45 (17%), Positives = 18/45 (40%), Gaps = 2/45 (4%)
Query: 219 VTRFEALKELDISNNLFSGSIPEGLTRLSLEKLNLSHNNFSGVLP 263
V++ + E++ + ++P L + L+LS N
Sbjct: 6 VSKVASHLEVNCDKRNLT-ALPPDLPK-DTTILHLSENLLYTFSL 48
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 40.0 bits (92), Expect = 4e-04
Identities = 28/202 (13%), Positives = 66/202 (32%), Gaps = 18/202 (8%)
Query: 77 PLSCSDISLPQWANLSLYKDSSI-HLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSL 135
PL I++P ++ D + + L ++T ++ + E + + + N + +
Sbjct: 2 PLGSETITVPTPIK-QIFSDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDI 58
Query: 136 KGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPN 195
K + Y +++++ L+ N T + + L L++ L +
Sbjct: 59 KSVQGIQ--YLPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKS 116
Query: 196 STCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSI----------PEGLTR 245
+ D+ + ++ + + L L
Sbjct: 117 LSLEHNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLAG 176
Query: 246 L-SLEKLNLSHNNFSGVLPVFS 266
L L+ L LS N+ S L +
Sbjct: 177 LTKLQNLYLSKNHISD-LRALA 197
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 37.3 bits (85), Expect = 0.003
Identities = 14/62 (22%), Positives = 27/62 (43%), Gaps = 7/62 (11%)
Query: 171 CDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDI 230
+L +L+ N ++ P +LPN L + L +N+ S P + L + +
Sbjct: 172 LSKLTTLKADDNKISDISPLASLPN-----LIEVHLKNNQISDVSP--LANTSNLFIVTL 224
Query: 231 SN 232
+N
Sbjct: 225 TN 226
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 36.5 bits (83), Expect = 0.004
Identities = 17/75 (22%), Positives = 25/75 (33%), Gaps = 2/75 (2%)
Query: 184 LTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNN-LFSGSIPEG 242
LTA L E A + + LDL K + +D S+N +
Sbjct: 3 LTAELIEQAAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGFPL 61
Query: 243 LTRLSLEKLNLSHNN 257
L RL +N +
Sbjct: 62 LRRLKTLLVNNNRIC 76
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 37.6 bits (85), Expect = 0.004
Identities = 15/100 (15%), Positives = 25/100 (25%), Gaps = 9/100 (9%)
Query: 168 WNLCDRLVSLRLHGNSLTAALPEP---ALPNSTCSDLQYLDLGSNKFSGSFPE-----FV 219
L L L+ L+A A LQ L L N+
Sbjct: 239 LKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVID 298
Query: 220 TRFEALKELDISNNLFSGSIPEGLTRLSLEKLNLSHNNFS 259
+ L L+++ N F + + +
Sbjct: 299 EKMPDLLFLELNGNRF-SEEDDVVDEIREVFSTRGRGELD 337
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 679 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.88 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.83 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.77 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.73 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.67 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.64 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.64 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.61 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.56 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.51 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.47 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.46 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.44 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.43 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.43 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.39 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.38 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.38 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.38 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.36 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.36 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.33 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.26 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.2 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.13 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.05 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.05 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.04 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.03 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 98.97 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 98.71 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 98.65 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 98.65 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 98.49 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 98.4 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 98.3 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.13 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.11 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 97.81 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.8 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.27 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.21 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.14 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.43 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.31 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.25 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.58 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 94.54 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-52 Score=425.72 Aligned_cols=250 Identities=19% Similarity=0.347 Sum_probs=195.0
Q ss_pred cCccccCCceEEEEEEeCCCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCCh
Q 005749 382 GQVIEKTTYGTAYKAKLADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRTL 461 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gsL 461 (679)
.+.||+|+||+||+|++.+++.||||+++... ...++|.+|++++++++|||||+++|+|.. .+..++|||||++|+|
T Consensus 10 ~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~~lv~E~~~~g~L 87 (263)
T d1sm2a_ 10 VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLE-QAPICLVFEFMEHGCL 87 (263)
T ss_dssp EEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSSCEEEEECCTTCBH
T ss_pred EEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceecc-CCceEEEEEecCCCcH
Confidence 36899999999999999889999999997643 345789999999999999999999999987 6789999999999999
Q ss_pred HHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccchhc
Q 005749 462 HDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVA 541 (679)
Q Consensus 462 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 541 (679)
.+++... ...++|..+++|+.|||+||+|||+++ |+||||||+|||+++++.+||+|||+++............
T Consensus 88 ~~~l~~~---~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~ 161 (263)
T d1sm2a_ 88 SDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG 161 (263)
T ss_dssp HHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC---------------
T ss_pred HHHhhcc---ccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCceeecc
Confidence 9998764 356899999999999999999999988 9999999999999999999999999998775544444445
Q ss_pred ccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcCCCC
Q 005749 542 LAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIRSP 621 (679)
Q Consensus 542 ~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~~~ 621 (679)
..||+.|+|||++.+..++.++|||||||++|||+|+..|+...... ..+... +..+.+..
T Consensus 162 ~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~--~~~~~~-----------------i~~~~~~~ 222 (263)
T d1sm2a_ 162 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN--SEVVED-----------------ISTGFRLY 222 (263)
T ss_dssp ---CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH--HHHHHH-----------------HHHTCCCC
T ss_pred eecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCH--HHHHHH-----------------HHhcCCCC
Confidence 67899999999999999999999999999999999965554232111 111111 11111111
Q ss_pred h-HHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhC
Q 005749 622 M-EEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENR 658 (679)
Q Consensus 622 ~-~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 658 (679)
. ....+++.+++.+||+.||++||||+||+++|+++.
T Consensus 223 ~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~ 260 (263)
T d1sm2a_ 223 KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260 (263)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence 1 122356778999999999999999999999999875
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-52 Score=422.97 Aligned_cols=254 Identities=22% Similarity=0.358 Sum_probs=197.0
Q ss_pred cCccccCCceEEEEEEeCCCCEEEEEEcccCc--ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCC
Q 005749 382 GQVIEKTTYGTAYKAKLADGATIALRLLREGS--CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSR 459 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~g 459 (679)
++.||+|+||+||+|+++ ..||||+++... ....+.|.+|+++|++++|||||++++++.+ +..++|||||++|
T Consensus 13 ~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~--~~~~lv~Ey~~~g 88 (276)
T d1uwha_ 13 GQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA--PQLAIVTQWCEGS 88 (276)
T ss_dssp CSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS--SSCEEEEECCCEE
T ss_pred EEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec--cEEEEEEecCCCC
Confidence 478999999999999864 369999997543 2345689999999999999999999998865 5789999999999
Q ss_pred ChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccc-cc
Q 005749 460 TLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVA-DE 538 (679)
Q Consensus 460 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~-~~ 538 (679)
+|.+++... +..+++..++.|+.||++||+|||+++ ||||||||+|||++.++.+||+|||+|+....... ..
T Consensus 89 ~L~~~l~~~---~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~ 162 (276)
T d1uwha_ 89 SLYHHLHII---ETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQ 162 (276)
T ss_dssp EHHHHHHTS---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC---------
T ss_pred CHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccCCccc
Confidence 999999754 345999999999999999999999988 99999999999999999999999999987643322 23
Q ss_pred hhcccccccccccccccc---cCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhh
Q 005749 539 MVALAKADGYKAPELQRM---KKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIM 615 (679)
Q Consensus 539 ~~~~~gt~~y~aPE~~~~---~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~ 615 (679)
.....||+.|||||++.+ ..|+.++|||||||++|||+||+.||.+....+ .+...+. .... .+..
T Consensus 163 ~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~--~~~~~~~----~~~~----~p~~- 231 (276)
T d1uwha_ 163 FEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--QIIFMVG----RGYL----SPDL- 231 (276)
T ss_dssp ---CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH--HHHHHHH----HTSC----CCCG-
T ss_pred ccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH--HHHHHHh----cCCC----CCcc-
Confidence 345689999999999864 358999999999999999999999995533211 1111111 1000 0000
Q ss_pred hcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCC
Q 005749 616 KGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRP 659 (679)
Q Consensus 616 ~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 659 (679)
.. ......+++.+++.+||+.||++||||+||++.|+.+.+
T Consensus 232 ~~---~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~ 272 (276)
T d1uwha_ 232 SK---VRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272 (276)
T ss_dssp GG---SCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hh---ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 00 011223567789999999999999999999999998753
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-52 Score=423.17 Aligned_cols=249 Identities=22% Similarity=0.341 Sum_probs=204.5
Q ss_pred cCccccCCceEEEEEEeCCCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCCh
Q 005749 382 GQVIEKTTYGTAYKAKLADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRTL 461 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gsL 461 (679)
.+.||+|+||+||+|++++++.||||+++... ...+.|.+|++++++++|||||+++|++.+ +..++|||||++|+|
T Consensus 18 ~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~--~~~~iv~Ey~~~g~L 94 (272)
T d1qpca_ 18 VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ--EPIYIITEYMENGSL 94 (272)
T ss_dssp EEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSCEEEEECCTTCBH
T ss_pred eEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc--CCeEEEEEeCCCCcH
Confidence 47899999999999999888999999997643 345689999999999999999999998864 568999999999999
Q ss_pred HHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccchhc
Q 005749 462 HDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVA 541 (679)
Q Consensus 462 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 541 (679)
.+++.... ...++|.++++|+.||++||+|||+++ |+||||||+|||+++++.+||+|||+|+.+..........
T Consensus 95 ~~~~~~~~--~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~~~ 169 (272)
T d1qpca_ 95 VDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG 169 (272)
T ss_dssp HHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTT
T ss_pred HHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCccccccc
Confidence 99886543 235899999999999999999999988 9999999999999999999999999999876554444455
Q ss_pred ccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcCCCC
Q 005749 542 LAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIRSP 621 (679)
Q Consensus 542 ~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~~~ 621 (679)
..||+.|||||++.++.++.++|||||||++|||+||..|+...... ..+.. .+..+.+..
T Consensus 170 ~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~--~~~~~-----------------~i~~~~~~~ 230 (272)
T d1qpca_ 170 AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN--PEVIQ-----------------NLERGYRMV 230 (272)
T ss_dssp CCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHH-----------------HHHTTCCCC
T ss_pred cCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCH--HHHHH-----------------HHHhcCCCC
Confidence 67899999999999889999999999999999999976665332211 11111 111221111
Q ss_pred h-HHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhh
Q 005749 622 M-EEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEEN 657 (679)
Q Consensus 622 ~-~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 657 (679)
. ....+++.+++.+||+.||++||||+||++.|++.
T Consensus 231 ~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ 267 (272)
T d1qpca_ 231 RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (272)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence 1 12235677899999999999999999999999875
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4e-52 Score=429.49 Aligned_cols=250 Identities=23% Similarity=0.421 Sum_probs=192.8
Q ss_pred CccccCCceEEEEEEeC-CC---CEEEEEEcccCc-ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecC
Q 005749 383 QVIEKTTYGTAYKAKLA-DG---ATIALRLLREGS-CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFP 457 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~~-~~---~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~ 457 (679)
++||+|+||+||+|+.+ ++ ..||||.+.... ....+.|.+|+++|++++|||||+++|+|.+ .+..++|||||+
T Consensus 32 ~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~-~~~~~iv~Ey~~ 110 (299)
T d1jpaa_ 32 QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTK-STPVMIITEFME 110 (299)
T ss_dssp EEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSSCEEEEECCT
T ss_pred eEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEee-CCEEEEEEEecC
Confidence 68999999999999964 33 268999987643 2345679999999999999999999999987 678999999999
Q ss_pred CCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCccccc
Q 005749 458 SRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVAD 537 (679)
Q Consensus 458 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 537 (679)
+|+|.+++... ...++|.++++|+.||++||+|||+++ |+||||||+|||++.++++||+|||+|+.+......
T Consensus 111 ~g~L~~~~~~~---~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~ 184 (299)
T d1jpaa_ 111 NGSLDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD 184 (299)
T ss_dssp TEEHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC------------
T ss_pred CCcceeeeccc---cCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccCCCCc
Confidence 99999988764 345999999999999999999999988 999999999999999999999999999876543221
Q ss_pred ----chhcccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHHhhcccccccchH
Q 005749 538 ----EMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDM 612 (679)
Q Consensus 538 ----~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 612 (679)
......||+.|||||.+.++.++.++|||||||++|||+| |+.||.+.... .+ ..
T Consensus 185 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~---~~---~~-------------- 244 (299)
T d1jpaa_ 185 PTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ---DV---IN-------------- 244 (299)
T ss_dssp -----------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HH---HH--------------
T ss_pred ceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH---HH---HH--------------
Confidence 1223457889999999999999999999999999999998 89998543221 11 11
Q ss_pred hhhhcCCC-ChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCC
Q 005749 613 EIMKGIRS-PMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRP 659 (679)
Q Consensus 613 ~i~~~~~~-~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 659 (679)
.+..+.+. .......++.+++.+||+.||++||||+||++.|+++.+
T Consensus 245 ~i~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 245 AIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 11122221 122234567789999999999999999999999998753
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.9e-51 Score=421.95 Aligned_cols=253 Identities=21% Similarity=0.310 Sum_probs=207.9
Q ss_pred cCccccCCceEEEEEEeC-CCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCC
Q 005749 382 GQVIEKTTYGTAYKAKLA-DGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRT 460 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gs 460 (679)
.+.||+|+||+||+|+.. +++.||||+++... ...++|.+|+++|++++|||||+++|+|.+ .+..++|||||++|+
T Consensus 22 ~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-~~~~~iv~E~~~~g~ 99 (287)
T d1opja_ 22 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR-EPPFYIITEFMTYGN 99 (287)
T ss_dssp EEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSSCEEEEECCTTCB
T ss_pred eeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEee-CCeeEEEeecccCcc
Confidence 478999999999999964 58899999997643 346789999999999999999999999987 678999999999999
Q ss_pred hHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccchh
Q 005749 461 LHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMV 540 (679)
Q Consensus 461 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 540 (679)
|.+++.... ...+++..++.|+.||++||+|||+++ |+||||||+|||+++++.+||+|||+|+...........
T Consensus 100 l~~~l~~~~--~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~~~ 174 (287)
T d1opja_ 100 LLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 174 (287)
T ss_dssp HHHHHHHSC--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEEET
T ss_pred hHHHhhhcc--ccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCCCceeec
Confidence 999997543 356899999999999999999999988 999999999999999999999999999987654444444
Q ss_pred cccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcCCC
Q 005749 541 ALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIRS 620 (679)
Q Consensus 541 ~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~~ 620 (679)
...|++.|||||++.++.|+.|+|||||||++|||++|..|+...... ...... +..+.+.
T Consensus 175 ~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~-----~~~~~~--------------i~~~~~~ 235 (287)
T d1opja_ 175 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-----SQVYEL--------------LEKDYRM 235 (287)
T ss_dssp TEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCH-----HHHHHH--------------HHTTCCC
T ss_pred cccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchH-----HHHHHH--------------HhcCCCC
Confidence 556888999999999999999999999999999999987776433221 111111 1111111
Q ss_pred Ch-HHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCCC
Q 005749 621 PM-EEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRPR 660 (679)
Q Consensus 621 ~~-~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 660 (679)
+. +...+++.+++.+||+.||++||||+||++.|+.+...
T Consensus 236 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~ 276 (287)
T d1opja_ 236 ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276 (287)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 11 12235677899999999999999999999999987543
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-51 Score=412.97 Aligned_cols=249 Identities=20% Similarity=0.355 Sum_probs=208.5
Q ss_pred hcCccccCCceEEEEEEeCCCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCC
Q 005749 381 TGQVIEKTTYGTAYKAKLADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRT 460 (679)
Q Consensus 381 ~~~~ig~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gs 460 (679)
..+.||+|+||+||+|+.++++.||||+++... ...++|++|++++++++|||||+++|+|.+ ++..++||||+++|+
T Consensus 8 ~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~-~~~~~iv~Ey~~~g~ 85 (258)
T d1k2pa_ 8 FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTK-QRPIFIITEYMANGC 85 (258)
T ss_dssp CCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECC-SSSEEEEEECCTTEE
T ss_pred EeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEee-CCceEEEEEccCCCc
Confidence 347899999999999999889999999998643 345789999999999999999999999987 678999999999999
Q ss_pred hHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccchh
Q 005749 461 LHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMV 540 (679)
Q Consensus 461 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 540 (679)
|.+++... ...+++..+++|+.|+++||+|||+++ |+||||||+|||+++++.+||+|||+++...........
T Consensus 86 l~~~~~~~---~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 159 (258)
T d1k2pa_ 86 LLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV 159 (258)
T ss_dssp HHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCC
T ss_pred HHHhhhcc---ccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCceeec
Confidence 99997764 345899999999999999999999988 999999999999999999999999999877555444445
Q ss_pred cccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcCC
Q 005749 541 ALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIR 619 (679)
Q Consensus 541 ~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~ 619 (679)
...||+.|+|||.+.+..++.|+|||||||++|||+| |+.||.+.... ++ .. .+..+.+
T Consensus 160 ~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~---~~---~~--------------~i~~~~~ 219 (258)
T d1k2pa_ 160 GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS---ET---AE--------------HIAQGLR 219 (258)
T ss_dssp CSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH---HH---HH--------------HHHTTCC
T ss_pred ccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH---HH---HH--------------HHHhCCC
Confidence 5678999999999999999999999999999999998 79898543321 11 11 1122222
Q ss_pred CChH-HHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhh
Q 005749 620 SPME-EGLVQALKLAMGCCAPVASVRPTMDEVVKQLEEN 657 (679)
Q Consensus 620 ~~~~-~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 657 (679)
.+.+ ...+++.+++.+||+.||++||||+|+++.|.++
T Consensus 220 ~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 220 LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred CCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 2221 2235677999999999999999999999999764
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-51 Score=412.09 Aligned_cols=241 Identities=20% Similarity=0.303 Sum_probs=200.1
Q ss_pred hcCccccCCceEEEEEEe-CCCCEEEEEEcccCc---ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEec
Q 005749 381 TGQVIEKTTYGTAYKAKL-ADGATIALRLLREGS---CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYF 456 (679)
Q Consensus 381 ~~~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~ 456 (679)
..+.||+|+||+||+|+. .+++.||+|++.... ....+.+.+|++++++++|||||++++++.+ .+..++|||||
T Consensus 10 i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-~~~~~ivmEy~ 88 (263)
T d2j4za1 10 IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD-ATRVYLILEYA 88 (263)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-SSEEEEEEECC
T ss_pred EEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEE-CCEEEEEEeec
Confidence 357899999999999995 578999999986432 2345678999999999999999999999998 68899999999
Q ss_pred CCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccc
Q 005749 457 PSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVA 536 (679)
Q Consensus 457 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 536 (679)
++|+|.+++... ..+++..++.|+.||++||+|||+++ |+||||||+|||+++++.+||+|||+|+.....
T Consensus 89 ~~g~L~~~l~~~----~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~-- 159 (263)
T d2j4za1 89 PLGTVYRELQKL----SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-- 159 (263)
T ss_dssp TTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC--
T ss_pred CCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC--
Confidence 999999999863 45999999999999999999999988 999999999999999999999999999876433
Q ss_pred cchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhh
Q 005749 537 DEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMK 616 (679)
Q Consensus 537 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~ 616 (679)
......||+.|||||++.+..++.++|||||||++|||++|+.||.+.... +.... +..
T Consensus 160 -~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~------~~~~~--------------i~~ 218 (263)
T d2j4za1 160 -RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ------ETYKR--------------ISR 218 (263)
T ss_dssp -CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHH--------------HHT
T ss_pred -cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHH------HHHHH--------------HHc
Confidence 234567999999999999999999999999999999999999999543211 11111 111
Q ss_pred cCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHH
Q 005749 617 GIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVK 652 (679)
Q Consensus 617 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 652 (679)
......+...+++.+++.+||+.||++|||++|+++
T Consensus 219 ~~~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 219 VEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp TCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 111111122356778999999999999999999986
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-51 Score=415.78 Aligned_cols=247 Identities=19% Similarity=0.302 Sum_probs=201.5
Q ss_pred ccccCCceEEEEEEeC---CCCEEEEEEcccCc-ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCC
Q 005749 384 VIEKTTYGTAYKAKLA---DGATIALRLLREGS-CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSR 459 (679)
Q Consensus 384 ~ig~G~~g~Vy~~~~~---~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~g 459 (679)
.||+|+||+||+|+++ ++..||||+++... ....+.|.+|+++|++++|||||+++|++.+ +..++|||||++|
T Consensus 16 ~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~~lvmE~~~~g 93 (285)
T d1u59a_ 16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA--EALMLVMEMAGGG 93 (285)
T ss_dssp EEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES--SSEEEEEECCTTE
T ss_pred EEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc--CeEEEEEEeCCCC
Confidence 4999999999999753 35579999997653 2345689999999999999999999999975 4689999999999
Q ss_pred ChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCccccc--
Q 005749 460 TLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVAD-- 537 (679)
Q Consensus 460 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~-- 537 (679)
+|.+++... ...+++..+++|+.||++||+|||+++ |+||||||+|||++.++.+||+|||+|+.+......
T Consensus 94 ~L~~~l~~~---~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~ 167 (285)
T d1u59a_ 94 PLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYT 167 (285)
T ss_dssp EHHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEEC
T ss_pred cHHHHhhcc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhcccccccccc
Confidence 999998653 346999999999999999999999988 999999999999999999999999999877543222
Q ss_pred chhcccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhh
Q 005749 538 EMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMK 616 (679)
Q Consensus 538 ~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~ 616 (679)
......||+.|||||++.++.++.++|||||||++|||+| |+.||.+.... ++.. .+..
T Consensus 168 ~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~---~~~~-----------------~i~~ 227 (285)
T d1u59a_ 168 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVMA-----------------FIEQ 227 (285)
T ss_dssp CCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH---HHHH-----------------HHHT
T ss_pred cccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH---HHHH-----------------HHHc
Confidence 2234568899999999998999999999999999999998 89999553321 1111 1122
Q ss_pred cCCCCh-HHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhC
Q 005749 617 GIRSPM-EEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENR 658 (679)
Q Consensus 617 ~~~~~~-~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 658 (679)
+.+.+. +...+++.+++.+||+.||++||||.+|++.|+...
T Consensus 228 ~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~ 270 (285)
T d1u59a_ 228 GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 270 (285)
T ss_dssp TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 222222 223356778999999999999999999999998754
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-51 Score=412.59 Aligned_cols=246 Identities=19% Similarity=0.240 Sum_probs=196.9
Q ss_pred cCccccCCceEEEEEEe-CCCCEEEEEEcccCc-ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCC
Q 005749 382 GQVIEKTTYGTAYKAKL-ADGATIALRLLREGS-CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSR 459 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~g 459 (679)
.+.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|+++|++++|||||++++++.+ .+..++|||||++|
T Consensus 10 ~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~-~~~~~ivmEy~~gg 88 (271)
T d1nvra_ 10 VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE-GNIQYLFLEYCSGG 88 (271)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEE-TTEEEEEEECCTTE
T ss_pred EEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CceeEEEEeccCCC
Confidence 37899999999999995 579999999997643 2345689999999999999999999999998 68899999999999
Q ss_pred ChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccc-cc
Q 005749 460 TLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVA-DE 538 (679)
Q Consensus 460 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~-~~ 538 (679)
+|.+++.. ...+++.+++.|+.||++||+|||+++ |+||||||+|||+++++.+||+|||+|+....... ..
T Consensus 89 ~L~~~l~~----~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~ 161 (271)
T d1nvra_ 89 ELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 161 (271)
T ss_dssp EGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred cHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCCcccc
Confidence 99999975 346999999999999999999999988 99999999999999999999999999997644322 22
Q ss_pred hhcccccccccccccccccCC-CCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhc
Q 005749 539 MVALAKADGYKAPELQRMKKC-SSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKG 617 (679)
Q Consensus 539 ~~~~~gt~~y~aPE~~~~~~~-~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~ 617 (679)
....+||+.|||||++.+..+ +.++||||+||++|||++|+.||........ .. ....... .
T Consensus 162 ~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~-~~----~~~~~~~------------~ 224 (271)
T d1nvra_ 162 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EY----SDWKEKK------------T 224 (271)
T ss_dssp BCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSH-HH----HHHHTTC------------T
T ss_pred ccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHH-HH----HHHhcCC------------C
Confidence 345689999999999987776 6789999999999999999999965433211 00 0000000 0
Q ss_pred CCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHH
Q 005749 618 IRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVK 652 (679)
Q Consensus 618 ~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 652 (679)
...+.....+++.+++.+||+.||++|||++|+++
T Consensus 225 ~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 225 YLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 00111222356678999999999999999999865
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-50 Score=413.91 Aligned_cols=254 Identities=22% Similarity=0.334 Sum_probs=200.4
Q ss_pred hcCccccCCceEEEEEEeCCCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCC
Q 005749 381 TGQVIEKTTYGTAYKAKLADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRT 460 (679)
Q Consensus 381 ~~~~ig~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gs 460 (679)
.++.||+|+||+||+|+.++++.||||+++... ...+.|.+|+.++++++|||||+++|+|.+ +..++|||||++|+
T Consensus 21 i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~--~~~~lv~Ey~~~g~ 97 (285)
T d1fmka3 21 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE--EPIYIVTEYMSKGS 97 (285)
T ss_dssp EEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSCEEEECCCTTCB
T ss_pred EeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec--CCeEEEEEecCCCc
Confidence 357899999999999999888899999997543 345789999999999999999999999864 56899999999999
Q ss_pred hHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccchh
Q 005749 461 LHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMV 540 (679)
Q Consensus 461 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 540 (679)
|.+++.... ...++|.+++.|+.||+.||+|||+++ |+||||||+|||+|+++++||+|||+|+...........
T Consensus 98 l~~~~~~~~--~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 172 (285)
T d1fmka3 98 LLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 172 (285)
T ss_dssp HHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-----------
T ss_pred hhhhhhhcc--cccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCceeec
Confidence 999987643 245999999999999999999999988 999999999999999999999999999877554444445
Q ss_pred cccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcCCC
Q 005749 541 ALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIRS 620 (679)
Q Consensus 541 ~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~~ 620 (679)
...||+.|+|||++..+.++.++|||||||++|||++|..|+...... ..+...+ ..+.+.
T Consensus 173 ~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~--~~~~~~i-----------------~~~~~~ 233 (285)
T d1fmka3 173 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--REVLDQV-----------------ERGYRM 233 (285)
T ss_dssp ---CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHHHH-----------------HTTCCC
T ss_pred cccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH--HHHHHHH-----------------HhcCCC
Confidence 567899999999999999999999999999999999987776443221 1111111 111111
Q ss_pred -ChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCCCC
Q 005749 621 -PMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRPRN 661 (679)
Q Consensus 621 -~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 661 (679)
..+...+++.+++.+||+.||++||||++|+++|++.....
T Consensus 234 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 234 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred CCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 11222356778999999999999999999999999876543
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-51 Score=415.86 Aligned_cols=249 Identities=16% Similarity=0.240 Sum_probs=189.0
Q ss_pred CccccCCceEEEEEE-eCCCCEEEEEEcccCcc--cCcccHHHHHHHHhccCCCCCccceEEeeCC-CCceEEEEEecCC
Q 005749 383 QVIEKTTYGTAYKAK-LADGATIALRLLREGSC--KDRSSCLPVIRQLGKVRHENLIPLRAFYQGK-RGEKLLIYDYFPS 458 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~-~~~~~lv~ey~~~ 458 (679)
+.||+|+||+||+|+ ..+|+.||||+++.... ...+.+.+|+++|++++|||||++++++.+. .+..|+|||||++
T Consensus 10 ~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~~ 89 (269)
T d2java1 10 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEG 89 (269)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEECCTT
T ss_pred EEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEecCCC
Confidence 789999999999999 46799999999976532 2345689999999999999999999988753 4568999999999
Q ss_pred CChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCC--CCCeeecCCCCCCeeecCCCceEEeecccccccCcccc
Q 005749 459 RTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGH--EIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVA 536 (679)
Q Consensus 459 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~--~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 536 (679)
|+|.+++.........+++..++.|+.|++.||+|||+++ ..+|+||||||+|||+++++.+||+|||+|+.+... .
T Consensus 90 g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~-~ 168 (269)
T d2java1 90 GDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD-T 168 (269)
T ss_dssp EEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC-----
T ss_pred CcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecccC-C
Confidence 9999999764433467999999999999999999999854 234999999999999999999999999999876443 2
Q ss_pred cchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhh
Q 005749 537 DEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMK 616 (679)
Q Consensus 537 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~ 616 (679)
.......||+.|||||++.+..|+.++|||||||++|||+||+.||.+.... ++ .. .+..
T Consensus 169 ~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~---~~---~~--------------~i~~ 228 (269)
T d2java1 169 SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK---EL---AG--------------KIRE 228 (269)
T ss_dssp -------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH---HH---HH--------------HHHH
T ss_pred CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH---HH---HH--------------HHHc
Confidence 2234568999999999999999999999999999999999999999543211 11 11 0111
Q ss_pred cCCC-ChHHHHHHHHHHHHhccCcCCCCCCCHHHHHH
Q 005749 617 GIRS-PMEEGLVQALKLAMGCCAPVASVRPTMDEVVK 652 (679)
Q Consensus 617 ~~~~-~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 652 (679)
+... ......+++.+++.+||+.||++|||++|+++
T Consensus 229 ~~~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 229 GKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 1111 11122356778999999999999999999975
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-50 Score=414.27 Aligned_cols=246 Identities=15% Similarity=0.202 Sum_probs=201.0
Q ss_pred CccccCCceEEEEEEe-CCCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCCh
Q 005749 383 QVIEKTTYGTAYKAKL-ADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRTL 461 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gsL 461 (679)
+.||+|+||+||+|+. .+|+.||||+++.......+.+.+|+++|++++|||||++++++.+ .+..++|||||++|+|
T Consensus 18 ~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-~~~~~lvmEy~~~g~L 96 (288)
T d2jfla1 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYY-ENNLWILIEFCAGGAV 96 (288)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEEEEECCTTEEH
T ss_pred EEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee-CCeEEEEEecCCCCcH
Confidence 6799999999999994 5799999999987666677889999999999999999999999997 6889999999999999
Q ss_pred HHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccchhc
Q 005749 462 HDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVA 541 (679)
Q Consensus 462 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 541 (679)
.+++... ...+++.+++.|+.||++||+|||+++ |+||||||+|||++.++.+||+|||+|+..... ......
T Consensus 97 ~~~~~~~---~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~-~~~~~~ 169 (288)
T d2jfla1 97 DAVMLEL---ERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT-IQRRDS 169 (288)
T ss_dssp HHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHH-HHHHTC
T ss_pred HHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCC-cccccc
Confidence 9998754 345999999999999999999999998 999999999999999999999999999865332 223345
Q ss_pred cccccccccccccc-----ccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhh
Q 005749 542 LAKADGYKAPELQR-----MKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMK 616 (679)
Q Consensus 542 ~~gt~~y~aPE~~~-----~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~ 616 (679)
..||+.|||||++. ...|+.++|||||||++|||++|+.||.+....+ .. ....... ...
T Consensus 170 ~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~---~~---~~i~~~~-~~~-------- 234 (288)
T d2jfla1 170 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR---VL---LKIAKSE-PPT-------- 234 (288)
T ss_dssp CCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG---HH---HHHHHSC-CCC--------
T ss_pred cccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH---HH---HHHHcCC-CCC--------
Confidence 68999999999874 4568999999999999999999999995543211 11 0000000 000
Q ss_pred cCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 617 GIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 617 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
........+++.+++.+||+.||++|||++|++++
T Consensus 235 --~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 235 --LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp --CSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred --CCccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 01112234567889999999999999999999763
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-50 Score=412.92 Aligned_cols=246 Identities=18% Similarity=0.278 Sum_probs=197.0
Q ss_pred CccccCCceEEEEEEeCC---CCEEEEEEcccCcc--cCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecC
Q 005749 383 QVIEKTTYGTAYKAKLAD---GATIALRLLREGSC--KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFP 457 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~~~---~~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~ 457 (679)
+.||+|+||+||+|.+++ ++.||||+++.... ...+.|.+|+++|++++|||||+++|+|.+ +..++|||||+
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~--~~~~lvmE~~~ 90 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA--ESWMLVMEMAE 90 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES--SSEEEEEECCT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc--CCEEEEEEcCC
Confidence 579999999999998543 46899999975432 234679999999999999999999999975 46899999999
Q ss_pred CCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCccccc
Q 005749 458 SRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVAD 537 (679)
Q Consensus 458 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 537 (679)
+|+|.++++.. ..+++..+++|+.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.+......
T Consensus 91 ~g~L~~~l~~~----~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~ 163 (277)
T d1xbba_ 91 LGPLNKYLQQN----RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 163 (277)
T ss_dssp TEEHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE
T ss_pred CCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccc
Confidence 99999999863 45999999999999999999999988 999999999999999999999999999876443222
Q ss_pred --chhcccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHHhhcccccccchHhh
Q 005749 538 --EMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEI 614 (679)
Q Consensus 538 --~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i 614 (679)
......||+.|||||.+.+..++.++|||||||++|||+| |+.||.+.... ++.. .+
T Consensus 164 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~---~~~~-----------------~i 223 (277)
T d1xbba_ 164 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---EVTA-----------------ML 223 (277)
T ss_dssp EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHH-----------------HH
T ss_pred cccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH---HHHH-----------------HH
Confidence 2334578999999999998999999999999999999998 89999543221 1111 11
Q ss_pred hhcCCCCh-HHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhh
Q 005749 615 MKGIRSPM-EEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEEN 657 (679)
Q Consensus 615 ~~~~~~~~-~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~ 657 (679)
..+.+.+. .....++.+++.+||+.||++||||+||++.|+..
T Consensus 224 ~~~~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 224 EKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred HcCCCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence 12222221 12235677899999999999999999999988764
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-50 Score=415.07 Aligned_cols=252 Identities=23% Similarity=0.392 Sum_probs=196.1
Q ss_pred cCccccCCceEEEEEEeCCC-----CEEEEEEcccCcc-cCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEe
Q 005749 382 GQVIEKTTYGTAYKAKLADG-----ATIALRLLREGSC-KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDY 455 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~~~-----~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey 455 (679)
+++||+|+||+||+|++++. ..||||+++.... ...++|.+|++++++++|||||+++|++.+ .+..++||||
T Consensus 12 ~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~-~~~~~~v~e~ 90 (283)
T d1mqba_ 12 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK-YKPMMIITEY 90 (283)
T ss_dssp EEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSSEEEEEEC
T ss_pred eeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEec-CCceEEEEEe
Confidence 37899999999999996542 3799999976432 334579999999999999999999999987 6789999999
Q ss_pred cCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCccc
Q 005749 456 FPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAV 535 (679)
Q Consensus 456 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 535 (679)
|.+|++.+++... ...++|.++++|+.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+....
T Consensus 91 ~~~~~l~~~~~~~---~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~ 164 (283)
T d1mqba_ 91 MENGALDKFLREK---DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 164 (283)
T ss_dssp CTTEEHHHHHHHT---TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--------
T ss_pred cccCcchhhhhcc---cccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhcccCCC
Confidence 9999999988764 356999999999999999999999988 9999999999999999999999999998764432
Q ss_pred c--cchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHh
Q 005749 536 A--DEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDME 613 (679)
Q Consensus 536 ~--~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 613 (679)
. .......||+.|||||++.++.++.++|||||||++|||++|..|+...... .+... .
T Consensus 165 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~-----~~~~~--------------~ 225 (283)
T d1mqba_ 165 EATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-----HEVMK--------------A 225 (283)
T ss_dssp ---------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----HHHHH--------------H
T ss_pred ccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH-----HHHHH--------------H
Confidence 2 1223456899999999999999999999999999999999977665333221 11111 1
Q ss_pred hhhcCCCChH-HHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCC
Q 005749 614 IMKGIRSPME-EGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRP 659 (679)
Q Consensus 614 i~~~~~~~~~-~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 659 (679)
+..+.+.+.+ ....++.+++.+||+.||++||||.||++.|+++.+
T Consensus 226 i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 226 INDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp HHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HhccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence 1122222222 233567789999999999999999999999998754
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-50 Score=411.66 Aligned_cols=244 Identities=18% Similarity=0.294 Sum_probs=201.2
Q ss_pred CccccCCceEEEEEE-eCCCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCCh
Q 005749 383 QVIEKTTYGTAYKAK-LADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRTL 461 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gsL 461 (679)
+.||+|+||+||+|+ ..+|+.||||+++.......+.+.+|++++++++|||||++++++.+ .+..|+|||||++|+|
T Consensus 26 ~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-~~~~~ivmEy~~gg~L 104 (293)
T d1yhwa1 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-GDELWVVMEYLAGGSL 104 (293)
T ss_dssp EECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEEEEECCTTCBH
T ss_pred EEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEE-CCEEEEEEEecCCCcH
Confidence 679999999999999 56799999999987655566789999999999999999999999998 6789999999999999
Q ss_pred HHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccchhc
Q 005749 462 HDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMVA 541 (679)
Q Consensus 462 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 541 (679)
.+++.. ..+++.+++.|+.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+.... .....
T Consensus 105 ~~~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~-~~~~~ 175 (293)
T d1yhwa1 105 TDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-SKRST 175 (293)
T ss_dssp HHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-CCBCC
T ss_pred HHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeecccc-ccccc
Confidence 998864 34899999999999999999999988 9999999999999999999999999998764432 23345
Q ss_pred ccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcCCCC
Q 005749 542 LAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIRSP 621 (679)
Q Consensus 542 ~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~~~ 621 (679)
.+||+.|||||++.+..++.++||||+||++|||++|+.||.+.... ........... .. ...
T Consensus 176 ~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~------~~~~~~~~~~~-~~----------~~~ 238 (293)
T d1yhwa1 176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL------RALYLIATNGT-PE----------LQN 238 (293)
T ss_dssp CCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHHCS-CC----------CSS
T ss_pred cccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHH------HHHHHHHhCCC-CC----------CCC
Confidence 67999999999999999999999999999999999999999543211 11111100000 00 011
Q ss_pred hHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 622 MEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 622 ~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
.+...+++.+++.+||+.||++|||++|++++
T Consensus 239 ~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 239 PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp GGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred cccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11223567789999999999999999999764
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-50 Score=405.47 Aligned_cols=242 Identities=20% Similarity=0.335 Sum_probs=193.7
Q ss_pred CccccCCceEEEEEEe-CCCCEEEEEEcccCc--ccCcccHHHHHHHHhccCCCCCccceEEeeCC---CCceEEEEEec
Q 005749 383 QVIEKTTYGTAYKAKL-ADGATIALRLLREGS--CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGK---RGEKLLIYDYF 456 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~---~~~~~lv~ey~ 456 (679)
+.||+|+||+||+|+. .+++.||+|++.... ....+.|.+|+++|++++|||||+++++|.+. ....++|||||
T Consensus 15 ~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~ 94 (270)
T d1t4ha_ 15 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELM 94 (270)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECC
T ss_pred eEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEeCC
Confidence 5799999999999995 568899999987543 23356789999999999999999999998642 34679999999
Q ss_pred CCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeec-CCCceEEeecccccccCccc
Q 005749 457 PSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVD-DFFVSRLTEFGLDQLMVPAV 535 (679)
Q Consensus 457 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~-~~~~~kl~DFGla~~~~~~~ 535 (679)
++|+|.+++... ..+++..++.++.||++||+|||+++ ++|+||||||+|||++ +++.+||+|||+|+.....
T Consensus 95 ~~g~L~~~l~~~----~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~- 168 (270)
T d1t4ha_ 95 TSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS- 168 (270)
T ss_dssp CSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT-
T ss_pred CCCcHHHHHhcc----ccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC-
Confidence 999999999763 45899999999999999999999865 4599999999999996 5789999999999865332
Q ss_pred ccchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhh
Q 005749 536 ADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIM 615 (679)
Q Consensus 536 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~ 615 (679)
......||+.|||||++.+ .++.++|||||||++|||++|+.||.+.... ....+. +.
T Consensus 169 --~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~-----~~~~~~--------------i~ 226 (270)
T d1t4ha_ 169 --FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA-----AQIYRR--------------VT 226 (270)
T ss_dssp --SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-----HHHHHH--------------HT
T ss_pred --ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccH-----HHHHHH--------------HH
Confidence 2235689999999998874 6999999999999999999999999543221 111111 11
Q ss_pred hcCCCC--hHHHHHHHHHHHHhccCcCCCCCCCHHHHHH
Q 005749 616 KGIRSP--MEEGLVQALKLAMGCCAPVASVRPTMDEVVK 652 (679)
Q Consensus 616 ~~~~~~--~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 652 (679)
.+..+. .....+++.+++.+||+.||++|||++|+++
T Consensus 227 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 227 SGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp TTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cCCCCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 111110 1112345778999999999999999999986
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-49 Score=414.80 Aligned_cols=253 Identities=21% Similarity=0.317 Sum_probs=200.2
Q ss_pred hcCccccCCceEEEEEEeCC-C-----CEEEEEEcccCc-ccCcccHHHHHHHHhcc-CCCCCccceEEeeCCCCceEEE
Q 005749 381 TGQVIEKTTYGTAYKAKLAD-G-----ATIALRLLREGS-CKDRSSCLPVIRQLGKV-RHENLIPLRAFYQGKRGEKLLI 452 (679)
Q Consensus 381 ~~~~ig~G~~g~Vy~~~~~~-~-----~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~~lv 452 (679)
.+++||+|+||+||+|+... + ..||||.+.... ......+.+|+++|.++ +|||||+++++|.+ .+..++|
T Consensus 41 l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~-~~~~~lv 119 (325)
T d1rjba_ 41 FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL-SGPIYLI 119 (325)
T ss_dssp EEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSSCEEE
T ss_pred EeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEee-CCeEEEE
Confidence 35889999999999998532 2 269999986543 34566799999999998 89999999999998 6789999
Q ss_pred EEecCCCChHHHhhcccC-------------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCee
Q 005749 453 YDYFPSRTLHDLLHDTIA-------------------GKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVL 513 (679)
Q Consensus 453 ~ey~~~gsL~~~l~~~~~-------------------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NIL 513 (679)
||||++|+|.++++.... ....+++..++.|+.||++||+|||+++ ||||||||+|||
T Consensus 120 ~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp~Nil 196 (325)
T d1rjba_ 120 FEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVL 196 (325)
T ss_dssp EECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSGGGEE
T ss_pred EEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCchhccc
Confidence 999999999999976431 1235899999999999999999999988 999999999999
Q ss_pred ecCCCceEEeecccccccCccccc-chhcccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCccc
Q 005749 514 VDDFFVSRLTEFGLDQLMVPAVAD-EMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFV 591 (679)
Q Consensus 514 l~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~ 591 (679)
++.++.+||+|||+|+........ ......||+.|||||++.++.++.++|||||||++|||+| |+.||.+....+
T Consensus 197 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~-- 274 (325)
T d1rjba_ 197 VTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA-- 274 (325)
T ss_dssp EETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH--
T ss_pred cccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHH--
Confidence 999999999999999876443222 2234568999999999999999999999999999999998 899996543321
Q ss_pred chhHHHHHHhhcccccccchHhhhhcCCCCh-HHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHh
Q 005749 592 DLPSIVKVAVLEETTMEVFDMEIMKGIRSPM-EEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEE 656 (679)
Q Consensus 592 ~l~~~~~~~~~~~~~~~~~~~~i~~~~~~~~-~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~ 656 (679)
.+... +..+.+.+. ....+++.+++.+||+.||++||||+||+++|..
T Consensus 275 ~~~~~-----------------~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 275 NFYKL-----------------IQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp HHHHH-----------------HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHH-----------------HhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence 11111 111111111 1223567789999999999999999999999963
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-50 Score=417.46 Aligned_cols=259 Identities=16% Similarity=0.283 Sum_probs=198.7
Q ss_pred CccccCCceEEEEEEe-CCCCEEEEEEcccCcc-cCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCC
Q 005749 383 QVIEKTTYGTAYKAKL-ADGATIALRLLREGSC-KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRT 460 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gs 460 (679)
+.||+|+||+||+|+. .+|+.||+|+++.... ...+.+.+|+++|++++|||||+++++|.+ .++.++|||||++|+
T Consensus 12 ~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-~~~~~iVmEy~~gg~ 90 (322)
T d1s9ja_ 12 SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-DGEISICMEHMDGGS 90 (322)
T ss_dssp EEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEEC-SSEEEEEEECCTTEE
T ss_pred EEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-CCEEEEEEEcCCCCc
Confidence 6899999999999994 5799999999976432 334678999999999999999999999998 688999999999999
Q ss_pred hHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccch
Q 005749 461 LHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTG-HEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEM 539 (679)
Q Consensus 461 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~-~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 539 (679)
|.+++... ..+++..++.++.|++.||+|||++ + |+||||||+|||+++++.+||+|||+|+..... ..
T Consensus 91 L~~~l~~~----~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~---~~ 160 (322)
T d1s9ja_ 91 LDQVLKKA----GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MA 160 (322)
T ss_dssp HHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH---TC
T ss_pred HHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCCC---cc
Confidence 99999864 3589999999999999999999974 6 999999999999999999999999999875332 23
Q ss_pred hcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHH-HHHHh-----------------
Q 005749 540 VALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSI-VKVAV----------------- 601 (679)
Q Consensus 540 ~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~-~~~~~----------------- 601 (679)
...+||+.|||||++.+..|+.++||||+||++|||++|+.||.+....+....... .....
T Consensus 161 ~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (322)
T d1s9ja_ 161 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSY 240 (322)
T ss_dssp ---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------------------
T ss_pred ccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccccccc
Confidence 456899999999999999999999999999999999999999966443211100000 00000
Q ss_pred -hccc-c---cccchHhhhhcCCCCh--HHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 602 -LEET-T---MEVFDMEIMKGIRSPM--EEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 602 -~~~~-~---~~~~~~~i~~~~~~~~--~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
.... . .+..+. +.....+.. .....++.+++.+||+.||++|||++|++++
T Consensus 241 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 241 GMDSRPPMAIFELLDY-IVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp -----CCCCHHHHHHH-HHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccchhHHHHHhh-hhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 0000 0 000000 011100000 1123567889999999999999999999884
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-50 Score=410.70 Aligned_cols=244 Identities=18% Similarity=0.266 Sum_probs=198.1
Q ss_pred cCccccCCceEEEEEEe-CCCCEEEEEEcccCc---ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecC
Q 005749 382 GQVIEKTTYGTAYKAKL-ADGATIALRLLREGS---CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFP 457 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~ 457 (679)
.+.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|+++|++++|||||++++++.+ .+..|+|||||+
T Consensus 13 ~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-~~~~~ivmEy~~ 91 (288)
T d1uu3a_ 13 GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD-DEKLYFGLSYAK 91 (288)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEEC-SSEEEEEECCCT
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEE-CCEEEEEEEccC
Confidence 47899999999999995 579999999986532 2345678999999999999999999999997 688999999999
Q ss_pred CCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCccc-c
Q 005749 458 SRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAV-A 536 (679)
Q Consensus 458 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~-~ 536 (679)
+|+|.+++... ..+++..++.++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+|+.+.... .
T Consensus 92 gg~L~~~~~~~----~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~ 164 (288)
T d1uu3a_ 92 NGELLKYIRKI----GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 164 (288)
T ss_dssp TEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred CCCHHHhhhcc----CCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccCCcc
Confidence 99999998864 45999999999999999999999988 9999999999999999999999999999775332 2
Q ss_pred cchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhh
Q 005749 537 DEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMK 616 (679)
Q Consensus 537 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~ 616 (679)
.......||+.|||||++.+..|+.++||||+||++|||++|+.||.+.... .... .+..
T Consensus 165 ~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~------~~~~--------------~i~~ 224 (288)
T d1uu3a_ 165 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY------LIFQ--------------KIIK 224 (288)
T ss_dssp -----CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHH--------------HHHT
T ss_pred cccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHH------HHHH--------------HHHc
Confidence 2334567999999999999999999999999999999999999999543211 1111 1111
Q ss_pred cCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 617 GIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 617 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
+.........+++.+++.+||+.||++|||++|+++.
T Consensus 225 ~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 225 LEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp TCCCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred CCCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence 1111112234567789999999999999999997553
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-49 Score=408.31 Aligned_cols=257 Identities=20% Similarity=0.345 Sum_probs=205.7
Q ss_pred cCccccCCceEEEEEEeCCC----CEEEEEEcccC-cccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEec
Q 005749 382 GQVIEKTTYGTAYKAKLADG----ATIALRLLREG-SCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYF 456 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~~~----~~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~ 456 (679)
+++||+|+||+||+|++.++ ..||||+++.. .....++|.+|+++|++++|||||+++|++...++..++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 47899999999999996442 26899999753 33445789999999999999999999999876567899999999
Q ss_pred CCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccc
Q 005749 457 PSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVA 536 (679)
Q Consensus 457 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 536 (679)
++|+|.+++... ...+++..+++++.|+++||.|+|+.+ |+||||||+|||+++++.+||+|||+++.......
T Consensus 112 ~~g~l~~~~~~~---~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 112 KHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185 (311)
T ss_dssp TTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred ecCchhhhhccc---cccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence 999999998764 345789999999999999999999988 99999999999999999999999999997654322
Q ss_pred c---chhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHh
Q 005749 537 D---EMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDME 613 (679)
Q Consensus 537 ~---~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 613 (679)
. ......||..|+|||.+....++.++||||||+++|||+||..||...... .++..+
T Consensus 186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~--~~~~~~----------------- 246 (311)
T d1r0pa_ 186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--FDITVY----------------- 246 (311)
T ss_dssp CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHH-----------------
T ss_pred ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH--HHHHHH-----------------
Confidence 2 223456899999999999999999999999999999999988887543221 111111
Q ss_pred hhhcCCCChH-HHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCCCCCC
Q 005749 614 IMKGIRSPME-EGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRPRNRS 663 (679)
Q Consensus 614 i~~~~~~~~~-~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~ 663 (679)
+..+.+...+ ...+++.+++.+||+.||++||+|.||++.|+++......
T Consensus 247 i~~g~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~ 297 (311)
T d1r0pa_ 247 LLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 297 (311)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred HHcCCCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhh
Confidence 1222222221 2235677899999999999999999999999999765444
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-49 Score=399.93 Aligned_cols=246 Identities=25% Similarity=0.379 Sum_probs=194.2
Q ss_pred hcCccccCCceEEEEEEeCCCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCC
Q 005749 381 TGQVIEKTTYGTAYKAKLADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRT 460 (679)
Q Consensus 381 ~~~~ig~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gs 460 (679)
..+.||+|+||.||+|+++ |+.||||+++.. ...+.|.+|++++++++|||||+++|+|.+..+..++||||+++|+
T Consensus 11 ~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~ 87 (262)
T d1byga_ 11 LLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS 87 (262)
T ss_dssp EEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEE
T ss_pred EeEEEecCCCeEEEEEEEC-CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCC
Confidence 3578999999999999984 789999999753 3457899999999999999999999998764567899999999999
Q ss_pred hHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccchh
Q 005749 461 LHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMV 540 (679)
Q Consensus 461 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 540 (679)
|.+++.... ...++|..+++|+.||+.||+|||+.+ |+||||||+|||++.++.+|++|||+++..... ..
T Consensus 88 L~~~l~~~~--~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~----~~ 158 (262)
T d1byga_ 88 LVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----QD 158 (262)
T ss_dssp HHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-------------
T ss_pred HHHHHHhcC--CCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCC----Cc
Confidence 999997542 235899999999999999999999988 999999999999999999999999999865332 23
Q ss_pred cccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcCC
Q 005749 541 ALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGIR 619 (679)
Q Consensus 541 ~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~ 619 (679)
...++..|+|||++.+..+++++|||||||++|||+| |+.||...... ++..++ ..+.+
T Consensus 159 ~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~---~~~~~i-----------------~~~~~ 218 (262)
T d1byga_ 159 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVPRV-----------------EKGYK 218 (262)
T ss_dssp ---CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG---GHHHHH-----------------TTTCC
T ss_pred cccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH---HHHHHH-----------------HcCCC
Confidence 4467889999999999999999999999999999998 67776432221 111111 12222
Q ss_pred CCh-HHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhC
Q 005749 620 SPM-EEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENR 658 (679)
Q Consensus 620 ~~~-~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 658 (679)
++. +...+++.+++.+||+.||++||||.|++++|++++
T Consensus 219 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~ 258 (262)
T d1byga_ 219 MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258 (262)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 222 122356778999999999999999999999999875
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-49 Score=401.59 Aligned_cols=250 Identities=23% Similarity=0.307 Sum_probs=192.0
Q ss_pred cCccccCCceEEEEEEeCC----CCEEEEEEcccCcc-cCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEec
Q 005749 382 GQVIEKTTYGTAYKAKLAD----GATIALRLLREGSC-KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYF 456 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~~----~~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~ 456 (679)
++.||+|+||.||+|+... +..||||.++.... ...+.|.+|+++|++++|||||+++|++.+ +..++|||||
T Consensus 12 ~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~~~~iv~E~~ 89 (273)
T d1mp8a_ 12 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE--NPVWIIMELC 89 (273)
T ss_dssp EEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS--SSCEEEEECC
T ss_pred EEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec--CeEEEEEEec
Confidence 4789999999999998542 34689999875433 335679999999999999999999999864 6789999999
Q ss_pred CCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccc
Q 005749 457 PSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVA 536 (679)
Q Consensus 457 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 536 (679)
++|+|.+++... ...+++..++.++.||++||+|||+++ |+||||||+||++++++.+||+|||+|+.......
T Consensus 90 ~~g~l~~~~~~~---~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~ 163 (273)
T d1mp8a_ 90 TLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY 163 (273)
T ss_dssp TTEEHHHHHHHT---TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC------------
T ss_pred cCCcHHhhhhcc---CCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheeccCCcc
Confidence 999999987654 346899999999999999999999988 99999999999999999999999999997754444
Q ss_pred cchhcccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhh
Q 005749 537 DEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIM 615 (679)
Q Consensus 537 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~ 615 (679)
.......||+.|+|||++.+..++.++|||||||++|||++ |.+||.+.... .+... +.
T Consensus 164 ~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~---~~~~~-----------------i~ 223 (273)
T d1mp8a_ 164 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVIGR-----------------IE 223 (273)
T ss_dssp -------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHHH-----------------HH
T ss_pred eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH---HHHHH-----------------HH
Confidence 44455678999999999999999999999999999999998 88898544322 11111 11
Q ss_pred hcCCC-ChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCC
Q 005749 616 KGIRS-PMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRP 659 (679)
Q Consensus 616 ~~~~~-~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 659 (679)
.+.+. ..+...+++.+++.+||+.||++||||+||++.|+++..
T Consensus 224 ~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 268 (273)
T d1mp8a_ 224 NGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268 (273)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 22111 112233567789999999999999999999999998753
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.1e-49 Score=406.69 Aligned_cols=246 Identities=19% Similarity=0.284 Sum_probs=183.5
Q ss_pred cCccccCCceEEEEEEe-CCCCEEEEEEcccCc-ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCC
Q 005749 382 GQVIEKTTYGTAYKAKL-ADGATIALRLLREGS-CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSR 459 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~g 459 (679)
.+.||+|+||+||+|+. .+|+.||||++.... ....+.+.+|+++|++++|||||++++++.+ .+..|+|||||++|
T Consensus 14 ~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-~~~~~lvmE~~~gg 92 (307)
T d1a06a_ 14 RDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYES-GGHLYLIMQLVSGG 92 (307)
T ss_dssp EEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEEC-SSEEEEEECCCCSC
T ss_pred EEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-CCEEEEEEeccCCC
Confidence 47899999999999995 579999999997643 2334578899999999999999999999998 68899999999999
Q ss_pred ChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeec---CCCceEEeecccccccCcccc
Q 005749 460 TLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVD---DFFVSRLTEFGLDQLMVPAVA 536 (679)
Q Consensus 460 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~---~~~~~kl~DFGla~~~~~~~~ 536 (679)
+|.+++.. ...+++..+..|+.||+.||+|||+++ |+||||||+|||+. +++.+||+|||+|+.....
T Consensus 93 ~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~-- 163 (307)
T d1a06a_ 93 ELFDRIVE----KGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG-- 163 (307)
T ss_dssp BHHHHHHT----CSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC-----------
T ss_pred cHHHhhhc----ccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEccCC--
Confidence 99999976 346999999999999999999999988 99999999999994 5789999999999876433
Q ss_pred cchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhh
Q 005749 537 DEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMK 616 (679)
Q Consensus 537 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~ 616 (679)
......+||+.|||||++.+..|+.++||||+||++|||++|+.||.+.... .+ ......... .+.
T Consensus 164 ~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~---~~---~~~i~~~~~---~~~----- 229 (307)
T d1a06a_ 164 SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA---KL---FEQILKAEY---EFD----- 229 (307)
T ss_dssp ---------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HH---HHHHHTTCC---CCC-----
T ss_pred CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH---HH---HHHHhccCC---CCC-----
Confidence 2234567999999999999999999999999999999999999999543211 11 111100000 000
Q ss_pred cCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 617 GIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 617 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
.+..+...+++.+++.+||+.||++|||++|++++
T Consensus 230 --~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 230 --SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp --TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred --CccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 01111233567889999999999999999999874
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-49 Score=409.00 Aligned_cols=248 Identities=22% Similarity=0.340 Sum_probs=197.1
Q ss_pred CccccCCceEEEEEEe-CCCC----EEEEEEcccCc-ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEec
Q 005749 383 QVIEKTTYGTAYKAKL-ADGA----TIALRLLREGS-CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYF 456 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~-~~~~----~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~ 456 (679)
++||+|+||+||+|+. .+|+ .||+|+++... .+..+.|.+|++++++++|||||+++|+|.+ +..++++||+
T Consensus 15 ~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~--~~~~~v~e~~ 92 (317)
T d1xkka_ 15 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT--STVQLITQLM 92 (317)
T ss_dssp EEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES--SSEEEEEECC
T ss_pred eEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec--CCeeEEEEec
Confidence 7899999999999985 3454 58999887543 3456789999999999999999999999986 4678999999
Q ss_pred CCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccc
Q 005749 457 PSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVA 536 (679)
Q Consensus 457 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 536 (679)
.+|+|.+++... ...+++..+++|+.|||+||+|||+++ |+||||||+|||++.++.+||+|||+|+.......
T Consensus 93 ~~~~l~~~~~~~---~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~ 166 (317)
T d1xkka_ 93 PFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 166 (317)
T ss_dssp TTCBHHHHHHHT---SSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC
T ss_pred cCCccccccccc---ccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecccccc
Confidence 999999988764 456999999999999999999999988 99999999999999999999999999997654332
Q ss_pred c-chhcccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHHhhcccccccchHhh
Q 005749 537 D-EMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEI 614 (679)
Q Consensus 537 ~-~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i 614 (679)
. ......||+.|||||++.++.++.++|||||||++|||+| |+.||.+.... .+.. .+
T Consensus 167 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~---~~~~-----------------~i 226 (317)
T d1xkka_ 167 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---EISS-----------------IL 226 (317)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG---GHHH-----------------HH
T ss_pred cccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH---HHHH-----------------HH
Confidence 2 2334568999999999999999999999999999999998 78888543221 1111 11
Q ss_pred hhcCCCCh-HHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhC
Q 005749 615 MKGIRSPM-EEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENR 658 (679)
Q Consensus 615 ~~~~~~~~-~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 658 (679)
..+.+.+. +...+++.+++.+||+.||++||||.||++.|+.+.
T Consensus 227 ~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~ 271 (317)
T d1xkka_ 227 EKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 271 (317)
T ss_dssp HHTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HcCCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHH
Confidence 22222222 223356778999999999999999999999998764
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.6e-49 Score=406.07 Aligned_cols=238 Identities=22% Similarity=0.315 Sum_probs=194.2
Q ss_pred CccccCCceEEEEEE-eCCCCEEEEEEcccCccc---CcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCC
Q 005749 383 QVIEKTTYGTAYKAK-LADGATIALRLLREGSCK---DRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPS 458 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~---~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~ 458 (679)
+.||+|+||+||+|+ ..+|+.||||+++..... ..+.+.+|+++|++++|||||++++++.+ .+..++|||||++
T Consensus 21 ~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-~~~~~iv~E~~~~ 99 (309)
T d1u5ra_ 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-EHTAWLVMEYCLG 99 (309)
T ss_dssp EEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-TTEEEEEEECCSE
T ss_pred EEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEE-CCEEEEEEEecCC
Confidence 679999999999999 567899999999764322 23568999999999999999999999987 6889999999999
Q ss_pred CChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccc
Q 005749 459 RTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADE 538 (679)
Q Consensus 459 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 538 (679)
|+|..++.. ...+++.+++.|+.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+.....
T Consensus 100 g~l~~~~~~----~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~---- 168 (309)
T d1u5ra_ 100 SASDLLEVH----KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---- 168 (309)
T ss_dssp EHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB----
T ss_pred CchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCCC----
Confidence 999877655 346999999999999999999999988 999999999999999999999999999875432
Q ss_pred hhcccccccccccccccc---cCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhh
Q 005749 539 MVALAKADGYKAPELQRM---KKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIM 615 (679)
Q Consensus 539 ~~~~~gt~~y~aPE~~~~---~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~ 615 (679)
....||+.|||||++.+ ..|+.++|||||||++|||++|+.||.+.... +.......
T Consensus 169 -~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~------~~~~~i~~------------- 228 (309)
T d1u5ra_ 169 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIAQ------------- 228 (309)
T ss_dssp -CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHH-------------
T ss_pred -CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHH------HHHHHHHh-------------
Confidence 34579999999999863 46899999999999999999999999543211 11111000
Q ss_pred hcCC-CChHHHHHHHHHHHHhccCcCCCCCCCHHHHHH
Q 005749 616 KGIR-SPMEEGLVQALKLAMGCCAPVASVRPTMDEVVK 652 (679)
Q Consensus 616 ~~~~-~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 652 (679)
.... .......+++.+++.+||+.||++|||++|+++
T Consensus 229 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 229 NESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp SCCCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 0000 011122356778999999999999999999986
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.2e-48 Score=404.53 Aligned_cols=253 Identities=20% Similarity=0.307 Sum_probs=202.4
Q ss_pred cCccccCCceEEEEEEeC------CCCEEEEEEcccCcc-cCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEE
Q 005749 382 GQVIEKTTYGTAYKAKLA------DGATIALRLLREGSC-KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYD 454 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~------~~~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~e 454 (679)
.+.||+|+||+||+|+.+ +++.||||+++.... ...++|.+|+++|++++||||++++++|.. .+..++|||
T Consensus 18 ~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~-~~~~~~v~e 96 (301)
T d1lufa_ 18 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV-GKPMCLLFE 96 (301)
T ss_dssp EEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSSCEEEEE
T ss_pred eEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeecc-CCceEEEEE
Confidence 478999999999999853 457899999976533 235679999999999999999999999987 688999999
Q ss_pred ecCCCChHHHhhcccC--------------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee
Q 005749 455 YFPSRTLHDLLHDTIA--------------------GKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLV 514 (679)
Q Consensus 455 y~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl 514 (679)
|+++|+|.++++.... ....+++..++.|+.|++.||+|||+++ ||||||||+|||+
T Consensus 97 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrDlKp~NILl 173 (301)
T d1lufa_ 97 YMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLV 173 (301)
T ss_dssp CCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred ecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEeeEEcccceEE
Confidence 9999999999975321 1235899999999999999999999988 9999999999999
Q ss_pred cCCCceEEeecccccccCccccc-chhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCC-CCCCCCCCCcccc
Q 005749 515 DDFFVSRLTEFGLDQLMVPAVAD-EMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGK-KPGKSGRNGEFVD 592 (679)
Q Consensus 515 ~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~-~p~~~~~~~~~~~ 592 (679)
|.++.+||+|||+|+.+...... ......|++.|+|||.+.+..|++++|||||||++|||++|. +||.+.... +
T Consensus 174 d~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~---e 250 (301)
T d1lufa_ 174 GENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE---E 250 (301)
T ss_dssp CGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH---H
T ss_pred CCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHH---H
Confidence 99999999999999876443222 233557889999999999999999999999999999999986 566432211 1
Q ss_pred hhHHHHHHhhcccccccchHhhhhcCCCCh-HHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhC
Q 005749 593 LPSIVKVAVLEETTMEVFDMEIMKGIRSPM-EEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENR 658 (679)
Q Consensus 593 l~~~~~~~~~~~~~~~~~~~~i~~~~~~~~-~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 658 (679)
+.. .+..+.+++. +...+++.+++.+||+.||++||||.||+++|+++.
T Consensus 251 ~~~-----------------~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 251 VIY-----------------YVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp HHH-----------------HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred HHH-----------------HHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 111 1112222211 123356778999999999999999999999999986
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-48 Score=396.13 Aligned_cols=242 Identities=17% Similarity=0.286 Sum_probs=198.5
Q ss_pred cCccccCCceEEEEEEe-CCCCEEEEEEcccCcc------cCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEE
Q 005749 382 GQVIEKTTYGTAYKAKL-ADGATIALRLLREGSC------KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYD 454 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~------~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~e 454 (679)
++.||+|+||+||+|+. .+|+.||||+++.... ...+.+.+|+++|++++|||||+++++|.+ .+..++|||
T Consensus 15 ~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-~~~~~iv~E 93 (293)
T d1jksa_ 15 GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN-KTDVILILE 93 (293)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEEEEE
T ss_pred eEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-CCEEEEEEE
Confidence 47899999999999995 6799999999865422 124578999999999999999999999998 689999999
Q ss_pred ecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCC----ceEEeecccccc
Q 005749 455 YFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFF----VSRLTEFGLDQL 530 (679)
Q Consensus 455 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~----~~kl~DFGla~~ 530 (679)
||++|+|.+++... ..+++..++.++.|++.||+|||+++ |+||||||+|||++.++ .+|++|||+|+.
T Consensus 94 ~~~gg~L~~~i~~~----~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~ 166 (293)
T d1jksa_ 94 LVAGGELFDFLAEK----ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 166 (293)
T ss_dssp CCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred cCCCccccchhccc----cccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchhhhhh
Confidence 99999999999764 45999999999999999999999988 99999999999998776 499999999987
Q ss_pred cCcccccchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccc
Q 005749 531 MVPAVADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVF 610 (679)
Q Consensus 531 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 610 (679)
.... .......||+.|+|||++.+..++.++||||+||++|||++|+.||.+....+ ....
T Consensus 167 ~~~~--~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~------~~~~----------- 227 (293)
T d1jksa_ 167 IDFG--NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE------TLAN----------- 227 (293)
T ss_dssp CTTS--CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHH-----------
T ss_pred cCCC--ccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH------HHHH-----------
Confidence 6433 22345678999999999999999999999999999999999999996432211 1110
Q ss_pred hHhhhhcCCCChH----HHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 611 DMEIMKGIRSPME----EGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 611 ~~~i~~~~~~~~~----~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
+..+...... ....++.+++.+||+.||++|||++|++++
T Consensus 228 ---i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 228 ---VSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp ---HHTTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ---HHhcCCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1111111111 123467789999999999999999999874
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-48 Score=402.60 Aligned_cols=243 Identities=20% Similarity=0.276 Sum_probs=201.4
Q ss_pred cCccccCCceEEEEEE-eCCCCEEEEEEcccC---cccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecC
Q 005749 382 GQVIEKTTYGTAYKAK-LADGATIALRLLREG---SCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFP 457 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~ 457 (679)
.++||+|+||+||+|+ ..+|+.||||+++.. .....+.+.+|+++|++++|||||++++++.+ .+..|+|||||+
T Consensus 10 ~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~-~~~~~iv~ey~~ 88 (337)
T d1o6la_ 10 LKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT-HDRLCFVMEYAN 88 (337)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC-SSEEEEEEECCT
T ss_pred EEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecc-ccccccceeccC
Confidence 4789999999999999 467999999999754 23345678999999999999999999999998 689999999999
Q ss_pred CCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCccccc
Q 005749 458 SRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVAD 537 (679)
Q Consensus 458 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 537 (679)
+|+|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+..... ..
T Consensus 89 gg~L~~~~~~~----~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~-~~ 160 (337)
T d1o6la_ 89 GGELFFHLSRE----RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-GA 160 (337)
T ss_dssp TCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT-TC
T ss_pred CCchhhhhhcc----cCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccC-Cc
Confidence 99999999874 45899999999999999999999998 999999999999999999999999999875432 22
Q ss_pred chhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhc
Q 005749 538 EMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKG 617 (679)
Q Consensus 538 ~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~ 617 (679)
.....+||+.|||||++.+..|+.++||||+||++|||++|+.||.+.... ...+. +..+
T Consensus 161 ~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~------~~~~~--------------i~~~ 220 (337)
T d1o6la_ 161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------RLFEL--------------ILME 220 (337)
T ss_dssp CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHH--------------HHHC
T ss_pred ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHH------HHHHH--------------HhcC
Confidence 345678999999999999999999999999999999999999999654321 11111 1111
Q ss_pred CCCChHHHHHHHHHHHHhccCcCCCCCCC-----HHHHHHH
Q 005749 618 IRSPMEEGLVQALKLAMGCCAPVASVRPT-----MDEVVKQ 653 (679)
Q Consensus 618 ~~~~~~~~~~~~~~l~~~cl~~dP~~RPs-----~~evl~~ 653 (679)
.........+++.+++.+||+.||++||+ ++|++++
T Consensus 221 ~~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 221 EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred CCCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 11112223456778999999999999995 7888763
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.4e-48 Score=409.12 Aligned_cols=247 Identities=16% Similarity=0.270 Sum_probs=201.2
Q ss_pred cCccccCCceEEEEEEe-CCCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCC
Q 005749 382 GQVIEKTTYGTAYKAKL-ADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRT 460 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gs 460 (679)
.+.||+|+||+||+|+. .+|+.||||++......+.+.+.+|+++|++++|||||++++++.+ .+..++|||||++|+
T Consensus 31 ~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-~~~~~ivmE~~~gg~ 109 (350)
T d1koaa2 31 HEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFED-DNEMVMIYEFMSGGE 109 (350)
T ss_dssp EEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEE-TTEEEEEECCCCSCB
T ss_pred EEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEE-CCEEEEEEEcCCCCC
Confidence 47899999999999994 5799999999987655556789999999999999999999999997 689999999999999
Q ss_pred hHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeec--CCCceEEeecccccccCcccccc
Q 005749 461 LHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVD--DFFVSRLTEFGLDQLMVPAVADE 538 (679)
Q Consensus 461 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~--~~~~~kl~DFGla~~~~~~~~~~ 538 (679)
|.+++... ...+++..++.|+.||+.||+|||+++ ||||||||+|||++ .++.+||+|||+|+.+.... .
T Consensus 110 L~~~l~~~---~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~--~ 181 (350)
T d1koaa2 110 LFEKVADE---HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ--S 181 (350)
T ss_dssp HHHHHTCT---TSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS--C
T ss_pred HHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheeccccc--c
Confidence 99999653 345999999999999999999999998 99999999999996 45789999999998764332 2
Q ss_pred hhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcC
Q 005749 539 MVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGI 618 (679)
Q Consensus 539 ~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~ 618 (679)
.....||+.|||||++.+..++.++||||+||++|||++|+.||.+.... +.......... .+...
T Consensus 182 ~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~------~~~~~i~~~~~---~~~~~----- 247 (350)
T d1koaa2 182 VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD------ETLRNVKSCDW---NMDDS----- 247 (350)
T ss_dssp EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHTCC---CSCCG-----
T ss_pred cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCC---CCCcc-----
Confidence 34568999999999999999999999999999999999999999543211 11111110000 00000
Q ss_pred CCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 619 RSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 619 ~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
..+...+++.+++.+||+.||++|||++|++++
T Consensus 248 --~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 248 --AFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp --GGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred --cccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 011223567789999999999999999999885
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-48 Score=400.11 Aligned_cols=256 Identities=20% Similarity=0.306 Sum_probs=194.4
Q ss_pred cCccccCCceEEEEEEeC------CCCEEEEEEcccCcc-cCcccHHHHHHHHhcc-CCCCCccceEEeeCCCCceEEEE
Q 005749 382 GQVIEKTTYGTAYKAKLA------DGATIALRLLREGSC-KDRSSCLPVIRQLGKV-RHENLIPLRAFYQGKRGEKLLIY 453 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~------~~~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~~lv~ 453 (679)
.+.||+|+||.||+|+.. +++.||||+++.... ...+.+.+|++++.++ +|+|||.+++++....+..++||
T Consensus 18 ~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~iv~ 97 (299)
T d1ywna1 18 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIV 97 (299)
T ss_dssp EEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEE
T ss_pred eeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeEEEEE
Confidence 478999999999999843 246899999976432 3355788888888887 68999999999887667789999
Q ss_pred EecCCCChHHHhhcccC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceE
Q 005749 454 DYFPSRTLHDLLHDTIA------------GKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSR 521 (679)
Q Consensus 454 ey~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~k 521 (679)
|||++|+|.++++.... ....+++.+++.|+.||++||+|||+++ ||||||||+|||+++++.+|
T Consensus 98 E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NILl~~~~~~K 174 (299)
T d1ywna1 98 EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVK 174 (299)
T ss_dssp ECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEE
T ss_pred EecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCccceeECCCCcEE
Confidence 99999999999975421 1245899999999999999999999988 99999999999999999999
Q ss_pred EeecccccccCcccc-cchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCC-CCCCCCCCCcccchhHHHHH
Q 005749 522 LTEFGLDQLMVPAVA-DEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGK-KPGKSGRNGEFVDLPSIVKV 599 (679)
Q Consensus 522 l~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~-~p~~~~~~~~~~~l~~~~~~ 599 (679)
|+|||+|+....... .......||+.|||||++.++.++.++|||||||++|||+||. .||.+....+ .+.
T Consensus 175 l~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~------~~~- 247 (299)
T d1ywna1 175 ICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE------EFC- 247 (299)
T ss_dssp ECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH------HHH-
T ss_pred EccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH------HHH-
Confidence 999999987643322 2234567999999999999999999999999999999999875 5664332211 111
Q ss_pred HhhcccccccchHhhhhcCCCCh-HHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCC
Q 005749 600 AVLEETTMEVFDMEIMKGIRSPM-EEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRP 659 (679)
Q Consensus 600 ~~~~~~~~~~~~~~i~~~~~~~~-~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 659 (679)
..+..+.+... +...+++.+++.+||+.||++||||+||+++|+++.+
T Consensus 248 ------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 248 ------------RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp ------------HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------------HHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 11112222211 1223567889999999999999999999999998753
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=4.2e-48 Score=407.62 Aligned_cols=247 Identities=17% Similarity=0.246 Sum_probs=201.1
Q ss_pred cCccccCCceEEEEEE-eCCCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCC
Q 005749 382 GQVIEKTTYGTAYKAK-LADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRT 460 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gs 460 (679)
.+.||+|+||+||+|+ ..+|+.||||+++.....+.+.+.+|+++|++++|||||+++++|.+ .+..|+|||||++|+
T Consensus 34 ~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-~~~~~ivmE~~~gg~ 112 (352)
T d1koba_ 34 LEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFED-KYEMVLILEFLSGGE 112 (352)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC-SSEEEEEEECCCCCB
T ss_pred EEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-CCEEEEEEEcCCCCh
Confidence 3789999999999999 46799999999977654556678999999999999999999999997 689999999999999
Q ss_pred hHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeec--CCCceEEeecccccccCcccccc
Q 005749 461 LHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVD--DFFVSRLTEFGLDQLMVPAVADE 538 (679)
Q Consensus 461 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~--~~~~~kl~DFGla~~~~~~~~~~ 538 (679)
|.+++... ...+++.+++.|+.||+.||+|||+++ |+||||||+|||++ .++.+||+|||+|+.+.... .
T Consensus 113 L~~~~~~~---~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~--~ 184 (352)
T d1koba_ 113 LFDRIAAE---DYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE--I 184 (352)
T ss_dssp HHHHTTCT---TCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS--C
T ss_pred HHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCCC--c
Confidence 99987653 345999999999999999999999988 99999999999998 57899999999998875432 2
Q ss_pred hhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcC
Q 005749 539 MVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGI 618 (679)
Q Consensus 539 ~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~ 618 (679)
.....||+.|||||++.+..++.++||||+||++|||++|+.||.+.... ........... .+. .
T Consensus 185 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------~~~~~i~~~~~---~~~----~-- 249 (352)
T d1koba_ 185 VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL------ETLQNVKRCDW---EFD----E-- 249 (352)
T ss_dssp EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH------HHHHHHHHCCC---CCC----S--
T ss_pred eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCC---CCC----c--
Confidence 34567899999999999999999999999999999999999999543221 11111000000 000 0
Q ss_pred CCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 619 RSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 619 ~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
...+...+++.+++.+||+.||++|||++|++++
T Consensus 250 -~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 250 -DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp -STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred -ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0111233567789999999999999999999874
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-48 Score=400.56 Aligned_cols=254 Identities=23% Similarity=0.339 Sum_probs=199.6
Q ss_pred cCccccCCceEEEEEEeC-CCC--EEEEEEcccC-cccCcccHHHHHHHHhcc-CCCCCccceEEeeCCCCceEEEEEec
Q 005749 382 GQVIEKTTYGTAYKAKLA-DGA--TIALRLLREG-SCKDRSSCLPVIRQLGKV-RHENLIPLRAFYQGKRGEKLLIYDYF 456 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~-~~~--~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~~lv~ey~ 456 (679)
+++||+|+||+||+|++. +|. .||||+++.. .....+.|.+|+++|.++ +|||||+++|+|.+ .+..++||||+
T Consensus 15 ~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~-~~~~~iV~ey~ 93 (309)
T d1fvra_ 15 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-RGYLYLAIEYA 93 (309)
T ss_dssp EEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE-TTEEEEEECCC
T ss_pred EEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEec-CCeeEEEEEec
Confidence 478999999999999954 444 5788888654 334567899999999999 79999999999997 68899999999
Q ss_pred CCCChHHHhhccc------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEee
Q 005749 457 PSRTLHDLLHDTI------------AGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTE 524 (679)
Q Consensus 457 ~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~D 524 (679)
++|+|.++++... .....+++.++++++.||++||.|+|+++ |+||||||+|||++.++.+||+|
T Consensus 94 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~kl~D 170 (309)
T d1fvra_ 94 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIAD 170 (309)
T ss_dssp TTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECC
T ss_pred CCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCceEEcc
Confidence 9999999997531 12356999999999999999999999988 99999999999999999999999
Q ss_pred cccccccCcccccchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCC-CCCCCCCCcccchhHHHHHHhhc
Q 005749 525 FGLDQLMVPAVADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKK-PGKSGRNGEFVDLPSIVKVAVLE 603 (679)
Q Consensus 525 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~-p~~~~~~~~~~~l~~~~~~~~~~ 603 (679)
||+++...... ......||..|+|||.+.++.++.++|||||||++|||++|.. ||.+... .+...
T Consensus 171 fG~a~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~------~~~~~----- 237 (309)
T d1fvra_ 171 FGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC------AELYE----- 237 (309)
T ss_dssp TTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHHH-----
T ss_pred ccccccccccc--cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCH------HHHHH-----
Confidence 99998654322 2234568999999999999999999999999999999999765 5533211 11111
Q ss_pred ccccccchHhhhhcCCCCh-HHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCCCC
Q 005749 604 ETTMEVFDMEIMKGIRSPM-EEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRPRN 661 (679)
Q Consensus 604 ~~~~~~~~~~i~~~~~~~~-~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 661 (679)
.+..+.+... ....+++.+++.+||+.||++||||+||++.|+++....
T Consensus 238 ---------~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~ 287 (309)
T d1fvra_ 238 ---------KLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 287 (309)
T ss_dssp ---------HGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred ---------HHHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 1112222221 122356778999999999999999999999999987543
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-48 Score=394.82 Aligned_cols=249 Identities=19% Similarity=0.304 Sum_probs=190.0
Q ss_pred CccccCCceEEEEEEeC--CC--CEEEEEEcccCcc---cCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEe
Q 005749 383 QVIEKTTYGTAYKAKLA--DG--ATIALRLLREGSC---KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDY 455 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~~--~~--~~vAvK~~~~~~~---~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey 455 (679)
+.||+|+||+||+|++. ++ ..||||+++.... ...+.|.+|+++|++++|||||+++|+|.+ +..++||||
T Consensus 14 ~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~--~~~~lv~e~ 91 (273)
T d1u46a_ 14 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT--PPMKMVTEL 91 (273)
T ss_dssp EECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSCEEEEEC
T ss_pred EEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee--cchheeeee
Confidence 67999999999999853 23 3789999876432 224579999999999999999999999975 467999999
Q ss_pred cCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCccc
Q 005749 456 FPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAV 535 (679)
Q Consensus 456 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 535 (679)
|++|++.+++... ...+++..+++++.|||+||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 92 ~~~~~l~~~~~~~---~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~ 165 (273)
T d1u46a_ 92 APLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 165 (273)
T ss_dssp CTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECCC-C
T ss_pred ecCcchhhhhhcc---cCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhcccCC
Confidence 9999999988764 345999999999999999999999988 9999999999999999999999999999874432
Q ss_pred cc--chhcccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHHHHHhhcccccccchH
Q 005749 536 AD--EMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDM 612 (679)
Q Consensus 536 ~~--~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 612 (679)
.. ......|+..|+|||.+.+..++.++|||||||++|||+| |+.||.+.... +......
T Consensus 166 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~------~~~~~i~----------- 228 (273)
T d1u46a_ 166 DHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS------QILHKID----------- 228 (273)
T ss_dssp CEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHHH-----------
T ss_pred CcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH------HHHHHHH-----------
Confidence 22 2234467889999999999999999999999999999998 89999543221 1111111
Q ss_pred hhhhcCCCCh-HHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhC
Q 005749 613 EIMKGIRSPM-EEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENR 658 (679)
Q Consensus 613 ~i~~~~~~~~-~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 658 (679)
..+.+.+. +....++.+++.+||+.||++||||.||++.|++++
T Consensus 229 --~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~~ 273 (273)
T d1u46a_ 229 --KEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273 (273)
T ss_dssp --TSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred --hCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcC
Confidence 11111111 122356778999999999999999999999998863
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1e-47 Score=399.02 Aligned_cols=240 Identities=20% Similarity=0.254 Sum_probs=199.6
Q ss_pred cCccccCCceEEEEEEe-CCCCEEEEEEcccC---cccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecC
Q 005749 382 GQVIEKTTYGTAYKAKL-ADGATIALRLLREG---SCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFP 457 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~ 457 (679)
.+.||+|+||+||+|+. .+|+.||||+++.. .....+.+.+|++++++++|||||++++++.+ .+..|+|||||+
T Consensus 9 ~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-~~~~~ivmE~~~ 87 (316)
T d1fota_ 9 LRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD-AQQIFMIMDYIE 87 (316)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC-SSEEEEEECCCC
T ss_pred EEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEee-CCeeeeEeeecC
Confidence 47899999999999995 67999999999653 23345678999999999999999999999998 689999999999
Q ss_pred CCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCccccc
Q 005749 458 SRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVAD 537 (679)
Q Consensus 458 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 537 (679)
+|+|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 88 gg~l~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~--- 157 (316)
T d1fota_ 88 GGELFSLLRKS----QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--- 157 (316)
T ss_dssp SCBHHHHHHHT----SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC---
T ss_pred Ccccccccccc----ccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc---
Confidence 99999998863 45889999999999999999999988 999999999999999999999999999876432
Q ss_pred chhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhc
Q 005749 538 EMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKG 617 (679)
Q Consensus 538 ~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~ 617 (679)
....+||+.|||||++.+..|+.++||||+||++|||++|+.||.+.... +... .+..+
T Consensus 158 -~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~------~~~~--------------~i~~~ 216 (316)
T d1fota_ 158 -TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM------KTYE--------------KILNA 216 (316)
T ss_dssp -BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHH--------------HHHHC
T ss_pred -cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHH------HHHH--------------HHHcC
Confidence 23568999999999999999999999999999999999999999543211 1111 11121
Q ss_pred CCCChHHHHHHHHHHHHhccCcCCCCCC-----CHHHHHHH
Q 005749 618 IRSPMEEGLVQALKLAMGCCAPVASVRP-----TMDEVVKQ 653 (679)
Q Consensus 618 ~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~evl~~ 653 (679)
.....+...+++.+++.+||+.||++|| |++|++++
T Consensus 217 ~~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 217 ELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred CCCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 1111122235677899999999999996 89999864
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-47 Score=392.16 Aligned_cols=263 Identities=24% Similarity=0.281 Sum_probs=194.2
Q ss_pred cCccccCCceEEEEEEeCCCCEEEEEEcccCcccCcccHHH--HHHHHhccCCCCCccceEEeeCCC---CceEEEEEec
Q 005749 382 GQVIEKTTYGTAYKAKLADGATIALRLLREGSCKDRSSCLP--VIRQLGKVRHENLIPLRAFYQGKR---GEKLLIYDYF 456 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~--Ei~~l~~l~H~nIv~l~~~~~~~~---~~~~lv~ey~ 456 (679)
.+.||+|+||.||+|++ +|+.||||+++... .+.+.+ |+..+.+++|||||+++++|.+.. ...++|||||
T Consensus 8 ~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~ 83 (303)
T d1vjya_ 8 QESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYH 83 (303)
T ss_dssp EEEEECCSSSEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECC
T ss_pred EEEEeeCCCeEEEEEEE-CCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecc
Confidence 36799999999999997 58899999986532 233444 455556789999999999998633 2579999999
Q ss_pred CCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-----CCCeeecCCCCCCeeecCCCceEEeeccccccc
Q 005749 457 PSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGH-----EIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLM 531 (679)
Q Consensus 457 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~-----~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 531 (679)
++|+|.++++. ..++|..+++++.|+|.||+|+|+.. ..+|+||||||+|||+++++.+||+|||+++..
T Consensus 84 ~~g~L~~~l~~-----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~ 158 (303)
T d1vjya_ 84 EHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 158 (303)
T ss_dssp TTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred cCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccc
Confidence 99999999975 34899999999999999999999741 245999999999999999999999999999876
Q ss_pred Cccccc---chhccccccccccccccccc------CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCccc--------chh
Q 005749 532 VPAVAD---EMVALAKADGYKAPELQRMK------KCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFV--------DLP 594 (679)
Q Consensus 532 ~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~--------~l~ 594 (679)
...... ......||+.|||||++.+. .++.|+|||||||++|||+||..|+......... ...
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~ 238 (303)
T d1vjya_ 159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 238 (303)
T ss_dssp ETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred cCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchH
Confidence 433211 23356799999999998754 2677999999999999999999887432221110 001
Q ss_pred HHHHHHhhcccccccchHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCC
Q 005749 595 SIVKVAVLEETTMEVFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRP 659 (679)
Q Consensus 595 ~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 659 (679)
.........+. +++.+... ....+....+.+++.+||+.||++||||.||++.|+++..
T Consensus 239 ~~~~~~~~~~~----~~p~~~~~--~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 297 (303)
T d1vjya_ 239 EEMRKVVCEQK----LRPNIPNR--WQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp HHHHHHHTTSC----CCCCCCGG--GGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHhccc----cCCCCCcc--cCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 11111111111 11110000 1122345668899999999999999999999999998763
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-47 Score=394.55 Aligned_cols=257 Identities=17% Similarity=0.276 Sum_probs=205.5
Q ss_pred hcCccccCCceEEEEEEeC------CCCEEEEEEcccCcc-cCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEE
Q 005749 381 TGQVIEKTTYGTAYKAKLA------DGATIALRLLREGSC-KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIY 453 (679)
Q Consensus 381 ~~~~ig~G~~g~Vy~~~~~------~~~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ 453 (679)
.++.||+|+||+||+|++. +++.||||+++.... .....|.+|++++++++|||||+++|+|.. .+..++||
T Consensus 24 l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~-~~~~~lv~ 102 (308)
T d1p4oa_ 24 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ-GQPTLVIM 102 (308)
T ss_dssp EEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS-SSSCEEEE
T ss_pred EeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec-CCceeEEE
Confidence 4578999999999999853 357899999975432 334568999999999999999999999987 67899999
Q ss_pred EecCCCChHHHhhccc------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeeccc
Q 005749 454 DYFPSRTLHDLLHDTI------AGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGL 527 (679)
Q Consensus 454 ey~~~gsL~~~l~~~~------~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 527 (679)
|||++|+|.+++.... .....+++..+.+|+.|+|+||.|||+++ |+||||||+|||+|+++++||+|||+
T Consensus 103 e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~DFGl 179 (308)
T d1p4oa_ 103 ELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGM 179 (308)
T ss_dssp ECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEECCTTC
T ss_pred eecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEeeccc
Confidence 9999999999987532 12245799999999999999999999988 99999999999999999999999999
Q ss_pred ccccCccccc-chhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCC-CCCCCCCCCcccchhHHHHHHhhccc
Q 005749 528 DQLMVPAVAD-EMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGK-KPGKSGRNGEFVDLPSIVKVAVLEET 605 (679)
Q Consensus 528 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~-~p~~~~~~~~~~~l~~~~~~~~~~~~ 605 (679)
|+.+...... ......||+.|+|||.+.++.+++++|||||||++|||+||. .||.+... .++...
T Consensus 180 a~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~------~~~~~~------ 247 (308)
T d1p4oa_ 180 TRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN------EQVLRF------ 247 (308)
T ss_dssp CCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH------HHHHHH------
T ss_pred ceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCH------HHHHHH------
Confidence 9876443222 234456899999999999999999999999999999999985 56633211 111111
Q ss_pred ccccchHhhhhcCCCCh-HHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCCCC
Q 005749 606 TMEVFDMEIMKGIRSPM-EEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRPRN 661 (679)
Q Consensus 606 ~~~~~~~~i~~~~~~~~-~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 661 (679)
+..+.+.+. ....+.+.+++.+||+.||++||||+||++.|++...+.
T Consensus 248 --------i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~ 296 (308)
T d1p4oa_ 248 --------VMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPG 296 (308)
T ss_dssp --------HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTT
T ss_pred --------HHhCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence 112222211 222356788999999999999999999999999876543
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-47 Score=393.85 Aligned_cols=257 Identities=18% Similarity=0.300 Sum_probs=204.0
Q ss_pred hcCccccCCceEEEEEEe------CCCCEEEEEEcccCcc-cCcccHHHHHHHHhcc-CCCCCccceEEeeCCCCceEEE
Q 005749 381 TGQVIEKTTYGTAYKAKL------ADGATIALRLLREGSC-KDRSSCLPVIRQLGKV-RHENLIPLRAFYQGKRGEKLLI 452 (679)
Q Consensus 381 ~~~~ig~G~~g~Vy~~~~------~~~~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~~lv 452 (679)
.++.||+|+||.||+|++ .+++.||||+++.... .....|.+|+.+++++ +|||||+++|+|.+ .+..++|
T Consensus 27 l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~-~~~~~lv 105 (311)
T d1t46a_ 27 FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI-GGPTLVI 105 (311)
T ss_dssp EEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSSCEEE
T ss_pred EeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEee-CCEEEEE
Confidence 357899999999999985 3466899999976532 3455789999999999 69999999999987 6789999
Q ss_pred EEecCCCChHHHhhcccC--------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCC
Q 005749 453 YDYFPSRTLHDLLHDTIA--------------GKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFF 518 (679)
Q Consensus 453 ~ey~~~gsL~~~l~~~~~--------------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~ 518 (679)
||||++|+|.++++.... ....+++..+++|+.||++||+|||+++ ||||||||+||+++.++
T Consensus 106 mE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~~~~~ 182 (311)
T d1t46a_ 106 TEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGR 182 (311)
T ss_dssp EECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEETTT
T ss_pred EEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccccccccC
Confidence 999999999999976431 1335899999999999999999999988 99999999999999999
Q ss_pred ceEEeecccccccCcccc-cchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHH
Q 005749 519 VSRLTEFGLDQLMVPAVA-DEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIV 597 (679)
Q Consensus 519 ~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~ 597 (679)
.+|++|||+++....... .......||+.|+|||.+.+..++.++|||||||++|||+|+..|+....... ..+...
T Consensus 183 ~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~-~~~~~~- 260 (311)
T d1t46a_ 183 ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD-SKFYKM- 260 (311)
T ss_dssp EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS-HHHHHH-
T ss_pred cccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH-HHHHHH-
Confidence 999999999997654322 22345678999999999999999999999999999999999554442322211 111111
Q ss_pred HHHhhcccccccchHhhhhcCCCChH-HHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCC
Q 005749 598 KVAVLEETTMEVFDMEIMKGIRSPME-EGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRP 659 (679)
Q Consensus 598 ~~~~~~~~~~~~~~~~i~~~~~~~~~-~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 659 (679)
+..+.++..+ .....+.+++.+||+.||++||||+||+++|+++..
T Consensus 261 ----------------i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~ 307 (311)
T d1t46a_ 261 ----------------IKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (311)
T ss_dssp ----------------HHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----------------HhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhc
Confidence 1122222221 223567789999999999999999999999987643
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-47 Score=391.68 Aligned_cols=253 Identities=23% Similarity=0.342 Sum_probs=198.7
Q ss_pred cCccccCCceEEEEEEeCC--------CCEEEEEEcccCcc-cCcccHHHHHHHHhcc-CCCCCccceEEeeCCCCceEE
Q 005749 382 GQVIEKTTYGTAYKAKLAD--------GATIALRLLREGSC-KDRSSCLPVIRQLGKV-RHENLIPLRAFYQGKRGEKLL 451 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~~~--------~~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~~l 451 (679)
++.||+|+||.||+|+... +..||||+++.... ....++.+|+..+.++ +|||||+++++|.+ ++..++
T Consensus 18 ~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~-~~~~~~ 96 (299)
T d1fgka_ 18 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ-DGPLYV 96 (299)
T ss_dssp EEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSSCEE
T ss_pred eeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccccc-CCeEEE
Confidence 5789999999999998432 34799999976543 3356789999999988 89999999999997 678999
Q ss_pred EEEecCCCChHHHhhcccC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCc
Q 005749 452 IYDYFPSRTLHDLLHDTIA------------GKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFV 519 (679)
Q Consensus 452 v~ey~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~ 519 (679)
|||||++|+|.+++..... ....+++.++++++.||+.||+|||+++ ||||||||+|||++.++.
T Consensus 97 v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl~~~~~ 173 (299)
T d1fgka_ 97 IVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNV 173 (299)
T ss_dssp EECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCC
T ss_pred EEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceeecCCCC
Confidence 9999999999999976431 1245899999999999999999999998 999999999999999999
Q ss_pred eEEeecccccccCccccc-chhcccccccccccccccccCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCcccchhHHH
Q 005749 520 SRLTEFGLDQLMVPAVAD-EMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILI-GKKPGKSGRNGEFVDLPSIV 597 (679)
Q Consensus 520 ~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~t-g~~p~~~~~~~~~~~l~~~~ 597 (679)
+||+|||+++........ ......+++.|+|||.+.++.|++++|||||||++|||++ |..||.+.... .+...
T Consensus 174 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~---~~~~~- 249 (299)
T d1fgka_ 174 MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE---ELFKL- 249 (299)
T ss_dssp EEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HHHHH-
T ss_pred eEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH---HHHHH-
Confidence 999999999977543222 2345678899999999999999999999999999999998 67787433211 11111
Q ss_pred HHHhhcccccccchHhhhhcCCCChH-HHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhC
Q 005749 598 KVAVLEETTMEVFDMEIMKGIRSPME-EGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENR 658 (679)
Q Consensus 598 ~~~~~~~~~~~~~~~~i~~~~~~~~~-~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 658 (679)
+..+.+.+.+ ...+++.+++.+||+.||++||||.||++.|+++.
T Consensus 250 ----------------i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~ 295 (299)
T d1fgka_ 250 ----------------LKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295 (299)
T ss_dssp ----------------HHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----------------HHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence 1111111111 12356778999999999999999999999999874
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.7e-47 Score=398.87 Aligned_cols=238 Identities=18% Similarity=0.224 Sum_probs=198.6
Q ss_pred CccccCCceEEEEEEe-CCCCEEEEEEcccCc---ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCC
Q 005749 383 QVIEKTTYGTAYKAKL-ADGATIALRLLREGS---CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPS 458 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~ 458 (679)
+.||+|+||.||+|+. .+|+.||||++.... ....+.+.+|+++|++++|||||++++++.+ ....++||||+.+
T Consensus 47 ~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-~~~~~~v~e~~~~ 125 (350)
T d1rdqe_ 47 KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD-NSNLYMVMEYVAG 125 (350)
T ss_dssp EEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEEEEEECCTT
T ss_pred EEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccc-ccccccccccccc
Confidence 6899999999999995 579999999986432 2345678999999999999999999999998 6789999999999
Q ss_pred CChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccc
Q 005749 459 RTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADE 538 (679)
Q Consensus 459 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 538 (679)
|+|.+++... ..+++..++.|+.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+.+...
T Consensus 126 g~l~~~l~~~----~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~---- 194 (350)
T d1rdqe_ 126 GEMFSHLRRI----GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR---- 194 (350)
T ss_dssp CBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC----
T ss_pred cchhhhHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc----
Confidence 9999999764 35899999999999999999999998 999999999999999999999999999876432
Q ss_pred hhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcC
Q 005749 539 MVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGI 618 (679)
Q Consensus 539 ~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~ 618 (679)
.....||+.|||||++.+..++.++|||||||++|||+||+.||.+... ..... .+..+.
T Consensus 195 ~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~------~~~~~--------------~i~~~~ 254 (350)
T d1rdqe_ 195 TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP------IQIYE--------------KIVSGK 254 (350)
T ss_dssp BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHH--------------HHHHCC
T ss_pred cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH------HHHHH--------------HHhcCC
Confidence 2356799999999999999999999999999999999999999954321 11111 111221
Q ss_pred CCChHHHHHHHHHHHHhccCcCCCCCC-----CHHHHHH
Q 005749 619 RSPMEEGLVQALKLAMGCCAPVASVRP-----TMDEVVK 652 (679)
Q Consensus 619 ~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~evl~ 652 (679)
........+++.+++.+||+.||++|+ |++|+++
T Consensus 255 ~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 255 VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 122223345677899999999999994 8999986
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-47 Score=392.83 Aligned_cols=260 Identities=22% Similarity=0.296 Sum_probs=193.4
Q ss_pred CccccCCceEEEEEE-eCCCCEEEEEEcccCccc-----CcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEec
Q 005749 383 QVIEKTTYGTAYKAK-LADGATIALRLLREGSCK-----DRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYF 456 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~-----~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~ 456 (679)
++||+|+||+||+|+ ..+|+.||||+++..... ..+.+.+|+++|++++|||||++++++.+ ++..++|||||
T Consensus 4 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~-~~~~~ivmE~~ 82 (299)
T d1ua2a_ 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH-KSNISLVFDFM 82 (299)
T ss_dssp EEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC-TTCCEEEEECC
T ss_pred eEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCceeehhhhh
Confidence 579999999999999 457999999999654321 23568999999999999999999999998 68899999999
Q ss_pred CCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccc
Q 005749 457 PSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVA 536 (679)
Q Consensus 457 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 536 (679)
.++++..+... ...+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+......
T Consensus 83 ~~~~~~~~~~~----~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~- 154 (299)
T d1ua2a_ 83 ETDLEVIIKDN----SLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN- 154 (299)
T ss_dssp SEEHHHHHTTC----CSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC-
T ss_pred cchHHhhhhhc----ccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCc-
Confidence 99877766653 345888999999999999999999988 9999999999999999999999999998764432
Q ss_pred cchhcccccccccccccccc-cCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhh--cccccccc---
Q 005749 537 DEMVALAKADGYKAPELQRM-KKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVL--EETTMEVF--- 610 (679)
Q Consensus 537 ~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~--~~~~~~~~--- 610 (679)
......+||+.|||||++.. ..|+.++||||+||++|||++|+.||.+....+ .+....+.... .+......
T Consensus 155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~--~l~~i~~~~~~~~~~~~~~~~~~~ 232 (299)
T d1ua2a_ 155 RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD--QLTRIFETLGTPTEEQWPDMCSLP 232 (299)
T ss_dssp CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCCCCTTTSSSTTSST
T ss_pred ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHH--HHHHHHHhcCCCChhhccchhccc
Confidence 22345679999999998865 457999999999999999999999996543211 11111111100 00000000
Q ss_pred hHhhhhcCC-CChH----HHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 611 DMEIMKGIR-SPME----EGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 611 ~~~i~~~~~-~~~~----~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
......... .+.. ...+++.+++.+||+.||++|||++|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 233 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp TCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 000000000 0001 123567899999999999999999999864
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.2e-46 Score=384.77 Aligned_cols=254 Identities=18% Similarity=0.264 Sum_probs=195.2
Q ss_pred cCccccCCceEEEEEE-eCCCCEEEEEEcccCcccC---cccHHHHHHHHhccCCCCCccceEEeeCCC---CceEEEEE
Q 005749 382 GQVIEKTTYGTAYKAK-LADGATIALRLLREGSCKD---RSSCLPVIRQLGKVRHENLIPLRAFYQGKR---GEKLLIYD 454 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~---~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~---~~~~lv~e 454 (679)
.+.||+|+||+||+|+ ..+|+.||||+++.....+ .+.|.+|++++++++|||||++++++.... ...|+|||
T Consensus 12 ~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~lvmE 91 (277)
T d1o6ya_ 12 GEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVME 91 (277)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred eEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEEEEE
Confidence 3789999999999999 4679999999997653322 346899999999999999999999987532 24789999
Q ss_pred ecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcc
Q 005749 455 YFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPA 534 (679)
Q Consensus 455 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 534 (679)
||++|+|.+++... ..+++.+++.|+.||+.||+|||+++ |+||||||+|||++.++..+++|||.++.....
T Consensus 92 ~~~g~~L~~~~~~~----~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~ 164 (277)
T d1o6ya_ 92 YVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADS 164 (277)
T ss_dssp CCCEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCEECC--
T ss_pred CCCCCEehhhhccc----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhhhhccc
Confidence 99999999998764 45999999999999999999999988 999999999999999999999999998765332
Q ss_pred c--ccchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchH
Q 005749 535 V--ADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDM 612 (679)
Q Consensus 535 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 612 (679)
. ........||+.|||||++.+..+++++||||+||++|||+||+.||.+.... +.......... ..+
T Consensus 165 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------~~~~~~~~~~~----~~~ 234 (277)
T d1o6ya_ 165 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV------SVAYQHVREDP----IPP 234 (277)
T ss_dssp --------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHCCC----CCG
T ss_pred cccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHH------HHHHHHHhcCC----CCC
Confidence 2 12334567999999999999999999999999999999999999999543211 11111111100 000
Q ss_pred hhhhcCCCChHHHHHHHHHHHHhccCcCCCCCC-CHHHHHHHHHhhC
Q 005749 613 EIMKGIRSPMEEGLVQALKLAMGCCAPVASVRP-TMDEVVKQLEENR 658 (679)
Q Consensus 613 ~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-s~~evl~~L~~~~ 658 (679)
.. . .+...+++.+++.+||+.||++|| |++++++.|.++.
T Consensus 235 ~~---~---~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 235 SA---R---HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp GG---T---SSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred ch---h---ccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 00 0 011235677899999999999999 8999999998874
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-46 Score=393.94 Aligned_cols=244 Identities=18% Similarity=0.253 Sum_probs=195.1
Q ss_pred cCccccCCceEEEEEE-eCCCCEEEEEEcccCcccCcccHHHHHHHHhcc-CCCCCccceEEeeC---CCCceEEEEEec
Q 005749 382 GQVIEKTTYGTAYKAK-LADGATIALRLLREGSCKDRSSCLPVIRQLGKV-RHENLIPLRAFYQG---KRGEKLLIYDYF 456 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~---~~~~~~lv~ey~ 456 (679)
+++||+|+||+||+|+ ..+++.||||+++. .+.+.+|++++.++ +|||||+++++|.+ .+...|+|||||
T Consensus 17 ~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~ 91 (335)
T d2ozaa1 17 SQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECL 91 (335)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECC
T ss_pred eEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECC
Confidence 4679999999999999 46799999999864 35678999997665 89999999999864 235689999999
Q ss_pred CCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecC---CCceEEeecccccccCc
Q 005749 457 PSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDD---FFVSRLTEFGLDQLMVP 533 (679)
Q Consensus 457 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~---~~~~kl~DFGla~~~~~ 533 (679)
++|+|.+++.... ...+++.+++.|+.||+.||+|||+++ |+||||||+|||+++ ++.+||+|||+|+....
T Consensus 92 ~gg~L~~~i~~~~--~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~ 166 (335)
T d2ozaa1 92 DGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 166 (335)
T ss_dssp CSEEHHHHHHSCS--CCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTTCEECCC
T ss_pred CCCcHHHHHHhcC--CCCcCHHHHHHHHHHHHHHHHHHHHcC---CccccccccccccccccccccccccccceeeeccC
Confidence 9999999997642 346999999999999999999999988 999999999999985 46799999999987644
Q ss_pred ccccchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHh
Q 005749 534 AVADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDME 613 (679)
Q Consensus 534 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 613 (679)
.. ......||+.|||||++.+..|+.++||||+||++|||+||+.||.+........ .... .
T Consensus 167 ~~--~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~---~~~~-------------~ 228 (335)
T d2ozaa1 167 HN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP---GMKT-------------R 228 (335)
T ss_dssp CC--CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC------------------------C
T ss_pred CC--ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHH---HHHH-------------H
Confidence 32 2345689999999999999999999999999999999999999996543321110 0000 0
Q ss_pred hhhcC-C---CChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 614 IMKGI-R---SPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 614 i~~~~-~---~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
+..+. . +......+++.+++.+||+.||++|||+.|++++
T Consensus 229 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 229 IRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp CCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 01110 0 1112334678899999999999999999999884
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-47 Score=394.53 Aligned_cols=242 Identities=19% Similarity=0.270 Sum_probs=196.9
Q ss_pred cCccccCCceEEEEEEe-CCCCEEEEEEcccCc---ccCcccHHHHHHHHh-ccCCCCCccceEEeeCCCCceEEEEEec
Q 005749 382 GQVIEKTTYGTAYKAKL-ADGATIALRLLREGS---CKDRSSCLPVIRQLG-KVRHENLIPLRAFYQGKRGEKLLIYDYF 456 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~-~l~H~nIv~l~~~~~~~~~~~~lv~ey~ 456 (679)
.+.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|+.++. .++|||||++++++.+ ++..|+|||||
T Consensus 7 ~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~-~~~~yivmEy~ 85 (320)
T d1xjda_ 7 HKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT-KENLFFVMEYL 85 (320)
T ss_dssp EEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC-SSEEEEEEECC
T ss_pred eeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEcc-CCceeEEEeec
Confidence 47899999999999994 579999999997532 334556788888776 6899999999999998 68899999999
Q ss_pred CCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccc
Q 005749 457 PSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVA 536 (679)
Q Consensus 457 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 536 (679)
++|+|.+++... ..+++.+++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++..... .
T Consensus 86 ~~g~L~~~i~~~----~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~-~ 157 (320)
T d1xjda_ 86 NGGDLMYHIQSC----HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLG-D 157 (320)
T ss_dssp TTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT-T
T ss_pred CCCcHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhcccc-c
Confidence 999999999864 45899999999999999999999998 999999999999999999999999999865433 2
Q ss_pred cchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhh
Q 005749 537 DEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMK 616 (679)
Q Consensus 537 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~ 616 (679)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||.+.... .+ .. .+..
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~---~~---~~--------------~i~~ 217 (320)
T d1xjda_ 158 AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE---EL---FH--------------SIRM 217 (320)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HH---HH--------------HHHH
T ss_pred ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH---HH---HH--------------HHHc
Confidence 2334567999999999999999999999999999999999999999653221 11 11 1111
Q ss_pred cCCCChHHHHHHHHHHHHhccCcCCCCCCCHH-HHHH
Q 005749 617 GIRSPMEEGLVQALKLAMGCCAPVASVRPTMD-EVVK 652 (679)
Q Consensus 617 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~-evl~ 652 (679)
+.........+++.+++.+||+.||++||++. |+++
T Consensus 218 ~~~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 218 DNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp CCCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred CCCCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 11111112235677899999999999999995 6754
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.9e-46 Score=382.10 Aligned_cols=246 Identities=18% Similarity=0.287 Sum_probs=197.5
Q ss_pred cCccccCCceEEEEEEe-CCCCEEEEEEcccCcccC---------cccHHHHHHHHhccC-CCCCccceEEeeCCCCceE
Q 005749 382 GQVIEKTTYGTAYKAKL-ADGATIALRLLREGSCKD---------RSSCLPVIRQLGKVR-HENLIPLRAFYQGKRGEKL 450 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~---------~~~~~~Ei~~l~~l~-H~nIv~l~~~~~~~~~~~~ 450 (679)
.+.||+|+||+||+|+. .+|+.||||+++...... .+.+.+|++++++++ |||||++++++.+ ++..|
T Consensus 8 ~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~-~~~~~ 86 (277)
T d1phka_ 8 KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET-NTFFF 86 (277)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC-SSEEE
T ss_pred ceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc-CcceE
Confidence 47899999999999994 679999999997643211 235889999999997 9999999999998 78999
Q ss_pred EEEEecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccc
Q 005749 451 LIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQL 530 (679)
Q Consensus 451 lv~ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 530 (679)
+|||||++|||.++++.. ..+++.+++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 87 ivmE~~~~g~L~~~l~~~----~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 159 (277)
T d1phka_ 87 LVFDLMKKGELFDYLTEK----VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQ 159 (277)
T ss_dssp EEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEcCCCchHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchheeE
Confidence 999999999999999764 45999999999999999999999988 99999999999999999999999999987
Q ss_pred cCcccccchhcccccccccccccccc------cCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcc
Q 005749 531 MVPAVADEMVALAKADGYKAPELQRM------KKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEE 604 (679)
Q Consensus 531 ~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~ 604 (679)
..... ......||+.|+|||.+.+ ..++.++||||+||++|||++|+.||.+.... ...+......
T Consensus 160 ~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~------~~~~~i~~~~ 231 (277)
T d1phka_ 160 LDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM------LMLRMIMSGN 231 (277)
T ss_dssp CCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHTC
T ss_pred ccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHH------HHHHHHHhCC
Confidence 75432 2345679999999998763 34688999999999999999999999643211 1111111100
Q ss_pred cccccchHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 605 TTMEVFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 605 ~~~~~~~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
. +. ..+..+...+++.+++.+||+.||++|||++||++.
T Consensus 232 ~--~~--------~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 232 Y--QF--------GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp C--CC--------CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred C--CC--------CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 0 00 001112334678899999999999999999998764
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.1e-46 Score=396.60 Aligned_cols=244 Identities=18% Similarity=0.239 Sum_probs=193.5
Q ss_pred cCccccCCceEEEEEEe-CCCCEEEEEEcccCc---ccCcccHHHH---HHHHhccCCCCCccceEEeeCCCCceEEEEE
Q 005749 382 GQVIEKTTYGTAYKAKL-ADGATIALRLLREGS---CKDRSSCLPV---IRQLGKVRHENLIPLRAFYQGKRGEKLLIYD 454 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~E---i~~l~~l~H~nIv~l~~~~~~~~~~~~lv~e 454 (679)
.++||+|+||.||+|+. .+|+.||||++.... ......+.+| +++++.++|||||++++++.+ .+..|+|||
T Consensus 9 ~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~-~~~~~ivmE 87 (364)
T d1omwa3 9 HRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT-PDKLSFILD 87 (364)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC-SSEEEEEEC
T ss_pred eeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEE-CCEEEEEEE
Confidence 47899999999999994 579999999986432 1223334444 667777889999999999998 688999999
Q ss_pred ecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcc
Q 005749 455 YFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPA 534 (679)
Q Consensus 455 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 534 (679)
||++|+|.+++... ..+++..++.|+.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+.+...
T Consensus 88 ~~~gg~L~~~l~~~----~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~ 160 (364)
T d1omwa3 88 LMNGGDLHYHLSQH----GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK 160 (364)
T ss_dssp CCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEECSSS
T ss_pred ecCCCcHHHHHHhc----ccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeecCCC
Confidence 99999999999864 45889999999999999999999998 999999999999999999999999999876433
Q ss_pred cccchhcccccccccccccccc-cCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHh
Q 005749 535 VADEMVALAKADGYKAPELQRM-KKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDME 613 (679)
Q Consensus 535 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 613 (679)
......||+.|||||++.. ..|+.++|||||||++|||+||+.||.+....+.. ...+..
T Consensus 161 ---~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~---~~~~~~------------- 221 (364)
T d1omwa3 161 ---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH---EIDRMT------------- 221 (364)
T ss_dssp ---CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHH---HHHHHS-------------
T ss_pred ---cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHhc-------------
Confidence 2345689999999999874 56899999999999999999999999654332211 111110
Q ss_pred hhhcCCCChHHHHHHHHHHHHhccCcCCCCCCC-----HHHHHHH
Q 005749 614 IMKGIRSPMEEGLVQALKLAMGCCAPVASVRPT-----MDEVVKQ 653 (679)
Q Consensus 614 i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs-----~~evl~~ 653 (679)
............+++.+++.+||+.||++||| ++|++++
T Consensus 222 -~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 222 -LTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp -SSCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred -ccCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 01101111122356778999999999999999 6888753
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-46 Score=389.53 Aligned_cols=242 Identities=20% Similarity=0.322 Sum_probs=198.0
Q ss_pred cCccccCCceEEEEEEe-CCCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCC
Q 005749 382 GQVIEKTTYGTAYKAKL-ADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRT 460 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gs 460 (679)
.+.||+|+||+||+|+. .+|+.||||+++... .+...+.+|+++|++++|||||++++++.+ .+..|+|||||++|+
T Consensus 10 ~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-~~~~~lvmE~~~gg~ 87 (321)
T d1tkia_ 10 AEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFES-MEELVMIFEFISGLD 87 (321)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEE-TTEEEEEECCCCCCB
T ss_pred EEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEE-CCEEEEEEecCCCCc
Confidence 47899999999999995 578999999997643 234568899999999999999999999997 689999999999999
Q ss_pred hHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCC--CceEEeecccccccCcccccc
Q 005749 461 LHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDF--FVSRLTEFGLDQLMVPAVADE 538 (679)
Q Consensus 461 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~--~~~kl~DFGla~~~~~~~~~~ 538 (679)
|.+++... ...+++.+++.|+.||+.||+|||+++ |+||||||+|||++.+ ..+||+|||+++..... ..
T Consensus 88 L~~~i~~~---~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~--~~ 159 (321)
T d1tkia_ 88 IFERINTS---AFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG--DN 159 (321)
T ss_dssp HHHHHTSS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT--CE
T ss_pred HHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccC--Cc
Confidence 99999764 235899999999999999999999988 9999999999999854 58999999999876433 22
Q ss_pred hhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccchHhhhhcC
Q 005749 539 MVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFDMEIMKGI 618 (679)
Q Consensus 539 ~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~ 618 (679)
.....+|+.|+|||...+..++.++||||+||++|||++|+.||.+.... +... .+..+.
T Consensus 160 ~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~------~~~~--------------~i~~~~ 219 (321)
T d1tkia_ 160 FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ------QIIE--------------NIMNAE 219 (321)
T ss_dssp EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHH--------------HHHHTC
T ss_pred ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH------HHHH--------------HHHhCC
Confidence 34457899999999999999999999999999999999999999553221 1111 111111
Q ss_pred CCChH----HHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 619 RSPME----EGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 619 ~~~~~----~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
..... ...+++.+++.+||+.||++|||++|++++
T Consensus 220 ~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 220 YTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp CCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11111 123467789999999999999999999874
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-46 Score=377.06 Aligned_cols=235 Identities=19% Similarity=0.318 Sum_probs=190.8
Q ss_pred cCccccCCceEEEEEE-eCCCCEEEEEEcccCcc------cCcccHHHHHHHHhccC--CCCCccceEEeeCCCCceEEE
Q 005749 382 GQVIEKTTYGTAYKAK-LADGATIALRLLREGSC------KDRSSCLPVIRQLGKVR--HENLIPLRAFYQGKRGEKLLI 452 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~------~~~~~~~~Ei~~l~~l~--H~nIv~l~~~~~~~~~~~~lv 452 (679)
+++||+|+||+||+|+ ..+|+.||||+++.... .....+.+|+++|++++ |||||++++++.+ .+..++|
T Consensus 9 ~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~-~~~~~lv 87 (273)
T d1xwsa_ 9 GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER-PDSFVLI 87 (273)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC-SSEEEEE
T ss_pred eEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEee-CCeEEEE
Confidence 4789999999999999 46799999999875422 22345789999999996 8999999999998 6889999
Q ss_pred EEecCC-CChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCC-CceEEeecccccc
Q 005749 453 YDYFPS-RTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDF-FVSRLTEFGLDQL 530 (679)
Q Consensus 453 ~ey~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~-~~~kl~DFGla~~ 530 (679)
|||+.+ +++.+++... ..+++..++.++.||++||+|||+++ |+||||||+|||++.+ +.+||+|||+|+.
T Consensus 88 ~e~~~~~~~l~~~~~~~----~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~a~~ 160 (273)
T d1xwsa_ 88 LERPEPVQDLFDFITER----GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGAL 160 (273)
T ss_dssp EECCSSEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEeccCcchHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECcccccee
Confidence 999976 6888888763 45899999999999999999999988 9999999999999854 7999999999987
Q ss_pred cCcccccchhcccccccccccccccccCC-CCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhccccccc
Q 005749 531 MVPAVADEMVALAKADGYKAPELQRMKKC-SSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEV 609 (679)
Q Consensus 531 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 609 (679)
.... ......||+.|||||++.+..+ +.++||||+||++|||++|+.||.+.. .
T Consensus 161 ~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--------~-------------- 215 (273)
T d1xwsa_ 161 LKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--------E-------------- 215 (273)
T ss_dssp CCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--------H--------------
T ss_pred cccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch--------H--------------
Confidence 5432 2345679999999999987665 667999999999999999999994311 0
Q ss_pred chHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 610 FDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 610 ~~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
+..+.....+...+++.+++.+||+.||++|||++|++++
T Consensus 216 ----i~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 216 ----IIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp ----HHHCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ----HhhcccCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 0011001111123567789999999999999999999874
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-45 Score=380.98 Aligned_cols=265 Identities=18% Similarity=0.249 Sum_probs=195.8
Q ss_pred CccccCCceEEEEEE-eCCCCEEEEEEcccCcc--cCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCC
Q 005749 383 QVIEKTTYGTAYKAK-LADGATIALRLLREGSC--KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSR 459 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~g 459 (679)
+.||+|+||+||+|+ ..+|+.||||+++.... ...+.+.+|+++|++++|||||++++++.+ .+..++||||+.+
T Consensus 8 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~-~~~~~iv~e~~~~- 85 (298)
T d1gz8a_ 8 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT-ENKLYLVFEFLHQ- 85 (298)
T ss_dssp EEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEE-TTEEEEEEECCSE-
T ss_pred cEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccccc-ccceeEEEeecCC-
Confidence 689999999999999 46799999999965432 345689999999999999999999999998 6899999999976
Q ss_pred ChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccch
Q 005749 460 TLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEM 539 (679)
Q Consensus 460 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 539 (679)
++.+++.... ...+++..++.++.|++.||+|||+++ ||||||||+|||++.++.+||+|||+|+..... ....
T Consensus 86 ~~~~~~~~~~--~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~-~~~~ 159 (298)
T d1gz8a_ 86 DLKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTY 159 (298)
T ss_dssp EHHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC-SBCT
T ss_pred chhhhhhhhc--ccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCC-cccc
Confidence 4555544322 345999999999999999999999988 999999999999999999999999999876433 2334
Q ss_pred hcccccccccccccccccC-CCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhh-ccc-ccccch-----
Q 005749 540 VALAKADGYKAPELQRMKK-CSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVL-EET-TMEVFD----- 611 (679)
Q Consensus 540 ~~~~gt~~y~aPE~~~~~~-~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~-~~~-~~~~~~----- 611 (679)
....||+.|+|||.+.... ++.++||||+||++|||++|+.||.+....+ .+......... .+. ......
T Consensus 160 ~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~--~~~~i~~~~~~~~~~~~~~~~~~~~~~ 237 (298)
T d1gz8a_ 160 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID--QLFRIFRTLGTPDEVVWPGVTSMPDYK 237 (298)
T ss_dssp TCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred eeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHH--HHHHHHHhcCCCchhhccccccccccc
Confidence 4568999999999877655 5889999999999999999999996432211 11111111000 000 000000
Q ss_pred HhhhhcCCCChH----HHHHHHHHHHHhccCcCCCCCCCHHHHHHH--HHhh
Q 005749 612 MEIMKGIRSPME----EGLVQALKLAMGCCAPVASVRPTMDEVVKQ--LEEN 657 (679)
Q Consensus 612 ~~i~~~~~~~~~----~~~~~~~~l~~~cl~~dP~~RPs~~evl~~--L~~~ 657 (679)
............ ...+++.+++.+||+.||++|||++|+++. ++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289 (298)
T ss_dssp TTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred cccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence 000000001111 112567889999999999999999999886 5444
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=5.2e-45 Score=374.52 Aligned_cols=259 Identities=19% Similarity=0.228 Sum_probs=193.6
Q ss_pred CccccCCceEEEEEEeCCCCEEEEEEcccCc--ccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCC
Q 005749 383 QVIEKTTYGTAYKAKLADGATIALRLLREGS--CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRT 460 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~~~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gs 460 (679)
+.||+|+||+||+|+.++|+.||||+++... ....+.+.+|+.+|++++|||||++++++.+ .+..+++|||+.++.
T Consensus 8 ~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-~~~~~i~~e~~~~~~ 86 (286)
T d1ob3a_ 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT-KKRLVLVFEHLDQDL 86 (286)
T ss_dssp EEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC-SSCEEEEEECCSEEH
T ss_pred cEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeeccc-CCceeEEEEeehhhh
Confidence 6799999999999999899999999997643 2335689999999999999999999999998 688999999998877
Q ss_pred hHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccchh
Q 005749 461 LHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEMV 540 (679)
Q Consensus 461 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 540 (679)
+..+... ...+++..++.|+.||+.||+|||+.+ ||||||||+|||++.++.+|++|||.+....... ....
T Consensus 87 ~~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~~ 158 (286)
T d1ob3a_ 87 KKLLDVC----EGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV-RKYT 158 (286)
T ss_dssp HHHHHTS----TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-------
T ss_pred HHHHHhh----cCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCc-cccc
Confidence 7666554 356999999999999999999999988 9999999999999999999999999998764332 2234
Q ss_pred cccccccccccccccc-cCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhh--cccccccc-----hH
Q 005749 541 ALAKADGYKAPELQRM-KKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVL--EETTMEVF-----DM 612 (679)
Q Consensus 541 ~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~--~~~~~~~~-----~~ 612 (679)
...+++.|+|||.+.+ ..++.++||||+||++|||++|+.||.+....+ .+......... ........ +.
T Consensus 159 ~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~--~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T d1ob3a_ 159 HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD--QLMRIFRILGTPNSKNWPNVTELPKYDP 236 (286)
T ss_dssp ---CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred eecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHH--HHHHHHHhhCCCChhhccchhhhhhccc
Confidence 4568899999998875 457999999999999999999999996543211 11111111100 00000000 00
Q ss_pred hhhhcCCC----ChHHHHHHHHHHHHhccCcCCCCCCCHHHHHH
Q 005749 613 EIMKGIRS----PMEEGLVQALKLAMGCCAPVASVRPTMDEVVK 652 (679)
Q Consensus 613 ~i~~~~~~----~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 652 (679)
........ ..+...+.+.+++.+||+.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000000 01112356779999999999999999999985
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-44 Score=375.61 Aligned_cols=265 Identities=18% Similarity=0.261 Sum_probs=195.4
Q ss_pred CccccCCceEEEEEEe-CC-CCEEEEEEcccCc--ccCcccHHHHHHHHhcc---CCCCCccceEEeeC----CCCceEE
Q 005749 383 QVIEKTTYGTAYKAKL-AD-GATIALRLLREGS--CKDRSSCLPVIRQLGKV---RHENLIPLRAFYQG----KRGEKLL 451 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~-~~-~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l---~H~nIv~l~~~~~~----~~~~~~l 451 (679)
+.||+|+||+||+|+. ++ ++.||||+++... ......+.+|+++|+.+ +|||||+++++|.. .....++
T Consensus 13 ~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~~~~ 92 (305)
T d1blxa_ 13 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTL 92 (305)
T ss_dssp EEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEE
T ss_pred EEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCceEEE
Confidence 6899999999999995 44 5679999986543 23355788899888776 79999999998853 2346899
Q ss_pred EEEecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeeccccccc
Q 005749 452 IYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLM 531 (679)
Q Consensus 452 v~ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 531 (679)
+|||+.++++....... ...+++..++.++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++..
T Consensus 93 ~~e~~~~~~~~~~~~~~---~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~dfg~~~~~ 166 (305)
T d1blxa_ 93 VFEHVDQDLTTYLDKVP---EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIY 166 (305)
T ss_dssp EEECCSCBHHHHHHHSC---TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSCCSCCCC
T ss_pred EEEeccCCchhhhhhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecchhhhhhh
Confidence 99999987765544432 355899999999999999999999988 999999999999999999999999999875
Q ss_pred CcccccchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhh--ccccc--
Q 005749 532 VPAVADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVL--EETTM-- 607 (679)
Q Consensus 532 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~--~~~~~-- 607 (679)
... .......||+.|||||++.+..|+.++||||+||++|||++|+.||.+....+ .+......... .....
T Consensus 167 ~~~--~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~--~~~~i~~~~~~~~~~~~~~~ 242 (305)
T d1blxa_ 167 SFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD--QLGKILDVIGLPGEEDWPRD 242 (305)
T ss_dssp CGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCCCCGGGSCTT
T ss_pred ccc--ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHH--HHHHHHHhhCCCchhccccc
Confidence 432 33456789999999999999999999999999999999999999996543211 11111111100 00000
Q ss_pred -ccchHhhhhcCCCC----hHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH--HHhh
Q 005749 608 -EVFDMEIMKGIRSP----MEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ--LEEN 657 (679)
Q Consensus 608 -~~~~~~i~~~~~~~----~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~--L~~~ 657 (679)
.............+ .....+.+.+++.+||+.||++|||++|++++ ++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i 299 (305)
T d1blxa_ 243 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 299 (305)
T ss_dssp CSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred ccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCc
Confidence 00000000000000 11123456789999999999999999999875 4444
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-43 Score=370.11 Aligned_cols=264 Identities=20% Similarity=0.261 Sum_probs=190.2
Q ss_pred CccccCCceEEEEEEe-CCCCEEEEEEcccCc--ccCcccHHHHHHHHhccCCCCCccceEEeeCC-------CCceEEE
Q 005749 383 QVIEKTTYGTAYKAKL-ADGATIALRLLREGS--CKDRSSCLPVIRQLGKVRHENLIPLRAFYQGK-------RGEKLLI 452 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~-------~~~~~lv 452 (679)
+.||+|+||+||+|+. .+|+.||||++.... ....+++.+|+++|++++||||+++++++... .+..++|
T Consensus 16 ~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~iv 95 (318)
T d3blha1 16 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLV 95 (318)
T ss_dssp EEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------CEEEE
T ss_pred EEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCceEEEE
Confidence 6899999999999994 679999999986543 23456789999999999999999999988652 3468999
Q ss_pred EEecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccC
Q 005749 453 YDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMV 532 (679)
Q Consensus 453 ~ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 532 (679)
|||+.++++...... ...++...++.|+.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 96 ~e~~~~~~~~~~~~~----~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~ 168 (318)
T d3blha1 96 FDFCEHDLAGLLSNV----LVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFS 168 (318)
T ss_dssp EECCCEEHHHHHTCT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EeccCCCccchhhhc----ccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecceeeecc
Confidence 999988766655443 345889999999999999999999988 9999999999999999999999999998664
Q ss_pred cccc---cchhccccccccccccccccc-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccc
Q 005749 533 PAVA---DEMVALAKADGYKAPELQRMK-KCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTME 608 (679)
Q Consensus 533 ~~~~---~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 608 (679)
.... .......||+.|+|||++.+. .+++++||||+||++|||++|+.||.+....+...................
T Consensus 169 ~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 248 (318)
T d3blha1 169 LAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN 248 (318)
T ss_dssp C-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred cccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccc
Confidence 3221 122345799999999998754 689999999999999999999999965332111111111000000000000
Q ss_pred c----chHhh--hhcCCCChHHH------HHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 609 V----FDMEI--MKGIRSPMEEG------LVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 609 ~----~~~~i--~~~~~~~~~~~------~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
. ....+ .........+. .+.+++++.+||+.||++|||++|++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 249 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp CCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred cchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 0 00000 00111111111 2456789999999999999999999865
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-44 Score=376.36 Aligned_cols=261 Identities=24% Similarity=0.295 Sum_probs=192.0
Q ss_pred CccccCCceEEEEEEe-CCCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCC-----CCceEEEEEec
Q 005749 383 QVIEKTTYGTAYKAKL-ADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGK-----RGEKLLIYDYF 456 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~-----~~~~~lv~ey~ 456 (679)
++||+|+||+||+|+. .+|+.||||+++... ..+.+|+++|++++|||||+++++|... ....++|||||
T Consensus 26 k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~ 101 (350)
T d1q5ka_ 26 KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV 101 (350)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEECCS----SSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEECC
T ss_pred eEEeeCcCeEEEEEEECCCCCEEEEEEECccc----hHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEecc
Confidence 6899999999999995 579999999997532 3445899999999999999999998542 23478999999
Q ss_pred CCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCC-ceEEeecccccccCccc
Q 005749 457 PSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFF-VSRLTEFGLDQLMVPAV 535 (679)
Q Consensus 457 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~-~~kl~DFGla~~~~~~~ 535 (679)
+++ +.+.+.........+++.+++.|+.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+++......
T Consensus 102 ~~~-~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~ 177 (350)
T d1q5ka_ 102 PET-VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 177 (350)
T ss_dssp SEE-HHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEECCTTS
T ss_pred CCc-cHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhccCCc
Confidence 875 44444332222556999999999999999999999988 99999999999999775 89999999998764332
Q ss_pred ccchhcccccccccccccccc-cCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhh------------
Q 005749 536 ADEMVALAKADGYKAPELQRM-KKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVL------------ 602 (679)
Q Consensus 536 ~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~------------ 602 (679)
......||..|+|||.+.+ ..++.++||||+||++|||++|+.||......+ .+..+.+..-.
T Consensus 178 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~--~l~~i~~~~g~~~~~~~~~~~~~ 253 (350)
T d1q5ka_ 178 --PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD--QLVEIIKVLGTPTREQIREMNPN 253 (350)
T ss_dssp --CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH--HHHHHHHHHCCCCHHHHHHHCC-
T ss_pred --ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHH--HHHHHHHHhCCChHHhhhhhccc
Confidence 2345678999999998764 568999999999999999999999996543211 11111111000
Q ss_pred --cccccccchHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH--HHhhC
Q 005749 603 --EETTMEVFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ--LEENR 658 (679)
Q Consensus 603 --~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~--L~~~~ 658 (679)
.............. ...+...+++.+++.+||+.||++|||+.|++++ ++++.
T Consensus 254 ~~~~~~~~~~~~~~~~---~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 310 (350)
T d1q5ka_ 254 YTEFKFPQIKAHPWTK---VFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310 (350)
T ss_dssp --CCCCCCCCCCCGGG---TSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred hhhccccccccCchhh---hcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence 00000000000000 0011223567889999999999999999999975 55554
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5e-43 Score=362.01 Aligned_cols=256 Identities=14% Similarity=0.156 Sum_probs=194.2
Q ss_pred cCccccCCceEEEEEE-eCCCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCCC
Q 005749 382 GQVIEKTTYGTAYKAK-LADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSRT 460 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~gs 460 (679)
.+.||+|+||+||+|+ ..+|+.||||++.... ..+++.+|++++++++|+|+|..++.+....+..++||||+. ++
T Consensus 12 ~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~~-~~ 88 (299)
T d1ckia_ 12 GRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLG-PS 88 (299)
T ss_dssp EEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECCC-CB
T ss_pred eEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEcC-Cc
Confidence 3789999999999999 4679999999987643 345789999999999988877776666554778899999995 57
Q ss_pred hHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeec---CCCceEEeecccccccCcccc-
Q 005749 461 LHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVD---DFFVSRLTEFGLDQLMVPAVA- 536 (679)
Q Consensus 461 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~---~~~~~kl~DFGla~~~~~~~~- 536 (679)
+.+.+... ...+++..++.++.|++.||+|||+++ |+||||||+|||++ .+..+|++|||+|+.+.....
T Consensus 89 l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~ 162 (299)
T d1ckia_ 89 LEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 162 (299)
T ss_dssp HHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTC
T ss_pred hhhhhhhc---cCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceeccccccc
Confidence 77766543 346999999999999999999999998 99999999999875 456799999999997643322
Q ss_pred -----cchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccch
Q 005749 537 -----DEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVFD 611 (679)
Q Consensus 537 -----~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 611 (679)
.......||+.|||||.+.+..++.++|||||||++|||+||+.||......+............. ....
T Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~-----~~~~ 237 (299)
T d1ckia_ 163 QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM-----STPI 237 (299)
T ss_dssp CBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHH-----HSCH
T ss_pred cceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccC-----CCCh
Confidence 123355799999999999999999999999999999999999999965443322211111000000 0000
Q ss_pred HhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhC
Q 005749 612 MEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENR 658 (679)
Q Consensus 612 ~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 658 (679)
+.+.. ...+++.+++.+||+.+|++||+++++.+.|+.+.
T Consensus 238 ~~~~~-------~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~ 277 (299)
T d1ckia_ 238 EVLCK-------GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 277 (299)
T ss_dssp HHHTT-------TSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHH
T ss_pred hHhcc-------CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 00000 11256778999999999999999999999888764
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-43 Score=373.45 Aligned_cols=268 Identities=18% Similarity=0.233 Sum_probs=193.1
Q ss_pred CccccCCceEEEEEE-eCCCCEEEEEEcccCcc-cCcccHHHHHHHHhccCCCCCccceEEeeCCC---CceEEEEEecC
Q 005749 383 QVIEKTTYGTAYKAK-LADGATIALRLLREGSC-KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKR---GEKLLIYDYFP 457 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~---~~~~lv~ey~~ 457 (679)
+.||+|+||+||+|+ ..+|+.||||+++.... ...+.+.+|+++|++++|||||++++++.... ...+++++|+.
T Consensus 14 ~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~~~~ 93 (345)
T d1pmea_ 14 SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLM 93 (345)
T ss_dssp EECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECC
T ss_pred EEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEEEeec
Confidence 789999999999998 56899999999975432 33457899999999999999999999987531 13355567777
Q ss_pred CCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCccccc
Q 005749 458 SRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVAD 537 (679)
Q Consensus 458 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 537 (679)
+|+|.+++.. ..+++..++.++.|++.||+|||+++ ||||||||+|||+++++.+||+|||+|+........
T Consensus 94 ~g~L~~~l~~-----~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~ 165 (345)
T d1pmea_ 94 GADLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 165 (345)
T ss_dssp CEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCB
T ss_pred CCchhhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeeccCCCcc
Confidence 9999999975 24899999999999999999999998 999999999999999999999999999876443222
Q ss_pred --chhcccccccccccccccc-cCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccccc----
Q 005749 538 --EMVALAKADGYKAPELQRM-KKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEVF---- 610 (679)
Q Consensus 538 --~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~---- 610 (679)
......||+.|+|||++.. ..++.++||||+||++|||++|+.||.+....+.....................
T Consensus 166 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (345)
T d1pmea_ 166 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 245 (345)
T ss_dssp CCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHH
T ss_pred ceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhh
Confidence 2345679999999999854 567899999999999999999999996543211111000000000000000000
Q ss_pred ---hHhhhhcCCCChH----HHHHHHHHHHHhccCcCCCCCCCHHHHHHH--HHhhC
Q 005749 611 ---DMEIMKGIRSPME----EGLVQALKLAMGCCAPVASVRPTMDEVVKQ--LEENR 658 (679)
Q Consensus 611 ---~~~i~~~~~~~~~----~~~~~~~~l~~~cl~~dP~~RPs~~evl~~--L~~~~ 658 (679)
..........+.. ....++.+++.+|++.||++|||++|++++ +++..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~ 302 (345)
T d1pmea_ 246 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 302 (345)
T ss_dssp HHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred hcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCC
Confidence 0000000011111 112467899999999999999999999986 44443
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-43 Score=372.63 Aligned_cols=261 Identities=22% Similarity=0.308 Sum_probs=190.0
Q ss_pred CccccCCceEEEEEE-eCCCCEEEEEEcccCcc--cCcccHHHHHHHHhccCCCCCccceEEeeCCC-----CceEEEEE
Q 005749 383 QVIEKTTYGTAYKAK-LADGATIALRLLREGSC--KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKR-----GEKLLIYD 454 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~-----~~~~lv~e 454 (679)
+.||+|+||+||+|+ ..+|+.||||+++.... ...+.+.+|+++|++++|||||+++++|.... .+.++|||
T Consensus 24 ~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e 103 (346)
T d1cm8a_ 24 QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMP 103 (346)
T ss_dssp EEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEE
T ss_pred EEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEEEEEe
Confidence 679999999999999 46799999999975422 23457889999999999999999999997632 25799999
Q ss_pred ecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcc
Q 005749 455 YFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPA 534 (679)
Q Consensus 455 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 534 (679)
|+ +.+|..+.+. ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+|++|||+|+.....
T Consensus 104 ~~-~~~l~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~ 174 (346)
T d1cm8a_ 104 FM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSE 174 (346)
T ss_dssp CC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCSS
T ss_pred cc-cccHHHHHHh-----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccceeccCCc
Confidence 99 5588887764 34999999999999999999999998 999999999999999999999999999876432
Q ss_pred cccchhcccccccccccccccc-cCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhh--cc---cccc
Q 005749 535 VADEMVALAKADGYKAPELQRM-KKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVL--EE---TTME 608 (679)
Q Consensus 535 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~--~~---~~~~ 608 (679)
.....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||.+....+ .+......... .+ ....
T Consensus 175 ----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 248 (346)
T d1cm8a_ 175 ----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD--QLKEIMKVTGTPPAEFVQRLQS 248 (346)
T ss_dssp ----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCCCCHHHHHTCSC
T ss_pred ----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHH--HHHHHHhccCCCcHHHHhhhcc
Confidence 345679999999998875 457899999999999999999999996543211 11111111000 00 0000
Q ss_pred cchHhhhhcC----CC----ChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH--HHhhC
Q 005749 609 VFDMEIMKGI----RS----PMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ--LEENR 658 (679)
Q Consensus 609 ~~~~~i~~~~----~~----~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~--L~~~~ 658 (679)
.......... .. ..+...+.+.+|+.+||..||++|||++|++++ ++++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 249 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp HHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred hhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 0000000000 00 011223567789999999999999999999986 66554
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-43 Score=365.22 Aligned_cols=248 Identities=21% Similarity=0.245 Sum_probs=198.4
Q ss_pred hcCccccCCceEEEEEEe----CCCCEEEEEEcccCc----ccCcccHHHHHHHHhccCC-CCCccceEEeeCCCCceEE
Q 005749 381 TGQVIEKTTYGTAYKAKL----ADGATIALRLLREGS----CKDRSSCLPVIRQLGKVRH-ENLIPLRAFYQGKRGEKLL 451 (679)
Q Consensus 381 ~~~~ig~G~~g~Vy~~~~----~~~~~vAvK~~~~~~----~~~~~~~~~Ei~~l~~l~H-~nIv~l~~~~~~~~~~~~l 451 (679)
..+.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|++++++++| |||+++++++.+ ....++
T Consensus 28 ~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~-~~~~~~ 106 (322)
T d1vzoa_ 28 LLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT-ETKLHL 106 (322)
T ss_dssp EEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE-TTEEEE
T ss_pred EEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc-CCceee
Confidence 347899999999999984 248899999986542 2345678899999999977 899999999987 678999
Q ss_pred EEEecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeeccccccc
Q 005749 452 IYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLM 531 (679)
Q Consensus 452 v~ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 531 (679)
|||||.+|+|.+++... ..++...++.++.|++.||+|+|+.+ |+||||||+|||++.++.+||+|||+++.+
T Consensus 107 v~e~~~~~~L~~~i~~~----~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~~~ 179 (322)
T d1vzoa_ 107 ILDYINGGELFTHLSQR----ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEF 179 (322)
T ss_dssp EECCCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred eeecccccHHHHHHHhc----ccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchhhh
Confidence 99999999999999874 34788899999999999999999988 999999999999999999999999999877
Q ss_pred Ccccccchhccccccccccccccccc--CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhccccccc
Q 005749 532 VPAVADEMVALAKADGYKAPELQRMK--KCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTMEV 609 (679)
Q Consensus 532 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 609 (679)
............|++.|+|||.+.+. .++.++||||+||+||||++|+.||.+....+... ......
T Consensus 180 ~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~--~i~~~~--------- 248 (322)
T d1vzoa_ 180 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQA--EISRRI--------- 248 (322)
T ss_dssp CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHH--HHHHHH---------
T ss_pred cccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHHhc---------
Confidence 55444445567899999999998754 46889999999999999999999996654332111 111111
Q ss_pred chHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCC-----HHHHHH
Q 005749 610 FDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPT-----MDEVVK 652 (679)
Q Consensus 610 ~~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs-----~~evl~ 652 (679)
............+++.+++.+||+.||++||| ++|+++
T Consensus 249 -----~~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 249 -----LKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp -----HHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred -----ccCCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 11111112234567888999999999999994 788876
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.7e-42 Score=354.93 Aligned_cols=256 Identities=15% Similarity=0.142 Sum_probs=200.2
Q ss_pred cCccccCCceEEEEEE-eCCCCEEEEEEcccCcccCcccHHHHHHHHhccCC-CCCccceEEeeCCCCceEEEEEecCCC
Q 005749 382 GQVIEKTTYGTAYKAK-LADGATIALRLLREGSCKDRSSCLPVIRQLGKVRH-ENLIPLRAFYQGKRGEKLLIYDYFPSR 459 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H-~nIv~l~~~~~~~~~~~~lv~ey~~~g 459 (679)
.+.||+|+||+||+|+ ..+|+.||||++.... +.+.+.+|++++..++| +||+.+++++.. ....++||||+ ++
T Consensus 10 ~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~-~~~~~~vme~~-~~ 85 (293)
T d1csna_ 10 GRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQE-GLHNVLVIDLL-GP 85 (293)
T ss_dssp EEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEE-TTEEEEEEECC-CC
T ss_pred EEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeec-CCccEEEEEec-CC
Confidence 4789999999999999 4579999999986532 34678899999999975 899999998887 68899999999 67
Q ss_pred ChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecC-----CCceEEeecccccccCcc
Q 005749 460 TLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDD-----FFVSRLTEFGLDQLMVPA 534 (679)
Q Consensus 460 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~-----~~~~kl~DFGla~~~~~~ 534 (679)
+|.+++... ...+++.++..++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||+|+.+...
T Consensus 86 ~l~~~~~~~---~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~ 159 (293)
T d1csna_ 86 SLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP 159 (293)
T ss_dssp BHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCT
T ss_pred CHHHHHHhh---ccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEEcccC
Confidence 999998764 346899999999999999999999988 999999999999974 578999999999876433
Q ss_pred cc------cchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhcccccc
Q 005749 535 VA------DEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEETTME 608 (679)
Q Consensus 535 ~~------~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 608 (679)
.. .......||+.|||||.+.+..++.++|||||||++|||+||+.||.+............+......
T Consensus 160 ~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~----- 234 (293)
T d1csna_ 160 VTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS----- 234 (293)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH-----
T ss_pred ccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCC-----
Confidence 21 1233457999999999999999999999999999999999999999655443222111111100000
Q ss_pred cchHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHHHHhhCC
Q 005749 609 VFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQLEENRP 659 (679)
Q Consensus 609 ~~~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 659 (679)
...+.+.. . ..+++.+++..|++.+|++||+++.+.+.|+++..
T Consensus 235 ~~~~~l~~----~---~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~ 278 (293)
T d1csna_ 235 TPLRELCA----G---FPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE 278 (293)
T ss_dssp SCHHHHTT----T---SCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred CChHHhcC----C---CCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHH
Confidence 00011111 1 12456788899999999999999999998888653
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-42 Score=355.53 Aligned_cols=260 Identities=18% Similarity=0.210 Sum_probs=197.1
Q ss_pred CccccCCceEEEEEE-eCCCCEEEEEEcccCcc--cCcccHHHHHHHHhccCCCCCccceEEeeCCCCceEEEEEecCCC
Q 005749 383 QVIEKTTYGTAYKAK-LADGATIALRLLREGSC--KDRSSCLPVIRQLGKVRHENLIPLRAFYQGKRGEKLLIYDYFPSR 459 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~~lv~ey~~~g 459 (679)
+.||+|+||+||+|+ ..+|+.||||+++.... ...+.+.+|+.+|++++|||||+++++|.+ ....++|+||+.++
T Consensus 8 ~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~-~~~~~iv~~~~~~~ 86 (292)
T d1unla_ 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS-DKKLTLVFEFCDQD 86 (292)
T ss_dssp EEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEEEEEECCSEE
T ss_pred eEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccccc-ccceeEEeeecccc
Confidence 689999999999999 56799999999965432 234678999999999999999999999998 68899999999999
Q ss_pred ChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcccccch
Q 005749 460 TLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAVADEM 539 (679)
Q Consensus 460 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 539 (679)
++..++.. ...+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||.++....... ..
T Consensus 87 ~l~~~~~~----~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~-~~ 158 (292)
T d1unla_ 87 LKKYFDSC----NGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-CY 158 (292)
T ss_dssp HHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS-CC
T ss_pred cccccccc----ccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCCc-cc
Confidence 99888765 345889999999999999999999988 99999999999999999999999999987644322 22
Q ss_pred hcccccccccccccccccC-CCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhccc--ccccchHh---
Q 005749 540 VALAKADGYKAPELQRMKK-CSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLEET--TMEVFDME--- 613 (679)
Q Consensus 540 ~~~~gt~~y~aPE~~~~~~-~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~~~--~~~~~~~~--- 613 (679)
....++..|+|||.+.... ++.++||||+||++|||++|+.||...... .+....+........ ........
T Consensus 159 ~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (292)
T d1unla_ 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV--DDQLKRIFRLLGTPTEEQWPSMTKLPDY 236 (292)
T ss_dssp CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSH--HHHHHHHHHHHCCCCTTTCTTGGGSTTC
T ss_pred eeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCH--HHHHHHHHhhcCCCChhhhhhhhhcccc
Confidence 3445778899999887655 689999999999999999999997543321 111111111111000 00000000
Q ss_pred -------hhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 614 -------IMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 614 -------i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
.........+...+.+.+++.+|++.||++|||++|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred cccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000001112223567789999999999999999999864
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.5e-41 Score=355.72 Aligned_cols=255 Identities=19% Similarity=0.256 Sum_probs=191.3
Q ss_pred cCccccCCceEEEEEEe-CCCCEEEEEEcccCcccCcccHHHHHHHHhccC-CCCCccceEEeeCC-CCceEEEEEecCC
Q 005749 382 GQVIEKTTYGTAYKAKL-ADGATIALRLLREGSCKDRSSCLPVIRQLGKVR-HENLIPLRAFYQGK-RGEKLLIYDYFPS 458 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~~~~~~~-~~~~~lv~ey~~~ 458 (679)
.+.||+|+||+||+|+. .+|+.||||+++.. ..+.+.+|+++|.+++ ||||+++++++... ....++|||||.+
T Consensus 40 ~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~ 116 (328)
T d3bqca1 40 VRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNN 116 (328)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECCCS
T ss_pred EEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeecCC
Confidence 37899999999999994 67999999998753 3567899999999995 99999999998753 4568999999999
Q ss_pred CChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCC-ceEEeecccccccCccccc
Q 005749 459 RTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFF-VSRLTEFGLDQLMVPAVAD 537 (679)
Q Consensus 459 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~-~~kl~DFGla~~~~~~~~~ 537 (679)
++|..+.+ .+++..++.++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+|+......
T Consensus 117 ~~L~~~~~-------~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~-- 184 (328)
T d3bqca1 117 TDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ-- 184 (328)
T ss_dssp CBGGGTTT-------SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC--
T ss_pred CcHHHHhc-------CCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccCCC--
Confidence 99977642 4899999999999999999999998 99999999999998654 68999999998764332
Q ss_pred chhccccccccccccccccc-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHH--------hhc--ccc
Q 005749 538 EMVALAKADGYKAPELQRMK-KCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVA--------VLE--ETT 606 (679)
Q Consensus 538 ~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~--------~~~--~~~ 606 (679)
......+|+.|+|||.+.+. .++.++||||+||++|||++|+.||...... ........... ... ...
T Consensus 185 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~-~~~~~~i~~~~g~~~~~~~~~~~~~~~ 263 (328)
T d3bqca1 185 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN-YDQLVRIAKVLGTEDLYDYIDKYNIEL 263 (328)
T ss_dssp CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH-HHHHHHHHHHHCHHHHHHHHHHTTCCC
T ss_pred cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchh-HHHHHHHHHHHCCchhhhhhhhccccc
Confidence 23456789999999998765 4799999999999999999999999544321 11111111000 000 000
Q ss_pred cccchHhh--------hhcCC-CChHHHHHHHHHHHHhccCcCCCCCCCHHHHHH
Q 005749 607 MEVFDMEI--------MKGIR-SPMEEGLVQALKLAMGCCAPVASVRPTMDEVVK 652 (679)
Q Consensus 607 ~~~~~~~i--------~~~~~-~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~ 652 (679)
...+.... ..... .......+++.+++.+||..||++|||++|+++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 264 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp CGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000000 00000 011122356789999999999999999999986
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-42 Score=362.33 Aligned_cols=257 Identities=16% Similarity=0.188 Sum_probs=184.4
Q ss_pred CccccCCceEEEEEEe-CCCCEEEEEEcccCcc--cCcccHHHHHHHHhccCCCCCccceEEeeCC-----CCceEEEEE
Q 005749 383 QVIEKTTYGTAYKAKL-ADGATIALRLLREGSC--KDRSSCLPVIRQLGKVRHENLIPLRAFYQGK-----RGEKLLIYD 454 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~-----~~~~~lv~e 454 (679)
++||+|+||+||+|+. .+|+.||||+++.... ...+.+.+|+.++++++|||||+++++|... ....|+|||
T Consensus 23 ~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~E 102 (355)
T d2b1pa1 23 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVME 102 (355)
T ss_dssp EECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEE
T ss_pred EEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEEEEe
Confidence 6899999999999994 5799999999975432 2345688999999999999999999998642 357899999
Q ss_pred ecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCcc
Q 005749 455 YFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPA 534 (679)
Q Consensus 455 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 534 (679)
||.++ +.+.+. ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+|++|||+++.....
T Consensus 103 y~~~~-l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~ 172 (355)
T d2b1pa1 103 LMDAN-LCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 172 (355)
T ss_dssp CCSEE-HHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred ccchH-HHHhhh------cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhhccccc
Confidence 99765 444443 24899999999999999999999998 999999999999999999999999998865432
Q ss_pred cccchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHH--------------
Q 005749 535 VADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVA-------------- 600 (679)
Q Consensus 535 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~-------------- 600 (679)
.......+|+.|+|||++.+..+++++||||+||+++||++|+.||.+..... .+.......
T Consensus 173 --~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~--~~~~i~~~~~~~~~~~~~~~~~~ 248 (355)
T d2b1pa1 173 --FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID--QWNKVIEQLGTPCPEFMKKLQPT 248 (355)
T ss_dssp ----------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCCCCHHHHTTSCHH
T ss_pred --cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHH--HHHHHHHhccCCCHHHHHHhhhh
Confidence 23345678999999999999999999999999999999999999996543211 111111000
Q ss_pred ----hhccc-c-----cccchHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 601 ----VLEET-T-----MEVFDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 601 ----~~~~~-~-----~~~~~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
..... . ...+.................++.+++.+|++.||++|||++|++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00000 0 00000000111111122345678899999999999999999999876
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-41 Score=358.64 Aligned_cols=271 Identities=17% Similarity=0.230 Sum_probs=195.2
Q ss_pred CccccCCceEEEEEE-eCCCCEEEEEEcccCcc--cCcccHHHHHHHHhccCCCCCccceEEeeCC----CCceEEEEEe
Q 005749 383 QVIEKTTYGTAYKAK-LADGATIALRLLREGSC--KDRSSCLPVIRQLGKVRHENLIPLRAFYQGK----RGEKLLIYDY 455 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~----~~~~~lv~ey 455 (679)
+.||+|+||+||+|+ ..+|+.||||+++.... ...+.+.+|+++|++++|||||++++++... ....+++++|
T Consensus 24 ~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~~ 103 (348)
T d2gfsa1 24 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTH 103 (348)
T ss_dssp EECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEEEEE
T ss_pred EEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEEEEEe
Confidence 689999999999999 56799999999976432 2345688999999999999999999998642 2345677788
Q ss_pred cCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceEEeecccccccCccc
Q 005749 456 FPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSRLTEFGLDQLMVPAV 535 (679)
Q Consensus 456 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 535 (679)
+.+|+|.+++.. ..+++..++.|+.||+.||+|||+++ |+||||||+|||++.++.+|++|||++.....
T Consensus 104 ~~gg~L~~~~~~-----~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~-- 173 (348)
T d2gfsa1 104 LMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDD-- 173 (348)
T ss_dssp CCSEEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----CCTG--
T ss_pred ecCCchhhhccc-----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhcccCc--
Confidence 889999999964 34999999999999999999999998 99999999999999999999999999976532
Q ss_pred ccchhccccccccccccccccc-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccchhHHHHHHhhc--cc---cccc
Q 005749 536 ADEMVALAKADGYKAPELQRMK-KCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVDLPSIVKVAVLE--ET---TMEV 609 (679)
Q Consensus 536 ~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~l~~~~~~~~~~--~~---~~~~ 609 (679)
......|++.|+|||...+. .++.++||||+||++|||++|+.||.+.+.... ........... +. ....
T Consensus 174 --~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~--~~~i~~~~~~~~~~~~~~~~~~ 249 (348)
T d2gfsa1 174 --EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ--LKLILRLVGTPGAELLKKISSE 249 (348)
T ss_dssp --GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCCCCHHHHTTCCCH
T ss_pred --ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHH--HHHHHHhcCCCChHHhhhccch
Confidence 23456789999999987665 468999999999999999999999965432111 11111110000 00 0000
Q ss_pred chHhhhh----cCCCChH----HHHHHHHHHHHhccCcCCCCCCCHHHHHHH--HHhhCCCCCCCCCC
Q 005749 610 FDMEIMK----GIRSPME----EGLVQALKLAMGCCAPVASVRPTMDEVVKQ--LEENRPRNRSALYS 667 (679)
Q Consensus 610 ~~~~i~~----~~~~~~~----~~~~~~~~l~~~cl~~dP~~RPs~~evl~~--L~~~~~~~~~~~~~ 667 (679)
....... ....... ...+++.+++.+|++.||++|||++|++++ +++........+..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~~~~~~~~ 317 (348)
T d2gfsa1 250 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVAD 317 (348)
T ss_dssp HHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSCCCCC
T ss_pred hhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCCccCCCCC
Confidence 0000000 0000000 123567789999999999999999999984 55554444333333
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.1e-37 Score=330.63 Aligned_cols=270 Identities=13% Similarity=0.166 Sum_probs=190.8
Q ss_pred cCccccCCceEEEEEE-eCCCCEEEEEEcccCcccCcccHHHHHHHHhccC-----------CCCCccceEEeeCC-CCc
Q 005749 382 GQVIEKTTYGTAYKAK-LADGATIALRLLREGSCKDRSSCLPVIRQLGKVR-----------HENLIPLRAFYQGK-RGE 448 (679)
Q Consensus 382 ~~~ig~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~-----------H~nIv~l~~~~~~~-~~~ 448 (679)
.+.||+|+||+||+|+ ..+|+.||||+++.... ..+.+.+|++++++++ |+|||++++++... ...
T Consensus 18 ~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~~~ 96 (362)
T d1q8ya_ 18 VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNG 96 (362)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTE
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeeccccc
Confidence 4789999999999999 46799999999976422 2356788999988875 57899999887642 345
Q ss_pred eEEEEEecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeeecCCCCCCeeecCCC------ceE
Q 005749 449 KLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHT-GHEIPITHGNVRSKNVLVDDFF------VSR 521 (679)
Q Consensus 449 ~~lv~ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~-~~~~~ivHrDlkp~NILl~~~~------~~k 521 (679)
.+++++++..+.......... ....+++..++.++.||+.||+|||+ .+ |+||||||+|||++.++ .+|
T Consensus 97 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~~~~k 172 (362)
T d1q8ya_ 97 VHVVMVFEVLGENLLALIKKY-EHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENLIQIK 172 (362)
T ss_dssp EEEEEEECCCCEEHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTEEEEE
T ss_pred eeeeeeecccccccccccccc-cccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCcccccceee
Confidence 677777776654433332222 24568899999999999999999997 66 99999999999998664 489
Q ss_pred EeecccccccCcccccchhcccccccccccccccccCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCcccc----hhHHH
Q 005749 522 LTEFGLDQLMVPAVADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGILLLEILIGKKPGKSGRNGEFVD----LPSIV 597 (679)
Q Consensus 522 l~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvvl~El~tg~~p~~~~~~~~~~~----l~~~~ 597 (679)
++|||.+..... ......||+.|+|||++....++.++||||+||+++||++|+.||.......... +...+
T Consensus 173 l~dfg~s~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~ 248 (362)
T d1q8ya_ 173 IADLGNACWYDE----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQII 248 (362)
T ss_dssp ECCCTTCEETTB----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHH
T ss_pred Eeeccccccccc----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHH
Confidence 999999886532 2245679999999999999999999999999999999999999996543322111 11111
Q ss_pred HHHhh-------c-cccccc----------------chHhhhhcCCCChHHHHHHHHHHHHhccCcCCCCCCCHHHHHHH
Q 005749 598 KVAVL-------E-ETTMEV----------------FDMEIMKGIRSPMEEGLVQALKLAMGCCAPVASVRPTMDEVVKQ 653 (679)
Q Consensus 598 ~~~~~-------~-~~~~~~----------------~~~~i~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~ 653 (679)
...-. . ...... .............+...+++.+++.+|++.||++|||++|++++
T Consensus 249 ~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~H 328 (362)
T d1q8ya_ 249 ELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNH 328 (362)
T ss_dssp HHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTC
T ss_pred HHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 11000 0 000000 00011111122345667788999999999999999999999986
Q ss_pred --HHhhCCC
Q 005749 654 --LEENRPR 660 (679)
Q Consensus 654 --L~~~~~~ 660 (679)
+++....
T Consensus 329 p~f~~~~~~ 337 (362)
T d1q8ya_ 329 PWLKDTLGM 337 (362)
T ss_dssp GGGTTCTTC
T ss_pred cccCCCCCc
Confidence 5555433
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=1.3e-33 Score=293.00 Aligned_cols=257 Identities=30% Similarity=0.483 Sum_probs=180.8
Q ss_pred CChHHHHHHHHHHHhhCCCCCCcccCCCCCCCCCCcc--cccceeecCCCC--C--cccCCCCCCccccccccCCCCccE
Q 005749 28 SASSDVELLLGKIKSSLQGDDENLLLSSWNISVPLCQ--WRGLKWISTNGS--P--LSCSDISLPQWANLSLYKDSSIHL 101 (679)
Q Consensus 28 ~~~~~~~~ll~~~k~~~~~~~~~~~l~~W~~~~~~C~--w~Gv~c~~~~~~--~--l~c~~~~~~~~~~l~~~~~~~~~l 101 (679)
|.++|++||+ +||+++.+ + ..+++|..++|||. |.||+|+..++. + ++-+.........+........+|
T Consensus 3 c~~~e~~aLl-~~k~~~~~--~-~~l~sW~~~~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L 78 (313)
T d1ogqa_ 3 CNPQDKQALL-QIKKDLGN--P-TTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYL 78 (313)
T ss_dssp SCHHHHHHHH-HHHHHTTC--C-GGGTTCCTTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTC
T ss_pred CCHHHHHHHH-HHHHHCCC--C-CcCCCCCCCCCCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCChHHhcCccc
Confidence 5678999999 99999976 3 36999998899995 999998765442 1 111111111000111111222356
Q ss_pred EEEEcCC-CCCcccCCccccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEEcc
Q 005749 102 LSIQLPS-ANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLH 180 (679)
Q Consensus 102 ~~l~l~~-n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls 180 (679)
+.|+|++ |+++|.||++|++|++|++|+|++|+|.|..|..+..+.+|+++++++|.+.+.+|..+..+ +.|+.++++
T Consensus 79 ~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l-~~L~~l~l~ 157 (313)
T d1ogqa_ 79 NFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSL-PNLVGITFD 157 (313)
T ss_dssp SEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGC-TTCCEEECC
T ss_pred cccccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccC-cccceeecc
Confidence 6666665 56666666666666666666666666666666656666666666666666666666666654 778888888
Q ss_pred CCCCcccCCCCCC-------------------------------------------C--CCCCCCccEEEccCccccccc
Q 005749 181 GNSLTAALPEPAL-------------------------------------------P--NSTCSDLQYLDLGSNKFSGSF 215 (679)
Q Consensus 181 ~N~l~~~~p~~~~-------------------------------------------~--~~~~~~L~~L~l~~N~l~g~~ 215 (679)
+|.++|.+|.... + ...+++|+.+++++|.+++.+
T Consensus 158 ~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~ 237 (313)
T d1ogqa_ 158 GNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDL 237 (313)
T ss_dssp SSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBG
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 8888877775210 0 012457888999999998776
Q ss_pred cccccCCCCCCEEEccCCcccccCCcccccc-ccCEEEccCCcCCCCCCCccc-CCCCcccccCCCCCCCCCCCCCCC
Q 005749 216 PEFVTRFEALKELDISNNLFSGSIPEGLTRL-SLEKLNLSHNNFSGVLPVFSE-SKFGAEVFEGNSPALCGFPLRDCS 291 (679)
Q Consensus 216 p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l-~L~~l~ls~N~l~g~ip~~~~-~~~~~~~~~~n~~~~c~~p~~~c~ 291 (679)
| .++.+++|+.|+|++|+|+|.+|+.++.+ +|+.|+|++|+|+|.||.... ..+....+.|| +.+||.|++.|+
T Consensus 238 ~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l~~N-~~l~g~plp~c~ 313 (313)
T d1ogqa_ 238 G-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANN-KCLCGSPLPACT 313 (313)
T ss_dssp G-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSS-SEEESTTSSCCC
T ss_pred c-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCcccCCCCCHHHhCCC-ccccCCCCCCCC
Confidence 5 58889999999999999999999999988 699999999999999997542 34455567777 789999998884
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.88 E-value=1.3e-23 Score=200.63 Aligned_cols=168 Identities=13% Similarity=0.113 Sum_probs=119.3
Q ss_pred hhcCccccCCceEEEEEEeCCCCEEEEEEcccCccc-----C-------------cccHHHHHHHHhccCCCCCccceEE
Q 005749 380 ATGQVIEKTTYGTAYKAKLADGATIALRLLREGSCK-----D-------------RSSCLPVIRQLGKVRHENLIPLRAF 441 (679)
Q Consensus 380 ~~~~~ig~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~-----~-------------~~~~~~Ei~~l~~l~H~nIv~l~~~ 441 (679)
+.++.||+|+||+||+|+..+|+.||||+++..... . ...+.+|...+.+++|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 457899999999999999889999999987643110 0 1123567888999999999988764
Q ss_pred eeCCCCceEEEEEecCCCChHHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCceE
Q 005749 442 YQGKRGEKLLIYDYFPSRTLHDLLHDTIAGKPVLNWARRHKIALGIARGLAYLHTGHEIPITHGNVRSKNVLVDDFFVSR 521 (679)
Q Consensus 442 ~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~k 521 (679)
. ..+++|||++++.+.+ ++......++.|+++||+|||+++ |+||||||+|||++++ .++
T Consensus 83 ~-----~~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~ 142 (191)
T d1zara2 83 E-----GNAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIW 142 (191)
T ss_dssp E-----TTEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEE
T ss_pred c-----CCEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEE
Confidence 2 2379999998865433 233445689999999999999988 9999999999999975 589
Q ss_pred EeecccccccCcccccchhcccccccccccccccccCCCCcchhHHHHHH
Q 005749 522 LTEFGLDQLMVPAVADEMVALAKADGYKAPELQRMKKCSSRTDVYAFGIL 571 (679)
Q Consensus 522 l~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gvv 571 (679)
++|||+|............. ..... -.|.+ .+.|+.++||||..--
T Consensus 143 liDFG~a~~~~~~~~~~~l~--rd~~~-~~~~f-~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 143 IIDFPQSVEVGEEGWREILE--RDVRN-IITYF-SRTYRTEKDINSAIDR 188 (191)
T ss_dssp ECCCTTCEETTSTTHHHHHH--HHHHH-HHHHH-HHHHCCCCCHHHHHHH
T ss_pred EEECCCcccCCCCCcHHHHH--HHHHH-HHHHH-cCCCCCcccHHHHHHH
Confidence 99999997654332211100 00000 01111 2567889999996543
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.83 E-value=4.6e-21 Score=197.55 Aligned_cols=188 Identities=24% Similarity=0.405 Sum_probs=160.5
Q ss_pred cccc-cceeecCCCCCcccCCCCCCccccccccCCCCccEEEEEcCCCCCcc--cCCccccCCCCCCeeeccc-Cccccc
Q 005749 63 CQWR-GLKWISTNGSPLSCSDISLPQWANLSLYKDSSIHLLSIQLPSANLTG--SLPRELGEFSMLQSLYLNV-NSLKGT 138 (679)
Q Consensus 63 C~w~-Gv~c~~~~~~~l~c~~~~~~~~~~l~~~~~~~~~l~~l~l~~n~l~g--~ip~~l~~l~~L~~L~L~~-N~l~g~ 138 (679)
=+|. |..|...+..-+.|+.... ..+|+.|+|++|+++| +||++|++|++|++|+|++ |+|+|.
T Consensus 25 ~sW~~~~d~C~~~w~gv~C~~~~~------------~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~ 92 (313)
T d1ogqa_ 25 SSWLPTTDCCNRTWLGVLCDTDTQ------------TYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGP 92 (313)
T ss_dssp TTCCTTSCTTTTCSTTEEECCSSS------------CCCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESC
T ss_pred CCCCCCCCCCCCcCCCeEEeCCCC------------cEEEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccc
Confidence 4584 5555433334455654321 1369999999999998 6899999999999999996 899999
Q ss_pred CCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEEccCCCCcccCCCCCCCCCCCCCccEEEccCcccccccccc
Q 005749 139 IPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEF 218 (679)
Q Consensus 139 ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~l~~N~l~g~~p~~ 218 (679)
+|.+++++++|++|||++|++.+..+..+... .+|+.+++++|++.+.+|... ..+++|+++++++|.++|.+|..
T Consensus 93 iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~-~~L~~l~l~~N~~~~~~p~~l---~~l~~L~~l~l~~n~l~~~ip~~ 168 (313)
T d1ogqa_ 93 IPPAIAKLTQLHYLYITHTNVSGAIPDFLSQI-KTLVTLDFSYNALSGTLPPSI---SSLPNLVGITFDGNRISGAIPDS 168 (313)
T ss_dssp CCGGGGGCTTCSEEEEEEECCEEECCGGGGGC-TTCCEEECCSSEEESCCCGGG---GGCTTCCEEECCSSCCEEECCGG
T ss_pred cccccccccccchhhhccccccccccccccch-hhhcccccccccccccCchhh---ccCcccceeeccccccccccccc
Confidence 99999999999999999999999877666664 899999999999999888654 56789999999999999999999
Q ss_pred ccCCCCC-CEEEccCCcccccCCccccccccCEEEccCCcCCCCCCCcc
Q 005749 219 VTRFEAL-KELDISNNLFSGSIPEGLTRLSLEKLNLSHNNFSGVLPVFS 266 (679)
Q Consensus 219 ~~~l~~L-~~L~ls~N~l~g~~p~~~~~l~L~~l~ls~N~l~g~ip~~~ 266 (679)
+..+..+ +.+++++|+++|..|..+..+....+++++|.+.|.+|...
T Consensus 169 ~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~~l~l~~~~~~~~~~~~~ 217 (313)
T d1ogqa_ 169 YGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLF 217 (313)
T ss_dssp GGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEECCSSEEEECCGGGC
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 9998886 89999999999999999998888899999999999998764
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.77 E-value=3.6e-18 Score=171.29 Aligned_cols=177 Identities=23% Similarity=0.215 Sum_probs=145.3
Q ss_pred cEEEEEcCCCCCcccCCccccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEEc
Q 005749 100 HLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRL 179 (679)
Q Consensus 100 ~l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~L 179 (679)
+++.|+|++|++++.-+..|.++++|++|+|++|+|+ .+|. ++.+++|++|+|++|++++. ++.+.. +++|+.|++
T Consensus 32 ~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~~-~~~l~~L~~L~Ls~N~l~~~-~~~~~~-l~~L~~L~l 107 (266)
T d1p9ag_ 32 DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQV-DGTLPVLGTLDLSHNQLQSL-PLLGQT-LPALTVLDV 107 (266)
T ss_dssp TCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEEC-CSCCTTCCEEECCSSCCSSC-CCCTTT-CTTCCEEEC
T ss_pred CCCEEECcCCcCCCcCHHHhhcccccccccccccccc-cccc-cccccccccccccccccccc-cccccc-ccccccccc
Confidence 5889999999999766678999999999999999998 5664 57899999999999999864 444545 489999999
Q ss_pred cCCCCcccCCCCCCCCCCCCCccEEEccCccccccccccccCCCCCCEEEccCCcccccCCcccccc-ccCEEEccCCcC
Q 005749 180 HGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRL-SLEKLNLSHNNF 258 (679)
Q Consensus 180 s~N~l~~~~p~~~~~~~~~~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l-~L~~l~ls~N~l 258 (679)
++|.+.+..+... ..+.++++|++++|.+++..+..+..+++|+.|++++|+|++..|..+..+ +|+.|+|++|+|
T Consensus 108 ~~~~~~~~~~~~~---~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L 184 (266)
T d1p9ag_ 108 SFNRLTSLPLGAL---RGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSL 184 (266)
T ss_dssp CSSCCCCCCSSTT---TTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCC
T ss_pred cccccceeecccc---ccccccccccccccccceeccccccccccchhcccccccccccCccccccccccceeecccCCC
Confidence 9999987544332 457899999999999997777788889999999999999998777878877 699999999999
Q ss_pred CCCCCCcccC--CCCcccccCCCCCCCCC
Q 005749 259 SGVLPVFSES--KFGAEVFEGNSPALCGF 285 (679)
Q Consensus 259 ~g~ip~~~~~--~~~~~~~~~n~~~~c~~ 285 (679)
+ .||..... ......+.|| |+.|.+
T Consensus 185 ~-~lp~~~~~~~~L~~L~L~~N-p~~CdC 211 (266)
T d1p9ag_ 185 Y-TIPKGFFGSHLLPFAFLHGN-PWLCNC 211 (266)
T ss_dssp C-CCCTTTTTTCCCSEEECCSC-CBCCSG
T ss_pred c-ccChhHCCCCCCCEEEecCC-CCCCCc
Confidence 9 77764432 2233345566 888864
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.73 E-value=2.5e-17 Score=166.73 Aligned_cols=205 Identities=19% Similarity=0.163 Sum_probs=144.1
Q ss_pred eecCCCCCcccCCCCCCccccccccCCCCccEEEEEcCCCCCcccCCccccCCCCCCeeecccCcccccC----------
Q 005749 70 WISTNGSPLSCSDISLPQWANLSLYKDSSIHLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTI---------- 139 (679)
Q Consensus 70 c~~~~~~~l~c~~~~~~~~~~l~~~~~~~~~l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~i---------- 139 (679)
|...+...+.|++.+...+ .... ...++.|+|++|++++.-+..|.++++|++|++++|.|.+..
T Consensus 8 C~~~~~~~v~c~~~~L~~i---P~~i--p~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~ 82 (284)
T d1ozna_ 8 CYNEPKVTTSCPQQGLQAV---PVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82 (284)
T ss_dssp EECSSSCEEECCSSCCSSC---CTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTC
T ss_pred EcCCCCeEEEcCCCCCCcc---CCCC--CCCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccc
Confidence 4444444556765443322 1111 124788999999998555557999999999999999876432
Q ss_pred ---------------CcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEEccCCCCcccCCCCCCCCCCCCCccEE
Q 005749 140 ---------------PFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYL 204 (679)
Q Consensus 140 ---------------p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L 204 (679)
|..+.++++|++|+|++|.+.+..+. .+...++|+.+++++|+|++..+. .+ ..+++|+.|
T Consensus 83 ~~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~-~~~~~~~L~~l~l~~N~l~~i~~~-~f--~~~~~L~~L 158 (284)
T d1ozna_ 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPG-LFRGLAALQYLYLQDNALQALPDD-TF--RDLGNLTHL 158 (284)
T ss_dssp CEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTT-TTTTCTTCCEEECCSSCCCCCCTT-TT--TTCTTCCEE
T ss_pred cccccccccccccccchhhcccccCCEEecCCccccccccc-ccchhcccchhhhccccccccChh-Hh--ccccchhhc
Confidence 34556677888888888888754433 334447888888888888864433 32 356789999
Q ss_pred EccCccccccccccccCCCCCCEEEccCCcccccCCcccccc-ccCEEEccCCcCCCCCCCccc--CCCCcccccCCCCC
Q 005749 205 DLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRL-SLEKLNLSHNNFSGVLPVFSE--SKFGAEVFEGNSPA 281 (679)
Q Consensus 205 ~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l-~L~~l~ls~N~l~g~ip~~~~--~~~~~~~~~~n~~~ 281 (679)
++++|+|++..|..|..+++|+.+++++|++++..|..+..+ +|+.|++++|.+++..|.... .......+.+| +.
T Consensus 159 ~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N-~l 237 (284)
T d1ozna_ 159 FLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDN-PW 237 (284)
T ss_dssp ECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSS-CE
T ss_pred ccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCC-CC
Confidence 999999987778888889999999999999998888888877 689999999999887665432 12223334455 66
Q ss_pred CCC
Q 005749 282 LCG 284 (679)
Q Consensus 282 ~c~ 284 (679)
.|.
T Consensus 238 ~C~ 240 (284)
T d1ozna_ 238 VCD 240 (284)
T ss_dssp ECS
T ss_pred CCC
Confidence 664
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.67 E-value=2.6e-16 Score=157.46 Aligned_cols=155 Identities=26% Similarity=0.312 Sum_probs=132.6
Q ss_pred CccEEEEEcCCCCCcccCCccccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEE
Q 005749 98 SIHLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSL 177 (679)
Q Consensus 98 ~~~l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L 177 (679)
..+|+.|+|++|+++ .+| .++.+++|++|+|++|+|+ .+|..+..+++|+.|++++|.+.+..+..+ ..+.+|+.|
T Consensus 54 l~~L~~L~L~~N~l~-~l~-~~~~l~~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~-~~l~~l~~L 129 (266)
T d1p9ag_ 54 YTRLTQLNLDRAELT-KLQ-VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGAL-RGLGELQEL 129 (266)
T ss_dssp CTTCCEEECTTSCCC-EEE-CCSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTT-TTCTTCCEE
T ss_pred ccccccccccccccc-ccc-ccccccccccccccccccc-ccccccccccccccccccccccceeecccc-ccccccccc
Confidence 457999999999997 455 4688999999999999998 467788999999999999999987554444 445899999
Q ss_pred EccCCCCcccCCCCCCCCCCCCCccEEEccCccccccccccccCCCCCCEEEccCCcccccCCcccccc-ccCEEEccCC
Q 005749 178 RLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRL-SLEKLNLSHN 256 (679)
Q Consensus 178 ~Ls~N~l~~~~p~~~~~~~~~~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l-~L~~l~ls~N 256 (679)
++++|.++...+. .+ ..+++|++|++++|+|++..+..|..+++|++|+|++|+|+ .+|..+..+ +|+.|+|++|
T Consensus 130 ~l~~n~l~~l~~~-~~--~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~N 205 (266)
T d1p9ag_ 130 YLKGNELKTLPPG-LL--TPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205 (266)
T ss_dssp ECTTSCCCCCCTT-TT--TTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSC
T ss_pred cccccccceeccc-cc--cccccchhcccccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCC
Confidence 9999999965443 32 45789999999999999888888999999999999999999 888887776 6999999999
Q ss_pred cCCC
Q 005749 257 NFSG 260 (679)
Q Consensus 257 ~l~g 260 (679)
.+.-
T Consensus 206 p~~C 209 (266)
T d1p9ag_ 206 PWLC 209 (266)
T ss_dssp CBCC
T ss_pred CCCC
Confidence 8864
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.64 E-value=2.6e-16 Score=149.38 Aligned_cols=155 Identities=20% Similarity=0.225 Sum_probs=110.0
Q ss_pred EEcCCCCCcccCCccccCCCCCCeeecccCcccccCC-cccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEEccCC
Q 005749 104 IQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIP-FELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGN 182 (679)
Q Consensus 104 l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip-~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N 182 (679)
++.++++|+ .||..+. +++++|+|++|.|++.++ ..+..+++|++|+|++|.+.+..+..+... ++|+.|+|++|
T Consensus 13 v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~-~~L~~L~Ls~N 88 (192)
T d1w8aa_ 13 VDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGA-SHIQELQLGEN 88 (192)
T ss_dssp EECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTC-TTCCEEECCSC
T ss_pred EEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccc-cccceeeeccc
Confidence 344556666 6776653 678888888888876554 446778888888888888887665555444 78888888888
Q ss_pred CCcccCCCCCCCCCCCCCccEEEccCccccccccccccCCCCCCEEEccCCcccccCCccccccccCEEEccCCcCCCCC
Q 005749 183 SLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRLSLEKLNLSHNNFSGVL 262 (679)
Q Consensus 183 ~l~~~~p~~~~~~~~~~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~L~~l~ls~N~l~g~i 262 (679)
+|+...|.. + ..+++|++|+|++|+|++..|..|..+++|++|+|++|.+....+.......++.+.+..|.++...
T Consensus 89 ~l~~l~~~~-F--~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~~~~~l~~~~l~~~~~~c~~ 165 (192)
T d1w8aa_ 89 KIKEISNKM-F--LGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGA 165 (192)
T ss_dssp CCCEECSSS-S--TTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCS
T ss_pred cccccCHHH-H--hCCCcccccccCCccccccCHHHhcCCcccccccccccccccccchHHHhhhhhhhcccCCCeEeCC
Confidence 888655543 2 4677888899999988877777888888899999998888754332211112555566777777666
Q ss_pred CCc
Q 005749 263 PVF 265 (679)
Q Consensus 263 p~~ 265 (679)
|..
T Consensus 166 p~~ 168 (192)
T d1w8aa_ 166 PSK 168 (192)
T ss_dssp STT
T ss_pred Chh
Confidence 643
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.64 E-value=5.5e-16 Score=147.09 Aligned_cols=133 Identities=27% Similarity=0.340 Sum_probs=115.4
Q ss_pred CCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEEccCCCCcccCCCCCCCCCCCCCccEE
Q 005749 125 LQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYL 204 (679)
Q Consensus 125 L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L 204 (679)
.++++.++|+|+ .||..+. +++++|+|++|+|++.+++..+..+++|+.|+|++|++++.++..+ ..+++|++|
T Consensus 10 ~~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~---~~~~~L~~L 83 (192)
T d1w8aa_ 10 GTTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAF---EGASHIQEL 83 (192)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTT---TTCTTCCEE
T ss_pred CCEEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeecccccccccccccc---cccccccee
Confidence 357999999999 8998774 7899999999999987767666666999999999999998766543 457899999
Q ss_pred EccCccccccccccccCCCCCCEEEccCCcccccCCcccccc-ccCEEEccCCcCCCCCC
Q 005749 205 DLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRL-SLEKLNLSHNNFSGVLP 263 (679)
Q Consensus 205 ~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l-~L~~l~ls~N~l~g~ip 263 (679)
+|++|+|++..|..|.++++|++|+|++|+|++..|..+..+ +|++|+|++|.+....+
T Consensus 84 ~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~ 143 (192)
T d1w8aa_ 84 QLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH 143 (192)
T ss_dssp ECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred eeccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccc
Confidence 999999998778889999999999999999998778888777 69999999999886544
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.61 E-value=1.4e-15 Score=153.57 Aligned_cols=160 Identities=22% Similarity=0.225 Sum_probs=133.1
Q ss_pred cEEEEEcCCCC-CcccCCccccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEE
Q 005749 100 HLLSIQLPSAN-LTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLR 178 (679)
Q Consensus 100 ~l~~l~l~~n~-l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~ 178 (679)
.+..+....++ +....|..+.++++|++|+|++|.+.+..+..+..+.+|+.+++++|+|++. |+..+..+++|+.|+
T Consensus 81 ~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i-~~~~f~~~~~L~~L~ 159 (284)
T d1ozna_ 81 LLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQAL-PDDTFRDLGNLTHLF 159 (284)
T ss_dssp TCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCC-CTTTTTTCTTCCEEE
T ss_pred cccccccccccccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhcccccccc-ChhHhccccchhhcc
Confidence 34555554444 4444466799999999999999999877777788899999999999999965 445455558999999
Q ss_pred ccCCCCcccCCCCCCCCCCCCCccEEEccCccccccccccccCCCCCCEEEccCCcccccCCcccccc-ccCEEEccCCc
Q 005749 179 LHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRL-SLEKLNLSHNN 257 (679)
Q Consensus 179 Ls~N~l~~~~p~~~~~~~~~~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l-~L~~l~ls~N~ 257 (679)
|++|+|++..+. .+ ..+++|+++++++|++++..|..|..+++|++||+++|++++..|..+..+ +|+.|+|++|.
T Consensus 160 l~~N~l~~l~~~-~f--~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~ 236 (284)
T d1ozna_ 160 LHGNRISSVPER-AF--RGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNP 236 (284)
T ss_dssp CCSSCCCEECTT-TT--TTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSC
T ss_pred cccCcccccchh-hh--ccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCC
Confidence 999999976554 33 467899999999999999999999999999999999999998888888777 69999999999
Q ss_pred CCCCCC
Q 005749 258 FSGVLP 263 (679)
Q Consensus 258 l~g~ip 263 (679)
+.+.-+
T Consensus 237 l~C~C~ 242 (284)
T d1ozna_ 237 WVCDCR 242 (284)
T ss_dssp EECSGG
T ss_pred CCCCcc
Confidence 987654
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.56 E-value=4e-14 Score=144.17 Aligned_cols=153 Identities=20% Similarity=0.255 Sum_probs=93.2
Q ss_pred cEEEEEcCCCCCcccCCccccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhH------------
Q 005749 100 HLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSI------------ 167 (679)
Q Consensus 100 ~l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~------------ 167 (679)
.++.|+|++|+++.--+..|.++++|++|++++|.+....|..+.++++|++|+|++|+++.. |...
T Consensus 32 ~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n~l~~l-~~~~~~~l~~L~~~~n 110 (305)
T d1xkua_ 32 DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKEL-PEKMPKTLQELRVHEN 110 (305)
T ss_dssp TCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCSBC-CSSCCTTCCEEECCSS
T ss_pred CCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecccCCccCcC-ccchhhhhhhhhcccc
Confidence 477888888887744445688888888888888888866677788888888888888877632 2111
Q ss_pred -----------------------------------HhhcccCcEEEccCCCCcccCCCCCCCCCCCCCccEEEccCcccc
Q 005749 168 -----------------------------------WNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFS 212 (679)
Q Consensus 168 -----------------------------------~~~~~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~l~~N~l~ 212 (679)
+..+++|+.+++++|+++. +|. ..+++|+.|++++|.++
T Consensus 111 ~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~~-l~~-----~~~~~L~~L~l~~n~~~ 184 (305)
T d1xkua_ 111 EITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT-IPQ-----GLPPSLTELHLDGNKIT 184 (305)
T ss_dssp CCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS-CCS-----SCCTTCSEEECTTSCCC
T ss_pred chhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCccc-cCc-----ccCCccCEEECCCCcCC
Confidence 1112345666666665552 222 12345555555555555
Q ss_pred ccccccccCCCCCCEEEccCCcccccCCcccccc-ccCEEEccCCcCC
Q 005749 213 GSFPEFVTRFEALKELDISNNLFSGSIPEGLTRL-SLEKLNLSHNNFS 259 (679)
Q Consensus 213 g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l-~L~~l~ls~N~l~ 259 (679)
+..+..+..++.++.|++++|.+++..|..+..+ +|+.|+|++|+|+
T Consensus 185 ~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~ 232 (305)
T d1xkua_ 185 KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV 232 (305)
T ss_dssp EECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS
T ss_pred CCChhHhhccccccccccccccccccccccccccccceeeeccccccc
Confidence 5555555555555555555555555444444444 4555555555555
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.51 E-value=5.3e-14 Score=133.93 Aligned_cols=145 Identities=23% Similarity=0.354 Sum_probs=118.5
Q ss_pred cEEEEEcCCCCCcccCCccccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEEc
Q 005749 100 HLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRL 179 (679)
Q Consensus 100 ~l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~L 179 (679)
+++.|++.+|++.. ++ .+..+++|++|+|++|+|++. ++ ++++++|++|++++|.+... + .+.. +++|+.|++
T Consensus 41 ~l~~L~l~~~~i~~-l~-~l~~l~nL~~L~Ls~N~l~~~-~~-l~~l~~L~~L~l~~n~~~~~-~-~l~~-l~~L~~L~l 113 (199)
T d2omxa2 41 QVTTLQADRLGIKS-ID-GVEYLNNLTQINFSNNQLTDI-TP-LKNLTKLVDILMNNNQIADI-T-PLAN-LTNLTGLTL 113 (199)
T ss_dssp TCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCCC-G-GGTT-CTTCSEEEC
T ss_pred CCCEEECCCCCCCC-cc-ccccCCCcCcCccccccccCc-cc-ccCCcccccccccccccccc-c-cccc-ccccccccc
Confidence 47889999999873 43 588999999999999999964 43 89999999999999998854 3 3544 489999999
Q ss_pred cCCCCcccCCCCCCCCCCCCCccEEEccCccccccccccccCCCCCCEEEccCCcccccCCcccccc-ccCEEEccCCcC
Q 005749 180 HGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRL-SLEKLNLSHNNF 258 (679)
Q Consensus 180 s~N~l~~~~p~~~~~~~~~~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l-~L~~l~ls~N~l 258 (679)
++|.+....+ ...+++|+.|++++|++.. +| .+..+++|+.|++++|++++ ++. +..+ +|+.|++++|++
T Consensus 114 ~~~~~~~~~~-----~~~l~~L~~L~l~~n~l~~-~~-~l~~~~~L~~L~l~~n~l~~-l~~-l~~l~~L~~L~ls~N~i 184 (199)
T d2omxa2 114 FNNQITDIDP-----LKNLTNLNRLELSSNTISD-IS-ALSGLTSLQQLNFSSNQVTD-LKP-LANLTTLERLDISSNKV 184 (199)
T ss_dssp CSSCCCCCGG-----GTTCTTCSEEECCSSCCCC-CG-GGTTCTTCSEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCC
T ss_pred cccccccccc-----cchhhhhHHhhhhhhhhcc-cc-cccccccccccccccccccC-Ccc-ccCCCCCCEEECCCCCC
Confidence 9999886432 2457899999999999973 44 58899999999999999985 333 5555 699999999999
Q ss_pred CC
Q 005749 259 SG 260 (679)
Q Consensus 259 ~g 260 (679)
+.
T Consensus 185 ~~ 186 (199)
T d2omxa2 185 SD 186 (199)
T ss_dssp CC
T ss_pred CC
Confidence 86
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.47 E-value=1.3e-13 Score=132.35 Aligned_cols=143 Identities=27% Similarity=0.357 Sum_probs=70.2
Q ss_pred EEEEEcCCCCCcccCCccccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEEcc
Q 005749 101 LLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLH 180 (679)
Q Consensus 101 l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls 180 (679)
++.|++++|++.. ++ .+..+++|++|+|++|.|++ ++ .++.+++|++|++++|++++. | .+..+ ++|+.|+++
T Consensus 48 L~~L~l~~~~i~~-l~-~l~~l~~L~~L~L~~n~i~~-l~-~~~~l~~L~~L~l~~n~i~~l-~-~l~~l-~~L~~L~l~ 120 (210)
T d1h6ta2 48 IDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTD-IK-PLANLKNLGWLFLDENKVKDL-S-SLKDL-KKLKSLSLE 120 (210)
T ss_dssp CCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCCG-G-GGTTC-TTCCEEECT
T ss_pred ccEEECcCCCCCC-ch-hHhhCCCCCEEeCCCccccC-cc-ccccCcccccccccccccccc-c-ccccc-ccccccccc
Confidence 4455555555543 22 25555555555555555553 22 245555555555555555542 2 23332 555555555
Q ss_pred CCCCcccCCCCCCCCCCCCCccEEEccCccccccccccccCCCCCCEEEccCCcccccCCcccccc-ccCEEEccCCcCC
Q 005749 181 GNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRL-SLEKLNLSHNNFS 259 (679)
Q Consensus 181 ~N~l~~~~p~~~~~~~~~~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l-~L~~l~ls~N~l~ 259 (679)
+|.+... +. ...+++|+.++++.|.+++ +..++.+++|+.+++++|++++ ++. +..+ +|+.|+|++|+++
T Consensus 121 ~~~~~~~-~~----l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~-i~~-l~~l~~L~~L~Ls~N~i~ 191 (210)
T d1h6ta2 121 HNGISDI-NG----LVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISD-IVP-LAGLTKLQNLYLSKNHIS 191 (210)
T ss_dssp TSCCCCC-GG----GGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCC
T ss_pred ccccccc-cc----ccccccccccccccccccc--cccccccccccccccccccccc-ccc-ccCCCCCCEEECCCCCCC
Confidence 5555421 10 1234455555555555543 2234455555555555555553 222 3333 3555555555554
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.46 E-value=1.6e-13 Score=131.69 Aligned_cols=142 Identities=25% Similarity=0.314 Sum_probs=117.5
Q ss_pred CccEEEEEcCCCCCcccCCccccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEE
Q 005749 98 SIHLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSL 177 (679)
Q Consensus 98 ~~~l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L 177 (679)
..+++.|+|++|.+++ ++ .++.+++|++|++++|+|++ +| .+..+++|+.|++++|.+... +.+..+ ++|+.+
T Consensus 67 l~~L~~L~L~~n~i~~-l~-~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~l~~~~~~~~--~~l~~l-~~l~~l 139 (210)
T d1h6ta2 67 LPNVTKLFLNGNKLTD-IK-PLANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGISDI--NGLVHL-PQLESL 139 (210)
T ss_dssp CTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCCCC--GGGGGC-TTCCEE
T ss_pred CCCCCEEeCCCccccC-cc-ccccCccccccccccccccc-cc-ccccccccccccccccccccc--cccccc-cccccc
Confidence 3469999999999986 44 47899999999999999984 66 588899999999999998753 345554 899999
Q ss_pred EccCCCCcccCCCCCCCCCCCCCccEEEccCccccccccccccCCCCCCEEEccCCcccccCCcccccc-ccCEEEccC
Q 005749 178 RLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRL-SLEKLNLSH 255 (679)
Q Consensus 178 ~Ls~N~l~~~~p~~~~~~~~~~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l-~L~~l~ls~ 255 (679)
++++|.+++..+ ...+++|+++++++|++++ ++ .++.+++|+.|+|++|+++ .+| .+..+ +|+.|+|++
T Consensus 140 ~~~~n~l~~~~~-----~~~l~~L~~l~l~~n~l~~-i~-~l~~l~~L~~L~Ls~N~i~-~l~-~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 140 YLGNNKITDITV-----LSRLTKLDTLSLEDNQISD-IV-PLAGLTKLQNLYLSKNHIS-DLR-ALAGLKNLDVLELFS 209 (210)
T ss_dssp ECCSSCCCCCGG-----GGGCTTCSEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCC-BCG-GGTTCTTCSEEEEEE
T ss_pred cccccccccccc-----ccccccccccccccccccc-cc-cccCCCCCCEEECCCCCCC-CCh-hhcCCCCCCEEEccC
Confidence 999999986422 2457899999999999985 44 3889999999999999998 466 46666 799999974
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.44 E-value=1.2e-13 Score=120.64 Aligned_cols=77 Identities=30% Similarity=0.381 Sum_probs=42.9
Q ss_pred EEEcCCCCCcccCCccccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEEccCC
Q 005749 103 SIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGN 182 (679)
Q Consensus 103 ~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N 182 (679)
.|+|++|+++ .+| .++.+++|++|+|++|.|+ .+|..++.+++|++|++++|.+++. +.+..+ ++|+.|++++|
T Consensus 2 ~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~l--~~~~~l-~~L~~L~l~~N 75 (124)
T d1dcea3 2 VLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENV--DGVANL-PRLQELLLCNN 75 (124)
T ss_dssp EEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCC--GGGTTC-SSCCEEECCSS
T ss_pred EEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccccc--Cccccc-cccCeEECCCC
Confidence 3556666665 333 3566666666666666665 4555566666666666666666542 233332 55555555555
Q ss_pred CCc
Q 005749 183 SLT 185 (679)
Q Consensus 183 ~l~ 185 (679)
+++
T Consensus 76 ~i~ 78 (124)
T d1dcea3 76 RLQ 78 (124)
T ss_dssp CCC
T ss_pred ccC
Confidence 555
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.43 E-value=3.2e-13 Score=137.29 Aligned_cols=156 Identities=24% Similarity=0.331 Sum_probs=127.6
Q ss_pred CCccEEEEEcCCCCCcccCCccccCCCCCCeeecccCcccccCCcc----------------------------------
Q 005749 97 SSIHLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFE---------------------------------- 142 (679)
Q Consensus 97 ~~~~l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip~~---------------------------------- 142 (679)
...+|+.|++++|.+....|..|.++++|++|+|++|+|+ .+|..
T Consensus 53 ~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n~l~-~l~~~~~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~ 131 (305)
T d1xkua_ 53 NLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVEL 131 (305)
T ss_dssp TCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCS-BCCSSCCTTCCEEECCSSCCCBBCHHHHTTCTTCCEEEC
T ss_pred ccccccccccccccccccchhhhhCCCccCEecccCCccC-cCccchhhhhhhhhccccchhhhhhhhhhcccccccccc
Confidence 3457999999999999877888999999999999999887 34432
Q ss_pred --------------cCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEEccCCCCcccCCCCCCCCCCCCCccEEEccC
Q 005749 143 --------------LGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGS 208 (679)
Q Consensus 143 --------------l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~l~~ 208 (679)
+..+++|+.+++++|.++. +|..+ +++|+.|++++|..++..+..+ ..++.+++|++++
T Consensus 132 ~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~~-l~~~~---~~~L~~L~l~~n~~~~~~~~~~---~~~~~l~~L~~s~ 204 (305)
T d1xkua_ 132 GTNPLKSSGIENGAFQGMKKLSYIRIADTNITT-IPQGL---PPSLTELHLDGNKITKVDAASL---KGLNNLAKLGLSF 204 (305)
T ss_dssp CSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS-CCSSC---CTTCSEEECTTSCCCEECTGGG---TTCTTCCEEECCS
T ss_pred ccccccccCCCccccccccccCccccccCCccc-cCccc---CCccCEEECCCCcCCCCChhHh---hcccccccccccc
Confidence 2234567778888877764 44332 4789999999999998766433 4567899999999
Q ss_pred ccccccccccccCCCCCCEEEccCCcccccCCcccccc-ccCEEEccCCcCCCC
Q 005749 209 NKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRL-SLEKLNLSHNNFSGV 261 (679)
Q Consensus 209 N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l-~L~~l~ls~N~l~g~ 261 (679)
|++++..|..+..+++|++|+|++|+|+ .+|..+..+ +|+.|+|++|+|+..
T Consensus 205 n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~i 257 (305)
T d1xkua_ 205 NSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAI 257 (305)
T ss_dssp SCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCC
T ss_pred ccccccccccccccccceeeeccccccc-ccccccccccCCCEEECCCCccCcc
Confidence 9999888889999999999999999998 678888877 699999999999853
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.43 E-value=4.8e-13 Score=129.94 Aligned_cols=152 Identities=24% Similarity=0.374 Sum_probs=94.6
Q ss_pred EEEEEcCCCCCcccCCccccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEEcc
Q 005749 101 LLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLH 180 (679)
Q Consensus 101 l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls 180 (679)
++.|++.+|+++ .++ .+.+|++|++|+|++|.+++..| +..+++|++|++++|.++. + +.+..+ ++|+.++++
T Consensus 43 L~~L~l~~~~i~-~l~-~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~~-i-~~l~~l-~~L~~l~l~ 115 (227)
T d1h6ua2 43 ITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKN-V-SAIAGL-QSIKTLDLT 115 (227)
T ss_dssp CCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSC-C-GGGTTC-TTCCEEECT
T ss_pred cCEEECCCCCCC-cch-hHhcCCCCcEeecCCceeecccc--ccccccccccccccccccc-c-cccccc-ccccccccc
Confidence 555666666655 242 45666666666666666654322 5556666666666666553 2 233332 556666666
Q ss_pred CCCCcccCCCC-----------------CCCCCCCCCccEEEccCccccccccccccCCCCCCEEEccCCcccccCCccc
Q 005749 181 GNSLTAALPEP-----------------ALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGL 243 (679)
Q Consensus 181 ~N~l~~~~p~~-----------------~~~~~~~~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~ 243 (679)
+|...+..+-. ..+...+.+|++|++++|.+++.. .++++++|+.|+|++|++++ +|. +
T Consensus 116 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~Ls~n~l~~-l~~-l 191 (227)
T d1h6ua2 116 STQITDVTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLT--PLANLSKLTTLKADDNKISD-ISP-L 191 (227)
T ss_dssp TSCCCCCGGGTTCTTCCEEECCSSCCCCCGGGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-CGG-G
T ss_pred cccccccchhccccchhhhhchhhhhchhhhhccccccccccccccccccch--hhcccccceecccCCCccCC-Chh-h
Confidence 66555432210 001134668999999999987533 37889999999999999985 443 5
Q ss_pred ccc-ccCEEEccCCcCCCCCC
Q 005749 244 TRL-SLEKLNLSHNNFSGVLP 263 (679)
Q Consensus 244 ~~l-~L~~l~ls~N~l~g~ip 263 (679)
..+ +|+.|+|++|++++..|
T Consensus 192 ~~l~~L~~L~Ls~N~lt~i~~ 212 (227)
T d1h6ua2 192 ASLPNLIEVHLKNNQISDVSP 212 (227)
T ss_dssp GGCTTCCEEECTTSCCCBCGG
T ss_pred cCCCCCCEEECcCCcCCCCcc
Confidence 555 69999999999986543
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.39 E-value=1.6e-12 Score=123.36 Aligned_cols=137 Identities=28% Similarity=0.398 Sum_probs=110.4
Q ss_pred ccEEEEEcCCCCCcccCCccccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEE
Q 005749 99 IHLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLR 178 (679)
Q Consensus 99 ~~l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~ 178 (679)
.+++.|+|++|.+++..| ++++++|++|++++|.+. .+| .+.++++|+.|++++|.+... +.+.. +++|+.|+
T Consensus 62 ~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~-~~~-~l~~l~~L~~L~l~~~~~~~~--~~~~~-l~~L~~L~ 134 (199)
T d2omxa2 62 NNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIA-DIT-PLANLTNLTGLTLFNNQITDI--DPLKN-LTNLNRLE 134 (199)
T ss_dssp TTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC-CCG-GGTTCTTCSEEECCSSCCCCC--GGGTT-CTTCSEEE
T ss_pred CCcCcCccccccccCccc--ccCCcccccccccccccc-ccc-ccccccccccccccccccccc--cccch-hhhhHHhh
Confidence 468999999999986433 999999999999999998 455 488999999999999999864 33444 48999999
Q ss_pred ccCCCCcccCCCCCCCCCCCCCccEEEccCccccccccccccCCCCCCEEEccCCcccccCCcccccc-ccCEE
Q 005749 179 LHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRL-SLEKL 251 (679)
Q Consensus 179 Ls~N~l~~~~p~~~~~~~~~~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l-~L~~l 251 (679)
+++|++... +. ...+++|++|++.+|++++ ++ .++++++|+.|++++|++++ +| .+..+ +|+.|
T Consensus 135 l~~n~l~~~-~~----l~~~~~L~~L~l~~n~l~~-l~-~l~~l~~L~~L~ls~N~i~~-i~-~l~~L~~L~~L 199 (199)
T d2omxa2 135 LSSNTISDI-SA----LSGLTSLQQLNFSSNQVTD-LK-PLANLTTLERLDISSNKVSD-IS-VLAKLTNLESL 199 (199)
T ss_dssp CCSSCCCCC-GG----GTTCTTCSEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCSEE
T ss_pred hhhhhhccc-cc----ccccccccccccccccccC-Cc-cccCCCCCCEEECCCCCCCC-Cc-cccCCCCCCcC
Confidence 999999753 31 2467899999999999985 44 48899999999999999985 44 34544 46554
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.38 E-value=5.5e-13 Score=116.25 Aligned_cols=103 Identities=23% Similarity=0.230 Sum_probs=84.0
Q ss_pred CeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEEccCCCCcccCCCCCCCCCCCCCccEEE
Q 005749 126 QSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLD 205 (679)
Q Consensus 126 ~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~ 205 (679)
|+|+|++|+|+ .+| .+..+++|++|||++|.++. +|+.+..+ ++|+.|++++|+|+.. |. ...+++|++|+
T Consensus 1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~~-lp~~~~~l-~~L~~L~l~~N~i~~l-~~----~~~l~~L~~L~ 71 (124)
T d1dcea3 1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLRA-LPPALAAL-RCLEVLQASDNALENV-DG----VANLPRLQELL 71 (124)
T ss_dssp SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCCC-CCGGGGGC-TTCCEEECCSSCCCCC-GG----GTTCSSCCEEE
T ss_pred CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccCc-chhhhhhh-hccccccccccccccc-Cc----cccccccCeEE
Confidence 68999999998 566 48899999999999999985 67777664 8999999999999864 32 24678899999
Q ss_pred ccCccccccc-cccccCCCCCCEEEccCCcccc
Q 005749 206 LGSNKFSGSF-PEFVTRFEALKELDISNNLFSG 237 (679)
Q Consensus 206 l~~N~l~g~~-p~~~~~l~~L~~L~ls~N~l~g 237 (679)
+++|+++... ...+..+++|+.|++++|.+++
T Consensus 72 l~~N~i~~~~~~~~l~~~~~L~~L~l~~N~i~~ 104 (124)
T d1dcea3 72 LCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104 (124)
T ss_dssp CCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGG
T ss_pred CCCCccCCCCCchhhcCCCCCCEEECCCCcCCc
Confidence 9999998432 2467888999999999999874
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.38 E-value=4e-13 Score=123.10 Aligned_cols=123 Identities=14% Similarity=0.178 Sum_probs=79.4
Q ss_pred cEEEEEcCCCCCcccCCccccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEEc
Q 005749 100 HLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRL 179 (679)
Q Consensus 100 ~l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~L 179 (679)
++..|+|++|+++ .||..+..+++|++|+|++|.|+ .++ .+..+++|++|+|++|+++. +|+.++..+++|+.|+|
T Consensus 19 ~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~-l~~~~~~~l~~L~~L~L 94 (162)
T d1a9na_ 19 RDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICR-IGEGLDQALPDLTELIL 94 (162)
T ss_dssp SCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCE-ECSCHHHHCTTCCEEEC
T ss_pred cCcEEECCCCCCC-ccCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccC-CCcccccccccccccee
Confidence 4677788877776 34655567777888888888777 454 46777778888888888775 34444444477777777
Q ss_pred cCCCCcccCCCCCCCCCCCCCccEEEccCccccccccc----cccCCCCCCEEE
Q 005749 180 HGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPE----FVTRFEALKELD 229 (679)
Q Consensus 180 s~N~l~~~~p~~~~~~~~~~~L~~L~l~~N~l~g~~p~----~~~~l~~L~~L~ 229 (679)
++|+++.. ++ ..+...+++|++|++++|.++ ..|. .+..+++|+.||
T Consensus 95 ~~N~i~~~-~~-l~~l~~l~~L~~L~l~~N~i~-~~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 95 TNNSLVEL-GD-LDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp CSCCCCCG-GG-GGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEET
T ss_pred cccccccc-cc-ccccccccccchhhcCCCccc-cccchHHHHHHHCCCcCeeC
Confidence 77777642 11 011134567777777777765 3332 356667777665
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.38 E-value=1.1e-12 Score=137.19 Aligned_cols=153 Identities=29% Similarity=0.395 Sum_probs=91.8
Q ss_pred cEEEEEcCCCCCcccCCccccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEEc
Q 005749 100 HLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRL 179 (679)
Q Consensus 100 ~l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~L 179 (679)
++..+.+++|.+++..| ++..++|+.|++++|.++. + +.+..+++|+.|++++|.+++..+ +.. +++|+.|++
T Consensus 198 ~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~l~~n~l~~~~~--~~~-~~~L~~L~l 270 (384)
T d2omza2 198 NLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD-I-GTLASLTNLTDLDLANNQISNLAP--LSG-LTKLTELKL 270 (384)
T ss_dssp TCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCCCGG--GTT-CTTCSEEEC
T ss_pred ccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCC-c-chhhcccccchhccccCccCCCCc--ccc-cccCCEeec
Confidence 34455555555554332 3444555555555555552 2 234455555555555555554321 222 245555555
Q ss_pred cCCCCcccCCCCC-----------------CCCCCCCCccEEEccCccccccccccccCCCCCCEEEccCCcccccCCcc
Q 005749 180 HGNSLTAALPEPA-----------------LPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEG 242 (679)
Q Consensus 180 s~N~l~~~~p~~~-----------------~~~~~~~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~ 242 (679)
++|++++..+-.. .....+.+++.|++++|++++.. .+..+++|+.|++++|+|++ +| .
T Consensus 271 ~~~~l~~~~~~~~~~~l~~l~~~~n~l~~~~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~-l~-~ 346 (384)
T d2omza2 271 GANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSD-VS-S 346 (384)
T ss_dssp CSSCCCCCGGGTTCTTCSEEECCSSCCSCCGGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCCC-CG-G
T ss_pred cCcccCCCCccccccccccccccccccccccccchhcccCeEECCCCCCCCCc--ccccCCCCCEEECCCCCCCC-Ch-h
Confidence 5555554322100 00134578899999999998643 37888999999999999974 44 4
Q ss_pred cccc-ccCEEEccCCcCCCCCC
Q 005749 243 LTRL-SLEKLNLSHNNFSGVLP 263 (679)
Q Consensus 243 ~~~l-~L~~l~ls~N~l~g~ip 263 (679)
+..+ +|+.|++++|+|++.+|
T Consensus 347 l~~l~~L~~L~l~~N~l~~l~~ 368 (384)
T d2omza2 347 LANLTNINWLSAGHNQISDLTP 368 (384)
T ss_dssp GGGCTTCCEEECCSSCCCBCGG
T ss_pred HcCCCCCCEEECCCCcCCCChh
Confidence 6666 69999999999998766
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.36 E-value=1.2e-12 Score=137.11 Aligned_cols=143 Identities=25% Similarity=0.335 Sum_probs=106.0
Q ss_pred cEEEEEcCCCCCcccCCccccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcCh---------------
Q 005749 100 HLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLA--------------- 164 (679)
Q Consensus 100 ~l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p--------------- 164 (679)
+++.|++.+|.++. + +.+..+++|+.|++++|.+++..| ++.+++|++|++++|.+++..+
T Consensus 220 ~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~~~l~~~~~~~~~~~l~~l~~~~n 295 (384)
T d2omza2 220 NLDELSLNGNQLKD-I-GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNEN 295 (384)
T ss_dssp TCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGGGTTCTTCSEEECCSS
T ss_pred CCCEEECCCCCCCC-c-chhhcccccchhccccCccCCCCc--ccccccCCEeeccCcccCCCCcccccccccccccccc
Confidence 56677777777664 2 356777777777777777775332 5667777777777777665321
Q ss_pred -----hhHHhhcccCcEEEccCCCCcccCCCCCCCCCCCCCccEEEccCccccccccccccCCCCCCEEEccCCcccccC
Q 005749 165 -----PSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSI 239 (679)
Q Consensus 165 -----~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~ 239 (679)
+.+ ..+++++.|++++|++++..+ ...+++|++|++++|+|++ +| .++.+++|++|++++|+|++.+
T Consensus 296 ~l~~~~~~-~~~~~l~~L~ls~n~l~~l~~-----l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~ 367 (384)
T d2omza2 296 QLEDISPI-SNLKNLTYLTLYFNNISDISP-----VSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLT 367 (384)
T ss_dssp CCSCCGGG-GGCTTCSEEECCSSCCSCCGG-----GGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCG
T ss_pred cccccccc-chhcccCeEECCCCCCCCCcc-----cccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCCh
Confidence 122 224788999999999987533 2467899999999999984 55 6899999999999999999765
Q ss_pred Ccccccc-ccCEEEccCC
Q 005749 240 PEGLTRL-SLEKLNLSHN 256 (679)
Q Consensus 240 p~~~~~l-~L~~l~ls~N 256 (679)
| +..+ +|+.|+|++|
T Consensus 368 ~--l~~l~~L~~L~L~~N 383 (384)
T d2omza2 368 P--LANLTRITQLGLNDQ 383 (384)
T ss_dssp G--GTTCTTCSEEECCCE
T ss_pred h--hccCCCCCEeeCCCC
Confidence 5 6666 6999999998
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.36 E-value=2.4e-13 Score=124.64 Aligned_cols=126 Identities=17% Similarity=0.100 Sum_probs=94.4
Q ss_pred cccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEEccCCCCcccCCCCCCCCCC
Q 005749 118 ELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNST 197 (679)
Q Consensus 118 ~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~~~~ 197 (679)
.+.+..+|+.|+|++|+|+ .||.....+++|+.|||++|.++.. +.+.. +++|+.|+|++|+++...+ ..+ ..
T Consensus 13 ~~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~l--~~~~~-l~~L~~L~ls~N~i~~l~~-~~~--~~ 85 (162)
T d1a9na_ 13 QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL--DGFPL-LRRLKTLLVNNNRICRIGE-GLD--QA 85 (162)
T ss_dssp EEECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCEE--CCCCC-CSSCCEEECCSSCCCEECS-CHH--HH
T ss_pred hccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCCcc--CCccc-CcchhhhhcccccccCCCc-ccc--cc
Confidence 4667888999999999998 5777667889999999999999853 33444 4889999999999986433 221 24
Q ss_pred CCCccEEEccCcccccccc--ccccCCCCCCEEEccCCcccccCCc----ccccc-ccCEEE
Q 005749 198 CSDLQYLDLGSNKFSGSFP--EFVTRFEALKELDISNNLFSGSIPE----GLTRL-SLEKLN 252 (679)
Q Consensus 198 ~~~L~~L~l~~N~l~g~~p--~~~~~l~~L~~L~ls~N~l~g~~p~----~~~~l-~L~~l~ 252 (679)
+++|+.|++++|+++. ++ ..+..+++|++|++++|.++. .|. .+..+ +|+.||
T Consensus 86 l~~L~~L~L~~N~i~~-~~~l~~l~~l~~L~~L~l~~N~i~~-~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 86 LPDLTELILTNNSLVE-LGDLDPLASLKSLTYLCILRNPVTN-KKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp CTTCCEEECCSCCCCC-GGGGGGGGGCTTCCEEECCSSGGGG-STTHHHHHHHHCTTCSEET
T ss_pred ccccccceeccccccc-cccccccccccccchhhcCCCcccc-ccchHHHHHHHCCCcCeeC
Confidence 6789999999999873 44 357888999999999999873 343 23333 467665
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.33 E-value=4.2e-12 Score=124.19 Aligned_cols=162 Identities=15% Similarity=0.105 Sum_probs=110.1
Q ss_pred cEEEEEcCCCCCcccCCccccCCCCCCeeecccCcccccCCc-ccCCCCCCCEEEccC-CCCCCcChhhHHhhcccCcEE
Q 005749 100 HLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPF-ELGYSSSLSEIDLSA-NLFTGVLAPSIWNLCDRLVSL 177 (679)
Q Consensus 100 ~l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip~-~l~~l~~L~~L~Ls~-N~l~g~~p~~~~~~~~~L~~L 177 (679)
+++.|+|++|+++..-+..|.++++|++|+|++|.+...+|. .+..++++++|++.. |++....+..+.+ +++|+.|
T Consensus 30 ~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~-l~~L~~l 108 (242)
T d1xwdc1 30 NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQN-LPNLQYL 108 (242)
T ss_dssp CCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSEEC-CTTCCEE
T ss_pred CCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccccccccccccccccc-ccccccc
Confidence 588999999998754444689999999999999998876654 467788999998764 6776554443434 4889999
Q ss_pred EccCCCCcccCCCCCCCC----------------------CC-CCCccEEEccCccccccccccccCCCCCCEE-EccCC
Q 005749 178 RLHGNSLTAALPEPALPN----------------------ST-CSDLQYLDLGSNKFSGSFPEFVTRFEALKEL-DISNN 233 (679)
Q Consensus 178 ~Ls~N~l~~~~p~~~~~~----------------------~~-~~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L-~ls~N 233 (679)
++++|+++...+...... .. ...++.|++++|+++. ++....+..++..+ ++++|
T Consensus 109 ~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~-i~~~~~~~~~l~~~~~l~~n 187 (242)
T d1xwdc1 109 LISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE-IHNCAFNGTQLDELNLSDNN 187 (242)
T ss_dssp EEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCE-ECTTTTTTCCEEEEECTTCT
T ss_pred ccchhhhcccccccccccccccccccccccccccccccccccccccceeeecccccccc-cccccccchhhhcccccccc
Confidence 999998875433211100 00 1356778888888874 44444445555444 46777
Q ss_pred cccccCCcccccc-ccCEEEccCCcCCCCCCC
Q 005749 234 LFSGSIPEGLTRL-SLEKLNLSHNNFSGVLPV 264 (679)
Q Consensus 234 ~l~g~~p~~~~~l-~L~~l~ls~N~l~g~ip~ 264 (679)
+++...+..+..+ +|+.|+|++|+|+ .+|.
T Consensus 188 ~l~~l~~~~f~~l~~L~~L~Ls~N~l~-~l~~ 218 (242)
T d1xwdc1 188 NLEELPNDVFHGASGPVILDISRTRIH-SLPS 218 (242)
T ss_dssp TCCCCCTTTTTTSCCCSEEECTTSCCC-CCCS
T ss_pred ccccccHHHhcCCCCCCEEECCCCcCC-ccCH
Confidence 7874333445555 6888888888887 4444
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.26 E-value=1.4e-11 Score=119.41 Aligned_cols=143 Identities=22% Similarity=0.330 Sum_probs=104.4
Q ss_pred ccEEEEEcCCCCCcccCCccccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcCh--------------
Q 005749 99 IHLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLA-------------- 164 (679)
Q Consensus 99 ~~l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p-------------- 164 (679)
.+|+.|++++|.+++..| +..+++|++|++++|.++ .++ .+..+++|+.|++++|...+..+
T Consensus 63 ~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~-~i~-~l~~l~~L~~l~l~~~~~~~~~~~~~~~~~~~l~~~~ 138 (227)
T d1h6ua2 63 NNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLK-NVS-AIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDL 138 (227)
T ss_dssp TTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCS-CCG-GGTTCTTCCEEECTTSCCCCCGGGTTCTTCCEEECCS
T ss_pred CCCcEeecCCceeecccc--cccccccccccccccccc-ccc-cccccccccccccccccccccchhccccchhhhhchh
Confidence 357777888887775433 777788888888887776 344 46677777777777776654321
Q ss_pred ------hhHHhhcccCcEEEccCCCCcccCCCCCCCCCCCCCccEEEccCccccccccccccCCCCCCEEEccCCccccc
Q 005749 165 ------PSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGS 238 (679)
Q Consensus 165 ------~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ 238 (679)
..+.. +++|+.|++++|.+++..+ ...+++|++|+|++|++++ +|. ++++++|++|+|++|++++
T Consensus 139 ~~~~~~~~~~~-~~~L~~L~l~~n~~~~~~~-----l~~l~~L~~L~Ls~n~l~~-l~~-l~~l~~L~~L~Ls~N~lt~- 209 (227)
T d1h6ua2 139 NQITNISPLAG-LTNLQYLSIGNAQVSDLTP-----LANLSKLTTLKADDNKISD-ISP-LASLPNLIEVHLKNNQISD- 209 (227)
T ss_dssp SCCCCCGGGGG-CTTCCEEECCSSCCCCCGG-----GTTCTTCCEEECCSSCCCC-CGG-GGGCTTCCEEECTTSCCCB-
T ss_pred hhhchhhhhcc-ccccccccccccccccchh-----hcccccceecccCCCccCC-Chh-hcCCCCCCEEECcCCcCCC-
Confidence 12223 3679999999998875432 2467899999999999985 543 8899999999999999995
Q ss_pred CCcccccc-ccCEEEccC
Q 005749 239 IPEGLTRL-SLEKLNLSH 255 (679)
Q Consensus 239 ~p~~~~~l-~L~~l~ls~ 255 (679)
+|. +..+ +|+.|++++
T Consensus 210 i~~-l~~l~~L~~L~lsn 226 (227)
T d1h6ua2 210 VSP-LANTSNLFIVTLTN 226 (227)
T ss_dssp CGG-GTTCTTCCEEEEEE
T ss_pred Ccc-cccCCCCCEEEeeC
Confidence 443 5566 699999974
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.20 E-value=1.7e-13 Score=130.03 Aligned_cols=118 Identities=19% Similarity=0.286 Sum_probs=95.4
Q ss_pred cCCccccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEEccCCCCcccCCCCCC
Q 005749 114 SLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPAL 193 (679)
Q Consensus 114 ~ip~~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~ 193 (679)
.+|..++.|++|++|+|++|+|+ .++ .+..+++|++|+|++|.++. +|. +...+++|+.|++++|+++.. +.
T Consensus 39 ~l~~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~~-i~~-~~~~~~~L~~L~l~~N~i~~l-~~--- 110 (198)
T d1m9la_ 39 KMDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIKK-IEN-LDAVADTLEELWISYNQIASL-SG--- 110 (198)
T ss_dssp CCHHHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEECS-CSS-HHHHHHHCCEEECSEEECCCH-HH---
T ss_pred hhhhHHhcccccceeECcccCCC-Ccc-cccCCccccChhhccccccc-ccc-ccccccccccccccccccccc-cc---
Confidence 45678999999999999999998 565 58889999999999999985 444 334447899999999999853 21
Q ss_pred CCCCCCCccEEEccCcccccccc--ccccCCCCCCEEEccCCcccccCCc
Q 005749 194 PNSTCSDLQYLDLGSNKFSGSFP--EFVTRFEALKELDISNNLFSGSIPE 241 (679)
Q Consensus 194 ~~~~~~~L~~L~l~~N~l~g~~p--~~~~~l~~L~~L~ls~N~l~g~~p~ 241 (679)
...+++|++|++++|+++. ++ ..+..+++|+.|+|++|.+....+.
T Consensus 111 -~~~l~~L~~L~L~~N~i~~-~~~~~~l~~l~~L~~L~L~~N~l~~~~~~ 158 (198)
T d1m9la_ 111 -IEKLVNLRVLYMSNNKITN-WGEIDKLAALDKLEDLLLAGNPLYNDYKE 158 (198)
T ss_dssp -HHHHHHSSEEEESEEECCC-HHHHHHHTTTTTCSEEEECSSHHHHHHCT
T ss_pred -ccccccccccccccchhcc-ccccccccCCCccceeecCCCccccCccc
Confidence 1356789999999999984 44 4688999999999999999865554
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.13 E-value=1.8e-10 Score=118.33 Aligned_cols=76 Identities=29% Similarity=0.321 Sum_probs=45.6
Q ss_pred ccEEEEEcCCCCCcccCCccccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEE
Q 005749 99 IHLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLR 178 (679)
Q Consensus 99 ~~l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~ 178 (679)
.+++.|+|++|+++ .+|..+ .+|+.|++++|+++ .++.- .+.|++|||++|.++. +|. +.. +++|+.|+
T Consensus 58 ~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L~~n~l~~-lp~-~~~-l~~L~~L~ 126 (353)
T d1jl5a_ 58 PHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSDL---PPLLEYLGVSNNQLEK-LPE-LQN-SSFLKIID 126 (353)
T ss_dssp TTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCSC---CTTCCEEECCSSCCSS-CCC-CTT-CTTCCEEE
T ss_pred CCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhhh---cccccccccccccccc-ccc-hhh-hccceeec
Confidence 46899999999988 778654 45666666666665 33321 1346666666666653 332 222 35566666
Q ss_pred ccCCCCc
Q 005749 179 LHGNSLT 185 (679)
Q Consensus 179 Ls~N~l~ 185 (679)
+++|.++
T Consensus 127 l~~~~~~ 133 (353)
T d1jl5a_ 127 VDNNSLK 133 (353)
T ss_dssp CCSSCCS
T ss_pred ccccccc
Confidence 6555554
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.05 E-value=1.6e-12 Score=123.25 Aligned_cols=123 Identities=24% Similarity=0.240 Sum_probs=97.6
Q ss_pred ccEEEEEcCCCCCcccCCccccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEE
Q 005749 99 IHLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLR 178 (679)
Q Consensus 99 ~~l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~ 178 (679)
.+++.|+|++|+++ .++ .+..|++|++|+|++|.|+ .+|.....+++|++|++++|.++.. +.+..+ ++|+.|+
T Consensus 48 ~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~l--~~~~~l-~~L~~L~ 121 (198)
T d1m9la_ 48 KACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASL--SGIEKL-VNLRVLY 121 (198)
T ss_dssp TTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCCH--HHHHHH-HHSSEEE
T ss_pred cccceeECcccCCC-Ccc-cccCCccccChhhcccccc-ccccccccccccccccccccccccc--cccccc-ccccccc
Confidence 36899999999987 565 5999999999999999998 6787666677899999999999964 456565 8999999
Q ss_pred ccCCCCcccCCCCCCCCCCCCCccEEEccCcccccccccc----------ccCCCCCCEEE
Q 005749 179 LHGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEF----------VTRFEALKELD 229 (679)
Q Consensus 179 Ls~N~l~~~~p~~~~~~~~~~~L~~L~l~~N~l~g~~p~~----------~~~l~~L~~L~ 229 (679)
|++|+++....-. ....+++|++|+|++|.+....+.. +..+++|+.||
T Consensus 122 L~~N~i~~~~~~~--~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp~L~~LD 180 (198)
T d1m9la_ 122 MSNNKITNWGEID--KLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180 (198)
T ss_dssp ESEEECCCHHHHH--HHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCSSCCEES
T ss_pred cccchhccccccc--cccCCCccceeecCCCccccCcccccchhhHHHHHHHHCCCcCEeC
Confidence 9999998532101 1245789999999999998654432 56688888886
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.05 E-value=2.4e-10 Score=103.40 Aligned_cols=80 Identities=18% Similarity=0.154 Sum_probs=35.1
Q ss_pred EEcCCCCCcccCCccccCCCCCCeeecccC-cccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEEccCC
Q 005749 104 IQLPSANLTGSLPRELGEFSMLQSLYLNVN-SLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGN 182 (679)
Q Consensus 104 l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N-~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N 182 (679)
++.+++++. .+|..+..+++|+.|+|++| .|+..-+..|.++++|+.|+|++|+|+...| ..+..+++|+.|+|++|
T Consensus 13 l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~-~~f~~l~~L~~L~Ls~N 90 (156)
T d2ifga3 13 LRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAP-DAFHFTPRLSRLNLSFN 90 (156)
T ss_dssp EECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECT-TGGGSCSCCCEEECCSS
T ss_pred EEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCccc-ccccccccccceeccCC
Confidence 334444443 33444455555555555433 2443222334455555555555555543222 22222244444444444
Q ss_pred CCc
Q 005749 183 SLT 185 (679)
Q Consensus 183 ~l~ 185 (679)
+|+
T Consensus 91 ~l~ 93 (156)
T d2ifga3 91 ALE 93 (156)
T ss_dssp CCS
T ss_pred CCc
Confidence 444
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.04 E-value=3.1e-10 Score=102.73 Aligned_cols=109 Identities=17% Similarity=0.098 Sum_probs=58.5
Q ss_pred CCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCC-CCCcChhhHHhhcccCcEEEccCCCCcccCCCCCCCCCCCC
Q 005749 121 EFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANL-FTGVLAPSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTCS 199 (679)
Q Consensus 121 ~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~-l~g~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~~~~~~ 199 (679)
.......++.+++++. .+|..+..+++|++|+|++|+ ++..-+..+.+ +++|+.|+|++|+|+
T Consensus 6 ~c~~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~-l~~L~~L~Ls~N~l~-------------- 69 (156)
T d2ifga3 6 CPHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRG-LGELRNLTIVKSGLR-------------- 69 (156)
T ss_dssp CCSSSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCS-CCCCSEEECCSSCCC--------------
T ss_pred CcCCCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhcc-ccccCcceeeccccC--------------
Confidence 3445566777777776 566666667777777776553 55332222222 244555555555544
Q ss_pred CccEEEccCccccccccccccCCCCCCEEEccCCcccccCCccccccccCEEEccCCcC
Q 005749 200 DLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRLSLEKLNLSHNNF 258 (679)
Q Consensus 200 ~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~L~~l~ls~N~l 258 (679)
...|..|..+++|++|+|++|+|+...+..+..++|+.|+|++|.|
T Consensus 70 -------------~i~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~~~l~~L~L~~Np~ 115 (156)
T d2ifga3 70 -------------FVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPL 115 (156)
T ss_dssp -------------EECTTGGGSCSCCCEEECCSSCCSCCCSTTTCSCCCCEEECCSSCC
T ss_pred -------------CcccccccccccccceeccCCCCcccChhhhccccccccccCCCcc
Confidence 3334445555555555555555553222333333555666666655
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.03 E-value=2.7e-10 Score=110.94 Aligned_cols=153 Identities=16% Similarity=0.145 Sum_probs=110.8
Q ss_pred EcCCCCCcccCCccccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEEccC-CC
Q 005749 105 QLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHG-NS 183 (679)
Q Consensus 105 ~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~-N~ 183 (679)
+.++++++ .+|+++- +++++|+|++|+|+...+..+.++++|++|+|++|.+...+++..+..+++++.|++.. |+
T Consensus 14 ~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~ 90 (242)
T d1xwdc1 14 LCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANN 90 (242)
T ss_dssp EEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTT
T ss_pred EEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccccccccc
Confidence 34455666 6777653 68999999999998544446889999999999999998877666555568899998864 67
Q ss_pred CcccCCCCCCCCCCCCCccEEEccCcccccccc-ccccCCCCCCEEEccCCcccccCCcccccc--ccCEEEccCCcCCC
Q 005749 184 LTAALPEPALPNSTCSDLQYLDLGSNKFSGSFP-EFVTRFEALKELDISNNLFSGSIPEGLTRL--SLEKLNLSHNNFSG 260 (679)
Q Consensus 184 l~~~~p~~~~~~~~~~~L~~L~l~~N~l~g~~p-~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l--~L~~l~ls~N~l~g 260 (679)
+....+..+ ..+++|++|++++|++....+ ..+..+..+..+..+++++....+..+..+ .++.|++++|+++.
T Consensus 91 l~~~~~~~~---~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~ 167 (242)
T d1xwdc1 91 LLYINPEAF---QNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE 167 (242)
T ss_dssp CCEECTTSE---ECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCE
T ss_pred ccccccccc---cccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeecccccccc
Confidence 776554422 457899999999999974322 234445666666777778875555555544 57889999999885
Q ss_pred CCC
Q 005749 261 VLP 263 (679)
Q Consensus 261 ~ip 263 (679)
..+
T Consensus 168 i~~ 170 (242)
T d1xwdc1 168 IHN 170 (242)
T ss_dssp ECT
T ss_pred ccc
Confidence 433
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.97 E-value=9.8e-11 Score=117.35 Aligned_cols=160 Identities=23% Similarity=0.297 Sum_probs=105.4
Q ss_pred cEEEEEcCCCCCccc-CCccccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccC-CCCCCcChhhHHhhcccCcEE
Q 005749 100 HLLSIQLPSANLTGS-LPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSA-NLFTGVLAPSIWNLCDRLVSL 177 (679)
Q Consensus 100 ~l~~l~l~~n~l~g~-ip~~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~-N~l~g~~p~~~~~~~~~L~~L 177 (679)
+++.|+|+++.+++. ++.-+.++++|++|+|++|.+++..+..++.+++|++|+|++ +.++..--..+...+++|++|
T Consensus 47 ~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L 126 (284)
T d2astb2 47 RVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDEL 126 (284)
T ss_dssp CCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEE
T ss_pred CCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhcccc
Confidence 578888888887654 455577889999999999988888888888888999999988 456532223344456889999
Q ss_pred EccCC-CCcccCCCCCCCCCCCCCccEEEccCc--cccc-cccccccCCCCCCEEEccCC-cccccCCcccccc-ccCEE
Q 005749 178 RLHGN-SLTAALPEPALPNSTCSDLQYLDLGSN--KFSG-SFPEFVTRFEALKELDISNN-LFSGSIPEGLTRL-SLEKL 251 (679)
Q Consensus 178 ~Ls~N-~l~~~~p~~~~~~~~~~~L~~L~l~~N--~l~g-~~p~~~~~l~~L~~L~ls~N-~l~g~~p~~~~~l-~L~~l 251 (679)
+++++ +++...-...+ ...+++|+.|+++++ .++. .+.....++++|++|++++| .+++..+..+..+ +|+.|
T Consensus 127 ~ls~c~~~~~~~~~~~~-~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L 205 (284)
T d2astb2 127 NLSWCFDFTEKHVQVAV-AHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHL 205 (284)
T ss_dssp ECCCCTTCCHHHHHHHH-HHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEE
T ss_pred ccccccccccccchhhh-cccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEE
Confidence 99884 45421000000 012457888888754 3432 23334456778888888774 4666666666655 58888
Q ss_pred EccC-CcCCC
Q 005749 252 NLSH-NNFSG 260 (679)
Q Consensus 252 ~ls~-N~l~g 260 (679)
+|++ +.++.
T Consensus 206 ~L~~C~~i~~ 215 (284)
T d2astb2 206 SLSRCYDIIP 215 (284)
T ss_dssp ECTTCTTCCG
T ss_pred ECCCCCCCCh
Confidence 8887 35554
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.71 E-value=4e-09 Score=105.30 Aligned_cols=157 Identities=20% Similarity=0.214 Sum_probs=117.1
Q ss_pred CccEEEEEcCCCCCcccCCccccCCCCCCeeeccc-Cccccc-CCcccCCCCCCCEEEccCC-CCCCc-ChhhHHhhccc
Q 005749 98 SIHLLSIQLPSANLTGSLPRELGEFSMLQSLYLNV-NSLKGT-IPFELGYSSSLSEIDLSAN-LFTGV-LAPSIWNLCDR 173 (679)
Q Consensus 98 ~~~l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~-N~l~g~-ip~~l~~l~~L~~L~Ls~N-~l~g~-~p~~~~~~~~~ 173 (679)
..+++.|+|.++++.+..+..++++++|++|+|++ +.++.. +..-..++++|++|+|+++ .++.. +...+...+++
T Consensus 70 c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~ 149 (284)
T d2astb2 70 CSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSET 149 (284)
T ss_dssp BCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTT
T ss_pred CCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccccccccccccccccchhhhcccccc
Confidence 45799999999999998899999999999999999 467632 3333456899999999985 55532 22234444578
Q ss_pred CcEEEccCC--CCcccCCCCCCCCCCCCCccEEEccCc-cccccccccccCCCCCCEEEccC-CcccccCCcccccc-cc
Q 005749 174 LVSLRLHGN--SLTAALPEPALPNSTCSDLQYLDLGSN-KFSGSFPEFVTRFEALKELDISN-NLFSGSIPEGLTRL-SL 248 (679)
Q Consensus 174 L~~L~Ls~N--~l~~~~p~~~~~~~~~~~L~~L~l~~N-~l~g~~p~~~~~l~~L~~L~ls~-N~l~g~~p~~~~~l-~L 248 (679)
|+.|++++. .++...-... ...|++|++|++++| .+++.....+.++++|++|+|++ +.+++.....+..+ +|
T Consensus 150 L~~L~l~~~~~~i~~~~l~~l--~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L 227 (284)
T d2astb2 150 ITQLNLSGYRKNLQKSDLSTL--VRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTL 227 (284)
T ss_dssp CCEEECCSCGGGSCHHHHHHH--HHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTC
T ss_pred cchhhhccccccccccccccc--ccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCC
Confidence 999999875 3432100000 024789999999986 58877888899999999999999 57876666666665 69
Q ss_pred CEEEccCC
Q 005749 249 EKLNLSHN 256 (679)
Q Consensus 249 ~~l~ls~N 256 (679)
+.|+++++
T Consensus 228 ~~L~l~~~ 235 (284)
T d2astb2 228 KTLQVFGI 235 (284)
T ss_dssp CEEECTTS
T ss_pred CEEeeeCC
Confidence 99999887
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=98.65 E-value=8.6e-08 Score=97.64 Aligned_cols=138 Identities=26% Similarity=0.318 Sum_probs=103.7
Q ss_pred cEEEEEcCCCCCcccCCccccCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEEc
Q 005749 100 HLLSIQLPSANLTGSLPRELGEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRL 179 (679)
Q Consensus 100 ~l~~l~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~L 179 (679)
+++.|+|++++++ .+|+. +++|++|+|++|+|+ .+|..+ .+|+.|++++|+++. ++ . +.+.|++|++
T Consensus 39 ~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~~-l~-~---lp~~L~~L~L 105 (353)
T d1jl5a_ 39 QAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLKA-LS-D---LPPLLEYLGV 105 (353)
T ss_dssp TCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCSC-CC-S---CCTTCCEEEC
T ss_pred CCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccch-hh-h---hccccccccc
Confidence 4788999999987 68853 578999999999998 788764 578999999999884 32 2 2357999999
Q ss_pred cCCCCcccCCCCCCCCCCCCCccEEEccCccccccccccccCCCCCCEEEccCCcccccCCcccccc-ccCEEEccCCcC
Q 005749 180 HGNSLTAALPEPALPNSTCSDLQYLDLGSNKFSGSFPEFVTRFEALKELDISNNLFSGSIPEGLTRL-SLEKLNLSHNNF 258 (679)
Q Consensus 180 s~N~l~~~~p~~~~~~~~~~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l-~L~~l~ls~N~l 258 (679)
++|.++. +|.. ..+++|++|++++|.+.. .|. ....+..+.+.++.... +..+..+ .++.+++++|.+
T Consensus 106 ~~n~l~~-lp~~----~~l~~L~~L~l~~~~~~~-~~~---~~~~l~~l~~~~~~~~~--~~~l~~l~~l~~L~l~~n~~ 174 (353)
T d1jl5a_ 106 SNNQLEK-LPEL----QNSSFLKIIDVDNNSLKK-LPD---LPPSLEFIAAGNNQLEE--LPELQNLPFLTAIYADNNSL 174 (353)
T ss_dssp CSSCCSS-CCCC----TTCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSS--CCCCTTCTTCCEEECCSSCC
T ss_pred ccccccc-ccch----hhhccceeeccccccccc-ccc---ccccccchhhccccccc--cccccccccceecccccccc
Confidence 9999985 4432 357899999999999874 333 24667788887776642 3334444 588999999987
Q ss_pred CCC
Q 005749 259 SGV 261 (679)
Q Consensus 259 ~g~ 261 (679)
...
T Consensus 175 ~~~ 177 (353)
T d1jl5a_ 175 KKL 177 (353)
T ss_dssp SSC
T ss_pred ccc
Confidence 754
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=98.65 E-value=4.7e-09 Score=107.77 Aligned_cols=159 Identities=21% Similarity=0.278 Sum_probs=99.7
Q ss_pred ccEEEEEcCCCCCccc----CCccccCCCCCCeeecccCcccccCC----c---------ccCCCCCCCEEEccCCCCCC
Q 005749 99 IHLLSIQLPSANLTGS----LPRELGEFSMLQSLYLNVNSLKGTIP----F---------ELGYSSSLSEIDLSANLFTG 161 (679)
Q Consensus 99 ~~l~~l~l~~n~l~g~----ip~~l~~l~~L~~L~L~~N~l~g~ip----~---------~l~~l~~L~~L~Ls~N~l~g 161 (679)
.+++.|+|++|.+... +...+...++|++|+|++|.|+..-. . .....+.|+.|++++|.++.
T Consensus 93 ~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~ 172 (344)
T d2ca6a1 93 PKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLEN 172 (344)
T ss_dssp TTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTG
T ss_pred CCcccccccccccccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeecccccccc
Confidence 4577888888877653 44455667888888888887752100 0 11345678888888887763
Q ss_pred cChhhH---HhhcccCcEEEccCCCCccc-----CCCCCCCCCCCCCccEEEccCcccccc----ccccccCCCCCCEEE
Q 005749 162 VLAPSI---WNLCDRLVSLRLHGNSLTAA-----LPEPALPNSTCSDLQYLDLGSNKFSGS----FPEFVTRFEALKELD 229 (679)
Q Consensus 162 ~~p~~~---~~~~~~L~~L~Ls~N~l~~~-----~p~~~~~~~~~~~L~~L~l~~N~l~g~----~p~~~~~l~~L~~L~ 229 (679)
..-..+ ....+.|+.|+|++|+++.. +.. . ...+++|+.|+|++|.++.. +...+..+++|++|+
T Consensus 173 ~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~-~--l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~ 249 (344)
T d2ca6a1 173 GSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLE-G--LAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELG 249 (344)
T ss_dssp GGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHT-T--GGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEE
T ss_pred cccccccchhhhhhhhcccccccccccccccccchhh-h--hcchhhhcccccccccccccccccccccccccccchhhh
Confidence 221222 12236788888888887632 111 1 12456788888888887632 445567778888888
Q ss_pred ccCCcccccCCcc----cc---ccccCEEEccCCcCCC
Q 005749 230 ISNNLFSGSIPEG----LT---RLSLEKLNLSHNNFSG 260 (679)
Q Consensus 230 ls~N~l~g~~p~~----~~---~l~L~~l~ls~N~l~g 260 (679)
|++|.|++.-... +. +.+|+.|++++|+++.
T Consensus 250 Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~ 287 (344)
T d2ca6a1 250 LNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIEL 287 (344)
T ss_dssp CTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBH
T ss_pred hhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCCh
Confidence 8888886532222 11 2258888888888754
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=98.49 E-value=9.1e-09 Score=105.55 Aligned_cols=161 Identities=19% Similarity=0.189 Sum_probs=109.3
Q ss_pred ccEEEEEcCCCCCcccCC----cc---------ccCCCCCCeeecccCccccc----CCcccCCCCCCCEEEccCCCCCC
Q 005749 99 IHLLSIQLPSANLTGSLP----RE---------LGEFSMLQSLYLNVNSLKGT----IPFELGYSSSLSEIDLSANLFTG 161 (679)
Q Consensus 99 ~~l~~l~l~~n~l~g~ip----~~---------l~~l~~L~~L~L~~N~l~g~----ip~~l~~l~~L~~L~Ls~N~l~g 161 (679)
.+++.|++++|.+...-. .. ....+.|+.|++++|.++.. +...+..++.|++|+|++|.++.
T Consensus 121 ~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~ 200 (344)
T d2ca6a1 121 TPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRP 200 (344)
T ss_dssp TTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCH
T ss_pred ccchheecccccccccccccccccccccccccccccCcccceeecccccccccccccccchhhhhhhhcccccccccccc
Confidence 468899999998753211 11 24578999999999998732 44445667899999999999874
Q ss_pred c-----ChhhHHhhcccCcEEEccCCCCcccCCCCCC-CCCCCCCccEEEccCcccccc----ccccccC--CCCCCEEE
Q 005749 162 V-----LAPSIWNLCDRLVSLRLHGNSLTAALPEPAL-PNSTCSDLQYLDLGSNKFSGS----FPEFVTR--FEALKELD 229 (679)
Q Consensus 162 ~-----~p~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~-~~~~~~~L~~L~l~~N~l~g~----~p~~~~~--l~~L~~L~ 229 (679)
. +...+ ..+++|+.|+|++|.++..-..... ....+++|++|+|++|.|++. +-..+.. ...|+.|+
T Consensus 201 ~g~~~~l~~~l-~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ 279 (344)
T d2ca6a1 201 EGIEHLLLEGL-AYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLR 279 (344)
T ss_dssp HHHHHHHHTTG-GGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEE
T ss_pred cccccchhhhh-cchhhhcccccccccccccccccccccccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEE
Confidence 2 11112 2347899999999998642100000 012467899999999999854 2233333 46799999
Q ss_pred ccCCccccc----CCcccc-cc-ccCEEEccCCcCCC
Q 005749 230 ISNNLFSGS----IPEGLT-RL-SLEKLNLSHNNFSG 260 (679)
Q Consensus 230 ls~N~l~g~----~p~~~~-~l-~L~~l~ls~N~l~g 260 (679)
+++|+++.. +...+. +. +|+.|+|++|.|..
T Consensus 280 ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~ 316 (344)
T d2ca6a1 280 LQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE 316 (344)
T ss_dssp CCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred CCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCCC
Confidence 999999743 223332 22 59999999999864
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.40 E-value=2.9e-08 Score=105.08 Aligned_cols=160 Identities=24% Similarity=0.163 Sum_probs=91.1
Q ss_pred cEEEEEcCCCCCccc----CCccccCCCCCCeeecccCcccccCCcc----c-CCCCCCCEEEccCCCCCCcChhhHHh-
Q 005749 100 HLLSIQLPSANLTGS----LPRELGEFSMLQSLYLNVNSLKGTIPFE----L-GYSSSLSEIDLSANLFTGVLAPSIWN- 169 (679)
Q Consensus 100 ~l~~l~l~~n~l~g~----ip~~l~~l~~L~~L~L~~N~l~g~ip~~----l-~~l~~L~~L~Ls~N~l~g~~p~~~~~- 169 (679)
.+..+++++|++... +...+..++.++.+++++|.++..-... + .....|+.+++++|.++......+..
T Consensus 256 ~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~ 335 (460)
T d1z7xw1 256 RLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSV 335 (460)
T ss_dssp CCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccchhhccccccccccccccccccchhhhhhhhcccc
Confidence 466677777766533 3334556677777777777775321111 1 12356777777777776543222221
Q ss_pred --hcccCcEEEccCCCCccc----CCCCCCCCCCCCCccEEEccCccccc----cccccccCCCCCCEEEccCCcccccC
Q 005749 170 --LCDRLVSLRLHGNSLTAA----LPEPALPNSTCSDLQYLDLGSNKFSG----SFPEFVTRFEALKELDISNNLFSGSI 239 (679)
Q Consensus 170 --~~~~L~~L~Ls~N~l~~~----~p~~~~~~~~~~~L~~L~l~~N~l~g----~~p~~~~~l~~L~~L~ls~N~l~g~~ 239 (679)
..++|+.|+|++|+++.. ++.... ...+.|++|+|++|+|+. .++..+...++|++|||++|+|+...
T Consensus 336 ~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~--~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g 413 (460)
T d1z7xw1 336 LAQNRFLLELQISNNRLEDAGVRELCQGLG--QPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAG 413 (460)
T ss_dssp HHHCSSCCEEECCSSBCHHHHHHHHHHHHT--STTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHH
T ss_pred cccccchhhhheeeecccCcccchhhhhhh--cccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCcCCHHH
Confidence 224677777777777532 111000 123457777777777763 24455566677777788777776432
Q ss_pred Cccc----c-cc-ccCEEEccCCcCCCC
Q 005749 240 PEGL----T-RL-SLEKLNLSHNNFSGV 261 (679)
Q Consensus 240 p~~~----~-~l-~L~~l~ls~N~l~g~ 261 (679)
...+ . .. .|+.|++++|.+...
T Consensus 414 ~~~l~~~l~~~~~~L~~l~l~~~~~~~~ 441 (460)
T d1z7xw1 414 ILQLVESVRQPGCLLEQLVLYDIYWSEE 441 (460)
T ss_dssp HHHHHHHHTSTTCCCCEEECTTCCCCHH
T ss_pred HHHHHHHHHhCCCccCEEECCCCCCCHH
Confidence 2222 1 11 477777777776643
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.30 E-value=1e-07 Score=100.66 Aligned_cols=61 Identities=20% Similarity=0.262 Sum_probs=44.8
Q ss_pred cEEEEEcCCCCCccc-CCccccCCCCCCeeecccCcccc----cCCcccCCCCCCCEEEccCCCCC
Q 005749 100 HLLSIQLPSANLTGS-LPRELGEFSMLQSLYLNVNSLKG----TIPFELGYSSSLSEIDLSANLFT 160 (679)
Q Consensus 100 ~l~~l~l~~n~l~g~-ip~~l~~l~~L~~L~L~~N~l~g----~ip~~l~~l~~L~~L~Ls~N~l~ 160 (679)
+|+.|+|++|++++. +..-+..+++|++|+|++|.|+- .++..+..+++|++|||++|.++
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~ 68 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELG 68 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCH
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCC
Confidence 578888888888764 34445677888888888888762 34555677788888888888775
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.13 E-value=4e-08 Score=89.02 Aligned_cols=106 Identities=24% Similarity=0.173 Sum_probs=48.9
Q ss_pred cCCCCCCeeecccCcccccCCcccCCCCCCCEEEccCCCCCCcCh-hhHHhhcccCcEEEccCCCCcccCCCCCCCCCCC
Q 005749 120 GEFSMLQSLYLNVNSLKGTIPFELGYSSSLSEIDLSANLFTGVLA-PSIWNLCDRLVSLRLHGNSLTAALPEPALPNSTC 198 (679)
Q Consensus 120 ~~l~~L~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~p-~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~~~~~ 198 (679)
..+..+..|++.+|... .++.....+++|++|||++|+++..-+ +..+..+++|+.|+|++|+++...+-.. ...
T Consensus 39 ~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~---l~~ 114 (162)
T d1koha1 39 VAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDK---IKG 114 (162)
T ss_dssp TTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHH---HTT
T ss_pred hhccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhh---hhc
Confidence 33444444444444332 233333345556666666666654211 1222223556666666666553211000 112
Q ss_pred CCccEEEccCcccccccc-------ccccCCCCCCEEE
Q 005749 199 SDLQYLDLGSNKFSGSFP-------EFVTRFEALKELD 229 (679)
Q Consensus 199 ~~L~~L~l~~N~l~g~~p-------~~~~~l~~L~~L~ 229 (679)
.+|+.|++++|.+..... ..+..+++|+.||
T Consensus 115 ~~L~~L~L~~Npl~~~~~~~~~y~~~i~~~~P~L~~LD 152 (162)
T d1koha1 115 LKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD 152 (162)
T ss_dssp CCCSSCCCTTSTTSSSSSSHHHHHHHHHTTSTTCCEET
T ss_pred cccceeecCCCCcCcCcccchhHHHHHHHHCCCCCEEC
Confidence 245556666666554332 2245677777775
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.11 E-value=1.1e-05 Score=78.37 Aligned_cols=130 Identities=15% Similarity=0.120 Sum_probs=89.7
Q ss_pred CceEEEEEEeCCCCEEEEEEcccCcccCcccHHHHHHHHhccC-CCCCccceEEeeCCCCceEEEEEecCCCChHHHhhc
Q 005749 389 TYGTAYKAKLADGATIALRLLREGSCKDRSSCLPVIRQLGKVR-HENLIPLRAFYQGKRGEKLLIYDYFPSRTLHDLLHD 467 (679)
Q Consensus 389 ~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~~~~~~~~~~~~lv~ey~~~gsL~~~l~~ 467 (679)
+.+.||+... +++.+.+|+...........+.+|...+..+. +--+-+++.+..+ .+..++||+++++.++.+....
T Consensus 26 s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~-~~~~~lv~~~l~G~~~~~~~~~ 103 (263)
T d1j7la_ 26 SPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERH-DGWSNLLMSEADGVLCSEEYED 103 (263)
T ss_dssp SSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE-TTEEEEEEECCSSEEHHHHTTT
T ss_pred CCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEec-CCceEEEEEecccccccccccc
Confidence 3468998875 45567788876655555667889999888774 3224556666665 5788999999999887665432
Q ss_pred ccCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-------------------------------------------------
Q 005749 468 TIAGKPVLNWARRHKIALGIARGLAYLHTGH------------------------------------------------- 498 (679)
Q Consensus 468 ~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~------------------------------------------------- 498 (679)
. . ....++.++++.++.||+..
T Consensus 104 ~------~---~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 174 (263)
T d1j7la_ 104 E------Q---SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFL 174 (263)
T ss_dssp C------S---CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHH
T ss_pred c------c---cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHH
Confidence 1 1 12234556666666666421
Q ss_pred -------CCCeeecCCCCCCeeecCCCceEEeeccccc
Q 005749 499 -------EIPITHGNVRSKNVLVDDFFVSRLTEFGLDQ 529 (679)
Q Consensus 499 -------~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 529 (679)
...++|+|+.|.||++++++.+-|.||+.+.
T Consensus 175 ~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 175 KTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 0127999999999999987767799998765
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.81 E-value=5.1e-07 Score=81.45 Aligned_cols=98 Identities=21% Similarity=0.194 Sum_probs=66.6
Q ss_pred CcccCCccccCCCCCCeeecccCccccc--CCcccCCCCCCCEEEccCCCCCCcChhhHHhhcccCcEEEccCCCCcccC
Q 005749 111 LTGSLPRELGEFSMLQSLYLNVNSLKGT--IPFELGYSSSLSEIDLSANLFTGVLAPSIWNLCDRLVSLRLHGNSLTAAL 188 (679)
Q Consensus 111 l~g~ip~~l~~l~~L~~L~L~~N~l~g~--ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N~l~~~~ 188 (679)
+...++.....+++|++|+|++|+|+.. ++..+..+++|+.|||++|.++..-+-..... .+|+.|+|++|.++...
T Consensus 53 ~~~~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~-~~L~~L~L~~Npl~~~~ 131 (162)
T d1koha1 53 MAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKG-LKLEELWLDGNSLSDTF 131 (162)
T ss_dssp HHHHHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTT-CCCSSCCCTTSTTSSSS
T ss_pred HhhhhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhc-cccceeecCCCCcCcCc
Confidence 3344444556789999999999999843 34456778999999999999986432233343 47899999999998654
Q ss_pred CCCC----CCCCCCCCccEEEccCccc
Q 005749 189 PEPA----LPNSTCSDLQYLDLGSNKF 211 (679)
Q Consensus 189 p~~~----~~~~~~~~L~~L~l~~N~l 211 (679)
.... .-...+++|+.|| ++.+
T Consensus 132 ~~~~~y~~~i~~~~P~L~~LD--g~~v 156 (162)
T d1koha1 132 RDQSTYISAIRERFPKLLRLD--GHEL 156 (162)
T ss_dssp SSHHHHHHHHHTTSTTCCEET--TEEC
T ss_pred ccchhHHHHHHHHCCCCCEEC--cCCC
Confidence 4210 0012467888876 4444
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.80 E-value=4.3e-05 Score=73.49 Aligned_cols=73 Identities=8% Similarity=0.077 Sum_probs=52.2
Q ss_pred ccCC-ceEEEEEEeCCCCEEEEEEcccCcccCcccHHHHHHHHhccCCCC--CccceEEeeCCCCceEEEEEecCCCChH
Q 005749 386 EKTT-YGTAYKAKLADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHEN--LIPLRAFYQGKRGEKLLIYDYFPSRTLH 462 (679)
Q Consensus 386 g~G~-~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~n--Iv~l~~~~~~~~~~~~lv~ey~~~gsL~ 462 (679)
..|. -+.||+....++..+.+|..... ....+..|.+.++.+.... +-+++++..+ .+..++||+|+++.++.
T Consensus 19 ~~G~s~~~v~r~~~~~~~~~vlK~~~~~---~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~-~~~~~~v~~~i~G~~~~ 94 (255)
T d1nd4a_ 19 TIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTE-AGRDWLLLGEVPGQDLL 94 (255)
T ss_dssp SCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEEC-SSCEEEEEECCSSEETT
T ss_pred CCcccCCeEEEEEeCCCCEEEEEeCCcc---CHhHHHHHHHHHHHHHhcCCCCCceeeeccc-ccceEEEEEeeeccccc
Confidence 3444 36799999888888999986553 2446788888888775333 4456776665 57889999999886553
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.27 E-value=6.7e-05 Score=67.36 Aligned_cols=37 Identities=14% Similarity=0.076 Sum_probs=18.5
Q ss_pred CCccEEEccCccccc-------cccccccCCCCCCEEEccCCcc
Q 005749 199 SDLQYLDLGSNKFSG-------SFPEFVTRFEALKELDISNNLF 235 (679)
Q Consensus 199 ~~L~~L~l~~N~l~g-------~~p~~~~~l~~L~~L~ls~N~l 235 (679)
++|++|+|++|.+.. .+...+..-+.|+.|+++.+..
T Consensus 100 ~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~~ 143 (167)
T d1pgva_ 100 QSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM 143 (167)
T ss_dssp CCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred CcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCCc
Confidence 345555555554331 1233444456666666655543
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.21 E-value=0.0008 Score=68.96 Aligned_cols=75 Identities=5% Similarity=-0.090 Sum_probs=47.2
Q ss_pred CccccCCceEEEEEEeCC-CCEEEEEEcccC----c---ccCcccHHHHHHHHhccC-C--CCCccceEEeeCCCCceEE
Q 005749 383 QVIEKTTYGTAYKAKLAD-GATIALRLLREG----S---CKDRSSCLPVIRQLGKVR-H--ENLIPLRAFYQGKRGEKLL 451 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~~~-~~~vAvK~~~~~----~---~~~~~~~~~Ei~~l~~l~-H--~nIv~l~~~~~~~~~~~~l 451 (679)
+.||.|....||+.+..+ ++.|+||.-.+. . ....+....|.+.|+.+. + ..+.+++.+. .+..++
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d---~~~~~l 108 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD---TEMAVT 108 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE---TTTTEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc---CCCCEE
Confidence 458889999999998654 678999975431 1 112334567888887663 2 3344555443 345689
Q ss_pred EEEecCCCC
Q 005749 452 IYDYFPSRT 460 (679)
Q Consensus 452 v~ey~~~gs 460 (679)
||||+.+..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997654
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.14 E-value=0.0001 Score=66.19 Aligned_cols=59 Identities=17% Similarity=0.160 Sum_probs=34.4
Q ss_pred CCccEEEccCcccccc----ccccccCCCCCCEEEccCCccccc-------CCcccc-ccccCEEEccCCc
Q 005749 199 SDLQYLDLGSNKFSGS----FPEFVTRFEALKELDISNNLFSGS-------IPEGLT-RLSLEKLNLSHNN 257 (679)
Q Consensus 199 ~~L~~L~l~~N~l~g~----~p~~~~~l~~L~~L~ls~N~l~g~-------~p~~~~-~l~L~~l~ls~N~ 257 (679)
+.|++|+|++|.++.. +-..+...+.|+.|+|++|.+... +...+. +-+|+.|+++.+.
T Consensus 72 ~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~ 142 (167)
T d1pgva_ 72 PSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFAS 142 (167)
T ss_dssp SSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCC
T ss_pred ccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCC
Confidence 3566666666666532 234566678899999998876421 111111 1157788876653
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.43 E-value=0.0062 Score=60.27 Aligned_cols=67 Identities=10% Similarity=0.139 Sum_probs=45.1
Q ss_pred eEEEEEEeCCCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCC--ccceE-----EeeCCCCceEEEEEecCCC
Q 005749 391 GTAYKAKLADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENL--IPLRA-----FYQGKRGEKLLIYDYFPSR 459 (679)
Q Consensus 391 g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nI--v~l~~-----~~~~~~~~~~lv~ey~~~g 459 (679)
-.||+++.++|+.+++|+.++.. ...+++..|.+.+..+....| +..+. .+. ..+..+.++++++|.
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~-~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLN-HQGFYFAVFPSVGGR 109 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEE-ETTEEEEEEECCCCE
T ss_pred ceeEEEEcCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeee-eeeEEEEEEeecCCc
Confidence 47999999999999999987642 235667888888887753222 11111 111 145678899998764
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.31 E-value=0.00063 Score=60.57 Aligned_cols=116 Identities=11% Similarity=0.080 Sum_probs=53.6
Q ss_pred cCCCCCCeeeccc-Cccccc----CCcccCCCCCCCEEEccCCCCCCcChhhHH---hhcccCcEEEccCCCCcccCCCC
Q 005749 120 GEFSMLQSLYLNV-NSLKGT----IPFELGYSSSLSEIDLSANLFTGVLAPSIW---NLCDRLVSLRLHGNSLTAALPEP 191 (679)
Q Consensus 120 ~~l~~L~~L~L~~-N~l~g~----ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~---~~~~~L~~L~Ls~N~l~~~~p~~ 191 (679)
.+.++|++|+|++ |.++.. +-..+...++|++|+|++|.++...-..+. ...++|+.|++++|.++...-..
T Consensus 14 ~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~ 93 (166)
T d1io0a_ 14 NNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILA 93 (166)
T ss_dssp TTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHH
T ss_pred hcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHH
Confidence 3456677777766 345421 223344566777777777766543212221 11245666666665554210000
Q ss_pred CC-CCCCCCCccEEEc--cCccccc----cccccccCCCCCCEEEccCCcc
Q 005749 192 AL-PNSTCSDLQYLDL--GSNKFSG----SFPEFVTRFEALKELDISNNLF 235 (679)
Q Consensus 192 ~~-~~~~~~~L~~L~l--~~N~l~g----~~p~~~~~l~~L~~L~ls~N~l 235 (679)
.. .....++|+.++| +.|.+.. .+...+...++|+.|+++.|..
T Consensus 94 l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~ 144 (166)
T d1io0a_ 94 LVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQ 144 (166)
T ss_dssp HHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSH
T ss_pred HHHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCC
Confidence 00 0012234554333 3444432 2333444555666666555443
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.25 E-value=0.00092 Score=59.43 Aligned_cols=114 Identities=11% Similarity=0.130 Sum_probs=73.9
Q ss_pred ccEEEEEcCC-CCCccc----CCccccCCCCCCeeecccCccccc----CCcccCCCCCCCEEEccCCCCCCcChhhHHh
Q 005749 99 IHLLSIQLPS-ANLTGS----LPRELGEFSMLQSLYLNVNSLKGT----IPFELGYSSSLSEIDLSANLFTGVLAPSIWN 169 (679)
Q Consensus 99 ~~l~~l~l~~-n~l~g~----ip~~l~~l~~L~~L~L~~N~l~g~----ip~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~ 169 (679)
..++.|+|.+ ++++.. +-..+...++|+.|+|++|.++.. +-..+...++|+.|++++|.++...-..+..
T Consensus 17 ~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~ 96 (166)
T d1io0a_ 17 PDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVE 96 (166)
T ss_dssp TTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHH
T ss_pred CCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHH
Confidence 4688999997 456532 455667899999999999999743 3234456789999999999987542222222
Q ss_pred h---cccCcEEEc--cCCCCcccCCCCCC-CCCCCCCccEEEccCcccc
Q 005749 170 L---CDRLVSLRL--HGNSLTAALPEPAL-PNSTCSDLQYLDLGSNKFS 212 (679)
Q Consensus 170 ~---~~~L~~L~L--s~N~l~~~~p~~~~-~~~~~~~L~~L~l~~N~l~ 212 (679)
. .++|+.++| ++|.+....-.... .....++|+.|+++.|...
T Consensus 97 ~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~~ 145 (166)
T d1io0a_ 97 ALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 145 (166)
T ss_dssp GGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCCc
Confidence 2 267887655 56667531100000 0013578999999887654
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.58 E-value=0.011 Score=60.05 Aligned_cols=72 Identities=18% Similarity=0.242 Sum_probs=46.9
Q ss_pred CccccCCceEEEEEEeCCC--------CEEEEEEcccCcccCcccHHHHHHHHhccCCCCCc-cceEEeeCCCCceEEEE
Q 005749 383 QVIEKTTYGTAYKAKLADG--------ATIALRLLREGSCKDRSSCLPVIRQLGKVRHENLI-PLRAFYQGKRGEKLLIY 453 (679)
Q Consensus 383 ~~ig~G~~g~Vy~~~~~~~--------~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv-~l~~~~~~~~~~~~lv~ 453 (679)
+.|+.|-.-.+|++...++ +.|.+++.-. ........+|.++++.+.-.+++ ++++++.+ .+|+
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~--~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~-----g~I~ 120 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN--PETESHLVAESVIFTLLSERHLGPKLYGIFSG-----GRLE 120 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS--CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT-----EEEE
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC--cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC-----ceEE
Confidence 3566677789999986543 4566666542 22233566889998888544554 66776542 5899
Q ss_pred EecCCCCh
Q 005749 454 DYFPSRTL 461 (679)
Q Consensus 454 ey~~~gsL 461 (679)
||+++..+
T Consensus 121 efi~g~~l 128 (395)
T d1nw1a_ 121 EYIPSRPL 128 (395)
T ss_dssp CCCCEEEC
T ss_pred EEeccccC
Confidence 99987544
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=94.54 E-value=0.057 Score=52.52 Aligned_cols=142 Identities=11% Similarity=0.090 Sum_probs=72.3
Q ss_pred cccCCceEEEEEEeCCCCEEEEEEcccCcccCcccHHHHHHHHhccCCCCC-----ccce-E-EeeCCCCceEEEEEecC
Q 005749 385 IEKTTYGTAYKAKLADGATIALRLLREGSCKDRSSCLPVIRQLGKVRHENL-----IPLR-A-FYQGKRGEKLLIYDYFP 457 (679)
Q Consensus 385 ig~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~nI-----v~l~-~-~~~~~~~~~~lv~ey~~ 457 (679)
|..|.--+.|+.+..+|+ +++|+.... ...++...|++++..+...++ +... | ......+....++.+..
T Consensus 26 i~~G~~N~ny~v~t~~g~-yVLri~~~~--~~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~~~~~~~~~ 102 (316)
T d2ppqa1 26 IAEGVENSNFLLHTTKDP-LILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFLE 102 (316)
T ss_dssp ECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECCC
T ss_pred CCCCcccCeEEEEECCCc-EEEEEcCCC--CCHHHHHHHHHHHHhhhhccccccccceecCCCcceeeecccceeeeecc
Confidence 445666788999987665 788887653 234556667777777753322 2110 0 00001334566677766
Q ss_pred CCChHHH--------------hhcccC-----C-CCCC-----------------CHHHHHHHHHHHHHHHHHHhcC-CC
Q 005749 458 SRTLHDL--------------LHDTIA-----G-KPVL-----------------NWARRHKIALGIARGLAYLHTG-HE 499 (679)
Q Consensus 458 ~gsL~~~--------------l~~~~~-----~-~~~l-----------------~~~~~~~i~~~ia~gL~~LH~~-~~ 499 (679)
+...... ++.... . .... ........+......+.-.+.. -.
T Consensus 103 g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~L~ 182 (316)
T d2ppqa1 103 GMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDLP 182 (316)
T ss_dssp CBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSSC
T ss_pred cccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhhhccCccccc
Confidence 5322110 000000 0 0000 0001112222333333333322 13
Q ss_pred CCeeecCCCCCCeeecCCCceEEeeccccc
Q 005749 500 IPITHGNVRSKNVLVDDFFVSRLTEFGLDQ 529 (679)
Q Consensus 500 ~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 529 (679)
.++||+|+.++||+++++...-|.||+.+.
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccCCcchhhhhcccccceeEecccccc
Confidence 359999999999999998777899999764
|